Citrus Sinensis ID: 026253
Local Sequence Feature Prediction
| Prediction and (Method) | Result |
|---|
|
|
Close Homologs for Annotation Transfer
Close Homologs in SWISS-PROT Database Detected by BLAST 
Original result of BLAST against SWISS-PROT Database
| ID | Alignment graph | Length |
Definition |
RBH(Q2H) |
RBH(H2Q) |
Q cover |
H cover |
Identity |
E-value |
| Query | 241 | 2.2.26 [Sep-21-2011] | |||||||
| Q5ZJH6 | 468 | Serine/threonine-protein | yes | no | 0.921 | 0.474 | 0.431 | 7e-47 | |
| Q3U3Q1 | 472 | Serine/threonine-protein | yes | no | 0.908 | 0.463 | 0.429 | 1e-43 | |
| D3ZHP7 | 472 | Serine/threonine-protein | yes | no | 0.908 | 0.463 | 0.429 | 2e-43 | |
| A7KAL2 | 960 | Serine/threonine-protein | yes | no | 0.900 | 0.226 | 0.360 | 6e-43 | |
| Q6PHR2 | 472 | Serine/threonine-protein | yes | no | 0.912 | 0.466 | 0.414 | 7e-43 | |
| Q4V7Q6 | 468 | Serine/threonine-protein | N/A | no | 0.921 | 0.474 | 0.422 | 3e-42 | |
| Q0CLX3 | 964 | Serine/threonine-protein | N/A | no | 0.900 | 0.225 | 0.356 | 7e-42 | |
| Q1DN93 | 969 | Serine/threonine-protein | N/A | no | 0.933 | 0.232 | 0.35 | 8e-42 | |
| Q2UGZ7 | 934 | Serine/threonine-protein | yes | no | 0.900 | 0.232 | 0.349 | 2e-41 | |
| Q4WPF2 | 973 | Serine/threonine-protein | yes | no | 0.908 | 0.225 | 0.350 | 3e-41 |
| >sp|Q5ZJH6|ULK3_CHICK Serine/threonine-protein kinase ULK3 OS=Gallus gallus GN=ULK3 PE=2 SV=1 | Back alignment and function desciption |
|---|
Score = 187 bits (474), Expect = 7e-47, Method: Compositional matrix adjust.
Identities = 97/225 (43%), Positives = 142/225 (63%), Gaps = 3/225 (1%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ LN+ L E+ L ++ HP+I+ L D + I+L++EFCAGG+LS +IR+
Sbjct: 49 RSLNRASVENLLTEIEILKTIRHPHIVELKDFQWDSDHIYLIMEFCAGGDLSRFIRMRRI 108
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+PE+ AR FLQQL L+ L+ H+I H DLKP+NILLS ++ LK+ADFG + + P
Sbjct: 109 LPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSPW 167
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINS 182
+ + GSPLYMAPE++ Q+YD +VD+WSVG IL+E L G PPF+ R+ +L I S
Sbjct: 168 DEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYEALFGRPPFASRSFAELEEKIRS 227
Query: 183 CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
+ + P L PDC D+ +LL + + R+SF EF+ H F+
Sbjct: 228 DRAIELPSR--PPLSPDCRDLLQRLLERDPLKRISFEEFFAHPFV 270
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Gallus gallus (taxid: 9031) EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 1 |
| >sp|Q3U3Q1|ULK3_MOUSE Serine/threonine-protein kinase ULK3 OS=Mus musculus GN=Ulk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 176 bits (447), Expect = 1e-43, Method: Compositional matrix adjust.
Identities = 98/228 (42%), Positives = 142/228 (62%), Gaps = 9/228 (3%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L I
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKIR 226
Query: 182 SCK--HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
S + LP P L DC D+ +LL + R+SF +F+ H ++
Sbjct: 227 SNRVIELPLR----PQLSLDCRDLLQRLLERDPARRISFKDFFAHPWV 270
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy. Mus musculus (taxid: 10090) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|D3ZHP7|ULK3_RAT Serine/threonine-protein kinase ULK3 OS=Rattus norvegicus GN=Ulk3 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 175 bits (444), Expect = 2e-43, Method: Compositional matrix adjust.
Identities = 98/228 (42%), Positives = 142/228 (62%), Gaps = 9/228 (3%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L I
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKIR 226
Query: 182 SCK--HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
S + LP P L DC D+ +LL + R+SF +F+ H ++
Sbjct: 227 SNRVIELPLR----PQLSLDCRDLLQRLLERDPSHRISFQDFFAHPWV 270
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy. Rattus norvegicus (taxid: 10116) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|A7KAL2|ATG1_PENCW Serine/threonine-protein kinase ATG1 OS=Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 6e-43, Method: Composition-based stats.
Identities = 98/272 (36%), Positives = 148/272 (54%), Gaps = 55/272 (20%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
L KLNK LK L E++ L ++HP+I+ L D ++ + I LV+E+CA G+LS +I+
Sbjct: 55 LSKLNKKLKENLSSEIDILKGLHHPHIVALIDCHESTSHIHLVMEYCALGDLSLFIKRRD 114
Query: 61 --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
G + E R FL+QL + L+ L ++IHRD+KP+N+LL
Sbjct: 115 TLGSHKYTRDMIAKYPNPPGGSLNEVVTRHFLKQLSSALKFLRDRNLIHRDIKPQNLLLC 174
Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+GL+ MLKIADFG + +L + AE +CGSPL
Sbjct: 175 PSPSSYRSGHAQVMPYKGSDDSYEPTTGLESLPMLKIADFGFARSLPATSLAETLCGSPL 234
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV 193
YMAPE+L++++YD K D+WSVG +L+E++ G PPF N+V+L+R I + ++
Sbjct: 235 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGRPPFRATNHVELLRKIEKGE----DRIRF 290
Query: 194 PALHP---DCVDMCLKLLSANTVDRLSFNEFY 222
P +P D + LL N V+RL+F EF+
Sbjct: 291 PEDNPASDDIKKLIRGLLKRNPVERLNFPEFF 322
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Penicillium chrysogenum (strain ATCC 28089 / DSM 1075 / Wisconsin 54-1255) (taxid: 500485) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q6PHR2|ULK3_HUMAN Serine/threonine-protein kinase ULK3 OS=Homo sapiens GN=ULK3 PE=1 SV=2 | Back alignment and function description |
|---|
Score = 174 bits (440), Expect = 7e-43, Method: Compositional matrix adjust.
Identities = 94/227 (41%), Positives = 139/227 (61%), Gaps = 7/227 (3%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K LNK L E+ L + HP+I++L D + I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKDFQWDSDNIYLIMEFCAGGDLSRFIHTRRI 108
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 109 LPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSPW 167
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINS 182
+ + GSPLYMAPE++ ++YD +VD+WS+G IL+E L G PPF+ R+ +L I S
Sbjct: 168 DEKHVLRGSPLYMAPEMVCQRQYDARVDLWSMGVILYEALFGQPPFASRSFSELEEKIRS 227
Query: 183 CK--HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
+ LP P L DC D+ +LL + R+SF +F+ H ++
Sbjct: 228 NRVIELPLR----PLLSRDCRDLLQRLLERDPSRRISFQDFFAHPWV 270
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Acts as a negative regulator of SHH signaling in the absence of SHH ligand: interacts with SUFU, thereby inactivating the protein kinase activity and preventing phosphorylation of GLI proteins (GLI1, GLI2 and/or GLI3). Positively regulates SHH signaling in the presence of SHH: dissociates from SUFU, autophosphorylates and mediates phosphorylation of GLI2, activating it and promoting its nuclear translocation. Phosphorylates in vitro GLI2, as well as GLI1 and GLI3, although less efficiently. Also acts as a regulator of autophagy: following cellular senescence, able to induce autophagy. Homo sapiens (taxid: 9606) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q4V7Q6|ULK3_XENLA Serine/threonine-protein kinase ULK3 OS=Xenopus laevis GN=ulk3 PE=2 SV=1 | Back alignment and function description |
|---|
Score = 172 bits (435), Expect = 3e-42, Method: Compositional matrix adjust.
Identities = 95/225 (42%), Positives = 138/225 (61%), Gaps = 3/225 (1%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K LNK L E+ L +V+HP+I+ L D ++ IFL+ E+CAGG+LS +IR
Sbjct: 48 KSLNKAAVENLLTEIEILKTVHHPHILELKDFQWDQDYIFLITEYCAGGDLSRFIRTRRI 107
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+PE+ + FLQQL + L+ L+ +I H DLKP+NILLS LD LK+ADFG + +
Sbjct: 108 LPERIVQVFLQQLASALKFLHEKNISHLDLKPQNILLSRLDRP-HLKLADFGFAQHMSSE 166
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINS 182
+ + + GSPLYMAPE++ + YD +VD+WSVG IL+E L G PF+ ++ +L I S
Sbjct: 167 DAPQALRGSPLYMAPEMVCSKHYDARVDLWSVGVILYEALFGKAPFASKSFSELEEKILS 226
Query: 183 CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
K + P L P+C D+ +LL + R+SF EF+ H F+
Sbjct: 227 HKTIELP--TRPRLSPECRDLLQQLLQRDPDKRISFIEFFAHLFV 269
|
Serine/threonine protein kinase that acts as a regulator of Sonic hedgehog (SHH) signaling and autophagy. Xenopus laevis (taxid: 8355) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q0CLX3|ATG1_ASPTN Serine/threonine-protein kinase atg1 OS=Aspergillus terreus (strain NIH 2624 / FGSC A1156) GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (431), Expect = 7e-42, Method: Composition-based stats.
Identities = 97/272 (35%), Positives = 145/272 (53%), Gaps = 55/272 (20%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
L +LNK LK L E++ L + HP+I+ L D + + I LV+E+CA G+LS +IR
Sbjct: 59 LSQLNKKLKENLFSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSQFIRHRN 118
Query: 61 --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
G + E R FL+QL + L+ L ++IHRD+KP+N+LL
Sbjct: 119 TLGEHRYTRDMIAKYPNPRGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 178
Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+GLD MLKIADFG + +L + AE +CGSPL
Sbjct: 179 PSPTSYRAGVAQIVPFKGSEDSFSPATGLDSLPMLKIADFGFARSLPATSLAETLCGSPL 238
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV 193
YMAPE+L++++YD K D+WSVG +L+E++ G PPF N+V+L+R I + +
Sbjct: 239 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGKPPFRASNHVELLRRIERGE----DNIKF 294
Query: 194 PALHP---DCVDMCLKLLSANTVDRLSFNEFY 222
P +P D + LL N V+R++F +F+
Sbjct: 295 PPENPASDDIKALIRMLLKRNPVERMNFADFF 326
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Aspergillus terreus (strain NIH 2624 / FGSC A1156) (taxid: 341663) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q1DN93|ATG1_COCIM Serine/threonine-protein kinase ATG1 OS=Coccidioides immitis (strain RS) GN=ATG1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 170 bits (430), Expect = 8e-42, Method: Composition-based stats.
Identities = 98/280 (35%), Positives = 143/280 (51%), Gaps = 55/280 (19%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
+ LN LK L E+ L + HP+I+ L D ++ +CI LV+E+CA G+LS +IR
Sbjct: 63 ISSLNPKLKDNLKLEIEILKGLQHPHIVALIDCDESTSCIHLVMEYCALGDLSLFIRKRD 122
Query: 61 --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS 100
G + E R FL+QL + L+ L + +IHRDLKP+N+LL+
Sbjct: 123 TLSKHELTRDMIAKYPNPPAGGLNEVIVRHFLKQLASALQFLRTKDLIHRDLKPQNLLLN 182
Query: 101 ---------------------------GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
G++ MLKIADFG + +L + AE +CGSPL
Sbjct: 183 PPPSTYAKGLLRIVPYKTREDSFTPLVGVESLPMLKIADFGFARSLPATSLAETLCGSPL 242
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK---HLPFSQ 190
YMAPE+L++++YD K D+WSVG +LFE++ G PF N+V L+R I + P
Sbjct: 243 YMAPEILRYEKYDAKADLWSVGTVLFEMVVGKSPFRAGNHVDLLRKIEQGEDNIRFPIQT 302
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
P L + LL N V+RLSF +F+ ++ N
Sbjct: 303 EASPPLK----KLIRSLLKRNPVERLSFKDFFESSVVKGN 338
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Coccidioides immitis (strain RS) (taxid: 246410) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q2UGZ7|ATG1_ASPOR Serine/threonine-protein kinase atg1 OS=Aspergillus oryzae (strain ATCC 42149 / RIB 40) GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 169 bits (427), Expect = 2e-41, Method: Composition-based stats.
Identities = 95/272 (34%), Positives = 146/272 (53%), Gaps = 55/272 (20%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
L KLNK LK L E++ L + HP+I+ L D + + I LV+E+CA G+LS +I+
Sbjct: 55 LSKLNKKLKENLSSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSLFIKRRD 114
Query: 61 --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
G + E R FL+QL + L+ L ++IHRD+KP+N+LL
Sbjct: 115 TLGDHRYTQDMIAKYPNPRGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 174
Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+GL+ MLKIADFG + +L + AE +CGSPL
Sbjct: 175 PSPSSYRSGVAQVVPFKGCDESFSPATGLESLPMLKIADFGFARSLPSTSLAETLCGSPL 234
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV 193
YMAPE+L++++YD K D+WSVG +L+E++ G PPF N+V+L+R I + ++
Sbjct: 235 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGKPPFRATNHVELLRKIEKGE----DRIKF 290
Query: 194 PALHP---DCVDMCLKLLSANTVDRLSFNEFY 222
P +P + LL N V+R++F++F+
Sbjct: 291 PEENPASEQIKSLIRMLLKRNPVERMNFSDFF 322
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Aspergillus oryzae (strain ATCC 42149 / RIB 40) (taxid: 510516) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
| >sp|Q4WPF2|ATG1_ASPFU Serine/threonine-protein kinase atg1 OS=Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) GN=atg1 PE=3 SV=1 | Back alignment and function description |
|---|
Score = 168 bits (426), Expect = 3e-41, Method: Composition-based stats.
Identities = 96/274 (35%), Positives = 149/274 (54%), Gaps = 55/274 (20%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
L KLNK LK L E++ L + HP+I+ L D + + I LV+E+CA G+LS +I+
Sbjct: 56 LSKLNKKLKDNLSSEIHILKGLYHPHIVALIDCHETTSHIHLVMEYCALGDLSLFIKRRD 115
Query: 61 --------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL- 99
G + E R FL+QL + L+ L ++IHRD+KP+N+LL
Sbjct: 116 TLGDHRYTRDMIAKYPNPPGGALNEVVVRHFLKQLASALKFLRDRNLIHRDIKPQNLLLC 175
Query: 100 --------------------------SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+GL+ +LKIADFG + +L + AE +CGSPL
Sbjct: 176 PSPSSYRSGVTQVVPFKGSEDSFNPATGLESLPLLKIADFGFARSLPATSLAETLCGSPL 235
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV 193
YMAPE+L++++YD K D+WSVG +L+E++ G PPF N+V+L+R I + ++
Sbjct: 236 YMAPEILRYEKYDAKADLWSVGTVLYEMVVGKPPFRATNHVELLRKIEKGE----DRIKF 291
Query: 194 PALHP--DCVDMCLK-LLSANTVDRLSFNEFYHH 224
P +P D + ++ LL N V+RL+F +F+ +
Sbjct: 292 PEENPASDEIKALIRALLKRNPVERLNFPDFFQN 325
|
Serine/threonine protein kinase probably involved in the cytoplasm to vacuole transport (Cvt) and in autophagy, where it may be required for the formation of autophagosomes. Neosartorya fumigata (strain ATCC MYA-4609 / Af293 / CBS 101355 / FGSC A1100) (taxid: 330879) EC: 2 EC: . EC: 7 EC: . EC: 1 EC: 1 EC: . EC: 1 |
Close Homologs in the Non-Redundant Database Detected by BLAST
Original result of BLAST against Nonredundant Database
| GI | Alignment Graph | Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 241 | ||||||
| 255581995 | 321 | serine/threonine-protein kinase, putativ | 0.950 | 0.713 | 0.772 | 9e-99 | |
| 225431573 | 275 | PREDICTED: serine/threonine-protein kina | 0.941 | 0.825 | 0.757 | 5e-98 | |
| 224116060 | 266 | predicted protein [Populus trichocarpa] | 0.941 | 0.853 | 0.720 | 1e-92 | |
| 359476946 | 260 | PREDICTED: serine/threonine-protein kina | 0.879 | 0.815 | 0.709 | 2e-88 | |
| 357464547 | 290 | Serine/threonine protein kinase GE16371 | 0.958 | 0.796 | 0.666 | 1e-86 | |
| 297852566 | 266 | hypothetical protein ARALYDRAFT_314341 [ | 0.941 | 0.853 | 0.660 | 6e-86 | |
| 110736434 | 295 | similar to MAP/ERK kinase kinase 3 [Arab | 0.941 | 0.769 | 0.647 | 2e-84 | |
| 326487810 | 278 | predicted protein [Hordeum vulgare subsp | 0.941 | 0.816 | 0.618 | 3e-80 | |
| 7770326 | 392 | F27J15.5 [Arabidopsis thaliana] | 0.912 | 0.561 | 0.622 | 2e-78 | |
| 334183174 | 376 | protein kinase-like protein [Arabidopsis | 0.912 | 0.585 | 0.622 | 2e-78 |
| >gi|255581995|ref|XP_002531795.1| serine/threonine-protein kinase, putative [Ricinus communis] gi|223528561|gb|EEF30583.1| serine/threonine-protein kinase, putative [Ricinus communis] | Back alignment and taxonomy information |
|---|
Score = 365 bits (937), Expect = 9e-99, Method: Compositional matrix adjust.
Identities = 177/229 (77%), Positives = 195/229 (85%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLNKHLK+CLDCELNFLSSVNHPNIIRLF FQAE+ IFLV+EFCAGG+LSSYIR HG
Sbjct: 53 LSKLNKHLKNCLDCELNFLSSVNHPNIIRLFHVFQAESSIFLVLEFCAGGSLSSYIRHHG 112
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E+ AR+ +QQLGAGLEIL+SHHIIHRDLKPENILLSG DV+LKIADFGLS + P
Sbjct: 113 RVQEEIARRLMQQLGAGLEILHSHHIIHRDLKPENILLSGQFADVVLKIADFGLSRRVQP 172
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
G YAE VCGSPLYMAPEVLQFQ YD+K DMWSVG ILFELLNGYPPF GR N QL++NI
Sbjct: 173 GKYAETVCGSPLYMAPEVLQFQSYDDKADMWSVGVILFELLNGYPPFHGRTNFQLLQNIK 232
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
SC LPFSQ I+P LHPD VD+C +LLS N V RLSF EFY+HRFLR+
Sbjct: 233 SCACLPFSQFILPTLHPDSVDICSRLLSVNPVHRLSFVEFYNHRFLRKE 281
|
Source: Ricinus communis Species: Ricinus communis Genus: Ricinus Family: Euphorbiaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|225431573|ref|XP_002282420.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 1 [Vitis vinifera] gi|296088603|emb|CBI37594.3| unnamed protein product [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 363 bits (931), Expect = 5e-98, Method: Compositional matrix adjust.
Identities = 172/227 (75%), Positives = 198/227 (87%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++LK+ LDCE+NFLSSV+HPNIIRL FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43 LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E AR+F+QQLGAGLE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
G +AE VCG+PLYMAPEVL+F++YDEKVDMWS+GAILFELLNGYPPF GR NVQL++NI
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMWSLGAILFELLNGYPPFCGRTNVQLLQNIE 222
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
SCK LPFSQLI P LHPDCVD+C KLLS N V RLSF+EF HRFLR
Sbjct: 223 SCKMLPFSQLISPGLHPDCVDLCTKLLSTNPVHRLSFDEFCRHRFLR 269
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|224116060|ref|XP_002332038.1| predicted protein [Populus trichocarpa] gi|222875263|gb|EEF12394.1| predicted protein [Populus trichocarpa] | Back alignment and taxonomy information |
|---|
Score = 344 bits (883), Expect = 1e-92, Method: Compositional matrix adjust.
Identities = 165/229 (72%), Positives = 192/229 (83%), Gaps = 2/229 (0%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLNK+L++CLDCELNFLSSVNH NIIRL D F+ + C+FLV+EFC+GGNL+SY++ HG
Sbjct: 38 LSKLNKNLRNCLDCELNFLSSVNHTNIIRLLDVFEDDCCMFLVLEFCSGGNLASYLQQHG 97
Query: 62 RVPEQTARKFLQQLGAG--LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
RV E+ A++F QQ+G+G L+IL SHHIIHRDLKPENILLSG + DV+LKIADFGLS +
Sbjct: 98 RVQEKIAKRFTQQMGSGDGLKILQSHHIIHRDLKPENILLSGKESDVVLKIADFGLSRRV 157
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRN 179
P NY E VCGSP YMAPEVLQFQRYD KVDMWSVG ILFELLNGYPPF GR N QL++N
Sbjct: 158 LPDNYVETVCGSPFYMAPEVLQFQRYDYKVDMWSVGVILFELLNGYPPFRGRTNFQLLQN 217
Query: 180 INSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
I S LPFSQ I+ LHPDCVD+C +LLSAN V RLSF+EFYHH+FLR
Sbjct: 218 IKSSSCLPFSQHILSGLHPDCVDICSRLLSANPVQRLSFDEFYHHKFLR 266
|
Source: Populus trichocarpa Species: Populus trichocarpa Genus: Populus Family: Salicaceae Order: Malpighiales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|359476946|ref|XP_003631917.1| PREDICTED: serine/threonine-protein kinase ULK3 isoform 2 [Vitis vinifera] | Back alignment and taxonomy information |
|---|
Score = 331 bits (848), Expect = 2e-88, Method: Compositional matrix adjust.
Identities = 161/227 (70%), Positives = 185/227 (81%), Gaps = 15/227 (6%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++LK+ LDCE+NFLSSV+HPNIIRL FQAE CIFLV+EFC+GG+L SYIR HG
Sbjct: 43 LSKLNRNLKTSLDCEINFLSSVSHPNIIRLLHVFQAEGCIFLVLEFCSGGDLESYIRHHG 102
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E AR+F+QQLGAGLE+L+SHHIIHRDLKP NILLSG + DV+LKIADFGLS T++P
Sbjct: 103 RVQEWVARRFMQQLGAGLEVLHSHHIIHRDLKPGNILLSGPESDVLLKIADFGLSRTVHP 162
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
G +AE VCG+PLYMAPEVL+F++YDEKVDMWS+GAILFELLNGYPPF GR NV
Sbjct: 163 GEHAETVCGTPLYMAPEVLRFKKYDEKVDMWSLGAILFELLNGYPPFCGRTNV------- 215
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
QLI P LHPDCVD+C KLLS N V RLSF+EF HRFLR
Sbjct: 216 --------QLISPGLHPDCVDLCTKLLSTNPVHRLSFDEFCRHRFLR 254
|
Source: Vitis vinifera Species: Vitis vinifera Genus: Vitis Family: Vitaceae Order: Vitales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|357464547|ref|XP_003602555.1| Serine/threonine protein kinase GE16371 [Medicago truncatula] gi|355491603|gb|AES72806.1| Serine/threonine protein kinase GE16371 [Medicago truncatula] | Back alignment and taxonomy information |
|---|
Score = 325 bits (832), Expect = 1e-86, Method: Compositional matrix adjust.
Identities = 154/231 (66%), Positives = 185/231 (80%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
L KLN HL++ LDCE+NFLSSVNHPNI+ L FQ C++LV+EFCAGGNL+SYIR H
Sbjct: 57 FLSKLNSHLRASLDCEINFLSSVNHPNIVHLLHFFQGNGCVYLVLEFCAGGNLASYIRCH 116
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
RV + TA+KF+QQLG+GL++L+SH IIHRDLKPENILLS D +LKIADFGLS T+
Sbjct: 117 ERVHQLTAKKFIQQLGSGLKVLHSHGIIHRDLKPENILLSSHGADAVLKIADFGLSRTVR 176
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
PG Y E VCG+P YMAPEVLQFQRYD K DMWSVGA+LFELLNGYPPF+GRNNVQ+++NI
Sbjct: 177 PGEYVETVCGTPSYMAPEVLQFQRYDHKADMWSVGAMLFELLNGYPPFNGRNNVQVLKNI 236
Query: 181 NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
SC LPFSQ ++ + C+D+C +LL N V+RLSF+EFY H FLR S
Sbjct: 237 RSCTCLPFSQSVLYGMDSACLDICSRLLCLNPVERLSFDEFYFHSFLRGKS 287
|
Source: Medicago truncatula Species: Medicago truncatula Genus: Medicago Family: Fabaceae Order: Fabales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|297852566|ref|XP_002894164.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata] gi|297340006|gb|EFH70423.1| hypothetical protein ARALYDRAFT_314341 [Arabidopsis lyrata subsp. lyrata] | Back alignment and taxonomy information |
|---|
Score = 323 bits (827), Expect = 6e-86, Method: Compositional matrix adjust.
Identities = 150/227 (66%), Positives = 186/227 (81%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L++CL+ EL FLSSV+HPNIIRL FQ E + +V+E+C GG LSSYI+ HG
Sbjct: 39 LSKLNRNLRTCLNNELEFLSSVDHPNIIRLLHVFQDEEFLVMVMEYCDGGTLSSYIQRHG 98
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++FL+Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L P
Sbjct: 99 RVEEDIAKRFLKQIGAGLEIIHDNHIIHRDLKPENILIVGSGDDLVLKIADFSLARKLLP 158
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF G NNVQ++RNI
Sbjct: 159 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPFRGNNNVQVLRNIK 218
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
S LPFS+LI+ +HPDC+D+C +LLS N V RLSF++FY+H+FLR
Sbjct: 219 SSTSLPFSRLILQQMHPDCIDVCSRLLSINPVTRLSFDDFYNHKFLR 265
|
Source: Arabidopsis lyrata subsp. lyrata Species: Arabidopsis lyrata Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|110736434|dbj|BAF00185.1| similar to MAP/ERK kinase kinase 3 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 317 bits (813), Expect = 2e-84, Method: Compositional matrix adjust.
Identities = 147/227 (64%), Positives = 185/227 (81%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 68 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 127
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 128 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 187
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF G NNVQ++RNI
Sbjct: 188 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPFRGNNNVQVLRNIK 247
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
S LPFS+LI+ +HPDC+D+C +LLS N V RLSF+EFY H+FLR
Sbjct: 248 SSTALPFSRLILQQMHPDCIDVCSRLLSINPVTRLSFDEFYKHKFLR 294
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|326487810|dbj|BAK05577.1| predicted protein [Hordeum vulgare subsp. vulgare] | Back alignment and taxonomy information |
|---|
Score = 303 bits (777), Expect = 3e-80, Method: Compositional matrix adjust.
Identities = 141/228 (61%), Positives = 175/228 (76%), Gaps = 1/228 (0%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLH 60
L L L+ LDCEL FL++V+HPNIIRL D + CI+LV+E C GG+L+SYI R
Sbjct: 50 LAGLPARLRDSLDCELRFLAAVSHPNIIRLLDVIRTPGCIYLVMELCEGGDLASYIERSG 109
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
GRV E AR F++Q+GAGL++L HH++HRDLKPENILLS D MLKI+DFGLS L+
Sbjct: 110 GRVDESVARNFMRQIGAGLQVLRRHHVVHRDLKPENILLSCRGSDAMLKISDFGLSRVLH 169
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
PG YAE CG+ LYMAPEV+ FQ+YD+KVD+WS+GAILFELLNGYPPF GR+NVQ+++ I
Sbjct: 170 PGEYAETACGTRLYMAPEVMLFQKYDDKVDLWSIGAILFELLNGYPPFRGRSNVQMLQCI 229
Query: 181 NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
N LPFSQL+VP+LHPD +D+C +LL N V RLS EF +H FLR
Sbjct: 230 NRTGSLPFSQLVVPSLHPDSIDICTRLLCTNPVKRLSLQEFINHGFLR 277
|
Source: Hordeum vulgare subsp. vulgare Species: Hordeum vulgare Genus: Hordeum Family: Poaceae Order: Poales Class: Liliopsida Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|7770326|gb|AAF69696.1|AC016041_1 F27J15.5 [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 298 bits (762), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 137/220 (62%), Positives = 174/220 (79%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 38 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 97
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 98 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 157
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF G NNVQ++RNI
Sbjct: 158 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPFRGNNNVQVLRNIK 217
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221
S LPFS+LI+ +HPDC+D+C +LLS N L +F
Sbjct: 218 SSTALPFSRLILQQMHPDCIDVCSRLLSINPAATLGIEDF 257
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
| >gi|334183174|ref|NP_001185178.1| protein kinase-like protein [Arabidopsis thaliana] gi|332194280|gb|AEE32401.1| protein kinase-like protein [Arabidopsis thaliana] | Back alignment and taxonomy information |
|---|
Score = 298 bits (762), Expect = 2e-78, Method: Compositional matrix adjust.
Identities = 137/220 (62%), Positives = 174/220 (79%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF G NNVQ++RNI
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPFRGNNNVQVLRNIK 219
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221
S LPFS+LI+ +HPDC+D+C +LLS N L +F
Sbjct: 220 SSTALPFSRLILQQMHPDCIDVCSRLLSINPAATLGIEDF 259
|
Source: Arabidopsis thaliana Species: Arabidopsis thaliana Genus: Arabidopsis Family: Brassicaceae Order: Brassicales Class: Phylum: Streptophyta Superkingdom: Eukaryota |
Prediction of Gene Ontology (GO) Terms
Close Homologs with Gene Ontology terms Detected by BLAST
Original result of BLAST against Gene Ontology (AMIGO)
| ID |
Alignment graph |
Length |
Definition |
Q cover |
H cover |
Identity |
E-value |
| Query | 241 | ||||||
| TAIR|locus:2028496 | 408 | AT1G49180 [Arabidopsis thalian | 0.912 | 0.539 | 0.622 | 6.5e-74 | |
| TAIR|locus:2084440 | 712 | AT3G53930 [Arabidopsis thalian | 0.933 | 0.316 | 0.530 | 1.9e-60 | |
| TAIR|locus:2079527 | 626 | AT3G61960 [Arabidopsis thalian | 0.937 | 0.361 | 0.495 | 3.1e-60 | |
| TAIR|locus:2065680 | 733 | AT2G37840 [Arabidopsis thalian | 0.933 | 0.306 | 0.517 | 8.1e-60 | |
| UNIPROTKB|Q5ZJH6 | 468 | ULK3 "Serine/threonine-protein | 0.917 | 0.472 | 0.438 | 1.9e-44 | |
| MGI|MGI:1918992 | 472 | Ulk3 "unc-51-like kinase 3" [M | 0.904 | 0.461 | 0.430 | 1.1e-41 | |
| RGD|1587417 | 472 | Ulk3 "unc-51-like kinase 3 (C. | 0.904 | 0.461 | 0.430 | 1.4e-41 | |
| UNIPROTKB|F1N332 | 472 | ULK3 "Uncharacterized protein" | 0.900 | 0.459 | 0.428 | 3.6e-41 | |
| UNIPROTKB|F1SJ29 | 479 | ULK3 "Uncharacterized protein" | 0.900 | 0.453 | 0.428 | 3.6e-41 | |
| UNIPROTKB|E1BH35 | 1037 | ULK2 "Uncharacterized protein" | 0.991 | 0.230 | 0.396 | 6.7e-41 |
| TAIR|locus:2028496 AT1G49180 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 746 (267.7 bits), Expect = 6.5e-74, P = 6.5e-74
Identities = 137/220 (62%), Positives = 174/220 (79%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L KLN++L+ CL+ EL FLSSV+HPNIIRL Q ++ + +V+E+C GG LSSYI+ +G
Sbjct: 40 LSKLNRNLRDCLNNELEFLSSVDHPNIIRLLHVSQDDDFLVMVLEYCDGGTLSSYIQRYG 99
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
RV E A++F++Q+GAGLEI++ +HIIHRDLKPENIL+ G DD++LKIADF L+ L+P
Sbjct: 100 RVEEDIAKRFMKQIGAGLEIIHDNHIIHRDLKPENILIDGSGDDLVLKIADFSLARKLHP 159
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
G Y E VCGSP YMAPEVLQFQRY+EK DMWSVGAILFELL+GYPPF G NNVQ++RNI
Sbjct: 160 GKYLETVCGSPFYMAPEVLQFQRYNEKADMWSVGAILFELLHGYPPFRGNNNVQVLRNIK 219
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221
S LPFS+LI+ +HPDC+D+C +LLS N L +F
Sbjct: 220 SSTALPFSRLILQQMHPDCIDVCSRLLSINPAATLGIEDF 259
|
|
| TAIR|locus:2084440 AT3G53930 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 619 (223.0 bits), Expect = 1.9e-60, P = 1.9e-60
Identities = 120/226 (53%), Positives = 156/226 (69%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
+ +LNK L+ L E+ L +NHPNIIR D +A I LV+E+C GG+LS YI HG
Sbjct: 53 MARLNKKLQESLMSEIIILRKINHPNIIRFIDMIEAPGKINLVLEYCKGGDLSMYIHKHG 112
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
VPE TA+ F+ QL AGL++L ++IIHRDLKP+N+LLS D+D LKIADFG + +L P
Sbjct: 113 SVPEATAKHFMLQLAAGLQVLRDNNIIHRDLKPQNLLLSTDDNDAALKIADFGFARSLQP 172
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
AE +CGSPLYMAPE++Q Q+YD K D+WSVGAILF+L+ G PF+G + +QL++NI
Sbjct: 173 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLLQNII 232
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
L F L DC D+C KLL N V+RL+F EF+HH FL
Sbjct: 233 RSTELHFPA-DCRDLSTDCKDLCQKLLRRNPVERLTFEEFFHHPFL 277
|
|
| TAIR|locus:2079527 AT3G61960 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 617 (222.3 bits), Expect = 3.1e-60, P = 3.1e-60
Identities = 112/226 (49%), Positives = 159/226 (70%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K L+ ++ L E++ LS+++HPNIIR ++A + + IFLV+E+C+GG+L+ YI HG+
Sbjct: 44 KLLSPKVRDNLLKEISILSTIDHPNIIRFYEAIETGDRIFLVLEYCSGGDLAGYINRHGK 103
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
VPE A+ F++QL GL++L H IHRDLKP+N+LLS + +LKI DFG + +L P
Sbjct: 104 VPEAVAKHFMRQLALGLQVLQEKHFIHRDLKPQNLLLSSKEVTPLLKIGDFGFARSLTPE 163
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINS 182
+ AE CGSPLYMAPE+++ Q+YD K D+WS GAILF+L+ G PPF G N++QL NI
Sbjct: 164 SMAETFCGSPLYMAPEIIRNQKYDAKADLWSAGAILFQLVTGKPPFDGNNHIQLFHNIVR 223
Query: 183 CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
L F + +HPDCVD+C LL N ++RL+F EF++H FLR
Sbjct: 224 DTELKFPEDTRNEIHPDCVDLCRSLLRRNPIERLTFREFFNHMFLR 269
|
|
| TAIR|locus:2065680 AT2G37840 [Arabidopsis thaliana (taxid:3702)] | Back alignment and assigned GO terms |
|---|
Score = 613 (220.8 bits), Expect = 8.1e-60, P = 8.1e-60
Identities = 117/226 (51%), Positives = 160/226 (70%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
+ +LNK L+ L E+ L +NHPNIIRL D ++ + LV+E+C GG+LS Y++ HG
Sbjct: 45 MDRLNKKLQESLMSEIFILRRINHPNIIRLIDMIKSPGKVHLVLEYCKGGDLSVYVQRHG 104
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
VPE TA+ F+QQL AGL++L ++IIHRDLKP+N+LLS ++D LKIADFG + +L P
Sbjct: 105 IVPEATAKHFMQQLAAGLQVLRDNNIIHRDLKPQNLLLSTNENDADLKIADFGFARSLQP 164
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
AE +CGSPLYMAPE++Q Q+YD K D+WSVGAILF+L+ G PF+G + +QL++NI
Sbjct: 165 RGLAETLCGSPLYMAPEIMQLQKYDAKADLWSVGAILFQLVTGRTPFTGNSQIQLLQNII 224
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
L F L DC+D+C KLL N V+RL+F EF++H FL
Sbjct: 225 RSTELHFPG-DCRDLSLDCIDLCQKLLRRNPVERLTFEEFFNHPFL 269
|
|
| UNIPROTKB|Q5ZJH6 ULK3 "Serine/threonine-protein kinase ULK3" [Gallus gallus (taxid:9031)] | Back alignment and assigned GO terms |
|---|
Score = 468 (169.8 bits), Expect = 1.9e-44, P = 1.9e-44
Identities = 99/226 (43%), Positives = 145/226 (64%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
+ LN+ L E+ L ++ HP+I+ L D FQ ++ I+L++EFCAGG+LS +IR+
Sbjct: 49 RSLNRASVENLLTEIEILKTIRHPHIVELKD-FQWDSDHIYLIMEFCAGGDLSRFIRMRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR FLQQL L+ L+ H+I H DLKP+NILLS ++ LK+ADFG + + P
Sbjct: 108 ILPEKVARIFLQQLACALKFLHDHNISHLDLKPQNILLS-TPENPQLKLADFGFAQYMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
+ + GSPLYMAPE++ Q+YD +VD+WSVG IL+E L G PPF+ R+ +L I
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRQQYDARVDLWSVGVILYEALFGRPPFASRSFAELEEKIR 226
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
S + + P L PDC D+ +LL + + R+SF EF+ H F+
Sbjct: 227 SDRAIELPSR--PPLSPDCRDLLQRLLERDPLKRISFEEFFAHPFV 270
|
|
| MGI|MGI:1918992 Ulk3 "unc-51-like kinase 3" [Mus musculus (taxid:10090)] | Back alignment and assigned GO terms |
|---|
Score = 442 (160.7 bits), Expect = 1.1e-41, P = 1.1e-41
Identities = 96/223 (43%), Positives = 140/223 (62%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L I
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKIR 226
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
S + + + P L DC D+ +LL + R+SF +F+ H
Sbjct: 227 SNRVIELP--LRPQLSLDCRDLLQRLLERDPARRISFKDFFAH 267
|
|
| RGD|1587417 Ulk3 "unc-51-like kinase 3 (C. elegans)" [Rattus norvegicus (taxid:10116)] | Back alignment and assigned GO terms |
|---|
Score = 441 (160.3 bits), Expect = 1.4e-41, P = 1.4e-41
Identities = 96/223 (43%), Positives = 140/223 (62%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG 61
K LNK L E+ L + HP+I++L D FQ +N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDNDNIYLIMEFCAGGDLSRFIHTRR 107
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + + P
Sbjct: 108 ILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMSP 166
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
+ + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L I
Sbjct: 167 WDEKHVLRGSPLYMAPEMVCRRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKIR 226
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
S + + + P L DC D+ +LL + R+SF +F+ H
Sbjct: 227 SNRVIELP--LRPQLSLDCRDLLQRLLERDPSHRISFQDFFAH 267
|
|
| UNIPROTKB|F1N332 ULK3 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 3.6e-41, P = 3.6e-41
Identities = 96/224 (42%), Positives = 141/224 (62%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH 60
K LNK L E+ L + HP+I++L D FQ ++N I+L++EFCAGG+LS +I
Sbjct: 49 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDSDN-IYLIMEFCAGGDLSRFIHTR 106
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + +
Sbjct: 107 RILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMS 165
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
P + + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L I
Sbjct: 166 PRDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKI 225
Query: 181 NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
S + + + P L DC D+ +LL + R+SF +F+ H
Sbjct: 226 RSNRVIELP--LRPQLSHDCRDLLQRLLERDPSRRISFQDFFAH 267
|
|
| UNIPROTKB|F1SJ29 ULK3 "Uncharacterized protein" [Sus scrofa (taxid:9823)] | Back alignment and assigned GO terms |
|---|
Score = 437 (158.9 bits), Expect = 3.6e-41, P = 3.6e-41
Identities = 96/224 (42%), Positives = 141/224 (62%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH 60
K LNK L E+ L + HP+I++L D FQ ++N I+L++EFCAGG+LS +I
Sbjct: 56 KSLNKASVENLLTEIEILKGIRHPHIVQLKD-FQWDSDN-IYLIMEFCAGGDLSRFIHTR 113
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE+ AR F+QQL + L+ L+ +I H DLKP+NILLS L+ LK+ADFG + +
Sbjct: 114 RILPEKVARVFMQQLASALQFLHERNISHLDLKPQNILLSSLEKP-HLKLADFGFAQHMS 172
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
P + + GSPLYMAPE++ ++YD +VD+WSVG IL+E L G PPF+ R+ +L I
Sbjct: 173 PWDEKHVLRGSPLYMAPEMVCQRQYDARVDLWSVGVILYEALFGQPPFASRSFSELEEKI 232
Query: 181 NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
S + + + P L DC D+ +LL + R+SF +F+ H
Sbjct: 233 RSNRVIELP--LRPLLSQDCRDLLQRLLERDPNRRISFQDFFAH 274
|
|
| UNIPROTKB|E1BH35 ULK2 "Uncharacterized protein" [Bos taurus (taxid:9913)] | Back alignment and assigned GO terms |
|---|
Score = 445 (161.7 bits), Expect = 6.7e-41, P = 6.7e-41
Identities = 99/250 (39%), Positives = 141/250 (56%)
Query: 2 LKKLNK-HL-KS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K +NK +L KS L E+ L + H NI+ L+D + N +FLV+E+C GG+L+ Y+
Sbjct: 38 IKSINKKNLSKSQILLGKEIKILKELQHENIVALYDVQELPNSVFLVMEYCNGGDLADYL 97
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD------DDVMLKIA 111
+ G + E T R FL Q+ A + IL+S IIHRDLKP+NILLS + +KIA
Sbjct: 98 QAKGTLSEDTIRVFLHQIAAAMRILHSKGIIHRDLKPQNILLSYASRKKSSVSGIRIKIA 157
Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
DFG + L+ A +CGSP+YMAPEV+ Q YD K D+WS+G ++++ L G PPF
Sbjct: 158 DFGFARYLHSNMMAATLCGSPMYMAPEVIMSQHYDAKADLWSIGTVIYQCLVGKPPFQQA 217
Query: 172 NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
N+ Q +R K+ I P ++ L LL N DR+ F F+ H FL +
Sbjct: 218 NSPQDLRMFYE-KNRNLMPSIPRETSPYLANLLLGLLQRNQKDRMDFEAFFSHPFLEQVP 276
Query: 232 AILRAPFHIP 241
A P +P
Sbjct: 277 AKKSCPVPVP 286
|
|
Prediction of Enzyme Commission (EC) Number
EC Number Prediction by Annotation Transfer from SWISS-PROT Entries
Original result of BLAST against SWISS-PROT
No confident hit for EC number transfering in SWISSPROT detected by BLAST
EC Number Prediction by Ezypred Server
Original result from Ezypred Server
Fail to connect to Ezypred Server
EC Number Prediction by EFICAz Software
| Prediction Level | EC number | Confidence of Prediction |
| 4th Layer | 2.7.11.1 | 0.737 |
| 3rd Layer | 2.7.11 | 0.691 |
Prediction of Functionally Associated Proteins
Functionally Associated Proteins Detected by STRING
Original result from the STRING server
| Your Input: |  |
 |
 |
 |
 |
 |
 |
 |
 |
||
 | GSVIVG00034887001 | SubName- Full=Chromosome chr4 scaffold_73, whole genome shotgun sequence; (275 aa) | |||||||||
(Vitis vinifera) | |||||||||||
Predicted Functional Partners: | |||||||||||
| Sorry, there are no predicted associations at the current settings. | |||||||||||
Conserved Domains and Related Protein Families
Conserved Domains Detected by RPS-BLAST
Original result of RPS-BLAST against CDD database part I
| ID | Alignment Graph | Length |
Definition |
E-value |
| Query | 241 | |||
| smart00220 | 254 | smart00220, S_TKc, Serine/Threonine protein kinase | 2e-79 | |
| pfam00069 | 260 | pfam00069, Pkinase, Protein kinase domain | 2e-67 | |
| cd05123 | 250 | cd05123, STKc_AGC, Catalytic domain of AGC family | 4e-60 | |
| cd08215 | 258 | cd08215, STKc_Nek, Catalytic domain of the Protein | 1e-55 | |
| cd00180 | 215 | cd00180, PKc, Catalytic domain of Protein Kinases | 5e-54 | |
| cd05579 | 265 | cd05579, STKc_MAST_like, Catalytic domain of Micro | 2e-53 | |
| cd06606 | 260 | cd06606, STKc_MAPKKK, Catalytic domain of the Prot | 1e-51 | |
| cd05581 | 280 | cd05581, STKc_PDK1, Catalytic domain of the Protei | 3e-50 | |
| cd05580 | 290 | cd05580, STKc_PKA, Catalytic domain of the Protein | 2e-48 | |
| cd05122 | 253 | cd05122, PKc_STE, Catalytic domain of STE family P | 2e-47 | |
| cd05572 | 262 | cd05572, STKc_cGK_PKG, Catalytic domain of the Pro | 3e-47 | |
| cd08217 | 265 | cd08217, STKc_Nek2, Catalytic domain of the Protei | 1e-45 | |
| cd07829 | 282 | cd07829, STKc_CDK_like, Catalytic domain of Cyclin | 3e-44 | |
| cd05578 | 258 | cd05578, STKc_Yank1, Catalytic domain of the Prote | 1e-43 | |
| cd08530 | 256 | cd08530, STKc_CNK2-like, Catalytic domain of the P | 2e-42 | |
| cd05573 | 350 | cd05573, STKc_ROCK_NDR_like, Catalytic domain of R | 2e-42 | |
| smart00219 | 257 | smart00219, TyrKc, Tyrosine kinase, catalytic doma | 7e-42 | |
| cd07830 | 283 | cd07830, STKc_MAK_like, Catalytic domain of Male g | 2e-41 | |
| cd06632 | 258 | cd06632, STKc_MEKK1_plant, Catalytic domain of the | 4e-41 | |
| cd07832 | 286 | cd07832, STKc_CCRK, Catalytic domain of the Serine | 1e-40 | |
| cd05570 | 318 | cd05570, STKc_PKC, Catalytic domain of the Protein | 1e-40 | |
| smart00221 | 258 | smart00221, STYKc, Protein kinase; unclassified sp | 2e-40 | |
| cd05611 | 260 | cd05611, STKc_Rim15_like, Catalytic domain of fung | 2e-40 | |
| cd05612 | 291 | cd05612, STKc_PRKX_like, Catalytic domain of PRKX- | 4e-40 | |
| pfam07714 | 258 | pfam07714, Pkinase_Tyr, Protein tyrosine kinase | 2e-39 | |
| cd05600 | 333 | cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun | 9e-39 | |
| cd08529 | 256 | cd08529, STKc_FA2-like, Catalytic domain of the Pr | 4e-38 | |
| cd05584 | 323 | cd05584, STKc_p70S6K, Catalytic domain of the Prot | 4e-38 | |
| cd05118 | 283 | cd05118, STKc_CMGC, Catalytic domain of CMGC famil | 5e-38 | |
| cd06625 | 263 | cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ | 8e-38 | |
| cd06627 | 254 | cd06627, STKc_Cdc7_like, Catalytic domain of Cell | 1e-37 | |
| cd00192 | 262 | cd00192, PTKc, Catalytic domain of Protein Tyrosin | 1e-37 | |
| cd06612 | 256 | cd06612, STKc_MST1_2, Catalytic domain of the Prot | 1e-37 | |
| COG0515 | 384 | COG0515, SPS1, Serine/threonine protein kinase [Ge | 3e-36 | |
| cd06610 | 267 | cd06610, STKc_OSR1_SPAK, Catalytic domain of the P | 4e-36 | |
| cd06626 | 264 | cd06626, STKc_MEKK4, Catalytic domain of the Prote | 1e-35 | |
| cd08220 | 256 | cd08220, STKc_Nek8, Catalytic domain of the Protei | 2e-35 | |
| cd06614 | 286 | cd06614, STKc_PAK, Catalytic domain of the Protein | 2e-35 | |
| cd05575 | 323 | cd05575, STKc_SGK, Catalytic domain of the Protein | 6e-35 | |
| PTZ00263 | 329 | PTZ00263, PTZ00263, protein kinase A catalytic sub | 8e-35 | |
| cd05609 | 305 | cd05609, STKc_MAST, Catalytic domain of the Protei | 9e-35 | |
| cd07836 | 284 | cd07836, STKc_Pho85, Catalytic domain of the Serin | 9e-35 | |
| cd07834 | 330 | cd07834, STKc_MAPK, Catalytic domain of the Serine | 1e-34 | |
| cd06629 | 272 | cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o | 1e-34 | |
| cd05592 | 316 | cd05592, STKc_nPKC_theta_delta, Catalytic domain o | 3e-34 | |
| cd05582 | 318 | cd05582, STKc_RSK_N, N-terminal catalytic domain o | 9e-34 | |
| cd06609 | 274 | cd06609, STKc_MST3_like, Catalytic domain of Mamma | 2e-33 | |
| cd06623 | 264 | cd06623, PKc_MAPKK_plant_like, Catalytic domain of | 2e-33 | |
| cd08224 | 267 | cd08224, STKc_Nek6_Nek7, Catalytic domain of the P | 4e-33 | |
| cd08221 | 256 | cd08221, STKc_Nek9, Catalytic domain of the Protei | 4e-33 | |
| cd05604 | 325 | cd05604, STKc_SGK3, Catalytic domain of the Protei | 8e-33 | |
| cd05591 | 321 | cd05591, STKc_nPKC_epsilon, Catalytic domain of th | 2e-32 | |
| cd07838 | 287 | cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc | 2e-32 | |
| cd05587 | 324 | cd05587, STKc_cPKC, Catalytic domain of the Protei | 6e-32 | |
| cd05602 | 325 | cd05602, STKc_SGK1, Catalytic domain of the Protei | 7e-32 | |
| cd06630 | 268 | cd06630, STKc_MEKK1, Catalytic domain of the Prote | 1e-31 | |
| cd05603 | 321 | cd05603, STKc_SGK2, Catalytic domain of the Protei | 1e-31 | |
| cd05589 | 324 | cd05589, STKc_PKN, Catalytic domain of the Protein | 2e-31 | |
| cd05574 | 316 | cd05574, STKc_phototropin_like, Catalytic domain o | 2e-31 | |
| cd07835 | 283 | cd07835, STKc_CDK1_like, Catalytic domain of Cycli | 3e-31 | |
| cd07852 | 337 | cd07852, STKc_MAPK15, Catalytic domain of the Seri | 4e-31 | |
| cd08225 | 257 | cd08225, STKc_Nek5, Catalytic domain of the Protei | 7e-31 | |
| cd05590 | 320 | cd05590, STKc_nPKC_eta, Catalytic domain of the Pr | 9e-31 | |
| cd06643 | 282 | cd06643, STKc_SLK, Catalytic domain of the Protein | 1e-30 | |
| cd07840 | 287 | cd07840, STKc_CDK9_like, Catalytic domain of Cycli | 1e-30 | |
| cd05588 | 329 | cd05588, STKc_aPKC, Catalytic domain of the Protei | 2e-30 | |
| cd05585 | 312 | cd05585, STKc_YPK1_like, Catalytic domain of Yeast | 3e-30 | |
| cd05599 | 364 | cd05599, STKc_NDR_like, Catalytic domain of Nuclea | 3e-30 | |
| cd06613 | 262 | cd06613, STKc_MAP4K3_like, Catalytic domain of Mit | 5e-30 | |
| cd05583 | 288 | cd05583, STKc_MSK_N, N-terminal catalytic domain o | 5e-30 | |
| cd07833 | 288 | cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep | 9e-30 | |
| cd07855 | 334 | cd07855, STKc_ERK5, Catalytic domain of the Serine | 1e-29 | |
| PTZ00267 | 478 | PTZ00267, PTZ00267, NIMA-related protein kinase; P | 1e-29 | |
| cd05577 | 277 | cd05577, STKc_GRK, Catalytic domain of the Protein | 1e-29 | |
| cd05618 | 329 | cd05618, STKc_aPKC_iota, Catalytic domain of the P | 1e-29 | |
| cd05620 | 316 | cd05620, STKc_nPKC_delta, Catalytic domain of the | 1e-29 | |
| cd05586 | 330 | cd05586, STKc_Sck1_like, Catalytic domain of Suppr | 2e-29 | |
| cd06611 | 280 | cd06611, STKc_SLK_like, Catalytic domain of Ste20- | 2e-29 | |
| cd06647 | 293 | cd06647, STKc_PAK_I, Catalytic domain of the Prote | 2e-29 | |
| cd05615 | 323 | cd05615, STKc_cPKC_alpha, Catalytic domain of the | 2e-29 | |
| cd05616 | 323 | cd05616, STKc_cPKC_beta, Catalytic domain of the P | 4e-29 | |
| cd07856 | 328 | cd07856, STKc_Sty1_Hog1, Catalytic domain of the S | 9e-29 | |
| cd07841 | 298 | cd07841, STKc_CDK7, Catalytic domain of the Serine | 1e-28 | |
| cd08228 | 267 | cd08228, STKc_Nek6, Catalytic domain of the Protei | 1e-28 | |
| cd05617 | 327 | cd05617, STKc_aPKC_zeta, Catalytic domain of the P | 1e-28 | |
| cd07831 | 282 | cd07831, STKc_MOK, Catalytic domain of the Serine/ | 2e-28 | |
| cd05598 | 376 | cd05598, STKc_LATS, Catalytic domain of the Protei | 3e-28 | |
| cd08229 | 267 | cd08229, STKc_Nek7, Catalytic domain of the Protei | 3e-28 | |
| PTZ00426 | 340 | PTZ00426, PTZ00426, cAMP-dependent protein kinase | 3e-28 | |
| PTZ00266 | 1021 | PTZ00266, PTZ00266, NIMA-related protein kinase; P | 4e-28 | |
| cd07839 | 284 | cd07839, STKc_CDK5, Catalytic domain of the Serine | 5e-28 | |
| cd07854 | 342 | cd07854, STKc_MAPK4_6, Catalytic domain of the Ser | 1e-27 | |
| cd06628 | 267 | cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o | 1e-27 | |
| cd07837 | 295 | cd07837, STKc_CdkB_plant, Catalytic domain of the | 2e-27 | |
| cd06605 | 265 | cd06605, PKc_MAPKK, Catalytic domain of the dual-s | 2e-27 | |
| cd05060 | 257 | cd05060, PTKc_Syk_like, Catalytic domain of Spleen | 4e-27 | |
| cd05619 | 316 | cd05619, STKc_nPKC_theta, Catalytic domain of the | 6e-27 | |
| cd06607 | 307 | cd06607, STKc_TAO, Catalytic domain of the Protein | 7e-27 | |
| cd05630 | 285 | cd05630, STKc_GRK6, Catalytic domain of the Protei | 9e-27 | |
| cd05596 | 370 | cd05596, STKc_ROCK, Catalytic domain of the Protei | 1e-26 | |
| cd06644 | 292 | cd06644, STKc_STK10_LOK, Catalytic domain of the P | 1e-26 | |
| cd06651 | 266 | cd06651, STKc_MEKK3, Catalytic domain of the Prote | 2e-26 | |
| cd06655 | 296 | cd06655, STKc_PAK2, Catalytic domain of the Protei | 2e-26 | |
| cd06621 | 287 | cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of | 3e-26 | |
| cd07857 | 332 | cd07857, STKc_MPK1, Catalytic domain of the Serine | 3e-26 | |
| cd08528 | 269 | cd08528, STKc_Nek10, Catalytic domain of the Prote | 3e-26 | |
| cd06648 | 285 | cd06648, STKc_PAK_II, Catalytic domain of the Prot | 3e-26 | |
| cd05571 | 323 | cd05571, STKc_PKB, Catalytic domain of the Protein | 3e-26 | |
| cd06654 | 296 | cd06654, STKc_PAK1, Catalytic domain of the Protei | 4e-26 | |
| cd08219 | 255 | cd08219, STKc_Nek3, Catalytic domain of the Protei | 4e-26 | |
| cd05632 | 285 | cd05632, STKc_GRK5, Catalytic domain of the Protei | 4e-26 | |
| cd05608 | 280 | cd05608, STKc_GRK1, Catalytic domain of the Protei | 5e-26 | |
| cd08222 | 260 | cd08222, STKc_Nek11, Catalytic domain of the Prote | 6e-26 | |
| cd06652 | 265 | cd06652, STKc_MEKK2, Catalytic domain of the Prote | 8e-26 | |
| cd07851 | 343 | cd07851, STKc_p38, Catalytic domain of the Serine/ | 8e-26 | |
| cd05605 | 285 | cd05605, STKc_GRK4_like, Catalytic domain of G pro | 1e-25 | |
| PTZ00024 | 335 | PTZ00024, PTZ00024, cyclin-dependent protein kinas | 1e-25 | |
| cd06608 | 275 | cd06608, STKc_myosinIII_like, Catalytic domain of | 1e-25 | |
| cd05629 | 377 | cd05629, STKc_NDR_like_fungal, Catalytic domain of | 1e-25 | |
| cd06620 | 284 | cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of | 3e-25 | |
| cd08218 | 256 | cd08218, STKc_Nek1, Catalytic domain of the Protei | 3e-25 | |
| cd07842 | 316 | cd07842, STKc_CDK8_like, Catalytic domain of Cycli | 4e-25 | |
| cd06653 | 264 | cd06653, STKc_MEKK3_like_1, Catalytic domain of MA | 5e-25 | |
| cd06631 | 265 | cd06631, STKc_YSK4, Catalytic domain of the Protei | 5e-25 | |
| cd08223 | 257 | cd08223, STKc_Nek4, Catalytic domain of the Protei | 6e-25 | |
| cd05626 | 381 | cd05626, STKc_LATS2, Catalytic domain of the Prote | 6e-25 | |
| cd06656 | 297 | cd06656, STKc_PAK3, Catalytic domain of the Protei | 8e-25 | |
| cd07846 | 286 | cd07846, STKc_CDKL2_3, Catalytic domain of the Ser | 1e-24 | |
| cd05048 | 283 | cd05048, PTKc_Ror, Catalytic Domain of the Protein | 1e-24 | |
| cd05625 | 382 | cd05625, STKc_LATS1, Catalytic domain of the Prote | 1e-24 | |
| cd05601 | 330 | cd05601, STKc_CRIK, Catalytic domain of the Protei | 2e-24 | |
| cd05041 | 251 | cd05041, PTKc_Fes_like, Catalytic domain of Fes-li | 2e-24 | |
| cd05084 | 252 | cd05084, PTKc_Fes, Catalytic domain of the Protein | 2e-24 | |
| cd06917 | 277 | cd06917, STKc_NAK1_like, Catalytic domain of Funga | 2e-24 | |
| cd05032 | 277 | cd05032, PTKc_InsR_like, Catalytic domain of Insul | 4e-24 | |
| cd07848 | 287 | cd07848, STKc_CDKL5, Catalytic domain of the Serin | 4e-24 | |
| cd05595 | 323 | cd05595, STKc_PKB_beta, Catalytic domain of the Pr | 4e-24 | |
| cd07845 | 309 | cd07845, STKc_CDK10, Catalytic domain of the Serin | 5e-24 | |
| cd05621 | 370 | cd05621, STKc_ROCK2, Catalytic domain of the Prote | 7e-24 | |
| cd07861 | 285 | cd07861, STKc_CDK1_euk, Catalytic domain of the Se | 8e-24 | |
| cd07862 | 290 | cd07862, STKc_CDK6, Catalytic domain of the Serine | 9e-24 | |
| cd05631 | 285 | cd05631, STKc_GRK4, Catalytic domain of the Protei | 1e-23 | |
| cd06633 | 313 | cd06633, STKc_TAO3, Catalytic domain of the Protei | 2e-23 | |
| cd06635 | 317 | cd06635, STKc_TAO1, Catalytic domain of the Protei | 2e-23 | |
| cd06642 | 277 | cd06642, STKc_STK25-YSK1, Catalytic domain of the | 2e-23 | |
| cd07860 | 284 | cd07860, STKc_CDK2_3, Catalytic domain of the Seri | 2e-23 | |
| cd06634 | 308 | cd06634, STKc_TAO2, Catalytic domain of the Protei | 3e-23 | |
| cd05622 | 371 | cd05622, STKc_ROCK1, Catalytic domain of the Prote | 4e-23 | |
| cd07850 | 353 | cd07850, STKc_JNK, Catalytic domain of the Serine/ | 6e-23 | |
| cd05623 | 332 | cd05623, STKc_MRCK_alpha, Catalytic domain of the | 7e-23 | |
| cd07849 | 336 | cd07849, STKc_ERK1_2_like, Catalytic domain of Ext | 7e-23 | |
| cd06640 | 277 | cd06640, STKc_MST4, Catalytic domain of the Protei | 8e-23 | |
| cd05040 | 257 | cd05040, PTKc_Ack_like, Catalytic domain of the Pr | 9e-23 | |
| cd05053 | 293 | cd05053, PTKc_FGFR, Catalytic domain of the Protei | 9e-23 | |
| cd07843 | 293 | cd07843, STKc_CDC2L1, Catalytic domain of the Seri | 1e-22 | |
| cd05606 | 278 | cd05606, STKc_beta_ARK, Catalytic domain of the Pr | 1e-22 | |
| PLN00009 | 294 | PLN00009, PLN00009, cyclin-dependent kinase A; Pro | 2e-22 | |
| cd05072 | 261 | cd05072, PTKc_Lyn, Catalytic domain of the Protein | 2e-22 | |
| cd05593 | 328 | cd05593, STKc_PKB_gamma, Catalytic domain of the P | 2e-22 | |
| cd05039 | 256 | cd05039, PTKc_Csk_like, Catalytic domain of C-term | 3e-22 | |
| cd05624 | 331 | cd05624, STKc_MRCK_beta, Catalytic domain of the P | 3e-22 | |
| PHA03390 | 267 | PHA03390, pk1, serine/threonine-protein kinase 1; | 5e-22 | |
| cd05113 | 256 | cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro | 5e-22 | |
| cd07876 | 359 | cd07876, STKc_JNK2, Catalytic domain of the Serine | 7e-22 | |
| cd05594 | 325 | cd05594, STKc_PKB_alpha, Catalytic domain of the P | 7e-22 | |
| cd07847 | 286 | cd07847, STKc_CDKL1_4, Catalytic domain of the Ser | 7e-22 | |
| cd05148 | 261 | cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro | 9e-22 | |
| cd06641 | 277 | cd06641, STKc_MST3, Catalytic domain of the Protei | 2e-21 | |
| cd07865 | 310 | cd07865, STKc_CDK9, Catalytic domain of the Serine | 2e-21 | |
| cd06639 | 291 | cd06639, STKc_myosinIIIB, Catalytic domain of the | 2e-21 | |
| TIGR03903 | 1266 | TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas | 2e-21 | |
| cd05613 | 290 | cd05613, STKc_MSK1_N, N-terminal catalytic domain | 3e-21 | |
| cd06657 | 292 | cd06657, STKc_PAK4, Catalytic domain of the Protei | 3e-21 | |
| cd06615 | 308 | cd06615, PKc_MEK, Catalytic domain of the dual-spe | 3e-21 | |
| cd05633 | 279 | cd05633, STKc_GRK3, Catalytic domain of the Protei | 4e-21 | |
| cd07880 | 343 | cd07880, STKc_p38gamma_MAPK12, Catalytic domain of | 4e-21 | |
| cd07844 | 291 | cd07844, STKc_PCTAIRE_like, Catalytic domain of PC | 5e-21 | |
| cd05597 | 331 | cd05597, STKc_DMPK_like, Catalytic domain of Myoto | 6e-21 | |
| cd06658 | 292 | cd06658, STKc_PAK5, Catalytic domain of the Protei | 6e-21 | |
| cd07863 | 288 | cd07863, STKc_CDK4, Catalytic domain of the Serine | 7e-21 | |
| cd05034 | 261 | cd05034, PTKc_Src_like, Catalytic domain of Src ki | 1e-20 | |
| cd05576 | 237 | cd05576, STKc_RPK118_like, Catalytic domain of the | 1e-20 | |
| cd06619 | 279 | cd06619, PKc_MKK5, Catalytic domain of the dual-sp | 1e-20 | |
| cd05607 | 277 | cd05607, STKc_GRK7, Catalytic domain of the Protei | 1e-20 | |
| cd05112 | 256 | cd05112, PTKc_Itk, Catalytic domain of the Protein | 1e-20 | |
| cd06622 | 286 | cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of | 1e-20 | |
| cd05049 | 280 | cd05049, PTKc_Trk, Catalytic domain of the Protein | 2e-20 | |
| cd06638 | 286 | cd06638, STKc_myosinIIIA, Catalytic domain of the | 2e-20 | |
| cd05614 | 332 | cd05614, STKc_MSK2_N, N-terminal catalytic domain | 2e-20 | |
| cd05059 | 256 | cd05059, PTKc_Tec_like, Catalytic domain of Tec-li | 2e-20 | |
| cd05091 | 283 | cd05091, PTKc_Ror2, Catalytic domain of the Protei | 3e-20 | |
| cd07877 | 345 | cd07877, STKc_p38alpha_MAPK14, Catalytic domain of | 3e-20 | |
| cd05035 | 273 | cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li | 4e-20 | |
| cd06650 | 333 | cd06650, PKc_MEK1, Catalytic domain of the dual-sp | 4e-20 | |
| cd06645 | 267 | cd06645, STKc_MAP4K3, Catalytic domain of the Prot | 4e-20 | |
| cd07870 | 291 | cd07870, STKc_PFTAIRE2, Catalytic domain of the Se | 5e-20 | |
| cd05045 | 290 | cd05045, PTKc_RET, Catalytic domain of the Protein | 5e-20 | |
| cd05036 | 277 | cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro | 6e-20 | |
| cd06659 | 297 | cd06659, STKc_PAK6, Catalytic domain of the Protei | 6e-20 | |
| cd07875 | 364 | cd07875, STKc_JNK1, Catalytic domain of the Serine | 6e-20 | |
| cd05075 | 272 | cd05075, PTKc_Axl, Catalytic domain of the Protein | 7e-20 | |
| PHA03209 | 357 | PHA03209, PHA03209, serine/threonine kinase US3; P | 1e-19 | |
| cd05052 | 263 | cd05052, PTKc_Abl, Catalytic domain of the Protein | 1e-19 | |
| cd05090 | 283 | cd05090, PTKc_Ror1, Catalytic domain of the Protei | 1e-19 | |
| cd05033 | 266 | cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec | 1e-19 | |
| cd07878 | 343 | cd07878, STKc_p38beta_MAPK11, Catalytic domain of | 1e-19 | |
| cd06649 | 331 | cd06649, PKc_MEK2, Catalytic domain of the dual-sp | 2e-19 | |
| cd05101 | 304 | cd05101, PTKc_FGFR2, Catalytic domain of the Prote | 2e-19 | |
| cd05100 | 334 | cd05100, PTKc_FGFR3, Catalytic domain of the Prote | 2e-19 | |
| cd05085 | 250 | cd05085, PTKc_Fer, Catalytic domain of the Protein | 2e-19 | |
| cd07879 | 342 | cd07879, STKc_p38delta_MAPK13, Catalytic domain of | 3e-19 | |
| cd07858 | 337 | cd07858, STKc_TEY_MAPK_plant, Catalytic domain of | 3e-19 | |
| cd05098 | 307 | cd05098, PTKc_FGFR1, Catalytic domain of the Prote | 4e-19 | |
| cd05068 | 261 | cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re | 4e-19 | |
| cd05073 | 260 | cd05073, PTKc_Hck, Catalytic domain of the Protein | 5e-19 | |
| cd05627 | 360 | cd05627, STKc_NDR2, Catalytic domain of the Protei | 5e-19 | |
| cd05051 | 296 | cd05051, PTKc_DDR, Catalytic domain of the Protein | 6e-19 | |
| cd05044 | 269 | cd05044, PTKc_c-ros, Catalytic domain of the Prote | 7e-19 | |
| cd05067 | 260 | cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro | 8e-19 | |
| PTZ00036 | 440 | PTZ00036, PTZ00036, glycogen synthase kinase; Prov | 8e-19 | |
| cd06624 | 268 | cd06624, STKc_ASK, Catalytic domain of the Protein | 9e-19 | |
| cd05099 | 314 | cd05099, PTKc_FGFR4, Catalytic domain of the Prote | 9e-19 | |
| cd06618 | 296 | cd06618, PKc_MKK7, Catalytic domain of the dual-sp | 1e-18 | |
| cd07874 | 355 | cd07874, STKc_JNK3, Catalytic domain of the Serine | 1e-18 | |
| cd05083 | 254 | cd05083, PTKc_Chk, Catalytic domain of the Protein | 1e-18 | |
| cd07871 | 288 | cd07871, STKc_PCTAIRE3, Catalytic domain of the Se | 1e-18 | |
| cd05114 | 256 | cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro | 1e-18 | |
| cd05056 | 270 | cd05056, PTKc_FAK, Catalytic domain of the Protein | 2e-18 | |
| cd05628 | 363 | cd05628, STKc_NDR1, Catalytic domain of the Protei | 2e-18 | |
| cd07869 | 303 | cd07869, STKc_PFTAIRE1, Catalytic domain of the Se | 2e-18 | |
| cd05057 | 279 | cd05057, PTKc_EGFR_like, Catalytic domain of Epide | 2e-18 | |
| cd05050 | 288 | cd05050, PTKc_Musk, Catalytic domain of the Protei | 3e-18 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 3e-18 | |
| cd05066 | 267 | cd05066, PTKc_EphR_A, Catalytic domain of the Prot | 3e-18 | |
| cd05093 | 288 | cd05093, PTKc_TrkB, Catalytic domain of the Protei | 4e-18 | |
| cd06637 | 272 | cd06637, STKc_TNIK, Catalytic domain of the Protei | 4e-18 | |
| PTZ00283 | 496 | PTZ00283, PTZ00283, serine/threonine protein kinas | 5e-18 | |
| cd07866 | 311 | cd07866, STKc_BUR1, Catalytic domain of the Serine | 6e-18 | |
| cd05089 | 297 | cd05089, PTKc_Tie1, Catalytic domain of the Protei | 7e-18 | |
| cd07859 | 338 | cd07859, STKc_TDY_MAPK_plant, Catalytic domain of | 8e-18 | |
| cd05070 | 260 | cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro | 8e-18 | |
| cd05097 | 295 | cd05097, PTKc_DDR_like, Catalytic domain of Discoi | 1e-17 | |
| cd05116 | 257 | cd05116, PTKc_Syk, Catalytic domain of the Protein | 1e-17 | |
| cd07853 | 372 | cd07853, STKc_NLK, Catalytic domain of the Serine/ | 1e-17 | |
| cd06636 | 282 | cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr | 2e-17 | |
| cd07872 | 309 | cd07872, STKc_PCTAIRE2, Catalytic domain of the Se | 3e-17 | |
| cd05065 | 269 | cd05065, PTKc_EphR_B, Catalytic domain of the Prot | 3e-17 | |
| cd05069 | 260 | cd05069, PTKc_Yes, Catalytic domain of the Protein | 3e-17 | |
| PHA03207 | 392 | PHA03207, PHA03207, serine/threonine kinase US3; P | 3e-17 | |
| cd05074 | 273 | cd05074, PTKc_Tyro3, Catalytic domain of the Prote | 4e-17 | |
| cd05092 | 280 | cd05092, PTKc_TrkA, Catalytic domain of the Protei | 4e-17 | |
| cd06646 | 267 | cd06646, STKc_MAP4K5, Catalytic domain of the Prot | 5e-17 | |
| cd07873 | 301 | cd07873, STKc_PCTAIRE1, Catalytic domain of the Se | 5e-17 | |
| cd05038 | 284 | cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai | 6e-17 | |
| PLN00034 | 353 | PLN00034, PLN00034, mitogen-activated protein kina | 1e-16 | |
| cd05046 | 275 | cd05046, PTK_CCK4, Pseudokinase domain of the Prot | 1e-16 | |
| cd05080 | 283 | cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma | 2e-16 | |
| cd06616 | 288 | cd06616, PKc_MKK4, Catalytic domain of the dual-sp | 2e-16 | |
| cd05047 | 270 | cd05047, PTKc_Tie, Catalytic domain of Tie Protein | 3e-16 | |
| cd05082 | 256 | cd05082, PTKc_Csk, Catalytic domain of the Protein | 3e-16 | |
| cd05111 | 279 | cd05111, PTK_HER3, Pseudokinase domain of the Prot | 3e-16 | |
| cd05063 | 268 | cd05063, PTKc_EphR_A2, Catalytic domain of the Pro | 3e-16 | |
| cd05071 | 262 | cd05071, PTKc_Src, Catalytic domain of the Protein | 7e-16 | |
| cd05115 | 257 | cd05115, PTKc_Zap-70, Catalytic domain of the Prot | 8e-16 | |
| cd05094 | 291 | cd05094, PTKc_TrkC, Catalytic domain of the Protei | 8e-16 | |
| cd05058 | 262 | cd05058, PTKc_Met_Ron, Catalytic domain of the Pro | 9e-16 | |
| cd05055 | 302 | cd05055, PTKc_PDGFR, Catalytic domain of the Prote | 1e-15 | |
| cd05095 | 296 | cd05095, PTKc_DDR2, Catalytic domain of the Protei | 2e-15 | |
| cd05088 | 303 | cd05088, PTKc_Tie2, Catalytic domain of the Protei | 4e-15 | |
| cd08216 | 314 | cd08216, PK_STRAD, Pseudokinase domain of STE20-re | 6e-15 | |
| cd07868 | 317 | cd07868, STKc_CDK8, Catalytic domain of the Serine | 9e-15 | |
| cd07867 | 317 | cd07867, STKc_CDC2L6, Catalytic domain of Serine/T | 1e-14 | |
| cd05042 | 269 | cd05042, PTKc_Aatyk, Catalytic domain of the Prote | 2e-14 | |
| cd05096 | 304 | cd05096, PTKc_DDR1, Catalytic domain of the Protei | 2e-14 | |
| cd06617 | 283 | cd06617, PKc_MKK3_6, Catalytic domain of the dual- | 2e-14 | |
| cd05061 | 288 | cd05061, PTKc_InsR, Catalytic domain of the Protei | 3e-14 | |
| cd05062 | 277 | cd05062, PTKc_IGF-1R, Catalytic domain of the Prot | 3e-14 | |
| cd05108 | 316 | cd05108, PTKc_EGFR, Catalytic domain of the Protei | 2e-13 | |
| cd07864 | 302 | cd07864, STKc_CDK12, Catalytic domain of the Serin | 4e-13 | |
| cd05064 | 266 | cd05064, PTKc_EphR_A10, Catalytic domain of the Pr | 4e-13 | |
| cd05054 | 337 | cd05054, PTKc_VEGFR, Catalytic domain of the Prote | 1e-12 | |
| cd05079 | 284 | cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma | 2e-12 | |
| cd05102 | 338 | cd05102, PTKc_VEGFR3, Catalytic domain of the Prot | 3e-12 | |
| cd05086 | 268 | cd05086, PTKc_Aatyk2, Catalytic domain of the Prot | 3e-12 | |
| cd05081 | 284 | cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) | 4e-12 | |
| cd05103 | 343 | cd05103, PTKc_VEGFR2, Catalytic domain of the Prot | 6e-12 | |
| cd08227 | 327 | cd08227, PK_STRAD_alpha, Pseudokinase domain of ST | 8e-12 | |
| cd05110 | 303 | cd05110, PTKc_HER4, Catalytic domain of the Protei | 8e-12 | |
| PHA03211 | 461 | PHA03211, PHA03211, serine/threonine kinase US3; P | 3e-11 | |
| cd05043 | 280 | cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Rece | 3e-11 | |
| PHA03212 | 391 | PHA03212, PHA03212, serine/threonine kinase US3; P | 3e-11 | |
| PLN00113 | 968 | PLN00113, PLN00113, leucine-rich repeat receptor-l | 2e-10 | |
| cd05105 | 400 | cd05105, PTKc_PDGFR_alpha, Catalytic domain of the | 1e-09 | |
| cd05109 | 279 | cd05109, PTKc_HER2, Catalytic domain of the Protei | 2e-09 | |
| cd05107 | 401 | cd05107, PTKc_PDGFR_beta, Catalytic domain of the | 5e-09 | |
| cd08226 | 328 | cd08226, PK_STRAD_beta, Pseudokinase domain of STE | 6e-09 | |
| PHA03210 | 501 | PHA03210, PHA03210, serine/threonine kinase US3; P | 7e-09 | |
| PRK13184 | 932 | PRK13184, pknD, serine/threonine-protein kinase; R | 7e-09 | |
| PTZ00284 | 467 | PTZ00284, PTZ00284, protein kinase; Provisional | 1e-08 | |
| cd05610 | 669 | cd05610, STKc_MASTL, Catalytic domain of the Prote | 2e-08 | |
| smart00750 | 176 | smart00750, KIND, kinase non-catalytic C-lobe doma | 2e-08 | |
| cd05106 | 374 | cd05106, PTKc_CSF-1R, Catalytic domain of the Prot | 3e-08 | |
| cd05104 | 375 | cd05104, PTKc_Kit, Catalytic domain of the Protein | 6e-08 | |
| cd05087 | 269 | cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t | 1e-07 | |
| cd05076 | 274 | cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) do | 6e-06 | |
| PLN03224 | 507 | PLN03224, PLN03224, probable serine/threonine prot | 2e-05 | |
| PLN03225 | 566 | PLN03225, PLN03225, Serine/threonine-protein kinas | 2e-05 | |
| cd05078 | 258 | cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat | 2e-04 | |
| cd05037 | 259 | cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) dom | 4e-04 | |
| cd05077 | 262 | cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) do | 4e-04 | |
| PHA02988 | 283 | PHA02988, PHA02988, hypothetical protein; Provisio | 0.001 | |
| PRK14879 | 211 | PRK14879, PRK14879, serine/threonine protein kinas | 0.001 | |
| cd05120 | 155 | cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphot | 0.004 |
| >gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Score = 238 bits (611), Expect = 2e-79
Identities = 91/230 (39%), Positives = 131/230 (56%), Gaps = 8/230 (3%)
Query: 2 LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K + K E+ L + HPNI+RL+D F+ E+ ++LV+E+C GG+L +
Sbjct: 29 IKVIKKKKIKKDRERILREIKILKKLKHPNIVRLYDVFEDEDKLYLVMEYCEGGDLFDLL 88
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ GR+ E AR +L+Q+ + LE L+S I+HRDLKPENIL LD+D +K+ADFGL+
Sbjct: 89 KKRGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENIL---LDEDGHVKLADFGLAR 145
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLV 177
L PG G+P YMAPEVL + Y + VD+WS+G IL+ELL G PPF G + + +
Sbjct: 146 QLDPGEKLTTFVGTPEYMAPEVLLGKGYGKAVDIWSLGVILYELLTGKPPFPGDDQLLEL 205
Query: 178 RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
PF + P+ D+ KLL + RL+ E H F
Sbjct: 206 FKKIGKPKPPFPP-PEWDISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 254
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254 |
| >gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain | Back alignment and domain information |
|---|
Score = 208 bits (532), Expect = 2e-67
Identities = 94/236 (39%), Positives = 134/236 (56%), Gaps = 14/236 (5%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
+K L K + E+ L ++HPNI+RL DAF+ ++ ++LV+E+C GG+L Y
Sbjct: 29 VKILKKRSEKSKKDQTARREIRILRRLSHPNIVRLIDAFEDKDHLYLVMEYCEGGDLFDY 88
Query: 57 IRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+ G + E A+K Q+ GLE L+S+ IIHRDLKPENIL LD++ ++KIADFGL+
Sbjct: 89 LSRGGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENIL---LDENGVVKIADFGLA 145
Query: 117 CTLY-PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
L + G+P YMAPEVL Y KVD+WS+G IL+ELL G PPFSG N +
Sbjct: 146 KKLLKSSSSLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENIL 205
Query: 175 ---QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
QL+R I L F + + + D+ K L+ + R + E H +
Sbjct: 206 DQLQLIRRILGPP-LEFDEPKWSSGSEEAKDLIKKCLNKDPSKRPTAEEILQHPWF 260
|
Length = 260 |
| >gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 189 bits (482), Expect = 4e-60
Identities = 83/216 (38%), Positives = 115/216 (53%), Gaps = 14/216 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E N LS +NHP I++L AFQ E ++LV+E+ GG L S++ GR E+ AR + ++
Sbjct: 43 ERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEI 102
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLY 134
LE L+S II+RDLKPENIL LD D +K+ DFGL+ L CG+P Y
Sbjct: 103 VLALEYLHSLGIIYRDLKPENIL---LDADGHIKLTDFGLAKELSSEGSRTNTFCGTPEY 159
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIV 193
+APEVL + Y + VD WS+G +L+E+L G PPF + ++ I P
Sbjct: 160 LAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYEKILKDPLRFPEF---- 215
Query: 194 PALHPDCVDMCLKLLSANTVDRL---SFNEFYHHRF 226
L P+ D+ LL + RL E H F
Sbjct: 216 --LSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPF 249
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250 |
| >gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Score = 178 bits (453), Expect = 1e-55
Identities = 67/210 (31%), Positives = 115/210 (54%), Gaps = 12/210 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARKF 71
E+ L +NHPNII+ +++F+ + + +V+E+ GG+LS I+ + PE+ +
Sbjct: 49 EVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDW 108
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCG 130
QL L+ L+S I+HRD+KP+NI L + ++K+ DFG+S L + A+ V G
Sbjct: 109 FVQLCLALKYLHSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVG 165
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+P Y++PE+ Q + Y+ K D+WS+G +L+EL PF G N ++L I ++ P
Sbjct: 166 TPYYLSPELCQNKPYNYKSDIWSLGCVLYELCTLKHPFEGENLLELALKILKGQYPPIPS 225
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNE 220
L ++ LL + +R S +
Sbjct: 226 QYSSELR----NLVSSLLQKDPEERPSIAQ 251
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258 |
| >gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 5e-54
Identities = 73/167 (43%), Positives = 104/167 (62%), Gaps = 9/167 (5%)
Query: 2 LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K + K S L E+ L +NHPNI++L+ F+ EN ++LV+E+C GG+L +
Sbjct: 23 IKIIKKEDSSSLLEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLL 82
Query: 58 -RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
G++ E + L Q+ GLE L+S+ IIHRDLKPENILL D+ +K+ADFGLS
Sbjct: 83 KENEGKLSEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLD--SDNGKVKLADFGLS 140
Query: 117 CTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFEL 161
L + + + G+P YMAPEVL + Y EK D+WS+G IL+EL
Sbjct: 141 KLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215 |
| >gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Score = 172 bits (439), Expect = 2e-53
Identities = 78/237 (32%), Positives = 129/237 (54%), Gaps = 18/237 (7%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ K+ + E + LS P +++L+ +FQ + ++LV+E+ GG+L+S + G
Sbjct: 30 DMIRKNQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGS 89
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS------ 116
+ E AR ++ ++ LE L+S+ IIHRDLKP+NIL +D + LK+ DFGLS
Sbjct: 90 LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNIL---IDSNGHLKLTDFGLSKVGLVR 146
Query: 117 --CTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
L + ++ G+P Y+APEV+ Q + + VD WS+G IL+E L G PPF G
Sbjct: 147 RQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCILYEFLVGIPPFHGETP 206
Query: 174 VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL---SFNEFYHHRFL 227
++ +NI + K + + + + + +D+ KLL + RL S E +H F
Sbjct: 207 EEIFQNILNGK-IEWPE--DVEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFF 260
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265 |
| >gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Score = 167 bits (426), Expect = 1e-51
Identities = 73/224 (32%), Positives = 122/224 (54%), Gaps = 14/224 (6%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
L+ E+ LSS+ HPNI+R + + + E N + + +E+ +GG+LSS ++ G++PE
Sbjct: 44 EALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVI 103
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYA 125
RK+ +Q+ GL L+S+ I+HRD+K NIL+ D ++K+ADFG + L G
Sbjct: 104 RKYTRQILEGLAYLHSNGIVHRDIKGANILVDS---DGVVKLADFGCAKRLGDIETGEGT 160
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ--LVRNINSC 183
V G+P +MAPEV++ + Y D+WS+G + E+ G PP+S N L + +S
Sbjct: 161 GSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMATGKPPWSELGNPMAALYKIGSSG 220
Query: 184 KHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
+ + + D + CL+ + R + +E H FL
Sbjct: 221 EPPEIPEHLSEEAK-DFLRKCLRR---DPKKRPTADELLQHPFL 260
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260 |
| >gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Score = 165 bits (419), Expect = 3e-50
Identities = 78/235 (33%), Positives = 112/235 (47%), Gaps = 35/235 (14%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L L+ HP II+L+ FQ E ++ V+E+ G L YIR +G + E+ R + ++
Sbjct: 55 LTRLN--GHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEIL 112
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----------------- 119
LE L+S IIHRDLKPENIL LD D+ +KI DFG + L
Sbjct: 113 LALEYLHSKGIIHRDLKPENIL---LDKDMHIKITDFGTAKVLDPNSSPESNKGDATNID 169
Query: 120 --YPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
N G+ Y++PE+L + + D+W++G I++++L G PPF G N
Sbjct: 170 SQIEKNRRRFASFVGTAEYVSPELLNEKPAGKSSDLWALGCIIYQMLTGKPPFRGSNEYL 229
Query: 176 LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY----HHRF 226
+ I + F PD D+ KLL + DRL NE Y H F
Sbjct: 230 TFQKILKLE-YSFPPNF----PPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPF 279
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280 |
| >gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 160 bits (408), Expect = 2e-48
Identities = 78/219 (35%), Positives = 122/219 (55%), Gaps = 17/219 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L S+ HP ++ L+ +FQ ++ ++LV+E+ GG L S++R GR PE AR + Q+
Sbjct: 51 EKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQV 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
LE L+S I++RDLKPEN+L LD D +KI DFG + + Y +CG+P Y+
Sbjct: 111 VLALEYLHSLDIVYRDLKPENLL---LDSDGYIKITDFGFAKRVKGRTYT--LCGTPEYL 165
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPA 195
APE++ + Y + VD W++G +++E+L GYPPF N +Q+ I K + P+
Sbjct: 166 APEIILSKGYGKAVDWWALGILIYEMLAGYPPFFDDNPIQIYEKILEGK------VRFPS 219
Query: 196 -LHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 228
PD D+ LL + RL N+ +H +
Sbjct: 220 FFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFA 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290 |
| >gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Score = 156 bits (398), Expect = 2e-47
Identities = 58/155 (37%), Positives = 91/155 (58%), Gaps = 4/155 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L HPNI++ + ++ ++ +++V+EFC+GG+L ++ + E ++
Sbjct: 47 EIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKE 106
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
L GLE L+S+ IIHRD+K NILL+ D +K+ DFGLS L + G+P +
Sbjct: 107 LLKGLEYLHSNGIIHRDIKAANILLT---SDGEVKLIDFGLSAQLSDTKARNTMVGTPYW 163
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
MAPEV+ + YD K D+WS+G EL G PP+S
Sbjct: 164 MAPEVINGKPYDYKADIWSLGITAIELAEGKPPYS 198
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253 |
| >gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Score = 157 bits (398), Expect = 3e-47
Identities = 77/239 (32%), Positives = 120/239 (50%), Gaps = 21/239 (8%)
Query: 2 LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
LK + K + + E L NHP I++L+ F+ + I++++E+C GG L +
Sbjct: 23 LKCVKKRHIVETGQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWT 82
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+R G E TAR ++ + E L++ II+RDLKPEN+L LD + +K+ DFG
Sbjct: 83 ILRDRGLFDEYTARFYIACVVLAFEYLHNRGIIYRDLKPENLL---LDSNGYVKLVDFGF 139
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ L G CG+P Y+APE++ + YD VD WS+G +L+ELL G PPF +
Sbjct: 140 AKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPPFGEDDEDP 199
Query: 176 LV--RNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRF 226
+ +I L F I A D+ +LL N +RL + H++
Sbjct: 200 MEIYNDILKGNGKLEFPNYIDKAAK----DLIKQLLRRNPEERLGNLKGGIKDIKKHKW 254
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262 |
| >gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Score = 152 bits (387), Expect = 1e-45
Identities = 65/189 (34%), Positives = 101/189 (53%), Gaps = 15/189 (7%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI---- 57
+ + K L E+N L + HPNI+R +D ++ +++V+E+C GG+L+ I
Sbjct: 37 NMTEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCK 96
Query: 58 RLHGRVPEQTARKFLQQLGAGLE-----ILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
+ + E+ + L QL L + ++HRDLKP NI L D + +K+ D
Sbjct: 97 KERKYIEEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGD 153
Query: 113 FGLSCTLYPGNYAEKVC-GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
FGL+ L + K G+P YM+PE L YDEK D+WS+G +++EL PPF+ R
Sbjct: 154 FGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWSLGCLIYELCALSPPFTAR 213
Query: 172 NNVQLVRNI 180
N +QL I
Sbjct: 214 NQLQLASKI 222
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265 |
| >gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 149 bits (379), Expect = 3e-44
Identities = 73/250 (29%), Positives = 113/250 (45%), Gaps = 53/250 (21%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E++ L + HPNI++L D E ++LV E+C +L Y+ + + + Q
Sbjct: 48 EISLLKELKHPNIVKLLDVIHTERKLYLVFEYCDM-DLKKYLDKRPGPLSPNLIKSIMYQ 106
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L GL +SH I+HRDLKP+NIL ++ D +LK+ADFGL+ + G PL
Sbjct: 107 LLRGLAYCHSHRILHRDLKPQNIL---INRDGVLKLADFGLA----------RAFGIPLR 153
Query: 134 ----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVR--- 178
Y APE+L + Y VD+WSVG I E++ G P F G + + QL +
Sbjct: 154 TYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQLFKIFQ 213
Query: 179 -----------NINSCKHL----------PFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217
+ +++ P L P+ +D+ K+L N R+S
Sbjct: 214 ILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVL-PRLDPEGIDLLSKMLQYNPAKRIS 272
Query: 218 FNEFYHHRFL 227
E H +
Sbjct: 273 AKEALKHPYF 282
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282 |
| >gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Score = 147 bits (373), Expect = 1e-43
Identities = 67/204 (32%), Positives = 103/204 (50%), Gaps = 5/204 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L +NHP ++ L+ +FQ E ++LVV+ GG+L ++ + E+ + ++ ++
Sbjct: 50 ERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEI 109
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
LE L+S IIHRD+KP+NIL LD+ + I DF ++ + P G+P YM
Sbjct: 110 VLALEYLHSKGIIHRDIKPDNIL---LDEQGHVHITDFNIATKVTPDTLTTSTSGTPGYM 166
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPA 195
APEVL Q Y VD WS+G +E L G P+ G + +R+ K L
Sbjct: 167 APEVLCRQGYSVAVDWWSLGVTAYECLRGKRPYRGHSRT--IRDQIRAKQETADVLYPAT 224
Query: 196 LHPDCVDMCLKLLSANTVDRLSFN 219
+ +D KLL + RL N
Sbjct: 225 WSTEAIDAINKLLERDPQKRLGDN 248
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258 |
| >gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Score = 144 bits (365), Expect = 2e-42
Identities = 73/209 (34%), Positives = 106/209 (50%), Gaps = 12/209 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
E+ L+SVNHPNII +AF N + +V+E+ G+LS I +PEQ +
Sbjct: 49 EIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRI 108
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
QL GL+ L+ I+HRDLK NILL D +KI D G+S + N A+ G+
Sbjct: 109 FIQLLRGLQALHEQKILHRDLKSANILLVANDL---VKIGDLGIS-KVLKKNMAKTQIGT 164
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQL 191
P YMAPEV + + Y K D+WS+G +L+E+ PPF R+ L + K+ P
Sbjct: 165 PHYMAPEVWKGRPYSYKSDIWSLGCLLYEMATFAPPFEARSMQDLRYKVQRGKYPP---- 220
Query: 192 IVPALHPDCVDMCLKLLSANTVDRLSFNE 220
I P D + +L R + ++
Sbjct: 221 IPPIYSQDLQNFIRSMLQVKPKLRPNCDK 249
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256 |
| >gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 146 bits (371), Expect = 2e-42
Identities = 79/245 (32%), Positives = 123/245 (50%), Gaps = 38/245 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L+ + P I++L+ +FQ E ++LV+E+ GG+L + + PE+TAR ++ +L
Sbjct: 51 ERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAEL 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-----------------CT 118
L+ ++ IHRD+KP+NIL +D D +K+ADFGL
Sbjct: 111 VLALDSVHKLGFIHRDIKPDNIL---IDADGHIKLADFGLCKKMNKAKDREYYLNDSHNL 167
Query: 119 LYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165
L+ N A G+P Y+APEVL+ Y + D WS+G IL+E+L G+
Sbjct: 168 LFRDNVLVRRRDHKQRRVRANSTVGTPDYIAPEVLRGTPYGLECDWWSLGVILYEMLYGF 227
Query: 166 PPFSGRNNVQLVRNI-NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-SFNEFYH 223
PPF + I N + L F P + P+ +D+ +LL + DRL SF E
Sbjct: 228 PPFYSDTLQETYNKIINWKESLRFPP--DPPVSPEAIDLICRLL-CDPEDRLGSFEEIKS 284
Query: 224 HRFLR 228
H F +
Sbjct: 285 HPFFK 289
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350 |
| >gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Score = 142 bits (361), Expect = 7e-42
Identities = 65/214 (30%), Positives = 114/214 (53%), Gaps = 21/214 (9%)
Query: 16 ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
E + ++HPN+++L + E +++V+E+ GG+L SY+R + ++ F
Sbjct: 51 EARIMRKLDHPNVVKLLGVCTEEEP-LYIVMEYMEGGDLLSYLRKNRPKLSLSDLLSFAL 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SP 132
Q+ G+E L S + IHRDL N L + +++++KI+DFGLS LY +Y K G P
Sbjct: 110 QIARGMEYLESKNFIHRDLAARNCL---VGENLVVKISDFGLSRDLYDDDYYRKRGGKLP 166
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+ +MAPE L+ ++ K D+WS G +L+E+ G P+ G +N +++ + + LP
Sbjct: 167 IRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLEYLKNGYRLPQP- 225
Query: 191 LIVPALHPDCVDMCLKLLS----ANTVDRLSFNE 220
P+C L+ + DR +F+E
Sbjct: 226 -------PNCPPELYDLMLQCWAEDPEDRPTFSE 252
|
Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257 |
| >gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 142 bits (360), Expect = 2e-41
Identities = 72/268 (26%), Positives = 116/268 (43%), Gaps = 57/268 (21%)
Query: 3 KKLNKHLKSCLDC----ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
KK+ K S +C E+ L +N HPNI++L + F+ + ++ V E+ G NL +
Sbjct: 30 KKMKKKFYSWEECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYMEG-NLYQLM 88
Query: 58 RLHGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ P E R + Q+ GL ++ H HRDLKPEN+L+SG + ++KIADFGL
Sbjct: 89 KDRKGKPFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPE---VVKIADFGL 145
Query: 116 SCTLYPGNYAEKVCGSP---------LYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGY 165
A ++ P Y APE+ L+ Y VD+W++G I+ EL
Sbjct: 146 ---------AREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196
Query: 166 PPFSGRNNV----------------------QLVRNIN----SCKHLPFSQLIVPALHPD 199
P F G + + +L + QLI A P+
Sbjct: 197 PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNA-SPE 255
Query: 200 CVDMCLKLLSANTVDRLSFNEFYHHRFL 227
+D+ +L + R + ++ H +
Sbjct: 256 AIDLIKDMLRWDPKKRPTASQALQHPYF 283
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283 |
| >gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 141 bits (356), Expect = 4e-41
Identities = 71/216 (32%), Positives = 116/216 (53%), Gaps = 7/216 (3%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
L+ E+ LS + HPNI++ + E+ +++ +E GG+L+ ++ +G PE R +
Sbjct: 49 LEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYT 108
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+Q+ GLE L+ + +HRD+K NIL +D + ++K+ADFG++ + ++A+ GSP
Sbjct: 109 RQILLGLEYLHDRNTVHRDIKGANIL---VDTNGVVKLADFGMAKQVVEFSFAKSFKGSP 165
Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQL 191
+MAPEV+ Q Y D+WS+G + E+ G PP+S V V I K LP
Sbjct: 166 YWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPWSQLEGVAAVFKIGRSKELP---P 222
Query: 192 IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
I L + D LK L + R + E H F+
Sbjct: 223 IPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258 |
| >gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Score = 140 bits (355), Expect = 1e-40
Identities = 77/243 (31%), Positives = 117/243 (48%), Gaps = 37/243 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L + HP +++L D F + LV+E+ LS +R R +PE + +++
Sbjct: 49 EIKALQACQHPYVVKLLDVFPHGSGFVLVMEYMPSD-LSEVLRDEERPLPEAQVKSYMRM 107
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGS 131
L G+ ++++ I+HRDLKP N+L+S D +LKIADFGL+ Y+ +V +
Sbjct: 108 LLKGVAYMHANGIMHRDLKPANLLIS---ADGVLKIADFGLARLFSEEEPRLYSHQV-AT 163
Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVRNINS------- 182
Y APE+L R YD VD+W+VG I ELLNG P F G N++ QL +
Sbjct: 164 RWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEE 223
Query: 183 ------------------CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
K +P + I P P+ +D+ LL + RLS E H
Sbjct: 224 TWPGLTSLPDYNKITFPESKPIPLEE-IFPDASPEALDLLKGLLVYDPSKRLSAAEALRH 282
Query: 225 RFL 227
+
Sbjct: 283 PYF 285
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286 |
| >gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Score = 140 bits (356), Expect = 1e-40
Identities = 73/231 (31%), Positives = 112/231 (48%), Gaps = 21/231 (9%)
Query: 12 CLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
C E L+ HP + +L FQ ++ +F V+E+ GG+L +I+ GR E AR
Sbjct: 41 CTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARF 100
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 128
+ ++ GL+ L+ II+RDLK +N+L LD + +KIADFG+ C + G
Sbjct: 101 YAAEIVLGLQFLHERGIIYRDLKLDNVL---LDSEGHIKIADFGM-CKEGILGGVTTSTF 156
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI-NSCKHLP 187
CG+P Y+APE+L +Q Y VD W++G +L+E+L G PF G + +L ++I P
Sbjct: 157 CGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAGQSPFEGDDEDELFQSILEDEVRYP 216
Query: 188 FSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 238
L + + L+ N RL I PF
Sbjct: 217 RW------LSKEAKSILKSFLTKNPEKRLGCLPTGEQ-------DIKGHPF 254
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318 |
| >gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Score = 138 bits (351), Expect = 2e-40
Identities = 65/215 (30%), Positives = 111/215 (51%), Gaps = 22/215 (10%)
Query: 16 ELNFLSSVNHPNIIRLF-DAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
E + ++HPNI++L + E + +V+E+ GG+L Y+R + + F
Sbjct: 51 EARIMRKLDHPNIVKLLGVCTEEEP-LMIVMEYMPGGDLLDYLRKNRPKELSLSDLLSFA 109
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-S 131
Q+ G+E L S + IHRDL N L+ +++++KI+DFGLS LY +Y + G
Sbjct: 110 LQIARGMEYLESKNFIHRDLAARNCLVG---ENLVVKISDFGLSRDLYDDDYYKVKGGKL 166
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLVRNINSCKHLPFS 189
P+ +MAPE L+ ++ K D+WS G +L+E+ G P+ G +N +++ + LP
Sbjct: 167 PIRWMAPESLKEGKFTSKSDVWSFGVLLWEIFTLGEEPYPGMSNAEVLEYLKKGYRLPKP 226
Query: 190 QLIVPALHPDCVDMCLKLLS----ANTVDRLSFNE 220
P+C KL+ + DR +F+E
Sbjct: 227 --------PNCPPELYKLMLQCWAEDPEDRPTFSE 253
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258 |
| >gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 2e-40
Identities = 71/206 (34%), Positives = 117/206 (56%), Gaps = 10/206 (4%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L+ +FQ+++ ++LV+E+ GG+ +S I+ G +PE A++++ ++ G+E L+
Sbjct: 57 PYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQR 116
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY 145
IIHRD+KPEN+L +D LK+ DFGLS G +K G+P Y+APE +
Sbjct: 117 GIIHRDIKPENLL---IDQTGHLKLTDFGLSRN---GLENKKFVGTPDYLAPETILGVGD 170
Query: 146 DEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCL 205
D+ D WS+G ++FE L GYPPF + NI S + + + + + P+ VD+
Sbjct: 171 DKMSDWWSLGCVIFEFLFGYPPFHAETPDAVFDNILS-RRINWPEEVKEFCSPEAVDLIN 229
Query: 206 KLLSANTVDRLSFN---EFYHHRFLR 228
+LL + RL N E H F +
Sbjct: 230 RLLCMDPAKRLGANGYQEIKSHPFFK 255
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260 |
| >gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 139 bits (351), Expect = 4e-40
Identities = 75/218 (34%), Positives = 119/218 (54%), Gaps = 15/218 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L V+HP IIRLF + +++++E+ GG L SY+R GR T + ++
Sbjct: 51 EKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
LE L+S I++RDLKPENIL LD + +K+ DFG + L + +CG+P Y+
Sbjct: 111 VCALEYLHSKEIVYRDLKPENIL---LDKEGHIKLTDFGFAKKLRDRTWT--LCGTPEYL 165
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPA 195
APEV+Q + +++ VD W++G +++E+L GYPPF N + I + K L F +
Sbjct: 166 APEVIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDNPFGIYEKILAGK-LEFPR----H 220
Query: 196 LHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 228
L D+ KLL + RL ++ +HR+ +
Sbjct: 221 LDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFK 258
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291 |
| >gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 2e-39
Identities = 56/177 (31%), Positives = 98/177 (55%), Gaps = 8/177 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + + ++HPNI+RL +++V E+ GG+L ++R HG + + + Q
Sbjct: 51 EASIMKKLSHPNIVRLLGVCTQGEPLYIVTEYMPGGDLLDFLRKHGEKLTLKDLLQMALQ 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+E L S + +HRDL N L+ +++++KI+DFGLS +Y +Y K G L
Sbjct: 111 IAKGMEYLESKNFVHRDLAARNCLV---TENLVVKISDFGLSRDIYEDDYYRKRGGGKLP 167
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLVRNINSCKHLP 187
+MAPE L+ ++ K D+WS G +L+E+ G P+ G +N +++ + LP
Sbjct: 168 IKWMAPESLKDGKFTSKSDVWSFGVLLWEIFTLGEQPYPGMSNEEVLELLEDGYRLP 224
|
Length = 258 |
| >gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 136 bits (345), Expect = 9e-39
Identities = 82/254 (32%), Positives = 129/254 (50%), Gaps = 21/254 (8%)
Query: 2 LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
LK++ K L L+ E + L++ +++L AFQ + ++L +E+ GG+ +
Sbjct: 31 LKRMKKSLLFKLNEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRT 90
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ G + E AR ++ ++ ++ L+ IHRDLKPEN L+ D +K+ DFGL
Sbjct: 91 LLNNLGVLSEDHARFYMAEMFEAVDALHELGYIHRDLKPENFLI---DASGHIKLTDFGL 147
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
S + YA V GSP YMAPEVL+ + YD VD WS+G +L+E L G+PPFSG +
Sbjct: 148 SKGIV--TYANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPPFSGSTPNE 205
Query: 176 LVRNINSCKHL---PFSQLIVPALHPDCVDMCLKLLSANTVDRL-SFNEFYHHRFLRR-N 230
N+ K P L + D+ KL++ + R S + +H F + +
Sbjct: 206 TWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPS-RRFGSLEDIKNHPFFKEVD 264
Query: 231 SAILR---APFHIP 241
LR PF +P
Sbjct: 265 WNELRELKPPF-VP 277
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333 |
| >gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Score = 133 bits (335), Expect = 4e-38
Identities = 63/210 (30%), Positives = 110/210 (52%), Gaps = 9/210 (4%)
Query: 2 LKKLNKHLKS-CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
L K+N+ + +D E L+ ++ IIR +++F + + +V+E+ G+L +++
Sbjct: 35 LSKMNRREREEAID-EARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQ 93
Query: 61 G--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+PE +F Q+ GL L+S I+HRD+K N+ L D+ +KI D G++
Sbjct: 94 RGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDN---VKIGDLGVAKL 150
Query: 119 LYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLV 177
L N+A + G+P Y++PE+ + + Y+EK D+W++G +L+E G PF N L+
Sbjct: 151 LSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECCTGKHPFDANNQGALI 210
Query: 178 RNINSCKHLPFSQLIVPALHPDCVDMCLKL 207
I P SQ+ L +D CL
Sbjct: 211 LKIIRGVFPPVSQMYSQQL-AQLIDQCLTK 239
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256 |
| >gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 134 bits (340), Expect = 4e-38
Identities = 78/204 (38%), Positives = 114/204 (55%), Gaps = 13/204 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E N L +V HP I+ L AFQ ++L++E+ +GG L ++ G E TA +L ++
Sbjct: 50 ERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEI 109
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPL 133
LE L+ II+RDLKPENIL LD +K+ DFGL C +++ G CG+
Sbjct: 110 SLALEHLHQQGIIYRDLKPENIL---LDAQGHVKLTDFGL-CKESIHEGTVTHTFCGTIE 165
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLI 192
YMAPE+L + + VD WS+GA+++++L G PPF+ N + + I K +LP
Sbjct: 166 YMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTIDKILKGKLNLP----- 220
Query: 193 VPALHPDCVDMCLKLLSANTVDRL 216
P L P+ D+ KLL N RL
Sbjct: 221 -PYLTPEARDLLKKLLKRNPSSRL 243
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323 |
| >gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 133 bits (337), Expect = 5e-38
Identities = 75/242 (30%), Positives = 114/242 (47%), Gaps = 36/242 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L +NHPNII+L D F+ + ++LV EF +L I+ R +PE + +L Q
Sbjct: 48 EIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMDT-DLYKLIKDRQRGLPESLIKSYLYQ 106
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 132
L GL +SH I+HRDLKPEN+L++ LK+ADFGL+ + Y V +
Sbjct: 107 LLQGLAFCHSHGILHRDLKPENLLINTEGV---LKLADFGLARSFGSPVRPYTHYVV-TR 162
Query: 133 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV----------------- 174
Y APE+L + Y VD+WSVG I ELL+ P F G++ +
Sbjct: 163 WYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEV 222
Query: 175 -----QLVRNIN----SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 225
L RN +P + P P +D+ ++L + R++ + H
Sbjct: 223 WPKFTSLARNYKFSFPKKAGMPLP-KLFPNASPQALDLLSQMLHYDPHKRITAEQALAHP 281
Query: 226 FL 227
+
Sbjct: 282 YF 283
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283 |
| >gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 132 bits (334), Expect = 8e-38
Identities = 64/228 (28%), Positives = 112/228 (49%), Gaps = 11/228 (4%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ K + + L+CE+ L ++ H I++ + + + + + +E+ GG++ ++ +G
Sbjct: 42 PETKKEVNA-LECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGA 100
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
+ E RK+ +Q+ G+E L+S+ I+HRD+K NIL D +K+ DFG S L
Sbjct: 101 LTETVTRKYTRQILEGVEYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTI 157
Query: 122 ---GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVR 178
G + V G+P +M+PEV+ + Y K D+WSVG + E+L PP++ + +
Sbjct: 158 CSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTEKPPWAEFEAMAAIF 217
Query: 179 NINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226
I QL + PD + + N R S E H F
Sbjct: 218 KI--ATQPTNPQL-PSHVSPDARNFLRRTFVENAKKRPSAEELLRHFF 262
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263 |
| >gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-37
Identities = 61/195 (31%), Positives = 103/195 (52%), Gaps = 5/195 (2%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K + LKS + E++ L ++ HPNI++ + + + +++++E+ G+L I+ G
Sbjct: 37 KIKEEALKSIMQ-EIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGP 95
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
PE ++ Q+ GL L+ +IHRD+K NIL + D ++K+ADFG++ L
Sbjct: 96 FPESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTK---DGVVKLADFGVATKLNDV 152
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
V G+P +MAPEV++ D+WS+G + ELL G PP+ N + + I
Sbjct: 153 SKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNPPYYDLNPMAALFRIV 212
Query: 182 SCKHLPFSQLIVPAL 196
H P + I P L
Sbjct: 213 QDDHPPLPEGISPEL 227
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254 |
| >gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 131 bits (333), Expect = 1e-37
Identities = 65/222 (29%), Positives = 106/222 (47%), Gaps = 20/222 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
E + + HPN++RL E ++LV+E+ GG+L Y+R + +
Sbjct: 46 EARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLK 105
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
F Q+ G+E L S +HRDL N L+ +D V+ KI+DFGLS +Y +Y
Sbjct: 106 DLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVG--EDLVV-KISDFGLSRDVYDDDYYR 162
Query: 127 KVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLVRNINS 182
K G L +MAPE L+ + K D+WS G +L+E+ G P+ G +N +++ +
Sbjct: 163 KKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRK 222
Query: 183 CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
LP + L+ ++ L + DR +F+E
Sbjct: 223 GYRLPKPEYCPDELY----ELMLSCWQLDPEDRPTFSELVER 260
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262 |
| >gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Score = 131 bits (332), Expect = 1e-37
Identities = 66/215 (30%), Positives = 111/215 (51%), Gaps = 9/215 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L + P I++ + ++ +++V+E+C G++S +++ + E+ L Q
Sbjct: 48 EISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQ 107
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 133
GLE L+S+ IHRD+K NILL +++ K+ADFG+S L V G+P
Sbjct: 108 TLKGLEYLHSNKKIHRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPF 164
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV 193
+MAPEV+Q Y+ K D+WS+G E+ G PP+S ++ +R I + P L
Sbjct: 165 WMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPPYS---DIHPMRAIFMIPNKPPPTLSD 221
Query: 194 PAL-HPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
P P+ D K L + +R S + H F+
Sbjct: 222 PEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256 |
| >gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Score = 131 bits (329), Expect = 3e-36
Identities = 82/224 (36%), Positives = 116/224 (51%), Gaps = 24/224 (10%)
Query: 16 ELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKF 71
E+ L+S+NHP NI++L+D FQ E ++LV+E+ GG+L ++ GR + E A
Sbjct: 47 EIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFI 106
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--- 128
L Q+ + LE L+S IIHRD+KPENILL D ++K+ DFGL+ L +
Sbjct: 107 LAQILSALEYLHSKGIIHRDIKPENILLD--RDGRVVKLIDFGLAKLLPDPGSTSSIPAL 164
Query: 129 ----CGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV----QLV 177
G+P YMAPEVL D+WS+G L+ELL G PPF G N Q +
Sbjct: 165 PSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYELLTGLPPFEGEKNSSATSQTL 224
Query: 178 RNINSCKH----LPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217
+ I P S + D+ KLL+ + +RLS
Sbjct: 225 KIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLS 268
|
Length = 384 |
| >gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Score = 128 bits (323), Expect = 4e-36
Identities = 61/163 (37%), Positives = 94/163 (57%), Gaps = 12/163 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFL 72
E+ +S NHPN+++ + +F + ++LV+ + +GG+L ++ G + E L
Sbjct: 49 EVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVL 108
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV--- 128
+++ GLE L+S+ IHRD+K NIL L +D +KIADFG+S +L G+ KV
Sbjct: 109 KEVLKGLEYLHSNGQIHRDIKAGNIL---LGEDGSVKIADFGVSASLADGGDRTRKVRKT 165
Query: 129 -CGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ Q YD K D+WS G EL G P+S
Sbjct: 166 FVGTPCWMAPEVMEQVHGYDFKADIWSFGITAIELATGAAPYS 208
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267 |
| >gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 1e-35
Identities = 57/170 (33%), Positives = 92/170 (54%), Gaps = 17/170 (10%)
Query: 16 ELNFLSSVNHPNIIRLF--DAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFL 72
E+ L + HPN+++ + + + + IF+ E+C+GG L + HGR+ E R +
Sbjct: 49 EMKVLELLKHPNLVKYYGVEVHREKVYIFM--EYCSGGTLEELLE-HGRILDEHVIRVYT 105
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-----TLYPGNYAEK 127
QL GL L+SH I+HRD+KP NI LD + ++K+ DFG + T G +
Sbjct: 106 LQLLEGLAYLHSHGIVHRDIKPANIF---LDHNGVIKLGDFGCAVKLKNNTTTMGEEVQS 162
Query: 128 VCGSPLYMAPEVLQFQRYDEK---VDMWSVGAILFELLNGYPPFSGRNNV 174
+ G+P YMAPEV+ + D+WS+G ++ E+ G P+S +N
Sbjct: 163 LAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKRPWSELDNE 212
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264 |
| >gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 2e-35
Identities = 65/211 (30%), Positives = 108/211 (51%), Gaps = 8/211 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L ++HPNII ++ F + + +V+E+ GG L+ YI+ + E T F
Sbjct: 49 ECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFV 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ L +++ I+HRDLK +NILL +++KI DFG+S L + A V G+P
Sbjct: 109 QILLALHHVHTKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPC 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV 193
Y++PE+ + + Y++K D+W++G +L+EL + F N LV I S P S
Sbjct: 167 YISPELCEGKPYNQKSDIWALGCVLYELASLKRAFEAANLPALVLKIMSGTFAPISDRYS 226
Query: 194 PALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
P L + L +L+ + R ++
Sbjct: 227 PDLR----QLILSMLNLDPSKRPQLSQIMAQ 253
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256 |
| >gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 2e-35
Identities = 55/147 (37%), Positives = 89/147 (60%), Gaps = 5/147 (3%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82
HPNI+ +D++ + +++V+E+ GG+L+ I + R+ E +++ GLE L
Sbjct: 73 KHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYL 132
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLYMAPEVLQ 141
+S ++IHRD+K +NILLS D V K+ADFG + L V G+P +MAPEV++
Sbjct: 133 HSQNVIHRDIKSDNILLS-KDGSV--KLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIK 189
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPF 168
+ Y KVD+WS+G + E+ G PP+
Sbjct: 190 RKDYGPKVDIWSLGIMCIEMAEGEPPY 216
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286 |
| >gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Score = 126 bits (319), Expect = 6e-35
Identities = 79/233 (33%), Positives = 120/233 (51%), Gaps = 20/233 (8%)
Query: 3 KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
KK KH+ + E N L +V HP ++ L +FQ + ++ V+++ GG L +++
Sbjct: 36 KKEQKHIMA----ERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRER 91
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--L 119
PE AR + ++ + L L+S +II+RDLKPENILL D + + DFGL C +
Sbjct: 92 SFPEPRARFYAAEIASALGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL-CKEGI 147
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRN 179
CG+P Y+APEVL+ Q YD VD W +GA+L+E+L G PPF R+ ++ N
Sbjct: 148 EHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRDTAEMYDN 207
Query: 180 INSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL----SFNEFYHHRFLR 228
I + P + P + + LL + RL F E +H F
Sbjct: 208 I---LNKPLR--LKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFS 255
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323 |
| >gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 126 bits (318), Expect = 8e-35
Identities = 62/160 (38%), Positives = 97/160 (60%), Gaps = 19/160 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L ++HP I+ + +FQ EN ++ ++EF GG L +++R GR P A+ + +L
Sbjct: 68 EKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAEL 127
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------- 128
E L+S II+RDLKPEN+L LD+ +K+ DFG +A+KV
Sbjct: 128 VLAFEYLHSKDIIYRDLKPENLL---LDNKGHVKVTDFG---------FAKKVPDRTFTL 175
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
CG+P Y+APEV+Q + + + VD W++G +L+E + GYPPF
Sbjct: 176 CGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPPF 215
|
Length = 329 |
| >gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Score = 125 bits (316), Expect = 9e-35
Identities = 79/261 (30%), Positives = 132/261 (50%), Gaps = 48/261 (18%)
Query: 2 LKKLNKH---LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+KK+NK L++ + E + L+ +P ++ +F +F+ + + +V+E+ GG+ ++
Sbjct: 31 MKKINKQNLILRNQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCAT 90
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++ G +P AR + + LE L+++ I+HRDLKP+N+L++ + +K+ DFGL
Sbjct: 91 LLKNIGALPVDMARMYFAETVLALEYLHNYGIVHRDLKPDNLLITSMGH---IKLTDFGL 147
Query: 116 S--------CTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159
S LY G+ ++VCG+P Y+APEV+ Q Y + VD W++G IL+
Sbjct: 148 SKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILY 207
Query: 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV---------PALHPDCVDMCLKLLSA 210
E L G PF G +L F Q+I AL D D+ +LL
Sbjct: 208 EFLVGCVPFFGDTPEEL-----------FGQVISDDIEWPEGDEALPADAQDLISRLLRQ 256
Query: 211 NTVDRLSFN---EFYHHRFLR 228
N ++RL E HRF
Sbjct: 257 NPLERLGTGGAFEVKQHRFFL 277
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305 |
| >gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Score = 125 bits (315), Expect = 9e-35
Identities = 71/239 (29%), Positives = 108/239 (45%), Gaps = 35/239 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
E++ + + H NI+RL D EN + LV E+ +L Y+ HG + T + F
Sbjct: 48 EISLMKELKHENIVRLHDVIHTENKLMLVFEYMDK-DLKKYMDTHGVRGALDPNTVKSFT 106
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGS 131
QL G+ + + ++HRDLKP+N+L++ LK+ADFGL+ P N +
Sbjct: 107 YQLLKGIAFCHENRVLHRDLKPQNLLINK---RGELKLADFGLARAFGIPVNTFSNEVVT 163
Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVR----------- 178
Y AP+VL R Y +D+WSVG I+ E++ G P F G NN QL++
Sbjct: 164 LWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTES 223
Query: 179 -------------NINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
QL P P +D+ +LL N R+S ++ H
Sbjct: 224 TWPGISQLPEYKPTFPRYPPQDLQQLF-PHADPLGIDLLHRLLQLNPELRISAHDALQH 281
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284 |
| >gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 125 bits (317), Expect = 1e-34
Identities = 79/285 (27%), Positives = 125/285 (43%), Gaps = 63/285 (22%)
Query: 3 KKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGN 52
KK++ +D E+ L + H NII L D + N +++V E +
Sbjct: 31 KKISNVFDDLIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTEL-METD 89
Query: 53 LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
L I+ + + + FL Q+ GL+ L+S ++IHRDLKP NIL+ + + LKI D
Sbjct: 90 LHKVIKSPQPLTDDHIQYFLYQILRGLKYLHSANVIHRDLKPSNILV---NSNCDLKICD 146
Query: 113 FGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELLN 163
FGL+ + P ++ L Y APE+ L RY + +D+WSVG I ELL
Sbjct: 147 FGLARGVDP----DEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLT 202
Query: 164 GYPPFSGRNNV-QL--------------------------VRNINSCKHLPFSQLIVPAL 196
P F GR+ + QL ++++ P S+L P
Sbjct: 203 RKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLF-PGA 261
Query: 197 HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
P+ +D+ K+L + R++ +E H +L A H P
Sbjct: 262 SPEAIDLLEKMLVFDPKKRITADEALAHPYL--------AQLHDP 298
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330 |
| >gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 124 bits (312), Expect = 1e-34
Identities = 69/230 (30%), Positives = 112/230 (48%), Gaps = 9/230 (3%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K + L E+ L ++H NI++ E + + +E+ GG++ S +R +GR
Sbjct: 45 DSRQKDMVKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGR 104
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL---SCTL 119
EQ R F +Q+ GL L+S I+HRDLK +N+L +D D + KI+DFG+ S +
Sbjct: 105 FEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLL---VDADGICKISDFGISKKSDDI 161
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLV 177
Y + + GS +MAPEV+ Y KVD+WS+G ++ E+ G P+S + +
Sbjct: 162 YDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRPWSDEEAIAAM 221
Query: 178 RNI-NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226
+ N P + L P +D + N +R + E H F
Sbjct: 222 FKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPF 271
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272 |
| >gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Score = 124 bits (313), Expect = 3e-34
Identities = 67/165 (40%), Positives = 98/165 (59%), Gaps = 5/165 (3%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84
HP + LF FQ + +F V+E+ GG+L +I+ GR E AR + ++ GL+ L+
Sbjct: 55 HPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHK 114
Query: 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N+LL D D +KIADFG+ + A CG+P Y+APE+L+ Q
Sbjct: 115 KGIIYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQ 171
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI-NSCKHLP 187
+Y+E VD WS G +L+E+L G PF G + +L +I N H P
Sbjct: 172 KYNESVDWWSFGVLLYEMLIGQSPFHGEDEDELFDSILNDRPHFP 216
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316 |
| >gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Score = 123 bits (310), Expect = 9e-34
Identities = 65/160 (40%), Positives = 99/160 (61%), Gaps = 8/160 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E + L+ VNHP I++L AFQ E ++L+++F GG+L + RL V E+ + +L
Sbjct: 48 ERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDL--FTRLSKEVMFTEEDVKFYLA 105
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSP 132
+L L+ L+S II+RDLKPENILL D++ +K+ DFGLS ++ A CG+
Sbjct: 106 ELALALDHLHSLGIIYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTV 162
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
YMAPEV+ + + + D WS G ++FE+L G PF G++
Sbjct: 163 EYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSLPFQGKD 202
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318 |
| >gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 121 bits (306), Expect = 2e-33
Identities = 71/224 (31%), Positives = 118/224 (52%), Gaps = 22/224 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FLS P I + + +F + +++++E+C GG+ ++ G++ E L+++
Sbjct: 49 EIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKP-GKLDETYIAFILREV 107
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 132
GLE L+ IHRD+K NILLS ++ +K+ADFG+S L + K G+P
Sbjct: 108 LLGLEYLHEEGKIHRDIKAANILLS---EEGDVKLADFGVSGQL--TSTMSKRNTFVGTP 162
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI--NSCKHLP--- 187
+MAPEV++ YDEK D+WS+G EL G PP S + ++++ I N+ L
Sbjct: 163 FWMAPEVIKQSGYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIPKNNPPSLEGNK 222
Query: 188 FSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
FS+ D V +CL + +R S E H+F+++
Sbjct: 223 FSKPF-----KDFVSLCLNK---DPKERPSAKELLKHKFIKKAK 258
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274 |
| >gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Score = 121 bits (305), Expect = 2e-33
Identities = 69/229 (30%), Positives = 105/229 (45%), Gaps = 33/229 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L S P +++ + AF E I +V+E+ GG+L+ ++ G++PE +Q+
Sbjct: 49 ELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQI 108
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCG 130
GL+ L HIIHRD+KP N+L++ +V KIADFG L TL N G
Sbjct: 109 LKGLDYLHTKRHIIHRDIKPSNLLIN-SKGEV--KIADFGISKVLENTLDQCNTF---VG 162
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN---VQLVRNINSCKHLP 187
+ YM+PE +Q + Y D+WS+G L E G PF +L++ I
Sbjct: 163 TVTYMSPERIQGESYSYAADIWSLGLTLLECALGKFPFLPPGQPSFFELMQAICDGP--- 219
Query: 188 FSQLIVPALHPDC--------VDMCLKLLSANTVDRLSFNEFYHHRFLR 228
P+L + + CL+ R S E H F++
Sbjct: 220 -----PPSLPAEEFSPEFRDFISACLQKDPK---KRPSAAELLQHPFIK 260
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264 |
| >gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Score = 120 bits (302), Expect = 4e-33
Identities = 64/207 (30%), Positives = 104/207 (50%), Gaps = 24/207 (11%)
Query: 14 DC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGR-VPEQT 67
DC E++ L ++HPN+I+ +F N + +V+E G+LS I + R +PE+T
Sbjct: 48 DCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERT 107
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--- 124
K+ QL + LE ++S I+HRD+KP N+ ++ ++K+ D GL G +
Sbjct: 108 IWKYFVQLCSALEHMHSKRIMHRDIKPANVFITA---TGVVKLGDLGL------GRFFSS 158
Query: 125 ----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR--NNVQLVR 178
A + G+P YM+PE + Y+ K D+WS+G +L+E+ PF G N L +
Sbjct: 159 KTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCK 218
Query: 179 NINSCKHLPFSQLIVPALHPDCVDMCL 205
I C + P D V C+
Sbjct: 219 KIEKCDYPPLPADHYSEELRDLVSRCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 4e-33
Identities = 58/177 (32%), Positives = 94/177 (53%), Gaps = 10/177 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQ 73
E+ LS + HPNII ++ F +N + + +E+ GG L I + E+ +L
Sbjct: 49 EIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLF 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVCG 130
Q+ + + ++ I+HRD+K NI L+ ++K+ DFG+S L Y AE V G
Sbjct: 109 QIVSAVSYIHKAGILHRDIKTLNIFLT---KAGLIKLGDFGISKILGSEYSM--AETVVG 163
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLP 187
+P YM+PE+ Q +Y+ K D+W++G +L+ELL F N + LV I + P
Sbjct: 164 TPYYMSPELCQGVKYNFKSDIWALGCVLYELLTLKRTFDATNPLNLVVKIVQGNYTP 220
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256 |
| >gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Score = 120 bits (303), Expect = 8e-33
Identities = 77/230 (33%), Positives = 117/230 (50%), Gaps = 16/230 (6%)
Query: 5 LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
LN+ + + E N L +V HP ++ L +FQ ++ V++F GG L +++
Sbjct: 34 LNRKEQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSF 93
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYP 121
PE AR + ++ + L L+S +I++RDLKPENILL V+ DFGL C +
Sbjct: 94 PEPRARFYAAEIASALGYLHSINIVYRDLKPENILLDSQGHVVL---TDFGL-CKEGIAQ 149
Query: 122 GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
+ CG+P Y+APEV++ Q YD VD W +GA+L+E+L G PPF R+ ++ NI
Sbjct: 150 SDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLPPFYCRDVAEMYDNI- 208
Query: 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL----SFNEFYHHRFL 227
H P + P + +LL + RL F E H F
Sbjct: 209 --LHKPLV--LRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFF 254
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325 |
| >gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 59/172 (34%), Positives = 93/172 (54%), Gaps = 7/172 (4%)
Query: 12 CLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
C E L+ + HP + L FQ ++ +F V+E+ GG+L I+ + E +R
Sbjct: 41 CTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRF 100
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKV 128
+ ++ L L+ H +I+RDLK +NILL D + K+ADFG+ C + G
Sbjct: 101 YAAEVTLALMFLHRHGVIYRDLKLDNILL---DAEGHCKLADFGM-CKEGILNGVTTTTF 156
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
CG+P Y+APE+LQ Y VD W++G +++E++ G PPF N L +I
Sbjct: 157 CGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNEDDLFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321 |
| >gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 118 bits (299), Expect = 2e-32
Identities = 77/238 (32%), Positives = 111/238 (46%), Gaps = 35/238 (14%)
Query: 20 LSSVNHPNIIRLFDAF---QAENC--IFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
L S HPNI+RL D + + + LV E +L++Y+ + +P +T + +
Sbjct: 55 LESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVDQ-DLATYLSKCPKPGLPPETIKDLM 113
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+QL G++ L+SH I+HRDLKP+NIL++ D +KIADFGL+ +Y A
Sbjct: 114 RQLLRGVDFLHSHRIVHRDLKPQNILVT---SDGQVKIADFGLA-RIYSFEMALTSVVVT 169
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLP---- 187
L Y APEVL Y VDMWSVG I EL P F G + + I LP
Sbjct: 170 LWYRAPEVLLQSSYATPVDMWSVGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEE 229
Query: 188 -----------FSQL-------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
F VP + + +D+ K+L+ N R+S E H +
Sbjct: 230 WPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287 |
| >gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Score = 118 bits (298), Expect = 6e-32
Identities = 69/211 (32%), Positives = 114/211 (54%), Gaps = 16/211 (7%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L FQ + ++ V+E+ GG+L +I+ G+ E A + ++ GL L+S
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N++L D + +KIADFG+ C ++ G CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DAEGHIKIADFGM-CKENIFGGKTTRTFCGTPDYIAPEIIAYQ 176
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDM 203
Y + VD W+ G +L+E+L G PPF G + +L ++I +H +L + V +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSI--MEHNVSYP---KSLSKEAVSI 231
Query: 204 CLKLLSANTVDRLSFN-----EFYHHRFLRR 229
C LL+ + RL + H F RR
Sbjct: 232 CKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324 |
| >gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Score = 118 bits (297), Expect = 7e-32
Identities = 69/181 (38%), Positives = 102/181 (56%), Gaps = 11/181 (6%)
Query: 3 KKLNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
KK KH+ S E N L +V HP ++ L +FQ + ++ V+++ GG L +++
Sbjct: 36 KKEEKHIMS----ERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRER 91
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TL 119
E AR + ++ + L L+S +I++RDLKPENILL D + + DFGL C +
Sbjct: 92 CFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENILL---DSQGHIVLTDFGL-CKENI 147
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRN 179
CG+P Y+APEVL Q YD VD W +GA+L+E+L G PPF RN ++ N
Sbjct: 148 EHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDN 207
Query: 180 I 180
I
Sbjct: 208 I 208
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325 |
| >gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Score = 116 bits (292), Expect = 1e-31
Identities = 70/221 (31%), Positives = 111/221 (50%), Gaps = 13/221 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ ++ +NHP+IIR+ A ++ L VE+ AGG++S + +G E + +QL
Sbjct: 53 EIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQL 112
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-----GNYAEKVCG 130
GL L+ + IIHRD+K N+L+ L+IADFG + L G + ++ G
Sbjct: 113 LRGLSYLHENQIIHRDVKGANLLIDSTGQR--LRIADFGAAARLAAKGTGAGEFQGQLLG 170
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR---NNVQLVRNINSCKHLP 187
+ +MAPEVL+ ++Y D+WSVG ++ E+ PP++ N++ L+ I S P
Sbjct: 171 TIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMATAKPPWNAEKHSNHLALIFKIASATTAP 230
Query: 188 FSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
I L P D+ L+ L DR E H R
Sbjct: 231 ---SIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268 |
| >gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 1e-31
Identities = 67/190 (35%), Positives = 103/190 (54%), Gaps = 13/190 (6%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
L ++ HP ++ L +FQ ++ V+++ GG L +++ E AR + ++ +
Sbjct: 49 LLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
+ L+S +II+RDLKPENILL D + + DFGL C + P CG+P Y+A
Sbjct: 109 IGYLHSLNIIYRDLKPENILL---DSQGHVVLTDFGL-CKEGVEPEETTSTFCGTPEYLA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINS-------CKHLPFS 189
PEVL+ + YD VD W +GA+L+E+L G PPF R+ Q+ NI K +
Sbjct: 165 PEVLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRDVSQMYDNILHKPLQLPGGKTVAAC 224
Query: 190 QLIVPALHPD 199
L+V LH D
Sbjct: 225 DLLVGLLHKD 234
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321 |
| >gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 57/152 (37%), Positives = 87/152 (57%), Gaps = 7/152 (4%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80
+S HP ++ LF FQ E+ + V+E+ AGG+L +I E A + + GL+
Sbjct: 57 NSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIH-TDVFSEPRAVFYAACVVLGLQ 115
Query: 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPE 138
L+ + I++RDLK +N+LL D + +KIADFGL C + G+ CG+P ++APE
Sbjct: 116 YLHENKIVYRDLKLDNLLL---DTEGFVKIADFGL-CKEGMGFGDRTSTFCGTPEFLAPE 171
Query: 139 VLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
VL Y VD W +G +++E+L G PF G
Sbjct: 172 VLTETSYTRAVDWWGLGVLIYEMLVGESPFPG 203
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324 |
| >gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 117 bits (295), Expect = 2e-31
Identities = 74/264 (28%), Positives = 113/264 (42%), Gaps = 51/264 (19%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGA 77
L++++HP + L+ +FQ E + LV+++C GG L ++ + E+ AR + ++
Sbjct: 55 LATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLL 114
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----------- 126
LE L+ I++RDLKPENILL +ML +DF LS
Sbjct: 115 ALEYLHLLGIVYRDLKPENILLHE-SGHIML--SDFDLSKQSDVEPPPVSKALRKGSRRS 171
Query: 127 ---------KVC----------GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
G+ Y+APEV+ + VD W++G +L+E+L G P
Sbjct: 172 SVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGDGHGSAVDWWTLGILLYEMLYGTTP 231
Query: 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHP---DCVDMCLKLLSANTVDRLSF----NE 220
F G N + NI ++ P P D+ KLL + RL E
Sbjct: 232 FKGSNRDETFSNILK------KEVTFPGSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAE 285
Query: 221 FYHHRFLRR-NSAILR--APFHIP 241
H F R N A++R P IP
Sbjct: 286 IKQHPFFRGVNWALIRHTTPPIIP 309
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316 |
| >gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 115 bits (291), Expect = 3e-31
Identities = 76/250 (30%), Positives = 114/250 (45%), Gaps = 52/250 (20%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E++ L +NHPNI+RL D +EN ++LV EF +L Y+ + +L
Sbjct: 48 EISLLKELNHPNIVRLLDVVHSENKLYLVFEFL-DLDLKKYMDSSPLTGLDPPLIKSYLY 106
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
QL G+ +SH ++HRDLKP+N+L +D + LK+ADFGL+ + G P+
Sbjct: 107 QLLQGIAYCHSHRVLHRDLKPQNLL---IDREGALKLADFGLA----------RAFGVPV 153
Query: 134 -----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVR-- 178
Y APE+L R Y VD+WS+G I E++N P F G + + QL R
Sbjct: 154 RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQLFRIF 213
Query: 179 ---------NINSCKHLP-----FSQL-------IVPALHPDCVDMCLKLLSANTVDRLS 217
LP F + +VP L D +D+ K+L + R+S
Sbjct: 214 RTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRIS 273
Query: 218 FNEFYHHRFL 227
H +
Sbjct: 274 AKAALQHPYF 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283 |
| >gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Score = 116 bits (293), Expect = 4e-31
Identities = 83/266 (31%), Positives = 125/266 (46%), Gaps = 57/266 (21%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
E+ FL + +HPNI++L + +AEN I+LV E+ +L + IR + + R +
Sbjct: 56 EIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEY-METDLHAVIR-ANILEDVHKRYIM 113
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
QL L+ ++S ++IHRDLKP NILL + D +K+ADFGL+ +L +P
Sbjct: 114 YQLLKALKYIHSGNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENP---ENP 167
Query: 133 L---------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-------- 174
+ Y APE+L RY + VDMWSVG IL E+L G P F G + +
Sbjct: 168 VLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQLEKIIE 227
Query: 175 -------------------QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDR 215
++ ++ S P +L+ P D +D+ KLL N R
Sbjct: 228 VIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELL-PKASDDALDLLKKLLVFNPNKR 286
Query: 216 LSFNEFYHHRFLRRNSAILRAPFHIP 241
L+ E H ++ A FH P
Sbjct: 287 LTAEEALEHPYV--------AQFHNP 304
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337 |
| >gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 7e-31
Identities = 71/215 (33%), Positives = 109/215 (50%), Gaps = 9/215 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV-PEQTARKFLQ 73
E+ L+ + HPNI+ F +FQ +F+V+E+C GG+L I R G + E +
Sbjct: 49 EVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFV 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSP 132
Q+ GL+ ++ I+HRD+K +NI LS + ++ K+ DFG++ L C G+P
Sbjct: 109 QISLGLKHIHDRKILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTP 166
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLI 192
Y++PE+ Q + Y+ K D+WS+G +L+EL PF G N QLV I P S
Sbjct: 167 YYLSPEICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQLVLKICQGYFAPIS--- 223
Query: 193 VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
P D + +L + DR S FL
Sbjct: 224 -PNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257 |
| >gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Score = 115 bits (289), Expect = 9e-31
Identities = 75/218 (34%), Positives = 113/218 (51%), Gaps = 19/218 (8%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
NHP + +L+ FQ + +F V+EF GG+L +I+ R E AR + ++ + L L+
Sbjct: 54 NHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLH 113
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMAPEVLQ 141
II+RDLK +N+L LD + K+ADFG+ C ++ G CG+P Y+APE+LQ
Sbjct: 114 DKGIIYRDLKLDNVL---LDHEGHCKLADFGM-CKEGIFNGKTTSTFCGTPDYIAPEILQ 169
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPA-LHPDC 200
Y VD W++G +L+E+L G+ PF N L I + +++ P L D
Sbjct: 170 EMLYGPSVDWWAMGVLLYEMLCGHAPFEAENEDDLFEAILN------DEVVYPTWLSQDA 223
Query: 201 VDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 238
VD+ ++ N RL L AILR PF
Sbjct: 224 VDILKAFMTKNPTMRLGSLT------LGGEEAILRHPF 255
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320 |
| >gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 75/224 (33%), Positives = 116/224 (51%), Gaps = 14/224 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
E++ L+S +HPNI++L DAF EN +++++EFCAGG + + + L + E R +Q
Sbjct: 52 EIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
L L+ + IIHRDLK NIL + LD D+ K+ADFG+S + G+P
Sbjct: 112 TLEALNYLHENKIIHRDLKAGNILFT-LDGDI--KLADFGVSAKNTRTIQRRDSFIGTPY 168
Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPF 188
+MAPEV+ + YD K D+WS+G L E+ PP N ++++ I +
Sbjct: 169 WMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL 228
Query: 189 SQLIVPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
+Q P+ + D K L N R + + H F+ NS
Sbjct: 229 AQ---PSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNS 269
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282 |
| >gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (287), Expect = 1e-30
Identities = 71/245 (28%), Positives = 118/245 (48%), Gaps = 40/245 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL 72
E+ L + HPNI+RL + + + I++V E+ +L+ + + E + ++
Sbjct: 48 EIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMDH-DLTGLLDSPEVKFTESQIKCYM 106
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---YPGNYAEKVC 129
+QL GL+ L+S+ I+HRD+K NIL+ ++D +LK+ADFGL+ +Y +V
Sbjct: 107 KQLLEGLQYLHSNGILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVI 163
Query: 130 GSPL-YMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI------- 180
L Y PE+L RY +VDMWSVG IL EL G P F G ++ + I
Sbjct: 164 --TLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQLEKIFELCGSP 221
Query: 181 -----NSCKHLPFSQLIVP--------------ALHPDCVDMCLKLLSANTVDRLSFNEF 221
LP+ + + P + P +D+ KLL+ + R+S ++
Sbjct: 222 TDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRISADQA 281
Query: 222 YHHRF 226
H +
Sbjct: 282 LQHEY 286
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287 |
| >gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 2e-30
Identities = 55/152 (36%), Positives = 95/152 (62%), Gaps = 6/152 (3%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F ++ NHP ++ L FQ E+ +F V+EF +GG+L +++ ++PE+ AR + ++
Sbjct: 49 FETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
L L+ II+RDLK +N+L LD + +K+ D+G+ C + PG+ CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDAEGHIKLTDYGM-CKEGIRPGDTTSTFCGTPNYIA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
PE+L+ + Y VD W++G ++FE++ G PF
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329 |
| >gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (286), Expect = 3e-30
Identities = 78/222 (35%), Positives = 113/222 (50%), Gaps = 24/222 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L+ VN P I+ L +FQ+ ++LV+ F GG L +++ GR AR + +L
Sbjct: 43 ERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAEL 102
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
LE L+ ++I+RDLKPENIL LD + + DFGL C L + CG+P
Sbjct: 103 LCALENLHKFNVIYRDLKPENIL---LDYQGHIALCDFGL-CKLNMKDDDKTNTFCGTPE 158
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV 193
Y+APE+L Y + VD W++G +L+E+L G PPF N ++ R I L
Sbjct: 159 YLAPELLLGHGYTKAVDWWTLGVLLYEMLTGLPPFYDENVNEMYRKI----------LQE 208
Query: 194 PALHPDCV-----DMCLKLLSANTVDRLSFN---EFYHHRFL 227
P PD D+ + LLS + RL +N E +H F
Sbjct: 209 PLRFPDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFF 250
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312 |
| >gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 114 bits (288), Expect = 3e-30
Identities = 74/274 (27%), Positives = 129/274 (47%), Gaps = 56/274 (20%)
Query: 1 MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
ML+K H+++ E + L+ ++P +++L+ +FQ EN ++L++E+ GG++ + +
Sbjct: 39 MLEKEQVAHVRA----ERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMK 94
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT- 118
E+ R ++ + ++ ++ IHRD+KP+N+LL D +K++DFGL CT
Sbjct: 95 KDTFTEEETRFYIAETILAIDSIHKLGYIHRDIKPDNLLL---DAKGHIKLSDFGL-CTG 150
Query: 119 --------LY-------PGNYAEKVC------------------------GSPLYMAPEV 139
Y P N+ + + G+P Y+APEV
Sbjct: 151 LKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYSTVGTPDYIAPEV 210
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKH-LPFSQLIVPALHP 198
Y+++ D WS+G I++E+L GYPPF N + R I + K L F + L P
Sbjct: 211 FLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPDEV--PLSP 268
Query: 199 DCVDMCLKLLSANTVDRLSF---NEFYHHRFLRR 229
+ D+ +L RL NE H F +
Sbjct: 269 EAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKG 301
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364 |
| >gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 5e-30
Identities = 59/166 (35%), Positives = 87/166 (52%), Gaps = 20/166 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPE-QTA---RK 70
E++ L HPNI+ F ++ + +++V+E+C GG+L Y G + E Q A R+
Sbjct: 50 EISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRE 109
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--- 127
L+ GL L+ IHRD+K NILL+ +D +K+ADFG+S L K
Sbjct: 110 TLK----GLAYLHETGKIHRDIKGANILLT---EDGDVKLADFGVSAQL--TATIAKRKS 160
Query: 128 VCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSG 170
G+P +MAPEV +R YD K D+W++G EL PP
Sbjct: 161 FIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAELQPPMFD 206
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262 |
| >gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Score = 112 bits (283), Expect = 5e-30
Identities = 68/214 (31%), Positives = 103/214 (48%), Gaps = 19/214 (8%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P ++ L AFQ + + L++++ GG L +++ E R ++ ++ L+ L+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQL 124
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ 143
II+RD+K ENIL LD + + + DFGLS A CG+ YMAPEV++
Sbjct: 125 GIIYRDIKLENIL---LDSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGG 181
Query: 144 R--YDEKVDMWSVGAILFELLNGYPPF--SGRNNVQ--LVRNINSCKHLPFSQLIVPALH 197
+D+ VD WS+G + FELL G PF G N Q + R I PF +
Sbjct: 182 SGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQSEISRRILKS-KPPFP----KTMS 236
Query: 198 PDCVDMCLKLLSANTVDRLSFN---EFYHHRFLR 228
+ D KLL + RL N E +H F +
Sbjct: 237 AEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQ 270
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288 |
| >gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 9e-30
Identities = 61/184 (33%), Positives = 96/184 (52%), Gaps = 11/184 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E+ L + H NI+ L +AF+ + ++LV E+ L + G +P R ++ Q
Sbjct: 50 EVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYV-ERTLLELLEASPGGLPPDAVRSYIWQ 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGS 131
L + +SH+IIHRD+KPENIL+S + +LK+ DFG + L + V +
Sbjct: 109 LLQAIAYCHSHNIIHRDIKPENILVS---ESGVLKLCDFGFARALRARPASPLTDYV-AT 164
Query: 132 PLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVRNINSCKHLPFS 189
Y APE+L Y + VD+W++G I+ ELL+G P F G +++ QL LP S
Sbjct: 165 RWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLIQKCLGPLPPS 224
Query: 190 QLIV 193
+
Sbjct: 225 HQEL 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288 |
| >gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Score = 113 bits (284), Expect = 1e-29
Identities = 72/260 (27%), Positives = 113/260 (43%), Gaps = 60/260 (23%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
EL L H NII + D + +++V++ +L I + E+ R F
Sbjct: 54 ELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDL-MESDLHHIIHSDQPLTEEHIRYF 112
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
L QL GL+ ++S ++IHRDLKP N+L++ D L+I DFG+ A + S
Sbjct: 113 LYQLLRGLKYIHSANVIHRDLKPSNLLVNE---DCELRIGDFGM---------ARGLSSS 160
Query: 132 PL--------------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-Q 175
P Y APE+L Y +DMWSVG I E+L F G+N V Q
Sbjct: 161 PTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFPGKNYVHQ 220
Query: 176 L----------------------VRN-INSCKH---LPFSQLIVPALHPDCVDMCLKLLS 209
L VR I + +P+S++ P P+ +D+ ++L
Sbjct: 221 LKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIF-PKASPEALDLLSQMLQ 279
Query: 210 ANTVDRLSFNEFYHHRFLRR 229
+ +R++ + H FL +
Sbjct: 280 FDPEERITVEQALQHPFLAQ 299
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334 |
| >gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 115 bits (288), Expect = 1e-29
Identities = 73/226 (32%), Positives = 122/226 (53%), Gaps = 26/226 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RLHGRVP--EQTARKF 71
EL+ L++ +H I++ FD F++++ + L++E+ +GG+L+ I RL +P E
Sbjct: 115 ELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLL 174
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLYPG---NYAE 126
Q+ L+ ++S ++HRDLK NI L +G+ +K+ DFG S + A
Sbjct: 175 FYQIVLALDEVHSRKMMHRDLKSANIFLMPTGI-----IKLGDFGFSKQYSDSVSLDVAS 229
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHL 186
CG+P Y+APE+ + +RY +K DMWS+G IL+ELL + PF G + ++++ + K+
Sbjct: 230 SFCGTPYYLAPELWERKRYSKKADMWSLGVILYELLTLHRPFKGPSQREIMQQVLYGKYD 289
Query: 187 PF----SQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
PF S + L P LLS N R + + H FL+
Sbjct: 290 PFPCPVSSGMKALLDP--------LLSKNPALRPTTQQLLHTEFLK 327
|
Length = 478 |
| >gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Score = 111 bits (280), Expect = 1e-29
Identities = 61/158 (38%), Positives = 89/158 (56%), Gaps = 5/158 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L V+ I+ L AF+ ++ + LV+ GG+L +I G PE A +
Sbjct: 43 EKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAA 102
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ GLE L+ I++RDLKPEN+LL DD ++I+D GL+ L G + G+P
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPG 159
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
YMAPEVLQ + YD VD +++G L+E++ G PF R
Sbjct: 160 YMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRSPFRQR 197
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277 |
| >gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 55/152 (36%), Positives = 93/152 (61%), Gaps = 6/152 (3%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F + NHP ++ L FQ E+ +F V+E+ GG+L +++ ++PE+ AR + ++
Sbjct: 49 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
L L+ II+RDLK +N+L LD + +K+ D+G+ C L PG+ CG+P Y+A
Sbjct: 109 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGM-CKEGLRPGDTTSTFCGTPNYIA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
PE+L+ + Y VD W++G ++FE++ G PF
Sbjct: 165 PEILRGEDYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329 |
| >gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Score = 112 bits (282), Expect = 1e-29
Identities = 62/159 (38%), Positives = 94/159 (59%), Gaps = 6/159 (3%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
+P + L+ FQ + +F V+EF GG+L +I+ GR A + ++ GL+ L+
Sbjct: 54 ENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLH 113
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQ 141
S II+RDLK +N++L D D +KIADFG+ C ++ N A CG+P Y+APE+LQ
Sbjct: 114 SKGIIYRDLKLDNVML---DRDGHIKIADFGM-CKENVFGDNRASTFCGTPDYIAPEILQ 169
Query: 142 FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
+Y VD WS G +L+E+L G PF G + +L +I
Sbjct: 170 GLKYTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316 |
| >gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 112 bits (281), Expect = 2e-29
Identities = 59/157 (37%), Positives = 93/157 (59%), Gaps = 5/157 (3%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P I+ L +FQ ++ ++LV ++ +GG L +++ GR E A+ ++ +L LE L+ +
Sbjct: 56 PFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKY 115
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAPEVLQFQR 144
I++RDLKPENIL LD + + DFGLS L CG+ Y+APEVL ++
Sbjct: 116 DIVYRDLKPENIL---LDATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEK 172
Query: 145 -YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
Y + VD WS+G ++FE+ G+ PF + Q+ RNI
Sbjct: 173 GYTKHVDFWSLGVLVFEMCCGWSPFYAEDTQQMYRNI 209
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330 |
| >gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-29
Identities = 66/165 (40%), Positives = 92/165 (55%), Gaps = 18/165 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ LS HPNI+ L++A+ EN +++++EFC GG L S + R E R +Q
Sbjct: 52 EIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-----VC 129
+ L L+SH +IHRDLK NILL+ LD DV K+ADFG+S N +
Sbjct: 112 MLEALNFLHSHKVIHRDLKAGNILLT-LDGDV--KLADFGVSAK----NKSTLQKRDTFI 164
Query: 130 GSPLYMAPEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ + YD K D+WS+G L EL PP
Sbjct: 165 GTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEPPHH 209
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280 |
| >gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 2e-29
Identities = 68/210 (32%), Positives = 112/210 (53%), Gaps = 17/210 (8%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFLQQLGAGLEI 81
HPNI+ D++ + +++V+E+ AGG+L+ + Q A R+ LQ LE
Sbjct: 75 HPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECLQ----ALEF 130
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVL 140
L+S+ +IHRD+K +NILL G+D V K+ DFG + P + + G+P +MAPEV+
Sbjct: 131 LHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVV 187
Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI--NSCKHLPFSQLIVPALHP 198
+ Y KVD+WS+G + E++ G PP+ N ++ + I N L + +
Sbjct: 188 TRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNPEKLSAIFR- 246
Query: 199 DCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
D ++ CL++ + R S E H FL+
Sbjct: 247 DFLNRCLEM---DVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293 |
| >gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Score = 112 bits (280), Expect = 2e-29
Identities = 66/211 (31%), Positives = 112/211 (53%), Gaps = 16/211 (7%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L FQ + ++ V+E+ GG+L +I+ G+ E A + ++ GL L+
Sbjct: 61 PFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRR 120
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N++L D + +KIADFG+ C + G CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKEHMVDGVTTRTFCGTPDYIAPEIIAYQ 176
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDM 203
Y + VD W+ G +L+E+L G PPF G + +L ++I + + +L + V +
Sbjct: 177 PYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDELFQSI-----MEHNVSYPKSLSKEAVSI 231
Query: 204 CLKLLSANTVDRLSFN-----EFYHHRFLRR 229
C L++ + RL + H F RR
Sbjct: 232 CKGLMTKHPSKRLGCGPEGERDIREHAFFRR 262
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323 |
| >gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Score = 111 bits (278), Expect = 4e-29
Identities = 62/193 (32%), Positives = 110/193 (56%), Gaps = 11/193 (5%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P + +L FQ + ++ V+E+ GG+L I+ GR E A + ++ GL L+S
Sbjct: 61 PFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSK 120
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVCGSPLYMAPEVLQFQ 143
II+RDLK +N++L D + +KIADFG+ C ++ G + CG+P Y+APE++ +Q
Sbjct: 121 GIIYRDLKLDNVML---DSEGHIKIADFGM-CKENMWDGVTTKTFCGTPDYIAPEIIAYQ 176
Query: 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDM 203
Y + VD W+ G +L+E+L G PF G + +L ++I ++ + + ++ + V +
Sbjct: 177 PYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDELFQSIME-HNVAYPK----SMSKEAVAI 231
Query: 204 CLKLLSANTVDRL 216
C L++ + RL
Sbjct: 232 CKGLMTKHPGKRL 244
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323 |
| >gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Score = 110 bits (276), Expect = 9e-29
Identities = 78/255 (30%), Positives = 117/255 (45%), Gaps = 45/255 (17%)
Query: 16 ELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
EL L + H NII L D F I+ V E G +L + + +Q + FL Q
Sbjct: 59 ELKLLKHLRHENIISLSDIFISPLEDIYFVTEL-LGTDLHRLLT-SRPLEKQFIQYFLYQ 116
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ GL+ ++S ++HRDLKP NIL+ +++ LKI DFGL+ P + Y
Sbjct: 117 ILRGLKYVHSAGVVHRDLKPSNILI---NENCDLKICDFGLARIQDP--QMTGYVSTRYY 171
Query: 135 MAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ------------------ 175
APE+ L +Q+YD +VD+WS G I E+L G P F G+++V
Sbjct: 172 RAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVIN 231
Query: 176 ------LVRNINSCKH---LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226
+R + S +PFS+ P +D+ K+L + R+S E H +
Sbjct: 232 TICSENTLRFVQSLPKREPVPFSEKF-KNADPSAIDLLEKMLVFDPQKRISAAEALAHPY 290
Query: 227 LRRNSAILRAPFHIP 241
L AP+H P
Sbjct: 291 L--------APYHDP 297
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328 |
| >gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 1e-28
Identities = 75/240 (31%), Positives = 111/240 (46%), Gaps = 36/240 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQ 73
E+ L + HPNII L D F ++ I LV EF +L I+ + A + ++
Sbjct: 52 EIKLLQELKHPNIIGLLDVFGHKSNINLVFEFMET-DLEKVIK-DKSIVLTPADIKSYML 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPG-NYAEKVCGS 131
GLE L+S+ I+HRDLKP N+L + D +LK+ADFGL+ + P +V +
Sbjct: 110 MTLRGLEYLHSNWILHRDLKPNNLL---IASDGVLKLADFGLARSFGSPNRKMTHQVV-T 165
Query: 132 PLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVRNINSC------ 183
Y APE+L R Y VDMWSVG I ELL P G +++ QL + +
Sbjct: 166 RWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDIDQLGKIFEALGTPTEE 225
Query: 184 -----------------KHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226
P Q+ PA D +D+ +LL+ N R++ + H +
Sbjct: 226 NWPGVTSLPDYVEFKPFPPTPLKQIF-PAASDDALDLLQRLLTLNPNKRITARQALEHPY 284
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298 |
| >gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Score = 108 bits (272), Expect = 1e-28
Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 12/205 (5%)
Query: 10 KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
K+ DC E++ L +NHPN+I+ D+F +N + +V+E G+LS I+ + +
Sbjct: 44 KARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLI 103
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
PE+T K+ QL + +E ++S ++HRD+KP N+ ++ ++K+ D GL
Sbjct: 104 PERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160
Query: 124 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG--RNNVQLVRNI 180
A + G+P YM+PE + Y+ K D+WS+G +L+E+ PF G N L + I
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLFSLCQKI 220
Query: 181 NSCKHLPFSQLIVPALHPDCVDMCL 205
C + P + V MC+
Sbjct: 221 EQCDYPPLPTEHYSEKLRELVSMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267 |
| >gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Score = 109 bits (274), Expect = 1e-28
Identities = 54/152 (35%), Positives = 93/152 (61%), Gaps = 6/152 (3%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F + ++P ++ L FQ + +FLV+E+ GG+L +++ ++PE+ AR + ++
Sbjct: 49 FEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIA 108
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPLYMA 136
L L+ II+RDLK +N+L LD D +K+ D+G+ C L PG+ CG+P Y+A
Sbjct: 109 LNFLHERGIIYRDLKLDNVL---LDADGHIKLTDYGM-CKEGLGPGDTTSTFCGTPNYIA 164
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
PE+L+ + Y VD W++G ++FE++ G PF
Sbjct: 165 PEILRGEEYGFSVDWWALGVLMFEMMAGRSPF 196
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327 |
| >gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Score = 108 bits (273), Expect = 2e-28
Identities = 75/261 (28%), Positives = 125/261 (47%), Gaps = 46/261 (17%)
Query: 3 KKLNKHLKSCLDCELNF-----LSSVN-HPNIIRL----FDAFQAENCIFLVVEFCAGGN 52
K + KH KS L+ N L ++ HPNI+RL FD + + LV E N
Sbjct: 30 KCMKKHFKS-LEQVNNLREIQALRRLSPHPNILRLIEVLFD--RKTGRLALVFEL-MDMN 85
Query: 53 LSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
L I+ R +PE+ + ++ QL L+ ++ + I HRD+KPENIL+ D +LK+A
Sbjct: 86 LYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI----KDDILKLA 141
Query: 112 DFGLSCTLYP-GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFG +Y Y E + + Y APE +L Y K+D+W+VG + FE+L+ +P F
Sbjct: 142 DFGSCRGIYSKPPYTEYI-STRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFP 200
Query: 170 GRNNVQLVRNINSCKHLPFSQLI------------------------VPALHPDCVDMCL 205
G N + + I+ P ++++ +P + +D+
Sbjct: 201 GTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLK 260
Query: 206 KLLSANTVDRLSFNEFYHHRF 226
KLL+ + +R++ + H +
Sbjct: 261 KLLAYDPDERITAKQALRHPY 281
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282 |
| >gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Score = 109 bits (275), Expect = 3e-28
Identities = 74/272 (27%), Positives = 122/272 (44%), Gaps = 64/272 (23%)
Query: 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67
H+K+ E + L+ ++ +++L+ +FQ ++ ++ V+++ GG++ S + G E
Sbjct: 47 HVKA----ERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDL 102
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY------- 120
AR ++ +L +E ++ IHRD+KP+NIL +D D +K+ DFGL CT +
Sbjct: 103 ARFYIAELTCAIESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CTGFRWTHDSK 158
Query: 121 ---PGNY-----------------------------------AEKVCGSPLYMAPEVLQF 142
G++ A + G+P Y+APEVL
Sbjct: 159 YYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRCLAHSLVGTPNYIAPEVLLR 218
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPF---SGRNNVQLVRNINSCKHLPFSQLIVPALHPD 199
Y + D WSVG IL+E+L G PPF + V N + H+P L +
Sbjct: 219 TGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIPSQA----KLSRE 274
Query: 200 CVDMCLKLLSANTVDRLSFN---EFYHHRFLR 228
D+ L+L DRL N E H F +
Sbjct: 275 ASDLILRLC-CGAEDRLGKNGADEIKAHPFFK 305
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376 |
| >gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 3e-28
Identities = 63/205 (30%), Positives = 107/205 (52%), Gaps = 12/205 (5%)
Query: 10 KSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----V 63
K+ DC E++ L +NHPN+I+ + +F +N + +V+E G+LS I+ + +
Sbjct: 44 KARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLI 103
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
PE+T K+ QL + LE ++S ++HRD+KP N+ ++ ++K+ D GL
Sbjct: 104 PEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATG---VVKLGDLGLGRFFSSKT 160
Query: 124 YA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG--RNNVQLVRNI 180
A + G+P YM+PE + Y+ K D+WS+G +L+E+ PF G N L + I
Sbjct: 161 TAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKI 220
Query: 181 NSCKHLPFSQLIVPALHPDCVDMCL 205
C + P V+MC+
Sbjct: 221 EQCDYPPLPSDHYSEELRQLVNMCI 245
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267 |
| >gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Score = 109 bits (273), Expect = 3e-28
Identities = 61/183 (33%), Positives = 100/183 (54%), Gaps = 17/183 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L+ +NHP + L+ +F+ E+ ++LV+EF GG +++R + R P + Q+
Sbjct: 81 ERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQI 140
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
E L S +I++RDLKPEN+L LD D +K+ DFG + + Y +CG+P Y+
Sbjct: 141 VLIFEYLQSLNIVYRDLKPENLL---LDKDGFIKMTDFGFAKVVDTRTYT--LCGTPEYI 195
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI------------NSC 183
APE+L + + D W++G ++E+L G PPF + + + I N+C
Sbjct: 196 APEILLNVGHGKAADWWTLGIFIYEILVGCPPFYANEPLLIYQKILEGIIYFPKFLDNNC 255
Query: 184 KHL 186
KHL
Sbjct: 256 KHL 258
|
Length = 340 |
| >gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 111 bits (279), Expect = 4e-28
Identities = 70/215 (32%), Positives = 108/215 (50%), Gaps = 30/215 (13%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI--- 57
+ L + KS L E+N + + H NI+R D F +A +++++EFC G+LS I
Sbjct: 49 RGLKEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKC 108
Query: 58 -RLHGRVPEQTARKFLQQLGAGLEIL-------NSHHIIHRDLKPENILLS--------- 100
++ G++ E +QL L N ++HRDLKP+NI LS
Sbjct: 109 YKMFGKIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKI 168
Query: 101 -----GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL--QFQRYDEKVDMWS 153
L+ + KI DFGLS + + A G+P Y +PE+L + + YD+K DMW+
Sbjct: 169 TAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDMWA 228
Query: 154 VGAILFELLNGYPPFSGRNNV-QLVRNINSCKHLP 187
+G I++EL +G PF NN QL+ + LP
Sbjct: 229 LGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP 263
|
Length = 1021 |
| >gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 5e-28
Identities = 77/245 (31%), Positives = 113/245 (46%), Gaps = 44/245 (17%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E+ L + H NI+RL+D ++ + LV E+C +L Y +G + + + F+ Q
Sbjct: 49 EICLLKELKHKNIVRLYDVLHSDKKLTLVFEYC-DQDLKKYFDSCNGDIDPEIVKSFMFQ 107
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSP- 132
L GL +SH+++HRDLKP+N+L++ + LK+ADFGL+ + V C S
Sbjct: 108 LLKGLAFCHSHNVLHRDLKPQNLLINKNGE---LKLADFGLA-----RAFGIPVRCYSAE 159
Query: 133 ----LYMAPEVLQFQR-YDEKVDMWSVGAILFELLN-GYPPFSGRNNV--QLVR------ 178
Y P+VL + Y +DMWS G I EL N G P F G N+V QL R
Sbjct: 160 VVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPG-NDVDDQLKRIFRLLG 218
Query: 179 -----NINSCKHLP------------FSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221
+ LP +VP L+ D+ LL N V R+S E
Sbjct: 219 TPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278
Query: 222 YHHRF 226
H +
Sbjct: 279 LQHPY 283
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284 |
| >gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 71/276 (25%), Positives = 130/276 (47%), Gaps = 57/276 (20%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHG 61
E+ + ++H NI+++++ N +++V E +L++ + G
Sbjct: 52 EIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQE-YMETDLANVLE-QG 109
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ E+ AR F+ QL GL+ ++S +++HRDLKP N+ ++ +D++LKI DFGL+ + P
Sbjct: 110 PLSEEHARLFMYQLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDP 167
Query: 122 -----GNYAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
G +E + + Y +P +L Y + +DMW+ G I E+L G P F+G + ++
Sbjct: 168 HYSHKGYLSEGLV-TKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPLFAGAHELE 226
Query: 176 L--------------------------VRNINSCKHLPFSQLIVPALHPDCVDMCLKLLS 209
VRN P L+ P ++P+ +D ++L+
Sbjct: 227 QMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLL-PGVNPEALDFLEQILT 285
Query: 210 ANTVDRLSFNEFYHHRFLRRNS-----AILRAPFHI 240
N +DRL+ E H ++ S + PFHI
Sbjct: 286 FNPMDRLTAEEALMHPYMSCYSCPFDEPVSLHPFHI 321
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342 |
| >gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-27
Identities = 55/187 (29%), Positives = 95/187 (50%), Gaps = 10/187 (5%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
K + + L E+ L + H NI++ + + + + +E+ GG++++ + +G
Sbjct: 43 KDRKRSMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGA 102
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP- 121
E R F++Q+ GL L++ IIHRD+K NIL +D+ +KI+DFG+S L
Sbjct: 103 FEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANIL---VDNKGGIKISDFGISKKLEAN 159
Query: 122 ------GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ GS +MAPEV++ Y K D+WS+G ++ E+L G PF +Q
Sbjct: 160 SLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVEMLTGKHPFPDCTQLQ 219
Query: 176 LVRNINS 182
+ I
Sbjct: 220 AIFKIGE 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267 |
| >gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Score = 106 bits (266), Expect = 2e-27
Identities = 68/248 (27%), Positives = 112/248 (45%), Gaps = 41/248 (16%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR-----VP 64
E++ L ++ I+RL D E ++LV E+ +L ++ +GR +P
Sbjct: 50 EISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLP 108
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPG 122
+T + F+ QL G+ + H ++HRDLKP+N+L+ +LKIAD GL ++
Sbjct: 109 AKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVK 166
Query: 123 NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
+Y ++ + Y APEVL Y VD+WSVG I E+ P F G + +Q + +I
Sbjct: 167 SYTHEIV-TLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDSELQQLLHIF 225
Query: 182 SCKHLPFSQL-----------------------IVPALHPDCVDMCLKLLSANTVDRLSF 218
P Q+ VP L P+ +D+ K+L + R+S
Sbjct: 226 KLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPAKRISA 285
Query: 219 NEFYHHRF 226
H +
Sbjct: 286 KAALTHPY 293
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295 |
| >gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Score = 105 bits (263), Expect = 2e-27
Identities = 73/227 (32%), Positives = 104/227 (45%), Gaps = 26/227 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
EL+ L N P I+ + AF I + +E+ GG+L ++ GR+PE+ K
Sbjct: 49 ELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVA 108
Query: 75 LGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+ GL L H IIHRD+KP NIL++ +K+ DFG+S L + A+ G+
Sbjct: 109 VLKGLTYLHEKHKIIHRDVKPSNILVNSRGQ---IKLCDFGVSGQLV-NSLAKTFVGTSS 164
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQL-- 191
YMAPE +Q Y K D+WS+G L EL G P+ N F L
Sbjct: 165 YMAPERIQGNDYSVKSDIWSLGLSLIELATGRFPYP---------PENDPPDGIFELLQY 215
Query: 192 IV----PAL-----HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
IV P L PD D L + +R S+ E H F+++
Sbjct: 216 IVNEPPPRLPSGKFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKK 262
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265 |
| >gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 104 bits (261), Expect = 4e-27
Identities = 62/220 (28%), Positives = 102/220 (46%), Gaps = 17/220 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + ++ ++HP I+RL + E + LV+E G L Y++ +P ++ Q+
Sbjct: 46 EASVMAQLDHPCIVRLIGVCKGEP-LMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQV 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGS-P 132
G+ L S H +HRDL N+LL + KI+DFG+S L G+ Y G P
Sbjct: 105 AMGMAYLESKHFVHRDLAARNVLLV---NRHQAKISDFGMSRALGAGSDYYRATTAGRWP 161
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQ 190
L + APE + + ++ K D+WS G L+E + G P+ +++ + S + LP
Sbjct: 162 LKWYAPECINYGKFSSKSDVWSYGVTLWEAFSYGAKPYGEMKGAEVIAMLESGERLP--- 218
Query: 191 LIVPALHPDCV-DMCLKLLSANTVDRLSFNEFYHHRFLRR 229
P P + + L DR +F+E RR
Sbjct: 219 --RPEECPQEIYSIMLSCWKYRPEDRPTFSEL--ESTFRR 254
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257 |
| >gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Score = 105 bits (262), Expect = 6e-27
Identities = 59/158 (37%), Positives = 92/158 (58%), Gaps = 4/158 (2%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
HP + L+ FQ + +F V+E+ GG+L +I+ + A + ++ GL+ L+
Sbjct: 54 EHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLH 113
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQF 142
S I++RDLK +NILL D D +KIADFG+ G+ CG+P Y+APE+L
Sbjct: 114 SKGIVYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLG 170
Query: 143 QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
Q+Y+ VD WS G +L+E+L G PF G + +L ++I
Sbjct: 171 QKYNTSVDWWSFGVLLYEMLIGQSPFHGHDEEELFQSI 208
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316 |
| >gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Score = 104 bits (262), Expect = 7e-27
Identities = 77/234 (32%), Positives = 112/234 (47%), Gaps = 46/234 (19%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I + E+ +LV+E+C G + S + +H +K LQ++
Sbjct: 65 EVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCLG-SASDILEVH--------KKPLQEV 115
Query: 76 -------GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
GA GL L+SH IHRD+K NILL+ + +K+ADFG + + P N
Sbjct: 116 EIAAICHGALQGLAYLHSHERIHRDIKAGNILLT---EPGTVKLADFGSASLVSPAN--- 169
Query: 127 KVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSC 183
G+P +MAPEV+ +YD KVD+WS+G EL PP N + + +I
Sbjct: 170 SFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--- 226
Query: 184 KHLPFSQLIVPALHP--------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
+Q P L + VD CL+ + DR S E HRF+ R
Sbjct: 227 -----AQNDSPTLSSNDWSDYFRNFVDSCLQKIPQ---DRPSSEELLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307 |
| >gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Score = 104 bits (260), Expect = 9e-27
Identities = 72/243 (29%), Positives = 112/243 (46%), Gaps = 31/243 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G E A +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ GLE L+ I++RDLKPENILL DD ++I+D GL+ + G + G+
Sbjct: 110 EICCGLEDLHQERIVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-------QLVRNINSCKHL 186
YMAPEV++ +RY D W++G +L+E++ G PF R +LV+ +
Sbjct: 167 YMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKKKIKREEVERLVKEVQEEYSE 226
Query: 187 PFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE-----------FYHHRFLRRNSAILR 235
FS PD +C LL + +RL F F R + +L
Sbjct: 227 KFS--------PDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQINFKRLEAGMLE 278
Query: 236 APF 238
PF
Sbjct: 279 PPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285 |
| >gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Score = 105 bits (264), Expect = 1e-26
Identities = 71/229 (31%), Positives = 113/229 (49%), Gaps = 25/229 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARKF 71
E + ++ N I++L AFQ + +++V+E+ GG+L S+Y +PE+ AR +
Sbjct: 93 ERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSNY-----DIPEKWARFY 147
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKV 128
++ L+ ++S IHRD+KP+N+L LD LK+ADFG +C N +
Sbjct: 148 TAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFG-TCMKMDANGMVRCDTA 203
Query: 129 CGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK 184
G+P Y++PEVL+ Q Y + D WSVG L+E+L G PF + V I K
Sbjct: 204 VGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFYADSLVGTYSKIMDHK 263
Query: 185 H-LPFSQLIVPALHPDCVDMCLKLLSANTV--DRLSFNEFYHHRFLRRN 230
+ L F I + D+ L+ V R +E H F + +
Sbjct: 264 NSLTFPDDI--EISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKND 310
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370 |
| >gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 1e-26
Identities = 67/221 (30%), Positives = 110/221 (49%), Gaps = 12/221 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS-YIRLHGRVPEQTARKFLQQ 74
E+ L++ NHP I++L AF + +++++EFC GG + + + L + E + +Q
Sbjct: 59 EIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQ 118
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVCGSPL 133
+ L+ L+S IIHRDLK N+LL+ LD D+ K+ADFG+S + + G+P
Sbjct: 119 MLEALQYLHSMKIIHRDLKAGNVLLT-LDGDI--KLADFGVSAKNVKTLQRRDSFIGTPY 175
Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPF 188
+MAPEV+ + YD K D+WS+G L E+ PP N ++++ I K P
Sbjct: 176 WMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHHELNPMRVLLKI--AKSEPP 233
Query: 189 SQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
+ + D L + R S + H F+
Sbjct: 234 TLSQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSS 274
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292 |
| >gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 2e-26
Identities = 53/165 (32%), Positives = 92/165 (55%), Gaps = 9/165 (5%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
S L+CE+ L ++ H I++ + + AE + + +E+ GG++ ++ +G + E
Sbjct: 49 SALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVT 108
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 124
RK+ +Q+ G+ L+S+ I+HRD+K NIL D +K+ DFG S L G
Sbjct: 109 RKYTRQILEGMSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRLQTICMSGTG 165
Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
V G+P +M+PEV+ + Y K D+WS+G + E+L PP++
Sbjct: 166 IRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266 |
| >gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Score = 103 bits (257), Expect = 2e-26
Identities = 69/219 (31%), Positives = 116/219 (52%), Gaps = 17/219 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
E+ + + +PNI+ D+F + +F+V+E+ AGG+L+ + Q A R+ L
Sbjct: 66 EILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTETCMDEAQIAAVCRECL 125
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
Q LE L+++ +IHRD+K +N+LL G+D V K+ DFG + P + G+
Sbjct: 126 Q----ALEFLHANQVIHRDIKSDNVLL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 178
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI--NSCKHLPFS 189
P +MAPEV+ + Y KVD+WS+G + E++ G PP+ N ++ + I N L
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 190 QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
+ + P D ++ CL++ + R S E H FL+
Sbjct: 239 EKLSPIFR-DFLNRCLEM---DVEKRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296 |
| >gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 3e-26
Identities = 56/162 (34%), Positives = 84/162 (51%), Gaps = 16/162 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
EL S P I++ + AF ++ + I + +E+C GG+L S ++ +V ++ R +
Sbjct: 49 ELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDS---IYKKVKKRGGRIGEK 105
Query: 74 QLG-------AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
LG GL L+S IIHRD+KP NIL L +K+ DFG+S L + A
Sbjct: 106 VLGKIAESVLKGLSYLHSRKIIHRDIKPSNIL---LTRKGQVKLCDFGVSGELV-NSLAG 161
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
G+ YMAPE +Q + Y D+WS+G L E+ PF
Sbjct: 162 TFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEVAQNRFPF 203
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287 |
| >gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Score = 103 bits (259), Expect = 3e-26
Identities = 72/250 (28%), Positives = 111/250 (44%), Gaps = 43/250 (17%)
Query: 16 ELNFLSSV-NHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
EL L H NI L+D N ++L E +L IR + + +
Sbjct: 51 ELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELMEA-DLHQIIRSGQPLTDAHFQS 109
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYA 125
F+ Q+ GL+ ++S +++HRDLKP N+L++ D LKI DFGL+ +
Sbjct: 110 FIYQILCGLKYIHSANVLHRDLKPGNLLVNA---DCELKICDFGLARGFSENPGENAGFM 166
Query: 126 EKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ--------- 175
+ + Y APE+ L FQ Y + +D+WSVG IL ELL P F G++ V
Sbjct: 167 TEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYVDQLNQILQVL 226
Query: 176 ------------------LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217
+R++ + PF I P +P +D+ KLL+ + R+S
Sbjct: 227 GTPDEETLSRIGSPKAQNYIRSLPNIPKKPFES-IFPNANPLALDLLEKLLAFDPTKRIS 285
Query: 218 FNEFYHHRFL 227
E H +L
Sbjct: 286 VEEALEHPYL 295
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332 |
| >gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 59/196 (30%), Positives = 93/196 (47%), Gaps = 9/196 (4%)
Query: 16 ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL----SSYIRLHGRVPEQTARK 70
E+ + + HPNI+R + F + +++V++ G L +S R E+
Sbjct: 58 EVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWN 117
Query: 71 FLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
Q+ L L+ I+HRDL P NI+L G DD V I DFGL+ P + V
Sbjct: 118 IFVQMVLALRYLHKEKRIVHRDLTPNNIML-GEDDKVT--ITDFGLAKQKQPESKLTSVV 174
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS 189
G+ LY PE+++ + Y EK D+W+ G IL+++ PPF N + L I + P
Sbjct: 175 GTILYSCPEIVKNEPYGEKADVWAFGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPLP 234
Query: 190 QLIVPALHPDCVDMCL 205
+ + D + CL
Sbjct: 235 EGMYSEDVTDVITSCL 250
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269 |
| >gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 3e-26
Identities = 56/172 (32%), Positives = 98/172 (56%), Gaps = 17/172 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E+ + HPNI+ ++ ++ + +++V+EF GG L+ I H R+ E Q A L
Sbjct: 66 EVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLAV 124
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------ 128
L A L L++ +IHRD+K ++ILL+ D +K++DFG C +++V
Sbjct: 125 LKA-LSFLHAQGVIHRDIKSDSILLT---SDGRVKLSDFGF-C----AQVSKEVPRRKSL 175
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
G+P +MAPEV+ Y +VD+WS+G ++ E+++G PP+ +Q ++ I
Sbjct: 176 VGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285 |
| >gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Score = 103 bits (258), Expect = 3e-26
Identities = 54/163 (33%), Positives = 89/163 (54%), Gaps = 6/163 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L +FQ + + V+E+ GG L ++ E AR + ++
Sbjct: 45 ESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
+ L L+S +++RDLK EN++L D D +KI DFGL C + G + CG+P
Sbjct: 105 VSALGYLHSCDVVYRDLKLENLML---DKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
Y+APEVL+ Y VD W +G +++E++ G PF +++ +L
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323 |
| >gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-26
Identities = 69/219 (31%), Positives = 117/219 (53%), Gaps = 17/219 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
E+ + +PNI+ D++ + +++V+E+ AGG+L+ + Q A R+ L
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 126
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGS 131
Q LE L+S+ +IHRD+K +NILL G+D V K+ DFG + P + + G+
Sbjct: 127 Q----ALEFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 179
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI--NSCKHLPFS 189
P +MAPEV+ + Y KVD+WS+G + E++ G PP+ N ++ + I N L
Sbjct: 180 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNP 239
Query: 190 QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
+ + A+ D ++ CL + + R S E H+FL+
Sbjct: 240 EKL-SAIFRDFLNRCLDM---DVEKRGSAKELLQHQFLK 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296 |
| >gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 4e-26
Identities = 59/174 (33%), Positives = 100/174 (57%), Gaps = 16/174 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV-PEQTARKFLQ 73
E L+ + HPNI+ ++F+A+ +++V+E+C GG+L I+L G++ PE T ++
Sbjct: 48 EAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFV 107
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSP 132
Q+ G++ ++ ++HRD+K +NI L+ + +K+ DFG + L PG YA G+P
Sbjct: 108 QMCLGVQHIHEKRVLHRDIKSKNIFLT---QNGKVKLGDFGSARLLTSPGAYACTYVGTP 164
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHL 186
Y+ PE+ + Y+ K D+WS+G IL+EL PF NS K+L
Sbjct: 165 YYVPPEIWENMPYNNKSDIWSLGCILYELCTLKHPFQA----------NSWKNL 208
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255 |
| >gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 4e-26
Identities = 70/236 (29%), Positives = 112/236 (47%), Gaps = 17/236 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G E+ A +
Sbjct: 50 EKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ GLE L+ + ++RDLKPENILL DD ++I+D GL+ + G G+
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV 193
YMAPEVL QRY D W +G +++E++ G PF GR ++ R + L ++
Sbjct: 167 YMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSPFRGRKE-KVKREEVDRRVLETEEVYS 225
Query: 194 PALHPDCVDMCLKLLSANTVDRLSFNE-----------FYHHRFLRRNSAILRAPF 238
+ +C LL+ + RL E F + F R + +L PF
Sbjct: 226 AKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNMNFKRLEAGMLDPPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285 |
| >gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 5e-26
Identities = 85/263 (32%), Positives = 122/263 (46%), Gaps = 36/263 (13%)
Query: 3 KKLNK-HLK-----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
KKLNK LK E L+ V+ I+ L AFQ + + LV+ GG+L +
Sbjct: 24 KKLNKKRLKKRKGYEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYH 83
Query: 57 I----RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
I + PE A + Q+ +GLE L+ II+RDLKPEN+LL D+D ++I+D
Sbjct: 84 IYNVDEENPGFPEPRACFYTAQIISGLEHLHQRRIIYRDLKPENVLL---DNDGNVRISD 140
Query: 113 FGLSCTLYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
GL+ L G K G+P +MAPE+LQ + YD VD +++G L+E++ PF R
Sbjct: 141 LGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAARGPFRAR 200
Query: 172 NNVQLVRNINSCKHLPFSQLIVPALHPD-----CVDMCLKLLSANTVDRLSF-----NEF 221
+ V N K L L +PD C LL+ + RL F +
Sbjct: 201 G--EKVEN----KELKQRILNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGL 254
Query: 222 YHHRFLRR------NSAILRAPF 238
H R + +L PF
Sbjct: 255 RTHPLFRDLNWRQLEAGMLPPPF 277
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280 |
| >gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Score = 101 bits (253), Expect = 6e-26
Identities = 56/170 (32%), Positives = 89/170 (52%), Gaps = 9/170 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
E LS ++HP I++ +F + ++ E+C G +L + + E ++
Sbjct: 52 EAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEW 111
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG 130
QL G+ ++ I+HRDLK +NI L + +LKI DFG+S L + A G
Sbjct: 112 FIQLLLGVHYMHQRRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTG 167
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
+P YM+PE L+ Q YD K D+WS+G IL+E+ F G+N + +V I
Sbjct: 168 TPYYMSPEALKHQGYDSKSDIWSLGCILYEMCCLAHAFEGQNFLSVVLRI 217
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260 |
| >gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 8e-26
Identities = 65/226 (28%), Positives = 112/226 (49%), Gaps = 19/226 (8%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
+ L+CE+ L ++ H I++ + + E + + +E GG++ ++ +G + E
Sbjct: 49 NALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVT 108
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL----YPGNY 124
RK+ +Q+ G+ L+S+ I+HRD+K NIL + + +K+ DFG S L G
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGN---VKLGDFGASKRLQTICLSGTG 165
Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK 184
+ V G+P +M+PEV+ + Y K D+WSVG + E+L PP++ + + I
Sbjct: 166 MKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEMLTEKPPWAEFEAMAAIFKIA--- 222
Query: 185 HLPFSQLIVPALHPDCVDMC---LKLLSANTVDRLSFNEFYHHRFL 227
+Q P L P D C LK + R S +E H F+
Sbjct: 223 ----TQPTNPVLPPHVSDHCRDFLKRIFVEAKLRPSADELLRHTFV 264
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265 |
| >gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 102 bits (257), Expect = 8e-26
Identities = 75/263 (28%), Positives = 125/263 (47%), Gaps = 56/263 (21%)
Query: 16 ELNFLSSVNHPNIIRLFDAF----QAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL L ++H N+I L D F E+ ++LV G +L++ ++ ++ + +
Sbjct: 64 ELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHL-MGADLNNIVK-CQKLSDDHIQ 121
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ Q+ GL+ ++S IIHRDLKP NI +++D LKI DFGL+ +++
Sbjct: 122 FLVYQILRGLKYIHSAGIIHRDLKPSNI---AVNEDCELKILDFGLARHT-----DDEMT 173
Query: 130 G---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVRNINSC- 183
G + Y APE+ L + Y++ VD+WSVG I+ ELL G F G +++ QL R +N
Sbjct: 174 GYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNLVG 233
Query: 184 -------------------KHLP------FSQLIVPALHPDCVDMCLKLLSANTVDRLSF 218
+ LP F ++ A +P +D+ K+L + R++
Sbjct: 234 TPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGA-NPLAIDLLEKMLVLDPDKRITA 292
Query: 219 NEFYHHRFLRRNSAILRAPFHIP 241
E H +L A +H P
Sbjct: 293 AEALAHPYL--------AEYHDP 307
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343 |
| >gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 101 bits (252), Expect = 1e-25
Identities = 62/210 (29%), Positives = 100/210 (47%), Gaps = 20/210 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G E+ A +
Sbjct: 50 EKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ GLE L+ I++RDLKPENILL DD ++I+D GL+ + G G+
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-------QLVRNINSCKHL 186
YMAPEV++ +RY D W +G +++E++ G PF R + V+
Sbjct: 167 YMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSPFRQRKEKVKREEVERRVKEDQEEYSE 226
Query: 187 PFSQLIVPALHPDCVDMCLKLLSANTVDRL 216
FS +C +LL+ + RL
Sbjct: 227 KFS--------EAARSICRQLLTKDPGFRL 248
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285 |
| >gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 102 bits (255), Expect = 1e-25
Identities = 75/254 (29%), Positives = 112/254 (44%), Gaps = 43/254 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL ++ + H NI+ L D + + I LV++ A +L + R+ E + L Q+
Sbjct: 70 ELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMAS-DLKKVVDRKIRLTESQVKCILLQI 128
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS----CTLYPGNYAEKVCGS 131
GL +L+ + +HRDL P NI + + + KIADFGL+ Y ++
Sbjct: 129 LNGLNVLHKWYFMHRDLSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQ 185
Query: 132 P-----------LYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVR 178
Y APE+L ++Y VDMWSVG I ELL G P F G N + QL R
Sbjct: 186 RREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAELLTGKPLFPGENEIDQLGR 245
Query: 179 -----------NINSCKHLP----FS-------QLIVPALHPDCVDMCLKLLSANTVDRL 216
N K LP F+ + I P D +D+ LL N ++R+
Sbjct: 246 IFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNPLERI 305
Query: 217 SFNEFYHHRFLRRN 230
S E H + + +
Sbjct: 306 SAKEALKHEYFKSD 319
|
Length = 335 |
| >gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (252), Expect = 1e-25
Identities = 60/171 (35%), Positives = 88/171 (51%), Gaps = 20/171 (11%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENC------IFLVVEFCAGG---NLSSYIRLHG-RVP 64
E N L NHPNI + AF +N ++LV+E C GG +L +R G R+
Sbjct: 52 EYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLK 111
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
E+ L++ GL L+ + +IHRD+K +NILL+ + +K+ DFG+S L
Sbjct: 112 EEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLT---KNAEVKLVDFGVSAQLDSTLG 168
Query: 125 AEKVC-GSPLYMAPEVL----QFQR-YDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ Q YD + D+WS+G EL +G PP
Sbjct: 169 RRNTFIGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIELADGKPPLC 219
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275 |
| >gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 102 bits (256), Expect = 1e-25
Identities = 80/297 (26%), Positives = 133/297 (44%), Gaps = 66/297 (22%)
Query: 1 MLKKLN-KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
M KK H+K+ E + L+ + P ++ L+ +FQ ++L++EF GG+L + +
Sbjct: 39 MFKKDQLAHVKA----ERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIK 94
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ E R ++ + +E ++ IHRD+KP+NIL+ D +K++DFGLS
Sbjct: 95 YDTFSEDVTRFYMAECVLAIEAVHKLGFIHRDIKPDNILI---DRGGHIKLSDFGLSTGF 151
Query: 120 YP---GNYAEKV---------------------------------------------CGS 131
+ Y +K+ G+
Sbjct: 152 HKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGT 211
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKH-LPFSQ 190
P Y+APE+ Q Y ++ D WS+GAI+FE L G+PPF N+ + R I + + L F
Sbjct: 212 PDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD 271
Query: 191 LIVPALHPDCVDMCLKLLSA--NTVDRLSFNEFYHHRFLRR-NSAILR---APFHIP 241
I L + D+ +L++ N + R +E H F R + +R APF IP
Sbjct: 272 DI--HLSVEAEDLIRRLITNAENRLGRGGAHEIKSHPFFRGVDWDTIRQIRAPF-IP 325
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377 |
| >gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 3e-25
Identities = 65/219 (29%), Positives = 99/219 (45%), Gaps = 15/219 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL + P I+ + AF EN I + +EF G+L + G +P + K +
Sbjct: 53 ELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAV 112
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L N H I+HRD+KP NIL++ +K+ DFG+S L + A+ G+ Y
Sbjct: 113 VEGLTYLYNVHRIMHRDIKPSNILVNSRGQ---IKLCDFGVSGELI-NSIADTFVGTSTY 168
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV- 193
M+PE +Q +Y K D+WS+G + EL G PF+ +N+ + L Q IV
Sbjct: 169 MSPERIQGGKYTVKSDVWSLGISIIELALGKFPFA-FSNIDDDGQDDPMGILDLLQQIVQ 227
Query: 194 ---PAL-----HPDCVDMCLKLLSANTVDRLSFNEFYHH 224
P L D D L + +R + +
Sbjct: 228 EPPPRLPSSDFPEDLRDFVDACLLKDPTERPTPQQLCAM 266
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284 |
| >gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Score = 99.5 bits (248), Expect = 3e-25
Identities = 60/217 (27%), Positives = 111/217 (51%), Gaps = 14/217 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
E+ LS++ HPNI++ ++F+ +++V+++C GG+L Y +++ + PE +
Sbjct: 49 EVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDL--YKKINAQRGVLFPEDQILDW 106
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-G 130
Q+ L+ ++ I+HRD+K +NI L+ D +K+ DFG++ L + C G
Sbjct: 107 FVQICLALKHVHDRKILHRDIKSQNIFLT---KDGTIKLGDFGIARVLNSTVELARTCIG 163
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+P Y++PE+ + + Y+ K D+W++G +L+E+ F N LV I + P S
Sbjct: 164 TPYYLSPEICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNMKNLVLKIIRGSYPPVS- 222
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
D ++ +L N DR S N F+
Sbjct: 223 ---SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256 |
| >gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 100 bits (250), Expect = 4e-25
Identities = 53/173 (30%), Positives = 88/173 (50%), Gaps = 20/173 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR-----VPEQTA 68
E+ L + H N++ L + F A+ ++L+ ++ A +L I+ H + +P
Sbjct: 52 EIALLRELKHENVVSLVEVFLEHADKSVYLLFDY-AEHDLWQIIKFHRQAKRVSIPPSMV 110
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLS-------CTLY 120
+ L Q+ G+ L+S+ ++HRDLKP NIL+ G + ++KI D GL+ L
Sbjct: 111 KSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLA 170
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRN 172
+ V + Y APE+L R Y + +D+W++G I ELL P F GR
Sbjct: 171 DLD---PVVVTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLTLEPIFKGRE 220
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316 |
| >gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 98.9 bits (246), Expect = 5e-25
Identities = 51/163 (31%), Positives = 91/163 (55%), Gaps = 9/163 (5%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
L+CE+ L ++ H I++ + + E + + VE+ GG++ ++ +G + E R+
Sbjct: 51 LECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRR 110
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS---CTLY-PGNYAE 126
+ +Q+ G+ L+S+ I+HRD+K NIL D +K+ DFG S T+ G +
Sbjct: 111 YTRQILQGVSYLHSNMIVHRDIKGANIL---RDSAGNVKLGDFGASKRIQTICMSGTGIK 167
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
V G+P +M+PEV+ + Y K D+WSV + E+L PP++
Sbjct: 168 SVTGTPYWMSPEVISGEGYGRKADVWSVACTVVEMLTEKPPWA 210
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264 |
| >gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.8 bits (246), Expect = 5e-25
Identities = 63/224 (28%), Positives = 113/224 (50%), Gaps = 22/224 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L S+ H NI++ +N I + +EF GG++SS + G +PE K+ +Q+
Sbjct: 52 EVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQI 111
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-------LSCTLYPGNYAEKV 128
G+ L+++ ++HRD+K N++L + ++K+ DFG + N + +
Sbjct: 112 LDGVAYLHNNCVVHRDIKGNNVMLM---PNGIIKLIDFGCARRLAWVGLHGTHSNMLKSM 168
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPF 188
G+P +MAPEV+ Y K D+WS+G +FE+ G PP + + + + I + + L
Sbjct: 169 HGTPYWMAPEVINESGYGRKSDIWSIGCTVFEMATGKPPLASMDRLAAMFYIGAHRGL-- 226
Query: 189 SQLIVPALHPD-----CVDMCLKLLSANTVDRLSFNEFYHHRFL 227
+P L PD +D L+ + +R S + H FL
Sbjct: 227 ----MPRL-PDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265 |
| >gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Score = 98.5 bits (245), Expect = 6e-25
Identities = 63/238 (26%), Positives = 119/238 (50%), Gaps = 20/238 (8%)
Query: 1 MLKKLN-----KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLS 54
++KKLN + + + E LS + HPNI+ ++++ E+ +++V+ FC GG+L
Sbjct: 29 VIKKLNLRNASRRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDL- 87
Query: 55 SYIRLHGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
Y +L + +PE ++ Q+ L+ L+ HI+HRDLK +N+ L+ + ++K+
Sbjct: 88 -YHKLKEQKGKLLPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTN---IIKV 143
Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
D G++ L A + G+P YM+PE+ + Y+ K D+W++G ++E+ F+
Sbjct: 144 GDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMATLKHAFN 203
Query: 170 GRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
++ LV I K P + P L ++ +LS R S ++
Sbjct: 204 AKDMNSLVYRIIEGKLPPMPKDYSPEL----GELIATMLSKRPEKRPSVKSILRQPYI 257
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257 |
| >gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Score = 100 bits (251), Expect = 6e-25
Identities = 77/278 (27%), Positives = 127/278 (45%), Gaps = 67/278 (24%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
LN++ + + E + L+ ++ +++L+ +FQ ++ ++ V+++ GG++ S + P
Sbjct: 40 LNRNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFP 99
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT------ 118
E AR ++ +L +E ++ IHRD+KP+NIL +D D +K+ DFGL CT
Sbjct: 100 EVLARFYIAELTLAIESVHKMGFIHRDIKPDNIL---IDLDGHIKLTDFGL-CTGFRWTH 155
Query: 119 ---------------LYPGNY----------------------------AEKVCGSPLYM 135
+ P + A + G+P Y+
Sbjct: 156 NSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATKQHQRCLAHSLVGTPNYI 215
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG--RNNVQL-VRNINSCKHLPFSQLI 192
APEVL + Y + D WSVG ILFE+L G PPF QL V N + H+P Q+
Sbjct: 216 APEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIP-PQV- 273
Query: 193 VPALHPDCVDMCLKL-------LSANTVDRLSFNEFYH 223
L P+ VD+ KL L N D + + F+
Sbjct: 274 --KLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFS 309
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381 |
| >gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Score = 99.0 bits (246), Expect = 8e-25
Identities = 70/220 (31%), Positives = 117/220 (53%), Gaps = 19/220 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA---RKFL 72
E+ + +PNI+ D++ + +++V+E+ AGG+L+ + Q A R+ L
Sbjct: 66 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTETCMDEGQIAAVCRECL 125
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGS 131
Q L+ L+S+ +IHRD+K +NILL G+D V K+ DFG + P + G+
Sbjct: 126 Q----ALDFLHSNQVIHRDIKSDNILL-GMDGSV--KLTDFGFCAQITPEQSKRSTMVGT 178
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI--NSCKHLPFS 189
P +MAPEV+ + Y KVD+WS+G + E++ G PP+ N ++ + I N L
Sbjct: 179 PYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRALYLIATNGTPELQNP 238
Query: 190 QLIVPALHPDCVDMCLKLLSANTVDRL-SFNEFYHHRFLR 228
+ + A+ D ++ CL++ VDR S E H FL+
Sbjct: 239 ERL-SAVFRDFLNRCLEM----DVDRRGSAKELLQHPFLK 273
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297 |
| >gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Score = 98.6 bits (246), Expect = 1e-24
Identities = 75/249 (30%), Positives = 120/249 (48%), Gaps = 31/249 (12%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
+K +K E+ L + H N++ L + F+ + ++LV EF L + + E
Sbjct: 40 DKMVKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDE 99
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNY 124
RK+L Q+ G+E +SH+IIHRD+KPENIL+S ++K+ DFG + TL PG
Sbjct: 100 SRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVS---QSGVVKLCDFGFARTLAAPGEV 156
Query: 125 AEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSC 183
+ Y APE+L +Y VD+W+VG ++ E+L G P F G +++ + +I C
Sbjct: 157 YTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHIIKC 216
Query: 184 ------KH--------------LPFSQLIVPA------LHPDCVDMCLKLLSANTVDRLS 217
+H LP + I P L +D+ + L + DR S
Sbjct: 217 LGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPS 276
Query: 218 FNEFYHHRF 226
++ HH F
Sbjct: 277 SSQLLHHEF 285
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286 |
| >gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Score = 98.3 bits (245), Expect = 1e-24
Identities = 57/192 (29%), Positives = 96/192 (50%), Gaps = 23/192 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK----- 70
E +S + HPNI+ L E ++ E+ A G+L ++ + + A
Sbjct: 58 EAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETV 117
Query: 71 --------FLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
FL Q+ AG+E L+SHH +HRDL N L+ + + +KI+DFGLS +
Sbjct: 118 KSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVG---EGLTVKISDFGLSRDI 174
Query: 120 YPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQ 175
Y +Y S L +M PE + + ++ + D+WS G +L+E+ + G P+ G +N +
Sbjct: 175 YSADYYRVQSKSLLPVRWMPPEAILYGKFTTESDIWSFGVVLWEIFSYGLQPYYGFSNQE 234
Query: 176 LVRNINSCKHLP 187
++ I S + LP
Sbjct: 235 VIEMIRSRQLLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283 |
| >gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Score = 100 bits (249), Expect = 1e-24
Identities = 76/281 (27%), Positives = 127/281 (45%), Gaps = 71/281 (25%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ H+K+ E + L+ ++ ++RL+ +FQ ++ ++ V+++ GG++ S +
Sbjct: 40 LLRNQVAHVKA----ERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRM 95
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
G PE AR ++ +L +E ++ IHRD+KP+NIL +D D +K+ DFGL CT +
Sbjct: 96 GIFPEDLARFYIAELTCAVESVHKMGFIHRDIKPDNIL---IDRDGHIKLTDFGL-CTGF 151
Query: 121 ----------------------------PGN---------------------YAEKVCGS 131
P N A + G+
Sbjct: 152 RWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAARQHQRCLAHSLVGT 211
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL---VRNINSCKHLPF 188
P Y+APEVL Y + D WSVG IL+E+L G PPF + ++ V N + H+P
Sbjct: 212 PNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP 271
Query: 189 SQLIVPALHPDCVDMCLKL-------LSANTVDRLSFNEFY 222
L P+ D+ +KL L N D + + F+
Sbjct: 272 QA----KLSPEASDLIIKLCRGPEDRLGKNGADEIKAHPFF 308
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382 |
| >gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Score = 99.1 bits (247), Expect = 2e-24
Identities = 69/221 (31%), Positives = 111/221 (50%), Gaps = 16/221 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E + LS N P I +L AFQ ++ ++LV+E+ GG+L S + R + E A+ +L +
Sbjct: 51 ERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAE 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSP 132
L + ++ +HRD+KPEN+L +D +K+ADFG + L ++ G+P
Sbjct: 111 LVLAIHSVHQMGYVHRDIKPENVL---IDRTGHIKLADFGSAARLTANKMVNSKLPVGTP 167
Query: 133 LYMAPEVLQFQR------YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI-NSCKH 185
Y+APEVL Y + D WS+G I +E++ G PF + + NI N +
Sbjct: 168 DYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRF 227
Query: 186 LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226
L F + P + D +D+ LL +RL + H F
Sbjct: 228 LKFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPF 265
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330 |
| >gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 2e-24
Identities = 65/212 (30%), Positives = 108/212 (50%), Gaps = 12/212 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E L +HPNI++L + I++V+E GG+L +++R R+ + +
Sbjct: 42 EAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLD 101
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSP 132
AG+E L S + IHRDL N L+ ++ +LKI+DFG+S G Y + + P
Sbjct: 102 AAAGMEYLESKNCIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIP 158
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+ + APE L + RY + D+WS G +L+E + G P+ G +N Q I S +P Q
Sbjct: 159 IKWTAPEALNYGRYTSESDVWSYGILLWETFSLGDTPYPGMSNQQTRERIESGYRMPAPQ 218
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222
L ++ + L+ + + +R SF+E Y
Sbjct: 219 LCPEEIY----RLMLQCWAYDPENRPSFSEIY 246
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251 |
| >gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 2e-24
Identities = 66/198 (33%), Positives = 101/198 (51%), Gaps = 13/198 (6%)
Query: 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQT 67
LK+ E L +HPNI+RL + I++V+E GG+ +++R G R+ +
Sbjct: 36 LKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKE 95
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
+ ++ AG+E L S H IHRDL N L++ + +LKI+DFG+S G YA
Sbjct: 96 LIQMVENAAAGMEYLESKHCIHRDLAARNCLVT---EKNVLKISDFGMSREEEDGVYAST 152
Query: 128 --VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSC 183
+ P+ + APE L + RY + D+WS G +L+E + G P++ +N Q I
Sbjct: 153 GGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEAFSLGAVPYANLSNQQTREAIEQG 212
Query: 184 KHLPFSQLIVPALHPDCV 201
LP P L PD V
Sbjct: 213 VRLP-----CPELCPDAV 225
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252 |
| >gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 97.5 bits (243), Expect = 2e-24
Identities = 58/228 (25%), Positives = 115/228 (50%), Gaps = 22/228 (9%)
Query: 16 ELNFLSSVNH---PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
E+ LS + PNI + + ++ +++++E+ GG++ + ++ G + E+ +
Sbjct: 49 EVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVII 107
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGS 131
+++ L+ ++ +IHRD+K NIL++ +V L DFG++ L + G+
Sbjct: 108 REVLVALKYIHKVGVIHRDIKAANILVT-NTGNVKL--CDFGVAALLNQNSSKRSTFVGT 164
Query: 132 PLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK--HLP- 187
P +MAPEV+ + YD K D+WS+G ++E+ G PP+S + + + I K L
Sbjct: 165 PYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMMLIPKSKPPRLED 224
Query: 188 --FSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233
+S+L+ + V CL +RLS E ++++ +S
Sbjct: 225 NGYSKLL-----REFVAACLD---EEPKERLSAEELLKSKWIKAHSKT 264
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277 |
| >gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 97.0 bits (242), Expect = 4e-24
Identities = 62/229 (27%), Positives = 106/229 (46%), Gaps = 35/229 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
E + + N +++RL +V+E A G+L SY+R R PE
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLR--SRRPEAENNPGLGPP 116
Query: 67 TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
T +KF+Q ++ G+ L + +HRDL N +++ +D+ +KI DFG++ +Y +
Sbjct: 117 TLQKFIQMAAEIADGMAYLAAKKFVHRDLAARNCMVA---EDLTVKIGDFGMTRDIYETD 173
Query: 124 YAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRN 179
Y K L +MAPE L+ + K D+WS G +L+E+ P+ G +N ++++
Sbjct: 174 YYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSFGVVLWEMATLAEQPYQGLSNEEVLKF 233
Query: 180 INSCKHLPFSQLIVPALHPD-CVDMCLKLLSA----NTVDRLSFNEFYH 223
+ HL P+ C D L+L+ N R +F E
Sbjct: 234 VIDGGHLDL---------PENCPDKLLELMRMCWQYNPKMRPTFLEIVS 273
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277 |
| >gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Score = 97.0 bits (241), Expect = 4e-24
Identities = 61/172 (35%), Positives = 92/172 (53%), Gaps = 7/172 (4%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
N+ +K EL L ++ NI+ L +AF+ ++LV E+ L + VP
Sbjct: 40 NEEVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPP 99
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 122
+ R ++ QL + + + I+HRD+KPEN+L+S D +LK+ DFG + L G
Sbjct: 100 EKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHND---VLKLCDFGFARNLSEGSNA 156
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
NY E V + Y +PE+L Y + VDMWSVG IL EL +G P F G + +
Sbjct: 157 NYTEYV-ATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQPLFPGESEI 207
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287 |
| >gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 4e-24
Identities = 56/167 (33%), Positives = 92/167 (55%), Gaps = 6/167 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L AFQ + + V+E+ GG L ++ E+ AR + ++
Sbjct: 45 ESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEI 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
+ LE L+S +++RD+K EN++L D D +KI DFGL C + G + CG+P
Sbjct: 105 VSALEYLHSRDVVYRDIKLENLML---DKDGHIKITDFGL-CKEGISDGATMKTFCGTPE 160
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
Y+APEVL+ Y VD W +G +++E++ G PF +++ +L I
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI 207
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323 |
| >gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Score = 97.1 bits (242), Expect = 5e-24
Identities = 63/171 (36%), Positives = 93/171 (54%), Gaps = 11/171 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
E+ L ++ HPNI+ L + + + IFLV+E+C +L+S + + E + +
Sbjct: 56 EITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCEQ-DLASLLDNMPTPFSESQVKCLM 114
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCG 130
QL GL+ L+ + IIHRDLK N+LL+ D LKIADFGL+ T L KV
Sbjct: 115 LQLLRGLQYLHENFIIHRDLKVSNLLLT---DKGCLKIADFGLARTYGLPAKPMTPKVV- 170
Query: 131 SPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
+ Y APE+L Y +DMW+VG IL ELL P G++ ++ + I
Sbjct: 171 TLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLDLI 221
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309 |
| >gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Score = 97.8 bits (243), Expect = 7e-24
Identities = 56/159 (35%), Positives = 93/159 (58%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + ++ N P +++LF AFQ + +++V+E+ GG+L + + + VPE+ A+ + ++
Sbjct: 93 ERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNYD-VPEKWAKFYTAEV 151
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL 133
L+ ++S +IHRD+KP+N+L LD LK+ADFG + + G+P
Sbjct: 152 VLALDAIHSMGLIHRDVKPDNML---LDKHGHLKLADFGTCMKMDETGMVRCDTAVGTPD 208
Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 168
Y++PEVL+ Q Y + D WSVG LFE+L G PF
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLFEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370 |
| >gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Score = 96.3 bits (240), Expect = 8e-24
Identities = 56/179 (31%), Positives = 91/179 (50%), Gaps = 30/179 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKFL 72
E++ L + HPNI+ L D E+ ++L+ EF + +L Y + + + + +L
Sbjct: 49 EISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYL 107
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
Q+ G+ +S ++HRDLKP+N+L +D+ ++K+ADFGL+ + G P
Sbjct: 108 YQILQGILFCHSRRVLHRDLKPQNLL---IDNKGVIKLADFGLA----------RAFGIP 154
Query: 133 L-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVR 178
+ Y APEVL RY VD+WS+G I E+ P F G + + QL R
Sbjct: 155 VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQLFR 213
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285 |
| >gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Score = 96.2 bits (239), Expect = 9e-24
Identities = 65/179 (36%), Positives = 92/179 (51%), Gaps = 13/179 (7%)
Query: 17 LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
L L + HPN++RLFD E + LV E +L++Y+ VP +T +
Sbjct: 55 LRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEH-VDQDLTTYLDKVPEPGVPTETIK 113
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ QL GL+ L+SH ++HRDLKP+NIL++ +K+ADFGL+ +Y A
Sbjct: 114 DMMFQLLRGLDFLHSHRVVHRDLKPQNILVT---SSGQIKLADFGLA-RIYSFQMALTSV 169
Query: 130 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLP 187
L Y APEVL Y VD+WSVG I E+ P F G ++V + I LP
Sbjct: 170 VVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLP 228
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290 |
| >gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Score = 95.8 bits (238), Expect = 1e-23
Identities = 71/243 (29%), Positives = 109/243 (44%), Gaps = 31/243 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E L VN ++ L A++ ++ + LV+ GG+L +I G EQ A +
Sbjct: 50 EKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+L GLE L I++RDLKPENILL DD ++I+D GL+ + G G+
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVG 166
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-------QLVRNINSCKHL 186
YMAPEV+ ++Y D W +G +++E++ G PF R + V+
Sbjct: 167 YMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSPFRKRKERVKREEVDRRVKEDQEEYSE 226
Query: 187 PFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE-----------FYHHRFLRRNSAILR 235
FS+ D +C LL+ N +RL F + F R + +L
Sbjct: 227 KFSE--------DAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNINFKRLEANMLE 278
Query: 236 APF 238
PF
Sbjct: 279 PPF 281
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285 |
| >gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-23
Identities = 74/228 (32%), Positives = 111/228 (48%), Gaps = 32/228 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I + E+ +LV+E+C G + S + +H + P Q
Sbjct: 71 EVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAITH 128
Query: 76 GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
GA GL L+SH++IHRD+K NILL+ + +K+ADFG + P N G+P
Sbjct: 129 GALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASKSSPAN---SFVGTPY 182
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+MAPEV+ +YD KVD+WS+G EL PP N + + +I +Q
Sbjct: 183 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHI--------AQ 234
Query: 191 LIVPALHPD--------CVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
P L + VD CL+ + +R + E H F+RR+
Sbjct: 235 NDSPTLQSNEWTDSFRGFVDYCLQKIPQ---ERPASAELLRHDFVRRD 279
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313 |
| >gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 2e-23
Identities = 71/219 (32%), Positives = 106/219 (48%), Gaps = 16/219 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I + E+ +LV+E+C G + S + +H + P Q
Sbjct: 75 EVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAITH 132
Query: 76 GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
GA GL L+SH++IHRD+K NILL+ + +K+ADFG + P N G+P
Sbjct: 133 GALQGLAYLHSHNMIHRDIKAGNILLT---EPGQVKLADFGSASIASPAN---SFVGTPY 186
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+MAPEV+ +YD KVD+WS+G EL PP N + + +I +
Sbjct: 187 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPTLQS 246
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
+ VD CL+ + DR + E H F+ R
Sbjct: 247 NEWSDYFRNFVDSCLQKIPQ---DRPTSEELLKHMFVLR 282
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317 |
| >gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 2e-23
Identities = 66/223 (29%), Positives = 110/223 (49%), Gaps = 25/223 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P I R + ++ +++++E+ GG+ ++ G + E L+++
Sbjct: 52 EITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLK-PGPLEETYIATILREI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
GL+ L+S IHRD+K N+LLS D +K+ADFG++ L G+P +
Sbjct: 111 LKGLDYLHSERKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI--NSCKHL------ 186
MAPEV++ YD K D+WS+G EL G PP S + ++++ I NS L
Sbjct: 168 MAPEVIKQSAYDFKADIWSLGITAIELAKGEPPNSDLHPMRVLFLIPKNSPPTLEGQYSK 227
Query: 187 PFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
PF + V+ C L+ + R + E H+F+ R
Sbjct: 228 PFK---------EFVEAC---LNKDPRFRPTAKELLKHKFITR 258
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277 |
| >gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Score = 94.9 bits (236), Expect = 2e-23
Identities = 58/178 (32%), Positives = 92/178 (51%), Gaps = 29/178 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
E++ L +NHPNI++L D EN ++LV EF +L ++ +P + +L
Sbjct: 49 EISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASPLSGIPLPLIKSYLF 107
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
QL GL +SH ++HRDLKP+N+L ++ + +K+ADFGL+ + G P+
Sbjct: 108 QLLQGLAFCHSHRVLHRDLKPQNLL---INTEGAIKLADFGLA----------RAFGVPV 154
Query: 134 -----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVR 178
Y APE+L + Y VD+WS+G I E++ F G + + QL R
Sbjct: 155 RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLFR 212
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284 |
| >gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Score = 95.1 bits (236), Expect = 3e-23
Identities = 71/219 (32%), Positives = 108/219 (49%), Gaps = 16/219 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I+ + E+ +LV+E+C G + S + +H + P Q
Sbjct: 65 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLG-SASDLLEVHKK-PLQEVEIAAVTH 122
Query: 76 GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
GA GL L+SH++IHRD+K NILLS + ++K+ DFG + + P N G+P
Sbjct: 123 GALQGLAYLHSHNMIHRDVKAGNILLS---EPGLVKLGDFGSASIMAPAN---XFVGTPY 176
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+MAPEV+ +YD KVD+WS+G EL PP N + + +I +
Sbjct: 177 WMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYHIAQNESPALQS 236
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
+ VD CL+ + DR + HRF+ R
Sbjct: 237 GHWSEYFRNFVDSCLQKIPQ---DRPTSEVLLKHRFVLR 272
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308 |
| >gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Score = 95.9 bits (238), Expect = 4e-23
Identities = 56/159 (35%), Positives = 92/159 (57%), Gaps = 10/159 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + ++ N P +++LF AFQ + +++V+E+ GG+L + + + VPE+ AR + ++
Sbjct: 93 ERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSNYD-VPEKWARFYTAEV 151
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPL 133
L+ ++S IHRD+KP+N+L LD LK+ADFG + + G+P
Sbjct: 152 VLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPD 208
Query: 134 YMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPF 168
Y++PEVL+ Q Y + D WSVG L+E+L G PF
Sbjct: 209 YISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPF 247
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371 |
| >gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Score = 95.2 bits (237), Expect = 6e-23
Identities = 60/168 (35%), Positives = 85/168 (50%), Gaps = 18/168 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRL---HGRVPEQ 66
EL + VNH NII L + F + ++LV+E NL I++ H R+
Sbjct: 65 ELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQMDLDHERM--- 120
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 121 --SYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMT 175
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
+ Y APEV+ Y E VD+WSVG I+ E++ G F G +++
Sbjct: 176 PYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIRGTVLFPGTDHI 223
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353 |
| >gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Score = 94.7 bits (235), Expect = 7e-23
Identities = 58/180 (32%), Positives = 102/180 (56%), Gaps = 13/180 (7%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRV 63
L + +C E + L + ++ I L AFQ EN ++LV+++ GG+L + + + R+
Sbjct: 40 LKRAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRL 99
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYP 121
PE AR +L ++ ++ ++ H +HRD+KP+NIL +D + +++ADFG SC +
Sbjct: 100 PEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG-SCLKLMED 155
Query: 122 GNYAEKVC-GSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
G V G+P Y++PE+LQ +Y + D WS+G ++E+L G PF + V+
Sbjct: 156 GTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCMYEMLYGETPFYAESLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332 |
| >gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 94.7 bits (236), Expect = 7e-23
Identities = 70/250 (28%), Positives = 116/250 (46%), Gaps = 45/250 (18%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
E+ L H NII + D + N +++V E +L I+ + +
Sbjct: 53 EIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELMET-DLYKLIKTQ-HLSNDHIQY 110
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYA 125
FL Q+ GL+ ++S +++HRDLKP N+LL+ D LKI DFGL + G
Sbjct: 111 FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCD---LKICDFGLARIADPEHDHTGFLT 167
Query: 126 EKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL------- 176
E V + Y APE+ L + Y + +D+WSVG IL E+L+ P F G++ + QL
Sbjct: 168 EYV-ATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGKDYLHQLNLILGVL 226
Query: 177 -------------------VRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217
++++ +P+++L P P +D+ K+L+ N R++
Sbjct: 227 GTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLF-PNADPKALDLLDKMLTFNPHKRIT 285
Query: 218 FNEFYHHRFL 227
E H +L
Sbjct: 286 VEEALAHPYL 295
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336 |
| >gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Score = 93.6 bits (232), Expect = 8e-23
Identities = 63/224 (28%), Positives = 110/224 (49%), Gaps = 23/224 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P + + + ++ +++++E+ GG+ +R G E L+++
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLY 134
GL+ L+S IHRD+K N+LLS D +K+ADFG++ L G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEQGD---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
MAPEV+Q YD K D+WS+G EL G PP S + ++++ +P + P
Sbjct: 168 MAPEVIQQSAYDSKADIWSLGITAIELAKGEPPNSDMHPMRVLF------LIP--KNNPP 219
Query: 195 ALHPD-------CVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
L + +D C L+ + R + E H+F+ +N+
Sbjct: 220 TLTGEFSKPFKEFIDAC---LNKDPSFRPTAKELLKHKFIVKNA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277 |
| >gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Score = 92.8 bits (231), Expect = 9e-23
Identities = 66/228 (28%), Positives = 99/228 (43%), Gaps = 25/228 (10%)
Query: 9 LKSCLD---CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRV 63
L +D E + S++H N+IRL+ + +V E G+L +R G
Sbjct: 36 LSDIMDDFLKEAAIMHSLDHENLIRLYGVVLTHP-LMMVTELAPLGSLLDRLRKDALGHF 94
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---- 119
T + Q+ G+ L S IHRDL NILL+ DD V KI DFGL L
Sbjct: 95 LISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLAS-DDKV--KIGDFGLMRALPQNE 151
Query: 120 --YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQ 175
Y KV P + APE L+ + + D+W G L+E+ G P++G + Q
Sbjct: 152 DHYVMEEHLKV---PFAWCAPESLRTRTFSHASDVWMFGVTLWEMFTYGEEPWAGLSGSQ 208
Query: 176 LVRNINSCKHLPFSQLIVP-ALHPDCVDMCLKLLSANTVDRLSFNEFY 222
+++ I+ L P A D ++ L+ + N DR +F
Sbjct: 209 ILKKIDKEGER----LERPEACPQDIYNVMLQCWAHNPADRPTFAALR 252
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257 |
| >gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 93.6 bits (233), Expect = 9e-23
Identities = 64/194 (32%), Positives = 93/194 (47%), Gaps = 29/194 (14%)
Query: 1 MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
MLK + K D E+ + + H NII L E +++VVE+ A GNL ++
Sbjct: 49 MLKD-DATEKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFL 107
Query: 58 RLHGRVPEQTARK-----------------FLQQLGAGLEILNSHHIIHRDLKPENILLS 100
R R P + A F Q+ G+E L S IHRDL N+L++
Sbjct: 108 RAR-RPPGEYASPDDPRPPEETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVT 166
Query: 101 GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAI 157
+D VM KIADFGL+ ++ +Y K L +MAPE L + Y + D+WS G +
Sbjct: 167 --EDHVM-KIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVL 223
Query: 158 LFELLN-GYPPFSG 170
L+E+ G P+ G
Sbjct: 224 LWEIFTLGGSPYPG 237
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293 |
| >gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Score = 93.4 bits (233), Expect = 1e-22
Identities = 60/176 (34%), Positives = 89/176 (50%), Gaps = 33/176 (18%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL- 72
E+N L + HPNI+ + + N I++V+E+ +L S + + Q+ K L
Sbjct: 54 EINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVEH-DLKSLMETMKQPFLQSEVKCLM 112
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
QL +G+ L+ + I+HRDLK N+LL+ G+ LKI DFGL+ + G
Sbjct: 113 LQLLSGVAHLHDNWILHRDLKTSNLLLNNRGI-----LKICDFGLA----------REYG 157
Query: 131 SPL-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
SPL Y APE+L + Y +DMWSVG I ELL P F G++ +
Sbjct: 158 SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEI 213
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293 |
| >gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Score = 92.7 bits (230), Expect = 1e-22
Identities = 58/203 (28%), Positives = 104/203 (51%), Gaps = 11/203 (5%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L+ +S+ + P I+ + AF + + +++ GG+L ++ HG E R + ++
Sbjct: 48 LSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEII 107
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
GLE +++ +++RDLKP NIL LD+ ++I+D GL+C + G+ YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163
Query: 137 PEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLI-VP 194
PEVLQ YD D +S+G +LF+LL G+ PF ++ + + + + +P
Sbjct: 164 PEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKT----KDKHEIDRMTLTMAVELP 219
Query: 195 -ALHPDCVDMCLKLLSANTVDRL 216
+ P+ + LL + RL
Sbjct: 220 DSFSPELRSLLEGLLQRDVNRRL 242
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278 |
| >gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Score = 93.0 bits (231), Expect = 2e-22
Identities = 69/258 (26%), Positives = 111/258 (43%), Gaps = 65/258 (25%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFC---------AGGNLSSYIRLHGRVPEQ 66
E++ L + H NI+RL D +E ++LV E+ + + + RL
Sbjct: 51 EISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLDLDLKKHMDSSPDFAKNPRL------- 103
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
+ +L Q+ G+ +SH ++HRDLKP+N+L+ + LK+ADFGL+
Sbjct: 104 -IKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTN--ALKLADFGLA---------- 150
Query: 127 KVCGSPL-----------YMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
+ G P+ Y APE+L R Y VD+WSVG I E++N P F G + +
Sbjct: 151 RAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEI 210
Query: 175 QLVRNINS------------CKHLP-----FSQ-------LIVPALHPDCVDMCLKLLSA 210
+ I LP F + +VP L P VD+ K+L
Sbjct: 211 DELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRL 270
Query: 211 NTVDRLSFNEFYHHRFLR 228
+ R++ H + +
Sbjct: 271 DPSKRITARAALEHEYFK 288
|
Length = 294 |
| >gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Score = 92.0 bits (228), Expect = 2e-22
Identities = 55/196 (28%), Positives = 100/196 (51%), Gaps = 9/196 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
E N + ++ H ++RL+ E I+++ E+ A G+L +++ G+V F
Sbjct: 51 EANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSA 110
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ G+ + + IHRDL+ N+L+S + +M KIADFGL+ + Y A + P
Sbjct: 111 QIAEGMAYIERKNYIHRDLRAANVLVS---ESLMCKIADFGLARVIEDNEYTAREGAKFP 167
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+ + APE + F + K D+WS G +L+E++ G P+ G +N ++ + +P +
Sbjct: 168 IKWTAPEAINFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPRME 227
Query: 191 LIVPALHPDCVDMCLK 206
L+ D + C K
Sbjct: 228 NCPDELY-DIMKTCWK 242
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261 |
| >gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Score = 93.2 bits (231), Expect = 2e-22
Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 6/163 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L +FQ ++ + V+E+ GG L ++ E R + ++
Sbjct: 45 ESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEI 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSPL 133
+ L+ L+S I++RDLK EN++L D D +KI DFGL C + + CG+P
Sbjct: 105 VSALDYLHSGKIVYRDLKLENLML---DKDGHIKITDFGL-CKEGITDAATMKTFCGTPE 160
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
Y+APEVL+ Y VD W +G +++E++ G PF +++ +L
Sbjct: 161 YLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKL 203
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328 |
| >gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 91.3 bits (227), Expect = 3e-22
Identities = 49/167 (29%), Positives = 87/167 (52%), Gaps = 16/167 (9%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
LK + ++ L E + ++++ HPN+++L N +++V E+ A G+L Y+R
Sbjct: 36 CLKDDSTAAQAFLA-EASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSR 94
Query: 61 GR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--- 115
GR + F + G+E L + +HRDL N+L+S +D++ K++DFGL
Sbjct: 95 GRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVS---EDLVAKVSDFGLAKE 151
Query: 116 -SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161
S G K + APE L+ +++ K D+WS G +L+E+
Sbjct: 152 ASQGQDSGKLPVK------WTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256 |
| >gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Score = 92.8 bits (230), Expect = 3e-22
Identities = 60/184 (32%), Positives = 101/184 (54%), Gaps = 16/184 (8%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
MLK+ +C E N L + + I L AFQ EN ++LV+++ GG+L + + +
Sbjct: 39 MLKRAET---ACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKF 95
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-- 117
R+PE AR ++ ++ + ++ H +HRD+KP+N+L LD + +++ADFG SC
Sbjct: 96 EDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVL---LDMNGHIRLADFG-SCLK 151
Query: 118 TLYPGNYAEKVC-GSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
G V G+P Y++PE+LQ +Y + D WS+G ++E+L G PF
Sbjct: 152 MNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCMYEMLYGETPFYAE 211
Query: 172 NNVQ 175
+ V+
Sbjct: 212 SLVE 215
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331 |
| >gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Score = 91.1 bits (227), Expect = 5e-22
Identities = 45/152 (29%), Positives = 77/152 (50%), Gaps = 19/152 (12%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
++PN I+L+ + L++++ G+L ++ G++ E +K ++QL L L+
Sbjct: 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLH 126
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL-------YMA 136
H+IIH D+K EN+L D + + D+GL K+ G+P Y +
Sbjct: 127 KHNIIHNDIKLENVLYDRAKDRI--YLCDYGLC----------KIIGTPSCYDGTLDYFS 174
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
PE ++ YD D W+VG + +ELL G PF
Sbjct: 175 PEKIKGHNYDVSFDWWAVGVLTYELLTGKHPF 206
|
Length = 267 |
| >gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Score = 90.7 bits (225), Expect = 5e-22
Identities = 50/181 (27%), Positives = 90/181 (49%), Gaps = 9/181 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E + ++H +++L+ + I++V E+ + G L +Y+R HG+ + + +
Sbjct: 49 EAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L S IHRDL N L +DD +K++DFGLS + Y V GS
Sbjct: 109 VCEGMAYLESKQFIHRDLAARNCL---VDDQGCVKVSDFGLSRYVLDDEYTSSV-GSKFP 164
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+ PEVL + ++ K D+W+ G +++E+ + G P+ NN + V ++ L
Sbjct: 165 VRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGKMPYERFNNSETVEKVSQGLRLYRPH 224
Query: 191 L 191
L
Sbjct: 225 L 225
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256 |
| >gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Score = 92.4 bits (229), Expect = 7e-22
Identities = 61/165 (36%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL L VNH NII L + F + ++LV+E NL I H + +
Sbjct: 70 ELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVI--HMELDHERMS 126
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 127 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTACTNFMMTPYV 183
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
+ Y APEV+ Y E VD+WSVG I+ EL+ G F G +++
Sbjct: 184 VTRYYRAPEVILGMGYKENVDIWSVGCIMGELVKGSVIFQGTDHI 228
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359 |
| >gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Score = 91.6 bits (227), Expect = 7e-22
Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 17/220 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E L + HP + L +FQ + + V+E+ GG L ++ E AR + ++
Sbjct: 45 ENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEI 104
Query: 76 GAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT--LYPGNYAEKVCGSP 132
+ L+ L+S ++++RDLK EN++L D D +KI DFGL C + G + CG+P
Sbjct: 105 VSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGL-CKEGIKDGATMKTFCGTP 160
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLI 192
Y+APEVL+ Y VD W +G +++E++ G PF +++ +L I + + F +
Sbjct: 161 EYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEKLFELI-LMEEIRFPR-- 217
Query: 193 VPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFL 227
L P+ + LL + RL E H+F
Sbjct: 218 --TLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFF 255
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325 |
| >gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Score = 90.9 bits (226), Expect = 7e-22
Identities = 54/165 (32%), Positives = 89/165 (53%), Gaps = 8/165 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L + HPN++ L + F+ + + LV E+C L+ + VPE +K + Q
Sbjct: 50 EIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQT 109
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPL 133
+ + H+ IHRD+KPENIL++ +K+ DFG + L +Y + V +
Sbjct: 110 LQAVNFCHKHNCIHRDVKPENILIT---KQGQIKLCDFGFARILTGPGDDYTDYV-ATRW 165
Query: 134 YMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
Y APE+L +Y VD+W++G + ELL G P + G+++V QL
Sbjct: 166 YRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQL 210
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286 |
| >gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Score = 90.2 bits (224), Expect = 9e-22
Identities = 58/221 (26%), Positives = 100/221 (45%), Gaps = 11/221 (4%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-H 60
LK + + E+ L + H ++I LF ++++ E G+L +++R
Sbjct: 38 LKSDDLLKQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPE 97
Query: 61 GRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
G+V P + Q+ G+ L + IHRDL NIL+ +D++ K+ADFGL+ +
Sbjct: 98 GQVLPVASLIDMACQVAEGMAYLEEQNSIHRDLAARNILV---GEDLVCKVADFGLARLI 154
Query: 120 YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLV 177
Y P + APE + K D+WS G +L+E+ G P+ G NN ++
Sbjct: 155 KEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVY 214
Query: 178 RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF 218
I + +P ++ + L+ +A DR SF
Sbjct: 215 DQITAGYRMPCPAKCPQEIY----KIMLECWAAEPEDRPSF 251
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261 |
| >gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Score = 89.8 bits (222), Expect = 2e-21
Identities = 59/229 (25%), Positives = 109/229 (47%), Gaps = 33/229 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P + + + ++ + +++++E+ GG+ + G + E L+++
Sbjct: 52 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 110
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSPLY 134
GL+ L+S IHRD+K N+LLS + +K+ADFG++ L G+P +
Sbjct: 111 LKGLDYLHSEKKIHRDIKAANVLLSEHGE---VKLADFGVAGQLTDTQIKRNTFVGTPFW 167
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
MAPEV++ YD K D+WS+G EL G PP S + ++++ ++P
Sbjct: 168 MAPEVIKQSAYDSKADIWSLGITAIELAKGEPPHSELHPMKVL-------------FLIP 214
Query: 195 ALHP------------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
+P + V+ C L+ R + E H+F+ R +
Sbjct: 215 KNNPPTLEGNYSKPLKEFVEAC---LNKEPSFRPTAKELLKHKFIVRFA 260
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277 |
| >gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Score = 90.5 bits (225), Expect = 2e-21
Identities = 61/212 (28%), Positives = 92/212 (43%), Gaps = 38/212 (17%)
Query: 16 ELNFLSSVNHPNIIRLFD-----AFQAENC---IFLVVEFC----AGGNLSSYIRLHGRV 63
E+ L + H N++ L + A +LV EFC AG L S + +
Sbjct: 61 EIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAG--LLSNKNVKFTL 118
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--- 120
E +K ++ L GL ++ + I+HRD+K NIL++ D +LK+ADFGL+
Sbjct: 119 SE--IKKVMKMLLNGLYYIHRNKILHRDMKAANILIT---KDGILKLADFGLARAFSLSK 173
Query: 121 ---PGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
P Y +V + Y PE+L +R Y +DMW G I+ E+ P G
Sbjct: 174 NSKPNRYTNRVV-TLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQ 232
Query: 177 VRNINSCKHLPFSQL---IVPALHPDCVDMCL 205
+ I SQL I P + P + L
Sbjct: 233 LTLI--------SQLCGSITPEVWPGVDKLEL 256
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310 |
| >gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Score = 90.1 bits (223), Expect = 2e-21
Identities = 58/184 (31%), Positives = 97/184 (52%), Gaps = 19/184 (10%)
Query: 13 LDCELNFLSSV-NHPNIIRLFDAF-QAENCI----FLVVEFCAGGNLSSYI----RLHGR 62
++ E N L S+ NHPN+++ + F +A+ + +LV+E C GG+++ + R
Sbjct: 65 IEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQR 124
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E L GL+ L+++ IIHRD+K NILL+ + +K+ DFG+S L
Sbjct: 125 LDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTT---EGGVKLVDFGVSAQLTST 181
Query: 123 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
G+P +MAPEV+ ++ YD + D+WS+G EL +G PP + V+
Sbjct: 182 RLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDPPLFDMHPVKT 241
Query: 177 VRNI 180
+ I
Sbjct: 242 LFKI 245
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291 |
| >gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein | Back alignment and domain information |
|---|
Score = 92.2 bits (229), Expect = 2e-21
Identities = 56/174 (32%), Positives = 83/174 (47%), Gaps = 13/174 (7%)
Query: 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVP-E 65
H ++ E + + HPNI+ L D+ +A +F V E+ G L + G +P
Sbjct: 20 HQRARFRRETALCARLYHPNIVALLDSGEAPPGLLFAVFEYVPGRTLREVLAADGALPAG 79
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--- 122
+T R LQ L A L ++ I+HRDLKP+NI++S K+ DFG+ TL PG
Sbjct: 80 ETGRLMLQVLDA-LACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIG-TLLPGVRD 137
Query: 123 ------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
+V G+P Y APE L+ + D+++ G I E L G G
Sbjct: 138 ADVATLTRTTEVLGTPTYCAPEQLRGEPVTPNSDLYAWGLIFLECLTGQRVVQG 191
|
This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266 |
| >gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Score = 89.7 bits (222), Expect = 3e-21
Identities = 53/156 (33%), Positives = 87/156 (55%), Gaps = 9/156 (5%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P ++ L AFQ + + L++++ GG L +++ R EQ + + ++ LE L+
Sbjct: 65 PFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKL 124
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ 143
II+RD+K ENIL LD + + + DFGLS + A CG+ YMAP++++
Sbjct: 125 GIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGG 181
Query: 144 R--YDEKVDMWSVGAILFELLNGYPPFS--GRNNVQ 175
+D+ VD WS+G +++ELL G PF+ G N Q
Sbjct: 182 DGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNSQ 217
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290 |
| >gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Score = 89.3 bits (221), Expect = 3e-21
Identities = 56/215 (26%), Positives = 111/215 (51%), Gaps = 7/215 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H N++ +++++ + +++V+EF GG L+ I H R+ E+ +
Sbjct: 67 EVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIAAVCLAV 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
L +L++ +IHRD+K ++ILL+ D +K++DFG + K + G+P +
Sbjct: 126 LKALSVLHAQGVIHRDIKSDSILLT---HDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYW 182
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
MAPE++ Y +VD+WS+G ++ E+++G PP+ ++ ++ I +LP +
Sbjct: 183 MAPELISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMIRD--NLPPKLKNLH 240
Query: 195 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
+ P +LL + R + E H FL +
Sbjct: 241 KVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAK 275
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292 |
| >gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Score = 89.4 bits (222), Expect = 3e-21
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ GR+PE K +
Sbjct: 49 ELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAV 108
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 109 LRGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 164
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 166
M+PE LQ Y + D+WS+G L E+ G YP
Sbjct: 165 MSPERLQGTHYTVQSDIWSLGLSLVEMAIGRYP 197
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308 |
| >gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Score = 88.9 bits (220), Expect = 4e-21
Identities = 52/153 (33%), Positives = 88/153 (57%), Gaps = 5/153 (3%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L+ +S+ + P I+ + AF + + +++ GG+L ++ HG E+ R + ++
Sbjct: 48 LSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEII 107
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMA 136
GLE +++ +++RDLKP NIL LD+ ++I+D GL+C + G+ YMA
Sbjct: 108 LGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLACD-FSKKKPHASVGTHGYMA 163
Query: 137 PEVLQF-QRYDEKVDMWSVGAILFELLNGYPPF 168
PEVLQ YD D +S+G +LF+LL G+ PF
Sbjct: 164 PEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279 |
| >gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 90.0 bits (223), Expect = 4e-21
Identities = 63/194 (32%), Positives = 101/194 (52%), Gaps = 25/194 (12%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
+KKL + +S L EL L + H N+I L D F + + +LV+ F G
Sbjct: 45 IKKLYRPFQSELFAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPF-MG 103
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L ++ H ++ E + + Q+ GL+ +++ IIHRDLKP N+ +++D LKI
Sbjct: 104 TDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNL---AVNEDCELKI 159
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
DFGL+ ++ G + Y APEV L + Y + VD+WSVG I+ E+L G P
Sbjct: 160 LDFGLA-----RQTDSEMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKP 214
Query: 167 PFSGRNNVQLVRNI 180
F G +++ + I
Sbjct: 215 LFKGHDHLDQLMEI 228
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343 |
| >gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.0 bits (221), Expect = 5e-21
Identities = 56/164 (34%), Positives = 83/164 (50%), Gaps = 9/164 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + L + H NI+ L D + + LV E+ +L Y+ G + R FL Q
Sbjct: 53 EASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLDT-DLKQYMDDCGGGLSMHNVRLFLFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGN-YAEKVCGSP 132
L GL + ++HRDLKP+N+L+S + LK+ADFGL+ P Y+ +V +
Sbjct: 112 LLRGLAYCHQRRVLHRDLKPQNLLISERGE---LKLADFGLARAKSVPSKTYSNEVV-TL 167
Query: 133 LYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
Y P+VL Y +DMW VG I +E+ G P F G +V+
Sbjct: 168 WYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVE 211
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291 |
| >gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Score = 89.1 bits (221), Expect = 6e-21
Identities = 66/211 (31%), Positives = 110/211 (52%), Gaps = 17/211 (8%)
Query: 28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQLGAGLEILNSHH 86
I L AFQ EN ++LV+++ GG+L + + + R+PE AR +L ++ ++ ++
Sbjct: 63 ITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQLG 122
Query: 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSC--TLYPGNYAEKVC-GSPLYMAPEVLQFQ 143
+HRD+KP+N+L LD + +++ADFG SC L G V G+P Y++PE+LQ
Sbjct: 123 YVHRDIKPDNVL---LDKNGHIRLADFG-SCLRLLADGTVQSNVAVGTPDYISPEILQAM 178
Query: 144 -----RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI-NSCKHLPFSQLIVPALH 197
RY + D WS+G ++E+L G PF + V+ I N +H F V +
Sbjct: 179 EDGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQFP-PDVTDVS 237
Query: 198 PDCVDMCLKLL--SANTVDRLSFNEFYHHRF 226
+ D+ +L+ + R +F H F
Sbjct: 238 EEAKDLIRRLICSPETRLGRNGLQDFKDHPF 268
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331 |
| >gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Score = 88.6 bits (219), Expect = 6e-21
Identities = 49/166 (29%), Positives = 94/166 (56%), Gaps = 5/166 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + +H N++ +++++ + +++V+EF GG L+ I H R+ E+ +
Sbjct: 69 EVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTD-IVTHTRMNEEQIATVCLSV 127
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
L L++ +IHRD+K ++ILL+ D +K++DFG + K + G+P +
Sbjct: 128 LRALSYLHNQGVIHRDIKSDSILLT---SDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYW 184
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
MAPEV+ Y +VD+WS+G ++ E+++G PP+ +Q +R I
Sbjct: 185 MAPEVISRLPYGTEVDIWSLGIMVIEMIDGEPPYFNEPPLQAMRRI 230
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292 |
| >gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Score = 88.5 bits (219), Expect = 7e-21
Identities = 75/241 (31%), Positives = 109/241 (45%), Gaps = 35/241 (14%)
Query: 17 LNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTAR 69
L L + +HPNI+RL D E + LV E +L +Y+ +P +T +
Sbjct: 53 LKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEH-VDQDLRTYLDKVPPPGLPAETIK 111
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKV 128
++Q GL+ L+++ I+HRDLKPENIL++ +K+ADFGL+ +Y A V
Sbjct: 112 DLMRQFLRGLDFLHANCIVHRDLKPENILVTSGG---QVKLADFGLA-RIYSCQMALTPV 167
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLP- 187
+ Y APEVL Y VDMWSVG I E+ P F G + + I LP
Sbjct: 168 VVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPP 227
Query: 188 --------------FS-------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226
FS Q +VP + + L++L+ N R+S H F
Sbjct: 228 EDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISAFRALQHPF 287
Query: 227 L 227
Sbjct: 288 F 288
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288 |
| >gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 87.4 bits (217), Expect = 1e-20
Identities = 54/218 (24%), Positives = 103/218 (47%), Gaps = 17/218 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR-VPEQTARKFLQ 73
E + + H +++L+ E I++V E+ + G+L +++ G+ +
Sbjct: 51 EAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAA 110
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ G+ L S + IHRDL NIL+ ++++ KIADFGL+ + Y + G+
Sbjct: 111 QIAEGMAYLESRNYIHRDLAARNILVG---ENLVCKIADFGLARLIEDDEYTARE-GAKF 166
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFS 189
+ APE + R+ K D+WS G +L E++ G P+ G N +++ + +P
Sbjct: 167 PIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTYGRVPYPGMTNREVLEQVERGYRMP-- 224
Query: 190 QLIVPALHPDCV-DMCLKLLSANTVDRLSFNEFYHHRF 226
P P+ + D+ L+ + +R +F E+
Sbjct: 225 ---RPPNCPEELYDLMLQCWDKDPEERPTF-EYLQSFL 258
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261 |
| >gnl|CDD|173667 cd05576, STKc_RPK118_like, Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Score = 86.8 bits (215), Expect = 1e-20
Identities = 52/160 (32%), Positives = 80/160 (50%), Gaps = 7/160 (4%)
Query: 7 KHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
K L+ + L+ + H PN++ L +E+ +FLV++ GG L S+I +P
Sbjct: 24 KGLRKSSEYSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIP 83
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
E+ +++ ++ L+ L+ I+ RDL P NIL LDD +++ F +
Sbjct: 84 EECVKRWAAEMVVALDALHREGIVCRDLNPNNIL---LDDRGHIQLTYFSRWSEVEDSCD 140
Query: 125 AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
E V +Y APEV E D WS+GAILFELL G
Sbjct: 141 GEAV--ENMYCAPEVGGISEETEACDWWSLGAILFELLTG 178
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phosphate (SPP), a lipid messenger involved in many cellular events. RPK118 may be involved in transmitting SPP-mediated signaling. RPK118 also binds the antioxidant peroxiredoxin-3 (PRDX3). RPK118 may be involved in the transport of PRDX3 from the cytoplasm to its site of function in the mitochondria. Length = 237 |
| >gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-20
Identities = 65/223 (29%), Positives = 100/223 (44%), Gaps = 22/223 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L + P II + AF EN I + EF GG+L Y ++PE + +
Sbjct: 49 ELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAV 104
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
GL L S I+HRD+KP N+L++ +K+ DFG+S L + A+ G+ YM
Sbjct: 105 VKGLTYLWSLKILHRDVKPSNMLVNTRGQ---VKLCDFGVSTQLV-NSIAKTYVGTNAYM 160
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNG---YPPFSGRNN----VQLVRNI--NSCKHL 186
APE + ++Y D+WS+G EL G YP +QL++ I L
Sbjct: 161 APERISGEQYGIHSDVWSLGISFMELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDPPVL 220
Query: 187 PFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
P Q +H + C++ +R + H F+ +
Sbjct: 221 PVGQFSEKFVH--FITQCMRKQPK---ERPAPENLMDHPFIVQ 258
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279 |
| >gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 1e-20
Identities = 52/155 (33%), Positives = 85/155 (54%), Gaps = 5/155 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E L VN P I+ L AF+++ + LV+ GG+L +I G + R +
Sbjct: 43 EKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSA 102
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ G+ L+S I++RD+KPEN+LL DD +++D GL+ L G + G+
Sbjct: 103 QITCGILHLHSMDIVYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNG 159
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168
YMAPE+L+ + Y VD +++G ++E++ G PF
Sbjct: 160 YMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTPF 194
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277 |
| >gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Score = 86.9 bits (215), Expect = 1e-20
Identities = 50/172 (29%), Positives = 91/172 (52%), Gaps = 9/172 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + ++HP +++L+ + I LV EF G LS Y+R G+ ++T
Sbjct: 49 EAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L S ++IHRDL N L+ ++ ++K++DFG++ + Y G+
Sbjct: 109 VCEGMAYLESSNVIHRDLAARNCLVG---ENQVVKVSDFGMTRFVLDDQYTSST-GTKFP 164
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINS 182
+ +PEV F +Y K D+WS G +++E+ + G P+ R+N ++V IN+
Sbjct: 165 VKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEVVETINA 216
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256 |
| >gnl|CDD|132953 cd06622, PKc_MAPKK_PBS2_like, Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Score = 87.6 bits (217), Expect = 1e-20
Identities = 66/235 (28%), Positives = 103/235 (43%), Gaps = 41/235 (17%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFL 72
EL+ L P I+ + AF E +++ +E+ G+L +PE R+
Sbjct: 49 ELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRIT 108
Query: 73 QQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
+ GL+ L H+IIHRD+KP N+L++G + +K+ DFG+S L + A+ G
Sbjct: 109 YAVVKGLKFLKEEHNIIHRDVKPTNVLVNG---NGQVKLCDFGVSGNLV-ASLAKTNIGC 164
Query: 132 PLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNG---YPPFSGRNNVQLVRNINS 182
YMAPE + Q Y + D+WS+G + E+ G YPP + NI
Sbjct: 165 QSYMAPERIKSGGPNQNPTYTVQSDVWSLGLSILEMALGRYPYPP-------ETYANI-- 215
Query: 183 CKHLPFSQL--IV--------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
F+QL IV D D K L+ R ++ + H +L
Sbjct: 216 -----FAQLSAIVDGDPPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWL 265
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Polymyxin B resistance protein 2 (PBS2) from Saccharomyces cerevisiae, Wis1 from Schizosaccharomyces pombe, and related proteins. PBS2 and Wis1 are components of stress-activated MAPK cascades in budding and fission yeast, respectively. PBS2 is the specific activator of the MAPK Hog1, which plays a central role in the response of budding yeast to stress including exposure to arsenite and hyperosmotic environments. Wis1 phosphorylates and activates the MAPK Sty1 (also called Spc1 or Phh1), which stimulates a transcriptional response to a wide range of cellular insults through the bZip transcription factors Atf1, Pcr1, and Pap1. Length = 286 |
| >gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Score = 87.1 bits (216), Expect = 2e-20
Identities = 48/186 (25%), Positives = 91/186 (48%), Gaps = 23/186 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------- 61
E L++ H NI++ + + +V E+ G+L+ ++R HG
Sbjct: 58 EAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMG 117
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ + Q+ +G+ L S H +HRDL N L+ D+++KI DFG+S +Y
Sbjct: 118 ELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVG---YDLVVKIGDFGMSRDVYT 174
Query: 122 GNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL 176
+Y +V G + +M PE + ++++ + D+WS G +L+E+ G P+ G +N ++
Sbjct: 175 TDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVVLWEIFTYGKQPWYGLSNEEV 233
Query: 177 VRNINS 182
+ I
Sbjct: 234 IECITQ 239
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280 |
| >gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 2e-20
Identities = 62/232 (26%), Positives = 115/232 (49%), Gaps = 23/232 (9%)
Query: 13 LDCELNFLSSV-NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSS----YIRLHGR 62
++ E N L ++ +HPN+++ + + ++ ++LV+E C GG+++ +++ R
Sbjct: 61 IEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGER 120
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E L + GL+ L+ + IHRD+K NILL+ + +K+ DFG+S L
Sbjct: 121 MEEPIIAYILHEALMGLQHLHVNKTIHRDVKGNNILLT---TEGGVKLVDFGVSAQLTST 177
Query: 123 NYAEKV-CGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
G+P +MAPEV+ ++ YD + D+WS+G EL +G PP + ++
Sbjct: 178 RLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDPPLA---DLHP 234
Query: 177 VRNINSCKHLPFSQLIVPAL-HPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
+R + P L P L + D K L+ + R + ++ H F+
Sbjct: 235 MRALFKIPRNPPPTLHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286 |
| >gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Score = 87.7 bits (217), Expect = 2e-20
Identities = 63/198 (31%), Positives = 101/198 (51%), Gaps = 15/198 (7%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P ++ L AFQ E + L++++ +GG + +++ E R + ++ LE L+
Sbjct: 65 PFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKL 124
Query: 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQ 143
I++RD+K ENIL LD + + + DFGLS CG+ YMAPE+++ +
Sbjct: 125 GIVYRDIKLENIL---LDSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGK 181
Query: 144 R-YDEKVDMWSVGAILFELLNGYPPFS--GRNNVQ--LVRNINSCKHLPFSQLIVPALHP 198
+ + VD WS+G ++FELL G PF+ G N Q + R I C PF + P
Sbjct: 182 GGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQSEVSRRILKCDP-PFP----SFIGP 236
Query: 199 DCVDMCLKLLSANTVDRL 216
+ D+ KLL + RL
Sbjct: 237 EAQDLLHKLLRKDPKKRL 254
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332 |
| >gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.3 bits (214), Expect = 2e-20
Identities = 48/170 (28%), Positives = 91/170 (53%), Gaps = 9/170 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + ++HPN+++L+ + IF+V E+ A G L +Y+R G++ +
Sbjct: 49 EAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 132
+ +E L S+ IHRDL N L+ +D ++K++DFGL+ + Y G+ P
Sbjct: 109 VCEAMEYLESNGFIHRDLAARNCLVG---EDNVVKVSDFGLARYVLDDQYTSSQ-GTKFP 164
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNI 180
+ + PEV + R+ K D+WS G +++E+ + G P+ +N ++V ++
Sbjct: 165 VKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGKMPYERFSNSEVVESV 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256 |
| >gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 3e-20
Identities = 52/187 (27%), Positives = 99/187 (52%), Gaps = 23/187 (12%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV----PEQTARKFLQ 73
S + HPNI+ L E + ++ +C+ +L ++ + H V ++T + L+
Sbjct: 63 SRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLE 122
Query: 74 ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
Q+ AG+E L+SHH++H+DL N+L+ D + +KI+D GL +Y +Y
Sbjct: 123 PADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVF---DKLNVKISDLGLFREVYAADY 179
Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNI 180
+ + S L +M+PE + + ++ D+WS G +L+E+ + G P+ G +N ++ I
Sbjct: 180 YKLMGNSLLPIRWMSPEAIMYGKFSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMI 239
Query: 181 NSCKHLP 187
+ + LP
Sbjct: 240 RNRQVLP 246
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283 |
| >gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 87.4 bits (216), Expect = 3e-20
Identities = 62/206 (30%), Positives = 109/206 (52%), Gaps = 25/206 (12%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F N ++LV G
Sbjct: 47 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 105
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L++ ++ ++ + + + Q+ GL+ ++S IIHRDLKP N+ +++D LKI
Sbjct: 106 ADLNNIVKCQ-KLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNL---AVNEDCELKI 161
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
DFGL+ + +++ G + Y APE+ L + Y++ VD+WSVG I+ ELL G
Sbjct: 162 LDFGLA-----RHTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRT 216
Query: 167 PFSGRNNVQLVRNINSCKHLPFSQLI 192
F G +++ ++ I P ++L+
Sbjct: 217 LFPGTDHIDQLKLILRLVGTPGAELL 242
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345 |
| >gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 86.0 bits (213), Expect = 4e-20
Identities = 63/220 (28%), Positives = 109/220 (49%), Gaps = 37/220 (16%)
Query: 24 NHPNIIRLFD-AFQAENC-----IFLVVEFCAGGNLSSYI---RLHG---RVPEQTARKF 71
+HPN+++L F+A + +++ F G+L S++ RL G ++P QT KF
Sbjct: 59 DHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKF 118
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
+ + G+E L++ + IHRDL N + L +D+ + +ADFGLS +Y G+Y + +
Sbjct: 119 MVDIALGMEYLSNRNFIHRDLAARNCM---LREDMTVCVADFGLSKKIYSGDYYRQGRIA 175
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN---VQLVRNINSCK 184
+ ++A E L + Y K D+W+ G ++E+ G P+ G N +R+ N K
Sbjct: 176 KMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLK 235
Query: 185 HLPFSQLIVPALHPDCVDMCLKLLS----ANTVDRLSFNE 220
P DC+D L+ A+ DR +F +
Sbjct: 236 Q-P----------EDCLDELYDLMYSCWRADPKDRPTFTK 264
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273 |
| >gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Score = 87.0 bits (215), Expect = 4e-20
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 5/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ GR+PEQ K +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 112
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 113 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
M+PE LQ Y + D+WS+G L E+ G P
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVEMAIGRYP 201
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333 |
| >gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 4e-20
Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 7/156 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H NI+ F ++ + +++ +EFC GG+L + G + E ++
Sbjct: 56 EIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRET 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
GL L+S +HRD+K NILL+ D+ +K+ADFG+S + K G+P +
Sbjct: 116 LQGLYYLHSKGKMHRDIKGANILLT---DNGHVKLADFGVSAQITATIAKRKSFIGTPYW 172
Query: 135 MAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPP 167
MAPEV +R Y++ D+W+VG EL PP
Sbjct: 173 MAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267 |
| >gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-20
Identities = 56/163 (34%), Positives = 87/163 (53%), Gaps = 9/163 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + L + H NI+ L D + + V E+ +L+ Y+ H G + R F+ Q
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTFVFEYMHT-DLAQYMIQHPGGLHPYNVRLFMFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL--SCTLYPGNYAEKVCGSP 132
L GL ++ HI+HRDLKP+N+L+S L + LK+ADFGL + ++ Y+ +V +
Sbjct: 112 LLRGLAYIHGQHILHRDLKPQNLLISYLGE---LKLADFGLARAKSIPSQTYSSEVV-TL 167
Query: 133 LYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
Y P+VL Y +D+W G I E+L G P F G ++V
Sbjct: 168 WYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDV 210
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291 |
| >gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Score = 86.2 bits (213), Expect = 5e-20
Identities = 55/183 (30%), Positives = 93/183 (50%), Gaps = 31/183 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------------ 63
E N L VNHP++I+L+ A + + L+VE+ G+L S++R +V
Sbjct: 53 EFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRN 112
Query: 64 ------PEQTAR------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
P++ A F Q+ G++ L ++HRDL N+L++ + +KI+
Sbjct: 113 SSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVA---EGRKMKIS 169
Query: 112 DFGLSCTLYPGN-YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 167
DFGLS +Y + Y ++ G P+ +MA E L Y + D+WS G +L+E++ G P
Sbjct: 170 DFGLSRDVYEEDSYVKRSKGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 229
Query: 168 FSG 170
+ G
Sbjct: 230 YPG 232
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290 |
| >gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Score = 85.6 bits (212), Expect = 6e-20
Identities = 57/175 (32%), Positives = 88/175 (50%), Gaps = 17/175 (9%)
Query: 16 ELNFL------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
E +FL S NH NI+RL F+++E AGG+L S++R + PE+ +
Sbjct: 53 ESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSS 112
Query: 70 KFLQQL-------GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
++ L G + L +H IHRD+ N LL+ + KIADFG++ +Y
Sbjct: 113 LTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRA 172
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN 173
+Y K + L +M PE + K D+WS G +L+E+ + GY P+ GR N
Sbjct: 173 SYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGVLLWEIFSLGYMPYPGRTN 227
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277 |
| >gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Score = 85.9 bits (212), Expect = 6e-20
Identities = 59/216 (27%), Positives = 112/216 (51%), Gaps = 13/216 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H N++ ++ ++ +++++EF GG L+ + R+ E+ + +
Sbjct: 68 EVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QTRLNEEQIATVCESV 126
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPL 133
L L+S +IHRD+K ++ILL+ LD V K++DFG C + ++ + G+P
Sbjct: 127 LQALCYLHSQGVIHRDIKSDSILLT-LDGRV--KLSDFGF-CAQISKDVPKRKSLVGTPY 182
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSC--KHLPFSQL 191
+MAPEV+ Y +VD+WS+G ++ E+++G PP+ + VQ ++ + L +
Sbjct: 183 WMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNAHK 242
Query: 192 IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
I P L D ++L+ +R + E H FL
Sbjct: 243 ISPVLR----DFLERMLTREPQERATAQELLDHPFL 274
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297 |
| >gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Score = 86.6 bits (214), Expect = 6e-20
Identities = 57/165 (34%), Positives = 84/165 (50%), Gaps = 12/165 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL + VNH NII L + F + +++V+E NL I++ + +
Sbjct: 73 ELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MDANLCQVIQME--LDHERMS 129
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 130 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 186
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
+ Y APEV+ Y E VD+WSVG I+ E++ G F G +++
Sbjct: 187 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPGTDHI 231
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364 |
| >gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 7e-20
Identities = 66/227 (29%), Positives = 111/227 (48%), Gaps = 39/227 (17%)
Query: 20 LSSVNHPNIIRLFDA-FQ-AENCIF----LVVEFCAGGNLSSYIRLHGRV-------PEQ 66
+ +HPN++RL Q E+ + +++ F G+L S++ L+ R+ P Q
Sbjct: 54 MKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFL-LYSRLGDCPQYLPTQ 112
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
KF+ + +G+E L+S IHRDL N + L++++ + +ADFGLS +Y G+Y
Sbjct: 113 MLVKFMTDIASGMEYLSSKSFIHRDLAARNCM---LNENMNVCVADFGLSKKIYNGDYYR 169
Query: 127 --KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL---VRN 179
++ P+ ++A E L + Y K D+WS G ++E+ G P+ G N ++ +R
Sbjct: 170 QGRIAKMPVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQ 229
Query: 180 INSCKHLPFSQLIVPALHPDCVDMCLKLLSA----NTVDRLSFNEFY 222
N K PDC+D L+S+ N DR SF
Sbjct: 230 GNRLKQ-----------PPDCLDGLYSLMSSCWLLNPKDRPSFETLR 265
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272 |
| >gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 86.1 bits (213), Expect = 1e-19
Identities = 52/156 (33%), Positives = 79/156 (50%), Gaps = 14/156 (8%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
E L +VNHP++IR+ D A C+ L +L +Y+ + +P A
Sbjct: 107 EAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS---DLYTYLTKRSRPLPIDQALIIE 163
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLY-PGNYAEKVCG 130
+Q+ GL L++ IIHRD+K ENI + +D + I D G + + P + G
Sbjct: 164 KQILEGLRYLHAQRIIHRDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLG--LAG 218
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166
+ APEVL +Y+ K D+WS G +LFE+L YP
Sbjct: 219 TVETNAPEVLARDKYNSKADIWSAGIVLFEML-AYP 253
|
Length = 357 |
| >gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Score = 84.5 bits (209), Expect = 1e-19
Identities = 48/160 (30%), Positives = 79/160 (49%), Gaps = 8/160 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E + + HPN+++L E +++ EF GNL Y+R R V
Sbjct: 52 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMAT 111
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ + +E L + IHRDL N L+ ++ ++K+ADFGLS + Y A P
Sbjct: 112 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLSRLMTGDTYTAHAGAKFP 168
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
+ + APE L + ++ K D+W+ G +L+E+ G P+ G
Sbjct: 169 IKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPG 208
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263 |
| >gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Score = 84.7 bits (209), Expect = 1e-19
Identities = 54/203 (26%), Positives = 102/203 (50%), Gaps = 24/203 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRV-----PEQT 67
E + ++ ++HPNI+ L E + ++ E+ G+L ++ + H V + T
Sbjct: 57 EASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGT 116
Query: 68 ARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ L Q+ AG+E L+SH +H+DL NIL+ + + +KI+D GLS
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIG---EQLHVKISDLGLSRE 173
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
+Y +Y S L +M PE + + ++ D+WS G +L+E+ + G P+ G +N
Sbjct: 174 IYSADYYRVQPKSLLPIRWMPPEAIMYGKFSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQ 233
Query: 175 QLVRNINSCKHLPFSQLIVPALH 197
+++ + + LP S+ P ++
Sbjct: 234 EVIEMVRKRQLLPCSEDCPPRMY 256
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283 |
| >gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 1e-19
Identities = 48/182 (26%), Positives = 95/182 (52%), Gaps = 14/182 (7%)
Query: 17 LNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTAR 69
L+FL+ +HPNIIRL + ++ E+ G+L ++R + G+
Sbjct: 50 LDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLV 109
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP--GNYAEK 127
L+ + +G++ L+ + +HRDL NIL++ +++ K++DFGLS L Y K
Sbjct: 110 GMLRGIASGMKYLSEMNYVHRDLAARNILVN---SNLVCKVSDFGLSRRLEDSEATYTTK 166
Query: 128 VCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKH 185
P+ + APE + ++++ D+WS G +++E+++ G P+ +N +++ +
Sbjct: 167 GGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSYGERPYWDMSNQDVIKAVEDGYR 226
Query: 186 LP 187
LP
Sbjct: 227 LP 228
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 1e-19
Identities = 76/267 (28%), Positives = 127/267 (47%), Gaps = 51/267 (19%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F N ++LV G
Sbjct: 45 VKKLSRPFQSLIHARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNL-MG 103
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L++ ++ ++ ++ + + QL GL+ ++S IIHRDLKP N+ +++D L+I
Sbjct: 104 ADLNNIVKCQ-KLSDEHVQFLIYQLLRGLKYIHSAGIIHRDLKPSNV---AVNEDCELRI 159
Query: 111 ADFGLSCTLYPGNYAEKVCG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYP 166
DFGL+ +++ G + Y APE+ L + Y++ VD+WSVG I+ ELL G
Sbjct: 160 LDFGLA-----RQADDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKA 214
Query: 167 PFSGRNNV-QLVR-----------------------NINSCKHLPFSQL--IVPALHPDC 200
F G + + QL R I S H+P L I +P
Sbjct: 215 LFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLA 274
Query: 201 VDMCLKLLSANTVDRLSFNEFYHHRFL 227
+D+ K+L ++ R+S +E H +
Sbjct: 275 IDLLEKMLVLDSDKRISASEALAHPYF 301
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343 |
| >gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-19
Identities = 55/153 (35%), Positives = 81/153 (52%), Gaps = 6/153 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ R+PE+ K +
Sbjct: 53 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAV 112
Query: 76 GAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 113 LRGLAYLREKHQIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 168
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNG-YP 166
M+PE LQ Y + D+WS+G L EL G YP
Sbjct: 169 MSPERLQGTHYSVQSDIWSMGLSLVELAIGRYP 201
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331 |
| >gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 85.1 bits (210), Expect = 2e-19
Identities = 55/166 (33%), Positives = 88/166 (53%), Gaps = 23/166 (13%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
H NII L A + ++++VE+ + GNL Y+R RVP++ T +
Sbjct: 80 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDL 139
Query: 72 LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+E L S IHRDL N+L++ +++VM KIADFGL+ + +Y +K
Sbjct: 140 VSCTYQVARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARDVNNIDYYKKT 196
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
L +MAPE L + Y + D+WS G +++E+ G P+ G
Sbjct: 197 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPG 242
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304 |
| >gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 85.5 bits (211), Expect = 2e-19
Identities = 56/166 (33%), Positives = 89/166 (53%), Gaps = 23/166 (13%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQ--TARKF 71
H NII L A + ++++VE+ + GNL Y+R ++PE+ T +
Sbjct: 77 HKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDL 136
Query: 72 LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+E L S IHRDL N+L++ +D+VM KIADFGL+ ++ +Y +K
Sbjct: 137 VSCAYQVARGMEYLASQKCIHRDLAARNVLVT--EDNVM-KIADFGLARDVHNIDYYKKT 193
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
L +MAPE L + Y + D+WS G +L+E+ G P+ G
Sbjct: 194 TNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLLWEIFTLGGSPYPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334 |
| >gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 2e-19
Identities = 57/175 (32%), Positives = 87/175 (49%), Gaps = 7/175 (4%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRV 63
L + LK E L +HPNI++L I++V+E GG+ S++R +
Sbjct: 31 LPQELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDEL 90
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ KF AG+ L S + IHRDL N L+ ++ +LKI+DFG+S G
Sbjct: 91 KTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVG---ENNVLKISDFGMSRQEDDGI 147
Query: 124 YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQ 175
Y+ P+ + APE L + RY + D+WS G +L+E + G P+ G N Q
Sbjct: 148 YSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFSLGVCPYPGMTNQQ 202
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250 |
| >gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Score = 85.0 bits (210), Expect = 3e-19
Identities = 72/250 (28%), Positives = 113/250 (45%), Gaps = 51/250 (20%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL L + H N+I L D F + +LV+ + +L + + E +
Sbjct: 64 ELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQT-DLQKIMGHP--LSEDKVQ 120
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KV 128
+ Q+ GL+ ++S IIHRDLKP N+ +++D LKI DFGL+ +A+ ++
Sbjct: 121 YLVYQMLCGLKYIHSAGIIHRDLKPGNL---AVNEDCELKILDFGLA------RHADAEM 171
Query: 129 CG---SPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI---- 180
G + Y APEV L + Y++ VD+WSVG I+ E+L G F G++ + + I
Sbjct: 172 TGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQLTQILKVT 231
Query: 181 -----------------NSCKHLP------FSQLIVPALHPDCVDMCLKLLSANTVDRLS 217
+ K LP FS L P P VD+ K+L + RL+
Sbjct: 232 GVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLF-PKASPQAVDLLEKMLELDVDKRLT 290
Query: 218 FNEFYHHRFL 227
E H +
Sbjct: 291 ATEALEHPYF 300
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342 |
| >gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 84.3 bits (209), Expect = 3e-19
Identities = 72/246 (29%), Positives = 117/246 (47%), Gaps = 39/246 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAF-----QAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
E+ L ++H N+I + D +A N +++V E +L IR + + +
Sbjct: 54 EIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYEL-MDTDLHQIIRSSQTLSDDHCQY 112
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVC 129
FL QL GL+ ++S +++HRDLKP N+LL+ D LKI DFGL+ T G++ +
Sbjct: 113 FLYQLLRGLKYIHSANVLHRDLKPSNLLLNANCD---LKICDFGLARTTSEKGDFMTEYV 169
Query: 130 GSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVR---------- 178
+ Y APE+ L Y +D+WSVG I ELL P F G++ V ++
Sbjct: 170 VTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDYVHQLKLITELLGSPS 229
Query: 179 -----NINS------CKHLP------FSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221
I + + LP F++L P +P +D+ K+L + R++ E
Sbjct: 230 EEDLGFIRNEKARRYIRSLPYTPRQSFARLF-PHANPLAIDLLEKMLVFDPSKRITVEEA 288
Query: 222 YHHRFL 227
H +L
Sbjct: 289 LAHPYL 294
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337 |
| >gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Score = 83.9 bits (207), Expect = 4e-19
Identities = 56/166 (33%), Positives = 89/166 (53%), Gaps = 23/166 (13%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQ--TARKF 71
H NII L A + ++++VE+ + GNL Y+R +VPE+ + +
Sbjct: 83 HKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDL 142
Query: 72 LQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+E L S IHRDL N+L++ +D+VM KIADFGL+ ++ +Y +K
Sbjct: 143 VSCAYQVARGMEYLASKKCIHRDLAARNVLVT--EDNVM-KIADFGLARDIHHIDYYKKT 199
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
L +MAPE L + Y + D+WS G +L+E+ G P+ G
Sbjct: 200 TNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPG 245
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307 |
| >gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 82.9 bits (205), Expect = 4e-19
Identities = 53/211 (25%), Positives = 100/211 (47%), Gaps = 18/211 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKF 71
E + + HP +I+L+ E I++V E G+L Y++ ++P+
Sbjct: 51 EAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLI--DM 108
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS 131
Q+ +G+ L + + IHRDL N+L+ ++ + K+ADFGL+ + Y + G+
Sbjct: 109 AAQVASGMAYLEAQNYIHRDLAARNVLVG---ENNICKVADFGLARVIKEDIYEARE-GA 164
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ APE + R+ K D+WS G +L E++ G P+ G N ++++ ++ +P
Sbjct: 165 KFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMP 224
Query: 188 FSQLIVPALHPDCVDMCLKLLSANTVDRLSF 218
L+ D+ L + DR +F
Sbjct: 225 CPPGCPKELY----DIMLDCWKEDPDDRPTF 251
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261 |
| >gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 5e-19
Identities = 54/208 (25%), Positives = 103/208 (49%), Gaps = 13/208 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
E N + ++ H +++L A + I+++ EF A G+L +++ + P F
Sbjct: 51 EANVMKTLQHDKLVKL-HAVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ G+ + + IHRDL+ NIL+S ++ KIADFGL+ + Y A + P
Sbjct: 110 QIAEGMAFIEQRNYIHRDLRAANILVSAS---LVCKIADFGLARVIEDNEYTAREGAKFP 166
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+ + APE + F + K D+WS G +L E++ G P+ G +N +++R + +P +
Sbjct: 167 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMPRPE 226
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSF 218
L+ ++ ++ +R +F
Sbjct: 227 NCPEELY----NIMMRCWKNRPEERPTF 250
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260 |
| >gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 5e-19
Identities = 54/213 (25%), Positives = 100/213 (46%), Gaps = 41/213 (19%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
L K + + E + L + ++++F +FQ + ++L++EF GG++ + + +
Sbjct: 40 LEKEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLS 99
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT------ 118
E+ + ++ + ++ ++ IHRD+KP+N+L LD +K++DFGL CT
Sbjct: 100 EEATQFYIAETVLAIDAIHQLGFIHRDIKPDNLL---LDAKGHVKLSDFGL-CTGLKKAH 155
Query: 119 ---LY-------PGNY---------------------AEKVCGSPLYMAPEVLQFQRYDE 147
Y P ++ A G+P Y+APEV Y++
Sbjct: 156 RTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFMQTGYNK 215
Query: 148 KVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
D WS+G I++E+L GYPPF + R +
Sbjct: 216 LCDWWSLGVIMYEMLIGYPPFCSETPQETYRKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360 |
| >gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Score = 83.2 bits (206), Expect = 6e-19
Identities = 61/244 (25%), Positives = 106/244 (43%), Gaps = 26/244 (10%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
+ + + E+ LS ++ PNI RL + + +++E+ G+L+ +++ H
Sbjct: 59 SDNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETS 118
Query: 66 QTARKFLQ-----------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
A Q+ +G+ L S + +HRDL N L+ +KIADFG
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKN---YTIKIADFG 175
Query: 115 LSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN--GYPPF 168
+S LY +Y +V G +MA E + ++ K D+W+ G L+E+L P+
Sbjct: 176 MSRNLYSSDYY-RVQGRAPLPIRWMAWESVLLGKFTTKSDVWAFGVTLWEILTLCREQPY 234
Query: 169 SGRNNVQLVRNIN--SCKHLPFSQLIVPALHP-DCVDMCLKLLSANTVDRLSFNEFYHHR 225
+ Q++ N L P P D ++ L+ + DR +F E H
Sbjct: 235 EHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREI--HL 292
Query: 226 FLRR 229
FL+R
Sbjct: 293 FLQR 296
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296 |
| >gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 7e-19
Identities = 56/180 (31%), Positives = 92/180 (51%), Gaps = 13/180 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + +S+ NHPNI++L ++++E GG+L SY+R L++L
Sbjct: 49 EAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKEL 108
Query: 76 GA-------GLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAE 126
G L H IHRDL N L+S G D D ++KI DFGL+ +Y +Y
Sbjct: 109 LDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYR 168
Query: 127 KVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINS 182
K L +MAPE L ++ + D+WS G +++E+L G P+ NN ++++++ +
Sbjct: 169 KEGEGLLPVRWMAPESLLDGKFTTQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTA 228
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269 |
| >gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 8e-19
Identities = 50/194 (25%), Positives = 93/194 (47%), Gaps = 21/194 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQ 73
E N + + HP ++RL+ A + I+++ E+ G+L +++ ++
Sbjct: 51 EANLMKQLQHPRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAA 109
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSP 132
Q+ G+ + + IHRDL+ NIL+S + + KIADFGL+ + Y A + P
Sbjct: 110 QIAEGMAFIERKNYIHRDLRAANILVS---ETLCCKIADFGLARLIEDNEYTAREGAKFP 166
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+ + APE + + + K D+WS G +L E++ G P+ G N ++++N+ +P
Sbjct: 167 IKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYGRIPYPGMTNPEVIQNLERGYRMP--- 223
Query: 191 LIVPALHPDCVDMC 204
D C
Sbjct: 224 ---------RPDNC 228
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260 |
| >gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Score = 84.3 bits (208), Expect = 8e-19
Identities = 64/179 (35%), Positives = 96/179 (53%), Gaps = 17/179 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAF------QAENCIFL--VVEFCAGGNLSSYIRLHGR----V 63
EL + ++NH NII L D + + E IFL V+EF + Y++ + R +
Sbjct: 109 ELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQ-TVHKYMKHYARNNHAL 167
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
P + + QL L ++S I HRDLKP+N+L+ + LK+ DFG + L G
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQ 225
Query: 124 YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVRNI 180
+ S Y APE+ L Y +D+WS+G I+ E++ GYP FSG+++V QLVR I
Sbjct: 226 RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVRII 284
|
Length = 440 |
| >gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 9e-19
Identities = 54/162 (33%), Positives = 86/162 (53%), Gaps = 14/162 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFL 72
E+ S + H NI++ + + +E GG+LS+ +R + EQT +
Sbjct: 55 EIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYT 114
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILL---SGLDDDVMLKIADFGLSCTLYPGN-YAEKV 128
+Q+ GL+ L+ + I+HRD+K +N+L+ SG+ +KI+DFG S L N E
Sbjct: 115 KQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGV-----VKISDFGTSKRLAGINPCTETF 169
Query: 129 CGSPLYMAPEVL-QFQR-YDEKVDMWSVGAILFELLNGYPPF 168
G+ YMAPEV+ + R Y D+WS+G + E+ G PPF
Sbjct: 170 TGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKPPF 211
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268 |
| >gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Score = 83.1 bits (205), Expect = 9e-19
Identities = 58/166 (34%), Positives = 88/166 (53%), Gaps = 23/166 (13%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPE-QTARKFL 72
H NII L E ++++VE+ A GNL ++R +VPE Q + K L
Sbjct: 77 HKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDL 136
Query: 73 ----QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
Q+ G+E L S IHRDL N+L++ +D+VM KIADFGL+ ++ +Y +K
Sbjct: 137 VSCAYQVARGMEYLESRRCIHRDLAARNVLVT--EDNVM-KIADFGLARGVHDIDYYKKT 193
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
L +MAPE L + Y + D+WS G +++E+ G P+ G
Sbjct: 194 SNGRLPVKWMAPEALFDRVYTHQSDVWSFGILMWEIFTLGGSPYPG 239
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314 |
| >gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Score = 82.8 bits (205), Expect = 1e-18
Identities = 61/216 (28%), Positives = 91/216 (42%), Gaps = 23/216 (10%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85
P I++ + F ++ +F+ +E + R+ G +PE K + L L
Sbjct: 74 PYIVKCYGYFITDSDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEK 133
Query: 86 H-IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL---- 140
H +IHRD+KP NIL LD +K+ DFG+S L + G YMAPE +
Sbjct: 134 HGVIHRDVKPSNIL---LDASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPD 190
Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLP-------FSQLIV 193
+YD + D+WS+G L EL G P+ V + P FS
Sbjct: 191 PNPKYDIRADVWSLGISLVELATGQFPYKNCKTEFEVLTKILQEEPPSLPPNEGFSPDFC 250
Query: 194 PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
VD+C L+ + R + E H F+RR
Sbjct: 251 -----SFVDLC---LTKDHRKRPKYRELLQHPFIRR 278
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296 |
| >gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Score = 83.2 bits (205), Expect = 1e-18
Identities = 58/165 (35%), Positives = 83/165 (50%), Gaps = 12/165 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
EL + VNH NII L + F + ++LV+E NL I++ + +
Sbjct: 66 ELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMEL-MDANLCQVIQM--ELDHERMS 122
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L Q+ G++ L+S IIHRDLKP NI++ D LKI DFGL+ T
Sbjct: 123 YLLYQMLCGIKHLHSAGIIHRDLKPSNIVVK---SDCTLKILDFGLARTAGTSFMMTPYV 179
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
+ Y APEV+ Y E VD+WSVG I+ E++ F GR+ +
Sbjct: 180 VTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPGRDYI 224
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355 |
| >gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Score = 81.9 bits (202), Expect = 1e-18
Identities = 50/157 (31%), Positives = 88/157 (56%), Gaps = 11/157 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E ++ ++H N++RL N +++V+E + GNL +++R GR V +F
Sbjct: 49 ETAVMTKLHHKNLVRLLGVI-LHNGLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSL 107
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+ G+E L S ++HRDL NIL+S +D + K++DFGL+ G K+ P+
Sbjct: 108 DVAEGMEYLESKKLVHRDLAARNILVS---EDGVAKVSDFGLARVGSMGVDNSKL---PV 161
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
+ APE L+ +++ K D+WS G +L+E+ + G P+
Sbjct: 162 KWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGRAPY 198
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254 |
| >gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Score = 82.4 bits (203), Expect = 1e-18
Identities = 55/159 (34%), Positives = 85/159 (53%), Gaps = 9/159 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E++ L ++ H NI+ L D E C+ LV E+ +L Y+ G + + F+ Q
Sbjct: 53 EVSLLKNLKHANIVTLHDIIHTERCLTLVFEYL-DSDLKQYLDNCGNLMSMHNVKIFMFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
L GL + I+HRDLKP+N+L+ ++ LK+ADFGL+ ++ Y+ +V +
Sbjct: 112 LLRGLSYCHKRKILHRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVV-TL 167
Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
Y P+VL Y +DMW VG IL+E+ G P F G
Sbjct: 168 WYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPG 206
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288 |
| >gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Score = 81.4 bits (201), Expect = 1e-18
Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 9/170 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQ 74
E + ++HP +++L+ + +++V EF G L +Y+R G++ + Q
Sbjct: 49 EAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQD 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+E L + IHRDL N L+S ++K++DFG++ + Y G+
Sbjct: 109 VCEGMEYLERNSFIHRDLAARNCLVS---STGVVKVSDFGMTRYVLDDEYTSS-SGAKFP 164
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNI 180
+ PEV F +Y K D+WS G +++E+ G PF ++N ++V I
Sbjct: 165 VKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256 |
| >gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-18
Identities = 59/209 (28%), Positives = 97/209 (46%), Gaps = 19/209 (9%)
Query: 4 KLNKHLKSC-LDCEL----NFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGN 52
K+ +K+C FL +HP+I++L EN +++V+E G
Sbjct: 34 KIAVAVKTCKNCTSPSVREKFLQEAYIMRQFDHPHIVKLIGVIT-ENPVWIVMELAPLGE 92
Query: 53 LSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
L SY++++ + + + QL L L S +HRD+ N+L+S D +K+
Sbjct: 93 LRSYLQVNKYSLDLASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPD---CVKLG 149
Query: 112 DFGLSCTL-YPGNYAEKVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
DFGLS L Y P+ +MAPE + F+R+ D+W G ++E+L G PF
Sbjct: 150 DFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILMLGVKPF 209
Query: 169 SGRNNVQLVRNINSCKHLPFSQLIVPALH 197
G N ++ I + + LP P L+
Sbjct: 210 QGVKNNDVIGRIENGERLPMPPNCPPTLY 238
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270 |
| >gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Score = 82.8 bits (204), Expect = 2e-18
Identities = 46/189 (24%), Positives = 88/189 (46%), Gaps = 39/189 (20%)
Query: 28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87
++++F +FQ + ++L++EF GG++ + + + E+ + ++ + ++ ++
Sbjct: 63 VVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122
Query: 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--------------------- 126
IHRD+KP+N+L LD +K++DFGL L + E
Sbjct: 123 IHRDIKPDNLL---LDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSK 179
Query: 127 ---------------KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
G+P Y+APEV Y++ D WS+G I++E+L GYPPF
Sbjct: 180 RKAETWKRNRRQLAFSTVGTPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSE 239
Query: 172 NNVQLVRNI 180
+ + +
Sbjct: 240 TPQETYKKV 248
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363 |
| >gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 82.0 bits (202), Expect = 2e-18
Identities = 55/163 (33%), Positives = 83/163 (50%), Gaps = 7/163 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + L + H NI+ L D + + LV E+ +L Y+ H G + + + FL Q
Sbjct: 53 EASLLKGLKHANIVLLHDIIHTKETLTLVFEY-VHTDLCQYMDKHPGGLHPENVKLFLFQ 111
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPL 133
L GL ++ +I+HRDLKP+N+L+S D LK+ADFGL+ P + +
Sbjct: 112 LLRGLSYIHQRYILHRDLKPQNLLIS---DTGELKLADFGLARAKSVPSHTYSNEVVTLW 168
Query: 134 YMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
Y P+V L Y +DMW VG I E++ G F G ++Q
Sbjct: 169 YRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQ 211
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303 |
| >gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 81.3 bits (201), Expect = 2e-18
Identities = 46/162 (28%), Positives = 78/162 (48%), Gaps = 9/162 (5%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
++SV+HP+++RL + + L+ + G L Y+R H + Q + Q+ G
Sbjct: 63 MASVDHPHVVRLLGICLSSQ-VQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKG 121
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--PL-YM 135
+ L ++HRDL N+L+ +KI DFGL+ L G P+ +M
Sbjct: 122 MSYLEEKRLVHRDLAARNVLVKTPQ---HVKITDFGLAKLLDVDEKEYHAEGGKVPIKWM 178
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL 176
A E + + Y K D+WS G ++EL+ G P+ G V++
Sbjct: 179 ALESILHRIYTHKSDVWSYGVTVWELMTFGAKPYEGIPAVEI 220
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279 |
| >gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Score = 81.0 bits (200), Expect = 3e-18
Identities = 54/202 (26%), Positives = 94/202 (46%), Gaps = 40/202 (19%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQT-------- 67
E ++ +HPNI++L + L+ E+ A G+L+ ++R R P
Sbjct: 58 EAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLR--HRSPRAQCSLSHSTS 115
Query: 68 -ARKFLQ---------------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
ARK Q+ AG+ L+ +HRDL N L+ ++++KIA
Sbjct: 116 SARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGE---NMVVKIA 172
Query: 112 DFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYP 166
DFGLS +Y +Y K + +M PE + + RY + D+W+ G +L+E+ + G
Sbjct: 173 DFGLSRNIYSADYY-KASENDAIPIRWMPPESIFYNRYTTESDVWAYGVVLWEIFSYGMQ 231
Query: 167 PFSGRNNVQLVR-----NINSC 183
P+ G + +++ N+ SC
Sbjct: 232 PYYGMAHEEVIYYVRDGNVLSC 253
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 82.6 bits (204), Expect = 3e-18
Identities = 39/112 (34%), Positives = 72/112 (64%), Gaps = 3/112 (2%)
Query: 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP 64
+NK++ + E + L+ P I+ L+ + Q+ N ++LV+E+ GG++ S + ++G
Sbjct: 43 INKNMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFD 102
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
E+ A K++ ++ L+ L+ H IIHRDLKP+N+L+S ++ +K+ DFGLS
Sbjct: 103 EEMAVKYISEVALALDYLHRHGIIHRDLKPDNMLIS---NEGHIKLTDFGLS 151
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Score = 80.7 bits (199), Expect = 3e-18
Identities = 52/195 (26%), Positives = 97/195 (49%), Gaps = 12/195 (6%)
Query: 15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
E + + +HPNII L + +V E+ G+L +++R H G+ L+
Sbjct: 54 SEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLR 113
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY---PGNYAEKVCG 130
+ +G++ L+ +HRDL NIL+ + +++ K++DFGLS L Y +
Sbjct: 114 GIASGMKYLSDMGYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGK 170
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPF 188
P+ + APE + ++++ D+WS G +++E+++ G P+ +N +++ I LP
Sbjct: 171 IPIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWEMSNQDVIKAIEEGYRLPA 230
Query: 189 SQLIVPALHP---DC 200
ALH DC
Sbjct: 231 PMDCPAALHQLMLDC 245
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267 |
| >gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Score = 80.9 bits (199), Expect = 4e-18
Identities = 48/189 (25%), Positives = 97/189 (51%), Gaps = 22/189 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------R 62
E L+++ H +I++ + + + +V E+ G+L+ ++R HG
Sbjct: 57 EAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAE 116
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ + QQ+ AG+ L S H +HRDL N L+ +++++KI DFG+S +Y
Sbjct: 117 LTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVG---ENLLVKIGDFGMSRDVYST 173
Query: 123 NYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLV 177
+Y +V G + +M PE + ++++ + D+WS+G +L+E+ G P+ +N +++
Sbjct: 174 DYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSLGVVLWEIFTYGKQPWYQLSNNEVI 232
Query: 178 RNINSCKHL 186
I + L
Sbjct: 233 ECITQGRVL 241
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288 |
| >gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Score = 80.5 bits (198), Expect = 4e-18
Identities = 53/168 (31%), Positives = 86/168 (51%), Gaps = 18/168 (10%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIR--LHGRVPEQ 66
E+N L +H NI + AF +N ++LV+EFC G+++ I+ + E+
Sbjct: 52 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 111
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
+++ GL L+ H +IHRD+K +N+LL+ ++ +K+ DFG+S L
Sbjct: 112 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 168
Query: 126 EKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 168
G+P +MAPEV+ YD K D+WS+G E+ G PP
Sbjct: 169 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPL 216
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272 |
| >gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 82.2 bits (203), Expect = 5e-18
Identities = 64/180 (35%), Positives = 95/180 (52%), Gaps = 32/180 (17%)
Query: 13 LDCELN--FLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQT 67
+ C LN F S V H + + D EN I LV+++ G+L I+ + T
Sbjct: 82 VCCLLNCDFFSIVKCHEDFAKK-DPRNPENVLMIALVLDYANAGDLRQEIKSRAK----T 136
Query: 68 ARKFLQQLGAGL---EIL------NSHHIIHRDLKPENILL--SGLDDDVMLKIADFGLS 116
R F + AGL ++L +S H+IHRD+K NILL +GL +K+ DFG S
Sbjct: 137 NRTFREH-EAGLLFIQVLLAVHHVHSKHMIHRDIKSANILLCSNGL-----VKLGDFGFS 190
Query: 117 CTLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
+Y ++ V CG+P Y+APE+ + + Y +K DM+S+G +L+ELL PF G N
Sbjct: 191 -KMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKADMFSLGVLLYELLTLKRPFDGEN 249
|
Length = 496 |
| >gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Score = 80.8 bits (200), Expect = 6e-18
Identities = 49/178 (27%), Positives = 77/178 (43%), Gaps = 28/178 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLHG---RVPE 65
E+ L + HPN++ L D + + +V +LS L ++ E
Sbjct: 57 EIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGL--LENPSVKLTE 114
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
+ ++ QL G+ L+ +HI+HRD+K NIL +D+ +LKIADFGL+
Sbjct: 115 SQIKCYMLQLLEGINYLHENHILHRDIKAANIL---IDNQGILKIADFGLARPYDGPPPN 171
Query: 126 EKVCGSPL------------YMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
K G Y PE +L +RY VD+W +G + E+ P G
Sbjct: 172 PKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311 |
| >gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Score = 80.4 bits (198), Expect = 7e-18
Identities = 58/183 (31%), Positives = 92/183 (50%), Gaps = 29/183 (15%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
EL L + +HPNII L A + +++ +E+ GNL ++R HG
Sbjct: 52 ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111
Query: 62 RVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
T+++ LQ + G++ L+ IHRDL N+L+ +++ KIADFGLS
Sbjct: 112 TASTLTSQQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVG---ENLASKIADFGLS-- 166
Query: 119 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN 173
G Y +K G P+ +MA E L + Y K D+WS G +L+E+++ G P+ G
Sbjct: 167 --RGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSDVWSFGVLLWEIVSLGGTPYCGMTC 224
Query: 174 VQL 176
+L
Sbjct: 225 AEL 227
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297 |
| >gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Score = 80.6 bits (199), Expect = 8e-18
Identities = 73/264 (27%), Positives = 119/264 (45%), Gaps = 51/264 (19%)
Query: 16 ELNFLSSVNHPNI-----IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
E+ L + HP+I I L + + I++V E +L I+ + + + +
Sbjct: 49 EIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFEL-MESDLHQVIKANDDLTPEHHQF 107
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--------CTLYPG 122
FL QL L+ +++ ++ HRDLKP+NIL + D LKI DFGL+ ++
Sbjct: 108 FLYQLLRALKYIHTANVFHRDLKPKNILANA---DCKLKICDFGLARVAFNDTPTAIFWT 164
Query: 123 NYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL--- 176
+Y + Y APE+ F +Y +D+WS+G I E+L G P F G+N V QL
Sbjct: 165 DYV----ATRWYRAPELCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNVVHQLDLI 220
Query: 177 --------------VRNINSCKHL---------PFSQLIVPALHPDCVDMCLKLLSANTV 213
VRN + ++L PFSQ P P + + +LL+ +
Sbjct: 221 TDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKF-PNADPLALRLLERLLAFDPK 279
Query: 214 DRLSFNEFYHHRFLRRNSAILRAP 237
DR + E + + + + R P
Sbjct: 280 DRPTAEEALADPYFKGLAKVEREP 303
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338 |
| >gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Score = 79.7 bits (196), Expect = 8e-18
Identities = 56/189 (29%), Positives = 97/189 (51%), Gaps = 13/189 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGR---VPEQTARKF 71
E + + H +++L+ A +E I++V E+ + G+L +++ GR +P
Sbjct: 51 EAQIMKKLRHDKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLV--DM 107
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
Q+ AG+ + + IHRDL+ NIL+ D ++ KIADFGL+ + Y A +
Sbjct: 108 AAQVAAGMAYIERMNYIHRDLRSANILVG---DGLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPF 188
P+ + APE + R+ K D+WS G +L EL+ G P+ G NN +++ + +P
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMNNREVLEQVERGYRMPC 224
Query: 189 SQLIVPALH 197
Q +LH
Sbjct: 225 PQDCPISLH 233
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260 |
| >gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 79.6 bits (196), Expect = 1e-17
Identities = 63/237 (26%), Positives = 116/237 (48%), Gaps = 33/237 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------LHGRVPEQ 66
E+ +S + +PNIIRL +++ + ++ E+ G+L+ ++ +P
Sbjct: 67 EIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSV 126
Query: 67 TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ L Q+ +G++ L S + +HRDL N L + + +KIADFG+S LY G+
Sbjct: 127 SIANLLYMAVQIASGMKYLASLNFVHRDLATRNCL---VGNHYTIKIADFGMSRNLYSGD 183
Query: 124 YAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYPPFSGRNNVQLV 177
Y ++ G + +MA E + ++ D+W+ G L+E+ L P+S ++ Q++
Sbjct: 184 YY-RIQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWEMFTLCKEQPYSLLSDEQVI 242
Query: 178 RNI-----NSCKHLPFSQLIVPALHPDCV-DMCLKLLSANTVDRLSFNEFYHHRFLR 228
N N + + SQ L P V + ++ S + DR +FN+ +H FLR
Sbjct: 243 ENTGEFFRNQGRQIYLSQ---TPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH--FLR 294
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295 |
| >gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Score = 79.2 bits (195), Expect = 1e-17
Identities = 57/204 (27%), Positives = 104/204 (50%), Gaps = 10/204 (4%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
+ LK L E N + +++P I+R+ +AE+ + LV+E G L+ +++ + V E
Sbjct: 36 DPALKDELLREANVMQQLDNPYIVRMIGICEAESWM-LVMELAELGPLNKFLQKNKHVTE 94
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-- 123
+ + + Q+ G++ L + +HRDL N+LL KI+DFGLS L
Sbjct: 95 KNITELVHQVSMGMKYLEETNFVHRDLAARNVLLV---TQHYAKISDFGLSKALGADENY 151
Query: 124 YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNI 180
Y K G P+ + APE + + ++ K D+WS G +++E + G P+ G ++ + I
Sbjct: 152 YKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVTQMI 211
Query: 181 NSCKHLPFSQLIVPALHPDCVDMC 204
S + + Q P ++ D + +C
Sbjct: 212 ESGERMECPQRCPPEMY-DLMKLC 234
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257 |
| >gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Score = 80.2 bits (198), Expect = 1e-17
Identities = 59/189 (31%), Positives = 89/189 (47%), Gaps = 21/189 (11%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
LKK+ ++ + C EL L H N++ D Q + I++V E
Sbjct: 30 LKKMPNVFQNLVSCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQS- 88
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L I + + FL Q+ GL+ L+S I+HRD+KP N+L ++ + +LKI
Sbjct: 89 DLHKIIVSPQPLSSDHVKVFLYQILRGLKYLHSAGILHRDIKPGNLL---VNSNCVLKIC 145
Query: 112 DFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYP 166
DFGL+ P E V + Y APE+L + Y VD+WSVG I ELL
Sbjct: 146 DFGLARVEEPDESKHMTQEVV--TQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRI 203
Query: 167 PFSGRNNVQ 175
F ++ +Q
Sbjct: 204 LFQAQSPIQ 212
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372 |
| >gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 2e-17
Identities = 50/168 (29%), Positives = 89/168 (52%), Gaps = 18/168 (10%)
Query: 16 ELNFLSSVNH-PNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQT 67
E+N L +H NI + AF ++ ++LV+EFC G+++ ++ G ++
Sbjct: 62 EINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKED 121
Query: 68 ARKFL-QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYA 125
++ +++ GL L++H +IHRD+K +N+LL+ ++ +K+ DFG+S L
Sbjct: 122 WIAYICREILRGLAHLHAHKVIHRDIKGQNVLLT---ENAEVKLVDFGVSAQLDRTVGRR 178
Query: 126 EKVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPF 168
G+P +MAPEV+ YD + D+WS+G E+ G PP
Sbjct: 179 NTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGITAIEMAEGAPPL 226
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282 |
| >gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Score = 78.9 bits (194), Expect = 3e-17
Identities = 68/243 (27%), Positives = 112/243 (46%), Gaps = 36/243 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-QTARKFLQQ 74
E++ L + H NI+ L D + + LV E+ +L Y+ G + + FL Q
Sbjct: 54 EVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYL-DKDLKQYMDDCGNIMSMHNVKIFLYQ 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
+ GL + ++HRDLKP+N+L++ + LK+ADFGL+ ++ Y+ +V +
Sbjct: 113 ILRGLAYCHRRKVLHRDLKPQNLLINERGE---LKLADFGLARAKSVPTKTYSNEVV-TL 168
Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSG---RNNVQLV----------- 177
Y P+VL Y ++DMW VG I FE+ +G P F G + + L+
Sbjct: 169 WYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELHLIFRLLGTPTEET 228
Query: 178 ----------RNINSCKHLPFSQLI--VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 225
+N N K+ P LI P L + +++ K L + R+S E H
Sbjct: 229 WPGISSNDEFKNYNFPKYKP-QPLINHAPRLDTEGIELLTKFLQYESKKRISAEEAMKHA 287
Query: 226 FLR 228
+ R
Sbjct: 288 YFR 290
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309 |
| >gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 3e-17
Identities = 54/199 (27%), Positives = 98/199 (49%), Gaps = 20/199 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + + +HPNII L + ++ EF G L S++R + G+ L+
Sbjct: 55 EASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRG 114
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--------YPGNYAE 126
+ AG++ L+ + +HRDL NIL ++ +++ K++DFGLS L Y +
Sbjct: 115 IAAGMKYLSEMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGG 171
Query: 127 KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCK 184
K+ P+ + APE + ++++ D+WS G +++E+++ G P+ +N ++ I
Sbjct: 172 KI---PIRWTAPEAIAYRKFTSASDVWSYGIVMWEVMSYGERPYWDMSNQDVINAIEQDY 228
Query: 185 HLPFSQLIVPALHP---DC 200
LP ALH DC
Sbjct: 229 RLPPPMDCPTALHQLMLDC 247
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269 |
| >gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Score = 78.2 bits (192), Expect = 3e-17
Identities = 55/198 (27%), Positives = 100/198 (50%), Gaps = 14/198 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
E + + H ++ L+ A +E I++V EF G+L +++ + ++P+
Sbjct: 51 EAQIMKKLRHDKLVPLY-AVVSEEPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLV--DM 107
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
Q+ G+ + + IHRDL+ NIL+ D+++ KIADFGL+ + Y A +
Sbjct: 108 AAQIADGMAYIERMNYIHRDLRAANILVG---DNLVCKIADFGLARLIEDNEYTARQGAK 164
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPF 188
P+ + APE + R+ K D+WS G +L EL+ G P+ G N +++ + +P
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKGRVPYPGMVNREVLEQVERGYRMPC 224
Query: 189 SQLIVPALHPDCVDMCLK 206
Q +LH + + +C K
Sbjct: 225 PQGCPESLH-ELMKLCWK 241
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260 |
| >gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 79.5 bits (196), Expect = 3e-17
Identities = 57/208 (27%), Positives = 92/208 (44%), Gaps = 33/208 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
E++ L +++H II L A++ ++ C+ + C +L +Y+ G +P + A +
Sbjct: 136 EIDILKTISHRAIINLIHAYRWKSTVCMVMPKYKC---DLFTYVDRSGPLPLEQAITIQR 192
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+L L L+ IIHRD+K ENI L ++ V+ DFG +C L + G
Sbjct: 193 RLLEALAYLHGRGIIHRDVKTENIFLDEPENAVL---GDFGAACKLDAHPDTPQCYGWSG 249
Query: 134 YM---APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN----VQL---VR----- 178
+ +PE+L Y K D+WS G +LFE+ G+ QL +R
Sbjct: 250 TLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVTLFGKQVKSSSSQLRSIIRCMQVH 309
Query: 179 --------NINSCKHLPFSQLIVPALHP 198
+ N CKH F Q + P
Sbjct: 310 PLEFPQNGSTNLCKH--FKQYAIVLRPP 335
|
Length = 392 |
| >gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Score = 78.0 bits (192), Expect = 4e-17
Identities = 51/178 (28%), Positives = 92/178 (51%), Gaps = 21/178 (11%)
Query: 16 ELNFLSSVNHPNIIRLFD------AFQAENCIFLVVEFCAGGNLSSYIRLHGR------- 62
E + +HPN+I+L A +++ F G+L +++ L R
Sbjct: 51 EAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFL-LMSRIGEEPFT 109
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+P QT +F+ + +G+E L+S + IHRDL N + L++++ + +ADFGLS +Y G
Sbjct: 110 LPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCM---LNENMTVCVADFGLSKKIYSG 166
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL 176
+Y + C S L ++A E L Y D+W+ G ++E++ G P++G N ++
Sbjct: 167 DYYRQGCASKLPVKWLALESLADNVYTTHSDVWAFGVTMWEIMTRGQTPYAGVENSEI 224
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273 |
| >gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Score = 77.7 bits (191), Expect = 4e-17
Identities = 51/205 (24%), Positives = 99/205 (48%), Gaps = 24/205 (11%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
LK+ ++ + E L+ + H +I+R + + +V E+ G+L+ ++R HG
Sbjct: 43 LKEASESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHG 102
Query: 62 ---RVPEQ---------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
++ T + L Q+ +G+ L S H +HRDL N L+ +
Sbjct: 103 PDAKILAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVG---QGL 159
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
++KI DFG+S +Y +Y +V G + +M PE + ++++ + D+WS G +L+E+
Sbjct: 160 VVKIGDFGMSRDIYSTDYY-RVGGRTMLPIRWMPPESILYRKFTTESDIWSFGVVLWEIF 218
Query: 163 N-GYPPFSGRNNVQLVRNINSCKHL 186
G P+ +N + + I + L
Sbjct: 219 TYGKQPWYQLSNTEAIECITQGREL 243
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280 |
| >gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Score = 77.8 bits (191), Expect = 5e-17
Identities = 48/161 (29%), Positives = 83/161 (51%), Gaps = 7/161 (4%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK 70
S + E+ + H NI+ F ++ + +++ +E+C GG+L + G + E
Sbjct: 51 SLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAY 110
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VC 129
++ GL L+S +HRD+K NILL+ D+ +K+ADFG++ + K
Sbjct: 111 VCRETLQGLAYLHSKGKMHRDIKGANILLT---DNGDVKLADFGVAAKITATIAKRKSFI 167
Query: 130 GSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPP 167
G+P +MAPEV ++ Y++ D+W+VG EL PP
Sbjct: 168 GTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPP 208
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267 |
| >gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Score = 78.1 bits (192), Expect = 5e-17
Identities = 52/159 (32%), Positives = 83/159 (52%), Gaps = 9/159 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E++ L + H NI+ L D E + LV E+ +L Y+ G + + FL Q
Sbjct: 54 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYL-DKDLKQYLDDCGNSINMHNVKLFLFQ 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
L GL + ++HRDLKP+N+L+ ++ LK+ADFGL+ ++ Y+ +V +
Sbjct: 113 LLRGLNYCHRRKVLHRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVV-TL 168
Query: 133 LYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
Y P++L Y ++DMW VG I +E+ G P F G
Sbjct: 169 WYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPG 207
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301 |
| >gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 77.4 bits (191), Expect = 6e-17
Identities = 45/154 (29%), Positives = 80/154 (51%), Gaps = 10/154 (6%)
Query: 16 ELNFLSSVNHPNIIRL--FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
E+ L +++H NI++ + L++E+ G+L Y++ H ++ + F
Sbjct: 56 EIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFS 115
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVC 129
Q+ G++ L S IHRDL NIL ++ + ++KI+DFGL+ L Y ++
Sbjct: 116 SQICKGMDYLGSQRYIHRDLAARNIL---VESEDLVKISDFGLAKVLPEDKDYYYVKEPG 172
Query: 130 GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP+ + APE L+ ++ D+WS G L+EL
Sbjct: 173 ESPIFWYAPECLRTSKFSSASDVWSFGVTLYELF 206
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284 |
| >gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Score = 77.6 bits (191), Expect = 1e-16
Identities = 55/162 (33%), Positives = 82/162 (50%), Gaps = 19/162 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L VNHPN+++ D F I +++EF GG+L + AR+ L
Sbjct: 122 EIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGTHIADEQFLADVARQIL--- 178
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG----LSCTLYPGNYAEKVCGS 131
+G+ L+ HI+HRD+KP N+L ++ +KIADFG L+ T+ P N + G+
Sbjct: 179 -SGIAYLHRRHIVHRDIKPSNLL---INSAKNVKIADFGVSRILAQTMDPCNSS---VGT 231
Query: 132 PLYMAPEV----LQFQRYDEKV-DMWSVGAILFELLNGYPPF 168
YM+PE L YD D+WS+G + E G PF
Sbjct: 232 IAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPF 273
|
Length = 353 |
| >gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Score = 76.7 bits (189), Expect = 1e-16
Identities = 59/237 (24%), Positives = 113/237 (47%), Gaps = 24/237 (10%)
Query: 1 MLKKLNK----HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
++K L K +L+S EL+ ++H N++RL + ++++E+ G+L +
Sbjct: 39 LVKALQKTKDENLQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQF 98
Query: 57 IRLHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
+R E+ L Q+ G++ L++ +HRDL N L+S
Sbjct: 99 LRATKSKDEKLKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSS---QRE 155
Query: 108 LKIADFGLSCTLYPGNYAE-KVCGSPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164
+K++ LS +Y Y + + PL ++APE +Q + K D+WS G +++E+ G
Sbjct: 156 VKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVLMWEVFTQG 215
Query: 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCV-DMCLKLLSANTVDRLSFNE 220
PF G ++ +++ + + K +L VP P + + + + N DR SF+E
Sbjct: 216 ELPFYGLSDEEVLNRLQAGK----LELPVPEGCPSRLYKLMTRCWAVNPKDRPSFSE 268
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275 |
| >gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 76.1 bits (187), Expect = 2e-16
Identities = 52/153 (33%), Positives = 82/153 (53%), Gaps = 10/153 (6%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
E+N L ++ H NI++ + Q + L++E+ G+L Y+ H Q F Q
Sbjct: 56 EINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKHKLNLAQLLL-FAQ 114
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---G 130
Q+ G+ L+S H IHRDL N+L LD+D ++KI DFGL+ + G+ +V
Sbjct: 115 QICEGMAYLHSQHYIHRDLAARNVL---LDNDRLVKIGDFGLAKAVPEGHEYYRVREDGD 171
Query: 131 SPLY-MAPEVLQFQRYDEKVDMWSVGAILFELL 162
SP++ A E L+ ++ D+WS G L+ELL
Sbjct: 172 SPVFWYAVECLKENKFSYASDVWSFGVTLYELL 204
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283 |
| >gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Score = 75.9 bits (187), Expect = 2e-16
Identities = 54/192 (28%), Positives = 75/192 (39%), Gaps = 34/192 (17%)
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
Y L +PE+ K L L IIHRD+KP NIL LD + +K+ DFG
Sbjct: 97 YEVLKSVIPEEILGKIAVATVKALNYLKEELKIIHRDVKPSNIL---LDRNGNIKLCDFG 153
Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVL---QFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
+S L + G YMAPE + YD + D+WS+G L+E+ G P+
Sbjct: 154 ISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKW 213
Query: 172 NNVQLVRNINSCKHLPFSQL--IV----PALHPD---CVDMCLK-----LLSANTVDRLS 217
N+V F QL +V P L L + R
Sbjct: 214 NSV-------------FDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPK 260
Query: 218 FNEFYHHRFLRR 229
+ E H F++
Sbjct: 261 YKELLEHPFIKD 272
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288 |
| >gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Score = 75.5 bits (185), Expect = 3e-16
Identities = 55/187 (29%), Positives = 89/187 (47%), Gaps = 29/187 (15%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-------------HG 61
EL L + +HPNII L A + ++L +E+ GNL ++R +
Sbjct: 45 ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 104
Query: 62 RVPEQTAR---KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+++ F + G++ L+ IHRDL NIL+ ++ + KIADFGLS
Sbjct: 105 TASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS-- 159
Query: 119 LYPGN--YAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN 173
G Y +K G P+ +MA E L + Y D+WS G +L+E+++ G P+ G
Sbjct: 160 --RGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 217
Query: 174 VQLVRNI 180
+L +
Sbjct: 218 AELYEKL 224
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270 |
| >gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-16
Identities = 44/150 (29%), Positives = 82/150 (54%), Gaps = 10/150 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
E + ++ + H N+++L E +++V E+ A G+L Y+R GR + KF
Sbjct: 49 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 108
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+ +E L +++ +HRDL N+L+S +D + K++DFGL+ K+ P
Sbjct: 109 LDVCEAMEYLEANNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 162
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+ + APE L+ +++ K D+WS G +L+E+
Sbjct: 163 VKWTAPEALREKKFSTKSDVWSFGILLWEI 192
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256 |
| >gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-16
Identities = 48/156 (30%), Positives = 84/156 (53%), Gaps = 9/156 (5%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
+ S++H I+RL + + LV + G+L ++R H + Q + Q+ G
Sbjct: 63 MGSLDHAYIVRLLGICPGAS-LQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKG 121
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPL-YM 135
+ L H ++HR+L NILL D +++IADFG++ LYP + Y +P+ +M
Sbjct: 122 MYYLEEHRMVHRNLAARNILLK---SDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWM 178
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
A E + F RY + D+WS G ++E+++ G P++G
Sbjct: 179 ALESILFGRYTHQSDVWSYGVTVWEMMSYGAEPYAG 214
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279 |
| >gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Score = 75.4 bits (185), Expect = 3e-16
Identities = 51/178 (28%), Positives = 91/178 (51%), Gaps = 9/178 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + + +H NIIRL ++ E+ G L Y+R H G L+
Sbjct: 56 EASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRG 115
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YP-GNYAEKVCGS 131
+ AG++ L+ + +HRDL NIL+ + ++ K++DFGLS L P G Y
Sbjct: 116 IAAGMKYLSDMNYVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKI 172
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
P+ + APE + ++++ D+WS G +++E+++ G P+ +N ++++ IN LP
Sbjct: 173 PIRWTAPEAIAYRKFTSASDVWSFGIVMWEVMSFGERPYWDMSNHEVMKAINDGFRLP 230
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268 |
| >gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Score = 74.3 bits (182), Expect = 7e-16
Identities = 49/189 (25%), Positives = 96/189 (50%), Gaps = 13/189 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKF 71
E + + H +++L+ A +E I++V E+ + G+L +++ + R+P+
Sbjct: 51 EAQVMKKLRHEKLVQLY-AVVSEEPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLV--DM 107
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCG 130
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+ + Y A +
Sbjct: 108 AAQIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAK 164
Query: 131 SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPF 188
P+ + APE + R+ K D+WS G +L EL G P+ G N +++ + +P
Sbjct: 165 FPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMPC 224
Query: 189 SQLIVPALH 197
+LH
Sbjct: 225 PPECPESLH 233
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262 |
| >gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Score = 74.2 bits (182), Expect = 8e-16
Identities = 47/161 (29%), Positives = 84/161 (52%), Gaps = 14/161 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
E + +++P I+R+ +AE + LV+E +GG L+ + L G+ + + +
Sbjct: 45 EAEIMHQLDNPYIVRMIGVCEAEA-LMLVMEMASGGPLNKF--LSGKKDEITVSNVVELM 101
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCG 130
Q+ G++ L + +HRDL N+LL + KI+DFGLS L + Y + G
Sbjct: 102 HQVSMGMKYLEGKNFVHRDLAARNVLLV---NQHYAKISDFGLSKALGADDSYYKARSAG 158
Query: 131 S-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF 168
PL + APE + F+++ + D+WS G ++E + G P+
Sbjct: 159 KWPLKWYAPECINFRKFSSRSDVWSYGITMWEAFSYGQKPY 199
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257 |
| >gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Score = 74.7 bits (183), Expect = 8e-16
Identities = 49/192 (25%), Positives = 95/192 (49%), Gaps = 25/192 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--------VPEQT 67
E L+++ H +I++ + + + +V E+ G+L+ ++R HG P Q
Sbjct: 57 EAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQA 116
Query: 68 ARKF--------LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ Q+ +G+ L S H +HRDL N L+ ++++KI DFG+S +
Sbjct: 117 KGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---ANLLVKIGDFGMSRDV 173
Query: 120 YPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
Y +Y +V G + +M PE + ++++ + D+WS G IL+E+ G P+ +N
Sbjct: 174 YSTDYY-RVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEIFTYGKQPWFQLSNT 232
Query: 175 QLVRNINSCKHL 186
+++ I + L
Sbjct: 233 EVIECITQGRVL 244
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291 |
| >gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Score = 74.0 bits (182), Expect = 9e-16
Identities = 53/178 (29%), Positives = 88/178 (49%), Gaps = 15/178 (8%)
Query: 20 LSSVNHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARK---FLQQL 75
+ +HPN++ L +E +V+ + G+L ++IR P T + F Q+
Sbjct: 50 MKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNP--TVKDLIGFGLQV 107
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPL 133
G+E L S +HRDL N +L D+ +K+ADFGL+ +Y Y G+ L
Sbjct: 108 AKGMEYLASKKFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKL 164
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+MA E LQ Q++ K D+WS G +L+EL+ G PP+ ++ + + + L
Sbjct: 165 PVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVDSFDITVYLLQGRRLL 222
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262 |
| >gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 74.1 bits (182), Expect = 1e-15
Identities = 58/186 (31%), Positives = 89/186 (47%), Gaps = 32/186 (17%)
Query: 1 MLK-KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
MLK + + L EL +S + NH NI+ L A I ++ E+C G+L +++R
Sbjct: 72 MLKPTAHSSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLR 131
Query: 59 LHGRVPEQTARKFLQ---------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLK 109
+ FL Q+ G+ L S + IHRDL N+LL+ ++K
Sbjct: 132 -------RKRESFLTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLT---HGKIVK 181
Query: 110 IADFGLSC-TLYPGNYAEKVCGS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--- 161
I DFGL+ + NY K G+ P+ +MAPE + Y + D+WS G +L+E+
Sbjct: 182 ICDFGLARDIMNDSNYVVK--GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSL 239
Query: 162 -LNGYP 166
N YP
Sbjct: 240 GSNPYP 245
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302 |
| >gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Score = 73.4 bits (180), Expect = 2e-15
Identities = 63/238 (26%), Positives = 111/238 (46%), Gaps = 26/238 (10%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE 65
NK+ ++ E+ +S + PNIIRL + + ++ E+ G+L+ ++ H E
Sbjct: 59 NKNARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRH-EPQE 117
Query: 66 Q------------TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
T Q+ +G++ L+S + +HRDL N L+ + +KIADF
Sbjct: 118 AAEKADVVTISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVG---KNYTIKIADF 174
Query: 114 GLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN--GYPP 167
G+S LY G+Y ++ G + +M+ E + ++ D+W+ G L+E+L P
Sbjct: 175 GMSRNLYSGDYY-RIQGRAVLPIRWMSWESILLGKFTTASDVWAFGVTLWEILTLCKEQP 233
Query: 168 FSGRNNVQLVRNINSCKHLPFSQ--LIVPALHPDCV-DMCLKLLSANTVDRLSFNEFY 222
+S ++ Q++ N Q L PAL PD + + L N +R SF E +
Sbjct: 234 YSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIH 291
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296 |
| >gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Score = 72.7 bits (178), Expect = 4e-15
Identities = 56/174 (32%), Positives = 83/174 (47%), Gaps = 30/174 (17%)
Query: 25 HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPE-----------------QT 67
HPNII L A + ++L +E+ GNL ++R RV E Q
Sbjct: 67 HPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLR-KSRVLETDPAFAIANSTASTLSSQQ 125
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YA 125
F + G++ L+ IHRDL NIL+ ++ + KIADFGLS G Y
Sbjct: 126 LLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLS----RGQEVYV 178
Query: 126 EKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL 176
+K G P+ +MA E L + Y D+WS G +L+E+++ G P+ G +L
Sbjct: 179 KKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAEL 232
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303 |
| >gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Score = 72.4 bits (178), Expect = 6e-15
Identities = 50/166 (30%), Positives = 79/166 (47%), Gaps = 15/166 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFLQ 73
E+ + HPNI+ +F ++ +++V A G+ ++ H PE L+
Sbjct: 49 EIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILK 108
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSP 132
+ L+ ++S IHR +K +ILLSG D V+L + S ++ G V P
Sbjct: 109 DVLNALDYIHSKGFIHRSVKASHILLSG-DGKVVL--SGLRYSVSMIKHGKRQRVVHDFP 165
Query: 133 LY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFS 169
++PEVLQ Q Y+EK D++SVG EL NG+ PF
Sbjct: 166 KSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACELANGHVPFK 211
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314 |
| >gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Score = 71.6 bits (175), Expect = 9e-15
Identities = 54/173 (31%), Positives = 87/173 (50%), Gaps = 18/173 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
E+ L + HPN+I L F A+ ++L+ ++ A +L I+ H ++P
Sbjct: 48 EIALLRELKHPNVISLQKVFLSHADRKVWLLFDY-AEHDLWHIIKFHRASKANKKPVQLP 106
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
+ L Q+ G+ L+++ ++HRDLKP NIL+ G + +KIAD G + L
Sbjct: 107 RGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGR 171
P + V + Y APE+L R Y + +D+W++G I ELL P F R
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317 |
| >gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Score = 71.3 bits (174), Expect = 1e-14
Identities = 53/173 (30%), Positives = 87/173 (50%), Gaps = 18/173 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHG---------RVP 64
E+ L + HPN+I L F ++ ++L+ ++ A +L I+ H ++P
Sbjct: 48 EIALLRELKHPNVIALQKVFLSHSDRKVWLLFDY-AEHDLWHIIKFHRASKANKKPMQLP 106
Query: 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLS----CTL 119
+ L Q+ G+ L+++ ++HRDLKP NIL+ G + +KIAD G + L
Sbjct: 107 RSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPL 166
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGR 171
P + V + Y APE+L R Y + +D+W++G I ELL P F R
Sbjct: 167 KPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPIFHCR 219
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317 |
| >gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Score = 70.3 bits (172), Expect = 2e-14
Identities = 46/174 (26%), Positives = 86/174 (49%), Gaps = 19/174 (10%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ-----LGA 77
+NHPN+++ LV+EFC G+L +Y+R + + Q A+K + Q + +
Sbjct: 52 LNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS 111
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLY 134
GL L+ IH DL N L+ D+ +KI D+GL+ YP +Y + +
Sbjct: 112 GLLWLHQADFIHSDLALRNCQLTA---DLSVKIGDYGLALEQYPEDYYITKDCHAVPLRW 168
Query: 135 MAPEVLQFQRYDEKV-------DMWSVGAILFELL-NGYPPFSGRNNVQLVRNI 180
+APE+++ + D ++WS+G ++EL P+ ++ Q+++ +
Sbjct: 169 LAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFTAADQPYPDLSDEQVLKQV 222
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269 |
| >gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Score = 70.7 bits (173), Expect = 2e-14
Identities = 52/199 (26%), Positives = 96/199 (48%), Gaps = 29/199 (14%)
Query: 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----- 60
NK+ ++ E+ LS + PNIIRL E+ + ++ E+ G+L+ ++ H
Sbjct: 59 NKNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDK 118
Query: 61 -----------GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
+P + L Q+ +G++ L+S + +HRDL N L+ ++
Sbjct: 119 EENGNDAVPPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGE---NL 175
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+KIADFG+S LY G+Y ++ G + +MA E + ++ D+W+ G L+E+L
Sbjct: 176 TIKIADFGMSRNLYAGDYY-RIQGRAVLPIRWMAWECILMGKFTTASDVWAFGVTLWEIL 234
Query: 163 N--GYPPFSGRNNVQLVRN 179
P+ + Q++ N
Sbjct: 235 MLCKEQPYGELTDEQVIEN 253
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304 |
| >gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Score = 70.1 bits (172), Expect = 2e-14
Identities = 53/171 (30%), Positives = 78/171 (45%), Gaps = 12/171 (7%)
Query: 62 RVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE K + LE L+S +IHRD+KP N+L ++ + +K+ DFG+S L
Sbjct: 99 TIPEDILGKIAVSIVKALEYLHSKLSVIHRDVKPSNVL---INRNGQVKLCDFGISGYLV 155
Query: 121 PGNYAEKVCGSPLYMAPE----VLQFQRYDEKVDMWSVGAILFELLNG-YPPFSGRNNVQ 175
G YMAPE L + YD K D+WS+G + EL G +P S + Q
Sbjct: 156 DSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKTPFQ 215
Query: 176 LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226
++ + P QL P+ D K L N +R ++ E H F
Sbjct: 216 QLKQV---VEEPSPQLPAEKFSPEFQDFVNKCLKKNYKERPNYPELLQHPF 263
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283 |
| >gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Score = 70.4 bits (172), Expect = 3e-14
Identities = 54/204 (26%), Positives = 95/204 (46%), Gaps = 20/204 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQT 67
E + + +++RL +V+E A G+L SY+R GR P T
Sbjct: 59 EASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGR-PPPT 117
Query: 68 ARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
++ +Q ++ G+ LN+ +HRDL N +++ D +KI DFG++ +Y +Y
Sbjct: 118 LQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVA---HDFTVKIGDFGMTRDIYETDY 174
Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNI 180
K L +MAPE L+ + DMWS G +L+E+ + P+ G +N Q+++ +
Sbjct: 175 YRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGVVLWEITSLAEQPYQGLSNEQVLKFV 234
Query: 181 NSCKHLPFSQLIVPALHPDCVDMC 204
+L + D + MC
Sbjct: 235 MDGGYLDQPDNCPERVT-DLMRMC 257
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288 |
| >gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 70.1 bits (171), Expect = 3e-14
Identities = 54/209 (25%), Positives = 96/209 (45%), Gaps = 29/209 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------T 67
E + + N +++RL +++E G+L SY+R R + +
Sbjct: 59 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLR-SLRPEMENNPVQAPPS 117
Query: 68 ARKFLQQLGA---GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
+K +Q G G+ LN++ +HRDL N +++ +D +KI DFG++ +Y +Y
Sbjct: 118 LKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDY 174
Query: 125 AEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNI 180
K L +M+PE L+ + D+WS G +L+E+ P+ G +N Q++R +
Sbjct: 175 YRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGMSNEQVLRFV 234
Query: 181 NSCKHLPFSQLIVPALHPD-CVDMCLKLL 208
L PD C DM +L+
Sbjct: 235 MEGGLLD---------KPDNCPDMLFELM 254
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277 |
| >gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Score = 68.1 bits (166), Expect = 2e-13
Identities = 46/166 (27%), Positives = 77/166 (46%), Gaps = 10/166 (6%)
Query: 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
K LD E ++SV++P++ RL + + L+ + G L Y+R H + Q
Sbjct: 54 KEILD-EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYL 111
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+ L ++HRDL N+L+ +KI DFGL+ L
Sbjct: 112 LNWCVQIAKGMNYLEERRLVHRDLAARNVLVKTPQH---VKITDFGLAKLLGADEKEYHA 168
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
G + +MA E + + Y + D+WS G ++EL+ G P+ G
Sbjct: 169 EGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316 |
| >gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Score = 67.1 bits (164), Expect = 4e-13
Identities = 70/245 (28%), Positives = 101/245 (41%), Gaps = 50/245 (20%)
Query: 16 ELNFLSSVNHPNIIRL----------FDAFQAENCIFLVVEFCAG---GNLSSYIRLHGR 62
E+ L +NH NI+ L D + + +LV E+ G L S G
Sbjct: 56 EIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES-----GL 110
Query: 63 V--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
V E + F++QL GL + + +HRD+K NIL L++ +K+ADFGL+ LY
Sbjct: 111 VHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNIL---LNNKGQIKLADFGLA-RLY 166
Query: 121 PGN----YAEKVCGSPLYMAPE-VLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
Y KV + Y PE +L +RY +D+WS G IL EL P F +
Sbjct: 167 NSEESRPYTNKVI-TLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225
Query: 176 LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 235
+ I+ P PA+ PD + + FN + RR LR
Sbjct: 226 QLELISRLCGSP-----CPAVWPDVIKLPY------------FNTMKPKKQYRRR---LR 265
Query: 236 APFHI 240
F
Sbjct: 266 EEFSF 270
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302 |
| >gnl|CDD|133195 cd05064, PTKc_EphR_A10, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Score = 66.5 bits (162), Expect = 4e-13
Identities = 49/196 (25%), Positives = 89/196 (45%), Gaps = 10/196 (5%)
Query: 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
E L +H NI+RL N + +V E+ + G L S++R H G++
Sbjct: 52 GFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMG 111
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG-LSCTLYPGNYAEKVC 129
L L +G++ L+ +H+ L +L++ D++ KI+ F L Y
Sbjct: 112 MLPGLASGMKYLSEMGYVHKGLAAHKVLVN---SDLVCKISGFRRLQEDKSEAIYTTMSG 168
Query: 130 GSP-LYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
SP L+ APE +Q+ + D+WS G +++E+++ G P+ + +++ + LP
Sbjct: 169 KSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSYGERPYWDMSGQDVIKAVEDGFRLP 228
Query: 188 FSQLIVPALHP---DC 200
+ LH DC
Sbjct: 229 APRNCPNLLHQLMLDC 244
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). EphA10, which contains an inactive tyr kinase domain, may function to attenuate signals of co-clustered active receptors. EphA10 is mainly expressed in the testis. Ephrin/EphR interaction results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266 |
| >gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Score = 65.6 bits (160), Expect = 1e-12
Identities = 41/103 (39%), Positives = 60/103 (58%), Gaps = 11/103 (10%)
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
Q+ G+E L S IHRDL NILLS ++ ++KI DFGL+ +Y +Y K G
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRK--GDA 235
Query: 132 --PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
PL +MAPE + + Y + D+WS G +L+E+ + G P+ G
Sbjct: 236 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG 278
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337 |
| >gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 65.0 bits (158), Expect = 2e-12
Identities = 62/229 (27%), Positives = 101/229 (44%), Gaps = 31/229 (13%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFL 72
E+ L ++ H NI++ + N I L++EF G+L Y+ R ++ + K+
Sbjct: 56 EIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYA 115
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY--PGNYAEK-VC 129
Q+ G++ L S +HRDL N+L ++ + +KI DFGL+ + Y K
Sbjct: 116 VQICKGMDYLGSRQYVHRDLAARNVL---VESEHQVKIGDFGLTKAIETDKEYYTVKDDL 172
Query: 130 GSPLY-MAPEVLQFQRYDEKVDMWSVGAILFELL----NGYPPFS----------GRNNV 174
SP++ APE L ++ D+WS G L+ELL + P + G+ V
Sbjct: 173 DSPVFWYAPECLIQSKFYIASDVWSFGVTLYELLTYCDSESSPMTLFLKMIGPTHGQMTV 232
Query: 175 -QLVRNINSCKHLPFSQLIVPALHPDCVDMCL-KLLSANTVDRLSFNEF 221
+LVR + K LP P P+ V + K R +F
Sbjct: 233 TRLVRVLEEGKRLP-----RPPNCPEEVYQLMRKCWEFQPSKRTTFQNL 276
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284 |
| >gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Score = 64.6 bits (157), Expect = 3e-12
Identities = 48/119 (40%), Positives = 69/119 (57%), Gaps = 16/119 (13%)
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
Q+ G+E L S IHRDL NILLS +++V +KI DFGL+ +Y +Y K GS
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLS--ENNV-VKICDFGLARDIYKDPDYVRK--GSA 236
Query: 132 --PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHL 186
PL +MAPE + + Y + D+WS G +L+E+ + G P+ G VQ+ N C+ L
Sbjct: 237 RLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPG---VQI--NEEFCQRL 290
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338 |
| >gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 64.1 bits (156), Expect = 3e-12
Identities = 43/167 (25%), Positives = 74/167 (44%), Gaps = 21/167 (12%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ----QLGAG 78
+ HPNI++ LV E+C G+L SY+ + LQ ++ AG
Sbjct: 52 LQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAG 111
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYM 135
+ ++ H+ +H DL N L+ D+ +K+ D+G+ + Y +Y E C ++
Sbjct: 112 VTHMHKHNFLHSDLALRNCFLTS---DLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWL 168
Query: 136 APE-VLQFQ------RYDEKVDMWSVGAILFELLNG----YPPFSGR 171
APE V +F + ++W++G L+EL Y S R
Sbjct: 169 APELVGEFHGGLITAEQTKPSNVWALGVTLWELFENAAQPYSHLSDR 215
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268 |
| >gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 64.0 bits (156), Expect = 4e-12
Identities = 50/156 (32%), Positives = 81/156 (51%), Gaps = 16/156 (10%)
Query: 16 ELNFLSSVNHPNIIRL----FDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARK 70
E+ L S+ H NI++ + A + LV+E+ G+L Y++ H R+ +
Sbjct: 55 EIEILKSLQHDNIVKYKGVCYSA--GRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLL 112
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEK 127
+ Q+ G+E L S +HRDL NIL ++ + +KI DFGL+ L P + Y +
Sbjct: 113 YASQICKGMEYLGSKRYVHRDLATRNIL---VESENRVKIGDFGLTKVL-PQDKEYYKVR 168
Query: 128 VCG-SPLY-MAPEVLQFQRYDEKVDMWSVGAILFEL 161
G SP++ APE L ++ D+WS G +L+EL
Sbjct: 169 EPGESPIFWYAPESLTESKFSVASDVWSFGVVLYEL 204
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284 |
| >gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Score = 63.9 bits (155), Expect = 6e-12
Identities = 40/101 (39%), Positives = 59/101 (58%), Gaps = 7/101 (6%)
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS- 131
Q+ G+E L S IHRDL NILLS ++ ++KI DFGL+ +Y +Y K
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLS---ENNVVKICDFGLARDIYKDPDYVRKGDARL 243
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
PL +MAPE + + Y + D+WS G +L+E+ + G P+ G
Sbjct: 244 PLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPG 284
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343 |
| >gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Score = 63.4 bits (154), Expect = 8e-12
Identities = 56/170 (32%), Positives = 81/170 (47%), Gaps = 19/170 (11%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK 70
L EL+ NHPNI+ F A+N +++V F A G+ I H + E
Sbjct: 46 LQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAY 105
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--- 127
LQ + L+ ++ +HR +K +IL+S +D V L GL L N+ ++
Sbjct: 106 ILQGVLKALDYIHHMGYVHRSVKASHILIS-VDGKVYLS----GLRSNLSMINHGQRLRV 160
Query: 128 VCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPF 168
V P Y ++PEVLQ Q YD K D++SVG EL NG+ PF
Sbjct: 161 VHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPF 210
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327 |
| >gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Score = 63.2 bits (153), Expect = 8e-12
Identities = 42/156 (26%), Positives = 76/156 (48%), Gaps = 9/156 (5%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78
++S++HP+++RL + I LV + G L Y+ H + Q + Q+ G
Sbjct: 63 MASMDHPHLVRLLGVCLSPT-IQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKG 121
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YM 135
+ L ++HRDL N+L+ + +KI DFGL+ L G + +M
Sbjct: 122 MMYLEERRLVHRDLAARNVLVKSPNH---VKITDFGLARLLEGDEKEYNADGGKMPIKWM 178
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
A E + ++++ + D+WS G ++EL+ G P+ G
Sbjct: 179 ALECIHYRKFTHQSDVWSYGVTIWELMTFGGKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303 |
| >gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 62.2 bits (151), Expect = 3e-11
Identities = 45/159 (28%), Positives = 75/159 (47%), Gaps = 28/159 (17%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
E L ++HP ++ L D C+ L +L +Y+ R + + TA
Sbjct: 210 EARLLRRLSHPAVLALLDVRVVGGLTCLVLPKYRS---DLYTYLGARLRPLGLAQVTA-- 264
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
+QL + ++ ++ IIHRD+K EN+L++G +D + + DFG +C +A
Sbjct: 265 VARQLLSAIDYIHGEGIIHRDIKTENVLVNGPED---ICLGDFGAAC------FARGSWS 315
Query: 131 SPLYM---------APEVLQFQRYDEKVDMWSVGAILFE 160
+P + APEVL Y VD+WS G ++FE
Sbjct: 316 TPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFE 354
|
Length = 461 |
| >gnl|CDD|133175 cd05043, PTK_Ryk, Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Score = 61.7 bits (150), Expect = 3e-11
Identities = 40/166 (24%), Positives = 73/166 (43%), Gaps = 21/166 (12%)
Query: 11 SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
+ L E L ++H NI+ + + F++ + GNL +++ +
Sbjct: 53 TLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQ 112
Query: 70 KFLQ--------QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
Q+ G+ L+ +IH+D+ N ++ D+++ +KI D LS L+P
Sbjct: 113 ALSTQQLVHMAIQIACGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFP 169
Query: 122 GNYAEKVC-----GSPL-YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
+Y C P+ +MA E L + Y D+WS G +L+EL
Sbjct: 170 MDYH---CLGDNENRPVKWMALESLVNKEYSSASDVWSFGVLLWEL 212
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It acts as a chemorepulsive axon guidance receptor of Wnt glycoproteins and is responsible for the establishment of axon tracts during the development of the central nervous system. In addition, studies in mice reveal that Ryk is essential in skeletal, craniofacial, and cardiac development. Thus, it appears Ryk is involved in signal transduction despite its lack of kinase activity. Ryk may function as an accessory protein that modulates the signals coming from catalytically active partner RTKs such as the Eph receptors. Length = 280 |
| >gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 61.9 bits (150), Expect = 3e-11
Identities = 43/154 (27%), Positives = 72/154 (46%), Gaps = 10/154 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L ++NHP+II+L F L++ +L Y+ + + +
Sbjct: 133 EAHILRAINHPSIIQLKGTFTYNKFTCLILPRYKT-DLYCYLAAKRNIAICDILAIERSV 191
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----GNYAEKVCGS 131
++ L+ + IIHRD+K ENI ++ D + + DFG +C +P N G+
Sbjct: 192 LRAIQYLHENRIIHRDIKAENIFINHPGD---VCLGDFGAAC--FPVDINANKYYGWAGT 246
Query: 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165
APE+L Y VD+WS G +LFE+ +
Sbjct: 247 IATNAPELLARDPYGPAVDIWSAGIVLFEMATCH 280
|
Length = 391 |
| >gnl|CDD|215061 PLN00113, PLN00113, leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 59.9 bits (145), Expect = 2e-10
Identities = 49/170 (28%), Positives = 83/170 (48%), Gaps = 14/170 (8%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
++K++N + S E+ + + HPNI++L ++E +L+ E+ G NLS +R
Sbjct: 719 VVKEIND-VNSIPSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR-- 775
Query: 61 GRVPEQTARKFLQQLGAGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ + RK + L L+ ++ +L PE I++ G D+ L+++ GL C
Sbjct: 776 -NLSWERRRKIAIGIAKALRFLHCRCSPAVVVGNLSPEKIIIDG-KDEPHLRLSLPGLLC 833
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
T K S Y+APE + + EK D++ G IL ELL G P
Sbjct: 834 T------DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSP 877
|
Length = 968 |
| >gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Score = 57.3 bits (138), Expect = 1e-09
Identities = 38/106 (35%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVC 129
F Q+ G+E L S + +HRDL N+LL+ ++KI DFGL+ ++ NY K
Sbjct: 242 FTYQVARGMEFLASKNCVHRDLAARNVLLA---QGKIVKICDFGLARDIMHDSNYVSK-- 296
Query: 130 GSPL----YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
GS +MAPE + Y D+WS G +L+E+ + G P+ G
Sbjct: 297 GSTFLPVKWMAPESIFDNLYTTLSDVWSYGILLWEIFSLGGTPYPG 342
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400 |
| >gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Score = 55.8 bits (134), Expect = 2e-09
Identities = 46/166 (27%), Positives = 76/166 (45%), Gaps = 10/166 (6%)
Query: 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTA 68
K LD E ++ V P + RL + + LV + G L Y+R + R+ Q
Sbjct: 54 KEILD-EAYVMAGVGSPYVCRLL-GICLTSTVQLVTQLMPYGCLLDYVRENKDRIGSQDL 111
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ Q+ G+ L ++HRDL N+L+ + +KI DFGL+ L
Sbjct: 112 LNWCVQIAKGMSYLEEVRLVHRDLAARNVLVKSPNH---VKITDFGLARLLDIDETEYHA 168
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
G + +MA E + +R+ + D+WS G ++EL+ G P+ G
Sbjct: 169 DGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWELMTFGAKPYDG 214
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279 |
| >gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Score = 55.4 bits (133), Expect = 5e-09
Identities = 39/103 (37%), Positives = 56/103 (54%), Gaps = 12/103 (11%)
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC-TLYPGNYAEKVC 129
F Q+ G+E L S + +HRDL N+L+ + ++KI DFGL+ + NY K
Sbjct: 244 FSYQVANGMEFLASKNCVHRDLAARNVLIC---EGKLVKICDFGLARDIMRDSNYISK-- 298
Query: 130 GS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFEL--LNGYP 166
GS PL +MAPE + Y D+WS G +L+E+ L G P
Sbjct: 299 GSTFLPLKWMAPESIFNNLYTTLSDVWSFGILLWEIFTLGGTP 341
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401 |
| >gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Score = 55.0 bits (132), Expect = 6e-09
Identities = 57/206 (27%), Positives = 96/206 (46%), Gaps = 32/206 (15%)
Query: 9 LKSCLDCELNFLSS-------VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L++C + L L + HPNI+ + F + ++++ F A G+ +S ++ +
Sbjct: 35 LENCTEEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTY- 93
Query: 62 RVPEQTARKFLQQL--GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
PE + + + GA GL L+ + IHR++K +IL+SG D V L GLS
Sbjct: 94 -FPEGMSEALIGNILFGALRGLNYLHQNGYIHRNIKASHILISG-DGLVSLS----GLSH 147
Query: 117 --CTLYPGNYAEKVCGSPLY-------MAPEVLQ--FQRYDEKVDMWSVGAILFELLNGY 165
+ G A+ V P + ++PE+L+ Y+ K D++SVG EL G
Sbjct: 148 LYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSVGITACELATGR 207
Query: 166 PPFSGRNNVQLVRNINSCKHLPFSQL 191
PF Q++ + K P+S L
Sbjct: 208 VPFQDMLRTQML--LQKLKGPPYSPL 231
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328 |
| >gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Score = 55.1 bits (132), Expect = 7e-09
Identities = 49/190 (25%), Positives = 90/190 (47%), Gaps = 25/190 (13%)
Query: 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVV---EFCAGGNLSSYI-----RLH 60
L+ E+ L +NH NI+++ + ++E +++ +F +L S++
Sbjct: 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKYDF----DLYSFMYDEAFDWK 261
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
R + R ++QL +E ++ +IHRD+K ENI L+ D + + DFG +
Sbjct: 262 DRPLLKQTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNC---DGKIVLGDFGTAMPFE 318
Query: 120 ---YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPF---SGRN 172
+Y G+ +PE+L Y E D+WS G IL ++L+ + P G+
Sbjct: 319 KEREAFDYG--WVGTVATNSPEILAGDGYCEITDIWSCGLILLDMLSHDFCPIGDGGGKP 376
Query: 173 NVQLVRNINS 182
QL++ I+S
Sbjct: 377 GKQLLKIIDS 386
|
Length = 501 |
| >gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Score = 55.2 bits (133), Expect = 7e-09
Identities = 44/164 (26%), Positives = 74/164 (45%), Gaps = 32/164 (19%)
Query: 77 AGLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFGLSCTLY 120
A +E ++S ++HRDLKP+NILL L+++ +L I D Y
Sbjct: 124 ATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDI-DVDERNICY 182
Query: 121 -----PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
PG K+ G+P YMAPE L E D++++G IL+++L P+ +
Sbjct: 183 SSMTIPG----KIVGTPDYMAPERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKG-- 236
Query: 176 LVRNINSCKHLPFSQLIVP--ALHPDCVDMCLKLLSANTVDRLS 217
R I+ + + P + P + +K L+ + +R S
Sbjct: 237 --RKISYRDVILSPIEVAPYREIPPFLSQIAMKALAVDPAERYS 278
|
Length = 932 |
| >gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 54.2 bits (130), Expect = 1e-08
Identities = 42/144 (29%), Positives = 63/144 (43%), Gaps = 16/144 (11%)
Query: 35 FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLK 93
FQ E +V G L +I HG + + + Q G L+ ++ H++H DLK
Sbjct: 200 FQNETGHMCIVMPKYGPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLK 259
Query: 94 PENILLSGLD-------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL 140
PENIL+ D D ++I D G C A + + Y +PEV+
Sbjct: 260 PENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERHSRTA--IVSTRHYRSPEVV 317
Query: 141 QFQRYDEKVDMWSVGAILFELLNG 164
+ DMWS+G I++EL G
Sbjct: 318 LGLGWMYSTDMWSMGCIIYELYTG 341
|
Length = 467 |
| >gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Score = 53.7 bits (129), Expect = 2e-08
Identities = 23/55 (41%), Positives = 35/55 (63%)
Query: 126 EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
E++ G+P Y+APE+L + + VD W++G LFE L G PPF+ Q+ +NI
Sbjct: 538 ERILGTPDYLAPELLLGKPHGPAVDWWALGVCLFEFLTGIPPFNDETPQQVFQNI 592
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669 |
| >gnl|CDD|214801 smart00750, KIND, kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Score = 52.0 bits (125), Expect = 2e-08
Identities = 37/118 (31%), Positives = 54/118 (45%), Gaps = 16/118 (13%)
Query: 51 GNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLK 109
+L+ + + GR + E+ Q L L HR K NILL+ D +LK
Sbjct: 1 VSLADILEVRGRPLNEEEIWAVCLQCLGALREL------HRQAKSGNILLT---WDGLLK 51
Query: 110 IADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
+ G S + P +MAPEV+Q Q Y EK D++S+G L+E L+ P
Sbjct: 52 L--DG-SVAFKTPEQSR---PDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELP 103
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features. Length = 176 |
| >gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Score = 52.9 bits (127), Expect = 3e-08
Identities = 38/107 (35%), Positives = 60/107 (56%), Gaps = 11/107 (10%)
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKV 128
+F Q+ G++ L S + IHRD+ N+LL+ D + KI DFGL+ + NY K
Sbjct: 216 RFSSQVAQGMDFLASKNCIHRDVAARNVLLT---DGRVAKICDFGLARDIMNDSNYVVK- 271
Query: 129 CGS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
G+ P+ +MAPE + Y + D+WS G +L+E+ + G P+ G
Sbjct: 272 -GNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPG 317
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374 |
| >gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Score = 52.2 bits (125), Expect = 6e-08
Identities = 39/106 (36%), Positives = 57/106 (53%), Gaps = 11/106 (10%)
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVC 129
F Q+ G+ L S + IHRDL NILL+ + KI DFGL+ + NY K
Sbjct: 219 FSYQVAKGMSFLASKNCIHRDLAARNILLT---HGRITKICDFGLARDIRNDSNYVVK-- 273
Query: 130 GS---PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG 170
G+ P+ +MAPE + Y + D+WS G +L+E+ + G P+ G
Sbjct: 274 GNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSPYPG 319
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375 |
| >gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Score = 51.1 bits (122), Expect = 1e-07
Identities = 51/193 (26%), Positives = 84/193 (43%), Gaps = 25/193 (12%)
Query: 22 SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA--RKFLQQLG--- 76
S+ H N+++ LV+EFC G+L Y+R R E LQ++
Sbjct: 51 SLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLR-SCRKAELMTPDPTTLQRMACEI 109
Query: 77 -AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 132
GL L+ ++ IH DL N LL+ D+ +KI D+GLS Y +Y +++
Sbjct: 110 ALGLLHLHKNNFIHSDLALRNCLLTA---DLTVKIGDYGLSHNKYKEDYYVTPDQLWVPL 166
Query: 133 LYMAPEV-------LQFQRYDEKVDMWSVGAILFELL----NGYPPFSGRNNVQLVRNIN 181
++APE+ L ++ ++WS+G ++EL Y S +
Sbjct: 167 RWIAPELVDEVHGNLLVVDQTKESNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQ 226
Query: 182 SCKHLPFSQLIVP 194
K LP +L +P
Sbjct: 227 QLK-LPKPRLKLP 238
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269 |
| >gnl|CDD|133207 cd05076, PTK_Tyk2_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Score = 46.1 bits (109), Expect = 6e-06
Identities = 42/136 (30%), Positives = 64/136 (47%), Gaps = 10/136 (7%)
Query: 43 LVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS- 100
+V EF G L +R GRVP QQL + L L +++H ++ +NILL+
Sbjct: 93 MVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNLVHGNVCAKNILLAR 152
Query: 101 -GLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGA 156
GL + +K++D G+S T + E+V P ++APE + D WS G
Sbjct: 153 LGLAEGTSPFIKLSDPGVSFTAL--SREERVERIP-WIAPECVPGGNSLSTAADKWSFGT 209
Query: 157 ILFEL-LNGYPPFSGR 171
L E+ +G P R
Sbjct: 210 TLLEICFDGEVPLKER 225
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 274 |
| >gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 45.1 bits (106), Expect = 2e-05
Identities = 40/161 (24%), Positives = 67/161 (41%), Gaps = 26/161 (16%)
Query: 51 GNLSSYIRLHGRVPEQTA---------RKFLQQLGAGLEILNSHHIIHRDLKPENILLSG 101
G L ++ ++P+ + ++Q+ GL L+ I+HRD+KPEN+L++
Sbjct: 285 GCLEEFMMAGKKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTV 344
Query: 102 LDDDVMLKIADFGLSCTLYPGNYAEKVCG--SPLYMAPEVLQFQRYDEKVDMWSVGAIL- 158
D +KI DFG + + G + G P Y PE L + + ++ A+L
Sbjct: 345 ---DGQVKIIDFGAAVDMCTGINFNPLYGMLDPRYSPPEELVMPQSCPRAPAPAMAALLS 401
Query: 159 -FELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHP 198
F L G P ++ Q+ VP L P
Sbjct: 402 PFAWLYGRPDLFDSYTAGVL----------LMQMCVPELRP 432
|
Length = 507 |
| >gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Score = 44.4 bits (105), Expect = 2e-05
Identities = 27/72 (37%), Positives = 39/72 (54%), Gaps = 4/72 (5%)
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEK 127
+ ++Q+ L+ L+S I+HRD+KP+NI+ S + KI D G + L G NY K
Sbjct: 258 QTIMRQILFALDGLHSTGIVHRDVKPQNIIFS--EGSGSFKIIDLGAAADLRVGINYIPK 315
Query: 128 -VCGSPLYMAPE 138
P Y APE
Sbjct: 316 EFLLDPRYAAPE 327
|
Length = 566 |
| >gnl|CDD|133209 cd05078, PTK_Jak2_Jak3_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Score = 41.0 bits (96), Expect = 2e-04
Identities = 38/175 (21%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 1 MLKKLNKHLKSCLDCEL---NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+LK L+K ++ + + +S ++H +++ + + +V E+ G+L +Y+
Sbjct: 31 LLKVLDKSHRNYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYL 90
Query: 58 RL-HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-----MLKIA 111
+ + + +QL L L + H ++ +N+LL +D +K++
Sbjct: 91 KKNKNLINISWKLEVAKQLAWALHFLEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLS 150
Query: 112 DFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNG 164
D G+S T+ P E++ P ++ PE ++ Q D WS G L+E+ +G
Sbjct: 151 DPGISITVLPKEILLERI---P-WVPPECIENPQNLSLAADKWSFGTTLWEIFSG 201
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 258 |
| >gnl|CDD|173627 cd05037, PTK_Jak_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Score = 40.5 bits (95), Expect = 4e-04
Identities = 37/161 (22%), Positives = 72/161 (44%), Gaps = 14/161 (8%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--LQQLGA 77
+S ++H ++++L+ + I +V E+ G L ++ K +QL +
Sbjct: 55 MSQLSHKHLVKLYGVCVRDENI-MVEEYVKFGPLDVFLHREKNNV-SLHWKLDVAKQLAS 112
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPL 133
L L ++H ++ +NIL++ + +K++D G+ T+ + E+V P
Sbjct: 113 ALHYLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITV--LSREERVERIP- 169
Query: 134 YMAPEVLQ--FQRYDEKVDMWSVGAILFELL-NGYPPFSGR 171
++APE ++ D WS G L E+ NG P S
Sbjct: 170 WIAPECIRNGQASLTIAADKWSFGTTLLEICSNGEEPLSTL 210
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 259 |
| >gnl|CDD|173643 cd05077, PTK_Jak1_rpt1, Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Score = 40.3 bits (94), Expect = 4e-04
Identities = 44/166 (26%), Positives = 77/166 (46%), Gaps = 20/166 (12%)
Query: 18 NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF--LQQL 75
+ + V+H +I+ L+ + +V EF G L ++ T KF +QL
Sbjct: 56 SMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSD-VLTTPWKFKVAKQL 114
Query: 76 GAGLEILNSHHIIHRDLKPENILLS--GLDDDV--MLKIADFGLSCTLYPGNYAEKVCGS 131
+ L L ++H ++ +NILL+ G+D + +K++D G+ T+ + E V
Sbjct: 115 ASALSYLEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVL--SRQECVERI 172
Query: 132 PLYMAPEVLQFQRYDEKV-----DMWSVGAILFEL-LNGYPPFSGR 171
P ++APE ++ D K D WS G L+E+ NG P +
Sbjct: 173 P-WIAPECVE----DSKNLSIAADKWSFGTTLWEICYNGEIPLKDK 213
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 262 |
| >gnl|CDD|165291 PHA02988, PHA02988, hypothetical protein; Provisional | Back alignment and domain information |
|---|
Score = 39.3 bits (92), Expect = 0.001
Identities = 41/180 (22%), Positives = 77/180 (42%), Gaps = 17/180 (9%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNL 53
KK +K K +D E+ L ++ NI++++ F + + L++E+C G L
Sbjct: 51 FKKFHKGHKVLIDITENEIKNLRRIDSNNILKIY-GFIIDIVDDLPRLSLILEYCTRGYL 109
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
+ + +T GL L + +++L + L+ ++ LKI
Sbjct: 110 REVLDKEKDLSFKTKLDMAIDCCKGLYNLYKYTNKPYKNLTSVSFLV---TENYKLKIIC 166
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFSG 170
GL L + K +Y + ++L F Y K D++S+G +L+E+ G PF
Sbjct: 167 HGLEKILSSPPF--KNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIFTGKIPFEN 224
|
Length = 283 |
| >gnl|CDD|237847 PRK14879, PRK14879, serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Score = 38.7 bits (91), Expect = 0.001
Identities = 29/94 (30%), Positives = 44/94 (46%), Gaps = 13/94 (13%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
VN P + D +V+E+ G L I +G + +R+ + +G L
Sbjct: 61 VNVP-AVYFVD----PENFIIVMEYIEGEPLKDLINSNGMEELELSREIGRLVG----KL 111
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+S IIH DL N++LSG + L I DFGL+
Sbjct: 112 HSAGIIHGDLTTSNMILSG--GKIYL-I-DFGLA 141
|
Length = 211 |
| >gnl|CDD|240159 cd05120, APH_ChoK_like, Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Score = 36.6 bits (85), Expect = 0.004
Identities = 26/108 (24%), Positives = 45/108 (41%), Gaps = 15/108 (13%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
L L+ P + ++ + +++ +L++E+ G L V E+ +QL
Sbjct: 45 LQLLARKGLP-VPKVLASGESDGWSYLLMEWIEGETLDE-------VSEEEKEDIAEQLA 96
Query: 77 AGLEILNSH---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
L L+ + H DL P NIL +DD +L I D+ P
Sbjct: 97 ELLAKLHQLPLLVLCHGDLHPGNIL---VDDGKILGIIDWE-YAGYGP 140
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves as precursors to the synthesis of important biological compounds, such as the major phospholipids, phosphatidylcholine and phosphatidylethanolamine and the amino acids, threonine, methionine, and isoleucine. Length = 155 |
Conserved Domains Detected by HHsearch
Original result of HHsearch against CDD database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 241 | |||
| KOG0581 | 364 | consensus Mitogen-activated protein kinase kinase | 100.0 | |
| KOG0615 | 475 | consensus Serine/threonine protein kinase Chk2 and | 100.0 | |
| KOG0575 | 592 | consensus Polo-like serine/threonine protein kinas | 100.0 | |
| KOG0595 | 429 | consensus Serine/threonine-protein kinase involved | 100.0 | |
| KOG0033 | 355 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0598 | 357 | consensus Ribosomal protein S6 kinase and related | 100.0 | |
| KOG0588 | 786 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| KOG0592 | 604 | consensus 3-phosphoinositide-dependent protein kin | 100.0 | |
| KOG0583 | 370 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0198 | 313 | consensus MEKK and related serine/threonine protei | 100.0 | |
| KOG0578 | 550 | consensus p21-activated serine/threonine protein k | 100.0 | |
| KOG0616 | 355 | consensus cAMP-dependent protein kinase catalytic | 100.0 | |
| KOG0591 | 375 | consensus NIMA (never in mitosis)-related G2-speci | 100.0 | |
| KOG0599 | 411 | consensus Phosphorylase kinase gamma subunit [Carb | 100.0 | |
| KOG0593 | 396 | consensus Predicted protein kinase KKIAMRE [Genera | 100.0 | |
| KOG0582 | 516 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| KOG0192 | 362 | consensus Tyrosine kinase specific for activated ( | 100.0 | |
| KOG0661 | 538 | consensus MAPK related serine/threonine protein ki | 100.0 | |
| KOG0197 | 468 | consensus Tyrosine kinases [Signal transduction me | 100.0 | |
| KOG0589 | 426 | consensus Serine/threonine protein kinase [General | 100.0 | |
| KOG0597 | 808 | consensus Serine-threonine protein kinase FUSED [G | 100.0 | |
| KOG0032 | 382 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| KOG0604 | 400 | consensus MAP kinase-activated protein kinase 2 [S | 100.0 | |
| cd05571 | 323 | STKc_PKB Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05612 | 291 | STKc_PRKX_like Catalytic domain of PRKX-like Prote | 100.0 | |
| PTZ00263 | 329 | protein kinase A catalytic subunit; Provisional | 100.0 | |
| KOG0660 | 359 | consensus Mitogen-activated protein kinase [Signal | 100.0 | |
| cd05631 | 285 | STKc_GRK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05585 | 312 | STKc_YPK1_like Catalytic domain of Yeast Protein K | 100.0 | |
| PTZ00426 | 340 | cAMP-dependent protein kinase catalytic subunit; P | 100.0 | |
| cd05595 | 323 | STKc_PKB_beta Catalytic domain of the Protein Seri | 100.0 | |
| cd05593 | 328 | STKc_PKB_gamma Catalytic domain of the Protein Ser | 100.0 | |
| KOG0659 | 318 | consensus Cdk activating kinase (CAK)/RNA polymera | 100.0 | |
| cd05600 | 333 | STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- | 100.0 | |
| cd05584 | 323 | STKc_p70S6K Catalytic domain of the Protein Serine | 100.0 | |
| cd07859 | 338 | STKc_TDY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd06649 | 331 | PKc_MEK2 Catalytic domain of the dual-specificity | 100.0 | |
| cd05590 | 320 | STKc_nPKC_eta Catalytic domain of the Protein Seri | 100.0 | |
| cd05594 | 325 | STKc_PKB_alpha Catalytic domain of the Protein Ser | 100.0 | |
| cd07848 | 287 | STKc_CDKL5 Catalytic domain of the Serine/Threonin | 100.0 | |
| PTZ00267 | 478 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd05582 | 318 | STKc_RSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd05588 | 329 | STKc_aPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05570 | 318 | STKc_PKC Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0694 | 694 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07871 | 288 | STKc_PCTAIRE3 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05591 | 321 | STKc_nPKC_epsilon Catalytic domain of the Protein | 100.0 | |
| KOG0600 | 560 | consensus Cdc2-related protein kinase [Cell cycle | 100.0 | |
| cd05628 | 363 | STKc_NDR1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0605 | 550 | consensus NDR and related serine/threonine kinases | 100.0 | |
| KOG0201 | 467 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05608 | 280 | STKc_GRK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05607 | 277 | STKc_GRK7 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05605 | 285 | STKc_GRK4_like Catalytic domain of G protein-coupl | 100.0 | |
| cd05573 | 350 | STKc_ROCK_NDR_like Catalytic domain of ROCK- and N | 100.0 | |
| cd05620 | 316 | STKc_nPKC_delta Catalytic domain of the Protein Se | 100.0 | |
| cd05629 | 377 | STKc_NDR_like_fungal Catalytic domain of Fungal Nu | 100.0 | |
| cd05575 | 323 | STKc_SGK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05599 | 364 | STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel | 100.0 | |
| KOG0658 | 364 | consensus Glycogen synthase kinase-3 [Carbohydrate | 100.0 | |
| cd06650 | 333 | PKc_MEK1 Catalytic domain of the dual-specificity | 100.0 | |
| KOG0611 | 668 | consensus Predicted serine/threonine protein kinas | 100.0 | |
| cd05592 | 316 | STKc_nPKC_theta_delta Catalytic domain of the Prot | 100.0 | |
| cd05618 | 329 | STKc_aPKC_iota Catalytic domain of the Protein Ser | 100.0 | |
| cd06625 | 263 | STKc_MEKK3_like Catalytic domain of MAP/ERK kinase | 100.0 | |
| PHA03212 | 391 | serine/threonine kinase US3; Provisional | 100.0 | |
| KOG0610 | 459 | consensus Putative serine/threonine protein kinase | 100.0 | |
| cd05625 | 382 | STKc_LATS1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05587 | 324 | STKc_cPKC Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05619 | 316 | STKc_nPKC_theta Catalytic domain of the Protein Se | 100.0 | |
| cd07862 | 290 | STKc_CDK6 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05589 | 324 | STKc_PKN Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05598 | 376 | STKc_LATS Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06628 | 267 | STKc_MAPKKK_Byr2_like Catalytic domain of fungal B | 100.0 | |
| cd05617 | 327 | STKc_aPKC_zeta Catalytic domain of the Protein Ser | 100.0 | |
| cd05626 | 381 | STKc_LATS2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07869 | 303 | STKc_PFTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd05596 | 370 | STKc_ROCK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd08529 | 256 | STKc_FA2-like Catalytic domain of the Protein Seri | 100.0 | |
| cd05601 | 330 | STKc_CRIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05614 | 332 | STKc_MSK2_N N-terminal catalytic domain of the Pro | 100.0 | |
| KOG0580 | 281 | consensus Serine/threonine protein kinase [Cell cy | 100.0 | |
| cd05604 | 325 | STKc_SGK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05627 | 360 | STKc_NDR2 Catalytic domain of the Protein Serine/T | 100.0 | |
| PTZ00036 | 440 | glycogen synthase kinase; Provisional | 100.0 | |
| cd05616 | 323 | STKc_cPKC_beta Catalytic domain of the Protein Ser | 100.0 | |
| KOG0584 | 632 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05572 | 262 | STKc_cGK_PKG Catalytic domain of the Protein Serin | 100.0 | |
| cd05603 | 321 | STKc_SGK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05602 | 325 | STKc_SGK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0585 | 576 | consensus Ca2+/calmodulin-dependent protein kinase | 100.0 | |
| cd05621 | 370 | STKc_ROCK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd08220 | 256 | STKc_Nek8 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06609 | 274 | STKc_MST3_like Catalytic domain of Mammalian Ste20 | 100.0 | |
| cd05580 | 290 | STKc_PKA Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05586 | 330 | STKc_Sck1_like Catalytic domain of Suppressor of l | 100.0 | |
| KOG0663 | 419 | consensus Protein kinase PITSLRE and related kinas | 100.0 | |
| PHA02988 | 283 | hypothetical protein; Provisional | 100.0 | |
| cd06631 | 265 | STKc_YSK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| PLN00034 | 353 | mitogen-activated protein kinase kinase; Provision | 100.0 | |
| cd06630 | 268 | STKc_MEKK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07876 | 359 | STKc_JNK2 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05632 | 285 | STKc_GRK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07853 | 372 | STKc_NLK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06643 | 282 | STKc_SLK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08221 | 256 | STKc_Nek9 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0986 | 591 | consensus G protein-coupled receptor kinase [Signa | 100.0 | |
| cd05597 | 331 | STKc_DMPK_like Catalytic domain of Myotonic Dystro | 100.0 | |
| cd06612 | 256 | STKc_MST1_2 Catalytic domain of the Protein Serine | 100.0 | |
| cd08227 | 327 | PK_STRAD_alpha Pseudokinase domain of STE20-relate | 100.0 | |
| KOG0667 | 586 | consensus Dual-specificity tyrosine-phosphorylatio | 100.0 | |
| cd05577 | 277 | STKc_GRK Catalytic domain of the Protein Serine/Th | 100.0 | |
| KOG0594 | 323 | consensus Protein kinase PCTAIRE and related kinas | 100.0 | |
| cd06613 | 262 | STKc_MAP4K3_like Catalytic domain of Mitogen-activ | 100.0 | |
| cd05630 | 285 | STKc_GRK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06615 | 308 | PKc_MEK Catalytic domain of the dual-specificity P | 100.0 | |
| cd08223 | 257 | STKc_Nek4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05623 | 332 | STKc_MRCK_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd05622 | 371 | STKc_ROCK1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05615 | 323 | STKc_cPKC_alpha Catalytic domain of the Protein Se | 100.0 | |
| cd07874 | 355 | STKc_JNK3 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07875 | 364 | STKc_JNK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06645 | 267 | STKc_MAP4K3 Catalytic domain of the Protein Serine | 100.0 | |
| cd06611 | 280 | STKc_SLK_like Catalytic domain of Ste20-like kinas | 100.0 | |
| cd07872 | 309 | STKc_PCTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| KOG1026 | 774 | consensus Nerve growth factor receptor TRKA and re | 100.0 | |
| cd08218 | 256 | STKc_Nek1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07863 | 288 | STKc_CDK4 Catalytic domain of the Serine/Threonine | 100.0 | |
| PHA03207 | 392 | serine/threonine kinase US3; Provisional | 100.0 | |
| PF00069 | 260 | Pkinase: Protein kinase domain Protein kinase; unc | 100.0 | |
| cd05574 | 316 | STKc_phototropin_like Catalytic domain of Phototro | 100.0 | |
| cd06655 | 296 | STKc_PAK2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06658 | 292 | STKc_PAK5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06632 | 258 | STKc_MEKK1_plant Catalytic domain of the Protein S | 100.0 | |
| cd06644 | 292 | STKc_STK10_LOK Catalytic domain of the Protein Ser | 100.0 | |
| cd06605 | 265 | PKc_MAPKK Catalytic domain of the dual-specificity | 100.0 | |
| cd07847 | 286 | STKc_CDKL1_4 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05578 | 258 | STKc_Yank1 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07873 | 301 | STKc_PCTAIRE1 Catalytic domain of the Serine/Threo | 100.0 | |
| cd06648 | 285 | STKc_PAK_II Catalytic domain of the Protein Serine | 100.0 | |
| KOG0579 | 1187 | consensus Ste20-like serine/threonine protein kina | 100.0 | |
| cd06619 | 279 | PKc_MKK5 Catalytic domain of the dual-specificity | 100.0 | |
| cd06640 | 277 | STKc_MST4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06651 | 266 | STKc_MEKK3 Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0607 | 463 | consensus MAP kinase-interacting kinase and relate | 100.0 | |
| cd06646 | 267 | STKc_MAP4K5 Catalytic domain of the Protein Serine | 100.0 | |
| cd05048 | 283 | PTKc_Ror Catalytic Domain of the Protein Tyrosine | 100.0 | |
| PTZ00283 | 496 | serine/threonine protein kinase; Provisional | 100.0 | |
| cd06629 | 272 | STKc_MAPKKK_Bck1_like Catalytic domain of fungal B | 100.0 | |
| cd05609 | 305 | STKc_MAST Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06610 | 267 | STKc_OSR1_SPAK Catalytic domain of the Protein Ser | 100.0 | |
| cd05579 | 265 | STKc_MAST_like Catalytic domain of Microtubule-ass | 100.0 | |
| KOG4717 | 864 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd05624 | 331 | STKc_MRCK_beta Catalytic domain of the Protein Ser | 100.0 | |
| cd05102 | 338 | PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd08217 | 265 | STKc_Nek2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05611 | 260 | STKc_Rim15_like Catalytic domain of fungal Rim15-l | 100.0 | |
| cd06642 | 277 | STKc_STK25-YSK1 Catalytic domain of the Protein Se | 100.0 | |
| cd07878 | 343 | STKc_p38beta_MAPK11 Catalytic domain of the Serine | 100.0 | |
| cd06654 | 296 | STKc_PAK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07868 | 317 | STKc_CDK8 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05064 | 266 | PTKc_EphR_A10 Catalytic domain of the Protein Tyro | 100.0 | |
| cd05093 | 288 | PTKc_TrkB Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06623 | 264 | PKc_MAPKK_plant_like Catalytic domain of Plant dua | 100.0 | |
| PF07714 | 259 | Pkinase_Tyr: Protein tyrosine kinase Protein kinas | 100.0 | |
| KOG4279 | 1226 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07841 | 298 | STKc_CDK7 Catalytic domain of the Serine/Threonine | 100.0 | |
| PTZ00024 | 335 | cyclin-dependent protein kinase; Provisional | 100.0 | |
| PTZ00284 | 467 | protein kinase; Provisional | 100.0 | |
| PHA03209 | 357 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06656 | 297 | STKc_PAK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07861 | 285 | STKc_CDK1_euk Catalytic domain of the Serine/Threo | 100.0 | |
| cd06637 | 272 | STKc_TNIK Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05094 | 291 | PTKc_TrkC Catalytic domain of the Protein Tyrosine | 100.0 | |
| PTZ00266 | 1021 | NIMA-related protein kinase; Provisional | 100.0 | |
| cd08225 | 257 | STKc_Nek5 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06622 | 286 | PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS | 100.0 | |
| cd06621 | 287 | PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek | 100.0 | |
| cd06659 | 297 | STKc_PAK6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07839 | 284 | STKc_CDK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG0983 | 391 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA03390 | 267 | pk1 serine/threonine-protein kinase 1; Provisional | 100.0 | |
| cd05116 | 257 | PTKc_Syk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08215 | 258 | STKc_Nek Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd07832 | 286 | STKc_CCRK Catalytic domain of the Serine/Threonine | 100.0 | |
| KOG4721 | 904 | consensus Serine/threonine protein kinase, contain | 100.0 | |
| cd05049 | 280 | PTKc_Trk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07834 | 330 | STKc_MAPK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd00192 | 262 | PTKc Catalytic domain of Protein Tyrosine Kinases. | 100.0 | |
| PHA03211 | 461 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd05036 | 277 | PTKc_ALK_LTK Catalytic domain of the Protein Tyros | 100.0 | |
| cd06620 | 284 | PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr | 100.0 | |
| cd05123 | 250 | STKc_AGC Catalytic domain of AGC family Protein Se | 100.0 | |
| cd05114 | 256 | PTKc_Tec_Rlk Catalytic domain of the Protein Tyros | 100.0 | |
| cd06626 | 264 | STKc_MEKK4 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06606 | 260 | STKc_MAPKKK Catalytic domain of the Protein Serine | 100.0 | |
| cd06652 | 265 | STKc_MEKK2 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd06917 | 277 | STKc_NAK1_like Catalytic domain of Fungal Nak1-lik | 100.0 | |
| cd07833 | 288 | STKc_CDKL Catalytic domain of Cyclin-Dependent pro | 100.0 | |
| cd05084 | 252 | PTKc_Fes Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05088 | 303 | PTKc_Tie2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06641 | 277 | STKc_MST3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06624 | 268 | STKc_ASK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd05113 | 256 | PTKc_Btk_Bmx Catalytic domain of the Protein Tyros | 100.0 | |
| cd06627 | 254 | STKc_Cdc7_like Catalytic domain of Cell division c | 100.0 | |
| cd07845 | 309 | STKc_CDK10 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd06614 | 286 | STKc_PAK Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08216 | 314 | PK_STRAD Pseudokinase domain of STE20-related kina | 100.0 | |
| cd06657 | 292 | STKc_PAK4 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd06636 | 282 | STKc_MAP4K4_6 Catalytic domain of the Protein Seri | 100.0 | |
| cd05089 | 297 | PTKc_Tie1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05122 | 253 | PKc_STE Catalytic domain of STE family Protein Kin | 100.0 | |
| cd05052 | 263 | PTKc_Abl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06639 | 291 | STKc_myosinIIIB Catalytic domain of the Protein Se | 100.0 | |
| cd06608 | 275 | STKc_myosinIII_like Catalytic domain of Class III | 100.0 | |
| cd08530 | 256 | STKc_CNK2-like Catalytic domain of the Protein Ser | 100.0 | |
| cd07831 | 282 | STKc_MOK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05092 | 280 | PTKc_TrkA Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05060 | 257 | PTKc_Syk_like Catalytic domain of Spleen Tyrosine | 100.0 | |
| cd05096 | 304 | PTKc_DDR1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| PLN00009 | 294 | cyclin-dependent kinase A; Provisional | 100.0 | |
| cd07855 | 334 | STKc_ERK5 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05062 | 277 | PTKc_IGF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05633 | 279 | STKc_GRK3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd07843 | 293 | STKc_CDC2L1 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd06616 | 288 | PKc_MKK4 Catalytic domain of the dual-specificity | 100.0 | |
| cd07867 | 317 | STKc_CDC2L6 Catalytic domain of Serine/Threonine K | 100.0 | |
| cd07850 | 353 | STKc_JNK Catalytic domain of the Serine/Threonine | 100.0 | |
| cd07860 | 284 | STKc_CDK2_3 Catalytic domain of the Serine/Threoni | 100.0 | |
| KOG1095 | 1025 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0596 | 677 | consensus Dual specificity; serine/threonine and t | 100.0 | |
| cd05047 | 270 | PTKc_Tie Catalytic domain of Tie Protein Tyrosine | 100.0 | |
| KOG0194 | 474 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| cd06607 | 307 | STKc_TAO Catalytic domain of the Protein Serine/Th | 100.0 | |
| cd08219 | 255 | STKc_Nek3 Catalytic domain of the Protein Serine/T | 100.0 | |
| KOG0577 | 948 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07835 | 283 | STKc_CDK1_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd05115 | 257 | PTKc_Zap-70 Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05059 | 256 | PTKc_Tec_like Catalytic domain of Tec-like Protein | 100.0 | |
| cd05033 | 266 | PTKc_EphR Catalytic domain of Ephrin Receptor Prot | 100.0 | |
| cd08226 | 328 | PK_STRAD_beta Pseudokinase domain of STE20-related | 100.0 | |
| cd06647 | 293 | STKc_PAK_I Catalytic domain of the Protein Serine/ | 100.0 | |
| cd07846 | 286 | STKc_CDKL2_3 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05106 | 374 | PTKc_CSF-1R Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05090 | 283 | PTKc_Ror1 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05068 | 261 | PTKc_Frk_like Catalytic domain of Fyn-related kina | 100.0 | |
| cd07858 | 337 | STKc_TEY_MAPK_plant Catalytic domain of the Serine | 100.0 | |
| cd05045 | 290 | PTKc_RET Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05104 | 375 | PTKc_Kit Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0574 | 502 | consensus STE20-like serine/threonine kinase MST [ | 100.0 | |
| cd05053 | 293 | PTKc_FGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05032 | 277 | PTKc_InsR_like Catalytic domain of Insulin Recepto | 100.0 | |
| cd05061 | 288 | PTKc_InsR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05039 | 256 | PTKc_Csk_like Catalytic domain of C-terminal Src k | 100.0 | |
| PHA03210 | 501 | serine/threonine kinase US3; Provisional | 100.0 | |
| cd06633 | 313 | STKc_TAO3 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05091 | 283 | PTKc_Ror2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05148 | 261 | PTKc_Srm_Brk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05099 | 314 | PTKc_FGFR4 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd06638 | 286 | STKc_myosinIIIA Catalytic domain of the Protein Se | 100.0 | |
| cd05072 | 261 | PTKc_Lyn Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08222 | 260 | STKc_Nek11 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05606 | 278 | STKc_beta_ARK Catalytic domain of the Protein Seri | 100.0 | |
| cd07849 | 336 | STKc_ERK1_2_like Catalytic domain of Extracellular | 100.0 | |
| cd07836 | 284 | STKc_Pho85 Catalytic domain of the Serine/Threonin | 100.0 | |
| cd05098 | 307 | PTKc_FGFR1 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05075 | 272 | PTKc_Axl Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05581 | 280 | STKc_PDK1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05040 | 257 | PTKc_Ack_like Catalytic domain of the Protein Tyro | 100.0 | |
| cd05066 | 267 | PTKc_EphR_A Catalytic domain of the Protein Tyrosi | 100.0 | |
| cd05101 | 304 | PTKc_FGFR2 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd07844 | 291 | STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like | 100.0 | |
| cd05085 | 250 | PTKc_Fer Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05035 | 273 | PTKc_Axl_like Catalytic Domain of Axl-like Protein | 100.0 | |
| cd07829 | 282 | STKc_CDK_like Catalytic domain of Cyclin-Dependent | 100.0 | |
| cd06617 | 283 | PKc_MKK3_6 Catalytic domain of the dual-specificit | 100.0 | |
| cd05118 | 283 | STKc_CMGC Catalytic domain of CMGC family Serine/T | 100.0 | |
| cd08228 | 267 | STKc_Nek6 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05082 | 256 | PTKc_Csk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07837 | 295 | STKc_CdkB_plant Catalytic domain of the Serine/Thr | 100.0 | |
| cd05063 | 268 | PTKc_EphR_A2 Catalytic domain of the Protein Tyros | 100.0 | |
| cd06653 | 264 | STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina | 100.0 | |
| cd05055 | 302 | PTKc_PDGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05044 | 269 | PTKc_c-ros Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05050 | 288 | PTKc_Musk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd08229 | 267 | STKc_Nek7 Catalytic domain of the Protein Serine/T | 100.0 | |
| smart00219 | 258 | TyrKc Tyrosine kinase, catalytic domain. Phosphotr | 100.0 | |
| cd05051 | 296 | PTKc_DDR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05065 | 269 | PTKc_EphR_B Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 100.0 | |
| cd05077 | 262 | PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| cd05041 | 251 | PTKc_Fes_like Catalytic domain of Fes-like Protein | 100.0 | |
| cd06635 | 317 | STKc_TAO1 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05069 | 260 | PTKc_Yes Catalytic domain of the Protein Tyrosine | 100.0 | |
| KOG0614 | 732 | consensus cGMP-dependent protein kinase [Signal tr | 100.0 | |
| cd05108 | 316 | PTKc_EGFR Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05112 | 256 | PTKc_Itk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05076 | 274 | PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th | 100.0 | |
| KOG0193 | 678 | consensus Serine/threonine protein kinase RAF [Sig | 100.0 | |
| cd05576 | 237 | STKc_RPK118_like Catalytic domain of the Protein S | 100.0 | |
| cd07865 | 310 | STKc_CDK9 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd06634 | 308 | STKc_TAO2 Catalytic domain of the Protein Serine/T | 100.0 | |
| cd05100 | 334 | PTKc_FGFR3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05080 | 283 | PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd07838 | 287 | STKc_CDK4_6_like Catalytic domain of Cyclin-Depend | 100.0 | |
| cd07851 | 343 | STKc_p38 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05070 | 260 | PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros | 100.0 | |
| KOG0586 | 596 | consensus Serine/threonine protein kinase [General | 100.0 | |
| cd05034 | 261 | PTKc_Src_like Catalytic domain of Src kinase-like | 100.0 | |
| cd07870 | 291 | STKc_PFTAIRE2 Catalytic domain of the Serine/Threo | 100.0 | |
| cd07854 | 342 | STKc_MAPK4_6 Catalytic domain of the Serine/Threon | 100.0 | |
| cd05071 | 262 | PTKc_Src Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05111 | 279 | PTK_HER3 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd07830 | 283 | STKc_MAK_like Catalytic domain of Male germ cell-A | 100.0 | |
| cd05105 | 400 | PTKc_PDGFR_alpha Catalytic domain of the Protein T | 100.0 | |
| cd05109 | 279 | PTKc_HER2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05056 | 270 | PTKc_FAK Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07840 | 287 | STKc_CDK9_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| KOG4236 | 888 | consensus Serine/threonine protein kinase PKC mu/P | 100.0 | |
| cd05613 | 290 | STKc_MSK1_N N-terminal catalytic domain of the Pro | 100.0 | |
| cd05037 | 259 | PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the | 100.0 | |
| cd05058 | 262 | PTKc_Met_Ron Catalytic domain of the Protein Tyros | 100.0 | |
| cd05042 | 269 | PTKc_Aatyk Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG1989 | 738 | consensus ARK protein kinase family [Signal transd | 100.0 | |
| cd08224 | 267 | STKc_Nek6_Nek7 Catalytic domain of the Protein Ser | 100.0 | |
| cd05078 | 258 | PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain | 100.0 | |
| cd05097 | 295 | PTKc_DDR_like Catalytic domain of Discoidin Domain | 100.0 | |
| cd05054 | 337 | PTKc_VEGFR Catalytic domain of the Protein Tyrosin | 100.0 | |
| cd05057 | 279 | PTKc_EGFR_like Catalytic domain of Epidermal Growt | 100.0 | |
| cd05043 | 280 | PTK_Ryk Pseudokinase domain of Ryk (Receptor relat | 100.0 | |
| KOG4645 | 1509 | consensus MAPKKK (MAP kinase kinase kinase) SSK2 a | 100.0 | |
| cd07852 | 337 | STKc_MAPK15 Catalytic domain of the Serine/Threoni | 100.0 | |
| cd05046 | 275 | PTK_CCK4 Pseudokinase domain of the Protein Tyrosi | 100.0 | |
| cd05073 | 260 | PTKc_Hck Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd06618 | 296 | PKc_MKK7 Catalytic domain of the dual-specificity | 100.0 | |
| cd05067 | 260 | PTKc_Lck_Blk Catalytic domain of the Protein Tyros | 100.0 | |
| cd05083 | 254 | PTKc_Chk Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05583 | 288 | STKc_MSK_N N-terminal catalytic domain of the Prot | 100.0 | |
| cd07842 | 316 | STKc_CDK8_like Catalytic domain of Cyclin-Dependen | 100.0 | |
| cd07877 | 345 | STKc_p38alpha_MAPK14 Catalytic domain of the Serin | 100.0 | |
| cd07864 | 302 | STKc_CDK12 Catalytic domain of the Serine/Threonin | 100.0 | |
| KOG1187 | 361 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG0690 | 516 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| cd07857 | 332 | STKc_MPK1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd05087 | 269 | PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein | 100.0 | |
| cd07879 | 342 | STKc_p38delta_MAPK13 Catalytic domain of the Serin | 100.0 | |
| KOG0196 | 996 | consensus Tyrosine kinase, EPH (ephrin) receptor f | 100.0 | |
| cd07880 | 343 | STKc_p38gamma_MAPK12 Catalytic domain of the Serin | 100.0 | |
| cd07866 | 311 | STKc_BUR1 Catalytic domain of the Serine/Threonine | 100.0 | |
| cd08528 | 269 | STKc_Nek10 Catalytic domain of the Protein Serine/ | 100.0 | |
| cd05079 | 284 | PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the | 100.0 | |
| cd05095 | 296 | PTKc_DDR2 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd07856 | 328 | STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre | 100.0 | |
| smart00220 | 244 | S_TKc Serine/Threonine protein kinases, catalytic | 100.0 | |
| cd05081 | 284 | PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of | 100.0 | |
| cd05086 | 268 | PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| PRK13184 | 932 | pknD serine/threonine-protein kinase; Reviewed | 100.0 | |
| KOG2345 | 302 | consensus Serine/threonine protein kinase/TGF-beta | 100.0 | |
| KOG0671 | 415 | consensus LAMMER dual specificity kinases [Signal | 100.0 | |
| cd05110 | 303 | PTKc_HER4 Catalytic domain of the Protein Tyrosine | 100.0 | |
| cd05107 | 401 | PTKc_PDGFR_beta Catalytic domain of the Protein Ty | 100.0 | |
| KOG4257 | 974 | consensus Focal adhesion tyrosine kinase FAK, cont | 100.0 | |
| KOG0612 | 1317 | consensus Rho-associated, coiled-coil containing p | 100.0 | |
| cd05074 | 273 | PTKc_Tyro3 Catalytic domain of the Protein Tyrosin | 100.0 | |
| KOG4278 | 1157 | consensus Protein tyrosine kinase [Signal transduc | 100.0 | |
| KOG0666 | 438 | consensus Cyclin C-dependent kinase CDK8 [Transcri | 100.0 | |
| cd05038 | 284 | PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P | 100.0 | |
| KOG0662 | 292 | consensus Cyclin-dependent kinase CDK5 [Intracellu | 100.0 | |
| cd05103 | 343 | PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi | 100.0 | |
| KOG0696 | 683 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG1094 | 807 | consensus Discoidin domain receptor DDR1 [Signal t | 100.0 | |
| KOG0665 | 369 | consensus Jun-N-terminal kinase (JNK) [Signal tran | 100.0 | |
| KOG0199 | 1039 | consensus ACK and related non-receptor tyrosine ki | 100.0 | |
| cd05610 | 669 | STKc_MASTL Catalytic domain of the Protein Serine/ | 100.0 | |
| KOG0587 | 953 | consensus Traf2- and Nck-interacting kinase and re | 100.0 | |
| KOG1027 | 903 | consensus Serine/threonine protein kinase and endo | 100.0 | |
| KOG1006 | 361 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PHA02882 | 294 | putative serine/threonine kinase; Provisional | 100.0 | |
| KOG0200 | 609 | consensus Fibroblast/platelet-derived growth facto | 100.0 | |
| KOG0670 | 752 | consensus U4/U6-associated splicing factor PRP4 [R | 100.0 | |
| KOG0668 | 338 | consensus Casein kinase II, alpha subunit [Signal | 100.0 | |
| KOG1151 | 775 | consensus Tousled-like protein kinase [Signal tran | 100.0 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 100.0 | |
| KOG0695 | 593 | consensus Serine/threonine protein kinase [Signal | 100.0 | |
| KOG4250 | 732 | consensus TANK binding protein kinase TBK1 [Signal | 100.0 | |
| KOG0669 | 376 | consensus Cyclin T-dependent kinase CDK9 [Cell cyc | 100.0 | |
| KOG0608 | 1034 | consensus Warts/lats-like serine threonine kinases | 100.0 | |
| KOG0984 | 282 | consensus Mitogen-activated protein kinase (MAPK) | 100.0 | |
| PLN03225 | 566 | Serine/threonine-protein kinase SNT7; Provisional | 100.0 | |
| PLN00181 | 793 | protein SPA1-RELATED; Provisional | 100.0 | |
| PLN03224 | 507 | probable serine/threonine protein kinase; Provisio | 99.98 | |
| PLN00113 | 968 | leucine-rich repeat receptor-like protein kinase; | 99.98 | |
| KOG1025 | 1177 | consensus Epidermal growth factor receptor EGFR an | 99.98 | |
| KOG2052 | 513 | consensus Activin A type IB receptor, serine/threo | 99.97 | |
| KOG1024 | 563 | consensus Receptor-like protein tyrosine kinase RY | 99.97 | |
| KOG1290 | 590 | consensus Serine/threonine protein kinase [Signal | 99.97 | |
| KOG3653 | 534 | consensus Transforming growth factor beta/activin | 99.97 | |
| smart00750 | 176 | KIND kinase non-catalytic C-lobe domain. It is an | 99.97 | |
| cd00180 | 215 | PKc Catalytic domain of Protein Kinases. Protein K | 99.97 | |
| KOG0664 | 449 | consensus Nemo-like MAPK-related serine/threonine | 99.97 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 99.97 | |
| KOG1167 | 418 | consensus Serine/threonine protein kinase of the C | 99.96 | |
| smart00221 | 225 | STYKc Protein kinase; unclassified specificity. Ph | 99.96 | |
| KOG1152 | 772 | consensus Signal transduction serine/threonine kin | 99.95 | |
| KOG1345 | 378 | consensus Serine/threonine kinase [Signal transduc | 99.94 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.94 | |
| KOG1165 | 449 | consensus Casein kinase (serine/threonine/tyrosine | 99.94 | |
| KOG1164 | 322 | consensus Casein kinase (serine/threonine/tyrosine | 99.91 | |
| COG0515 | 384 | SPS1 Serine/threonine protein kinase [General func | 99.91 | |
| KOG1163 | 341 | consensus Casein kinase (serine/threonine/tyrosine | 99.9 | |
| KOG0603 | 612 | consensus Ribosomal protein S6 kinase [Signal tran | 99.89 | |
| KOG1240 | 1431 | consensus Protein kinase containing WD40 repeats [ | 99.88 | |
| KOG0195 | 448 | consensus Integrin-linked kinase [Signal transduct | 99.88 | |
| KOG1023 | 484 | consensus Natriuretic peptide receptor, guanylate | 99.87 | |
| KOG4158 | 598 | consensus BRPK/PTEN-induced protein kinase [Signal | 99.86 | |
| KOG1033 | 516 | consensus eIF-2alpha kinase PEK/EIF2AK3 [Translati | 99.85 | |
| PF14531 | 288 | Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_ | 99.84 | |
| PRK12274 | 218 | serine/threonine protein kinase; Provisional | 99.81 | |
| PRK09188 | 365 | serine/threonine protein kinase; Provisional | 99.8 | |
| PRK10359 | 232 | lipopolysaccharide core biosynthesis protein; Prov | 99.8 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.78 | |
| PRK10345 | 210 | hypothetical protein; Provisional | 99.76 | |
| cd05147 | 190 | RIO1_euk RIO kinase family; eukaryotic RIO1, catal | 99.76 | |
| KOG0590 | 601 | consensus Checkpoint kinase and related serine/thr | 99.73 | |
| cd05145 | 190 | RIO1_like RIO kinase family; RIO1, RIO3 and simila | 99.72 | |
| KOG1166 | 974 | consensus Mitotic checkpoint serine/threonine prot | 99.68 | |
| KOG1266 | 458 | consensus Protein kinase [Signal transduction mech | 99.67 | |
| PRK14879 | 211 | serine/threonine protein kinase; Provisional | 99.64 | |
| KOG1243 | 690 | consensus Protein kinase [General function predict | 99.64 | |
| TIGR03724 | 199 | arch_bud32 Kae1-associated kinase Bud32. Members o | 99.62 | |
| smart00090 | 237 | RIO RIO-like kinase. | 99.6 | |
| PRK09605 | 535 | bifunctional UGMP family protein/serine/threonine | 99.6 | |
| PRK01723 | 239 | 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | 99.6 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.59 | |
| cd05144 | 198 | RIO2_C RIO kinase family; RIO2, C-terminal catalyt | 99.48 | |
| KOG0606 | 1205 | consensus Microtubule-associated serine/threonine | 99.46 | |
| COG3642 | 204 | Mn2+-dependent serine/threonine protein kinase [Si | 99.39 | |
| cd05120 | 155 | APH_ChoK_like Aminoglycoside 3'-phosphotransferase | 99.39 | |
| cd05146 | 197 | RIO3_euk RIO kinase family; eukaryotic RIO3, catal | 99.38 | |
| KOG2137 | 700 | consensus Protein kinase [Signal transduction mech | 99.35 | |
| KOG3087 | 229 | consensus Serine/threonine protein kinase [General | 99.3 | |
| cd05119 | 187 | RIO RIO kinase family, catalytic domain. The RIO k | 99.26 | |
| PRK15123 | 268 | lipopolysaccharide core heptose(I) kinase RfaP; Pr | 99.24 | |
| PF06293 | 206 | Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; | 99.2 | |
| KOG0601 | 524 | consensus Cyclin-dependent kinase WEE1 [Cell cycle | 99.17 | |
| TIGR01982 | 437 | UbiB 2-polyprenylphenol 6-hydroxylase. This model | 99.16 | |
| cd05151 | 170 | ChoK Choline Kinase (ChoK). The ChoK subfamily is | 99.16 | |
| PF01163 | 188 | RIO1: RIO1 family; InterPro: IPR018934 Protein pho | 99.14 | |
| COG4248 | 637 | Uncharacterized protein with protein kinase and he | 99.09 | |
| KOG1035 | 1351 | consensus eIF-2alpha kinase GCN2 [Translation, rib | 99.07 | |
| KOG3741 | 655 | consensus Poly(A) ribonuclease subunit [RNA proces | 99.04 | |
| PRK04750 | 537 | ubiB putative ubiquinone biosynthesis protein UbiB | 98.94 | |
| COG0478 | 304 | RIO-like serine/threonine protein kinase fused to | 98.89 | |
| PRK09902 | 216 | hypothetical protein; Provisional | 98.85 | |
| cd05154 | 223 | ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an | 98.76 | |
| PF06176 | 229 | WaaY: Lipopolysaccharide core biosynthesis protein | 98.74 | |
| KOG0576 | 829 | consensus Mitogen-activated protein kinase kinase | 98.66 | |
| PF10707 | 199 | YrbL-PhoP_reg: PhoP regulatory network protein Yrb | 98.45 | |
| cd05150 | 244 | APH Aminoglycoside 3'-phosphotransferase (APH). Th | 98.28 | |
| TIGR02172 | 226 | Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou | 98.13 | |
| COG1718 | 268 | RIO1 Serine/threonine protein kinase involved in c | 98.1 | |
| PF12260 | 188 | PIP49_C: Protein-kinase domain of FAM69; InterPro: | 98.06 | |
| COG0661 | 517 | AarF Predicted unusual protein kinase [General fun | 98.05 | |
| KOG1093 | 725 | consensus Predicted protein kinase (contains TBC a | 97.95 | |
| cd05155 | 235 | APH_ChoK_like_1 Uncharacterized bacterial proteins | 97.76 | |
| KOG1235 | 538 | consensus Predicted unusual protein kinase [Genera | 97.69 | |
| KOG1826 | 2724 | consensus Ras GTPase activating protein RasGAP/neu | 97.61 | |
| PLN02876 | 822 | acyl-CoA dehydrogenase | 97.61 | |
| PF01636 | 239 | APH: Phosphotransferase enzyme family This family | 97.43 | |
| KOG2268 | 465 | consensus Serine/threonine protein kinase [Signal | 97.36 | |
| COG2112 | 201 | Predicted Ser/Thr protein kinase [Signal transduct | 97.31 | |
| cd05153 | 296 | HomoserineK_II Homoserine Kinase, type II. Homoser | 97.28 | |
| TIGR02721 | 256 | ycfN_thiK thiamine kinase. Members of this family | 96.91 | |
| COG5072 | 488 | ALK1 Serine/threonine kinase of the haspin family | 96.38 | |
| PLN02421 | 330 | phosphotransferase, alcohol group as acceptor/kina | 96.18 | |
| COG3001 | 286 | Uncharacterized protein conserved in bacteria [Fun | 96.13 | |
| COG3173 | 321 | Predicted aminoglycoside phosphotransferase [Gener | 95.89 | |
| KOG2270 | 520 | consensus Serine/threonine protein kinase involved | 95.76 | |
| PTZ00384 | 383 | choline kinase; Provisional | 95.67 | |
| cd05157 | 235 | ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes. | 95.23 | |
| TIGR00938 | 307 | thrB_alt homoserine kinase, Neisseria type. Homose | 95.07 | |
| PRK05231 | 319 | homoserine kinase; Provisional | 94.96 | |
| PF13095 | 207 | FTA2: Kinetochore Sim4 complex subunit FTA2 | 94.86 | |
| TIGR02906 | 313 | spore_CotS spore coat protein, CotS family. Member | 94.82 | |
| cd05156 | 302 | ChoK_euk Choline Kinase (ChoK) in eukaryotes. The | 94.68 | |
| COG0510 | 269 | ycfN Thiamine kinase and related kinases [Coenzyme | 94.64 | |
| PRK10593 | 297 | hypothetical protein; Provisional | 94.34 | |
| PRK10271 | 188 | thiK thiamine kinase; Provisional | 94.06 | |
| PF07387 | 308 | Seadorna_VP7: Seadornavirus VP7; InterPro: IPR0099 | 93.85 | |
| PLN02236 | 344 | choline kinase | 93.38 | |
| PF01633 | 211 | Choline_kinase: Choline/ethanolamine kinase; Inter | 92.93 | |
| TIGR02904 | 309 | spore_ysxE spore coat protein YsxE. Members of thi | 92.84 | |
| COG2334 | 331 | Putative homoserine kinase type II (protein kinase | 92.65 | |
| PHA03111 | 444 | Ser/Thr kinase; Provisional | 92.16 | |
| smart00587 | 196 | CHK ZnF_C4 abd HLH domain containing kinases domai | 92.16 | |
| KOG1236 | 565 | consensus Predicted unusual protein kinase [Genera | 92.04 | |
| cd05152 | 276 | MPH2' Macrolide 2'-Phosphotransferase (MPH2'). MPH | 91.72 | |
| PF03881 | 288 | Fructosamin_kin: Fructosamine kinase; InterPro: IP | 91.28 | |
| PRK11768 | 325 | serine/threonine protein kinase; Provisional | 91.05 | |
| PF05445 | 434 | Pox_ser-thr_kin: Poxvirus serine/threonine protein | 89.99 |
| >KOG0581 consensus Mitogen-activated protein kinase kinase (MAP2K) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-56 Score=339.13 Aligned_cols=219 Identities=29% Similarity=0.493 Sum_probs=202.7
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC-eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
++..++++.+|+++++.++||+||++||.|..++ ...++||||+||+|.+++...+++++..+.+++.++++||.|||+
T Consensus 117 ~~~~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~~~isI~mEYMDgGSLd~~~k~~g~i~E~~L~~ia~~VL~GL~YLh~ 196 (364)
T KOG0581|consen 117 DPALQKQILRELEILRSCQSPYIVGFYGAFYSNGEEISICMEYMDGGSLDDILKRVGRIPEPVLGKIARAVLRGLSYLHE 196 (364)
T ss_pred CHHHHHHHHHHHHHHhhCCCCCeeeEeEEEEeCCceEEeehhhcCCCCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 7788999999999999999999999999999988 499999999999999999998999999999999999999999996
Q ss_pred -CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 85 -HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 -~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
.+|+||||||+|||+ +..+.|||||||.+....+. ...+..||..|||||.+.+..|+.++||||||++++|+++
T Consensus 197 ~~~IIHRDIKPsNlLv---NskGeVKicDFGVS~~lvnS-~a~tfvGT~~YMsPERi~g~~Ys~~sDIWSLGLsllE~a~ 272 (364)
T KOG0581|consen 197 ERKIIHRDIKPSNLLV---NSKGEVKICDFGVSGILVNS-IANTFVGTSAYMSPERISGESYSVKSDIWSLGLSLLELAI 272 (364)
T ss_pred ccCeeeccCCHHHeee---ccCCCEEeccccccHHhhhh-hcccccccccccChhhhcCCcCCcccceecccHHHHHHhh
Confidence 899999999999999 78999999999999887665 5567889999999999999999999999999999999999
Q ss_pred CCCCCCCC-----ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 164 GYPPFSGR-----NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 164 g~~p~~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|+.||... +..+++..|..+..+..+.. .+|+++++|+..||++||.+|||+.|+++|||+++..
T Consensus 273 GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~lP~~---~fS~ef~~FV~~CL~Kdp~~R~s~~qLl~Hpfi~~~~ 342 (364)
T KOG0581|consen 273 GRFPYPPPNPPYLDIFELLCAIVDEPPPRLPEG---EFSPEFRSFVSCCLRKDPSERPSAKQLLQHPFIKKFE 342 (364)
T ss_pred CCCCCCCcCCCCCCHHHHHHHHhcCCCCCCCcc---cCCHHHHHHHHHHhcCCcccCCCHHHHhcCHHHhhcc
Confidence 99999764 67788888887776666653 4999999999999999999999999999999999743
|
|
| >KOG0615 consensus Serine/threonine protein kinase Chk2 and related proteins [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-55 Score=341.84 Aligned_cols=220 Identities=34% Similarity=0.612 Sum_probs=198.8
Q ss_pred hHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 026253 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (241)
Q Consensus 12 ~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (241)
.+.+|+++|++|+|||||+++++|+..+..|+||||++||+|.+.+-.++.+.+..-..+++|++.|+.|||++||+|||
T Consensus 222 ~v~~EieILkkL~HP~IV~~~d~f~~~ds~YmVlE~v~GGeLfd~vv~nk~l~ed~~K~~f~Qll~avkYLH~~GI~HRD 301 (475)
T KOG0615|consen 222 DVQNEIEILKKLSHPNIVRIKDFFEVPDSSYMVLEYVEGGELFDKVVANKYLREDLGKLLFKQLLTAVKYLHSQGIIHRD 301 (475)
T ss_pred hhHHHHHHHHhcCCCCEEEEeeeeecCCceEEEEEEecCccHHHHHHhccccccchhHHHHHHHHHHHHHHHHcCccccc
Confidence 36799999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC---CCchhHHHHHHHHHHHHhCCCCC
Q 026253 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY---DEKVDMWSVGAILFELLNGYPPF 168 (241)
Q Consensus 92 l~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~---~~~~Dv~slG~~l~~l~~g~~p~ 168 (241)
|||+|||++...++-.+||.|||+|+..+......+.+||+.|.|||++.+... ..+.|+||+||++|-+++|.+||
T Consensus 302 iKPeNILl~~~~e~~llKItDFGlAK~~g~~sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSlGcvLfvcLsG~pPF 381 (475)
T KOG0615|consen 302 IKPENILLSNDAEDCLLKITDFGLAKVSGEGSFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSLGCVLFVCLSGYPPF 381 (475)
T ss_pred CCcceEEeccCCcceEEEecccchhhccccceehhhhcCCccccChhheecCCeecccchheeeeccceEEEEeccCCCc
Confidence 999999997656678899999999999998888899999999999999986653 34789999999999999999999
Q ss_pred CCCChHH-HHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 169 SGRNNVQ-LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 169 ~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
.+..... +.++|..+. ..+....+..+|++..++|.+||..||++|||++|+|+||||+..+.
T Consensus 382 S~~~~~~sl~eQI~~G~-y~f~p~~w~~Iseea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~ 445 (475)
T KOG0615|consen 382 SEEYTDPSLKEQILKGR-YAFGPLQWDRISEEALDLINWMLVVDPENRPSADEALNHPWFKDAPC 445 (475)
T ss_pred ccccCCccHHHHHhcCc-ccccChhhhhhhHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccc
Confidence 8766555 777775554 45555667789999999999999999999999999999999997553
|
|
| >KOG0575 consensus Polo-like serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-53 Score=344.72 Aligned_cols=224 Identities=33% Similarity=0.600 Sum_probs=206.3
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+..+++.+.+|++|.++|+|||||+++++|++.++.|+|.|+|..++|..+++++++++|..+..+++||+.|+.|||++
T Consensus 58 k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs~nVYivLELC~~~sL~el~Krrk~ltEpEary~l~QIv~GlkYLH~~ 137 (592)
T KOG0575|consen 58 KPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDSNNVYIVLELCHRGSLMELLKRRKPLTEPEARYFLRQIVEGLKYLHSL 137 (592)
T ss_pred CcchHHHHHHHHHHHHhcCCCcEEeeeeEeecCCceEEEEEecCCccHHHHHHhcCCCCcHHHHHHHHHHHHHHHHHHhc
Confidence 67789999999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
+|+|||||..|+|+ +++.++||+|||+|.....+ ....+.+||+-|.|||++.....+..+||||+||+||.++.|
T Consensus 138 ~IiHRDLKLGNlfL---~~~~~VKIgDFGLAt~le~~~Erk~TlCGTPNYIAPEVl~k~gHsfEvDiWSlGcvmYtLL~G 214 (592)
T KOG0575|consen 138 GIIHRDLKLGNLFL---NENMNVKIGDFGLATQLEYDGERKKTLCGTPNYIAPEVLNKSGHSFEVDIWSLGCVMYTLLVG 214 (592)
T ss_pred Cceecccchhheee---cCcCcEEecccceeeeecCcccccceecCCCcccChhHhccCCCCCchhhhhhhhHHHhhhhC
Confidence 99999999999999 78889999999999988754 566778999999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCCCC
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 237 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~ 237 (241)
++||+..+..+.++.|+... -.+|. .+|.+.+++|++||+.||.+|||++++|.|+||+....-..-|
T Consensus 215 ~PPFetk~vkety~~Ik~~~-Y~~P~----~ls~~A~dLI~~lL~~~P~~Rpsl~~vL~h~Ff~~g~~p~~lp 282 (592)
T KOG0575|consen 215 RPPFETKTVKETYNKIKLNE-YSMPS----HLSAEAKDLIRKLLRPNPSERPSLDEVLDHPFFKSGFTPARLP 282 (592)
T ss_pred CCCcccchHHHHHHHHHhcC-ccccc----ccCHHHHHHHHHHhcCCcccCCCHHHHhcCHhhhCCCcCCCCC
Confidence 99999999999999996544 33444 8899999999999999999999999999999996644433333
|
|
| >KOG0595 consensus Serine/threonine-protein kinase involved in autophagy [Posttranslational modification, protein turnover, chaperones; Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-50 Score=313.72 Aligned_cols=233 Identities=46% Similarity=0.817 Sum_probs=211.1
Q ss_pred hhhHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 4 ~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+++....+.+..|+.+|+.++|||||.++++.++++..|+|||||+||+|.+|+++.+.+++..+..++.|++.|+++||
T Consensus 47 ~l~~k~~e~L~~Ei~iLkel~H~nIV~l~d~~~~~~~i~lVMEyC~gGDLs~yi~~~~~l~e~t~r~Fm~QLA~alq~L~ 126 (429)
T KOG0595|consen 47 KLNKKLVELLLSEIKILKELKHPNIVRLLDCIEDDDFIYLVMEYCNGGDLSDYIRRRGRLPEATARHFMQQLASALQFLH 126 (429)
T ss_pred ccCHHHHHHHHHHHHHHHhcCCcceeeEEEEEecCCeEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34667889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCC---ceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDD---VMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~---~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+++|+||||||+|||++..... ..+||.|||+|+...+.......+|++.|||||++...+|+.|+|+||+|+++|+
T Consensus 127 ~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~~~a~tlcGSplYMAPEV~~~~~YdAKADLWSiG~Ilyq 206 (429)
T KOG0595|consen 127 ENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPGSMAETLCGSPLYMAPEVIMSQQYDAKADLWSIGTILYQ 206 (429)
T ss_pred HCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCchhHHHHhhCCccccCHHHHHhccccchhhHHHHHHHHHH
Confidence 9999999999999999743122 6799999999999998888899999999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCCCCC
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 238 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~ 238 (241)
|++|..||...+..+++..++.+...... .....+..+.+++...++.++..|.+..+.+.|+++...+......+
T Consensus 207 ~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~--~~~~~s~~~~~Ll~~ll~~~~~~~~~~~~~~~~~~l~~~p~~~~~~~ 282 (429)
T KOG0595|consen 207 CLTGKPPFDAETPKELLLYIKKGNEIVPV--LPAELSNPLRELLISLLQRNPKDRISFEDFFDHPFLAANPQDRADAF 282 (429)
T ss_pred HHhCCCCccccCHHHHHHHHhccccccCc--hhhhccCchhhhhhHHHhcCccccCchHHhhhhhhcccCcccccCcc
Confidence 99999999999999999988776654322 22367788889999999999999999999999999998876555444
|
|
| >KOG0033 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-50 Score=293.84 Aligned_cols=230 Identities=32% Similarity=0.537 Sum_probs=213.0
Q ss_pred hhhhhHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
+++++....+.+.+|++|-+.|+||||+++.+.+.+.+..|+|+|+++|++|..-+-.+.-+++..+.-.++||+++|.|
T Consensus 46 ~~k~~~~~~e~l~rEarIC~~LqHP~IvrL~~ti~~~~~~ylvFe~m~G~dl~~eIV~R~~ySEa~aSH~~rQiLeal~y 125 (355)
T KOG0033|consen 46 TKKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILEALAY 125 (355)
T ss_pred hhhhccccHHHHHHHHHHHHhcCCCcEeehhhhhcccceeEEEEecccchHHHHHHHHHHHHHHHHHHHHHHHHHHHHHH
Confidence 45677888999999999999999999999999999999999999999999998777666678889999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
+|.+||+|||+||+|+++.+++...-+||+|||+|...+.........|++.|+|||++...+++..+|+|+-|+++|-+
T Consensus 126 CH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g~~~~G~~GtP~fmaPEvvrkdpy~kpvDiW~cGViLfiL 205 (355)
T KOG0033|consen 126 CHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDGEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYIL 205 (355)
T ss_pred HHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCccccccccCCCcccCHHHhhcCCCCCcchhhhhhHHHHHH
Confidence 99999999999999999998888999999999999999877777888999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
+.|.+||.+.+...+++.|+.+. ..++...++.++++.++++++||..||.+|.|+.|.|+|||+.+...
T Consensus 206 L~G~~PF~~~~~~rlye~I~~g~-yd~~~~~w~~is~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~ 275 (355)
T KOG0033|consen 206 LVGYPPFWDEDQHRLYEQIKAGA-YDYPSPEWDTVTPEAKSLIRRMLTVNPKKRITADEALKHPWICNRER 275 (355)
T ss_pred HhCCCCCCCccHHHHHHHHhccc-cCCCCcccCcCCHHHHHHHHHHhccChhhhccHHHHhCCchhcchHH
Confidence 99999999999999999996655 45666677899999999999999999999999999999999987543
|
|
| >KOG0598 consensus Ribosomal protein S6 kinase and related proteins [General function prediction only; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-49 Score=305.22 Aligned_cols=217 Identities=37% Similarity=0.604 Sum_probs=201.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+...+|..|+.+++||.||+++..|++...+|+|+||+.||.|..++++.+.+++..+.-++..|+.||.|||++
T Consensus 65 ~~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~~kLylVld~~~GGeLf~hL~~eg~F~E~~arfYlaEi~lAL~~LH~~ 144 (357)
T KOG0598|consen 65 EKKEVRHTKAERNILSKIKHPFIVKLIYSFQTEEKLYLVLDYLNGGELFYHLQREGRFSEDRARFYLAEIVLALGYLHSK 144 (357)
T ss_pred hhhhHHHHHHHHHHHHhCCCCcEeeeEEecccCCeEEEEEeccCCccHHHHHHhcCCcchhHHHHHHHHHHHHHHHHHhC
Confidence 34567889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
||+|||+||+|||+ +.+|+++|+|||+++.... +..+...+||+.|+|||++.+..++...|.||||+++|+|++|
T Consensus 145 gIiyRDlKPENILL---d~~GHi~LtDFgL~k~~~~~~~~t~tfcGT~eYmAPEil~~~gy~~~vDWWsLGillYeML~G 221 (357)
T KOG0598|consen 145 GIIYRDLKPENILL---DEQGHIKLTDFGLCKEDLKDGDATRTFCGTPEYMAPEILLGKGYDKAVDWWSLGILLYEMLTG 221 (357)
T ss_pred CeeeccCCHHHeee---cCCCcEEEeccccchhcccCCCccccccCCccccChHHHhcCCCCcccchHhHHHHHHHHhhC
Confidence 99999999999999 8999999999999986544 4556678999999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC----CHHHHhcCccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL----SFNEFYHHRFLRR 229 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~il~~~~~~~ 229 (241)
.+||.+.+.....+.|..++....+. .++.+.+++++++|..||.+|. ++.++-+||||.+
T Consensus 222 ~pPF~~~~~~~~~~~I~~~k~~~~p~----~ls~~ardll~~LL~rdp~~RLg~~~d~~~ik~HpfF~~ 286 (357)
T KOG0598|consen 222 KPPFYAEDVKKMYDKILKGKLPLPPG----YLSEEARDLLKKLLKRDPRQRLGGPGDAEEIKRHPFFKG 286 (357)
T ss_pred CCCCcCccHHHHHHHHhcCcCCCCCc----cCCHHHHHHHHHHhccCHHHhcCCCCChHHhhcCccccc
Confidence 99999999999999998877444443 5899999999999999999995 7999999999998
|
|
| >KOG0588 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-49 Score=319.23 Aligned_cols=220 Identities=33% Similarity=0.649 Sum_probs=204.5
Q ss_pred hhHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+.+..-..+.+|+-|++.+.||||+++|+.+++..++|+|.||++||.|++++.+.+++++.....+++||+.|+.|+|.
T Consensus 51 ~s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~~~lylvlEyv~gGELFdylv~kG~l~e~eaa~ff~QIi~gv~yCH~ 130 (786)
T KOG0588|consen 51 LSSSQPAGIEREIVIMKLIEHPNVLRLYDVWENKQHLYLVLEYVPGGELFDYLVRKGPLPEREAAHFFRQILDGVSYCHA 130 (786)
T ss_pred cccccccchhhhhHHHHHhcCCCeeeeeeeeccCceEEEEEEecCCchhHHHHHhhCCCCCHHHHHHHHHHHHHHHHHhh
Confidence 35556778999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~ 163 (241)
.+|+|||+||+|+|+ +..+.+||+|||+|..-.++....+.||.+.|.+||++.|.+| +.++||||-|+++|.+++
T Consensus 131 ~~icHRDLKpENlLL---d~~~nIKIADFGMAsLe~~gklLeTSCGSPHYA~PEIV~G~pYdG~~sDVWSCGVILfALLt 207 (786)
T KOG0588|consen 131 FNICHRDLKPENLLL---DVKNNIKIADFGMASLEVPGKLLETSCGSPHYAAPEIVSGRPYDGRPSDVWSCGVILFALLT 207 (786)
T ss_pred hcceeccCCchhhhh---hcccCEeeeccceeecccCCccccccCCCcccCCchhhcCCCCCCCccccchhHHHHHHHHh
Confidence 999999999999999 6666799999999988888888888999999999999999988 689999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
|.+||++.+-..++.+++.+. ..+|. .+|.+++++|++||.+||++|.|.+||++|||+..+..
T Consensus 208 G~LPFdDdNir~LLlKV~~G~-f~MPs----~Is~eaQdLLr~ml~VDp~~RiT~~eI~kHP~l~g~~~ 271 (786)
T KOG0588|consen 208 GKLPFDDDNIRVLLLKVQRGV-FEMPS----NISSEAQDLLRRMLDVDPSTRITTEEILKHPFLSGYTS 271 (786)
T ss_pred CCCCCCCccHHHHHHHHHcCc-ccCCC----cCCHHHHHHHHHHhccCccccccHHHHhhCchhhcCCC
Confidence 999999999999999996655 44443 89999999999999999999999999999999998543
|
|
| >KOG0592 consensus 3-phosphoinositide-dependent protein kinase (PDK1) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-48 Score=309.85 Aligned_cols=216 Identities=33% Similarity=0.598 Sum_probs=199.1
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
++.-.+++..|-..|.+| .||+|++++..|.++..+|+|+||+++|+|.+++++.+.|++.....++.+|+.||+|||+
T Consensus 113 ke~KvkYV~~Ek~~l~~L~~hPgivkLy~TFQD~~sLYFvLe~A~nGdll~~i~K~Gsfde~caR~YAAeIldAleylH~ 192 (604)
T KOG0592|consen 113 KEKKVKYVTREKEALTQLSGHPGIVKLYFTFQDEESLYFVLEYAPNGDLLDLIKKYGSFDETCARFYAAEILDALEYLHS 192 (604)
T ss_pred hhcccchhhHHHHHHHHhhCCCCeEEEEEEeecccceEEEEEecCCCcHHHHHHHhCcchHHHHHHHHHHHHHHHHHHHh
Confidence 566678999999999999 8999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc--------------ccccCCCCccCcccccccCCCCchh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------------EKVCGSPLYMAPEVLQFQRYDEKVD 150 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~--------------~~~~~~~~~~~PE~~~~~~~~~~~D 150 (241)
.||+||||||+|||+ +.+++++|.|||.|+...+.... ...+||..|.+||++.....++.+|
T Consensus 193 ~GIIHRDlKPENILL---d~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~~~~~sD 269 (604)
T KOG0592|consen 193 NGIIHRDLKPENILL---DKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSPAGPSSD 269 (604)
T ss_pred cCceeccCChhheeE---cCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCCCCcccc
Confidence 999999999999999 89999999999999877542211 3478999999999999999999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 151 MWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 151 v~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
+|+|||++|+|+.|++||.+.++.-++++|.... ..+++ ++++.+.+||+++|..||++|+|+++|-+||||..
T Consensus 270 iWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~-y~fp~----~fp~~a~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~ 343 (604)
T KOG0592|consen 270 LWALGCILYQMLAGQPPFRAANEYLIFQKIQALD-YEFPE----GFPEDARDLIKKLLVRDPSDRLTSQQIKAHPFFEG 343 (604)
T ss_pred hHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhc-ccCCC----CCCHHHHHHHHHHHccCccccccHHHHhhCccccc
Confidence 9999999999999999999999999999996543 34444 88999999999999999999999999999999987
|
|
| >KOG0583 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.4e-48 Score=309.20 Aligned_cols=214 Identities=38% Similarity=0.691 Sum_probs=195.8
Q ss_pred HhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|+.++++++ ||||+++++++.....+++||||+.||+|.+++.+.+++.+.....+.+|+++|++|||++|
T Consensus 61 ~~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~~~~~ivmEy~~gGdL~~~i~~~g~l~E~~ar~~F~Qlisav~y~H~~g 140 (370)
T KOG0583|consen 61 KLDELIKREISILRRLRSHPNIIRLLEVFATPTKIYIVMEYCSGGDLFDYIVNKGRLKEDEARKYFRQLISAVAYCHSRG 140 (370)
T ss_pred ccchhhHHHHHHHHHhccCCCEeEEEEEEecCCeEEEEEEecCCccHHHHHHHcCCCChHHHHHHHHHHHHHHHHHHhCC
Confidence 34667779999999998 99999999999999999999999999999999999899999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCC-ceEEEeecCCcccc-CCCCccccccCCCCccCcccccccC-CC-CchhHHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDD-VMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQR-YD-EKVDMWSVGAILFELL 162 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~-~~~~l~df~~a~~~-~~~~~~~~~~~~~~~~~PE~~~~~~-~~-~~~Dv~slG~~l~~l~ 162 (241)
|+||||||+|+++ +.+ +.+||+|||++... .........+|++.|.|||++.+.. |+ .++||||+|+++|.|+
T Consensus 141 i~HRDLK~ENill---d~~~~~~Kl~DFG~s~~~~~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS~GViLy~ml 217 (370)
T KOG0583|consen 141 IVHRDLKPENILL---DGNEGNLKLSDFGLSAISPGEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWSLGVILYVLL 217 (370)
T ss_pred EeeCCCCHHHEEe---cCCCCCEEEeccccccccCCCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhhhHHHHHHHH
Confidence 9999999999999 555 89999999999887 5666777889999999999999877 74 8999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCC-ChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPAL-HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~-~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
+|..||...+...++..|..+ ...++. .+ |.++.+++++||..||.+|+|+.+++.||||+.
T Consensus 218 ~G~~PF~d~~~~~l~~ki~~~-~~~~p~----~~~S~~~~~Li~~mL~~~P~~R~t~~~i~~h~w~~~ 280 (370)
T KOG0583|consen 218 CGRLPFDDSNVPNLYRKIRKG-EFKIPS----YLLSPEARSLIEKMLVPDPSTRITLLEILEHPWFQK 280 (370)
T ss_pred hCCCCCCCccHHHHHHHHhcC-CccCCC----CcCCHHHHHHHHHHcCCCcccCCCHHHHhhChhhcc
Confidence 999999999998999887444 344444 44 999999999999999999999999999999998
|
|
| >KOG0198 consensus MEKK and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-48 Score=303.35 Aligned_cols=217 Identities=34% Similarity=0.578 Sum_probs=184.7
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecC--eEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.+.+.+|+++|++++|||||+++|...... .++++|||+.+|+|.+++++.+ .+++..+..+.+|+++||+|||++|
T Consensus 58 ~~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~ylHs~g 137 (313)
T KOG0198|consen 58 SESLEREIRILSRLNHPNIVQYYGSSSSRENDEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAYLHSKG 137 (313)
T ss_pred HHHHHHHHHHHHhCCCCCEEeeCCccccccCeeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 567999999999999999999999855444 6999999999999999999887 7999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCC-CceEEEeecCCccccCC----CCccccccCCCCccCccccccc-CCCCchhHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYP----GNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~-~~~~~l~df~~a~~~~~----~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~ 160 (241)
++||||||.|||+ +. ++.+||+|||.+..... ........||+.|+|||.+.++ ...+++|+|||||++.|
T Consensus 138 ~vH~DiK~~NiLl---~~~~~~~KlaDFG~a~~~~~~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCtVvE 214 (313)
T KOG0198|consen 138 IVHCDIKPANILL---DPSNGDVKLADFGLAKKLESKGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCTVVE 214 (313)
T ss_pred EeccCcccceEEE---eCCCCeEEeccCccccccccccccccccccccCCccccCchhhcCCCcCCccchhhhcCCEEEe
Confidence 9999999999999 56 68999999999887653 2224457799999999999853 34469999999999999
Q ss_pred HHhCCCCCCC-CChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 161 LLNGYPPFSG-RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 161 l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
|+||+.||.. .......-.+......+ .++..+|.+..+||++|+..+|++|||++++|+|||.+....
T Consensus 215 M~Tg~~PW~~~~~~~~~~~~ig~~~~~P---~ip~~ls~~a~~Fl~~C~~~~p~~Rpta~eLL~hpf~~~~~~ 284 (313)
T KOG0198|consen 215 MLTGKPPWSEFFEEAEALLLIGREDSLP---EIPDSLSDEAKDFLRKCFKRDPEKRPTAEELLEHPFLKQNSI 284 (313)
T ss_pred ccCCCCcchhhcchHHHHHHHhccCCCC---CCCcccCHHHHHHHHHHhhcCcccCcCHHHHhhChhhhcccc
Confidence 9999999987 44444333333333222 445589999999999999999999999999999999988655
|
|
| >KOG0578 consensus p21-activated serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-48 Score=313.26 Aligned_cols=219 Identities=29% Similarity=0.536 Sum_probs=197.5
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.+.-++-+.+|+.+++..+|+|||++++.|--++.+|+||||++||+|.|.+... .+++.++..+++.++.||++||.+
T Consensus 310 ~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~deLWVVMEym~ggsLTDvVt~~-~~~E~qIA~Icre~l~aL~fLH~~ 388 (550)
T KOG0578|consen 310 KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVGDELWVVMEYMEGGSLTDVVTKT-RMTEGQIAAICREILQGLKFLHAR 388 (550)
T ss_pred cCCchhhhHHHHHHHHhccchHHHHHHHHhcccceeEEEEeecCCCchhhhhhcc-cccHHHHHHHHHHHHHHHHHHHhc
Confidence 3444677899999999999999999999998889999999999999999998754 599999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
||+|+|||.+||++ +.++.+||+|||++....... ......||++|+|||+.....|+++.||||||++++||+.|
T Consensus 389 gIiHrDIKSDnILL---~~~g~vKltDFGFcaqi~~~~~KR~TmVGTPYWMAPEVvtrk~YG~KVDIWSLGIMaIEMveG 465 (550)
T KOG0578|consen 389 GIIHRDIKSDNILL---TMDGSVKLTDFGFCAQISEEQSKRSTMVGTPYWMAPEVVTRKPYGPKVDIWSLGIMAIEMVEG 465 (550)
T ss_pred ceeeeccccceeEe---ccCCcEEEeeeeeeeccccccCccccccCCCCccchhhhhhcccCccccchhhhhHHHHHhcC
Confidence 99999999999999 788899999999998876655 45567899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
++||-..++..-+..|.......+.. +..+|+.+++|+.+||+.|+.+|+++.|+|+||||+..
T Consensus 466 EPPYlnE~PlrAlyLIa~ng~P~lk~--~~klS~~~kdFL~~cL~~dv~~RasA~eLL~HpFl~~a 529 (550)
T KOG0578|consen 466 EPPYLNENPLRALYLIATNGTPKLKN--PEKLSPELKDFLDRCLVVDVEQRASAKELLEHPFLKMA 529 (550)
T ss_pred CCCccCCChHHHHHHHhhcCCCCcCC--ccccCHHHHHHHHHHhhcchhcCCCHHHHhcChhhhhc
Confidence 99999988888777776666554443 34899999999999999999999999999999999653
|
|
| >KOG0616 consensus cAMP-dependent protein kinase catalytic subunit (PKA) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-47 Score=285.16 Aligned_cols=214 Identities=34% Similarity=0.664 Sum_probs=200.0
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+-.+.+...+|..+|+.+.||.++++++.+.+.+..++||||++||.|.+++++.+++++..+.-++.+|+.|++|||++
T Consensus 84 klKQveH~~nEk~vL~~v~~PFlv~l~~t~~d~~~lymvmeyv~GGElFS~Lrk~~rF~e~~arFYAAeivlAleylH~~ 163 (355)
T KOG0616|consen 84 KLKQVEHTHNEKRVLKAVSHPFLVKLYGTFKDNSNLYMVMEYVPGGELFSYLRKSGRFSEPHARFYAAEIVLALEYLHSL 163 (355)
T ss_pred HHHHHHHHhhHHHHHhhccCceeEEEEEeeccCCeEEEEEeccCCccHHHHHHhcCCCCchhHHHHHHHHHHHHHHHHhc
Confidence 45667888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|++||+||+|||+ +.+|.+||.|||+|+..... +-..+||+.|+|||.+.++.+..+.|-|+||+++|||+.|.
T Consensus 164 ~iiYRDLKPENiLl---D~~G~iKitDFGFAK~v~~r--T~TlCGTPeYLAPEii~sk~ynkavDWWalGVLIYEMlaG~ 238 (355)
T KOG0616|consen 164 DIIYRDLKPENLLL---DQNGHIKITDFGFAKRVSGR--TWTLCGTPEYLAPEIIQSKGYNKAVDWWALGVLIYEMLAGY 238 (355)
T ss_pred CeeeccCChHHeee---ccCCcEEEEeccceEEecCc--EEEecCCccccChHHhhcCCCCcchhHHHHHHHHHHHHcCC
Confidence 99999999999999 89999999999999987655 56789999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
+||.+.++.+++++|..+. ..+|. .++++++++++++|+.|-.+|. ..++|..||||+.
T Consensus 239 pPF~~~~~~~iY~KI~~~~-v~fP~----~fs~~~kdLl~~LL~vD~t~R~gnlknG~~dIk~H~wF~~ 302 (355)
T KOG0616|consen 239 PPFYDDNPIQIYEKILEGK-VKFPS----YFSSDAKDLLKKLLQVDLTKRFGNLKNGVEDIKNHPWFKG 302 (355)
T ss_pred CCCcCCChHHHHHHHHhCc-ccCCc----ccCHHHHHHHHHHHhhhhHhhhcCcCCCccccccCccccc
Confidence 9999999999999996554 44454 8899999999999999999994 5789999999997
|
|
| >KOG0591 consensus NIMA (never in mitosis)-related G2-specific serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-49 Score=291.58 Aligned_cols=208 Identities=30% Similarity=0.543 Sum_probs=187.2
Q ss_pred hhHHhhhhHHHHHHHHhcCCCcCeeeeee-EEeecCe-EEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHH
Q 026253 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFD-AFQAENC-IFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~~~~i~~~~~-~~~~~~~-~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~ 78 (241)
++...+.....|+.+|++|+||||+++++ .+..++. ++||||+|++|+|++.++.. +.+++..+++++.|++.|
T Consensus 57 md~k~rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~A 136 (375)
T KOG0591|consen 57 MDAKARQDCVKEISLLKQLNHPNIVQYYAHSFIEDNEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCRA 136 (375)
T ss_pred ccHHHHHHHHHHHHHHHhcCCchHHHHHHHhhhccchhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHHH
Confidence 47788999999999999999999999998 5555554 99999999999999998643 459999999999999999
Q ss_pred HHHHHh--CC--ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHH
Q 026253 79 LEILNS--HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (241)
Q Consensus 79 l~~lh~--~~--i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 153 (241)
|..+|+ .. ++||||||.||++ +.++.+||+|||+++......+ ..+..||+.||+||.+.+.+|+++|||||
T Consensus 137 L~~cH~~~~r~~VmHRDIKPaNIFl---~~~gvvKLGDfGL~r~l~s~~tfA~S~VGTPyYMSPE~i~~~~Y~~kSDiWs 213 (375)
T KOG0591|consen 137 LYHCHSKIPRGTVMHRDIKPANIFL---TANGVVKLGDFGLGRFLSSKTTFAHSLVGTPYYMSPERIHESGYNFKSDIWS 213 (375)
T ss_pred HHHHhccccccceeeccCcchheEE---cCCCceeeccchhHhHhcchhHHHHhhcCCCcccCHHHHhcCCCCcchhHHH
Confidence 999998 44 9999999999999 7899999999999988765443 45688999999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH
Q 026253 154 VGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF 218 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 218 (241)
+||++|||+.-++||.+.+-.++.++|..+.-.+.|.. .+|.++..+|..|+.+||..||+.
T Consensus 214 lGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p~~---~YS~~l~~li~~ci~vd~~~RP~t 275 (375)
T KOG0591|consen 214 LGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLPDE---HYSTDLRELINMCIAVDPEQRPDT 275 (375)
T ss_pred HHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCcHH---HhhhHHHHHHHHHccCCcccCCCc
Confidence 99999999999999999999999999988876666643 789999999999999999999985
|
|
| >KOG0599 consensus Phosphorylase kinase gamma subunit [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-48 Score=286.26 Aligned_cols=220 Identities=35% Similarity=0.667 Sum_probs=202.9
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.+..+.-++|+.||+++ .||+|+++.++|+++...++|+|.|..|.|.|++.+.-.+++....++.+|+++|++|||.+
T Consensus 63 ~~~~EaT~~Ev~ILRqv~GHP~II~l~D~yes~sF~FlVFdl~prGELFDyLts~VtlSEK~tR~iMrqlfegVeylHa~ 142 (411)
T KOG0599|consen 63 YEMREATRQEISILRQVMGHPYIIDLQDVYESDAFVFLVFDLMPRGELFDYLTSKVTLSEKETRRIMRQLFEGVEYLHAR 142 (411)
T ss_pred HHHHHHHHHHHHHHHHhcCCCcEEEeeeeccCcchhhhhhhhcccchHHHHhhhheeecHHHHHHHHHHHHHHHHHHHHh
Confidence 34567788999999999 79999999999999999999999999999999999888899999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc------ccCCCCchhHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~Dv~slG~~l~ 159 (241)
+|+||||||+||++ +++-+++|+|||+|+...++......+||++|+|||.+. ...|+...|+|+.|++||
T Consensus 143 ~IVHRDLKpENILl---ddn~~i~isDFGFa~~l~~GekLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~Wa~GVImy 219 (411)
T KOG0599|consen 143 NIVHRDLKPENILL---DDNMNIKISDFGFACQLEPGEKLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEWACGVIMY 219 (411)
T ss_pred hhhhcccChhheee---ccccceEEeccceeeccCCchhHHHhcCCCcccChhheeeecccCCCCccchhhHHHHHHHHH
Confidence 99999999999999 788899999999999999998888999999999999875 345889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
.++.|.+||......-+++.|..++- .+....+.++|..+.++|++||+.||.+|.|++|+|.||||.+.
T Consensus 220 TLLaGcpPFwHRkQmlMLR~ImeGky-qF~speWadis~~~KdLIsrlLqVdp~~Ritake~LaHpff~q~ 289 (411)
T KOG0599|consen 220 TLLAGCPPFWHRKQMLMLRMIMEGKY-QFRSPEWADISATVKDLISRLLQVDPTKRITAKEALAHPFFIQI 289 (411)
T ss_pred HHHcCCCchhHHHHHHHHHHHHhccc-ccCCcchhhccccHHHHHHHHHeeCchhcccHHHHhcChHHHHH
Confidence 99999999999988889999977763 34444566899999999999999999999999999999999663
|
|
| >KOG0593 consensus Predicted protein kinase KKIAMRE [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-48 Score=291.30 Aligned_cols=219 Identities=29% Similarity=0.524 Sum_probs=190.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+...+-..+|+++|++|+|+|+|.+++.|.-.+..++|+|||+. ++.+-+++. ..++.+.+.++++|++.|+.++|++
T Consensus 42 ~~VkKIAlREIrmLKqLkH~NLVnLiEVFrrkrklhLVFE~~dh-TvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~~cHk~ 120 (396)
T KOG0593|consen 42 PVVKKIALREIRMLKQLKHENLVNLIEVFRRKRKLHLVFEYCDH-TVLHELERYPNGVPSELVKKYLYQLLKAIHFCHKN 120 (396)
T ss_pred HHHHHHHHHHHHHHHhcccchHHHHHHHHHhcceeEEEeeecch-HHHHHHHhccCCCCHHHHHHHHHHHHHHhhhhhhc
Confidence 45578889999999999999999999999999999999999975 555556554 4589999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccC-CCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHh
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~-~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+++||||||+||++ +.++.+||||||+|+... +...-..+..|.+|.|||.+.+ .+|+...|||++||++.||++
T Consensus 121 n~IHRDIKPENILi---t~~gvvKLCDFGFAR~L~~pgd~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv~aEl~~ 197 (396)
T KOG0593|consen 121 NCIHRDIKPENILI---TQNGVVKLCDFGFARTLSAPGDNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCVFAELLT 197 (396)
T ss_pred CeecccCChhheEE---ecCCcEEeccchhhHhhcCCcchhhhhhhhhhccChhhhcccCcCCCcccchhhhHHHHHHhc
Confidence 99999999999999 899999999999999876 5555566788999999999987 789999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCC--------------------------CccCCCCChHHHHHHHHhcccCccccCC
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFS--------------------------QLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
|++.|++.++.+++-.|........+ +...+.++.-+.+++++||..||.+|++
T Consensus 198 G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p~~s~~~ld~~k~cL~~dP~~R~s 277 (396)
T KOG0593|consen 198 GEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYPKISNVLLDLLKKCLKMDPDDRLS 277 (396)
T ss_pred CCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcccchHHHHHHHHHHhcCCcccccc
Confidence 99999999888777666553221111 1124567778999999999999999999
Q ss_pred HHHHhcCccccc
Q 026253 218 FNEFYHHRFLRR 229 (241)
Q Consensus 218 ~~~il~~~~~~~ 229 (241)
.+|++.|+||.+
T Consensus 278 c~qll~H~yFd~ 289 (396)
T KOG0593|consen 278 CEQLLHHPYFDG 289 (396)
T ss_pred HHHHhcChHHHH
Confidence 999999999954
|
|
| >KOG0582 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=296.13 Aligned_cols=222 Identities=28% Similarity=0.457 Sum_probs=189.8
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+++|++.++.++||||++++..|..+..+|+||++|.+|++.+.++.. ..+++..+..++++++.||.|||.+|
T Consensus 67 ~ld~l~kE~~~msl~~HPNIv~~~~sFvv~~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~YLH~~G 146 (516)
T KOG0582|consen 67 DLDALRKEVQTMSLIDHPNIVTYHCSFVVDSELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALDYLHQNG 146 (516)
T ss_pred hHHHHHHHHHHhhhcCCCCcceEEEEEEecceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHHHHHhcC
Confidence 3799999999999999999999999999999999999999999999999875 34999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----c-ccccCCCCccCccccc--ccCCCCchhHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----A-EKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~-~~~~~~~~~~~PE~~~--~~~~~~~~Dv~slG~~l~ 159 (241)
.+|||+|+.|||+ +.+|.|+|+|||.+........ . ....++++|+|||++. ...|+.|+||||||++..
T Consensus 147 ~IHRdvKAgnILi---~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGITA~ 223 (516)
T KOG0582|consen 147 HIHRDVKAGNILI---DSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGITAC 223 (516)
T ss_pred ceecccccccEEE---cCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhHHHH
Confidence 9999999999999 8999999999998765544322 1 3457899999999954 346999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCC-----CCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHL-----PFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~-----~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
|+++|..||....+.+.+-.--.+... ..+......++.++..++..||++||.+|||++++|+|+||++.+..
T Consensus 224 ELA~G~aPf~k~pPmkvLl~tLqn~pp~~~t~~~~~d~~k~~~ksf~e~i~~CL~kDP~kRptAskLlkh~FFk~~k~~ 302 (516)
T KOG0582|consen 224 ELAHGHAPFSKYPPMKVLLLTLQNDPPTLLTSGLDKDEDKKFSKSFREMIALCLVKDPSKRPTASKLLKHAFFKKAKSK 302 (516)
T ss_pred HHhcCCCCcccCChHHHHHHHhcCCCCCcccccCChHHhhhhcHHHHHHHHHHhhcCcccCCCHHHHhccHHHhhccch
Confidence 999999999998887755333222222 12222334577889999999999999999999999999999986543
|
|
| >KOG0192 consensus Tyrosine kinase specific for activated (GTP-bound) p21cdc42Hs [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=299.90 Aligned_cols=207 Identities=33% Similarity=0.516 Sum_probs=185.1
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecC-eEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.+.+.+|+.++++++|||||+++|++.+.. ..++||||+++|+|.+++.+ .+.++...+..++.+|+.|+.|||+++
T Consensus 83 ~~~f~~E~~il~~l~HpNIV~f~G~~~~~~~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~YLH~~~ 162 (362)
T KOG0192|consen 83 RKAFRREASLLSRLRHPNIVQFYGACTSPPGSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGMEYLHSEG 162 (362)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 679999999999999999999999999887 79999999999999999987 578999999999999999999999999
Q ss_pred -ccccCCCCCCeEEeecCCCc-eEEEeecCCccccCCC-CccccccCCCCccCccccc--ccCCCCchhHHHHHHHHHHH
Q 026253 87 -IIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 87 -i~H~dl~~~nil~~~~~~~~-~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~--~~~~~~~~Dv~slG~~l~~l 161 (241)
|+||||||.|||+ +... ++||+|||+++..... .......||..|+|||++. ...++.++||||||+++|||
T Consensus 163 ~iIHrDLK~~NiLv---~~~~~~~KI~DFGlsr~~~~~~~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySFgIvlWEl 239 (362)
T KOG0192|consen 163 PIIHRDLKSDNILV---DLKGKTLKIADFGLSREKVISKTSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSFGIVLWEL 239 (362)
T ss_pred CeeecccChhhEEE---cCCCCEEEECCCccceeeccccccccCCCCCccccChhhhcCCCCcCCccchhhhHHHHHHHH
Confidence 9999999999999 6775 9999999999877654 3334467999999999999 56899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhh-cCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LNGYPPFSGRNNVQLVRNIN-SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+||..||.+....+....+. .+.+.+++. .+++.+..++..||+.||++||++.+++.
T Consensus 240 ~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p~----~~~~~l~~l~~~CW~~dp~~RP~f~ei~~ 298 (362)
T KOG0192|consen 240 LTGEIPFEDLAPVQVASAVVVGGLRPPIPK----ECPPHLSSLMERCWLVDPSRRPSFLEIVS 298 (362)
T ss_pred HHCCCCCCCCCHHHHHHHHHhcCCCCCCCc----cCCHHHHHHHHHhCCCCCCcCCCHHHHHH
Confidence 99999999998877766665 444444454 58999999999999999999999999873
|
|
| >KOG0661 consensus MAPK related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-47 Score=298.13 Aligned_cols=219 Identities=30% Similarity=0.476 Sum_probs=190.3
Q ss_pred hhhHHHHHHHHhcCC-CcCeeeeeeEEeecC-eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.-.-.+|++.|++|+ ||||+++.+.+.+.+ ++++||||| ..+|.++++.+ +.|++..+..|+.||++||+++|.+|
T Consensus 52 e~~nLREvksL~kln~hpniikL~Evi~d~~~~L~fVfE~M-d~NLYqLmK~R~r~fse~~irnim~QilqGL~hiHk~G 130 (538)
T KOG0661|consen 52 ECMNLREVKSLRKLNPHPNIIKLKEVIRDNDRILYFVFEFM-DCNLYQLMKDRNRLFSESDIRNIMYQILQGLAHIHKHG 130 (538)
T ss_pred HHHHHHHHHHHHhcCCCCcchhhHHHhhccCceEeeeHHhh-hhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 344568999999998 999999999988776 999999999 57999999866 45999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc-ccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+.|||+||+|||+ .....+||+|||+|+.......-..+..|.+|.|||++. +..|+.+.|+|++||+++|+++-+
T Consensus 131 fFHRDlKPENiLi---~~~~~iKiaDFGLARev~SkpPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~aEl~sLr 207 (538)
T KOG0661|consen 131 FFHRDLKPENILI---SGNDVIKIADFGLAREVRSKPPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIMAELYSLR 207 (538)
T ss_pred cccccCChhheEe---cccceeEecccccccccccCCCcchhhhcccccchHHhhhccccCCchHHHHHHHHHHHHHHhc
Confidence 9999999999999 568889999999999988777777888999999999864 567899999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCC------------------CC-------ccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPF------------------SQ-------LIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~------------------~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
+.|.|.+..+++-+|......+. ++ ...+..+.++.++|.+|++.||.+||||+|
T Consensus 208 PLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~~s~~~~~li~~ll~WDP~kRpTA~~ 287 (538)
T KOG0661|consen 208 PLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPNASSEAASLIERLLAWDPDKRPTASQ 287 (538)
T ss_pred ccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcccCHHHHHHHHHHhcCCCccCccHHH
Confidence 99999888877766644322221 11 124457889999999999999999999999
Q ss_pred HhcCcccccccc
Q 026253 221 FYHHRFLRRNSA 232 (241)
Q Consensus 221 il~~~~~~~~~~ 232 (241)
+|+||||+...+
T Consensus 288 al~~pffq~~~~ 299 (538)
T KOG0661|consen 288 ALQHPFFQVGRA 299 (538)
T ss_pred HhcCcccccccc
Confidence 999999997443
|
|
| >KOG0197 consensus Tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-46 Score=298.34 Aligned_cols=206 Identities=26% Similarity=0.510 Sum_probs=188.6
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+|++++++|+|++||++++++..++-++||||||..|+|.+||+. .+.+.......++.||++|++||+++++
T Consensus 245 ~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIaeGM~YLes~~~ 324 (468)
T KOG0197|consen 245 PEAFLREAQIMKKLRHEKLVKLYGVCTKQEPIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIAEGMAYLESKNY 324 (468)
T ss_pred hhHHHHHHHHHHhCcccCeEEEEEEEecCCceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHHHHHHHHHhCCc
Confidence 46777999999999999999999999998899999999999999999987 4568999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcccc--ccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~--~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+||||-+.|||| +++..+||+|||+|+...++..... ..-...|.|||.+....++.+|||||||+++||++| |
T Consensus 325 IHRDLAARNiLV---~~~~~vKIsDFGLAr~~~d~~Y~~~~~~kfPIkWtAPEa~~~~~FS~kSDVWSFGVlL~E~fT~G 401 (468)
T KOG0197|consen 325 IHRDLAARNILV---DEDLVVKISDFGLARLIGDDEYTASEGGKFPIKWTAPEALNYGKFSSKSDVWSFGVLLWELFTYG 401 (468)
T ss_pred cchhhhhhheee---ccCceEEEcccccccccCCCceeecCCCCCCceecCHHHHhhCCcccccceeehhhhHHHHhccC
Confidence 999999999999 7899999999999996555443322 223567999999999999999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
+.||.+.+..+.++.+..+.+.+.|. .+|.++.+++..||..+|++|||++.+.
T Consensus 402 ~~py~~msn~ev~~~le~GyRlp~P~----~CP~~vY~lM~~CW~~~P~~RPtF~~L~ 455 (468)
T KOG0197|consen 402 RVPYPGMSNEEVLELLERGYRLPRPE----GCPDEVYELMKSCWHEDPEDRPTFETLR 455 (468)
T ss_pred CCCCCCCCHHHHHHHHhccCcCCCCC----CCCHHHHHHHHHHhhCCcccCCCHHHHH
Confidence 99999999999999999999999887 8899999999999999999999999765
|
|
| >KOG0589 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-46 Score=298.83 Aligned_cols=218 Identities=32% Similarity=0.548 Sum_probs=204.1
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCe-EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~-~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~l 82 (241)
++..++...+|+.+++++.||||+.+++.|+.++. .+|||+||+||++.+.+.+.+ -++++.+..|+.|++.|+.||
T Consensus 43 t~~~r~~A~~E~~lis~~~hP~iv~y~ds~~~~~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~yl 122 (426)
T KOG0589|consen 43 TEPERRSAIQEMDLLSKLLHPNIVEYKDSFEEDGQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVNYL 122 (426)
T ss_pred CchhhHHHHHHHHHHHhccCCCeeeeccchhcCCceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHHHH
Confidence 66778899999999999999999999999998888 999999999999999998764 489999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|+++|+|||||+.|||+ +.++.|+|+|||+|+..++.. ......||+.|++||.+.+.+|..|+|+|||||++|||
T Consensus 123 H~~~iLHRDlK~~Nifl---tk~~~VkLgDfGlaK~l~~~~~~a~tvvGTp~YmcPEil~d~pYn~KSDiWsLGC~~yEm 199 (426)
T KOG0589|consen 123 HENRVLHRDLKCANIFL---TKDKKVKLGDFGLAKILNPEDSLASTVVGTPYYMCPEILSDIPYNEKSDIWSLGCCLYEM 199 (426)
T ss_pred Hhhhhhcccchhhhhhc---cccCceeecchhhhhhcCCchhhhheecCCCcccCHHHhCCCCCCccCcchhhcchHHHH
Confidence 99999999999999999 788889999999999998876 67788999999999999999999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
++-+++|.+.+...+..+|..+...+.+. .++.+++.+++.||..+|..||++.++|.+|.+...
T Consensus 200 ~~lk~aF~a~~m~~Li~ki~~~~~~Plp~----~ys~el~~lv~~~l~~~P~~RPsa~~LL~~P~l~~~ 264 (426)
T KOG0589|consen 200 CTLKPAFKASNMSELILKINRGLYSPLPS----MYSSELRSLVKSMLRKNPEHRPSALELLRRPHLLRY 264 (426)
T ss_pred HhcccccCccchHHHHHHHhhccCCCCCc----cccHHHHHHHHHHhhcCCccCCCHHHHhhChhhhhH
Confidence 99999999999999999998888666665 889999999999999999999999999999988854
|
|
| >KOG0597 consensus Serine-threonine protein kinase FUSED [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-46 Score=301.69 Aligned_cols=219 Identities=34% Similarity=0.614 Sum_probs=198.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
++.+.+.+++|++|++.++||||+.+++.|++..+.|+|+||+.| +|..++...+.++++.+..++.+++.||.|||+.
T Consensus 41 ~~k~l~~l~~ev~i~r~lkHpniv~m~esfEt~~~~~vVte~a~g-~L~~il~~d~~lpEe~v~~~a~~LVsaL~yLhs~ 119 (808)
T KOG0597|consen 41 NEKELKNLRQEVRILRSLKHPNIVEMLESFETSAHLWVVTEYAVG-DLFTILEQDGKLPEEQVRAIAYDLVSALYYLHSN 119 (808)
T ss_pred chHHHHHHHHHHHHHHhcCCcchhhHHHhhcccceEEEEehhhhh-hHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhc
Confidence 345667799999999999999999999999999999999999976 9999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
+|.|+|+||.||++ +.++.+|+||||+|+....... .....||+.|+|||...+++|+..+|+||+||++||++.|
T Consensus 120 rilhrd~kPqniLl---~~~~~~KlcdFg~Ar~m~~~t~vltsikGtPlYmAPElv~e~pyd~~sDlWslGcilYE~~~G 196 (808)
T KOG0597|consen 120 RILHRDMKPQNILL---EKGGTLKLCDFGLARAMSTNTSVLTSIKGTPLYMAPELVEEQPYDHTSDLWSLGCILYELYVG 196 (808)
T ss_pred CcccccCCcceeee---cCCCceeechhhhhhhcccCceeeeeccCcccccCHHHHcCCCccchhhHHHHHHHHHHHhcC
Confidence 99999999999999 8999999999999988766543 3456799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
++||......++.+.|...... .+ ...|..+..|+..+|.+||.+|.|+.+++.|||.++.-..
T Consensus 197 ~PPF~a~si~~Lv~~I~~d~v~-~p----~~~S~~f~nfl~gLL~kdP~~RltW~~Ll~HpF~k~~~~~ 260 (808)
T KOG0597|consen 197 QPPFYARSITQLVKSILKDPVK-PP----STASSSFVNFLQGLLIKDPAQRLTWTDLLGHPFWKGKINI 260 (808)
T ss_pred CCCchHHHHHHHHHHHhcCCCC-Cc----ccccHHHHHHHHHHhhcChhhcccHHHHhcChHHhhhhhh
Confidence 9999999999999988554322 22 2789999999999999999999999999999999874433
|
|
| >KOG0032 consensus Ca2+/calmodulin-dependent protein kinase, EF-Hand protein superfamily [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-45 Score=294.64 Aligned_cols=225 Identities=32% Similarity=0.581 Sum_probs=205.9
Q ss_pred hhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
....+.+|+++++++. ||||+.+++.|++....++|||+++||.|.+.+.+. .+++..+..++.|++.++++||+.|+
T Consensus 78 ~~~~v~~Ev~il~~l~~hpniv~l~~~~e~~~~~~lvmEL~~GGeLfd~i~~~-~~sE~da~~~~~~il~av~~lH~~gv 156 (382)
T KOG0032|consen 78 DREDVRREVAILQQLSGHPNIVQLKDAFEDPDSVYLVMELCEGGELFDRIVKK-HYSERDAAGIIRQILEAVKYLHSLGV 156 (382)
T ss_pred cHHHHHHHHHHHHhccCCCCEEEEEEEEEcCCeEEEEEEecCCchHHHHHHHc-cCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 4579999999999997 999999999999999999999999999999999876 49999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCC-CceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~-~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+|+||+|+++....+ .+.++++|||++............+||+.|+|||++....++...|+||+|+++|.|++|.+
T Consensus 157 vHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~~~~~~~~Gtp~y~APEvl~~~~y~~~~DiWS~Gvi~yiLL~G~~ 236 (382)
T KOG0032|consen 157 VHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPGERLHTIVGTPEYVAPEVLGGRPYGDEVDVWSIGVILYILLSGVP 236 (382)
T ss_pred eeccCCHHHeeeccccCCCCcEEEeeCCCceEccCCceEeeecCCccccCchhhcCCCCCcccchhHHHHHHHHHhhCCC
Confidence 99999999999976444 45899999999999887667788899999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCC
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 235 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 235 (241)
||.+.+.......+..+. ..+....++.+|..+.++|+.||..||.+|+|+.++|+|||++.......
T Consensus 237 PF~~~~~~~~~~~i~~~~-~~f~~~~w~~is~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~~~~~ 304 (382)
T KOG0032|consen 237 PFWGETEFEIFLAILRGD-FDFTSEPWDDISESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIGEATN 304 (382)
T ss_pred CCcCCChhHHHHHHHcCC-CCCCCCCccccCHHHHHHHHHhcccCcccCCCHHHHhcCccccCCccccc
Confidence 999999888888885554 46777778899999999999999999999999999999999998644443
|
|
| >KOG0604 consensus MAP kinase-activated protein kinase 2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-46 Score=280.24 Aligned_cols=230 Identities=31% Similarity=0.577 Sum_probs=204.9
Q ss_pred hhhHHHHHHHHhcC-CCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 10 ~~~~~~E~~~l~~l-~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~l 82 (241)
....++|+++.... .|+|||.++++|+. ...+.+|||+++||.|.+-++.++. +++..+..|.+||..|+.||
T Consensus 98 s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~Av~~l 177 (400)
T KOG0604|consen 98 SPKARREVELHWMASGHPHIVSIIDVYENSYQGRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLAVRYL 177 (400)
T ss_pred CHHHHhHhhhhhhhcCCCceEEeehhhhhhccCceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHHHHHH
Confidence 45678999999888 69999999998864 4578899999999999999988765 99999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
|+.+|.||||||+|+|+.....+..+||+|||+|+.........+.+.|++|.|||++...+|+...|+||+|+++|.|+
T Consensus 178 H~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~~~L~TPc~TPyYvaPevlg~eKydkscdmwSlgVimYIlL 257 (400)
T KOG0604|consen 178 HSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEPGDLMTPCFTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 257 (400)
T ss_pred HhcchhhccCChhheeeecCCCCcceEecccccccccCCCccccCCcccccccCHHHhCchhcCCCCCccchhHHHHHhh
Confidence 99999999999999999988889999999999999887777777888999999999999999999999999999999999
Q ss_pred hCCCCCCCCCh----HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCCCCC
Q 026253 163 NGYPPFSGRNN----VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 238 (241)
Q Consensus 163 ~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~ 238 (241)
+|.+||.+... ..+-.+|+ .....|+...+..+|++.+++|+++|..+|.+|.|+.+++.|||+.++...=.+|+
T Consensus 258 CGyPPFYS~hg~aispgMk~rI~-~gqy~FP~pEWs~VSe~aKdlIR~LLkt~PteRlTI~~~m~hpwi~~~~~vp~tpl 336 (400)
T KOG0604|consen 258 CGYPPFYSNHGLAISPGMKRRIR-TGQYEFPEPEWSCVSEAAKDLIRKLLKTEPTERLTIEEVMDHPWINQYEAVPQTPL 336 (400)
T ss_pred cCCCcccccCCccCChhHHhHhh-ccCccCCChhHhHHHHHHHHHHHHHhcCCchhheeHHHhhcCchhcccccCCCCCc
Confidence 99999975432 34445553 44566777778899999999999999999999999999999999999998888777
Q ss_pred CC
Q 026253 239 HI 240 (241)
Q Consensus 239 ~~ 240 (241)
++
T Consensus 337 ~t 338 (400)
T KOG0604|consen 337 ST 338 (400)
T ss_pred hh
Confidence 53
|
|
| >cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-45 Score=294.96 Aligned_cols=214 Identities=30% Similarity=0.512 Sum_probs=190.0
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|+.++++++||||+++++.+..++..++||||+.+++|.+++...+.+++..+..++.|++.||++||+.|+
T Consensus 37 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 116 (323)
T cd05571 37 DEVAHTLTESRVLQNTRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALGYLHSCDV 116 (323)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44567789999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+||||||+||++ +.++.++|+|||++..... ........+++.|+|||.+.+..++.++|+||+||++|+|++|..
T Consensus 117 vHrDlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 193 (323)
T cd05571 117 VYRDLKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (323)
T ss_pred EeCCCCHHHEEE---CCCCCEEEeeCCCCcccccCCCcccceecCccccChhhhcCCCCCccccCcccchhhhhhhcCCC
Confidence 999999999999 7788999999999875322 223344568999999999998899999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
||.+.+.......+.... ..++ ..++.++.++|++||+.||.+|| ++.++++||||..
T Consensus 194 Pf~~~~~~~~~~~~~~~~-~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~h~~f~~ 256 (323)
T cd05571 194 PFYNQDHEKLFELILMEE-IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPEDAKEIMEHRFFAS 256 (323)
T ss_pred CCCCCCHHHHHHHHHcCC-CCCC----CCCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHHcCCCcCC
Confidence 999888877777664432 2333 37899999999999999999999 8999999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be |
| >cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-45 Score=289.59 Aligned_cols=212 Identities=35% Similarity=0.631 Sum_probs=189.7
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
+..+.+.+|+.++++++||||+++++++.+++..++||||+.+++|.+++.+.+.+++..+..++.|++.||++||++|+
T Consensus 43 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 122 (291)
T cd05612 43 KQEQHVHNEKRVLKEVSHPFIIRLFWTEHDQRFLYMLMEYVPGGELFSYLRNSGRFSNSTGLFYASEIVCALEYLHSKEI 122 (291)
T ss_pred HHHHHHHHHHHHHHhCCCCcHhhhHhhhccCCeEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34667899999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|+||++ +.++.++|+|||++...... .....+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 123 ~H~dlkp~NIli---~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~~l~~g~~p 197 (291)
T cd05612 123 VYRDLKPENILL---DKEGHIKLTDFGFAKKLRDR--TWTLCGTPEYLAPEVIQSKGHNKAVDWWALGILIYEMLVGYPP 197 (291)
T ss_pred eecCCCHHHeEE---CCCCCEEEEecCcchhccCC--cccccCChhhcCHHHHcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 999999999999 67889999999998765432 2234688999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 229 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~ 229 (241)
|.+.+..+..+.+..+. ..++ ..++..+.++|++||+.||.+||+ ++++++||||+.
T Consensus 198 f~~~~~~~~~~~i~~~~-~~~~----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~ 259 (291)
T cd05612 198 FFDDNPFGIYEKILAGK-LEFP----RHLDLYAKDLIKKLLVVDRTRRLGNMKNGADDVKNHRWFKS 259 (291)
T ss_pred CCCCCHHHHHHHHHhCC-cCCC----ccCCHHHHHHHHHHcCCCHHHccCCccCCHHHHhcCccccC
Confidence 99988888887775543 2233 366889999999999999999995 999999999976
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt |
| >PTZ00263 protein kinase A catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.5e-45 Score=293.27 Aligned_cols=212 Identities=32% Similarity=0.608 Sum_probs=190.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++.+++..++||||+.+++|.+++.+.+.+++..+..++.|++.||++||+.|+
T Consensus 60 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 139 (329)
T PTZ00263 60 KQVQHVAQEKSILMELSHPFIVNMMCSFQDENRVYFLLEFVVGGELFTHLRKAGRFPNDVAKFYHAELVLAFEYLHSKDI 139 (329)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCcEEEEEEcCCEEEEEEcCCCCChHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34567899999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||||+||++ +.++.++|+|||++....... ....+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 140 vH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~--~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~p 214 (329)
T PTZ00263 140 IYRDLKPENLLL---DNKGHVKVTDFGFAKKVPDRT--FTLCGTPEYLAPEVIQSKGHGKAVDWWTMGVLLYEFIAGYPP 214 (329)
T ss_pred eecCCCHHHEEE---CCCCCEEEeeccCceEcCCCc--ceecCChhhcCHHHHcCCCCCCcceeechHHHHHHHHcCCCC
Confidence 999999999999 788899999999997654332 235688999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 229 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~ 229 (241)
|.+.+..+....+..+. ..++ ..++..+.++|++||+.||.+|++ +++++.||||++
T Consensus 215 f~~~~~~~~~~~i~~~~-~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~ll~hp~f~~ 276 (329)
T PTZ00263 215 FFDDTPFRIYEKILAGR-LKFP----NWFDGRARDLVKGLLQTDHTKRLGTLKGGVADVKNHPYFHG 276 (329)
T ss_pred CCCCCHHHHHHHHhcCC-cCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCccCC
Confidence 99888888887775543 3333 257889999999999999999997 799999999987
|
|
| >KOG0660 consensus Mitogen-activated protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-45 Score=281.16 Aligned_cols=228 Identities=33% Similarity=0.521 Sum_probs=193.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee-----cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (241)
+....++..+|+++++.++|+||+.+.+.+.. -+..|+|+|+| +.+|.+.++.+..++++++..+++|++.||+
T Consensus 61 ~~~~akRtlRElklLr~~~HeNIi~l~di~~p~~~~~f~DvYiV~elM-etDL~~iik~~~~L~d~H~q~f~YQiLrgLK 139 (359)
T KOG0660|consen 61 NQIDAKRTLRELKLLRHLRHENIIGLLDIFRPPSRDKFNDVYLVFELM-ETDLHQIIKSQQDLTDDHAQYFLYQILRGLK 139 (359)
T ss_pred chHHHHHHHHHHHHHHHhcCCCcceEEeecccccccccceeEEehhHH-hhHHHHHHHcCccccHHHHHHHHHHHHHhcc
Confidence 35567888999999999999999999998865 35799999999 6899999998877999999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCC---CCccccccCCCCccCccccc-ccCCCCchhHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGA 156 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~---~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~ 156 (241)
|+|+.|++|||+||.|+++ +.+..+||+|||+|+.... .........|.+|.|||.+. ...|+.+.||||+||
T Consensus 140 yiHSAnViHRDLKPsNll~---n~~c~lKI~DFGLAR~~~~~~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGC 216 (359)
T KOG0660|consen 140 YIHSANVIHRDLKPSNLLL---NADCDLKICDFGLARYLDKFFEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGC 216 (359)
T ss_pred hhhcccccccccchhheee---ccCCCEEeccccceeeccccCcccchhcceeeeeecCHHHHhccccccchhhhhhhhH
Confidence 9999999999999999999 7888899999999988753 33345677899999999864 467999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC--------------------------CccCCCCChHHHHHHHHhccc
Q 026253 157 ILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS--------------------------QLIVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~ 210 (241)
++.||++|++.|.|.+...+++.|......+-. ....+..++...+++.+||..
T Consensus 217 I~AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp~a~p~AidLlekmL~f 296 (359)
T KOG0660|consen 217 ILAEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFPNANPLAIDLLEKMLVF 296 (359)
T ss_pred HHHHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcCCCCHHHHHHHHHHhcc
Confidence 999999999999998877666655443222211 123568889999999999999
Q ss_pred CccccCCHHHHhcCcccccccccCCCC
Q 026253 211 NTVDRLSFNEFYHHRFLRRNSAILRAP 237 (241)
Q Consensus 211 ~p~~Rps~~~il~~~~~~~~~~~~~~~ 237 (241)
||.+|+|++|+|+||||....--...|
T Consensus 297 dP~kRita~eAL~hPYl~~~hdp~dEP 323 (359)
T KOG0660|consen 297 DPKKRITAEEALAHPYLAPYHDPEDEP 323 (359)
T ss_pred CccccCCHHHHhcChhhhhhcCCccCC
Confidence 999999999999999999865554444
|
|
| >cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-45 Score=286.22 Aligned_cols=217 Identities=29% Similarity=0.454 Sum_probs=183.3
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+|++++++++|++|+++++.+.+++..++||||+.+++|.+++... ..+++..+..++.|++.|+.+||+.|+
T Consensus 44 ~~~~~~E~~il~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05631 44 EAMALNEKRILEKVNSRFVVSLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLEDLQRERI 123 (285)
T ss_pred HHHHHHHHHHHHhcCCCcEEEEEEEEccCCeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 456789999999999999999999999999999999999999999888643 358999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||||+||++ ++++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 124 iH~dikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p 200 (285)
T cd05631 124 VYRDLKPENILL---DDRGHIRISDLGLAVQIPEGETVRGRVGTVGYMAPEVINNEKYTFSPDWWGLGCLIYEMIQGQSP 200 (285)
T ss_pred EeCCCCHHHEEE---CCCCCEEEeeCCCcEEcCCCCeecCCCCCCCccCHhhhcCCCCCcccCchhHHHHHHHHHhCCCC
Confidence 999999999999 77888999999999776444444455689999999999988999999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCcccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 230 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~ 230 (241)
|.+.+.......+..... .........++.++.+++++||+.||.+||+ ++++++||||++.
T Consensus 201 f~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~h~~~~~~ 267 (285)
T cd05631 201 FRKRKERVKREEVDRRVK-EDQEEYSEKFSEDAKSICRMLLTKNPKERLGCRGNGAAGVKQHPIFKNI 267 (285)
T ss_pred CCCCCcchhHHHHHHHhh-cccccCCccCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHhcCHhhcCC
Confidence 987654332222211111 1112233478999999999999999999997 8999999999984
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i |
| >cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-45 Score=289.46 Aligned_cols=216 Identities=34% Similarity=0.554 Sum_probs=190.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
......+.+|+.++++++||||+++++.+.+++..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|
T Consensus 34 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 113 (312)
T cd05585 34 RSEVTHTLAERTVLAQVNCPFIVPLKFSFQSPEKLYLVLAFINGGELFHHLQREGRFDLSRARFYTAELLCALENLHKFN 113 (312)
T ss_pred hhHHHHHHHHHHHHHhCCCCcEeceeeEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34556788999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++||||||.||++ +.++.++|+|||++..... ........+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 114 i~HrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~tg~ 190 (312)
T cd05585 114 VIYRDLKPENILL---DYQGHIALCDFGLCKLNMKDDDKTNTFCGTPEYLAPELLLGHGYTKAVDWWTLGVLLYEMLTGL 190 (312)
T ss_pred eEeCCCCHHHeEE---CCCCcEEEEECcccccCccCCCccccccCCcccCCHHHHcCCCCCCccceechhHHHHHHHhCC
Confidence 9999999999999 7888999999999875432 22233456899999999999889999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC---CHHHHhcCcccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL---SFNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 230 (241)
.||.+.+..+..+.+.... ..+ ...+++++.+++.+||+.||.+|| ++.+++.||||++.
T Consensus 191 ~pf~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~li~~~L~~dp~~R~~~~~~~e~l~hp~~~~~ 253 (312)
T cd05585 191 PPFYDENVNEMYRKILQEP-LRF----PDGFDRDAKDLLIGLLSRDPTRRLGYNGAQEIKNHPFFSQL 253 (312)
T ss_pred CCcCCCCHHHHHHHHHcCC-CCC----CCcCCHHHHHHHHHHcCCCHHHcCCCCCHHHHHcCCCcCCC
Confidence 9999888888777765432 222 247889999999999999999997 58999999999974
|
Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl |
| >PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-44 Score=292.09 Aligned_cols=214 Identities=30% Similarity=0.563 Sum_probs=191.1
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|+++++.++||||+++++++.+++..++||||+.+++|.+++.+.+.+++..+..++.|++.||.+||+.|
T Consensus 72 ~~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 151 (340)
T PTZ00426 72 QKQVDHVFSERKILNYINHPFCVNLYGSFKDESYLYLVLEFVIGGEFFTFLRRNKRFPNDVGCFYAAQIVLIFEYLQSLN 151 (340)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34456788999999999999999999999999999999999999999999998889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
++||||||+||++ +.++.++|+|||++...... .....+++.|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 152 ivHrDLkp~NILl---~~~~~ikL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~G~~ 226 (340)
T PTZ00426 152 IVYRDLKPENLLL---DKDGFIKMTDFGFAKVVDTR--TYTLCGTPEYIAPEILLNVGHGKAADWWTLGIFIYEILVGCP 226 (340)
T ss_pred eEccCCCHHHEEE---CCCCCEEEecCCCCeecCCC--cceecCChhhcCHHHHhCCCCCccccccchhhHHHHHhcCCC
Confidence 9999999999999 78889999999998765432 234568899999999988889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCcccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 230 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~ 230 (241)
||.+.+.....+.+..+. ..++ +.++..+.+++++||+.||.+|+ +++++++||||++.
T Consensus 227 Pf~~~~~~~~~~~i~~~~-~~~p----~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~hp~f~~~ 290 (340)
T PTZ00426 227 PFYANEPLLIYQKILEGI-IYFP----KFLDNNCKHLMKKLLSHDLTKRYGNLKKGAQNVKEHPWFGNI 290 (340)
T ss_pred CCCCCCHHHHHHHHhcCC-CCCC----CCCCHHHHHHHHHHcccCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 999988888787775543 2222 36789999999999999999995 89999999999873
|
|
| >cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-44 Score=288.87 Aligned_cols=215 Identities=30% Similarity=0.504 Sum_probs=189.4
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|++++++++||||+++++.+..++..++||||+++++|.+++...+.+++..+..++.|++.||.+||++|+
T Consensus 37 ~~~~~~~~E~~~l~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 116 (323)
T cd05595 37 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 116 (323)
T ss_pred HHHHHHHHHHHHHHhCCCCCCcceeeEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 44567788999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||||+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 117 vH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~ell~g~~ 193 (323)
T cd05595 117 VYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 193 (323)
T ss_pred EecCCCHHHEEE---cCCCCEEecccHHhccccCCCCccccccCCcCcCCcccccCCCCCchhchhhhHHHHHHHHhCCC
Confidence 999999999999 77889999999998754322 22334568899999999998899999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCcccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 230 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~ 230 (241)
||...+.......+.... ..++ ..+++++.++|.+||+.||.+|+ ++.++++||||.+.
T Consensus 194 Pf~~~~~~~~~~~~~~~~-~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~l~h~~~~~~ 257 (323)
T cd05595 194 PFYNQDHERLFELILMEE-IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSI 257 (323)
T ss_pred CCCCCCHHHHHHHHhcCC-CCCC----CCCCHHHHHHHHHHccCCHHHhCCCCCCCHHHHHcCCCcCCC
Confidence 999888877777664332 2223 37889999999999999999998 89999999999873
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in |
| >cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-44 Score=289.20 Aligned_cols=215 Identities=30% Similarity=0.488 Sum_probs=189.1
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
......+.+|+++++.++||||+++++.+..++..++||||+++++|.+++...+.+++..+..++.|++.||.+||++|
T Consensus 36 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ 115 (328)
T cd05593 36 KDEVAHTLTESRVLKNTRHPFLTSLKYSFQTKDRLCFVMEYVNGGELFFHLSRERVFSEDRTRFYGAEIVSALDYLHSGK 115 (328)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34566788999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||||+||++ +.++.++|+|||++..... ........+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 116 ivHrDikp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~ 192 (328)
T cd05593 116 IVYRDLKLENLML---DKDGHIKITDFGLCKEGITDAATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 192 (328)
T ss_pred eEecccCHHHeEE---CCCCcEEEecCcCCccCCCcccccccccCCcCccChhhhcCCCCCccCCccccchHHHHHhhCC
Confidence 9999999999999 7788999999999875332 22233456899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
.||.+.+..+..+.+.... ..++ ..++.++.++|++||+.||.+|+ ++.++++||||..
T Consensus 193 ~Pf~~~~~~~~~~~~~~~~-~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~ 256 (328)
T cd05593 193 LPFYNQDHEKLFELILMED-IKFP----RTLSADAKSLLSGLLIKDPNKRLGGGPDDAKEIMRHSFFTG 256 (328)
T ss_pred CCCCCCCHHHHHHHhccCC-ccCC----CCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 9999888777766664322 2233 37899999999999999999997 8999999999976
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate |
| >KOG0659 consensus Cdk activating kinase (CAK)/RNA polymerase II transcription initiation/nucleotide excision repair factor TFIIH/TFIIK, kinase subunit CDK7 [Cell cycle control, cell division, chromosome partitioning; Transcription; Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-44 Score=266.31 Aligned_cols=222 Identities=31% Similarity=0.481 Sum_probs=193.1
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
++.......+|++.|+.++|+||+.+++.|...+...+|+||++ .+|...++.. ..++..++..++.++++|++|||+
T Consensus 41 kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~~~l~lVfEfm~-tdLe~vIkd~~i~l~pa~iK~y~~m~LkGl~y~H~ 119 (318)
T KOG0659|consen 41 KDGINRTALREIKLLQELKHPNIIELIDVFPHKSNLSLVFEFMP-TDLEVVIKDKNIILSPADIKSYMLMTLKGLAYCHS 119 (318)
T ss_pred ccCccHHHHHHHHHHHHccCcchhhhhhhccCCCceEEEEEecc-ccHHHHhcccccccCHHHHHHHHHHHHHHHHHHHh
Confidence 34446688999999999999999999999999999999999995 6999999755 458999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc-ccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~-~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~ 162 (241)
+.|+|||+||+|+++ +.++.+||+|||+|+.++..... .....|.+|.|||.+.|. .|+...|+||+||++.|++
T Consensus 120 ~~IlHRDlKPnNLLi---s~~g~lKiADFGLAr~f~~p~~~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWavGCI~AELl 196 (318)
T KOG0659|consen 120 KWILHRDLKPNNLLI---SSDGQLKIADFGLARFFGSPNRIQTHQVVTRWYRAPELLFGSRQYGTGVDMWAVGCIFAELL 196 (318)
T ss_pred hhhhcccCCccceEE---cCCCcEEeecccchhccCCCCcccccceeeeeccChHHhccchhcCCcchhhhHHHHHHHHH
Confidence 999999999999999 89999999999999988765433 234679999999988764 6999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCc-----------------------cCCCCChHHHHHHHHhcccCccccCCHH
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQL-----------------------IVPALHPDCVDMCLKLLSANTVDRLSFN 219 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~-----------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~ 219 (241)
.|.+.|.+.++-+++..|-.....+.++. ..+..+++..+++.+|+..||.+|+|++
T Consensus 197 lr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~lf~aas~d~ldLl~~m~~ynP~~Rita~ 276 (318)
T KOG0659|consen 197 LRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNNLFPAASSDALDLLSKMLTYNPKKRITAS 276 (318)
T ss_pred ccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCccccccccccHHHHHHHHhhhccCchhcccHH
Confidence 99999999998888877766544333322 3456677889999999999999999999
Q ss_pred HHhcCccccccc
Q 026253 220 EFYHHRFLRRNS 231 (241)
Q Consensus 220 ~il~~~~~~~~~ 231 (241)
|+|+|+||+..+
T Consensus 277 qaL~~~yf~~~P 288 (318)
T KOG0659|consen 277 QALKHPYFKSLP 288 (318)
T ss_pred HHhcchhhhcCC
Confidence 999999999743
|
|
| >cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-44 Score=289.47 Aligned_cols=218 Identities=32% Similarity=0.541 Sum_probs=190.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
+..+.+.+|+.++++++|+||+++++++..++..++||||++|++|.+++...+.+++..+..++.|++.||.+||+.|+
T Consensus 43 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 122 (333)
T cd05600 43 NEVRHVLTERDILTTTKSEWLVKLLYAFQDDEYLYLAMEYVPGGDFRTLLNNLGVLSEDHARFYMAEMFEAVDALHELGY 122 (333)
T ss_pred hHHHHHHHHHHHHHhCCCCCCccEEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34567889999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|+||++ +.++.++|+|||++..... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 123 vH~dlkp~Nil~---~~~~~~kL~Dfg~a~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~p 197 (333)
T cd05600 123 IHRDLKPENFLI---DASGHIKLTDFGLSKGIVT--YANSVVGSPDYMAPEVLRGKGYDFTVDYWSLGCMLYEFLCGFPP 197 (333)
T ss_pred cccCCCHHHEEE---CCCCCEEEEeCcCCccccc--ccCCcccCccccChhHhcCCCCCCccceecchHHHhhhhhCCCC
Confidence 999999999999 7888999999999876543 23445688999999999988999999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCC-CC--ccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPF-SQ--LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~-~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
|.+.+..+....+........ +. .....++.++.++|.+||..+|.+||+++++++||||++.
T Consensus 198 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~s~~~~~li~~~l~~~~~rr~s~~~ll~h~~~~~~ 263 (333)
T cd05600 198 FSGSTPNETWENLKYWKETLQRPVYDDPRFNLSDEAWDLITKLINDPSRRFGSLEDIKNHPFFKEV 263 (333)
T ss_pred CCCCCHHHHHHHHHhccccccCCCCCccccccCHHHHHHHHHHhhChhhhcCCHHHHHhCcccCCC
Confidence 999888877776654332111 11 1112568999999999999999999999999999999974
|
Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. |
| >cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-44 Score=286.57 Aligned_cols=214 Identities=37% Similarity=0.604 Sum_probs=189.1
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
....+.+|+.++++++||||+++++.+..++..++||||+.+++|.+++...+.+.+..+..++.|++.||.+||+.|++
T Consensus 43 ~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 122 (323)
T cd05584 43 DTAHTKAERNILEAVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMHLEREGIFMEDTACFYLSEISLALEHLHQQGII 122 (323)
T ss_pred hHHHHHHHHHHHHhCCCCchhceeeEEecCCeEEEEEeCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34567899999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|+||||+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 123 H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~~p 199 (323)
T cd05584 123 YRDLKPENILL---DAQGHVKLTDFGLCKESIHEGTVTHTFCGTIEYMAPEILMRSGHGKAVDWWSLGALMYDMLTGAPP 199 (323)
T ss_pred cCCCCHHHeEE---CCCCCEEEeeCcCCeecccCCCcccccCCCccccChhhccCCCCCCcceecccHHHHHHHhcCCCC
Confidence 99999999999 7888999999999865432 2223345689999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCcccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 230 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~ 230 (241)
|.+.+.......+..+. ... .+.++.++.++|++||+.+|.+|| +++++++||||+..
T Consensus 200 f~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~l~~h~~~~~~ 262 (323)
T cd05584 200 FTAENRKKTIDKILKGK-LNL----PPYLTPEARDLLKKLLKRNPSSRLGAGPGDAAEVQSHPFFRHV 262 (323)
T ss_pred CCCCCHHHHHHHHHcCC-CCC----CCCCCHHHHHHHHHHcccCHhHcCCCCCCCHHHHhcCCCcCCC
Confidence 99888877777775443 222 346789999999999999999999 89999999999763
|
Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in |
| >cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-44 Score=288.03 Aligned_cols=224 Identities=28% Similarity=0.488 Sum_probs=182.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeec-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+|++++++++||||+++++++... ...++||||+ +++|.+++.....+++..+..++.|++.||.+||
T Consensus 42 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH 120 (338)
T cd07859 42 DATRILREIKLLRLLRHPDIVEIKHIMLPPSRREFKDIYVVFELM-ESDLHQVIKANDDLTPEHHQFFLYQLLRALKYIH 120 (338)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeecceEeccCCCCCceEEEEEecC-CCCHHHHHHhcccCCHHHHHHHHHHHHHHHHHHH
Confidence 345688999999999999999999987543 3589999999 5799999988888999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccc--cCCCCchhHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAI 157 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~ 157 (241)
+.|++|+||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||+|++
T Consensus 121 ~~~ivH~dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvv 197 (338)
T cd07859 121 TANVFHRDLKPKNILA---NADCKLKICDFGLARVAFNDTPTAIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCI 197 (338)
T ss_pred HCCeecCCCCHHHeEE---CCCCcEEEccCccccccccccCccccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHH
Confidence 9999999999999999 7888999999999875432211 133568899999999865 578899999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhcC---------------------------CCCCCCCccCCCCChHHHHHHHHhccc
Q 026253 158 LFELLNGYPPFSGRNNVQLVRNINSC---------------------------KHLPFSQLIVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~~~~~~i~~~---------------------------~~~~~~~~~~~~~~~~~~~li~~~l~~ 210 (241)
+|+|++|++||.+.+.......+... ...+. ....+.+++.+.+++.+||+.
T Consensus 198 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~li~~~l~~ 276 (338)
T cd07859 198 FAEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPF-SQKFPNADPLALRLLERLLAF 276 (338)
T ss_pred HHHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCch-HHhcCCCChHHHHHHHHHcCc
Confidence 99999999999876654433222111 11111 112345788899999999999
Q ss_pred CccccCCHHHHhcCcccccccccCCCC
Q 026253 211 NTVDRLSFNEFYHHRFLRRNSAILRAP 237 (241)
Q Consensus 211 ~p~~Rps~~~il~~~~~~~~~~~~~~~ 237 (241)
||.+|||++|+++||||++.......+
T Consensus 277 ~P~~Rpt~~e~l~hp~f~~~~~~~~~~ 303 (338)
T cd07859 277 DPKDRPTAEEALADPYFKGLAKVEREP 303 (338)
T ss_pred CcccCCCHHHHhcCchhhhcCcccccc
Confidence 999999999999999999877766544
|
Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos |
| >cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-43 Score=285.08 Aligned_cols=221 Identities=29% Similarity=0.478 Sum_probs=185.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH- 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~- 85 (241)
....+.+.+|++++++++|+||+++++++..++..++||||+++++|.+++.....+++..+..++.|++.|+.+||+.
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 123 (331)
T cd06649 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKEAKRIPEEILGKVSIAVLRGLAYLREKH 123 (331)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEeecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhhcC
Confidence 4456789999999999999999999999999999999999999999999999888899999999999999999999986
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+++|+||||.||++ +.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||+|+++|++++|+
T Consensus 124 ~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~ 199 (331)
T cd06649 124 QIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVELAIGR 199 (331)
T ss_pred CEEcCCCChhhEEE---cCCCcEEEccCccccccccc-ccccCCCCcCcCCHhHhcCCCCCchHhHHHHHHHHHHHHhCC
Confidence 69999999999999 67888999999998765432 233456889999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCC-------------------------------------------CCCCCCccCCCCChHHHH
Q 026253 166 PPFSGRNNVQLVRNINSCK-------------------------------------------HLPFSQLIVPALHPDCVD 202 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~-------------------------------------------~~~~~~~~~~~~~~~~~~ 202 (241)
.||...+..+....+.... ....+......++.++.+
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ 279 (331)
T cd06649 200 YPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNGVFTPDFQE 279 (331)
T ss_pred CCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCccccHHHHH
Confidence 9998766555433321100 000011111246789999
Q ss_pred HHHHhcccCccccCCHHHHhcCccccccc
Q 026253 203 MCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 203 li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
+|++||+.||++|||++++++||||+...
T Consensus 280 li~~~L~~~P~~Rpt~~ell~h~~~~~~~ 308 (331)
T cd06649 280 FVNKCLIKNPAERADLKMLMNHTFIKRSE 308 (331)
T ss_pred HHHHHccCCcccCCCHHHHhcChHHhhcc
Confidence 99999999999999999999999998753
|
Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst |
| >cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-44 Score=284.97 Aligned_cols=214 Identities=34% Similarity=0.559 Sum_probs=188.8
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|..+++.+ +||||+++++++.+.+..++||||+++++|.+++.+.+.+++..+..++.|++.||.+||+.|
T Consensus 37 ~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~iv~Ey~~~g~L~~~i~~~~~l~~~~~~~~~~ql~~~L~~lH~~~ 116 (320)
T cd05590 37 DDVECTMTEKRILSLARNHPFLTQLYCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEITSALMFLHDKG 116 (320)
T ss_pred cHHHHHHHHHHHHHhccCCCchhceeeEEEcCCEEEEEEcCCCCchHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456677888898877 799999999999999999999999999999999988889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++||||||.||++ +.++.++|+|||++..... ........+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 117 ivH~dlkp~NIli---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 193 (320)
T cd05590 117 IIYRDLKLDNVLL---DHEGHCKLADFGMCKEGIFNGKTTSTFCGTPDYIAPEILQEMLYGPSVDWWAMGVLLYEMLCGH 193 (320)
T ss_pred eEeCCCCHHHeEE---CCCCcEEEeeCCCCeecCcCCCcccccccCccccCHHHHcCCCCCCccchhhhHHHHHHHhhCC
Confidence 9999999999999 7888999999999865422 22333456899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH------HHHhcCccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF------NEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~il~~~~~~~ 229 (241)
.||.+.+..+....+..... ..+ ..++.++.+++++||+.||.+||++ +++++||||+.
T Consensus 194 ~Pf~~~~~~~~~~~i~~~~~-~~~----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~~~~h~~f~~ 258 (320)
T cd05590 194 APFEAENEDDLFEAILNDEV-VYP----TWLSQDAVDILKAFMTKNPTMRLGSLTLGGEEAILRHPFFKE 258 (320)
T ss_pred CCCCCCCHHHHHHHHhcCCC-CCC----CCCCHHHHHHHHHHcccCHHHCCCCCCCCCHHHHHcCCCcCC
Confidence 99999988888887754332 222 3678999999999999999999998 99999999986
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal |
| >cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-44 Score=287.26 Aligned_cols=215 Identities=30% Similarity=0.505 Sum_probs=188.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~ 86 (241)
.....+.+|+++++.++|+||+++++.+..++..++||||+++++|.+++...+.+++..+..++.|++.||.|||+ .|
T Consensus 37 ~~~~~~~~e~~~l~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~~ 116 (325)
T cd05594 37 DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 116 (325)
T ss_pred hHHHHHHHHHHHHHhCCCCCCCceEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhcCC
Confidence 34567788999999999999999999999999999999999999999999888889999999999999999999997 79
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||||+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 117 ivHrDikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~tG~ 193 (325)
T cd05594 117 VVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 193 (325)
T ss_pred EEecCCCCCeEEE---CCCCCEEEecCCCCeecCCCCcccccccCCcccCCHHHHccCCCCCccccccccceeeeeccCC
Confidence 9999999999999 7888999999999865432 22233456899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCcccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~ 230 (241)
.||.+.+.....+.+... ...++ ..+++++.+++++||+.||.+|+ ++.++++||||.+.
T Consensus 194 ~Pf~~~~~~~~~~~i~~~-~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~il~h~~~~~~ 258 (325)
T cd05594 194 LPFYNQDHEKLFELILME-EIRFP----RTLSPEAKSLLSGLLKKDPKQRLGGGPDDAKEIMQHKFFAGI 258 (325)
T ss_pred CCCCCCCHHHHHHHHhcC-CCCCC----CCCCHHHHHHHHHHhhcCHHHhCCCCCCCHHHHhcCCCcCCC
Confidence 999988887777766433 22333 36889999999999999999997 99999999999863
|
Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien |
| >cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.1e-44 Score=280.93 Aligned_cols=217 Identities=30% Similarity=0.495 Sum_probs=179.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++|+||+++++++..++..++||||++++.+..+......+++..+..++.|++.||.+||+.|+
T Consensus 42 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i 121 (287)
T cd07848 42 EVKETTLRELKMLRTLKQENIVELKEAFRRRGKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHWCHKNDI 121 (287)
T ss_pred cchhhHHHHHHHHHhCCCccccchhhhEecCCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34567889999999999999999999999999999999999887777665555679999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|+
T Consensus 122 ~H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~ 198 (287)
T cd07848 122 VHRDIKPENLLI---SHNDVLKLCDFGFARNLSEGSNANYTEYVATRWYRSPELLLGAPYGKAVDMWSVGCILGELSDGQ 198 (287)
T ss_pred ecCCCCHHHEEE---cCCCcEEEeeccCcccccccccccccccccccccCCcHHHcCCCCCCchhHHhHHHHHHHHHhCC
Confidence 999999999999 778899999999987654322 222346788999999998888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCC------------------CCCC---------CccCCCCChHHHHHHHHhcccCccccCCH
Q 026253 166 PPFSGRNNVQLVRNINSCKH------------------LPFS---------QLIVPALHPDCVDMCLKLLSANTVDRLSF 218 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~------------------~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 218 (241)
+||.+.+..+....+..... ...+ ......+|.++.+++++||+.||.+|||+
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~P~~R~s~ 278 (287)
T cd07848 199 PLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPTDRYLT 278 (287)
T ss_pred CCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCCcccCCCH
Confidence 99988765544433322110 0000 01122367889999999999999999999
Q ss_pred HHHhcCccc
Q 026253 219 NEFYHHRFL 227 (241)
Q Consensus 219 ~~il~~~~~ 227 (241)
+++++||||
T Consensus 279 ~~~l~hp~f 287 (287)
T cd07848 279 EQCLNHPAF 287 (287)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes |
| >PTZ00267 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-43 Score=295.83 Aligned_cols=216 Identities=31% Similarity=0.551 Sum_probs=190.3
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
......+.+|+.+++.++||||+++++++..++..++||||++|++|.+++.. ..++++..+..++.|++.||.+|
T Consensus 106 ~~~~~~~~~E~~~l~~l~Hpniv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~l 185 (478)
T PTZ00267 106 ERQAAYARSELHCLAACDHFGIVKHFDDFKSDDKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLALDEV 185 (478)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEEEEEEECCEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 44456788999999999999999999999999999999999999999988753 34689999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
|+.|++||||||.||++ +..+.++|+|||++....... ......+++.|+|||.+.+..++.++|+||+||++|
T Consensus 186 H~~~ivHrDlkp~NIll---~~~~~~kL~DFgla~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~~l~ 262 (478)
T PTZ00267 186 HSRKMMHRDLKSANIFL---MPTGIIKLGDFGFSKQYSDSVSLDVASSFCGTPYYLAPELWERKRYSKKADMWSLGVILY 262 (478)
T ss_pred HhCCEEECCcCHHhEEE---CCCCcEEEEeCcCceecCCccccccccccCCCccccCHhHhCCCCCCcHHhHHHHHHHHH
Confidence 99999999999999999 778899999999998654332 233456899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
+|++|..||.+.+..+....+..+...+.+ ..++.++.++|.+||+.||.+|||+++++.|+|++.
T Consensus 263 el~tg~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~Rps~~~~l~~~~~~~ 328 (478)
T PTZ00267 263 ELLTLHRPFKGPSQREIMQQVLYGKYDPFP----CPVSSGMKALLDPLLSKNPALRPTTQQLLHTEFLKY 328 (478)
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhCCCCCCC----ccCCHHHHHHHHHHhccChhhCcCHHHHHhCHHHHH
Confidence 999999999988888888777665544433 367899999999999999999999999999999975
|
|
| >cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-44 Score=287.12 Aligned_cols=214 Identities=35% Similarity=0.576 Sum_probs=189.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|++++++++|+||+++++++.+++..|+||||+++++|.+++.+...+++..+..++.|++.||.+||+.|+
T Consensus 40 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 119 (318)
T cd05582 40 RDRVRTKMERDILAEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 119 (318)
T ss_pred hhHHHHHHHHHHHHhCCCCCcccEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 34556788999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|+.
T Consensus 120 ~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~tg~~ 196 (318)
T cd05582 120 IYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGSL 196 (318)
T ss_pred ecCCCCHHHeEE---CCCCcEEEeeccCCcccCCCCCceecccCChhhcCHHHHcCCCCCCccceeccceEeeeeccCCC
Confidence 999999999999 77889999999998765433 22334568899999999988888999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 229 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~ 229 (241)
||...+..+....+.... ..++ ..++..+.++|++||+.||.+||| +++++.||||+.
T Consensus 197 p~~~~~~~~~~~~i~~~~-~~~p----~~~~~~~~~li~~~l~~~P~~R~~a~~~~~~~~~~~~~~~~ 259 (318)
T cd05582 197 PFQGKDRKETMTMILKAK-LGMP----QFLSPEAQSLLRALFKRNPANRLGAGPDGVEEIKRHPFFST 259 (318)
T ss_pred CCCCCCHHHHHHHHHcCC-CCCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhCCCCcCC
Confidence 999888887777775433 2222 367899999999999999999999 788999999976
|
Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate |
| >cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=284.34 Aligned_cols=214 Identities=30% Similarity=0.582 Sum_probs=182.6
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|..+++++ +||||+++++++.+++..++||||+++++|.+++.+.+++++..+..++.|++.||.+||++|
T Consensus 37 ~~~~~~~~e~~il~~~~~hp~Iv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ 116 (329)
T cd05588 37 EDIDWVQTEKHVFETASNHPFLVGLHSCFQTESRLFFVIEFVSGGDLMFHMQRQRKLPEEHARFYSAEISLALNFLHERG 116 (329)
T ss_pred hHHHHHHHHHHHHHhccCCCCCCceEEEEEcCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999999 799999999999999999999999999999999988889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCcccc-CCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~-~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++||||||+||++ +.++.++|+|||++... ..........++..|+|||.+.+..++.++|+||+|+++|++++|.
T Consensus 117 ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~~l~el~~g~ 193 (329)
T cd05588 117 IIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGIRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193 (329)
T ss_pred eEecCCCHHHeEE---CCCCCEEECcCccccccccCCCccccccCCccccCHHHHcCCCCCCccceechHHHHHHHHHCC
Confidence 9999999999999 77889999999998653 2223334467899999999999889999999999999999999999
Q ss_pred CCCCCCC---------hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC------HHHHhcCccccc
Q 026253 166 PPFSGRN---------NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS------FNEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~~il~~~~~~~ 229 (241)
.||.... .....+.+. ......+ ..++..+.++|++||+.||.+|+| ++++++||||+.
T Consensus 194 ~Pf~~~~~~~~~~~~~~~~~~~~~~-~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~ 267 (329)
T cd05588 194 SPFDIVGMSDNPDQNTEDYLFQVIL-EKQIRIP----RSLSVKASSVLKGFLNKDPKERLGCHPQTGFRDIKSHPFFRN 267 (329)
T ss_pred CCcccccccccccccchHHHHHHHH-cCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 9996321 112333332 2333333 367899999999999999999997 789999999986
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl |
| >cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-43 Score=282.24 Aligned_cols=216 Identities=33% Similarity=0.592 Sum_probs=189.8
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.+..+.+.+|..+++.+ +|+||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.|++.||.+||+.
T Consensus 36 ~~~~~~~~~e~~il~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 115 (318)
T cd05570 36 DDDVECTMTEKRVLALAGKHPFLTQLHSCFQTKDRLFFVMEYVNGGDLMFHIQRSGRFDEPRARFYAAEIVLGLQFLHER 115 (318)
T ss_pred hhHHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34566778899999988 79999999999999999999999999999999998888899999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
|++|+||+|+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 116 ~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslGvil~~l~~G 192 (318)
T cd05570 116 GIIYRDLKLDNVLL---DSEGHIKIADFGMCKEGILGGVTTSTFCGTPDYIAPEILSYQPYGPAVDWWALGVLLYEMLAG 192 (318)
T ss_pred CeEccCCCHHHeEE---CCCCcEEecccCCCeecCcCCCcccceecCccccCHHHhcCCCCCcchhhhhHHHHHHHHhhC
Confidence 99999999999999 7788999999999865322 2223345688999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH-----HHHhcCcccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF-----NEFYHHRFLRRN 230 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~~ 230 (241)
..||.+.+..+....+.... ..++ ..++..+.++|++||+.||.+|||+ .++++||||+..
T Consensus 193 ~~pf~~~~~~~~~~~i~~~~-~~~~----~~~~~~~~~li~~~l~~dP~~R~s~~~~~~~~ll~~~~~~~~ 258 (318)
T cd05570 193 QSPFEGDDEDELFQSILEDE-VRYP----RWLSKEAKSILKSFLTKNPEKRLGCLPTGEQDIKGHPFFREI 258 (318)
T ss_pred CCCCCCCCHHHHHHHHHcCC-CCCC----CcCCHHHHHHHHHHccCCHHHcCCCCCCCHHHHhcCCCcCCC
Confidence 99999888888777775433 2222 3678999999999999999999999 999999999873
|
Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re |
| >KOG0694 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-44 Score=293.62 Aligned_cols=216 Identities=33% Similarity=0.612 Sum_probs=197.7
Q ss_pred hhHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 5 LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+.+++.+....|.+|++.. +||.++.++..|.+.+++|+||||+.||++..+ ...+.+++..+.-++..++.||.|||
T Consensus 407 l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~~~l~fvmey~~Ggdm~~~-~~~~~F~e~rarfyaAev~l~L~fLH 485 (694)
T KOG0694|consen 407 LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTKEHLFFVMEYVAGGDLMHH-IHTDVFSEPRARFYAAEVVLGLQFLH 485 (694)
T ss_pred eccccHHHHHHHHHHHHHhccCCeEeecccccccCCeEEEEEEecCCCcEEEE-EecccccHHHHHHHHHHHHHHHHHHH
Confidence 3678889999999999999 599999999999999999999999999995544 44578999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccC-CCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
++||+|||||.+|||+ +.+|.+||.|||+++... .+..+.+.+||+.|+|||++.+..|+.+.|-|+||+++|+|+
T Consensus 486 ~~~IIYRDlKLdNiLL---D~eGh~kiADFGlcKe~m~~g~~TsTfCGTpey~aPEil~e~~Yt~aVDWW~lGVLlyeML 562 (694)
T KOG0694|consen 486 ENGIIYRDLKLDNLLL---DTEGHVKIADFGLCKEGMGQGDRTSTFCGTPEFLAPEVLTEQSYTRAVDWWGLGVLLYEML 562 (694)
T ss_pred hcCceeeecchhheEE---cccCcEEecccccccccCCCCCccccccCChhhcChhhhccCcccchhhHHHHHHHHHHHH
Confidence 9999999999999999 899999999999998765 566788899999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 229 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~ 229 (241)
.|+.||.+.+.++++..|.... ..+|. .+|.+..++++++|.++|++|.. +++|..||||+.
T Consensus 563 ~Gq~PF~gddEee~FdsI~~d~-~~yP~----~ls~ea~~il~~ll~k~p~kRLG~~e~d~~~i~~hpFFr~ 629 (694)
T KOG0694|consen 563 VGESPFPGDDEEEVFDSIVNDE-VRYPR----FLSKEAIAIMRRLLRKNPEKRLGSGERDAEDIKKHPFFRS 629 (694)
T ss_pred cCCCCCCCCCHHHHHHHHhcCC-CCCCC----cccHHHHHHHHHHhccCcccccCCCCCCchhhhhCCcccc
Confidence 9999999999999999995443 33343 78999999999999999999984 689999999998
|
|
| >cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-43 Score=279.08 Aligned_cols=214 Identities=31% Similarity=0.513 Sum_probs=177.7
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|++++++++|+||+++++++.+++..++||||+. ++|.+++...+ .+++..+..++.|++.||.+||+.|++
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 125 (288)
T cd07871 47 PCTAIREVSLLKNLKHANIVTLHDIIHTERCLTLVFEYLD-SDLKQYLDNCGNLMSMHNVKIFMFQLLRGLSYCHKRKIL 125 (288)
T ss_pred chhHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEeCCC-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 4567899999999999999999999999999999999996 59999887654 478999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
||||||+||++ +.++.++|+|||++....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|+.
T Consensus 126 H~dlkp~Nil~---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~l~~g~~ 202 (288)
T cd07871 126 HRDLKPQNLLI---NEKGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRP 202 (288)
T ss_pred cCCCCHHHEEE---CCCCCEEECcCcceeeccCCCccccCceecccccChHHhcCCcccCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 778899999999987543222 2233457889999998865 468999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCC------------------CCC-------ccCCCCChHHHHHHHHhcccCccccCCHHHH
Q 026253 167 PFSGRNNVQLVRNINSCKHLP------------------FSQ-------LIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~------------------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 221 (241)
||.+.+..+....+......+ ++. ...+.++.+..++|++||+.||.+|||++|+
T Consensus 203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dp~~R~t~~~~ 282 (288)
T cd07871 203 MFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHAPRLDTDGIDLLSSLLLYETKSRISAEAA 282 (288)
T ss_pred CCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHhCCCCCHHHHHHHHHhcCcCcccCCCHHHH
Confidence 999877766555443221111 000 0123567889999999999999999999999
Q ss_pred hcCccc
Q 026253 222 YHHRFL 227 (241)
Q Consensus 222 l~~~~~ 227 (241)
++||||
T Consensus 283 l~hp~f 288 (288)
T cd07871 283 LRHSYF 288 (288)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament |
| >cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-43 Score=282.91 Aligned_cols=214 Identities=30% Similarity=0.534 Sum_probs=188.8
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
+..+.+..|.+++..+ +||||+++++++.+++..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|
T Consensus 37 ~~~~~~~~e~~il~~~~~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 116 (321)
T cd05591 37 DDVDCTMTEKRILALAAKHPFLTALHCCFQTKDRLFFVMEYVNGGDLMFQIQRSRKFDEPRSRFYAAEVTLALMFLHRHG 116 (321)
T ss_pred hHHHHHHHHHHHHHhccCCCCccceeeEEEcCCeEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4456678899999877 899999999999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++||||||+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|+
T Consensus 117 ivHrDikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~tg~ 193 (321)
T cd05591 117 VIYRDLKLDNILL---DAEGHCKLADFGMCKEGILNGVTTTTFCGTPDYIAPEILQELEYGPSVDWWALGVLMYEMMAGQ 193 (321)
T ss_pred eeccCCCHHHeEE---CCCCCEEEeecccceecccCCccccccccCccccCHHHHcCCCCCCccceechhHHHHHHhcCC
Confidence 9999999999999 7888999999999875432 22233456889999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-------CHHHHhcCccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-------SFNEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-------s~~~il~~~~~~~ 229 (241)
.||.+.+..+....+..... ..+ ..++.++.+++.+||+.||.+|+ +++++++||||..
T Consensus 194 ~Pf~~~~~~~~~~~i~~~~~-~~p----~~~~~~~~~ll~~~L~~dp~~R~~~~~~~~~~~~~~~hp~~~~ 259 (321)
T cd05591 194 PPFEADNEDDLFESILHDDV-LYP----VWLSKEAVSILKAFMTKNPNKRLGCVASQGGEDAIKQHPFFKE 259 (321)
T ss_pred CCCCCCCHHHHHHHHHcCCC-CCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCCHHHHhcCCccCC
Confidence 99999998888887755432 222 35789999999999999999999 8999999999976
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to |
| >KOG0600 consensus Cdc2-related protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-43 Score=281.79 Aligned_cols=220 Identities=30% Similarity=0.462 Sum_probs=189.2
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l 82 (241)
++..-....+|+.||++|+||||+++.+...+. +.+|+|+|||+ -+|.-++... -.|++.++.-+.+|++.||+|+
T Consensus 156 ~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~~siYlVFeYMd-hDL~GLl~~p~vkft~~qIKc~mkQLl~Gl~~c 234 (560)
T KOG0600|consen 156 KEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLSGSIYLVFEYMD-HDLSGLLSSPGVKFTEPQIKCYMKQLLEGLEYC 234 (560)
T ss_pred CCcchHHHHHHHHHHHhcCCCcccceeeEEEecCCceEEEEEeccc-chhhhhhcCCCcccChHHHHHHHHHHHHHHHHH
Confidence 344567789999999999999999999998876 78999999996 5898888764 3699999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCccccccc-CCCCchhHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILF 159 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~ 159 (241)
|++|++|||||..|||+ ++++.+||+|||+|+.+.... .....+-|.+|.|||.+.|. .|+.+.|+||.||++.
T Consensus 235 H~~gvlHRDIK~SNiLi---dn~G~LKiaDFGLAr~y~~~~~~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS~GCIl~ 311 (560)
T KOG0600|consen 235 HSRGVLHRDIKGSNILI---DNNGVLKIADFGLARFYTPSGSAPYTSRVVTLWYRPPELLLGATSYGTAVDLWSVGCILA 311 (560)
T ss_pred hhcCeeeccccccceEE---cCCCCEEeccccceeeccCCCCcccccceEEeeccChHHhcCCcccccceeehhhhHHHH
Confidence 99999999999999999 899999999999999765543 34456679999999998765 6999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCCc------------------------cCCCCChHHHHHHHHhcccCcccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQL------------------------IVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
||++|++.|.+.+..+++..|-+-...+.... ....+++...+|+..||..||.+|
T Consensus 312 El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~~~kLP~~~~~kp~~~y~r~l~E~~~~~~~~~l~Ll~~lL~ldP~kR 391 (560)
T KOG0600|consen 312 ELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWPVSKLPHATIFKPQQPYKRRLRETFKDFPASALDLLEKLLSLDPDKR 391 (560)
T ss_pred HHHcCCCCcCCccHHHHHHHHHHHhCCCChhccccccCCcccccCCCCcccchHHHHhccCCHHHHHHHHHHhccCcccc
Confidence 99999999999999988887765432221110 134567889999999999999999
Q ss_pred CCHHHHhcCccccc
Q 026253 216 LSFNEFYHHRFLRR 229 (241)
Q Consensus 216 ps~~~il~~~~~~~ 229 (241)
.|+.++|.++||..
T Consensus 392 ~tA~~aL~seyF~t 405 (560)
T KOG0600|consen 392 GTASSALQSEYFTT 405 (560)
T ss_pred ccHHHHhcCccccc
Confidence 99999999999944
|
|
| >cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-43 Score=285.41 Aligned_cols=217 Identities=25% Similarity=0.502 Sum_probs=186.3
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|+.++.+++|++|+++++.+.++...++||||++|++|.+++.+.+.+++..+..++.|++.||.+||++|+
T Consensus 43 ~~~~~~~~E~~il~~~~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~gi 122 (363)
T cd05628 43 EQVGHIRAERDILVEADSLWVVKMFYSFQDKLNLYLIMEFLPGGDMMTLLMKKDTLTEEETQFYIAETVLAIDSIHQLGF 122 (363)
T ss_pred hHHHHHHHHHHHHHhCCCCCcceEEEEEecCCeEEEEEcCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 44567889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC------------------------------------ccccccCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCGS 131 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~------------------------------------~~~~~~~~ 131 (241)
+||||||+||++ +.++.++|+|||++....... ......||
T Consensus 123 vHrDlKp~NILi---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Gt 199 (363)
T cd05628 123 IHRDIKPDNLLL---DSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFSTVGT 199 (363)
T ss_pred EecCCCHHHeEE---CCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccccCC
Confidence 999999999999 678899999999986542210 01234689
Q ss_pred CCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCChHHHHHHHHhccc
Q 026253 132 PLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 132 ~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~ 210 (241)
+.|+|||.+.+..++.++|+||+|+++|+|++|..||.+.+..+.+..+.... ...++.. ..+++++.++|.+|+.
T Consensus 200 ~~Y~aPE~~~~~~~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~~- 276 (363)
T cd05628 200 PDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLIFPPE--VPISEKAKDLILRFCC- 276 (363)
T ss_pred ccccCHHHHcCCCCCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCcccCCCc--CCCCHHHHHHHHHHcC-
Confidence 99999999998899999999999999999999999999988888888776543 2333332 2578899999999775
Q ss_pred Ccc---ccCCHHHHhcCcccccc
Q 026253 211 NTV---DRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 211 ~p~---~Rps~~~il~~~~~~~~ 230 (241)
+|. .||+++|+++||||++.
T Consensus 277 ~~~~r~~r~~~~ei~~hp~f~~~ 299 (363)
T cd05628 277 EWEHRIGAPGVEEIKTNPFFEGV 299 (363)
T ss_pred ChhhcCCCCCHHHHhCCCCCCCC
Confidence 444 45899999999999874
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus |
| >KOG0605 consensus NDR and related serine/threonine kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-43 Score=280.74 Aligned_cols=218 Identities=31% Similarity=0.599 Sum_probs=193.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+-++.|-.+|...+++.||++|..|.+...+||||||++||++..+|.+.+.++++.+..++.+++.|+..+|+.
T Consensus 181 ~~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~~~LYLiMEylPGGD~mTLL~~~~~L~e~~arfYiaE~vlAI~~iH~~ 260 (550)
T KOG0605|consen 181 KKNQVEHVRAERDILAEVDSPWVVKLYYSFQDKEYLYLIMEYLPGGDMMTLLMRKDTLTEDWARFYIAETVLAIESIHQL 260 (550)
T ss_pred hhhhHHHHHHHHHHhhhcCCCcEEEEEEEecCCCeeEEEEEecCCccHHHHHHhcCcCchHHHHHHHHHHHHHHHHHHHc
Confidence 45567788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCC----------------------CC-c------------------
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP----------------------GN-Y------------------ 124 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~----------------------~~-~------------------ 124 (241)
|++||||||+|+|+ +..|++||.|||++.-... .. .
T Consensus 261 gyIHRDIKPdNlLi---D~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~w 337 (550)
T KOG0605|consen 261 GYIHRDIKPDNLLI---DAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRREQLQTW 337 (550)
T ss_pred CcccccCChhheee---cCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHHHHHHH
Confidence 99999999999999 8999999999999743211 00 0
Q ss_pred -------cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCC
Q 026253 125 -------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPAL 196 (241)
Q Consensus 125 -------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~ 196 (241)
.....|||-|+|||++.+..|+...|.|||||++|||+.|.+||.+.++.+.+++|.... ...+|... .+
T Consensus 338 ~~nrr~~a~StVGTPDYiAPEVll~kgY~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~fP~~~--~~ 415 (550)
T KOG0605|consen 338 KRNRRQLAYSTVGTPDYIAPEVLLGKGYGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLKFPEEV--DL 415 (550)
T ss_pred HhhhhhhhhcccCCccccchHHHhcCCCCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhccCCCcC--cc
Confidence 002468999999999999999999999999999999999999999999999999987655 23344432 67
Q ss_pred ChHHHHHHHHhcccCccccCC---HHHHhcCccccc
Q 026253 197 HPDCVDMCLKLLSANTVDRLS---FNEFYHHRFLRR 229 (241)
Q Consensus 197 ~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~ 229 (241)
+.+..|+|.+||. ||.+|.. ++||-+||||++
T Consensus 416 s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~ 450 (550)
T KOG0605|consen 416 SDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG 450 (550)
T ss_pred cHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence 7999999999999 9999984 999999999998
|
|
| >KOG0201 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-46 Score=289.35 Aligned_cols=219 Identities=28% Similarity=0.497 Sum_probs=194.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
..++...+.+|+.++.+++++||.++|+.|..+..++++||||.||++.+.++....+.+..+.-++++++.|+.|||.+
T Consensus 51 ~~deIediqqei~~Ls~~~~~~it~yygsyl~g~~LwiiMey~~gGsv~~lL~~~~~~~E~~i~~ilre~l~~l~ylH~~ 130 (467)
T KOG0201|consen 51 AEDEIEDIQQEISVLSQCDSPNITEYYGSYLKGTKLWIIMEYCGGGSVLDLLKSGNILDEFEIAVILREVLKGLDYLHSE 130 (467)
T ss_pred cchhhHHHHHHHHHHHhcCcchHHhhhhheeecccHHHHHHHhcCcchhhhhccCCCCccceeeeehHHHHHHhhhhhhc
Confidence 34567789999999999999999999999999999999999999999999999877779999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
+.+|+|||+.||++ ...+.++|+|||.+........ ..+..||+.|||||++.+..|+.++|+||||++++||++|
T Consensus 131 ~kiHrDIKaanil~---s~~g~vkl~DfgVa~ql~~~~~rr~tfvGTPfwMAPEVI~~~~Y~~KADIWSLGITaiEla~G 207 (467)
T KOG0201|consen 131 KKIHRDIKAANILL---SESGDVKLADFGVAGQLTNTVKRRKTFVGTPFWMAPEVIKQSGYDTKADIWSLGITAIELAKG 207 (467)
T ss_pred ceecccccccceeE---eccCcEEEEecceeeeeechhhccccccccccccchhhhccccccchhhhhhhhHHHHHHhcC
Confidence 99999999999999 5669999999999987765433 3678899999999999988999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
.+|+....+...+-.|-+.. |+.+...+|..+++|+..||++||+.||||.++|+|+|++..+
T Consensus 208 ePP~s~~hPmrvlflIpk~~----PP~L~~~~S~~~kEFV~~CL~k~P~~RpsA~~LLKh~FIk~a~ 270 (467)
T KOG0201|consen 208 EPPHSKLHPMRVLFLIPKSA----PPRLDGDFSPPFKEFVEACLDKNPEFRPSAKELLKHKFIKRAK 270 (467)
T ss_pred CCCCcccCcceEEEeccCCC----CCccccccCHHHHHHHHHHhhcCcccCcCHHHHhhhHHHHhcC
Confidence 99999988855554443332 2333348899999999999999999999999999999999844
|
|
| >cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-43 Score=275.61 Aligned_cols=217 Identities=32% Similarity=0.469 Sum_probs=179.9
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.+.+..|++++++++|+||+++.+++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.+||+.
T Consensus 37 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 116 (280)
T cd05608 37 YEGAMVEKRILAKVHSRFIVSLAYAFQTKTDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISGLEHLHQR 116 (280)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeEEEcCCCeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 35678899999999999999999999999999999999999999988743 34689999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
|++|+||+|.||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 117 ~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g 193 (280)
T cd05608 117 RIIYRDLKPENVLL---DNDGNVRISDLGLAVELKDGQSKTKGYAGTPGFMAPELLQGEEYDFSVDYFALGVTLYEMIAA 193 (280)
T ss_pred CcccCCCCHHHEEE---CCCCCEEEeeCccceecCCCCccccccCCCcCccCHHHhcCCCCCccccHHHHHHHHHHHHhC
Confidence 99999999999999 6788899999999876543322 2334678899999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCcccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 230 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~ 230 (241)
..||...+.......+.... ...+......++..+.+++.+||+.||.+|| +++++++||||++.
T Consensus 194 ~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~l~h~~~~~~ 263 (280)
T cd05608 194 RGPFRARGEKVENKELKQRI-LNDSVTYPDKFSPASKSFCEALLAKDPEKRLGFRDGNCDGLRTHPLFRDL 263 (280)
T ss_pred CCCCCCCCcchhHHHHHHhh-cccCCCCcccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHhcChhhhcC
Confidence 99998654322111111111 1111223346899999999999999999999 88999999999883
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g |
| >cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-43 Score=274.54 Aligned_cols=213 Identities=29% Similarity=0.492 Sum_probs=179.0
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+.+..|++++++++||||+++.+.++++...++||||++|++|.+++.... .+++..+..++.|++.|+++||+.|+
T Consensus 37 ~~~~~~E~~il~~l~hp~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 116 (277)
T cd05607 37 EKMALLEKEILEKVNSPFIVNLAYAFESKTHLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGILHLHSMDI 116 (277)
T ss_pred hHHHHHHHHHHHhcCCCcEEEEEEEEecCCeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 4456779999999999999999999999999999999999999999886543 48899999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|.||++ +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 117 vH~dikp~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslGv~l~el~~g~~p 193 (277)
T cd05607 117 VYRDMKPENVLL---DDQGNCRLSDLGLAVELKDGKTITQRAGTNGYMAPEILKEEPYSYPVDWFAMGCSIYEMVAGRTP 193 (277)
T ss_pred EEccCChHhEEE---cCCCCEEEeeceeeeecCCCceeeccCCCCCccCHHHHccCCCCCchhHHHHHHHHHHHHhCCCC
Confidence 999999999999 67888999999998776544433445678899999999888899999999999999999999999
Q ss_pred CCCCCh----HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH----HHHhcCccccc
Q 026253 168 FSGRNN----VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF----NEFYHHRFLRR 229 (241)
Q Consensus 168 ~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~il~~~~~~~ 229 (241)
|..... .+........ ..... ...++.++.+++++||+.||.+||++ ++++.||||+.
T Consensus 194 ~~~~~~~~~~~~~~~~~~~~-~~~~~---~~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~~~~h~~f~~ 259 (277)
T cd05607 194 FKDHKEKVAKEELKRRTLED-EVKFE---HQNFTEESKDICRLFLAKKPEDRLGSREKNDDPRKHEFFKT 259 (277)
T ss_pred CCCCcchhhHHHHHHHhhcc-ccccc---cccCCHHHHHHHHHHhccCHhhCCCCccchhhhhcChhhcC
Confidence 976432 2222222211 11111 23678999999999999999999999 77889999976
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr |
| >cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-43 Score=276.24 Aligned_cols=216 Identities=29% Similarity=0.455 Sum_probs=183.1
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+|+++++.++|+||+++++.+.+++..++||||+++++|.+++... ..+++..+..++.|++.|+.+||+.|+
T Consensus 44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05605 44 EAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLEDLHRERI 123 (285)
T ss_pred HHHHHHHHHHHHhcCCCCEeeeeeeecCCCeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 455778999999999999999999999999999999999999999988654 358999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|.||++ ++.+.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 124 vH~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Diws~G~~l~el~~g~~p 200 (285)
T cd05605 124 VYRDLKPENILL---DDYGHIRISDLGLAVEIPEGETIRGRVGTVGYMAPEVVKNERYTFSPDWWGLGCLIYEMIEGKSP 200 (285)
T ss_pred EecCCCHHHEEE---CCCCCEEEeeCCCceecCCCCccccccCCCCccCcHHhcCCCCCccccchhHHHHHHHHHHCCCC
Confidence 999999999999 77889999999998765443333445678999999999888899999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
|.+.+.......+..... .........++..+.+++.+||+.||.+|| +++++++||||+.
T Consensus 201 f~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~ 266 (285)
T cd05605 201 FRQRKEKVKREEVERRVK-EDQEEYSEKFSEAARSICRQLLTKDPGFRLGCRGEGAEEVKAHPFFRT 266 (285)
T ss_pred CCCCchhhHHHHHHHHhh-hcccccCcccCHHHHHHHHHHccCCHHHhcCCCCCCHHHHhcCcCccC
Confidence 987665443333321111 111223346889999999999999999999 8999999999997
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, |
| >cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=286.81 Aligned_cols=216 Identities=35% Similarity=0.656 Sum_probs=189.7
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|++++..++|+||+++++.+.+++..++||||+.+++|.+++.+.+.+++..+..++.|++.||++||+.|+
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi 122 (350)
T cd05573 43 NQIAHVRAERDILADADSPWIVKLYYSFQDEEHLYLVMEYMPGGDLMNLLIRKDVFPEETARFYIAELVLALDSVHKLGF 122 (350)
T ss_pred cHHHHHHHHHHHHHhcCCCCccchhhheecCCeEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45677899999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC------------------------------ccccccCCCCccCc
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------YAEKVCGSPLYMAP 137 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~------------------------------~~~~~~~~~~~~~P 137 (241)
+|+||||+||++ +.++.++|+|||++....... ......+++.|+||
T Consensus 123 iH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aP 199 (350)
T cd05573 123 IHRDIKPDNILI---DADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPDYIAP 199 (350)
T ss_pred eccCCCHHHeEE---CCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCccccCH
Confidence 999999999999 788899999999987654432 22334688999999
Q ss_pred ccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCChHHHHHHHHhcccCccccC
Q 026253 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRL 216 (241)
Q Consensus 138 E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 216 (241)
|.+.+..++.++|+|||||++|+|++|..||...+..+....+.... ....+. ...+++++.++|.+||. ||.+||
T Consensus 200 E~~~~~~~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~~~~~~~li~~ll~-dp~~R~ 276 (350)
T cd05573 200 EVLRGTPYGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFPP--DPPVSPEAIDLICRLLC-DPEDRL 276 (350)
T ss_pred HHHcCCCCCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCCC--CCCCCHHHHHHHHHHcc-ChhhcC
Confidence 99999999999999999999999999999999888877777665522 122222 12479999999999997 999999
Q ss_pred C-HHHHhcCccccc
Q 026253 217 S-FNEFYHHRFLRR 229 (241)
Q Consensus 217 s-~~~il~~~~~~~ 229 (241)
+ ++++++||||++
T Consensus 277 ~s~~~ll~hp~~~~ 290 (350)
T cd05573 277 GSFEEIKSHPFFKG 290 (350)
T ss_pred CCHHHHhcCCCcCC
Confidence 9 999999999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the |
| >cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-43 Score=279.56 Aligned_cols=215 Identities=33% Similarity=0.544 Sum_probs=186.9
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+..|..++..+ +|++|+++++++.+++..++||||+.+++|.+++...+.+++..+..++.|++.||++||+.|
T Consensus 37 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 116 (316)
T cd05620 37 DDVECTMVEKRVLALAWENPFLTHLYCTFQTKEHLFFVMEFLNGGDLMFHIQDKGRFDLYRATFYAAEIVCGLQFLHSKG 116 (316)
T ss_pred chHHHHHHHHHHHHhccCCCCccCeeEEEEeCCEEEEEECCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456677788888765 899999999999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++||||||+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 117 ivHrDlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~el~~g~ 193 (316)
T cd05620 117 IIYRDLKLDNVML---DRDGHIKIADFGMCKENVFGDNRASTFCGTPDYIAPEILQGLKYTFSVDWWSFGVLLYEMLIGQ 193 (316)
T ss_pred eEecCCCHHHeEE---CCCCCEEeCccCCCeecccCCCceeccCCCcCccCHHHHcCCCCCcccchhhhHHHHHHHHhCC
Confidence 9999999999999 7788999999999864321 22234456899999999999889999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH-HHHhcCcccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF-NEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~~~~~~~ 230 (241)
.||.+.+..+..+.+.... ...+ ..++.++.+++++||+.||.+||++ +++++||||+..
T Consensus 194 ~Pf~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~li~~~l~~dP~~R~~~~~~~~~h~~f~~~ 254 (316)
T cd05620 194 SPFHGDDEDELFESIRVDT-PHYP----RWITKESKDILEKLFERDPTRRLGVVGNIRGHPFFKTI 254 (316)
T ss_pred CCCCCCCHHHHHHHHHhCC-CCCC----CCCCHHHHHHHHHHccCCHHHcCCChHHHHcCCCcCCC
Confidence 9999888888877775432 2222 3578999999999999999999997 589999999874
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I |
| >cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-43 Score=287.39 Aligned_cols=218 Identities=31% Similarity=0.559 Sum_probs=185.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.+..+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++...+.+++..+..++.|++.||++||+.|
T Consensus 42 ~~~~~~~~~E~~il~~l~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~g 121 (377)
T cd05629 42 KDQLAHVKAERDVLAESDSPWVVSLYYSFQDAQYLYLIMEFLPGGDLMTMLIKYDTFSEDVTRFYMAECVLAIEAVHKLG 121 (377)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCeeEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34567789999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-------------------------------------------
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------------- 123 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~------------------------------------------- 123 (241)
++||||||+||++ +.++.++|+|||+++......
T Consensus 122 ivHrDlkp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (377)
T cd05629 122 FIHRDIKPDNILI---DRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIATWK 198 (377)
T ss_pred eeccCCCHHHEEE---CCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhhhh
Confidence 9999999999999 678899999999986321100
Q ss_pred -----ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCC
Q 026253 124 -----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALH 197 (241)
Q Consensus 124 -----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ 197 (241)
......+++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+.+..+.... ...++. ...++
T Consensus 199 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~s 276 (377)
T cd05629 199 KNRRLMAYSTVGTPDYIAPEIFLQQGYGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLYFPD--DIHLS 276 (377)
T ss_pred hcccccccccCCCccccCHHHHccCCCCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccCCCC--CCCCC
Confidence 0012358899999999998889999999999999999999999999888877777665432 222222 12578
Q ss_pred hHHHHHHHHhcccCcccc---CCHHHHhcCcccccc
Q 026253 198 PDCVDMCLKLLSANTVDR---LSFNEFYHHRFLRRN 230 (241)
Q Consensus 198 ~~~~~li~~~l~~~p~~R---ps~~~il~~~~~~~~ 230 (241)
.++.++|.+||. +|.+| +|+.+++.||||++.
T Consensus 277 ~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~~ 311 (377)
T cd05629 277 VEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRGV 311 (377)
T ss_pred HHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 899999999997 77775 599999999999863
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of |
| >cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-43 Score=281.31 Aligned_cols=211 Identities=34% Similarity=0.592 Sum_probs=183.5
Q ss_pred hhHHHHHH-HHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 11 SCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 11 ~~~~~E~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
..+.+|.. +++.++||||+++++.+..++..++||||+++++|.+++.+.+.+++..+..++.|++.||.+||++|++|
T Consensus 40 ~~~~~e~~~~~~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~givH 119 (323)
T cd05575 40 KHIMAERNVLLKNVKHPFLVGLHYSFQTADKLYFVLDYVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSLNIIY 119 (323)
T ss_pred HHHHHHHHHHHhhCCCCCCCCeeEEEEeCCEEEEEEcCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 34445544 56788999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 168 (241)
|||||.||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 120 ~dikp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~g~~pf 196 (323)
T cd05575 120 RDLKPENILL---DSQGHVVLTDFGLCKEGIEHSKTTSTFCGTPEYLAPEVLRKQPYDRTVDWWCLGAVLYEMLYGLPPF 196 (323)
T ss_pred CCCCHHHeEE---CCCCcEEEeccCCCcccccCCCccccccCChhhcChhhhcCCCCCccccccccchhhhhhhcCCCCC
Confidence 9999999999 7888999999999865322 22333456899999999999888999999999999999999999999
Q ss_pred CCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH----HHHhcCccccc
Q 026253 169 SGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF----NEFYHHRFLRR 229 (241)
Q Consensus 169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~il~~~~~~~ 229 (241)
.+.+..+....+..... ...+.++..+.++|++||+.||.+||++ .++++||||..
T Consensus 197 ~~~~~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~il~~~~~~~ 256 (323)
T cd05575 197 YSRDTAEMYDNILNKPL-----RLKPNISVSARHLLEGLLQKDRTKRLGAKDDFLEIKNHVFFSS 256 (323)
T ss_pred CCCCHHHHHHHHHcCCC-----CCCCCCCHHHHHHHHHHhhcCHHhCCCCCCCHHHHHcCCCcCC
Confidence 99888887777754332 2234679999999999999999999987 69999999976
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr |
| >cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-43 Score=285.87 Aligned_cols=217 Identities=31% Similarity=0.604 Sum_probs=187.7
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|+++++.++|+||+++++.+.+++..++||||+.+++|.+++...+.+++..+..++.|++.||.+||+.|+
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~lH~~~i 122 (364)
T cd05599 43 EQVAHVRAERDILAEADNPWVVKLYYSFQDENYLYLIMEYLPGGDMMTLLMKKDTFTEEETRFYIAETILAIDSIHKLGY 122 (364)
T ss_pred hHHHHHHHHHHHHHhCCCCCCcceEEEEEcCCeEEEEECCCCCcHHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 44567889999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---------------------------------------ccccc
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------------------------------------YAEKV 128 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---------------------------------------~~~~~ 128 (241)
+||||||+||++ +.++.++|+|||++....... .....
T Consensus 123 vH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (364)
T cd05599 123 IHRDIKPDNLLL---DAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALAYST 199 (364)
T ss_pred EeccCCHHHeEE---CCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhccccccccc
Confidence 999999999999 788899999999986542211 00123
Q ss_pred cCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCC-CCCCCccCCCCChHHHHHHHHh
Q 026253 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKH-LPFSQLIVPALHPDCVDMCLKL 207 (241)
Q Consensus 129 ~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~li~~~ 207 (241)
.||+.|+|||.+.+..++.++|+|||||++|+|++|..||.+.+..+....+..... ...+. ...+++++.++|++|
T Consensus 200 ~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~l 277 (364)
T cd05599 200 VGTPDYIAPEVFLQTGYNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQFPD--EVPLSPEAKDLIKRL 277 (364)
T ss_pred ccCccccCHHHHcCCCCCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccCCCC--CCCCCHHHHHHHHHH
Confidence 588999999999988899999999999999999999999999888877776654332 22222 125789999999999
Q ss_pred cccCccccCC---HHHHhcCcccccc
Q 026253 208 LSANTVDRLS---FNEFYHHRFLRRN 230 (241)
Q Consensus 208 l~~~p~~Rps---~~~il~~~~~~~~ 230 (241)
+. +|.+|++ ++++++||||+..
T Consensus 278 l~-~p~~R~~~~~~~~ll~h~~~~~~ 302 (364)
T cd05599 278 CC-EAERRLGNNGVNEIKSHPFFKGV 302 (364)
T ss_pred cc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence 97 9999998 9999999999864
|
Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica |
| >KOG0658 consensus Glycogen synthase kinase-3 [Carbohydrate transport and metabolism] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-44 Score=275.63 Aligned_cols=218 Identities=34% Similarity=0.528 Sum_probs=188.3
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeec--C---eEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--N---CIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~---~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~ 80 (241)
.+.-.+|+++++.++||||+++..+|... + ...+||||+ ..+|.++++. +.+++.-.+.-+.+||++||+
T Consensus 61 ~r~knrEl~im~~l~HpNIV~L~~~f~~~~~~d~~~lnlVleym-P~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~ 139 (364)
T KOG0658|consen 61 KRYKNRELQIMRKLDHPNIVRLLYFFSSSTESDEVYLNLVLEYM-PETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLA 139 (364)
T ss_pred CCcCcHHHHHHHhcCCcCeeeEEEEEEecCCCchhHHHHHHHhc-hHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHH
Confidence 44567899999999999999999887643 2 356999999 5799999874 456888899999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccccc-CCCCchhHHHHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILF 159 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~ 159 (241)
|||+.||+||||||.|+|++ .+.+.+||||||.|+....+.....+..+..|.|||.+.+. .|+.+.|+||.||++.
T Consensus 140 yLh~~~IcHRDIKPqNlLvD--~~tg~LKicDFGSAK~L~~~epniSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~a 217 (364)
T KOG0658|consen 140 YLHSHGICHRDIKPQNLLVD--PDTGVLKICDFGSAKVLVKGEPNISYICSRYYRAPELIFGATEYTTSIDIWSAGCVMA 217 (364)
T ss_pred HHHhcCcccCCCChheEEEc--CCCCeEEeccCCcceeeccCCCceeEEEeccccCHHHHcCccccCceeEEhhhhHHHH
Confidence 99999999999999999996 67799999999999999888888888899999999998764 6999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCC------------------------CccCCCCChHHHHHHHHhcccCcccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFS------------------------QLIVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
||+.|++.|.|.+...++..|.+....+.. +......+++..+|+.++|..+|.+|
T Consensus 218 ELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y~~~~~p~ik~~~~~~~~~~~~~~d~~dll~~~L~Y~P~~R 297 (364)
T KOG0658|consen 218 ELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNYTEFKFPQIKAHPWHKVFFKRLPPDALDLLSKLLQYSPSKR 297 (364)
T ss_pred HHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCcccccccCcccccccceeecccCCCHHHHHHHHHHhccChhhc
Confidence 999999999999888777766553322211 11345678899999999999999999
Q ss_pred CCHHHHhcCcccccc
Q 026253 216 LSFNEFYHHRFLRRN 230 (241)
Q Consensus 216 ps~~~il~~~~~~~~ 230 (241)
.++.|++.||||...
T Consensus 298 ~~~~~~l~h~fFdel 312 (364)
T KOG0658|consen 298 LSALEALAHPFFDEL 312 (364)
T ss_pred CCHHHHhcchhhHHh
Confidence 999999999999873
|
|
| >cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=279.27 Aligned_cols=222 Identities=30% Similarity=0.480 Sum_probs=183.6
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH- 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~- 85 (241)
......+.+|++++++++|+||+++++++.+++..++||||+.+++|.+++...+.+++..+..++.+++.|+.|||+.
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~~ 123 (333)
T cd06650 44 PAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREKH 123 (333)
T ss_pred HHHHHHHHHHHHHHHHCCCCcccceeEEEEECCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 4456779999999999999999999999999999999999999999999999888899999999999999999999985
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+++|+||||+||++ +.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||+|+++|++++|.
T Consensus 124 ~ivH~dlkp~Nili---~~~~~~kL~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~ 199 (333)
T cd06650 124 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAIGR 199 (333)
T ss_pred CEEecCCChhhEEE---cCCCCEEEeeCCcchhhhhh-ccccCCCCccccCHHHhcCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 79999999999999 67788999999998655332 223346788999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCC-----------------------------------------CCCCCCccCCCCChHHHHHH
Q 026253 166 PPFSGRNNVQLVRNINSCK-----------------------------------------HLPFSQLIVPALHPDCVDMC 204 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~-----------------------------------------~~~~~~~~~~~~~~~~~~li 204 (241)
.||......+....+.... ....+......++.++.+++
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 279 (333)
T cd06650 200 YPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFV 279 (333)
T ss_pred CCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCcCHHHHHHH
Confidence 9998655443322211000 00000111123677899999
Q ss_pred HHhcccCccccCCHHHHhcCcccccccc
Q 026253 205 LKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 205 ~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
.+||+.||++|||++|++.||||+....
T Consensus 280 ~~~L~~~P~~Rpt~~ell~h~~~~~~~~ 307 (333)
T cd06650 280 NKCLIKNPAERADLKQLMVHAFIKRSEA 307 (333)
T ss_pred HHhccCCcccCcCHHHHhhCHHHhcCcc
Confidence 9999999999999999999999988643
|
Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst |
| >KOG0611 consensus Predicted serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-43 Score=273.41 Aligned_cols=215 Identities=33% Similarity=0.624 Sum_probs=200.2
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
++++.-.+++|++|++.|+||||+.+|+.|+..+...+||||..+|.|.||+.+++++++.....+.+||.+|+.|+|.+
T Consensus 93 deqDlvhIRREIeIMSsLNHPhII~IyEVFENkdKIvivMEYaS~GeLYDYiSer~~LsErEaRhfFRQIvSAVhYCHkn 172 (668)
T KOG0611|consen 93 DEQDLVHIRREIEIMSSLNHPHIIQIYEVFENKDKIVIVMEYASGGELYDYISERGSLSEREARHFFRQIVSAVHYCHKN 172 (668)
T ss_pred cHHHHHHHHHHHHHHhhcCCCceeehhhhhcCCceEEEEEEecCCccHHHHHHHhccccHHHHHHHHHHHHHHHHHHhhc
Confidence 45556789999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g 164 (241)
+++|||||.+|||+ +.++.+||.|||++..+.........+|++.|.+||.+.+.+| ++..|.||||+++|.+..|
T Consensus 173 rVvHRDLKLENILL---D~N~NiKIADFGLSNly~~~kfLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLLYtLVyG 249 (668)
T KOG0611|consen 173 RVVHRDLKLENILL---DQNNNIKIADFGLSNLYADKKFLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLLYTLVYG 249 (668)
T ss_pred cceecccchhheee---cCCCCeeeeccchhhhhccccHHHHhcCCcccCCccccCCCCCCCCccchhhHHHHHHHHhhc
Confidence 99999999999999 8899999999999988888888888999999999999999987 6899999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
.+||++.+...+.++|..+..... .-+....-+|+.||-+||.+|-|+++|-.|=|.+=
T Consensus 250 tMPFDG~Dhk~lvrQIs~GaYrEP------~~PSdA~gLIRwmLmVNP~RRATieDiAsHWWvNw 308 (668)
T KOG0611|consen 250 TMPFDGRDHKRLVRQISRGAYREP------ETPSDASGLIRWMLMVNPERRATIEDIASHWWVNW 308 (668)
T ss_pred ccccCCchHHHHHHHhhcccccCC------CCCchHHHHHHHHHhcCcccchhHHHHhhhheeec
Confidence 999999999999999988765443 34678889999999999999999999999988753
|
|
| >cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=278.07 Aligned_cols=214 Identities=36% Similarity=0.596 Sum_probs=185.6
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+..|..++..+ +||||+++++++..++..++||||++|++|.+++...+.+++..+..++.|++.||.+||+.|+
T Consensus 38 ~~~~~~~e~~~l~~~~~hp~i~~~~~~~~~~~~~~lv~e~~~gg~L~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i 117 (316)
T cd05592 38 DVECTMVERRVLALAWEHPFLTHLFCTFQTKEHLFFVMEYLNGGDLMFHIQSSGRFDEARARFYAAEIICGLQFLHKKGI 117 (316)
T ss_pred hHHHHHHHHHHHHhccCCCCccceeeEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 345566677777765 8999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+||||||+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 118 vH~dlkp~Nill---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~ell~G~~ 194 (316)
T cd05592 118 IYRDLKLDNVLL---DKDGHIKIADFGMCKENMNGEGKASTFCGTPDYIAPEILKGQKYNESVDWWSFGVLLYEMLIGQS 194 (316)
T ss_pred EeCCCCHHHeEE---CCCCCEEEccCcCCeECCCCCCccccccCCccccCHHHHcCCCCCCcccchhHHHHHHHHHhCCC
Confidence 999999999999 7888999999999875432 223344568999999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH-HHHhcCcccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF-NEFYHHRFLRRN 230 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-~~il~~~~~~~~ 230 (241)
||.+.+..+....+... ...+ ...++.++.+++.+||+.||.+||++ .++++||||+..
T Consensus 195 Pf~~~~~~~~~~~i~~~-~~~~----~~~~~~~~~~ll~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05592 195 PFHGEDEDELFDSILND-RPHF----PRWISKEAKDCLSKLFERDPTKRLGVDGDIRQHPFFRGI 254 (316)
T ss_pred CCCCCCHHHHHHHHHcC-CCCC----CCCCCHHHHHHHHHHccCCHHHcCCChHHHHcCcccCCC
Confidence 99998888888777443 2222 23688999999999999999999986 589999999863
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp |
| >cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.9e-43 Score=279.90 Aligned_cols=214 Identities=29% Similarity=0.566 Sum_probs=181.5
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|+.++.++ +||||+++++++..++..++||||+++++|.+++...+.+++..+..++.|++.|+.+||++|
T Consensus 37 ~~~~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~~~ 116 (329)
T cd05618 37 EDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHERG 116 (329)
T ss_pred hHHHHHHHHHHHHHhcCCCCcCCceeeEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456688899998887 899999999999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++||||||+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 117 ivH~Dikp~Nili---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~ 193 (329)
T cd05618 117 IIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGR 193 (329)
T ss_pred eeeCCCCHHHEEE---CCCCCEEEeeCCccccccCCCCccccccCCccccCHHHHcCCCCCCccceecccHHHHHHhhCC
Confidence 9999999999999 7888999999999865322 22333456899999999999889999999999999999999999
Q ss_pred CCCCCC---------ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC------HHHHhcCccccc
Q 026253 166 PPFSGR---------NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS------FNEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~~il~~~~~~~ 229 (241)
.||... ......+.+ ......++ ..++..+.+++++||+.||.+||| +.++++||||+.
T Consensus 194 ~Pf~~~~~~~~~~~~~~~~~~~~i-~~~~~~~p----~~~~~~~~~ll~~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~ 267 (329)
T cd05618 194 SPFDIVGSSDNPDQNTEDYLFQVI-LEKQIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 267 (329)
T ss_pred CCCccCCCcCCcccccHHHHHHHH-hcCCCCCC----CCCCHHHHHHHHHHhcCCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence 999521 112233333 22333333 377899999999999999999998 589999999976
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o |
| >cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-42 Score=268.49 Aligned_cols=213 Identities=28% Similarity=0.532 Sum_probs=184.5
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|++++++++||||+++++++.++...++++|++++++|.+++...+.+++..+..++.|++.|+.+||+.|++
T Consensus 47 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 126 (263)
T cd06625 47 EVNALECEIQLLKNLQHERIVQYYGCLRDDETLSIFMEYMPGGSVKDQLKAYGALTETVTRKYTRQILEGVEYLHSNMIV 126 (263)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeeEEEEccCCeEEEEEEECCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 35678999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc----ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
|+||+|.||++ ++++.++|+|||.+......... ....++..|+|||.+.+..++.++|+||+|+++|++++|
T Consensus 127 H~dl~p~nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~g 203 (263)
T cd06625 127 HRDIKGANILR---DSAGNVKLGDFGASKRLQTICSSGTGMKSVTGTPYWMSPEVISGEGYGRKADVWSVGCTVVEMLTE 203 (263)
T ss_pred cCCCCHHHEEE---cCCCCEEEeecccceeccccccccccccCCCcCccccCcceeccCCCCchhhhHHHHHHHHHHHhC
Confidence 99999999999 67888999999998765432111 234567889999999988899999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+.||...+.......+...... ......++..+.+++++||..+|.+|||+.++++||||
T Consensus 204 ~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 263 (263)
T cd06625 204 KPPWAEFEAMAAIFKIATQPTN---PQLPSHVSPDARNFLRRTFVENAKKRPSAEELLRHFFV 263 (263)
T ss_pred CCCccccchHHHHHHHhccCCC---CCCCccCCHHHHHHHHHHhhcCcccCCCHHHHhhCCCC
Confidence 9999877666555544333221 22334788999999999999999999999999999997
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t |
| >PHA03212 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-42 Score=284.89 Aligned_cols=224 Identities=23% Similarity=0.310 Sum_probs=178.8
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
...+.+|++++++++||||+++++++..++..++|+|++ +++|..++.....+++..+..++.|++.||.|||+.|++|
T Consensus 127 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~l~~~~~~~i~~qi~~aL~ylH~~~IvH 205 (391)
T PHA03212 127 RGGTATEAHILRAINHPSIIQLKGTFTYNKFTCLILPRY-KTDLYCYLAAKRNIAICDILAIERSVLRAIQYLHENRIIH 205 (391)
T ss_pred hhhhHHHHHHHHhCCCCCCCCEeEEEEECCeeEEEEecC-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Confidence 456789999999999999999999999999999999999 5799999988788999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCC--CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~--~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|||||+||++ +..+.++|+|||++...... .......+|+.|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 206 rDiKP~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~p 282 (391)
T PHA03212 206 RDIKAENIFI---NHPGDVCLGDFGAACFPVDINANKYYGWAGTIATNAPELLARDPYGPAVDIWSAGIVLFEMATCHDS 282 (391)
T ss_pred CCCChHhEEE---cCCCCEEEEeCCcccccccccccccccccCccCCCChhhhcCCCCCcHHHHHHHHHHHHHHHHCCCC
Confidence 9999999999 67888999999998654322 122345689999999999988999999999999999999999987
Q ss_pred CCCCC-------hHHHHHHhhcCCC---------------------------CCCCC---ccCCCCChHHHHHHHHhccc
Q 026253 168 FSGRN-------NVQLVRNINSCKH---------------------------LPFSQ---LIVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 168 ~~~~~-------~~~~~~~i~~~~~---------------------------~~~~~---~~~~~~~~~~~~li~~~l~~ 210 (241)
|...+ ....+..+..... .+... .....++.++.++|++||+.
T Consensus 283 ~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~Li~~mL~~ 362 (391)
T PHA03212 283 LFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLICKMLAF 362 (391)
T ss_pred cCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhHHHHHHHHhcC
Confidence 64321 1111111111000 00000 00113566899999999999
Q ss_pred CccccCCHHHHhcCcccccccccCCCC
Q 026253 211 NTVDRLSFNEFYHHRFLRRNSAILRAP 237 (241)
Q Consensus 211 ~p~~Rps~~~il~~~~~~~~~~~~~~~ 237 (241)
||.+|||++|+|+||||+........|
T Consensus 363 dP~~Rpta~elL~hp~f~~~~~~~~~~ 389 (391)
T PHA03212 363 DAHHRPSAEALLDFAAFQDIPDPYPNP 389 (391)
T ss_pred ChhhCCCHHHHhcChhhccCCCCCCCC
Confidence 999999999999999998855444333
|
|
| >KOG0610 consensus Putative serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=268.12 Aligned_cols=219 Identities=32% Similarity=0.532 Sum_probs=191.6
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+.+...++..|-+||+.++||.++++|+.++++...|++||||.||+|..+.+++ +.+++..+.-++..++.||+|||
T Consensus 117 ~rkKl~Ra~tE~eIL~~lDHPFlPTLYa~fet~~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~ALEYLH 196 (459)
T KOG0610|consen 117 SRKKLKRAQTEREILSLLDHPFLPTLYASFETDKYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLALEYLH 196 (459)
T ss_pred hhhHHHHHHHHHHHHHhcCCCccchhhheeeccceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHHHHHH
Confidence 3555678889999999999999999999999999999999999999999999876 45999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC--------------------------------C-c------
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------------------------------N-Y------ 124 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~--------------------------------~-~------ 124 (241)
-.||++|||||+|||+ .++|++.|.||.++...... . .
T Consensus 197 mlGivYRDLKPENILv---redGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~~ 273 (459)
T KOG0610|consen 197 MLGIVYRDLKPENILV---REDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKKD 273 (459)
T ss_pred hhceeeccCCcceeEE---ecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhcccccccccc
Confidence 9999999999999999 89999999999886433100 0 0
Q ss_pred ------------------cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCC
Q 026253 125 ------------------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHL 186 (241)
Q Consensus 125 ------------------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~ 186 (241)
....+||-.|.|||++.|..-+.+.|.|+||+++|||+.|..||.+.+..+.+..|. ....
T Consensus 274 ~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~GHgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv-~~~l 352 (459)
T KOG0610|consen 274 ESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEGHGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIV-GQPL 352 (459)
T ss_pred ccccccchhhhcCCCCccccccccccccccceeeecCCCCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHh-cCCC
Confidence 012356778999999999999999999999999999999999999999999998884 3444
Q ss_pred CCCCccCCCCChHHHHHHHHhcccCccccCC----HHHHhcCcccccc
Q 026253 187 PFSQLIVPALHPDCVDMCLKLLSANTVDRLS----FNEFYHHRFLRRN 230 (241)
Q Consensus 187 ~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps----~~~il~~~~~~~~ 230 (241)
.++.. +.++..++|+|+++|.+||.+|.. +.||-+||||++.
T Consensus 353 ~Fp~~--~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~gV 398 (459)
T KOG0610|consen 353 KFPEE--PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEGV 398 (459)
T ss_pred cCCCC--CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccCC
Confidence 44443 378899999999999999999998 9999999999984
|
|
| >cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=284.75 Aligned_cols=218 Identities=31% Similarity=0.585 Sum_probs=185.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
......+.+|+.++++++|+||+++++.+.+++..++||||+++++|.+++.+.+.+++..+..++.|++.||.+||+.|
T Consensus 42 ~~~~~~~~~E~~il~~~~h~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~al~~lH~~~ 121 (382)
T cd05625 42 RNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFPEDLARFYIAELTCAVESVHKMG 121 (382)
T ss_pred HHHHHHHHHHHHHHHhCCCCcCCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34567889999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCC--------------------------------------------
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-------------------------------------------- 122 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-------------------------------------------- 122 (241)
++||||||+||++ +.++.++|+|||++......
T Consensus 122 ivHrDlKp~NILl---~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (382)
T cd05625 122 FIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRAAR 198 (382)
T ss_pred eecCCCCHHHEEE---CCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhhcc
Confidence 9999999999999 78889999999987432100
Q ss_pred ----CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCC
Q 026253 123 ----NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALH 197 (241)
Q Consensus 123 ----~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ 197 (241)
.......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.++.+....+.... ....+. ...++
T Consensus 199 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~s 276 (382)
T cd05625 199 QHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIPP--QAKLS 276 (382)
T ss_pred ccccccccccccCcccCCHHHhcCCCCCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCCC--cccCC
Confidence 00112357899999999998899999999999999999999999999888777666654322 222222 23688
Q ss_pred hHHHHHHHHhcccCccccCC---HHHHhcCcccccc
Q 026253 198 PDCVDMCLKLLSANTVDRLS---FNEFYHHRFLRRN 230 (241)
Q Consensus 198 ~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 230 (241)
+++.++|.+|+ .+|.+|++ ++++++||||+..
T Consensus 277 ~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~ 311 (382)
T cd05625 277 PEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI 311 (382)
T ss_pred HHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence 99999999986 59999997 9999999999873
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an |
| >cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=277.54 Aligned_cols=215 Identities=33% Similarity=0.635 Sum_probs=187.9
Q ss_pred HHhhhhHHHHHHHHhcCCCc-CeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+..|.+++..++|+ +|+++++++...+..++||||+++++|.+++...+.+++..+..++.|++.||.|||+.
T Consensus 41 ~~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~ 120 (324)
T cd05587 41 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPHAVFYAAEIAIGLFFLHSK 120 (324)
T ss_pred hhHHHHHHHHHHHHHhcCCCCceeeeEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34566788999999999764 58889999999999999999999999999998888899999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccC-CCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
|++||||||+||++ +.++.++|+|||++.... .........++..|+|||.+.+..++.++|+||+|+++|+|++|
T Consensus 121 ~ivH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG 197 (324)
T cd05587 121 GIIYRDLKLDNVML---DAEGHIKIADFGMCKENIFGGKTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 197 (324)
T ss_pred CeEecCCCHHHeEE---cCCCCEEEeecCcceecCCCCCceeeecCCccccChhhhcCCCCCcccchhhhHHHHHHHHhC
Confidence 99999999999999 678899999999986532 22233345689999999999988899999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH-----HHHhcCccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF-----NEFYHHRFLRR 229 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~ 229 (241)
+.||.+.+..+....+.... ..++ ..++.++.+++++||+.||.+|++. +++++||||+.
T Consensus 198 ~~pf~~~~~~~~~~~i~~~~-~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~~~~hp~~~~ 262 (324)
T cd05587 198 QPPFDGEDEDELFQSIMEHN-VSYP----KSLSKEAVSICKGLLTKHPAKRLGCGPTGERDIREHAFFRR 262 (324)
T ss_pred CCCCCCCCHHHHHHHHHcCC-CCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCCCcCC
Confidence 99999988888888775433 2223 3688999999999999999999986 89999999986
|
Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory |
| >cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=277.05 Aligned_cols=214 Identities=33% Similarity=0.552 Sum_probs=186.5
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+....|..+++.+ +||||+++++++.+++..++||||+++++|.+++.....+++..+..++.|++.||.+||+.|+
T Consensus 38 ~~~~~~~e~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~al~~LH~~~i 117 (316)
T cd05619 38 DVECTMVEKRVLSLAWEHPFLTHLYCTFQTKENLFFVMEYLNGGDLMFHIQSCHKFDLPRATFYAAEIICGLQFLHSKGI 117 (316)
T ss_pred hHHHHHHHHHHHHhccCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 345667788888765 9999999999999999999999999999999999887889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||||+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 118 vHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~ 194 (316)
T cd05619 118 VYRDLKLDNILL---DTDGHIKIADFGMCKENMLGDAKTCTFCGTPDYIAPEILLGQKYNTSVDWWSFGVLLYEMLIGQS 194 (316)
T ss_pred EeCCCCHHHEEE---CCCCCEEEccCCcceECCCCCCceeeecCCccccCHHHHcCCCCCchhhhhhHHHHHHHHHhCCC
Confidence 999999999999 7788999999999865322 222334568899999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHH-HHhcCcccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN-EFYHHRFLRRN 230 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~~~~~~~ 230 (241)
||.+.+..+..+.+.... ..++ ..++.++.+++.+||+.||.+||++. ++++||||+..
T Consensus 195 pf~~~~~~~~~~~i~~~~-~~~~----~~~~~~~~~li~~~l~~~P~~R~~~~~~l~~h~~~~~~ 254 (316)
T cd05619 195 PFHGHDEEELFQSIRMDN-PCYP----RWLTREAKDILVKLFVREPERRLGVKGDIRQHPFFREI 254 (316)
T ss_pred CCCCCCHHHHHHHHHhCC-CCCC----ccCCHHHHHHHHHHhccCHhhcCCChHHHHcCcccCCC
Confidence 999988888887775433 2222 35788999999999999999999996 99999999884
|
Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in |
| >cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-42 Score=274.91 Aligned_cols=214 Identities=34% Similarity=0.508 Sum_probs=178.5
Q ss_pred hhhHHHHHHHHhcC---CCcCeeeeeeEEe-----ecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 10 ~~~~~~E~~~l~~l---~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l 79 (241)
...+.+|+.+++.+ +||||+++++++. .....++|||++. ++|.+++... ..+++..+..++.|++.||
T Consensus 45 ~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~i~~qi~~aL 123 (290)
T cd07862 45 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 123 (290)
T ss_pred hHHHHHHHHHHHhhcccCCCCcceEEEEEecccCCCCCcEEEEEccCC-CCHHHHHHhCCCCCCCHHHHHHHHHHHHHHH
Confidence 34566777777766 6999999999875 2456899999995 6999998754 3489999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
.+||+.|++|+||||+||++ +.++.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++|
T Consensus 124 ~~lH~~~iiH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~il~ 200 (290)
T cd07862 124 DFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 200 (290)
T ss_pred HHHHHCCeeeCCCCHHHEEE---cCCCCEEEccccceEeccCCcccccccccccccChHHHhCCCCCCccchHHHHHHHH
Confidence 99999999999999999999 778899999999997765444444566889999999998888999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCC----------------------ccCCCCChHHHHHHHHhcccCccccCC
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ----------------------LIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
+|++|.+||.+.+..+.+..+......+.+. ...+.++..+.+++.+||+.||++|||
T Consensus 201 el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s 280 (290)
T cd07862 201 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 280 (290)
T ss_pred HHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchhccCCCCCCHHHHccCCCHHHHHHHHHHhccCchhcCC
Confidence 9999999999888777766665432221111 122467888999999999999999999
Q ss_pred HHHHhcCccc
Q 026253 218 FNEFYHHRFL 227 (241)
Q Consensus 218 ~~~il~~~~~ 227 (241)
+.++++||||
T Consensus 281 ~~~~l~hp~f 290 (290)
T cd07862 281 AYSALSHPYF 290 (290)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla |
| >cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-42 Score=277.63 Aligned_cols=213 Identities=32% Similarity=0.576 Sum_probs=184.3
Q ss_pred HhhhhHHHHHHHHh---cCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 8 HLKSCLDCELNFLS---SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 8 ~~~~~~~~E~~~l~---~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
...+.+.+|++++. .++||||+++++++..++..|+||||+++++|..++.. +.+++..+..++.|++.||.+||+
T Consensus 41 ~~~~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~~~~~lv~E~~~~~~L~~~~~~-~~l~~~~~~~~~~qi~~al~~lH~ 119 (324)
T cd05589 41 DEVESLMCEKRIFETANSERHPFLVNLFACFQTEDHVCFVMEYAAGGDLMMHIHT-DVFSEPRAVFYAACVVLGLQYLHE 119 (324)
T ss_pred hHHHHHHHHHHHHHhccccCCCChhceeeEEEcCCEEEEEEcCCCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34566777777664 56799999999999999999999999999999988764 579999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
.|++|+||||+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 120 ~~ivHrdlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~il~el~~ 196 (324)
T cd05589 120 NKIVYRDLKLDNLLL---DTEGFVKIADFGLCKEGMGFGDRTSTFCGTPEFLAPEVLTETSYTRAVDWWGLGVLIYEMLV 196 (324)
T ss_pred CCeEecCCCHHHeEE---CCCCcEEeCcccCCccCCCCCCcccccccCccccCHhHhcCCCCCcccchhhHHHHHHHHHh
Confidence 999999999999999 7888999999999865332 222334568899999999998889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
|..||.+.+..+....+..... ..+ ..++..+.++|++||+.||.+|| ++.++++||||++
T Consensus 197 G~~pf~~~~~~~~~~~i~~~~~-~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~l~~~~~f~~ 262 (324)
T cd05589 197 GESPFPGDDEEEVFDSIVNDEV-RYP----RFLSREAISIMRRLLRRNPERRLGSGEKDAEDVKKQPFFRD 262 (324)
T ss_pred CCCCCCCCCHHHHHHHHHhCCC-CCC----CCCCHHHHHHHHHHhhcCHhHcCCCCCCCHHHHhhCCCcCC
Confidence 9999999888888777755432 222 36799999999999999999999 6999999999987
|
Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved |
| >cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-43 Score=285.59 Aligned_cols=217 Identities=29% Similarity=0.542 Sum_probs=184.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|+.++++++|+||+++++.+.+++..++||||+++++|.+++.+.+.+++..+..++.|++.||++||+.|+
T Consensus 43 ~~~~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~E~~~~g~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 122 (376)
T cd05598 43 NQAAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRLGIFEEDLARFYIAELTCAIESVHKMGF 122 (376)
T ss_pred hhHHHHHHHHHHHHhCCCCCcceEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34567889999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCC--------------------------------------------C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------------------------------------------N 123 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~--------------------------------------------~ 123 (241)
+||||||+||++ +.++.++|+|||++...... .
T Consensus 123 vHrDlkp~Nill---~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 199 (376)
T cd05598 123 IHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQHQRC 199 (376)
T ss_pred EeCCCCHHHEEE---CCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhcccc
Confidence 999999999999 78889999999987432100 0
Q ss_pred ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHH
Q 026253 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDM 203 (241)
Q Consensus 124 ~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l 203 (241)
......|++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+..+....+...... ........++.++.++
T Consensus 200 ~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~s~~~~~l 278 (376)
T cd05598 200 LAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETT-LHIPSQAKLSREASDL 278 (376)
T ss_pred cccccCCCccccCHHHHcCCCCCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCcc-ccCCCCCCCCHHHHHH
Confidence 011246889999999999889999999999999999999999999988877766655433211 1111223688999999
Q ss_pred HHHhcccCccccC---CHHHHhcCccccc
Q 026253 204 CLKLLSANTVDRL---SFNEFYHHRFLRR 229 (241)
Q Consensus 204 i~~~l~~~p~~Rp---s~~~il~~~~~~~ 229 (241)
|.+|+ .+|.+|+ |+.++++||||+.
T Consensus 279 i~~l~-~~p~~R~~~~t~~ell~h~~~~~ 306 (376)
T cd05598 279 ILRLC-CGAEDRLGKNGADEIKAHPFFKG 306 (376)
T ss_pred HHHHh-cCHhhcCCCCCHHHHhCCCCcCC
Confidence 99976 5999999 9999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. |
| >cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=268.14 Aligned_cols=213 Identities=29% Similarity=0.526 Sum_probs=185.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.++++++|+||+++++++.+.+..+++|||+++++|.+++...+.+++..+..++.|++.|+.+||+.|+
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lH~~~i 127 (267)
T cd06628 48 SMLDALAREIALLKELQHENIVQYLGSSLDADHLNIFLEYVPGGSVAALLNNYGAFEETLVRNFVRQILKGLNYLHNRGI 127 (267)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEEeCCccEEEEEecCCCCHHHHHHhccCccHHHHHHHHHHHHHHHHHHHhcCc
Confidence 34578899999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-------cccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+|+||+|+||++ ++++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+
T Consensus 128 vH~di~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~ 204 (267)
T cd06628 128 IHRDIKGANILV---DNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTSYTRKADIWSLGCLVVE 204 (267)
T ss_pred ccccCCHHHEEE---cCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCCCCchhhhHHHHHHHHH
Confidence 999999999999 7888999999999876642211 112346788999999988888999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+++|..||...+.......+........+ ..++..+.+++++||+.||.+||++.++++||||
T Consensus 205 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 267 (267)
T cd06628 205 MLTGKHPFPDCTQLQAIFKIGENASPEIP----SNISSEAIDFLEKTFEIDHNKRPTAAELLKHPFL 267 (267)
T ss_pred HhhCCCCCCCccHHHHHHHHhccCCCcCC----cccCHHHHHHHHHHccCCchhCcCHHHHhhCCCC
Confidence 99999999887766655555443333322 3678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate |
| >cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=277.37 Aligned_cols=215 Identities=30% Similarity=0.558 Sum_probs=183.2
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|..++.++ +|++|+++++++.+.+..++||||+++++|.+++...+.+++..+..++.|++.|+++||++|
T Consensus 37 ~~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qi~~al~~lH~~~ 116 (327)
T cd05617 37 EDIDWVQTEKHVFEQASSNPFLVGLHSCFQTTSRLFLVIEYVNGGDLMFHMQRQRKLPEEHARFYAAEICIALNFLHERG 116 (327)
T ss_pred hHHHHHHHHHHHHHhhcCCCCEeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4566788999999998 699999999999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccC-CCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||||+||++ +.++.++|+|||++.... .........++..|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 117 ivHrDlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~ell~g~ 193 (327)
T cd05617 117 IIYRDLKLDNVLL---DADGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAGR 193 (327)
T ss_pred eeccCCCHHHEEE---eCCCCEEEeccccceeccCCCCceecccCCcccCCHHHHCCCCCCchheeehhHHHHHHHHhCC
Confidence 9999999999999 678889999999987532 223334566899999999999889999999999999999999999
Q ss_pred CCCCCC------ChH-HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC------HHHHhcCcccccc
Q 026253 166 PPFSGR------NNV-QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS------FNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~------~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~~il~~~~~~~~ 230 (241)
.||... ... ...+.+ .......+ ..++..+.+++++||+.||.+|++ ++++++||||+..
T Consensus 194 ~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~~~~~~i~~h~~f~~~ 266 (327)
T cd05617 194 SPFDIITDNPDMNTEDYLFQVI-LEKPIRIP----RFLSVKASHVLKGFLNKDPKERLGCQPQTGFSDIKSHTFFRSI 266 (327)
T ss_pred CCCCccCCCcccccHHHHHHHH-HhCCCCCC----CCCCHHHHHHHHHHhccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence 999632 122 233333 23333333 367899999999999999999998 5799999999873
|
Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways |
| >cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-42 Score=283.13 Aligned_cols=218 Identities=30% Similarity=0.550 Sum_probs=183.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|++++++++|+||+++++++.+++..++||||++|++|.+++.+.+.+++..+..++.|++.||.+||+.|
T Consensus 42 ~~~~~~~~~E~~il~~l~h~~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~~LH~~g 121 (381)
T cd05626 42 RNQVAHVKAERDILAEADNEWVVKLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIESVHKMG 121 (381)
T ss_pred hHHHHHHHHHHHHHHhcCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34566789999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-------------------------------------------
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------------- 123 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~------------------------------------------- 123 (241)
++||||||+||++ +.++.++|+|||++.......
T Consensus 122 ivHrDlKp~Nili---~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 198 (381)
T cd05626 122 FIHRDIKPDNILI---DLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRATK 198 (381)
T ss_pred eeecCCcHHHEEE---CCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccccc
Confidence 9999999999999 678899999999875321000
Q ss_pred -----ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCC
Q 026253 124 -----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALH 197 (241)
Q Consensus 124 -----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~ 197 (241)
......||..|+|||.+.+..++.++|+||+||++|+|++|..||...+..+....+.... ....+. ...++
T Consensus 199 ~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~s 276 (381)
T cd05626 199 QHQRCLAHSLVGTPNYIAPEVLLRKGYTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIPP--QVKLS 276 (381)
T ss_pred cccccccccccCCccccCHHHHcCCCCCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCCC--CCCCC
Confidence 0123468899999999998889999999999999999999999999887766665554322 222222 22578
Q ss_pred hHHHHHHHHhc--ccCccccCCHHHHhcCccccc
Q 026253 198 PDCVDMCLKLL--SANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 198 ~~~~~li~~~l--~~~p~~Rps~~~il~~~~~~~ 229 (241)
.++.++|.+|+ ..++..|++++++++||||++
T Consensus 277 ~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~ 310 (381)
T cd05626 277 PEAVDLITKLCCSAEERLGRNGADDIKAHPFFSE 310 (381)
T ss_pred HHHHHHHHHHccCcccccCCCCHHHHhcCcccCC
Confidence 99999999965 455556999999999999986
|
Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po |
| >cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-42 Score=275.39 Aligned_cols=220 Identities=29% Similarity=0.451 Sum_probs=175.5
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|+++++.++|+||+++++++.++...++||||+. ++|.+++... +.++++.+..++.|++.||.+||+.|++
T Consensus 47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~iv 125 (303)
T cd07869 47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTLVFEYVH-TDLCQYMDKHPGGLHPENVKLFLFQLLRGLSYIHQRYIL 125 (303)
T ss_pred chhHHHHHHHHhhCCCCCcCeEEEEEecCCeEEEEEECCC-cCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3467889999999999999999999999999999999995 6888887654 5689999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
|+||||+||++ +..+.++|+|||++..... ........++..|+|||.+.+ ..++.++|+||+|+++|+|++|..
T Consensus 126 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~ 202 (303)
T cd07869 126 HRDLKPQNLLI---SDTGELKLADFGLARAKSVPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVA 202 (303)
T ss_pred cCCCCHHHEEE---CCCCCEEECCCCcceeccCCCccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 7788899999999865432 222234567889999998865 457889999999999999999999
Q ss_pred CCCCCChH-HHHHHhhcCCCCC------------------C----CCc-----cCCCCChHHHHHHHHhcccCccccCCH
Q 026253 167 PFSGRNNV-QLVRNINSCKHLP------------------F----SQL-----IVPALHPDCVDMCLKLLSANTVDRLSF 218 (241)
Q Consensus 167 p~~~~~~~-~~~~~i~~~~~~~------------------~----~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~ 218 (241)
||.+.... +.+..+......+ + +.. .....+.++.+++.+||+.||.+|||+
T Consensus 203 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dp~~R~s~ 282 (303)
T cd07869 203 AFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQCFPKNRLSA 282 (303)
T ss_pred CCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhccCchhccCH
Confidence 99875432 2222221110000 0 000 001245678999999999999999999
Q ss_pred HHHhcCccccccccc
Q 026253 219 NEFYHHRFLRRNSAI 233 (241)
Q Consensus 219 ~~il~~~~~~~~~~~ 233 (241)
+|+++||||++.+..
T Consensus 283 ~~~l~h~~f~~~~~~ 297 (303)
T cd07869 283 QAALSHEYFSDLPPR 297 (303)
T ss_pred HHHhcCcccccCChh
Confidence 999999999986543
|
Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an |
| >cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-42 Score=281.70 Aligned_cols=216 Identities=31% Similarity=0.524 Sum_probs=186.0
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.+++.++||||+++++++.+++..++||||++|++|.+++.. ..+++..+..++.|++.||++||+.|+
T Consensus 85 ~~~~~~~~e~~il~~~~h~~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~-~~l~~~~~~~~~~qi~~aL~~LH~~~i 163 (370)
T cd05596 85 SDSAFFWEERDIMAHANSEWIVQLHYAFQDDKYLYMVMEYMPGGDLVNLMSN-YDIPEKWARFYTAEVVLALDAIHSMGF 163 (370)
T ss_pred hhHHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3445678999999999999999999999999999999999999999999865 468899999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCccccccc----CCCCchhHHHHHHHHHHH
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~----~~~~~~Dv~slG~~l~~l 161 (241)
+||||||+||++ +.++.++|+|||.+....... ......+++.|+|||.+.+. .++.++|+|||||++|+|
T Consensus 164 vHrDLkp~NILl---~~~~~~kL~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlGvilyel 240 (370)
T cd05596 164 IHRDVKPDNMLL---DKSGHLKLADFGTCMKMDANGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240 (370)
T ss_pred eccCCCHHHEEE---cCCCCEEEEeccceeeccCCCcccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehhHHHHHH
Confidence 999999999999 788899999999987654322 12345689999999998653 378999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCC-CCCCCccCCCCChHHHHHHHHhcccCccc--cCCHHHHhcCccccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKH-LPFSQLIVPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRR 229 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~il~~~~~~~ 229 (241)
++|..||.+.+....+..+..... ..++. ...+|.++.++|++||+.+|.+ |+|++++++||||++
T Consensus 241 ltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~~L~~~p~r~~R~s~~ell~h~~~~~ 309 (370)
T cd05596 241 LVGDTPFYADSLVGTYSKIMDHKNSLTFPD--DIEISKQAKDLICAFLTDREVRLGRNGVDEIKSHPFFKN 309 (370)
T ss_pred HhCCCCcCCCCHHHHHHHHHcCCCcCCCCC--cCCCCHHHHHHHHHHccChhhccCCCCHHHHhcCcccCC
Confidence 999999999888888877755432 22232 2257999999999999999988 999999999999986
|
Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in |
| >cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-42 Score=265.42 Aligned_cols=215 Identities=27% Similarity=0.487 Sum_probs=188.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
.....+.+.+|++++++++|+|++++++++.+++..++||||+++++|.+++... ..+++..+..++.+++.|+.+||
T Consensus 39 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al~~lH 118 (256)
T cd08529 39 NRREREEAIDEARVLAKLDSSYIIRYYESFLDKGKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGLAHLH 118 (256)
T ss_pred CHHHHHHHHHHHHHHHhcCCCCeehheeeeccCCEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4566788999999999999999999999999999999999999999999999764 56899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
+.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|.|||...+..++.++|+||||+++++++
T Consensus 119 ~~~i~h~dl~~~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 195 (256)
T cd08529 119 SKKILHRDIKSLNLFL---DAYDNVKIGDLGVAKLLSDNTNFANTIVGTPYYLSPELCEDKPYNEKSDVWALGVVLYECC 195 (256)
T ss_pred HCCcccCCCCcceEEE---eCCCCEEEcccccceeccCccchhhccccCccccCHHHhcCCCCCCccchHHHHHHHHHHH
Confidence 9999999999999999 678899999999987654332 223345778899999998888999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+|..||...+.......+..+...+.+. .++.++.+++++||+.+|++||++.++++|||+
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 256 (256)
T cd08529 196 TGKHPFDANNQGALILKIIRGVFPPVSQ----MYSQQLAQLIDQCLTKDYRQRPDTFQLLRNPSL 256 (256)
T ss_pred hCCCCCCCCCHHHHHHHHHcCCCCCCcc----ccCHHHHHHHHHHccCCcccCcCHHHHhhCCCC
Confidence 9999999888777777775554443333 678899999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc |
| >cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-43 Score=281.02 Aligned_cols=217 Identities=31% Similarity=0.550 Sum_probs=187.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.+..+.+.+|+.+++.++|+||+++++++.+++..++||||+++++|.+++.+. ..+++..+..++.|++.||.+||+.
T Consensus 42 ~~~~~~~~~e~~i~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~lH~~ 121 (330)
T cd05601 42 QETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQM 121 (330)
T ss_pred hhHHHHHHHHHHHHHhCCCCCCcceeeEEecCCeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678899999999999999999999999999999999999999999999876 6799999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCccccc------ccCCCCchhHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAI 157 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~------~~~~~~~~Dv~slG~~ 157 (241)
|++||||||+||++ +.++.++|+|||++........ .....++..|+|||.+. +..++.++|+||+|++
T Consensus 122 ~i~H~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~DiwslG~i 198 (330)
T cd05601 122 GYVHRDIKPENVLI---DRTGHIKLADFGSAARLTANKMVNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVI 198 (330)
T ss_pred CeEcccCchHheEE---CCCCCEEeccCCCCeECCCCCceeeecccCCccccCHHHhccccccccCCCCCcceeecccce
Confidence 99999999999999 7888999999999976543322 22345789999999986 4557889999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhcCCC-CCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 158 LFELLNGYPPFSGRNNVQLVRNINSCKH-LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
+|+|++|..||...+....+..+..... ..++. .+.++.++.+++++||+ +|.+|||++++++||||..
T Consensus 199 l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~li~~ll~-~p~~R~t~~~l~~h~~~~~ 268 (330)
T cd05601 199 AYEMIYGRSPFHEGTSAKTYNNIMNFQRFLKFPE--DPKVSSDFLDLIQSLLC-GQKERLGYEGLCCHPFFSK 268 (330)
T ss_pred eeeeccCCCCCCCCCHHHHHHHHHcCCCccCCCC--CCCCCHHHHHHHHHHcc-ChhhCCCHHHHhCCCCcCC
Confidence 9999999999998888777777654432 22222 23678999999999998 9999999999999999986
|
Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor |
| >cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-42 Score=277.69 Aligned_cols=214 Identities=30% Similarity=0.497 Sum_probs=181.0
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|+++++++ .|++|+++++++..++..++||||+.+++|.+++.....+++..+..++.|++.||.+||+.|+
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 126 (332)
T cd05614 47 TVEHTRTERNVLEHVRQSPFLVTLHYAFQTEAKLHLILDYVSGGEMFTHLYQRDNFSEDEVRFYSGEIILALEHLHKLGI 126 (332)
T ss_pred HHHHHHHHHHHHHhccCCCCcccEEEEEecCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 356688999999999 5999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g 164 (241)
+||||||+||++ +.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||||+++|+|++|
T Consensus 127 vHrDlkp~Nili---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~elltg 203 (332)
T cd05614 127 VYRDIKLENILL---DSEGHVVLTDFGLSKEFLSEEKERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTG 203 (332)
T ss_pred EecCCCHHHeEE---CCCCCEEEeeCcCCccccccCCCccccccCCccccCHHHhcCCCCCCCccccccchhhhhhhhcC
Confidence 999999999999 678899999999987653322 22345689999999998765 478899999999999999999
Q ss_pred CCCCCCCC----hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCcccccc
Q 026253 165 YPPFSGRN----NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 230 (241)
Q Consensus 165 ~~p~~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~ 230 (241)
..||.... .......+.. .... ....++..+.+++.+||+.||++|| +++++++||||++.
T Consensus 204 ~~pf~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~l~h~~~~~~ 273 (332)
T cd05614 204 ASPFTLEGERNTQSEVSRRILK-CDPP----FPSFIGPEAQDLLHKLLRKDPKKRLGAGPQGASEIKEHPFFKGL 273 (332)
T ss_pred CCCCCCCCCCCCHHHHHHHHhc-CCCC----CCCCCCHHHHHHHHHHcCCCHHHcCCCCCCCHHHHHcCCCcCCC
Confidence 99996432 2233333322 2222 2346889999999999999999999 88999999999873
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >KOG0580 consensus Serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-43 Score=256.75 Aligned_cols=217 Identities=32% Similarity=0.603 Sum_probs=198.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHH--hcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR--LHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~--~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
......++++|++|.+.|+||||+++|++|.++...|+++||..+|++...++ ..+++++...+.++.|++.|+.|+|
T Consensus 62 ~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q~A~Al~y~h 141 (281)
T KOG0580|consen 62 KTQVEHQLRREIEIQSHLRHPNILRLYGYFHDSKRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQLANALLYCH 141 (281)
T ss_pred HhcchhhhhheeEeecccCCccHHhhhhheeccceeEEEEEecCCchHHHHHHhcccccccccchhHHHHHHHHHHHHhc
Confidence 34557889999999999999999999999999999999999999999999998 5678999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
..+++||||||+|+|+ +..+.+++.|||-+.... .......+||.-|.+||...+...+...|+|++|++.||++.
T Consensus 142 ~k~VIhRdiKpenlLl---g~~~~lkiAdfGwsV~~p-~~kR~tlcgt~dyl~pEmv~~~~hd~~Vd~w~lgvl~yeflv 217 (281)
T KOG0580|consen 142 LKRVIHRDIKPENLLL---GSAGELKIADFGWSVHAP-SNKRKTLCGTLDYLPPEMVEGRGHDKFVDLWSLGVLCYEFLV 217 (281)
T ss_pred cCCcccCCCCHHHhcc---CCCCCeeccCCCceeecC-CCCceeeecccccCCHhhcCCCCccchhhHHHHHHHHHHHHh
Confidence 9999999999999999 788899999999886654 555667899999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|.+||+..+..+.++.|.... ..++ +.++.+++|+|.+|+.++|.+|.+..|++.|||....+
T Consensus 218 g~ppFes~~~~etYkrI~k~~-~~~p----~~is~~a~dlI~~ll~~~p~~r~~l~~v~~hpwI~a~~ 280 (281)
T KOG0580|consen 218 GLPPFESQSHSETYKRIRKVD-LKFP----STISGGAADLISRLLVKNPIERLALTEVMDHPWIVANG 280 (281)
T ss_pred cCCchhhhhhHHHHHHHHHcc-ccCC----cccChhHHHHHHHHhccCccccccHHHHhhhHHHHhcC
Confidence 999999999999999996544 3333 48999999999999999999999999999999997654
|
|
| >cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-42 Score=277.96 Aligned_cols=214 Identities=33% Similarity=0.569 Sum_probs=184.9
Q ss_pred hhhhHHHHHH-HHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
....+.+|.. +++.++||||+++++.+..++..++||||+.+++|..++.+.+.+++..+..++.|++.||.+||+.|+
T Consensus 38 ~~~~~~~e~~~~l~~~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~gi 117 (325)
T cd05604 38 EQKHIMAERNVLLKNVKHPFLVGLHYSFQTTEKLYFVLDFVNGGELFFHLQRERSFPEPRARFYAAEIASALGYLHSINI 117 (325)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3445555554 567789999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+||||||+||++ +.++.++|+|||++..... ........++..|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 118 vH~Dlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslG~il~el~~G~~ 194 (325)
T cd05604 118 VYRDLKPENILL---DSQGHVVLTDFGLCKEGIAQSDTTTTFCGTPEYLAPEVIRKQPYDNTVDWWCLGAVLYEMLYGLP 194 (325)
T ss_pred eecCCCHHHeEE---CCCCCEEEeecCCcccCCCCCCCcccccCChhhCCHHHHcCCCCCCcCccccccceehhhhcCCC
Confidence 999999999999 7888999999999865322 223344568999999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH----HHHhcCcccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF----NEFYHHRFLRRN 230 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~il~~~~~~~~ 230 (241)
||.+.+..+....+..... ...+..+..+.+++++||+.+|.+||++ .++++||||+..
T Consensus 195 pf~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~ll~~ll~~~p~~R~~~~~~~~~i~~h~~f~~~ 257 (325)
T cd05604 195 PFYCRDVAEMYDNILHKPL-----VLRPGASLTAWSILEELLEKDRQRRLGAKEDFLEIQEHPFFESL 257 (325)
T ss_pred CCCCCCHHHHHHHHHcCCc-----cCCCCCCHHHHHHHHHHhccCHHhcCCCCCCHHHHhcCCCcCCC
Confidence 9999888887777754331 2234688999999999999999999976 599999999863
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, |
| >cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=282.06 Aligned_cols=218 Identities=27% Similarity=0.557 Sum_probs=187.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
......+.+|+.++.+++|++|+++++.+.+++..++||||++|++|.+++.+.+.+++..+..++.|++.||.+||+.|
T Consensus 42 ~~~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~~L~~lH~~g 121 (360)
T cd05627 42 KEQVAHIRAERDILVEADGAWVVKMFYSFQDKRNLYLIMEFLPGGDMMTLLMKKDTLSEEATQFYIAETVLAIDAIHQLG 121 (360)
T ss_pred hhhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44567888999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC------------------------------------ccccccC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------------------------------------YAEKVCG 130 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~------------------------------------~~~~~~~ 130 (241)
++||||||+||++ +.++.++|+|||++....... ......|
T Consensus 122 ivHrDLkp~NIli---~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g 198 (360)
T cd05627 122 FIHRDIKPDNLLL---DAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYSTVG 198 (360)
T ss_pred eEccCCCHHHEEE---CCCCCEEEeeccCCcccccccccccccccccCCcccccccccccccccccccccccccccccCC
Confidence 9999999999999 778899999999986442110 0113468
Q ss_pred CCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCChHHHHHHHHhcc
Q 026253 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLS 209 (241)
Q Consensus 131 ~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~li~~~l~ 209 (241)
++.|+|||.+.+..++.++|+||+||++|+|++|..||.+.+.......+.... ...++.. ..++.++.++|.+|+
T Consensus 199 t~~Y~APE~~~~~~~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~l~- 275 (360)
T cd05627 199 TPDYIAPEVFMQTGYNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETLVFPPE--VPISEKAKDLILRFC- 275 (360)
T ss_pred CccccCHHHHcCCCCCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCceecCCC--CCCCHHHHHHHHHhc-
Confidence 899999999999999999999999999999999999999988888877775532 2233322 247889999999987
Q ss_pred cCccccC---CHHHHhcCcccccc
Q 026253 210 ANTVDRL---SFNEFYHHRFLRRN 230 (241)
Q Consensus 210 ~~p~~Rp---s~~~il~~~~~~~~ 230 (241)
.||.+|+ +++++++||||++.
T Consensus 276 ~~p~~R~~~~~~~ei~~hp~f~~~ 299 (360)
T cd05627 276 TDSENRIGSNGVEEIKSHPFFEGV 299 (360)
T ss_pred cChhhcCCCCCHHHHhcCCCCCCC
Confidence 4999998 48999999999873
|
Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul |
| >PTZ00036 glycogen synthase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-42 Score=286.62 Aligned_cols=218 Identities=29% Similarity=0.476 Sum_probs=175.0
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeec--------CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHH
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~ 78 (241)
....+|+.++++++|+||+++++++... ...++||||+. ++|.+++.. ...+++..+..++.|++.|
T Consensus 104 ~~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~-~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~g 182 (440)
T PTZ00036 104 QYKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIP-QTVHKYMKHYARNNHALPLFLVKLYSYQLCRA 182 (440)
T ss_pred chHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCC-ccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHH
Confidence 3456799999999999999999876432 24679999995 578777643 4568999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccccc-CCCCchhHHHHHHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAI 157 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~ 157 (241)
|.|||+.|++||||||+||+++ ..++.++|+|||+|+............+++.|+|||.+.+. .++.++|+||+||+
T Consensus 183 L~yLH~~~IiHrDLKp~NILl~--~~~~~vkL~DFGla~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvi 260 (440)
T PTZ00036 183 LAYIHSKFICHRDLKPQNLLID--PNTHTLKLCDFGSAKNLLAGQRSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCI 260 (440)
T ss_pred HHHHHHCCEecCCcCHHHEEEc--CCCCceeeeccccchhccCCCCcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHHH
Confidence 9999999999999999999994 24457999999999876554444456778999999998654 68999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhcCCCCC----------------CC--------CccCCCCChHHHHHHHHhcccCcc
Q 026253 158 LFELLNGYPPFSGRNNVQLVRNINSCKHLP----------------FS--------QLIVPALHPDCVDMCLKLLSANTV 213 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------------~~--------~~~~~~~~~~~~~li~~~l~~~p~ 213 (241)
+|+|++|.+||.+.+..+.+..+......+ ++ ...+...+.++.+||.+||+.||.
T Consensus 261 l~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~l~~~~p~~~~~~~~~li~~~L~~dP~ 340 (440)
T PTZ00036 261 IAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMNPNYADIKFPDVKPKDLKKVFPKGTPDDAINFISQFLKYEPL 340 (440)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhchhhhcccCCccCchhHHHHhccCCCHHHHHHHHHHCCCChh
Confidence 999999999999877665554443221110 11 112234678999999999999999
Q ss_pred ccCCHHHHhcCccccccc
Q 026253 214 DRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 214 ~Rps~~~il~~~~~~~~~ 231 (241)
+|||+.|+++||||+...
T Consensus 341 ~R~ta~e~l~hp~f~~~~ 358 (440)
T PTZ00036 341 KRLNPIEALADPFFDDLR 358 (440)
T ss_pred HCcCHHHHhCChhHHhhh
Confidence 999999999999998743
|
|
| >cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-42 Score=274.91 Aligned_cols=213 Identities=31% Similarity=0.603 Sum_probs=187.1
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.......|..++..+ .|++|+++++++.+.+..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|+
T Consensus 43 ~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~E~~~~g~L~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 122 (323)
T cd05616 43 DVECTMVEKRVLALSGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYQIQQVGRFKEPHAVFYAAEIAIGLFFLHSKGI 122 (323)
T ss_pred HHHHHHHHHHHHHhccCCCeEeeEEEEEecCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 345677788888888 5899999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+||||||+||++ +.++.++|+|||++..... ........+++.|+|||.+.+..++.++|+||+||++|+|++|+.
T Consensus 123 vHrDlkp~Nill---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~elltg~~ 199 (323)
T cd05616 123 IYRDLKLDNVML---DSEGHIKIADFGMCKENMWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQA 199 (323)
T ss_pred EecCCCHHHeEE---CCCCcEEEccCCCceecCCCCCccccCCCChhhcCHHHhcCCCCCCccchhchhHHHHHHHhCCC
Confidence 999999999999 7888999999999875432 223334568999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH-----HHHhcCccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF-----NEFYHHRFLRR 229 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~ 229 (241)
||.+.+..+....+.... ..++ ..++.++.+++.+||+.+|.+|++. .++++||||+.
T Consensus 200 Pf~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~~~~ 262 (323)
T cd05616 200 PFEGEDEDELFQSIMEHN-VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 262 (323)
T ss_pred CCCCCCHHHHHHHHHhCC-CCCC----CcCCHHHHHHHHHHcccCHHhcCCCCCCCHHHHhcCCCcCC
Confidence 999988888888775543 2233 3689999999999999999999984 89999999985
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and |
| >KOG0584 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-42 Score=281.73 Aligned_cols=219 Identities=30% Similarity=0.514 Sum_probs=195.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCe--EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~--~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+....++..|+.+|+.|+|+||+++|+++.+... ..+|+|.+.+|+|..|.++.++.....+..|++||+.||.|||+
T Consensus 82 ~~~leR~~~Ev~lLKsL~H~NIirfy~SW~d~~n~~in~iTEL~TSGtLr~Y~kk~~~vn~kaik~W~RQILkGL~yLHs 161 (632)
T KOG0584|consen 82 PEELERLYSEVHLLKSLKHPNIIRFYDSWVDTDNKTINFITELFTSGTLREYRKKHRRVNIKAIKSWCRQILKGLVYLHS 161 (632)
T ss_pred hHHHHHHHHHHHHHccCCCCceeeeeeheecCCCceeeeeeecccCCcHHHHHHHhccCCHHHHHHHHHHHHHHhhhhhc
Confidence 3445899999999999999999999999987654 78999999999999999999999999999999999999999999
Q ss_pred CC--ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 85 HH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 85 ~~--i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
+. |+|||||..|||++ +..|.|||||+|+|......... ...|||-|||||... ..|....||||||++++||+
T Consensus 162 ~~PPIIHRDLKCDNIFin--G~~G~VKIGDLGLAtl~r~s~ak-svIGTPEFMAPEmYE-E~YnE~VDVYaFGMCmLEMv 237 (632)
T KOG0584|consen 162 QDPPIIHRDLKCDNIFVN--GNLGEVKIGDLGLATLLRKSHAK-SVIGTPEFMAPEMYE-ENYNELVDVYAFGMCMLEMV 237 (632)
T ss_pred CCCCccccccccceEEEc--CCcCceeecchhHHHHhhccccc-eeccCccccChHHHh-hhcchhhhhhhhhHHHHHHH
Confidence 84 99999999999997 78899999999999877655443 378999999999998 78999999999999999999
Q ss_pred hCCCCCC-CCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 163 NGYPPFS-GRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 163 ~g~~p~~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
|+..||. +.++.++++++..+..+. .+..--.+++++||.+||.. .+.|||+.|+|+||||......
T Consensus 238 T~eYPYsEC~n~AQIYKKV~SGiKP~---sl~kV~dPevr~fIekCl~~-~~~R~sa~eLL~d~Ff~~d~g~ 305 (632)
T KOG0584|consen 238 TSEYPYSECTNPAQIYKKVTSGIKPA---ALSKVKDPEVREFIEKCLAT-KSERLSAKELLKDPFFDEDGGI 305 (632)
T ss_pred hccCChhhhCCHHHHHHHHHcCCCHH---HhhccCCHHHHHHHHHHhcC-chhccCHHHHhhChhhcccccc
Confidence 9999996 789999999998776432 22223478999999999999 9999999999999999997654
|
|
| >cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-42 Score=265.66 Aligned_cols=216 Identities=33% Similarity=0.628 Sum_probs=188.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+++++.++|+||+++++.+.+++..+++|||+++++|.+++.+...+++..+..++.|++.||.+||+.|+
T Consensus 35 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lH~~~~ 114 (262)
T cd05572 35 GQQEHIFSEKEILEECNHPFIVKLYRTFKDKKYIYMLMEYCLGGELWTILRDRGLFDEYTARFYIACVVLAFEYLHNRGI 114 (262)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeEEcCCccEEEEecCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 45678999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|.||++ +.++.++|+|||.+.............++..|++||.+.+..++.++|+||+|+++|++++|..|
T Consensus 115 ~h~dl~~~nilv---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~p 191 (262)
T cd05572 115 IYRDLKPENLLL---DSNGYVKLVDFGFAKKLKSGQKTWTFCGTPEYVAPEIILNKGYDFSVDYWSLGILLYELLTGRPP 191 (262)
T ss_pred ccCCCCHHHEEE---cCCCCEEEeeCCcccccCcccccccccCCcCccChhHhcCCCCCChhhhhhhHHHHHHHHhCCCC
Confidence 999999999999 67889999999998776544333345678889999999888889999999999999999999999
Q ss_pred CCCCC--hHHHHHHhhcC-CCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCcccccc
Q 026253 168 FSGRN--NVQLVRNINSC-KHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 230 (241)
Q Consensus 168 ~~~~~--~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~ 230 (241)
|...+ ..+....+..+ .....+ ...+.++.+++.+||+.+|.+||+ ++|+++||||++.
T Consensus 192 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~ 258 (262)
T cd05572 192 FGEDDEDPMEIYNDILKGNGKLEFP----NYIDKAAKDLIKQLLRRNPEERLGNLKGGIKDIKKHKWFNGF 258 (262)
T ss_pred cCCCCCCHHHHHHHHhccCCCCCCC----cccCHHHHHHHHHHccCChhhCcCCcccCHHHHhcChhhhCC
Confidence 98776 56666665432 222222 245889999999999999999999 9999999999864
|
Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi |
| >cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=275.38 Aligned_cols=212 Identities=33% Similarity=0.548 Sum_probs=182.8
Q ss_pred hhhHHHHH-HHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|. .+++.++|+||+++++.+.+.+..++||||+++++|.+++.....+++..+..++.|++.||.+||+.|++
T Consensus 39 ~~~~~~e~~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~lH~~~iv 118 (321)
T cd05603 39 QNHIMAERNVLLKNLKHPFLVGLHYSFQTAEKLYFVLDYVNGGELFFHLQRERCFLEPRARFYAAEVASAIGYLHSLNII 118 (321)
T ss_pred HHHHHHHHHHHHHhCCCCCccceeeEEEcCCEEEEEEcCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 44455555 46788899999999999999999999999999999999998888899999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
||||||+||++ +.++.++|+|||++..... ........+++.|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 119 H~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~p 195 (321)
T cd05603 119 YRDLKPENILL---DSQGHVVLTDFGLCKEGVEPEETTSTFCGTPEYLAPEVLRKEPYDRTVDWWCLGAVLYEMLYGLPP 195 (321)
T ss_pred eccCCHHHeEE---CCCCCEEEccCCCCccCCCCCCccccccCCcccCCHHHhcCCCCCCcCcccccchhhhhhhcCCCC
Confidence 99999999999 7788999999999875322 2233445688999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH----HHHhcCccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF----NEFYHHRFLRR 229 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~il~~~~~~~ 229 (241)
|.+.+..+....+.... .. ..+..+..+.+++.+||+.||.+||++ .++++|+||..
T Consensus 196 f~~~~~~~~~~~i~~~~-~~----~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~~~~~~ 256 (321)
T cd05603 196 FYSRDVSQMYDNILHKP-LQ----LPGGKTVAACDLLVGLLHKDQRRRLGAKADFLEIKNHVFFSP 256 (321)
T ss_pred CCCCCHHHHHHHHhcCC-CC----CCCCCCHHHHHHHHHHccCCHhhcCCCCCCHHHHhCCCCcCC
Confidence 99888877777764432 22 234678899999999999999999975 59999999975
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. |
| >cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-42 Score=275.79 Aligned_cols=210 Identities=33% Similarity=0.573 Sum_probs=182.4
Q ss_pred hHHHHH-HHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 026253 12 CLDCEL-NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (241)
Q Consensus 12 ~~~~E~-~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (241)
.+.+|. .+++.++|+||+++++++.+++..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++||
T Consensus 41 ~~~~e~~~~l~~~~h~~Iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~giiHr 120 (325)
T cd05602 41 HIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLNIVYR 120 (325)
T ss_pred HHHHHHHHHHHhCCCCCCCceeEEEEcCCeEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeEec
Confidence 344444 4567889999999999999999999999999999999999888889999999999999999999999999999
Q ss_pred CCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026253 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (241)
Q Consensus 91 dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 169 (241)
||||+||++ +.++.++|+|||++..... ........+++.|+|||.+.+..++.++|+||+|+++|+|++|..||.
T Consensus 121 Dlkp~Nili---~~~~~~kl~DfG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~pf~ 197 (325)
T cd05602 121 DLKPENILL---DSQGHIVLTDFGLCKENIEHNGTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFY 197 (325)
T ss_pred CCCHHHeEE---CCCCCEEEccCCCCcccccCCCCcccccCCccccCHHHHcCCCCCCccccccccHHHHHHhcCCCCCC
Confidence 999999999 6788999999999875432 223344568999999999998899999999999999999999999999
Q ss_pred CCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHH----HHhcCccccc
Q 026253 170 GRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN----EFYHHRFLRR 229 (241)
Q Consensus 170 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~----~il~~~~~~~ 229 (241)
+.+..+.+..+..... ...+.++..+.++|++||+.||.+|+++. ++++|+||..
T Consensus 198 ~~~~~~~~~~i~~~~~-----~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~i~~~~~~~~ 256 (325)
T cd05602 198 SRNTAEMYDNILNKPL-----QLKPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKNHIFFSP 256 (325)
T ss_pred CCCHHHHHHHHHhCCc-----CCCCCCCHHHHHHHHHHcccCHHHCCCCCCCHHHHhcCcccCC
Confidence 9888887777754321 22347899999999999999999999875 8999999965
|
Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt |
| >KOG0585 consensus Ca2+/calmodulin-dependent protein kinase kinase beta and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.2e-43 Score=274.88 Aligned_cols=215 Identities=30% Similarity=0.566 Sum_probs=184.3
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.+..++|+.++++|.|+|||+++++..+ .+.+|+|+|||..|.+... ...++ +++.+.++++.+++.||.|||.+|
T Consensus 152 ~ekv~~EIailKkl~H~nVV~LiEvLDDP~s~~~YlVley~s~G~v~w~-p~d~~els~~~Ar~ylrDvv~GLEYLH~Qg 230 (576)
T KOG0585|consen 152 IEKVRREIAILKKLHHPNVVKLIEVLDDPESDKLYLVLEYCSKGEVKWC-PPDKPELSEQQARKYLRDVVLGLEYLHYQG 230 (576)
T ss_pred HHHHHHHHHHHHhcCCcCeeEEEEeecCcccCceEEEEEeccCCccccC-CCCcccccHHHHHHHHHHHHHHHHHHHhcC
Confidence 3578999999999999999999999875 4679999999998887643 23344 899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC------CCccccccCCCCccCcccccccC----CCCchhHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP------GNYAEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGA 156 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~------~~~~~~~~~~~~~~~PE~~~~~~----~~~~~Dv~slG~ 156 (241)
|+||||||.|+|+ +.++++||+|||.+..... ........||+.|+|||...+.. .+.+.|+||+|+
T Consensus 231 iiHRDIKPsNLLl---~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWalGV 307 (576)
T KOG0585|consen 231 IIHRDIKPSNLLL---SSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWALGV 307 (576)
T ss_pred eeccccchhheEE---cCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhhhh
Confidence 9999999999999 7889999999999876522 22233467999999999986532 468999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 157 ILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
++|+++.|+.||.+....+++.+|.+.. ..++. .+.+++++.++|.+||++||.+|.+..++..|||..+..
T Consensus 308 TLYCllfG~~PF~~~~~~~l~~KIvn~p-L~fP~--~pe~~e~~kDli~~lL~KdP~~Ri~l~~ik~Hpwvt~~g 379 (576)
T KOG0585|consen 308 TLYCLLFGQLPFFDDFELELFDKIVNDP-LEFPE--NPEINEDLKDLIKRLLEKDPEQRITLPDIKLHPWVTRDG 379 (576)
T ss_pred hHHHhhhccCCcccchHHHHHHHHhcCc-ccCCC--cccccHHHHHHHHHHhhcChhheeehhhheecceeccCC
Confidence 9999999999999999999999996544 33333 236789999999999999999999999999999998764
|
|
| >cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=279.43 Aligned_cols=217 Identities=31% Similarity=0.542 Sum_probs=185.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|+.+++.++||||+++++.+.+++..++||||+++++|.+++... .+++..+..++.|++.||++||+.|+
T Consensus 85 ~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~-~~~~~~~~~~~~qil~aL~~LH~~~I 163 (370)
T cd05621 85 SDSAFFWEERDIMAFANSPWVVQLFCAFQDDKYLYMVMEYMPGGDLVNLMSNY-DVPEKWAKFYTAEVVLALDAIHSMGL 163 (370)
T ss_pred hhHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEcCCCCCcHHHHHHhc-CCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34566889999999999999999999999999999999999999999998754 68999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCccccccc----CCCCchhHHHHHHHHHHH
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~----~~~~~~Dv~slG~~l~~l 161 (241)
+||||||+||++ +.++.++|+|||++........ .....+++.|+|||.+.+. .++.++|+||+|+++|+|
T Consensus 164 vHrDLKp~NILl---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG~ilyel 240 (370)
T cd05621 164 IHRDVKPDNMLL---DKHGHLKLADFGTCMKMDETGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLFEM 240 (370)
T ss_pred EecCCCHHHEEE---CCCCCEEEEecccceecccCCceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeehHHHHHH
Confidence 999999999999 7888999999999976543222 2345689999999998654 378899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCC-CCCCCccCCCCChHHHHHHHHhcccCccc--cCCHHHHhcCcccccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKH-LPFSQLIVPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRRN 230 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~il~~~~~~~~ 230 (241)
++|..||.+.+....+..+..... ..++.. ..++..+.+++..||..++.+ |+|++|+++||||+..
T Consensus 241 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~~--~~~s~~~~~li~~~L~~~~~r~~R~~~~e~l~hp~~~~~ 310 (370)
T cd05621 241 LVGDTPFYADSLVGTYSKIMDHKNSLNFPED--VEISKHAKNLICAFLTDREVRLGRNGVEEIKQHPFFKND 310 (370)
T ss_pred HhCCCCCCCCCHHHHHHHHHhCCcccCCCCc--ccCCHHHHHHHHHHccCchhccCCCCHHHHhcCcccCCC
Confidence 999999999888888877765432 233322 357899999999999866544 8899999999999874
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found |
| >cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=263.81 Aligned_cols=216 Identities=31% Similarity=0.541 Sum_probs=188.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+....+.+.+|++++++++|+|++++++.+..++..++|||++++++|.+++... ..+++..+..++.+++.++.+||
T Consensus 39 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lh 118 (256)
T cd08220 39 TKDERLAAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALHHVH 118 (256)
T ss_pred ccHHHHHHHHHHHHHhhCCCCchhheeeeEecCCEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3455778999999999999999999999999999999999999999999999764 34899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
++|++|+||+|.||+++ .++..++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++|++++
T Consensus 119 ~~~i~h~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~~ 196 (256)
T cd08220 119 TKLILHRDLKTQNILLD--KHKMVVKIGDFGISKILSSKSKAYTVVGTPCYISPELCEGKPYNQKSDIWALGCVLYELAS 196 (256)
T ss_pred hCCeecCCCCHHHEEEc--CCCCEEEEccCCCceecCCCccccccccCCcccCchhccCCCCCcccchHHHHHHHHHHHh
Confidence 99999999999999994 3455689999999987665544445567889999999988888999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
|..||...+.......+......+.+ ..++..+.+++.+||+.+|.+|||++|+++||||
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~ll~~p~~ 256 (256)
T cd08220 197 LKRAFEAANLPALVLKIMSGTFAPIS----DRYSPDLRQLILSMLNLDPSKRPQLSQIMAQPIC 256 (256)
T ss_pred CCCCcccCchHHHHHHHHhcCCCCCC----CCcCHHHHHHHHHHccCChhhCCCHHHHhhCCCC
Confidence 99999988877777666554443333 3678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with |
| >cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-41 Score=266.43 Aligned_cols=219 Identities=28% Similarity=0.513 Sum_probs=190.3
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|+++++.++|+|++++.+++.++...++|+|++.+++|.+++... ++++..+..++.|++.|+.+||+.++
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~-~~~~~~~~~~~~ql~~~l~~lh~~~i 119 (274)
T cd06609 41 DEIEDIQQEIQFLSQCRSPYITKYYGSFLKGSKLWIIMEYCGGGSCLDLLKPG-KLDETYIAFILREVLLGLEYLHEEGK 119 (274)
T ss_pred hHHHHHHHHHHHHHHcCCCCeeeeeEEEEECCeEEEEEEeeCCCcHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 44567889999999999999999999999999999999999999999999765 88999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|.||++ ++++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus 120 ~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~sDv~slG~il~~l~tg~~ 196 (274)
T cd06609 120 IHRDIKAANILL---SEEGDVKLADFGVSGQLTSTMSKRNTFVGTPFWMAPEVIKQSGYDEKADIWSLGITAIELAKGEP 196 (274)
T ss_pred ccCCCCHHHEEE---CCCCCEEEcccccceeecccccccccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 77889999999998776543 22334557788999999988889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
||...+.......+.......... ..++.++.+++.+||..+|++|||++++++||||++.+..
T Consensus 197 p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~~l~~~p~~Rpt~~~il~~~~~~~~~~~ 260 (274)
T cd06609 197 PLSDLHPMRVLFLIPKNNPPSLEG---NKFSKPFKDFVSLCLNKDPKERPSAKELLKHKFIKKAKKT 260 (274)
T ss_pred CcccCchHHHHHHhhhcCCCCCcc---cccCHHHHHHHHHHhhCChhhCcCHHHHhhChhhcCCCcc
Confidence 998877766666655443333222 1378899999999999999999999999999999986654
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) |
| >cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-41 Score=267.13 Aligned_cols=214 Identities=36% Similarity=0.665 Sum_probs=189.9
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++|+||+++++++..++..++||||+++++|.+++.+.+.+++..+..++.|++.||.+||+.|+
T Consensus 43 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~qil~~l~~lH~~~i 122 (290)
T cd05580 43 KQVEHVLNEKRILQSIRHPFLVNLYGSFQDDSNLYLVMEYVPGGELFSHLRKSGRFPEPVARFYAAQVVLALEYLHSLDI 122 (290)
T ss_pred hHHHHHHHHHHHHHhCCCCCccceeeEEEcCCeEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 45677899999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|.||++ +.++.++|+|||++...... .....++..|+|||.+.+...+.++|+||||+++|+|++|..|
T Consensus 123 ~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 197 (290)
T cd05580 123 VYRDLKPENLLL---DSDGYIKITDFGFAKRVKGR--TYTLCGTPEYLAPEIILSKGYGKAVDWWALGILIYEMLAGYPP 197 (290)
T ss_pred ecCCCCHHHEEE---CCCCCEEEeeCCCccccCCC--CCCCCCCccccChhhhcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999 77889999999998776544 3344678899999999888889999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRNS 231 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~~ 231 (241)
|...+.....+.+..+. ..++ ..++..+.+++.+||+.||.+|+ +++++++||||+...
T Consensus 198 ~~~~~~~~~~~~~~~~~-~~~~----~~~~~~l~~li~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 261 (290)
T cd05580 198 FFDDNPIQIYEKILEGK-VRFP----SFFSPDAKDLIRNLLQVDLTKRLGNLKNGVNDIKNHPWFAGID 261 (290)
T ss_pred CCCCCHHHHHHHHhcCC-ccCC----ccCCHHHHHHHHHHccCCHHHccCcccCCHHHHHcCcccccCC
Confidence 99888776666664332 2333 36789999999999999999999 899999999998854
|
Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi |
| >cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-42 Score=277.84 Aligned_cols=213 Identities=34% Similarity=0.543 Sum_probs=183.0
Q ss_pred hhHHHHHHHHhcC---CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 11 SCLDCELNFLSSV---NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 11 ~~~~~E~~~l~~l---~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....|..++..+ +||+|+++++.+.+++..++||||+.+++|.+++.+.+.+++..+..++.|++.||+|||++|+
T Consensus 38 ~~~~~e~~~l~~~~~~~~p~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~qil~al~~LH~~~i 117 (330)
T cd05586 38 AHTIGERNILVRTLLDESPFIVGLKFSFQTDSDLYLVTDYMSGGELFWHLQKEGRFSEDRAKFYIAELVLALEHLHKYDI 117 (330)
T ss_pred HHHHHHHHHHHHhccCCCCcCcceEEEEecCCeEEEEEcCCCCChHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3445566777665 6999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||||+||++ +.++.++|+|||++..... ........++..|+|||.+.+. .++.++|+||+|+++|+|++|.
T Consensus 118 vHrDlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvil~elltG~ 194 (330)
T cd05586 118 VYRDLKPENILL---DATGHIALCDFGLSKANLTDNKTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW 194 (330)
T ss_pred EeccCCHHHeEE---CCCCCEEEecCCcCcCCCCCCCCccCccCCccccCHHHHcCCCCCCCccceeccccEEEEeccCC
Confidence 999999999999 7788999999999865432 2233445689999999998754 4789999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC----CHHHHhcCcccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL----SFNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp----s~~~il~~~~~~~~ 230 (241)
.||.+.+..+..+.+..+.. .++. ..++.++.+++++||+.||.+|| ++.++++||||++.
T Consensus 195 ~Pf~~~~~~~~~~~i~~~~~-~~~~---~~~~~~~~~li~~~L~~~P~~R~~~~~~~~~ll~h~~~~~~ 259 (330)
T cd05586 195 SPFYAEDTQQMYRNIAFGKV-RFPK---NVLSDEGRQFVKGLLNRNPQHRLGAHRDAVELKEHPFFADI 259 (330)
T ss_pred CCCCCCCHHHHHHHHHcCCC-CCCC---ccCCHHHHHHHHHHcCCCHHHCCCCCCCHHHHhcCccccCC
Confidence 99999888888877755432 2222 25789999999999999999998 79999999999863
|
Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of |
| >KOG0663 consensus Protein kinase PITSLRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-42 Score=260.16 Aligned_cols=217 Identities=29% Similarity=0.441 Sum_probs=185.7
Q ss_pred HHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 13 LDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 13 ~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
-.+|+.+|.+++|||||.+..+.... +..|+|||||+ -+|..++...+ +|....+.-+..|++.|++|||.+.|+|
T Consensus 122 sLREIniLl~~~H~NIV~vkEVVvG~~~d~iy~VMe~~E-hDLksl~d~m~q~F~~~evK~L~~QlL~glk~lH~~wilH 200 (419)
T KOG0663|consen 122 SLREINILLKARHPNIVEVKEVVVGSNMDKIYIVMEYVE-HDLKSLMETMKQPFLPGEVKTLMLQLLRGLKHLHDNWILH 200 (419)
T ss_pred hHHHHHHHHhcCCCCeeeeEEEEeccccceeeeeHHHHH-hhHHHHHHhccCCCchHHHHHHHHHHHHHHHHHhhceeEe
Confidence 46899999999999999999987643 56999999996 69999998876 7999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
||||++|+|+ +..|.+||+|||+|+.++... ......-|.+|.|||.+.+. .|+.+.|+||+||++.|++++.+.
T Consensus 201 RDLK~SNLLm---~~~G~lKiaDFGLAR~ygsp~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSvGCI~aE~l~~kPl 277 (419)
T KOG0663|consen 201 RDLKTSNLLL---SHKGILKIADFGLAREYGSPLKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSVGCIFAELLTQKPL 277 (419)
T ss_pred cccchhheee---ccCCcEEecccchhhhhcCCcccCcceEEEeeecCHHHhcCCcccCcchhhhhHHHHHHHHHhcCCC
Confidence 9999999999 799999999999999987653 33455679999999998765 589999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCc-------------------------cCC--CCChHHHHHHHHhcccCccccCCHHH
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQL-------------------------IVP--ALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~--~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
|.+.+..+++..|......+.... ..+ .+++...++++.+|..||.+|.|++|
T Consensus 278 f~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~ 357 (419)
T KOG0663|consen 278 FPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKLLTYDPGKRITAED 357 (419)
T ss_pred CCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHHhccCccccccHHH
Confidence 999988888877755332221100 011 25688999999999999999999999
Q ss_pred HhcCccccccccc
Q 026253 221 FYHHRFLRRNSAI 233 (241)
Q Consensus 221 il~~~~~~~~~~~ 233 (241)
.|+|+||.+.+.-
T Consensus 358 ~L~h~~F~e~P~p 370 (419)
T KOG0663|consen 358 GLKHEYFRETPLP 370 (419)
T ss_pred hhcccccccCCCC
Confidence 9999999995543
|
|
| >PHA02988 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=266.53 Aligned_cols=205 Identities=19% Similarity=0.264 Sum_probs=177.7
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS- 84 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~- 84 (241)
.+.+.+|+.++++++||||+++++++.+ ....++||||+++|+|.+++.+.+.+++.....++.+++.|+.+||+
T Consensus 62 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 141 (283)
T PHA02988 62 IDITENEIKNLRRIDSNNILKIYGFIIDIVDDLPRLSLILEYCTRGYLREVLDKEKDLSFKTKLDMAIDCCKGLYNLYKY 141 (283)
T ss_pred HHHHHHHHHHHHhcCCCCEEEEeeeEEecccCCCceEEEEEeCCCCcHHHHHhhCCCCChhHHHHHHHHHHHHHHHHHhc
Confidence 4678899999999999999999999876 35689999999999999999988889999999999999999999998
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc--cCCCCchhHHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~ 162 (241)
.+++|+||+|.||++ ++++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||||+++|+++
T Consensus 142 ~~~~Hrdlkp~nill---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGvil~el~ 216 (283)
T PHA02988 142 TNKPYKNLTSVSFLV---TENYKLKIICHGLEKILSSP--PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGVVLWEIF 216 (283)
T ss_pred CCCCCCcCChhhEEE---CCCCcEEEcccchHhhhccc--cccccCcccccCHHHhhhccccccchhhhhHHHHHHHHHH
Confidence 499999999999999 77889999999998765332 223457889999999876 67899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+|..||.+.+..+....+.... ..+.+ ...+.++.+++.+||+.||.+|||++++++
T Consensus 217 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~Rps~~ell~ 274 (283)
T PHA02988 217 TGKIPFENLTTKEIYDLIINKNNSLKLP----LDCPLEIKCIVEACTSHDSIKRPNIKEILY 274 (283)
T ss_pred HCCCCCCCCCHHHHHHHHHhcCCCCCCC----CcCcHHHHHHHHHHhcCCcccCcCHHHHHH
Confidence 9999999888877777664332 22222 367899999999999999999999999985
|
|
| >cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=263.27 Aligned_cols=216 Identities=28% Similarity=0.518 Sum_probs=184.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
......+.+|++++++++|+||+++.+++.+.+..++++||+.+++|.+++.+..++++..+..++.|++.|+++||+.|
T Consensus 43 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 122 (265)
T cd06631 43 EKEYEKLQEEVDLLKSLKHVNIVQYLGTCLDDNTISIFMEFVPGGSISSILNRFGPLPEPVFCKYTKQILDGVAYLHNNC 122 (265)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeEeeEeecCCeEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34456799999999999999999999999999999999999999999999988788999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-------CccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
++|+||+|.||++ +.++.++|+|||.+...... .......++..|.|||.+.+..++.++|+||+|+++|
T Consensus 123 i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~ 199 (265)
T cd06631 123 VVHRDIKGNNVML---MPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESGYGRKSDIWSIGCTVF 199 (265)
T ss_pred cccCCcCHHhEEE---CCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCCCcchhhHHHHHHHHH
Confidence 9999999999999 77889999999988754221 1122345788899999999888999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
++++|..||...+.......+...... .......++.++.+++++||+.+|.+||++.++++||||
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~ 265 (265)
T cd06631 200 EMATGKPPLASMDRLAAMFYIGAHRGL--MPRLPDSFSAAAIDFVTSCLTRDQHERPSALQLLRHDFL 265 (265)
T ss_pred HHHhCCCccccCChHHHHHHhhhccCC--CCCCCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcCCCC
Confidence 999999999877665544444332111 112234688999999999999999999999999999997
|
Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. |
| >PLN00034 mitogen-activated protein kinase kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.4e-42 Score=277.18 Aligned_cols=214 Identities=27% Similarity=0.418 Sum_probs=175.3
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
......+.+|++++++++|+||+++++++..++..++||||+++++|.+. ....+..+..++.|++.||.+||+.|
T Consensus 113 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~----~~~~~~~~~~i~~qi~~aL~~LH~~~ 188 (353)
T PLN00034 113 DTVRRQICREIEILRDVNHPNVVKCHDMFDHNGEIQVLLEFMDGGSLEGT----HIADEQFLADVARQILSGIAYLHRRH 188 (353)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceeeeEeccCCeEEEEEecCCCCccccc----ccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567889999999999999999999999999999999999999998653 34567888899999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccc-----cCCCCchhHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l~~ 160 (241)
++|+||||+||++ ++++.++|+|||++....... ......++..|+|||.+.. ...+.++||||||+++|+
T Consensus 189 ivHrDlkp~NIll---~~~~~~kL~DfG~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwslGvil~e 265 (353)
T PLN00034 189 IVHRDIKPSNLLI---NSAKNVKIADFGVSRILAQTMDPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILE 265 (353)
T ss_pred EeecCCCHHHEEE---cCCCCEEEcccccceecccccccccccccCccccCccccccccccCcCCCcchhHHHHHHHHHH
Confidence 9999999999999 788899999999987654322 2234568899999998743 234578999999999999
Q ss_pred HHhCCCCCCCCChH---HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 161 LLNGYPPFSGRNNV---QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 161 l~~g~~p~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|++|+.||...... .....+..... ......++.++.++|.+||+.||++|||+.|+++||||.+..
T Consensus 266 l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~l~~li~~~l~~~P~~Rpt~~ell~hp~~~~~~ 335 (353)
T PLN00034 266 FYLGRFPFGVGRQGDWASLMCAICMSQP----PEAPATASREFRHFISCCLQREPAKRWSAMQLLQHPFILRAQ 335 (353)
T ss_pred HHhCCCCCCCCCCccHHHHHHHHhccCC----CCCCCccCHHHHHHHHHHccCChhhCcCHHHHhcCcccccCC
Confidence 99999999743322 22222222222 222347889999999999999999999999999999999963
|
|
| >cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=266.07 Aligned_cols=219 Identities=30% Similarity=0.502 Sum_probs=181.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++|+||+++++++.+.+..++|+||+.+++|.+++.+.+++++..+..++.|++.|+.+||+.|+
T Consensus 45 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ql~~al~~LH~~~i 124 (268)
T cd06630 45 EVVEALRKEIRLMARLNHPHIIRMLGATCEDSHFNLFVEWMAGGSVSHLLSKYGAFKEAVIINYTEQLLRGLSYLHENQI 124 (268)
T ss_pred HHHHHHHHHHHHHHHcCCCceehhhceeccCCeEEEEEeccCCCcHHHHHHHhCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 35688999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
+|+||+|.||+++ ..+..++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++++++
T Consensus 125 ~H~~i~~~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 202 (268)
T cd06630 125 IHRDVKGANLLID--STGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQYGRSCDVWSVGCVIIEMA 202 (268)
T ss_pred ecCCCCHHHEEEc--CCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCCCCcccchHHHHHHHHHHH
Confidence 9999999999994 2334699999999876543211 12235678899999998888899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 228 (241)
+|..||...+.......+...............+++++.+++.+||..+|.+|||+.++++||||+
T Consensus 203 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ll~~~~~~ 268 (268)
T cd06630 203 TAKPPWNAEKHSNHLALIFKIASATTAPSIPEHLSPGLRDVTLRCLELQPEDRPPSRELLKHPVFR 268 (268)
T ss_pred hCCCCCCCCCCcchHHHHHHHhccCCCCCCchhhCHHHHHHHHHHcCCCcccCcCHHHHhcCcccC
Confidence 999999755433222222111111112223346789999999999999999999999999999985
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their |
| >cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-41 Score=274.81 Aligned_cols=216 Identities=31% Similarity=0.447 Sum_probs=175.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
.....+.+|+.++++++||||+++++++...+ ..++||||++ ++|.+.+. ..+++..+..++.|++.||.+
T Consensus 62 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~~~~qi~~~L~~ 138 (359)
T cd07876 62 THAKRAYRELVLLKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIH--MELDHERMSYLLYQMLCGIKH 138 (359)
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCCccccceeEEEEeCCC-cCHHHHHh--ccCCHHHHHHHHHHHHHHHHH
Confidence 44667889999999999999999999886543 5799999996 56776664 357889999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
||+.|++||||||+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus 139 LH~~~ivHrDlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 215 (359)
T cd07876 139 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTACTNFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEL 215 (359)
T ss_pred HHhCCcccCCCCHHHEEE---CCCCCEEEecCCCccccccCccCCCCcccCCCCCchhccCCCCCcchhhHHHHHHHHHH
Confidence 999999999999999999 77889999999999765444444456678999999999988999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCC---------------------CCC----------------CccCCCCChHHHHHH
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHL---------------------PFS----------------QLIVPALHPDCVDMC 204 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~---------------------~~~----------------~~~~~~~~~~~~~li 204 (241)
++|..||.+.+.......+...... ..+ .......++.+.++|
T Consensus 216 ~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 295 (359)
T cd07876 216 VKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERDKLKTSQARDLL 295 (359)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHhhCCCCCCcchhhhccccccccccccccccchhHHHHH
Confidence 9999999877654433222111100 000 001112467899999
Q ss_pred HHhcccCccccCCHHHHhcCccccc
Q 026253 205 LKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 205 ~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
.+||+.||++|||+.|+++||||+.
T Consensus 296 ~~mL~~dP~~R~t~~e~l~hp~~~~ 320 (359)
T cd07876 296 SKMLVIDPDKRISVDEALRHPYITV 320 (359)
T ss_pred HHHhccCcccCCCHHHHhcCchhhh
Confidence 9999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=266.24 Aligned_cols=217 Identities=30% Similarity=0.492 Sum_probs=184.2
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+|++++++++|++++++.+.+..++..+++|||+.+++|.+++... .++++..+..++.|++.||.+||+.|+
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~i 123 (285)
T cd05632 44 ESMALNEKQILEKVNSQFVVNLAYAYETKDALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLEDLHRENT 123 (285)
T ss_pred HHHHHHHHHHHHHcCCcCceeEEEEEecCCEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 456788999999999999999999999999999999999999999988654 369999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|.||++ ++++.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 124 iH~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~g~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~~P 200 (285)
T cd05632 124 VYRDLKPENILL---DDYGHIRISDLGLAVKIPEGESIRGRVGTVGYMAPEVLNNQRYTLSPDYWGLGCLIYEMIEGQSP 200 (285)
T ss_pred eecCCCHHHEEE---CCCCCEEEecCCcceecCCCCcccCCCCCcCccChHHhcCCCCCcccchHHHHHHHHHHHhCCCC
Confidence 999999999999 67788999999998765433333445688999999999888899999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCcccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 230 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~ 230 (241)
|.+.........+.... ..........++.++.+++..||+.||.+||+ +.+++.|+||+..
T Consensus 201 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~~~l~~~~~~~~~ 267 (285)
T cd05632 201 FRGRKEKVKREEVDRRV-LETEEVYSAKFSEEAKSICKMLLTKDPKQRLGCQEEGAGEVKRHPFFRNM 267 (285)
T ss_pred CCCCCHHHHHHHHHHhh-hccccccCccCCHHHHHHHHHHccCCHhHcCCCcccChHHHHcChhhhcC
Confidence 98776654443332211 11122334578899999999999999999999 8899999999873
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with |
| >cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-42 Score=278.51 Aligned_cols=218 Identities=28% Similarity=0.432 Sum_probs=181.9
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
..+.+.+|+.+++.++|+||+++++++...+ ..++||||+. ++|.+++.....+++..+..++.|++.||.+||
T Consensus 42 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH 120 (372)
T cd07853 42 SCKRVFRELKMLCFFKHDNVLSALDILQPPHIDPFEEIYVVTELMQ-SDLHKIIVSPQPLSSDHVKVFLYQILRGLKYLH 120 (372)
T ss_pred HHHHHHHHHHHHHhCCCCCcCCHhheecCCCccccceEEEEeeccc-cCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999998776 7899999995 689998887788999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~ 160 (241)
+.|++|+||||+||++ +.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+||++|+
T Consensus 121 ~~~ivH~dlkp~Nili---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~e 197 (372)
T cd07853 121 SAGILHRDIKPGNLLV---NSNCVLKICDFGLARVEEPDESKHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAE 197 (372)
T ss_pred hCCeeCCCCChHHEEE---CCCCCEEeccccceeecccCccccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHHH
Confidence 9999999999999999 788899999999987643322 22234568889999998764 47899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCC----------------------CC-----ccCCCCChHHHHHHHHhcccCcc
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPF----------------------SQ-----LIVPALHPDCVDMCLKLLSANTV 213 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------------~~-----~~~~~~~~~~~~li~~~l~~~p~ 213 (241)
|++|+.||.+.+..+.+..+......+. +. ......++++.++|.+||+.||.
T Consensus 198 l~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dP~ 277 (372)
T cd07853 198 LLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHKPPSLPVLYTLSSQATHEAVHLLCRMLVFDPD 277 (372)
T ss_pred HHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCCCCchHHhcccCCCCCHHHHHHHHHhCCCChh
Confidence 9999999998887766655533211100 00 12235678899999999999999
Q ss_pred ccCCHHHHhcCcccccc
Q 026253 214 DRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 214 ~Rps~~~il~~~~~~~~ 230 (241)
+|||++|+++||||+..
T Consensus 278 ~R~t~~e~l~hp~~~~~ 294 (372)
T cd07853 278 KRISAADALAHPYLDEG 294 (372)
T ss_pred hCcCHHHHhcCHhhCCC
Confidence 99999999999999873
|
Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription |
| >cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-41 Score=264.76 Aligned_cols=221 Identities=32% Similarity=0.500 Sum_probs=186.2
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|+++++.++|+|++++++++..++..++|+||+.+++|..++.+ ..++++..+..++.|++.||.+||+.
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~LH~~ 122 (282)
T cd06643 43 EEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNYLHEN 122 (282)
T ss_pred HHHHHHHHHHHHHHHHCCCCCeeeEEEEEeeCCEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34566788999999999999999999999999999999999999999998765 45789999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCccccc-----ccCCCCchhHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~ 159 (241)
|++|+||+|.||++ +.++.++|+|||++...... .......++..|+|||.+. +..++.++|+||+|+++|
T Consensus 123 ~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slGvil~ 199 (282)
T cd06643 123 KIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLI 199 (282)
T ss_pred CeeecCCCcccEEE---ccCCCEEEccccccccccccccccccccccccccCHhhccccCCCCCCCCccchhhhHHHHHH
Confidence 99999999999999 67888999999998654322 1223345788899999873 345778999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
++++|.+||...+..+....+......... ....++.++.+++++||+.||.+|||++++++||||+....
T Consensus 200 el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~ 270 (282)
T cd06643 200 EMAQIEPPHHELNPMRVLLKIAKSEPPTLA--QPSRWSSEFKDFLKKCLEKNVDARWTTTQLLQHPFVTVNSN 270 (282)
T ss_pred HHccCCCCccccCHHHHHHHHhhcCCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCCCEeccCC
Confidence 999999999988776666665443322221 22367889999999999999999999999999999997654
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. |
| >cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-41 Score=261.25 Aligned_cols=215 Identities=29% Similarity=0.484 Sum_probs=189.3
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
++...+.+.+|++++++++|+||+++++++.+.+..+++|||+++++|.+++... ..+++..+..++.|++.++.+||
T Consensus 39 ~~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh 118 (256)
T cd08221 39 SEKERRDALNEIVILSLLQHPNIIAYYNHFMDDNTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVSYIH 118 (256)
T ss_pred chhHHHHHHHHHHHHHhCCCCCeeEEEeEEecCCeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 4566778899999999999999999999999999999999999999999999765 45899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
+.|++|+||+|.||++ +.++.++|+|||.+....... ......++..|.|||...+..++.++|+||+|+++|+|+
T Consensus 119 ~~~i~h~dl~p~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~y~ape~~~~~~~~~~~Dv~slG~i~~~l~ 195 (256)
T cd08221 119 KAGILHRDIKTLNIFL---TKAGLIKLGDFGISKILGSEYSMAETVVGTPYYMSPELCQGVKYNFKSDIWALGCVLYELL 195 (256)
T ss_pred hCCccccCCChHhEEE---eCCCCEEECcCcceEEcccccccccccCCCccccCHhhcCCCCCCCcchhHHHHHHHHHHH
Confidence 9999999999999999 678889999999987654433 233456788999999998888899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+|..||...+..+....+..+...+.+ ..++.++.+++.+||..+|.+|||++++++|+|+
T Consensus 196 ~g~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~R~s~~~ll~~~~l 256 (256)
T cd08221 196 TLKRTFDATNPLNLVVKIVQGNYTPVV----SVYSSELISLVHSLLQQDPEKRPTADEVLDQPLL 256 (256)
T ss_pred HCCCCCCCCCHHHHHHHHHcCCCCCCc----cccCHHHHHHHHHHcccCcccCCCHHHHhhCcCC
Confidence 999999988888877777554433322 4778999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa |
| >KOG0986 consensus G protein-coupled receptor kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-42 Score=272.15 Aligned_cols=229 Identities=33% Similarity=0.482 Sum_probs=202.1
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (241)
.........+|-+||++++.+.||.+-..|++.+.+|+|+..|+||+|.-++.+.+ .+++..+..++.+|+.||.+||
T Consensus 225 kr~ge~maLnEk~iL~kV~s~FiVslaYAfeTkd~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGLehlH 304 (591)
T KOG0986|consen 225 KRKGETMALNEKQILEKVSSPFIVSLAYAFETKDALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGLEHLH 304 (591)
T ss_pred HhhhhHHhhHHHHHHHHhccCcEEEEeeeecCCCceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhHHHHH
Confidence 34456778899999999999999999999999999999999999999999998776 6999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+.+||+||+||+|||+ ++.++++|+|+|+|.............||.+|||||++.+..|+...|.|||||++|+|+.
T Consensus 305 ~~~iVYRDLKPeNILL---Dd~GhvRISDLGLAvei~~g~~~~~rvGT~GYMAPEvl~ne~Y~~s~Dwf~lGCllYemi~ 381 (591)
T KOG0986|consen 305 RRRIVYRDLKPENILL---DDHGHVRISDLGLAVEIPEGKPIRGRVGTVGYMAPEVLQNEVYDFSPDWFSLGCLLYEMIA 381 (591)
T ss_pred hcceeeccCChhheee---ccCCCeEeeccceEEecCCCCccccccCcccccCHHHHcCCcccCCccHHHHHhHHHHHHc
Confidence 9999999999999999 8999999999999999988888878899999999999999999999999999999999999
Q ss_pred CCCCCCCCChHH---HHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc-----c
Q 026253 164 GYPPFSGRNNVQ---LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR-----N 230 (241)
Q Consensus 164 g~~p~~~~~~~~---~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~-----~ 230 (241)
|+.||....... ...+.... .+..+...+|++..++++.+|++||++|.. +.++.+||||++ .
T Consensus 382 G~sPFr~~KeKvk~eEvdrr~~~----~~~ey~~kFS~eakslc~~LL~Kdp~~RLGcrg~ga~evk~HpfFk~lnw~rl 457 (591)
T KOG0986|consen 382 GHSPFRQRKEKVKREEVDRRTLE----DPEEYSDKFSEEAKSLCEGLLTKDPEKRLGCRGEGAQEVKEHPFFKDLNWRRL 457 (591)
T ss_pred ccCchhhhhhhhhHHHHHHHHhc----chhhcccccCHHHHHHHHHHHccCHHHhccCCCcCcchhhhCcccccCCHhHH
Confidence 999997543322 22222222 234445589999999999999999999985 679999999987 6
Q ss_pred cccCCCCCCCC
Q 026253 231 SAILRAPFHIP 241 (241)
Q Consensus 231 ~~~~~~~~~~~ 241 (241)
.+.+..|+++|
T Consensus 458 eagml~PPfiP 468 (591)
T KOG0986|consen 458 EAGMLEPPFIP 468 (591)
T ss_pred hccCCCCCCCC
Confidence 77888888887
|
|
| >cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=271.95 Aligned_cols=219 Identities=29% Similarity=0.559 Sum_probs=183.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|..+++.++|+||+++++.+.+++..++||||+.|++|.+++.+ ...+++..+..++.|++.||++||++
T Consensus 42 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 121 (331)
T cd05597 42 RAETACFREERDVLVNGDRRWITNLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDSVHQL 121 (331)
T ss_pred hhhHHHHHHHHHHHHhCCCCCCCceEEEEecCCeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34456788999999999999999999999999999999999999999999976 45689999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccc-----cCCCCchhHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAIL 158 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l 158 (241)
|++|+||||.||++ +.++.++|+|||++........ .....+++.|+|||.+.+ ..++.++|+||+|+++
T Consensus 122 ~ivH~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwslG~~l 198 (331)
T cd05597 122 GYVHRDIKPDNVLL---DKNGHIRLADFGSCLRLLADGTVQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSLGVCM 198 (331)
T ss_pred CeEECCCCHHHEEE---CCCCCEEEEECCceeecCCCCCccccceeccccccCHHHHhhccccccCCCCcceeehhhhHH
Confidence 99999999999999 7888999999999876543322 122458999999999863 3468899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCCC-CCCCCccCCCCChHHHHHHHHhcccCccc--cCCHHHHhcCccccc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCKH-LPFSQLIVPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRR 229 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~il~~~~~~~ 229 (241)
|+|++|+.||.+.+..+....+..... ..++. ..+.++.++.+++++||..++.+ |++++++++||||.+
T Consensus 199 ~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~li~~ll~~~~~r~~r~~~~~~l~hp~~~~ 271 (331)
T cd05597 199 YEMLYGETPFYAESLVETYGKIMNHKEHFQFPP-DVTDVSEEAKDLIRRLICSPETRLGRNGLQDFKDHPFFEG 271 (331)
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHcCCCcccCCC-ccCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCCCCCC
Confidence 999999999998887777776654332 22222 22458999999999998765444 789999999999976
|
Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, |
| >cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-41 Score=262.53 Aligned_cols=213 Identities=29% Similarity=0.506 Sum_probs=182.7
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
.+.+.+|++++++++|+||+++++++.++...++++|++.+++|.+++... ..+++..+..++.|++.|+.+||+.|++
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~~lh~~~i~ 121 (256)
T cd06612 42 LQEIIKEISILKQCDSPYIVKYYGSYFKNTDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLEYLHSNKKI 121 (256)
T ss_pred HHHHHHHHHHHHhCCCCcEeeeeeeeecCCcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 678999999999999999999999999999999999999999999999763 5689999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 122 H~dl~~~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~s~G~il~~l~~g~~p 198 (256)
T cd06612 122 HRDIKAGNILL---NEEGQAKLADFGVSGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNNKADIWSLGITAIEMAEGKPP 198 (256)
T ss_pred cCCCCcceEEE---CCCCcEEEcccccchhcccCccccccccCCccccCHHHHhcCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 678889999999987664433 22334467889999999888899999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
|...+.......+........ .....++..+.+++.+||+.||++|||++|+++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~il~~~~~ 256 (256)
T cd06612 199 YSDIHPMRAIFMIPNKPPPTL--SDPEKWSPEFNDFVKKCLVKDPEERPSAIQLLQHPFI 256 (256)
T ss_pred CCCcchhhhhhhhccCCCCCC--CchhhcCHHHHHHHHHHHhcChhhCcCHHHHhcCCCC
Confidence 987766554444422222111 1223577899999999999999999999999999997
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a |
| >cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=271.01 Aligned_cols=224 Identities=25% Similarity=0.339 Sum_probs=177.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+...+.+.+|+++++.++||||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||+
T Consensus 40 ~~~~~~~~~e~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~ 119 (327)
T cd08227 40 NEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALDYIHH 119 (327)
T ss_pred HHHHHHHHHHHHHHHhcCCCCeeeEEEEEEECCEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678889999999999999999999999999999999999999999999653 458999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--------ccccccCCCCccCcccccc--cCCCCchhHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSV 154 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--------~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~sl 154 (241)
.|++|+||||.||++ +.++.+++.||+.+....... ......++..|+|||.+.+ ..++.++|+||+
T Consensus 120 ~~iiH~dlkp~Nil~---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl 196 (327)
T cd08227 120 MGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSV 196 (327)
T ss_pred CCEecCCCChhhEEE---ecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHHH
Confidence 999999999999999 677889999998654332111 0112235667999999875 458899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCC-----------------------------------------CCccC
Q 026253 155 GAILFELLNGYPPFSGRNNVQLVRNINSCKHLPF-----------------------------------------SQLIV 193 (241)
Q Consensus 155 G~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-----------------------------------------~~~~~ 193 (241)
|+++|++++|..||.................... .....
T Consensus 197 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (327)
T cd08227 197 GITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSHPYN 276 (327)
T ss_pred HHHHHHHHHCCCCCCCcchhHHHHHHhcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCcccccc
Confidence 9999999999999986554443322211110000 00011
Q ss_pred CCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 194 PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 194 ~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
..+++++.+++++||+.||++|||++++++||||++.+..
T Consensus 277 ~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~~~~~ 316 (327)
T cd08227 277 RTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKRR 316 (327)
T ss_pred cccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhhcchh
Confidence 2356789999999999999999999999999999886543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype |
| >KOG0667 consensus Dual-specificity tyrosine-phosphorylation regulated kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-42 Score=281.33 Aligned_cols=219 Identities=33% Similarity=0.479 Sum_probs=185.5
Q ss_pred HhhhhHHHHHHHHhcCC-C-----cCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVN-H-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-~-----~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l 79 (241)
.-..+...|+.+|+.|+ | -|+|+++++|...++.|||+|.+ +.+|.++++.+ ..++...+..++.||+.||
T Consensus 224 ~f~~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr~HlciVfELL-~~NLYellK~n~f~Glsl~~ir~~~~Qil~~L 302 (586)
T KOG0667|consen 224 RFLRQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFRNHLCIVFELL-STNLYELLKNNKFRGLSLPLVRKFAQQILTAL 302 (586)
T ss_pred HHHHHHHHHHHHHHHHhccCCCCCeeEEEeeeccccccceeeeehhh-hhhHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence 34667788999999996 3 47999999999999999999999 68999999876 3589999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
.+||+.||+|+||||+|||+.+. ....|||+|||+|+....... .+..+..|.|||++.|.+|+.+.|+|||||+++
T Consensus 303 ~~L~~l~IIHcDLKPENILL~~~-~r~~vKVIDFGSSc~~~q~vy--tYiQSRfYRAPEVILGlpY~~~IDmWSLGCIlA 379 (586)
T KOG0667|consen 303 LFLHELGIIHCDLKPENILLKDP-KRSRIKVIDFGSSCFESQRVY--TYIQSRFYRAPEVILGLPYDTAIDMWSLGCILA 379 (586)
T ss_pred HHHHhCCeeeccCChhheeeccC-CcCceeEEecccccccCCcce--eeeeccccccchhhccCCCCCccceeehhhhHH
Confidence 99999999999999999999653 334799999999998765544 677889999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCCc----------------------------------------------cC
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQL----------------------------------------------IV 193 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~----------------------------------------------~~ 193 (241)
||++|.+.|.+.+..+++..|......+.... ..
T Consensus 380 EL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~~~~~~~~~~ 459 (586)
T KOG0667|consen 380 ELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYYRKARLERRG 459 (586)
T ss_pred hHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhhhhhcccccC
Confidence 99999999999998888877755322211100 00
Q ss_pred C------------CCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 194 P------------ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 194 ~------------~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+ .....+.+||++||..||.+|+|+.++|+||||...
T Consensus 460 P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~ 508 (586)
T KOG0667|consen 460 PPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT 508 (586)
T ss_pred CCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence 1 112358999999999999999999999999999953
|
|
| >cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=265.05 Aligned_cols=217 Identities=33% Similarity=0.501 Sum_probs=182.0
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+|++++++++|+||+++++.+...+..|+||||+++++|.+++.+.+ .+++..+..++.|++.|+.+||+.|
T Consensus 36 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ 115 (277)
T cd05577 36 GEQMALNEKKILEKVSSRFIVSLAYAFETKDDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGLEHLHQRR 115 (277)
T ss_pred hhHHHHHHHHHHHhCCCCCEeeeeeEEecCCeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35566789999999999999999999999999999999999999999998765 6899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
++|+||+|.||++ ++++.++|+|||.+.............++..|.|||.+.+..++.++|+||+|++++++++|..
T Consensus 116 i~H~di~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~~g~~ 192 (277)
T cd05577 116 IVYRDLKPENVLL---DDHGNVRISDLGLAVELKGGKKIKGRAGTPGYMAPEVLQGEVYDFSVDWFALGCTLYEMIAGRS 192 (277)
T ss_pred cccCCCCHHHEEE---CCCCCEEEccCcchhhhccCCccccccCCCCcCCHHHhcCCCCCchhhhHHHHHHHHHHhhCCC
Confidence 9999999999999 7788999999999876544333334556788999999988889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
||...........+.... ...+......+++.+.++|++||+.+|.+|| ++.+++.||||++
T Consensus 193 p~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~h~~~~~ 259 (277)
T cd05577 193 PFRQRKEKVEKEELKRRT-LEMAVEYPDKFSPEAKDLCEALLQKDPEKRLGCRGGSADEVREHPLFKD 259 (277)
T ss_pred CCCCCcccccHHHHHhcc-ccccccCCccCCHHHHHHHHHHccCChhHccCCCcccHHHHHhChhhhc
Confidence 998755422222221111 1122233346799999999999999999999 8889999999966
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of |
| >KOG0594 consensus Protein kinase PCTAIRE and related kinases [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-41 Score=259.38 Aligned_cols=222 Identities=32% Similarity=0.533 Sum_probs=189.0
Q ss_pred hhhhHHHHHHHHhcCCCcC-eeeeeeEEeecC------eEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPN-IIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGA 77 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~-i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~ 77 (241)
.-....+|+.+++.|+|+| |+++++++.+.+ ..++|+|++ ..+|.+++.... .++...+..+.+|++.
T Consensus 53 ~P~taiREisllk~L~~~~~iv~L~dv~~~~~~~~~~~~l~lvfe~~-d~DL~~ymd~~~~~~~g~~~~~ik~~m~Qll~ 131 (323)
T KOG0594|consen 53 VPSTAIREISLLKRLSHANHIVRLHDVIHTSNNHRGIGKLYLVFEFL-DRDLKKYMDSLPKKPQGLPPRLIKSFMRQLLR 131 (323)
T ss_pred CCchhhHHHHHHHHhCCCcceEEEEeeeeecccccccceEEEEEEee-cccHHHHHHhccccccCCCHHHHHHHHHHHHH
Confidence 3456789999999999999 999999998776 799999999 579999998765 4777899999999999
Q ss_pred HHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccC-CCCccccccCCCCccCccccccc-CCCCchhHHHHH
Q 026253 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG 155 (241)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~-~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG 155 (241)
|++|||+++|+||||||+||++ ++.+.+||+|||+|+... +...-.....|.+|.|||++.+. .|+...|+||+|
T Consensus 132 gl~~~H~~~IlHRDLKPQNlLi---~~~G~lKlaDFGlAra~~ip~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDiWs~G 208 (323)
T KOG0594|consen 132 GLAFLHSHGILHRDLKPQNLLI---SSSGVLKLADFGLARAFSIPMRTYTPEVVTLWYRAPEVLLGSTSYSTSVDIWSLG 208 (323)
T ss_pred HHHHHHhCCeecccCCcceEEE---CCCCcEeeeccchHHHhcCCcccccccEEEeeccCHHHhcCCCcCCCCcchHhHH
Confidence 9999999999999999999999 779999999999998776 44445566789999999998876 799999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCc-------------------------cCCCCChHHHHHHHHhccc
Q 026253 156 AILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQL-------------------------IVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 156 ~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~ 210 (241)
|+++||+++++.|.+....+++..|-.....+-.+. ..+..+.+..+++.+||+.
T Consensus 209 cIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~~~~~~~dll~~~L~y 288 (323)
T KOG0594|consen 209 CIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPKLDPDGIELLSKLLQY 288 (323)
T ss_pred HHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccccCccHHHHHHHHhcc
Confidence 999999999999999998888777755433321111 1123345899999999999
Q ss_pred CccccCCHHHHhcCcccccccccC
Q 026253 211 NTVDRLSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 211 ~p~~Rps~~~il~~~~~~~~~~~~ 234 (241)
+|.+|.|++.+|.||||.......
T Consensus 289 ~p~~R~Sa~~al~h~yf~~~~~~~ 312 (323)
T KOG0594|consen 289 DPAKRISAKGALTHPYFSELPEKS 312 (323)
T ss_pred CcccCcCHHHHhcChhhcccccch
Confidence 999999999999999999975544
|
|
| >cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=262.65 Aligned_cols=216 Identities=28% Similarity=0.470 Sum_probs=183.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|++++++++|+||+++++++..++..+++|||+.+++|.+++... ..+++..+..++.|++.|+.+||+.|
T Consensus 42 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~~ 121 (262)
T cd06613 42 DDFEIIQQEISMLKECRHPNIVAYFGSYLRRDKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAYLHETG 121 (262)
T ss_pred hhHHHHHHHHHHHHhCCCCChhceEEEEEeCCEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35678999999999999999999999999999999999999999999999876 78999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc---CCCCchhHHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~~l~~l~ 162 (241)
++|+||+|+||++ ++++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++|+|+
T Consensus 122 i~h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~~l~~~~ 198 (262)
T cd06613 122 KIHRDIKGANILL---TEDGDVKLADFGVSAQLTATIAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELA 198 (262)
T ss_pred ceecCCChhhEEE---CCCCCEEECccccchhhhhhhhccccccCCccccCchhhcccccCCcCchhhhHHHHHHHHHHH
Confidence 9999999999999 678889999999987654322 22334577889999998766 7889999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 226 (241)
+|..||...+.......+......+........++.++.+++++||..+|.+|||+++++.|+|
T Consensus 199 tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~ 262 (262)
T cd06613 199 ELQPPMFDLHPMRALFLISKSNFPPPKLKDKEKWSPVFHDFIKKCLTKDPKKRPTATKLLQHPF 262 (262)
T ss_pred hCCCCCCCCCHHHHHHHHHhccCCCccccchhhhhHHHHHHHHHHcCCChhhCCCHHHHhcCCC
Confidence 9999998877666555443332111111122356788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ |
| >cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-41 Score=267.55 Aligned_cols=213 Identities=31% Similarity=0.513 Sum_probs=180.2
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+.+.+|+.++++++|++++++++.+.+++..++||||+.|++|.+++...+ .+++..+..++.|++.|+.+||+.|+
T Consensus 44 ~~~~~~E~~il~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 123 (285)
T cd05630 44 ESMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLEDLHQERI 123 (285)
T ss_pred HHHHHHHHHHHHhCCCCCeeeeeEEEecCCEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4567789999999999999999999999999999999999999999986543 58999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|+||++ +..+.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 124 iH~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~~P 200 (285)
T cd05630 124 VYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSP 200 (285)
T ss_pred EeCCCCHHHEEE---CCCCCEEEeeccceeecCCCccccCCCCCccccChHHHcCCCCCCccccHHHHHHHHHHHhCCCC
Confidence 999999999999 67888999999998765433333345688999999999988899999999999999999999999
Q ss_pred CCCCChH---HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc
Q 026253 168 FSGRNNV---QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 229 (241)
Q Consensus 168 ~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~ 229 (241)
|...... +....+..... ......++.++.+++++||+.||.+||| ++|+++||||++
T Consensus 201 f~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~~~~~h~~~~~ 266 (285)
T cd05630 201 FQQRKKKIKREEVERLVKEVQ----EEYSEKFSPDARSLCKMLLCKDPKERLGCQGGGAREVKEHPLFKQ 266 (285)
T ss_pred CCCCCccchHHHHHhhhhhhh----hhcCccCCHHHHHHHHHHhhcCHHHccCCCCCchHHHHcChhhhc
Confidence 9865432 22222211111 1233468889999999999999999999 999999999986
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as |
| >cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.8e-41 Score=267.69 Aligned_cols=223 Identities=30% Similarity=0.464 Sum_probs=184.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~ 85 (241)
......+.+|++++++++||||+++++++.+++..++||||+++++|.+++++.+++++..+..++.|++.||.|||+ .
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~ey~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 119 (308)
T cd06615 40 PAIRNQIIRELKVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPENILGKISIAVLRGLTYLREKH 119 (308)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCEEEEEeeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 344567889999999999999999999999999999999999999999999988889999999999999999999998 5
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+++|+||+|.||++ +.++.++|+|||.+...... ......++..|.|||.+.+..++.++|+||+|+++|++++|.
T Consensus 120 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~DiwslG~~l~~l~~g~ 195 (308)
T cd06615 120 KIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYTVQSDIWSLGLSLVEMAIGR 195 (308)
T ss_pred CEEECCCChHHEEE---ecCCcEEEccCCCccccccc-ccccCCCCcCccChhHhcCCCCCccchHHHHHHHHHHHHhCC
Confidence 89999999999999 67788999999998654332 223456788999999998888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCC---------------------------------CCCccCCCCChHHHHHHHHhcccCc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLP---------------------------------FSQLIVPALHPDCVDMCLKLLSANT 212 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~---------------------------------~~~~~~~~~~~~~~~li~~~l~~~p 212 (241)
.||...+.......+....... .+..-...++.++.+++.+||..+|
T Consensus 196 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 275 (308)
T cd06615 196 YPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFVDKCLKKNP 275 (308)
T ss_pred CCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHHHHHccCCh
Confidence 9997655444333221110000 0000011367789999999999999
Q ss_pred cccCCHHHHhcCccccccccc
Q 026253 213 VDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 213 ~~Rps~~~il~~~~~~~~~~~ 233 (241)
++|||+.++++||||.+....
T Consensus 276 ~~Rpt~~~ll~~~~~~~~~~~ 296 (308)
T cd06615 276 KERADLKELTKHPFIKRAELE 296 (308)
T ss_pred hhCcCHHHHhcChhhhhcccc
Confidence 999999999999999885443
|
Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down |
| >cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-41 Score=260.14 Aligned_cols=214 Identities=26% Similarity=0.544 Sum_probs=183.2
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEee-cCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+.+|++++++++|+|++++.+.+.. ++..+++||++++++|.+++... ..+++..+..++.+++.|+.+||
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~~lH 119 (257)
T cd08223 40 RRERKAAEQEAQLLSQLKHPNIVAYRESWEGEDGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQYLH 119 (257)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeeecCCCCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456778999999999999999999998764 45689999999999999999763 45899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
+.|++|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||...+..++.++|+||+|+++++++
T Consensus 120 ~~~i~H~di~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~l~ 196 (257)
T cd08223 120 EKHILHRDLKTQNVFL---TRTNIIKVGDLGIARVLENQCDMASTLIGTPYYMSPELFSNKPYNYKSDVWALGCCVYEMA 196 (257)
T ss_pred hCCeeccCCCchhEEE---ecCCcEEEecccceEEecccCCccccccCCcCccChhHhcCCCCCchhhhHHHHHHHHHHH
Confidence 9999999999999999 67889999999998765332 2223345788899999999888999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+|..||...+.......+..+..... ...++.++.+++.+|++.+|.+|||+.++++||||
T Consensus 197 ~g~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 257 (257)
T cd08223 197 TLKHAFNAKDMNSLVYRIIEGKLPPM----PKDYSPELGELIATMLSKRPEKRPSVKSILRQPYI 257 (257)
T ss_pred cCCCCCCCCCHHHHHHHHHhcCCCCC----ccccCHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 99999988777666655544443222 23688999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. |
| >cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=271.57 Aligned_cols=219 Identities=29% Similarity=0.559 Sum_probs=185.2
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
......+.+|+.++..++|++|+++++.+.+++..++||||+.+++|.+++.+ ...+++..+..++.|++.|+.+||+.
T Consensus 42 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~lH~~ 121 (332)
T cd05623 42 RAETACFREERDVLVNGDNQWITTLHYAFQDENNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQL 121 (332)
T ss_pred hhHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34455688999999999999999999999999999999999999999999986 36789999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCccccc-----ccCCCCchhHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l 158 (241)
|++||||||+||++ +.++.++|+|||++........ .....+++.|+|||.+. ...++.++|+||+|+++
T Consensus 122 ~iiHrDlkp~Nili---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlGvil 198 (332)
T cd05623 122 HYVHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLGVCM 198 (332)
T ss_pred CeEecCCCHHHEEE---CCCCCEEEeecchheecccCCcceecccccCccccCHHHHhccccCCCCCCCcCCEEeeHHHH
Confidence 99999999999999 7888999999999876533222 22356899999999885 34578899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCCC-CCCCCccCCCCChHHHHHHHHhcccCccc--cCCHHHHhcCccccc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCKH-LPFSQLIVPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRR 229 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~il~~~~~~~ 229 (241)
|+|++|..||...+..+....+..... ..++. ....++.++.+++++||..++.+ |++++++++||||.+
T Consensus 199 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~~li~~ll~~~~~r~~r~~~~~~~~h~~f~~ 271 (332)
T cd05623 199 YEMLYGETPFYAESLVETYGKIMNHKERFQFPA-QVTDVSEDAKDLIRRLICSREHRLGQNGIEDFKQHPFFTG 271 (332)
T ss_pred HHHhcCCCCCCCCCHHHHHHHHhCCCccccCCC-ccccCCHHHHHHHHHHccChhhhcCCCCHHHHhCCCCcCC
Confidence 999999999999888888877755432 22222 23467999999999999765554 689999999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw |
| >cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-41 Score=274.90 Aligned_cols=217 Identities=31% Similarity=0.542 Sum_probs=184.7
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.+++.++||||+++++.+.+++..++||||++|++|.+++.. ..+++..+..++.|++.||.+||+.|+
T Consensus 85 ~~~~~~~~e~~i~~~~~hp~iv~~~~~~~~~~~~~lv~Ey~~gg~L~~~~~~-~~~~~~~~~~~~~qi~~aL~~LH~~~i 163 (371)
T cd05622 85 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGF 163 (371)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 4456688999999999999999999999999999999999999999999875 468999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccC----CCCchhHHHHHHHHHHH
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFEL 161 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~----~~~~~Dv~slG~~l~~l 161 (241)
+||||||+||++ +.++.++|+|||++....... ......+++.|+|||.+.+.. ++.++|+||+|+++|+|
T Consensus 164 vHrDLkp~NIll---~~~~~ikL~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlGvilyel 240 (371)
T cd05622 164 IHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 240 (371)
T ss_pred EeCCCCHHHEEE---CCCCCEEEEeCCceeEcCcCCcccccCcccCccccCHHHHhccCCCccCCCccceeehhHHHHHH
Confidence 999999999999 778899999999997654322 123456899999999986543 78899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCC-CCCCCccCCCCChHHHHHHHHhcccCccc--cCCHHHHhcCcccccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKH-LPFSQLIVPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRRN 230 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~il~~~~~~~~ 230 (241)
++|..||.+.+....+..+..... ..++. ...++..+.++|..||..++.+ |++++++++|+||++.
T Consensus 241 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~--~~~~s~~~~~li~~~L~~~~~r~~r~~~~ei~~h~~~~~~ 310 (371)
T cd05622 241 LVGDTPFYADSLVGTYSKIMNHKNSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 310 (371)
T ss_pred HhCCCCCCCCCHHHHHHHHHcCCCcccCCC--cCCCCHHHHHHHHHHcCChhhhcCCCCHHHHhcCcccCCC
Confidence 999999999888888887765432 23332 2468999999999999854443 7899999999999873
|
Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an |
| >cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-41 Score=269.90 Aligned_cols=215 Identities=31% Similarity=0.603 Sum_probs=186.8
Q ss_pred HhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+..|..+++.+. |++|+++++++.+.+..++||||++|++|.+++...+.+++..+..++.|++.||.+||+.|
T Consensus 42 ~~~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~Ey~~~g~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ 121 (323)
T cd05615 42 DDVECTMVEKRVLALQDKPPFLTQLHSCFQTVDRLYFVMEYVNGGDLMYHIQQVGKFKEPQAVFYAAEISVGLFFLHRRG 121 (323)
T ss_pred hHHHHHHHHHHHHHhccCCCchhheeeEEecCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34566788999999885 57788899999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||||+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 122 ivHrDikp~Nill---~~~~~ikL~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~elltG~ 198 (323)
T cd05615 122 IIYRDLKLDNVML---DSEGHIKIADFGMCKEHMVDGVTTRTFCGTPDYIAPEIIAYQPYGKSVDWWAYGVLLYEMLAGQ 198 (323)
T ss_pred eeccCCCHHHeEE---CCCCCEEEeccccccccCCCCccccCccCCccccCHHHHcCCCCCCccchhhhHHHHHHHHhCC
Confidence 9999999999999 77889999999998754322 2233456889999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCcccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~ 230 (241)
.||.+.+.....+.+.... ... +..++.++.+++.+||+.+|.+|++ .+++++||||+..
T Consensus 199 ~pf~~~~~~~~~~~i~~~~-~~~----p~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~i~~h~~f~~~ 263 (323)
T cd05615 199 PPFDGEDEDELFQSIMEHN-VSY----PKSLSKEAVSICKGLMTKHPSKRLGCGPEGERDIREHAFFRRI 263 (323)
T ss_pred CCCCCCCHHHHHHHHHhCC-CCC----CccCCHHHHHHHHHHcccCHhhCCCCCCCCHHHHhcCcccCCC
Confidence 9999988888877775433 222 2367899999999999999999997 5799999999973
|
Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a |
| >cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-41 Score=273.68 Aligned_cols=218 Identities=30% Similarity=0.442 Sum_probs=176.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (241)
......+.+|+.+++.++|+||+++++++... ...++||||++ +++.+.+.. .+++..+..++.|++.||.
T Consensus 57 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~l~~~~~~~~~~qi~~aL~ 133 (355)
T cd07874 57 QTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIK 133 (355)
T ss_pred hHHHHHHHHHHHHHHHhCCCchhceeeeeeccccccccceeEEEhhhhc-ccHHHHHhh--cCCHHHHHHHHHHHHHHHH
Confidence 34456788999999999999999999987643 35799999996 577777653 5788999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+||+.|++||||||+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+
T Consensus 134 ~LH~~givHrDikp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~e 210 (355)
T cd07874 134 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 210 (355)
T ss_pred HHHhCCcccCCCChHHEEE---CCCCCEEEeeCcccccCCCccccCCccccCCccCHHHHcCCCCCchhhHHHHHHHHHH
Confidence 9999999999999999999 7788999999999987655544455678999999999998889999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCC--------------------------CC-----------CCccCCCCChHHHHH
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHL--------------------------PF-----------SQLIVPALHPDCVDM 203 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~--------------------------~~-----------~~~~~~~~~~~~~~l 203 (241)
|++|..||.+.+..+....+...... .. ........+.++.++
T Consensus 211 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (355)
T cd07874 211 MVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDL 290 (355)
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHHH
Confidence 99999999887654443322111100 00 011112345678999
Q ss_pred HHHhcccCccccCCHHHHhcCcccccc
Q 026253 204 CLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 204 i~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
|.+||+.||.+|||+.|+++||||+..
T Consensus 291 i~~mL~~dP~~Rps~~ell~hp~~~~~ 317 (355)
T cd07874 291 LSKMLVIDPAKRISVDEALQHPYINVW 317 (355)
T ss_pred HHHHhcCCchhcCCHHHHhcCcchhcc
Confidence 999999999999999999999999753
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok |
| >cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-41 Score=273.47 Aligned_cols=216 Identities=30% Similarity=0.454 Sum_probs=177.9
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
.....+.+|+.+++.++|+||+++++++... ...++||||+. ++|.+++.. .+++..+..++.|++.||.+
T Consensus 65 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~--~~~~~~~~~~~~qi~~aL~~ 141 (364)
T cd07875 65 THAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQM--ELDHERMSYLLYQMLCGIKH 141 (364)
T ss_pred hhHHHHHHHHHHHHhcCCCCccccceeecccccccccCeEEEEEeCCC-CCHHHHHHh--cCCHHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999987543 35799999995 578877753 57889999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
||++|++||||||+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 142 LH~~~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~el 218 (364)
T cd07875 142 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 218 (364)
T ss_pred HhhCCeecCCCCHHHEEE---CCCCcEEEEeCCCccccCCCCcccCCcccCCcCCHHHHhCCCCCchhhHHhHHHHHHHH
Confidence 999999999999999999 77889999999999876554444556789999999999998999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCCC-------------------------------------CccCCCCChHHHHHH
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPFS-------------------------------------QLIVPALHPDCVDMC 204 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~-------------------------------------~~~~~~~~~~~~~li 204 (241)
++|+.||.+.+..+....+......+.+ .......+..+.++|
T Consensus 219 l~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dll 298 (364)
T cd07875 219 IKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDLL 298 (364)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHHHHH
Confidence 9999999987776655544332111100 001112346789999
Q ss_pred HHhcccCccccCCHHHHhcCccccc
Q 026253 205 LKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 205 ~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
.+||+.||.+|||+.|+|+||||..
T Consensus 299 ~~mL~~dP~~R~t~~e~L~hp~~~~ 323 (364)
T cd07875 299 SKMLVIDASKRISVDEALQHPYINV 323 (364)
T ss_pred HHhcCcCcccCCCHHHHhcCccccc
Confidence 9999999999999999999999975
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn |
| >cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.2e-41 Score=262.27 Aligned_cols=215 Identities=25% Similarity=0.416 Sum_probs=179.0
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
....+.+|+.+++.++|+||+++++.+..++..+++|||+++++|.+++...+.+++..+..++.|++.|+.+||+.|++
T Consensus 49 ~~~~~~~e~~~~~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 128 (267)
T cd06645 49 DFAVVQQEIIMMKDCKHSNIVAYFGSYLRRDKLWICMEFCGGGSLQDIYHVTGPLSESQIAYVSRETLQGLYYLHSKGKM 128 (267)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEEeCCEEEEEEeccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 34567899999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccc---ccCCCCchhHHHHHHHHHHHHhC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+. +..++.++|+||+|+++|++++|
T Consensus 129 H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~il~~l~~~ 205 (267)
T cd06645 129 HRDIKGANILL---TDNGHVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred cCCCCHHHEEE---CCCCCEEECcceeeeEccCcccccccccCcccccChhhhccccCCCCCchhhhHHHHHHHHHHhcC
Confidence 99999999999 678889999999986554322 223446788999999874 45578899999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 226 (241)
..||....+.............+........++..+.+++++||+.+|++|||++++++|||
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~ll~~~~ 267 (267)
T cd06645 206 QPPMFDLHPMRALFLMTKSNFQPPKLKDKMKWSNSFHHFVKMALTKNPKKRPTAEKLLQHPF 267 (267)
T ss_pred CCCcccccchhhHHhhhccCCCCCcccccCCCCHHHHHHHHHHccCCchhCcCHHHHhcCCC
Confidence 99997665544333332222111111112256788999999999999999999999999998
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-41 Score=263.79 Aligned_cols=219 Identities=32% Similarity=0.494 Sum_probs=186.3
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|++++++++|+||+++++.+..++..++||||+++++|.+++.+. ..+++..+..++.|++.|+.+||+.
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lh~~ 122 (280)
T cd06611 43 EEELEDFMVEIDILSECKHPNIVGLYEAYFYENKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNFLHSH 122 (280)
T ss_pred HHHHHHHHHHHHHHHhCCCCceeEEEEEEecCCeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344567889999999999999999999999999999999999999999998764 4689999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccc-----ccCCCCchhHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~ 159 (241)
|++|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+. ...++.++|+||+|+++|
T Consensus 123 ~i~h~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~slG~il~ 199 (280)
T cd06611 123 KVIHRDLKAGNILL---TLDGDVKLADFGVSAKNKSTLQKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLI 199 (280)
T ss_pred CcccCCCChhhEEE---CCCCCEEEccCccchhhcccccccceeecchhhcCHHHHhhcccCCCCCCccccHHHHHHHHH
Confidence 99999999999999 778899999999876543322 223345788899999874 344678999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+|++|..||.+.+..+....+......... ....++.++.+++.+||+.+|.+||++.++++||||++.
T Consensus 200 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 268 (280)
T cd06611 200 ELAQMEPPHHELNPMRVLLKILKSEPPTLD--QPSKWSSSFNDFLKSCLVKDPDDRPTAAELLKHPFVSDQ 268 (280)
T ss_pred HHHhCCCCcccCCHHHHHHHHhcCCCCCcC--CcccCCHHHHHHHHHHhccChhhCcCHHHHhcChhhccc
Confidence 999999999988877766666544332221 123678899999999999999999999999999999875
|
Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti |
| >cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-41 Score=269.38 Aligned_cols=220 Identities=28% Similarity=0.477 Sum_probs=180.1
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|++++++++|+||+++++++..++..++||||+. ++|.+++...+ .++...+..++.|++.||.+||+.|++
T Consensus 48 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~iv 126 (309)
T cd07872 48 PCTAIREVSLLKDLKHANIVTLHDIVHTDKSLTLVFEYLD-KDLKQYMDDCGNIMSMHNVKIFLYQILRGLAYCHRRKVL 126 (309)
T ss_pred chhHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeCCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3467789999999999999999999999999999999996 58888886654 478999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
||||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|++|++
T Consensus 127 H~dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~el~tg~~ 203 (309)
T cd07872 127 HRDLKPQNLLI---NERGELKLADFGLARAKSVPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRP 203 (309)
T ss_pred cCCCCHHHEEE---CCCCCEEECccccceecCCCccccccccccccccCCHHHhCCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 778899999999987543322 2233456889999998865 457899999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCC------------------CCC-------ccCCCCChHHHHHHHHhcccCccccCCHHHH
Q 026253 167 PFSGRNNVQLVRNINSCKHLP------------------FSQ-------LIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~------------------~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 221 (241)
||.+.+..+....+......+ .+. ...+.++.++.++|++||+.||.+|||++|+
T Consensus 204 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R~t~~e~ 283 (309)
T cd07872 204 LFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINHAPRLDTEGIELLTKFLQYESKKRISAEEA 283 (309)
T ss_pred CCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhhccCCCHHHHHHHHHhccCChhhCCCHHHH
Confidence 998877655544432211110 000 1123578899999999999999999999999
Q ss_pred hcCccccccccc
Q 026253 222 YHHRFLRRNSAI 233 (241)
Q Consensus 222 l~~~~~~~~~~~ 233 (241)
++||||+..+..
T Consensus 284 l~h~~~~~~~~~ 295 (309)
T cd07872 284 MKHAYFRSLGTR 295 (309)
T ss_pred hcChhhhhcccc
Confidence 999999986543
|
Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play |
| >KOG1026 consensus Nerve growth factor receptor TRKA and related tyrosine kinases [Signal transduction mechanisms; Intracellular trafficking, secretion, and vesicular transport] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=285.35 Aligned_cols=210 Identities=27% Similarity=0.554 Sum_probs=190.7
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC--------------CCHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--------------VPEQTARKF 71 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------~~~~~~~~~ 71 (241)
+++.+..|++|+.++..++|||||+++|.+.+++-.++|+|||..|+|.++|+..++ ++..+...+
T Consensus 529 ~~~~~~dF~REaeLla~l~H~nIVrLlGVC~~~~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q~L~i 608 (774)
T KOG1026|consen 529 ENQARQDFRREAELLAELQHPNIVRLLGVCREGDPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQFLHI 608 (774)
T ss_pred cHHHHHHHHHHHHHHHhccCCCeEEEEEEEccCCeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHHHHHH
Confidence 344788999999999999999999999999999999999999999999999975432 778899999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc---cccCCCCccCcccccccCCCCc
Q 026253 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEK 148 (241)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~ 148 (241)
+.||+.|+.||.++.+|||||-..|+|| +++..|||+|||+++......+-. ...-..+|||||.+..+++|.+
T Consensus 609 A~QIAaGM~YLs~~~FVHRDLATRNCLV---ge~l~VKIsDfGLsRdiYssDYYk~~~~t~lPIRWMppEsIly~kFTte 685 (774)
T KOG1026|consen 609 ATQIAAGMEYLSSHHFVHRDLATRNCLV---GENLVVKISDFGLSRDIYSSDYYKVRGNTLLPIRWMPPESILYGKFTTE 685 (774)
T ss_pred HHHHHHHHHHHHhCcccccchhhhhcee---ccceEEEecccccchhhhhhhhhcccCCceeeeecCCHHHhhcCcccch
Confidence 9999999999999999999999999999 899999999999998876543321 2234578999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 149 VDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
|||||+|+++||+++ |..||.+.+..+.++.|+.+...+-++ .+|.++.+++..||+.+|++||+++||-
T Consensus 686 SDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe----~CP~~vY~LM~~CW~~~P~~RPsF~eI~ 756 (774)
T KOG1026|consen 686 SDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPE----NCPTEVYSLMLECWNENPKRRPSFKEIH 756 (774)
T ss_pred hhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCC----CCCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence 999999999999999 999999999999999999988877666 8999999999999999999999999974
|
|
| >cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.8e-41 Score=260.04 Aligned_cols=214 Identities=28% Similarity=0.528 Sum_probs=186.6
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+.+.+|++++++++|+||+++.+++..++..++||||+.+++|.+++.... .+++..+..++.|++.|+.+||+
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~ 119 (256)
T cd08218 40 PKEREESRKEVAVLSNMKHPNIVQYQESFEENGNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALKHVHD 119 (256)
T ss_pred hHHHHHHHHHHHHHHhCCCCCeeeeEeeecCCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 4456789999999999999999999999999999999999999999999987643 57899999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
.|++|+||+|+||++ +.++.++++|||.+........ .....++..|.|||...+...+.++|+||+|++++++++
T Consensus 120 ~~i~h~~l~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~i~~~l~~ 196 (256)
T cd08218 120 RKILHRDIKSQNIFL---TKDGTIKLGDFGIARVLNSTVELARTCIGTPYYLSPEICENRPYNNKSDIWALGCVLYEMCT 196 (256)
T ss_pred CCEecCCCCHHHEEE---cCCCCEEEeeccceeecCcchhhhhhccCCccccCHHHhCCCCCCCccchhHHHHHHHHHHc
Confidence 999999999999999 6788899999999876543221 223456788999999988888999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
|..||...+..+....+..+...+.+ ..++.++.+++.+||+.+|.+||++.++++||||
T Consensus 197 g~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~vl~~~~~ 256 (256)
T cd08218 197 LKHAFEAGNMKNLVLKIIRGSYPPVS----SHYSYDLRNLVSQLFKRNPRDRPSVNSILEKNFI 256 (256)
T ss_pred CCCCccCCCHHHHHHHHhcCCCCCCc----ccCCHHHHHHHHHHhhCChhhCcCHHHHhhCcCC
Confidence 99999988877777766555443333 3678999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti |
| >cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=265.56 Aligned_cols=213 Identities=33% Similarity=0.521 Sum_probs=174.8
Q ss_pred hhHHHHHHHHhcC---CCcCeeeeeeEEee-----cCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHH
Q 026253 11 SCLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 11 ~~~~~E~~~l~~l---~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~ 80 (241)
..+.+|+.+++.+ +|+||+++++++.. ....+++||++. ++|.+++... ..+++..+..++.|++.||.
T Consensus 44 ~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~ 122 (288)
T cd07863 44 LSTVREVALLKRLEAFDHPNIVRLMDVCATSRTDRETKVTLVFEHVD-QDLRTYLDKVPPPGLPAETIKDLMRQFLRGLD 122 (288)
T ss_pred hHHHHHHHHHHHhhhcCCCCeeeeeeeeccccCCCCceEEEEEcccc-cCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence 3566788877766 69999999998764 345899999996 5899988764 34899999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+||+.|++|+||||+||++ +.++.++|+|||++.............++..|+|||.+.+..++.++|+||+|+++|+
T Consensus 123 ~lH~~~ivH~dikp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~~l~~ 199 (288)
T cd07863 123 FLHANCIVHRDLKPENILV---TSGGQVKLADFGLARIYSCQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAE 199 (288)
T ss_pred HHHhCCeecCCCCHHHEEE---CCCCCEEECccCccccccCcccCCCccccccccCchHhhCCCCCCcchhhhHHHHHHH
Confidence 9999999999999999999 7888999999999977654443444567889999999988889999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCC----------------------CCccCCCCChHHHHHHHHhcccCccccCCH
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPF----------------------SQLIVPALHPDCVDMCLKLLSANTVDRLSF 218 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 218 (241)
|++|.+||.+....+....+......+. .....+.++..+.+++.+||+.||.+|||+
T Consensus 200 l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~ 279 (288)
T cd07863 200 MFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGAFSPRGPRPVQSVVPEIEESGAQLLLEMLTFNPHKRISA 279 (288)
T ss_pred HHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccccCCCCCCchHHhCcCcCHHHHHHHHHHhccCcccCCCH
Confidence 9999999988776655544432111000 011234678889999999999999999999
Q ss_pred HHHhcCccc
Q 026253 219 NEFYHHRFL 227 (241)
Q Consensus 219 ~~il~~~~~ 227 (241)
+|++.||||
T Consensus 280 ~~~l~hp~f 288 (288)
T cd07863 280 FRALQHPFF 288 (288)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou |
| >PHA03207 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=276.53 Aligned_cols=220 Identities=26% Similarity=0.412 Sum_probs=179.8
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (241)
+...+|++++++++|+||+++++++...+..+++||++ +++|.+++.....+++..+..++.|++.||.+||+.|++||
T Consensus 131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~l~~~~~~~i~~ql~~aL~~LH~~givHr 209 (392)
T PHA03207 131 KTPGREIDILKTISHRAIINLIHAYRWKSTVCMVMPKY-KCDLFTYVDRSGPLPLEQAITIQRRLLEALAYLHGRGIIHR 209 (392)
T ss_pred ccHHHHHHHHHhcCCCCccceeeeEeeCCEEEEEehhc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcccc
Confidence 34578999999999999999999999999999999999 57899999777889999999999999999999999999999
Q ss_pred CCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 91 dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
||||.||++ +..+.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 210 Dlkp~Nill---~~~~~~~l~DfG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DvwslGvil~el~~g~~p 286 (392)
T PHA03207 210 DVKTENIFL---DEPENAVLGDFGAACKLDAHPDTPQCYGWSGTLETNSPELLALDPYCAKTDIWSAGLVLFEMSVKNVT 286 (392)
T ss_pred CCCHHHEEE---cCCCCEEEccCccccccCcccccccccccccccCccCHhHhcCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 999999999 7888999999999876543322 2235689999999999988899999999999999999999999
Q ss_pred CCCCCh---HHHHHHhhcCCC---CCC-------------------------CCc-cCCCCChHHHHHHHHhcccCcccc
Q 026253 168 FSGRNN---VQLVRNINSCKH---LPF-------------------------SQL-IVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 168 ~~~~~~---~~~~~~i~~~~~---~~~-------------------------~~~-~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
|.+... ...+..+..... ..+ +.. ....++.++.++|++||..||.+|
T Consensus 287 f~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R 366 (392)
T PHA03207 287 LFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKMLTFDQEFR 366 (392)
T ss_pred CCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHHhccChhhC
Confidence 976432 112221111100 000 000 012456789999999999999999
Q ss_pred CCHHHHhcCcccccccccC
Q 026253 216 LSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 216 ps~~~il~~~~~~~~~~~~ 234 (241)
||+.++|.||||++.+.+.
T Consensus 367 psa~e~l~~p~f~~~~~~~ 385 (392)
T PHA03207 367 PSAQDILSLPLFTKEPINL 385 (392)
T ss_pred CCHHHHhhCchhhccchhh
Confidence 9999999999999866543
|
|
| >PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-41 Score=264.73 Aligned_cols=215 Identities=35% Similarity=0.606 Sum_probs=179.2
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
.....+|+.++++++|+||+++++++..++..++|||++.+++|.+++...+.++...+..++.|++.||.+||+.|++|
T Consensus 42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~v~~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~L~~Lh~~~i~H 121 (260)
T PF00069_consen 42 REENIREIKILRRLRHPNIVQILDVFQDDNYLYIVMEYCPGGSLQDYLQKNKPLSEEEILKIAYQILEALAYLHSKGIVH 121 (260)
T ss_dssp HHHHHHHHHHHHHHTBTTBCHEEEEEEESSEEEEEEEEETTEBHHHHHHHHSSBBHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred cchhhhhhhccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 33445699999999999999999999999999999999998899999997888999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCcccc-CCCCccccccCCCCccCccccc-ccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~-~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||+|+||++ +.++.++|+|||.+... ..........++..|.|||... +...+.++|+||+|+++++|++|..|
T Consensus 122 ~dikp~NIl~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~p 198 (260)
T PF00069_consen 122 RDIKPENILL---DENGEVKLIDFGSSVKLSENNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYELLTGKLP 198 (260)
T ss_dssp SSBSGGGEEE---STTSEEEESSGTTTEESTSTTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHHHHHSSSS
T ss_pred cccccccccc---ccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 9999999999 78899999999998753 3333445566788999999998 78899999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCc--cCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQL--IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
|...........+........... .....+..+.+++++||+.||++|||++++++||||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~R~~~~~l~~~~~~ 260 (260)
T PF00069_consen 199 FEESNSDDQLEIIEKILKRPLPSSSQQSREKSEELRDLIKKMLSKDPEQRPSAEELLKHPWF 260 (260)
T ss_dssp STTSSHHHHHHHHHHHHHTHHHHHTTSHTTSHHHHHHHHHHHSSSSGGGSTTHHHHHTSGGG
T ss_pred cccccchhhhhhhhhcccccccccccccchhHHHHHHHHHHHccCChhHCcCHHHHhcCCCC
Confidence 998733332222221111111110 011234799999999999999999999999999998
|
Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A .... |
| >cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=266.06 Aligned_cols=217 Identities=31% Similarity=0.511 Sum_probs=185.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+.+|+++++.++|+||+++++.+..++..++||||+.+++|.+++... ..+++..+..++.|++.||++||+.
T Consensus 43 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~ 122 (316)
T cd05574 43 NKVKRVLTEQEILATLDHPFLPTLYASFQTETYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALEYLHLL 122 (316)
T ss_pred HHHHHHHHHHHHHHhCCCCCchhheeeeecCCEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHHHHHHC
Confidence 35567899999999999999999999999999999999999999999998754 4689999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc------------------------------cccccCCCCcc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY------------------------------AEKVCGSPLYM 135 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~------------------------------~~~~~~~~~~~ 135 (241)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+
T Consensus 123 ~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~y~ 199 (316)
T cd05574 123 GIVYRDLKPENILL---HESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYI 199 (316)
T ss_pred CeeccCCChHHeEE---cCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccCCc
Confidence 99999999999999 6778899999998865432111 11234677899
Q ss_pred CcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCcccc
Q 026253 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 136 ~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
|||...+..++.++|+||||+++|++++|..||.+.+....+..+.... ...+.. ..++..+.+++.+||+.||.+|
T Consensus 200 aPE~~~~~~~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~li~~~l~~~p~~R 276 (316)
T cd05574 200 APEVISGDGHGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKE-VTFPGS--PPVSSSARDLIRKLLVKDPSKR 276 (316)
T ss_pred CHHHHcCCCCCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCC-ccCCCc--cccCHHHHHHHHHHccCCHhHC
Confidence 9999988889999999999999999999999999888777666654322 222221 2378999999999999999999
Q ss_pred CC----HHHHhcCcccccc
Q 026253 216 LS----FNEFYHHRFLRRN 230 (241)
Q Consensus 216 ps----~~~il~~~~~~~~ 230 (241)
|| +++++.||||++.
T Consensus 277 ~s~~~~~~~ll~~~~~~~~ 295 (316)
T cd05574 277 LGSKRGAAEIKQHPFFRGV 295 (316)
T ss_pred CCchhhHHHHHcCchhhcC
Confidence 99 9999999999873
|
Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin |
| >cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=263.77 Aligned_cols=219 Identities=28% Similarity=0.509 Sum_probs=186.8
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|+.+++.++|+|++++++++..++..++|+||+.+++|.+++.. ..+++..+..++.+++.|+.+||+.|++
T Consensus 59 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~~i~ 137 (296)
T cd06655 59 KKELIINEILVMKELKNPNIVNFLDSFLVGDELFVVMEYLAGGSLTDVVTE-TCMDEAQIAAVCRECLQALEFLHANQVI 137 (296)
T ss_pred hHHHHHHHHHHHHhcCCCceeeeeeeEecCceEEEEEEecCCCcHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 356788999999999999999999999999999999999999999999864 4689999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 138 H~dL~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~~lltg~~p 214 (296)
T cd06655 138 HRDIKSDNVLL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (296)
T ss_pred cCCCCHHHEEE---CCCCCEEEccCccchhcccccccCCCcCCCccccCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 6788999999998876543322 2234578889999999888899999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
|...+.......+........ .....++..+.+++++||..||.+|||+.+++.||||+.....
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~dp~~Rpt~~~il~~~~~~~~~~~ 278 (296)
T cd06655 215 YLNENPLRALYLIATNGTPEL--QNPEKLSPIFRDFLNRCLEMDVEKRGSAKELLQHPFLKLAKPL 278 (296)
T ss_pred CCCCCHHHHHHHHHhcCCccc--CCcccCCHHHHHHHHHHhhcChhhCCCHHHHhhChHhhhcccc
Confidence 998777655554433222111 1234688899999999999999999999999999999976653
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-41 Score=267.01 Aligned_cols=219 Identities=25% Similarity=0.482 Sum_probs=186.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|+.++++++|+||+++++.+..++..++||||+++++|.+++. ...+++..+..++.|++.|+.+||+.|
T Consensus 60 ~~~~~~~~~e~~~l~~l~h~~ii~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~l~~~~~~~~~~qi~~~l~~LH~~~ 138 (292)
T cd06658 60 QQRRELLFNEVVIMRDYHHENVVDMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIATVCLSVLRALSYLHNQG 138 (292)
T ss_pred HHHHHHHHHHHHHHHhCCCCcHHHHHHheecCCeEEEEEeCCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4456778999999999999999999999999999999999999999999885 456899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||+|.||++ ++++.++|+|||++....... ......++..|+|||...+..++.++|+||+|+++|++++|.
T Consensus 139 ivH~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGvil~el~~g~ 215 (292)
T cd06658 139 VIHRDIKSDSILL---TSDGRIKLSDFGFCAQVSKEVPKRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMIDGE 215 (292)
T ss_pred EeecCCCHHHEEE---cCCCCEEEccCcchhhcccccccCceeecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999 677899999999986543222 223345788999999998888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
.||...+.......+.......... ...++..+.+++.+||..||.+|||++++++||||+..+
T Consensus 216 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~P~~Rpt~~~il~~~~~~~~~ 279 (292)
T cd06658 216 PPYFNEPPLQAMRRIRDNLPPRVKD--SHKVSSVLRGFLDLMLVREPSQRATAQELLQHPFLKLAG 279 (292)
T ss_pred CCCCCCCHHHHHHHHHhcCCCcccc--ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhhccC
Confidence 9999877776666554433222221 225788999999999999999999999999999999643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express |
| >cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=258.76 Aligned_cols=215 Identities=33% Similarity=0.585 Sum_probs=186.1
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
++..+.+.+|++++++++|+||+++++++.+++..++++||+++++|.+++.+.+++++..+..++.|++.|+++||+.|
T Consensus 43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 122 (258)
T cd06632 43 QEAVKQLEQEIALLSKLQHPNIVQYLGTEREEDNLYIFLELVPGGSLAKLLKKYGSFPEPVIRLYTRQILLGLEYLHDRN 122 (258)
T ss_pred hHHHHHHHHHHHHHHhcCCCCchheeeeEecCCeEEEEEEecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567899999999999999999999999999999999999999999999988888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccC-CCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||+|.||++ +.++.++|+|||.+.............++..|++||.+.... ++.++|+||+|+++|++++|.
T Consensus 123 i~H~dl~~~ni~~---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l~~l~~g~ 199 (258)
T cd06632 123 TVHRDIKGANILV---DTNGVVKLADFGMAKQVVEFSFAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTVLEMATGK 199 (258)
T ss_pred cccCCCCHHHEEE---CCCCCEEEccCccceeccccccccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHHHHHHhCC
Confidence 9999999999999 678899999999987655444344556788899999987766 899999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
.||...........+......+ .....++..+.+++++||+.+|.+||++++++.|||+
T Consensus 200 ~pf~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~~~~ 258 (258)
T cd06632 200 PPWSQLEGVAAVFKIGRSKELP---PIPDHLSDEAKDFILKCLQRDPSLRPTAAELLEHPFV 258 (258)
T ss_pred CCcccCcHHHHHHHHHhcccCC---CcCCCcCHHHHHHHHHHhhcCcccCcCHHHHhcCCCC
Confidence 9998776555554443322221 2234678999999999999999999999999999996
|
Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops |
| >cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=261.96 Aligned_cols=221 Identities=28% Similarity=0.447 Sum_probs=184.3
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+....+.+.+|++++++++|+||+++++.+..++..++||||+++++|..++.+ ...+++..+..++.|++.++.+||+
T Consensus 49 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~ 128 (292)
T cd06644 49 SEEELEDYMVEIEILATCNHPYIVKLLGAFYWDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQYLHS 128 (292)
T ss_pred CHHHHHHHHHHHHHHHhCCCCcEeeeEEEEEeCCeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 345567788999999999999999999999999999999999999999988754 4568999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccc-----ccCCCCchhHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l 158 (241)
.|++|+||+|.||++ +.++.++|+|||.+....... ......++..|.|||.+. ...++.++|+||+|+++
T Consensus 129 ~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~slG~il 205 (292)
T cd06644 129 MKIIHRDLKAGNVLL---TLDGDIKLADFGVSAKNVKTLQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITL 205 (292)
T ss_pred CCeeecCCCcceEEE---cCCCCEEEccCccceeccccccccceecCCccccCceeeccccccCCCCCchhhhHhHHHHH
Confidence 999999999999999 678899999999886543321 223345778899999874 34467899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|+|++|..||...+.......+........ .....++.++.+++++||+.+|++||+++++++||||+...
T Consensus 206 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 276 (292)
T cd06644 206 IEMAQIEPPHHELNPMRVLLKIAKSEPPTL--SQPSKWSMEFRDFLKTALDKHPETRPSAAQLLEHPFVSSVT 276 (292)
T ss_pred HHHhcCCCCCccccHHHHHHHHhcCCCccC--CCCcccCHHHHHHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence 999999999988776665555543332221 12336788999999999999999999999999999998643
|
Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. |
| >cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-41 Score=263.17 Aligned_cols=218 Identities=31% Similarity=0.515 Sum_probs=184.9
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS- 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~- 84 (241)
+...+.+.+|++++++++|+||+++++.+..++..++++|++.+++|.+++... ..+++..+..++.|++.|+++||+
T Consensus 40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 119 (265)
T cd06605 40 EAIQKQILRELDILHKCNSPYIVGFYGAFYNNGDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTYLHEK 119 (265)
T ss_pred hHHHHHHHHHHHHHHHCCCCchhhhheeeecCCEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHcCC
Confidence 355678899999999999999999999999999999999999999999999876 789999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
.|++|+||+|.||++ +.++.++|+|||.+......... ...++..|+|||...+..++.++|+||+|+++|++++|
T Consensus 120 ~~i~H~dl~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~-~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 195 (265)
T cd06605 120 HKIIHRDVKPSNILV---NSRGQIKLCDFGVSGQLVNSLAK-TFVGTSSYMAPERIQGNDYSVKSDIWSLGLSLIELATG 195 (265)
T ss_pred CCeecCCCCHHHEEE---CCCCCEEEeecccchhhHHHHhh-cccCChhccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999999 67888999999988655332222 25678889999999888899999999999999999999
Q ss_pred CCCCCCC-----ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 165 YPPFSGR-----NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 165 ~~p~~~~-----~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
..||... ...+..+.+........+.. .++.++.++|.+||..+|.+|||+.+++.||||++..
T Consensus 196 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~~~~~ 264 (265)
T cd06605 196 RFPYPPENDPPDGIFELLQYIVNEPPPRLPSG---KFSPDFQDFVNLCLIKDPRERPSYKELLEHPFIKKYE 264 (265)
T ss_pred CCCCCccccccccHHHHHHHHhcCCCCCCChh---hcCHHHHHHHHHHcCCCchhCcCHHHHhhCchhhccc
Confidence 9999754 23334444433333222221 2788999999999999999999999999999998753
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity |
| >cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-41 Score=263.94 Aligned_cols=215 Identities=28% Similarity=0.502 Sum_probs=179.0
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
.+.+.+|++++++++|+|++++++++..++..++||||+++++|..+......+++..+..++.|++.||.+||+.|++|
T Consensus 44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~LH~~~i~H 123 (286)
T cd07847 44 KKIALREIRMLKQLKHPNLVNLIEVFRRKRKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNFCHKHNCIH 123 (286)
T ss_pred cHHHHHHHHHHHhCCCCCEeeeeeEEeeCCEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 45678999999999999999999999999999999999999888888776677999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||+|.||++ +.++.++|+|||.+....... ......++..|.|||.+.+ ..++.++|+||+|+++|+|++|..|
T Consensus 124 ~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~~~l~~g~~p 200 (286)
T cd07847 124 RDVKPENILI---TKQGQIKLCDFGFARILTGPGDDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPL 200 (286)
T ss_pred cCCChhhEEE---cCCCcEEECccccceecCCCcccccCcccccccCCHHHHhCCCCcCchhhhHHHHHHHHHHHhCCCC
Confidence 9999999999 677889999999987654432 2223456788999999865 4578999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCC--------------------CCCC------CccCCCCChHHHHHHHHhcccCccccCCHHHH
Q 026253 168 FSGRNNVQLVRNINSCKH--------------------LPFS------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~--------------------~~~~------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 221 (241)
|.+.+..+....+..... .+.+ ....+.++..+.+++.+||+.+|++|||+.|+
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~ei 280 (286)
T cd07847 201 WPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSPALSFLKGCLQMDPTERLSCEEL 280 (286)
T ss_pred CCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhccCCHHHHHHHHHHhcCCccccCCHHHH
Confidence 987766544433321100 0000 01124578889999999999999999999999
Q ss_pred hcCccc
Q 026253 222 YHHRFL 227 (241)
Q Consensus 222 l~~~~~ 227 (241)
+.||||
T Consensus 281 l~~~~f 286 (286)
T cd07847 281 LEHPYF 286 (286)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio |
| >cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-41 Score=261.88 Aligned_cols=212 Identities=31% Similarity=0.527 Sum_probs=185.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++.+++..++|+||+.|++|.+++....++++..+..++.|++.||.+||+.|+
T Consensus 42 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i 121 (258)
T cd05578 42 GSVRNVLNERRILQELNHPFLVNLWYSFQDEENMYLVVDLLLGGDLRYHLSQKVKFSEEQVKFWICEIVLALEYLHSKGI 121 (258)
T ss_pred hHHHHHHHHHHHHHhCCCCChHHHHHhhcCCCeEEEEEeCCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 45678999999999999999999999999999999999999999999999887789999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|.||++ ++++.++|+|||.+.............++..|.|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 122 ~h~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~~g~~p 198 (258)
T cd05578 122 IHRDIKPDNILL---DEQGHVHITDFNIATKVTPDTLTTSTSGTPGYMAPEVLCRQGYSVAVDWWSLGVTAYECLRGKRP 198 (258)
T ss_pred eccCCCHHHeEE---cCCCCEEEeecccccccCCCccccccCCChhhcCHHHHcccCCCCcccchhhHHHHHHHHhCCCC
Confidence 999999999999 78889999999998776555444455678889999999888899999999999999999999999
Q ss_pred CCCCCh---HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH--HHHhcCccc
Q 026253 168 FSGRNN---VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF--NEFYHHRFL 227 (241)
Q Consensus 168 ~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~--~~il~~~~~ 227 (241)
|...+. ....+.. ...... .....+.++.++|++||+.||.+||++ +|+++||||
T Consensus 199 ~~~~~~~~~~~~~~~~-~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~l~~~~~~ 258 (258)
T cd05578 199 YRGHSRTIRDQIRAKQ-ETADVL----YPATWSTEAIDAINKLLERDPQKRLGDNLKDLKNHPYF 258 (258)
T ss_pred CCCCCccHHHHHHHHh-cccccc----CcccCcHHHHHHHHHHccCChhHcCCccHHHHhcCCCC
Confidence 997764 3333332 222222 233678999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. |
| >cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-41 Score=265.35 Aligned_cols=220 Identities=28% Similarity=0.454 Sum_probs=180.8
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|++++++++|+||+++++++..++..++||||+. ++|.+++... ..+++..+..++.|++.||.+||+.|++
T Consensus 48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~lH~~~i~ 126 (301)
T cd07873 48 PCTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNSINMHNVKLFLFQLLRGLNYCHRRKVL 126 (301)
T ss_pred hhHHHHHHHHHHhcCCCCcceEEEEEecCCeEEEEEeccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 4467789999999999999999999999999999999996 6899888754 4688999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|.+
T Consensus 127 H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~tg~~ 203 (301)
T cd07873 127 HRDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRP 203 (301)
T ss_pred CCCCCHHHEEE---CCCCcEEECcCcchhccCCCCCcccccceeecccCcHHHhCCCCCccHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 778899999999986543222 22234467889999987654 47889999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCC------------------CC-------CccCCCCChHHHHHHHHhcccCccccCCHHHH
Q 026253 167 PFSGRNNVQLVRNINSCKHLP------------------FS-------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~------------------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 221 (241)
||.+.+..+....+......+ .+ ....+.+++.+.++|.+||+.||.+|||++|+
T Consensus 204 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~ei 283 (301)
T cd07873 204 LFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRLDSDGAELLSKLLQFEGRKRISAEEA 283 (301)
T ss_pred CCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHhhcCCCCHHHHHHHHHHhcCCcccCcCHHHH
Confidence 999877665554432211110 00 01123578899999999999999999999999
Q ss_pred hcCccccccccc
Q 026253 222 YHHRFLRRNSAI 233 (241)
Q Consensus 222 l~~~~~~~~~~~ 233 (241)
++||||+..+..
T Consensus 284 l~h~~f~~~~~~ 295 (301)
T cd07873 284 MKHPYFHCLGER 295 (301)
T ss_pred hcCcccccccch
Confidence 999999987654
|
Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl |
| >cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=261.71 Aligned_cols=218 Identities=25% Similarity=0.508 Sum_probs=188.0
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.+++.++|+||+++++++..++..++++||+.+++|.+++.. +++++..+..++.|++.|+++||+.|+
T Consensus 58 ~~~~~~~~e~~~l~~~~h~~vv~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~-~~~~~~~~~~~~~ql~~~l~~lH~~~i 136 (285)
T cd06648 58 QRRELLFNEVVIMRDYQHPNIVEMYSSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIATVCLAVLKALSFLHAQGV 136 (285)
T ss_pred hHHHHHHHHHHHHHHcCCCChheEEEEEEcCCeEEEEEeccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4456788999999999999999999999999999999999999999999886 678999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||+|+++|++++|..
T Consensus 137 ~H~dl~p~Nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slGv~l~ell~g~~ 213 (285)
T cd06648 137 IHRDIKSDSILL---TSDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPEVISRLPYGTEVDIWSLGIMVIEMVDGEP 213 (285)
T ss_pred ecCCCChhhEEE---cCCCcEEEcccccchhhccCCcccccccCCccccCHHHhcCCCCCCcccHHHHHHHHHHHHhCCC
Confidence 999999999999 778899999999876543322 1223457889999999988889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
||...++......+......... ....++..+.+++++||+.+|.+|||+.++++||||+...
T Consensus 214 p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~ 276 (285)
T cd06648 214 PYFNEPPLQAMKRIRDNLPPKLK--NLHKVSPRLRSFLDRMLVRDPAQRATAAELLNHPFLAKAG 276 (285)
T ss_pred CCcCCCHHHHHHHHHhcCCCCCc--ccccCCHHHHHHHHHHcccChhhCcCHHHHccCcccccCC
Confidence 99888877777766554322211 1224788999999999999999999999999999998855
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun |
| >KOG0579 consensus Ste20-like serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=277.41 Aligned_cols=224 Identities=29% Similarity=0.456 Sum_probs=194.9
Q ss_pred hhHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
-....-..+.=|+.||..++||+|+++++.|.-++.++++.|||.||.+...+-.- ..+++.++..+++|++.||.|||
T Consensus 68 kseEELEDylVEIeILa~CdHP~ivkLl~ayy~enkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~LH 147 (1187)
T KOG0579|consen 68 KSEEELEDYLVEIEILAECDHPVIVKLLSAYYFENKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNWLH 147 (1187)
T ss_pred cchhHHhhhhhhhhhhhcCCChHHHHHHHHHhccCceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHHHh
Confidence 35566777888999999999999999999998889999999999999999887654 56999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCcccc-CCCCccccccCCCCccCcccc-----cccCCCCchhHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVL-----QFQRYDEKVDMWSVGAI 157 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~-~~~~~~~~~~~~~~~~~PE~~-----~~~~~~~~~Dv~slG~~ 157 (241)
+++|+|||||..|||+ +-+|.++|.|||.+... ..........||++|+|||+. ...+|..++||||||++
T Consensus 148 s~~iIHRDLKAGNiL~---TldGdirLADFGVSAKn~~t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSlGIT 224 (1187)
T KOG0579|consen 148 SQNIIHRDLKAGNILL---TLDGDIRLADFGVSAKNKSTRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSLGIT 224 (1187)
T ss_pred hcchhhhhccccceEE---EecCcEeeecccccccchhHHhhhccccCCcccccchheeeccccCCCchhhhhHHhhhhH
Confidence 9999999999999999 89999999999987443 222334567899999999986 35689999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 158 LFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
+.+|+.+.+|-...++...+-.|.....+.+.+ +...+..+.||+..||.+||..||++.++|+|||+++...+
T Consensus 225 LIEMAqiEPPHhelnpMRVllKiaKSePPTLlq--PS~Ws~~F~DfLk~cL~Knp~~Rp~aaqll~Hpfv~~~~Sn 298 (1187)
T KOG0579|consen 225 LIEMAQIEPPHHELNPMRVLLKIAKSEPPTLLQ--PSHWSRSFSDFLKRCLVKNPRNRPPAAQLLKHPFVQNAPSN 298 (1187)
T ss_pred HHHHhccCCCccccchHHHHHHHhhcCCCcccC--cchhhhHHHHHHHHHHhcCCccCCCHHHHhhCcccccCCcc
Confidence 999999999999999998888886665544433 23678899999999999999999999999999999975543
|
|
| >cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=260.84 Aligned_cols=215 Identities=29% Similarity=0.474 Sum_probs=179.2
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|++++++++||||+++++++..++..++||||+++++|..+ ..+++..+..++.|++.|+.+||+.|
T Consensus 40 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~lH~~~ 115 (279)
T cd06619 40 VELQKQIMSELEILYKCDSPYIIGFYGAFFVENRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYLWSLK 115 (279)
T ss_pred hHHHHHHHHHHHHHHhCCCCCeeeEEEEEEECCEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34556789999999999999999999999999999999999999999765 35788899999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
++|+||+|.||++ +.++.++|+|||++...... ......++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus 116 i~H~dlkp~Nill---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l~~g~~ 191 (279)
T cd06619 116 ILHRDVKPSNMLV---NTRGQVKLCDFGVSTQLVNS-IAKTYVGTNAYMAPERISGEQYGIHSDVWSLGISFMELALGRF 191 (279)
T ss_pred EeeCCCCHHHEEE---CCCCCEEEeeCCcceecccc-cccCCCCChhhcCceeecCCCCCCcchHHHHHHHHHHHHhCCC
Confidence 9999999999999 77889999999998765433 2334567889999999998889999999999999999999999
Q ss_pred CCCCCCh-------HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 167 PFSGRNN-------VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 167 p~~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
||..... .+..+.+........ .....++++.+++.+||+.+|.+||+++++++||||+....
T Consensus 192 pf~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~P~~Rp~~~eil~~~~~~~~~~ 261 (279)
T cd06619 192 PYPQIQKNQGSLMPLQLLQCIVDEDPPVL---PVGQFSEKFVHFITQCMRKQPKERPAPENLMDHPFIVQYND 261 (279)
T ss_pred CchhhcccccccchHHHHHHHhccCCCCC---CCCcCCHHHHHHHHHHhhCChhhCCCHHHHhcCcccccccC
Confidence 9965322 122233322222111 12357889999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p |
| >cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=260.81 Aligned_cols=219 Identities=26% Similarity=0.468 Sum_probs=187.9
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
......+.+|++++++++|+||+++++++.+++..++||||+.|++|.+++.. +++++..+..++.+++.|+.+||+.+
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~-~~l~~~~~~~~~~~l~~~l~~lh~~~ 121 (277)
T cd06640 43 EDEIEDIQQEITVLSQCDSPYVTKYYGSYLKGTKLWIIMEYLGGGSALDLLRA-GPFDEFQIATMLKEILKGLDYLHSEK 121 (277)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEecCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34567899999999999999999999999999999999999999999999874 57899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||+|.||++ +.++.++++|||.+....... ......++..|.|||.+.+..++.++|+||||+++|+|++|.
T Consensus 122 ivH~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Dv~slG~il~el~tg~ 198 (277)
T cd06640 122 KIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIQQSAYDSKADIWSLGITAIELAKGE 198 (277)
T ss_pred ccCcCCChhhEEE---cCCCCEEEcccccceeccCCccccccccCcccccCHhHhccCCCccHHHHHHHHHHHHHHHHCC
Confidence 9999999999999 678889999999986654322 222345677899999998888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
.||...++......+...... .....++..+.+++.+||+.+|.+||+++++++|+||......
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 262 (277)
T cd06640 199 PPNSDMHPMRVLFLIPKNNPP----TLTGEFSKPFKEFIDACLNKDPSFRPTAKELLKHKFIVKNAKK 262 (277)
T ss_pred CCCCCcChHhHhhhhhcCCCC----CCchhhhHHHHHHHHHHcccCcccCcCHHHHHhChHhhhcchh
Confidence 999887776666555333322 2233678899999999999999999999999999999876543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter |
| >cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-40 Score=259.10 Aligned_cols=214 Identities=27% Similarity=0.507 Sum_probs=179.3
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.....+.+|++++++++|+||+++++++.. +...++++|++.+++|.+++...+.+++..+..++.|++.|+++||+.
T Consensus 46 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~l~~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~LH~~ 125 (266)
T cd06651 46 KEVSALECEIQLLKNLQHERIVQYYGCLRDRAEKTLTIFMEYMPGGSVKDQLKAYGALTESVTRKYTRQILEGMSYLHSN 125 (266)
T ss_pred HHHHHHHHHHHHHHHcCCCCeeeEEEEEEcCCCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 345678999999999999999999998865 367889999999999999998888899999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC----ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
+++|+||+|.||++ +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++|++
T Consensus 126 ~i~H~~l~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~el 202 (266)
T cd06651 126 MIVHRDIKGANILR---DSAGNVKLGDFGASKRLQTICMSGTGIRSVTGTPYWMSPEVISGEGYGRKADVWSLGCTVVEM 202 (266)
T ss_pred CeeeCCCCHHHEEE---CCCCCEEEccCCCccccccccccCCccccCCccccccCHHHhCCCCCCchhhhHHHHHHHHHH
Confidence 99999999999999 678889999999987543211 11223467889999999888899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 228 (241)
++|+.||...+..+....+..... .......+++.+.+++ .||..+|++||+++|+++||||+
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li-~~~~~~p~~Rp~~~eil~hp~~~ 265 (266)
T cd06651 203 LTEKPPWAEYEAMAAIFKIATQPT---NPQLPSHISEHARDFL-GCIFVEARHRPSAEELLRHPFAQ 265 (266)
T ss_pred HHCCCCccccchHHHHHHHhcCCC---CCCCchhcCHHHHHHH-HHhcCChhhCcCHHHHhcCcccc
Confidence 999999987766555544433221 1222336788899999 57778999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development |
| >KOG0607 consensus MAP kinase-interacting kinase and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-41 Score=257.05 Aligned_cols=227 Identities=32% Similarity=0.521 Sum_probs=193.9
Q ss_pred hhhhHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 3 KKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 3 ~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
.+.....++++.+|++++.++ .|+||++++++|+++..+|+|||-|.||+|.+++.+++-|++..+.+++++|+.||.+
T Consensus 112 dKq~gHsR~RvfREVe~f~~Cqgh~nilqLiefFEdd~~FYLVfEKm~GGplLshI~~~~~F~E~EAs~vvkdia~aLdF 191 (463)
T KOG0607|consen 112 DKQPGHSRSRVFREVETFYQCQGHKNILQLIEFFEDDTRFYLVFEKMRGGPLLSHIQKRKHFNEREASRVVKDIASALDF 191 (463)
T ss_pred hcCCchHHHHHHHHHHHHHHhcCCccHHHHHHHhcccceEEEEEecccCchHHHHHHHhhhccHHHHHHHHHHHHHHHHH
Confidence 334556799999999999999 6999999999999999999999999999999999999999999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--------ccccccCCCCccCccccc-----ccCCCCc
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQ-----FQRYDEK 148 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--------~~~~~~~~~~~~~PE~~~-----~~~~~~~ 148 (241)
||.+||.|||+||+|||...-+.-.-+|||||.++....... ...+.+|+..|||||+.. ...|..+
T Consensus 192 lH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YDKr 271 (463)
T KOG0607|consen 192 LHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYDKR 271 (463)
T ss_pred HhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcccccccccc
Confidence 999999999999999999543444459999998875432211 122356778899999853 2358899
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCC---------------hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCcc
Q 026253 149 VDMWSVGAILFELLNGYPPFSGRN---------------NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTV 213 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~g~~p~~~~~---------------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~ 213 (241)
.|.||||+++|.|+.|.+||.+.= ...++..|..++ ..+|...+..+|.+..++++.+|..|+.
T Consensus 272 CDlwSLGvIlYImLsGYpPFvG~Cg~dCGWdrGe~Cr~CQ~~LFesIQEGk-YeFPdkdWahIS~eakdlisnLlvrda~ 350 (463)
T KOG0607|consen 272 CDLWSLGVILYIMLSGYPPFVGHCGADCGWDRGEVCRVCQNKLFESIQEGK-YEFPDKDWAHISSEAKDLISNLLVRDAK 350 (463)
T ss_pred ccHHHHHHHHHHHHhCCCCccCccCCcCCccCCCccHHHHHHHHHHHhccC-CcCChhhhHHhhHHHHHHHHHHHhccHH
Confidence 999999999999999999997421 236777886554 5678888889999999999999999999
Q ss_pred ccCCHHHHhcCcccccc
Q 026253 214 DRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 214 ~Rps~~~il~~~~~~~~ 230 (241)
+|.++.+++.|||++..
T Consensus 351 ~rlsa~~vlnhPw~~~~ 367 (463)
T KOG0607|consen 351 QRLSAAQVLNHPWVQRC 367 (463)
T ss_pred hhhhhhhccCCcccccc
Confidence 99999999999999984
|
|
| >cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.3e-41 Score=260.83 Aligned_cols=215 Identities=25% Similarity=0.405 Sum_probs=178.4
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|+.++++++|+||+++++++..++..++||||+.+++|.+++...+++++..+..++.|++.|+.+||+.|++
T Consensus 49 ~~~~~~~e~~~l~~~~h~~ii~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 128 (267)
T cd06646 49 DFSLIQQEIFMVKECKHCNIVAYFGSYLSREKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLAYLHSKGKM 128 (267)
T ss_pred hHHHHHHHHHHHHhcCCCCeeeeeEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 34568899999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccc---ccCCCCchhHHHHHHHHHHHHhC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
|+|++|.||++ +..+.++|+|||.+....... ......++..|+|||.+. +..++.++|+||+|+++|+|++|
T Consensus 129 H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~il~el~~g 205 (267)
T cd06646 129 HRDIKGANILL---TDNGDVKLADFGVAAKITATIAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAEL 205 (267)
T ss_pred ccCCCHHHEEE---CCCCCEEECcCccceeecccccccCccccCccccCHhHcccccCCCCcchhhHHHHHHHHHHHHhC
Confidence 99999999999 678889999999987654322 223345778899999874 34477899999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 226 (241)
+.||...++.+....+......+........++..+.+++++||+.+|.+|||++++++|+|
T Consensus 206 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~l~ 267 (267)
T cd06646 206 QPPMFDLHPMRALFLMSKSNFQPPKLKDKTKWSSTFHNFVKISLTKNPKKRPTAERLLTHLF 267 (267)
T ss_pred CCCccccchhhhheeeecCCCCCCCCccccccCHHHHHHHHHHhhCChhhCcCHHHHhcCCC
Confidence 99997665544433332222111111112357889999999999999999999999999987
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated |
| >cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=261.58 Aligned_cols=211 Identities=26% Similarity=0.496 Sum_probs=182.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARK 70 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~ 70 (241)
......+.+|++++++++|+||+++++++...+..+++|||+++++|.+++... ..+++..+..
T Consensus 49 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 128 (283)
T cd05048 49 PKVQQEFRQEAELMSDLQHPNIVCLLGVCTKEQPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCSDFLH 128 (283)
T ss_pred HHHHHHHHHHHHHHHhcCCcccceEEEEEcCCCceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHHHHHH
Confidence 344667899999999999999999999999989999999999999999999764 3478889999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCC
Q 026253 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE 147 (241)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~ 147 (241)
++.|++.|+.+||+.|++|+||+|+||++ ++++.++|+|||++....... ......++..|+|||.+.+..++.
T Consensus 129 ~~~~l~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 205 (283)
T cd05048 129 IAIQIAAGMEYLSSHHFVHRDLAARNCLV---GEGLTVKISDFGLSRDIYSADYYRVQSKSLLPVRWMPPEAILYGKFTT 205 (283)
T ss_pred HHHHHHHHHHHHHhCCeeccccccceEEE---cCCCcEEECCCcceeeccccccccccCCCcccccccCHHHhccCcCch
Confidence 99999999999999999999999999999 678889999999987643322 122334567899999998888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 148 KVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 148 ~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
++|+||||+++|+|++ |..||.+.+..+....+........+ ..++.++.+++.+||+.||.+||++.+++++
T Consensus 206 ~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~ 279 (283)
T cd05048 206 ESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLPCP----EDCPARVYALMIECWNEIPARRPRFKDIHTR 279 (283)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCc----ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999999999999998 99999988888888877655544333 4789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer |
| >PTZ00283 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=280.39 Aligned_cols=219 Identities=27% Similarity=0.476 Sum_probs=188.3
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC--------eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQ 73 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~ 73 (241)
+......+.+|+..+..++|+|++++++.+...+ ..++||||+++++|.+++... ..+++..+..++.
T Consensus 71 ~~~~~~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~ 150 (496)
T PTZ00283 71 SEADKNRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFI 150 (496)
T ss_pred CHHHHHHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHH
Confidence 4556778899999999999999999998765322 368999999999999998653 4589999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC---CccccccCCCCccCcccccccCCCCchh
Q 026253 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVD 150 (241)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~D 150 (241)
|++.||.|||+.|++||||||+||++ +.++.++|+|||+++..... .......+++.|+|||.+.+..++.++|
T Consensus 151 qll~aL~~lH~~~IiHrDLKP~NILl---~~~~~vkL~DFGls~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~s~k~D 227 (496)
T PTZ00283 151 QVLLAVHHVHSKHMIHRDIKSANILL---CSNGLVKLGDFGFSKMYAATVSDDVGRTFCGTPYYVAPEIWRRKPYSKKAD 227 (496)
T ss_pred HHHHHHHHHHhCCEecCCCCHHHEEE---eCCCCEEEEecccCeeccccccccccccccCCcceeCHHHhCCCCCCcHHH
Confidence 99999999999999999999999999 67889999999998765432 2233456899999999999889999999
Q ss_pred HHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 151 MWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 151 v~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+||||+++|+|++|..||.+.+..+....+..+...+.+ +.+++++.+++.+||+.||.+||++.++++|||++..
T Consensus 228 VwSlGvilyeLltG~~Pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~L~~dP~~RPs~~ell~~p~~~~~ 303 (496)
T PTZ00283 228 MFSLGVLLYELLTLKRPFDGENMEEVMHKTLAGRYDPLP----PSISPEMQEIVTALLSSDPKRRPSSSKLLNMPICKLF 303 (496)
T ss_pred HHHHHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHHhCHHHHHh
Confidence 999999999999999999998888877777655544433 4789999999999999999999999999999998764
Q ss_pred c
Q 026253 231 S 231 (241)
Q Consensus 231 ~ 231 (241)
.
T Consensus 304 ~ 304 (496)
T PTZ00283 304 I 304 (496)
T ss_pred h
Confidence 3
|
|
| >cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=258.45 Aligned_cols=215 Identities=31% Similarity=0.517 Sum_probs=183.2
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
.+.+.+|++++++++|+|++++++++...+..++||||+.+++|.+++.+.+.+++..+..++.|++.|+.+||+.|++|
T Consensus 52 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H 131 (272)
T cd06629 52 VKALRSEIETLKDLDHLNIVQYLGFETTEEYLSIFLEYVPGGSIGSCLRTYGRFEEQLVRFFTEQVLEGLAYLHSKGILH 131 (272)
T ss_pred HHHHHHHHHHHHhcCCCCcceEEEEeccCCceEEEEecCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCeee
Confidence 45788999999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccC--CCCchhHHHHHHHHHHHHhC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l~~g 164 (241)
+||+|+||++ +.++.++++|||.+....... ......++..|.|||.+.+.. ++.++|+||+|+++|++++|
T Consensus 132 ~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l~~l~~g 208 (272)
T cd06629 132 RDLKADNLLV---DADGICKISDFGISKKSDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAG 208 (272)
T ss_pred cCCChhhEEE---cCCCeEEEeeccccccccccccccccccccCCccccCHHHhccccCCCCccchhHHHHHHHHHHHhC
Confidence 9999999999 778899999999987643221 122345678899999987654 78999999999999999999
Q ss_pred CCCCCCCChHHHHHHhh-cCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 165 YPPFSGRNNVQLVRNIN-SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~-~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
..||...+..+....+. .......+....+.++.++.+++.+||..+|.+|||++++++|||+
T Consensus 209 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 272 (272)
T cd06629 209 RRPWSDEEAIAAMFKLGNKRSAPPIPPDVSMNLSPVALDFLNACFTINPDNRPTARELLQHPFI 272 (272)
T ss_pred CCCCcCcchHHHHHHhhccccCCcCCccccccCCHHHHHHHHHHhcCChhhCCCHHHHhhCCCC
Confidence 99998666554443332 2233344444455789999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte |
| >cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=262.22 Aligned_cols=217 Identities=32% Similarity=0.545 Sum_probs=185.3
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+++++.++|+||+++++.+..++..++|||+++|++|.++++..+.+++..+..++.|++.|+.+||+.|+
T Consensus 43 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 122 (305)
T cd05609 43 NQIQQVFVERDILTFAENPFVVSMFCSFETKRHLCMVMEYVEGGDCATLLKNIGALPVDMARMYFAETVLALEYLHNYGI 122 (305)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeEEEEecCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34567889999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC----------------ccccccCCCCccCcccccccCCCCchhH
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------YAEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~----------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv 151 (241)
+|+||+|.||++ +..+.++++|||.+....... ......++..|+|||.+.+..++.++|+
T Consensus 123 ~H~dl~p~NIll---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 199 (305)
T cd05609 123 VHRDLKPDNLLI---TSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQGYGKPVDW 199 (305)
T ss_pred cccCCchHHEEE---CCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCCCCchhhH
Confidence 999999999999 778899999999876321100 0112345778999999988889999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC---HHHHhcCcccc
Q 026253 152 WSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS---FNEFYHHRFLR 228 (241)
Q Consensus 152 ~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~ 228 (241)
||+|+++|++++|..||.+.+..+....+...... .+.. ...++.++.+++++||+.+|.+||+ +.++++||||.
T Consensus 200 ~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~-~~~~~~~~~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~ 277 (305)
T cd05609 200 WAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIE-WPEG-DEALPADAQDLISRLLRQNPLERLGTGGAFEVKQHRFFL 277 (305)
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccC-CCCc-cccCCHHHHHHHHHHhccChhhccCccCHHHHHhCcccc
Confidence 99999999999999999988887777766544322 1211 1267889999999999999999997 79999999996
Q ss_pred c
Q 026253 229 R 229 (241)
Q Consensus 229 ~ 229 (241)
.
T Consensus 278 ~ 278 (305)
T cd05609 278 G 278 (305)
T ss_pred C
Confidence 6
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a |
| >cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-40 Score=258.72 Aligned_cols=216 Identities=30% Similarity=0.489 Sum_probs=184.2
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
..+.+.+|++.++.++|+|++++++.+..++..+++||++++++|.+++... ..+++..+..++.|++.|+++||+.
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al~~lh~~ 121 (267)
T cd06610 42 SVDELRKEVQAMSQCNHPNVVKYYTSFVVGDELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGLEYLHSN 121 (267)
T ss_pred HHHHHHHHHHHHHhcCCCCEEEEEEEEeeCCEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 5678999999999999999999999999999999999999999999999764 3589999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc-----ccccCCCCccCccccccc-CCCCchhHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILF 159 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~-----~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~ 159 (241)
|++|+||+|.||++ ++++.++|+|||.+......... ....++..|+|||.+... .++.++|+||+|+++|
T Consensus 122 ~i~h~~l~p~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~i~~ 198 (267)
T cd06610 122 GQIHRDIKAGNILL---GEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGITAI 198 (267)
T ss_pred CeecCCCCHHhEEE---cCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhHHHH
Confidence 99999999999999 67788999999998765543222 234577889999998766 6889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCCcc-CCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLI-VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+|++|+.||...+..+................. ...+++.+.+++.+||+.||.+|||++++++||||
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~ll~~p~~ 267 (267)
T cd06610 199 ELATGAAPYSKYPPMKVLMLTLQNDPPSLETGADYKKYSKSFRKMISLCLQKDPSKRPTAEELLKHKFF 267 (267)
T ss_pred HHHhCCCCccccChhhhHHHHhcCCCCCcCCccccccccHHHHHHHHHHcCCChhhCcCHHHHhhCCCC
Confidence 999999999887776666555444322222211 23678899999999999999999999999999998
|
Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 |
| >cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=259.40 Aligned_cols=216 Identities=35% Similarity=0.613 Sum_probs=188.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++|+||+++++.+..++..+++||++.+++|.+++.+.+.+++..+..++.|++.||.+||+.|+
T Consensus 35 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~lH~~~i 114 (265)
T cd05579 35 NQVDQVLTERDILSQAQSPYVVKLYYSFQGKKNLYLVMEYLPGGDLASLLENVGSLDEDVARIYIAEIVLALEYLHSNGI 114 (265)
T ss_pred hHHHHHHHHHHHHHhCCCcchhHHHHheecCcEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHcCe
Confidence 45678999999999999999999999999999999999999999999999887889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---------ccccccCCCCccCcccccccCCCCchhHHHHHHHH
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 158 (241)
+|+||+|.||++ ++++.++|+|||++....... ......++..|.+||...+...+.++|+||||+++
T Consensus 115 ~H~di~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~~~ 191 (265)
T cd05579 115 IHRDLKPDNILI---DSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQGHSKTVDWWSLGCIL 191 (265)
T ss_pred ecCCCCHHHeEE---cCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCCCCcchhhHHHHHHH
Confidence 999999999999 778899999999886543321 12234567789999999888889999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH---HHHhcCccccc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF---NEFYHHRFLRR 229 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~~il~~~~~~~ 229 (241)
+++++|..||...+..+....+..+. ...+.. ..++..+.+++++||+.+|.+|||+ .++++||||++
T Consensus 192 ~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~i~~~l~~~p~~Rpt~~~~~~~l~~~~~~~ 262 (265)
T cd05579 192 YEFLVGIPPFHGETPEEIFQNILNGK-IEWPED--VEVSDEAIDLISKLLVPDPEKRLGAKSIEEIKNHPFFKG 262 (265)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHhcCC-cCCCcc--ccCCHHHHHHHHHHhcCCHhhcCCCccHHHHhcCccccC
Confidence 99999999999888888777775533 222321 1358999999999999999999999 99999999985
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re |
| >KOG4717 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-41 Score=266.84 Aligned_cols=221 Identities=32% Similarity=0.604 Sum_probs=202.9
Q ss_pred hhHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
++.-....+.+|++-++.++|||||++|+...+...+|+|.|.-++|+|.||+-+. ..+.++...++..||+.|+.|+|
T Consensus 56 lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQTKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI~~AI~YCH 135 (864)
T KOG4717|consen 56 LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQTKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQIVHAISYCH 135 (864)
T ss_pred cchhhhhHHHHHHHHHHHhcCcCeeeeeehhcccceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHHHHHHHHHh
Confidence 35556778999999999999999999999999999999999999999999999665 56999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCC-CchhHHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELL 162 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~ 162 (241)
...++||||||+|+.+- .+.+-+||.|||++-.+.++......+|...|.|||.+.+..|. ++.||||||+++|-+.
T Consensus 136 qLHVVHRDLKPENVVFF--EKlGlVKLTDFGFSNkf~PG~kL~TsCGSLAYSAPEILLGDsYDAPAVDiWSLGVILyMLV 213 (864)
T KOG4717|consen 136 QLHVVHRDLKPENVVFF--EKLGLVKLTDFGFSNKFQPGKKLTTSCGSLAYSAPEILLGDSYDAPAVDIWSLGVILYMLV 213 (864)
T ss_pred hhhhhcccCCcceeEEe--eecCceEeeeccccccCCCcchhhcccchhhccCchhhhcCccCCcchhhhHHHHHHHHHH
Confidence 99999999999998875 78889999999999999999888899999999999999998885 8999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
+|++||+..+..+.+..|.+++..- +..+|.+++++|..||..||.+|-|.++|..++|++..-.
T Consensus 214 CGq~PFqeANDSETLTmImDCKYtv-----PshvS~eCrdLI~sMLvRdPkkRAslEeI~s~~Wlq~~D~ 278 (864)
T KOG4717|consen 214 CGQPPFQEANDSETLTMIMDCKYTV-----PSHVSKECRDLIQSMLVRDPKKRASLEEIVSTSWLQAGDR 278 (864)
T ss_pred hCCCccccccchhhhhhhhcccccC-----chhhhHHHHHHHHHHHhcCchhhccHHHHhccccccCCCC
Confidence 9999999999999999998877532 2378999999999999999999999999999999997443
|
|
| >cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-40 Score=267.85 Aligned_cols=219 Identities=27% Similarity=0.549 Sum_probs=185.2
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
......+.+|..++..++|++|+++++++.+++..|+||||+.|++|.+++.+ ...+++..+..++.|++.||.+||+.
T Consensus 42 ~~~~~~~~~e~~~l~~~~~~~i~~l~~~~~~~~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~lH~~ 121 (331)
T cd05624 42 RAETACFREERNVLVNGDCQWITTLHYAFQDENYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQL 121 (331)
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34456688999999999999999999999999999999999999999999987 46789999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccc-----cCCCCchhHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAIL 158 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~slG~~l 158 (241)
|++|+||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 122 ~iiHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSlGvil 198 (331)
T cd05624 122 HYVHRDIKPDNVLL---DMNGHIRLADFGSCLKMNQDGTVQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSLGVCM 198 (331)
T ss_pred CeeeccCchHHEEE---cCCCCEEEEeccceeeccCCCceeeccccCCcccCCHHHHhccccCCCCCCCcccEEeeehhh
Confidence 99999999999999 7788899999999876543322 223468999999998865 4578899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCChHHHHHHHHhcccCccc--cCCHHHHhcCccccc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRR 229 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~il~~~~~~~ 229 (241)
|+|++|..||...+..+.+..+.... ..+++. ....++.++.+++.+||..++.+ |++++++++||||+.
T Consensus 199 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~~~~~~~li~~ll~~~~~~~~~~~~~~~~~h~~f~~ 271 (331)
T cd05624 199 YEMLYGETPFYAESLVETYGKIMNHEERFQFPS-HITDVSEEAKDLIQRLICSRERRLGQNGIEDFKKHAFFEG 271 (331)
T ss_pred hhhhhCCCCccCCCHHHHHHHHHcCCCcccCCC-ccccCCHHHHHHHHHHccCchhhcCCCCHHHHhcCCCcCC
Confidence 99999999999888877777765443 223332 23467899999999999876654 468999999999986
|
Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. |
| >cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-40 Score=266.65 Aligned_cols=209 Identities=27% Similarity=0.496 Sum_probs=172.1
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeec-CeEEEEEeccCCCChHHHHHhc-------------------------
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLH------------------------- 60 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~------------------------- 60 (241)
...+.+.+|+.+++++ +||||+++++++... +..+++|||+++|+|.+++...
T Consensus 52 ~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (338)
T cd05102 52 SEHKALMSELKILIHIGNHLNVVNLLGACTKPNGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAMVEQS 131 (338)
T ss_pred HHHHHHHHHHHHHHHhccCcceeeEEeEecCCCCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhhhhhh
Confidence 4456789999999999 899999999987754 4689999999999999999753
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecC
Q 026253 61 -------------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103 (241)
Q Consensus 61 -------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~ 103 (241)
.++++..+..++.|++.||.|||+.|++|+||||.||++ +
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~---~ 208 (338)
T cd05102 132 RVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL---S 208 (338)
T ss_pred ccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE---c
Confidence 236778889999999999999999999999999999999 6
Q ss_pred CCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH-HHHH
Q 026253 104 DDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV-QLVR 178 (241)
Q Consensus 104 ~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~-~~~~ 178 (241)
.++.++|+|||+++....... .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||.+.... ....
T Consensus 209 ~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDiwslG~il~el~~~g~~pf~~~~~~~~~~~ 288 (338)
T cd05102 209 ENNVVKICDFGLARDIYKDPDYVRKGSARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQINEEFCQ 288 (338)
T ss_pred CCCcEEEeecccccccccCcchhcccCCCCCccccCcHHhhcCCCCcccCHHHHHHHHHHHHhCCCCCCCCCCccHHHHH
Confidence 788899999999976532211 112234577999999988889999999999999999997 99999875543 3444
Q ss_pred HhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 179 NINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 179 ~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
.+..+.....+ ...++++.+++.+||+.||.+|||+.++++
T Consensus 289 ~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~el~~ 329 (338)
T cd05102 289 RLKDGTRMRAP----ENATPEIYRIMLACWQGDPKERPTFSALVE 329 (338)
T ss_pred HHhcCCCCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 44444333322 367889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V |
| >cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=257.98 Aligned_cols=215 Identities=33% Similarity=0.581 Sum_probs=186.7
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l 79 (241)
.+...+.+.+|++++++++|+||+++++++.. +...+++|||+++++|.+++.. ..++++..+..++.+++.|+
T Consensus 39 ~~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~l 118 (265)
T cd08217 39 TEKEKQQLVSEVNILRELKHPNIVRYYDRIIDRSNQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLAL 118 (265)
T ss_pred CHHHHHHHHHHHHHHHhcCCCccceeeeeeecCCCCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHHH
Confidence 45567789999999999999999999997753 4568999999999999999975 35689999999999999999
Q ss_pred HHHH-----hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHH
Q 026253 80 EILN-----SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (241)
Q Consensus 80 ~~lh-----~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 153 (241)
.+|| +.+++|+||+|.||++ ++++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||
T Consensus 119 ~~lH~~~~~~~~i~h~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Dv~s 195 (265)
T cd08217 119 YECHNRSDPGNTVLHRDLKPANIFL---DANNNVKLGDFGLAKILGHDSSFAKTYVGTPYYMSPEQLNHMSYDEKSDIWS 195 (265)
T ss_pred HHHhcCccccCcceecCCCHHHEEE---ecCCCEEEecccccccccCCcccccccccCCCccChhhhcCCCCCchhHHHH
Confidence 9999 8899999999999999 6788999999999877654432 33456788999999998888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 154 VGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
||++++++++|..||...+..+..+.+..+.....+ ...+..+.+++.+||+.+|.+|||+.++++|||+
T Consensus 196 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rp~~~~il~~~~~ 265 (265)
T cd08217 196 LGCLIYELCALSPPFTARNQLQLASKIKEGKFRRIP----YRYSSELNEVIKSMLNVDPDKRPSTEELLQLPLI 265 (265)
T ss_pred HHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCCCCc----cccCHHHHHHHHHHccCCcccCCCHHHHhhCCCC
Confidence 999999999999999988877777777655433333 3778999999999999999999999999999996
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi |
| >cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-40 Score=256.79 Aligned_cols=214 Identities=33% Similarity=0.616 Sum_probs=181.1
Q ss_pred hhHHHHHHHH-hcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 11 SCLDCELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 11 ~~~~~E~~~l-~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
..+..|..++ .+.+|+|++++++++..++..++|+||+++++|.++++..+.+++..+..++.|++.||.+||+.|++|
T Consensus 41 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~i~H 120 (260)
T cd05611 41 TNVKAERAIMMIQGESPYVAKLYYSFQSKDYLYLVMEYLNGGDCASLIKTLGGLPEDWAKQYIAEVVLGVEDLHQRGIIH 120 (260)
T ss_pred HHHHHHHHHHhhcCCCCCeeeeeeeEEcCCeEEEEEeccCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 3444555444 445899999999999999999999999999999999988888999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 169 (241)
+||+|.||++ +.++.++|+|||.+..... .....++..|++||.+.+..++.++|+||+|+++|++++|..||.
T Consensus 121 ~dl~p~nil~---~~~~~~~l~dfg~~~~~~~---~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~il~~l~~g~~p~~ 194 (260)
T cd05611 121 RDIKPENLLI---DQTGHLKLTDFGLSRNGLE---NKKFVGTPDYLAPETILGVGDDKMSDWWSLGCVIFEFLFGYPPFH 194 (260)
T ss_pred CCCCHHHeEE---CCCCcEEEeecccceeccc---cccCCCCcCccChhhhcCCCCcchhhhHHHHHHHHHHHHCCCCCC
Confidence 9999999999 6788899999998865433 223456788999999988888999999999999999999999999
Q ss_pred CCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC---HHHHhcCccccccc
Q 026253 170 GRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS---FNEFYHHRFLRRNS 231 (241)
Q Consensus 170 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~~ 231 (241)
..+..+....+.... ...+......+++.+.+++.+||+.+|++||+ ++|++.||||++.+
T Consensus 195 ~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~~~~~l~~~~~~~~~ 258 (260)
T cd05611 195 AETPDAVFDNILSRR-INWPEEVKEFCSPEAVDLINRLLCMDPAKRLGANGYQEIKSHPFFKSIN 258 (260)
T ss_pred CCCHHHHHHHHHhcc-cCCCCcccccCCHHHHHHHHHHccCCHHHccCCCcHHHHHcChHhhcCC
Confidence 888877776664433 22233333468899999999999999999994 57999999998753
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do |
| >cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-41 Score=262.42 Aligned_cols=217 Identities=26% Similarity=0.463 Sum_probs=185.9
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|++++++++|+||+++++.+..++..++||||+.+++|.+++.. ..+++..+..++.+++.|+.+||+.|
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~i~~~l~~lH~~~ 121 (277)
T cd06642 43 EDEIEDIQQEITVLSQCDSPYITRYYGSYLKGTKLWIIMEYLGGGSALDLLKP-GPLEETYIATILREILKGLDYLHSER 121 (277)
T ss_pred hHHHHHHHHHHHHHHcCCCCccHhhhcccccCCceEEEEEccCCCcHHHHhhc-CCCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 34567899999999999999999999999999999999999999999999864 57899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||+|+||++ ++++.++++|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|++++|.
T Consensus 122 ivH~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~tg~ 198 (277)
T cd06642 122 KIHRDIKAANVLL---SEQGDVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDFKADIWSLGITAIELAKGE 198 (277)
T ss_pred eeccCCChheEEE---eCCCCEEEccccccccccCcchhhhcccCcccccCHHHhCcCCCchhhhHHHHHHHHHHHHhCC
Confidence 9999999999999 677889999999987654322 122345678899999998888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
.||....+......+...... .....++.++.+++.+||+.+|.+|||+.++++||||+...
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 260 (277)
T cd06642 199 PPNSDLHPMRVLFLIPKNSPP----TLEGQYSKPFKEFVEACLNKDPRFRPTAKELLKHKFITRYT 260 (277)
T ss_pred CCCcccchhhHHhhhhcCCCC----CCCcccCHHHHHHHHHHccCCcccCcCHHHHHHhHHHHHHh
Confidence 999877666655555333322 22336788999999999999999999999999999998644
|
Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 |
| >cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-40 Score=268.94 Aligned_cols=216 Identities=30% Similarity=0.519 Sum_probs=176.4
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
..+.+.+|++++++++|+||+++++++... ...+++++++ +++|.++++ ...+++..+..++.|++.||.+|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~aL~~L 134 (343)
T cd07878 57 HARRTYRELRLLKHMKHENVIGLLDVFTPATSIENFNEVYLVTNLM-GADLNNIVK-CQKLSDEHVQFLIYQLLRGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHHhcCCCchhhhhhhhcccccccccCcEEEEeecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence 345677899999999999999999987543 4578999998 789998875 45799999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l 161 (241)
|+.|++|+||||.||++ +.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|
T Consensus 135 H~~~ivHrdikp~Nil~---~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~el 209 (343)
T cd07878 135 HSAGIIHRDLKPSNVAV---NEDCELRILDFGLARQADDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 209 (343)
T ss_pred HHCCeecccCChhhEEE---CCCCCEEEcCCccceecCCC--cCCccccccccCchHhcCCccCCchhhhHhHHHHHHHH
Confidence 99999999999999999 78889999999999765432 234567899999999876 5688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCC----------------------C----CccCCCCChHHHHHHHHhcccCcccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPF----------------------S----QLIVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------------~----~~~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
++|..||.+.+..+.+..+......+. + .......++.+.+++.+||+.||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~dp~~R 289 (343)
T cd07878 210 LKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRGANPLAIDLLEKMLVLDSDKR 289 (343)
T ss_pred HHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhccCCCHHHHHHHHHHcCCChhhC
Confidence 999999987766554444322111110 0 00122456778999999999999999
Q ss_pred CCHHHHhcCccccccc
Q 026253 216 LSFNEFYHHRFLRRNS 231 (241)
Q Consensus 216 ps~~~il~~~~~~~~~ 231 (241)
||+.|+++||||....
T Consensus 290 ~s~~ell~hp~~~~~~ 305 (343)
T cd07878 290 ISASEALAHPYFSQYH 305 (343)
T ss_pred CCHHHHhcCcchhccC
Confidence 9999999999998754
|
Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is |
| >cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-40 Score=262.47 Aligned_cols=217 Identities=28% Similarity=0.482 Sum_probs=183.1
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
....+.+|+.+++.++|+||+++++.+..+...++||||+.+++|.+++.. ..+++..+..++.|++.|+.+||+.|++
T Consensus 60 ~~~~~~~e~~~l~~~~h~~v~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~i~~ql~~aL~~LH~~gi~ 138 (296)
T cd06654 60 KKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI 138 (296)
T ss_pred hHHHHHHHHHHHHhCCCCCEeeEEEEEEeCCEEEEeecccCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 356788999999999999999999999999999999999999999999864 4688999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|++++|..|
T Consensus 139 H~dLkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~s~Gvil~~l~~g~~p 215 (296)
T cd06654 139 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPP 215 (296)
T ss_pred cCCCCHHHEEE---cCCCCEEECccccchhccccccccCcccCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999 678899999999887643322 12234578899999999888889999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|...++......+....... ......++..+.+++.+||..+|.+|||++++++||||....
T Consensus 216 f~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~ 277 (296)
T cd06654 216 YLNENPLRALYLIATNGTPE--LQNPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (296)
T ss_pred CCCCCHHHhHHHHhcCCCCC--CCCccccCHHHHHHHHHHCcCCcccCcCHHHHhhChhhhccC
Confidence 98776654443332222111 112346788999999999999999999999999999997643
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-40 Score=265.60 Aligned_cols=217 Identities=25% Similarity=0.460 Sum_probs=167.2
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~ 78 (241)
...+.+|++++++++||||+++++.+.. +...+++|||+ +++|.+++... ..+++..+..++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07868 42 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYA-EHDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhcCCCCCcceeeeEecCCCcEEEEEEecc-CCCHHHHHHhcccccccCCcccCCHHHHHHHHHHHHHH
Confidence 3467899999999999999999998854 46789999999 56898887532 248899999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeec-CCCceEEEeecCCccccCCCC----ccccccCCCCccCccccccc-CCCCchhHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMW 152 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~-~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~ 152 (241)
|.+||+.|++|+||||+||++... +..+.++|+|||++....... ......++..|+|||.+.+. .++.++|+|
T Consensus 121 l~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 200 (317)
T cd07868 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200 (317)
T ss_pred HHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCccccccCCccccccccCCHHHcCCCCcCchhhHH
Confidence 999999999999999999999532 355689999999997654321 22345678899999998764 588999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH---------HHHHHhhcCCCCC---------------------------------CCC
Q 026253 153 SVGAILFELLNGYPPFSGRNNV---------QLVRNINSCKHLP---------------------------------FSQ 190 (241)
Q Consensus 153 slG~~l~~l~~g~~p~~~~~~~---------~~~~~i~~~~~~~---------------------------------~~~ 190 (241)
|+||++|+|++|.+||.+.... ..+..+......+ ...
T Consensus 201 slG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (317)
T cd07868 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 280 (317)
T ss_pred HHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCcccccchHH
Confidence 9999999999999999753321 1111111100000 000
Q ss_pred ccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 191 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
......+..+.++|++||+.||.+|||++|+|+||||
T Consensus 281 ~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07868 281 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317 (317)
T ss_pred hcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence 0011235678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p |
| >cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-40 Score=257.46 Aligned_cols=209 Identities=21% Similarity=0.391 Sum_probs=180.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|++++++++||||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.|+++||+.|
T Consensus 48 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~lH~~~ 127 (266)
T cd05064 48 KQRRGFLAEALTLGQFDHSNIVRLEGVITRGNTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKYLSEMG 127 (266)
T ss_pred HHHHHHHHHHHHHhcCCCCCcCeEEEEEecCCCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44567899999999999999999999999999999999999999999999764 57899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
++|+||+|.||++ +.++.++++|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|++++
T Consensus 128 iiH~dikp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~~ 204 (266)
T cd05064 128 YVHKGLAAHKVLV---NSDLVCKISGFRRLQEDKSEAIYTTMSGKSPVLWAAPEAIQYHHFSSASDVWSFGIVMWEVMSY 204 (266)
T ss_pred EeeccccHhhEEE---cCCCcEEECCCcccccccccchhcccCCCCceeecCHHHHhhCCccchhHHHHHHHHHHHHhcC
Confidence 9999999999999 7788999999998755432211 112234567999999988899999999999999999775
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||.+.+..+..+.+..+...+.+ ..++..+.+++.+||+.+|.+|||++++++
T Consensus 205 g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~c~~~~p~~RP~~~~i~~ 260 (266)
T cd05064 205 GERPYWDMSGQDVIKAVEDGFRLPAP----RNCPNLLHQLMLDCWQKERGERPRFSQIHS 260 (266)
T ss_pred CCCCcCcCCHHHHHHHHHCCCCCCCC----CCCCHHHHHHHHHHcCCCchhCCCHHHHHH
Confidence 99999998888888887666544433 378899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor |
| >cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B | Back alignment and domain information |
|---|
Probab=100.00 E-value=5e-40 Score=259.50 Aligned_cols=211 Identities=24% Similarity=0.517 Sum_probs=181.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------RVPEQTARKFL 72 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~ 72 (241)
.+...+.+.+|++++++++|+||+++++++..++..++||||+++++|.+++...+ .+++..+..++
T Consensus 47 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~~~~ 126 (288)
T cd05093 47 SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQMLHIA 126 (288)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHHHHH
Confidence 34556789999999999999999999999999999999999999999999997543 38999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCch
Q 026253 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV 149 (241)
Q Consensus 73 ~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~ 149 (241)
.|++.||++||+.|++|+||+|.||++ ++++.++|+|||.+........ .....++..|+|||.+.+..++.++
T Consensus 127 ~ql~~aL~~lH~~~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~s 203 (288)
T cd05093 127 QQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 203 (288)
T ss_pred HHHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEeccCCccccccCCceeecCCCCCccccccCHHHhccCCCCchh
Confidence 999999999999999999999999999 6788999999999875533221 1122345679999999988899999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 150 DMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 150 Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|+||||+++|+|++ |..||......+....+..+.....+ ...+.++.+++.+||+.||.+|||+.++++
T Consensus 204 DiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~~v~~ 274 (288)
T cd05093 204 DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRP----RTCPKEVYDLMLGCWQREPHMRLNIKEIHS 274 (288)
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999999998 99999988887777777665543333 267889999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly |
| >cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.9e-40 Score=256.66 Aligned_cols=216 Identities=31% Similarity=0.510 Sum_probs=188.4
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~ 86 (241)
...+.+.+|++.+++++|+|++++++++..++..+++|||+++++|.+++.....+++..+..++.|++.|+.+||+ .|
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~~l~~~l~~lh~~~~ 120 (264)
T cd06623 41 EFRKQLLRELKTLRSCESPYVVKCYGAFYKEGEISIVLEYMDGGSLADLLKKVGKIPEPVLAYIARQILKGLDYLHTKRH 120 (264)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEccCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHhccCC
Confidence 45678999999999999999999999999999999999999999999999888889999999999999999999999 99
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc-ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~-~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||+|+||++ +.++.++|+|||.+......... ....++..|.|||.+.+..++.++|+||||+++|++++|.
T Consensus 121 ~~H~~l~~~ni~~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~tg~ 197 (264)
T cd06623 121 IIHRDIKPSNLLI---NSKGEVKIADFGISKVLENTLDQCNTFVGTVTYMSPERIQGESYSYAADIWSLGLTLLECALGK 197 (264)
T ss_pred CccCCCCHHHEEE---CCCCCEEEccCccceecccCCCcccceeecccccCHhhhCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999 78889999999998766443322 2445678899999998888999999999999999999999
Q ss_pred CCCCCC---ChHHHHHHhhcCCCCCCCCccCCC-CChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 166 PPFSGR---NNVQLVRNINSCKHLPFSQLIVPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~---~~~~~~~~i~~~~~~~~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
.||... +..+..+.+........+ .. ++..+.+++.+||..+|++|||+.++++|||+++.
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~R~~~~~ll~~~~~~~~ 262 (264)
T cd06623 198 FPFLPPGQPSFFELMQAICDGPPPSLP----AEEFSPEFRDFISACLQKDPKKRPSAAELLQHPFIKKA 262 (264)
T ss_pred CCCccccccCHHHHHHHHhcCCCCCCC----cccCCHHHHHHHHHHccCChhhCCCHHHHHhCHHHHhc
Confidence 999876 445555555443333222 24 78999999999999999999999999999999764
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of |
| >PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-41 Score=261.48 Aligned_cols=210 Identities=31% Similarity=0.539 Sum_probs=177.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.+..+.+.+|++.+++++||||++++|++...+..++||||+.+++|.+++... ..++...+..++.|++.||.|||+
T Consensus 42 ~~~~~~~~~e~~~l~~l~h~ni~~~~g~~~~~~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~~Lh~ 121 (259)
T PF07714_consen 42 EEEEEEFLNEIQILRKLRHPNIVKLYGFCIENEPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALSYLHS 121 (259)
T ss_dssp HHHHHHHHHHHHHHHTHSBTTBE-EEEEEESSSSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHHHHHH
T ss_pred cccceeeeeccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 445789999999999999999999999999888899999999999999999886 679999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
++++|++|++.||++ +.++.+||+|||++........ .........|.|||.+.+..++.++||||||+++|++
T Consensus 122 ~~iiH~~l~~~nill---~~~~~~Kl~~f~~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~ksDVysfG~~l~ei 198 (259)
T PF07714_consen 122 NNIIHGNLSPSNILL---DSNGQVKLSDFGLSRPISEKSKYKNDSSQQLPLRYLAPEVLKDGEYTKKSDVYSFGMLLYEI 198 (259)
T ss_dssp TTEEEST-SGGGEEE---ETTTEEEEESTTTGEETTTSSSEEESTTSESGGGGS-HHHHHHSEESHHHHHHHHHHHHHHH
T ss_pred ccccccccccccccc---cccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Confidence 999999999999999 6788999999999877632211 2233456779999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++ |+.||...+..+....+..+...+.+. .++..+.+++..||+.+|.+|||++++++
T Consensus 199 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~C~~~~p~~RPs~~~i~~ 257 (259)
T PF07714_consen 199 LTLGKFPFSDYDNEEIIEKLKQGQRLPIPD----NCPKDIYSLIQQCWSHDPEKRPSFQEILQ 257 (259)
T ss_dssp HTTSSGTTTTSCHHHHHHHHHTTEETTSBT----TSBHHHHHHHHHHT-SSGGGS--HHHHHH
T ss_pred cccccccccccccccccccccccccceecc----chhHHHHHHHHHHcCCChhhCcCHHHHHh
Confidence 99 789999999888888886666655443 68999999999999999999999999874
|
Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A .... |
| >KOG4279 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-42 Score=281.16 Aligned_cols=228 Identities=29% Similarity=0.476 Sum_probs=195.0
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~l 82 (241)
+.+...-+..|+.+.++|+|.|||++.|.+.+++++-|.||-++||+|+++++.. +++ .+..+..+.+||++||+||
T Consensus 612 dsr~~QPLhEEIaLH~~LrHkNIVrYLGs~senGf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeGLkYL 691 (1226)
T KOG4279|consen 612 DSREVQPLHEEIALHSTLRHKNIVRYLGSVSENGFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEGLKYL 691 (1226)
T ss_pred cchhhccHHHHHHHHHHHhhHhHHHHhhccCCCCeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHHhhhh
Confidence 3444566889999999999999999999999999999999999999999999764 677 8889999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccC-CCCccccccCCCCccCccccccc--CCCCchhHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILF 159 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~-~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~ 159 (241)
|++.|+|||||..|++++ +-.|.+||+|||-+++.. -...+....||..|+|||++..+ .|+.++|||||||++.
T Consensus 692 Hen~IVHRDIKGDNVLvN--TySGvlKISDFGTsKRLAginP~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS~GCT~v 769 (1226)
T KOG4279|consen 692 HENKIVHRDIKGDNVLVN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDQGPRGYGKAADIWSFGCTMV 769 (1226)
T ss_pred hhcceeeccccCCcEEEe--eccceEEecccccchhhccCCccccccccchhhhChHhhccCCcCCCchhhhhhccceeE
Confidence 999999999999999997 778899999999988764 35567788999999999999765 4889999999999999
Q ss_pred HHHhCCCCCCCCChH--HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCCCC
Q 026253 160 ELLNGYPPFSGRNNV--QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 237 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~ 237 (241)
||+||++||-..... .+++-=.-...+++| ..+|.+.+.||.+|+.++|.+||++.++|..||++..+.+..++
T Consensus 770 EMATGrPPF~ElgspqAAMFkVGmyKvHP~iP----eelsaeak~FilrcFepd~~~R~sA~~LL~DpFlq~~~kk~r~~ 845 (1226)
T KOG4279|consen 770 EMATGRPPFVELGSPQAAMFKVGMYKVHPPIP----EELSAEAKNFILRCFEPDPCDRPSAKDLLQDPFLQHNNKKPRPK 845 (1226)
T ss_pred eeccCCCCeeecCChhHhhhhhcceecCCCCc----HHHHHHHHHHHHHHcCCCcccCccHHHhccCcccccCCCCCCCC
Confidence 999999999754433 233221122233333 48899999999999999999999999999999999987777666
Q ss_pred CC
Q 026253 238 FH 239 (241)
Q Consensus 238 ~~ 239 (241)
+.
T Consensus 846 ls 847 (1226)
T KOG4279|consen 846 LS 847 (1226)
T ss_pred CC
Confidence 53
|
|
| >cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=262.52 Aligned_cols=223 Identities=32% Similarity=0.496 Sum_probs=183.8
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
....+.+|++++++++|+||+++++++.+++..++||||+ +++|.+++.... .+++..+..++.|++.||.+||+.|+
T Consensus 45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 123 (298)
T cd07841 45 INFTALREIKLLQELKHPNIIGLLDVFGHKSNINLVFEFM-ETDLEKVIKDKSIVLTPADIKSYMLMTLRGLEYLHSNWI 123 (298)
T ss_pred hhHHHHHHHHHHhhcCCCCChhhhheeecCCEEEEEEccc-CCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4556788999999999999999999999999999999999 899999998765 79999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|.|||.+.+ ..++.++|+||+|++++++++|.
T Consensus 124 ~H~dl~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~e~~~g~ 200 (298)
T cd07841 124 LHRDLKPNNLLI---ASDGVLKLADFGLARSFGSPNRKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRV 200 (298)
T ss_pred eecCCChhhEEE---cCCCCEEEccceeeeeccCCCccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHHHHHHHcCC
Confidence 999999999999 678899999999987664432 1222345678999998754 45789999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCC-----------------------CccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFS-----------------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
++|.+.+..+....+......+.. .......+..+.+++.+||+.+|.+|||+.|++
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~s~~e~l 280 (298)
T cd07841 201 PFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPPTPLKQIFPAASDDALDLLQRLLTLNPNKRITARQAL 280 (298)
T ss_pred ccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCCcchhhhcccccHHHHHHHHHHhcCCcccCcCHHHHh
Confidence 889877766555444322111000 011234578899999999999999999999999
Q ss_pred cCcccccccccCC
Q 026253 223 HHRFLRRNSAILR 235 (241)
Q Consensus 223 ~~~~~~~~~~~~~ 235 (241)
+|+||++...-..
T Consensus 281 ~~~~~~~~~~~~~ 293 (298)
T cd07841 281 EHPYFSNDPAPTP 293 (298)
T ss_pred hCccccCCCCCCC
Confidence 9999999766543
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is |
| >PTZ00024 cyclin-dependent protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-40 Score=264.96 Aligned_cols=225 Identities=31% Similarity=0.491 Sum_probs=185.9
Q ss_pred hHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 026253 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (241)
Q Consensus 12 ~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (241)
.+.+|++++++++|+||+++++++..++..+++||++. ++|.+++.....+++..+..++.|++.||.+||+.|++|+|
T Consensus 66 ~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~ql~~aL~~LH~~~i~H~d 144 (335)
T PTZ00024 66 TTLRELKIMNEIKHENIMGLVDVYVEGDFINLVMDIMA-SDLKKVVDRKIRLTESQVKCILLQILNGLNVLHKWYFMHRD 144 (335)
T ss_pred hHHHHHHHHHhCCCcceeeeeEEEecCCcEEEEEeccc-cCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeccc
Confidence 57899999999999999999999999999999999996 69999998878899999999999999999999999999999
Q ss_pred CCCCCeEEeecCCCceEEEeecCCccccCCCC---------------ccccccCCCCccCccccccc-CCCCchhHHHHH
Q 026253 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------------YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG 155 (241)
Q Consensus 92 l~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---------------~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG 155 (241)
|+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|
T Consensus 145 l~~~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG 221 (335)
T PTZ00024 145 LSPANIFI---NSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVG 221 (335)
T ss_pred ccHHHeEE---CCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHHHHHHHH
Confidence 99999999 778899999999987654111 11123357789999998764 468999999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC-----------------------CccCCCCChHHHHHHHHhcccCc
Q 026253 156 AILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS-----------------------QLIVPALHPDCVDMCLKLLSANT 212 (241)
Q Consensus 156 ~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p 212 (241)
+++|++++|.+||.+.+..+....+......+.. ....+..+.++.++|.+||+.+|
T Consensus 222 ~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 301 (335)
T PTZ00024 222 CIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRKPKDLKTIFPNASDDAIDLLQSLLKLNP 301 (335)
T ss_pred HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCCcccHHHhCcCCChHHHHHHHHHcCCCc
Confidence 9999999999999988776665544332111110 01123457889999999999999
Q ss_pred cccCCHHHHhcCcccccccccCCCCCCCC
Q 026253 213 VDRLSFNEFYHHRFLRRNSAILRAPFHIP 241 (241)
Q Consensus 213 ~~Rps~~~il~~~~~~~~~~~~~~~~~~~ 241 (241)
++|||++|++.||||+.....+. ++.+|
T Consensus 302 ~~R~s~~~~l~~~~~~~~~~~~~-~~~~~ 329 (335)
T PTZ00024 302 LERISAKEALKHEYFKSDPLPCD-PSQLP 329 (335)
T ss_pred hhccCHHHHhcCcccCCCCCCCC-cccCC
Confidence 99999999999999999887765 55454
|
|
| >PTZ00284 protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-40 Score=278.46 Aligned_cols=220 Identities=24% Similarity=0.381 Sum_probs=172.5
Q ss_pred hhhHHHHHHHHhcCCCc------CeeeeeeEEeec-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHP------NIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~------~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
.+....|+++++.++|. +++++++++..+ +++|+||+++ |++|.+++.+.+.+++..+..++.|++.||.||
T Consensus 169 ~~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~~~~~~iv~~~~-g~~l~~~l~~~~~l~~~~~~~i~~qi~~aL~yL 247 (467)
T PTZ00284 169 TRDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNETGHMCIVMPKY-GPCLLDWIMKHGPFSHRHLAQIIFQTGVALDYF 247 (467)
T ss_pred HHHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcCCceEEEEEecc-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHH
Confidence 44567788888887544 588888888754 5799999998 789999998888899999999999999999999
Q ss_pred Hh-CCccccCCCCCCeEEeecC-------------CCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCc
Q 026253 83 NS-HHIIHRDLKPENILLSGLD-------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK 148 (241)
Q Consensus 83 h~-~~i~H~dl~~~nil~~~~~-------------~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~ 148 (241)
|+ .||+||||||+||+++..+ +...+||+|||.+..... ......++..|+|||.+.+..++.+
T Consensus 248 H~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~--~~~~~~gt~~Y~APE~~~~~~~~~~ 325 (467)
T PTZ00284 248 HTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH--SRTAIVSTRHYRSPEVVLGLGWMYS 325 (467)
T ss_pred HhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc--ccccccCCccccCcHHhhcCCCCcH
Confidence 98 5999999999999995211 112599999998754332 2334578999999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC----------------------Ccc--------------
Q 026253 149 VDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS----------------------QLI-------------- 192 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~----------------------~~~-------------- 192 (241)
+|||||||++|+|++|+.||.+.+..+.+..+......... ...
T Consensus 326 ~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 405 (467)
T PTZ00284 326 TDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWAGRCGTEEARLLYNSAGQLRPCTDPKHLARIARARPV 405 (467)
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHHhhccchhHHHHhhhcccccccCCHHHHHhhhcccch
Confidence 99999999999999999999987766555443222110000 000
Q ss_pred -CCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 193 -VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 193 -~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
....+..+.+||++||+.||.+|||++|+|+||||++...
T Consensus 406 ~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~~~ 446 (467)
T PTZ00284 406 REVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKYYP 446 (467)
T ss_pred hhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccccCC
Confidence 0011356789999999999999999999999999998544
|
|
| >PHA03209 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-41 Score=270.87 Aligned_cols=215 Identities=27% Similarity=0.373 Sum_probs=170.7
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
.....|+.++++++|+||+++++++..++..++|||++. ++|.+++.. ..++++..+..++.|++.||.+||+.|++|
T Consensus 102 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH 180 (357)
T PHA03209 102 GTTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYS-SDLYTYLTKRSRPLPIDQALIIEKQILEGLRYLHAQRIIH 180 (357)
T ss_pred cccHHHHHHHHhCCCCCCcChhheEEeCCeeEEEEEccC-CcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCeec
Confidence 345679999999999999999999999999999999994 688888865 456899999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC-CC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP-PF 168 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~-p~ 168 (241)
|||||.||++ +..+.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++|+|+++.. +|
T Consensus 181 rDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvvl~ell~~~~~~f 257 (357)
T PHA03209 181 RDVKTENIFI---NDVDQVCIGDLGAAQFPVVAPAFLGLAGTVETNAPEVLARDKYNSKADIWSAGIVLFEMLAYPSTIF 257 (357)
T ss_pred CCCCHHHEEE---CCCCCEEEecCccccccccCcccccccccccccCCeecCCCCCCchhhHHHHHHHHHHHHHcCCccc
Confidence 9999999999 7788899999999875443333344568899999999998899999999999999999998544 44
Q ss_pred CCCCh----------HHHHHHhhcCC--CCCCC--------------------------CccCCCCChHHHHHHHHhccc
Q 026253 169 SGRNN----------VQLVRNINSCK--HLPFS--------------------------QLIVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 169 ~~~~~----------~~~~~~i~~~~--~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~ 210 (241)
..... ..+...+.... ...++ ......++.+..++|++||+.
T Consensus 258 ~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~mL~~ 337 (357)
T PHA03209 258 EDPPSTPEEYVKSCHSHLLKIISTLKVHPEEFPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNLPIDGEFLVHKMLTF 337 (357)
T ss_pred cCCCCcHHHHHHHHHHHHHHHHHHhccChhhcCCCCccHHHHHHHhhcccCCCcccccHHHhccCCCchHHHHHHHHHcC
Confidence 43211 11111111100 00000 000124567788899999999
Q ss_pred CccccCCHHHHhcCccccc
Q 026253 211 NTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 211 ~p~~Rps~~~il~~~~~~~ 229 (241)
||.+|||+.|+|+||||++
T Consensus 338 dP~~Rpta~e~l~hp~f~~ 356 (357)
T PHA03209 338 DAAMRPSAEEILNYPMFAQ 356 (357)
T ss_pred CcccCcCHHHHhcCchhcc
Confidence 9999999999999999986
|
|
| >cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-40 Score=262.50 Aligned_cols=220 Identities=27% Similarity=0.470 Sum_probs=184.3
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.+++.++|+||+++++++..++..++||||+++++|.+++.+ ..+++..+..++.|++.|+.+||+.|+
T Consensus 58 ~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~l~~~L~~LH~~~i 136 (297)
T cd06656 58 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALDFLHSNQV 136 (297)
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCEEEEeecccCCCCHHHHHHh-CCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 3456788999999999999999999999999999999999999999999864 468899999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|+||++ +.++.++|+|||.+........ .....++..|.|||...+..++.++|+||+|+++|++++|..
T Consensus 137 ~H~dL~p~Nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slGvil~~l~tg~~ 213 (297)
T cd06656 137 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEP 213 (297)
T ss_pred ccCCCCHHHEEE---CCCCCEEECcCccceEccCCccCcCcccCCccccCHHHHcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999 7788999999999866543322 223457888999999988889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
||...+.......+....... ......++..+.+++.+||+.+|.+|||++++++||||+.....
T Consensus 214 pf~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 278 (297)
T cd06656 214 PYLNENPLRALYLIATNGTPE--LQNPERLSAVFRDFLNRCLEMDVDRRGSAKELLQHPFLKLAKPL 278 (297)
T ss_pred CCCCCCcchheeeeccCCCCC--CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCchhcccccc
Confidence 998766544333332222111 11223678899999999999999999999999999999875543
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding |
| >cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-40 Score=259.99 Aligned_cols=214 Identities=29% Similarity=0.465 Sum_probs=173.9
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.+.+.+|+.++++++|+||+++++++.+++..++||||+. ++|.+++... ..+++..+..++.|++.||.+||+.|
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~ 121 (285)
T cd07861 43 PSTAIREISLLKELQHPNIVCLQDVLMQESRLYLIFEFLS-MDLKKYLDSLPKGQYMDAELVKSYLYQILQGILFCHSRR 121 (285)
T ss_pred hHHHHHHHHHHHhcCCCCEeeeEEEEeeCCeEEEEEecCC-CCHHHHHhcCCCCCcCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4678899999999999999999999999999999999996 6898888653 45899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g 164 (241)
++|+||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+. .++.++|+||+|++++++++|
T Consensus 122 i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg 198 (285)
T cd07861 122 VLHRDLKPQNLLI---DNKGVIKLADFGLARAFGIPVRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATK 198 (285)
T ss_pred eeecCCCHHHEEE---cCCCcEEECcccceeecCCCcccccCCcccccccChHHhcCCCCcCcHHHHHHHHHHHHHHHHC
Confidence 9999999999999 778899999999987554322 11223457889999987654 468899999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCC------------------------CCCCCCccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 165 YPPFSGRNNVQLVRNINSCK------------------------HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~------------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
++||.+.+.......+.... ...........+++++.++|++||+.||.+|||+++
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rpt~~~ 278 (285)
T cd07861 199 KPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNTFPKWKKGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKK 278 (285)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhhccccCcchhHHhcCCCCHHHHHHHHHHhcCChhhCCCHHH
Confidence 99998765543222211100 000001122357889999999999999999999999
Q ss_pred HhcCccc
Q 026253 221 FYHHRFL 227 (241)
Q Consensus 221 il~~~~~ 227 (241)
+++||||
T Consensus 279 ll~~~~~ 285 (285)
T cd07861 279 ALNHPYF 285 (285)
T ss_pred HhcCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 |
| >cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.1e-40 Score=256.86 Aligned_cols=213 Identities=28% Similarity=0.491 Sum_probs=177.0
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l 79 (241)
....+.+|+.+++++ +|+||+++++++... ...+++|||+.+++|.+++... ..+++..+..++.|++.|+
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l 124 (272)
T cd06637 45 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRGL 124 (272)
T ss_pred cHHHHHHHHHHHHHhcCCCCeeeEeeEEeecCCCCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 456788999999999 799999999998653 4689999999999999999864 3589999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCccccc-----ccCCCCchhHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWS 153 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~s 153 (241)
++||+.+++|+|++|.||++ ++++.++|+|||++...... .......++..|+|||.+. +..++.++|+||
T Consensus 125 ~~LH~~~ivh~dl~~~nili---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 201 (272)
T cd06637 125 SHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLWS 201 (272)
T ss_pred HHHHHCCCccCCCCHHHEEE---CCCCCEEEccCCCceecccccccCCcccccccccCHhHhccccCcCCCCCchhhHHH
Confidence 99999999999999999999 67888999999998764322 2233456788899999885 335788999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 154 VGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+|+++|++++|..||...........+..... .......++.++.+++.+||..+|.+|||+.++++||||
T Consensus 202 lGv~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~~~~ 272 (272)
T cd06637 202 LGITAIEMAEGAPPLCDMHPMRALFLIPRNPA---PRLKSKKWSKKFQSFIESCLVKNHSQRPTTEQLMKHPFI 272 (272)
T ss_pred HHHHHHHHHhCCCCccccCHHHHHHHHhcCCC---CCCCCCCcCHHHHHHHHHHcCCChhhCCCHHHHhhCCCC
Confidence 99999999999999987666555544433222 222233678899999999999999999999999999997
|
Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ |
| >cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=258.85 Aligned_cols=209 Identities=24% Similarity=0.520 Sum_probs=179.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARKF 71 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~~ 71 (241)
...+.+.+|++++++++|+||+++++++..++..++||||+++++|.+++...+ .+++..+..+
T Consensus 49 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 128 (291)
T cd05094 49 AARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLSQMLHI 128 (291)
T ss_pred HHHHHHHHHHHHHhcCCCCCcceEEEEEccCCceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHHHHHHH
Confidence 345678999999999999999999999999999999999999999999997543 3788999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCc
Q 026253 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK 148 (241)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~ 148 (241)
+.|++.|+++||++|++|+||+|.||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.+
T Consensus 129 ~~~i~~al~~lH~~~i~H~dlkp~Nil~---~~~~~~~l~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 205 (291)
T cd05094 129 ASQIASGMVYLASQHFVHRDLATRNCLV---GANLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTE 205 (291)
T ss_pred HHHHHHHHHHHHhCCeeecccCcceEEE---ccCCcEEECCCCcccccCCCceeecCCCCCcceeecChHHhccCCCCch
Confidence 9999999999999999999999999999 6788999999999876543221 122335678999999998889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 149 VDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+|+||+|+++|+|++ |..||...+..+..+.+..+.....+ ...+..+.+++.+||+.+|++|||++++++
T Consensus 206 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~v~~ 277 (291)
T cd05094 206 SDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQGRVLERP----RVCPKEVYDIMLGCWQREPQQRLNIKEIYK 277 (291)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhCCCCCCCC----ccCCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence 999999999999998 99999888888777777555443332 357889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n |
| >PTZ00266 NIMA-related protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-40 Score=287.18 Aligned_cols=222 Identities=32% Similarity=0.550 Sum_probs=182.2
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l 79 (241)
.......+..|+.++++++||||+++++++.. ...+|+||||+.+++|.+++... +.+++..++.++.||+.||
T Consensus 52 ~e~~~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~AL 131 (1021)
T PTZ00266 52 KEREKSQLVIEVNVMRELKHKNIVRYIDRFLNKANQKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLHAL 131 (1021)
T ss_pred CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEecCCCEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence 45567789999999999999999999998854 45789999999999999998753 5699999999999999999
Q ss_pred HHHHhC-------CccccCCCCCCeEEeec--------------CCCceEEEeecCCccccCCCCccccccCCCCccCcc
Q 026253 80 EILNSH-------HIIHRDLKPENILLSGL--------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE 138 (241)
Q Consensus 80 ~~lh~~-------~i~H~dl~~~nil~~~~--------------~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE 138 (241)
.|||+. +|+|+||||.|||+... +....++|+|||++.............+++.|+|||
T Consensus 132 aYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s~~~s~vGTp~YmAPE 211 (1021)
T PTZ00266 132 AYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIESMAHSCVGTPYYWSPE 211 (1021)
T ss_pred HHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccccccccCCCccccCHH
Confidence 999984 49999999999999521 223458999999997765444445567899999999
Q ss_pred cccc--cCCCCchhHHHHHHHHHHHHhCCCCCCCCChH-HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCcccc
Q 026253 139 VLQF--QRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 139 ~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
.+.+ ..++.++|||||||++|+|++|..||...+.. .....+......+ ....+.++.+||..||+.+|.+|
T Consensus 212 vL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~~p~lp-----i~~~S~eL~dLI~~~L~~dPeeR 286 (1021)
T PTZ00266 212 LLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKRGPDLP-----IKGKSKELNILIKNLLNLSAKER 286 (1021)
T ss_pred HHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhcCCCCC-----cCCCCHHHHHHHHHHhcCChhHC
Confidence 9854 45789999999999999999999999865544 3444443332211 23678999999999999999999
Q ss_pred CCHHHHhcCcccccccc
Q 026253 216 LSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 216 ps~~~il~~~~~~~~~~ 232 (241)
||+.|+|.|||++....
T Consensus 287 PSa~QlL~h~~ik~i~~ 303 (1021)
T PTZ00266 287 PSALQCLGYQIIKNVGP 303 (1021)
T ss_pred cCHHHHhccHHHhhcCC
Confidence 99999999999986543
|
|
| >cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.6e-40 Score=255.37 Aligned_cols=214 Identities=33% Similarity=0.595 Sum_probs=182.9
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+.+|++++++++|+||+++++.+..++..++|+||+.+++|.+++.... .+++..+..++.+++.|+.+||+.
T Consensus 41 ~~~~~~~~E~~~l~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (257)
T cd08225 41 KEKEASKKEVILLAKMKHPNIVTFFASFQENGRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGLKHIHDR 120 (257)
T ss_pred hhhHHHHHHHHHHHhCCCCChhhhhheeccCCeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 456788899999999999999999999999999999999999999999997643 478999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
+++|+||+|.||+++ +++..++++|||.+........ .....++..|.|||...+..++.++|+||+|++++++++|
T Consensus 121 ~i~H~dl~~~nil~~--~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l~~g 198 (257)
T cd08225 121 KILHRDIKSQNIFLS--KNGMVAKLGDFGIARQLNDSMELAYTCVGTPYYLSPEICQNRPYNNKTDIWSLGCVLYELCTL 198 (257)
T ss_pred CcccccCCHHHEEEc--CCCCeEEecccccchhccCCcccccccCCCccccCHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 999999999999994 3334579999999876654322 2234578889999999888899999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
..||...+..+....+....... ..+.++.++.+++.+||..+|++|||+.++++||||
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~~~~~ 257 (257)
T cd08225 199 KHPFEGNNLHQLVLKICQGYFAP----ISPNFSRDLRSLISQLFKVSPRDRPSITSILKRPFL 257 (257)
T ss_pred CCCCCCccHHHHHHHHhcccCCC----CCCCCCHHHHHHHHHHhccChhhCcCHHHHhhCCCC
Confidence 99998877766666554433222 234678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. |
| >cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-40 Score=260.10 Aligned_cols=221 Identities=25% Similarity=0.458 Sum_probs=182.3
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~l~~l 82 (241)
+....+.+.+|++++++++|+||+++++.+..++..++||||+++++|..++... ..+++..+..++.+++.|+.+|
T Consensus 39 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 118 (286)
T cd06622 39 DESKFNQIIMELDILHKAVSPYIVDFYGAFFIEGAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGLKFL 118 (286)
T ss_pred CHHHHHHHHHHHHHHHhcCCCcHHhhhhheecCCeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHHHHH
Confidence 3444678899999999999999999999999999999999999999999998763 3789999999999999999999
Q ss_pred Hh-CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccC------CCCchhHHHHH
Q 026253 83 NS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR------YDEKVDMWSVG 155 (241)
Q Consensus 83 h~-~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~------~~~~~Dv~slG 155 (241)
|+ .|++|+||+|+||++ +.++.++|+|||.+...... ......++..|+|||.+.+.. ++.++|+||+|
T Consensus 119 H~~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~DiwslG 194 (286)
T cd06622 119 KEEHNIIHRDVKPTNVLV---NGNGQVKLCDFGVSGNLVAS-LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSDVWSLG 194 (286)
T ss_pred HhcCCEeeCCCCHHHEEE---CCCCCEEEeecCCcccccCC-ccccCCCccCccCcchhcCCCCCccCCCCcccchHhHH
Confidence 97 599999999999999 67888999999998665332 222345677899999985443 47899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 156 AILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 156 ~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
+++|++++|..||...+.......+....... +....+.++.++.+++.+||+.+|.+||++++++.||||....
T Consensus 195 ~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~~~~~~~~~ 269 (286)
T cd06622 195 LSILEMALGRYPYPPETYANIFAQLSAIVDGD-PPTLPSGYSDDAQDFVAKCLNKIPNRRPTYAQLLEHPWLVKYK 269 (286)
T ss_pred HHHHHHHhCCCCCCCcchhhHHHHHHHHhhcC-CCCCCcccCHHHHHHHHHHcccCcccCCCHHHHhcChhhhhcc
Confidence 99999999999998765554444332211111 1223346899999999999999999999999999999998754
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=257.27 Aligned_cols=222 Identities=28% Similarity=0.449 Sum_probs=180.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
.....+.+|++++++++|+||+++++++.+ .+..++||||+++++|.+++.. ...+++..+..++.|++.||.+
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~~L~~ 120 (287)
T cd06621 41 DLQKQILRELEINKSCKSPYIVKYYGAFLDESSSSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLKGLSY 120 (287)
T ss_pred HHHHHHHHHHHHHHhCCCCCeeeeeeEEEccCCCeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence 456778999999999999999999998864 3478999999999999998753 2458899999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
||+.|++|+||+|.||++ +.++.++|+|||++........ ....++..|++||.+.+..++.++|+||+|+++|+|
T Consensus 121 lH~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l 196 (287)
T cd06621 121 LHSRKIIHRDIKPSNILL---TRKGQVKLCDFGVSGELVNSLA-GTFTGTSFYMAPERIQGKPYSITSDVWSLGLTLLEV 196 (287)
T ss_pred HHHCCcccCCCCHHHEEE---ecCCeEEEeecccccccccccc-ccccCCccccCHHHhcCCCCCchhhHHHHHHHHHHH
Confidence 999999999999999999 6778899999999865543221 234567889999999888899999999999999999
Q ss_pred HhCCCCCCCC-----ChHHHHHHhhcCCCCCCCCccC--CCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 162 LNGYPPFSGR-----NNVQLVRNINSCKHLPFSQLIV--PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 162 ~~g~~p~~~~-----~~~~~~~~i~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
++|..||... ...+....+............. ...++.+.+++.+||..+|++|||+.|+++||||++...+
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~eil~~~~~~~~~~~ 275 (287)
T cd06621 197 AQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFKDFIKQCLEKDPTRRPTPWDMLEHPWIKAQMKK 275 (287)
T ss_pred HhCCCCCCcccCCCCChHHHHHHHhcCCchhhccCCCCCCchHHHHHHHHHHHcCCCcccCCCHHHHHhCccccccccc
Confidence 9999999865 2334444443322222221111 2356789999999999999999999999999999886654
|
Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-40 Score=261.74 Aligned_cols=218 Identities=25% Similarity=0.490 Sum_probs=187.4
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.+++.++|||++++++++..++..+++|||+++++|.+++.. ..+++..+..++.|++.|+.+||+.|+
T Consensus 60 ~~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~LH~~~i 138 (297)
T cd06659 60 QRRELLFNEVVIMRDYQHQNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-TRLNEEQIATVCESVLQALCYLHSQGV 138 (297)
T ss_pred chHHHHHHHHHHHHhCCCCchhhhhhheeeCCeEEEEEecCCCCCHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3456788999999999999999999999999999999999999999998754 568999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|++++++++|..
T Consensus 139 vH~dl~p~Nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 215 (297)
T cd06659 139 IHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRTPYGTEVDIWSLGIMVIEMVDGEP 215 (297)
T ss_pred ecCCCCHHHeEE---ccCCcEEEeechhHhhcccccccccceecCccccCHHHHccCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 788899999999886543322 2234567889999999988889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
||...+..+....+....... ......++..+.+++++||+.+|.+||+++++++||||.+..
T Consensus 216 p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~l~~~i~~~l~~~P~~Rps~~~ll~~~~~~~~~ 278 (297)
T cd06659 216 PYFSDSPVQAMKRLRDSPPPK--LKNAHKISPVLRDFLERMLTREPQERATAQELLDHPFLLQTG 278 (297)
T ss_pred CCCCCCHHHHHHHHhccCCCC--ccccCCCCHHHHHHHHHHhcCCcccCcCHHHHhhChhhccCC
Confidence 999887777776664433221 122346788999999999999999999999999999999764
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i |
| >cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-40 Score=262.07 Aligned_cols=214 Identities=31% Similarity=0.523 Sum_probs=173.6
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|++++++++|+||+++++++.+.+..++++||+. ++|.+++.+ .+.+++..+..++.|++.||.+||+.|++
T Consensus 43 ~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH~~~i~ 121 (284)
T cd07839 43 PSSALREICLLKELKHKNIVRLYDVLHSDKKLTLVFEYCD-QDLKKYFDSCNGDIDPEIVKSFMFQLLKGLAFCHSHNVL 121 (284)
T ss_pred ccchhHHHHHHHhcCCCCeeeHHHHhccCCceEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEe
Confidence 4567889999999999999999999999999999999996 588888765 46799999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++|+|++|..
T Consensus 122 H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~tg~~ 198 (284)
T cd07839 122 HRDLKPQNLLI---NKNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGR 198 (284)
T ss_pred cCCCCHHHEEE---cCCCcEEECccchhhccCCCCCCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHHHHHHHhcCC
Confidence 99999999999 678899999999987654322 22234567889999988664 46899999999999999999887
Q ss_pred CC-CCCChHHHHHHhhcCCCC-------------------CCC-----CccCCCCChHHHHHHHHhcccCccccCCHHHH
Q 026253 167 PF-SGRNNVQLVRNINSCKHL-------------------PFS-----QLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221 (241)
Q Consensus 167 p~-~~~~~~~~~~~i~~~~~~-------------------~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 221 (241)
|+ .+.+..+.++.+...... ..+ ....+.+++++.++|++||+.||.+|||++++
T Consensus 199 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~~i 278 (284)
T cd07839 199 PLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTSLVNVVPKLNSTGRDLLQNLLVCNPVQRISAEEA 278 (284)
T ss_pred CCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcchhhhhcccCCHHHHHHHHHHhcCChhhcCCHHHH
Confidence 75 444444444433221100 000 11234578899999999999999999999999
Q ss_pred hcCccc
Q 026253 222 YHHRFL 227 (241)
Q Consensus 222 l~~~~~ 227 (241)
++||||
T Consensus 279 l~h~~f 284 (284)
T cd07839 279 LQHPYF 284 (284)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also |
| >KOG0983 consensus Mitogen-activated protein kinase (MAPK) kinase MKK7/JNKK2 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-41 Score=249.52 Aligned_cols=221 Identities=26% Similarity=0.490 Sum_probs=191.3
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+.++.+++...+.++.+. ++|+||+++|+|..+...++.||.| +..+..++++ .+++++..+-++...++.||.||.
T Consensus 130 Nkee~kRILmDldvv~~s~dcpyIV~c~GyFi~n~dV~IcMelM-s~C~ekLlkrik~piPE~ilGk~tva~v~AL~YLK 208 (391)
T KOG0983|consen 130 NKEENKRILMDLDVVLKSHDCPYIVQCFGYFITNTDVFICMELM-STCAEKLLKRIKGPIPERILGKMTVAIVKALYYLK 208 (391)
T ss_pred CHHHHHHHHHhhhHHhhccCCCeeeeeeeEEeeCchHHHHHHHH-HHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHHHH
Confidence 567788888899988887 5999999999999999999999999 5677777754 467999999999999999999999
Q ss_pred hC-CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc---ccCCCCchhHHHHHHHHH
Q 026253 84 SH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 84 ~~-~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~ 159 (241)
++ |++|||+||+|||+ ++.+++|+||||.+.+.-++.......|.+.|+|||.+. ...|..++||||||++++
T Consensus 209 eKH~viHRDvKPSNILl---De~GniKlCDFGIsGrlvdSkAhtrsAGC~~YMaPERidp~~~~kYDiRaDVWSlGITlv 285 (391)
T KOG0983|consen 209 EKHGVIHRDVKPSNILL---DERGNIKLCDFGISGRLVDSKAHTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLGITLV 285 (391)
T ss_pred HhcceeecccCccceEE---ccCCCEEeecccccceeecccccccccCCccccCccccCCCCCCccchhhhhhhhccchh
Confidence 74 89999999999999 899999999999998888777777778999999999985 346889999999999999
Q ss_pred HHHhCCCCCCC-CChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 160 ELLNGYPPFSG-RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 160 ~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
|++||+.||.+ .+..+.+..+-+...+.++.. ..+|+.+.+|+..||++|+.+||.+.++|+|||++.+..
T Consensus 286 eLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~~--~gFSp~F~~fv~~CL~kd~r~RP~Y~~Ll~h~Fi~~ye~ 357 (391)
T KOG0983|consen 286 ELATGQYPYKGCKTDFEVLTKVLNEEPPLLPGH--MGFSPDFQSFVKDCLTKDHRKRPKYNKLLEHPFIKRYET 357 (391)
T ss_pred hhhcccCCCCCCCccHHHHHHHHhcCCCCCCcc--cCcCHHHHHHHHHHhhcCcccCcchHHHhcCcceeecch
Confidence 99999999986 455666666655444433333 248999999999999999999999999999999988654
|
|
| >PHA03390 pk1 serine/threonine-protein kinase 1; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-40 Score=257.12 Aligned_cols=198 Identities=27% Similarity=0.497 Sum_probs=166.5
Q ss_pred CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecC
Q 026253 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103 (241)
Q Consensus 24 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~ 103 (241)
+|+||+++++.+..++..++||||+++++|.+++.....+++..+..++.|++.|+.+||+.|++|+||+|.||+++
T Consensus 67 ~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i~H~dl~p~nil~~--- 143 (267)
T PHA03390 67 DNPNFIKLYYSVTTLKGHVLIMDYIKDGDLFDLLKKEGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVLYD--- 143 (267)
T ss_pred cCCCEEEEEEEEecCCeeEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeeeCCCCHHHEEEe---
Confidence 79999999999999999999999999999999998878899999999999999999999999999999999999994
Q ss_pred CCc-eEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH-HHHhh
Q 026253 104 DDV-MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL-VRNIN 181 (241)
Q Consensus 104 ~~~-~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~-~~~i~ 181 (241)
..+ .++|+|||.+...... ....++..|+|||.+.+..++.++|+||+|+++|++++|..||........ ...+.
T Consensus 144 ~~~~~~~l~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~~l~~g~~p~~~~~~~~~~~~~~~ 220 (267)
T PHA03390 144 RAKDRIYLCDYGLCKIIGTP---SCYDGTLDYFSPEKIKGHNYDVSFDWWAVGVLTYELLTGKHPFKEDEDEELDLESLL 220 (267)
T ss_pred CCCCeEEEecCccceecCCC---ccCCCCCcccChhhhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCCcchhhHHHHH
Confidence 455 8999999988665432 223578889999999888899999999999999999999999985543321 11121
Q ss_pred cCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-HHHHhcCccccc
Q 026253 182 SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-FNEFYHHRFLRR 229 (241)
Q Consensus 182 ~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~il~~~~~~~ 229 (241)
... .......+.+++.+.++|.+||+.+|.+||+ ++++++||||+.
T Consensus 221 ~~~--~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~l~h~~~~~ 267 (267)
T PHA03390 221 KRQ--QKKLPFIKNVSKNANDFVQSMLKYNINYRLTNYNEIIKHPFLKI 267 (267)
T ss_pred Hhh--cccCCcccccCHHHHHHHHHHhccChhhCCchHHHHhcCCcccC
Confidence 111 1112233478999999999999999999996 699999999974
|
|
| >cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=253.04 Aligned_cols=209 Identities=25% Similarity=0.439 Sum_probs=180.1
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|+.+++.++|+||+++++++.. ...++||||+.+++|.+++...+.+++..+..++.|++.|+.+||+.|
T Consensus 37 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 115 (257)
T cd05116 37 PALKDELLREANVMQQLDNPYIVRMIGICEA-ESWMLVMELAELGPLNKFLQKNKHVTEKNITELVHQVSMGMKYLEETN 115 (257)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEcC-CCcEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456789999999999999999999998764 567899999999999999988788999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
++|+||+|.||++ ++++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+++
T Consensus 116 i~H~dlkp~nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05116 116 FVHRDLAARNVLL---VTQHYAKISDFGLSKALGADENYYKAKTHGKWPVKWYAPECMNYYKFSSKSDVWSFGVLMWEAF 192 (257)
T ss_pred EeecccchhhEEE---cCCCeEEECCCccccccCCCCCeeeecCCCCCCccccCHhHhccCCcCchhHHHHHHHHHHHHH
Confidence 9999999999999 6778899999999876543321 11122346899999998888899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+ |..||...+..+....+..+...+.+ ..++.++.++|.+||+.||.+||++++|.+
T Consensus 193 t~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~~l~~li~~~~~~~p~~Rp~~~~i~~ 250 (257)
T cd05116 193 SYGQKPYKGMKGNEVTQMIESGERMECP----QRCPPEMYDLMKLCWTYGVDERPGFAVVEL 250 (257)
T ss_pred hCCCCCCCCCCHHHHHHHHHCCCCCCCC----CCCCHHHHHHHHHHhccCchhCcCHHHHHH
Confidence 8 99999988888888888766554443 368899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio |
| >cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=253.38 Aligned_cols=214 Identities=31% Similarity=0.582 Sum_probs=189.1
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~l 82 (241)
....+.+.+|++++++++|+|++++.+.+..++..++++|++++++|.+++... ..+++..+..++.+++.|+.+|
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~l 119 (258)
T cd08215 40 EKEREDALNEVKILKKLNHPNIIKYYESFEEKGKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCLALKYL 119 (258)
T ss_pred hHHHHHHHHHHHHHHhcCCCChhheEEEEecCCEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHHHHHHH
Confidence 356778999999999999999999999999999999999999999999999764 6799999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|+.|++|+||+|+||++ ++++.++|+|||.+....... ......+++.|+|||...+..++.++|+||+|++++++
T Consensus 120 h~~~~~H~dl~~~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~~~~l 196 (258)
T cd08215 120 HSRKILHRDIKPQNIFL---TSNGLVKLGDFGISKVLSSTVDLAKTVVGTPYYLSPELCQNKPYNYKSDIWSLGCVLYEL 196 (258)
T ss_pred HhCCEecccCChHHeEE---cCCCcEEECCccceeecccCcceecceeeeecccChhHhccCCCCccccHHHHHHHHHHH
Confidence 99999999999999999 678899999999987665443 23334678889999999888899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
++|..||...+..+....+......+.+ ..++..+.+++++||..+|.+|||+.++++||||
T Consensus 197 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 258 (258)
T cd08215 197 CTLKHPFEGENLLELALKILKGQYPPIP----SQYSSELRNLVSSLLQKDPEERPSIAQILQSPFI 258 (258)
T ss_pred HcCCCCCCCCcHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHhcCCCC
Confidence 9999999988877777776555443333 3788999999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They |
| >cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-40 Score=258.44 Aligned_cols=218 Identities=32% Similarity=0.545 Sum_probs=180.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+.....+.+|+.++++++|+||+++++++..++..++||||+ +++|.+++... ..+++..+..++.|++.||.+||+.
T Consensus 40 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 118 (286)
T cd07832 40 GGIPNQALREIKALQACQHPYVVKLLDVFPHGSGFVLVMEYM-PSDLSEVLRDEERPLPEAQVKSYMRMLLKGVAYMHAN 118 (286)
T ss_pred chhhHHHHHHHHHHHhCCCCCCcceeeEEecCCeeEEEeccc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 334578899999999999999999999999999999999999 99999998653 5689999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~ 162 (241)
|++|+||+|+||++ +..+.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++++++
T Consensus 119 ~i~H~dl~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~ 195 (286)
T cd07832 119 GIMHRDLKPANLLI---SADGVLKIADFGLARLFSEEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELL 195 (286)
T ss_pred CeecCCcCHHHEEE---cCCCcEEEeeeeecccccCCCCCccccccCcccccCceeeeccccCCchhHHHHHHHHHHHHH
Confidence 99999999999999 678889999999987664432 12234578889999998654 4689999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCC------------------C-------CccCCCCChHHHHHHHHhcccCccccCC
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPF------------------S-------QLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~------------------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
+|.++|.+.+....+..+......+. + ....+..+..+.++|++||+.+|.+|||
T Consensus 196 tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~~ 275 (286)
T cd07832 196 NGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFPDASPEALDLLKGLLVYDPSKRLS 275 (286)
T ss_pred cCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCCCccHHHHHHHHHHhccChhhCCC
Confidence 99999987776555544432211110 0 1122456789999999999999999999
Q ss_pred HHHHhcCcccc
Q 026253 218 FNEFYHHRFLR 228 (241)
Q Consensus 218 ~~~il~~~~~~ 228 (241)
++++++||||.
T Consensus 276 ~~~~l~h~~~~ 286 (286)
T cd07832 276 AAEALRHPYFT 286 (286)
T ss_pred HHHHhhCcCcC
Confidence 99999999984
|
Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea |
| >KOG4721 consensus Serine/threonine protein kinase, contains leucine zipper domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-41 Score=270.78 Aligned_cols=208 Identities=27% Similarity=0.481 Sum_probs=183.8
Q ss_pred hHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 026253 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (241)
Q Consensus 12 ~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (241)
--..+++-|++|+|+||+.+.|+|.....+|||||||..|.|..+|+....++......|.++|+.|+.|||.+.|+|||
T Consensus 158 lkETdIKHLRkLkH~NII~FkGVCtqsPcyCIiMEfCa~GqL~~VLka~~~itp~llv~Wsk~IA~GM~YLH~hKIIHRD 237 (904)
T KOG4721|consen 158 LKETDIKHLRKLKHPNIITFKGVCTQSPCYCIIMEFCAQGQLYEVLKAGRPITPSLLVDWSKGIAGGMNYLHLHKIIHRD 237 (904)
T ss_pred hhhhhHHHHHhccCcceeeEeeeecCCceeEEeeeccccccHHHHHhccCccCHHHHHHHHHHhhhhhHHHHHhhHhhhc
Confidence 33567899999999999999999999999999999999999999999988999999999999999999999999999999
Q ss_pred CCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCC
Q 026253 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171 (241)
Q Consensus 92 l~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~ 171 (241)
||.-|||+ .-+..|||+|||-++......+...+.||..|||||++.+.+.+.|.||||||+|+|||+||..||.+.
T Consensus 238 LKSPNiLI---s~~d~VKIsDFGTS~e~~~~STkMSFaGTVaWMAPEvIrnePcsEKVDIwSfGVVLWEmLT~EiPYkdV 314 (904)
T KOG4721|consen 238 LKSPNILI---SYDDVVKISDFGTSKELSDKSTKMSFAGTVAWMAPEVIRNEPCSEKVDIWSFGVVLWEMLTGEIPYKDV 314 (904)
T ss_pred cCCCceEe---eccceEEeccccchHhhhhhhhhhhhhhhHhhhCHHHhhcCCcccccceehhHHHHHHHHhcCCCcccc
Confidence 99999999 688899999999998877777777889999999999999999999999999999999999999999876
Q ss_pred ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCc
Q 026253 172 NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 225 (241)
Q Consensus 172 ~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 225 (241)
+...++=-+ ....+.-..+..++..+.-++++||+..|.+||++.+||.|-
T Consensus 315 dssAIIwGV---GsNsL~LpvPstcP~GfklL~Kqcw~sKpRNRPSFrqil~Hl 365 (904)
T KOG4721|consen 315 DSSAIIWGV---GSNSLHLPVPSTCPDGFKLLLKQCWNSKPRNRPSFRQILLHL 365 (904)
T ss_pred chheeEEec---cCCcccccCcccCchHHHHHHHHHHhcCCCCCccHHHHHHHH
Confidence 664433211 111112223347889999999999999999999999999883
|
|
| >cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-39 Score=256.11 Aligned_cols=208 Identities=24% Similarity=0.513 Sum_probs=180.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--------------CCCHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------------RVPEQTARKFLQQ 74 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--------------~~~~~~~~~~~~~ 74 (241)
..+.+.+|++++++++|+||+++++++..++..++||||+++++|.+++...+ .+++..+..++.|
T Consensus 51 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~ 130 (280)
T cd05049 51 ARKDFEREAELLTNFQHENIVKFYGVCTEGDPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQLLQIAVQ 130 (280)
T ss_pred HHHHHHHHHHHHHhcCCCCchheeeEEecCCCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHHHHHHHH
Confidence 56789999999999999999999999999999999999999999999997643 3788899999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhH
Q 026253 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (241)
Q Consensus 75 i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv 151 (241)
++.|+.+||++|++|+||+|.||++ +.++.++|+|||.+........ ......+..|+|||.+.+..++.++|+
T Consensus 131 i~~~l~~lH~~~i~h~dlkp~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di 207 (280)
T cd05049 131 IASGMVYLASQHFVHRDLATRNCLV---GYDLVVKIGDFGMSRDVYTTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDV 207 (280)
T ss_pred HHHHHHHHhhCCeeccccccceEEE---cCCCeEEECCcccceecccCcceecCCCCcccceecChhhhccCCcchhhhH
Confidence 9999999999999999999999999 7789999999999875432211 122334577999999998999999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 152 WSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 152 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
||||+++|+|++ |..||.+.+..+....+..+.....+ ..++..+.+++++||+.||.+|||+.|+++
T Consensus 208 ~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~eil~ 276 (280)
T cd05049 208 WSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQRP----RTCPSEVYDIMLGCWKRDPQQRINIKDIHE 276 (280)
T ss_pred HHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 999999999998 99999988888888777655433333 368899999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt |
| >cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-40 Score=266.09 Aligned_cols=228 Identities=30% Similarity=0.510 Sum_probs=190.9
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
....+.+.+|+.++++++|+||+++.+++...+ ..+++|+|+. ++|.+++....++++..+..++.+++.||++
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~l~~~~~~~i~~~l~~~l~~ 118 (330)
T cd07834 40 LIDAKRILREIKLLRHLRHENIIGLLDILRPPSPEDFNDVYIVTELME-TDLHKVIKSPQPLTDDHIQYFLYQILRGLKY 118 (330)
T ss_pred chhhhhHHHHHHHHHhcCCcchhhhhhhhcccCcccccceEEEecchh-hhHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999987764 7899999996 6899999877789999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC----ccccccCCCCccCccccccc-CCCCchhHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA 156 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~ 156 (241)
||+.|++|+||+|.||++ +.++.++|+|||.+....... ......++..|.|||.+.+. .++.++|+||+|+
T Consensus 119 LH~~gi~H~dlkp~nili---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~ 195 (330)
T cd07834 119 LHSANVIHRDLKPSNILV---NSNCDLKICDFGLARGVDPDEDEKGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGC 195 (330)
T ss_pred HHhCCeecCCCCHHHEEE---cCCCCEEEcccCceEeecccccccccccccccccCcCCceeeecccCCCcchhHHHHHH
Confidence 999999999999999999 677899999999998765442 23344568889999999877 7899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCC--------------------------ccCCCCChHHHHHHHHhccc
Q 026253 157 ILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ--------------------------LIVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~--------------------------~~~~~~~~~~~~li~~~l~~ 210 (241)
++|+|++|.+||.+.+..+..+.+......+.+. ...+.++..+.+++++||+.
T Consensus 196 il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 275 (330)
T cd07834 196 IFAELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPEAIDLLEKMLVF 275 (330)
T ss_pred HHHHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhcccCCHHHHHHHHHHccC
Confidence 9999999999999888776666554432221111 11245788999999999999
Q ss_pred CccccCCHHHHhcCcccccccccCCCCC
Q 026253 211 NTVDRLSFNEFYHHRFLRRNSAILRAPF 238 (241)
Q Consensus 211 ~p~~Rps~~~il~~~~~~~~~~~~~~~~ 238 (241)
+|.+|||+++++.||||++.......+.
T Consensus 276 ~P~~Rpt~~~ll~~~~~~~~~~~~~~~~ 303 (330)
T cd07834 276 DPKKRITADEALAHPYLAQLHDPEDEPV 303 (330)
T ss_pred ChhhCCCHHHHHhCccHHhhcccccCCC
Confidence 9999999999999999998766555443
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and |
| >cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=253.60 Aligned_cols=209 Identities=28% Similarity=0.515 Sum_probs=185.9
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~l 79 (241)
..+.+.+|+++++.++|+|++++++++..+...+++|||+++++|.+++... ..+++..+..++.|++.|+
T Consensus 39 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~l~~al 118 (262)
T cd00192 39 ERKDFLKEARVMKKLGHPNVVRLLGVCTEEEPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAIQIAKGM 118 (262)
T ss_pred HHHHHHHHHHHHhhcCCCChheeeeeecCCCceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHHHHHHHH
Confidence 4678999999999999999999999999999999999999999999999875 6799999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCCchhHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~ 156 (241)
++||++|++|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+
T Consensus 119 ~~lH~~~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ 195 (262)
T cd00192 119 EYLASKKFVHRDLAARNCLV---GEDLVVKISDFGLSRDVYDDDYYRKKTGGKLPIRWMAPESLKDGIFTSKSDVWSFGV 195 (262)
T ss_pred HHHHcCCcccCccCcceEEE---CCCCcEEEcccccccccccccccccccCCCcCccccCHHHhccCCcchhhccHHHHH
Confidence 99999999999999999999 777999999999997765432 233345677899999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 157 ILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 157 ~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+++++++ |..||...+..+..+.+........+. .++.++.+++.+||+.+|.+|||++|++++
T Consensus 196 il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 260 (262)
T cd00192 196 LLWEIFTLGATPYPGLSNEEVLEYLRKGYRLPKPE----YCPDELYELMLSCWQLDPEDRPTFSELVER 260 (262)
T ss_pred HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCCc----cCChHHHHHHHHHccCCcccCcCHHHHHHh
Confidence 9999999 699999998888888887655444443 678999999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan |
| >PHA03211 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.7e-40 Score=272.23 Aligned_cols=216 Identities=23% Similarity=0.325 Sum_probs=173.1
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|++++++++|+||+++++++..++..++||+++ .++|.+++... ..+++..+..++.|++.||.|||++|++
T Consensus 204 ~~~~~~E~~iL~~L~HpnIv~l~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~yLH~~gIv 282 (461)
T PHA03211 204 YASSVHEARLLRRLSHPAVLALLDVRVVGGLTCLVLPKY-RSDLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGII 282 (461)
T ss_pred ccCHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEEcc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 345678999999999999999999999999999999999 46888888654 4699999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
|+||||+||++ +..+.++|+|||+++....... .....++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 283 HrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~sDvwSlGviL~El~~g~ 359 (461)
T PHA03211 283 HRDIKTENVLV---NGPEDICLGDFGAACFARGSWSTPFHYGIAGTVDTNAPEVLAGDPYTPSVDIWSAGLVIFEAAVHT 359 (461)
T ss_pred ECcCCHHHEEE---CCCCCEEEcccCCceecccccccccccccCCCcCCcCHHHHcCCCCCchHHHHHHHHHHHHHHHcC
Confidence 99999999999 6788899999999876533221 22345899999999999889999999999999999999977
Q ss_pred CCCCCC--------ChHHHHHHhhcCCCC--CCCC---------------------------ccCCCCChHHHHHHHHhc
Q 026253 166 PPFSGR--------NNVQLVRNINSCKHL--PFSQ---------------------------LIVPALHPDCVDMCLKLL 208 (241)
Q Consensus 166 ~p~~~~--------~~~~~~~~i~~~~~~--~~~~---------------------------~~~~~~~~~~~~li~~~l 208 (241)
.++... ...++.+.+...... .++. .....++.++.++|++||
T Consensus 360 ~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL 439 (461)
T PHA03211 360 ASLFSASRGDERRPYDAQILRIIRQAQVHVDEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDLDVEYLVCRAL 439 (461)
T ss_pred CCcccCCcccccCCcHHHHHHHHHhhccccccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccchHHHHHHHHc
Confidence 554321 122333333221110 0000 001135668999999999
Q ss_pred ccCccccCCHHHHhcCccccc
Q 026253 209 SANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 209 ~~~p~~Rps~~~il~~~~~~~ 229 (241)
+.||.+|||+.|+|+||||+.
T Consensus 440 ~~DP~~RPsa~elL~hp~f~~ 460 (461)
T PHA03211 440 TFDGARRPSAAELLRLPLFQS 460 (461)
T ss_pred ccChhhCcCHHHHhhCcccCC
Confidence 999999999999999999975
|
|
| >cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=256.14 Aligned_cols=214 Identities=26% Similarity=0.427 Sum_probs=180.3
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~l 79 (241)
......+.+|+.++++++|+||+++++++.+.+..++||||+.|++|.+++...+ .+++..+..++.|++.|+
T Consensus 50 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi~~~l 129 (277)
T cd05036 50 EQDESDFLMEALIMSKFNHQNIVRLIGVSFERLPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDVAKGC 129 (277)
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHHHHHH
Confidence 3345678899999999999999999999998889999999999999999997653 488999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc---ccccCCCCccCcccccccCCCCchhHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~ 156 (241)
.+||+.+++|+||+|+||+++..++...++|+|||++......... .....+..|+|||.+.+..++.++|+||||+
T Consensus 130 ~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslG~ 209 (277)
T cd05036 130 KYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASYYRKGGRAMLPIKWMPPEAFLDGIFTSKTDVWSFGV 209 (277)
T ss_pred HHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccceecCCCCCccHhhCCHHHHhcCCcCchhHHHHHHH
Confidence 9999999999999999999964444557999999998765322211 1122245799999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 157 ILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 157 ~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
++|++++ |..||.+.+..+....+........+ ..++..+.+++++||+.+|++|||+.++++|
T Consensus 210 il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~cl~~~p~~Rps~~~vl~~ 274 (277)
T cd05036 210 LLWEIFSLGYMPYPGRTNQEVMEFVTGGGRLDPP----KGCPGPVYRIMTDCWQHTPEDRPNFATILER 274 (277)
T ss_pred HHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999997 99999988887777776554443333 3678999999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well |
| >cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.7e-40 Score=257.63 Aligned_cols=219 Identities=27% Similarity=0.428 Sum_probs=184.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~ 85 (241)
....+.+.+|+++++.++|+||+++++++...+..++||||+++++|.+++.+.+++++..+..++.+++.++.+||+ .
T Consensus 44 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~ 123 (284)
T cd06620 44 SSVRKQILRELQIMHECRSPYIVSFYGAFLNENNICMCMEFMDCGSLDRIYKKGGPIPVEILGKIAVAVVEGLTYLYNVH 123 (284)
T ss_pred chHHHHHHHHHHHHHHcCCCCcceEeeeEecCCEEEEEEecCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHhc
Confidence 345678899999999999999999999999999999999999999999999888889999999999999999999997 5
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+++|+||+|.||++ ++++.++|+|||++...... ......++..|+|||.+.+..++.++|+||+|+++|++++|.
T Consensus 124 ~i~H~dl~p~nil~---~~~~~~~l~d~gl~~~~~~~-~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~~l~tg~ 199 (284)
T cd06620 124 RIMHRDIKPSNILV---NSRGQIKLCDFGVSGELINS-IADTFVGTSTYMSPERIQGGKYTVKSDVWSLGISIIELALGK 199 (284)
T ss_pred CeeccCCCHHHEEE---CCCCcEEEccCCcccchhhh-ccCccccCcccCCHHHHccCCCCccchHHHHHHHHHHHHhCC
Confidence 89999999999999 77889999999988654322 223446788999999998888999999999999999999999
Q ss_pred CCCCCCChH-----------HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 166 PPFSGRNNV-----------QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 166 ~p~~~~~~~-----------~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
.||...... +....+........+. ..++.++.+++.+||+.||.+|||++|+++|+||.+...
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~~ 274 (284)
T cd06620 200 FPFAFSNIDDDGQDDPMGILDLLQQIVQEPPPRLPS---SDFPEDLRDFVDACLLKDPTERPTPQQLCAMPPFIQALR 274 (284)
T ss_pred CCCcccchhhhhhhhhhHHHHHHHHHhhccCCCCCc---hhcCHHHHHHHHHHhcCCcccCcCHHHHhcCcccccccc
Confidence 999865432 2233332222222221 237789999999999999999999999999999987543
|
Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include |
| >cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-39 Score=252.12 Aligned_cols=211 Identities=40% Similarity=0.652 Sum_probs=186.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|++++++++|+||+++++.++.++..+++||++.+++|.+++.....+++..+..++.|++.|+.+||+.+++
T Consensus 36 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~~l~~lh~~~~~ 115 (250)
T cd05123 36 EVEHTLTERNILSRINHPFIVKLHYAFQTEEKLYLVLEYAPGGELFSHLSKEGRFSEERARFYAAEIVLALEYLHSLGII 115 (250)
T ss_pred HHHHHHHHHHHHHHcCCCcHHHHHHHeecCCeeEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCce
Confidence 56689999999999999999999999999999999999999999999998887899999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|+||+|.||++ +.++.++|+|||.+...... .......++..|.|||...+...+.++|+||||+++|++++|..|
T Consensus 116 H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~~g~~p 192 (250)
T cd05123 116 YRDLKPENILL---DADGHIKLTDFGLAKELSSEGSRTNTFCGTPEYLAPEVLLGKGYGKAVDWWSLGVLLYEMLTGKPP 192 (250)
T ss_pred ecCCCcceEEE---cCCCcEEEeecCcceecccCCCcccCCcCCccccChHHhCCCCCCchhhHHHHHHHHHHHHHCCCC
Confidence 99999999999 67788999999998765443 223345577889999999888889999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH---HHHhcCccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF---NEFYHHRFL 227 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~---~~il~~~~~ 227 (241)
|...+..+..+.+.. ....++. ..+..+.+++++||..||.+||++ +++++||||
T Consensus 193 ~~~~~~~~~~~~~~~-~~~~~~~----~~~~~l~~~i~~~l~~~p~~R~~~~~~~~l~~~~~f 250 (250)
T cd05123 193 FYAEDRKEIYEKILK-DPLRFPE----FLSPEARDLISGLLQKDPTKRLGSGGAEEIKAHPFF 250 (250)
T ss_pred CCCCCHHHHHHHHhc-CCCCCCC----CCCHHHHHHHHHHhcCCHhhCCCcccHHHHHhCCCC
Confidence 988877776666644 2233333 568999999999999999999999 999999998
|
Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the |
| >cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=251.64 Aligned_cols=207 Identities=24% Similarity=0.470 Sum_probs=179.8
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
.+.+.+|++++++++||||+++++++..++..++||||+++++|.+++... +.+++..+..++.+++.||.+||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05114 43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQKPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGMEYLERNSFI 122 (256)
T ss_pred HHHHHHHHHHHHHCCCCCceeEEEEEccCCCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 457889999999999999999999999999999999999999999998753 4689999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc--ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~ 165 (241)
|+||+|+||++ ++++.++++|||.+......... ....++..|+|||.+.+..++.++|+||+|+++|++++ |+
T Consensus 123 H~dl~p~ni~i---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s~G~~l~el~~~g~ 199 (256)
T cd05114 123 HRDLAARNCLV---SSTGVVKVSDFGMTRYVLDDEYTSSSGAKFPVKWSPPEVFNFSKYSSKSDVWSFGVLMWEVFTEGK 199 (256)
T ss_pred ccccCcceEEE---cCCCeEEECCCCCccccCCCceeccCCCCCchhhCChhhcccCccchhhhhHHHHHHHHHHHcCCC
Confidence 99999999999 67888999999998765432221 12234557999999988889999999999999999999 99
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
.||...+..+....+..+.....+. ..+..+.+++++||+.+|.+|||++++++
T Consensus 200 ~p~~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~li~~c~~~~p~~Rps~~~l~~ 253 (256)
T cd05114 200 MPFEKKSNYEVVEMISRGFRLYRPK----LASMTVYEVMYSCWHEKPEGRPTFAELLR 253 (256)
T ss_pred CCCCCCCHHHHHHHHHCCCCCCCCC----CCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999988888888887665443333 56788999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h |
| >cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=252.38 Aligned_cols=215 Identities=28% Similarity=0.560 Sum_probs=182.0
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+++++.++|+||++++++....+..++|+||+.+++|.+++.....+++..+..++.+++.|+.+||+.|+
T Consensus 41 ~~~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i 120 (264)
T cd06626 41 KTIKEIADEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTLEELLEHGRILDEHVIRVYTLQLLEGLAYLHSHGI 120 (264)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeeEecCCEEEEEEecCCCCcHHHHHhhcCCCChHHHHHHHHHHHHHHHHHHHCCc
Confidence 46788999999999999999999999999999999999999999999999887778999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc-----ccccCCCCccCcccccccC---CCCchhHHHHHHHHH
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILF 159 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~-----~~~~~~~~~~~PE~~~~~~---~~~~~Dv~slG~~l~ 159 (241)
+|+||+|.||++ ++++.++|+|||.+......... ....++..|+|||.+.+.. .+.++|+||+|++++
T Consensus 121 ~H~dl~~~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G~il~ 197 (264)
T cd06626 121 VHRDIKPANIFL---DHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVL 197 (264)
T ss_pred ccCCCCHHHEEE---CCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHHHHHH
Confidence 999999999999 67889999999998766433221 1245678899999988766 789999999999999
Q ss_pred HHHhCCCCCCCCCh-HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 160 ELLNGYPPFSGRNN-VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 160 ~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
++++|+.||...+. ......+........+. ...++..+.+++++||+.+|.+|||+.+++.|||+
T Consensus 198 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~p~~R~~~~~i~~~~~~ 264 (264)
T cd06626 198 EMATGKRPWSELDNEFQIMFHVGAGHKPPIPD--SLQLSPEGKDFLDRCLESDPKKRPTASELLQHPFV 264 (264)
T ss_pred HHHhCCCCccCCcchHHHHHHHhcCCCCCCCc--ccccCHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence 99999999976533 33333333322222222 12458899999999999999999999999999996
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4 |
| >cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=251.65 Aligned_cols=214 Identities=35% Similarity=0.590 Sum_probs=185.5
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+.+|+.++++++|+||+++++.+... +..++++|++++++|.+++.....+++..+..++.+++.++++||+.
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~ 120 (260)
T cd06606 41 EELEALEREIRILSSLQHPNIVRYYGSERDEEKNTLNIFLEYVSGGSLSSLLKKFGKLPEPVIRKYTRQILEGLAYLHSN 120 (260)
T ss_pred HHHHHHHHHHHHHHHcCCCCEeeEEEEEecCCCCeEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 5578899999999999999999999999988 89999999999999999998888899999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
|++|+|++|.||++ ++++.++|+|||.+........ .....++..|.|||...+...+.++|+||||+++++++
T Consensus 121 ~~~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~~l~ 197 (260)
T cd06606 121 GIVHRDIKGANILV---DSDGVVKLADFGCAKRLGDIETGEGTGSVRGTPYWMAPEVIRGEEYGRAADIWSLGCTVIEMA 197 (260)
T ss_pred CccccCCCHHHEEE---cCCCCEEEcccccEEecccccccccccCCCCCccccCHhhhcCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999 6788999999999887765543 34456788999999998888999999999999999999
Q ss_pred hCCCCCCCCC-hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 163 NGYPPFSGRN-NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 163 ~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+|..||...+ .......+..... ........+..+.+++.+|++.+|.+||++.+++.||||
T Consensus 198 ~g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~ll~~~~~ 260 (260)
T cd06606 198 TGKPPWSELGNPMAALYKIGSSGE---PPEIPEHLSEEAKDFLRKCLRRDPKKRPTADELLQHPFL 260 (260)
T ss_pred hCCCCCCCCCchHHHHHhccccCC---CcCCCcccCHHHHHHHHHhCcCChhhCCCHHHHhhCCCC
Confidence 9999998765 3333333322111 122334678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK |
| >cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=253.16 Aligned_cols=214 Identities=28% Similarity=0.528 Sum_probs=179.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+.+|++++++++|+||+++++++.+. ...+++|||+++++|.+++.+.+.+++..+..++.|++.||.+||+.
T Consensus 46 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 125 (265)
T cd06652 46 KEVNALECEIQLLKNLLHERIVQYYGCLRDPMERTLSIFMEHMPGGSIKDQLKSYGALTENVTRKYTRQILEGVSYLHSN 125 (265)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEeEeccCCCceEEEEEEecCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456889999999999999999999988763 56889999999999999998877889999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCC----CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|++|+||+|.||++ +.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||||+++|++
T Consensus 126 ~i~H~dl~p~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el 202 (265)
T cd06652 126 MIVHRDIKGANILR---DSVGNVKLGDFGASKRLQTICLSGTGMKSVTGTPYWMSPEVISGEGYGRKADIWSVGCTVVEM 202 (265)
T ss_pred CEecCCCCHHHEEe---cCCCCEEECcCccccccccccccccccccCCCCccccChhhhcCCCCCcchhHHHHHHHHHHH
Confidence 99999999999999 67889999999988754321 112234577889999999888899999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 228 (241)
++|..||...+.......+..... .....+.++..+.+++++|+. +|.+||+++++++|||+.
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~i~~~l~-~p~~Rp~~~~il~~~~~~ 265 (265)
T cd06652 203 LTEKPPWAEFEAMAAIFKIATQPT---NPVLPPHVSDHCRDFLKRIFV-EAKLRPSADELLRHTFVH 265 (265)
T ss_pred hhCCCCCCccchHHHHHHHhcCCC---CCCCchhhCHHHHHHHHHHhc-ChhhCCCHHHHhcCcccC
Confidence 999999987665555544433221 122234678889999999995 999999999999999984
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re |
| >cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=255.43 Aligned_cols=219 Identities=24% Similarity=0.490 Sum_probs=183.6
Q ss_pred HHhhhhHHHHHHHHhcCC---CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+.+|+.++++++ |+|++++++++..++..++||||+++++|.++++. +.+++..+..++.+++.|+.+||
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~i~~~l~~lh 118 (277)
T cd06917 40 DDDVSDIQREVALLSQLRQSQPPNITKYYGSYLKGPRLWIIMEYAEGGSVRTLMKA-GPIAEKYISVIIREVLVALKYIH 118 (277)
T ss_pred chhHHHHHHHHHHHHHhccCCCCCeeeEeeeeeeCCEEEEEEecCCCCcHHHHHHc-cCCCHHHHHHHHHHHHHHHHHHH
Confidence 345667889999999996 99999999999999999999999999999999865 47899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l 161 (241)
+.|++|+||+|.||++ ++.+.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++|+|
T Consensus 119 ~~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l 195 (277)
T cd06917 119 KVGVIHRDIKAANILV---TNTGNVKLCDFGVAALLNQNSSKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEM 195 (277)
T ss_pred hCCcccCCcCHHHEEE---cCCCCEEEccCCceeecCCCccccccccCCcceeCHHHhccCCccccchhHHHHHHHHHHH
Confidence 9999999999999999 678899999999987665432 2233457888999998765 4468999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
++|..||.+.+.......+........+ ...++.++.+++++||+.||.+||++.++++|+||++...
T Consensus 196 l~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~i~~~l~~~p~~R~~~~~il~~~~~~~~~~ 263 (277)
T cd06917 196 ATGNPPYSDVDAFRAMMLIPKSKPPRLE---DNGYSKLLREFVAACLDEEPKERLSAEELLKSKWIKAHSK 263 (277)
T ss_pred HhCCCCCCCCChhhhhhccccCCCCCCC---cccCCHHHHHHHHHHcCCCcccCcCHHHHhhChHhhcccc
Confidence 9999999887765555444332211111 1237889999999999999999999999999999987553
|
Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent |
| >cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=257.53 Aligned_cols=217 Identities=29% Similarity=0.527 Sum_probs=179.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++|+||+++++++..++..+++|||+.++.+..+..+...+++..+..++.+++.|+.+||+.|+
T Consensus 42 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 121 (288)
T cd07833 42 DVKKTALREVKVLRQLRHENIVNLKEAFRRKGRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAYCHSHNI 121 (288)
T ss_pred cchhHHHHHHHHHHhcCCCCeeehhheEEECCEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34678999999999999999999999999999999999999887777776666779999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g 164 (241)
+|+|++|.||++ ++++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++|++++|
T Consensus 122 ~H~dl~~~ni~~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g 198 (288)
T cd07833 122 IHRDIKPENILV---SESGVLKLCDFGFARALRARPASPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDG 198 (288)
T ss_pred ecCCCCHHHeEE---CCCCCEEEEeeecccccCCCccccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHHHHHHhC
Confidence 999999999999 678899999999987765433 22334567889999999877 789999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCC------------------CCCC---------CccCCCCChHHHHHHHHhcccCccccCC
Q 026253 165 YPPFSGRNNVQLVRNINSCKH------------------LPFS---------QLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~------------------~~~~---------~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
.+||.+.+..+....+..... ..++ ......++.++.+++++||..+|++|||
T Consensus 199 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 278 (288)
T cd07833 199 EPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPKERLT 278 (288)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHHhcCCccchHHHHHHHHHhccCchhccc
Confidence 999987665544333221100 0000 0112235888999999999999999999
Q ss_pred HHHHhcCccc
Q 026253 218 FNEFYHHRFL 227 (241)
Q Consensus 218 ~~~il~~~~~ 227 (241)
++++++||||
T Consensus 279 ~~~il~~~~f 288 (288)
T cd07833 279 CDELLQHPYF 288 (288)
T ss_pred HHHHhcCCCC
Confidence 9999999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning |
| >cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=250.90 Aligned_cols=211 Identities=30% Similarity=0.495 Sum_probs=178.0
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
..+....+.+|++++++++|+||+++++++..++..++||||+.+++|.+++...+ .+++..+..++.|++.||.+||+
T Consensus 33 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~ 112 (252)
T cd05084 33 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEYLES 112 (252)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCcceEEEEEcCCCCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34556789999999999999999999999999999999999999999999997644 58999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc---cccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
.|++|+||+|.||++ +.++.++|+|||.+.......... ....+..|+|||.+.+..++.++|+||||+++|++
T Consensus 113 ~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~e~ 189 (252)
T cd05084 113 KHCIHRDLAARNCLV---TEKNVLKISDFGMSREEEDGVYASTGGMKQIPVKWTAPEALNYGRYSSESDVWSFGILLWEA 189 (252)
T ss_pred CCccccccchheEEE---cCCCcEEECccccCcccccccccccCCCCCCceeecCchhhcCCCCChHHHHHHHHHHHHHH
Confidence 999999999999999 677889999999986543321111 11123469999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++ |..||...+.......+........+ ...+..+.+++.+||+.+|++|||++++++
T Consensus 190 ~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 248 (252)
T cd05084 190 FSLGAVPYANLSNQQTREAIEQGVRLPCP----ELCPDAVYRLMERCWEYDPGQRPSFSTVHQ 248 (252)
T ss_pred HhCCCCCccccCHHHHHHHHHcCCCCCCc----ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 97 89999887776666666544333332 367889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular |
| >cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-40 Score=260.23 Aligned_cols=211 Identities=27% Similarity=0.440 Sum_probs=178.3
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (241)
....+.+.+|+.++.++ +|+||+++++++..++..++||||+++++|.+++.+.+ .+++..+.
T Consensus 48 ~~~~~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 127 (303)
T cd05088 48 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 127 (303)
T ss_pred HHHHHHHHHHHHHHHHhcCCCCcceEEEEECCCCCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCHHHHH
Confidence 34567888999999999 89999999999999999999999999999999997543 47889999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCch
Q 026253 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149 (241)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 149 (241)
.++.|++.|+++||+.|++|+||+|+||++ +.++.++|+|||++..............+..|+|||.+.+..++.++
T Consensus 128 ~~~~qi~~al~~LH~~gi~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 204 (303)
T cd05088 128 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 204 (303)
T ss_pred HHHHHHHHHHHHHHhCCccccccchheEEe---cCCCcEEeCccccCcccchhhhcccCCCcccccCHHHHhccCCcccc
Confidence 999999999999999999999999999999 67889999999998543221111122235679999999888889999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 150 DMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 150 Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|+||+|+++|++++ |..||...+..+..+.+........+ ...+.++.+++.+||+.+|.+|||+++++..
T Consensus 205 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~ 276 (303)
T cd05088 205 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVS 276 (303)
T ss_pred cchhhhhHHHHHHhcCCCCcccCChHHHHHHHhcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999998 99999988887777766544333322 2578899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A |
| >cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=254.32 Aligned_cols=217 Identities=25% Similarity=0.467 Sum_probs=186.4
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.++++++|+||+++++++..++..++||||+.+++|.+++.. ..+++..+..++.+++.++.+||+.|+
T Consensus 44 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~-~~~~~~~~~~~~~~l~~~l~~lh~~~i 122 (277)
T cd06641 44 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 122 (277)
T ss_pred HHHHHHHHHHHHHHhcCCCCEeEEEEEEEeCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHccCCe
Confidence 3456789999999999999999999999999999999999999999999864 568999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|.||++ +.++.++++|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus 123 ~h~dl~p~Ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 199 (277)
T cd06641 123 IHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELAKGEP 199 (277)
T ss_pred ecCCCCHHhEEE---CCCCCEEEeecccceecccchhhhccccCCccccChhhhccCCCCchhhHHHHHHHHHHHHcCCC
Confidence 999999999999 677889999999886553322 1223456788999999988888999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
||...........+....... ....++.++.+++.+||+.+|.+||++.++++||||++...
T Consensus 200 p~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~l~~~~~~~~~~ 261 (277)
T cd06641 200 PHSELHPMKVLFLIPKNNPPT----LEGNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFIVRFAK 261 (277)
T ss_pred CCCccchHHHHHHHhcCCCCC----CCcccCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhhhhh
Confidence 998877766666654433222 23467899999999999999999999999999999988543
|
Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int |
| >cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-39 Score=253.48 Aligned_cols=217 Identities=28% Similarity=0.445 Sum_probs=176.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCC--CHHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRV--PEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~--~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+.+|+.++++++|+||+++++++..++..++++||+.+++|.+++... ..+ ++..+..++.|++.|+.+||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al~~lH 125 (268)
T cd06624 46 SRYVQPLHEEIALHSYLKHRNIVQYLGSDSENGFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGLKYLH 125 (268)
T ss_pred HHHHHHHHHHHHHHHhcCCCCeeeeeeeeccCCEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999999999999999999999999999764 455 88889999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccC--CCCchhHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFE 160 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~ 160 (241)
+.|++|+||+|.||+++ ...+.++|+|||.+....... ......++..|+|||.+.+.. ++.++|+||+|+++|+
T Consensus 126 ~~~i~h~dl~p~nil~~--~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~slGvvl~~ 203 (268)
T cd06624 126 DNQIVHRDIKGDNVLVN--TYSGVVKISDFGTSKRLAGINPCTETFTGTLQYMAPEVIDKGPRGYGAPADIWSLGCTIVE 203 (268)
T ss_pred HCCEeecCCCHHHEEEc--CCCCeEEEecchhheecccCCCccccCCCCccccChhhhccccccCCchhhhHHHHHHHHH
Confidence 99999999999999994 336789999999986653322 222345788899999986543 7889999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+++|..||............... ..........+++++.+++++||+.+|.+|||+.+++.||||
T Consensus 204 l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rpt~~~ll~~~~~ 268 (268)
T cd06624 204 MATGKPPFIELGEPQAAMFKVGM--FKIHPEIPESLSAEAKNFILRCFEPDPDKRASAHDLLQDPFL 268 (268)
T ss_pred HHhCCCCCccccChhhhHhhhhh--hccCCCCCcccCHHHHHHHHHHcCCCchhCCCHHHHHhCCCC
Confidence 99999999764432221111000 011122234678899999999999999999999999999997
|
Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina |
| >cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=251.71 Aligned_cols=208 Identities=23% Similarity=0.437 Sum_probs=179.5
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
.+.+.+|++++++++||||+++++++...+..+++|||+.+++|.+++... ..+++..+..++.|++.|+.+||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 122 (256)
T cd05113 43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQRPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMAYLESKQFI 122 (256)
T ss_pred HHHHHHHHHHHhcCCCCCeeeEEEEEccCCCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 456899999999999999999999999888999999999999999999764 4689999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc--ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~ 165 (241)
|+||+|.||++ ++++.++|+|||.+......... ....++..|.|||...+..++.++|+||||+++|++++ |.
T Consensus 123 H~dl~p~nili---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~~l~~~g~ 199 (256)
T cd05113 123 HRDLAARNCLV---DDQGCVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLLYSKFSSKSDVWAFGVLMWEVYSLGK 199 (256)
T ss_pred ccccCcceEEE---cCCCCEEECCCccceecCCCceeecCCCccChhhCCHHHHhcCcccchhHHHHHHHHHHHHhcCCC
Confidence 99999999999 67888999999998765433221 11234567999999988889999999999999999998 99
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.||...+..+....+..+.....+. ..+..+.+++.+||+.+|.+|||+.+++++
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~ll~~ 254 (256)
T cd05113 200 MPYERFNNSETVEKVSQGLRLYRPH----LASEKVYAIMYSCWHEKAEERPTFQQLLSS 254 (256)
T ss_pred CCcCcCCHHHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCCcccCCCHHHHHHh
Confidence 9999888777777776655443333 568899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds |
| >cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-39 Score=249.83 Aligned_cols=213 Identities=27% Similarity=0.556 Sum_probs=186.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++|+|++++.+++.+++..+++||++++++|.+++.....+++..+..++.|++.++.+||+.|+
T Consensus 41 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~~l~~lH~~~i 120 (254)
T cd06627 41 EALKSIMQEIDLLKNLKHPNIVKYIGSIETSDSLYIILEYAENGSLRQIIKKFGPFPESLVAVYVYQVLQGLAYLHEQGV 120 (254)
T ss_pred HHHHHHHHHHHHHHhCCCCCccEEEEEEEeCCEEEEEEecCCCCcHHHHHHhccCCCHHHHHHHHHHHHHHHHHHhhCCc
Confidence 45678999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|.||++ +.++.++|+|||.+........ .....++..|.+||...+..++.++|+|++|++++++++|..
T Consensus 121 ~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~~lG~~l~~l~~g~~ 197 (254)
T cd06627 121 IHRDIKAANILT---TKDGVVKLADFGVATKLNDVSKDDASVVGTPYWMAPEVIEMSGASTASDIWSLGCTVIELLTGNP 197 (254)
T ss_pred ccCCCCHHHEEE---CCCCCEEEeccccceecCCCcccccccccchhhcCHhhhcCCCCCcchhHHHHHHHHHHHHhCCC
Confidence 999999999999 6688999999999877654332 233457888999999888788999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
||...+.......+........ ...++..+.+++.+||..+|++|||+.+++.||||
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~i~~~l~~~p~~R~~~~~~l~~~~~ 254 (254)
T cd06627 198 PYYDLNPMAALFRIVQDDHPPL----PEGISPELKDFLMQCFQKDPNLRPTAKQLLKHPWI 254 (254)
T ss_pred CCCCccHHHHHHHHhccCCCCC----CCCCCHHHHHHHHHHHhCChhhCcCHHHHhcCCCC
Confidence 9987766555544433333332 33678999999999999999999999999999997
|
Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast |
| >cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-39 Score=259.42 Aligned_cols=221 Identities=30% Similarity=0.427 Sum_probs=180.5
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
....+|+.++++++|+|++++++++.+. +..++||||+. ++|.+++... ..+++..+..++.|++.|+.+||+.|+
T Consensus 51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~i 129 (309)
T cd07845 51 ISSLREITLLLNLRHPNIVELKEVVVGKHLDSIFLVMEYCE-QDLASLLDNMPTPFSESQVKCLMLQLLRGLQYLHENFI 129 (309)
T ss_pred chhhHHHHHHHhCCCCCCcceEEEEecCCCCeEEEEEecCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3466899999999999999999998754 56899999995 5898888753 568999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|+++|++++|.
T Consensus 130 ~H~dl~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el~~g~ 206 (309)
T cd07845 130 IHRDLKVSNLLL---TDKGCLKIADFGLARTYGLPAKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHK 206 (309)
T ss_pred ecCCCCHHHEEE---CCCCCEEECccceeeecCCccCCCCcccccccccChhhhcCCCCcCchHHHHHHHHHHHHHHhCC
Confidence 999999999999 778899999999987665432 2222345778999999865 45789999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCC------------------c-------cCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQ------------------L-------IVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~------------------~-------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
+||.+.+..+.+..+......+... . .....++++.++|++||+.||++|||+++
T Consensus 207 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ml~~dp~~R~t~~~ 286 (309)
T cd07845 207 PLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKFPWLSEAGLRLLNFLLMYDPKKRATAEE 286 (309)
T ss_pred CCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhccccCHHHHHHHHHHhcCChhhCcCHHH
Confidence 9999888877776665432211100 0 01235788999999999999999999999
Q ss_pred HhcCcccccccccCC
Q 026253 221 FYHHRFLRRNSAILR 235 (241)
Q Consensus 221 il~~~~~~~~~~~~~ 235 (241)
++.||||++.+.-..
T Consensus 287 il~h~~f~~~~~~~~ 301 (309)
T cd07845 287 ALESSYFKEKPLPCE 301 (309)
T ss_pred HhcChhhccCCCCCC
Confidence 999999997665544
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing |
| >cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.2e-39 Score=255.55 Aligned_cols=216 Identities=31% Similarity=0.550 Sum_probs=186.5
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|++++++++|+|++++++++..++..++++||+++++|.+++.... .++...+..++.+++.||.+||+.|+
T Consensus 58 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~~lH~~gi 137 (286)
T cd06614 58 NKELIINEILIMKDCKHPNIVDYYDSYLVGDELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLEYLHSQNV 137 (286)
T ss_pred hHHHHHHHHHHHHHCCCCCeeEEEEEEEECCEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 46778899999999999999999999999999999999999999999998876 89999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|++++|..
T Consensus 138 ~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slGvil~~l~~g~~ 214 (286)
T cd06614 138 IHRDIKSDNILL---SKDGSVKLADFGFAAQLTKEKSKRNSVVGTPYWMAPEVIKRKDYGPKVDIWSLGIMCIEMAEGEP 214 (286)
T ss_pred eeCCCChhhEEE---cCCCCEEECccchhhhhccchhhhccccCCcccCCHhHhcCCCCCCccccHHHHHHHHHHHhCCC
Confidence 999999999999 778889999999876543321 1123346778999999988889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
||...+.......+.......... ...++..+.+++++||+.+|.+|||+.++++|+||++
T Consensus 215 p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~ 275 (286)
T cd06614 215 PYLREPPLRALFLITTKGIPPLKN--PEKWSPEFKDFLNKCLVKDPEKRPSAEELLQHPFLKK 275 (286)
T ss_pred CCCCCCHHHHHHHHHhcCCCCCcc--hhhCCHHHHHHHHHHhccChhhCcCHHHHhhChHhhc
Confidence 999877766665554433322221 2247889999999999999999999999999999998
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou |
| >cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-40 Score=261.58 Aligned_cols=223 Identities=23% Similarity=0.360 Sum_probs=179.0
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
.....+.+.+|++++++++|+||+++++++..++..+++|||+.+++|.+++... ..+++..+..++.|++.||.+||
T Consensus 39 ~~~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~~LH 118 (314)
T cd08216 39 SKEDLKLLQQEIITSRQLQHPNILPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALDYIH 118 (314)
T ss_pred chhHHHHHHHHHHHHHhcCCcchhhhhheeecCCeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3456678999999999999999999999999999999999999999999999764 45889999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--------cccccCCCCccCcccccc--cCCCCchhHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVDMWS 153 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--------~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~s 153 (241)
+.|++|+||+|+||++ +.++.++++||+.+........ .....++..|+|||.+.+ ..++.++|+||
T Consensus 119 ~~~ivH~dlk~~Nili---~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws 195 (314)
T cd08216 119 SKGFIHRSVKASHILL---SGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYS 195 (314)
T ss_pred HCCeecCCCCcceEEE---ecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHH
Confidence 9999999999999999 6778899999998865432111 122345667999999865 35789999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHH-HHhhcCCCC----------------------------CCCCccCCCCChHHHHHH
Q 026253 154 VGAILFELLNGYPPFSGRNNVQLV-RNINSCKHL----------------------------PFSQLIVPALHPDCVDMC 204 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~~~~~~-~~i~~~~~~----------------------------~~~~~~~~~~~~~~~~li 204 (241)
+|+++|++++|..||......... ..+...... .........++.++.+++
T Consensus 196 ~G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 275 (314)
T cd08216 196 VGITACELANGHVPFKDMPATQMLLEKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQFV 275 (314)
T ss_pred HHHHHHHHHhCCCCCCCCCHHHHHHHHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHHHH
Confidence 999999999999999876544332 222111000 000111123456788999
Q ss_pred HHhcccCccccCCHHHHhcCccccccc
Q 026253 205 LKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 205 ~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
++||+.||++|||++++++||||+...
T Consensus 276 ~~~l~~~P~~Rpt~~~ll~~p~~~~~~ 302 (314)
T cd08216 276 ELCLQRDPESRPSASQLLNHSFFKQCK 302 (314)
T ss_pred HHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence 999999999999999999999999764
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc |
| >cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=256.69 Aligned_cols=219 Identities=24% Similarity=0.509 Sum_probs=187.2
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|+.+++.++|+|++++++.+..++..+++|||+++++|.+++. ...+++..+..++.|++.++++||+.|
T Consensus 58 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~~~~ql~~~l~~lH~~g 136 (292)
T cd06657 58 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVT-HTRMNEEQIAAVCLAVLKALSVLHAQG 136 (292)
T ss_pred hhHHHHHHHHHHHHHhcCCcchhheeeEEEeCCEEEEEEecCCCCcHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456678999999999999999999999999999999999999999999875 456899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||+|.||++ +.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||+|+++|++++|.
T Consensus 137 ivH~dl~p~Nilv---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slGvil~el~tg~ 213 (292)
T cd06657 137 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 213 (292)
T ss_pred eecCCCCHHHEEE---CCCCCEEEcccccceecccccccccccccCccccCHHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999 677889999999876554322 222345788899999998888899999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
.||.+.+..+....+.......... ...++..+.+++.+||+.+|.+||++.++++||||.+..
T Consensus 214 ~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~P~~R~~~~~ll~~~~~~~~~ 277 (292)
T cd06657 214 PPYFNEPPLKAMKMIRDNLPPKLKN--LHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 277 (292)
T ss_pred CCCCCCCHHHHHHHHHhhCCcccCC--cccCCHHHHHHHHHHHhCCcccCcCHHHHhcChHHhccC
Confidence 9999877776666654433222221 235788999999999999999999999999999999865
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo |
| >cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=255.67 Aligned_cols=215 Identities=27% Similarity=0.505 Sum_probs=176.6
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEee------cCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGA 77 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~ 77 (241)
......+..|+.+++++ +|+||+++++++.. ++..+++|||+.+++|.+++... ..+++..+..++.|++.
T Consensus 53 ~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~ 132 (282)
T cd06636 53 EDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILR 132 (282)
T ss_pred hHHHHHHHHHHHHHHHhcCCCcEEEEeeehhcccccCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHH
Confidence 34556788999999999 79999999998853 46789999999999999999754 34888899999999999
Q ss_pred HHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCccccc-----ccCCCCchhH
Q 026253 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDM 151 (241)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv 151 (241)
|+.+||+.|++|+|++|.||++ ++++.++|+|||.+...... .......++..|+|||.+. +..++.++|+
T Consensus 133 al~~LH~~~ivH~dl~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dv 209 (282)
T cd06636 133 GLAHLHAHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDI 209 (282)
T ss_pred HHHHHHHCCcccCCCCHHHEEE---CCCCCEEEeeCcchhhhhccccCCCcccccccccCHhhcCcccCcCcCCCcccch
Confidence 9999999999999999999999 67888999999998654322 1223355788899999875 3457889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 152 WSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 152 ~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
||||+++|++++|..||....+......+..... .......++.++.++|++||+.||.+|||+.|+++||||
T Consensus 210 wslG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~ell~~~~~ 282 (282)
T cd06636 210 WSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPP---PKLKSKKWSKKFIDFIEGCLVKNYLSRPSTEQLLKHPFI 282 (282)
T ss_pred hHHHHHHHHHHhCCCCccccCHHhhhhhHhhCCC---CCCcccccCHHHHHHHHHHhCCChhhCcCHHHHhcCCCC
Confidence 9999999999999999987665554444333222 122223678999999999999999999999999999997
|
Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea |
| >cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=256.43 Aligned_cols=210 Identities=25% Similarity=0.429 Sum_probs=177.8
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHHH
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTARK 70 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~~ 70 (241)
...+.+.+|+++++++ +||||+++++++...+..+++|||+++++|.+++.+.. .+++..+..
T Consensus 44 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 123 (297)
T cd05089 44 NDHRDFAGELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTSQQLLQ 123 (297)
T ss_pred HHHHHHHHHHHHHHhhcCCCchhheEEEEccCCcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCHHHHHH
Confidence 3456789999999999 79999999999999999999999999999999997542 478889999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchh
Q 026253 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVD 150 (241)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~D 150 (241)
++.|++.|+++||+.|++|+||||+||++ +.++.++|+|||++..............+..|+|||...+..++.++|
T Consensus 124 i~~qi~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 200 (297)
T cd05089 124 FASDVATGMQYLSEKQFIHRDLAARNVLV---GENLASKIADFGLSRGEEVYVKKTMGRLPVRWMAIESLNYSVYTTKSD 200 (297)
T ss_pred HHHHHHHHHHHHHHCCcccCcCCcceEEE---CCCCeEEECCcCCCccccceeccCCCCcCccccCchhhccCCCCchhh
Confidence 99999999999999999999999999999 678889999999986432211111222345699999998888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 151 MWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 151 v~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+||||+++|+|++ |..||.+.+..+....+..+.....+ ..++.++.+++.+||+.+|.+|||++++++.
T Consensus 201 vwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~ 271 (297)
T cd05089 201 VWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRMEKP----RNCDDEVYELMRQCWRDRPYERPPFAQISVQ 271 (297)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999999999997 99999988888877777554433333 3688999999999999999999999999754
|
Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. |
| >cd05122 PKc_STE Catalytic domain of STE family Protein Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-39 Score=248.89 Aligned_cols=213 Identities=31% Similarity=0.542 Sum_probs=183.7
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|+.++++++|+|++++.+.+..++..++++||+.+++|.+++... ..+++..+..++.+++.++.+||+.|+
T Consensus 40 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lh~~~i 119 (253)
T cd05122 40 KKEKIINEIQILKKCKHPNIVKYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLEYLHSNGI 119 (253)
T ss_pred HHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHhhcCCE
Confidence 5678999999999999999999999999999999999999999999999876 578999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|.||++ ++++.++|+|||.+.............++..|.|||...+..++.++|+||+|++++++++|..|
T Consensus 120 ~h~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~il~~l~~g~~p 196 (253)
T cd05122 120 IHRDIKAANILL---TSDGEVKLIDFGLSAQLSDTKARNTMVGTPYWMAPEVINGKPYDYKADIWSLGITAIELAEGKPP 196 (253)
T ss_pred ecCCCCHHHEEE---ccCCeEEEeeccccccccccccccceecCCcccCHHHHcCCCCCccccHHHHHHHHHHHHhCCCC
Confidence 999999999999 67889999999998776554323455678889999999888889999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 226 (241)
|...+................+. ...++..+.+++.+||+.||++|||+.++++|||
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~R~t~~~~l~~~~ 253 (253)
T cd05122 197 YSELPPMKALFKIATNGPPGLRN--PEKWSDEFKDFLKKCLQKNPEKRPTAEQLLKHPF 253 (253)
T ss_pred CCCCchHHHHHHHHhcCCCCcCc--ccccCHHHHHHHHHHccCChhhCCCHHHHhcCCC
Confidence 98876555544443322222211 1124889999999999999999999999999998
|
Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core |
| >cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=252.05 Aligned_cols=207 Identities=26% Similarity=0.448 Sum_probs=179.4
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+.+.+|++++++++|+||+++++++..++..+++|||+.+++|.+++.... .+++..+..++.|++.||++||++|+
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i 125 (263)
T cd05052 46 VEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAMEYLEKKNF 125 (263)
T ss_pred HHHHHHHHHHHHhCCCCChhheEEEEcCCCCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4578899999999999999999999999999999999999999999997543 48899999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc--cccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+|+||+|.||++ ++++.++|+|||.+.......... ....+..|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 126 ~H~dlkp~nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~el~t~g 202 (263)
T cd05052 126 IHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYG 202 (263)
T ss_pred eecccCcceEEE---cCCCcEEeCCCccccccccceeeccCCCCCccccCCHHHhccCCCCchhHHHHHHHHHHHHHcCC
Confidence 999999999999 788899999999987654432211 1223457999999988889999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
..||.+.+..+....+........+ ..++.++.+++.+||+.+|++|||+.++++
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~l~~ 257 (263)
T cd05052 203 MSPYPGIDLSQVYELLEKGYRMERP----EGCPPKVYELMRACWQWNPSDRPSFAEIHQ 257 (263)
T ss_pred CCCCCCCCHHHHHHHHHCCCCCCCC----CCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 9999988888877777655444333 478899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays |
| >cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-39 Score=255.21 Aligned_cols=215 Identities=29% Similarity=0.507 Sum_probs=177.0
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeec-----CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~ 78 (241)
....+.+|+.+++++ +|+|++++++++... +..++||||+++++|.++++. ...+++..+..++.|++.|
T Consensus 61 ~~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~~a 140 (291)
T cd06639 61 VDEEIEAEYNILQSLPNHPNVVKFYGMFYKADKLVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGALLG 140 (291)
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEEeccccCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHHHH
Confidence 346778999999999 899999999988643 468999999999999998863 3568999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-----CCCCchhHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-----RYDEKVDMW 152 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-----~~~~~~Dv~ 152 (241)
|.+||+.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+... .++.++|+|
T Consensus 141 l~~lH~~~ivH~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 217 (291)
T cd06639 141 LQHLHNNRIIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVW 217 (291)
T ss_pred HHHHHhCCeeccCCCHHHEEE---cCCCCEEEeecccchhcccccccccCccCCccccChhhhcCCCCcccccCCccchH
Confidence 999999999999999999999 678889999999987654322 12234577889999987543 367899999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 026253 153 SVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228 (241)
Q Consensus 153 slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 228 (241)
|+|+++|++++|..||...+.......+......... .....+..+.+++.+||+.+|++||++.++++||||+
T Consensus 218 slGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rps~~~il~~~~~~ 291 (291)
T cd06639 218 SLGITAIELGDGDPPLFDMHPVKTLFKIPRNPPPTLL--HPEKWCRSFNHFISQCLIKDFEARPSVTHLLEHPFIK 291 (291)
T ss_pred HHHHHHHHHhhCCCCCCCCcHHHHHHHHhcCCCCCCC--cccccCHHHHHHHHHHhhcChhhCcCHHHHhcCcccC
Confidence 9999999999999999887766655555433322211 1235678899999999999999999999999999995
|
Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre |
| >cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=254.63 Aligned_cols=214 Identities=30% Similarity=0.514 Sum_probs=177.4
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeecC------eEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGA 77 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~ 77 (241)
..+.+.+|+.+++++ +|+||+++++++.... ..++||||+++++|.+++... ..+++..+..++.|++.
T Consensus 45 ~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~~ 124 (275)
T cd06608 45 EEEEIKEEYNILRKYSNHPNIATFYGAFIKKNPPGNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETLR 124 (275)
T ss_pred hHHHHHHHHHHHHHhcCCCChheEEEEEEecCCCCcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHHH
Confidence 456789999999999 7999999999987644 489999999999999998753 47899999999999999
Q ss_pred HHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccc-----cCCCCchhH
Q 026253 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDM 151 (241)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv 151 (241)
|+.+||+.|++|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.. ..++.++|+
T Consensus 125 al~~lH~~~i~H~~l~p~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv 201 (275)
T cd06608 125 GLAYLHENKVIHRDIKGQNILL---TKNAEVKLVDFGVSAQLDSTLGRRNTFIGTPYWMAPEVIACDEQPDASYDARSDV 201 (275)
T ss_pred HHHHHhcCCcccCCCCHHHEEE---ccCCeEEECCCccceecccchhhhcCccccccccCHhHhcccccccCCccccccH
Confidence 9999999999999999999999 678899999999986543322 2233457888999998753 346789999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 152 WSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 152 ~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
||+|++++++++|..||...........+.......... ...+++.+.+++++||..||++|||+.++++|||+
T Consensus 202 ~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rpt~~~ll~~~~~ 275 (275)
T cd06608 202 WSLGITAIELADGKPPLCDMHPMRALFKIPRNPPPTLKS--PENWSKKFNDFISECLIKNYEQRPFMEELLEHPFI 275 (275)
T ss_pred HHhHHHHHHHHhCCCCccccchHHHHHHhhccCCCCCCc--hhhcCHHHHHHHHHHhhcChhhCcCHHHHhcCCCC
Confidence 999999999999999998776666555554433222221 12478899999999999999999999999999996
|
Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I |
| >cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-39 Score=251.07 Aligned_cols=213 Identities=33% Similarity=0.510 Sum_probs=186.3
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
+.....+.+|++++++++|+||+++.+++.+++..++|||++++++|.+++.. ...+++..+..++.+++.|+.+|
T Consensus 40 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~al~~l 119 (256)
T cd08530 40 QKEREDAVNEIRILASVNHPNIISYKEAFLDGNKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRGLQAL 119 (256)
T ss_pred HHHHHHHHHHHHHHHhCCCCCchhhhhhhccCCEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 44566788999999999999999999999999999999999999999999876 35689999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
|+.|++|+||+|.||++ +.++.++|+|||.+...... ......++..|.|||...+..++.++|+||+|+++++++
T Consensus 120 h~~~i~h~~l~~~ni~~---~~~~~~kl~d~g~~~~~~~~-~~~~~~~~~~~~~Pe~~~~~~~~~~~D~~slG~~~~~l~ 195 (256)
T cd08530 120 HEQKILHRDLKSANILL---VANDLVKIGDLGISKVLKKN-MAKTQIGTPHYMAPEVWKGRPYSYKSDIWSLGCLLYEMA 195 (256)
T ss_pred hhCCcccCCCCcceEEE---ecCCcEEEeeccchhhhccC-CcccccCCccccCHHHHCCCCCCchhhHHHHHHHHHHHH
Confidence 99999999999999999 56788999999998776544 333455788999999998888999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+|+.||...+..+....+........+ ..++.++.+++.+||+.+|.+|||+.++++||++
T Consensus 196 ~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~~l~~p~~ 256 (256)
T cd08530 196 TFAPPFEARSMQDLRYKVQRGKYPPIP----PIYSQDLQNFIRSMLQVKPKLRPNCDKILASPAV 256 (256)
T ss_pred hCCCCCCCCCHHHHHHHHhcCCCCCCc----hhhCHHHHHHHHHHcCCCcccCCCHHHHhcCCCC
Confidence 999999988877766666544433333 3678899999999999999999999999999974
|
Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an |
| >cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=255.78 Aligned_cols=211 Identities=30% Similarity=0.529 Sum_probs=173.0
Q ss_pred hHHHHHHHHhcC-CCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 12 CLDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 12 ~~~~E~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+|+.+++++ +|+|++++++++.++ +..++||||+. ++|.+++... ..+++..+..++.|++.||.+||+.|+
T Consensus 43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~i 121 (282)
T cd07831 43 NNLREIQALRRLSPHPNILRLIEVLFDRKTGRLALVFELMD-MNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHMHRNGI 121 (282)
T ss_pred hHHHHHHHHhhcCCCCCccceEEEEecCCCCcEEEEEecCC-ccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 445789999998 599999999999887 88999999996 5888887654 568999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc-ccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|.||++ +. +.++|+|||.+.............++..|+|||.+. +..++.++|+||+|+++|+|++|..
T Consensus 122 ~H~dl~p~ni~l---~~-~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~el~~~~~ 197 (282)
T cd07831 122 FHRDIKPENILI---KD-DILKLADFGSCRGIYSKPPYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFP 197 (282)
T ss_pred eecccCHHHEEE---cC-CCeEEEecccccccccCCCcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHHHHHcCCc
Confidence 999999999999 45 899999999997765444334455788899999764 4557889999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCC-----------------CCCC-------ccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 167 PFSGRNNVQLVRNINSCKHL-----------------PFSQ-------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~-----------------~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
||.+.+..+....+...... .++. ...+.++.++.++|.+||+.+|++|||+++++
T Consensus 198 p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~~~~~~l 277 (282)
T cd07831 198 LFPGTNELDQIAKIHDVLGTPDAEVLKKFRKSRHMNYNFPSKKGTGLRKLLPNASAEGLDLLKKLLAYDPDERITAKQAL 277 (282)
T ss_pred CCCCCCHHHHHHHHHHHcCCCCHHHHHhhcccccccccCcccccccHHHHcccccHHHHHHHHHHhccCcccccCHHHHh
Confidence 99887766555444321111 1111 11235688999999999999999999999999
Q ss_pred cCccc
Q 026253 223 HHRFL 227 (241)
Q Consensus 223 ~~~~~ 227 (241)
+||||
T Consensus 278 ~~~~~ 282 (282)
T cd07831 278 RHPYF 282 (282)
T ss_pred hCCCC
Confidence 99997
|
Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. |
| >cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-39 Score=253.71 Aligned_cols=211 Identities=22% Similarity=0.489 Sum_probs=180.3
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC---------------CCCHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------------RVPEQTARK 70 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------------~~~~~~~~~ 70 (241)
.......+.+|+++++.++|+||+++++++..++..+++|||+.+++|.+++...+ .+++..+..
T Consensus 47 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 126 (280)
T cd05092 47 SESARQDFQREAELLTVLQHQHIVRFYGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQMLA 126 (280)
T ss_pred CHHHHHHHHHHHHHHhcCCCCCCceEEEEEecCCceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHHHHH
Confidence 44556789999999999999999999999999999999999999999999997653 378899999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCC
Q 026253 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (241)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~ 147 (241)
++.|++.|+++||+.|++|+||+|+||++ ++++.++|+|||++........ .....++..|+|||.+.+..++.
T Consensus 127 ~~~qi~~al~~LH~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (280)
T cd05092 127 IASQIASGMVYLASLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT 203 (280)
T ss_pred HHHHHHHHHHHHHHCCeecccccHhhEEE---cCCCCEEECCCCceeEcCCCceeecCCCccccccccCHHHhccCCcCc
Confidence 99999999999999999999999999999 6788899999999865433221 11222356799999998888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 148 KVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 148 ~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++|+||||+++|++++ |.+||......+....+..+.....+ ..++..+.+++.+||+.||.+||++.++++
T Consensus 204 ~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~P~~Rp~~~~l~~ 276 (280)
T cd05092 204 ESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELERP----RTCPPEVYAIMQGCWQREPQQRMVIKDIHS 276 (280)
T ss_pred hhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999999999999998 99999888777777766555443333 367899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory |
| >cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.4e-39 Score=250.06 Aligned_cols=208 Identities=26% Similarity=0.450 Sum_probs=178.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++|+||+++++++. .+..++||||+.+++|.+++.....+++..+..++.|++.|+++||+.|+
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lh~~~i 116 (257)
T cd05060 38 AGKKEFLREASVMAQLDHPCIVRLIGVCK-GEPLMLVMELAPLGPLLKYLKKRREIPVSDLKELAHQVAMGMAYLESKHF 116 (257)
T ss_pred HHHHHHHHHHHHHHhcCCCCeeeEEEEEc-CCceEEEEEeCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHhhcCe
Confidence 34567899999999999999999999876 45689999999999999999888789999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc----cccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~----~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+|+||+|+||++ +.++.++|+|||.+.......... ...++..|.|||.+.+..++.++|+||||+++|++++
T Consensus 117 ~H~di~p~nili---~~~~~~kl~df~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~~~~ 193 (257)
T cd05060 117 VHRDLAARNVLL---VNRHQAKISDFGMSRALGAGSDYYRATTAGRWPLKWYAPECINYGKFSSKSDVWSYGVTLWEAFS 193 (257)
T ss_pred eccCcccceEEE---cCCCcEEeccccccceeecCCcccccccCccccccccCHHHhcCCCCCccchHHHHHHHHHHHHc
Confidence 999999999999 778899999999987654332211 1122357999999988889999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 -GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 -g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||...+..+....+......+.+ ..++..+.+++.+||..+|++|||+.++++
T Consensus 194 ~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~~l~~ 250 (257)
T cd05060 194 YGAKPYGEMKGAEVIAMLESGERLPRP----EECPQEIYSIMLSCWKYRPEDRPTFSELES 250 (257)
T ss_pred CCCCCcccCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 99999988888777777655543333 367899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi |
| >cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=256.25 Aligned_cols=213 Identities=25% Similarity=0.461 Sum_probs=173.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-------------------CCCHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------------RVPEQT 67 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------------~~~~~~ 67 (241)
...+..+.+|++++++++|+||+++++++.+.+..++||||+.+++|.+++.... .+++..
T Consensus 60 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 139 (304)
T cd05096 60 KNARNDFLKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAISYSS 139 (304)
T ss_pred HHHHHHHHHHHHHHhhcCCCCeeEEEEEEecCCceEEEEecCCCCcHHHHHHhccccccccccccccccccccccccHHH
Confidence 3456789999999999999999999999999999999999999999999986532 257788
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccC
Q 026253 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR 144 (241)
Q Consensus 68 ~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~ 144 (241)
+..++.|++.||.+||+.|++|+||||+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..
T Consensus 140 ~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill---~~~~~~kl~DfG~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~ 216 (304)
T cd05096 140 LLHVALQIASGMKYLSSLNFVHRDLATRNCLV---GENLTIKIADFGMSRNLYAGDYYRIQGRAVLPIRWMAWECILMGK 216 (304)
T ss_pred HHHHHHHHHHHHHHHHHCCccccCcchhheEE---cCCccEEECCCccceecccCceeEecCcCCCCccccCHHHHhcCC
Confidence 99999999999999999999999999999999 6788999999999876533221 12233467899999998888
Q ss_pred CCCchhHHHHHHHHHHHHh--CCCCCCCCChHHHHHHhhcCC---CCCCCCccCCCCChHHHHHHHHhcccCccccCCHH
Q 026253 145 YDEKVDMWSVGAILFELLN--GYPPFSGRNNVQLVRNINSCK---HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN 219 (241)
Q Consensus 145 ~~~~~Dv~slG~~l~~l~~--g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 219 (241)
++.++|+||||+++|+|++ +..||...+..+....+.... .........+.+++.+.+++.+||+.+|++|||++
T Consensus 217 ~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RPs~~ 296 (304)
T cd05096 217 FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVYLFRPPPCPQGLYELMLQCWSRDCRERPSFS 296 (304)
T ss_pred CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhccccccccCCCCCCHHHHHHHHHHccCCchhCcCHH
Confidence 9999999999999999987 567888777666554443211 11111112346788999999999999999999999
Q ss_pred HHh
Q 026253 220 EFY 222 (241)
Q Consensus 220 ~il 222 (241)
++.
T Consensus 297 ~i~ 299 (304)
T cd05096 297 DIH 299 (304)
T ss_pred HHH
Confidence 985
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k |
| >PLN00009 cyclin-dependent kinase A; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-39 Score=255.63 Aligned_cols=221 Identities=29% Similarity=0.463 Sum_probs=178.0
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|++++++++|+||+++++++.+++..++||||+. ++|.+++..... +++..+..++.|++.||.+||++|
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 122 (294)
T PLN00009 44 VPSTAIREISLLKEMQHGNIVRLQDVVHSEKRLYLVFEYLD-LDLKKHMDSSPDFAKNPRLIKTYLYQILRGIAYCHSHR 122 (294)
T ss_pred chHHHHHHHHHHHhccCCCEeeEEEEEecCCeEEEEEeccc-ccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34678899999999999999999999999999999999995 688888865443 578889999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g 164 (241)
++|+||+|+||+++ ..++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+|+++|++++|
T Consensus 123 i~H~dl~p~nill~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~i~~~l~tg 200 (294)
T PLN00009 123 VLHRDLKPQNLLID--RRTNALKLADFGLARAFGIPVRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQ 200 (294)
T ss_pred eeCCCCCcceEEEE--CCCCEEEEcccccccccCCCccccccCceeecccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 99999999999994 3456799999999876543221 1233457889999988654 578999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCC------------------------CCccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPF------------------------SQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
.+||...+..+....+......+. .....+.+++++.+++.+||+.+|.+||++.+
T Consensus 201 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~~ 280 (294)
T PLN00009 201 KPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSAFPKWPPKDLATVVPTLEPAGVDLLSKMLRLDPSKRITARA 280 (294)
T ss_pred CCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhhcccCCCCCHHHhCcCCChHHHHHHHHHccCChhhCcCHHH
Confidence 999987766555444322111100 00123467889999999999999999999999
Q ss_pred HhcCcccccccc
Q 026253 221 FYHHRFLRRNSA 232 (241)
Q Consensus 221 il~~~~~~~~~~ 232 (241)
+++||||++...
T Consensus 281 ~l~~~~~~~~~~ 292 (294)
T PLN00009 281 ALEHEYFKDLGD 292 (294)
T ss_pred HhcCchHhHHhc
Confidence 999999998654
|
|
| >cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=264.12 Aligned_cols=228 Identities=30% Similarity=0.490 Sum_probs=183.9
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
...+.+.+|+.++++++|+||+++++++.. ....++||||+. ++|.+++...+.+++..+..++.|++.||.+||
T Consensus 46 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH 124 (334)
T cd07855 46 TLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFKDVYVVMDLME-SDLHHIIHSDQPLTEEHIRYFLYQLLRGLKYIH 124 (334)
T ss_pred cchHHHHHHHHHHHhcCCCCccCHHHhccccCCCCceEEEEEehhh-hhHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345677889999999999999999998753 356899999995 699999987778999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----cccccCCCCccCcccccc-cCCCCchhHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAI 157 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~ 157 (241)
+.|++|+||+|+||++ +.++.++|+|||.+........ .....++..|.|||.+.+ ..++.++|+||+|++
T Consensus 125 ~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~ 201 (334)
T cd07855 125 SANVIHRDLKPSNLLV---NEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCI 201 (334)
T ss_pred HCCeecCCCCHHHEEE---cCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHH
Confidence 9999999999999999 7888999999999866533221 123457888999998765 457899999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhcCCCCC-------------------------C-CCccCCCCChHHHHHHHHhcccC
Q 026253 158 LFELLNGYPPFSGRNNVQLVRNINSCKHLP-------------------------F-SQLIVPALHPDCVDMCLKLLSAN 211 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------------------------~-~~~~~~~~~~~~~~li~~~l~~~ 211 (241)
+|+|++|..||.+.+.......+......+ . .....+..+.++.++|++||+.+
T Consensus 202 l~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~ 281 (334)
T cd07855 202 FAEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIFPKASPEALDLLSQMLQFD 281 (334)
T ss_pred HHHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHcccCCHHHHHHHHHHccCC
Confidence 999999999998776554433322211100 0 01123467899999999999999
Q ss_pred ccccCCHHHHhcCcccccccccCCCCCC
Q 026253 212 TVDRLSFNEFYHHRFLRRNSAILRAPFH 239 (241)
Q Consensus 212 p~~Rps~~~il~~~~~~~~~~~~~~~~~ 239 (241)
|.+|||+++++.||||++.+.....+..
T Consensus 282 P~~Rpt~~~~l~~~~~~~~~~~~~~~~~ 309 (334)
T cd07855 282 PEERITVEQALQHPFLAQYHDPDDEPTC 309 (334)
T ss_pred hhhCcCHHHHHhChhhhhccCCcccccC
Confidence 9999999999999999987776655543
|
Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the |
| >cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=252.60 Aligned_cols=209 Identities=23% Similarity=0.376 Sum_probs=177.5
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGAG 78 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~ 78 (241)
....+.+|+.+++.++|+||+++++++..++..++||||+.+++|.+++.+.+ .++...+..++.|++.|
T Consensus 52 ~~~~~~~e~~~l~~l~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~ 131 (277)
T cd05062 52 ERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAGEIADG 131 (277)
T ss_pred HHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHHHHHHH
Confidence 45568899999999999999999999999999999999999999999997532 25678899999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 155 (241)
+.+||+.|++|+||||.||++ ++++.++|+|||++........ .....++..|+|||.+.+..++.++|+||||
T Consensus 132 l~~lH~~~~vH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 208 (277)
T cd05062 132 MAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFG 208 (277)
T ss_pred HHHHHHCCcccCCcchheEEE---cCCCCEEECCCCCccccCCcceeecCCCCccCHhhcChhHhhcCCcCchhHHHHHH
Confidence 999999999999999999999 6788899999999875433221 1122346679999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 156 AILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 156 ~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+++|++++ |..||.+.+..+....+........+ ...+..+.+++.+||+.+|++|||+.+++++
T Consensus 209 ~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 274 (277)
T cd05062 209 VVLWEIATLAEQPYQGMSNEQVLRFVMEGGLLDKP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 274 (277)
T ss_pred HHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999998 78999988887777766555443333 3678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh |
| >cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-39 Score=252.61 Aligned_cols=209 Identities=29% Similarity=0.490 Sum_probs=172.8
Q ss_pred HHHHHHHHhc---CCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 13 LDCELNFLSS---VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 13 ~~~E~~~l~~---l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
..+|..+++. .+|++|+.+++.+..++..++||||+.+++|.+++...+.+++..+..++.|++.||.+||+.|++|
T Consensus 41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~l~~~~~~~i~~qi~~al~~lH~~~ivH 120 (279)
T cd05633 41 ALNERIMLSLVSTGDCPFIVCMTYAFHTPDKLCFILDLMNGGDLHYHLSQHGVFSEKEMRFYATEIILGLEHMHNRFVVY 120 (279)
T ss_pred HHHHHHHHHHHhhCCCCcEeEEEEEEecCCeEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcCC
Confidence 4445444443 4799999999999999999999999999999999988888999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc-ccCCCCchhHHHHHHHHHHHHhCCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPF 168 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~~p~ 168 (241)
+||+|+||++ +.++.++|+|||++....... .....++..|+|||... +..++.++|+||+|+++|++++|..||
T Consensus 121 ~dikp~Nil~---~~~~~~~l~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~pf 196 (279)
T cd05633 121 RDLKPANILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPF 196 (279)
T ss_pred CCCCHHHEEE---CCCCCEEEccCCcceeccccC-ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHHHHHHHhCCCCc
Confidence 9999999999 778899999999986554322 22346789999999886 456789999999999999999999999
Q ss_pred CCCChH--HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 169 SGRNNV--QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 169 ~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
...... .......... +......++.++.++|++||..||.+|| |+.++++||||++
T Consensus 197 ~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~~~~~h~~~~~ 260 (279)
T cd05633 197 RQHKTKDKHEIDRMTLTV----NVELPDSFSPELKSLLEGLLQRDVSKRLGCLGRGAQEVKEHVFFKG 260 (279)
T ss_pred CCCCCcCHHHHHHHhhcC----CcCCccccCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHhCccccC
Confidence 754322 2222222222 2223347889999999999999999999 6999999999998
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi |
| >cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=255.64 Aligned_cols=213 Identities=28% Similarity=0.471 Sum_probs=175.0
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+|+.++++++|+||+++++++..+ +..++||||+. ++|.+++.... .+++..+..++.|++.||++||+.|+
T Consensus 49 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~i 127 (293)
T cd07843 49 ITSLREINILLKLQHPNIVTVKEVVVGSNLDKIYMVMEYVE-HDLKSLMETMKQPFLQSEVKCLMLQLLSGVAHLHDNWI 127 (293)
T ss_pred hhHHHHHHHHHhcCCCCEEEEEEEEEecCCCcEEEEehhcC-cCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3567899999999999999999998877 89999999996 59999887643 58999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccC-CCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+||+|+++|+|++|.
T Consensus 128 ~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (293)
T cd07843 128 LHRDLKTSNLLL---NNRGILKICDFGLAREYGSPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKK 204 (293)
T ss_pred eeccCCHHHEEE---CCCCcEEEeecCceeeccCCccccccccccccccCchhhcCCccccchhhHHHHHHHHHHHHhCC
Confidence 999999999999 77889999999998766543 2223344678899999887544 688999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCC--------------------------CCCccCCC-CChHHHHHHHHhcccCccccCCH
Q 026253 166 PPFSGRNNVQLVRNINSCKHLP--------------------------FSQLIVPA-LHPDCVDMCLKLLSANTVDRLSF 218 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~-~~~~~~~li~~~l~~~p~~Rps~ 218 (241)
.||...+..+....+......+ ........ +++.+.++|++||+.+|++|||+
T Consensus 205 ~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R~t~ 284 (293)
T cd07843 205 PLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISA 284 (293)
T ss_pred CCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhccCccccCCH
Confidence 9998877665554443211100 00111112 58889999999999999999999
Q ss_pred HHHhcCccc
Q 026253 219 NEFYHHRFL 227 (241)
Q Consensus 219 ~~il~~~~~ 227 (241)
.|+++||||
T Consensus 285 ~ell~~~~f 293 (293)
T cd07843 285 EDALKHPYF 293 (293)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the |
| >cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=254.99 Aligned_cols=220 Identities=26% Similarity=0.434 Sum_probs=177.6
Q ss_pred HhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHH-----hcCCCCHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-----LHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-----~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
.....+.+|+.++.++. |+||+++++++..++..+++||++. +++.++.. ....+++..+..++.+++.||++
T Consensus 44 ~~~~~~~~e~~~l~~~~~~~~iv~~~~~~~~~~~~~~~~e~~~-~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~~l~~ 122 (288)
T cd06616 44 KEQKRLLMDLDVVMRSSDCPYIVKFYGALFREGDCWICMELMD-ISLDKFYKYVYEVLKSVIPEEILGKIAVATVKALNY 122 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeeeEEecCCcEEEEEeccc-CCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 45667889999999995 9999999999999999999999984 56665432 23568999999999999999999
Q ss_pred HHhC-CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccccc---CCCCchhHHHHHHH
Q 026253 82 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ---RYDEKVDMWSVGAI 157 (241)
Q Consensus 82 lh~~-~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~---~~~~~~Dv~slG~~ 157 (241)
||+. |++|+||+|+||++ +.++.++|+|||++.............++..|+|||.+.+. .++.++|+||+|++
T Consensus 123 lh~~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i 199 (288)
T cd06616 123 LKEELKIIHRDVKPSNILL---DRNGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSARDGYDVRSDVWSLGIT 199 (288)
T ss_pred HhhcCCeeccCCCHHHEEE---ccCCcEEEeecchhHHhccCCccccccCccCccCHHHhccccccCCcchhhhhHHHHH
Confidence 9975 99999999999999 67788999999998765544433444678889999998765 68899999999999
Q ss_pred HHHHHhCCCCCCCCCh-HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 158 LFELLNGYPPFSGRNN-VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
+|++++|..||..... .+....+...............++.++.+++.+||+.+|++|||++++++||||++..
T Consensus 200 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~i~~~~~~~~~~ 274 (288)
T cd06616 200 LYEVATGKFPYPKWNSVFDQLTQVVKGDPPILSNSEEREFSPSFVNFINLCLIKDESKRPKYKELLEHPFIKDYE 274 (288)
T ss_pred HHHHHhCCCCchhcchHHHHHhhhcCCCCCcCCCcCCCccCHHHHHHHHHHccCChhhCcCHHHHhcChhhhchh
Confidence 9999999999976542 2222333222222222222235889999999999999999999999999999998743
|
Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates |
| >cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-39 Score=261.07 Aligned_cols=217 Identities=25% Similarity=0.440 Sum_probs=166.0
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEe--ecCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~ 78 (241)
...+.+|++++++++||||+++++++. .+...++||||+. ++|.+++... ..+++..+..++.|++.|
T Consensus 42 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 120 (317)
T cd07867 42 SMSACREIALLRELKHPNVIALQKVFLSHSDRKVWLLFDYAE-HDLWHIIKFHRASKANKKPMQLPRSMVKSLLYQILDG 120 (317)
T ss_pred cHHHHHHHHHHHhCCCCCeeeEEEEEeccCCCeEEEEEeeeC-CcHHHHHHhhhccccCCCCccCCHHHHHHHHHHHHHH
Confidence 346789999999999999999999885 3567899999995 6888887532 247889999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeec-CCCceEEEeecCCccccCCCCc----cccccCCCCccCccccccc-CCCCchhHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMW 152 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~-~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~ 152 (241)
|.+||+.|++|+||||+||++... +..+.++|+|||+++....... .....++..|+|||.+.+. .++.++|+|
T Consensus 121 L~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw 200 (317)
T cd07867 121 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 200 (317)
T ss_pred HHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcccccccCcceecccccCcHHhcCCCccCcHHHHH
Confidence 999999999999999999999532 3556899999999976543321 2234578899999998764 578999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH---------HHHHHhhcCCCC-------------C--------------------CCC
Q 026253 153 SVGAILFELLNGYPPFSGRNNV---------QLVRNINSCKHL-------------P--------------------FSQ 190 (241)
Q Consensus 153 slG~~l~~l~~g~~p~~~~~~~---------~~~~~i~~~~~~-------------~--------------------~~~ 190 (241)
|+|+++|+|++|.+||...... .....+...... . ...
T Consensus 201 SlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 280 (317)
T cd07867 201 AIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANSSLIKYME 280 (317)
T ss_pred hHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCchhhhhhh
Confidence 9999999999999999753321 011110000000 0 000
Q ss_pred ccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 191 ~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
......+..+.+++.+||+.||.+|||++|+|+||||
T Consensus 281 ~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f 317 (317)
T cd07867 281 KHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF 317 (317)
T ss_pred cccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence 0111345678899999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as |
| >cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-39 Score=263.34 Aligned_cols=216 Identities=31% Similarity=0.467 Sum_probs=176.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
.....+.+|+.++++++|+||+++++++... ...++||||+. ++|.+.+... +++..+..++.|++.||++
T Consensus 57 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~--l~~~~~~~~~~ql~~aL~~ 133 (353)
T cd07850 57 THAKRAYRELVLMKLVNHKNIIGLLNVFTPQKSLEEFQDVYLVMELMD-ANLCQVIQMD--LDHERMSYLLYQMLCGIKH 133 (353)
T ss_pred hHHHHHHHHHHHHHhcCCCCCcceeeeeccCCCccccCcEEEEEeccC-CCHHHHHhhc--CCHHHHHHHHHHHHHHHHH
Confidence 3456778899999999999999999987643 35799999995 6888887643 8899999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
||+.|++|+||+|+||++ +.++.++|+|||.+.............++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus 134 LH~~gi~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~~l 210 (353)
T cd07850 134 LHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEM 210 (353)
T ss_pred HHhCCeeeCCCCHHHEEE---CCCCCEEEccCccceeCCCCCCCCCCcccccccCHHHHhCCCCCCchhhHhHHHHHHHH
Confidence 999999999999999999 77889999999999876554444445678889999999988999999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCC--------------------------CCcc------------CCCCChHHHHH
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPF--------------------------SQLI------------VPALHPDCVDM 203 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~--------------------------~~~~------------~~~~~~~~~~l 203 (241)
++|..||.+.+.......+......+. .... ....+..+.++
T Consensus 211 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 290 (353)
T cd07850 211 IRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQARDL 290 (353)
T ss_pred HHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHHHH
Confidence 999999987776554444322111110 0000 11345678999
Q ss_pred HHHhcccCccccCCHHHHhcCccccc
Q 026253 204 CLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 204 i~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
|++||+.||.+|||+.|+|.||||+.
T Consensus 291 i~~~L~~dP~~R~t~~eiL~~~~~~~ 316 (353)
T cd07850 291 LSKMLVIDPEKRISVDDALQHPYINV 316 (353)
T ss_pred HHHHcCCChhhCcCHHHHhcChhHhh
Confidence 99999999999999999999999874
|
Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK |
| >cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-39 Score=256.11 Aligned_cols=214 Identities=31% Similarity=0.517 Sum_probs=174.8
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+.+.+|++++++++|+||+++++++.+++..++||||+. ++|.+++... ..+++..+..++.|++.|+++||+.|+
T Consensus 43 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~~lh~~~i 121 (284)
T cd07860 43 PSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLH-QDLKKFMDASPLSGIPLPLIKSYLFQLLQGLAFCHSHRV 121 (284)
T ss_pred chHHHHHHHHHHhcCCCCCcchhhhcccCCcEEEEeeccc-cCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4578899999999999999999999999999999999995 6899988653 458999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccC-CCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.+.. ++.++|+||||+++|++++|.
T Consensus 122 ~H~~l~p~nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~~l~tg~ 198 (284)
T cd07860 122 LHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRR 198 (284)
T ss_pred ecCCCCHHHEEE---CCCCCEEEeeccchhhcccCccccccccccccccCCeEEecCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 999999999999 778899999999987554322 122234577899999876544 588999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCC-----------------C-------CccCCCCChHHHHHHHHhcccCccccCCHHHH
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPF-----------------S-------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~-----------------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 221 (241)
.||...+.......+......+. + ....+.++.++.++|.+||+.||.+|||++++
T Consensus 199 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~~ 278 (284)
T cd07860 199 ALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKPSFPKWARQDFSKVVPPLDEDGRDLLSQMLHYDPNKRISAKAA 278 (284)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHhhcccccccCHHHHcccCCHHHHHHHHHhcCCCcccCCCHHHH
Confidence 99987665444333322111110 0 11123578889999999999999999999999
Q ss_pred hcCccc
Q 026253 222 YHHRFL 227 (241)
Q Consensus 222 l~~~~~ 227 (241)
++||||
T Consensus 279 l~~~~f 284 (284)
T cd07860 279 LAHPFF 284 (284)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex |
| >KOG1095 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-40 Score=283.51 Aligned_cols=211 Identities=27% Similarity=0.476 Sum_probs=190.7
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAG 78 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~ 78 (241)
+.++...|.+|..++++++|||||+++|++-+....+|++|||+||+|..|+++.+ .++......++.+++.|
T Consensus 735 ~~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~a~dvA~G 814 (1025)
T KOG1095|consen 735 SEQEVSDFLKEALLMSKFDHPNIVSLIGVCLDSGPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAFALDVAKG 814 (1025)
T ss_pred CHHHHHHHHHHHHHHhcCCCcceeeEEEeecCCCCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHHHHHHhhh
Confidence 67789999999999999999999999999999999999999999999999998762 38999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcccc---ccCCCCccCcccccccCCCCchhHHHHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~---~~~~~~~~~PE~~~~~~~~~~~Dv~slG 155 (241)
+.||++++++||||...|+|+ +....+||+|||+|+......+... ..-...|+|||.+....++.++||||||
T Consensus 815 ~~YLe~~~fvHRDLAaRNCLL---~~~r~VKIaDFGlArDiy~~~yyr~~~~a~lPvkWm~PEsl~d~iFtskSDvWsFG 891 (1025)
T KOG1095|consen 815 MNYLESKHFVHRDLAARNCLL---DERRVVKIADFGLARDIYDKDYYRKHGEAMLPVKWMPPESLKDGIFTSKSDVWSFG 891 (1025)
T ss_pred hHHHHhCCCcCcchhhhheee---cccCcEEEcccchhHhhhhchheeccCccccceecCCHHHHhhcccccccchhhhH
Confidence 999999999999999999999 6779999999999995544332211 1234679999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 156 AILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 156 ~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+++||+++ |..||.+.+..+.......+.+.+.|. .++..+.+++.+||+.+|++||++..|++
T Consensus 892 VllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~----~CP~~ly~lM~~CW~~~pe~RP~F~~i~~ 956 (1025)
T KOG1095|consen 892 VLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPS----YCPEKLYQLMLQCWKHDPEDRPSFRTIVE 956 (1025)
T ss_pred HHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCC----CCChHHHHHHHHHccCChhhCccHHHHHh
Confidence 99999999 999999999999999887888777776 88999999999999999999999999987
|
|
| >KOG0596 consensus Dual specificity; serine/threonine and tyrosine kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=261.44 Aligned_cols=219 Identities=25% Similarity=0.454 Sum_probs=180.8
Q ss_pred hhhhHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHH
Q 026253 3 KKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 3 ~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~ 80 (241)
...+.....-+.+|+..|.+| .|.+|+++++|-..++.+|+||||- ..+|..+|++.+. .+.-.+..+.+|++.|+.
T Consensus 396 ~~~D~qtl~gy~nEI~lL~KLkg~~~IIqL~DYEv~d~~lYmvmE~G-d~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~ 474 (677)
T KOG0596|consen 396 LEADNQTLDGYRNEIALLNKLKGHDKIIQLYDYEVTDGYLYMVMECG-DIDLNKILKKKKSIDPDWFLKFYWKQMLLAVK 474 (677)
T ss_pred hhcCHHHHHHHHHHHHHHHHhcCCceEEEEeeeeccCceEEEEeecc-cccHHHHHHhccCCCchHHHHHHHHHHHHHHH
Confidence 345777788999999999999 6999999999999999999999976 6899999987765 333478889999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccC-----------CC
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR-----------YD 146 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~-----------~~ 146 (241)
++|..||+|.||||.|+++ ..|.+||+|||.|....++.+ ....+||.-|+|||.+.... .+
T Consensus 475 ~IH~~gIVHSDLKPANFLl----VkG~LKLIDFGIA~aI~~DTTsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~ 550 (677)
T KOG0596|consen 475 TIHQHGIVHSDLKPANFLL----VKGRLKLIDFGIANAIQPDTTSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKIS 550 (677)
T ss_pred HHHHhceeecCCCcccEEE----EeeeEEeeeechhcccCccccceeeccccCcccccCHHHHhhccccccCCCcceeec
Confidence 9999999999999999998 678999999999988876654 35678999999999885332 56
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhhcC-CCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 147 EKVDMWSVGAILFELLNGYPPFSGRN-NVQLVRNINSC-KHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 147 ~~~Dv~slG~~l~~l~~g~~p~~~~~-~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+++|||||||++|+|+.|++||.... ....+..|.+- ..++++.. .-..++.++++.||+.||.+|||+.++|+|
T Consensus 551 r~SDvWSLGCILYqMvYgktPf~~~~n~~aKl~aI~~P~~~Iefp~~---~~~~~li~~mK~CL~rdPkkR~si~eLLqh 627 (677)
T KOG0596|consen 551 RKSDVWSLGCILYQMVYGKTPFGQIINQIAKLHAITDPNHEIEFPDI---PENDELIDVMKCCLARDPKKRWSIPELLQH 627 (677)
T ss_pred CccchhhhhhHHHHHHhcCCchHHHHHHHHHHHhhcCCCccccccCC---CCchHHHHHHHHHHhcCcccCCCcHHHhcC
Confidence 79999999999999999999998543 33444444322 22344432 112239999999999999999999999999
Q ss_pred ccccc
Q 026253 225 RFLRR 229 (241)
Q Consensus 225 ~~~~~ 229 (241)
||++-
T Consensus 628 pFl~~ 632 (677)
T KOG0596|consen 628 PFLQI 632 (677)
T ss_pred ccccc
Confidence 99976
|
|
| >cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=252.05 Aligned_cols=210 Identities=27% Similarity=0.442 Sum_probs=177.7
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (241)
....+.+.+|+++++++ +||||+++++++...+..+++|||+.+++|.+++.... .+++..+.
T Consensus 36 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 115 (270)
T cd05047 36 KDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQLL 115 (270)
T ss_pred HHHHHHHHHHHHHHHhhccCCCeeeEEEEEecCCCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCHHHHH
Confidence 34556788999999999 89999999999999999999999999999999997543 37889999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCch
Q 026253 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKV 149 (241)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~ 149 (241)
.++.|++.|+++||+.|++|+||+|+||++ ++++.++++|||++..............+..|+|||.+.+..++.++
T Consensus 116 ~~~~~i~~al~~lH~~~i~H~dikp~nili---~~~~~~kl~dfgl~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~ 192 (270)
T cd05047 116 HFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNS 192 (270)
T ss_pred HHHHHHHHHHHHHHHCCEeecccccceEEE---cCCCeEEECCCCCccccchhhhccCCCCccccCChHHHccCCCCchh
Confidence 999999999999999999999999999999 78889999999998533221111122235569999999888899999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 150 DMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 150 Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|+||||+++|+|++ |..||.+.+..+..+.+........+ ...+.++.+++.+|+..+|.+|||+.+++.
T Consensus 193 Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (270)
T cd05047 193 DVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILV 263 (270)
T ss_pred hHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCCCCCCC----CcCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence 99999999999997 99999988877777777554433333 257889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l |
| >KOG0194 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-40 Score=267.50 Aligned_cols=212 Identities=26% Similarity=0.463 Sum_probs=189.2
Q ss_pred hhHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHH
Q 026253 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh 83 (241)
....++.++.+|++++++++||||+++||+...+.-+++|||+|.||+|.++|++.+. ++..+...++.+++.||+|||
T Consensus 200 ~~~~~~~e~m~EArvMr~l~H~NVVr~yGVa~~~~Pl~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~YLh 279 (474)
T KOG0194|consen 200 LTKEQIKEFMKEARVMRQLNHPNVVRFYGVAVLEEPLMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEYLH 279 (474)
T ss_pred ccHHHHHHHHHHHHHHHhCCCCCEEEEEEEEcCCCccEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHHHH
Confidence 4578899999999999999999999999999999999999999999999999998874 999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc-cccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~-~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
+++++||||-..|+|+ ..+..+||+|||+++......... ...-...|+|||.+....++.++||||+|+++||++
T Consensus 280 ~k~~IHRDIAARNcL~---~~~~~vKISDFGLs~~~~~~~~~~~~~klPirWLAPEtl~~~~~s~kTDV~sfGV~~~Eif 356 (474)
T KOG0194|consen 280 SKNCIHRDIAARNCLY---SKKGVVKISDFGLSRAGSQYVMKKFLKKLPIRWLAPETLNTGIFSFKTDVWSFGVLLWEIF 356 (474)
T ss_pred HCCCcchhHhHHHhee---cCCCeEEeCccccccCCcceeeccccccCcceecChhhhccCccccccchhheeeeEEeee
Confidence 9999999999999999 677789999999986653211111 123457899999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHh-hcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 163 N-GYPPFSGRNNVQLVRNI-NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+ |..||.+....+..+.| ..+.+.+.+. ..+.++..++.+|+..+|+.|||+.++.+
T Consensus 357 ~~g~~Py~g~~~~~v~~kI~~~~~r~~~~~----~~p~~~~~~~~~c~~~~p~~R~tm~~i~~ 415 (474)
T KOG0194|consen 357 ENGAEPYPGMKNYEVKAKIVKNGYRMPIPS----KTPKELAKVMKQCWKKDPEDRPTMSTIKK 415 (474)
T ss_pred ccCCCCCCCCCHHHHHHHHHhcCccCCCCC----CCHHHHHHHHHHhccCChhhccCHHHHHH
Confidence 9 88899999999999999 6677777666 77889999999999999999999988763
|
|
| >cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-39 Score=255.55 Aligned_cols=214 Identities=31% Similarity=0.476 Sum_probs=180.3
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
+..+.+.+|+++++.++|+||+++.+++.+++..++||||+. +++.+++.. ...+++..+..++.|++.||.+||+.|
T Consensus 57 ~~~~~~~~Ei~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~LH~~~ 135 (307)
T cd06607 57 EKWQDIIKEVRFLQQLRHPNTIEYKGCYLREHTAWLVMEYCL-GSASDILEVHKKPLQEVEIAAICHGALQGLAYLHSHE 135 (307)
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEEeCCeEEEEHHhhC-CCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345678899999999999999999999999999999999996 577777654 456899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc---ccCCCCchhHHHHHHHHHHHHh
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
++|+||+|.||++ ++++.++|+|||++...... ....++..|+|||.+. ...++.++|+||+|+++|++++
T Consensus 136 i~H~dl~p~nIl~---~~~~~~kL~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~il~el~t 209 (307)
T cd06607 136 RIHRDIKAGNILL---TEPGTVKLADFGSASLVSPA---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (307)
T ss_pred ceecCCCcccEEE---CCCCCEEEeecCcceecCCC---CCccCCccccCceeeeccCCCCCCcccchHHHHHHHHHHHc
Confidence 9999999999999 77889999999988654322 2345678899999874 3557889999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|..||.+.+.......+......... ....+..+.+++.+||+.+|.+||++.+++.||||....
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~ 274 (307)
T cd06607 210 RKPPLFNMNAMSALYHIAQNDSPTLS---SNDWSDYFRNFVDSCLQKIPQDRPSSEELLKHRFVLRER 274 (307)
T ss_pred CCCCCCCccHHHHHHHHhcCCCCCCC---chhhCHHHHHHHHHHhcCChhhCcCHHHHhcChhhcccC
Confidence 99999988776666555443322222 235688999999999999999999999999999998754
|
Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily |
| >cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-39 Score=250.00 Aligned_cols=211 Identities=27% Similarity=0.516 Sum_probs=182.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+.+.+|+.+++.++|+||+++.+.+.+++..+++|||+++++|.+++... ..+++..+..++.|++.|+.+||+
T Consensus 39 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~ 118 (255)
T cd08219 39 SSAVEDSRKEAVLLAKMKHPNIVAFKESFEADGHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGVQHIHE 118 (255)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 345677889999999999999999999999999999999999999999988653 358899999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
.|++|+||+|.||++ ++++.++++|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 119 ~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Dv~slG~i~~~l~~ 195 (255)
T cd08219 119 KRVLHRDIKSKNIFL---TQNGKVKLGDFGSARLLTSPGAYACTYVGTPYYVPPEIWENMPYNNKSDIWSLGCILYELCT 195 (255)
T ss_pred CCcccCCCCcceEEE---CCCCcEEEcccCcceeecccccccccccCCccccCHHHHccCCcCchhhhhhhchhheehhh
Confidence 999999999999999 778889999999987654322 2233457888999999988889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|..||...+.......+..+...+.+ ..++..+.+++++||+.||.+|||+.+++.-
T Consensus 196 g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rp~~~~il~~ 252 (255)
T cd08219 196 LKHPFQANSWKNLILKVCQGSYKPLP----SHYSYELRSLIKQMFKRNPRSRPSATTILSR 252 (255)
T ss_pred ccCCCCCCCHHHHHHHHhcCCCCCCC----cccCHHHHHHHHHHHhCCcccCCCHHHHhhc
Confidence 99999988877777776555444333 3678899999999999999999999999864
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati |
| >KOG0577 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-40 Score=269.45 Aligned_cols=215 Identities=30% Similarity=0.489 Sum_probs=194.0
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+.+-+..+.+|+++|++++|||++.+.|+|-.+...|+||||| -|+.+|++.-. +++.+..+..|..+.+.||+|||+
T Consensus 66 s~EKWqDIlKEVrFL~~l~HPntieYkgCyLre~TaWLVMEYC-lGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYLHS 144 (948)
T KOG0577|consen 66 SNEKWQDILKEVRFLRQLRHPNTIEYKGCYLREHTAWLVMEYC-LGSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHS 144 (948)
T ss_pred cHHHHHHHHHHHHHHHhccCCCcccccceeeccchHHHHHHHH-hccHHHHHHHHhccchHHHHHHHHHHHHHHHHHHHH
Confidence 4456889999999999999999999999999999999999999 67999998754 679999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc---ccCCCCchhHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l 161 (241)
.+.+|||||..|||+ ++.+.|||+|||.|....+ ...+.||++|+|||++. .+.|+-+.||||||++..++
T Consensus 145 ~~~IHRDiKAGNILL---se~g~VKLaDFGSAsi~~P---AnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGITCIEL 218 (948)
T KOG0577|consen 145 HNRIHRDIKAGNILL---SEPGLVKLADFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIEL 218 (948)
T ss_pred hhHHhhhccccceEe---cCCCeeeeccccchhhcCc---hhcccCCccccchhHheeccccccCCccceeeccchhhhh
Confidence 999999999999999 8999999999999977654 44678999999999874 56799999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
...++|..+++...-+..|.....+.+.. +..|..+..|+..||++-|.+|||.+++|+|+|..+.
T Consensus 219 AERkPPlFnMNAMSALYHIAQNesPtLqs---~eWS~~F~~Fvd~CLqKipqeRptse~ll~H~fv~R~ 284 (948)
T KOG0577|consen 219 AERKPPLFNMNAMSALYHIAQNESPTLQS---NEWSDYFRNFVDSCLQKIPQERPTSEELLKHRFVLRE 284 (948)
T ss_pred hhcCCCccCchHHHHHHHHHhcCCCCCCC---chhHHHHHHHHHHHHhhCcccCCcHHHHhhcchhccC
Confidence 99999999999988888887766655553 4788999999999999999999999999999998764
|
|
| >cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-39 Score=254.68 Aligned_cols=214 Identities=32% Similarity=0.518 Sum_probs=176.5
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+.+.+|++++++++|+|++++++++.+++..+++|||++ ++|.+++.... .+++..+..++.|++.||++||+.++
T Consensus 42 ~~~~~~E~~~l~~l~~~~iv~~~~~~~~~~~~~iv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~L~~lH~~~~ 120 (283)
T cd07835 42 PSTAIREISLLKELNHPNIVRLLDVVHSENKLYLVFEFLD-LDLKKYMDSSPLTGLDPPLIKSYLYQLLQGIAYCHSHRV 120 (283)
T ss_pred hhHHHHHHHHHHhcCCCCccCHhheeccCCeEEEEEeccC-cCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 4568899999999999999999999999999999999994 69999998765 68999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.+. .++.++|+||+|+++|++++|+
T Consensus 121 ~H~dl~p~nil~---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~ 197 (283)
T cd07835 121 LHRDLKPQNLLI---DREGALKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRR 197 (283)
T ss_pred eCCCCCHHHEEE---cCCCcEEEeecccccccCCCccccCccccccCCCCCceeecCcccCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999 668899999999986553221 11223457889999987654 4688999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCC------------------------CCCCCccCCCCChHHHHHHHHhcccCccccCCHHHH
Q 026253 166 PPFSGRNNVQLVRNINSCKH------------------------LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 221 (241)
+||...+.......+..... ........+.++.++.+++++||+.+|.+|||++|+
T Consensus 198 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rpt~~~i 277 (283)
T cd07835 198 PLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPTFPKWARQDLSKVVPNLDEDGLDLLSKMLVYDPAKRISAKAA 277 (283)
T ss_pred CCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhhcccccccchhhhcCCCCHHHHHHHHHHhcCChhhCcCHHHH
Confidence 99987765544333322110 011112245678899999999999999999999999
Q ss_pred hcCccc
Q 026253 222 YHHRFL 227 (241)
Q Consensus 222 l~~~~~ 227 (241)
++||||
T Consensus 278 l~~~~~ 283 (283)
T cd07835 278 LQHPYF 283 (283)
T ss_pred hcCCCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc |
| >cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa | Back alignment and domain information |
|---|
Probab=100.00 E-value=8e-39 Score=248.67 Aligned_cols=208 Identities=23% Similarity=0.439 Sum_probs=177.5
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|+.++++++|+||+++++++.. +..++||||+++++|.+++.. ...+++..+..++.|++.|+.+||++|
T Consensus 37 ~~~~~~~~E~~~l~~l~h~~ii~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 115 (257)
T cd05115 37 SVRDEMMREAEIMHQLDNPYIVRMIGVCEA-EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKYLEGKN 115 (257)
T ss_pred HHHHHHHHHHHHHHhcCCCCeEEEEEEEcC-CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhcC
Confidence 345678999999999999999999998764 578999999999999999975 456899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
++|+||+|.||++ +.++.++|+|||.+........ ......+..|+|||.+.+..++.++|+||||+++|+++
T Consensus 116 i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~ 192 (257)
T cd05115 116 FVHRDLAARNVLL---VNQHYAKISDFGLSKALGADDSYYKARSAGKWPLKWYAPECINFRKFSSRSDVWSYGITMWEAF 192 (257)
T ss_pred eeecccchheEEE---cCCCcEEeccCCccccccCCccceeccCCCCCCcccCCHHHHccCCCCchhhHHHHHHHHHHHh
Confidence 9999999999999 6788899999999875533221 11122246799999998888999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+ |..||......+....+..+.....+ +..++++.+++.+||+.+|++||++.++.+
T Consensus 193 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~c~~~~~~~Rp~~~~i~~ 250 (257)
T cd05115 193 SYGQKPYKKMKGPEVMSFIEQGKRLDCP----AECPPEMYALMKDCWIYKWEDRPNFAKVEE 250 (257)
T ss_pred cCCCCCcCcCCHHHHHHHHHCCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 6 99999988888887777666654444 367899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho |
| >cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-39 Score=248.85 Aligned_cols=208 Identities=24% Similarity=0.468 Sum_probs=178.6
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|+.++++++|+||+++++++...+..++|||++++++|.+++... ..+++..+..++.|++.|+++||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i~ 122 (256)
T cd05059 43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQRPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAMEYLESNGFI 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCEEEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 346788999999999999999999999999999999999999999999764 4689999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc--cccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~ 165 (241)
|+||+|.||++ +.++.++|+|||.+.......... ....+..|+|||.+.+..++.++|+||+|+++|++++ |.
T Consensus 123 H~dl~p~ni~i---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~il~~l~~~g~ 199 (256)
T cd05059 123 HRDLAARNCLV---GEDNVVKVSDFGLARYVLDDQYTSSQGTKFPVKWAPPEVFDYSRFSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred cccccHhhEEE---CCCCcEEECCcccceecccccccccCCCCCCccccCHHHhccCCCCchhhHHHHHHHHHHHhccCC
Confidence 99999999999 678889999999987654322111 1122346999999988889999999999999999998 89
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.||...+..+....+........+ ...+.++.+++.+||..+|.+|||++++++.
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rpt~~~~l~~ 254 (256)
T cd05059 200 MPYERFSNSEVVESVSAGYRLYRP----KLAPTEVYTIMYSCWHEKPEDRPAFKKLLSQ 254 (256)
T ss_pred CCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999988888777777655444333 3678999999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows |
| >cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.1e-39 Score=250.11 Aligned_cols=211 Identities=22% Similarity=0.448 Sum_probs=182.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
......+.+|+.++++++|+||+++++++..++..+++||++++++|.+++... +.+++..+..++.|++.|+.+||+.
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~ 125 (266)
T cd05033 46 DKQRLDFLTEASIMGQFDHPNIIRLEGVVTKSRPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKYLSEM 125 (266)
T ss_pred hHHHHHHHHHHHHHHhCCCCCcceEeEEEecCCceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 445667889999999999999999999999999999999999999999999764 4689999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
|++|+||+|.||++ ++++.++|+|||.+........ ......+..|+|||.+.+..++.++|+||+|+++|+++
T Consensus 126 ~i~H~di~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Dv~slG~~l~~l~ 202 (266)
T cd05033 126 NYVHRDLAARNILV---NSNLVCKVSDFGLSRRLEDSEATYTTKGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEVM 202 (266)
T ss_pred CcccCCCCcceEEE---cCCCCEEECccchhhcccccccceeccCCCCCccccChhhhccCCCccccchHHHHHHHHHHH
Confidence 99999999999999 7788899999999987642111 11223356799999998888999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+ |..||......+....+......+.+ ...+..+.+++.+||+.+|++||++++++++
T Consensus 203 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rp~~~ei~~~ 261 (266)
T cd05033 203 SYGERPYWDMSNQDVIKAVEDGYRLPPP----MDCPSALYQLMLDCWQKDRNERPTFSQIVST 261 (266)
T ss_pred ccCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 8 99999888888877777655444333 3678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment |
| >cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=260.89 Aligned_cols=226 Identities=20% Similarity=0.314 Sum_probs=178.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+.+.+|+.+++.++|+||+++++++..++..++|+||+.+++|.+++.... .+++..+..++.|++.||++||+
T Consensus 40 ~~~~~~~~~e~~~~~~l~h~niv~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~~lH~ 119 (328)
T cd08226 40 EEHLKALQNEVVLSHFFRHPNIMTSWTVFTTGSWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLNYLHQ 119 (328)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEeeeEecCCceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3456789999999999999999999999999999999999999999999998643 48999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--------cccccCCCCccCccccccc--CCCCchhHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSV 154 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--------~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~sl 154 (241)
.|++|+||||+||++ +.++.++++||+.+........ .....++..|+|||.+.+. .++.++|+||+
T Consensus 120 ~~ivHrDlkp~Nill---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diwsl 196 (328)
T cd08226 120 NGYIHRNIKASHILI---SGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYSV 196 (328)
T ss_pred CCeecCCCCHHHEEE---eCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHHH
Confidence 999999999999999 6778899999975433221111 0112235569999998764 47899999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHhhcCCCC-C-----------------------------------------CCCcc
Q 026253 155 GAILFELLNGYPPFSGRNNVQLVRNINSCKHL-P-----------------------------------------FSQLI 192 (241)
Q Consensus 155 G~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~-~-----------------------------------------~~~~~ 192 (241)
|+++|++++|..||.................. + .....
T Consensus 197 G~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (328)
T cd08226 197 GITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTPS 276 (328)
T ss_pred HHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccchh
Confidence 99999999999999876654443332221110 0 00001
Q ss_pred CCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCC
Q 026253 193 VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 235 (241)
Q Consensus 193 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 235 (241)
...++..+.+++++||+.||++|||++++++||||+..+....
T Consensus 277 ~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~~~~~~~ 319 (328)
T cd08226 277 SKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQVKEQTQ 319 (328)
T ss_pred hhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHHHHHhcc
Confidence 1235678999999999999999999999999999998776543
|
Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig |
| >cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-39 Score=256.28 Aligned_cols=220 Identities=28% Similarity=0.487 Sum_probs=184.4
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|+.++++++||||+++++++..++..++|+||+++++|.+++.+ ..+++..+..++.|++.|+.+||+.|++
T Consensus 59 ~~~~~~~e~~~l~~l~hp~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~l~~~~~~~i~~~l~~al~~LH~~gi~ 137 (293)
T cd06647 59 KKELIINEILVMRENKHPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQVI 137 (293)
T ss_pred HHHHHHHHHHHHhhcCCCCeeehhheeeeCCcEEEEEecCCCCcHHHHHhh-cCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 456788999999999999999999999999999999999999999999875 3578999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|+||+|.||++ +.++.++|+|||.+....... ......++..|++||.+.+..++.++|+||+|+++|++++|..|
T Consensus 138 H~dL~p~Nili---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~ll~~ll~g~~p 214 (293)
T cd06647 138 HRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMVEGEPP 214 (293)
T ss_pred eccCCHHHEEE---cCCCCEEEccCcceecccccccccccccCChhhcCchhhccCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 678889999999876554322 22234577889999999888889999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccC
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 234 (241)
|...+.......+......... ....++..+.+++++||+.+|.+||++++++.|+||+......
T Consensus 215 f~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~h~~~~~~~~~~ 279 (293)
T cd06647 215 YLNENPLRALYLIATNGTPELQ--NPEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHPFLKIAKPLS 279 (293)
T ss_pred CCCCChhhheeehhcCCCCCCC--CccccCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcCcccc
Confidence 9877665444333222222221 1235678899999999999999999999999999999877433
|
Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi |
| >cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-39 Score=256.10 Aligned_cols=216 Identities=31% Similarity=0.547 Sum_probs=178.2
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|+++++.++|+||+++++++..++..++||||+++++|..+......+++..+..++.|++.|+.+||+.|++
T Consensus 43 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 122 (286)
T cd07846 43 VKKIAMREIRMLKQLRHENLVNLIEVFRRKKRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEFCHSHNII 122 (286)
T ss_pred hhHHHHHHHHHHHhcCCcchhhHHHhcccCCeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 35568899999999999999999999999999999999999999988877666799999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
|+|++|.||++ ++++.++|+|||++....... ......++..|+|||...+ ..++.++|+||+|+++|++++|.+
T Consensus 123 h~~l~p~ni~~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~el~~g~~ 199 (286)
T cd07846 123 HRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEP 199 (286)
T ss_pred ccCCCHHHEEE---CCCCcEEEEeeeeeeeccCCccccCcccceeeccCcHHhccccccCchHhHHHHHHHHHHHHcCCC
Confidence 99999999999 778899999999987653322 2223456788999998865 346789999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCC------------------CCC--------CccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 167 PFSGRNNVQLVRNINSCKHL------------------PFS--------QLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~------------------~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
||...+..+....+...... ..+ ....+.++..+.+++.+||+.+|.+||++.+
T Consensus 200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~Rp~~~~ 279 (286)
T cd07846 200 LFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKLSGLVLDLAKQCLRIDPDDRPSSSQ 279 (286)
T ss_pred CCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHhCCCcCHHHHHHHHHHhcCCcccchhHHH
Confidence 99876654443333211000 000 0123467889999999999999999999999
Q ss_pred HhcCccc
Q 026253 221 FYHHRFL 227 (241)
Q Consensus 221 il~~~~~ 227 (241)
+++||||
T Consensus 280 il~~~~~ 286 (286)
T cd07846 280 LLHHEFF 286 (286)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI |
| >cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-39 Score=263.62 Aligned_cols=210 Identities=24% Similarity=0.428 Sum_probs=173.2
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-------------------------
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------- 60 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------- 60 (241)
.+....+.+|+++++++ +|+||+++++++...+..++||||+.+++|.+++...
T Consensus 82 ~~~~~~~~~E~~il~~l~~h~nIv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (374)
T cd05106 82 TDEREALMSELKILSHLGQHKNIVNLLGACTHGGPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDYKNIT 161 (374)
T ss_pred HHHHHHHHHHHHHHHhhccCCceeeEeeEecCCCCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccccccc
Confidence 34456788999999999 8999999999999999999999999999999998642
Q ss_pred ---------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 026253 61 ---------------------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPE 95 (241)
Q Consensus 61 ---------------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~ 95 (241)
.++++..+..++.|++.||.|||++|++||||||+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrDLkp~ 241 (374)
T cd05106 162 LEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRDVAAR 241 (374)
T ss_pred hhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEeccCchh
Confidence 23678889999999999999999999999999999
Q ss_pred CeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCCCCC
Q 026253 96 NILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGR 171 (241)
Q Consensus 96 nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~ 171 (241)
||++ ++++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|++ |..||...
T Consensus 242 Nil~---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlGvil~ellt~G~~Pf~~~ 318 (374)
T cd05106 242 NVLL---TDGRVAKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGKSPYPGI 318 (374)
T ss_pred eEEE---eCCCeEEEeeceeeeeccCCcceeeccCCCCccceeCHHHhcCCCCCccccHHHHHHHHHHHHhCCCCCCccc
Confidence 9999 6788899999999876543221 111223467999999988889999999999999999997 99999876
Q ss_pred ChHHHH-HHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 172 NNVQLV-RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 172 ~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
...... ..+..+.....+ ...+.++.+++.+||+.||.+|||+.++++
T Consensus 319 ~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dp~~RPs~~~l~~ 367 (374)
T cd05106 319 LVNSKFYKMVKRGYQMSRP----DFAPPEIYSIMKMCWNLEPTERPTFSQISQ 367 (374)
T ss_pred cccHHHHHHHHcccCccCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 554433 333332222222 356899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti |
| >cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-39 Score=251.59 Aligned_cols=210 Identities=24% Similarity=0.508 Sum_probs=178.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-----------------CCCHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------------RVPEQTARK 70 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------------~~~~~~~~~ 70 (241)
.....+.+|+.++++++|+||+++++++..++..+++|||+.+++|.+++.... .+++..+..
T Consensus 49 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 128 (283)
T cd05090 49 QQWGEFQQEASLMAELHHPNIVCLLGVVTQEQPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDHGDFLH 128 (283)
T ss_pred HHHHHHHHHHHHHhhCCCCCeeeEEEEEecCCceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCHHHHHH
Confidence 345678899999999999999999999999999999999999999999985332 367888999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCC
Q 026253 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDE 147 (241)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~ 147 (241)
++.|++.||.+||++|++|+||+|.||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.
T Consensus 129 i~~~i~~al~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 205 (283)
T cd05090 129 IAIQIAAGMEYLSSHFFVHKDLAARNILI---GEQLHVKISDLGLSREIYSADYYRVQPKSLLPIRWMPPEAIMYGKFSS 205 (283)
T ss_pred HHHHHHHHHHHHHhcCeehhccccceEEE---cCCCcEEeccccccccccCCcceecccCCCccceecChHHhccCCCCc
Confidence 99999999999999999999999999999 6778899999999876543221 22233456799999998888999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 148 KVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 148 ~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
++|+||||+++|+|++ |..||.+.+.......+......+.+ ..++..+.+++.+||+.||.+||++.+++++
T Consensus 206 ~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~ 279 (283)
T cd05090 206 DSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQLLPCS----EDCPPRMYSLMTECWQEGPSRRPRFKDIHTR 279 (283)
T ss_pred hhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 9999999999999998 99999887777777766555544333 3678999999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-38 Score=248.61 Aligned_cols=207 Identities=25% Similarity=0.476 Sum_probs=178.9
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+.+.+|++++++++|+||+++++++..++..+++||++.+++|.+++.... .+++..+..++.|++.|+.+||+.|+
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 124 (261)
T cd05068 45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGMAYLEAQNY 124 (261)
T ss_pred HHHHHHHHHHHHHCCCCCccceeEEEecCCCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4668899999999999999999999999999999999999999999997654 68999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc--ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+|+||+|+||++ +.++.++|+|||.+......... .....+..|+|||...+..++.++|+||||+++|++++ |
T Consensus 125 ~H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~t~g 201 (261)
T cd05068 125 IHRDLAARNVLV---GENNICKVADFGLARVIKEDIYEAREGAKFPIKWTAPEAALYNRFSIKSDVWSFGILLTEIVTYG 201 (261)
T ss_pred eeccCCcceEEE---cCCCCEEECCcceEEEccCCcccccCCCcCceeccCccccccCCCCchhhHHHHHHHHHHHHhcC
Confidence 999999999999 67888999999998776532211 11122357999999988889999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+.||.+.+.......+......+.+ ...+..+.+++.+|++.+|.+||+++++++
T Consensus 202 ~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rp~~~~l~~ 256 (261)
T cd05068 202 RMPYPGMTNAEVLQQVDQGYRMPCP----PGCPKELYDIMLDCWKEDPDDRPTFETLQW 256 (261)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC----CcCCHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 9999988888877777655433322 367899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a |
| >cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-39 Score=261.01 Aligned_cols=221 Identities=29% Similarity=0.472 Sum_probs=179.2
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeec-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+|+.+++.++|+||+++++++... ...++++||+ +++|.+++...+++++..+..++.|++.||.+||
T Consensus 47 ~~~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 125 (337)
T cd07858 47 DAKRTLREIKLLRHLDHENVIAIKDIMPPPHREAFNDVYIVYELM-DTDLHQIIRSSQTLSDDHCQYFLYQLLRGLKYIH 125 (337)
T ss_pred hhHHHHHHHHHHHhcCCCCccchHHheecccccccCcEEEEEeCC-CCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 355677899999999999999999987643 3589999999 4799999988888999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l 161 (241)
+.+++|+||+|.||++ +.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|+++|++
T Consensus 126 ~~~i~H~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~~l 202 (337)
T cd07858 126 SANVLHRDLKPSNLLL---NANCDLKICDFGLARTTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAEL 202 (337)
T ss_pred hCCEecCCCCHHHEEE---cCCCCEEECcCccccccCCCcccccccccccCccChHHHhcCCCCCCcccHHHHHHHHHHH
Confidence 9999999999999999 67888999999998765433 22233456788999998764 4688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCC--------------------------CCCCccCCCCChHHHHHHHHhcccCcccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHL--------------------------PFSQLIVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
++|++||.+.+.......+...... .......+.+++++.+++++||+.+|++|
T Consensus 203 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R 282 (337)
T cd07858 203 LGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARLFPHANPLAIDLLEKMLVFDPSKR 282 (337)
T ss_pred HcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHHcccCCHHHHHHHHHHhcCChhhc
Confidence 9999999876654433333211100 00011234688999999999999999999
Q ss_pred CCHHHHhcCccccccccc
Q 026253 216 LSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 216 ps~~~il~~~~~~~~~~~ 233 (241)
||++++++||||+.....
T Consensus 283 ps~~ell~h~~~~~~~~~ 300 (337)
T cd07858 283 ITVEEALAHPYLASLHDP 300 (337)
T ss_pred cCHHHHHcCcchhhhcCc
Confidence 999999999999874433
|
Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati |
| >cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.2e-39 Score=252.52 Aligned_cols=209 Identities=26% Similarity=0.441 Sum_probs=179.0
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc------------------------CCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------GRV 63 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~~~ 63 (241)
.....+.+|++++++++||||+++++.+..++..++++||+.+++|.+++... .++
T Consensus 45 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 124 (290)
T cd05045 45 SELRDLLSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNPDERAL 124 (290)
T ss_pred HHHHHHHHHHHHHhhCCCCCEeeEEEEEecCCCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCcccccc
Confidence 34567899999999999999999999999999999999999999999998642 237
Q ss_pred CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccc
Q 026253 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVL 140 (241)
Q Consensus 64 ~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~ 140 (241)
++..+..++.|++.|+.+||+.|++|+||+|.||++ ++++.++|+|||.+........ .....++..|+|||..
T Consensus 125 ~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~apE~~ 201 (290)
T cd05045 125 TMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLV---AEGRKMKISDFGLSRDVYEEDSYVKRSKGRIPVKWMAIESL 201 (290)
T ss_pred CHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEE---cCCCcEEeccccccccccCccchhcccCCCCCccccCHHHH
Confidence 788999999999999999999999999999999999 6788999999999876533221 1222345679999998
Q ss_pred cccCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHH
Q 026253 141 QFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN 219 (241)
Q Consensus 141 ~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 219 (241)
.+..++.++|+||||+++|+|++ |..||.+..+.+..+.+......+.+ ..++.++.+++..||+.+|.+||++.
T Consensus 202 ~~~~~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~cl~~~P~~Rp~~~ 277 (290)
T cd05045 202 FDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRMERP----ENCSEEMYNLMLTCWKQEPDKRPTFA 277 (290)
T ss_pred ccCCcchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCCCC----CCCCHHHHHHHHHHccCCcccCCCHH
Confidence 88889999999999999999998 99999988888877777655444333 36789999999999999999999999
Q ss_pred HHhc
Q 026253 220 EFYH 223 (241)
Q Consensus 220 ~il~ 223 (241)
++++
T Consensus 278 ~i~~ 281 (290)
T cd05045 278 DISK 281 (290)
T ss_pred HHHH
Confidence 9874
|
Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi |
| >cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.3e-39 Score=262.69 Aligned_cols=210 Identities=26% Similarity=0.430 Sum_probs=173.7
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-------------------------
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------- 61 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------- 61 (241)
...+.+.+|+++++.+ +||||+++++++..++..++||||+++|+|.+++....
T Consensus 80 ~~~~~~~~Ei~il~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (375)
T cd05104 80 TEREALMSELKVLSYLGNHINIVNLLGACTVGGPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNLLHQRE 159 (375)
T ss_pred HHHHHHHHHHHHHHHhcCCcceeeeeeeeccCCcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhhhhhhc
Confidence 3456788999999999 89999999999999999999999999999999986432
Q ss_pred --------------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 026253 62 --------------------------------------------------RVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (241)
Q Consensus 62 --------------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (241)
.+++..+..++.|++.||.+||+.|++|+|
T Consensus 160 ~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~ivH~D 239 (375)
T cd05104 160 MSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKNCIHRD 239 (375)
T ss_pred ccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCCeeccC
Confidence 367888999999999999999999999999
Q ss_pred CCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CCCC
Q 026253 92 LKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 167 (241)
Q Consensus 92 l~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p 167 (241)
|||.||++ +.+..++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+|++ |..|
T Consensus 240 lkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDi~slG~~l~ellt~g~~p 316 (375)
T cd05104 240 LAARNILL---THGRITKICDFGLARDIRNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWEIFSLGSSP 316 (375)
T ss_pred CchhhEEE---ECCCcEEEecCccceeccCcccccccCCCCCCcceeChhHhcCCCCCCCCCHHHHHHHHHHHHhcCCCC
Confidence 99999999 5678899999999876543221 111223567999999998899999999999999999998 8999
Q ss_pred CCCCChH-HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 168 FSGRNNV-QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 168 ~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|...... ...+.+..+.....+ ...+.++.+++.+||+.||++|||+.++++.
T Consensus 317 ~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPs~~eil~~ 370 (375)
T cd05104 317 YPGMPVDSKFYKMIKEGYRMLSP----ECAPSEMYDIMKSCWDADPLKRPTFKQIVQL 370 (375)
T ss_pred CCCCCchHHHHHHHHhCccCCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 9876543 444444444332222 2567899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce |
| >KOG0574 consensus STE20-like serine/threonine kinase MST [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-41 Score=253.53 Aligned_cols=221 Identities=25% Similarity=0.464 Sum_probs=191.1
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+.+..++.+|+.++++++.+++|++||.|-....+|+|||||..|++++.++.+ +++++..+..+++..+.||.|||..
T Consensus 69 ~sDLQEIIKEISIMQQC~S~yVVKYYGSYFK~sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL~YLH~~ 148 (502)
T KOG0574|consen 69 DTDLQEIIKEISIMQQCKSKYVVKYYGSYFKHSDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGLQYLHDL 148 (502)
T ss_pred cchHHHHHHHHHHHHHcCCchhhhhhhhhccCCceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHHHHHHHH
Confidence 455778999999999999999999999999999999999999999999999754 6799999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
.-+|||||..|||+ +.++..||.|||.|...-.- ...+...||+.|+|||++..-.|..++|+||||++..+|..|
T Consensus 149 ~KIHRDIKAGNILL---NT~G~AKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVI~EIGY~~~ADIWSLGITaIEMAEG 225 (502)
T KOG0574|consen 149 KKIHRDIKAGNILL---NTDGIAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIEEIGYDTKADIWSLGITAIEMAEG 225 (502)
T ss_pred HHHHhhcccccEEE---cccchhhhhhccccchhhhhHHhhCccccCcccccHHHHHHhccchhhhHhhhcchhhhhhcC
Confidence 99999999999999 89999999999999765432 234567899999999999988999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
++||....+..-+-.|-....+.+.. +...|.++.||+++||-++|++|-|+-++++|||.++.+.
T Consensus 226 ~PPYsDIHPMRAIFMIPT~PPPTF~K--PE~WS~~F~DFi~~CLiK~PE~R~TA~~L~~H~FiknA~g 291 (502)
T KOG0574|consen 226 RPPYSDIHPMRAIFMIPTKPPPTFKK--PEEWSSEFNDFIRSCLIKKPEERKTALRLCEHTFIKNAPG 291 (502)
T ss_pred CCCcccccccceeEeccCCCCCCCCC--hHhhhhHHHHHHHHHhcCCHHHHHHHHHHhhhhhhcCCCc
Confidence 99999877755444442222222221 2246788999999999999999999999999999998654
|
|
| >cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-39 Score=254.23 Aligned_cols=211 Identities=27% Similarity=0.462 Sum_probs=180.9
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTAR 69 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~ 69 (241)
+.....+.+|+++++++ +|+||+++++++..++..+++|||+.+++|.++++.. ..+++..+.
T Consensus 56 ~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 135 (293)
T cd05053 56 EKDLSDLVSEMEMMKMIGKHKNIINLLGVCTQEGPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQKDLV 135 (293)
T ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeEEEEEcCCCCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHHHHH
Confidence 34556788999999999 8999999999999999999999999999999999642 358899999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCC
Q 026253 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (241)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~ 146 (241)
.++.|++.|+++||+.|++|+||+|.||++ ++++.++|+|||.+........ .....++..|+|||...+..++
T Consensus 136 ~i~~qi~~al~~LH~~~ivH~dlkp~Nil~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 212 (293)
T cd05053 136 SFAYQVARGMEFLASKKCIHRDLAARNVLV---TEDHVMKIADFGLARDIHHIDYYRKTTNGRLPVKWMAPEALFDRVYT 212 (293)
T ss_pred HHHHHHHHHHHHHHHCCccccccceeeEEE---cCCCeEEeCccccccccccccceeccCCCCCCccccCHHHhccCCcC
Confidence 999999999999999999999999999999 6788999999999876543221 1122234679999999888899
Q ss_pred CchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 147 EKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 147 ~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.++|+||||+++|++++ |..||.+....+..+.+........+ ...+..+.+++.+||..||.+|||+.+++++
T Consensus 213 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~eil~~ 287 (293)
T cd05053 213 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYRMEKP----QNCTQELYHLMRDCWHEVPSQRPTFKQLVED 287 (293)
T ss_pred cccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence 99999999999999997 99999988888888777665544333 3678899999999999999999999999865
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, |
| >cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9e-39 Score=250.87 Aligned_cols=209 Identities=24% Similarity=0.416 Sum_probs=180.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGA 77 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~ 77 (241)
.....+.+|+++++.++|+||+++++++..++..++||||+++++|.+++.... .+++..+..++.|++.
T Consensus 51 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~ 130 (277)
T cd05032 51 RERIEFLNEASVMKEFNCHHVVRLLGVVSTGQPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMAAEIAD 130 (277)
T ss_pred HHHHHHHHHHHHHHhCCCCceeEEEEEEcCCCCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHHHHHHH
Confidence 445678899999999999999999999999999999999999999999996532 3677889999999999
Q ss_pred HHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHH
Q 026253 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSV 154 (241)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl 154 (241)
|+.+||+.|++|+||+|.||++ +.++.++|+|||.++....... .....++..|.|||.+.+..++.++|+|||
T Consensus 131 ~l~~lH~~~i~H~di~p~nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~sl 207 (277)
T cd05032 131 GMAYLAAKKFVHRDLAARNCMV---AEDLTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTKSDVWSF 207 (277)
T ss_pred HHHHHHhCCccccccChheEEE---cCCCCEEECCcccchhhccCcccccCCCCCccccccCHHHHhcCCCCcccchHHH
Confidence 9999999999999999999999 7888999999999876543321 122335678999999988889999999999
Q ss_pred HHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 155 GAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 155 G~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|+++|++++ |..||.+.+..+..+.+........+. ..+..+.+++.+||+.+|++|||+.++++
T Consensus 208 G~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 273 (277)
T cd05032 208 GVVLWEMATLAEQPYQGLSNEEVLKFVIDGGHLDLPE----NCPDKLLELMRMCWQYNPKMRPTFLEIVS 273 (277)
T ss_pred HHHHHHhhccCCCCCccCCHHHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999998 999999888888888886554444443 56899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological |
| >cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=250.88 Aligned_cols=214 Identities=24% Similarity=0.389 Sum_probs=180.9
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------CCCHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------RVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------~~~~~~~~~~~~~i~~~l 79 (241)
...+.+|+.+++.++|+||+++++++.+.+..++||||+.+++|.+++...+ ..+...+..++.|++.||
T Consensus 53 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l 132 (288)
T cd05061 53 RIEFLNEASVMKGFTCHHVVRLLGVVSKGQPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAAEIADGM 132 (288)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHHHHHHHH
Confidence 4467889999999999999999999999999999999999999999997532 245678899999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~ 156 (241)
.+||+.|++|+||+|+||++ +.++.++|+|||.++....... .....++..|+|||.+.+..++.++|+||+|+
T Consensus 133 ~~lH~~~i~H~dikp~nili---~~~~~~~L~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~DvwslG~ 209 (288)
T cd05061 133 AYLNAKKFVHRDLAARNCMV---AHDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMAPESLKDGVFTTSSDMWSFGV 209 (288)
T ss_pred HHHHhCCCcCCCCChheEEE---cCCCcEEECcCCccccccccccccccCCCcccccccCHHHhccCCCChHhHHHHHHH
Confidence 99999999999999999999 6788899999999875432211 11223456799999998888999999999999
Q ss_pred HHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc------Cccccc
Q 026253 157 ILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH------HRFLRR 229 (241)
Q Consensus 157 ~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~------~~~~~~ 229 (241)
++|++++ |..||.+.+..+..+.+..+.....+. ..++.+.+++.+||+.+|.+|||+.++++ ||||+.
T Consensus 210 ~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~ 285 (288)
T cd05061 210 VLWEITSLAEQPYQGLSNEQVLKFVMDGGYLDQPD----NCPERVTDLMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE 285 (288)
T ss_pred HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence 9999998 788999888877777765554443333 56889999999999999999999999987 898876
Q ss_pred c
Q 026253 230 N 230 (241)
Q Consensus 230 ~ 230 (241)
.
T Consensus 286 ~ 286 (288)
T cd05061 286 V 286 (288)
T ss_pred C
Confidence 3
|
Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta |
| >cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=246.75 Aligned_cols=206 Identities=23% Similarity=0.462 Sum_probs=180.1
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|+.++++++|+||+++++++.+++..++|||++++++|.+++.... .+++..+..++.|++.|+.+||+.|
T Consensus 43 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lh~~~ 122 (256)
T cd05039 43 AAQAFLAEASVMTTLRHPNLVQLLGVVLQGNPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGMEYLEEKN 122 (256)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEEcCCCCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 46788999999999999999999999998999999999999999999998765 6899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~ 165 (241)
++|+||+|.||++ +.++.++|+|||.+........ ....+..|.|||.+.+..++.++|+||+|++++++++ |.
T Consensus 123 i~H~di~p~Nili---~~~~~~~l~d~g~~~~~~~~~~--~~~~~~~~~ape~~~~~~~~~~~Di~slG~il~~l~~~g~ 197 (256)
T cd05039 123 FVHRDLAARNVLV---SEDLVAKVSDFGLAKEASQGQD--SGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGR 197 (256)
T ss_pred ccchhcccceEEE---eCCCCEEEcccccccccccccc--cCCCcccccCchhhcCCcCCcHHHHHHHHHHHHHHHhcCC
Confidence 9999999999999 6788899999999877633222 2334567999999988889999999999999999997 99
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
.||...+..+....+........+ ..+++.+.+++++||..+|++|||++++++
T Consensus 198 ~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 251 (256)
T cd05039 198 VPYPRIPLKDVVPHVEKGYRMEAP----EGCPPEVYKVMKDCWELDPAKRPTFKQLRE 251 (256)
T ss_pred CCCCCCCHHHHHHHHhcCCCCCCc----cCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999988887777777554433222 367899999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk |
| >PHA03210 serine/threonine kinase US3; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-39 Score=270.82 Aligned_cols=219 Identities=23% Similarity=0.321 Sum_probs=170.7
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+|++++++++|+||+++++++...+..+++++++ +++|.+++... .......+..++.|++.||.|||
T Consensus 206 ~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~aL~yLH 284 (501)
T PHA03210 206 AAIQLENEILALGRLNHENILKIEEILRSEANTYMITQKY-DFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCAVEYIH 284 (501)
T ss_pred HHHHHHHHHHHHHhCCCCCcCcEeEEEEECCeeEEEEecc-ccCHHHHHhhccccccccccHHHHHHHHHHHHHHHHHHH
Confidence 4567889999999999999999999999999999999999 56787776532 12345677889999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
++|++||||||+||++ +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+|||||++|+|
T Consensus 285 ~~gIiHrDLKP~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvil~el 361 (501)
T PHA03210 285 DKKLIHRDIKLENIFL---NCDGKIVLGDFGTAMPFEKEREAFDYGWVGTVATNSPEILAGDGYCEITDIWSCGLILLDM 361 (501)
T ss_pred hCCeecCCCCHHHEEE---CCCCCEEEEeCCCceecCcccccccccccCCcCCCCchhhcCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999999 778899999999997764432 22235689999999999998999999999999999999
Q ss_pred HhCCC-CCCCC--ChHHHHHHhhcCCC---CCCCC-----------------------c-cCCCCChHHHHHHHHhcccC
Q 026253 162 LNGYP-PFSGR--NNVQLVRNINSCKH---LPFSQ-----------------------L-IVPALHPDCVDMCLKLLSAN 211 (241)
Q Consensus 162 ~~g~~-p~~~~--~~~~~~~~i~~~~~---~~~~~-----------------------~-~~~~~~~~~~~li~~~l~~~ 211 (241)
++|.. |+... .....+..+..... ..++. . ....++.++.++|.+||+.|
T Consensus 362 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~li~kmL~~D 441 (501)
T PHA03210 362 LSHDFCPIGDGGGKPGKQLLKIIDSLSVCDEEFPDPPCKLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYPLVKMLTFD 441 (501)
T ss_pred HHCCCCCccCCCCCHHHHHHHHHHhcccChhhcCCcHHHHHHHhhhhhcccCccchhhHHHhcCCChHHHHHHHHHhccC
Confidence 99765 44322 22222222111110 00000 0 01135667888999999999
Q ss_pred ccccCCHHHHhcCccccccc
Q 026253 212 TVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 212 p~~Rps~~~il~~~~~~~~~ 231 (241)
|.+|||+.|+|.||||....
T Consensus 442 P~~Rpsa~elL~hp~f~~~~ 461 (501)
T PHA03210 442 WHLRPGAAELLALPLFSAEE 461 (501)
T ss_pred cccCcCHHHHhhChhhhcCC
Confidence 99999999999999998743
|
|
| >cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-38 Score=252.45 Aligned_cols=214 Identities=30% Similarity=0.480 Sum_probs=180.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.....+.+|+++++.++|+|++++++++.+++..++||||+. +++.+++.. ..++++..+..++.|++.++.+||+.|
T Consensus 63 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~LH~~g 141 (313)
T cd06633 63 EKWQDIIKEVKFLQQLKHPNTIEYKGCYLKEHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 141 (313)
T ss_pred HHHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEEecCC-CCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345678899999999999999999999999999999999995 578777765 456899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc---ccCCCCchhHHHHHHHHHHHHh
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
++|+||+|.||++ +.++.++|+|||.+..... .....++..|+|||.+. +..++.++|+||+|+++|++++
T Consensus 142 i~H~dl~p~nili---~~~~~~kL~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvil~el~~ 215 (313)
T cd06633 142 MIHRDIKAGNILL---TEPGQVKLADFGSASKSSP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 215 (313)
T ss_pred eecCCCChhhEEE---CCCCCEEEeecCCCcccCC---CCCccccccccChhhccccCCCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999 6788899999998864332 23446788899999974 3567889999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|..||...+.......+...... ....+.++..+.+++.+||+.+|.+||++.+++.||||+...
T Consensus 216 g~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~~P~~Rp~~~~~l~~~~~~~~~ 280 (313)
T cd06633 216 RKPPLFNMNAMSALYHIAQNDSP---TLQSNEWTDSFRGFVDYCLQKIPQERPASAELLRHDFVRRDR 280 (313)
T ss_pred CCCCCCCCChHHHHHHHHhcCCC---CCCccccCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCc
Confidence 99999887766666555443322 222346778899999999999999999999999999998743
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co |
| >cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=250.48 Aligned_cols=209 Identities=24% Similarity=0.502 Sum_probs=180.1
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKFL 72 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~~ 72 (241)
..+.+.+|+.++++++|+||+++++++.+.+..++++||+.+++|.+++... ..+++..+..++
T Consensus 51 ~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 130 (283)
T cd05091 51 LREEFKHEAMMRSRLQHPNIVCLLGVVTKEQPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPADFVHIV 130 (283)
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEcCCCceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHHHHHHHH
Confidence 4567889999999999999999999999999999999999999999998532 247888899999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCch
Q 026253 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV 149 (241)
Q Consensus 73 ~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~ 149 (241)
.|++.||.+||+.|++|+||||.||++ ++++.++|+|||++........ .....++..|+|||.+.+..++.++
T Consensus 131 ~ql~~aL~~lH~~gi~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 207 (283)
T cd05091 131 TQIAAGMEFLSSHHVVHKDLATRNVLV---FDKLNVKISDLGLFREVYAADYYKLMGNSLLPIRWMSPEAIMYGKFSIDS 207 (283)
T ss_pred HHHHHHHHHHHHcCccccccchhheEe---cCCCceEecccccccccccchheeeccCccCCccccCHHHHhcCCCCcch
Confidence 999999999999999999999999999 6778899999999876543221 1223346789999999888899999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 150 DMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 150 Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|+||+|+++|+|++ |..||.+.+..+....+......+.+ .+++.++.+++.+||+.+|.+||++++++..
T Consensus 208 Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~RP~~~~i~~~ 279 (283)
T cd05091 208 DIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPCP----DDCPAWVYTLMLECWNEFPSRRPRFKDIHSR 279 (283)
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence 99999999999998 88899988888888888766654443 3789999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly |
| >cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=247.59 Aligned_cols=208 Identities=25% Similarity=0.466 Sum_probs=180.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+|+++++.++|+||+++++++.+.+..++||||+++++|.+++.+. ..+++..+..++.|++.|+.+||+.|
T Consensus 45 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al~~lH~~~ 124 (261)
T cd05148 45 KQQDFQKEVQALKRLRHKHLISLFAVCSVGEPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGMAYLEEQN 124 (261)
T ss_pred hHHHHHHHHHHHhcCCCcchhheeeeEecCCCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567899999999999999999999999999999999999999999999753 45899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
++|+||+|.||++ ++++.++|+|||.+........ .....++..|++||...+..++.++|+||||++++++++ |
T Consensus 125 i~h~dl~~~nilv---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~DiwslG~~l~~l~~~g 201 (261)
T cd05148 125 SIHRDLAARNILV---GEDLVCKVADFGLARLIKEDVYLSSDKKIPYKWTAPEAASHGTFSTKSDVWSFGILLYEMFTYG 201 (261)
T ss_pred eeccccCcceEEE---cCCceEEEccccchhhcCCccccccCCCCceEecCHHHHccCCCCchhhHHHHHHHHHHHHcCC
Confidence 9999999999999 7888999999999876543321 112234567999999988889999999999999999998 8
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
..||...+..+.+..+......+.+ ...++.+.+++.+||+.||.+|||+.++++
T Consensus 202 ~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rpt~~~l~~ 256 (261)
T cd05148 202 QVPYPGMNNHEVYDQITAGYRMPCP----AKCPQEIYKIMLECWAAEPEDRPSFKALRE 256 (261)
T ss_pred CCCCCcCCHHHHHHHHHhCCcCCCC----CCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 9999988888888777655444333 377899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom |
| >cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=253.37 Aligned_cols=210 Identities=26% Similarity=0.437 Sum_probs=179.0
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (241)
......+.+|+++++++ +|+||+++++++..++..+++|||+.+++|.+++.... .++...+.
T Consensus 58 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 137 (314)
T cd05099 58 DKDLADLISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFKDLV 137 (314)
T ss_pred hHHHHHHHHHHHHHHhccCCCCeeeEEEEEccCCceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHHHHH
Confidence 34456788999999999 69999999999999899999999999999999997632 37888999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCC
Q 026253 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (241)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~ 146 (241)
.++.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.++....... .....++..|+|||.+.+..++
T Consensus 138 ~~~~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 214 (314)
T cd05099 138 SCAYQVARGMEYLESRRCIHRDLAARNVLV---TEDNVMKIADFGLARGVHDIDYYKKTSNGRLPVKWMAPEALFDRVYT 214 (314)
T ss_pred HHHHHHHHHHHHHHHCCeeeccccceeEEE---cCCCcEEEccccccccccccccccccccCCCCccccCHHHHccCCcC
Confidence 999999999999999999999999999999 6788899999999976543211 1122234579999999888899
Q ss_pred CchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 147 EKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 147 ~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
.++|+||||+++|++++ |..||.+.+..+.+..+..+.....+ ..++.++.+++.+||+.+|++|||+.++++
T Consensus 215 ~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~~ll~ 288 (314)
T cd05099 215 HQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHRMDKP----SNCTHELYMLMRECWHAVPTQRPTFKQLVE 288 (314)
T ss_pred ccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999999999998 89999988888888877665443333 367889999999999999999999999885
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=251.47 Aligned_cols=213 Identities=27% Similarity=0.516 Sum_probs=173.6
Q ss_pred hhhHHHHHHHHhcC-CCcCeeeeeeEEe-----ecCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 10 ~~~~~~E~~~l~~l-~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l 79 (241)
...+.+|+.+++.+ +|+||+++++++. .++..++||||+++++|.+++.. ...+++..+..++.|++.|+
T Consensus 58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l 137 (286)
T cd06638 58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDVKNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEALMGL 137 (286)
T ss_pred HHHHHHHHHHHHHHhcCCCeeeeeeeeeecccCCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHHHHH
Confidence 46788999999999 7999999999873 34678999999999999998753 24588999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccc-----cCCCCchhHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWS 153 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~s 153 (241)
.+||+.+++|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.. ..++.++|+||
T Consensus 138 ~~lH~~~i~H~dlkp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~s 214 (286)
T cd06638 138 QHLHVNKTIHRDVKGNNILL---TTEGGVKLVDFGVSAQLTSTRLRRNTSVGTPFWMAPEVIACEQQLDSTYDARCDVWS 214 (286)
T ss_pred HHHHhCCccccCCCHHhEEE---CCCCCEEEccCCceeecccCCCccccccCCCcccChhhhchhhhccccccchhhhhh
Confidence 99999999999999999999 677889999999987654322 2223457888999998753 44788999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 154 VGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+|+++|++++|+.||...........+....... .......+..+.+++.+||+.||.+|||+.++++|+||
T Consensus 215 lGvi~~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ell~~~~~ 286 (286)
T cd06638 215 LGITAIELGDGDPPLADLHPMRALFKIPRNPPPT--LHQPELWSNEFNDFIRKCLTKDYEKRPTVSDLLQHVFI 286 (286)
T ss_pred HHHHHHHHhcCCCCCCCCchhHHHhhccccCCCc--ccCCCCcCHHHHHHHHHHccCCcccCCCHHHHhhcccC
Confidence 9999999999999998776655444432222111 11122467889999999999999999999999999997
|
Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear |
| >cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-38 Score=247.36 Aligned_cols=208 Identities=25% Similarity=0.491 Sum_probs=179.1
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|+.+++.++|+||+++++.+.+++..+++||++.+++|.+++.+. ..++...+..++.+++.|+++||+.+
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l~~LH~~~ 123 (261)
T cd05072 44 SVQAFLEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGMAYIERKN 123 (261)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEcCCCCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3567889999999999999999999999999999999999999999999753 45888999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
++|+||+|.||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||+|+++|++++
T Consensus 124 i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~t~ 200 (261)
T cd05072 124 YIHRDLRAANVLV---SESLMCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLYEIVTY 200 (261)
T ss_pred eeccccchhhEEe---cCCCcEEECCCccceecCCCceeccCCCccceecCCHHHhccCCCChhhhhhhhHHHHHHHHcc
Confidence 9999999999999 7788999999999976543221 112234567999999988889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||...+.......+......+.. ..++.++.+++.+||+.+|++|||++++++
T Consensus 201 g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 256 (261)
T cd05072 201 GKIPYPGMSNSDVMSALQRGYRMPRM----ENCPDELYDIMKTCWKEKAEERPTFDYLQS 256 (261)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 99999988888777777655443322 367899999999999999999999999863
|
Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa |
| >cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-39 Score=249.77 Aligned_cols=211 Identities=29% Similarity=0.510 Sum_probs=180.1
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+..|+.++++++||||+++++++.+.+..++||||+.+++|.+++.. ...+++..+..++.|++.|+.+||+
T Consensus 45 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~ 124 (260)
T cd08222 45 ETVQANQEAQLLSKLDHPAIVKFHASFLERDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQ 124 (260)
T ss_pred hHHHHHHHHHHHHhCCCCcHHHHHHHHhcCCceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHHHHHHHH
Confidence 344677899999999999999999999999999999999999999998864 3468999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
.|++|+|++|+||+++ ++.++|+|||.+....... ......++..|.|||...+..++.++|+||+|+++|++++
T Consensus 125 ~~i~h~~l~~~nili~----~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv~slG~~~~~l~~ 200 (260)
T cd08222 125 RRILHRDLKAKNIFLK----NNLLKIGDFGVSRLLMGSCDLATTFTGTPYYMSPEALKHQGYDSKSDIWSLGCILYEMCC 200 (260)
T ss_pred cCccccCCChhheEee----cCCEeecccCceeecCCCcccccCCCCCcCccCHHHHccCCCCchhhHHHHHHHHHHHHh
Confidence 9999999999999993 3469999999987654332 2334457788999999988888999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
|..||...+.......+..+..... ...++.++.+++.+||..+|.+||++.++++||||
T Consensus 201 ~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~il~~~~~ 260 (260)
T cd08222 201 LAHAFEGQNFLSVVLRIVEGPTPSL----PETYSRQLNSIMQSMLNKDPSLRPSAAEILRNPFI 260 (260)
T ss_pred CCCCCCCccHHHHHHHHHcCCCCCC----cchhcHHHHHHHHHHhcCChhhCcCHHHHhhCCCC
Confidence 9999987776666666544433332 23678899999999999999999999999999997
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check |
| >cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-38 Score=248.70 Aligned_cols=204 Identities=30% Similarity=0.512 Sum_probs=171.4
Q ss_pred HHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCe
Q 026253 18 NFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENI 97 (241)
Q Consensus 18 ~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~ni 97 (241)
+.++...|++|+++.+++.+.+..++||||+.|++|.+++...+.+++..+..++.|++.|+.+||+.+++|+||+|.||
T Consensus 49 ~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~g~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~di~p~ni 128 (278)
T cd05606 49 SLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANI 128 (278)
T ss_pred HHHHhCCCCcEeeeeeeeecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCEEcCCCCHHHE
Confidence 34445589999999999999999999999999999999998888899999999999999999999999999999999999
Q ss_pred EEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCCCCCC---h
Q 026253 98 LLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGRN---N 173 (241)
Q Consensus 98 l~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~---~ 173 (241)
++ +.++.++|+|||.+...... ......++..|+|||.+.+. .++.++|+||+|+++|++++|..||.... .
T Consensus 129 li---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~p~~~~~~~~~ 204 (278)
T cd05606 129 LL---DEHGHVRISDLGLACDFSKK-KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204 (278)
T ss_pred EE---CCCCCEEEccCcCccccCcc-CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCCCCCCCCccch
Confidence 99 67888999999998755332 22344688999999998744 68899999999999999999999998653 2
Q ss_pred HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCcccccc
Q 026253 174 VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 230 (241)
Q Consensus 174 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~ 230 (241)
......+ ...... ....++.++.+++++||..+|.+|| ++.++++||||+..
T Consensus 205 ~~~~~~~-~~~~~~----~~~~~s~~~~~li~~~l~~~p~~R~~~~~~~~~~ll~~~~~~~~ 261 (278)
T cd05606 205 HEIDRMT-LTMAVE----LPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKEHPFFRSL 261 (278)
T ss_pred HHHHHHh-hccCCC----CCCcCCHHHHHHHHHHhhcCHHhccCCCCCCHHHHHhCccccCC
Confidence 2222222 222222 2335789999999999999999999 99999999999874
|
Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co |
| >cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-39 Score=258.09 Aligned_cols=226 Identities=29% Similarity=0.514 Sum_probs=178.3
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeec-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+|+.++++++|+||+++++++... ...++++|++. ++|.+++. ...+++..+..++.|++.||.+||
T Consensus 46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~-~~~l~~~~~~~i~~ql~~aL~~LH 123 (336)
T cd07849 46 FCQRTLREIKILRRFKHENIIGILDIIRPPSFESFNDVYIVQELME-TDLYKLIK-TQHLSNDHIQYFLYQILRGLKYIH 123 (336)
T ss_pred hHHHHHHHHHHHHhCCCCCcCchhheeecccccccceEEEEehhcc-cCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 345678899999999999999999987543 35899999995 58888775 457999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccc-cCCCCchhHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l 158 (241)
+.|++|+||+|+||++ +.++.++|+|||++........ .....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 124 ~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil 200 (336)
T cd07849 124 SANVLHRDLKPSNLLL---NTNCDLKICDFGLARIADPEHDHTGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCIL 200 (336)
T ss_pred hCCeeccCCCHHHEEE---CCCCCEEECcccceeeccccccccCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHH
Confidence 9999999999999999 7888999999999876543221 123456888999998654 4688999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCCCCC---------------------CC-----CccCCCCChHHHHHHHHhcccCc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCKHLP---------------------FS-----QLIVPALHPDCVDMCLKLLSANT 212 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~~---------------------~~-----~~~~~~~~~~~~~li~~~l~~~p 212 (241)
|+|++|+.||.+.+.......+......+ .. ....+..+.++.+++.+||+.+|
T Consensus 201 ~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP 280 (336)
T cd07849 201 AEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLFPNADPKALDLLDKMLTFNP 280 (336)
T ss_pred HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHhcccCcHHHHHHHHHcCCCh
Confidence 99999999998765544333221111100 00 01124568889999999999999
Q ss_pred cccCCHHHHhcCcccccccccCCCCCC
Q 026253 213 VDRLSFNEFYHHRFLRRNSAILRAPFH 239 (241)
Q Consensus 213 ~~Rps~~~il~~~~~~~~~~~~~~~~~ 239 (241)
++|||+.++++||||+........|..
T Consensus 281 ~~Rpt~~e~l~hp~~~~~~~~~~~~~~ 307 (336)
T cd07849 281 HKRITVEEALAHPYLEQYHDPSDEPVA 307 (336)
T ss_pred hhCcCHHHHhcCccccccCCCCCcccC
Confidence 999999999999999987665444443
|
Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase |
| >cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-38 Score=251.26 Aligned_cols=214 Identities=32% Similarity=0.526 Sum_probs=176.0
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.+.+.+|++++++++|+||+++++++.+++..++||||+. ++|.+++...+ .+++..+..++.|++.||.+||+.|
T Consensus 42 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (284)
T cd07836 42 PSTAIREISLMKELKHENIVRLHDVIHTENKLMLVFEYMD-KDLKKYMDTHGVRGALDPNTVKSFTYQLLKGIAFCHENR 120 (284)
T ss_pred hHHHHHHHHHHHhhcCCCEeeeeeeEeeCCcEEEEEecCC-ccHHHHHHhcCCCCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4567789999999999999999999999999999999997 58988886543 5899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g 164 (241)
++|+||+|.||++ ++++.++|+|||.+....... ......++..|++||.+.+. .++.++|+||+|+++|++++|
T Consensus 121 i~h~dl~p~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~~l~~g 197 (284)
T cd07836 121 VLHRDLKPQNLLI---NKRGELKLADFGLARAFGIPVNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITG 197 (284)
T ss_pred eeeCCCCHHHEEE---CCCCcEEEeecchhhhhcCCccccccccccccccChHHhcCCCCCCcHHHHHHHHHHHHHHHhC
Confidence 9999999999999 678889999999986543321 12234457789999987654 468899999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCC------------------------CccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFS------------------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
..||.+.+..+....+......+.. ....+..+..+.+++.+||+.||.+||++++
T Consensus 198 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~p~~R~~~~~ 277 (284)
T cd07836 198 RPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYKPTFPRYPPQDLQQLFPHADPLGIDLLHRLLQLNPELRISAHD 277 (284)
T ss_pred CCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhcccccCCChHHHHHHhhhcCcHHHHHHHHHhcCCcccCCCHHH
Confidence 9999987776655544322111100 0112356788999999999999999999999
Q ss_pred HhcCccc
Q 026253 221 FYHHRFL 227 (241)
Q Consensus 221 il~~~~~ 227 (241)
+++||||
T Consensus 278 ~l~~~~f 284 (284)
T cd07836 278 ALQHPWF 284 (284)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. |
| >cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2e-38 Score=252.61 Aligned_cols=211 Identities=27% Similarity=0.448 Sum_probs=179.3
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (241)
......+.+|+.+++.+ +|+||+++++++..++..++||||+.+++|.+++...+ .++...+.
T Consensus 64 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 143 (307)
T cd05098 64 EKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSFKDLV 143 (307)
T ss_pred hHHHHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHH
Confidence 34456788999999999 79999999999999999999999999999999997642 37888999
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCC
Q 026253 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (241)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~ 146 (241)
.++.|++.||++||+.|++|+||+|+||++ +.++.++|+|||.+........ ......+..|+|||.+.+..++
T Consensus 144 ~~~~qi~~aL~~lH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 220 (307)
T cd05098 144 SCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYT 220 (307)
T ss_pred HHHHHHHHHHHHHHHCCcccccccHHheEE---cCCCcEEECCCcccccccccchhhccccCCCccceeChHHhccCCCC
Confidence 999999999999999999999999999999 6778999999999876543211 1122234679999999888899
Q ss_pred CchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 147 EKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 147 ~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.++|+||+|+++|+|++ |..||.+.+..+....+........+ ...+.++.+++.+||..+|.+|||+.+++++
T Consensus 221 ~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~evl~~ 295 (307)
T cd05098 221 HQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRPTFKQLVED 295 (307)
T ss_pred cHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCCCCCCC----CcCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 99999999999999998 88999888877777777655443333 3678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-38 Score=248.43 Aligned_cols=212 Identities=26% Similarity=0.448 Sum_probs=177.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee------cCeEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQ 73 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~ 73 (241)
++...+.+.+|+++++.++|+||+++++++.. ....+++|||+.+++|.+++... ..+++..+..++.
T Consensus 40 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~ 119 (272)
T cd05075 40 TRSEMEDFLSEAVCMKEFDHPNVMRLIGVCLQTVESEGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMT 119 (272)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCcceEEEEEccCCcccCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHH
Confidence 34557788999999999999999999997643 23578999999999999987422 2478999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchh
Q 026253 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVD 150 (241)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~D 150 (241)
|++.||.+||+.|++|+||||+||++ +.++.++|+|||.+........ ......+..|++||...+..++.++|
T Consensus 120 ~i~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~D 196 (272)
T cd05075 120 DIASGMEYLSSKSFIHRDLAARNCML---NENMNVCVADFGLSKKIYNGDYYRQGRIAKMPVKWIAIESLADRVYTTKSD 196 (272)
T ss_pred HHHHHHHHHHHCCeeccccchhheEE---cCCCCEEECCCCcccccCcccceecCCcccCCcccCCHHHccCCCcChHHH
Confidence 99999999999999999999999999 7788999999999876543221 12223456799999999888999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 151 MWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 151 v~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+||+|+++|++++ |..||.+....+....+..+.....+ +.++..+.+++.+||+.||.+|||++++++.
T Consensus 197 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~l~~~ 267 (272)
T cd05075 197 VWSFGVTMWEIATRGQTPYPGVENSEIYDYLRQGNRLKQP----PDCLDGLYSLMSSCWLLNPKDRPSFETLRCE 267 (272)
T ss_pred HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999999 89999988888888877665544333 3678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor |
| >cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.8e-39 Score=251.41 Aligned_cols=213 Identities=37% Similarity=0.665 Sum_probs=185.9
Q ss_pred HHhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|++++++++ |+||+++++.+..++..++|||++++++|.+++.+.+.+++..+..++.|++.|+.+||+.
T Consensus 42 ~~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~i~~ql~~~l~~Lh~~ 121 (280)
T cd05581 42 EKKVKYVKIEKEVLTRLNGHPGIIKLYYTFQDEENLYFVLEYAPNGELLQYIRKYGSLDEKCTRFYAAEILLALEYLHSK 121 (280)
T ss_pred hHHHHHHHHHHHHHHhcccCCCchhHHHHhcCCceEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344678899999999998 9999999999999999999999999999999999888899999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---------------------cccccCCCCccCcccccccC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---------------------AEKVCGSPLYMAPEVLQFQR 144 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---------------------~~~~~~~~~~~~PE~~~~~~ 144 (241)
|++|+|++|+||++ +.++.++++|||.+........ .....++..|.|||...+..
T Consensus 122 ~~~H~dl~~~ni~i---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~ 198 (280)
T cd05581 122 GIIHRDLKPENILL---DKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP 198 (280)
T ss_pred CeeecCCCHHHeEE---CCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCCCC
Confidence 99999999999999 6788999999999876543221 11234577899999998888
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH----HH
Q 026253 145 YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF----NE 220 (241)
Q Consensus 145 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~ 220 (241)
++.++|+||+|++++++++|..||...+....++.+.... ...+ ..+++.+.+++.+||+.+|++|||+ ++
T Consensus 199 ~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ 273 (280)
T cd05581 199 AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLE-YSFP----PNFPPDAKDLIEKLLVLDPQDRLGVNEGYDE 273 (280)
T ss_pred CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcC-CCCC----CccCHHHHHHHHHHhcCCHhhCCCcccCHHH
Confidence 9999999999999999999999999888777666664322 2222 3678999999999999999999999 99
Q ss_pred HhcCccc
Q 026253 221 FYHHRFL 227 (241)
Q Consensus 221 il~~~~~ 227 (241)
+++||||
T Consensus 274 ll~~~~~ 280 (280)
T cd05581 274 LKAHPFF 280 (280)
T ss_pred HhcCCCC
Confidence 9999998
|
Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto |
| >cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=245.27 Aligned_cols=209 Identities=27% Similarity=0.425 Sum_probs=179.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+.+|++++++++|+||+++++.+.. ...+++||++++++|.+++.... .+++..+..++.|++.||.+||++
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~ 116 (257)
T cd05040 38 DIMDDFLKEAAIMHSLDHENLIRLYGVVLT-HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMRYLESK 116 (257)
T ss_pred HHHHHHHHHHHHHhhcCCCCccceeEEEcC-CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHHHHHhC
Confidence 556789999999999999999999999888 88999999999999999998764 689999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC----ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus 117 ~i~H~di~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Di~slG~~l~el 193 (257)
T cd05040 117 RFIHRDLAARNILL---ASDDKVKIGDFGLMRALPQNEDHYVMEEHLKVPFAWCAPESLRTRTFSHASDVWMFGVTLWEM 193 (257)
T ss_pred CccccccCcccEEE---ecCCEEEeccccccccccccccceecccCCCCCceecCHHHhcccCcCchhhhHHHHHHHHHH
Confidence 99999999999999 677899999999987664321 11223456789999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++ |..||...+..+..+.+....... ......+..+.+++.+||+.+|++|||+.++++
T Consensus 194 ~t~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 253 (257)
T cd05040 194 FTYGEEPWAGLSGSQILKKIDKEGERL---ERPEACPQDIYNVMLQCWAHNPADRPTFAALRE 253 (257)
T ss_pred HhCCCCCCCCCCHHHHHHHHHhcCCcC---CCCccCCHHHHHHHHHHCCCCcccCCCHHHHHH
Confidence 98 999999888887777665422111 122367889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and |
| >cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.9e-38 Score=246.82 Aligned_cols=210 Identities=23% Similarity=0.448 Sum_probs=180.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+...+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++.+. +.++...+..++.|++.|+.+||+.
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 125 (267)
T cd05066 46 EKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSKPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKYLSDM 125 (267)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 445678999999999999999999999999999999999999999999999765 4689999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc----ccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|++|+||+|.||++ +.++.++++|||.+......... .....+..|++||.+.+..++.++|+||+|+++|++
T Consensus 126 ~i~h~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el 202 (267)
T cd05066 126 GYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTRGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWEV 202 (267)
T ss_pred CEeehhhchhcEEE---CCCCeEEeCCCCcccccccccceeeecCCCccceeecCHhHhccCccCchhhhHHHHHHHHHH
Confidence 99999999999999 67889999999998765433211 112224579999999988899999999999999998
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++ |..||...+..+....+......+.+ ..++..+.+++.+|++.+|.+||++.++++
T Consensus 203 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 261 (267)
T cd05066 203 MSYGERPYWEMSNQDVIKAIEEGYRLPAP----MDCPAALHQLMLDCWQKDRNERPKFEQIVS 261 (267)
T ss_pred hcCCCCCcccCCHHHHHHHHhCCCcCCCC----CCCCHHHHHHHHHHcccCchhCCCHHHHHH
Confidence 86 99999988887777777665443332 367889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul |
| >cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-38 Score=251.19 Aligned_cols=211 Identities=26% Similarity=0.441 Sum_probs=181.3
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (241)
....+.+.+|+.+++.+ +|+||+++++++...+..+++|||+.+++|.+++.+.. .++...+.
T Consensus 61 ~~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 140 (304)
T cd05101 61 EKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTFKDLV 140 (304)
T ss_pred hHHHHHHHHHHHHHHhhccCCCchheeEEEecCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccHHHHH
Confidence 34567899999999999 89999999999999999999999999999999997642 36778899
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCC
Q 026253 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (241)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~ 146 (241)
.++.|++.||.+||+.|++|+||||+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++
T Consensus 141 ~~~~qi~~al~~LH~~givH~dlkp~Nili---~~~~~~kl~D~g~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 217 (304)
T cd05101 141 SCTYQVARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDVNNIDYYKKTTNGRLPVKWMAPEALFDRVYT 217 (304)
T ss_pred HHHHHHHHHHHHHHHCCeeecccccceEEE---cCCCcEEECCCccceecccccccccccCCCCCceeeCchhhccCCCC
Confidence 999999999999999999999999999999 6788999999999876643221 1223345679999999888899
Q ss_pred CchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 147 EKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 147 ~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.++|+||||+++|++++ |..||.+.+..+..+.+........+ ..++..+.+++.+||..+|.+|||+.++++.
T Consensus 218 ~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~e~l~~ 292 (304)
T cd05101 218 HQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAIPSHRPTFKQLVED 292 (304)
T ss_pred chhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence 99999999999999998 88999988888888888665544333 3678999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-38 Score=251.00 Aligned_cols=213 Identities=30% Similarity=0.476 Sum_probs=170.1
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
..+.+|++++++++|+||+++++++.+++..++||||+. ++|.+++... ..+++..+..++.|++.||.+||+.|++|
T Consensus 48 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~lH~~~i~H 126 (291)
T cd07844 48 FTAIREASLLKDLKHANIVTLHDIIHTKKTLTLVFEYLD-TDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAYCHQRRVLH 126 (291)
T ss_pred hhHHHHHHHHhhCCCcceeeEEEEEecCCeEEEEEecCC-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 456789999999999999999999999999999999996 5999988764 46899999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||+|+||++ +.++.++|+|||.+....... ......++..|.|||.+.+ ..++.++|+||+|+++|+|++|..|
T Consensus 127 ~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il~~l~~g~~~ 203 (291)
T cd07844 127 RDLKPQNLLI---SERGELKLADFGLARAKSVPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPL 203 (291)
T ss_pred ccCCHHHEEE---cCCCCEEECccccccccCCCCccccccccccccCCcHHhhcCcccCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999 678889999999986543211 1122345778999998865 4578999999999999999999999
Q ss_pred CCCCC-hHHHHHHhhcCCCCCCC-------------------------CccCCCCC--hHHHHHHHHhcccCccccCCHH
Q 026253 168 FSGRN-NVQLVRNINSCKHLPFS-------------------------QLIVPALH--PDCVDMCLKLLSANTVDRLSFN 219 (241)
Q Consensus 168 ~~~~~-~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~--~~~~~li~~~l~~~p~~Rps~~ 219 (241)
|.+.. ..+....+......+.+ ....+.++ .++.+++++||+.+|.+|||++
T Consensus 204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~~p~~Rps~~ 283 (291)
T cd07844 204 FPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQYEPKKRISAA 283 (291)
T ss_pred CCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhccCcccccCHH
Confidence 97655 33333222111100000 00112334 7889999999999999999999
Q ss_pred HHhcCccc
Q 026253 220 EFYHHRFL 227 (241)
Q Consensus 220 ~il~~~~~ 227 (241)
++++||||
T Consensus 284 e~l~~~~f 291 (291)
T cd07844 284 EAMKHPYF 291 (291)
T ss_pred HHhcCCCC
Confidence 99999998
|
Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the |
| >cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=243.08 Aligned_cols=210 Identities=28% Similarity=0.479 Sum_probs=178.6
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+.....+.+|++++++++|+||+++++++...+..++||||+.+++|.+++... ..+++..+..++.+++.++.++|+.
T Consensus 33 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 112 (250)
T cd05085 33 QELKIKFLSEARILKQYDHPNIVKLIGVCTQRQPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAYLESK 112 (250)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCeEEEEEecCCccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 344557889999999999999999999999999999999999999999998754 4578999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc--ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
|++|+||+|+||++ +.++.++|+|||.+......... .....+..|+|||.+.+..++.++|+||+|+++|++++
T Consensus 113 ~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~ll~~~~~ 189 (250)
T cd05085 113 NCIHRDLAARNCLV---GENNVLKISDFGMSRQEDDGIYSSSGLKQIPIKWTAPEALNYGRYSSESDVWSYGILLWETFS 189 (250)
T ss_pred CeeecccChheEEE---cCCCeEEECCCccceeccccccccCCCCCCcccccCHHHhccCCCCchhHHHHHHHHHHHHhc
Confidence 99999999999999 77889999999998654332211 11223456999999988889999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 -GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 -g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||...........+........ ...++..+.+++.+|++.+|.+|||+.++++
T Consensus 190 ~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 246 (250)
T cd05085 190 LGVCPYPGMTNQQAREQVEKGYRMSC----PQKCPDDVYKVMQRCWDYKPENRPKFSELQK 246 (250)
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCC----CCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 9999998877777766655443332 2367899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c |
| >cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-38 Score=247.24 Aligned_cols=211 Identities=25% Similarity=0.460 Sum_probs=178.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCe------EEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQ 74 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~ 74 (241)
......+.+|++.++.++|+||+++++++...+. .++++||+++++|..++... ..+++..+..++.|
T Consensus 42 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~ 121 (273)
T cd05035 42 YSEIEEFLSEAACMKDFDHPNVMKLIGVCFEASSLQKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVD 121 (273)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeEEeeeccCCccccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHH
Confidence 3456788999999999999999999998765443 79999999999999998542 25899999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhH
Q 026253 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (241)
Q Consensus 75 i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv 151 (241)
++.||.+||+.|++|+||+|+||++ ++++.++|+|||.+........ ......+..|++||...+..++.++|+
T Consensus 122 i~~aL~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~Dv 198 (273)
T cd05035 122 IALGMEYLSNRNFIHRDLAARNCML---REDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDV 198 (273)
T ss_pred HHHHHHHHHhCCeeccccchheEEE---CCCCeEEECCccceeeccccccccccccccCCccccCHhhcccCCCCcccch
Confidence 9999999999999999999999999 6788999999999876543321 111234567999999988889999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 152 WSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 152 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
||+|+++|++++ |..||.+.+..+....+..+.....+ ..++..+.+++.+||+.||.+|||+.+++++
T Consensus 199 ~SlG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~e~~~~ 268 (273)
T cd05035 199 WAFGVTMWEIATRGQTPYPGVENHEIYDYLRHGNRLKQP----EDCLDELYDLMYSCWRADPKDRPTFTKLREV 268 (273)
T ss_pred HHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCC----cCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999 99999988888888777666544443 3778999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu |
| >cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-39 Score=251.22 Aligned_cols=215 Identities=34% Similarity=0.602 Sum_probs=179.0
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|+.++++++|+|++++++++.+.+..++|||++. ++|.+++.+. ..+++..+..++.+++.|+.+||+.|+
T Consensus 41 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 119 (282)
T cd07829 41 IPSTALREISLLKELKHPNIVKLLDVIHTERKLYLVFEYCD-MDLKKYLDKRPGPLSPNLIKSIMYQLLRGLAYCHSHRI 119 (282)
T ss_pred ccHHHHHHHHHHHhcCCCCHHHHHhhhhcCCceEEEecCcC-cCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34677889999999999999999999999999999999996 6999999876 579999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||+|+||++ ++++.++|+|||.+....... .......+..|+|||.+.+. .++.++|+||+|++++++++|.
T Consensus 120 ~H~~l~~~ni~~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~~~ 196 (282)
T cd07829 120 LHRDLKPQNILI---NRDGVLKLADFGLARAFGIPLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGK 196 (282)
T ss_pred ccCCCChheEEE---cCCCCEEEecCCcccccCCCccccCccccCcCcCChHHhcCCcCCCccccHHHHHHHHHHHHhCC
Confidence 999999999999 678899999999987654432 22233456789999998766 7899999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCC-----------------CC-------CccCCCCChHHHHHHHHhcccCccccCCHHHH
Q 026253 166 PPFSGRNNVQLVRNINSCKHLP-----------------FS-------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~-----------------~~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 221 (241)
.||.+.+..+....+......+ ++ ....+..+..+.+++++||+.+|++||+++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~~ 276 (282)
T cd07829 197 PLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLPDYKPTFPKFPPKDLEKVLPRLDPEGIDLLSKMLQYNPAKRISAKEA 276 (282)
T ss_pred CCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccccccccccccCccchHHhcccccHHHHHHHHHhhccCcccCCCHHHH
Confidence 9998877665554443211100 00 11223457889999999999999999999999
Q ss_pred hcCccc
Q 026253 222 YHHRFL 227 (241)
Q Consensus 222 l~~~~~ 227 (241)
+.||||
T Consensus 277 l~~p~~ 282 (282)
T cd07829 277 LKHPYF 282 (282)
T ss_pred hhCcCC
Confidence 999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the |
| >cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=249.29 Aligned_cols=217 Identities=26% Similarity=0.449 Sum_probs=175.3
Q ss_pred hhhHHHHHHH-HhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 10 KSCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 10 ~~~~~~E~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
...+..|+.. ++.++|+||+++++++..++..+++|||++ ++|.+++... ..+++..+..++.|++.|+.+||+
T Consensus 43 ~~~~~~e~~~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 121 (283)
T cd06617 43 QKRLLMDLDISMRSVDCPYTVTFYGALFREGDVWICMEVMD-TSLDKFYKKVYDKGLTIPEDILGKIAVSIVKALEYLHS 121 (283)
T ss_pred HHHHHHHHHHHHHHcCCCCeeeeeEEEecCCcEEEEhhhhc-ccHHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 3445556665 566699999999999999999999999995 6888887642 358999999999999999999999
Q ss_pred C-CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc----cCCCCchhHHHHHHHHH
Q 026253 85 H-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF----QRYDEKVDMWSVGAILF 159 (241)
Q Consensus 85 ~-~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~----~~~~~~~Dv~slG~~l~ 159 (241)
+ +++|+||+|+||++ +.++.++|+|||.+.............++..|+|||.+.+ ..++.++|+||+|+++|
T Consensus 122 ~~~i~h~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~~l~ 198 (283)
T cd06617 122 KLSVIHRDVKPSNVLI---NRNGQVKLCDFGISGYLVDSVAKTIDAGCKPYMAPERINPELNQKGYDVKSDVWSLGITMI 198 (283)
T ss_pred cCCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccCCccccChhhcCCcccccccCccccchhhHHHHH
Confidence 7 99999999999999 7788999999999876544333333457888999998864 44688999999999999
Q ss_pred HHHhCCCCCCCC-ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 160 ELLNGYPPFSGR-NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 160 ~l~~g~~p~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
+|++|+.||... ...+....+........+. ..+|.++.+++.+||..+|.+|||++++++||||+.....
T Consensus 199 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~ 270 (283)
T cd06617 199 ELATGRFPYDSWKTPFQQLKQVVEEPSPQLPA---EKFSPEFQDFVNKCLKKNYKERPNYPELLQHPFFELHLSK 270 (283)
T ss_pred HHHhCCCCCCccccCHHHHHHHHhcCCCCCCc---cccCHHHHHHHHHHccCChhhCcCHHHHhcCchhhhcccc
Confidence 999999999753 3334444443333332222 2578999999999999999999999999999999987644
|
Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs |
| >cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.6e-39 Score=251.93 Aligned_cols=215 Identities=33% Similarity=0.551 Sum_probs=179.5
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
....+.+|++++++++|+||+++++++..++..++++||+. +++.+++... .++++..+..++.|++.|+.+||+.|+
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i 119 (283)
T cd05118 41 IPKTALREIKLLKELNHPNIIKLLDVFRHKGDLYLVFEFMD-TDLYKLIKDRQRGLPESLIKSYLYQLLQGLAFCHSHGI 119 (283)
T ss_pred hHHHHHHHHHHHHHhcCCCcchHHHhhccCCCEEEEEeccC-CCHHHHHHhhcccCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45678899999999999999999999999999999999996 5888888764 578999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||+|.||++ +.++.++|+|||.+....... ......++..|.|||.+.+. .++.++|+||+|+++|++++|+
T Consensus 120 ~H~dl~p~nili---~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l~~l~tg~ 196 (283)
T cd05118 120 LHRDLKPENLLI---NTEGVLKLADFGLARSFGSPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRR 196 (283)
T ss_pred eecCcCHHHEEE---CCCCcEEEeeeeeeEecCCCcccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHHHHHHhCC
Confidence 999999999999 678899999999987665443 22234567789999998776 6899999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCC-------------------------CccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFS-------------------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
.||.+.+..+....+......+.+ ....+.++.++.++|.+||+.||.+||++++
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp~~~~ 276 (283)
T cd05118 197 PLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLFPNASPQALDLLSQMLHYDPHKRITAEQ 276 (283)
T ss_pred CCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhhhhhCHHHHHHHHHHhccCcccCcCHHH
Confidence 999887766555444322111100 1122356889999999999999999999999
Q ss_pred HhcCccc
Q 026253 221 FYHHRFL 227 (241)
Q Consensus 221 il~~~~~ 227 (241)
++.||||
T Consensus 277 ll~~~~~ 283 (283)
T cd05118 277 ALAHPYF 283 (283)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They |
| >cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-38 Score=246.80 Aligned_cols=212 Identities=27% Similarity=0.517 Sum_probs=176.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
.+....+.+|+++++.++||||+++++++.+.+..++++||+++++|.+++.. ...+++..+..++.|++.|+.+|
T Consensus 43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 122 (267)
T cd08228 43 AKARQDCVKEIDLLKQLNHPNVIKYLDSFIEDNELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSAVEHM 122 (267)
T ss_pred HHHHHHHHHHHHHHHhCCCcceeeeeeeEEECCeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHHHHHH
Confidence 45566789999999999999999999999999999999999999999998853 23478999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|++|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|++
T Consensus 123 H~~~i~H~dl~~~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~slG~~l~el 199 (267)
T cd08228 123 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred hhCCeeCCCCCHHHEEE---cCCCCEEECccccceeccchhHHHhcCCCCccccChhhhccCCCCchhhHHHHHHHHHHH
Confidence 99999999999999999 6788899999998876543221 2234577889999999888889999999999999999
Q ss_pred HhCCCCCCCCC--hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 162 LNGYPPFSGRN--NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 162 ~~g~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
++|..||.... .......+......+. ....++..+.+++.+||+.+|++|||+.++++.
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~cl~~~p~~Rp~~~~vl~~ 261 (267)
T cd08228 200 AALQSPFYGDKMNLFSLCQKIEQCDYPPL---PTEHYSEKLRELVSMCIYPDPDQRPDIGYVHQI 261 (267)
T ss_pred hcCCCCCccccccHHHHHHHHhcCCCCCC---ChhhcCHHHHHHHHHHCCCCcccCcCHHHHHHH
Confidence 99999986543 3444455443332222 223678899999999999999999999999853
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase |
| >cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=245.02 Aligned_cols=206 Identities=23% Similarity=0.430 Sum_probs=176.1
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEE-eecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
..+.+.+|+.++++++|+|++++++++ ..++..+++|||+++++|.+++.+.. .+++..+..++.|++.||++||++
T Consensus 42 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 121 (256)
T cd05082 42 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEAN 121 (256)
T ss_pred hHHHHHHHHHHHHhCCCCCeeeEEEEEEcCCCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 356788999999999999999999975 45567999999999999999997654 378999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
|++|+||+|+||++ ++++.++|+|||++....... .....+..|+|||.+.+..++.++|+||+|+++|+|++ |
T Consensus 122 ~i~H~dlkp~nil~---~~~~~~kl~dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~i~~~l~~~g 196 (256)
T cd05082 122 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 196 (256)
T ss_pred CEeccccchheEEE---cCCCcEEecCCccceeccccC--CCCccceeecCHHHHccCCCCchhhhHHHHHHHHHHHhCC
Confidence 99999999999999 788899999999987543322 12234567999999988889999999999999999997 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
..||...+..+....+..+..... ...++..+.+++.+||+.+|++|||+.++++
T Consensus 197 ~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~l~~ 251 (256)
T cd05082 197 RVPYPRIPLKDVVPRVEKGYKMDA----PDGCPPVVYDVMKQCWHLDAATRPSFLQLRE 251 (256)
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCC----CCCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999998888777777755543332 2477899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re |
| >cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.5e-38 Score=249.74 Aligned_cols=216 Identities=30% Similarity=0.477 Sum_probs=172.7
Q ss_pred hhhHHHHHHHHhcCC-CcCeeeeeeEEeecCe-----EEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~ 78 (241)
...+.+|+.++++++ |+||+++++++...+. .+++|||+++ +|.+++... ..+++..+..++.|++.|
T Consensus 44 ~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~~qi~~~ 122 (295)
T cd07837 44 PPTALREISLLQMLSESIYIVRLLDVEHVEEKNGKPSLYLVFEYLDS-DLKKFMDSNGRGPGRPLPAKTIKSFMYQLLKG 122 (295)
T ss_pred chHHHHHHHHHHHccCCCCccceeeeEeecCCCCCceEEEEeeccCc-CHHHHHHHhcccCCCCCCHHHHHHHHHHHHHH
Confidence 356888999999995 6999999999877655 8999999975 898888643 347999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccc-cCCCCchhHHHHHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~ 156 (241)
|.+||+.|++|+||+|+||+++ ..++.++|+|||.+...... .......+++.|.|||.+.+ ..++.++|+||+|+
T Consensus 123 L~~LH~~~i~H~dl~~~nil~~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~ 200 (295)
T cd07837 123 VAHCHKHGVMHRDLKPQNLLVD--KQKGLLKIADLGLGRAFSIPVKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGC 200 (295)
T ss_pred HHHHHHCCeeecCCChHHEEEe--cCCCeEEEeecccceecCCCccccCCcccccCCCChHHhhCCCCCCchHHHHHHHH
Confidence 9999999999999999999994 23788999999998754322 11223345778999998765 45789999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCCCCCC-----------------------CCccCCCCChHHHHHHHHhcccCcc
Q 026253 157 ILFELLNGYPPFSGRNNVQLVRNINSCKHLPF-----------------------SQLIVPALHPDCVDMCLKLLSANTV 213 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-----------------------~~~~~~~~~~~~~~li~~~l~~~p~ 213 (241)
++|+|++|..||.+.+.......+......+. .....+.+++.+.++|.+||..||.
T Consensus 201 ~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~ 280 (295)
T cd07837 201 IFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEFPQWKPQDLSRAVPDLSPEGLDLLQKMLRYDPA 280 (295)
T ss_pred HHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhcCcccchhHHHhccccCHHHHHHHHHHccCChh
Confidence 99999999999988776555444322111000 0111246788999999999999999
Q ss_pred ccCCHHHHhcCcccc
Q 026253 214 DRLSFNEFYHHRFLR 228 (241)
Q Consensus 214 ~Rps~~~il~~~~~~ 228 (241)
+|||++|++.||||+
T Consensus 281 ~R~~~~eil~~~~~~ 295 (295)
T cd07837 281 KRISAKAALTHPYFD 295 (295)
T ss_pred hcCCHHHHhcCCCcC
Confidence 999999999999985
|
Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm |
| >cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=245.28 Aligned_cols=210 Identities=24% Similarity=0.431 Sum_probs=180.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|++++++++|+|++++.+++...+..++|||++++++|.+++... +.+++..+..++.+++.|+++||+.
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~ 126 (268)
T cd05063 47 EKQRQDFLSEASIMGQFSHHNIIRLEGVVTKFKPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKYLSDM 126 (268)
T ss_pred HHHHHHHHHHHHHHhcCCCCCeeEEEEEEccCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 445677899999999999999999999999999999999999999999999764 5689999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc----cccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~----~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|++|+||+|.||++ +.++.++++|||.+.......... ....+..|+|||.+.+..++.++|+||+|+++|++
T Consensus 127 ~i~H~dlkp~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Dv~slG~il~el 203 (268)
T cd05063 127 NYVHRDLAARNILV---NSNLECKVSDFGLSRVLEDDPEGTYTTSGGKIPIRWTAPEAIAYRKFTSASDVWSFGIVMWEV 203 (268)
T ss_pred CeeccccchhhEEE---cCCCcEEECCCccceecccccccceeccCCCcCceecCHHHhhcCCcChHhHHHHHHHHHHHH
Confidence 99999999999999 678889999999987654322111 11223469999999888889999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++ |..||...+..+....+......+.+ ...+.++.+++.+||+.+|.+||++.++++
T Consensus 204 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~i~~ 262 (268)
T cd05063 204 MSFGERPYWDMSNHEVMKAINDGFRLPAP----MDCPSAVYQLMLQCWQQDRARRPRFVDIVN 262 (268)
T ss_pred HhCCCCCCCcCCHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 97 99999988888888888665443333 267889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored |
| >cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.6e-38 Score=244.84 Aligned_cols=213 Identities=25% Similarity=0.505 Sum_probs=180.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+.+.+|+.++++++|+||+++++++.+. +..++++|++.+++|.+++.+.+.+++..+..++.|++.|+.+||+
T Consensus 45 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~i~~al~~LH~ 124 (264)
T cd06653 45 SKEVNALECEIQLLKNLRHDRIVQYYGCLRDPEEKKLSIFVEYMPGGSIKDQLKAYGALTENVTRRYTRQILQGVSYLHS 124 (264)
T ss_pred hHHHHHHHHHHHHHHHcCCCCcceEEEEEEcCCCCEEEEEEEeCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567899999999999999999999998764 5688999999999999999887889999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC----CccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
.|++|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||+|+++++
T Consensus 125 ~~i~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 201 (264)
T cd06653 125 NMIVHRDIKGANILR---DSAGNVKLGDFGASKRIQTICMSGTGIKSVTGTPYWMSPEVISGEGYGRKADVWSVACTVVE 201 (264)
T ss_pred CCEecCCCCHHHEEE---cCCCCEEECccccccccccccccCccccccCCcccccCHhhhcCCCCCccccHHHHHHHHHH
Confidence 999999999999999 67888999999998765321 11123457888999999988888999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcc
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 226 (241)
+++|..||...........+.... .....+..++..+.+++.+||+ +|.+||++.+++.|||
T Consensus 202 l~~g~~p~~~~~~~~~~~~~~~~~---~~~~~p~~~~~~~~~~i~~~l~-~~~~r~~~~~~~~~~~ 263 (264)
T cd06653 202 MLTEKPPWAEYEAMAAIFKIATQP---TKPMLPDGVSDACRDFLKQIFV-EEKRRPTAEFLLRHPF 263 (264)
T ss_pred HHhCCCCCCccCHHHHHHHHHcCC---CCCCCCcccCHHHHHHHHHHhc-CcccCccHHHHhcCCC
Confidence 999999998776665555443322 2223345788999999999999 5799999999999998
|
Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho |
| >cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=249.60 Aligned_cols=210 Identities=25% Similarity=0.430 Sum_probs=175.4
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+.+|+.+++++ +|+||+++++++...+..+++|||+.+++|.+++.... .+++..+..++.+++.|+.+||
T Consensus 79 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l~~lH 158 (302)
T cd05055 79 SSEREALMSELKIMSHLGNHENIVNLLGACTIGGPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGMAFLA 158 (302)
T ss_pred hHHHHHHHHHHHHHHhccCCCCcceEEEEEecCCceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 34456789999999999 79999999999999999999999999999999997543 3899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+++++|+||+|.||++ ++++.++++|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+
T Consensus 159 ~~~ivH~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DiwslGvil~e 235 (302)
T cd05055 159 SKNCIHRDLAARNVLL---THGKIVKICDFGLARDIMNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGILLWE 235 (302)
T ss_pred HCCeehhhhccceEEE---cCCCeEEECCCcccccccCCCceeecCCCCcccccCCHhhhccCCCCcHhHHHHHHHHHHH
Confidence 9999999999999999 6788899999999876543221 112234667999999988889999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHh-hcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 161 LLN-GYPPFSGRNNVQLVRNI-NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 161 l~~-g~~p~~~~~~~~~~~~i-~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+++ |..||......+.+... ..+.... .....+..+.+++.+||+.+|.+|||+.++++
T Consensus 236 l~t~g~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ell~ 296 (302)
T cd05055 236 IFSLGSNPYPGMPVDSKFYKLIKEGYRMA----QPEHAPAEIYDIMKTCWDADPLKRPTFKQIVQ 296 (302)
T ss_pred HHhCCCCCcCCCCchHHHHHHHHcCCcCC----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 998 99999876655444333 2222222 22367889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept |
| >cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-38 Score=246.31 Aligned_cols=212 Identities=25% Similarity=0.452 Sum_probs=177.4
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-------CCCCHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-------GRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-------~~~~~~~~~~~~~~i~~~l~ 80 (241)
.....+.+|+++++.++|+||+++++++...+..+++|||+++++|.+++... ..+++..+..++.|++.|++
T Consensus 41 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~ 120 (269)
T cd05044 41 QEKKEFLKEAHLMSNFNHPNIVKLLGVCLLNEPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLDVAKGCV 120 (269)
T ss_pred hhHHHHHHHHHHHHhcCCCCeeeEeeeecCCCCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHHHHHHHH
Confidence 45678889999999999999999999999999999999999999999999743 23778999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecC--CCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~--~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 155 (241)
+||+.+++|+||+|+||+++..+ ....++++|||++........ ......+..|+|||.+.+..++.++|+||||
T Consensus 121 ~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG 200 (269)
T cd05044 121 YLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYYRKEGEGLLPVRWMAPESLLDGKFTTQSDVWSFG 200 (269)
T ss_pred HHHhCCcccCCCChheEEEecCCCCCCcceEECCcccccccccccccccCcccCCCccccCHHHHccCCcccchhHHHHH
Confidence 99999999999999999995322 123799999999875533221 1122345789999999988899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 156 AILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 156 ~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+++|+|++ |..||...+..+....+........+ ..++..+.+++.+||+.+|.+||+++++++
T Consensus 201 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 265 (269)
T cd05044 201 VLMWEILTLGQQPYPALNNQEVLQHVTAGGRLQKP----ENCPDKIYQLMTNCWAQDPSERPTFDRIQE 265 (269)
T ss_pred HHHHHHHHcCCCCCcccCHHHHHHHHhcCCccCCc----ccchHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999998 99999988877777776554443333 367889999999999999999999999875
|
Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male |
| >cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-38 Score=248.86 Aligned_cols=210 Identities=25% Similarity=0.491 Sum_probs=178.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------------CCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------RVP 64 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------~~~ 64 (241)
.+..+.+.+|+.++++++|+||+++++++..++..+++|||+.+++|.+++.... .++
T Consensus 49 ~~~~~~~~~ei~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~l~ 128 (288)
T cd05050 49 ADMQADFQREAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNPLPLS 128 (288)
T ss_pred HHHHHHHHHHHHHHHhcCCCchheEEEEEcCCCccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccccccC
Confidence 3456779999999999999999999999999999999999999999999997532 367
Q ss_pred HHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCccccc
Q 026253 65 EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQ 141 (241)
Q Consensus 65 ~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~ 141 (241)
+..+..++.|++.||.+||+.|++|+||+|.||++ +.++.++|+|||.+........ ......+..|+|||.+.
T Consensus 129 ~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~ 205 (288)
T cd05050 129 CTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKASENDAIPIRWMPPESIF 205 (288)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCeecccccHhheEe---cCCCceEECccccceecccCccccccCCCccChhhcCHHHHh
Confidence 88899999999999999999999999999999999 7788999999999865432211 11223355799999998
Q ss_pred ccCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 142 FQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 142 ~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
+..++.++|+||||+++|+|++ |..||.+.+..+....+..+...+.+ ..++.++.+++.+||+.+|.+|||+.|
T Consensus 206 ~~~~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rpt~~e 281 (288)
T cd05050 206 YNRYTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRDGNVLSCP----DNCPLELYNLMRLCWSKLPSDRPSFAS 281 (288)
T ss_pred cCCCCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcccCcccCCCHHH
Confidence 8889999999999999999997 88899888888888777655543333 367889999999999999999999999
Q ss_pred Hhc
Q 026253 221 FYH 223 (241)
Q Consensus 221 il~ 223 (241)
+++
T Consensus 282 l~~ 284 (288)
T cd05050 282 INR 284 (288)
T ss_pred HHH
Confidence 874
|
Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M |
| >cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-38 Score=245.86 Aligned_cols=211 Identities=27% Similarity=0.538 Sum_probs=175.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
......+.+|+++++.++|+||+++++++.+++..+++||++++++|.+++.. ...+++..+..++.|++.|+.+|
T Consensus 43 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~L 122 (267)
T cd08229 43 AKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSALEHM 122 (267)
T ss_pred HHHHHHHHHHHHHHHHccCCchhhhhheeEeCCeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 34567888999999999999999999999999999999999999999999864 34589999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|+.|++|+||+|.||++ +.++.++++|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|++
T Consensus 123 H~~~i~H~dl~p~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~ape~~~~~~~~~~~Dv~slG~il~~l 199 (267)
T cd08229 123 HSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred HHCCeecCCCCHHHEEE---cCCCCEEECcchhhhccccCCcccccccCCcCccCHHHhcCCCccchhhHHHHHHHHHHH
Confidence 99999999999999999 6788899999998876543222 2334578899999999888899999999999999999
Q ss_pred HhCCCCCCCCCh--HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LNGYPPFSGRNN--VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~g~~p~~~~~~--~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++|..||.+... ....+.+......+. ....++..+.+++.+||+.+|.+|||++++++
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rpt~~~i~~ 260 (267)
T cd08229 200 AALQSPFYGDKMNLYSLCKKIEQCDYPPL---PSDHYSEELRQLVNMCINPDPEKRPDITYVYD 260 (267)
T ss_pred HhCCCCcccccchHHHHhhhhhcCCCCCC---CcccccHHHHHHHHHhcCCCcccCCCHHHHHH
Confidence 999999975443 233344433222222 22357889999999999999999999997764
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. |
| >smart00219 TyrKc Tyrosine kinase, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=243.59 Aligned_cols=208 Identities=29% Similarity=0.550 Sum_probs=182.8
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|+.+++.++|+||+++++++.+.+..+++||++.+++|.+++..... +++..+..++.|++.|+++||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~~lh~~~ 123 (258)
T smart00219 44 QIEEFLREARIMRKLDHPNIVKLLGVCTEEEPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGMEYLESKN 123 (258)
T ss_pred HHHHHHHHHHHHHhcCCCchheEEEEEcCCCeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHHHHhcCC
Confidence 577899999999999999999999999999999999999999999999976554 899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc--cccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
++|+||+|+||++ +.++.++|+|||.+.......... ...++..|+|||...+..++.++|+||+|++++++++
T Consensus 124 ~~h~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~i~~~l~~~ 200 (258)
T smart00219 124 FIHRDLAARNCLV---GENLVVKISDFGLSRDLYDDDYYKKKGGKLPIRWMAPESLKDGKFTSKSDVWSFGVLLWEIFTL 200 (258)
T ss_pred eeecccccceEEE---ccCCeEEEcccCCceecccccccccccCCCcccccChHHhccCCCCcchhHHHHHHHHHHHHhC
Confidence 9999999999999 678899999999987665432211 1235678999999988889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||...+.....+.+........+. ..+.++.+++.+||..+|.+|||+.|+++
T Consensus 201 g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rpt~~~ll~ 256 (258)
T smart00219 201 GESPYPGMSNEEVLEYLKKGYRLPKPE----NCPPEIYKLMLQCWAEDPEDRPTFSELVE 256 (258)
T ss_pred CCCCCCCCCHHHHHHHHhcCCCCCCCC----cCCHHHHHHHHHHCcCChhhCcCHHHHHh
Confidence 899999888888888876666544433 58899999999999999999999999985
|
Phosphotransferases. Tyrosine-specific kinase subfamily. |
| >cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.8e-38 Score=248.57 Aligned_cols=214 Identities=24% Similarity=0.413 Sum_probs=178.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQL 75 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i 75 (241)
....+.+.+|++++++++|+||+++++++..++..+++||++.+++|.+++.... .+++..+..++.|+
T Consensus 60 ~~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 139 (296)
T cd05051 60 DNAREDFLKEVKILSRLSDPNIARLLGVCTVDPPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYMATQI 139 (296)
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeEEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHHHHHH
Confidence 3457788999999999999999999999999999999999999999999998765 68999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCCchhHH
Q 026253 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (241)
Q Consensus 76 ~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~ 152 (241)
+.||++||+.|++|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+|
T Consensus 140 ~~al~~LH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~ 216 (296)
T cd05051 140 ASGMRYLESLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSSDYYRVQGRAPLPIRWMAWESVLLGKFTTKSDVW 216 (296)
T ss_pred HHHHHHHHHcCccccccchhceee---cCCCceEEccccceeecccCcceeecCcCCCCceecCHHHhhcCCCCccchhh
Confidence 999999999999999999999999 677899999999987653322 12233456689999999888899999999
Q ss_pred HHHHHHHHHHh--CCCCCCCCChHHHHHHhhcCCC---CCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 153 SVGAILFELLN--GYPPFSGRNNVQLVRNINSCKH---LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 153 slG~~l~~l~~--g~~p~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|||+++|++++ |..||...+..+.+..+..... ........+.++.++.+++.+||+.||.+|||+.++++
T Consensus 217 slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rpt~~el~~ 292 (296)
T cd05051 217 AFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIYLPRPPNCPKDIYELMLECWRRDEEDRPTFREIHL 292 (296)
T ss_pred hhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhccccccccccCCCccCCCHHHHHHHHHHhccChhcCCCHHHHHH
Confidence 99999999998 7788887777776666543311 11111123356789999999999999999999999963
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke |
| >cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-38 Score=245.59 Aligned_cols=211 Identities=23% Similarity=0.434 Sum_probs=179.7
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.+.....+.+|+.++++++||||+++.+++.+++..++||||+.+++|.+++... +.+++..+..++.|++.|+.+||+
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~lH~ 124 (269)
T cd05065 45 TEKQRRDFLSEASIMGQFDHPNIIHLEGVVTKSRPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLSE 124 (269)
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcceEEEEECCCCceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3556778999999999999999999999999999999999999999999999764 568999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccc------cCCCCccCcccccccCCCCchhHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV------CGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~------~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 158 (241)
.|++|+||+|.||++ +.++.++++|||.+............ ..+..|+|||.+.+..++.++|+||+|+++
T Consensus 125 ~g~~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l 201 (269)
T cd05065 125 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVM 201 (269)
T ss_pred CCEeecccChheEEE---cCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCcccchhhhhhhHHHH
Confidence 999999999999999 67889999999998655432211111 113469999999888899999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 159 FELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 159 ~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|++++ |..||...+.......+......+.+ ..++..+.+++.+||+.+|.+||++++++.
T Consensus 202 ~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 263 (269)
T cd05065 202 WEVMSYGERPYWDMSNQDVINAIEQDYRLPPP----MDCPTALHQLMLDCWQKDRNARPKFGQIVS 263 (269)
T ss_pred HHHhcCCCCCCCCCCHHHHHHHHHcCCcCCCc----ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99886 99999988887777777554433333 367889999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr |
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3e-39 Score=263.18 Aligned_cols=206 Identities=30% Similarity=0.495 Sum_probs=177.1
Q ss_pred hhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
.....+|+.++... +|+||++..+.+.++.+.|+|||.++|+-+.+-+...+.+. ..+..|+.+|+.|+.+||++|++
T Consensus 359 ~~~~~~e~~~~~~~~~h~niv~~~~v~~~~~~~~~v~e~l~g~ell~ri~~~~~~~-~e~~~w~~~lv~Av~~LH~~gvv 437 (612)
T KOG0603|consen 359 ADDNQDEIPISLLVRDHPNIVKSHDVYEDGKEIYLVMELLDGGELLRRIRSKPEFC-SEASQWAAELVSAVDYLHEQGVV 437 (612)
T ss_pred ccccccccchhhhhcCCCcceeecceecCCceeeeeehhccccHHHHHHHhcchhH-HHHHHHHHHHHHHHHHHHhcCee
Confidence 44566777777777 79999999999999999999999999999988887665554 67778999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 168 (241)
||||||+|||+. +..++++|+|||.++..... -...+-|..|.|||+.....+++++|+||||+++|+|++|+.||
T Consensus 438 hRDLkp~NIL~~--~~~g~lrltyFG~a~~~~~~--~~tp~~t~~y~APEvl~~~~yt~acD~WSLGvlLy~ML~G~tp~ 513 (612)
T KOG0603|consen 438 HRDLKPGNILLD--GSAGHLRLTYFGFWSELERS--CDTPALTLQYVAPEVLAIQEYTEACDWWSLGVLLYEMLTGRTLF 513 (612)
T ss_pred ecCCChhheeec--CCCCcEEEEEechhhhCchh--hcccchhhcccChhhhccCCCCcchhhHHHHHHHHHHHhCCCcc
Confidence 999999999994 47788999999999877655 22345688899999999999999999999999999999999999
Q ss_pred CCCChH-HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 169 SGRNNV-QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 169 ~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
...... ++...+..+. +. ..+|...+++|++||+.||.+||++.+++.||||
T Consensus 514 ~~~P~~~ei~~~i~~~~---~s----~~vS~~AKdLl~~LL~~dP~~Rl~~~~i~~h~w~ 566 (612)
T KOG0603|consen 514 AAHPAGIEIHTRIQMPK---FS----ECVSDEAKDLLQQLLQVDPALRLGADEIGAHPWF 566 (612)
T ss_pred ccCCchHHHHHhhcCCc---cc----cccCHHHHHHHHHhccCChhhCcChhhhccCcch
Confidence 876555 5555553322 22 4899999999999999999999999999999999
|
|
| >cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=244.22 Aligned_cols=209 Identities=19% Similarity=0.304 Sum_probs=168.6
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.+....+.+|+.++++++||||+++++++..+...+++|||+++++|..++... ..+++..+..++.|++.|++|||+.
T Consensus 45 ~~~~~~~~~~~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 124 (262)
T cd05077 45 RDISLAFFETASMMRQVSHKHIVLLYGVCVRDVENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSYLEDK 124 (262)
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHhhhC
Confidence 344557888999999999999999999999999999999999999999998754 5689999999999999999999999
Q ss_pred CccccCCCCCCeEEeecC----CCceEEEeecCCccccCCCCccccccCCCCccCccccc-ccCCCCchhHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~----~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~ 160 (241)
|++|+||+|.||+++... ....++++|||.+...... ....++..|+|||.+. +..++.++|+||+|+++|+
T Consensus 125 ~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~e 201 (262)
T cd05077 125 DLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR---QECVERIPWIAPECVEDSKNLSIAADKWSFGTTLWE 201 (262)
T ss_pred CeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc---ccccccccccChhhhcCCCCCCchhHHHHHHHHHHH
Confidence 999999999999995211 1123899999988654322 2344677899999886 4668899999999999999
Q ss_pred HH-hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 161 LL-NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 161 l~-~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
++ .|..||......+......... . .....+.++.+++.+||+.||.+||++.+|+++
T Consensus 202 l~~~~~~p~~~~~~~~~~~~~~~~~--~----~~~~~~~~~~~li~~cl~~dp~~Rp~~~~il~~ 260 (262)
T cd05077 202 ICYNGEIPLKDKTLAEKERFYEGQC--M----LVTPSCKELADLMTHCMNYDPNQRPFFRAIMRD 260 (262)
T ss_pred HHhCCCCCCCCcchhHHHHHHhcCc--c----CCCCChHHHHHHHHHHcCCChhhCcCHHHHHHh
Confidence 97 5888888766554433222111 1 112346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom |
| >cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.1e-38 Score=241.79 Aligned_cols=209 Identities=31% Similarity=0.515 Sum_probs=178.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.....+.+|++++++++|+||+++++++.+.+..++|||++.+++|.+++... ..++...+..++.+++.++.+||++|
T Consensus 34 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~lH~~~ 113 (251)
T cd05041 34 DLKRKFLQEAEILKQYDHPNIVKLIGVCVQKQPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEYLESKN 113 (251)
T ss_pred HHHHHHHHHHHHHHhCCCCCeEEEEEEEecCCCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 35678999999999999999999999999999999999999999999999654 46889999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc---ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
++|+||+|+||++ +.++.++|+|||.+......... .....+..|.|||.+.+..++.++|+||+|+++|++++
T Consensus 114 i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~i~~~l~t 190 (251)
T cd05041 114 CIHRDLAARNCLV---GENNVLKISDFGMSREEEGGIYTVSDGLKQIPIKWTAPEALNYGRYTSESDVWSYGILLWETFS 190 (251)
T ss_pred EehhhcCcceEEE---cCCCcEEEeeccccccccCCcceeccccCcceeccCChHhhccCCCCcchhHHHHHHHHHHHHh
Confidence 9999999999999 77889999999998765422111 11222456999999988889999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 -GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 -g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||...........+........+ ...+.++.+++.+||..+|.+|||++++++
T Consensus 191 ~~~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~ell~ 247 (251)
T cd05041 191 LGDTPYPGMSNQQTRERIESGYRMPAP----QLCPEEIYRLMLQCWAYDPENRPSFSEIYN 247 (251)
T ss_pred ccCCCCccCCHHHHHHHHhcCCCCCCC----ccCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 88999888877777666544333332 367889999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k |
| >cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=248.70 Aligned_cols=215 Identities=30% Similarity=0.472 Sum_probs=181.3
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
+..+.+.+|++++++++|+|++++++++.+++..++||||+. +++.+.+.. ..++++..+..++.+++.|+.+||+.|
T Consensus 67 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 145 (317)
T cd06635 67 EKWQDIIKEVKFLQRIKHPNSIEYKGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAITHGALQGLAYLHSHN 145 (317)
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCeEEEEEeCCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 445678899999999999999999999999999999999996 577777754 456899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc---ccCCCCchhHHHHHHHHHHHHh
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
++|+||+|.||++ +.++.++|+|||.+..... .....++..|+|||.+. +..++.++|+||+|+++|+|++
T Consensus 146 i~H~dL~p~Nil~---~~~~~~kl~dfg~~~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvil~el~~ 219 (317)
T cd06635 146 MIHRDIKAGNILL---TEPGQVKLADFGSASIASP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 219 (317)
T ss_pred cccCCCCcccEEE---CCCCCEEEecCCCccccCC---cccccCCccccChhhhhcCCCCCCCccccHHHHHHHHHHHHh
Confidence 9999999999999 6788999999998765432 22345788899999873 4567889999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
|..||...+.......+......... ....++.+.+++.+||+.+|.+||++.++++|+|+.....
T Consensus 220 g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~~p~~Rpt~~~il~~~~~~~~~~ 285 (317)
T cd06635 220 RKPPLFNMNAMSALYHIAQNESPTLQ---SNEWSDYFRNFVDSCLQKIPQDRPTSEELLKHMFVLRERP 285 (317)
T ss_pred CCCCCCCccHHHHHHHHHhccCCCCC---CccccHHHHHHHHHHccCCcccCcCHHHHHhChhhhccCc
Confidence 99999887766666666544433222 2367889999999999999999999999999999976544
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron |
| >cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-38 Score=243.24 Aligned_cols=206 Identities=23% Similarity=0.424 Sum_probs=174.8
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+.+.+|++++++++|+|++++++++.. +..+++|||+.+++|.+++.... .+++..+..++.|++.|+.+||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i 123 (260)
T cd05069 45 PEAFLQEAQIMKKLRHDKLVPLYAVVSE-EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGMAYIERMNY 123 (260)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEcC-CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 4568899999999999999999988754 56889999999999999997643 47899999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc--ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+|+||+|.||++ ++++.++|+|||.+......... ....++..|+|||...+..++.++|+||||+++|++++ |
T Consensus 124 ~H~dl~~~Nill---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~Di~slG~~l~el~t~g 200 (260)
T cd05069 124 IHRDLRAANILV---GDNLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG 200 (260)
T ss_pred eecccCcceEEE---cCCCeEEECCCccceEccCCcccccCCCccchhhCCHHHhccCCcChHHHHHHHHHHHHHHHhCC
Confidence 999999999999 78889999999998765432211 12234567999999988889999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
..||.+....+....+......+.+ ...+..+.+++++||+.||.+||+++++++
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~i~~ 255 (260)
T cd05069 201 RVPYPGMVNREVLEQVERGYRMPCP----QGCPESLHELMKLCWKKDPDERPTFEYIQS 255 (260)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC----cccCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9999988887777777554433322 367899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an |
| >KOG0614 consensus cGMP-dependent protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-39 Score=259.42 Aligned_cols=229 Identities=31% Similarity=0.562 Sum_probs=208.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+.++.+-+..|-+|+.+++++.||++|..|.++...|++||-|-||.|...++.++.|++.....++..+++|+.|||++
T Consensus 460 dtkQqeHv~sEr~Im~~~~s~fIvrLYrTfrd~kyvYmLmEaClGGElWTiLrdRg~Fdd~tarF~~acv~EAfeYLH~k 539 (732)
T KOG0614|consen 460 DTKQQEHVFSERNIMMECRSDFIVRLYRTFRDSKYVYMLMEACLGGELWTILRDRGSFDDYTARFYVACVLEAFEYLHRK 539 (732)
T ss_pred chhHHHHHHhHHHHHHhcCchHHHHHHHHhccchhhhhhHHhhcCchhhhhhhhcCCcccchhhhhHHHHHHHHHHHHhc
Confidence 55677888999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
||++|||||+|.++ +.++-+||.|||+|+..+.+..+-+.+||+.|.|||.+.++.-..+.|.||||+++||+++|.
T Consensus 540 ~iIYRDLKPENllL---d~~Gy~KLVDFGFAKki~~g~KTwTFcGTpEYVAPEIILnKGHD~avDyWaLGIli~ELL~G~ 616 (732)
T KOG0614|consen 540 GIIYRDLKPENLLL---DNRGYLKLVDFGFAKKIGSGRKTWTFCGTPEYVAPEIILNKGHDRAVDYWALGILIYELLTGS 616 (732)
T ss_pred CceeccCChhheee---ccCCceEEeehhhHHHhccCCceeeecCCcccccchhhhccCcchhhHHHHHHHHHHHHHcCC
Confidence 99999999999999 899999999999999999988888999999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCC-CCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc-----ccccC
Q 026253 166 PPFSGRNNVQLVRNINSCKH-LPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR-----NSAIL 234 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~-----~~~~~ 234 (241)
+||.+.++...++.|-.+-. ..+|. .++....++++++...+|.+|.. +.+|-+|.||.+ ..+..
T Consensus 617 pPFs~~dpmktYn~ILkGid~i~~Pr----~I~k~a~~Lik~LCr~~P~ERLG~~~~gI~DIkkH~Wf~gfdweglr~~~ 692 (732)
T KOG0614|consen 617 PPFSGVDPMKTYNLILKGIDKIEFPR----RITKTATDLIKKLCRDNPTERLGYQKGGINDIKKHRWFEGFDWEGLRSRT 692 (732)
T ss_pred CCCCCCchHHHHHHHHhhhhhhhccc----ccchhHHHHHHHHHhcCcHhhhccccCChHHHHhhhhhhcCChhhhhhcc
Confidence 99999999999988866543 34443 78889999999999999999986 899999999987 34444
Q ss_pred CCCCCCC
Q 026253 235 RAPFHIP 241 (241)
Q Consensus 235 ~~~~~~~ 241 (241)
.+|+.+|
T Consensus 693 L~pPi~~ 699 (732)
T KOG0614|consen 693 LPPPIIP 699 (732)
T ss_pred CCCCccc
Confidence 4444443
|
|
| >cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-38 Score=251.17 Aligned_cols=210 Identities=24% Similarity=0.392 Sum_probs=177.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|+.+++.++|+||+++++++..+ ..+++++++.+|+|.+++... ..++...+..++.|++.||+|||+.
T Consensus 50 ~~~~~~~~~e~~~l~~l~h~niv~~~g~~~~~-~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~LH~~ 128 (316)
T cd05108 50 PKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEER 128 (316)
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEcCC-CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHhc
Confidence 34567788999999999999999999998764 467999999999999999865 4588999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc---ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
|++|+||||.||++ +.++.++|+|||++......... .....+..|++||.+.+..++.++|+||||+++|+++
T Consensus 129 ~iiH~dlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slGv~l~el~ 205 (316)
T cd05108 129 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGADEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 205 (316)
T ss_pred CeeccccchhheEe---cCCCcEEEccccccccccCCCcceeccCCccceeecChHHhccCCCCchhhhHHHHHHHHHHH
Confidence 99999999999999 67888999999999866433221 1222356799999999889999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+ |..||.+....+....+......+.+ +.++.++.+++.+||..+|.+|||+.+++.+
T Consensus 206 t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~cl~~~p~~Rps~~~l~~~ 264 (316)
T cd05108 206 TFGSKPYDGIPASEISSILEKGERLPQP----PICTIDVYMIMVKCWMIDADSRPKFRELIIE 264 (316)
T ss_pred cCCCCCCCCCCHHHHHHHHhCCCCCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 7 99999988777766666554444333 3678899999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor |
| >cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.5e-38 Score=242.38 Aligned_cols=208 Identities=26% Similarity=0.504 Sum_probs=179.1
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|++++++++|+|++++++++......+++|||+++++|.+++... +.++++.+..++.+++.++++||+.|++
T Consensus 43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~i~ 122 (256)
T cd05112 43 EEDFIEEAQVMMKLSHPKLVQLYGVCTERSPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMAYLESSNVI 122 (256)
T ss_pred HHHHHHHHHHHHhCCCCCeeeEEEEEccCCceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 356889999999999999999999999999999999999999999999764 4689999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc--ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~ 165 (241)
|+||+|.||++ +.++.++|+|||.+......... .....+..|+|||...+..++.++|+||+|+++|++++ |.
T Consensus 123 h~dl~p~ni~i---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~aPe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 199 (256)
T cd05112 123 HRDLAARNCLV---GENQVVKVSDFGMTRFVLDDQYTSSTGTKFPVKWSSPEVFSFSKYSSKSDVWSFGVLMWEVFSEGK 199 (256)
T ss_pred ccccccceEEE---cCCCeEEECCCcceeecccCcccccCCCccchhhcCHhHhccCCcChHHHHHHHHHHHHHHHcCCC
Confidence 99999999999 67888999999998765433221 12224567999999988889999999999999999998 99
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.||...........+..+.....+. ..+..+.+++++||+.+|.+|||+.++++.
T Consensus 200 ~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~l~~~~l~~~p~~Rp~~~~~l~~ 254 (256)
T cd05112 200 TPYENRSNSEVVETINAGFRLYKPR----LASQSVYELMQHCWKERPEDRPSFSLLLHQ 254 (256)
T ss_pred CCCCcCCHHHHHHHHhCCCCCCCCC----CCCHHHHHHHHHHcccChhhCCCHHHHHHh
Confidence 9999888888888776554433332 468899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ |
| >cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=244.38 Aligned_cols=207 Identities=23% Similarity=0.334 Sum_probs=169.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
....+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++.+ .+.+++..+..++.|++.||.|||++|+
T Consensus 59 ~~~~~~~~~~~~~~l~h~niv~~~~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 138 (274)
T cd05076 59 IALAFFETASLMSQVSHIHLAFVHGVCVRGSENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSYLEDKNL 138 (274)
T ss_pred HHHHHHHHHHHHhcCCCCCeeeEEEEEEeCCceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHcCCc
Confidence 355788899999999999999999999999999999999999999999875 4568999999999999999999999999
Q ss_pred cccCCCCCCeEEeec----CCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHH
Q 026253 88 IHRDLKPENILLSGL----DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 88 ~H~dl~~~nil~~~~----~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~ 162 (241)
+|+||||.||+++.. .....++++|||.+...... ....++..|+|||.+.+ ..++.++|+||||+++|+++
T Consensus 139 iH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~---~~~~~~~~~~aPe~~~~~~~~~~~~Dv~slG~~l~el~ 215 (274)
T cd05076 139 VHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR---EERVERIPWIAPECVPGGNSLSTAADKWSFGTTLLEIC 215 (274)
T ss_pred cCCCCCcccEEEeccCcccCccceeeecCCccccccccc---cccccCCcccCchhhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999999532 12334899999987554322 22346778999998865 56899999999999999985
Q ss_pred -hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 163 -NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 163 -~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+|..||......+.......... .+ ...+..+.+++.+||+.+|++|||+.+++++
T Consensus 216 ~~g~~p~~~~~~~~~~~~~~~~~~--~~----~~~~~~~~~li~~cl~~~p~~Rps~~~il~~ 272 (274)
T cd05076 216 FDGEVPLKERTPSEKERFYEKKHR--LP----EPSCKELATLISQCLTYEPTQRPSFRTILRD 272 (274)
T ss_pred hCCCCCccccChHHHHHHHHhccC--CC----CCCChHHHHHHHHHcccChhhCcCHHHHHHh
Confidence 69999988776655444332221 22 2346789999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt |
| >KOG0193 consensus Serine/threonine protein kinase RAF [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-39 Score=262.52 Aligned_cols=215 Identities=25% Similarity=0.406 Sum_probs=185.3
Q ss_pred hhHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
.++++.+.|++|+.++++-+|.||+=+.|++...+. .||+.+|+|.+|..++.-. ..|.......|++|+++|+.|||
T Consensus 427 pt~~qlqaFKnEVa~lkkTRH~NIlLFMG~~~~p~~-AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~YLH 505 (678)
T KOG0193|consen 427 PTPEQLQAFKNEVAVLKKTRHENILLFMGACMNPPL-AIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDYLH 505 (678)
T ss_pred CCHHHHHHHHHHHHHHhhcchhhheeeehhhcCCce-eeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhhhh
Confidence 466789999999999999999999999999999887 9999999999999999654 35899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCC---CCccccccCCCCccCccccc---ccCCCCchhHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAI 157 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~---~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~ 157 (241)
.++|+|+|||..|||+ .+++.|+|+|||++..... ........+...|+|||+++ ..+|++.+||||+|+|
T Consensus 506 AK~IIHrDLKSnNIFl---~~~~kVkIgDFGLatvk~~w~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGiV 582 (678)
T KOG0193|consen 506 AKNIIHRDLKSNNIFL---HEDLKVKIGDFGLATVKTRWSGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGIV 582 (678)
T ss_pred hhhhhhhhccccceEE---ccCCcEEEecccceeeeeeeccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhHH
Confidence 9999999999999999 7779999999999865432 22333455778899999986 3469999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 158 LFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+|||++|..||......+.+-.+-.+...+-......+.++++.+|+..||..++++||.+.+||.
T Consensus 583 ~YELltg~lPysi~~~dqIifmVGrG~l~pd~s~~~s~~pk~mk~Ll~~C~~~~~~eRP~F~~il~ 648 (678)
T KOG0193|consen 583 WYELLTGELPYSIQNRDQIIFMVGRGYLMPDLSKIRSNCPKAMKRLLSDCWKFDREERPLFPQLLS 648 (678)
T ss_pred HHHHHhCcCCcCCCChhheEEEecccccCccchhhhccCHHHHHHHHHHHHhcCcccCccHHHHHH
Confidence 999999999999766666666665554444444455678889999999999999999999999886
|
|
| >cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-38 Score=244.24 Aligned_cols=201 Identities=29% Similarity=0.430 Sum_probs=167.9
Q ss_pred HHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 026253 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL 92 (241)
Q Consensus 13 ~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl 92 (241)
..+|...+....||||+++++++.+++..+++|||++|++|.+++.+..++++..+..++.|++.||.+||+.|++|+||
T Consensus 32 ~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H~dl 111 (237)
T cd05576 32 YSRERLTIIPHCVPNMVCLHKYIVSEDSVFLVLQHAEGGKLWSHISKFLNIPEECVKRWAAEMVVALDALHREGIVCRDL 111 (237)
T ss_pred hhhHHHHHHhcCCCceeehhhheecCCeEEEEEecCCCCCHHHHHHHhcCCCHHHHHHHHHHHHHHHHHHHhCCeeccCC
Confidence 44566666667899999999999999999999999999999999988778999999999999999999999999999999
Q ss_pred CCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026253 93 KPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172 (241)
Q Consensus 93 ~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 172 (241)
+|+||++ +.++.++++|||.+....... .....+..|+|||...+..++.++|+||+|+++|++++|..|+....
T Consensus 112 kp~Nil~---~~~~~~~l~df~~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el~~g~~~~~~~~ 186 (237)
T cd05576 112 NPNNILL---DDRGHIQLTYFSRWSEVEDSC--DGEAVENMYCAPEVGGISEETEACDWWSLGAILFELLTGKTLVECHP 186 (237)
T ss_pred CHHHEEE---cCCCCEEEecccchhcccccc--ccCCcCccccCCcccCCCCCCchhhHHHHHHHHHHHHHCcchhhcCc
Confidence 9999999 678889999999876554322 22345677999999988888999999999999999999998876432
Q ss_pred hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH-----HHHhcCccc
Q 026253 173 NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF-----NEFYHHRFL 227 (241)
Q Consensus 173 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~ 227 (241)
.. +....... ..+.++..+.++|.+||+.||++||++ +++++||||
T Consensus 187 ~~-----~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~R~~~~~~~~~~~~~h~~~ 237 (237)
T cd05576 187 SG-----INTHTTLN----IPEWVSEEARSLLQQLLQFNPTERLGAGVAGVEDIKSHPFF 237 (237)
T ss_pred hh-----cccccccC----CcccCCHHHHHHHHHHccCCHHHhcCCCccchHHHHcCCCC
Confidence 11 11111111 223678899999999999999999986 999999997
|
Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha |
| >cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9 | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-38 Score=250.94 Aligned_cols=214 Identities=25% Similarity=0.432 Sum_probs=168.9
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecC--------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN--------CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~--------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~ 80 (241)
...+.+|++++++++||||+++++++...+ ..++||||+. ++|.+++... ..+++..+..++.|++.||.
T Consensus 55 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~ 133 (310)
T cd07865 55 PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCE-HDLAGLLSNKNVKFTLSEIKKVMKMLLNGLY 133 (310)
T ss_pred hhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCC-cCHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999876543 4599999995 5888887654 36899999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----cccccCCCCccCccccccc-CCCCchhHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSV 154 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~sl 154 (241)
+||+.|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+||+
T Consensus 134 ~lH~~~i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~sl 210 (310)
T cd07865 134 YIHRNKILHRDMKAANILI---TKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGA 210 (310)
T ss_pred HHHHCCeeccCCCHHHEEE---CCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHH
Confidence 9999999999999999999 7888999999999876533221 1223467789999987654 36889999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHhhcCCCC------------------CCCCc--------c-CCCCChHHHHHHHHh
Q 026253 155 GAILFELLNGYPPFSGRNNVQLVRNINSCKHL------------------PFSQL--------I-VPALHPDCVDMCLKL 207 (241)
Q Consensus 155 G~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~------------------~~~~~--------~-~~~~~~~~~~li~~~ 207 (241)
|+++|++++|..||.+.+.......+...... ..+.. . ....+..+.++|.+|
T Consensus 211 G~~l~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~ 290 (310)
T cd07865 211 GCIMAEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKL 290 (310)
T ss_pred HHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHH
Confidence 99999999999999887765544433221110 00000 0 011356788999999
Q ss_pred cccCccccCCHHHHhcCccc
Q 026253 208 LSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 208 l~~~p~~Rps~~~il~~~~~ 227 (241)
|..||.+|||++++++||||
T Consensus 291 l~~~P~~R~t~~e~l~h~~f 310 (310)
T cd07865 291 LVLDPAKRIDADTALNHDFF 310 (310)
T ss_pred hcCChhhccCHHHHhcCCCC
Confidence 99999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl |
| >cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.2e-38 Score=249.44 Aligned_cols=214 Identities=29% Similarity=0.476 Sum_probs=179.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|+++++.++|+|++++.+++..+...++||||+. +++.+++.. ..++++..+..++.+++.|+.+||+.+
T Consensus 57 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~LH~~~ 135 (308)
T cd06634 57 EKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSHN 135 (308)
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEEcCCeeEEEEEccC-CCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345567899999999999999999999999999999999995 688877754 456899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc---ccCCCCchhHHHHHHHHHHHHh
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
++|+||+|.||++ +.++.++|+|||.+...... ....++..|+|||.+. ...++.++|+||+|+++|++++
T Consensus 136 i~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~il~el~~ 209 (308)
T cd06634 136 MIHRDVKAGNILL---SEPGLVKLGDFGSASIMAPA---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAE 209 (308)
T ss_pred cccCCCCHHhEEE---CCCCcEEECCcccceeecCc---ccccCCccccCHHHHhhcccCCCCcccchHHHHHHHHHHHc
Confidence 9999999999999 67889999999998665432 2345678899999874 3457889999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|..||...+.......+......... ...++..+.++|++||+.+|.+||+++++++|||+....
T Consensus 210 g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~li~~cl~~~P~~Rp~~~~ll~~~~~~~~~ 274 (308)
T cd06634 210 RKPPLFNMNAMSALYHIAQNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 274 (308)
T ss_pred CCCCCccccHHHHHHHHhhcCCCCcC---cccccHHHHHHHHHHhhCCcccCCCHHHHhhCccccccC
Confidence 99999877666555555443332222 236788999999999999999999999999999998853
|
Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin |
| >cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=252.01 Aligned_cols=211 Identities=27% Similarity=0.443 Sum_probs=180.3
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTAR 69 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~~ 69 (241)
....+.+.+|+++++++ +|+||+++++++..++..+++|||+.+++|.+++.+.. .++...+.
T Consensus 58 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~~ 137 (334)
T cd05100 58 DKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTFKDLV 137 (334)
T ss_pred HHHHHHHHHHHHHHHhhcCCCCeeeeeEEEccCCceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCHHHHH
Confidence 34467889999999999 89999999999999999999999999999999997532 36778899
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCC
Q 026253 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (241)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~ 146 (241)
.++.|++.||.+||++|++|+||+|.||++ +.++.++|+|||.++....... .....++..|+|||.+.+..++
T Consensus 138 ~~~~qi~~al~~LH~~givH~dlkp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 214 (334)
T cd05100 138 SCAYQVARGMEYLASQKCIHRDLAARNVLV---TEDNVMKIADFGLARDVHNIDYYKKTTNGRLPVKWMAPEALFDRVYT 214 (334)
T ss_pred HHHHHHHHHHHHHHHCCeeccccccceEEE---cCCCcEEECCcccceecccccccccccCCCcCceEcCHHHhccCCcC
Confidence 999999999999999999999999999999 6778899999999876543221 1122234579999999888899
Q ss_pred CchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 147 EKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 147 ~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.++|+||||+++|+|++ |..||.+.+..+....+......+.+ ...+..+.+++.+||+.+|.+|||+.+++++
T Consensus 215 ~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~~p~~Rps~~ell~~ 289 (334)
T cd05100 215 HQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP----ANCTHELYMIMRECWHAVPSQRPTFKQLVED 289 (334)
T ss_pred chhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence 99999999999999998 89999998888888877655444333 3678899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to |
| >cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.1e-37 Score=245.64 Aligned_cols=208 Identities=26% Similarity=0.407 Sum_probs=168.3
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+.+|++++++++|+||+++++++... ...+++|||+++++|.+++... .+++..+..++.|++.|+.+||++
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~-~l~~~~~~~i~~~l~~~l~~lH~~ 126 (283)
T cd05080 48 QNTSGWKKEINILKTLYHENIVKYKGCCSEQGGKGLQLIMEYVPLGSLRDYLPKH-KLNLAQLLLFAQQICEGMAYLHSQ 126 (283)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCceEEEEecCCCCCCHHHHHHHc-CCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3567788999999999999999999987653 4688999999999999999754 699999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|++|+||||+||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++|+|
T Consensus 127 ~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~slG~~l~el 203 (283)
T cd05080 127 HYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAVECLKENKFSYASDVWSFGVTLYEL 203 (283)
T ss_pred CeeccccChheEEE---cCCCcEEEeecccccccCCcchhhccCCCCCCCceeeCHhHhcccCCCcccccHHHHHHHHHH
Confidence 99999999999999 6788999999999876543221 1122345669999999888899999999999999999
Q ss_pred HhCCCCCCCCChH---------------HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LNGYPPFSGRNNV---------------QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~g~~p~~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++|..||...... .....+......+ ....++.++.+++.+||+.+|++|||++++++
T Consensus 204 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rps~~~i~~ 276 (283)
T cd05080 204 LTHCDSKQSPPKKFEEMIGPKQGQMTVVRLIELLERGMRLP----CPKNCPQEVYILMKNCWETEAKFRPTFRSLIP 276 (283)
T ss_pred HhCCCCCCCCcchhhhhhcccccccchhhhhhhhhcCCCCC----CCCCCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999998643321 0111111111111 23467889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign |
| >cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.9e-38 Score=247.77 Aligned_cols=214 Identities=35% Similarity=0.539 Sum_probs=176.1
Q ss_pred hhhHHHHHHHHhcC---CCcCeeeeeeEEeecCe-----EEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSV---NHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 10 ~~~~~~E~~~l~~l---~~~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l 79 (241)
...+.+|+.+++++ +|+|++++++++...+. .+++||++. ++|.+++.... .+++..+..++.|++.||
T Consensus 42 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~l~~e~~~-~~l~~~l~~~~~~~l~~~~~~~~~~~i~~al 120 (287)
T cd07838 42 PLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTDRELKLTLVFEHVD-QDLATYLSKCPKPGLPPETIKDLMRQLLRGV 120 (287)
T ss_pred hhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCCCCceeEEEehhcc-cCHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence 44567788877766 59999999999987766 999999996 58999887643 489999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
.+||+.|++|+|++|.||++ +.++.++|+|||.+.............++..|.|||.+.+..++.++|+||+|+++|
T Consensus 121 ~~LH~~~i~h~~l~~~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Di~s~G~~l~ 197 (287)
T cd07838 121 DFLHSHRIVHRDLKPQNILV---TSDGQVKIADFGLARIYSFEMALTSVVVTLWYRAPEVLLQSSYATPVDMWSVGCIFA 197 (287)
T ss_pred HHHHHCCeeeccCChhhEEE---ccCCCEEEeccCcceeccCCcccccccccccccChHHhccCCCCCcchhhhHHHHHH
Confidence 99999999999999999999 677899999999987765443333445678899999999888999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCC----------------------CCccCCCCChHHHHHHHHhcccCccccCC
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPF----------------------SQLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
+|++|.+||.+.+..+....+......+. .....+.++..+.+++.+||+.||.+||+
T Consensus 198 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rp~ 277 (287)
T cd07838 198 ELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSSFPSYTPRSFKSFVPEICEEGLDLLKKMLTFNPHKRIS 277 (287)
T ss_pred HHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhhcccccccchhhhhhhhhHHHHHHHHHHhccCCccCCC
Confidence 99999999998877766655533211100 01112345678899999999999999999
Q ss_pred HHHHhcCccc
Q 026253 218 FNEFYHHRFL 227 (241)
Q Consensus 218 ~~~il~~~~~ 227 (241)
+++++.||||
T Consensus 278 ~~~il~~~~~ 287 (287)
T cd07838 278 AFEALQHPYF 287 (287)
T ss_pred HHHHhcCcCC
Confidence 9999999997
|
Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both |
| >cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-38 Score=255.87 Aligned_cols=223 Identities=29% Similarity=0.493 Sum_probs=181.7
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCe------EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
...+.+.+|+.++++++|+|++++.+++...+. .++|+|++ +++|.+++.. .++++..+..++.|++.|+.+
T Consensus 56 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~ql~~aL~~ 133 (343)
T cd07851 56 IHAKRTYRELRLLKHMDHENVIGLLDVFTPASSLEDFQDVYLVTHLM-GADLNNIVKC-QKLSDDHIQFLVYQILRGLKY 133 (343)
T ss_pred hHHHHHHHHHHHHHhccCCCHHHHHHHhhccccccccccEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence 345667889999999999999999998765544 89999999 7799999874 579999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~ 160 (241)
||+.|++|+||+|.||++ +.++.++|+|||.+...... .....++..|.|||.+.+ ..++.++|+||+|+++|+
T Consensus 134 LH~~gi~H~dlkp~Nill---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~e 208 (343)
T cd07851 134 IHSAGIIHRDLKPSNIAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 208 (343)
T ss_pred HHHCCeecCCCCHHHeEE---CCCCCEEEcccccccccccc--ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHHH
Confidence 999999999999999999 67888999999998765433 233456788999998765 367899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCCC--------------------------CccCCCCChHHHHHHHHhcccCccc
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPFS--------------------------QLIVPALHPDCVDMCLKLLSANTVD 214 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~ 214 (241)
+++|..||.+.+..+.+..+......+.+ .......+..+.+++++||+.+|.+
T Consensus 209 lltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~l~dli~~~l~~~P~~ 288 (343)
T cd07851 209 LLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGANPLAIDLLEKMLVLDPDK 288 (343)
T ss_pred HHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHhccCCHHHHHHHHHhCCCChhh
Confidence 99999999887776655554332211110 0111346889999999999999999
Q ss_pred cCCHHHHhcCcccccccccCCCC
Q 026253 215 RLSFNEFYHHRFLRRNSAILRAP 237 (241)
Q Consensus 215 Rps~~~il~~~~~~~~~~~~~~~ 237 (241)
|||+.++++||||++.......+
T Consensus 289 Rpt~~ell~h~~~~~~~~~~~~~ 311 (343)
T cd07851 289 RITAAEALAHPYLAEYHDPEDEP 311 (343)
T ss_pred CCCHHHHhcCCCccccCCCcccc
Confidence 99999999999999866554433
|
Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK |
| >cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=241.93 Aligned_cols=205 Identities=24% Similarity=0.447 Sum_probs=174.7
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+|+.++++++|++++++++++.. +..+++|||+.+++|.+++... ..+++..+..++.+++.|+.+||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al~~lH~~~i 123 (260)
T cd05070 45 PESFLEEAQIMKKLRHDKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGMAYIERMNY 123 (260)
T ss_pred HHHHHHHHHHHHhcCCCceEEEEeEECC-CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4568899999999999999999998754 5688999999999999999753 358999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+|+||+|.||++ ++++.++|+|||.+........ .....++..|+|||...+..++.++|+||||+++|++++ |
T Consensus 124 ~H~di~p~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~~g 200 (260)
T cd05070 124 IHRDLRSANILV---GDGLVCKIADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELVTKG 200 (260)
T ss_pred ccCCCccceEEE---eCCceEEeCCceeeeeccCcccccccCCCCCccccChHHHhcCCCcchhhhHHHHHHHHHHHhcC
Confidence 999999999999 6778899999999876543221 112234457999999988889999999999999999999 8
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
..||.+.+..+....+......+.+ ...+..+.+++.+||..+|.+|||+.+++
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rpt~~~l~ 254 (260)
T cd05070 201 RVPYPGMNNREVLEQVERGYRMPCP----QDCPISLHELMLQCWKKDPEERPTFEYLQ 254 (260)
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCC----CcCCHHHHHHHHHHcccCcccCcCHHHHH
Confidence 9999988888877777655443333 36788999999999999999999999987
|
Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r |
| >KOG0586 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-39 Score=261.13 Aligned_cols=215 Identities=36% Similarity=0.651 Sum_probs=193.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|+++++.|+||||++++.+.+....+|+||||+.++.+.+|+.+.++..+..+.....|+.+|++|||++++
T Consensus 97 ~~~~k~~rev~imk~l~HPnIvkl~~v~~t~~~lylV~eya~~ge~~~yl~~~gr~~e~~ar~~F~q~vsaveYcH~k~i 176 (596)
T KOG0586|consen 97 SKRQKLGREVDIMKSLNHPNIVKLFSVIETEATLYLVMEYASGGELFDYLVKHGRMKEKEARAKFRQIVSAVEYCHSKNI 176 (596)
T ss_pred HHHHHHHHHHHHHHhcCCcceeeeeeeeeecceeEEEEEeccCchhHHHHHhcccchhhhhhhhhHHHHHHHHHHhhcce
Confidence 33455899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|||||++|+++ +.+-.++|+|||++..+.........+|++.|.|||++.+..+ ++..|+||+|+++|.++.|.+
T Consensus 177 vHrdLk~eNilL---~~~mnikIaDfgfS~~~~~~~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvly~LV~GsL 253 (596)
T KOG0586|consen 177 VHRDLKAENILL---DENMNIKIADFGFSTFFDYGLMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVLYALVEGSL 253 (596)
T ss_pred eccccchhhccc---ccccceeeeccccceeecccccccccCCCCCccChHhhcCcccCCcceehhhhhhhheeeeeccc
Confidence 999999999999 7788899999999999888888889999999999999998876 689999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
||++.+-.++-.....++ ...+ ..++.++.++|+++|..+|.+|++.+++.+|.|....
T Consensus 254 PFDG~~lk~Lr~rvl~gk-~rIp----~~ms~dce~lLrk~lvl~Pskr~~~dqim~~~W~n~~ 312 (596)
T KOG0586|consen 254 PFDGQNLKELRPRVLRGK-YRIP----FYMSCDCEDLLRKFLVLNPSKRGPCDQIMKDRWRNDL 312 (596)
T ss_pred ccCCcccccccchheeee-eccc----ceeechhHHHHHHhhccCccccCCHHHhhhhcccchh
Confidence 999877666555443333 1222 2678899999999999999999999999999998864
|
|
| >cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=242.43 Aligned_cols=208 Identities=24% Similarity=0.462 Sum_probs=179.4
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|+.++++++|+||+++++++..+...+++||++++++|.+++.... .+++..+..++.+++.|+.+||++|
T Consensus 44 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al~~lh~~~ 123 (261)
T cd05034 44 SPEAFLQEAQIMKKLRHDKLVQLYAVCSEEEPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGMAYLESRN 123 (261)
T ss_pred CHHHHHHHHHHHhhCCCCCEeeeeeeeecCCceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 34678999999999999999999999999899999999999999999997653 5899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc--ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
++|+||+|+||++ ++++.++++|||.+......... .....+..|.|||.+.+..++.++|+||+|++++++++
T Consensus 124 i~h~di~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~il~~l~t~ 200 (261)
T cd05034 124 YIHRDLAARNILV---GENLVCKIADFGLARLIEDDEYTAREGAKFPIKWTAPEAANYGRFTIKSDVWSFGILLTEIVTY 200 (261)
T ss_pred cccCCcchheEEE---cCCCCEEECccccceeccchhhhhhhccCCCccccCHHHhccCCcCchhHHHHHHHHHHHHHhC
Confidence 9999999999999 77899999999998765432111 12223467999999998889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|+.||.+.+.......+......+.+. ..+.++.+++.+||+.+|.+||+++++++
T Consensus 201 g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 256 (261)
T cd05034 201 GRVPYPGMTNREVLEQVERGYRMPRPP----NCPEELYDLMLQCWDKDPEERPTFEYLQS 256 (261)
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence 999999888888888776554443333 56889999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t |
| >cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.5e-38 Score=247.79 Aligned_cols=214 Identities=29% Similarity=0.468 Sum_probs=168.3
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|+.+++.++|+||+++++++..++..++||||+. +++.+++.. ...+++..+..++.|++.||.+||+.|++
T Consensus 47 ~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~lH~~~i~ 125 (291)
T cd07870 47 PFTAIREASLLKGLKHANIVLLHDIIHTKETLTFVFEYMH-TDLAQYMIQHPGGLHPYNVRLFMFQLLRGLAYIHGQHIL 125 (291)
T ss_pred cHHHHHHHHHHHhcCCCCEeEEEEEEecCCeEEEEEeccc-CCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 3467889999999999999999999999999999999995 677777654 35678889999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+. .++.++|+||+|+++|++++|..
T Consensus 126 H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 202 (291)
T cd07870 126 HRDLKPQNLLI---SYLGELKLADFGLARAKSIPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQP 202 (291)
T ss_pred cCCCChHHEEE---cCCCcEEEeccccccccCCCCCCCCCccccccccCCceeecCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 99999999999 67889999999998654322 122334468889999998654 47889999999999999999999
Q ss_pred CCCCCChH-HHHHHhhcCCCCCC----------------------CC---ccC--CCCChHHHHHHHHhcccCccccCCH
Q 026253 167 PFSGRNNV-QLVRNINSCKHLPF----------------------SQ---LIV--PALHPDCVDMCLKLLSANTVDRLSF 218 (241)
Q Consensus 167 p~~~~~~~-~~~~~i~~~~~~~~----------------------~~---~~~--~~~~~~~~~li~~~l~~~p~~Rps~ 218 (241)
||.+.+.. +.+..+......+. +. ... -..+..+.+++.+|+..||++|||+
T Consensus 203 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~~dp~~R~t~ 282 (291)
T cd07870 203 AFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLMMFPKDRISA 282 (291)
T ss_pred CCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhCcCcccCcCH
Confidence 99865432 22222211000000 00 000 0235688999999999999999999
Q ss_pred HHHhcCccc
Q 026253 219 NEFYHHRFL 227 (241)
Q Consensus 219 ~~il~~~~~ 227 (241)
+|++.||||
T Consensus 283 ~~~l~h~~~ 291 (291)
T cd07870 283 QDALLHPYF 291 (291)
T ss_pred HHHhcCCCC
Confidence 999999998
|
Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess |
| >cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6 | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-38 Score=254.78 Aligned_cols=219 Identities=28% Similarity=0.562 Sum_probs=174.0
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeec--------------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~ 73 (241)
...+.+.+|++++++++|+||+++++.+... ...++||||+. ++|.+++. ...+++..+..++.
T Consensus 44 ~~~~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~l~~~~~~~~~~ 121 (342)
T cd07854 44 QSVKHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLSEEHARLFMY 121 (342)
T ss_pred chHHHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeeccc-ccHHHHHH-cCCCCHHHHHHHHH
Confidence 3456788999999999999999999876543 35789999996 68988876 35789999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC----ccccccCCCCccCcccccc-cCCCCc
Q 026253 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEK 148 (241)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~~-~~~~~~ 148 (241)
|++.|+.+||+.|++|+||+|+||+++ ..+..++++|||.+....... ......++..|.|||.+.+ ..++.+
T Consensus 122 qi~~aL~~LH~~givH~dikp~Nili~--~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~ 199 (342)
T cd07854 122 QLLRGLKYIHSANVLHRDLKPANVFIN--TEDLVLKIGDFGLARIVDPHYSHKGYLSEGLVTKWYRSPRLLLSPNNYTKA 199 (342)
T ss_pred HHHHHHHHHHhCCcccCCCCHHHEEEc--CCCceEEECCcccceecCCccccccccccccccccccCHHHHhCccccCch
Confidence 999999999999999999999999994 356679999999987643221 1122346778999998654 457889
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCC-------------------------CCCccCCCCChHHHHH
Q 026253 149 VDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLP-------------------------FSQLIVPALHPDCVDM 203 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------------------------~~~~~~~~~~~~~~~l 203 (241)
+|+||||+++|++++|..||.+.+..+....+....... ......+.++.++.++
T Consensus 200 ~DiwSlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 279 (342)
T cd07854 200 IDMWAAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLLPGVNPEALDF 279 (342)
T ss_pred hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHccCCCHHHHHH
Confidence 999999999999999999998776655544432211000 0011234678899999
Q ss_pred HHHhcccCccccCCHHHHhcCcccccc
Q 026253 204 CLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 204 i~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+++||+.||.+|||++++++||||+..
T Consensus 280 i~~~L~~dP~~R~t~~ell~h~~~~~~ 306 (342)
T cd07854 280 LEQILTFNPMDRLTAEEALMHPYMSCY 306 (342)
T ss_pred HHHHhCCCchhccCHHHHhCCCccccc
Confidence 999999999999999999999999854
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi |
| >cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=242.14 Aligned_cols=206 Identities=22% Similarity=0.429 Sum_probs=174.4
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+.+.+|++++++++|+||+++++.+.+ +..++||||+.+++|.+++.+. ..+++..+..++.+++.||++||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~i 123 (262)
T cd05071 45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNY 123 (262)
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEECC-CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 4568899999999999999999998754 5579999999999999999763 347899999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc--ccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~--~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+|+||+|.||++ ++++.++|+|||.+......... ....++..|+|||...+..++.++|+||||+++|++++ |
T Consensus 124 ~H~dl~p~Nill---~~~~~~~L~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DvwslG~~l~ellt~g 200 (262)
T cd05071 124 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 200 (262)
T ss_pred cccccCcccEEE---cCCCcEEeccCCceeeccccccccccCCcccceecCHhHhccCCCCchhhHHHHHHHHHHHHcCC
Confidence 999999999999 67888999999998765433221 12334567999999988889999999999999999999 8
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
..||.+....+....+......+. ...++..+.+++.+|++.+|.+|||+.++++
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~~p~~Rp~~~~~~~ 255 (262)
T cd05071 201 RVPYPGMVNREVLDQVERGYRMPC----PPECPESLHDLMCQCWRKEPEERPTFEYLQA 255 (262)
T ss_pred CCCCCCCChHHHHHHHhcCCCCCC----ccccCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence 889998887777777655443332 2367899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo |
| >cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=243.73 Aligned_cols=207 Identities=26% Similarity=0.427 Sum_probs=174.8
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
....+.+|+..+++++|+||+++++++.. ...++++|++.+++|.+++... +.+++..+..++.|++.|+.+||+.|+
T Consensus 52 ~~~~~~~~~~~l~~l~h~~iv~~~~~~~~-~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 130 (279)
T cd05111 52 TFQEITDHMLAMGSLDHAYIVRLLGICPG-ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYYLEEHRM 130 (279)
T ss_pred HHHHHHHHHHHHhcCCCCCcceEEEEECC-CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 45678888889999999999999998754 5577899999999999999764 568999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
+|+||||.||++ +.++.++|+|||.+........ .....++..|++||.+.+..++.++|+||||+++|++++
T Consensus 131 iH~dlkp~nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~Dv~slG~il~el~t~ 207 (279)
T cd05111 131 VHRNLAARNILL---KSDSIVQIADFGVADLLYPDDKKYFYSEHKTPIKWMALESILFGRYTHQSDVWSYGVTVWEMMSY 207 (279)
T ss_pred eccccCcceEEE---cCCCcEEEcCCccceeccCCCcccccCCCCCcccccCHHHhccCCcCchhhHHHHHHHHHHHHcC
Confidence 999999999999 6788999999999976543221 122335667999999988889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||.+.........+..+.....+. ..+.++.+++.+||..+|++|||+.++++
T Consensus 208 g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~c~~~~p~~Rps~~el~~ 263 (279)
T cd05111 208 GAEPYAGMRPHEVPDLLEKGERLAQPQ----ICTIDVYMVMVKCWMIDENVRPTFKELAN 263 (279)
T ss_pred CCCCCCCCCHHHHHHHHHCCCcCCCCC----CCCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 999999887777666665554444333 46778999999999999999999999876
|
Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r |
| >cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.7e-38 Score=246.66 Aligned_cols=214 Identities=29% Similarity=0.513 Sum_probs=176.8
Q ss_pred hhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.....+|+..+++++ |+|++++++++.+++..++||||+ +++|.+++.... .+++..+..++.|++.+|.+||++|
T Consensus 41 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~Lh~~~ 119 (283)
T cd07830 41 ECMNLREVKSLRKLNEHPNIVKLKEVFRENDELYFVFEYM-EGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAHIHKHG 119 (283)
T ss_pred HHHHHHHHHHHHhccCCCCchhHHHHhhcCCcEEEEEecC-CCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 334567999999998 999999999999999999999999 789999887765 6899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc-ccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~-~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||+|.||++ ++++.++|+|||.+.............++..|+|||.+. +..++.++|+||+|++++++++|+
T Consensus 120 i~H~dl~~~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l~el~~g~ 196 (283)
T cd07830 120 FFHRDLKPENLLV---SGPEVVKIADFGLAREIRSRPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLR 196 (283)
T ss_pred cccCCCChhhEEE---cCCCCEEEeecccceeccCCCCcCCCCCcccccCceeeecCcCcCCccchhhHHHHHHHHHhCC
Confidence 9999999999999 778899999999987765544434456788899999874 445789999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCC-------------------------CccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFS-------------------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
+||...+.......+......+.. ....+..+..+.+++++||+.+|.+|||++|
T Consensus 197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rpt~~e 276 (283)
T cd07830 197 PLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLIPNASPEAIDLIKDMLRWDPKKRPTASQ 276 (283)
T ss_pred CccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHcccCCHHHHHHHHHhcccCcccCCCHHH
Confidence 999877665554433221111100 0111234678999999999999999999999
Q ss_pred HhcCccc
Q 026253 221 FYHHRFL 227 (241)
Q Consensus 221 il~~~~~ 227 (241)
++.||||
T Consensus 277 i~~~~~~ 283 (283)
T cd07830 277 ALQHPYF 283 (283)
T ss_pred HhhCCCC
Confidence 9999997
|
Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili |
| >cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=255.67 Aligned_cols=210 Identities=26% Similarity=0.443 Sum_probs=173.6
Q ss_pred HHhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-------------------------
Q 026253 7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------- 60 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------- 60 (241)
....+.+.+|++++++++ ||||+++++++.+.+..++||||+++++|.+++...
T Consensus 81 ~~~~~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 160 (400)
T cd05105 81 SSEKQALMSELKIMTHLGPHLNIVNLLGACTKSGPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGINPAD 160 (400)
T ss_pred hHHHHHHHHHHHHHHhcCCCCCeeeEEEEEccCCceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCCCccc
Confidence 344567899999999995 999999999999999999999999999999998643
Q ss_pred -----------------------------------------------------------------------CCCCHHHHH
Q 026253 61 -----------------------------------------------------------------------GRVPEQTAR 69 (241)
Q Consensus 61 -----------------------------------------------------------------------~~~~~~~~~ 69 (241)
..+++..+.
T Consensus 161 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~~~~ 240 (400)
T cd05105 161 ESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTTLDLL 240 (400)
T ss_pred ccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCHHHHH
Confidence 136777888
Q ss_pred HHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCC
Q 026253 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYD 146 (241)
Q Consensus 70 ~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~ 146 (241)
.++.|++.|+.+||+.|++|+||||.||++ ++++.++|+|||++........ .....++..|+|||.+.+..++
T Consensus 241 ~~~~qi~~aL~~LH~~~ivH~dikp~Nill---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~ 317 (400)
T cd05105 241 SFTYQVARGMEFLASKNCVHRDLAARNVLL---AQGKIVKICDFGLARDIMHDSNYVSKGSTFLPVKWMAPESIFDNLYT 317 (400)
T ss_pred HHHHHHHHHHHHHHhCCeeCCCCChHhEEE---eCCCEEEEEeCCcceeccccccccccCCcCCCcceEChhhhcCCCCC
Confidence 999999999999999999999999999999 6778899999999876533221 1223356779999999888899
Q ss_pred CchhHHHHHHHHHHHHh-CCCCCCCCChH-HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 147 EKVDMWSVGAILFELLN-GYPPFSGRNNV-QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 147 ~~~Dv~slG~~l~~l~~-g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
.++|+||||+++|+|++ |..||...... .....+..+.....+ ..++.++.+++.+||+.+|++|||+.++.+
T Consensus 318 ~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~RPt~~~l~~ 392 (400)
T cd05105 318 TLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIKSGYRMAKP----DHATQEVYDIMVKCWNSEPEKRPSFLHLSD 392 (400)
T ss_pred chhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHhcCCCCCCC----ccCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence 99999999999999997 99999875443 344445444333322 367889999999999999999999998875
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF- |
| >cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-37 Score=244.13 Aligned_cols=210 Identities=24% Similarity=0.381 Sum_probs=177.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+.+.+|+.+++.++|+||+++++++... ..+++++++++++|.+++... +.+++..+..++.|++.||.+||+
T Consensus 49 ~~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~lH~ 127 (279)
T cd05109 49 SPKANKEILDEAYVMAGVGSPYVCRLLGICLTS-TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSYLEE 127 (279)
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCceEEEEEcCC-CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 344567889999999999999999999988754 467899999999999999764 568999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc---ccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
+|++|+||||+||++ ++++.++|+|||++......... ....++..|+|||...+..++.++|+||||+++|++
T Consensus 128 ~~iiH~dlkp~Nil~---~~~~~~kL~dfG~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el 204 (279)
T cd05109 128 VRLVHRDLAARNVLV---KSPNHVKITDFGLARLLDIDETEYHADGGKVPIKWMALESILHRRFTHQSDVWSYGVTVWEL 204 (279)
T ss_pred CCeeccccccceEEE---cCCCcEEECCCCceeecccccceeecCCCccchhhCCHHHhccCCCCchhHHHHHHHHHHHH
Confidence 999999999999999 67788999999998765432221 122345679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++ |..||...........+..+...+.+ ...+.++.+++.+||+.||++||++.++++
T Consensus 205 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rp~~~~l~~ 263 (279)
T cd05109 205 MTFGAKPYDGIPAREIPDLLEKGERLPQP----PICTIDVYMIMVKCWMIDSECRPRFRELVD 263 (279)
T ss_pred HcCCCCCCCCCCHHHHHHHHHCCCcCCCC----ccCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 98 99999888777777766655444433 367889999999999999999999999984
|
Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve |
| >cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=243.24 Aligned_cols=210 Identities=27% Similarity=0.496 Sum_probs=178.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.+..+.+.+|++++++++|+||+++++++.+ +..++||||+++++|.+++.+.. .+++..+..++.+++.|+++||+.
T Consensus 48 ~~~~~~~~~e~~~l~~~~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~ 126 (270)
T cd05056 48 PSVREKFLQEAYIMRQFDHPHIVKLIGVITE-NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAYLESK 126 (270)
T ss_pred HHHHHHHHHHHHHHHhCCCCchhceeEEEcC-CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4456789999999999999999999998875 45789999999999999997644 589999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
|++|+||+|.||++ +..+.++++|||++........ .........|+|||.+.+..++.++|+||||+++|++++
T Consensus 127 ~~~H~dl~p~nili---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~ 203 (270)
T cd05056 127 RFVHRDIAARNVLV---SSPDCVKLGDFGLSRYLEDESYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 203 (270)
T ss_pred CeeccccChheEEE---ecCCCeEEccCceeeecccccceecCCCCccccccChhhhccCCCCchhhhHHHHHHHHHHHH
Confidence 99999999999999 6778899999999876533221 112223457999999988889999999999999999986
Q ss_pred -CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 164 -GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 164 -g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|..||.+.+..+....+..+...+.+ +.++..+.+++.+|+..+|.+|||+.++++.
T Consensus 204 ~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~P~~Rpt~~~~~~~ 261 (270)
T cd05056 204 LGVKPFQGVKNNDVIGRIENGERLPMP----PNCPPTLYSLMTKCWAYDPSKRPRFTELKAQ 261 (270)
T ss_pred cCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999988887777777666555443 3778999999999999999999999998754
|
Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions |
| >cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=7e-38 Score=246.82 Aligned_cols=215 Identities=31% Similarity=0.520 Sum_probs=177.2
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+|++++++++|+|++++++++... +..++||||+. ++|.+++... ..+++..+..++.|++.|+++||+.
T Consensus 41 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~ 119 (287)
T cd07840 41 FPITAIREIKLLQKLRHPNIVRLKEIVTSKGKGSIYMVFEYMD-HDLTGLLDSPEVKFTESQIKCYMKQLLEGLQYLHSN 119 (287)
T ss_pred chHHHHHHHHHHHhccCCCeeeheeeEecCCCCcEEEEecccc-ccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345688999999999999999999999887 89999999996 5899888765 5799999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~ 162 (241)
|++|+||+|.||++ ++++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||||+++|+++
T Consensus 120 ~~~h~dl~p~nil~---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l~el~ 196 (287)
T cd07840 120 GILHRDIKGSNILI---NNDGVLKLADFGLARPYTKRNSADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELF 196 (287)
T ss_pred CceeccCcHHHeEE---cCCCCEEEccccceeeccCCCcccccccccccccCCceeeEccccCChHHHHHHHHHHHHHHH
Confidence 99999999999999 778899999999987665433 1223345778999998764 45789999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCC-------------------------ccCCC-CChHHHHHHHHhcccCccccC
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQ-------------------------LIVPA-LHPDCVDMCLKLLSANTVDRL 216 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~-------------------------~~~~~-~~~~~~~li~~~l~~~p~~Rp 216 (241)
+|..||...+.......+......+... ..... ++..+.+++++||+.+|.+||
T Consensus 197 t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rp 276 (287)
T cd07840 197 LGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKHLIDPSALDLLDKLLTLDPKKRI 276 (287)
T ss_pred hCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcccCCHHHHHHHHHHcCCChhhCc
Confidence 9999999877766555543322111000 00112 388899999999999999999
Q ss_pred CHHHHhcCccc
Q 026253 217 SFNEFYHHRFL 227 (241)
Q Consensus 217 s~~~il~~~~~ 227 (241)
+++++++||||
T Consensus 277 ~~~~~l~~~~~ 287 (287)
T cd07840 277 SADQALQHEYF 287 (287)
T ss_pred CHHHHhhCcCC
Confidence 99999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po |
| >KOG4236 consensus Serine/threonine protein kinase PKC mu/PKD and related proteins [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.7e-40 Score=261.04 Aligned_cols=222 Identities=29% Similarity=0.527 Sum_probs=194.1
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHH-H-hcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-R-LHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~-~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
......++++|+.||+++.||+||.+..++++.+..++|||-+.| +..+.+ . +.+++++.....++.||+.||+|||
T Consensus 603 p~kqesqlR~EVaILq~l~HPGiV~le~M~ET~ervFVVMEKl~G-DMLEMILSsEkgRL~er~TkFlvtQIL~ALr~LH 681 (888)
T KOG4236|consen 603 PTKQESQLRNEVAILQNLHHPGIVNLECMFETPERVFVVMEKLHG-DMLEMILSSEKGRLPERITKFLVTQILVALRYLH 681 (888)
T ss_pred CCchHHHHHHHHHHHHhcCCCCeeEEEEeecCCceEEEEehhhcc-hHHHHHHHhhcccchHHHHHHHHHHHHHHHHHhh
Confidence 445668999999999999999999999999999999999999965 555444 3 3578999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
-+||+|+||||+|||+.+.++-.++||||||+|+..++........||+.|+|||++.++.|...-|+||+|+++|--+.
T Consensus 682 ~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEksFRrsVVGTPAYLaPEVLrnkGyNrSLDMWSVGVIiYVsLS 761 (888)
T KOG4236|consen 682 FKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEKSFRRSVVGTPAYLAPEVLRNKGYNRSLDMWSVGVIIYVSLS 761 (888)
T ss_pred hcceeeccCCchheeeccCCCCCceeeccccceeecchhhhhhhhcCCccccCHHHHhhccccccccceeeeEEEEEEec
Confidence 99999999999999998888888999999999999999888888999999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|..||... +++-.+|.+ ...-++..-+..++....|+|..+|+..-.+|.|.+..|.|||++++.
T Consensus 762 GTFPFNEd--EdIndQIQN-AaFMyPp~PW~eis~~AidlIn~LLqVkm~kRysvdk~lsh~Wlq~yq 826 (888)
T KOG4236|consen 762 GTFPFNED--EDINDQIQN-AAFMYPPNPWSEISPEAIDLINNLLQVKMRKRYSVDKSLSHPWLQDYQ 826 (888)
T ss_pred ccccCCCc--cchhHHhhc-cccccCCCchhhcCHHHHHHHHHHHHHHHHHhcchHhhccchhhhcch
Confidence 99999642 223333322 233445555568999999999999999999999999999999999864
|
|
| >cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.3e-38 Score=247.37 Aligned_cols=215 Identities=29% Similarity=0.501 Sum_probs=179.5
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|+++++++ +|++|+++++.++.++..++||||+++++|.+++....++++..+..++.|++.||.+||+.|+
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~~i 126 (290)
T cd05613 47 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTDTKLHLILDYINGGELFTHLSQRERFKEQEVQIYSGEIVLALEHLHKLGI 126 (290)
T ss_pred HHHHHHHHHHHHHhcccCCChhceeeEeecCCeEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 356788999999999 6999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCccccccc--CCCCchhHHHHHHHHHHHHh
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~ 163 (241)
+|+||+|.||++ +.++.++|+|||.+........ .....++..|+|||...+. .++.++|+||+|+++|++++
T Consensus 127 ~H~dl~p~nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~~l~~ll~ 203 (290)
T cd05613 127 IYRDIKLENILL---DSNGHVVLTDFGLSKEFHEDEVERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLT 203 (290)
T ss_pred eccCCCHHHeEE---CCCCCEEEeeCccceecccccccccccccCCcccCChhhccCCCCCCCccccHHHHHHHHHHHhc
Confidence 999999999999 6788999999999876543221 2234578889999998653 46789999999999999999
Q ss_pred CCCCCCCCCh----HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccccc
Q 026253 164 GYPPFSGRNN----VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRNS 231 (241)
Q Consensus 164 g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~~ 231 (241)
|..||..... ......+.. ...+. ...++..+.+++++||+.+|++|| ++++++.||||+...
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~-~~~~~----~~~~~~~~~~ll~~~l~~~p~~R~~~~~~~~~~l~~~~~~~~~~ 275 (290)
T cd05613 204 GASPFTVDGEKNSQAEISRRILK-SEPPY----PQEMSALAKDIIQRLLMKDPKKRLGCGPSDADEIKKHPFFQKIN 275 (290)
T ss_pred CCCCCCcCCccccHHHHHHHhhc-cCCCC----CccCCHHHHHHHHHHhcCCHHHhcCCCCCCHHHHHcCcccccCC
Confidence 9999974322 223333322 12222 336788999999999999999997 899999999999854
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph |
| >cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-37 Score=241.92 Aligned_cols=204 Identities=19% Similarity=0.316 Sum_probs=167.7
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|+.++++++|+||+++++++.. ...++||||+.+++|.+++.... .++...+..++.|++.||++||+.|++
T Consensus 45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~LH~~~i~ 123 (259)
T cd05037 45 SLAFFETASLMSQLSHKHLVKLYGVCVR-DENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALHYLEDKKLV 123 (259)
T ss_pred HHHHHHHHHHHHcCCCcchhheeeEEec-CCcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhhCCee
Confidence 6788999999999999999999999887 77899999999999999998765 689999999999999999999999999
Q ss_pred ccCCCCCCeEEeecC----CCceEEEeecCCccccCCCCccccccCCCCccCccccccc--CCCCchhHHHHHHHHHHHH
Q 026253 89 HRDLKPENILLSGLD----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 89 H~dl~~~nil~~~~~----~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~ 162 (241)
|+||||.||+++... ....++|+|||.+..... .....+...|.|||.+.+. .++.++|+||+|+++|+++
T Consensus 124 H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~---~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~~~~~l~ 200 (259)
T cd05037 124 HGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS---REERVERIPWIAPECIRNGQASLTIAADKWSFGTTLLEIC 200 (259)
T ss_pred cccCccceEEEecCccccCCceeEEeCCCCccccccc---ccccccCCCccChhhhcCCCCCcchhhHHHHHHHHHHHHH
Confidence 999999999995211 112699999999876543 2233456679999998776 7899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+ |..||...+..+...........+. .....+.+++.+||+.+|.+|||+.++++
T Consensus 201 ~~~~~p~~~~~~~~~~~~~~~~~~~~~------~~~~~~~~li~~~l~~~p~~Rpt~~~il~ 256 (259)
T cd05037 201 SNGEEPLSTLSSSEKERFYQDQHRLPM------PDCAELANLINQCWTYDPTKRPSFRAILR 256 (259)
T ss_pred hCCCCCcccCCchhHHHHHhcCCCCCC------CCchHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9 5888877655444433332221111 22378999999999999999999999985
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki |
| >cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=240.92 Aligned_cols=210 Identities=25% Similarity=0.411 Sum_probs=173.7
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEe-ecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+.+|+.+++.++||||+++++++. .++..+++|||+.+++|.+++.+. ...+...+..++.|++.|+.+||+.
T Consensus 38 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 117 (262)
T cd05058 38 EEVEQFLKEGIIMKDFSHPNVLSLLGICLPSEGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEYLASK 117 (262)
T ss_pred HHHHHHHHHHHHHccCCCCCcceEEEEeecCCCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 44668889999999999999999999765 456689999999999999999764 3467788889999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-----ccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+..++.++|+||||+++|+
T Consensus 118 ~i~H~dlk~~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~e 194 (262)
T cd05058 118 KFVHRDLAARNCML---DESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWE 194 (262)
T ss_pred CccccccCcceEEE---cCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCccchHHHHHHHHHHHHH
Confidence 99999999999999 678889999999987543221 1112234567999999988889999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 161 LLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 161 l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+++ |.+||...+..+....+..+.....+. ..+..+.+++.+||+.+|++||++.++++.
T Consensus 195 l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~cl~~~p~~Rp~~~~il~~ 255 (262)
T cd05058 195 LMTRGAPPYPDVDSFDITVYLLQGRRLLQPE----YCPDPLYEVMLSCWHPKPEMRPTFSELVSR 255 (262)
T ss_pred HHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC----cCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 999 577888777777776665544333332 568899999999999999999999999853
|
Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca |
| >cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.9e-37 Score=242.43 Aligned_cols=212 Identities=21% Similarity=0.398 Sum_probs=171.7
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC-----CCHHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-----VPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-----~~~~~~~~~~~~i~~~l~~l 82 (241)
.....+.+|+++++.++|+||+++++.+...+..++||||+.+++|.+++..... .++..+..++.|++.|+++|
T Consensus 37 ~~~~~~~~e~~~~~~l~h~nii~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l 116 (269)
T cd05042 37 DEQLLFLQEVQPYRELNHPNVLQCLGQCIESIPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVASGLLWL 116 (269)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEECCCCceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999976432 46778889999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccc-------cCCCCchhHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-------QRYDEKVDMW 152 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~ 152 (241)
|+.|++|+||||.||++ +.++.++|+|||.+........ .....++..|+|||.... ..++.++|+|
T Consensus 117 H~~~ivH~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw 193 (269)
T cd05042 117 HQADFIHSDLALRNCQL---TADLSVKIGDYGLALEQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIW 193 (269)
T ss_pred HhcCEecccccHhheEe---cCCCcEEEeccccccccccchheeccCCCCCcccccCHHHHhhccccccccccchhhHHH
Confidence 99999999999999999 7788999999999865432211 122334567999998642 3567899999
Q ss_pred HHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCC-ccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 153 SVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQ-LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 153 slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|+|+++|++++ |..||......+.............+. .....++..+.+++..|+ .||++|||++++++
T Consensus 194 slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~dp~~Rpt~~~v~~ 265 (269)
T cd05042 194 SLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKPQLDLKYSDRWYEVMQFCW-LDPETRPTAEEVHE 265 (269)
T ss_pred HHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCCcccccCCHHHHHHHHHHh-cCcccccCHHHHHH
Confidence 99999999998 788998877766665554444333322 234467888999999998 59999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina |
| >KOG1989 consensus ARK protein kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.3e-38 Score=267.57 Aligned_cols=211 Identities=25% Similarity=0.448 Sum_probs=174.0
Q ss_pred hHHhhhhHHHHHHHHhcCC-CcCeeeeeeE-Eee---cC---eEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDA-FQA---EN---CIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQL 75 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~-~~~---~~---~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i 75 (241)
++..-+.+++|++++++|+ |+|||.++|. ... ++ .+.|+||||.|+.|-|+++.+ .+|++..+++|+.++
T Consensus 74 de~~L~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv 153 (738)
T KOG1989|consen 74 DEEALNAVKREIDIMKLLSGHKNIVSYIDSSAINRSSNNGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDV 153 (738)
T ss_pred CHHHHHHHHHHHHHHHHhcCCCceeeEeccccccccCCCceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHH
Confidence 6777889999999999995 9999999993 321 12 477999999999999999854 459999999999999
Q ss_pred HHHHHHHHhCC--ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc----------ccccCCCCccCcccc---
Q 026253 76 GAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----------EKVCGSPLYMAPEVL--- 140 (241)
Q Consensus 76 ~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~----------~~~~~~~~~~~PE~~--- 140 (241)
++|+.+||... ++|||||-+|||+ ..++.+||||||.|+-....... .....|+.|.|||.+
T Consensus 154 ~~AVa~mH~~~pPiIHRDLKiENvLl---s~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDly 230 (738)
T KOG1989|consen 154 CEAVAAMHYLKPPIIHRDLKIENVLL---SADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLY 230 (738)
T ss_pred HHHHHHHhcCCCccchhhhhhhheEE---cCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhh
Confidence 99999999997 9999999999999 78889999999999765443311 123468999999986
Q ss_pred cccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 141 QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 141 ~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
.+...+.|+|||+|||++|-++....||+...... .+......+.. +.++..+.+||+.||+.||.+||++-|
T Consensus 231 sg~pI~eKsDIWALGclLYkLCy~t~PFe~sg~la---Ilng~Y~~P~~----p~ys~~l~~LI~~mL~~nP~~RPnI~Q 303 (738)
T KOG1989|consen 231 SGLPIGEKSDIWALGCLLYKLCYFTTPFEESGKLA---ILNGNYSFPPF----PNYSDRLKDLIRTMLQPNPDERPNIYQ 303 (738)
T ss_pred cCCCCcchhHHHHHHHHHHHHHHhCCCcCcCccee---EEeccccCCCC----ccHHHHHHHHHHHHhccCcccCCCHHH
Confidence 57789999999999999999999999999764432 22222233322 478999999999999999999999999
Q ss_pred HhcCcc
Q 026253 221 FYHHRF 226 (241)
Q Consensus 221 il~~~~ 226 (241)
++++-+
T Consensus 304 v~~~~~ 309 (738)
T KOG1989|consen 304 VLEEIF 309 (738)
T ss_pred HHHHHH
Confidence 886544
|
|
| >cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=241.41 Aligned_cols=211 Identities=27% Similarity=0.532 Sum_probs=176.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~l 82 (241)
....+.+.+|++++++++|++++++++++..++..+++|||+++++|.+++... ..+++..+..++.+++.|+.+|
T Consensus 43 ~~~~~~~~~ei~~l~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~l 122 (267)
T cd08224 43 AKARQDCLKEIDLLKQLDHPNVIKYLASFIENNELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCSALEHM 122 (267)
T ss_pred hhhHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHHHHHHH
Confidence 345778999999999999999999999999999999999999999999998642 3489999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|+.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|.|||.+.+..++.++|+||+|+++|++
T Consensus 123 h~~~i~h~dl~p~nil~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~~l 199 (267)
T cd08224 123 HSKRIMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYEM 199 (267)
T ss_pred HhCCEecCCcChhhEEE---CCCCcEEEeccceeeeccCCCcccceecCCccccCHHHhccCCCCchhcHHHHHHHHHHH
Confidence 99999999999999999 678889999999986543322 22334577889999999888899999999999999999
Q ss_pred HhCCCCCCCCC--hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LNGYPPFSGRN--NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~g~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++|..||.... .......+..+...+.+. +.++..+.+++.+||..+|.+|||+.++++
T Consensus 200 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~i~~cl~~~p~~Rp~~~~il~ 260 (267)
T cd08224 200 AALQSPFYGDKMNLYSLCKKIEKCDYPPLPA---DHYSEELRDLVSRCINPDPEKRPDISYVLQ 260 (267)
T ss_pred HHCCCCcccCCccHHHHHhhhhcCCCCCCCh---hhcCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 99999996543 234444444433333322 267889999999999999999999999874
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a |
| >cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=240.62 Aligned_cols=208 Identities=17% Similarity=0.303 Sum_probs=169.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|+.++++++|+||+++++++..++..++||||+.+++|.+++...+ .+++..+..++.|++.|+++||+.|
T Consensus 41 ~~~~~~~~e~~~l~~~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 120 (258)
T cd05078 41 NYSESFFEAASMMSQLSHKHLVLNYGVCVCGDESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHFLEDKG 120 (258)
T ss_pred HHHHHHHHHHHHHHhCCCCChhheeeEEEeCCCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345678899999999999999999999999999999999999999999997654 4899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecC-----CCceEEEeecCCccccCCCCccccccCCCCccCccccccc-CCCCchhHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLD-----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~-----~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~ 160 (241)
++|+||||.||+++..+ ....++++|||.+...... ....++..|+|||.+.+. .++.++|+||+|+++|+
T Consensus 121 iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~l~~ 197 (258)
T cd05078 121 LTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK---EILLERIPWVPPECIENPQNLSLAADKWSFGTTLWE 197 (258)
T ss_pred eecCCCccceEEEecccccccCCCceEEecccccccccCCc---hhccccCCccCchhccCCCCCCchhhHHHHHHHHHH
Confidence 99999999999995321 1123799999988665432 224567789999998764 57899999999999999
Q ss_pred HHhC-CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 161 LLNG-YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 161 l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+++| ..||...+.......... ....+ ...+.++.+++.+||+.+|++|||++++++.
T Consensus 198 l~~g~~~~~~~~~~~~~~~~~~~--~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 256 (258)
T cd05078 198 IFSGGDKPLSALDSQKKLQFYED--RHQLP----APKWTELANLINQCMDYEPDFRPSFRAIIRD 256 (258)
T ss_pred HHcCCCCChhhccHHHHHHHHHc--cccCC----CCCcHHHHHHHHHHhccChhhCCCHHHHHHh
Confidence 9998 567776665544433322 12222 2566889999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity |
| >cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=245.01 Aligned_cols=214 Identities=25% Similarity=0.448 Sum_probs=174.2
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC------------CCCHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------RVPEQTARKFLQQ 74 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------~~~~~~~~~~~~~ 74 (241)
......+.+|++++++++|+|++++++++..++..++||||+.+++|.+++.... .+++..+..++.|
T Consensus 58 ~~~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i~~~ 137 (295)
T cd05097 58 KTARNDFLKEIKIMSRLKNPNIIRLLGVCVSDDPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYMAVQ 137 (295)
T ss_pred HHHHHHHHHHHHHHHhCCCCCcCeEEEEEcCCCccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHHHHH
Confidence 3456678999999999999999999999999999999999999999999986532 3678889999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhH
Q 026253 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (241)
Q Consensus 75 i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv 151 (241)
++.|+.+||+.|++|+||+|.||++ ++++.++|+|||.+........ .....++..|+|||...+..++.++|+
T Consensus 138 i~~al~~lH~~~i~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv 214 (295)
T cd05097 138 IASGMKYLASLNFVHRDLATRNCLV---GNHYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMAWESILLGKFTTASDV 214 (295)
T ss_pred HHHHHHHHHhcCeeccccChhhEEE---cCCCcEEecccccccccccCcceeccCcCcCceeecChhhhccCCcCchhhH
Confidence 9999999999999999999999999 6777899999999876433221 112234567999999988889999999
Q ss_pred HHHHHHHHHHHh--CCCCCCCCChHHHHHHhhcCC---CCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 152 WSVGAILFELLN--GYPPFSGRNNVQLVRNINSCK---HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 152 ~slG~~l~~l~~--g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
||||++++++++ |..||...+..+....+.... .........+.++..+.+++++|++.+|.+|||++++++
T Consensus 215 wSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~RPs~~~i~~ 291 (295)
T cd05097 215 WAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIYLSQTPLCPSPVFKLMMRCWSRDIKDRPTFNKIHH 291 (295)
T ss_pred HHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhccccccCCCCCCCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999988 677888777666555442211 111111123457889999999999999999999999974
|
Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including |
| >cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=250.36 Aligned_cols=211 Identities=28% Similarity=0.490 Sum_probs=172.5
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEee-cCeEEEEEeccCCCChHHHHHhc------------------------
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH------------------------ 60 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~------------------------ 60 (241)
.+..+.+.+|+++++++ +|+||+++++++.. +...+++|||+.+++|.+++...
T Consensus 51 ~~~~~~~~~E~~~~~~l~~h~niv~~~~~~~~~~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~ 130 (337)
T cd05054 51 ASEYKALMTELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKEGKK 130 (337)
T ss_pred HHHHHHHHHHHHHHHhhccCcchhheeeeEecCCCCEEEEEecCCCCCHHHHHHhccccccccccccccccccccccccc
Confidence 34456788999999999 89999999998754 56788999999999999998642
Q ss_pred -------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecC
Q 026253 61 -------------------------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103 (241)
Q Consensus 61 -------------------------------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~ 103 (241)
.++++..+..++.|++.||.+||++|++|+||||.||++ +
T Consensus 131 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill---~ 207 (337)
T cd05054 131 QRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILL---S 207 (337)
T ss_pred cccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---e
Confidence 257889999999999999999999999999999999999 5
Q ss_pred CCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH-HHH
Q 026253 104 DDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQ-LVR 178 (241)
Q Consensus 104 ~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~-~~~ 178 (241)
.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+||++|++++ |..||.+....+ ...
T Consensus 208 ~~~~vkL~DfG~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~~~~ 287 (337)
T cd05054 208 ENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPESIFDKVYTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEEFCR 287 (337)
T ss_pred CCCcEEEeccccchhcccCcchhhccCCCCCccccCcHHhcCCCCCccccHHHHHHHHHHHHHcCCCCCCCCCccHHHHH
Confidence 678899999999976533221 122334567999999998999999999999999999998 999998754433 334
Q ss_pred HhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 179 NINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 179 ~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.+........+ ...++++.+++.+||+.+|++||+++++++|
T Consensus 288 ~~~~~~~~~~~----~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~ 329 (337)
T cd05054 288 RLKEGTRMRAP----EYATPEIYSIMLDCWHNNPEDRPTFSELVEI 329 (337)
T ss_pred HHhccCCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 44333333222 3678899999999999999999999999875
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto |
| >cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-37 Score=242.00 Aligned_cols=208 Identities=25% Similarity=0.400 Sum_probs=178.0
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.....+.+|++++++++|+||+++++++.. ...++||||+.+++|.+++... ..+++..+..++.|++.|+++||+.|
T Consensus 51 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 129 (279)
T cd05057 51 KANKEILDEAYVMASVDHPHVVRLLGICLS-SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSYLEEKR 129 (279)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEec-CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345678899999999999999999999887 7899999999999999999764 46899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc---cccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
++|+||+|.||++ +.++.++|+|||.+.......... ....+..|+|||.+.+..++.++|+||+|+++|++++
T Consensus 130 i~H~di~p~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~el~~ 206 (279)
T cd05057 130 LVHRDLAARNVLV---KTPQHVKITDFGLAKLLDVDEKEYHAEGGKVPIKWMALESILHRIYTHKSDVWSYGVTVWELMT 206 (279)
T ss_pred EEecccCcceEEE---cCCCeEEECCCcccccccCcccceecCCCcccccccCHHHhhcCCcCchhhHHHHHHHHHHHhc
Confidence 9999999999999 678889999999997654322111 1122457999999988889999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 -GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 -g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||.+....+....+......+.+. ..+..+.+++.+||..+|.+|||+.++++
T Consensus 207 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~~l~~~p~~Rp~~~~l~~ 263 (279)
T cd05057 207 FGAKPYEGIPAVEIPDLLEKGERLPQPP----ICTIDVYMVLVKCWMIDAESRPTFKELIN 263 (279)
T ss_pred CCCCCCCCCCHHHHHHHHhCCCCCCCCC----CCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 999999988888777776555444333 57789999999999999999999999873
|
Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea |
| >cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase) | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.5e-37 Score=243.12 Aligned_cols=211 Identities=21% Similarity=0.374 Sum_probs=178.6
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee-cCeEEEEEeccCCCChHHHHHhc--------CCCCHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--------GRVPEQTARKFLQQLG 76 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--------~~~~~~~~~~~~~~i~ 76 (241)
+......+.+|++++++++|+||+++++++.. +...+++++++.+++|.+++... ..+++..+..++.+++
T Consensus 48 ~~~~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~i~ 127 (280)
T cd05043 48 SEIQVTLLLQESCLLYGLSHQNILPILHVCIEDGEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQIA 127 (280)
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHHHH
Confidence 45557788999999999999999999998765 56789999999999999999754 3488999999999999
Q ss_pred HHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHH
Q 026253 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (241)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 153 (241)
.||.+||+.+++|+||+|.||++ ++++.++|+|||+++....... .....++..|+|||.+.+..++.++|+||
T Consensus 128 ~~l~~LH~~~i~H~di~p~nil~---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~s 204 (280)
T cd05043 128 CGMSYLHKRGVIHKDIAARNCVI---DEELQVKITDNALSRDLFPMDYHCLGDNENRPVKWMALESLVNKEYSSASDVWS 204 (280)
T ss_pred HHHHHHHHCCEeecccCHhhEEE---cCCCcEEECCCCCcccccCCceEEeCCCCCcchhccCHHHHhcCCCCchhhHHH
Confidence 99999999999999999999999 6788999999999876543221 11223456799999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 154 VGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 154 lG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+|+++|++++ |..||...++.+....+..+.....+ ..+++++.+++.+||..+|++|||+.++++
T Consensus 205 lG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~~~~ 271 (280)
T cd05043 205 FGVLLWELMTLGQTPYVEIDPFEMAAYLKDGYRLAQP----INCPDELFAVMACCWALDPEERPSFSQLVQ 271 (280)
T ss_pred hHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCCCCCCC----CcCCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 9999999998 99999988887777777655433322 357889999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It |
| >KOG4645 consensus MAPKKK (MAP kinase kinase kinase) SSK2 and related serine/threonine protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-40 Score=283.77 Aligned_cols=218 Identities=26% Similarity=0.506 Sum_probs=191.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|..+++-++|||+|++||+-......+|.||||++|+|.+.++..+..++.....+..|++.|+++||+.|
T Consensus 1275 ~k~~~~i~eEm~vlE~lnHpNlV~YyGVEvHRekv~IFMEyC~~GsLa~ll~~gri~dE~vt~vyt~qll~gla~LH~~g 1354 (1509)
T KOG4645|consen 1275 HKTFKLIAEEMKVLEGLNHPNLVRYYGVEVHREKVYIFMEYCEGGSLASLLEHGRIEDEMVTRVYTKQLLEGLAYLHEHG 1354 (1509)
T ss_pred cccCcchHHHHHHHHhccCccccccCceeecHHHHHHHHHHhccCcHHHHHHhcchhhhhHHHHHHHHHHHHHHHHHhcC
Confidence 44567889999999999999999999999999999999999999999999987777788788888899999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----cccccCCCCccCcccccccC---CCCchhHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAIL 158 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~---~~~~~Dv~slG~~l 158 (241)
||||||||.||++ +.++.+|++|||.|....+... .....||+.|||||++.+.. -..+.||||||||+
T Consensus 1355 IVHRDIK~aNI~L---d~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGCVV 1431 (1509)
T KOG4645|consen 1355 IVHRDIKPANILL---DFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGCVV 1431 (1509)
T ss_pred ceecCCCccceee---ecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccceE
Confidence 9999999999999 7888999999999988766532 23467999999999997644 45789999999999
Q ss_pred HHHHhCCCCCCCCC-hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 159 FELLNGYPPFSGRN-NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 159 ~~l~~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
.||+||+.||...+ ...+.-++..+..+++|+ .+|++..+||..||+.||++|.++.|+++|-|-+...
T Consensus 1432 lEM~tGkrPW~~~dne~aIMy~V~~gh~Pq~P~----~ls~~g~dFle~Cl~~dP~~Rw~~~qlle~~f~~~~~ 1501 (1509)
T KOG4645|consen 1432 LEMATGKRPWAELDNEWAIMYHVAAGHKPQIPE----RLSSEGRDFLEHCLEQDPKMRWTASQLLEHAFGKSCT 1501 (1509)
T ss_pred EEeecCCCchhhccchhHHHhHHhccCCCCCch----hhhHhHHHHHHHHHhcCchhhhHHHHHHHhhcccccc
Confidence 99999999998654 556667776777777776 6999999999999999999999999999999877643
|
|
| >cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=250.66 Aligned_cols=219 Identities=34% Similarity=0.515 Sum_probs=176.8
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+.+|+.+++++ +|+||+++++++... ...++|||++. ++|.+++... .+++..+..++.|++.||.+||+
T Consensus 48 ~~~~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~-~~~~~~~~~i~~qi~~~L~~LH~ 125 (337)
T cd07852 48 TDAQRTFREIMFLQELGDHPNIVKLLNVIKAENDKDIYLVFEYME-TDLHAVIRAN-ILEDVHKRYIMYQLLKALKYIHS 125 (337)
T ss_pred hhhhhhhHHHHHHHHhcCCCCccceeeeeccCCCceEEEEecccc-cCHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHH
Confidence 3455677899999999 999999999988643 46899999996 6999998765 78889999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC------ccccccCCCCccCcccccc-cCCCCchhHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAI 157 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~------~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~ 157 (241)
.|++|+||+|.||++ +.++.++|+|||.+....... ......++..|+|||.+.+ ..++.++|+||+|++
T Consensus 126 ~~i~H~dl~p~nill---~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~ 202 (337)
T cd07852 126 GNVIHRDLKPSNILL---NSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCI 202 (337)
T ss_pred CCeecCCCCHHHEEE---cCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHH
Confidence 999999999999999 788899999999987654322 1223456888999998754 457889999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhcCCC--------------------------CCCCCccCCCCChHHHHHHHHhcccC
Q 026253 158 LFELLNGYPPFSGRNNVQLVRNINSCKH--------------------------LPFSQLIVPALHPDCVDMCLKLLSAN 211 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~~~~~~i~~~~~--------------------------~~~~~~~~~~~~~~~~~li~~~l~~~ 211 (241)
+|++++|+.||.+.........+..... ........+.++.++.+++.+||+.+
T Consensus 203 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~ 282 (337)
T cd07852 203 LGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPKASDDALDLLKKLLVFN 282 (337)
T ss_pred HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccCCCHHHHHHHHHhccCC
Confidence 9999999999987665544333322111 01111223457889999999999999
Q ss_pred ccccCCHHHHhcCccccccc
Q 026253 212 TVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 212 p~~Rps~~~il~~~~~~~~~ 231 (241)
|.+|||+.++++||||++..
T Consensus 283 P~~Rps~~~il~~~~~~~~~ 302 (337)
T cd07852 283 PNKRLTAEEALEHPYVAQFH 302 (337)
T ss_pred cccccCHHHHhhChhhhhhc
Confidence 99999999999999998853
|
Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul |
| >cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=242.39 Aligned_cols=210 Identities=22% Similarity=0.426 Sum_probs=177.7
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC---------CCCHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---------RVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---------~~~~~~~~~~~~~i~~~l 79 (241)
..+.+.+|++++++++|+||+++++++.+.+..++||||+++++|.+++.... .+++..+..++.|++.||
T Consensus 51 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~~l~~~l 130 (275)
T cd05046 51 LQSEFRRELDMFRKLSHKNVVRLLGLCREAEPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCTQIALGM 130 (275)
T ss_pred HHHHHHHHHHHHHhcCCcceeeeEEEECCCCcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHHHHHHHH
Confidence 45779999999999999999999999999899999999999999999998765 689999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccCCCCchhHHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~ 157 (241)
.+||+.|++|+||+|.||++ +.++.++++|||++....... ......++..|+|||.+.+..++.++|+||||++
T Consensus 131 ~~LH~~~i~H~dlkp~Nili---~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~ 207 (275)
T cd05046 131 DHLSNARFVHRDLAARNCLV---SSQREVKVSLLSLSKDVYNSEYYKLRNALIPLRWLAPEAVQEDDFSTKSDVWSFGVL 207 (275)
T ss_pred HHhhhcCcccCcCccceEEE---eCCCcEEEcccccccccCcccccccCCceeEEeecChhhhccCCCCchhhHHHHHHH
Confidence 99999999999999999999 678889999999876443211 1122334567999999988888999999999999
Q ss_pred HHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 158 LFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 158 l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+|++++ |..||...........+..+... .. ....++..+.+++.+||+.+|.+|||+.+++..
T Consensus 208 l~~l~~~~~~p~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~~i~~~l~~~p~~Rp~~~~~l~~ 272 (275)
T cd05046 208 MWEVFTQGELPFYGLSDEEVLNRLQAGKLE-LP--VPEGCPSRLYKLMTRCWAVNPKDRPSFSELVSA 272 (275)
T ss_pred HHHHHhCCCCCccccchHHHHHHHHcCCcC-CC--CCCCCCHHHHHHHHHHcCCCcccCCCHHHHHHH
Confidence 999998 88899877777766666443321 11 223678899999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s |
| >cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.1e-37 Score=239.45 Aligned_cols=207 Identities=24% Similarity=0.486 Sum_probs=176.2
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|++++++++|+||+++++++.. ...+++|||+++++|.+++.+. ..+++..+..++.|++.||.+||+.|
T Consensus 44 ~~~~~~~e~~~l~~l~~~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL~~lH~~~ 122 (260)
T cd05073 44 SVEAFLAEANVMKTLQHDKLVKLHAVVTK-EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 122 (260)
T ss_pred HHHHHHHHHHHHHhcCCCCcceEEEEEcC-CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45678899999999999999999999887 7789999999999999999764 35788899999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
++|+||+|.||++ +..+.++|+|||.+........ .....++..|.|||.+.+..++.++|+||||+++|++++
T Consensus 123 i~H~dl~p~ni~i---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~Di~slG~~l~~l~t~ 199 (260)
T cd05073 123 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 199 (260)
T ss_pred ccccccCcceEEE---cCCCcEEECCCcceeeccCCCcccccCCcccccccCHhHhccCCcCccccchHHHHHHHHHHhc
Confidence 9999999999999 7888999999999876543221 112234566999999988889999999999999999998
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||.+.+.......+......+.+ ...+.++.+++.+|++.+|.+||++.++++
T Consensus 200 g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~i~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05073 200 GRIPYPGMSNPEVIRALERGYRMPRP----ENCPEELYNIMMRCWKNRPEERPTFEYIQS 255 (260)
T ss_pred CCCCCCCCCHHHHHHHHhCCCCCCCc----ccCCHHHHHHHHHHcccCcccCcCHHHHHH
Confidence 99999988887777777655443322 367889999999999999999999998863
|
Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa |
| >cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-37 Score=245.12 Aligned_cols=221 Identities=26% Similarity=0.469 Sum_probs=177.6
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS-H 85 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~-~ 85 (241)
....+..|+.++.++ +|+||+++++++.++...+++|||+ ++++.+++.. .+.+++..+..++.+++.|+.+||+ .
T Consensus 56 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~-~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~lH~~~ 134 (296)
T cd06618 56 ENKRILMDLDVVLKSHDCPYIVKCYGYFITDSDVFICMELM-STCLDKLLKRIQGPIPEDILGKMTVAIVKALHYLKEKH 134 (296)
T ss_pred HHHHHHHHHHHHHhccCCCchHhhheeeecCCeEEEEeecc-CcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 445566777777666 5999999999999999999999998 4578877765 4578999999999999999999997 5
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccC----CCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~----~~~~~Dv~slG~~l~~l 161 (241)
|++|+||+|.||++ ++++.++|+|||.+.............++..|+|||.+.+.. ++.++|+||+|+++|++
T Consensus 135 ~i~H~dl~p~nill---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~slG~il~el 211 (296)
T cd06618 135 GVIHRDVKPSNILL---DASGNVKLCDFGISGRLVDSKAKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSLGISLVEL 211 (296)
T ss_pred CEecCCCcHHHEEE---cCCCCEEECccccchhccCCCcccCCCCCccccCHhhcCCCCCccccccchhHHHHHHHHHHH
Confidence 99999999999999 678899999999987654433333445678899999986543 78899999999999999
Q ss_pred HhCCCCCCCCCh-HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCC
Q 026253 162 LNGYPPFSGRNN-VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 235 (241)
Q Consensus 162 ~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 235 (241)
++|..||..... .+.+..+........+. ...++.++.+++.+||+.||.+||+++++++||||+.......
T Consensus 212 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~~p~~Rp~~~~il~~~~~~~~~~~~~ 284 (296)
T cd06618 212 ATGQFPYKNCKTEFEVLTKILQEEPPSLPP--NEGFSPDFCSFVDLCLTKDHRKRPKYRELLQHPFIRRYETAEV 284 (296)
T ss_pred HhCCCCCCcchhHHHHHHHHhcCCCCCCCC--CCCCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhccchhHH
Confidence 999999976433 34444443333222221 1247889999999999999999999999999999998665443
|
Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it |
| >cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-37 Score=239.91 Aligned_cols=206 Identities=23% Similarity=0.475 Sum_probs=175.8
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+|+.++++++|+||+++++++. ++..+++||++.+++|.+++... ..+++..+..++.|++.||++||+.|+
T Consensus 45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~-~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al~~LH~~~i 123 (260)
T cd05067 45 PEAFLAEANLMKQLQHPRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGMAFIERKNY 123 (260)
T ss_pred HHHHHHHHHHHHhcCCcCeeeEEEEEc-cCCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHhcCCe
Confidence 457889999999999999999999874 45689999999999999998653 358899999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+|+||+|.||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|++++ |
T Consensus 124 ~H~dl~p~ni~i---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~~~~~~Di~slG~~l~el~~~g 200 (260)
T cd05067 124 IHRDLRAANILV---SETLCCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTYG 200 (260)
T ss_pred ecccccHHhEEE---cCCCCEEEccCcceeecCCCCcccccCCcccccccCHHHhccCCcCcccchHHHHHHHHHHHhCC
Confidence 999999999999 7788999999999866542221 122334567999999988889999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
..||.+.+..+....+......+.+ ...+.++.+++.+||+.+|.+|||++++++
T Consensus 201 ~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 255 (260)
T cd05067 201 RIPYPGMTNPEVIQNLERGYRMPRP----DNCPEELYELMRLCWKEKPEERPTFEYLRS 255 (260)
T ss_pred CCCCCCCChHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 9999988888877777655444333 367889999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr |
| >cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=239.68 Aligned_cols=205 Identities=24% Similarity=0.442 Sum_probs=174.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+|+.++++++|+|++++++++..+ ..+++|||+.+++|.+++.... .+++..+..++.|++.|+.+||+.|
T Consensus 42 ~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~ 120 (254)
T cd05083 42 TAQAFLEETAVMTKLHHKNLVRLLGVILHN-GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGMEYLESKK 120 (254)
T ss_pred hHHHHHHHHHHHHhCCCCCcCeEEEEEcCC-CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 346788999999999999999999988664 4799999999999999997653 4789999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~ 165 (241)
++|+||+|.||++ +.++.++|+|||.+...... ......+..|.|||.+.+..++.++|+||+|+++|++++ |.
T Consensus 121 ~~H~dl~p~nili---~~~~~~kl~Dfg~~~~~~~~--~~~~~~~~~y~~pe~~~~~~~~~~~Dv~slG~~l~el~~~g~ 195 (254)
T cd05083 121 LVHRDLAARNILV---SEDGVAKVSDFGLARVGSMG--VDNSKLPVKWTAPEALKHKKFSSKSDVWSYGVLLWEVFSYGR 195 (254)
T ss_pred eeccccCcceEEE---cCCCcEEECCCccceecccc--CCCCCCCceecCHHHhccCCcCchhhHHHHHHHHHHHHhCCC
Confidence 9999999999999 67889999999998654322 112233567999999988889999999999999999997 99
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
.||...+..+....+..+.....+ ..++..+.+++++||+.+|.+||+++++++
T Consensus 196 ~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~~p~~Rp~~~~l~~ 249 (254)
T cd05083 196 APYPKMSLKEVKECVEKGYRMEPP----EGCPADVYVLMTSCWETEPKKRPSFHKLRE 249 (254)
T ss_pred CCCccCCHHHHHHHHhCCCCCCCC----CcCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999988887777776555433322 367899999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki |
| >cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-37 Score=246.00 Aligned_cols=215 Identities=31% Similarity=0.505 Sum_probs=178.2
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|+++++++ +|++|+++.+.+..++..++||||+.+++|.+++.....+++..+..++.|++.+|.+||+.|
T Consensus 46 ~~~~~~~~E~~~l~~~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~ql~~~l~~lH~~~ 125 (288)
T cd05583 46 KTAEHTRTERQVLEAVRRCPFLVTLHYAFQTDTKLHLILDYVNGGELFTHLYQREHFTESEVRVYIAEIVLALDHLHQLG 125 (288)
T ss_pred hHHHHHHHHHHHHHhccCCcchhhhheeeecCCEEEEEEecCCCCcHHHHHhhcCCcCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999999 699999999999999999999999999999999987778999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccC--CCCchhHHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELL 162 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l~ 162 (241)
++|+||+|.||++ +.++.++|+|||++........ .....++..|++||...+.. .+.++|+||+|+++|+|+
T Consensus 126 ~~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~il~el~ 202 (288)
T cd05583 126 IIYRDIKLENILL---DSEGHVVLTDFGLSKEFLAEEEERAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELL 202 (288)
T ss_pred eeccCCCHHHeEE---CCCCCEEEEECccccccccccccccccccCCccccCHHHhcCCCCCCcchhhhHHHHHHHHHHH
Confidence 9999999999999 6778899999999876543321 12235788899999987654 788999999999999999
Q ss_pred hCCCCCCCCCh----HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC---HHHHhcCcccccc
Q 026253 163 NGYPPFSGRNN----VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS---FNEFYHHRFLRRN 230 (241)
Q Consensus 163 ~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~ 230 (241)
+|..||...+. .+..+.+... ..+ ....++..+.+++.+||+.||++||| +.++++||||+..
T Consensus 203 tg~~p~~~~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~l~~li~~~l~~~p~~R~t~~~~~~~l~~~~~~~~ 272 (288)
T cd05583 203 TGASPFTVDGEQNSQSEISRRILKS-KPP----FPKTMSAEARDFIQKLLEKDPKKRLGANGADEIKNHPFFQGI 272 (288)
T ss_pred hCCCCcccCcccchHHHHHHHHHcc-CCC----CCcccCHHHHHHHHHHhcCCHhhccCcchHHHHhcCcccccC
Confidence 99999964322 2223333221 122 22367889999999999999999998 5778999999883
|
Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines |
| >cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.8e-38 Score=249.69 Aligned_cols=217 Identities=27% Similarity=0.472 Sum_probs=168.5
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~l 82 (241)
.+.+.+|+.++++++||||+++++++.+. +..++|||+++ +++.+++... ..+++..+..++.|++.|+.+|
T Consensus 46 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 124 (316)
T cd07842 46 SQSACREIALLRELKHENVVSLVEVFLEHADKSVYLLFDYAE-HDLWQIIKFHRQAKRVSIPPSMVKSLLWQILNGVHYL 124 (316)
T ss_pred cHHHHHHHHHHHhcCCCCccceEEEEeCCCCceEEEEEeCCC-cCHHHHHHhhccCCCcCcCHHHHHHHHHHHHHHHHHH
Confidence 46778899999999999999999999887 88999999996 5777776432 2588999999999999999999
Q ss_pred HhCCccccCCCCCCeEEee-cCCCceEEEeecCCccccCCCCc----cccccCCCCccCccccccc-CCCCchhHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGA 156 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~-~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~ 156 (241)
|+.|++|+||+|+||+++. .+..+.++|+|||++........ .....++..|+|||.+.+. .++.++|+||+|+
T Consensus 125 H~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~ 204 (316)
T cd07842 125 HSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKPLADLDPVVVTIWYRAPELLLGARHYTKAIDIWAIGC 204 (316)
T ss_pred HhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCcccccccCCccccccccCHHHHhCCCCCCcHHHHHHHHH
Confidence 9999999999999999932 11288899999999876543221 2234567889999987654 5789999999999
Q ss_pred HHHHHHhCCCCCCCCChHH---------HHHHhhc-------------------------CCCCCCCC-----cc--CCC
Q 026253 157 ILFELLNGYPPFSGRNNVQ---------LVRNINS-------------------------CKHLPFSQ-----LI--VPA 195 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~---------~~~~i~~-------------------------~~~~~~~~-----~~--~~~ 195 (241)
+++++++|.+||.+..... ....+.. ......+. .. ...
T Consensus 205 ~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (316)
T cd07842 205 IFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSLAKWMEKHKK 284 (316)
T ss_pred HHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccHHHHHHhccC
Confidence 9999999999997654321 0110000 00000000 00 015
Q ss_pred CChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 196 LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 196 ~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
.+..+.+++.+||+.||++|||+.|+++||||
T Consensus 285 ~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f 316 (316)
T cd07842 285 PDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316 (316)
T ss_pred CCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence 66789999999999999999999999999998
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the |
| >cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.6e-37 Score=249.80 Aligned_cols=220 Identities=28% Similarity=0.474 Sum_probs=176.7
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
..+.+.+|+.++++++|+||+++++++... +..+++++++ +++|.++++. ..+++..+..++.|++.|+.+|
T Consensus 59 ~~~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~~~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~~L 136 (345)
T cd07877 59 HAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLKYI 136 (345)
T ss_pred HHHHHHHHHHHHHHcCCCcccceeeeeeecccccccccEEEEehhc-ccCHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 356688899999999999999999988643 3478899987 7899988764 4689999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l 161 (241)
|+.|++|+||+|.||++ +.++.++|+|||++...... .....++..|+|||.+.+ ..++.++|+||+|+++|++
T Consensus 137 H~~~ivH~dlkp~NIll---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~el 211 (345)
T cd07877 137 HSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 211 (345)
T ss_pred HHCCeeecCCChHHEEE---cCCCCEEEeccccccccccc--ccccccCCCccCHHHHhCccCCCchhhHHHHHHHHHHH
Confidence 99999999999999999 67888999999998765332 233456888999998865 4678899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCC----------------------C----CccCCCCChHHHHHHHHhcccCcccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPF----------------------S----QLIVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------------~----~~~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
++|..||...+....+..+......+. + .......+.++.++|.+||+.||.+|
T Consensus 212 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~~R 291 (345)
T cd07877 212 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDKR 291 (345)
T ss_pred HhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhhcCCCCHHHHHHHHHHcCCChhhc
Confidence 999999987766554444322211100 0 00112457889999999999999999
Q ss_pred CCHHHHhcCcccccccccCC
Q 026253 216 LSFNEFYHHRFLRRNSAILR 235 (241)
Q Consensus 216 ps~~~il~~~~~~~~~~~~~ 235 (241)
||+.+++.||||++......
T Consensus 292 ~t~~e~l~h~~f~~~~~~~~ 311 (345)
T cd07877 292 ITAAQALAHAYFAQYHDPDD 311 (345)
T ss_pred CCHHHHhcChhhhhcCCCCc
Confidence 99999999999997554443
|
Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14 |
| >cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.5e-37 Score=246.80 Aligned_cols=214 Identities=25% Similarity=0.395 Sum_probs=172.9
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecC----------eEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN----------CIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~----------~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~ 78 (241)
...+.+|++++++++||||+++++++.+.. ..++|+||+++ ++.+.+... ..+++..+..++.|++.|
T Consensus 50 ~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~a 128 (302)
T cd07864 50 PITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDH-DLMGLLESGLVHFSEDHIKSFMKQLLEG 128 (302)
T ss_pred hHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCc-cHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence 356778999999999999999999887654 79999999965 777777654 468999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCccccccc-CCCCchhHHHHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVG 155 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG 155 (241)
|.+||+.|++|+||+|.||++ ++++.++|+|||.+........ ......+..|+|||.+.+. ..+.++|+||+|
T Consensus 129 L~~LH~~~i~H~dl~p~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG 205 (302)
T cd07864 129 LNYCHKKNFLHRDIKCSNILL---NNKGQIKLADFGLARLYNSEESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG 205 (302)
T ss_pred HHHHHhCCeecCCCCHHHEEE---CCCCcEEeCcccccccccCCcccccccceeccCccChHHhcCCCCCCchhHHHHHH
Confidence 999999999999999999999 7888999999999876543221 1222346779999987643 468899999999
Q ss_pred HHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC-------------------------CccCCCCChHHHHHHHHhccc
Q 026253 156 AILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS-------------------------QLIVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 156 ~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~ 210 (241)
++++++++|++||...+..+.+..+......+.+ ......++..+.+++.+||+.
T Consensus 206 ~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~ 285 (302)
T cd07864 206 CILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTPALDLLDHMLTL 285 (302)
T ss_pred HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcCCCCHHHHHHHHHHccC
Confidence 9999999999999877666555444332111110 011235688999999999999
Q ss_pred CccccCCHHHHhcCccc
Q 026253 211 NTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 211 ~p~~Rps~~~il~~~~~ 227 (241)
+|.+|||++++++||||
T Consensus 286 ~P~~Rp~~~~il~~~~~ 302 (302)
T cd07864 286 DPSKRCTAEEALNSPWL 302 (302)
T ss_pred ChhhCCCHHHHhcCCCC
Confidence 99999999999999997
|
Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely |
| >KOG1187 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-38 Score=253.54 Aligned_cols=211 Identities=26% Similarity=0.376 Sum_probs=168.9
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecC-eEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.+++.+|+.++.+++|||+++++|||.+.+ ..+||+||+.+|+|.+++.... +++|....+|+.+++.||+|||...
T Consensus 115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~gL~yLH~~~ 194 (361)
T KOG1187|consen 115 EREFLNEVEILSRLRHPNLVKLLGYCLEGGEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARGLAYLHEGC 194 (361)
T ss_pred hhHHHHHHHHHhcCCCcCcccEEEEEecCCceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHHHHHHccCC
Confidence 566999999999999999999999999988 5999999999999999997654 8999999999999999999999864
Q ss_pred ---ccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccc-cCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 87 ---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKV-CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 87 ---i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~-~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|+|||||+.|||+ +.+...||+|||+|+.... ....... .||.+|++||+...+..+.++||||+|++++|+
T Consensus 195 ~~~iiHrDiKssNILL---D~~~~aKlsDFGLa~~~~~~~~~~~~~~~gt~gY~~PEy~~~g~lt~KsDVySFGVvllEl 271 (361)
T KOG1187|consen 195 PPPIIHRDIKSSNILL---DEDFNAKLSDFGLAKLGPEGDTSVSTTVMGTFGYLAPEYASTGKLTEKSDVYSFGVVLLEL 271 (361)
T ss_pred CCCEecCCCCHHHeeE---CCCCCEEccCccCcccCCccccceeeecCCCCccCChhhhccCCcCcccccccchHHHHHH
Confidence 9999999999999 8999999999999955543 3322223 789999999999988999999999999999999
Q ss_pred HhCCCCCCCCC---hHHHH----HHhhcCCCCCCC-CccC-CCCC--h---HHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LNGYPPFSGRN---NVQLV----RNINSCKHLPFS-QLIV-PALH--P---DCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~g~~p~~~~~---~~~~~----~~i~~~~~~~~~-~~~~-~~~~--~---~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++|+.+.+... ...+. ..+.++....+. ..+. ...+ . .+..+...|++.+|.+||++.|+++
T Consensus 272 itgr~~~d~~~~~~~~~l~~w~~~~~~~~~~~eiiD~~l~~~~~~~~~~~~~~~~~a~~C~~~~~~~RP~m~~Vv~ 347 (361)
T KOG1187|consen 272 ITGRKAVDQSRPRGELSLVEWAKPLLEEGKLREIVDPRLKEGEYPDEKEVKKLAELALRCLRPDPKERPTMSQVVK 347 (361)
T ss_pred HhCCcccCCCCCcccccHHHHHHHHHHCcchhheeCCCccCCCCChHHHHHHHHHHHHHHcCcCCCcCcCHHHHHH
Confidence 99998776432 11111 222222111111 1111 1222 2 2667888999999999999999754
|
|
| >KOG0690 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-38 Score=241.49 Aligned_cols=216 Identities=32% Similarity=0.533 Sum_probs=195.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
..++.+--..|-++|+..+||.+..+...|+..+++|+||||.+||.|.-++++.+.+++.....+-..|++||.|||++
T Consensus 208 akdEVAHTlTE~RVL~~~~HPFLt~LKYsFQt~drlCFVMeyanGGeLf~HLsrer~FsE~RtRFYGaEIvsAL~YLHs~ 287 (516)
T KOG0690|consen 208 AKDEVAHTLTENRVLQNCRHPFLTSLKYSFQTQDRLCFVMEYANGGELFFHLSRERVFSEDRTRFYGAEIVSALGYLHSR 287 (516)
T ss_pred ehHHhhhhhhHHHHHHhccCcHHHHhhhhhccCceEEEEEEEccCceEeeehhhhhcccchhhhhhhHHHHHHhhhhhhC
Confidence 44555666778899999999999999999999999999999999999999999888899999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCcccc-CCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~-~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
+|++||+|.+|.++ +.++++||.|||+++.- .........+||+.|+|||++....|+.+.|.|.+|++||+|++|
T Consensus 288 ~ivYRDlKLENLlL---DkDGHIKitDFGLCKE~I~~g~t~kTFCGTPEYLAPEVleDnDYgraVDWWG~GVVMYEMmCG 364 (516)
T KOG0690|consen 288 NIVYRDLKLENLLL---DKDGHIKITDFGLCKEEIKYGDTTKTFCGTPEYLAPEVLEDNDYGRAVDWWGVGVVMYEMMCG 364 (516)
T ss_pred Ceeeeechhhhhee---ccCCceEeeecccchhcccccceeccccCChhhcCchhhccccccceeehhhhhHHHHHHHhc
Confidence 99999999999999 89999999999999754 345567789999999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
+.||.+.+...++.-|. .....+|. .++++...++..+|.+||.+|. ++.|+.+|+||..
T Consensus 365 RLPFyn~dh~kLFeLIl-~ed~kFPr----~ls~eAktLLsGLL~kdP~kRLGgGpdDakEi~~h~FF~~ 429 (516)
T KOG0690|consen 365 RLPFYNKDHEKLFELIL-MEDLKFPR----TLSPEAKTLLSGLLKKDPKKRLGGGPDDAKEIMRHRFFAS 429 (516)
T ss_pred cCcccccchhHHHHHHH-hhhccCCc----cCCHHHHHHHHHHhhcChHhhcCCCchhHHHHHhhhhhcc
Confidence 99999999988888773 33445554 8899999999999999999997 4899999999987
|
|
| >cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-37 Score=248.61 Aligned_cols=218 Identities=32% Similarity=0.492 Sum_probs=175.0
Q ss_pred hhhHHHHHHHHhcC-CCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 10 ~~~~~~E~~~l~~l-~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.+.+.+|+.+++++ +|+||+++++.... ....+++++++ +++|.+++.....+++..+..++.|++.||.+||+
T Consensus 45 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~ 123 (332)
T cd07857 45 AKRALRELKLLRHFRGHKNITCLYDMDIVFPGNFNELYLYEELM-EADLHQIIRSGQPLTDAHFQSFIYQILCGLKYIHS 123 (332)
T ss_pred HHHHHHHHHHHHHhcCCCChheeeeeeeeccccCCcEEEEEecc-cCCHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45678899999999 59999999987532 24578999998 47999999878889999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-----ccccccCCCCccCcccccc-cCCCCchhHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l 158 (241)
.|++|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||...+ ..++.++|+||+|+++
T Consensus 124 ~givH~dlkp~Nili---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l 200 (332)
T cd07857 124 ANVLHRDLKPGNLLV---NADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL 200 (332)
T ss_pred CCcccCCCCHHHeEE---cCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHH
Confidence 999999999999999 678889999999987654321 1223457888999998765 4678999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCCCCC--------------------------CCCccCCCCChHHHHHHHHhcccCc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCKHLP--------------------------FSQLIVPALHPDCVDMCLKLLSANT 212 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p 212 (241)
|++++|.+||...+....+..+......+ ......+..+..+.+++.+||+.||
T Consensus 201 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P 280 (332)
T cd07857 201 AELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIFPNANPLALDLLEKLLAFDP 280 (332)
T ss_pred HHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhCCCCCHHHHHHHHHHccCCc
Confidence 99999999998766544443322211100 0011223567899999999999999
Q ss_pred cccCCHHHHhcCccccccc
Q 026253 213 VDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 213 ~~Rps~~~il~~~~~~~~~ 231 (241)
.+|||+.+++.||||+...
T Consensus 281 ~~R~t~~~ll~~~~~~~~~ 299 (332)
T cd07857 281 TKRISVEEALEHPYLAIWH 299 (332)
T ss_pred ccCCCHHHHhcChhhhhhc
Confidence 9999999999999997543
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co |
| >cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=239.51 Aligned_cols=212 Identities=23% Similarity=0.372 Sum_probs=169.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-----CCCHHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----RVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----~~~~~~~~~~~~~i~~~l~~l 82 (241)
.....+.+|+.++++++|+||+++++++.+....++||||+++++|.+++.... ..+...+..++.|++.|+.+|
T Consensus 37 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~l 116 (269)
T cd05087 37 QEQMKFLEEAQPYRSLQHSNLLQCLGQCTEVTPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIALGLLHL 116 (269)
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHH
Confidence 344578889999999999999999999999899999999999999999997532 356677889999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCccccccc-------CCCCchhHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQ-------RYDEKVDMW 152 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~-------~~~~~~Dv~ 152 (241)
|+.|++|+||||.||++ +.++.++|+|||.+........ .....++..|+|||.+.+. .++.++|+|
T Consensus 117 H~~~i~H~dlkp~nil~---~~~~~~kL~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diw 193 (269)
T cd05087 117 HKNNFIHSDLALRNCLL---TADLTVKIGDYGLSHNKYKEDYYVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKESNVW 193 (269)
T ss_pred HHCCEeccccCcceEEE---cCCCcEEECCccccccccCcceeecCCCcCCcccccCHhHhccccccccccCCCccchhH
Confidence 99999999999999999 6788899999999865433221 1223456789999988642 357899999
Q ss_pred HHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCC-ccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 153 SVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQ-LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 153 slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|+|+++|++++ |..||...+..+.............+. ......+..+.+++..|+ .+|.+|||+++++.
T Consensus 194 slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rpt~~~l~~ 265 (269)
T cd05087 194 SLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPKPRLKLPLSDRWYEVMQFCW-LQPEQRPSAEEVHL 265 (269)
T ss_pred HHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCCCccCCCCChHHHHHHHHHh-cCcccCCCHHHHHH
Confidence 99999999996 999998777666554433332222222 222356788999999998 68999999999874
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells |
| >cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.4e-37 Score=251.11 Aligned_cols=216 Identities=30% Similarity=0.512 Sum_probs=174.2
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
...+.+|++++++++|+||+++++++... ..+++|+|++. .+|.++. ...+++..+..++.|++.|+++||
T Consensus 58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~--~~~~~~~~~~~~~~qi~~aL~~LH 134 (342)
T cd07879 58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVSGDEFQDFYLVMPYMQ-TDLQKIM--GHPLSEDKVQYLVYQMLCGLKYIH 134 (342)
T ss_pred hhHHHHHHHHHHhcCCCCccchhheecccccCCCCceEEEEecccc-cCHHHHH--cCCCCHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999998754 34699999995 5777764 346899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~ 162 (241)
+.|++|+||+|+||++ +.++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||+|+++|+|+
T Consensus 135 ~~~i~H~dlkp~NIll---~~~~~~kL~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil~el~ 209 (342)
T cd07879 135 SAGIIHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEML 209 (342)
T ss_pred HCCcccCCCCHHHEEE---CCCCCEEEeeCCCCcCCCCC--CCCceeeecccChhhhcCccccCchHHHHHHHHHHHHHH
Confidence 9999999999999999 77889999999998764322 223456788999999865 45889999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCC----------------------CC----CccCCCCChHHHHHHHHhcccCccccC
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLP----------------------FS----QLIVPALHPDCVDMCLKLLSANTVDRL 216 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~----------------------~~----~~~~~~~~~~~~~li~~~l~~~p~~Rp 216 (241)
+|+.||.+.+....+..+......+ .+ ....+..+..+.++|++||+.||.+||
T Consensus 210 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R~ 289 (342)
T cd07879 210 TGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFPKASPQAVDLLEKMLELDVDKRL 289 (342)
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhcCCCHHHHHHHHHHcCCChhhCc
Confidence 9999999877655444433211110 00 001235678899999999999999999
Q ss_pred CHHHHhcCccccccccc
Q 026253 217 SFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 217 s~~~il~~~~~~~~~~~ 233 (241)
++++++.||||+.....
T Consensus 290 ~~~e~l~h~~f~~~~~~ 306 (342)
T cd07879 290 TATEALEHPYFDSFRDA 306 (342)
T ss_pred CHHHHhcCcchhhcccc
Confidence 99999999999986543
|
Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13 |
| >KOG0196 consensus Tyrosine kinase, EPH (ephrin) receptor family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-39 Score=267.40 Aligned_cols=212 Identities=23% Similarity=0.440 Sum_probs=194.5
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.++++..|..|+.|+-+++||||+++.|.....+-..||+|||++|+|+.+|+++ ++|+.-++..+++.|+.|++||.+
T Consensus 670 tekqrrdFL~EAsIMGQFdHPNIIrLEGVVTks~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkYLsd 749 (996)
T KOG0196|consen 670 TEKQRRDFLSEASIMGQFDHPNIIRLEGVVTKSKPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKYLSD 749 (996)
T ss_pred cHHHHhhhhhhhhhcccCCCCcEEEEEEEEecCceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHHHhh
Confidence 5788999999999999999999999999999999999999999999999999876 679999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc----ccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
.|+|||||-..|||+ +.+..+|+.|||+++...++... ....-..+|.|||.+...+++.+|||||+|++|||
T Consensus 750 m~YVHRDLAARNILV---NsnLvCKVsDFGLSRvledd~~~~ytt~GGKIPiRWTAPEAIa~RKFTsASDVWSyGIVmWE 826 (996)
T KOG0196|consen 750 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEAAYTTLGGKIPIRWTAPEAIAYRKFTSASDVWSYGIVMWE 826 (996)
T ss_pred cCchhhhhhhhheee---ccceEEEeccccceeecccCCCccccccCCccceeecChhHhhhcccCchhhccccceEEEE
Confidence 999999999999999 89999999999999877554311 11112467999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 161 LLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 161 l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.++ |..||..++..+.++.|..+.+.+.|- +++..+.+|+..||++|-.+||.+.||+.+
T Consensus 827 VmSyGERPYWdmSNQdVIkaIe~gyRLPpPm----DCP~aL~qLMldCWqkdR~~RP~F~qiV~~ 887 (996)
T KOG0196|consen 827 VMSYGERPYWDMSNQDVIKAIEQGYRLPPPM----DCPAALYQLMLDCWQKDRNRRPKFAQIVST 887 (996)
T ss_pred ecccCCCcccccchHHHHHHHHhccCCCCCC----CCcHHHHHHHHHHHHHHhhcCCCHHHHHHH
Confidence 887 999999999999999999999998887 899999999999999999999999998854
|
|
| >cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.2e-37 Score=249.12 Aligned_cols=218 Identities=30% Similarity=0.509 Sum_probs=177.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
....+.+|++++++++|+||+++++++..+. .+++||+++ +++|.+++. ...+++..+..++.|++.|+.+|
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~i~~qi~~al~~L 134 (343)
T cd07880 57 FAKRAYRELRLLKHMKHENVIGLLDVFTPDLSLDRFHDFYLVMPFM-GTDLGKLMK-HEKLSEDRIQFLVYQMLKGLKYI 134 (343)
T ss_pred HHHHHHHHHHHHHhcCCCCccceeeeecCCccccccceEEEEEecC-CCCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence 3557889999999999999999999887553 468999999 789998876 45799999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l 161 (241)
|+.|++|+||+|.||++ +.++.++++|||.+...... .....++..|++||.+.+ ..++.++|+||+|+++|++
T Consensus 135 H~~gi~H~dlkp~Nill---~~~~~~kl~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~~l 209 (343)
T cd07880 135 HAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQTDSE--MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEM 209 (343)
T ss_pred HhCCeecCCCCHHHEEE---cCCCCEEEeecccccccccC--ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHHHH
Confidence 99999999999999999 67888999999998765432 223456788999998865 4578999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCC--------------------------CCCccCCCCChHHHHHHHHhcccCcccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLP--------------------------FSQLIVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
++|..||.+.+.......+....... ......+.++.++.++|.+||+.||.+|
T Consensus 210 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~R 289 (343)
T cd07880 210 LTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLLPNANPLAVNVLEKMLVLDAESR 289 (343)
T ss_pred HhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHhccCCChHHHHHHHHHcCCChhhC
Confidence 99999998776554444332211100 0011224678889999999999999999
Q ss_pred CCHHHHhcCccccccccc
Q 026253 216 LSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 216 ps~~~il~~~~~~~~~~~ 233 (241)
||+.+++.||||+.....
T Consensus 290 ~t~~~~l~~~~~~~~~~~ 307 (343)
T cd07880 290 ITAAEALAHPYFEEFHDP 307 (343)
T ss_pred CCHHHHhcCccHhhhcCc
Confidence 999999999999985443
|
Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12 |
| >cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-37 Score=248.66 Aligned_cols=214 Identities=27% Similarity=0.484 Sum_probs=169.5
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeec--------CeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~ 80 (241)
...+.+|++++++++|+||+++++++.+. ...++||+|+. +++...+.. ...+++..+..++.|+++||.
T Consensus 51 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~-~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~ 129 (311)
T cd07866 51 PITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMD-HDLSGLLENPSVKLTESQIKCYMLQLLEGIN 129 (311)
T ss_pred chhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCC-cCHHHHHhccccCCCHHHHHHHHHHHHHHHH
Confidence 34578899999999999999999987543 34799999995 577777654 346999999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc------------ccccCCCCccCccccccc-CCCC
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------------EKVCGSPLYMAPEVLQFQ-RYDE 147 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~------------~~~~~~~~~~~PE~~~~~-~~~~ 147 (241)
+||+.|++|+||+|.||++ +.++.++|+|||++......... ....++..|+|||.+.+. .++.
T Consensus 130 ~lH~~~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 206 (311)
T cd07866 130 YLHENHILHRDIKAANILI---DNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTT 206 (311)
T ss_pred HHHhCCeecCCCCHHHEEE---CCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCc
Confidence 9999999999999999999 78889999999998765332211 112356779999987654 5789
Q ss_pred chhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC-------------------------CccCCCCChHHHH
Q 026253 148 KVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS-------------------------QLIVPALHPDCVD 202 (241)
Q Consensus 148 ~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~~ 202 (241)
++|+||+|+++|+|++|.+||.+.+.......+......+.+ .......++.+.+
T Consensus 207 ~~Dv~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 286 (311)
T cd07866 207 AVDIWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPEGLD 286 (311)
T ss_pred hhHhHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcccCChhHHH
Confidence 999999999999999999999887776555444321111000 0011245578999
Q ss_pred HHHHhcccCccccCCHHHHhcCccc
Q 026253 203 MCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 203 li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
++.+||+.||.+|||+.+++.||||
T Consensus 287 ~i~~~l~~~p~~R~t~~ell~~~~f 311 (311)
T cd07866 287 LLSKLLSLDPYKRLTASDALEHPYF 311 (311)
T ss_pred HHHHHcccCcccCcCHHHHhcCCCC
Confidence 9999999999999999999999998
|
Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic |
| >cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.6e-37 Score=239.36 Aligned_cols=212 Identities=26% Similarity=0.491 Sum_probs=179.4
Q ss_pred HHhhhhHHHHHHHHhc-CCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSS-VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~-l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
......+.+|+.++.+ ++|+||+++++++.+++..+++|||+++++|.+++.. ...+++..++.++.|++.++.+
T Consensus 49 ~~~~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~~l~~ 128 (269)
T cd08528 49 DKSIGDIVSEVTIIKEQLRHPNIVRYYKTFLENDRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVLALRY 128 (269)
T ss_pred hHHHHHHHHHHHHHhhcCCCCCeeeEEeeEccCCeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 3445667889998876 6999999999999999999999999999999998743 3458999999999999999999
Q ss_pred HHh-CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 82 LNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 82 lh~-~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
||+ .|++|+||+|.||++ +.++.++|+|||.+.............++..|.+||...+..++.++|+||+|+++|+
T Consensus 129 lh~~~~i~H~dl~~~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Dv~slG~ll~~ 205 (269)
T cd08528 129 LHKEKRIVHRDLTPNNIML---GEDDKVTITDFGLAKQKQPESKLTSVVGTILYSCPEIVKNEPYGEKADVWAFGCILYQ 205 (269)
T ss_pred hccCCceeecCCCHHHEEE---CCCCcEEEecccceeecccccccccccCcccCcChhhhcCCCCchHHHHHHHHHHHHH
Confidence 996 689999999999999 7788999999999877654433344567888999999988889999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+++|..||...+.......+......+... ..++.++.+++.+||+.||++||++.|+..+
T Consensus 206 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~cl~~~p~~Rp~~~e~~~~ 266 (269)
T cd08528 206 MCTLQPPFYSTNMLSLATKIVEAVYEPLPE---GMYSEDVTDVITSCLTPDAEARPDIIQVSAM 266 (269)
T ss_pred HHhCCCcccccCHHHHHHHHhhccCCcCCc---ccCCHHHHHHHHHHCCCCCccCCCHHHHHHH
Confidence 999999998877766666665544333222 2578899999999999999999999998753
|
Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. |
| >cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=6e-37 Score=241.46 Aligned_cols=211 Identities=26% Similarity=0.427 Sum_probs=170.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
......+.+|++++++++|+|++++.+++... ...++||||++|++|.+++.+. ..+++..+..++.|++.||.+||
T Consensus 47 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~lH 126 (284)
T cd05079 47 GNHIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDYLG 126 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCCceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44456899999999999999999999988765 5689999999999999999765 35899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
+.|++|+||+|.||++ +.++.++|+|||.+........ .....++..|+|||...+..++.++|+||+|+++|
T Consensus 127 ~~gi~H~dlkp~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~apE~~~~~~~~~~~Di~slG~il~ 203 (284)
T cd05079 127 SRQYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDLDSPVFWYAPECLIQSKFYIASDVWSFGVTLY 203 (284)
T ss_pred HCCeeecccchheEEE---cCCCCEEECCCccccccccCccceeecCCCCCCccccCHHHhccCCCCccccchhhhhhhh
Confidence 9999999999999999 6778899999999876543221 12234566799999998888999999999999999
Q ss_pred HHHhCCCCCCCC---------------ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 160 ELLNGYPPFSGR---------------NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 160 ~l~~g~~p~~~~---------------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+++++..|+... ........+......+. ...++..+.+++.+||+.+|.+|||++++++.
T Consensus 204 ellt~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~~l~~~p~~Rpt~~~il~~ 279 (284)
T cd05079 204 ELLTYCDSESSPMTLFLKMIGPTHGQMTVTRLVRVLEEGKRLPR----PPNCPEEVYQLMRKCWEFQPSKRTTFQNLIEG 279 (284)
T ss_pred hhhcCCCCCccccchhhhhcccccccccHHHHHHHHHcCccCCC----CCCCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 999976654321 11112222222222222 23688999999999999999999999999864
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a |
| >cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.6e-37 Score=241.95 Aligned_cols=213 Identities=24% Similarity=0.431 Sum_probs=172.0
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-----------CCCHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-----------RVPEQTARKFLQQLG 76 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-----------~~~~~~~~~~~~~i~ 76 (241)
.....+.+|++++++++|+||+++++++..++..+++|||+.+++|.+++.... .+++..+..++.|++
T Consensus 61 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~ 140 (296)
T cd05095 61 NARNDFLKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFMATQIA 140 (296)
T ss_pred HHHHHHHHHHHHHHhCCCCCcceEEEEEecCCccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHHHHHHH
Confidence 345788999999999999999999999999999999999999999999997643 256778999999999
Q ss_pred HHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHH
Q 026253 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (241)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 153 (241)
.|+++||+.|++|+||||+||++ +.++.++|+|||++........ ......+..|++||...+..++.++|+||
T Consensus 141 ~al~~lH~~~i~H~dlkp~Nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~DiwS 217 (296)
T cd05095 141 SGMKYLSSLNFVHRDLATRNCLV---GKNYTIKIADFGMSRNLYSGDYYRIQGRAVLPIRWMSWESILLGKFTTASDVWA 217 (296)
T ss_pred HHHHHHHHCCeecccCChheEEE---cCCCCEEeccCcccccccCCcceeccCcCcCccccCCHHHHhcCCccchhhhhH
Confidence 99999999999999999999999 6788899999999876533221 11122356799999888888999999999
Q ss_pred HHHHHHHHHh--CCCCCCCCChHHHHHHhhcC---CCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 154 VGAILFELLN--GYPPFSGRNNVQLVRNINSC---KHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 154 lG~~l~~l~~--g~~p~~~~~~~~~~~~i~~~---~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+|+++|+|++ |..||...+..+........ ............++..+.+++.+||+.||.+|||+.++++
T Consensus 218 lG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~Rp~~~~i~~ 292 (296)
T cd05095 218 FGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQVYLPKPALCPDSLYKLMLSCWRRNAKERPSFQEIHA 292 (296)
T ss_pred HHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccccCCCCCCCCHHHHHHHHHHcCCCcccCCCHHHHHH
Confidence 9999999998 77899877665554433110 0000011112357789999999999999999999999874
|
Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit |
| >cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1 | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.1e-37 Score=246.44 Aligned_cols=222 Identities=32% Similarity=0.487 Sum_probs=177.8
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEee-cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|++++++++||||+++.+++.. +...++++|++ +++|.++++ ..++++..+..++.|++.||.+||+.|+
T Consensus 52 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~-~~~~~~~~~~~~~~ql~~aL~~LH~~~i 129 (328)
T cd07856 52 LAKRTYRELKLLKHLRHENIISLSDIFISPLEDIYFVTELL-GTDLHRLLT-SRPLEKQFIQYFLYQILRGLKYVHSAGV 129 (328)
T ss_pred hhHHHHHHHHHHHhcCCCCeeeEeeeEecCCCcEEEEeehh-ccCHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 45678899999999999999999998865 56789999999 678988876 3568888999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|.||++ ++++.++|+|||.+...... .....++..|+|||.+.+ ..++.++|+||+|+++|++++|..
T Consensus 130 iH~dl~p~Nili---~~~~~~~l~dfg~~~~~~~~--~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il~el~tg~~ 204 (328)
T cd07856 130 VHRDLKPSNILI---NENCDLKICDFGLARIQDPQ--MTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKP 204 (328)
T ss_pred ccCCCCHHHEeE---CCCCCEEeCccccccccCCC--cCCCcccccccCceeeeccCCcCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999 67888999999998754322 223456778999998765 568999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCC--------------------------CCCCCccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 167 PFSGRNNVQLVRNINSCKH--------------------------LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~--------------------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
||...+.......+.+... ........+.++..+.++|++||+.+|.+|||+++
T Consensus 205 ~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~P~~R~t~~e 284 (328)
T cd07856 205 LFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLPKREPVPFSEKFKNADPSAIDLLEKMLVFDPQKRISAAE 284 (328)
T ss_pred CCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhccccCCCcHHHHcCCCCHHHHHHHHHHcCCChhhCCCHHH
Confidence 9987665333222211100 00011122457889999999999999999999999
Q ss_pred HhcCcccccccccCCCC
Q 026253 221 FYHHRFLRRNSAILRAP 237 (241)
Q Consensus 221 il~~~~~~~~~~~~~~~ 237 (241)
++.||||.........|
T Consensus 285 ll~~~~~~~~~~~~~~~ 301 (328)
T cd07856 285 ALAHPYLAPYHDPTDEP 301 (328)
T ss_pred HhcCCccccccCCcccc
Confidence 99999998766554443
|
Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U |
| >smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.7e-37 Score=236.54 Aligned_cols=213 Identities=42% Similarity=0.734 Sum_probs=185.0
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
.+.+.+|++.+++++|+|++++.+++..+...++++|++.+++|.+++.....++...+..++.+++.++.+||+.+++|
T Consensus 31 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i~h 110 (244)
T smart00220 31 RERILREISILKKLKHPNIVRLYDVFEDEDKLYLVMEYCDGGDLFDLLKKRGRLSEDEARFYARQILSALEYLHSNGIIH 110 (244)
T ss_pred HHHHHHHHHHHHhCCCCcHHHHHhheeeCCEEEEEEeCCCCCCHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHcCeec
Confidence 68899999999999999999999999999999999999998899999987766899999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 169 (241)
+||+|.||++ ++++.++++|||.+.............++..|++||...+..++.++|+|++|++++++++|..||.
T Consensus 111 ~~i~~~ni~~---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~pE~~~~~~~~~~~Di~slG~~l~~l~~~~~p~~ 187 (244)
T smart00220 111 RDLKPENILL---DEDGHVKLADFGLARQLDPGGLLTTFVGTPEYMAPEVLLGKGYGKAVDVWSLGVILYELLTGKPPFP 187 (244)
T ss_pred CCcCHHHeEE---CCCCcEEEccccceeeeccccccccccCCcCCCCHHHHccCCCCchhhHHHHHHHHHHHHhCCCCCC
Confidence 9999999999 6778999999999987765544455667888999999988888999999999999999999999998
Q ss_pred C-CChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 170 G-RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 170 ~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
. .+.....+.+.......... ...++.++.+++.+|+..+|++||++.++++||||
T Consensus 188 ~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~i~~~l~~~p~~Rp~~~~~~~~~~~ 244 (244)
T smart00220 188 GDDQLLELFKKIGKPKPPFPPP--EWKISPEAKDLIRKLLVKDPEKRLTAEEALQHPFF 244 (244)
T ss_pred CCCcHHHHHHHHhccCCCCccc--cccCCHHHHHHHHHHccCCchhccCHHHHhhCCCC
Confidence 7 55555555554333222111 11278899999999999999999999999999997
|
Phosphotransferases. Serine or threonine-specific kinase subfamily. |
| >cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.8e-36 Score=238.73 Aligned_cols=210 Identities=25% Similarity=0.404 Sum_probs=167.2
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+.+|++++++++|+||+++++++.. ....++||||+.+++|.+++... ..+++..+..++.|++.||.+||
T Consensus 46 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~LH 125 (284)
T cd05081 46 AEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEYLG 125 (284)
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeEEEEEEccCCCCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999997643 45689999999999999999764 45899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc----ccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~----~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
+.|++|+||+|.||++ ++++.++|+|||++......... ........|+|||...+..++.++|+||+|++++
T Consensus 126 ~~~i~H~dlkp~nili---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ 202 (284)
T cd05081 126 SKRYVHRDLATRNILV---ESENRVKIGDFGLTKVLPQDKEYYKVREPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 202 (284)
T ss_pred HCCceeccCCHhhEEE---CCCCeEEECCCcccccccCCCcceeecCCCCCceEeeCHHHhccCCcChHHHHHHHHHHHH
Confidence 9999999999999999 77888999999998765432211 1122344599999998888999999999999999
Q ss_pred HHHhCCCCCCCCChH----------------HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 160 ELLNGYPPFSGRNNV----------------QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++++|..++...... .....+......+ ....++.++.+++.+||+.+|++|||+.++++
T Consensus 203 el~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05081 203 ELFTYSDKSCSPPAEFMRMMGNDKQGQMIVYHLIELLKNNGRLP----APPGCPAEIYAIMKECWNNDPSQRPSFSELAL 278 (284)
T ss_pred HHhhcCCcCCCcchhhhhhcccccccccchHHHHHHHhcCCcCC----CCCCCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 999987765432211 1111122222211 12367889999999999999999999999975
|
Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th |
| >cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.8e-36 Score=235.80 Aligned_cols=212 Identities=18% Similarity=0.351 Sum_probs=171.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
...+.+.+|+.+++.++||||+++++.+.+....++||||+++++|.+++.+. ...+...+..++.|++.||++||
T Consensus 37 ~~~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~al~~lH 116 (268)
T cd05086 37 KEQNEFLQQGDPYRILQHPNILQCLGQCVEAIPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAAGVTHMH 116 (268)
T ss_pred HHHHHHHHHHHHHhccCCcchhheEEEecCCCccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHHHHHHHH
Confidence 45678999999999999999999999999999999999999999999999754 23567778899999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC---CccccccCCCCccCcccccc-------cCCCCchhHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQF-------QRYDEKVDMWS 153 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~---~~~~~~~~~~~~~~PE~~~~-------~~~~~~~Dv~s 153 (241)
+.+++|+||||.||++ +.++.++|+|||.+...... .......++..|+|||.... ..++.++|+||
T Consensus 117 ~~~i~H~dikp~nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~~Diws 193 (268)
T cd05086 117 KHNFLHSDLALRNCFL---TSDLTVKVGDYGIGPSRYKEDYIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKPSNVWA 193 (268)
T ss_pred HCCeeccCCccceEEE---cCCccEEecccccccccCcchhhhcccCCcCcccccCchhcccccCccccCCCCCcchhHH
Confidence 9999999999999999 67888999999987543211 11223456788999998743 23578999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCC-CCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 154 VGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP-FSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 154 lG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+|+++|+|++ |..||...+..+.+..+....... ........++..+.+++..|+ .+|.+||+++++++
T Consensus 194 lG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~c~-~~P~~Rp~~~~i~~ 264 (268)
T cd05086 194 LGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQLELPYSERWYEVLQFCW-LSPEKRATAEEVHR 264 (268)
T ss_pred HHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCccCCCCcHHHHHHHHHHh-hCcccCCCHHHHHH
Confidence 9999999997 577898777766666543333222 222333457889999999999 67999999999875
|
Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage |
| >PRK13184 pknD serine/threonine-protein kinase; Reviewed | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-36 Score=263.49 Aligned_cols=211 Identities=22% Similarity=0.328 Sum_probs=169.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-----------CCCCHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-----------GRVPEQTARKFLQQLG 76 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-----------~~~~~~~~~~~~~~i~ 76 (241)
...+++.+|++++++++||||+++++++.+++..+++|||++|++|.+++... .+.+...+..++.|++
T Consensus 44 ~~~~rflrEi~ILs~L~HPNIVkl~~v~~d~~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I~~QIa 123 (932)
T PRK13184 44 LLKKRFLREAKIAADLIHPGIVPVYSICSDGDPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSIFHKIC 123 (932)
T ss_pred HHHHHHHHHHHHHHhCCCcCcCeEEEEEeeCCEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHHHHHHH
Confidence 34667899999999999999999999999999999999999999999998642 2345667889999999
Q ss_pred HHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-------------------ccccccCCCCccCc
Q 026253 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------------------YAEKVCGSPLYMAP 137 (241)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-------------------~~~~~~~~~~~~~P 137 (241)
.||++||+.|++||||||+||++ +.++.++|+|||++....... ......|++.|+||
T Consensus 124 ~AL~yLHs~GIIHRDLKPeNILL---d~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~YmAP 200 (932)
T PRK13184 124 ATIEYVHSKGVLHRDLKPDNILL---GLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAP 200 (932)
T ss_pred HHHHHHHHCCccccCCchheEEE---cCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCCCH
Confidence 99999999999999999999999 788889999999997652110 11124589999999
Q ss_pred ccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC
Q 026253 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 138 E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
|.+.+..++.++|+||+|+++|+|++|..||...+................ .....++..+.+++.+||+.||.+|++
T Consensus 201 E~l~g~~~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~~~i~~P~~~--~p~~~iP~~L~~LI~rcL~~DP~kR~s 278 (932)
T PRK13184 201 ERLLGVPASESTDIYALGVILYQMLTLSFPYRRKKGRKISYRDVILSPIEV--APYREIPPFLSQIAMKALAVDPAERYS 278 (932)
T ss_pred HHhcCCCCCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhhhhccChhhc--cccccCCHHHHHHHHHHccCChhhCcC
Confidence 999988999999999999999999999999987554433222111111111 112367889999999999999999987
Q ss_pred HHHHhc
Q 026253 218 FNEFYH 223 (241)
Q Consensus 218 ~~~il~ 223 (241)
..+.+.
T Consensus 279 s~eeLl 284 (932)
T PRK13184 279 SVQELK 284 (932)
T ss_pred HHHHHH
Confidence 655443
|
|
| >KOG2345 consensus Serine/threonine protein kinase/TGF-beta stimulated factor [Transcription; Lipid transport and metabolism; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.4e-38 Score=229.21 Aligned_cols=213 Identities=22% Similarity=0.314 Sum_probs=169.3
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee-----cCeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLG 76 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~ 76 (241)
+.++.+...+|++..++++|||+++++++... ....|++++|...|+|.+.++..+ -+++.++..|..+++
T Consensus 58 ~~~~~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic 137 (302)
T KOG2345|consen 58 SQEDIEEALREIDNHRKFNSPNVLRLVDHQLREEKDGKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGIC 137 (302)
T ss_pred chHHHHHHHHHHHHHHhhCCcchHHHHHHHHHhhccCceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHH
Confidence 56789999999999999999999999987532 235899999999999999997642 489999999999999
Q ss_pred HHHHHHHhCC--ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----------cccccCCCCccCccccccc-
Q 026253 77 AGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----------AEKVCGSPLYMAPEVLQFQ- 143 (241)
Q Consensus 77 ~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----------~~~~~~~~~~~~PE~~~~~- 143 (241)
+||++||+.. +.|+||||.||++ .+.+.+.+.|||.++...-.-. ......|..|.|||.+.-+
T Consensus 138 ~gL~~lH~~~~~yAH~DiKP~NILl---s~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~ 214 (302)
T KOG2345|consen 138 RGLEALHEKEPPYAHRDIKPANILL---SDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKS 214 (302)
T ss_pred HHHHHHhccCCcccccCCCcceeEe---cCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheeccc
Confidence 9999999998 9999999999999 6688999999999866532111 1123457889999998644
Q ss_pred --CCCCchhHHHHHHHHHHHHhCCCCCCCCChH--HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHH
Q 026253 144 --RYDEKVDMWSVGAILFELLNGYPPFSGRNNV--QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN 219 (241)
Q Consensus 144 --~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~--~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 219 (241)
..+.++|||||||++|.|+.|..||+..-.. .+.-.+ ......+|.. +.+|+.+.++|+.||+.||.+||++.
T Consensus 215 ~~ti~ertDIWSLGCtLYa~mf~~sPfe~~~~~GgSlaLAv-~n~q~s~P~~--~~yse~l~~lik~mlqvdP~qRP~i~ 291 (302)
T KOG2345|consen 215 HCTITERTDIWSLGCTLYAMMFGESPFERIYQQGGSLALAV-QNAQISIPNS--SRYSEALHQLIKSMLQVDPNQRPTIP 291 (302)
T ss_pred CcccccccchhhhhHHHHHHHHcCCcchHHhhcCCeEEEee-eccccccCCC--CCccHHHHHHHHHHhcCCcccCCCHH
Confidence 4678999999999999999999999731110 000001 1112233332 34899999999999999999999999
Q ss_pred HHhcC
Q 026253 220 EFYHH 224 (241)
Q Consensus 220 ~il~~ 224 (241)
+++.+
T Consensus 292 ~ll~~ 296 (302)
T KOG2345|consen 292 ELLSK 296 (302)
T ss_pred HHHHH
Confidence 99864
|
|
| >KOG0671 consensus LAMMER dual specificity kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-38 Score=240.93 Aligned_cols=222 Identities=24% Similarity=0.394 Sum_probs=177.1
Q ss_pred HhhhhHHHHHHHHhcCC--CcC----eeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVN--HPN----IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~--~~~----i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l 79 (241)
.-++..+-|+++++++. -|+ ++.+.++|.-.++.|+|+|.+ |.++.+++.++ .+++..++..+++|++.++
T Consensus 127 kYreAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdyrghiCivfell-G~S~~dFlk~N~y~~fpi~~ir~m~~QL~~sv 205 (415)
T KOG0671|consen 127 KYREAALIEIEVLQKINESDPNGKFRCVQMRDWFDYRGHICIVFELL-GLSTFDFLKENNYIPFPIDHIRHMGYQLLESV 205 (415)
T ss_pred HHhhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhccCceEEEEecc-ChhHHHHhccCCccccchHHHHHHHHHHHHHH
Confidence 44677888999999993 222 777778899999999999998 78999999875 4699999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEee-----------------cCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc
Q 026253 80 EILNSHHIIHRDLKPENILLSG-----------------LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF 142 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~-----------------~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~ 142 (241)
++||+.+++|.||||+||++.+ ..+...|+++|||.|+...... .....|..|.|||++.+
T Consensus 206 ~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~h--s~iVsTRHYRAPEViLg 283 (415)
T KOG0671|consen 206 AFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEHH--STIVSTRHYRAPEVILG 283 (415)
T ss_pred HHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccCc--ceeeeccccCCchheec
Confidence 9999999999999999999841 1124569999999997754433 45678999999999999
Q ss_pred cCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCC--------------------CCCCCccCCC-------
Q 026253 143 QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKH--------------------LPFSQLIVPA------- 195 (241)
Q Consensus 143 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~--------------------~~~~~~~~~~------- 195 (241)
-.++..+||||+||++.|+++|...|...+..+.+..+..... ...+......
T Consensus 284 LGwS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~~~~~~~k~v~~ 363 (415)
T KOG0671|consen 284 LGWSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEVSSKGKSKYVFE 363 (415)
T ss_pred cCcCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccccccccchhhhc
Confidence 9999999999999999999999999987776553332222111 1111110000
Q ss_pred --------------CChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 196 --------------LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 196 --------------~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
....+.|++++||..||.+|+|+.|+|.||||+....
T Consensus 364 ~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~~~ 414 (415)
T KOG0671|consen 364 PCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARLTP 414 (415)
T ss_pred CCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcCCC
Confidence 1124899999999999999999999999999998653
|
|
| >cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4 | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.4e-36 Score=240.19 Aligned_cols=207 Identities=25% Similarity=0.421 Sum_probs=173.6
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
...+.+|+.++++++|+||+++++++... ..+++++++.+++|.+++.... .+++..+..++.|++.||.+||+.|++
T Consensus 53 ~~~~~~e~~~~~~l~h~niv~~~~~~~~~-~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~LH~~~iv 131 (303)
T cd05110 53 NVEFMDEALIMASMDHPHLVRLLGVCLSP-TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYLEERRLV 131 (303)
T ss_pred HHHHHHHHHHHHhCCCCCcccEEEEEcCC-CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHhhcCee
Confidence 44688999999999999999999988754 4678999999999999987654 588999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
|+||+|.||++ ++++.++|+|||.+........ .....++..|++||.+.+..++.++|+||||+++|++++ |
T Consensus 132 H~dikp~Nill---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~DiwslG~~l~el~t~g 208 (303)
T cd05110 132 HRDLAARNVLV---KSPNHVKITDFGLARLLEGDEKEYNADGGKMPIKWMALECIHYRKFTHQSDVWSYGVTIWELMTFG 208 (303)
T ss_pred ccccccceeee---cCCCceEEccccccccccCcccccccCCCccccccCCHHHhccCCCChHHHHHHHHHHHHHHHhCC
Confidence 99999999999 6778899999999976543221 112334567999999988889999999999999999997 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
..||.+....+....+..+...+.+ +..+..+.+++..||..+|.+||+++++++.
T Consensus 209 ~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~c~~~~p~~Rp~~~~l~~~ 264 (303)
T cd05110 209 GKPYDGIPTREIPDLLEKGERLPQP----PICTIDVYMVMVKCWMIDADSRPKFKELAAE 264 (303)
T ss_pred CCCCCCCCHHHHHHHHHCCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999887766666666554444333 3567899999999999999999999998764
|
Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin |
| >cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.4e-36 Score=246.66 Aligned_cols=210 Identities=25% Similarity=0.412 Sum_probs=173.2
Q ss_pred HhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-------------------------
Q 026253 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------- 61 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------- 61 (241)
.....+.+|+.++.++. |+||+++++++...+..++||||+.+|+|.+++.+.+
T Consensus 82 ~~~~~~~~E~~~l~~l~~H~niv~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 161 (401)
T cd05107 82 SEKQALMSELKIMSHLGPHLNIVNLLGACTKGGPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISGGSTPL 161 (401)
T ss_pred hHHHHHHHHHHHHHhcCCCCCeEEEEEEEccCCCcEEEEeccCCCcHHHHHHhccccchhhhcccccccccccccccccc
Confidence 33457889999999997 9999999999999999999999999999999996532
Q ss_pred -------------------------------------------------------------------------CCCHHHH
Q 026253 62 -------------------------------------------------------------------------RVPEQTA 68 (241)
Q Consensus 62 -------------------------------------------------------------------------~~~~~~~ 68 (241)
.+++..+
T Consensus 162 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~ 241 (401)
T cd05107 162 SQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPALSYMDL 241 (401)
T ss_pred cccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCCCHHHH
Confidence 2466678
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCC
Q 026253 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY 145 (241)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~ 145 (241)
..++.|++.||.+||+.+++|+||+|.||++ ++.+.++|+|||++....... ......++..|+|||.+.+..+
T Consensus 242 ~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl---~~~~~~kL~DfGla~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 318 (401)
T cd05107 242 VGFSYQVANGMEFLASKNCVHRDLAARNVLI---CEGKLVKICDFGLARDIMRDSNYISKGSTFLPLKWMAPESIFNNLY 318 (401)
T ss_pred HHHHHHHHHHHHHHhcCCcCcccCCcceEEE---eCCCEEEEEecCcceecccccccccCCCcCCCCceeChHHhcCCCC
Confidence 8899999999999999999999999999999 678889999999987643221 1122345678999999988889
Q ss_pred CCchhHHHHHHHHHHHHh-CCCCCCCCChHHH-HHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 146 DEKVDMWSVGAILFELLN-GYPPFSGRNNVQL-VRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 146 ~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+.++|+||+|+++|++++ |..||......+. ...+..+.....+ ..++.++.+++.+||..+|.+||+++++++
T Consensus 319 ~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~p----~~~~~~l~~li~~cl~~~P~~RPs~~ell~ 394 (401)
T cd05107 319 TTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIKRGYRMAKP----AHASDEIYEIMQKCWEEKFEIRPDFSQLVH 394 (401)
T ss_pred CcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 999999999999999998 8899987655444 3444444333322 367899999999999999999999999986
Q ss_pred C
Q 026253 224 H 224 (241)
Q Consensus 224 ~ 224 (241)
.
T Consensus 395 ~ 395 (401)
T cd05107 395 L 395 (401)
T ss_pred H
Confidence 4
|
Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D |
| >KOG4257 consensus Focal adhesion tyrosine kinase FAK, contains FERM domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.3e-37 Score=251.53 Aligned_cols=210 Identities=27% Similarity=0.472 Sum_probs=187.9
Q ss_pred hhHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHH
Q 026253 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh 83 (241)
...+..+.|.+|..+++.++||||++++|++.+. -.|+|||.+..|.|..|++.++ .++......++.||+.||+|||
T Consensus 430 ~t~d~tekflqEa~iMrnfdHphIikLIGv~~e~-P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~talaYLe 508 (974)
T KOG4257|consen 430 CTPDDTEKFLQEASIMRNFDHPHIIKLIGVCVEQ-PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALAYLE 508 (974)
T ss_pred CChhhHHHHHHHHHHHHhCCCcchhheeeeeecc-ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHHHHH
Confidence 3556789999999999999999999999999874 5899999999999999998764 5899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc--cccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~--~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
+.+++||||-..||++ .....+||+|||+++.......-. ...-...|+|||.+.-..++.++|||.||+++||+
T Consensus 509 SkrfVHRDIAaRNiLV---sSp~CVKLaDFGLSR~~ed~~yYkaS~~kLPIKWmaPESINfRrFTtASDVWMFgVCmWEI 585 (974)
T KOG4257|consen 509 SKRFVHRDIAARNILV---SSPQCVKLADFGLSRYLEDDAYYKASRGKLPIKWMAPESINFRRFTTASDVWMFGVCMWEI 585 (974)
T ss_pred hhchhhhhhhhhheee---cCcceeeecccchhhhccccchhhccccccceeecCccccchhcccchhhHHHHHHHHHHH
Confidence 9999999999999999 677789999999998876654322 22235569999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
+. |..||.+....+.+-.+.++.+.+.|+ .+++.+..++.+||+.+|.+||.+.++.
T Consensus 586 l~lGvkPfqgvkNsDVI~~iEnGeRlP~P~----nCPp~LYslmskcWayeP~kRPrftei~ 643 (974)
T KOG4257|consen 586 LSLGVKPFQGVKNSDVIGHIENGERLPCPP----NCPPALYSLMSKCWAYEPSKRPRFTEIK 643 (974)
T ss_pred HHhcCCccccccccceEEEecCCCCCCCCC----CCChHHHHHHHHHhccCcccCCcHHHHH
Confidence 88 999999999999999999999999887 7889999999999999999999987754
|
|
| >KOG0612 consensus Rho-associated, coiled-coil containing protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4e-37 Score=263.61 Aligned_cols=231 Identities=30% Similarity=0.520 Sum_probs=201.0
Q ss_pred hhHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
++.-+.+.|..|-.++.--+.+=|+.+.-.|.+++++|+||||+.||+|-.++.+.++++++.+..++..++.||..+|+
T Consensus 114 lKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~~~LYlVMdY~pGGDlltLlSk~~~~pE~~ArFY~aEiVlAldslH~ 193 (1317)
T KOG0612|consen 114 LKRAETACFREERDIMVFGNSEWIVQLHYAFQDERYLYLVMDYMPGGDLLTLLSKFDRLPEDWARFYTAEIVLALDSLHS 193 (1317)
T ss_pred hhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCccceEEEEecccCchHHHHHhhcCCChHHHHHHHHHHHHHHHHHHHh
Confidence 45667788999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCccccc----c-cCCCCchhHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ----F-QRYDEKVDMWSVGAI 157 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~----~-~~~~~~~Dv~slG~~ 157 (241)
.|++||||||+|||+ +..|+++|.|||.+-....+++ ....+|||-|.|||++. + +.|++..|.||+|++
T Consensus 194 mgyVHRDiKPDNvLl---d~~GHikLADFGsClkm~~dG~V~s~~aVGTPDYISPEvLqs~~~~~g~yG~ecDwWSlGV~ 270 (1317)
T KOG0612|consen 194 MGYVHRDIKPDNVLL---DKSGHIKLADFGSCLKMDADGTVRSSVAVGTPDYISPEVLQSQGDGKGEYGRECDWWSLGVF 270 (1317)
T ss_pred ccceeccCCcceeEe---cccCcEeeccchhHHhcCCCCcEEeccccCCCCccCHHHHHhhcCCccccCCccchhhhHHH
Confidence 999999999999999 8999999999999877764443 34467999999999985 2 468999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCChHHHHHHHHhcccCccccCC---HHHHhcCcccccc---
Q 026253 158 LFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS---FNEFYHHRFLRRN--- 230 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps---~~~il~~~~~~~~--- 230 (241)
+|||+.|..||...+-.+.+.+|.+.+ ...+|.. ..+|++..++|++.+. +|+.|.. ++++-.||||.+.
T Consensus 271 ~YEMlyG~TPFYadslveTY~KIm~hk~~l~FP~~--~~VSeeakdLI~~ll~-~~e~RLgrngiedik~HpFF~g~~W~ 347 (1317)
T KOG0612|consen 271 MYEMLYGETPFYADSLVETYGKIMNHKESLSFPDE--TDVSEEAKDLIEALLC-DREVRLGRNGIEDIKNHPFFEGIDWD 347 (1317)
T ss_pred HHHHHcCCCcchHHHHHHHHHHHhchhhhcCCCcc--cccCHHHHHHHHHHhc-ChhhhcccccHHHHHhCccccCCChh
Confidence 999999999999999999998887764 4455633 3699999999999886 6788988 9999999999983
Q ss_pred cccCCCCCCCC
Q 026253 231 SAILRAPFHIP 241 (241)
Q Consensus 231 ~~~~~~~~~~~ 241 (241)
..-...|+.||
T Consensus 348 ~iR~~~pP~vP 358 (1317)
T KOG0612|consen 348 NIRESVPPVVP 358 (1317)
T ss_pred hhhhcCCCCCC
Confidence 33334444444
|
|
| >cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3 | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.5e-36 Score=233.83 Aligned_cols=211 Identities=25% Similarity=0.452 Sum_probs=174.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC------eEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQ 74 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~ 74 (241)
....+.+.+|++++++++||||+++++++...+ ..+++++|+.+++|.+++... ..++...+..++.|
T Consensus 42 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~ 121 (273)
T cd05074 42 SSDIEEFLREAACMKEFDHPNVIKLIGVSLRSRAKGRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMID 121 (273)
T ss_pred hHHHHHHHHHHHHHhcCCCCCcceEEEEEccCCCCCcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHH
Confidence 345667889999999999999999999876432 247889999999999887432 24788999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhH
Q 026253 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (241)
Q Consensus 75 i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv 151 (241)
++.|+++||+.|++|+||+|.||++ +.++.++++|||.+........ .....++..|++||...+..++.++|+
T Consensus 122 i~~~l~~lH~~~i~H~dikp~nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~sDi 198 (273)
T cd05074 122 IASGMEYLSSKNFIHRDLAARNCML---NENMTVCVADFGLSKKIYSGDYYRQGCASKLPVKWLALESLADNVYTTHSDV 198 (273)
T ss_pred HHHHHHHHHhCCEeecccchhhEEE---cCCCCEEECcccccccccCCcceecCCCccCchhhcCHhHHhcCccchhhhh
Confidence 9999999999999999999999999 6788899999999876543221 112234567999999988888999999
Q ss_pred HHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 152 WSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 152 ~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
||+|+++|++++ |.+||.+.+..+....+........+ +..+..+.+++.+||+.+|++|||+.++++.
T Consensus 199 ~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~l~~~~l~~~p~~Rps~~~~~~~ 268 (273)
T cd05074 199 WAFGVTMWEIMTRGQTPYAGVENSEIYNYLIKGNRLKQP----PDCLEDVYELMCQCWSPEPKCRPSFQHLRDQ 268 (273)
T ss_pred HHHHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999998 89999988877777777655433322 3678899999999999999999999998753
|
Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac |
| >KOG4278 consensus Protein tyrosine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1e-36 Score=248.12 Aligned_cols=214 Identities=26% Similarity=0.459 Sum_probs=193.0
Q ss_pred hhhhhHHh--hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHH
Q 026253 2 LKKLNKHL--KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGA 77 (241)
Q Consensus 2 ~~~~~~~~--~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~ 77 (241)
+|.++++. ..+|..|+-+++.++|||+|++.|.|..+.-+|||+|||..|+|.+||++..+ ++.-.+..++.||.+
T Consensus 297 VKtLKEDtMeveEFLkEAAvMKeikHpNLVqLLGVCT~EpPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsS 376 (1157)
T KOG4278|consen 297 VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTHEPPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISS 376 (1157)
T ss_pred hhhhhhcchhHHHHHHHHHHHHhhcCccHHHHhhhhccCCCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHH
Confidence 56776665 57899999999999999999999999999999999999999999999987644 677778899999999
Q ss_pred HHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcccc--ccCCCCccCcccccccCCCCchhHHHHH
Q 026253 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (241)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~--~~~~~~~~~PE~~~~~~~~~~~Dv~slG 155 (241)
|+.||..++++||||-..|+|+ .++..+|+.|||+++....+.++.. ......|.|||.+....++.++|||+||
T Consensus 377 aMeYLEkknFIHRDLAARNCLV---gEnhiVKvADFGLsRlMtgDTYTAHAGAKFPIKWTAPEsLAyNtFSiKSDVWAFG 453 (1157)
T KOG4278|consen 377 AMEYLEKKNFIHRDLAARNCLV---GENHIVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNTFSIKSDVWAFG 453 (1157)
T ss_pred HHHHHHHhhhhhhhhhhhhccc---cccceEEeeccchhhhhcCCceecccCccCcccccCcccccccccccchhhHHHH
Confidence 9999999999999999999999 7999999999999988765544321 2235669999999999999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 156 AILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 156 ~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
+++||+.| |-.||.+.+-.+.+.-+.++.++.-++ ++++.+..+++.||+.+|++||++.|+-
T Consensus 454 VLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~Pe----GCPpkVYeLMraCW~WsPsDRPsFaeiH 517 (1157)
T KOG4278|consen 454 VLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPE----GCPPKVYELMRACWNWSPSDRPSFAEIH 517 (1157)
T ss_pred HHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCC----CCCHHHHHHHHHHhcCCcccCccHHHHH
Confidence 99999999 888999999999999999999988887 8999999999999999999999998864
|
|
| >KOG0666 consensus Cyclin C-dependent kinase CDK8 [Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-37 Score=230.60 Aligned_cols=221 Identities=28% Similarity=0.485 Sum_probs=175.5
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEee-cCeEEEEEeccCCCChHHHHHhc-----CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH-----GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-----~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
..+.-+|+-+++.++|||++.+..++-+ +...++++||.+ -+|...++-. +.++...+..++.||+.|+.|||
T Consensus 71 S~SAcREiaL~REl~h~nvi~Lv~Vfl~~d~~v~l~fdYAE-hDL~~II~fHr~~~~~~lp~~mvKsilwQil~Gv~YLH 149 (438)
T KOG0666|consen 71 SMSACREIALLRELKHPNVISLVKVFLSHDKKVWLLFDYAE-HDLWHIIKFHRASKAKQLPRSMVKSILWQILDGVHYLH 149 (438)
T ss_pred CHHHHHHHHHHHHhcCCcchhHHHHHhccCceEEEEehhhh-hhHHHHHHHhccchhccCCHHHHHHHHHHHHhhhHHHh
Confidence 4567899999999999999999998876 889999999996 5898888532 45899999999999999999999
Q ss_pred hCCccccCCCCCCeEEee-cCCCceEEEeecCCccccCCCC----ccccccCCCCccCccccccc-CCCCchhHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAI 157 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~-~~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~ 157 (241)
++-+.||||||.||++-. ..+.+.+||+|||+++.+.+.- ......-|.+|.|||.+.|. .|+.+.|+|++||+
T Consensus 150 ~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plkpl~s~d~VVVTiWYRAPELLLGa~hYT~AiDvWAiGCI 229 (438)
T KOG0666|consen 150 SNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLKPLASLDPVVVTIWYRAPELLLGARHYTKAIDVWAIGCI 229 (438)
T ss_pred hhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhccccccccCCceEEEEEecChHHhcccccccchhhhHHHHHH
Confidence 999999999999999942 2345899999999998875432 23445678899999998876 48999999999999
Q ss_pred HHHHHhCCCCCCCCCh---------HHHHHHhhcCCCCCCCCc--------------------c------------CCCC
Q 026253 158 LFELLNGYPPFSGRNN---------VQLVRNINSCKHLPFSQL--------------------I------------VPAL 196 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~---------~~~~~~i~~~~~~~~~~~--------------------~------------~~~~ 196 (241)
+.|+++.++.|.+... ..++..|......+.... . ...-
T Consensus 230 faElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~sL~~~~~~~k~k 309 (438)
T KOG0666|consen 230 FAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVSLHKYYHKHKVK 309 (438)
T ss_pred HHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcchHHHHHHHhcCC
Confidence 9999999998875322 123333322221111100 0 1112
Q ss_pred ChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 197 HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 197 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
++...+++.+||+.||.+|.|++++++|+||...+
T Consensus 310 ~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~ 344 (438)
T KOG0666|consen 310 DPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDP 344 (438)
T ss_pred CchHHHHHHHHhccCchhhccHHHHhcccccccCC
Confidence 44588999999999999999999999999999863
|
|
| >cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.3e-36 Score=235.43 Aligned_cols=208 Identities=26% Similarity=0.454 Sum_probs=170.5
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
..+.+.+|++++++++|+||+++++++.. +...+++|||+++++|.+++.... .+++..+..++.|++.||++||+.
T Consensus 49 ~~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~~lH~~ 128 (284)
T cd05038 49 HRSDFEREIEILRTLDHENIVKYKGVCEKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMDYLGSQ 128 (284)
T ss_pred HHHHHHHHHHHHHhCCCCChheEEeeeecCCCCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHHHHHhC
Confidence 46789999999999999999999998877 567999999999999999997654 589999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|++|+||+|.||++ +.++.++|+|||.+........ ......+..|.+||...+..++.++|+||+|+++++|
T Consensus 129 ~i~H~dl~p~nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~~~~~~Di~slG~~l~el 205 (284)
T cd05038 129 RYIHRDLAARNILV---ESEDLVKISDFGLAKVLPEDKDYYYVKEPGESPIFWYAPECLRTSKFSSASDVWSFGVTLYEL 205 (284)
T ss_pred CeecCCCCHHhEEE---cCCCCEEEcccccccccccCCcceeccCCCCCcccccCcHHHccCCCCcccchHHHhhhhhee
Confidence 99999999999999 6778999999999877653221 1122344569999999888899999999999999999
Q ss_pred HhCCCCCCCCChH---------------HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LNGYPPFSGRNNV---------------QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~g~~p~~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++|..|+...... .....+......+. ...++.++.+++.+||+.+|.+|||+.++++
T Consensus 206 ~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~li~~cl~~~p~~Rpt~~ei~~ 278 (284)
T cd05038 206 FTYGDPSQSPPAEFLRMIGIAQGQMIVTRLLELLKEGERLPR----PPSCPDEVYDLMKLCWEAEPQDRPSFADLIL 278 (284)
T ss_pred eccCCCcccccchhccccccccccccHHHHHHHHHcCCcCCC----CccCCHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 9999988643221 12222322222222 2356789999999999999999999999884
|
Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut |
| >KOG0662 consensus Cyclin-dependent kinase CDK5 [Intracellular trafficking, secretion, and vesicular transport; Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.6e-37 Score=213.49 Aligned_cols=219 Identities=33% Similarity=0.539 Sum_probs=188.2
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.-.+..+|+-+++.++|+||+++++...+++...+|+|+| ..+|..+... ++.++.+.+..+..|++.||.++|+.++
T Consensus 44 vpssalreicllkelkhknivrl~dvlhsdkkltlvfe~c-dqdlkkyfdslng~~d~~~~rsfmlqllrgl~fchshnv 122 (292)
T KOG0662|consen 44 VPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFC-DQDLKKYFDSLNGDLDPEIVRSFMLQLLRGLGFCHSHNV 122 (292)
T ss_pred CcHHHHHHHHHHHHhhhcceeehhhhhccCceeEEeHHHh-hHHHHHHHHhcCCcCCHHHHHHHHHHHHhhhhhhhhhhh
Confidence 3567899999999999999999999999999999999999 5799998865 4679999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccC-CCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~-g 164 (241)
.|||+||+|.++ +.++.+|+.|||+++.++-.. .-.....|.+|.+|.++.+.+ |+.+.|+||-||++.|+.. |
T Consensus 123 lhrdlkpqnlli---n~ngelkladfglarafgipvrcysaevvtlwyrppdvlfgakly~tsidmwsagcifaelanag 199 (292)
T KOG0662|consen 123 LHRDLKPQNLLI---NRNGELKLADFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAG 199 (292)
T ss_pred hhccCCcceEEe---ccCCcEEecccchhhhcCCceEeeeceeeeeeccCcceeeeeehhccchHhhhcchHHHHHhhcC
Confidence 999999999999 899999999999998876443 334456789999999988765 7999999999999999987 8
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCc------------------------cCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQL------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
.+.|.+.+..++++.|-.....+.... +.+.++..-+++++++|.-+|..|.++++
T Consensus 200 rplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp~lns~grdllqkll~cnp~qrisaea 279 (292)
T KOG0662|consen 200 RPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVPKLNSTGRDLLQKLLKCNPAQRISAEA 279 (292)
T ss_pred CCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhhhhcchhHHHHHHHhccCcccccCHHH
Confidence 889999999888888755433322111 23344556789999999999999999999
Q ss_pred HhcCccccccc
Q 026253 221 FYHHRFLRRNS 231 (241)
Q Consensus 221 il~~~~~~~~~ 231 (241)
.++||||.+.+
T Consensus 280 alqhpyf~d~s 290 (292)
T KOG0662|consen 280 ALQHPYFSDFS 290 (292)
T ss_pred HhcCccccccC
Confidence 99999998764
|
|
| >cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2 | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.2e-35 Score=239.93 Aligned_cols=210 Identities=29% Similarity=0.495 Sum_probs=170.0
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEee-cCeEEEEEeccCCCChHHHHHhcC------------------------
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHG------------------------ 61 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~------------------------ 61 (241)
...+.+.+|+.++.++ +|+||+++++++.. +...+++|||+++++|.+++....
T Consensus 52 ~~~~~~~~E~~~l~~l~~h~niv~~~~~~~~~~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 131 (343)
T cd05103 52 SEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGYGDIS 131 (343)
T ss_pred HHHHHHHHHHHHHHhccCCccHhhhcceeecCCCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccccchh
Confidence 3456788999999999 68999999998764 456889999999999999986431
Q ss_pred -------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 026253 62 -------------------------------------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENIL 98 (241)
Q Consensus 62 -------------------------------------------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil 98 (241)
.++...+..++.|++.|+.+||+.|++|+||||.||+
T Consensus 132 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil 211 (343)
T cd05103 132 EDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAARNIL 211 (343)
T ss_pred hhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCccCeEE
Confidence 3577788899999999999999999999999999999
Q ss_pred EeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCCCCCChH
Q 026253 99 LSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174 (241)
Q Consensus 99 ~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~ 174 (241)
+ +.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|++++ |..||......
T Consensus 212 ~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~g~~p~~~~~~~ 288 (343)
T cd05103 212 L---SENNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 288 (343)
T ss_pred E---cCCCcEEEEecccccccccCcchhhcCCCCCCcceECcHHhcCCCCCchhhHHHHHHHHHHHHHCCCCCCCCcccc
Confidence 9 6788999999999876532211 111234567999999988889999999999999999997 99999865433
Q ss_pred -HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 175 -QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 175 -~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.....+..+.....+. ..++++.+++..||+.+|.+|||+.++++|
T Consensus 289 ~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~cl~~~p~~Rps~~eil~~ 335 (343)
T cd05103 289 EEFCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 335 (343)
T ss_pred HHHHHHHhccCCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 3344444444333332 467899999999999999999999999976
|
Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp |
| >KOG0696 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.9e-37 Score=238.52 Aligned_cols=216 Identities=32% Similarity=0.624 Sum_probs=194.6
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
..++.+--..|-++|... +-|.++.+...|++-+.+|+||||++||+|--+++..+.+.+..+.-++..|+-||-+||+
T Consensus 389 QdDDvectm~EKrvLAL~~kppFL~qlHScFQTmDRLyFVMEyvnGGDLMyhiQQ~GkFKEp~AvFYAaEiaigLFFLh~ 468 (683)
T KOG0696|consen 389 QDDDVECTMVEKRVLALPGKPPFLVQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGKFKEPVAVFYAAEIAIGLFFLHS 468 (683)
T ss_pred ecCcccceehhhhheecCCCCchHHHHHHHhhhhhheeeEEEEecCchhhhHHHHhcccCCchhhhhhHHHHHHhhhhhc
Confidence 344455566788888887 6788899999999999999999999999999999999999999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCcccc-CCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~-~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+||++||||..||++ +.++++||.|||+++.. ....++...+||+-|+|||.+..++|+.+.|.||+|+++|||+.
T Consensus 469 kgIiYRDLKLDNvmL---d~eGHiKi~DFGmcKEni~~~~TTkTFCGTPdYiAPEIi~YqPYgksvDWWa~GVLLyEmla 545 (683)
T KOG0696|consen 469 KGIIYRDLKLDNVML---DSEGHIKIADFGMCKENIFDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLA 545 (683)
T ss_pred CCeeeeeccccceEe---ccCCceEeeecccccccccCCcceeeecCCCcccccceEEecccccchhHHHHHHHHHHHHc
Confidence 999999999999999 89999999999998754 44566778999999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH-----HHHhcCccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF-----NEFYHHRFLRR 229 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~ 229 (241)
|++||++.+..++++.|.+.. .. ++.++|.+..++++..|.+.|.+|... .+|..||||+.
T Consensus 546 GQpPFdGeDE~elF~aI~ehn-vs----yPKslSkEAv~ickg~ltK~P~kRLGcg~~ge~di~~H~FFR~ 611 (683)
T KOG0696|consen 546 GQPPFDGEDEDELFQAIMEHN-VS----YPKSLSKEAVAICKGLLTKHPGKRLGCGPEGERDIREHPFFRR 611 (683)
T ss_pred CCCCCCCCCHHHHHHHHHHcc-Cc----CcccccHHHHHHHHHHhhcCCccccCCCCccccchhhCcchhh
Confidence 999999999999999996544 33 344899999999999999999999864 78999999987
|
|
| >KOG1094 consensus Discoidin domain receptor DDR1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.7e-36 Score=243.47 Aligned_cols=215 Identities=26% Similarity=0.454 Sum_probs=181.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh 83 (241)
+...++.|.+|+++|.+|+||||+++.|.|..++-+++|+||++.|+|.+++.++.. .....-.+++.||++|++||.
T Consensus 575 ~~~~r~~F~kEIkiLsqLkhPNIveLvGVC~~DePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgmaYLe 654 (807)
T KOG1094|consen 575 TKNARNDFLKEIKILSRLKHPNIVELLGVCVQDDPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMAYLE 654 (807)
T ss_pred chhHHHHHHHHHHHHhccCCCCeeEEEeeeecCCchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHHHHH
Confidence 445679999999999999999999999999999999999999999999999987732 344556679999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+.+++|||+.+.|+|+ +.+.++||+|||+++....... .....-..+|+|||.+..++++.++|+|++|+++||
T Consensus 655 s~nfVHrd~a~rNcLv---~~e~~iKiadfgmsR~lysg~yy~vqgr~vlpiRwmawEsillgkFttaSDvWafgvTlwE 731 (807)
T KOG1094|consen 655 SLNFVHRDLATRNCLV---DGEFTIKIADFGMSRNLYSGDYYRVQGRAVLPIRWMAWESILLGKFTTASDVWAFGVTLWE 731 (807)
T ss_pred hhchhhccccccceee---cCcccEEecCcccccccccCCceeeecceeeeeeehhHHHHHhccccchhhhhhhHHHHHH
Confidence 9999999999999999 8999999999999986654332 222344678999999999999999999999999999
Q ss_pred HHh--CCCCCCCCChHHHHHHhhcCCCCCCCCc---cCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 161 LLN--GYPPFSGRNNVQLVRNINSCKHLPFSQL---IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 161 l~~--g~~p~~~~~~~~~~~~i~~~~~~~~~~~---~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+++ ...||...+.++.........+..-.+. .++-++..+.+++..||..+-++|||++++..
T Consensus 732 ~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l~~P~~cp~~lyelml~Cw~~es~~RPsFe~lh~ 799 (807)
T KOG1094|consen 732 VFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVLSRPPACPQGLYELMLRCWRRESEQRPSFEQLHL 799 (807)
T ss_pred HHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceeccCCCcCcHHHHHHHHHHhchhhhcCCCHHHHHH
Confidence 876 7889999888887776644333322222 24467889999999999999999999999853
|
|
| >KOG0665 consensus Jun-N-terminal kinase (JNK) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.5e-37 Score=230.33 Aligned_cols=216 Identities=32% Similarity=0.477 Sum_probs=181.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (241)
....++..+|+..+..++|+||++++.+|.-. ...|+|||+| ..+|.+.+. -.++.+.+..++.|++.|++
T Consensus 56 ~~~akra~rel~l~~~v~~~nii~l~n~ftP~~~l~~~~e~y~v~e~m-~~nl~~vi~--~elDH~tis~i~yq~~~~ik 132 (369)
T KOG0665|consen 56 QTHAKRAYRELKLMKCVNHKNIISLLNVFTPQKTLEEFQEVYLVMELM-DANLCQVIL--MELDHETISYILYQMLCGIK 132 (369)
T ss_pred CccchhhhhhhhhhhhhcccceeeeeeccCccccHHHHHhHHHHHHhh-hhHHHHHHH--HhcchHHHHHHHHHHHHHHH
Confidence 45578899999999999999999999998643 4689999999 579998887 35688899999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+||+.||+||||||+||++ +.+..+||.|||+|+..+..-.......+..|.|||++.+..+....|+||+||++.|
T Consensus 133 ~lhs~~IihRdLkPsnivv---~~~~~lKi~dfg~ar~e~~~~~mtpyVvtRyyrapevil~~~~ke~vdiwSvGci~gE 209 (369)
T KOG0665|consen 133 HLHSAGIIHRDLKPSNIVV---NSDCTLKILDFGLARTEDTDFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 209 (369)
T ss_pred HHHhcceeecccCccccee---cchhheeeccchhhcccCcccccCchhheeeccCchheeccCCcccchhhhhhhHHHH
Confidence 9999999999999999999 7899999999999988877766777888999999999999999999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCC--------------------------CCC----cc-------CCCCChHHHHH
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLP--------------------------FSQ----LI-------VPALHPDCVDM 203 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~--------------------------~~~----~~-------~~~~~~~~~~l 203 (241)
|++|...|.+.+.-+.+.++......+ +.+ .. .+.-+....++
T Consensus 210 li~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ardl 289 (369)
T KOG0665|consen 210 LILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLARDL 289 (369)
T ss_pred HhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHHHH
Confidence 999999998877655554443321111 000 00 11223458899
Q ss_pred HHHhcccCccccCCHHHHhcCcccc
Q 026253 204 CLKLLSANTVDRLSFNEFYHHRFLR 228 (241)
Q Consensus 204 i~~~l~~~p~~Rps~~~il~~~~~~ 228 (241)
+.+||..||++|.|++++|+|||++
T Consensus 290 l~~MLvi~pe~Risv~daL~HPY~~ 314 (369)
T KOG0665|consen 290 LSKMLVIDPEKRISVDDALRHPYIK 314 (369)
T ss_pred HHHhhccChhhcccHHHHhcCCeee
Confidence 9999999999999999999999997
|
|
| >KOG0199 consensus ACK and related non-receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.6e-36 Score=247.15 Aligned_cols=213 Identities=23% Similarity=0.407 Sum_probs=190.2
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....|.+|+.++.+|+|+|++++||...+ .-..+|+|.+++|+|.+-|.+. ..|....++.++.||+.|+.||.+++
T Consensus 154 ~mddflrEas~M~~L~H~hliRLyGvVl~-qp~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM~YLeskr 232 (1039)
T KOG0199|consen 154 IMDDFLREASHMLKLQHPHLIRLYGVVLD-QPAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAMQYLESKR 232 (1039)
T ss_pred hHHHHHHHHHHHHhccCcceeEEeeeecc-chhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHHHHHhhhh
Confidence 67889999999999999999999999988 6678999999999999999873 45888999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc----cccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~----~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
++||||-..|+++ .....|||+|||+.+..+...... ...-...|.|||.+....++.++|+|++|+++|||+
T Consensus 233 lvHRDLAARNlll---asprtVKI~DFGLmRaLg~ned~Yvm~p~rkvPfAWCaPEsLrh~kFShaSDvWmyGVTiWEMF 309 (1039)
T KOG0199|consen 233 LVHRDLAARNLLL---ASPRTVKICDFGLMRALGENEDMYVMAPQRKVPFAWCAPESLRHRKFSHASDVWMYGVTIWEMF 309 (1039)
T ss_pred hhhhhhhhhhhee---cccceeeeecccceeccCCCCcceEecCCCcCcccccCHhHhccccccccchhhhhhhhHHhhh
Confidence 9999999999999 668899999999998876654322 233356699999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
+ |..||.+....++++.|..+.+.+.+. .+|+++.+++..||..+|.+|||+..|.+.-++..
T Consensus 310 tyGEePW~G~~g~qIL~~iD~~erLpRPk----~csedIY~imk~cWah~paDRptFsair~~~~l~e 373 (1039)
T KOG0199|consen 310 TYGEEPWVGCRGIQILKNIDAGERLPRPK----YCSEDIYQIMKNCWAHNPADRPTFSAIREDLVLAE 373 (1039)
T ss_pred ccCCCCCCCCCHHHHHHhccccccCCCCC----CChHHHHHHHHHhccCCccccccHHHHHHhHHHHh
Confidence 9 899999999999999998877777766 88999999999999999999999999976655544
|
|
| >cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase | Back alignment and domain information |
|---|
Probab=100.00 E-value=6.2e-35 Score=252.98 Aligned_cols=107 Identities=34% Similarity=0.644 Sum_probs=100.4
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|+.+++.++|+||+++++.+...+..|+||||+.|++|.+++...+.+++..+..++.||+.||.|||+.||
T Consensus 46 ~~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lVmEy~~g~~L~~li~~~~~l~~~~~~~i~~qil~aL~yLH~~gI 125 (669)
T cd05610 46 NMVHQVQAERDALALSKSPFIVHLYYSLQSANNVYLVMEYLIGGDVKSLLHIYGYFDEEMAVKYISEVALALDYLHRHGI 125 (669)
T ss_pred HHHHHHHHHHHHHHhcCCCCcCeEEEEEEECCEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 34578999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCcc
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~ 117 (241)
+|+||||+||++ +.++.++|+|||+++
T Consensus 126 iHrDLKP~NILl---~~~g~vkL~DFGls~ 152 (669)
T cd05610 126 IHRDLKPDNMLI---SNEGHIKLTDFGLSK 152 (669)
T ss_pred EeCCccHHHEEE---cCCCCEEEEeCCCCc
Confidence 999999999999 677889999999875
|
Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481 |
| >KOG0587 consensus Traf2- and Nck-interacting kinase and related germinal center kinase (GCK) family protein kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.5e-36 Score=251.06 Aligned_cols=223 Identities=28% Similarity=0.514 Sum_probs=190.9
Q ss_pred hhhhHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEee-----cCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHH
Q 026253 3 KKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQ 74 (241)
Q Consensus 3 ~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~ 74 (241)
+..+.+...++..|..+++.. .|||++.+||+|.. ++.+|||||||.||++.|+++.. .++.++.+..|++.
T Consensus 52 ~~~~~d~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re 131 (953)
T KOG0587|consen 52 MDPTEDEEEEIELEYNMLKKYSHHPNVATFYGAFIKKDPGNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILRE 131 (953)
T ss_pred ecCCccccHHHHHHHHHHHhccCCCCcceEEEEEEEecCCCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHH
Confidence 344778889999999999999 79999999998864 46899999999999999999764 56899999999999
Q ss_pred HHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCccccccc-----CCCCc
Q 026253 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQ-----RYDEK 148 (241)
Q Consensus 75 i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~-----~~~~~ 148 (241)
++.|+.+||.+.++|||+|-.||++ +.++.+||+|||.+.+... -.......||++|+|||++... .|+.+
T Consensus 132 ~lrgl~HLH~nkviHRDikG~NiLL---T~e~~VKLvDFGvSaQldsT~grRnT~iGtP~WMAPEViac~e~~d~tyd~R 208 (953)
T KOG0587|consen 132 ILRGLAHLHNNKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDSTVGRRNTFIGTPYWMAPEVIACDESPDATYDYR 208 (953)
T ss_pred HHHHHHHHhhcceeeecccCceEEE---eccCcEEEeeeeeeeeeecccccccCcCCCcccccceeeecccCCCCCcccc
Confidence 9999999999999999999999999 8999999999999876532 2345567899999999998643 36789
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCcc-CCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 149 VDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLI-VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~-~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+|+||||++..||.-|.+|+-.+.+...+-.|.. .+.+... +...++++.+||..||.+|..+||+..++|+|||+
T Consensus 209 ~D~WsLGITaIEladG~PPl~DmHPmraLF~IpR---NPPPkLkrp~kWs~~FndFIs~cL~Kd~e~RP~~~~ll~hpFi 285 (953)
T KOG0587|consen 209 SDLWSLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPPKLKRPKKWSKKFNDFISTCLVKDYEQRPSTEELLKHPFI 285 (953)
T ss_pred cchhhccceeehhcCCCCCccCcchhhhhccCCC---CCCccccchhhHHHHHHHHHHHHHhhccccCcchhhhccCCcc
Confidence 9999999999999999999998888766555533 3333333 34678899999999999999999999999999999
Q ss_pred cccc
Q 026253 228 RRNS 231 (241)
Q Consensus 228 ~~~~ 231 (241)
++.+
T Consensus 286 ~e~~ 289 (953)
T KOG0587|consen 286 TEQP 289 (953)
T ss_pred cccc
Confidence 9654
|
|
| >KOG1027 consensus Serine/threonine protein kinase and endoribonuclease ERN1/IRE1, sensor of the unfolded protein response pathway [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.3e-36 Score=251.31 Aligned_cols=225 Identities=28% Similarity=0.458 Sum_probs=180.1
Q ss_pred hhhhhHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC----CCHHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKFLQQLG 76 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----~~~~~~~~~~~~i~ 76 (241)
+|.+-.+-.+.+.+|++.|+.- +||||+++++.-.++.+.||..|.| ..+|.++++..+. ........++.|++
T Consensus 538 VKrll~e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~qF~YIalELC-~~sL~dlie~~~~d~~~~~~i~~~~~l~q~~ 616 (903)
T KOG1027|consen 538 VKRLLEEFFDFAQREIQLLQESDEHPNVIRYYCSEQDRQFLYIALELC-ACSLQDLIESSGLDVEMQSDIDPISVLSQIA 616 (903)
T ss_pred HHHHhhHhHHHHHHHHHHHHhccCCCceEEEEeeccCCceEEEEehHh-hhhHHHHHhccccchhhcccccHHHHHHHHH
Confidence 6777888889999999999999 7999999999999999999999999 5799999987411 12244578889999
Q ss_pred HHHHHHHhCCccccCCCCCCeEEeec--CCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchh
Q 026253 77 AGLEILNSHHIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVD 150 (241)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nil~~~~--~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~D 150 (241)
+||++||+.+|+||||||+|||++.. +....++|.|||+++....+.. .....||.+|.|||.+.....+.+.|
T Consensus 617 ~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS~~r~s~~sGt~GW~APE~L~~~~~~~avD 696 (903)
T KOG1027|consen 617 SGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSSFSRLSGGSGTSGWQAPEQLREDRKTQAVD 696 (903)
T ss_pred HHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcchhhcccCCCCcccccCHHHHhccccCcccc
Confidence 99999999999999999999999642 2346689999999998866543 34567899999999999888888999
Q ss_pred HHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 151 MWSVGAILFELLNG-YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 151 v~slG~~l~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
+||+||++|+.++| ..||+..-. ...+.+........-. +....+..++|.+|++++|..||++.++|.||+|=.
T Consensus 697 iFslGCvfyYvltgG~HpFGd~~~-R~~NIl~~~~~L~~L~---~~~d~eA~dLI~~ml~~dP~~RPsa~~VL~HPlFW~ 772 (903)
T KOG1027|consen 697 IFSLGCVFYYVLTGGSHPFGDSLE-RQANILTGNYTLVHLE---PLPDCEAKDLISRMLNPDPQLRPSATDVLNHPLFWD 772 (903)
T ss_pred hhhcCceEEEEecCCccCCCchHH-hhhhhhcCccceeeec---cCchHHHHHHHHHhcCCCcccCCCHHHHhCCCccCC
Confidence 99999999999995 889975322 2222222222211111 111228899999999999999999999999999965
Q ss_pred cc
Q 026253 230 NS 231 (241)
Q Consensus 230 ~~ 231 (241)
..
T Consensus 773 ~e 774 (903)
T KOG1027|consen 773 SE 774 (903)
T ss_pred hH
Confidence 44
|
|
| >KOG1006 consensus Mitogen-activated protein kinase (MAPK) kinase MKK4 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.2e-37 Score=226.91 Aligned_cols=223 Identities=24% Similarity=0.355 Sum_probs=185.4
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l 79 (241)
.+.+.+++..|.....+- ++||||++||..-.++..|+.||.| ..+|..+.+. ...++++.+..+.-..+.||
T Consensus 102 ~~keq~rll~e~d~~mks~~cp~IVkfyGa~F~EGdcWiCMELM-d~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV~AL 180 (361)
T KOG1006|consen 102 IEKEQKRLLMEHDTVMKSSNCPNIVKFYGALFSEGDCWICMELM-DISLDKLYKRVYSVQKSRIPENILGHITVATVDAL 180 (361)
T ss_pred chHHHHHHHHHHHHHHhhcCCcHHHHHhhhhhcCCceeeeHHHH-hhhHHHHHHHHHHHHhccCcHhhhhheeeeehhHH
Confidence 456788899999988887 7999999999988889999999999 5788877642 35689999999999999999
Q ss_pred HHHHh-CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc--cCCCCchhHHHHHH
Q 026253 80 EILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGA 156 (241)
Q Consensus 80 ~~lh~-~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~ 156 (241)
.||.. .+++|||+||+|||+ +..+.+||||||.+....++-......|...|+|||.+.. ..|..+||+||||+
T Consensus 181 ~yLK~~lkiIHRDvKPSNILl---dr~G~vKLCDFGIcGqLv~SiAkT~daGCrpYmAPERi~p~~~gyDiRSDvWSLGI 257 (361)
T KOG1006|consen 181 DYLKEELKIIHRDVKPSNILL---DRHGDVKLCDFGICGQLVDSIAKTVDAGCRPYMAPERIDPSDKGYDIRSDVWSLGI 257 (361)
T ss_pred HHHHHHhhhhhccCChhheEE---ecCCCEeeecccchHhHHHHHHhhhccCCccccChhccCCccCCcchhhhhhhhcc
Confidence 99986 589999999999999 7899999999999988776666666778999999999853 35899999999999
Q ss_pred HHHHHHhCCCCCCCCCh-HHHHHHhhcCCCCCCCCc-cCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 157 ILFELLNGYPPFSGRNN-VQLVRNINSCKHLPFSQL-IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
+++|++||..|+.+.+. .+++.++..+....+... ..-.++..+..+|..||.+|.+.||.+.+++++||++.+..
T Consensus 258 TL~EvAtG~fPyr~w~svfeql~~Vv~gdpp~l~~~~~~~~~s~~~~~fintCl~Kd~~~Rpky~~Lk~~~fyr~y~~ 335 (361)
T KOG1006|consen 258 TLYEVATGNFPYRKWDSVFEQLCQVVIGDPPILLFDKECVHYSFSMVRFINTCLIKDRSDRPKYDDLKKFPFYRMYAV 335 (361)
T ss_pred eEeeeecCCCCcchHHHHHHHHHHHHcCCCCeecCcccccccCHHHHHHHHHHhhcccccCcchhhhhcCchhhhhhh
Confidence 99999999999998654 345555544443222211 11247889999999999999999999999999999988643
|
|
| >PHA02882 putative serine/threonine kinase; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.8e-35 Score=229.96 Aligned_cols=205 Identities=15% Similarity=0.208 Sum_probs=158.9
Q ss_pred HHHHHHhcCCCcCeeeeeeEEeecC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 026253 15 CELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (241)
Q Consensus 15 ~E~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (241)
.++..+..++|++++++++...... ..+++++++ ..++.+.+......++..+..++.|++.|+.+||+.+++||
T Consensus 72 ~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~iiHr 150 (294)
T PHA02882 72 ALWKNIHNIDHLGIPKYYGCGSFKRCRMYYRFILLEKL-VENTKEIFKRIKCKNKKLIKNIMKDMLTTLEYIHEHGISHG 150 (294)
T ss_pred HHHHHhccCCCCCCCcEEEeeeEecCCceEEEEEEehh-ccCHHHHHHhhccCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 4445566778999999998765543 346788877 46788877766667889999999999999999999999999
Q ss_pred CCCCCCeEEeecCCCceEEEeecCCccccCCCC--------ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 91 dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
||||+||++ +.++.++|+|||+|+...... ......+|+.|+|||...+..++.++|+||+|+++++|+
T Consensus 151 DiKp~Nill---~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~~~~~~DiwSlG~~l~el~ 227 (294)
T PHA02882 151 DIKPENIMV---DGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGACVTRRGDLESLGYCMLKWA 227 (294)
T ss_pred CCCHHHEEE---cCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCCCCcHHHHHHHHHHHHHHH
Confidence 999999999 677889999999997653221 112245899999999999999999999999999999999
Q ss_pred hCCCCCCCCCh-HHHHHHhhcC--CCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 163 NGYPPFSGRNN-VQLVRNINSC--KHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 163 ~g~~p~~~~~~-~~~~~~i~~~--~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+|+.||.+... .......... ..........+..+..+.++++.|+..+|++||+++++++
T Consensus 228 ~g~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~rp~~~~l~~ 291 (294)
T PHA02882 228 GIKLPWKGFGHNGNLIHAAKCDFIKRLHEGKIKIKNANKFIYDFIECVTKLSYEEKPDYDALIK 291 (294)
T ss_pred hCCCCCCccccchHHHHHhHHHHHHHhhhhhhccCCCCHHHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 99999987632 2222111100 1111111123466889999999999999999999999875
|
|
| >KOG0200 consensus Fibroblast/platelet-derived growth factor receptor and related receptor tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=9.9e-35 Score=248.54 Aligned_cols=210 Identities=29% Similarity=0.508 Sum_probs=187.5
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHH
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA 68 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~ 68 (241)
...+.+.+..|+++++.+ .|+||+.+.|.+.+++..++|+||++.|+|.++++..+ .++...+
T Consensus 341 ~~~~~~~~~~El~~m~~~g~H~niv~llG~~t~~~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~~dL 420 (609)
T KOG0200|consen 341 SSSEKKDLMSELNVLKELGKHPNIVNLLGACTQDGPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTTKDL 420 (609)
T ss_pred CcHHHHHHHHHHHHHHHhcCCcchhhheeeeccCCceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCHHHH
Confidence 457789999999999999 79999999999999999999999999999999998766 3888999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc-c-cc--CCCCccCcccccccC
Q 026253 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-K-VC--GSPLYMAPEVLQFQR 144 (241)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~-~-~~--~~~~~~~PE~~~~~~ 144 (241)
..++.||+.|++||++.+++||||-+.||++ ..+..+||+|||+|+...+..... . .. -...|+|||.+....
T Consensus 421 lsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi---~~~~~~kIaDFGlar~~~~~~~y~~~~~~~~LP~kWmApEsl~~~~ 497 (609)
T KOG0200|consen 421 LSFAYQIANGMEYLASVPCVHRDLAARNVLI---TKNKVIKIADFGLARDHYNKDYYRTKSSAGTLPVKWMAPESLFDRV 497 (609)
T ss_pred HHHHHHHHHHHHHHhhCCccchhhhhhhEEe---cCCCEEEEccccceeccCCCCceEecCCCCccceeecCHHHhccCc
Confidence 9999999999999999999999999999999 788999999999998765443322 1 11 244599999999999
Q ss_pred CCCchhHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 145 YDEKVDMWSVGAILFELLN-GYPPFSGRN-NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 145 ~~~~~Dv~slG~~l~~l~~-g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
++.++||||+|+++||+++ |..||.+.. ..++.+.++.+.+...|. .++.++.++++.||+.+|.+||++.++.
T Consensus 498 ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~~~P~----~c~~eiY~iM~~CW~~~p~~RP~F~~~~ 573 (609)
T KOG0200|consen 498 FTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRMEQPE----HCSDEIYDLMKSCWNADPEDRPTFSECV 573 (609)
T ss_pred ccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHhCCCcccCCCHHHHH
Confidence 9999999999999999999 899999866 677788899999888887 6799999999999999999999999987
|
|
| >KOG0670 consensus U4/U6-associated splicing factor PRP4 [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=100.00 E-value=2.1e-36 Score=241.35 Aligned_cols=220 Identities=30% Similarity=0.456 Sum_probs=184.4
Q ss_pred hHHhhhhHHHHHHHHhcCC------CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVN------HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLG 76 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~------~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~ 76 (241)
++-..+.=..|++||++|+ --|+++++..|...+++|+|+|.+ ..+|.+++++.+. +....+..++.|++
T Consensus 468 NE~M~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hknHLClVFE~L-slNLRevLKKyG~nvGL~ikaVRsYaqQLf 546 (752)
T KOG0670|consen 468 NEVMHKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHKNHLCLVFEPL-SLNLREVLKKYGRNVGLHIKAVRSYAQQLF 546 (752)
T ss_pred chHHhhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhcceeEEEehhh-hchHHHHHHHhCcccceeehHHHHHHHHHH
Confidence 4455778889999999994 347999999999999999999998 6899999998765 78889999999999
Q ss_pred HHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHH
Q 026253 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (241)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~ 156 (241)
.||..|...|++|.||||.||||+ .....+||||||.|...+.+..+ .+..+..|.|||++.|.+|+...|+||+||
T Consensus 547 lALklLK~c~vlHaDIKPDNiLVN--E~k~iLKLCDfGSA~~~~eneit-PYLVSRFYRaPEIiLG~~yd~~iD~WSvgc 623 (752)
T KOG0670|consen 547 LALKLLKKCGVLHADIKPDNILVN--ESKNILKLCDFGSASFASENEIT-PYLVSRFYRAPEIILGLPYDYPIDTWSVGC 623 (752)
T ss_pred HHHHHHHhcCeeecccCccceEec--cCcceeeeccCcccccccccccc-HHHHHHhccCcceeecCcccCCccceeece
Confidence 999999999999999999999996 66777999999999887766544 344577899999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCc------------------------------------c--------
Q 026253 157 ILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQL------------------------------------I-------- 192 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~------------------------------------~-------- 192 (241)
++||+.||+..|++.+..++++..+..+..-.... .
T Consensus 624 tLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vkPtkdl~s 703 (752)
T KOG0670|consen 624 TLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVKPTKDLGS 703 (752)
T ss_pred eeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccCcchhHHH
Confidence 99999999999999998887765544332111000 0
Q ss_pred ----CCCCC-------hHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 193 ----VPALH-------PDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 193 ----~~~~~-------~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
...++ ..+.+|+.+||..||++|.|.+++|+||||..
T Consensus 704 ~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~ 751 (752)
T KOG0670|consen 704 ELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE 751 (752)
T ss_pred HHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence 00112 35889999999999999999999999999974
|
|
| >KOG0668 consensus Casein kinase II, alpha subunit [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning; Transcription] | Back alignment and domain information |
|---|
Probab=100.00 E-value=7.9e-35 Score=210.86 Aligned_cols=227 Identities=25% Similarity=0.430 Sum_probs=184.8
Q ss_pred ChhhhhHHhhhhHHHHHHHHhcCC-CcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHH
Q 026253 1 MLKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGA 77 (241)
Q Consensus 1 ~~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 77 (241)
|+|.+++--.+.+.+|++||+.|+ ||||+++++...+. ....+|+|++++.+...+.. .++.-.+...+.+++.
T Consensus 67 ViKiLKPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~SktpaLiFE~v~n~Dfk~ly~---tl~d~dIryY~~elLk 143 (338)
T KOG0668|consen 67 VIKILKPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPESKTPSLIFEYVNNTDFKQLYP---TLTDYDIRYYIYELLK 143 (338)
T ss_pred EEeeechHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccccCchhHhhhhccccHHHHhh---hhchhhHHHHHHHHHH
Confidence 467778888999999999999995 99999999998753 56789999999887776644 5678889999999999
Q ss_pred HHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHH
Q 026253 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (241)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~ 156 (241)
||.|+|+.||+|||+||.|++++ .....++|+|+|+|.+.-+...-+-...+..|.-||.+.. ..|..+.|+|||||
T Consensus 144 ALdyCHS~GImHRDVKPhNvmId--h~~rkLrlIDWGLAEFYHp~~eYnVRVASRyfKGPELLVdy~~YDYSLD~WS~Gc 221 (338)
T KOG0668|consen 144 ALDYCHSMGIMHRDVKPHNVMID--HELRKLRLIDWGLAEFYHPGKEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGC 221 (338)
T ss_pred HHhHHHhcCcccccCCcceeeec--hhhceeeeeecchHhhcCCCceeeeeeehhhcCCchheeechhccccHHHHHHHH
Confidence 99999999999999999999996 5677799999999998877766666778888999999865 45789999999999
Q ss_pred HHHHHHhCCCCCC-CCChHHHHHHhhcCC------------CCCCCC--------------------ccCCCCChHHHHH
Q 026253 157 ILFELLNGYPPFS-GRNNVQLVRNINSCK------------HLPFSQ--------------------LIVPALHPDCVDM 203 (241)
Q Consensus 157 ~l~~l~~g~~p~~-~~~~~~~~~~i~~~~------------~~~~~~--------------------~~~~~~~~~~~~l 203 (241)
++..|+..+.||. +.+..+++.+|.... ....++ ....-.+++..|+
T Consensus 222 mlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~~~~~rk~w~~Fi~~~n~hl~~peaiDl 301 (338)
T KOG0668|consen 222 MLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDILGRHSRKPWSRFINSENQHLVSPEAIDL 301 (338)
T ss_pred HHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHhhccccccHHHhCCccccccCChHHHHH
Confidence 9999999877764 555555444443211 111111 1112356899999
Q ss_pred HHHhcccCccccCCHHHHhcCcccccccc
Q 026253 204 CLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 204 i~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
+.++|..|-.+|+|+.|++.||||.....
T Consensus 302 ldklLrYDHqeRlTakEam~HpyF~~~~~ 330 (338)
T KOG0668|consen 302 LDKLLRYDHQERLTAKEAMAHPYFAPVRE 330 (338)
T ss_pred HHHHHhhccccccchHHHhcCchHHHHHH
Confidence 99999999999999999999999987443
|
|
| >KOG1151 consensus Tousled-like protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=227.19 Aligned_cols=218 Identities=29% Similarity=0.523 Sum_probs=185.5
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEee-cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--C
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH--H 86 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~--~ 86 (241)
.+-.-+|.+|.+.|+||.||++|+++.- .+.+|-|.|||+|.+|.-|++..+.+++..+..|+.||+.||.||.+. -
T Consensus 511 hKHAcREyrIHKeLDHpRIVKlYDyfslDtdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~YLNEikpP 590 (775)
T KOG1151|consen 511 HKHACREYRIHKELDHPRIVKLYDYFSLDTDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKYLNEIKPP 590 (775)
T ss_pred HHHHHHHHhhhhccCcceeeeeeeeeeeccccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHHHhccCCC
Confidence 4567799999999999999999999975 467999999999999999999999999999999999999999999976 5
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--------cccccCCCCccCccccccc----CCCCchhHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSV 154 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--------~~~~~~~~~~~~PE~~~~~----~~~~~~Dv~sl 154 (241)
|+|.||||.|||+-+.+..+.+||.|||+++....... +....||.+|++||.+... +.+.+.||||+
T Consensus 591 IIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsnKVDVWSv 670 (775)
T KOG1151|consen 591 IIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISNKVDVWSV 670 (775)
T ss_pred eeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCccccceeeEee
Confidence 99999999999998778888999999999987755432 3456789999999998644 36889999999
Q ss_pred HHHHHHHHhCCCCCCCCChH-HHH--HHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 155 GAILFELLNGYPPFSGRNNV-QLV--RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 155 G~~l~~l~~g~~p~~~~~~~-~~~--~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
|+++|.++.|+.||...... +++ +.|.+.....+|. .|-++++..+||++||+..-++|.+..++-.||+|.-
T Consensus 671 GVIFyQClYGrKPFGhnqsQQdILqeNTIlkAtEVqFP~--KPvVsseAkaFIRRCLaYRKeDR~DV~qLA~dpyllP 746 (775)
T KOG1151|consen 671 GVIFYQCLYGRKPFGHNQSQQDILQENTILKATEVQFPP--KPVVSSEAKAFIRRCLAYRKEDRIDVQQLACDPYLLP 746 (775)
T ss_pred ehhhhhhhccCCCCCCchhHHHHHhhhchhcceeccCCC--CCccCHHHHHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence 99999999999999864432 222 3333444444444 3578999999999999999999999999999999975
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.7e-34 Score=249.21 Aligned_cols=182 Identities=31% Similarity=0.538 Sum_probs=144.5
Q ss_pred EEEEEeccCCCChHHHHHhcCCC-CHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCcccc
Q 026253 41 IFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (241)
Q Consensus 41 ~~lv~e~~~~~~L~~~l~~~~~~-~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~ 119 (241)
+||-||||+..++.++++.+... .....+++.++|++||.|+|+.|++||||||.|||+ +..+.|||+|||+|+..
T Consensus 671 LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFL---d~~~~VKIGDFGLAt~~ 747 (1351)
T KOG1035|consen 671 LYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFL---DSRNSVKIGDFGLATDL 747 (1351)
T ss_pred EEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEE---cCCCCeeecccccchhh
Confidence 68999999988888888766543 477899999999999999999999999999999999 78999999999999872
Q ss_pred C-------------------CCCccccccCCCCccCcccccccC---CCCchhHHHHHHHHHHHHhCCCCCC-CCChHHH
Q 026253 120 Y-------------------PGNYAEKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFS-GRNNVQL 176 (241)
Q Consensus 120 ~-------------------~~~~~~~~~~~~~~~~PE~~~~~~---~~~~~Dv~slG~~l~~l~~g~~p~~-~~~~~~~ 176 (241)
. +........||..|.|||.+.+.. |+.|.|+||||++++||+. ||. .+.....
T Consensus 748 ~~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~TsMERa~i 824 (1351)
T KOG1035|consen 748 KENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGTSMERASI 824 (1351)
T ss_pred hhhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCchHHHHHH
Confidence 1 011334567899999999987654 9999999999999999985 454 3444455
Q ss_pred HHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 177 VRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 177 ~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
+..++ ....+.+..+.-.--+.-+.+|+.|++.||++||||.|+|.+.||-.
T Consensus 825 L~~LR-~g~iP~~~~f~~~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llpp 876 (1351)
T KOG1035|consen 825 LTNLR-KGSIPEPADFFDPEHPEEASLIRWLLSHDPSKRPTATELLNSELLPP 876 (1351)
T ss_pred HHhcc-cCCCCCCcccccccchHHHHHHHHHhcCCCccCCCHHHHhhccCCCc
Confidence 55665 23333332222233345679999999999999999999999999973
|
|
| >KOG0695 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=4.7e-34 Score=217.72 Aligned_cols=216 Identities=30% Similarity=0.591 Sum_probs=190.4
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.++.+-...|..+..+. +||.+|-+..+|.+++.+++|.||++||+|--++++++.++++++..+...|+.||.+||+.
T Consensus 291 dedidwvqtek~vfe~asn~pflvglhscfqtesrlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~flh~r 370 (593)
T KOG0695|consen 291 DEDIDWVQTEKHVFEQASNNPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNFLHER 370 (593)
T ss_pred cccchhHHhhHHHHHhccCCCeEEehhhhhcccceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHHHhhc
Confidence 34466778888899888 79999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc-cCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT-LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~-~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
||++||||..|+++ +.++++||.|+|+++. ..+...+...+||+.|.|||.+.+..|..+.|.|+||+++++|+.|
T Consensus 371 giiyrdlkldnvll---daeghikltdygmcke~l~~gd~tstfcgtpnyiapeilrgeeygfsvdwwalgvlmfemmag 447 (593)
T KOG0695|consen 371 GIIYRDLKLDNVLL---DAEGHIKLTDYGMCKEGLGPGDTTSTFCGTPNYIAPEILRGEEYGFSVDWWALGVLMFEMMAG 447 (593)
T ss_pred CeeeeeccccceEE---ccCCceeecccchhhcCCCCCcccccccCCCcccchhhhcccccCceehHHHHHHHHHHHHcC
Confidence 99999999999999 8999999999999875 4566778889999999999999999999999999999999999999
Q ss_pred CCCCC--C-----CChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC------HHHHhcCccccc
Q 026253 165 YPPFS--G-----RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS------FNEFYHHRFLRR 229 (241)
Q Consensus 165 ~~p~~--~-----~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps------~~~il~~~~~~~ 229 (241)
+.||+ + .+.++-+-++...+.+..|. ++|-....+++.-|++||.+|.. +.++-.|+||+.
T Consensus 448 rspfdivgm~n~d~ntedylfqvilekqiripr----slsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~ 521 (593)
T KOG0695|consen 448 RSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPR----SLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS 521 (593)
T ss_pred CCCcceecCCCcccchhHHHHHHHhhhcccccc----eeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence 99996 2 22233333444555555555 77888899999999999999974 689999999986
|
|
| >KOG4250 consensus TANK binding protein kinase TBK1 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=5.3e-34 Score=234.81 Aligned_cols=209 Identities=29% Similarity=0.467 Sum_probs=167.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhc---CCCCHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLH---GRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~---~~~~~~~~~~~~~~i~~~ 78 (241)
..++..-+|++++++|+|+|||+++++-++. +...+|||||.||+|...+++. ..+++..+..++.++..|
T Consensus 53 r~~e~~~~EieilkKLnh~NIVk~f~iee~~~~~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~a 132 (732)
T KOG4250|consen 53 RPRERWCREIEILKKLNHPNIVKLFDIEETKFLGLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSA 132 (732)
T ss_pred chHHHHHHHHHHHHHcCchhhhhhcccCCccccCcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHH
Confidence 5578889999999999999999999886654 4678999999999999999753 459999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEee-cCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~-~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~ 156 (241)
|.+||++||+||||||.||++-. .+.....||+|||.|+....+..-....||..|.+||...+ +.|+...|.||||+
T Consensus 133 l~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~s~~~S~vGT~~YLhPel~E~q~~y~~tVDLWS~Gv 212 (732)
T KOG4250|consen 133 LRHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDNSLFTSLVGTEEYLHPELYERQKKYTATVDLWSFGV 212 (732)
T ss_pred HHHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCCCeeeeecCchhhcChHHHhhccCcCceeehhhhhh
Confidence 99999999999999999999854 33555689999999999988888888999999999999984 78999999999999
Q ss_pred HHHHHHhCCCCCCCCChH-----HHHHHhhcCC-------------------CCCCCCccCCCCChHHHHHHHHhcccCc
Q 026253 157 ILFELLNGYPPFSGRNNV-----QLVRNINSCK-------------------HLPFSQLIVPALHPDCVDMCLKLLSANT 212 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~-----~~~~~i~~~~-------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p 212 (241)
++|+++||..||...... -.+..+.+.. ..+++-...+..-..+..++..+|..+|
T Consensus 213 tlY~caTG~lPF~p~~~pk~~~~~~~~~~tkkp~~v~i~~~~~eNgpv~~s~~lP~p~~Ls~~l~~~~~kwLa~~L~~~~ 292 (732)
T KOG4250|consen 213 TLYECATGELPFIPFGGPKNNKEIMWHIITKKPSGVAIGAQEEENGPVEWSSTLPQPNHLSRGLATRLTKWLASMLEWNP 292 (732)
T ss_pred HHHHHhccCCCCCcCCCccccchhhhhhhccCCCceeEeeecccCCceeeeccCCCcccccHHHHhhhhHHHHHHHhhhH
Confidence 999999999999632221 2233332211 1111111111222335678888999999
Q ss_pred cccC
Q 026253 213 VDRL 216 (241)
Q Consensus 213 ~~Rp 216 (241)
.+|-
T Consensus 293 ~~~~ 296 (732)
T KOG4250|consen 293 RKRG 296 (732)
T ss_pred HHhC
Confidence 9998
|
|
| >KOG0669 consensus Cyclin T-dependent kinase CDK9 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-34 Score=210.10 Aligned_cols=216 Identities=24% Similarity=0.442 Sum_probs=174.3
Q ss_pred hHHHHHHHHhcCCCcCeeeeeeEEee--------cCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 026253 12 CLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 12 ~~~~E~~~l~~l~~~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l 82 (241)
...+|+++|..|+|+|++.+++++.. ...+|+|+++|+ -+|.-++... -+++..++.++.+++..||.++
T Consensus 62 talreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~ce-hDLaGlLsn~~vr~sls~Ikk~Mk~Lm~GL~~i 140 (376)
T KOG0669|consen 62 TALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCE-HDLAGLLSNRKVRFSLSEIKKVMKGLMNGLYYI 140 (376)
T ss_pred HHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhh-hhHHHHhcCccccccHHHHHHHHHHHHHHHHHH
Confidence 45789999999999999999988743 235899999996 5888888765 5699999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----cccccCCCCccCcccccc-cCCCCchhHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~ 156 (241)
|+..|+|||+|+.|+++ +.++.++|.|||+++.+..... -.....|.+|.+||.+.| ..++++.|+|.-||
T Consensus 141 Hr~kilHRDmKaaNvLI---t~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgAgC 217 (376)
T KOG0669|consen 141 HRNKILHRDMKAANVLI---TKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGAGC 217 (376)
T ss_pred HHhhHHhhcccHhhEEE---cCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhHHH
Confidence 99999999999999999 8999999999999965533221 122345889999998875 46899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCCCC---------------------CCCCccC---------CCCChHHHHHHHH
Q 026253 157 ILFELLNGYPPFSGRNNVQLVRNINSCKHL---------------------PFSQLIV---------PALHPDCVDMCLK 206 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~---------------------~~~~~~~---------~~~~~~~~~li~~ 206 (241)
++.+|++|.+.+.+.+..+.+..|..-... +.++... -.-+++..+++.+
T Consensus 218 imaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLle~ 297 (376)
T KOG0669|consen 218 IMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLLEK 297 (376)
T ss_pred HHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHHHH
Confidence 999999999999988887766665432110 0111000 0113468899999
Q ss_pred hcccCccccCCHHHHhcCccccccc
Q 026253 207 LLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 207 ~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
+|..||.+|+++++++.|.||...+
T Consensus 298 ll~~DP~kR~~ad~alnh~~F~kdp 322 (376)
T KOG0669|consen 298 LLKLDPTKRIDADQALNHDFFWKDP 322 (376)
T ss_pred HhccCcccCcchHhhhchhhhhcCC
Confidence 9999999999999999999998754
|
|
| >KOG0608 consensus Warts/lats-like serine threonine kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.8e-33 Score=227.53 Aligned_cols=219 Identities=29% Similarity=0.544 Sum_probs=185.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+..-.+.|-.||...+++-||++|-.|.+++.+|+||+|+.||++-.+|-+.+-|+++.+..++..+..|++++|..
T Consensus 669 ~rnQvaHVKAERDILAEADn~WVVrLyySFQDkdnLYFVMdYIPGGDmMSLLIrmgIFeE~LARFYIAEltcAiesVHkm 748 (1034)
T KOG0608|consen 669 MRNQVAHVKAERDILAEADNEWVVRLYYSFQDKDNLYFVMDYIPGGDMMSLLIRMGIFEEDLARFYIAELTCAIESVHKM 748 (1034)
T ss_pred hhhhhhhhhhhhhhHhhcCCcceEEEEEEeccCCceEEEEeccCCccHHHHHHHhccCHHHHHHHHHHHHHHHHHHHHhc
Confidence 44556677889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCcccc---------CCCCc--------------------------------
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL---------YPGNY-------------------------------- 124 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~---------~~~~~-------------------------------- 124 (241)
|++||||||+|||+ +.+++|||.|||++.-+ +.+..
T Consensus 749 GFIHRDiKPDNILI---DrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~r 825 (1034)
T KOG0608|consen 749 GFIHRDIKPDNILI---DRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQR 825 (1034)
T ss_pred cceecccCccceEE---ccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhhh
Confidence 99999999999999 89999999999997432 11100
Q ss_pred --cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHH
Q 026253 125 --AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVD 202 (241)
Q Consensus 125 --~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~ 202 (241)
.....||.-|+|||++....++...|.||.|+++|+|+.|++||-..++.+...++.+... .+.-.....+|.++.+
T Consensus 826 ~~ahslvgt~nyiapevl~r~g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~nw~~-~l~~~~~~~ls~e~~~ 904 (1034)
T KOG0608|consen 826 ILAHSLVGTPNYIAPEVLARTGYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVINWRN-FLHIPYQGNLSKEALD 904 (1034)
T ss_pred hhhhhhcCCCcccChHHhcccCccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeeehhh-ccccccccccCHHHHH
Confidence 0124689999999999999999999999999999999999999998888776666544332 2233344589999999
Q ss_pred HHHHhcccCccccC---CHHHHhcCccccc
Q 026253 203 MCLKLLSANTVDRL---SFNEFYHHRFLRR 229 (241)
Q Consensus 203 li~~~l~~~p~~Rp---s~~~il~~~~~~~ 229 (241)
+|.++.. +++.|. .++|+-.||||+.
T Consensus 905 li~kLc~-sad~RLGkng~d~vKaHpfFkg 933 (1034)
T KOG0608|consen 905 LIQKLCC-SADSRLGKNGADQVKAHPFFKG 933 (1034)
T ss_pred HHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence 9998654 567777 4788999999987
|
|
| >KOG0984 consensus Mitogen-activated protein kinase (MAPK) kinase MKK3/MKK6 [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=100.00 E-value=1.6e-32 Score=195.83 Aligned_cols=183 Identities=27% Similarity=0.445 Sum_probs=157.7
Q ss_pred hhhHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHH
Q 026253 4 KLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 4 ~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~ 78 (241)
+.++++.+++.+|+.+.... .+|.+|++||.+...+..++.||.| ..+|+.+.+ +.+..++..+-+++..++.|
T Consensus 82 tvn~q~q~r~L~dldi~~r~~~CPf~V~FyGa~~regdvwIcME~M-~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~a 160 (282)
T KOG0984|consen 82 TVNSQEQKRLLMDLDIIMRTVDCPFTVHFYGALFREGDVWICMELM-DTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHA 160 (282)
T ss_pred hcChHHHHHHHHhhhhhccCCCCCeEEEeehhhhccccEEEeHHHh-hhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHH
Confidence 34677888999999998888 7999999999988889999999999 579987764 34669999999999999999
Q ss_pred HHHHHhC-CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc----ccCCCCchhHHH
Q 026253 79 LEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ----FQRYDEKVDMWS 153 (241)
Q Consensus 79 l~~lh~~-~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~----~~~~~~~~Dv~s 153 (241)
|.+||++ .++|||+||+|||+ +..+++|+||||.+....++-...-..|...|+|||.+. ...|+.++|+||
T Consensus 161 l~~L~~kL~vIHRDvKPsNiLI---n~~GqVKiCDFGIsG~L~dSiAkt~daGCkpYmaPEri~~e~n~~gY~vksDvWS 237 (282)
T KOG0984|consen 161 LEFLHSKLSVIHRDVKPSNILI---NYDGQVKICDFGISGYLVDSIAKTMDAGCKPYMAPERINPELNQKGYSVKSDVWS 237 (282)
T ss_pred HHHHHHHhhhhhccCCcceEEE---ccCCcEEEcccccceeehhhhHHHHhcCCCccCChhhcCcccCcccceeehhhhh
Confidence 9999985 89999999999999 899999999999997776655444466888999999875 346899999999
Q ss_pred HHHHHHHHHhCCCCCCC-CChHHHHHHhhcCCCCCCCC
Q 026253 154 VGAILFELLNGYPPFSG-RNNVQLVRNINSCKHLPFSQ 190 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~ 190 (241)
||+++.||++++.||+. .++.++++++.....+.++.
T Consensus 238 LGItmiElA~lr~PY~~w~tpF~qLkqvVeep~P~Lp~ 275 (282)
T KOG0984|consen 238 LGITMIEMAILRFPYESWGTPFQQLKQVVEEPSPQLPA 275 (282)
T ss_pred hhhhhhhhhhccccccccCCHHHHHHHHhcCCCCCCcc
Confidence 99999999999999985 57888888887776655554
|
|
| >PLN03225 Serine/threonine-protein kinase SNT7; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=3.1e-32 Score=231.17 Aligned_cols=195 Identities=20% Similarity=0.300 Sum_probs=137.7
Q ss_pred eecCeEEEEEeccCCCChHHHHHhcCC--------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCC
Q 026253 36 QAENCIFLVVEFCAGGNLSSYIRLHGR--------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPE 95 (241)
Q Consensus 36 ~~~~~~~lv~e~~~~~~L~~~l~~~~~--------------------~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~ 95 (241)
..+...++||||+.+++|.+++..... .....+..++.|++.||.|||+.||+||||||+
T Consensus 205 ~~~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~ 284 (566)
T PLN03225 205 KKEDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQ 284 (566)
T ss_pred ccCCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHH
Confidence 356679999999999999999875321 123456689999999999999999999999999
Q ss_pred CeEEeecCCCceEEEeecCCccccCCC--CccccccCCCCccCccccccc----------------------CCCCchhH
Q 026253 96 NILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQ----------------------RYDEKVDM 151 (241)
Q Consensus 96 nil~~~~~~~~~~~l~df~~a~~~~~~--~~~~~~~~~~~~~~PE~~~~~----------------------~~~~~~Dv 151 (241)
||+++ .+.+.++|+|||+|...... .......+++.|+|||.+... .+..++||
T Consensus 285 NILl~--~~~~~~KL~DFGlA~~l~~~~~~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DV 362 (566)
T PLN03225 285 NIIFS--EGSGSFKIIDLGAAADLRVGINYIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDI 362 (566)
T ss_pred HEEEe--CCCCcEEEEeCCCccccccccccCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCccc
Confidence 99994 34678999999999754322 223345678899999965322 12345699
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCC----------CCCCCc------cCCCCChHHHHHHHHhcccCcccc
Q 026253 152 WSVGAILFELLNGYPPFSGRNNVQLVRNINSCKH----------LPFSQL------IVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 152 ~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~----------~~~~~~------~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
||+||++|+|+++..++... .....+.+..... ...... .....+....+||.+||+.||.+|
T Consensus 363 wSlGviL~el~~~~~~~~~~-~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~d~~~~~~~dLi~~mL~~dP~kR 441 (566)
T PLN03225 363 YSAGLIFLQMAFPNLRSDSN-LIQFNRQLKRNDYDLVAWRKLVEPRASPDLRRGFEVLDLDGGAGWELLKSMMRFKGRQR 441 (566)
T ss_pred HHHHHHHHHHHhCcCCCchH-HHHHHHHHHhcCCcHHHHHHhhccccchhhhhhhhhccccchHHHHHHHHHccCCcccC
Confidence 99999999999876654321 1111122211110 000000 001122345689999999999999
Q ss_pred CCHHHHhcCccccccccc
Q 026253 216 LSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 216 ps~~~il~~~~~~~~~~~ 233 (241)
||++++|+||||++....
T Consensus 442 ~ta~e~L~Hpff~~~~~~ 459 (566)
T PLN03225 442 ISAKAALAHPYFDREGLL 459 (566)
T ss_pred CCHHHHhCCcCcCCCCcc
Confidence 999999999999986654
|
|
| >PLN00181 protein SPA1-RELATED; Provisional | Back alignment and domain information |
|---|
Probab=100.00 E-value=8.4e-33 Score=244.72 Aligned_cols=203 Identities=18% Similarity=0.233 Sum_probs=150.7
Q ss_pred hcCCC-cCeeeeeeEE-------eecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccC
Q 026253 21 SSVNH-PNIIRLFDAF-------QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRD 91 (241)
Q Consensus 21 ~~l~~-~~i~~~~~~~-------~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~d 91 (241)
+.++| +||+++.+++ .....++.++|++ +++|.+++... ..+++..+..++.||+.||.|||++||+|||
T Consensus 27 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHrD 105 (793)
T PLN00181 27 KSLSHIDYVRSLLGSHKEGNLDGLDDDSIVRALECE-DVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVHN 105 (793)
T ss_pred chhhHHHHHHHhhcccCCccccccccchhhhhhccC-CccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeecc
Confidence 34456 6888888887 2334677888988 67999999753 4589999999999999999999999999999
Q ss_pred CCCCCeEEee----------------cCCCceEEEeecCCccccCCCC-----------------ccccccCCCCccCcc
Q 026253 92 LKPENILLSG----------------LDDDVMLKIADFGLSCTLYPGN-----------------YAEKVCGSPLYMAPE 138 (241)
Q Consensus 92 l~~~nil~~~----------------~~~~~~~~l~df~~a~~~~~~~-----------------~~~~~~~~~~~~~PE 138 (241)
|||+|||++. .+.++.++++|||+++...... ......+|+.|+|||
T Consensus 106 lKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 185 (793)
T PLN00181 106 VRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSPE 185 (793)
T ss_pred CCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceEChh
Confidence 9999999942 1234456777777765421100 001134688899999
Q ss_pred cccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH
Q 026253 139 VLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF 218 (241)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 218 (241)
.+.+..++.++|||||||++|||++|.+|+.... .....+..... +.... .......+++.+||+++|.+|||+
T Consensus 186 ~~~~~~~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~~---~~~~~-~~~~~~~~~~~~~L~~~P~~Rps~ 259 (793)
T PLN00181 186 EDNGSSSNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRVL---PPQIL-LNWPKEASFCLWLLHPEPSCRPSM 259 (793)
T ss_pred hhccCCCCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhhc---Chhhh-hcCHHHHHHHHHhCCCChhhCcCh
Confidence 9998999999999999999999999988876422 12222221111 11111 124456789999999999999999
Q ss_pred HHHhcCcccccc
Q 026253 219 NEFYHHRFLRRN 230 (241)
Q Consensus 219 ~~il~~~~~~~~ 230 (241)
.|+++||||...
T Consensus 260 ~eil~h~~~~~~ 271 (793)
T PLN00181 260 SELLQSEFINEP 271 (793)
T ss_pred HHHhhchhhhhh
Confidence 999999999864
|
|
| >PLN03224 probable serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=3.7e-31 Score=219.99 Aligned_cols=211 Identities=23% Similarity=0.314 Sum_probs=154.0
Q ss_pred HHHHHHHHhcCCCcCe-----eeeeeEEee--------cCeEEEEEeccCCCChHHHHHhcC------------------
Q 026253 13 LDCELNFLSSVNHPNI-----IRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHG------------------ 61 (241)
Q Consensus 13 ~~~E~~~l~~l~~~~i-----~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~------------------ 61 (241)
...|+.++.+++|.++ +++++++.. ++..++||||+.+++|.+++....
T Consensus 219 ~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g~~l~ 298 (507)
T PLN03224 219 GMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAGKKIP 298 (507)
T ss_pred hHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcCCchh
Confidence 4457778888866554 667776643 356899999999999999986421
Q ss_pred ------CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc--cccCCCC
Q 026253 62 ------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--KVCGSPL 133 (241)
Q Consensus 62 ------~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~--~~~~~~~ 133 (241)
.+++..+..++.|++.+|.+||+.+++|+||||.||++ +.++.++|+|||++.......... ....++.
T Consensus 299 ~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~g~~tp~ 375 (507)
T PLN03224 299 DNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLV---TVDGQVKIIDFGAAVDMCTGINFNPLYGMLDPR 375 (507)
T ss_pred hhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEE---CCCCcEEEEeCcCccccccCCccCccccCCCcc
Confidence 13566788899999999999999999999999999999 677889999999986654322211 2334788
Q ss_pred ccCcccccccCC----------------------CCchhHHHHHHHHHHHHhCCC-CCCCCChH-----------HHHHH
Q 026253 134 YMAPEVLQFQRY----------------------DEKVDMWSVGAILFELLNGYP-PFSGRNNV-----------QLVRN 179 (241)
Q Consensus 134 ~~~PE~~~~~~~----------------------~~~~Dv~slG~~l~~l~~g~~-p~~~~~~~-----------~~~~~ 179 (241)
|+|||.+..... ..+.|+||+||++++|++|.. |+...... ...+.
T Consensus 376 Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~~~~~~~~~~r~ 455 (507)
T PLN03224 376 YSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELRQYDNDLNRWRM 455 (507)
T ss_pred eeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHhhccchHHHHHh
Confidence 999998753221 124699999999999999875 66532111 11111
Q ss_pred hhcCCCCCCCCccCCCCChHHHHHHHHhcccCc---cccCCHHHHhcCccccc
Q 026253 180 INSCKHLPFSQLIVPALHPDCVDMCLKLLSANT---VDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 180 i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p---~~Rps~~~il~~~~~~~ 229 (241)
+ ......++ .....+....+++.+||..+| .+|+|++|+|+||||..
T Consensus 456 ~-~~~~~~~~--~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~~ 505 (507)
T PLN03224 456 Y-KGQKYDFS--LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFLP 505 (507)
T ss_pred h-cccCCCcc--cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcCC
Confidence 1 11122222 234678899999999999876 68999999999999964
|
|
| >PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.98 E-value=1e-31 Score=243.21 Aligned_cols=202 Identities=24% Similarity=0.371 Sum_probs=153.1
Q ss_pred HHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH---hCCccc
Q 026253 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN---SHHIIH 89 (241)
Q Consensus 13 ~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh---~~~i~H 89 (241)
..+|++.+++++||||+++++++.+++..++||||+++++|.++++ .+++..+..++.+++.|++||| +.+++|
T Consensus 730 ~~~~~~~l~~l~HpnIv~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~---~l~~~~~~~i~~~ia~~L~yLH~~~~~~iiH 806 (968)
T PLN00113 730 PSSEIADMGKLQHPNIVKLIGLCRSEKGAYLIHEYIEGKNLSEVLR---NLSWERRRKIAIGIAKALRFLHCRCSPAVVV 806 (968)
T ss_pred cHHHHHHHhhCCCCCcceEEEEEEcCCCCEEEEeCCCCCcHHHHHh---cCCHHHHHHHHHHHHHHHHHhccCCCCCeec
Confidence 3467999999999999999999999999999999999999999996 4788999999999999999999 669999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 169 (241)
||+||.||++ +.+...++. ++.+..... .....++..|+|||.+.+..++.++||||+|+++|||++|+.||.
T Consensus 807 ~dlkp~Nil~---~~~~~~~~~-~~~~~~~~~---~~~~~~t~~y~aPE~~~~~~~~~~sDv~S~Gvvl~el~tg~~p~~ 879 (968)
T PLN00113 807 GNLSPEKIII---DGKDEPHLR-LSLPGLLCT---DTKCFISSAYVAPETRETKDITEKSDIYGFGLILIELLTGKSPAD 879 (968)
T ss_pred CCCCHHhEEE---CCCCceEEE-ecccccccc---CCCccccccccCcccccCCCCCcccchhhHHHHHHHHHhCCCCCC
Confidence 9999999999 555555554 444332211 122356789999999998899999999999999999999999985
Q ss_pred CCCh-----HHHHHHhhcCC------CCCCCC--ccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 170 GRNN-----VQLVRNINSCK------HLPFSQ--LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 170 ~~~~-----~~~~~~i~~~~------~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.... .+..+...... ...... ........++.+++.+||+.||.+|||++|+++.
T Consensus 880 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~Cl~~~P~~RPt~~evl~~ 947 (968)
T PLN00113 880 AEFGVHGSIVEWARYCYSDCHLDMWIDPSIRGDVSVNQNEIVEVMNLALHCTATDPTARPCANDVLKT 947 (968)
T ss_pred cccCCCCcHHHHHHHhcCccchhheeCccccCCCCccHHHHHHHHHHHHhhCcCCchhCcCHHHHHHH
Confidence 3211 11111110000 000000 0000112357789999999999999999999865
|
|
| >KOG1025 consensus Epidermal growth factor receptor EGFR and related tyrosine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.98 E-value=4.6e-32 Score=226.47 Aligned_cols=209 Identities=25% Similarity=0.406 Sum_probs=187.3
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
..+...++.+|+.++.+++|+|++++++++.... ..||++|+++|+|.||++.. +.+.......|..||++|+.|||+
T Consensus 738 ~~~~s~e~LdeAl~masldHpnl~RLLgvc~~s~-~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~YLe~ 816 (1177)
T KOG1025|consen 738 SPKASIELLDEALRMASLDHPNLLRLLGVCMLST-LQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMKYLEE 816 (1177)
T ss_pred CchhhHHHHHHHHHHhcCCCchHHHHhhhcccch-HHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHHHHHh
Confidence 4456788999999999999999999999998765 88999999999999999865 568889999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcccc---ccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~---~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
++++||||-..|||| .....+|+.|||+++...+...... ......|+|-|.+....++.++||||+|+++||+
T Consensus 817 qrlVHrdLaaRNVLV---ksP~hvkitdfgla~ll~~d~~ey~~~~gK~pikwmale~i~~~~~thqSDVWsfGVtiWEl 893 (1177)
T KOG1025|consen 817 QRLVHRDLAARNVLV---KSPNHVKITDFGLAKLLAPDEKEYSAPGGKVPIKWMALESIRIRKYTHQSDVWSFGVTIWEL 893 (1177)
T ss_pred cchhhhhhhhhheee---cCCCeEEEEecchhhccCcccccccccccccCcHHHHHHHhhccCCCchhhhhhhhhhHHHH
Confidence 999999999999999 7888999999999988766543322 2335669999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
+| |..|+.+....++-..++.+.+.+.|+ ..+.++..++.+||-.|+..||+++++.
T Consensus 894 mTFGa~Py~gi~~~eI~dlle~geRLsqPp----iCtiDVy~~mvkCwmid~~~rp~fkel~ 951 (1177)
T KOG1025|consen 894 MTFGAKPYDGIPAEEIPDLLEKGERLSQPP----ICTIDVYMVMVKCWMIDADSRPTFKELA 951 (1177)
T ss_pred HhcCCCccCCCCHHHhhHHHhccccCCCCC----CccHHHHHHHHHHhccCcccCccHHHHH
Confidence 99 999999999999999999998877665 7899999999999999999999998865
|
|
| >KOG2052 consensus Activin A type IB receptor, serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.1e-31 Score=207.48 Aligned_cols=217 Identities=24% Similarity=0.325 Sum_probs=169.7
Q ss_pred hhhhhHHhhhhHHHHHHHHhcC--CCcCeeeeeeEEeec----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l--~~~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (241)
+|.++..++++..+|.+|+++. +|+||+.+++.=..+ ..++||++|.+.|||.|||.+ ..++.+...+++..+
T Consensus 239 VKiF~srdE~SWfrEtEIYqTvmLRHENILgFIaaD~~~~gs~TQLwLvTdYHe~GSL~DyL~r-~tv~~~~ml~LalS~ 317 (513)
T KOG2052|consen 239 VKIFSSRDERSWFRETEIYQTVMLRHENILGFIAADNKDNGSWTQLWLVTDYHEHGSLYDYLNR-NTVTTEGMLKLALSI 317 (513)
T ss_pred EEEecccchhhhhhHHHHHHHHHhccchhhhhhhccccCCCceEEEEEeeecccCCcHHHHHhh-ccCCHHHHHHHHHHH
Confidence 6888999999999999999998 999999999764432 368999999999999999986 579999999999999
Q ss_pred HHHHHHHHhC--------CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-----ccccccCCCCccCcccccc
Q 026253 76 GAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF 142 (241)
Q Consensus 76 ~~~l~~lh~~--------~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~~~~~~~~~PE~~~~ 142 (241)
+.||++||-. .|.|||||+.||+| ..++.+-|+|+|+|....... ..+..+||.+|+|||++..
T Consensus 318 AsGLaHLH~eI~GTqgKPaIAHRDlKSKNILV---Kkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLde 394 (513)
T KOG2052|consen 318 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDE 394 (513)
T ss_pred hhhHHHHHHHHhcCCCCchhhccccccccEEE---ccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhh
Confidence 9999999954 49999999999999 799999999999998776542 3456789999999999864
Q ss_pred c------CCCCchhHHHHHHHHHHHHhC----------CCCCCCCC----hHHHHHHhhcCCCC-CCCCccCCCCC--hH
Q 026253 143 Q------RYDEKVDMWSVGAILFELLNG----------YPPFSGRN----NVQLVRNINSCKHL-PFSQLIVPALH--PD 199 (241)
Q Consensus 143 ~------~~~~~~Dv~slG~~l~~l~~g----------~~p~~~~~----~~~~~~~i~~~~~~-~~~~~~~~~~~--~~ 199 (241)
. ..-..+||||||.++||++.+ ++||.+.. ..+..+.+....+. +.....+.+.+ ..
T Consensus 395 tin~~~Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l~~ 474 (513)
T KOG2052|consen 395 TINMKHFESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPALRV 474 (513)
T ss_pred hcChhhhhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHHHH
Confidence 3 123579999999999999862 66876422 22333333222222 22222222222 24
Q ss_pred HHHHHHHhcccCccccCCHHHHh
Q 026253 200 CVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 200 ~~~li~~~l~~~p~~Rps~~~il 222 (241)
+..+++.||..||..|.|+-.+-
T Consensus 475 m~klMkeCW~~Np~aRltALriK 497 (513)
T KOG2052|consen 475 MAKLMKECWYANPAARLTALRIK 497 (513)
T ss_pred HHHHHHHhhcCCchhhhHHHHHH
Confidence 77899999999999999986554
|
|
| >KOG1024 consensus Receptor-like protein tyrosine kinase RYK/derailed [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.3e-30 Score=200.76 Aligned_cols=212 Identities=23% Similarity=0.376 Sum_probs=184.5
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEe-ecCeEEEEEeccCCCChHHHHHhcC--------CCCHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQTARKFLQQLG 76 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--------~~~~~~~~~~~~~i~ 76 (241)
++-+...+..|--.+.-+.|||++.+.+... +....++++.++.-|+|+.++...+ .++..++..++.|++
T Consensus 327 S~iQv~~~L~es~lly~~sH~nll~V~~V~ie~~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQla 406 (563)
T KOG1024|consen 327 SQIQVNLLLQESMLLYGASHPNLLSVLGVSIEDYATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQLA 406 (563)
T ss_pred cHHHHHHHHHHHHHHhcCcCCCccceeEEEeeccCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHHH
Confidence 4455667788888888889999999999765 5567889999999999999998332 266777888999999
Q ss_pred HHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc---ccccCCCCccCcccccccCCCCchhHHH
Q 026253 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (241)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~---~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 153 (241)
.|+++||+.|++|.||-..|.++ ++..++||+|=.+++...+..+. ...-....|+++|.+.+..++.++|+||
T Consensus 407 ~am~hlh~~~ViHkDiAaRNCvI---dd~LqVkltDsaLSRDLFP~DYhcLGDnEnRPvkWMslEal~n~~yssasDvWs 483 (563)
T KOG1024|consen 407 MAMEHLHNHGVIHKDIAARNCVI---DDQLQVKLTDSALSRDLFPGDYHCLGDNENRPVKWMSLEALQNSHYSSASDVWS 483 (563)
T ss_pred HHHHHHHhcCcccchhhhhccee---hhheeEEeccchhccccCcccccccCCCCCCcccccCHHHHhhhhhcchhhhHH
Confidence 99999999999999999999999 78899999999999887665432 1222356799999999999999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 154 VGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 154 lG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
||+++||+++ |+.|+...++.++...++++.+...|- ++|.++..++..||+..|++||+++|+..+
T Consensus 484 fGVllWELmtlg~~PyaeIDPfEm~~ylkdGyRlaQP~----NCPDeLf~vMacCWallpeeRPsf~Qlv~c 551 (563)
T KOG1024|consen 484 FGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYRLAQPF----NCPDELFTVMACCWALLPEERPSFSQLVIC 551 (563)
T ss_pred HHHHHHHHHhcCCCCccccCHHHHHHHHhccceecCCC----CCcHHHHHHHHHHHhcCcccCCCHHHHHHH
Confidence 9999999998 999999999999999999999987776 889999999999999999999999998754
|
|
| >KOG1290 consensus Serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.8e-30 Score=204.88 Aligned_cols=223 Identities=26% Similarity=0.402 Sum_probs=166.9
Q ss_pred HHhhhhHHHHHHHHhcCC--------CcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVN--------HPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~--------~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~ 72 (241)
+.-.+....|+++|++++ ..+||++++.|.. +.+.|+|+|+. |.+|..++... +.++...+..|+
T Consensus 115 qhYtEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGpNG~HVCMVfEvL-GdnLLklI~~s~YrGlpl~~VK~I~ 193 (590)
T KOG1290|consen 115 QHYTEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGPNGQHVCMVFEVL-GDNLLKLIKYSNYRGLPLSCVKEIC 193 (590)
T ss_pred hHHHHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCCCCcEEEEEehhh-hhHHHHHHHHhCCCCCcHHHHHHHH
Confidence 445677889999999993 2469999999864 46899999999 88999999865 458999999999
Q ss_pred HHHHHHHHHHHhC-CccccCCCCCCeEEe---------------------------------------------------
Q 026253 73 QQLGAGLEILNSH-HIIHRDLKPENILLS--------------------------------------------------- 100 (241)
Q Consensus 73 ~~i~~~l~~lh~~-~i~H~dl~~~nil~~--------------------------------------------------- 100 (241)
+|++.||.|||++ ||+|.||||+|||+-
T Consensus 194 ~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~ 273 (590)
T KOG1290|consen 194 RQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKM 273 (590)
T ss_pred HHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHH
Confidence 9999999999975 999999999999984
Q ss_pred --------------------------------------------------------------ec----------------
Q 026253 101 --------------------------------------------------------------GL---------------- 102 (241)
Q Consensus 101 --------------------------------------------------------------~~---------------- 102 (241)
..
T Consensus 274 ~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~ 353 (590)
T KOG1290|consen 274 KKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQ 353 (590)
T ss_pred HHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchh
Confidence 00
Q ss_pred ----------------------------------CCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCc
Q 026253 103 ----------------------------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK 148 (241)
Q Consensus 103 ----------------------------------~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~ 148 (241)
.....+||.|||-|+...... .....|..|.|||++.+..|+..
T Consensus 354 ~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~khF--T~DIQTRQYRapEVllGsgY~~~ 431 (590)
T KOG1290|consen 354 LRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVHKHF--TEDIQTRQYRAPEVLLGSGYSTS 431 (590)
T ss_pred cccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhhhhh--chhhhhhhccCcceeecCCCCCc
Confidence 001126677777766543222 22345778999999999999999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCC-------CChHHHHHHhhcCCCCCC-------------C---------Cc--------
Q 026253 149 VDMWSVGAILFELLNGYPPFSG-------RNNVQLVRNINSCKHLPF-------------S---------QL-------- 191 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~g~~p~~~-------~~~~~~~~~i~~~~~~~~-------------~---------~~-------- 191 (241)
+|+||++|+++|++||...|+- .+...+...+.....+|. . ..
T Consensus 432 ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~WpL~~V 511 (590)
T KOG1290|consen 432 ADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKPWPLYEV 511 (590)
T ss_pred hhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCCCcHHHH
Confidence 9999999999999999888852 222222222211111000 0 00
Q ss_pred ------cCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 192 ------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 192 ------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
....-..++.+|+.-||+.+|++||||.++|+||||+....
T Consensus 512 L~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~ 558 (590)
T KOG1290|consen 512 LIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAG 558 (590)
T ss_pred HHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCC
Confidence 01112346899999999999999999999999999997554
|
|
| >KOG3653 consensus Transforming growth factor beta/activin receptor subfamily of serine/threonine kinases [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=1e-30 Score=206.54 Aligned_cols=214 Identities=25% Similarity=0.378 Sum_probs=168.9
Q ss_pred hhhhhHHhhhhHHHHHHHHhcC--CCcCeeeeeeEEeec----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l--~~~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (241)
+|.+...+.+++.+|-.|++.. +|+||+++++.-+-. ..++||++|.+.|+|.+||+.+ ..++....+++..+
T Consensus 238 VKifp~~~kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~~~~eywLVt~fh~kGsL~dyL~~n-tisw~~~cria~Sm 316 (534)
T KOG3653|consen 238 VKIFPEQEKQSFQNEKNIYSLPGMKHENILQFIGAEKRGTADRMEYWLVTEFHPKGSLCDYLKAN-TISWNSLCRIAESM 316 (534)
T ss_pred EEecCHHHHHHHHhHHHHHhccCccchhHHHhhchhccCCccccceeEEeeeccCCcHHHHHHhc-cccHHHHHHHHHHH
Confidence 6888999999999999999988 799999999876543 4899999999999999999854 78999999999999
Q ss_pred HHHHHHHHhC---------CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCccccccc
Q 026253 76 GAGLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQ 143 (241)
Q Consensus 76 ~~~l~~lh~~---------~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~ 143 (241)
+.||+|||+. .|+|||||..|||+ ..+...-|+|||+|..+.+.. ......||.+|||||++.+.
T Consensus 317 arGLa~LHee~p~~d~~Kp~IaHRDlkSkNVLv---K~DlTccIaDFGLAl~~~p~~~~~d~~~qVGT~RYMAPEvLEga 393 (534)
T KOG3653|consen 317 ARGLAHLHEELPRGDHHKPPIAHRDLKSKNVLV---KNDLTCCIADFGLALRLEPGKPQGDTHGQVGTRRYMAPEVLEGA 393 (534)
T ss_pred HHHHHHhcccCCcCCCCCCccccccccccceEE---ccCCcEEeeccceeEEecCCCCCcchhhhhhhhhhcCHHHHhhh
Confidence 9999999964 59999999999999 789999999999998876533 33457899999999998654
Q ss_pred C------CCCchhHHHHHHHHHHHHhCCC------------CCCC-----CChHHHHHHhhcCC-CCCCCCccCCC-CCh
Q 026253 144 R------YDEKVDMWSVGAILFELLNGYP------------PFSG-----RNNVQLVRNINSCK-HLPFSQLIVPA-LHP 198 (241)
Q Consensus 144 ~------~~~~~Dv~slG~~l~~l~~g~~------------p~~~-----~~~~~~~~~i~~~~-~~~~~~~~~~~-~~~ 198 (241)
- .-.+.||||+|.++||++++.. ||+. -+.+++...+...+ ++.++...... .-.
T Consensus 394 inl~d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlpfe~evG~hPt~e~mq~~VV~kK~RP~~p~~W~~h~~~~ 473 (534)
T KOG3653|consen 394 INLQDRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLPFEAEVGNHPTLEEMQELVVRKKQRPKIPDAWRKHAGMA 473 (534)
T ss_pred cccccHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCchhHHhcCCCCHHHHHHHHHhhccCCCChhhhhcCccHH
Confidence 2 2357999999999999998533 3331 12233443333333 33333322222 234
Q ss_pred HHHHHHHHhcccCccccCCHH
Q 026253 199 DCVDMCLKLLSANTVDRLSFN 219 (241)
Q Consensus 199 ~~~~li~~~l~~~p~~Rps~~ 219 (241)
.+.+.+..||+.||+.|.|+.
T Consensus 474 ~l~et~EeCWDhDaeARLTA~ 494 (534)
T KOG3653|consen 474 VLCETIEECWDHDAEARLTAG 494 (534)
T ss_pred HHHHHHHHHcCCchhhhhhhH
Confidence 588999999999999999973
|
|
| >smart00750 KIND kinase non-catalytic C-lobe domain | Back alignment and domain information |
|---|
Probab=99.97 E-value=5.8e-31 Score=193.15 Aligned_cols=166 Identities=23% Similarity=0.240 Sum_probs=130.9
Q ss_pred CChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcccccc
Q 026253 51 GNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129 (241)
Q Consensus 51 ~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~ 129 (241)
|+|.+++... .++++..+..++.|++.||.|||+.+ ||+||++ +.++.+++ ||.+....... ..
T Consensus 1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~---~~~~~~~~--fG~~~~~~~~~----~~ 65 (176)
T smart00750 1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILL---TWDGLLKL--DGSVAFKTPEQ----SR 65 (176)
T ss_pred CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeE---cCccceee--ccceEeecccc----CC
Confidence 6899999874 45999999999999999999999998 9999999 77888888 99887654322 25
Q ss_pred CCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhcCCCCCCCC--ccCCCCCh--HHHHHH
Q 026253 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN-VQLVRNINSCKHLPFSQ--LIVPALHP--DCVDMC 204 (241)
Q Consensus 130 ~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~--~~~~~~~~--~~~~li 204 (241)
+++.|+|||.+.+..++.++||||+|+++|+|++|..||..... ......+........+. .....++. ++.+++
T Consensus 66 g~~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i 145 (176)
T smart00750 66 VDPYFMAPEVIQGQSYTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMPADDPRDRSNLESVSAARSFADFM 145 (176)
T ss_pred CcccccChHHhcCCCCcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhccCCccccccHHHHHhhhhHHHHH
Confidence 78999999999999999999999999999999999999976443 23333332222111111 11113333 699999
Q ss_pred HHhcccCccccCCHHHHhcCccccccc
Q 026253 205 LKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 205 ~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
.+||+.+|.+|||+.++++|+|+....
T Consensus 146 ~~cl~~~p~~Rp~~~~ll~~~~~~~~~ 172 (176)
T smart00750 146 RVCASRLPQRREAANHYLAHCRALFAE 172 (176)
T ss_pred HHHHhcccccccCHHHHHHHHHHHHHH
Confidence 999999999999999999999987644
|
It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features |
| >cd00180 PKc Catalytic domain of Protein Kinases | Back alignment and domain information |
|---|
Probab=99.97 E-value=8.1e-30 Score=191.44 Aligned_cols=177 Identities=44% Similarity=0.756 Sum_probs=158.8
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
.+.+.+|++.++.++|++++++++++......++++|++.+++|.+++... ..++...+..++.+++.++.+||+.|++
T Consensus 35 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~~~ 114 (215)
T cd00180 35 LEELLREIEILKKLNHPNIVKLYGVFEDENHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEYLHSNGII 114 (215)
T ss_pred HHHHHHHHHHHHhcCCCCeeeEeeeeecCCeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 478999999999999999999999999999999999999989999999865 5789999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCC-CceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCC
Q 026253 89 HRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 89 H~dl~~~nil~~~~~~-~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
|+||+|.||++ +. ++.++|+|||.+....... ......+...|.+||..... ..+.++|+|++|++++++
T Consensus 115 H~dl~~~ni~~---~~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~~~~l---- 187 (215)
T cd00180 115 HRDLKPENILL---DSDNGKVKLADFGLSKLLTSDKSLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL---- 187 (215)
T ss_pred ccCCCHhhEEE---eCCCCcEEEecCCceEEccCCcchhhcccCCCCccChhHhcccCCCCchhhhHHHHHHHHHH----
Confidence 99999999999 55 7889999999987654432 12334567889999998876 788999999999999998
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 225 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 225 (241)
..+.+++.+|++.+|++||++.++++++
T Consensus 188 --------------------------------~~~~~~l~~~l~~~p~~R~~~~~l~~~~ 215 (215)
T cd00180 188 --------------------------------PELKDLIRKMLQKDPEKRPSAKEILEHL 215 (215)
T ss_pred --------------------------------HHHHHHHHHHhhCCcccCcCHHHHhhCC
Confidence 5899999999999999999999999875
|
Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which |
| >KOG0664 consensus Nemo-like MAPK-related serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=4.7e-32 Score=201.48 Aligned_cols=217 Identities=30% Similarity=0.472 Sum_probs=176.2
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
.-+.+-+|++++.-.+|.|++...++..-.. ..|+++|.+. .+|-..+-....++.+++.-+++||+.||+|||
T Consensus 95 s~krvFre~kmLcfFkHdNVLSaLDILQPph~dfFqEiYV~TELmQ-SDLHKIIVSPQ~Ls~DHvKVFlYQILRGLKYLH 173 (449)
T KOG0664|consen 95 SCKRVFREIKMLSSFRHDNVLSLLDILQPANPSFFQELYVLTELMQ-SDLHKIIVSPQALTPDHVKVFVYQILRGLKYLH 173 (449)
T ss_pred HHHHHHHHHHHHHhhccccHHHHHHhcCCCCchHHHHHHHHHHHHH-hhhhheeccCCCCCcchhhhhHHHHHhhhHHHh
Confidence 3577889999999999999999998876432 4678889884 588877776677999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~ 160 (241)
+.||.||||||.|.++ +.+..+||||||+++...... ......-|.+|.+||.+.|. .|+.+.|+||+||++.|
T Consensus 174 sA~ILHRDIKPGNLLV---NSNCvLKICDFGLARvee~d~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIFaE 250 (449)
T KOG0664|consen 174 TANILHRDIKPGNLLV---NSNCILKICDFGLARTWDQRDRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIFAE 250 (449)
T ss_pred hcchhhccCCCccEEe---ccCceEEecccccccccchhhhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHHHH
Confidence 9999999999999999 788899999999998765432 22334567889999999875 58999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCC-------------------------CCcc----CCCCChHHHHHHHHhcccC
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPF-------------------------SQLI----VPALHPDCVDMCLKLLSAN 211 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~----~~~~~~~~~~li~~~l~~~ 211 (241)
++.++..|...++.+.++.|.+-...+- +..+ ...-..+..+++.+++..|
T Consensus 251 LLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~~d 330 (449)
T KOG0664|consen 251 LLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLHFD 330 (449)
T ss_pred HHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhCCC
Confidence 9999999998888877776654322111 1111 0012235678999999999
Q ss_pred ccccCCHHHHhcCccccc
Q 026253 212 TVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 212 p~~Rps~~~il~~~~~~~ 229 (241)
|.+|.+..+.+.|+++.+
T Consensus 331 ~dkris~~~A~~~~~~~e 348 (449)
T KOG0664|consen 331 PDKRISVEEALQHRYLEE 348 (449)
T ss_pred CcccccHhhhcccccccc
Confidence 999999999999999876
|
|
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.97 E-value=2.1e-31 Score=218.10 Aligned_cols=222 Identities=25% Similarity=0.424 Sum_probs=190.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
..+..+-+.+|+-+++.++|+||+.+++.|-.....++.||||.||+|.+...-.+++++.++....+..+.|++|||+.
T Consensus 52 p~dd~~~iqqei~~~~dc~h~nivay~gsylr~dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~ylhs~ 131 (829)
T KOG0576|consen 52 PGDDFSGIQQEIGMLRDCRHPNIVAYFGSYLRRDKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYLHSQ 131 (829)
T ss_pred CCccccccccceeeeecCCCcChHHHHhhhhhhcCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhhhcC
Confidence 45667788999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccc---cccCCCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVL---QFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~---~~~~~~~~~Dv~slG~~l~~l 161 (241)
|-+|||||..||++ ++.+.+++.|||.+..+... .......||++|+|||+. ....|...+|+|++|++..++
T Consensus 132 gk~hRdiKGanill---td~gDvklaDfgvsaqitati~KrksfiGtpywmapEvaaverkggynqlcdiwa~gitAiel 208 (829)
T KOG0576|consen 132 GKIHRDIKGANILL---TDEGDVKLADFGVSAQITATIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGITAIEL 208 (829)
T ss_pred Ccccccccccceee---cccCceeecccCchhhhhhhhhhhhcccCCccccchhHHHHHhcccccccccccccccchhhh
Confidence 99999999999999 89999999999998666432 234457899999999985 345688999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
..-++|.....+...+.......-.+..-......++.+..|++.+|.++|++|||++.+|.|||....
T Consensus 209 ~eLqpplfdlhpmr~l~LmTkS~~qpp~lkDk~kws~~fh~fvK~altknpKkRptaeklL~h~fvs~~ 277 (829)
T KOG0576|consen 209 GELQPPLFDLHPMRALFLMTKSGFQPPTLKDKTKWSEFFHNFVKGALTKNPKKRPTAEKLLQHPFVSQT 277 (829)
T ss_pred hhcCCcccccchHHHHHHhhccCCCCCcccCCccchHHHHHHHHHHhcCCCccCCChhhheeceeeccc
Confidence 998998877777666655544443333333344578889999999999999999999999999998764
|
|
| >KOG1167 consensus Serine/threonine protein kinase of the CDC7 subfamily involved in DNA synthesis, repair and recombination [Replication, recombination and repair] | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.2e-28 Score=192.37 Aligned_cols=218 Identities=25% Similarity=0.370 Sum_probs=167.2
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
+.-.++.+|++++..+ .+.||+++.+.+..++...+|+||++.....++.. .++...+..+++.++.||+++|.+|
T Consensus 76 s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnnd~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~Al~~~h~~G 152 (418)
T KOG1167|consen 76 SSPSRILNELEMLYRLGGSDNIIKLNGCFRNNDQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKALAHLHKNG 152 (418)
T ss_pred cCchHHHHHHHHHHHhccchhhhcchhhhccCCeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHHhhhhhccC
Confidence 3456799999999999 68999999999999999999999999998888876 3567889999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--------------c----------------------------
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------------Y---------------------------- 124 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--------------~---------------------------- 124 (241)
|+|||+||.|++++ ...+...|.|||+|....... .
T Consensus 153 IvHRDiKpsNFL~n--~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~~~~~~r 230 (418)
T KOG1167|consen 153 IVHRDIKPSNFLYN--RRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYRRCNDGR 230 (418)
T ss_pred ccccCCCccccccc--cccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCceeccCCCc
Confidence 99999999999997 556667899999987221000 0
Q ss_pred ---cccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCCCCCC-hHHHHHHhh------------c--CC-
Q 026253 125 ---AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSGRN-NVQLVRNIN------------S--CK- 184 (241)
Q Consensus 125 ---~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~-~~~~~~~i~------------~--~~- 184 (241)
.....||++|.|||++.+ ...+++.|+||.|++++.++++..||.... ...-+..|. . +.
T Consensus 231 ~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A~l~g~~ 310 (418)
T KOG1167|consen 231 PSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCAALPGRI 310 (418)
T ss_pred cceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHhhcCCce
Confidence 001358999999999764 446889999999999999999999885321 111000000 0 00
Q ss_pred -------------------CC--------C----CCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 185 -------------------HL--------P----FSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 185 -------------------~~--------~----~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
.. + .........+..+.+++.+||+.||.+|.|++++|+||||...
T Consensus 311 ~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF~~~ 387 (418)
T KOG1167|consen 311 LLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFFDEA 387 (418)
T ss_pred eeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCCcch
Confidence 00 0 0000112234578999999999999999999999999999864
|
|
| >smart00221 STYKc Protein kinase; unclassified specificity | Back alignment and domain information |
|---|
Probab=99.96 E-value=1.8e-27 Score=180.88 Aligned_cols=175 Identities=42% Similarity=0.709 Sum_probs=152.4
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|++.+++++|+|++++++++......++++|++.+++|.+++..... +++..+..++.+++.++.+||+.++
T Consensus 40 ~~~~~~~e~~~~~~~~~~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~lh~~~i 119 (225)
T smart00221 40 QREEFLREIRILKKLKHPNIVKLYGVFEDPEPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALEYLHSLGI 119 (225)
T ss_pred HHHHHHHHHHHHHhCCCCChhhheeeeecCCceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 577999999999999999999999999998999999999999999999987766 8999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccc-cccCCCCchhHHHHHHHHHHHHhC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
+|+|++|.||++ +.++.++|+|||.+....... ......+...|++||.. ....++.++|+|++|++++++++|
T Consensus 120 ~h~di~~~ni~v---~~~~~~~l~d~g~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~~~~l~~g 196 (225)
T smart00221 120 VHRDLKPENILL---GMDGLVKLADFGLARFIHRDLAALLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVILYELLWG 196 (225)
T ss_pred ecCCCCHHHEEE---cCCCCEEEeeCceeeEecCcccccccceeccCCcCCHhHhcCCCCCCchhhHHHHHHHHHHHHHC
Confidence 999999999999 667899999999987765543 33445677889999998 666778899999999999999999
Q ss_pred CCCCCC--CChHHHHHHhhcCCCC
Q 026253 165 YPPFSG--RNNVQLVRNINSCKHL 186 (241)
Q Consensus 165 ~~p~~~--~~~~~~~~~i~~~~~~ 186 (241)
+.||.. .+.....+.+..+...
T Consensus 197 ~~pf~~~~~~~~~~~~~~~~~~~~ 220 (225)
T smart00221 197 PEPFSGEGEFTSLLSDVWSFGVPL 220 (225)
T ss_pred CCCccccchhHHHHHHHHhcCCcc
Confidence 999987 4444677777655533
|
Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. |
| >KOG1152 consensus Signal transduction serine/threonine kinase with PAS/PAC sensor domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.95 E-value=5.5e-28 Score=195.49 Aligned_cols=155 Identities=30% Similarity=0.599 Sum_probs=139.0
Q ss_pred hHHHHHHHHhcCC---CcCeeeeeeEEeecCeEEEEEecc-CCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 12 CLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFC-AGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 12 ~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~-~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+-.|++|+..|+ |+||++++++|++++.+||+||.- +|.+|.++++...++++.....|.+|++.|+++||+.||
T Consensus 612 tVp~EIqIla~l~~~sH~NIlKlLdfFEddd~yyl~te~hg~gIDLFd~IE~kp~m~E~eAk~IFkQV~agi~hlh~~~i 691 (772)
T KOG1152|consen 612 TVPSEIQILATLNKHSHENILKLLDFFEDDDYYYLETEVHGEGIDLFDFIEFKPRMDEPEAKLIFKQVVAGIKHLHDQGI 691 (772)
T ss_pred ccchhHHHHHHhhhcCccchhhhhheeecCCeeEEEecCCCCCcchhhhhhccCccchHHHHHHHHHHHhccccccccCc
Confidence 4567999999996 999999999999999999999854 578999999988899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|||||-+|+.+ +.++-+||+|||.|.....+ ......||..|.|||++.|.+| +..-|+|+||+++|.+.....
T Consensus 692 vhrdikdenviv---d~~g~~klidfgsaa~~ksg-pfd~f~gtv~~aapevl~g~~y~gk~qdiwalgillytivyken 767 (772)
T KOG1152|consen 692 VHRDIKDENVIV---DSNGFVKLIDFGSAAYTKSG-PFDVFVGTVDYAAPEVLGGEKYLGKPQDIWALGILLYTIVYKEN 767 (772)
T ss_pred eecccccccEEE---ecCCeEEEeeccchhhhcCC-CcceeeeeccccchhhhCCCccCCCcchhhhhhheeeEEEeccC
Confidence 999999999999 78999999999998665443 3445679999999999998876 678999999999999888888
Q ss_pred CCCC
Q 026253 167 PFSG 170 (241)
Q Consensus 167 p~~~ 170 (241)
||.+
T Consensus 768 pyyn 771 (772)
T KOG1152|consen 768 PYYN 771 (772)
T ss_pred CCcC
Confidence 8753
|
|
| >KOG1345 consensus Serine/threonine kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.8e-27 Score=173.63 Aligned_cols=216 Identities=24% Similarity=0.351 Sum_probs=165.2
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeee-EEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFD-AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~-~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|+..---| -|.||+.-|+ .|++.+.++++||+++.|+|.+-+.. ..+.+..-.+++.|+++|+.++|+++
T Consensus 63 t~~dF~rEfhY~~~Ls~H~hIi~tY~vaFqt~d~YvF~qE~aP~gdL~snv~~-~GigE~~~K~v~~ql~SAi~fMHskn 141 (378)
T KOG1345|consen 63 TQADFVREFHYSFFLSPHQHIIDTYEVAFQTSDAYVFVQEFAPRGDLRSNVEA-AGIGEANTKKVFAQLLSAIEFMHSKN 141 (378)
T ss_pred hHHHHHHHhccceeeccchhhhHHHHHHhhcCceEEEeeccCccchhhhhcCc-ccccHHHHHHHHHHHHHHHHHhhccc
Confidence 456778888776666 5899998886 57888899999999999999987764 35778888999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc---cc--CCCCchhHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQ--RYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~---~~--~~~~~~Dv~slG~~l~~l 161 (241)
++|||||.+|||+-+.+ ...+||||||.++..+.-.. ..-....|.+||... +. ...+.+|+|+||++++.+
T Consensus 142 lVHRdlK~eNiLif~~d-f~rvKlcDFG~t~k~g~tV~--~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~WqfGIi~f~c 218 (378)
T KOG1345|consen 142 LVHRDLKAENILIFDAD-FYRVKLCDFGLTRKVGTTVK--YLEYVNNYHAPELCDTVVNEKLVVNPSTDIWQFGIIFFYC 218 (378)
T ss_pred hhhcccccceEEEecCC-ccEEEeeecccccccCceeh--hhhhhcccCCcHHHhhccccceEecccccchheeeeeeee
Confidence 99999999999996433 34799999999877654322 222345578888753 22 356889999999999999
Q ss_pred HhCCCCCCCCC----hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCcccc---CCHHHHhcCccccc
Q 026253 162 LNGYPPFSGRN----NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDR---LSFNEFYHHRFLRR 229 (241)
Q Consensus 162 ~~g~~p~~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~~il~~~~~~~ 229 (241)
++|.+||.... +.-.+.+...++....|.. ...+++....+.++-|..++++| -++.....+.|...
T Consensus 219 ltG~~PWQka~~~d~~Y~~~~~w~~rk~~~~P~~-F~~fs~~a~r~Fkk~lt~~~~drcki~~~kk~rk~~w~E~ 292 (378)
T KOG1345|consen 219 LTGKFPWQKASIMDKPYWEWEQWLKRKNPALPKK-FNPFSEKALRLFKKSLTPRFKDRCKIWTAKKMRKCLWKEK 292 (378)
T ss_pred ecCCCcchhhhccCchHHHHHHHhcccCccCchh-hcccCHHHHHHHHHhcCCcccccchhHHHHHHHHHHHHHh
Confidence 99999998422 2334444445555544443 45688899999999999999999 45666666666544
|
|
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.94 E-value=1.2e-27 Score=202.94 Aligned_cols=215 Identities=27% Similarity=0.456 Sum_probs=174.8
Q ss_pred HHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 026253 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL 92 (241)
Q Consensus 13 ~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl 92 (241)
+..|+-+-.++.|+|++.....+.+.....-.||||++ +|...+...+.+....+.-+.+|++.|++|+|+.|+.|+|+
T Consensus 368 i~sE~~i~~~l~h~~~~e~l~~~~~~~~~~~~mE~~~~-Dlf~~~~~~~~~~~~e~~c~fKqL~~Gv~y~h~~Giahrdl 446 (601)
T KOG0590|consen 368 ITSEFCIGSSLSHPNIIETLDIVQEIDGILQSMEYCPY-DLFSLVMSNGKLTPLEADCFFKQLLRGVKYLHSMGLAHRDL 446 (601)
T ss_pred hhhheeecccccCCchhhhHHHHhhcccchhhhhcccH-HHHHHHhcccccchhhhhHHHHHHHHHHHHHHhcCceeccC
Confidence 77888888899999998888877666555555999998 99999988778999999999999999999999999999999
Q ss_pred CCCCeEEeecCCCceEEEeecCCccccCCC-----CccccccCCCCccCcccccccCCC-CchhHHHHHHHHHHHHhCCC
Q 026253 93 KPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 93 ~~~nil~~~~~~~~~~~l~df~~a~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g~~ 166 (241)
|++|+++ ...+.+||+|||.+...... .......|+..|.|||.+.+..|. ...||||.|+++..|.+|+.
T Consensus 447 K~enll~---~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m~~~~~ 523 (601)
T KOG0590|consen 447 KLENLLV---TENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICMILGRF 523 (601)
T ss_pred ccccEEE---ecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEEecCCC
Confidence 9999999 78889999999988654322 223456789999999999998886 46999999999999999999
Q ss_pred CCCCCChHHHH-HHh---hcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 167 PFSGRNNVQLV-RNI---NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 167 p~~~~~~~~~~-~~i---~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
||......+.. ... .......-+......++...+.+|.+||+.||.+|.|+++|++.+||+.-.
T Consensus 524 ~Wk~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~lp~~~~~~~~~~l~~~P~~R~ti~~i~~d~W~~~i~ 592 (601)
T KOG0590|consen 524 PWKVAKKSDNSFKTNNYSDQRNIFEGPNRLLSLLPRETRIIIYRMLQLDPTKRITIEQILNDEWIRSIE 592 (601)
T ss_pred ccccccccccchhhhccccccccccChHHHHHhchhhHHHHHHHHccCChhheecHHHHhhChHhhhcc
Confidence 99754433221 111 111111222333456788999999999999999999999999999999854
|
|
| >KOG1165 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.94 E-value=6.2e-26 Score=172.92 Aligned_cols=213 Identities=18% Similarity=0.282 Sum_probs=188.0
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+...+++.|.+.++.| ..++|+.+|-+..++.+..+|+|.. |.+|.|+..-++ .|+..++..++.|++.-++++|++
T Consensus 65 S~APQLrdEYr~YKlL~g~~GIP~vYYFGqeG~~NiLVidLL-GPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~vH~k 143 (449)
T KOG1165|consen 65 SEAPQLRDEYRTYKLLGGTEGIPQVYYFGQEGKYNILVIDLL-GPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEYVHEK 143 (449)
T ss_pred CCcchHHHHHHHHHHHcCCCCCCceeeeccccchhhhhhhhh-CcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHHHHhc
Confidence 4567899999999999 6899999998989999999999998 899999998664 599999999999999999999999
Q ss_pred CccccCCCCCCeEEee--cCCCceEEEeecCCccccCCCCcc--------ccccCCCCccCcccccccCCCCchhHHHHH
Q 026253 86 HIIHRDLKPENILLSG--LDDDVMLKIADFGLSCTLYPGNYA--------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~--~~~~~~~~l~df~~a~~~~~~~~~--------~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 155 (241)
.+++|||||+|+|++. ..+...+.++|||+|+.+.+..+. ....||.+||+-....+...+.+.|+-|||
T Consensus 144 ~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrEQSRRDDLEaLG 223 (449)
T KOG1165|consen 144 DLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGREQSRRDDLEALG 223 (449)
T ss_pred ceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccchhhhhhhHHHhh
Confidence 9999999999999964 345666999999999988765432 245789999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCC---CChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHH
Q 026253 156 AILFELLNGYPPFSG---RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221 (241)
Q Consensus 156 ~~l~~l~~g~~p~~~---~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 221 (241)
.++.+++.|.+||.+ .+..+.+++|-..++......++.++|.++...++..-..+-.+-|+++-+
T Consensus 224 HvFmYFLRGsLPWQGLKA~tnK~kYeKIGe~Kr~T~i~~Lc~g~P~efa~Yl~yvR~L~F~E~PDYdyl 292 (449)
T KOG1165|consen 224 HVFMYFLRGSLPWQGLKADTNKEKYEKIGETKRSTPIEVLCEGFPEEFATYLRYVRRLDFFETPDYDYL 292 (449)
T ss_pred hhhhhhccCCCccccccCcchHHHHHHhccccccCCHHHHHhcCHHHHHHHHHHHHhcCcccCCCHHHH
Confidence 999999999999986 456788899988888877777888999999999999988888888987653
|
|
| >KOG1164 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.91 E-value=5.8e-23 Score=164.36 Aligned_cols=212 Identities=21% Similarity=0.258 Sum_probs=166.0
Q ss_pred hHHHHHHHHhcCC----CcCeeeeeeEE-eecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 12 CLDCELNFLSSVN----HPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 12 ~~~~E~~~l~~l~----~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.+..|..++..+. .+++..+++.. ..++..++||+.+ |.+|.++.... +.++..++..++.|++.+|+++|+
T Consensus 62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~~~~~iVM~l~-G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~~l~~lH~ 140 (322)
T KOG1164|consen 62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTEDFNFIVMSLL-GPSLEDLRKRNPPGRFSRKTVLRIAIQNLNALEDLHS 140 (322)
T ss_pred cchhHHHHHHHHhhhcCCCCCCEEEEeccCCCceeEEEEecc-CccHHHHHHhCCCCCcCHhHHHHHHHHHHHHHHHHHh
Confidence 7889999999996 36899999999 5888999999988 89999988654 469999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecC--CCceEEEeecCCccccC--CCC--------c-cccccCCCCccCcccccccCCCCchhH
Q 026253 85 HHIIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLY--PGN--------Y-AEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~--~~~~~~l~df~~a~~~~--~~~--------~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv 151 (241)
.|++||||||.|+.++... +...+.+.|||+++... ... . .....||..|.|++...+...+++.|+
T Consensus 141 ~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e~~r~DDl 220 (322)
T KOG1164|consen 141 KGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIEQGRRDDL 220 (322)
T ss_pred cCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCccCCchhh
Confidence 9999999999999996432 22679999999998322 111 1 123448999999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 152 WSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 152 ~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
||+++++.++..|..||.+..........................+.++.++...+-..+...+|.+..+...
T Consensus 221 es~~Y~l~el~~g~LPW~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pdy~~~~~~ 293 (322)
T KOG1164|consen 221 ESLFYMLLELLKGSLPWEALEMTDLKSKFEKDPRKLLTDRFGDLKPEEFAKILEYIDSLDYEDKPDYEKLAEL 293 (322)
T ss_pred hhHHHHHHHHhcCCCCCccccccchHHHHHHHhhhhccccccCCChHHHHHHHHHhhccCCcCCCCHHHHHHH
Confidence 9999999999999999987554322222221111111110233566788899888888999999998887654
|
|
| >COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair] | Back alignment and domain information |
|---|
Probab=99.91 E-value=3.5e-22 Score=159.83 Aligned_cols=219 Identities=38% Similarity=0.593 Sum_probs=179.0
Q ss_pred hhhhHHHHHHHHhcCCCc-CeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh
Q 026253 9 LKSCLDCELNFLSSVNHP-NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~-~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+.+|+++++.+.|+ +++++.+.+...+..+++++++.++++.+++.... .++......++.|++.++.++|+
T Consensus 40 ~~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~H~ 119 (384)
T COG0515 40 EVERFLREIQILASLNHPPNIVKLYDFFQDEGSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILSALEYLHS 119 (384)
T ss_pred HHHHHHHHHHHHHHccCCcceeeEEEEEecCCEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 477899999999999888 79999999987777899999999999998887665 79999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCc-eEEEeecCCccccCCCC-------ccccccCCCCccCcccccc---cCCCCchhHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGN-------YAEKVCGSPLYMAPEVLQF---QRYDEKVDMWS 153 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~-~~~l~df~~a~~~~~~~-------~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~s 153 (241)
.+++|+|+||+||++ +..+ .++++|||.+....... ......++..|.+||...+ ...+...|+|+
T Consensus 120 ~~~~hrd~kp~nil~---~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~D~~s 196 (384)
T COG0515 120 KGIIHRDIKPENILL---DRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWS 196 (384)
T ss_pred CCeeccCCCHHHeee---cCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchHhHHH
Confidence 999999999999999 5555 79999999987554432 2356678999999999987 57889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh----HHHHHHhhcCCCCCCCCccCCCC----ChHHHHHHHHhcccCccccCCHHHHhcCc
Q 026253 154 VGAILFELLNGYPPFSGRNN----VQLVRNINSCKHLPFSQLIVPAL----HPDCVDMCLKLLSANTVDRLSFNEFYHHR 225 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~----~~~~~~li~~~l~~~p~~Rps~~~il~~~ 225 (241)
+|++++++++|..||..... ......+................ ...+.+++..++..+|..|.+..+...++
T Consensus 197 ~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~r~~~~~~~~~~ 276 (384)
T COG0515 197 LGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKAASDLLKKLLAKDPKNRLSSSSDLSHD 276 (384)
T ss_pred HHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCccccchhhHHHHHHHHHHHhcCchhcCCHHHHhhch
Confidence 99999999999999887663 45555554433220121111122 25799999999999999999999988886
Q ss_pred ccccc
Q 026253 226 FLRRN 230 (241)
Q Consensus 226 ~~~~~ 230 (241)
+....
T Consensus 277 ~~~~~ 281 (384)
T COG0515 277 LLAHL 281 (384)
T ss_pred HhhCc
Confidence 66553
|
|
| >KOG1163 consensus Casein kinase (serine/threonine/tyrosine protein kinase) [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.90 E-value=1.2e-23 Score=154.08 Aligned_cols=210 Identities=18% Similarity=0.185 Sum_probs=179.3
Q ss_pred hhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.-|.++++.|+ ..+|+.+..+..+.....+||+.. |.+|.++.+-. +.++..++.-++-|++.-++++|.+++
T Consensus 54 hpqL~yEskvY~iL~~g~GiP~i~~y~~e~~ynvlVMdLL-GPsLEdLfnfC~R~ftmkTvLMLaDQml~RiEyvH~r~f 132 (341)
T KOG1163|consen 54 HPQLLYESKVYRILQGGVGIPHIRHYGTEKDYNVLVMDLL-GPSLEDLFNFCSRRFTMKTVLMLADQMLSRIEYVHLRNF 132 (341)
T ss_pred CcchhHHHHHHHHhccCCCCchhhhhccccccceeeeecc-CccHHHHHHHHhhhhhHHhHHHHHHHHHHHHHHHHhhcc
Confidence 456788999999995 688999999999999999999998 89999998754 569999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--------cccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
+||||||+|++.+-......+.++|||+|+.+.+..+ .....||.+|.|-....+...+.+.|+-|+|+++.
T Consensus 133 iHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~eqSRRDDmeSvgYvLm 212 (341)
T KOG1163|consen 133 IHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIEQSRRDDMESVGYVLM 212 (341)
T ss_pred ccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhhhhhhhhhhhhcceee
Confidence 9999999999996556677799999999988754332 33467899999988888888899999999999999
Q ss_pred HHHhCCCCCCCCC---hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 160 ELLNGYPPFSGRN---NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 160 ~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
++-.|..||.+.. ..+.++.|...+.....+..+.++|.++.-.+..|-..--++-|+..-
T Consensus 213 YfnrG~LPWQglka~tk~QKyEkI~EkK~s~~ie~LC~G~P~EF~myl~Y~R~L~F~E~Pdy~y 276 (341)
T KOG1163|consen 213 YFNRGSLPWQGLKAATKKQKYEKISEKKMSTPIEVLCKGFPAEFAMYLNYCRGLGFEEKPDYMY 276 (341)
T ss_pred eeecCCCcccccchhhHHHHHHHHHHhhcCCCHHHHhCCCcHHHHHHHHHHhhcCCCCCCcHHH
Confidence 9999999999754 456667777777666677788899999999999998877777887543
|
|
| >KOG0603 consensus Ribosomal protein S6 kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.89 E-value=8.9e-24 Score=173.14 Aligned_cols=201 Identities=30% Similarity=0.497 Sum_probs=175.3
Q ss_pred hHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 026253 12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (241)
Q Consensus 12 ~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (241)
.-..|-+++..++ ||.++++...++.++..+++.++..|+.|...+.+...+.+.........++.++.++|+.+++|+
T Consensus 42 ~t~~er~il~~~~~~~f~v~lhyafqt~~kl~l~ld~~rgg~lft~l~~~~~f~~~~~~~~~aelaLald~lh~l~iiyr 121 (612)
T KOG0603|consen 42 HTKQERIILAFVHNTPFLVKLHYAFQTDGKLYLILDFLRGGDLFTRLSKEVMFDELDVAFYLAELALALDHLHKLGIAYR 121 (612)
T ss_pred ccccHHHHHhhccCCCceeeeeeeeccccchhHhhhhcccchhhhccccCCchHHHHHHHHHHHHHHHHhhcchhHHHHh
Confidence 5567788888885 999999999999999999999999999999998887788999999999999999999999999999
Q ss_pred CCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026253 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170 (241)
Q Consensus 91 dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 170 (241)
|+|++||++ +.+|++++.|||.++..-..... +|+..|+|||++. ....+.|.||+|++++++++|..||..
T Consensus 122 d~k~enill---d~~Ghi~~tdfglske~v~~~~~---cgt~eymApEI~~--gh~~a~D~ws~gvl~felltg~~pf~~ 193 (612)
T KOG0603|consen 122 DYKLENVLL---LLEGHIKLTDFGLSKEAVKEKIA---CGTYEYRAPEIIN--GHLSAADWWSFGVLAFELLTGTLPFGG 193 (612)
T ss_pred cccccceee---cccCccccCCchhhhHhHhhhhc---ccchhhhhhHhhh--ccCCcccchhhhhhHHHHhhCCCCCch
Confidence 999999999 89999999999998776443332 8899999999998 457789999999999999999999997
Q ss_pred CChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc
Q 026253 171 RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 229 (241)
Q Consensus 171 ~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~ 229 (241)
+..+.|-. ....+++ ..+....+++..++..+|.+|.- ..++++|+||+.
T Consensus 194 ----~~~~~Il~-~~~~~p~----~l~~~a~~~~~~l~~r~p~nrLg~~~~~~~eik~h~f~~~ 248 (612)
T KOG0603|consen 194 ----DTMKRILK-AELEMPR----ELSAEARSLFRQLFKRNPENRLGAGPDGVDEIKQHEFFQS 248 (612)
T ss_pred ----HHHHHHhh-hccCCch----hhhHHHHHHHHHHHhhCHHHHhccCcchhHHHhccchhee
Confidence 55555533 2233444 67889999999999999999975 489999999987
|
|
| >KOG1240 consensus Protein kinase containing WD40 repeats [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.3e-23 Score=181.06 Aligned_cols=196 Identities=20% Similarity=0.264 Sum_probs=154.0
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..++...|++ ...+++||++++.-..++++-.|+|-+|. .-+|.|-+..+.-+..-+..-++.|++.|+..+|..|++
T Consensus 65 ~~~qrL~~ik-~~l~~~pn~lPfqk~~~t~kAAylvRqyv-khnLyDRlSTRPFL~~iEKkWiaFQLL~al~qcH~~gVc 142 (1431)
T KOG1240|consen 65 PFKQRLEEIK-FALMKAPNCLPFQKVLVTDKAAYLVRQYV-KHNLYDRLSTRPFLVLIEKKWIAFQLLKALSQCHKLGVC 142 (1431)
T ss_pred HHHHHHHHHH-HHhhcCCcccchHHHHHhhHHHHHHHHHH-hhhhhhhhccchHHHHHHHHHHHHHHHHHHHHHHHcCcc
Confidence 3455556666 66779999999998888888899999999 469999887665577778888999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc--------cccCCCCccCccccccc----------C-CCCch
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--------KVCGSPLYMAPEVLQFQ----------R-YDEKV 149 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~--------~~~~~~~~~~PE~~~~~----------~-~~~~~ 149 (241)
|||||.+|||+ +.-+++.|.||...+...-..... +.....+|.|||.+... . .+++.
T Consensus 143 HGDIKsENILi---TSWNW~~LtDFAsFKPtYLPeDNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~paM 219 (1431)
T KOG1240|consen 143 HGDIKSENILI---TSWNWLYLTDFASFKPTYLPEDNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTPAM 219 (1431)
T ss_pred ccccccceEEE---eeechhhhhcccccCCccCCCCCcccceEEEecCCceeeecChHhhhccccccccCCcccccChhh
Confidence 99999999999 788899999998765433222111 11234569999987541 1 67899
Q ss_pred hHHHHHHHHHHHHh-CCCCCCC-----------CChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC
Q 026253 150 DMWSVGAILFELLN-GYPPFSG-----------RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 150 Dv~slG~~l~~l~~-g~~p~~~-----------~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
|+||+||+++|+++ |+++|.- .+++..++.| -+..++.+|..|++.||++|.+
T Consensus 220 DIFS~GCViaELf~Eg~PlF~LSQL~aYr~~~~~~~e~~Le~I---------------ed~~~Rnlil~Mi~rdPs~RlS 284 (1431)
T KOG1240|consen 220 DIFSAGCVIAELFLEGRPLFTLSQLLAYRSGNADDPEQLLEKI---------------EDVSLRNLILSMIQRDPSKRLS 284 (1431)
T ss_pred hhhhhhHHHHHHHhcCCCcccHHHHHhHhccCccCHHHHHHhC---------------cCccHHHHHHHHHccCchhccC
Confidence 99999999999988 8999951 2223333333 1347899999999999999999
Q ss_pred HHHHhcC
Q 026253 218 FNEFYHH 224 (241)
Q Consensus 218 ~~~il~~ 224 (241)
+++.|+.
T Consensus 285 AedyL~~ 291 (1431)
T KOG1240|consen 285 AEDYLQK 291 (1431)
T ss_pred HHHHHHh
Confidence 9998865
|
|
| >KOG0195 consensus Integrin-linked kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.88 E-value=1.8e-22 Score=150.58 Aligned_cols=205 Identities=21% Similarity=0.318 Sum_probs=164.2
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh 83 (241)
.....+.+..|+--++-+.||||+++++.+.+..+..++..||+.++|...+..... .+..+..+++.+++.|++|||
T Consensus 227 t~risrdfneefp~lrifshpnilpvlgacnsppnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargmaflh 306 (448)
T KOG0195|consen 227 TARISRDFNEEFPALRIFSHPNILPVLGACNSPPNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGMAFLH 306 (448)
T ss_pred chhhcchhhhhCcceeeecCCchhhhhhhccCCCCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhHHHHh
Confidence 344567788899999999999999999999999999999999999999999986543 577788999999999999999
Q ss_pred hCC--ccccCCCCCCeEEeecCCCceEEE--eecCCccccCCCCccccccCCCCccCcccccccCC---CCchhHHHHHH
Q 026253 84 SHH--IIHRDLKPENILLSGLDDDVMLKI--ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY---DEKVDMWSVGA 156 (241)
Q Consensus 84 ~~~--i~H~dl~~~nil~~~~~~~~~~~l--~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~---~~~~Dv~slG~ 156 (241)
+.. +---.++...+++ +++.+.+| +|--++. ........+.|++||.+..++- -.+.|+|||++
T Consensus 307 slep~ipr~~lns~hvmi---dedltarismad~kfsf------qe~gr~y~pawmspealqrkped~n~raadmwsfai 377 (448)
T KOG0195|consen 307 SLEPMIPRFYLNSKHVMI---DEDLTARISMADTKFSF------QEVGRAYSPAWMSPEALQRKPEDLNIRAADMWSFAI 377 (448)
T ss_pred hcchhhhhhhcccceEEe---cchhhhheecccceeee------eccccccCcccCCHHHHhcCchhcchhhhhHHHHHH
Confidence 874 4455678889999 55554443 4433321 1223446788999999987653 35899999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 157 ILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
++||+.|...||....+.+.--+|..... ...++++++..+..++.-|++.||.+||.++.++
T Consensus 378 llwel~trevpfadlspmecgmkialegl---rv~ippgis~hm~klm~icmnedpgkrpkfdmiv 440 (448)
T KOG0195|consen 378 LLWELNTREVPFADLSPMECGMKIALEGL---RVHIPPGISRHMNKLMNICMNEDPGKRPKFDMIV 440 (448)
T ss_pred HHHHhhccccccccCCchhhhhhhhhccc---cccCCCCccHHHHHHHHHHhcCCCCcCCCcceeh
Confidence 99999999999999998887766644332 2234459999999999999999999999998875
|
|
| >KOG1023 consensus Natriuretic peptide receptor, guanylate cyclase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.87 E-value=1e-21 Score=160.57 Aligned_cols=201 Identities=23% Similarity=0.373 Sum_probs=159.3
Q ss_pred HhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc-cccCCCCCCe
Q 026253 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI-IHRDLKPENI 97 (241)
Q Consensus 20 l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i-~H~dl~~~ni 97 (241)
++.+.|.|+.+++|.+.+++..++|.++|..|+|.|.+... -.+++.-...++++++.||.|+|+..+ +|+.++..|.
T Consensus 1 l~~l~h~n~~~f~g~~~~~~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~hg~l~s~nC 80 (484)
T KOG1023|consen 1 LRQLDHDNLNKFIGASVDGPEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYHGALKSSNC 80 (484)
T ss_pred CcccchhhhhhheeeEecCCceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceeeeeeccccc
Confidence 46789999999999999999999999999999999999863 347777788899999999999998755 9999999999
Q ss_pred EEeecCCCceEEEeecCCccccCC---CCccccccCCCCccCccccccc-------CCCCchhHHHHHHHHHHHHhCCCC
Q 026253 98 LLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 98 l~~~~~~~~~~~l~df~~a~~~~~---~~~~~~~~~~~~~~~PE~~~~~-------~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
++ +....+|+.|||+...... ............|.|||.+.+. ..+.+.|+||+|++++++++.+.|
T Consensus 81 lv---d~~w~lklt~~Gl~~~~~~~~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~ei~~r~~~ 157 (484)
T KOG1023|consen 81 LV---DSRWVLKLTDFGLNSLLEETAEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYEILFRSGP 157 (484)
T ss_pred ee---eeeEEEEechhhhcccccccccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHHHHhccCc
Confidence 99 7899999999999866532 1111222245569999998753 146789999999999999999999
Q ss_pred CCC----CChHHHHHHhhcCCCCCCCCccC-C-CCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 168 FSG----RNNVQLVRNINSCKHLPFSQLIV-P-ALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 168 ~~~----~~~~~~~~~i~~~~~~~~~~~~~-~-~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|.. .++.+....++++...++.+... . ..++++..+++.||..+|.+||+++++-.
T Consensus 158 ~~~~~~~~~~~eii~~~~~~~~~~~rP~i~~~~e~~~~l~~l~~~cw~e~P~~rPs~~~i~~ 219 (484)
T KOG1023|consen 158 FDLRNLVEDPDEIILRVKKGGSNPFRPSIELLNELPPELLLLVARCWEEIPEKRPSIEQIRS 219 (484)
T ss_pred cccccccCChHHHHHHHHhcCCCCcCcchhhhhhcchHHHHHHHHhcccChhhCccHHHHHh
Confidence 974 33456677776633332222221 1 45567999999999999999999998753
|
|
| >KOG4158 consensus BRPK/PTEN-induced protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.86 E-value=6e-21 Score=149.25 Aligned_cols=190 Identities=29% Similarity=0.429 Sum_probs=139.5
Q ss_pred CCcCeeeeeeEEee---------------------------cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHH
Q 026253 24 NHPNIIRLFDAFQA---------------------------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76 (241)
Q Consensus 24 ~~~~i~~~~~~~~~---------------------------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~ 76 (241)
+||||+++.++|.+ ....|+||... ..+|..++-.+.+ +.....-++.|++
T Consensus 274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY-~~tLr~yl~~~~~-s~r~~~~~laQlL 351 (598)
T KOG4158|consen 274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRY-RQTLREYLWTRHR-SYRTGRVILAQLL 351 (598)
T ss_pred CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcc-hhhHHHHHhcCCC-chHHHHHHHHHHH
Confidence 69999999987633 23689999887 5799999976543 4456667889999
Q ss_pred HHHHHHHhCCccccCCCCCCeEEee-cCCCceEEEeecCCccccCC-------CCccccccCCCCccCcccccccC----
Q 026253 77 AGLEILNSHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYP-------GNYAEKVCGSPLYMAPEVLQFQR---- 144 (241)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nil~~~-~~~~~~~~l~df~~a~~~~~-------~~~~~~~~~~~~~~~PE~~~~~~---- 144 (241)
+|+.+||.+|+.|||+|.+||++-- .+.-.++.+.|||.+-.... .......-|+-..+|||+....+
T Consensus 352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a 431 (598)
T KOG4158|consen 352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA 431 (598)
T ss_pred HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence 9999999999999999999999942 24445688999997633221 11122345677889999976432
Q ss_pred --CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH-HhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHH
Q 026253 145 --YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVR-NINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN 219 (241)
Q Consensus 145 --~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~-~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 219 (241)
--.++|.|+.|.+.||+++...||.+.....+-. .-.....+ ..+..+++.+++++..+|+.||++|+++.
T Consensus 432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~~r~Yqe~qLP----alp~~vpp~~rqlV~~lL~r~pskRvsp~ 505 (598)
T KOG4158|consen 432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLDTRTYQESQLP----ALPSRVPPVARQLVFDLLKRDPSKRVSPN 505 (598)
T ss_pred eeccchhhhhhhhhhHHHHhccCCcccccchheechhhhhhhhCC----CCcccCChHHHHHHHHHhcCCccccCCcc
Confidence 1248999999999999999999998743322111 11111122 23347889999999999999999999854
|
|
| >KOG1033 consensus eIF-2alpha kinase PEK/EIF2AK3 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.85 E-value=5.9e-22 Score=159.62 Aligned_cols=176 Identities=30% Similarity=0.499 Sum_probs=135.8
Q ss_pred eEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCc
Q 026253 40 CIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116 (241)
Q Consensus 40 ~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a 116 (241)
.+++.|++|+..+|.+|+..+. ..+......++.|++.++.| +|.+|+|++|.||++ ..+.+++|+|||+.
T Consensus 330 ~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~---~~d~q~kIgDFgl~ 403 (516)
T KOG1033|consen 330 YLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFF---SDDDQLKIGDFGLV 403 (516)
T ss_pred chhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhcccccccc---ccchhhhhhhhhhe
Confidence 5889999999999999997543 36777889999999999999 999999999999999 67778999999998
Q ss_pred cccCCCC-------ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC
Q 026253 117 CTLYPGN-------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS 189 (241)
Q Consensus 117 ~~~~~~~-------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~ 189 (241)
....... ......+|..|++||.+.+..|+.+.|+|+||++++|++.- |. +..+............++
T Consensus 404 ts~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~y~~kvdIyaLGlil~EL~~~---f~--T~~er~~t~~d~r~g~ip 478 (516)
T KOG1033|consen 404 TSQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQYSEKVDIYALGLILAELLIQ---FS--TQFERIATLTDIRDGIIP 478 (516)
T ss_pred eecccCCcccchhhhhhhcccccccCCHHHHhhhhhhhhcchhhHHHHHHHHHHH---hc--cHHHHHHhhhhhhcCCCC
Confidence 7665443 33456799999999999999999999999999999999872 21 222222222222222233
Q ss_pred CccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 190 QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 190 ~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
+...-++ +.-.+|+.+|+...|.+||++.+.-.|.|.
T Consensus 479 ~~~~~d~-p~e~~ll~~lls~~p~~RP~~~~~~~~~~~ 515 (516)
T KOG1033|consen 479 PEFLQDY-PEEYTLLQQLLSPSPEERPSAIEVALHEFL 515 (516)
T ss_pred hHHhhcC-cHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence 2222222 345689999999999999988777777765
|
|
| >PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A | Back alignment and domain information |
|---|
Probab=99.84 E-value=2.7e-21 Score=149.03 Aligned_cols=194 Identities=20% Similarity=0.211 Sum_probs=123.6
Q ss_pred HHhhhhHHHHHHHHhcCCC----------cCeeeeeeEEe---------ec---C-----eEEEEEeccCCCChHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNH----------PNIIRLFDAFQ---------AE---N-----CIFLVVEFCAGGNLSSYIRL 59 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~----------~~i~~~~~~~~---------~~---~-----~~~lv~e~~~~~~L~~~l~~ 59 (241)
....+.+++|...+..+.+ -.++-..+... .. + ..+++|+-+ -++|.+++..
T Consensus 53 ~~~~~~~~~e~l~~~~~~~~~~p~~a~~~~r~l~P~d~~~i~~~~~~~~~~~~~~~~~v~n~~~l~P~~-~~dL~~~~~~ 131 (288)
T PF14531_consen 53 ANEYEQLKEEQLAITLFPGVKNPKEAYRHLRFLVPLDLLRIPGKPPFFERGPGQSIYWVLNRFLLMPRA-QGDLQDLVEA 131 (288)
T ss_dssp TTHHHHHHHHHHGGGGSTT--SHHHHHHHH-B---SEEEEETTS-SEEEECETTEEEEEESEEEEEE---SEEHHHHHHH
T ss_pred hHHHHHHHHHHHHhhhhccCCCHHHHHHhceEEeeeEEEEEcCCCcceecCCCCccceeehhhhccchh-hhcHHHHHHH
Confidence 3456777777777766532 23444444332 11 1 347889988 5799888653
Q ss_pred ---cCC----CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCC
Q 026253 60 ---HGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132 (241)
Q Consensus 60 ---~~~----~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~ 132 (241)
... +.......+..|++..+++||+.|++|+||+|+|+++ +.++.+.|+||+.....+..... ...+.
T Consensus 132 l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll---~~~G~v~Lg~F~~~~r~g~~~~~--~~~~~ 206 (288)
T PF14531_consen 132 LFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLL---DQDGGVFLGDFSSLVRAGTRYRC--SEFPV 206 (288)
T ss_dssp HHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE----TTS-EEE--GGGEEETTEEEEG--GGS-T
T ss_pred HhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEE---cCCCCEEEcChHHHeecCceeec--cCCCc
Confidence 222 2223334455789999999999999999999999999 78999999999988776543332 33457
Q ss_pred CccCcccccc--------cCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHH
Q 026253 133 LYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMC 204 (241)
Q Consensus 133 ~~~~PE~~~~--------~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li 204 (241)
.|.|||.... ..++.+.|.|+||+++|.+++|..||+.......... .+ ..+. ++|+.++++|
T Consensus 207 ~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~~-------~f-~~C~-~~Pe~v~~LI 277 (288)
T PF14531_consen 207 AFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPEW-------DF-SRCR-DMPEPVQFLI 277 (288)
T ss_dssp TTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSGG-------GG-TTSS----HHHHHHH
T ss_pred ccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCccccccc-------cc-hhcC-CcCHHHHHHH
Confidence 7999997643 2478899999999999999999999986544221110 11 2222 7889999999
Q ss_pred HHhcccCcccc
Q 026253 205 LKLLSANTVDR 215 (241)
Q Consensus 205 ~~~l~~~p~~R 215 (241)
+.+|+.||.+|
T Consensus 278 ~~lL~~~~~~R 288 (288)
T PF14531_consen 278 RGLLQRNPEDR 288 (288)
T ss_dssp HHHT-SSGGGS
T ss_pred HHHccCCcccC
Confidence 99999999988
|
|
| >PRK12274 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.81 E-value=4.7e-19 Score=130.22 Aligned_cols=146 Identities=18% Similarity=0.154 Sum_probs=111.2
Q ss_pred hhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 11 SCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 11 ~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
..+.+|++++++|. ++++++++++ +..+++|+|+.|.+|.+.... ....+..|++.++.++|+.|++|
T Consensus 46 ~l~~rE~~iL~~L~~~~~vP~ll~~----~~~~lvmeyI~G~~L~~~~~~-------~~~~~~~qi~~~L~~lH~~GIvH 114 (218)
T PRK12274 46 WLARREALALRQLDGLPRTPRLLHW----DGRHLDRSYLAGAAMYQRPPR-------GDLAYFRAARRLLQQLHRCGVAH 114 (218)
T ss_pred HHHHHHHHHHHhcCCCCCCCEEEEE----cCEEEEEeeecCccHHhhhhh-------hhHHHHHHHHHHHHHHHHCcCcc
Confidence 36889999999994 5889999885 456999999999998764321 12357789999999999999999
Q ss_pred cCC-CCCCeEEeecCCCceEEEeecCCccccCCCCcc--------------ccccCCCCccCccccccc-CCC-CchhHH
Q 026253 90 RDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNYA--------------EKVCGSPLYMAPEVLQFQ-RYD-EKVDMW 152 (241)
Q Consensus 90 ~dl-~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~--------------~~~~~~~~~~~PE~~~~~-~~~-~~~Dv~ 152 (241)
+|| +|+||++ +.++.++|+|||+|......... .....++.+++|+...-. ..+ .+.+.+
T Consensus 115 rDL~kp~NILv---~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~~~~w~ 191 (218)
T PRK12274 115 NDLAKEANWLV---QEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWIRELWF 191 (218)
T ss_pred CCCCCcceEEE---cCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhHHHHHH
Confidence 999 7999999 67778999999999865543311 112246667777654321 233 567888
Q ss_pred HHHHHHHHHHhCCCCCCC
Q 026253 153 SVGAILFELLNGYPPFSG 170 (241)
Q Consensus 153 slG~~l~~l~~g~~p~~~ 170 (241)
+.|+-+|.++|+..+..+
T Consensus 192 ~~g~~~~~~~~~~~~~~~ 209 (218)
T PRK12274 192 ATGKPVYRFVTRRVLHWE 209 (218)
T ss_pred HhcchHHHHHhccCCccc
Confidence 899999999998887654
|
|
| >PRK09188 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=3.3e-19 Score=143.07 Aligned_cols=119 Identities=22% Similarity=0.238 Sum_probs=93.5
Q ss_pred hhhhHHHHHHHHhcCCCcCeee-eeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIR-LFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~-~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
....+.+|++++++++|+|+++ +++ .+..++||||++|++|... . +.. ...++.+++.+|.+||+.|+
T Consensus 64 ~~~~~~~E~~iL~~L~h~~iv~~l~~----~~~~~LVmE~~~G~~L~~~-~---~~~---~~~~~~~i~~aL~~lH~~gI 132 (365)
T PRK09188 64 ARHLAAREIRALKTVRGIGVVPQLLA----TGKDGLVRGWTEGVPLHLA-R---PHG---DPAWFRSAHRALRDLHRAGI 132 (365)
T ss_pred HHHHHHHHHHHHHhccCCCCCcEEEE----cCCcEEEEEccCCCCHHHh-C---ccc---hHHHHHHHHHHHHHHHHCCC
Confidence 4677999999999999999885 443 2468999999999999732 1 111 14678899999999999999
Q ss_pred cccCC-CCCCeEEeecCCCceEEEeecCCccccCCCCcc---------ccccCCCCccCccccc
Q 026253 88 IHRDL-KPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------EKVCGSPLYMAPEVLQ 141 (241)
Q Consensus 88 ~H~dl-~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~---------~~~~~~~~~~~PE~~~ 141 (241)
+|||| ||+||++ +.++.++|+|||+|+........ ....++..|.+||.+.
T Consensus 133 iHrDL~KP~NILv---~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~ 193 (365)
T PRK09188 133 THNDLAKPQNWLM---GPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALT 193 (365)
T ss_pred eeCCCCCcceEEE---cCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCC
Confidence 99999 9999999 66778999999999876543321 1234567788999875
|
|
| >PRK10359 lipopolysaccharide core biosynthesis protein; Provisional | Back alignment and domain information |
|---|
Probab=99.80 E-value=8.5e-20 Score=136.78 Aligned_cols=127 Identities=16% Similarity=0.233 Sum_probs=98.3
Q ss_pred HHHHHHHHhcCCCcCeeeeeeEEeec--------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 13 LDCELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 13 ~~~E~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+.+|++.+.++.|++|..+.+++... +..+++|||++|.+|.++.. +++ ....+++.++..+|+
T Consensus 82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~~----~~~----~~~~~i~~~l~~lH~ 153 (232)
T PRK10359 82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMPE----ISE----DVKAKIKASIESLHQ 153 (232)
T ss_pred HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhhh----ccH----HHHHHHHHHHHHHHH
Confidence 68999999999999999999986633 35889999999999988732 233 245689999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
.|++|+|++|.||++ ++++ ++++|||............ .......+..++|+|+||+++....
T Consensus 154 ~gi~H~Dikp~Nili---~~~g-i~liDfg~~~~~~e~~a~d-----------~~vler~y~~~~di~~lg~~~~~~~ 216 (232)
T PRK10359 154 HGMVSGDPHKGNFIV---SKNG-LRIIDLSGKRCTAQRKAKD-----------RIDLERHYGIKNEIKDLGYYLLIYK 216 (232)
T ss_pred cCCccCCCChHHEEE---eCCC-EEEEECCCcccccchhhHH-----------HHHHHhHhcccccccceeEeehHHH
Confidence 999999999999999 4555 9999999875542211110 0223344667899999999987654
|
|
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.78 E-value=3.4e-19 Score=153.78 Aligned_cols=166 Identities=34% Similarity=0.559 Sum_probs=134.8
Q ss_pred ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--------
Q 026253 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-------- 123 (241)
Q Consensus 52 ~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-------- 123 (241)
+-...++.-++++... +.+++|||+.||+|+|+||.|.++ +.-+.+|+.|||+++...-..
T Consensus 137 Dc~tllk~~g~lPvdm--------vla~Eylh~ygivhrdlkpdnllI---T~mGhiKlTDfgLsk~GLms~atnl~eg~ 205 (1205)
T KOG0606|consen 137 DCATLLKNIGPLPVDM--------VLAVEYLHSYGIVHRDLKPDNLLI---TSMGHIKLTDFGLSKKGLMSLATNLKEGH 205 (1205)
T ss_pred hhhhhcccCCCCcchh--------hHHhHhhccCCeecCCCCCCccee---eecccccccchhhhhhhhhhccchhhhcc
Confidence 3344444444555433 778999999999999999999999 789999999999976542111
Q ss_pred --------ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCC
Q 026253 124 --------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPA 195 (241)
Q Consensus 124 --------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~ 195 (241)
.....++|+.|.|||++....|+...|.|++|+++|+++-|..||.+.++++++..+.... ..+++. ...
T Consensus 206 I~k~t~Ef~dKqvcgTPeyiaPeVilrqgygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~-i~wpE~-dea 283 (1205)
T KOG0606|consen 206 IEKDTHEFQDKQVCGTPEYIAPEVILRQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDD-IEWPEE-DEA 283 (1205)
T ss_pred hHHHHHHhhhccccCCccccChhhhhhhccCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhh-cccccc-CcC
Confidence 1123479999999999999999999999999999999999999999999999998875443 334443 456
Q ss_pred CChHHHHHHHHhcccCccccC---CHHHHhcCcccccc
Q 026253 196 LHPDCVDMCLKLLSANTVDRL---SFNEFYHHRFLRRN 230 (241)
Q Consensus 196 ~~~~~~~li~~~l~~~p~~Rp---s~~~il~~~~~~~~ 230 (241)
++++.++++.++|+.+|..|. .+-++-+|+||+..
T Consensus 284 ~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~L 321 (1205)
T KOG0606|consen 284 LPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLL 321 (1205)
T ss_pred CCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeec
Confidence 889999999999999999996 57788899999873
|
|
| >PRK10345 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=99.76 E-value=4.9e-18 Score=126.74 Aligned_cols=105 Identities=21% Similarity=0.292 Sum_probs=84.5
Q ss_pred hhhhHHHHHHHHhcC-----CCcCeeeeeeEEeecC---e-EEEEEec--cCCCChHHHHHhcCCCCHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSV-----NHPNIIRLFDAFQAEN---C-IFLVVEF--CAGGNLSSYIRLHGRVPEQTARKFLQQLGA 77 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-----~~~~i~~~~~~~~~~~---~-~~lv~e~--~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~ 77 (241)
..+.+.+|+++++++ +||||++++|+++++. . +.+|+|| +.+++|.+++++ +.+++. ..++.+++.
T Consensus 39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g~g~v~~~I~e~~G~~~~tL~~~l~~-~~~~e~--~~~~~~~L~ 115 (210)
T PRK10345 39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCGTGYVYDVIADFDGKPSITLTEFAEQ-CRYEED--VAQLRQLLK 115 (210)
T ss_pred hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCCCeEEEEEEecCCCCcchhHHHHHHc-ccccHh--HHHHHHHHH
Confidence 457799999999999 5799999999998863 3 3378999 447999999975 456655 356788887
Q ss_pred HH-HHHHhCCccccCCCCCCeEEeecC-CCceEEEeecCCc
Q 026253 78 GL-EILNSHHIIHRDLKPENILLSGLD-DDVMLKIADFGLS 116 (241)
Q Consensus 78 ~l-~~lh~~~i~H~dl~~~nil~~~~~-~~~~~~l~df~~a 116 (241)
++ +|||+++|+|+||||+||+++..+ .+..++|+|++.+
T Consensus 116 ~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~ 156 (210)
T PRK10345 116 KLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE 156 (210)
T ss_pred HHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence 77 899999999999999999996433 3447999995433
|
|
| >cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain | Back alignment and domain information |
|---|
Probab=99.76 E-value=6.7e-18 Score=124.79 Aligned_cols=103 Identities=22% Similarity=0.208 Sum_probs=83.4
Q ss_pred hHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcccc
Q 026253 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHR 90 (241)
Q Consensus 12 ~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~H~ 90 (241)
...+|++.+.++.++++.....+.. .. .++||||++|+++.......++++...+..++.|++.+|.++ |+.|++|+
T Consensus 65 ~~~~E~~~l~~l~~~~v~~p~~~~~-~~-~~iVmE~i~g~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~l~H~~giiHr 142 (190)
T cd05147 65 WAEKEMRNLKRLVTAGIPCPEPILL-KS-HVLVMEFIGDDGWAAPRLKDAPLSESKARELYLQVIQIMRILYQDCRLVHA 142 (190)
T ss_pred HHHHHHHHHHHHHHCCCCCCcEEEe-cC-CEEEEEEeCCCCCcchhhhcCCCCHHHHHHHHHHHHHHHHHHHHhCCcccC
Confidence 4456999999998888755443322 22 389999998887766544457899999999999999999999 79999999
Q ss_pred CCCCCCeEEeecCCCceEEEeecCCccccC
Q 026253 91 DLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (241)
Q Consensus 91 dl~~~nil~~~~~~~~~~~l~df~~a~~~~ 120 (241)
||||+||+++ ++.++|+|||+|....
T Consensus 143 DlkP~NIli~----~~~v~LiDFG~a~~~~ 168 (190)
T cd05147 143 DLSEYNLLYH----DGKLYIIDVSQSVEHD 168 (190)
T ss_pred CCCHHHEEEE----CCcEEEEEccccccCC
Confidence 9999999994 3679999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c |
| >KOG0590 consensus Checkpoint kinase and related serine/threonine protein kinases [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.73 E-value=2e-19 Score=153.10 Aligned_cols=218 Identities=30% Similarity=0.476 Sum_probs=176.8
Q ss_pred HhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHH-HhcC-CCCHHHHHHHHHHHHHHHHHHH-
Q 026253 8 HLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHG-RVPEQTARKFLQQLGAGLEILN- 83 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l-~~~~-~~~~~~~~~~~~~i~~~l~~lh- 83 (241)
.....+..|..+-..+. |+|++.+++.....+..++++++..|+++.+-+ .... ..+.......+.|+..++.|+|
T Consensus 62 ~~~~~i~~e~~~~~~~s~h~n~~~~~~~~~~~~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l~~~H~ 141 (601)
T KOG0590|consen 62 DSSEHIDTETDIQKKLSKHSNTVHMIEPSSSPRSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGLSYLHP 141 (601)
T ss_pred chhhhcCccccccccccccccccccCCccCCCcccccccCcccccccccccccCCccCCCCcchhhhhhhhccCccccCc
Confidence 33455666888888886 999999999999999999999999999999988 5444 5677788899999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCc-eEEEeecCCccccCC-CC---ccccccC-CCCccCccccccc-CCCCchhHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYP-GN---YAEKVCG-SPLYMAPEVLQFQ-RYDEKVDMWSVGA 156 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~-~~~l~df~~a~~~~~-~~---~~~~~~~-~~~~~~PE~~~~~-~~~~~~Dv~slG~ 156 (241)
..++.|+|++|+|.++ +..+ .+++.|||+|..+.. .. .....++ +..|.+||...+. ...+..|+||.|+
T Consensus 142 ~~~~~h~~ikP~n~~l---~~s~~~l~~~df~~At~~~~~~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S~g~ 218 (601)
T KOG0590|consen 142 ENGVTHRDIKPSNSLL---DESGSALKIADFGLATAYRNKNGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWSLGI 218 (601)
T ss_pred ccccccCCCCCccchh---ccCCCcccCCCchhhccccccCCcceeeecccCCCCCCCCcccccchhhcCCCcccccccc
Confidence 9999999999999999 5666 899999999987655 22 2334567 8999999999874 5578999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHH-HHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 157 ILFELLNGYPPFSGRNNVQLV-RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
++..+++|..||......... ....... ..+....+..++....+++.+++..+|++|.+.+++-.++|+..
T Consensus 219 ~l~~~~~g~~p~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~l~k~l~~~~~~r~s~~~~~~d~~~~~ 291 (601)
T KOG0590|consen 219 VLSAMLTGELPWDFPSRKDGRYSSWKSNK-GRFTQLPWNSISDQAHDLLHKILKENPSNRLSIEELKLDNWLSS 291 (601)
T ss_pred cccccccCCCCccccccccccceeecccc-cccccCccccCChhhhhcccccccCCchhccccccccccccccc
Confidence 999999999999854433211 1111111 12223344578899999999999999999999999999999988
|
|
| >cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain | Back alignment and domain information |
|---|
Probab=99.72 E-value=6.1e-17 Score=120.01 Aligned_cols=104 Identities=19% Similarity=0.165 Sum_probs=84.5
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CCccc
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HHIIH 89 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H 89 (241)
..+.+|++.+.++.++++.....+.... .++||||++|+++........+++......++.|++.++.++|+ .|++|
T Consensus 64 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~--~~lVmE~~~g~~~~~~~l~~~~~~~~~~~~i~~~l~~~l~~lH~~~givH 141 (190)
T cd05145 64 AWAEKEFRNLKRLYEAGVPVPEPILLKK--NVLVMEFIGDDGSPAPRLKDVPLEEEEAEELYEQVVEQMRRLYQEAGLVH 141 (190)
T ss_pred HHHHHHHHHHHHHHhCCCCCceEEEecC--CEEEEEEecCCCchhhhhhhccCCHHHHHHHHHHHHHHHHHHHHhCCEec
Confidence 3457899999999999886555544332 48999999887654443334678888999999999999999999 99999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~ 120 (241)
+||||+||++ + ++.++|+|||++....
T Consensus 142 rDlkP~NIll---~-~~~~~liDFG~a~~~~ 168 (190)
T cd05145 142 GDLSEYNILY---H-DGKPYIIDVSQAVELD 168 (190)
T ss_pred CCCChhhEEE---E-CCCEEEEEcccceecC
Confidence 9999999999 4 6789999999986654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro |
| >KOG1166 consensus Mitotic checkpoint serine/threonine protein kinase [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.68 E-value=2.8e-16 Score=137.49 Aligned_cols=185 Identities=22% Similarity=0.234 Sum_probs=138.6
Q ss_pred cCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEee----
Q 026253 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSG---- 101 (241)
Q Consensus 26 ~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~---- 101 (241)
+.|..+...+.-.+.-++|++|.+-|+|.++++..+.+++..++.++.|++..+.+||..+|+||||||+|+++..
T Consensus 754 ~~~~~~~~a~~~~~~S~lv~ey~~~Gtlld~~N~~~~m~e~lv~~~~~qml~ive~lH~~~IIHgDiKPDNfll~~~~~~ 833 (974)
T KOG1166|consen 754 PSIMHISSAHVFQNASVLVSEYSPYGTLLDLINTNKVMDEYLVMFFSCQMLRIVEHLHAMGIIHGDIKPDNFLLRREICA 833 (974)
T ss_pred cchHHHHHHHccCCcceeeeeccccccHHHhhccCCCCCchhhhHHHHHHHHHHHHHHhcceecccCCcceeEeecccCC
Confidence 3555666666666778899999999999999998888999999999999999999999999999999999999952
Q ss_pred cCCCceEEEeecCCccccCC---CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHH
Q 026253 102 LDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVR 178 (241)
Q Consensus 102 ~~~~~~~~l~df~~a~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~ 178 (241)
..+...++|+|||.+..... .......+.+..+-++|...|.+++...|.|.|+.+++.|+.|+.- +
T Consensus 834 ~~~~~~l~lIDfG~siDm~lfp~~~~F~~~~~td~f~C~EM~~grpWtYq~DyfGlAa~~h~mLFG~y~----------q 903 (974)
T KOG1166|consen 834 DSDSKGLYLIDFGRSIDMKLFPDGTKFKAVWHTDLFDCIEMREGRPWTYQIDYFGLAATVHVMLFGKYM----------E 903 (974)
T ss_pred CCcccceEEEecccceeeeEcCCCcEEeeeeccccchhHHHhcCCCCchhhhhHHHHHHHHHHHHHHHH----------H
Confidence 23455699999999976543 2244567789999999999999999999999999999999987421 1
Q ss_pred HhhcCCCCCCCCccCCCCC-hHHHHHHHHhcccCccccCCHHHH
Q 026253 179 NINSCKHLPFSQLIVPALH-PDCVDMCLKLLSANTVDRLSFNEF 221 (241)
Q Consensus 179 ~i~~~~~~~~~~~~~~~~~-~~~~~li~~~l~~~p~~Rps~~~i 221 (241)
..++..-...+.+..... ..+..|...+|+.|-..=|.+.++
T Consensus 904 -~~~g~~~~~~~~~~Ry~~~~~W~~~F~~lLN~~~~~~p~l~~l 946 (974)
T KOG1166|consen 904 -VKNGSSWMVKTNFPRYWKRDMWNKFFDLLLNPDCDTLPNLQEL 946 (974)
T ss_pred -hcCCcceeccccchhhhhHHHHHHHHHHHhCcCcccchhHHHH
Confidence 222222222221111111 236678888888554444555444
|
|
| >KOG1266 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.67 E-value=1.4e-16 Score=122.12 Aligned_cols=201 Identities=17% Similarity=0.220 Sum_probs=143.9
Q ss_pred HHHhcCCCcCeeeeeeEEeec-----CeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHhC--C
Q 026253 18 NFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNSH--H 86 (241)
Q Consensus 18 ~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~~--~ 86 (241)
.-+-++.|.|++++..|+.+. ....+++||+..|++.++|++. ..+......+|+-||+.||.|||+. -
T Consensus 119 dnllqlvHsnlvkfH~yw~d~K~~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~Pp 198 (458)
T KOG1266|consen 119 DNLLQLVHSNLVKFHKYWTDKKYEEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDPP 198 (458)
T ss_pred HHHHHHHHHHHHHHHHhhcccccccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCCc
Confidence 334455799999999988653 4578999999999999999764 3478889999999999999999987 5
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-----CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-----~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
++|+++....|++ ..++-++++.-......... .....-.+.++|.+||.=.-.+.+-++|||++|...++|
T Consensus 199 iihgnlTc~tifi---q~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~tn~~~a~dIy~fgmcAlem 275 (458)
T KOG1266|consen 199 IIHGNLTCDTIFI---QHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTTTNTTGASDIYKFGMCALEM 275 (458)
T ss_pred cccCCcchhheee---cCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcccccccchhhhhhhHHHHHH
Confidence 9999999999999 77777887653322111110 011123457789999987666778899999999999999
Q ss_pred HhCCCCCC-CCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 162 LNGYPPFS-GRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 162 ~~g~~p~~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
..+..--. +.........+.+.- ...-..--++++.+|++..|..||++.+++.||-+-+
T Consensus 276 ailEiq~tnseS~~~~ee~ia~~i--------~~len~lqr~~i~kcl~~eP~~rp~ar~llfHpllfe 336 (458)
T KOG1266|consen 276 AILEIQSTNSESKVEVEENIANVI--------IGLENGLQRGSITKCLEGEPNGRPDARLLLFHPLLFE 336 (458)
T ss_pred HHheeccCCCcceeehhhhhhhhe--------eeccCccccCcCcccccCCCCCCcchhhhhcCceeee
Confidence 88755322 222221111111100 0011223457889999999999999999999997654
|
|
| >PRK14879 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=99.64 E-value=2.4e-15 Score=113.42 Aligned_cols=101 Identities=23% Similarity=0.322 Sum_probs=89.1
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
...+.+|+.++..+.|+++.....++...+..+++|||++|++|.+++..... ....++.+++.++.++|+.|++|
T Consensus 43 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~G~~L~~~~~~~~~----~~~~i~~~i~~~l~~lH~~~i~H 118 (211)
T PRK14879 43 RERTRREARIMSRARKAGVNVPAVYFVDPENFIIVMEYIEGEPLKDLINSNGM----EELELSREIGRLVGKLHSAGIIH 118 (211)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCeEEEEeCCCCEEEEEEeCCcCHHHHHHhccH----HHHHHHHHHHHHHHHHHhCCccc
Confidence 45688999999999999998888777777888999999999999999875432 78889999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
+|++|.||++ + .+.++++|||.+..
T Consensus 119 ~Dl~p~Nil~---~-~~~~~liDf~~a~~ 143 (211)
T PRK14879 119 GDLTTSNMIL---S-GGKIYLIDFGLAEF 143 (211)
T ss_pred CCCCcccEEE---E-CCCEEEEECCcccC
Confidence 9999999999 4 67799999998855
|
|
| >KOG1243 consensus Protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.64 E-value=4.4e-15 Score=123.62 Aligned_cols=145 Identities=22% Similarity=0.362 Sum_probs=116.8
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~ 88 (241)
...+.+.++.++.++||||+++++.++.++..|+|+|.+ ..|..++++.+ ...+.--+.||+.||.+|| +.+++
T Consensus 53 ~~~~~~A~k~lKtlRHP~Il~yL~t~e~~~~~ylvTErV--~Pl~~~lk~l~---~~~v~~Gl~qIl~AL~FL~~d~~lv 127 (690)
T KOG1243|consen 53 TELAKRAVKRLKTLRHPNILSYLDTTEEEGTLYLVTERV--RPLETVLKELG---KEEVCLGLFQILAALSFLNDDCNLV 127 (690)
T ss_pred hHHHHHHHHHhhhccCchhhhhhhhhcccCceEEEeecc--ccHHHHHHHhH---HHHHHHHHHHHHHHHHHHhccCCee
Confidence 456888999999999999999999999999999999998 58888887654 7788888999999999998 57899
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
|++++-..|+| +..|..+|++|..+........ .......-.|..|+.+... .-..|.|.|||++++++.|
T Consensus 128 HgNv~~~SVfV---n~~GeWkLggle~v~~~~~~~~~~~~~~~~~s~~~P~~~~~s--~~s~D~~~Lg~li~el~ng 199 (690)
T KOG1243|consen 128 HGNVCKDSVFV---NESGEWKLGGLELVSKASGFNAPAKSLYLIESFDDPEEIDPS--EWSIDSWGLGCLIEELFNG 199 (690)
T ss_pred eccEeeeeEEE---cCCCcEEEeeeEEEeccccCCcccccchhhhcccChhhcCcc--ccchhhhhHHHHHHHHhCc
Confidence 99999999999 8999999999998765433221 1222223335556554322 1356999999999999988
|
|
| >TIGR03724 arch_bud32 Kae1-associated kinase Bud32 | Back alignment and domain information |
|---|
Probab=99.62 E-value=3e-15 Score=111.86 Aligned_cols=98 Identities=23% Similarity=0.301 Sum_probs=83.8
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
.+++.+|+++++.+.++++.....++...+..+++||+++|++|.+++..... .++.+++.++.++|+.|++|
T Consensus 41 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~e~~~g~~l~~~~~~~~~-------~~~~~i~~~l~~lH~~gi~H 113 (199)
T TIGR03724 41 RERTRNEARLLSRARKAGVNTPVVYDVDPDNKTIVMEYIEGKPLKDVIEEGND-------ELLREIGRLVGKLHKAGIVH 113 (199)
T ss_pred HHHHHHHHHHHHHHHHCCCCCCEEEEEECCCCEEEEEEECCccHHHHHhhcHH-------HHHHHHHHHHHHHHHCCeec
Confidence 46788999999999988776666666666778999999999999998764321 78899999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
+|++|.||++ + ++.+++.|||.+..
T Consensus 114 ~Dl~~~Nil~---~-~~~~~liDfg~a~~ 138 (199)
T TIGR03724 114 GDLTTSNIIV---R-DDKLYLIDFGLGKY 138 (199)
T ss_pred CCCCcceEEE---E-CCcEEEEECCCCcC
Confidence 9999999999 4 67899999998755
|
Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine. |
| >smart00090 RIO RIO-like kinase | Back alignment and domain information |
|---|
Probab=99.60 E-value=3.7e-15 Score=113.87 Aligned_cols=103 Identities=20% Similarity=0.212 Sum_probs=82.0
Q ss_pred hhhHHHHHHHHhcCCCcC--eeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q 026253 10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH- 86 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~- 86 (241)
...+.+|+++++++.+.+ ++++++ . +..++||||+.|.+|..............+..++.|++.++.+||+.|
T Consensus 94 ~~~~~~E~~~L~~L~~~~i~~p~~~~---~-~~~~lV~E~~~g~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~g~ 169 (237)
T smart00090 94 RLWAEKEFRNLQRLYEAGVPVPKPIA---W-RRNVLVMEFIGGDGLPAPRLKDVEPEEEEEFELYDDILEEMRKLYKEGE 169 (237)
T ss_pred HHHHHHHHHHHHHHHhcCCCCCeeeE---e-cCceEEEEEecCCcccccccccCCcchHHHHHHHHHHHHHHHHHHhcCC
Confidence 345789999999997533 344443 2 235899999999888776544456667778899999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~ 120 (241)
++|+|++|.||++ + ++.++|+|||.+....
T Consensus 170 iiH~Dikp~NIli---~-~~~i~LiDFg~a~~~~ 199 (237)
T smart00090 170 LVHGDLSEYNILV---H-DGKVVIIDVSQSVELD 199 (237)
T ss_pred EEeCCCChhhEEE---E-CCCEEEEEChhhhccC
Confidence 9999999999999 4 6789999999886543
|
|
| >PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated | Back alignment and domain information |
|---|
Probab=99.60 E-value=7.4e-15 Score=125.26 Aligned_cols=97 Identities=21% Similarity=0.289 Sum_probs=86.1
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
.+++.+|++++++++|++++....+..+....++||||++|++|.+++. ....++.+++.++.+||+.|++|
T Consensus 380 ~~~~~~E~~~l~~l~~~~i~~p~~~~~~~~~~~lv~E~~~g~~L~~~l~--------~~~~~~~~i~~~L~~lH~~giiH 451 (535)
T PRK09605 380 TERTRAEARLLSEARRAGVPTPVIYDVDPEEKTIVMEYIGGKDLKDVLE--------GNPELVRKVGEIVAKLHKAGIVH 451 (535)
T ss_pred HHHHHHHHHHHHhhcccCCCeeEEEEEeCCCCEEEEEecCCCcHHHHHH--------HHHHHHHHHHHHHHHHHhCCCcc
Confidence 4678899999999999999988877777777899999999999999885 34678899999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
||+||.||++ +++.++|+|||+++.
T Consensus 452 rDlkp~NILl----~~~~~~liDFGla~~ 476 (535)
T PRK09605 452 GDLTTSNFIV----RDDRLYLIDFGLGKY 476 (535)
T ss_pred CCCChHHEEE----ECCcEEEEeCccccc
Confidence 9999999999 345799999999855
|
|
| >PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed | Back alignment and domain information |
|---|
Probab=99.60 E-value=1.1e-14 Score=111.40 Aligned_cols=102 Identities=21% Similarity=0.275 Sum_probs=81.5
Q ss_pred hhhhHHHHHHHHhcCCCcCe--eeeeeEEeec-Ce---EEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNI--IRLFDAFQAE-NC---IFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i--~~~~~~~~~~-~~---~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
....+.+|+.++.+|+|+++ ++.+++...+ +. .++|||+++| .+|.+++.. .++++.. +.+++.++.+
T Consensus 83 ~~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~~~~~~~lV~e~l~G~~~L~~~l~~-~~l~~~~----~~~i~~~l~~ 157 (239)
T PRK01723 83 ERTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHGLFYRADILIERIEGARDLVALLQE-APLSEEQ----WQAIGQLIAR 157 (239)
T ss_pred hhhHHHHHHHHHHHHHhCCCCCceeEeeeeeecCcceeeeEEEEecCCCCCHHHHHhc-CCCCHHH----HHHHHHHHHH
Confidence 35678999999999988875 6677664432 22 3599999997 699988864 4555543 5689999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
||+.|++|+||+|.||++ +.++.++|+|||.+..
T Consensus 158 lH~~GI~HrDlkp~NILv---~~~~~v~LIDfg~~~~ 191 (239)
T PRK01723 158 FHDAGVYHADLNAHNILL---DPDGKFWLIDFDRGEL 191 (239)
T ss_pred HHHCCCCCCCCCchhEEE---cCCCCEEEEECCCccc
Confidence 999999999999999999 5667899999998755
|
|
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.59 E-value=2.3e-15 Score=123.75 Aligned_cols=210 Identities=23% Similarity=0.311 Sum_probs=170.3
Q ss_pred hhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHH----HHHHHH
Q 026253 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGA----GLEILN 83 (241)
Q Consensus 10 ~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~----~l~~lh 83 (241)
..+=.+|+...+++ .|++.++.+..+++++..++-+|.+ +.+|.++...... +++..++....+... |+.++|
T Consensus 161 ~~~k~~~~~s~~~i~~~~~~v~~~~~~e~~~~lfiqtE~~-~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al~~~h 239 (524)
T KOG0601|consen 161 SKRKLREFLSHHKIDSHENPVRDSPAWEGSGILFIQTELC-GESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTALSHLH 239 (524)
T ss_pred cccccchhhcccccCccccccccCcccccCCcceeeeccc-cchhHHhhhcccccCCchhhhhHHhhhhhcccccccccC
Confidence 44556777888888 5999999999999999999999999 6899998876655 888999999999999 999999
Q ss_pred hCCccccCCCCCCeEEeecCCC-ceEEEeecCCccccCCCCccc-c-----ccCCCCccCcccccccCCCCchhHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDD-VMLKIADFGLSCTLYPGNYAE-K-----VCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~-~~~~l~df~~a~~~~~~~~~~-~-----~~~~~~~~~PE~~~~~~~~~~~Dv~slG~ 156 (241)
+.+++|.|++|.||+. ..+ ..++++|||+....+...... . ..+...|++||... .-++..+|++++|.
T Consensus 240 s~~~~~~~~kp~~i~~---~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~-~l~~~~~di~sl~e 315 (524)
T KOG0601|consen 240 SNNIVHDDLKPANIFT---TSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLN-GLATFASDIFSLGE 315 (524)
T ss_pred CCcccccccchhheec---ccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhc-cccchHhhhcchhh
Confidence 9999999999999999 555 789999999988776654221 1 14677799999986 45788999999999
Q ss_pred HHHHHHhCCCCCCCC--ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 157 ILFELLNGYPPFSGR--NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
++.+..++....... +.+..+... ..+..+....+.++...+..|++.+|-.|++++.++.+.+....
T Consensus 316 v~l~~~l~~~~~~~g~~~~W~~~r~~------~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~ 385 (524)
T KOG0601|consen 316 VILEAILGSHLPSVGKNSSWSQLRQG------YIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSK 385 (524)
T ss_pred hhHhhHhhcccccCCCCCCccccccc------cCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccch
Confidence 999999887766544 444333322 13444555777888889999999999999999999999998753
|
|
| >cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain | Back alignment and domain information |
|---|
Probab=99.48 E-value=1.9e-13 Score=102.09 Aligned_cols=98 Identities=24% Similarity=0.276 Sum_probs=78.5
Q ss_pred hhhHHHHHHHHhcCCCcC--eeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+|+.++.++.+.+ +++.++ ....++||||++|++|.+.... .....++.+++.++.++|+.|+
T Consensus 77 ~~~~~~E~~~l~~l~~~~i~v~~~~~----~~~~~lv~e~~~g~~L~~~~~~------~~~~~~~~~i~~~l~~lh~~gi 146 (198)
T cd05144 77 RLAAQKEFAALKALYEEGFPVPKPID----WNRHAVVMEYIDGVELYRVRVL------EDPEEVLDEILEEIVKAYKHGI 146 (198)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCceee----cCCceEEEEEeCCcchhhcccc------ccHHHHHHHHHHHHHHHHHCCC
Confidence 345788999999997774 444443 2445899999999998875431 3456788999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~ 120 (241)
+|+||+|.||++ ++++.++|+|||.+....
T Consensus 147 ~H~Dl~p~Nill---~~~~~~~liDfg~~~~~~ 176 (198)
T cd05144 147 IHGDLSEFNILV---DDDEKIYIIDWPQMVSTD 176 (198)
T ss_pred CcCCCCcccEEE---cCCCcEEEEECCccccCC
Confidence 999999999999 678899999999985543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom |
| >KOG0606 consensus Microtubule-associated serine/threonine kinase and related proteins [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=99.46 E-value=4.7e-14 Score=122.62 Aligned_cols=202 Identities=30% Similarity=0.426 Sum_probs=163.3
Q ss_pred CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecC
Q 026253 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103 (241)
Q Consensus 24 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~ 103 (241)
.+|-+++..-.+......++++++..+++|...+.+.+..+.+-....+..+..++++||+..+.|+|++|.|.+. .
T Consensus 862 ~~P~v~~~~~s~~~rsP~~L~~~~~~~~~~~Skl~~~~~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~---~ 938 (1205)
T KOG0606|consen 862 RSPAVVRSFPSFPCRSPLPLVGHYLNGGDLPSKLHNSGCLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLI---A 938 (1205)
T ss_pred CCCceecccCCCCCCCCcchhhHHhccCCchhhhhcCCCcccccccchhHHHHhhhhccccchhhcccccccchhh---c
Confidence 3455555554455677889999999999999999888878877888888889999999999999999999999999 7
Q ss_pred CCceEEEeecCCccccCCC--------------------------------CccccccCCCCccCcccccccCCCCchhH
Q 026253 104 DDVMLKIADFGLSCTLYPG--------------------------------NYAEKVCGSPLYMAPEVLQFQRYDEKVDM 151 (241)
Q Consensus 104 ~~~~~~l~df~~a~~~~~~--------------------------------~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv 151 (241)
..+...+.+|+.....+.- .......+++.|.+||...+......+|.
T Consensus 939 ~~gh~~l~~~~t~~~vg~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~hgs~ad~ 1018 (1205)
T KOG0606|consen 939 YDGHRPLTDFGTLSKVGLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRRHGSAADW 1018 (1205)
T ss_pred ccCCcccCccccccccccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCcccccccCCCcchh
Confidence 8888888888733222110 00122457889999999999999999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHH---HHhcCcccc
Q 026253 152 WSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN---EFYHHRFLR 228 (241)
Q Consensus 152 ~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~---~il~~~~~~ 228 (241)
|+.|.++++.++|.+||...++.+.++.|-.....- ..-....+...++++...+..+|.+|..+. +.-.|+||+
T Consensus 1019 ~~~g~~l~e~l~g~pp~na~tpq~~f~ni~~~~~~~--p~g~~~~s~~aq~~~~~ll~~~~~qr~~a~~~~e~k~~~~~~ 1096 (1205)
T KOG0606|consen 1019 WSSGVCLFEVLTGIPPFNAETPQQIFENILNRDIPW--PEGPEEGSYEAQDLINRLLTEEPTQRLGAKGAAEVKGHPFFQ 1096 (1205)
T ss_pred hhhhhhhhhhhcCCCCCCCcchhhhhhccccCCCCC--CCCccccChhhhhhhhhhhccCchhccCcccccccccCCccC
Confidence 999999999999999999999999998875444322 122336788999999999999999999887 899999999
Q ss_pred cc
Q 026253 229 RN 230 (241)
Q Consensus 229 ~~ 230 (241)
..
T Consensus 1097 ~~ 1098 (1205)
T KOG0606|consen 1097 DV 1098 (1205)
T ss_pred CC
Confidence 84
|
|
| >COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.39 E-value=2.8e-12 Score=91.58 Aligned_cols=99 Identities=21% Similarity=0.250 Sum_probs=82.2
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
+.+-.+|++++.++.--+|...+=+..+.+...++|||++|..|.+++... ...++..+=.-+.-||..|++|
T Consensus 43 r~Rt~~Earil~~a~~~GV~~P~v~dvD~~~~~I~me~I~G~~lkd~l~~~-------~~~~~r~vG~~vg~lH~~givH 115 (204)
T COG3642 43 RERTRREARILAKAREAGVPVPIVYDVDPDNGLIVMEYIEGELLKDALEEA-------RPDLLREVGRLVGKLHKAGIVH 115 (204)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCEEEEEEeCChhHHHHHHhc-------chHHHHHHHHHHHHHHhcCeec
Confidence 567889999999998778877777777778888999999999999998765 2456666777778899999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCcccc
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~ 119 (241)
|||+++||+++ ++.+.++|||++...
T Consensus 116 GDLTtsNiIl~----~~~i~~IDfGLg~~s 141 (204)
T COG3642 116 GDLTTSNIILS----GGRIYFIDFGLGEFS 141 (204)
T ss_pred CCCccceEEEe----CCcEEEEECCccccc
Confidence 99999999994 333999999998543
|
|
| >cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family | Back alignment and domain information |
|---|
Probab=99.39 E-value=1.5e-12 Score=92.53 Aligned_cols=98 Identities=23% Similarity=0.374 Sum_probs=84.5
Q ss_pred hhhHHHHHHHHhcCCC--cCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC--
Q 026253 10 KSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-- 85 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-- 85 (241)
...+.+|+.+++.+++ .++++++++...++..+++|||+.|.++..+ +......++.+++.+++.+|..
T Consensus 35 ~~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~~lh~~~~ 107 (155)
T cd05120 35 GADREREVAILQLLARKGLPVPKVLASGESDGWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLAKLHQLPL 107 (155)
T ss_pred hhHHHHHHHHHHHHHHcCCCCCeEEEEcCCCCccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHHHHhCCCc
Confidence 4578999999999976 5899999888888899999999988777654 4566777889999999999985
Q ss_pred -CccccCCCCCCeEEeecCCCceEEEeecCCcc
Q 026253 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (241)
Q Consensus 86 -~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~ 117 (241)
+++|+|++|.||++ ++.+.+++.||+.+.
T Consensus 108 ~~i~H~Dl~~~Nil~---~~~~~~~l~Df~~~~ 137 (155)
T cd05120 108 LVLCHGDLHPGNILV---DDGKILGIIDWEYAG 137 (155)
T ss_pred eEEEecCCCcceEEE---ECCcEEEEEeccccc
Confidence 69999999999999 557889999999874
|
The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves |
| >cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain | Back alignment and domain information |
|---|
Probab=99.38 E-value=5.1e-12 Score=92.94 Aligned_cols=101 Identities=15% Similarity=0.150 Sum_probs=76.0
Q ss_pred hHHHHHHHHhcCCC--cCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH-HhCCcc
Q 026253 12 CLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHII 88 (241)
Q Consensus 12 ~~~~E~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l-h~~~i~ 88 (241)
..++|++.|+++.. -++++++++ ...++|||++.+..+..-.-+...++.+....+..+++.++..+ |+.|++
T Consensus 72 wa~kE~r~L~rl~~~Gv~vP~pi~~----~~~~lvME~Ig~~~~~~~~Lkd~~~~~~~~~~i~~~i~~~l~~l~H~~glV 147 (197)
T cd05146 72 WAEKEMHNLKRMQKAGIPCPEVVVL----KKHVLVMSFIGDDQVPAPKLKDAKLNDEEMKNAYYQVLSMMKQLYKECNLV 147 (197)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEEEe----cCCEEEEEEcCCCCccchhhhccccCHHHHHHHHHHHHHHHHHHHHhCCee
Confidence 34599999999953 456677754 56789999997643322211223455666778889999999988 899999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~ 120 (241)
||||++.||++. ++.+.++|||.+....
T Consensus 148 HGDLs~~NIL~~----~~~v~iIDF~qav~~~ 175 (197)
T cd05146 148 HADLSEYNMLWH----DGKVWFIDVSQSVEPT 175 (197)
T ss_pred cCCCCHHHEEEE----CCcEEEEECCCceeCC
Confidence 999999999993 3579999999886654
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown. |
| >KOG2137 consensus Protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=99.35 E-value=3.1e-13 Score=113.15 Aligned_cols=166 Identities=15% Similarity=0.184 Sum_probs=121.6
Q ss_pred HHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc----------ccccCCCCcc
Q 026253 67 TARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA----------EKVCGSPLYM 135 (241)
Q Consensus 67 ~~~~~~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~----------~~~~~~~~~~ 135 (241)
....-+.+++.|+.++|. .+++|++|.|++|++ +..+.+|+++|+++....+...- .-.....-|.
T Consensus 100 ~~f~nl~~v~dgl~flh~sAk~VH~ni~p~~i~~---na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~ 176 (700)
T KOG2137|consen 100 DGFANLGNVADGLAFLHRSAKVVHGNIQPEAIVV---NANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFL 176 (700)
T ss_pred HhhhhhhcccchhhhhccCcceeecccchhheee---ccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccc
Confidence 333444566799999996 489999999999999 89999999999987655432110 0112345699
Q ss_pred CcccccccCCCCchhHHHHHHHHHHHH-hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccc
Q 026253 136 APEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVD 214 (241)
Q Consensus 136 ~PE~~~~~~~~~~~Dv~slG~~l~~l~-~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~ 214 (241)
+||++.+...+.++|+||+|+++|-+. .|+..+.+.........-.... ..-..-+...+++++.+=+.+++..++..
T Consensus 177 apE~~~~~~~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~~~~~~-~~~~~~~s~~~p~el~~~l~k~l~~~~~~ 255 (700)
T KOG2137|consen 177 APEYLLGTTNTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSFSRNLL-NAGAFGYSNNLPSELRESLKKLLNGDSAV 255 (700)
T ss_pred cchhhccccccccccceeeeeEEEEEecCCcchhhccCCcchhhhhhccc-ccccccccccCcHHHHHHHHHHhcCCccc
Confidence 999999888899999999999999988 4666665543332222221111 11111223578999999999999999999
Q ss_pred cCCHHHHhcCcccccccccCCC
Q 026253 215 RLSFNEFYHHRFLRRNSAILRA 236 (241)
Q Consensus 215 Rps~~~il~~~~~~~~~~~~~~ 236 (241)
||++.+++..|||.+.......
T Consensus 256 rp~~~~l~~~~ff~D~~~~aLr 277 (700)
T KOG2137|consen 256 RPTLDLLLSIPFFSDPGLKALR 277 (700)
T ss_pred CcchhhhhcccccCCchhhhhh
Confidence 9999999999999997765443
|
|
| >KOG3087 consensus Serine/threonine protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.30 E-value=4.1e-11 Score=85.49 Aligned_cols=113 Identities=22% Similarity=0.269 Sum_probs=91.2
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCC-CChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+-.+++..+|++.+.++.--+|.-..=++.+.....++|||++| .++.+++.+.. +...+....++.++-+.+.-||
T Consensus 51 kLtr~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~igklH 130 (229)
T KOG3087|consen 51 KLTRKRTKQEARLLAKCRALGIPAPRLIFIDTYGGQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGELIGKLH 130 (229)
T ss_pred HHHHHHHHHHHHHHHHHHHhCCCCceEEEEecCCCeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHHHHHhh
Confidence 34478889999999999766777666677777888899999976 48888887642 2333444788899999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCcccc
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~ 119 (241)
.++++||||..+||++.+.+....+.++|||++...
T Consensus 131 ~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~s 166 (229)
T KOG3087|consen 131 DNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSVS 166 (229)
T ss_pred hCCeecccccccceEEecCCCcCceEEEeecchhcc
Confidence 999999999999999976566666799999998554
|
|
| >cd05119 RIO RIO kinase family, catalytic domain | Back alignment and domain information |
|---|
Probab=99.26 E-value=2.9e-11 Score=89.38 Aligned_cols=93 Identities=24% Similarity=0.288 Sum_probs=70.4
Q ss_pred HHHHHHHhcCCCcC--eeeeeeEEeecCeEEEEEeccCCCC-----hHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-C
Q 026253 14 DCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGN-----LSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-H 85 (241)
Q Consensus 14 ~~E~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~-----L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~ 85 (241)
..|.+.+.++.+.+ ++++++. ...++||||++++. |.+... ......++.+++.++.++|. .
T Consensus 65 ~~e~~~l~~l~~~~~~~~~~~~~----~~~~lv~e~~~g~~~~~~~l~~~~~------~~~~~~~~~~~~~~l~~lh~~~ 134 (187)
T cd05119 65 EKEFRNLKRLYEAGVPVPKPIDL----NRHVLVMEFIGGDGIPAPRLKDVRL------LEDPEELYDQILELMRKLYREA 134 (187)
T ss_pred HHHHHHHHHHHHcCCCCCceEec----CCCEEEEEEeCCCCccChhhhhhhh------cccHHHHHHHHHHHHHHHhhcc
Confidence 56777777775443 4445443 24689999998843 333221 15678899999999999999 9
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~ 120 (241)
|++|+|++|+||++ + ++.++++|||.+....
T Consensus 135 ~ivH~Dl~p~Nili---~-~~~~~liDfg~a~~~~ 165 (187)
T cd05119 135 GLVHGDLSEYNILV---D-DGKVYIIDVPQAVEID 165 (187)
T ss_pred CcCcCCCChhhEEE---E-CCcEEEEECccccccc
Confidence 99999999999999 4 7789999999986543
|
The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct |
| >PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional | Back alignment and domain information |
|---|
Probab=99.24 E-value=1.4e-10 Score=89.99 Aligned_cols=106 Identities=16% Similarity=0.146 Sum_probs=83.2
Q ss_pred hHHHHHHHHhcCCCcCee--eeeeEEee-----cCeEEEEEeccCCC-ChHHHHHh--cCCCCHHHHHHHHHHHHHHHHH
Q 026253 12 CLDCELNFLSSVNHPNII--RLFDAFQA-----ENCIFLVVEFCAGG-NLSSYIRL--HGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 12 ~~~~E~~~l~~l~~~~i~--~~~~~~~~-----~~~~~lv~e~~~~~-~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
.+.+|++.+.+|...+|. ++.++.+. ....++|||++++. +|.+++.. ..+.+......++.+++..+..
T Consensus 74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~i~~ 153 (268)
T PRK15123 74 GADREWRAIHRLHEVGVDTMTGVAFGERGSNPATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATMVRD 153 (268)
T ss_pred HHHHHHHHHHHHHHcCCCCCCeeEEEEecCCCccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence 478999999999544544 44556543 23578999999875 89999864 2445667788999999999999
Q ss_pred HHhCCccccCCCCCCeEEee----cCCCceEEEeecCCcc
Q 026253 82 LNSHHIIHRDLKPENILLSG----LDDDVMLKIADFGLSC 117 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~----~~~~~~~~l~df~~a~ 117 (241)
||+.|++|+|+++.||+++. .++...+.++||+.+.
T Consensus 154 LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~ 193 (268)
T PRK15123 154 MHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ 193 (268)
T ss_pred HHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence 99999999999999999953 1235679999999774
|
|
| >PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.20 E-value=3.2e-10 Score=85.04 Aligned_cols=110 Identities=19% Similarity=0.221 Sum_probs=87.4
Q ss_pred hhhhHHHHHHHHhcCCCcC--eeeeeeEEeecC----eEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPN--IIRLFDAFQAEN----CIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~--i~~~~~~~~~~~----~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
......+|...+..|...+ +++++++.+... ..++|+|.+++ .+|.+++......+......++.+++..++-
T Consensus 54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~~~~~s~lite~l~~~~~L~~~~~~~~~~~~~~~~~ll~~l~~~i~~ 133 (206)
T PF06293_consen 54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKGGGYRSYLITEALPGAQDLRDLLQQWEQLDPSQRRELLRALARLIAK 133 (206)
T ss_pred cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCCCceeEEEEEEeCCCcccHHHHHHhhcccchhhHHHHHHHHHHHHHH
Confidence 4567889999999985444 556666665532 45899999987 4899999875556777888999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
||+.|++|+|+++.|||+...+....+.++||+.+..
T Consensus 134 lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~ 170 (206)
T PF06293_consen 134 LHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF 170 (206)
T ss_pred HHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence 9999999999999999996433445899999997654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane |
| >KOG0601 consensus Cyclin-dependent kinase WEE1 [Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=99.17 E-value=2e-11 Score=100.87 Aligned_cols=209 Identities=22% Similarity=0.245 Sum_probs=152.0
Q ss_pred hhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 11 ~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
..-..|+.+...+ .|.+++..+..+...+..++--|||+++++.......--+.+..++++..|++.++.++|+..++|
T Consensus 310 i~sl~ev~l~~~l~~~~~~~g~~~~W~~~r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~i~s~~~~~ 389 (524)
T KOG0601|consen 310 IFSLGEVILEAILGSHLPSVGKNSSWSQLRQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNVIHSKLFVH 389 (524)
T ss_pred hcchhhhhHhhHhhcccccCCCCCCccccccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhccccccchhhhc
Confidence 3445566676666 689999999888888888899999999998877644444788889999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCc-cCcccccccCCCCchhHHHHHHHHHHHHhCCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY-MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~-~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 168 (241)
.|++|.||++. .+++..+++||+......-.. ......+..| .++.......+..+.|++++|..+.+.+++...-
T Consensus 390 ~d~~psni~i~--~~~~~~~~~~~~~~t~~~~~~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~~~~e~~~~~~ls 466 (524)
T KOG0601|consen 390 LDVKPSNILIS--NDGFFSKLGDFGCWTRLAFSS-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGLSVDEAITGSPLS 466 (524)
T ss_pred ccccccceeec--cchhhhhccccccccccceec-ccccccccccccchhhccccccccccccccccccccccccCcccC
Confidence 99999999995 223778899999876522111 1111122333 3455555566788999999999999998876644
Q ss_pred CCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 169 SGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+..+... .+..+.-. ..++...++..+.+.+...++..||.+.++..|.=|.+.
T Consensus 467 ~~~~~~~---~i~~~~~p-----~~~~~~~~~q~~~kv~~~~~~~~~~l~~~l~~~~~~~~~ 520 (524)
T KOG0601|consen 467 ESGVQSL---TIRSGDTP-----NLPGLKLQLQVLLKVMINPDRKRRPSAVELSLHSEFYRD 520 (524)
T ss_pred cccccce---eeeccccc-----CCCchHHhhhhhhhhhcCCccccchhhhhhcccchhhhh
Confidence 4333322 22222111 122445788899999999999999999999988766553
|
|
| >TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase | Back alignment and domain information |
|---|
Probab=99.16 E-value=1.9e-10 Score=95.59 Aligned_cols=103 Identities=22% Similarity=0.251 Sum_probs=71.5
Q ss_pred HHHHHHHHhcCC-----CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHH-HHHHHHhC
Q 026253 13 LDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGA-GLEILNSH 85 (241)
Q Consensus 13 ~~~E~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~-~l~~lh~~ 85 (241)
+.+|++.+.+++ ++++.-..-+..-.+..++||||++|++|.++.... .... ...++..++. .+..+|..
T Consensus 200 f~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~~l~ql~~~ 276 (437)
T TIGR01982 200 LRREAANASELGENFKNDPGVYVPEVYWDRTSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARSFLNQVLRD 276 (437)
T ss_pred HHHHHHHHHHHHHhcCCCCCEEeCCEehhhcCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHHHHHHHHhC
Confidence 555666666662 333322222222234578999999999999886532 1222 3345555555 47889999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~ 121 (241)
|++|+|++|.||++ .+++.++++|||++....+
T Consensus 277 g~~H~D~hPgNilv---~~~g~i~liDfG~~~~l~~ 309 (437)
T TIGR01982 277 GFFHADLHPGNIFV---LKDGKIIALDFGIVGRLSE 309 (437)
T ss_pred CceeCCCCcccEEE---CCCCcEEEEeCCCeeECCH
Confidence 99999999999999 6788999999999876643
|
This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species. |
| >cd05151 ChoK Choline Kinase (ChoK) | Back alignment and domain information |
|---|
Probab=99.16 E-value=5e-11 Score=86.64 Aligned_cols=93 Identities=25% Similarity=0.269 Sum_probs=70.0
Q ss_pred hhHHHHHHHHhcCCCcCe-eeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc--
Q 026253 11 SCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI-- 87 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i-- 87 (241)
..+.+|+.+++.+.+.++ ++++... ....++|||+++|.++.+. . ......+.+++.+++.||+.++
T Consensus 37 ~~~~~E~~~l~~l~~~~~~P~~~~~~--~~~~~lv~e~i~G~~l~~~-----~---~~~~~~~~~l~~~l~~LH~~~~~~ 106 (170)
T cd05151 37 INRENEAENSKLAAEAGIGPKLYYFD--PETGVLITEFIEGSELLTE-----D---FSDPENLEKIAKLLKKLHSSPLPD 106 (170)
T ss_pred cCHHHHHHHHHHHHHhCCCCceEEEe--CCCCeEEEEecCCCccccc-----c---ccCHHHHHHHHHHHHHHhCCCCCC
Confidence 457899999999965554 4455443 3345799999999887653 1 1123456789999999999885
Q ss_pred ---cccCCCCCCeEEeecCCCceEEEeecCCcc
Q 026253 88 ---IHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (241)
Q Consensus 88 ---~H~dl~~~nil~~~~~~~~~~~l~df~~a~ 117 (241)
+|+|++|.||++ + ++.++++||+.+.
T Consensus 107 ~~~~HgD~~~~Nil~---~-~~~~~liDf~~a~ 135 (170)
T cd05151 107 LVPCHNDLLPGNFLL---D-DGRLWLIDWEYAG 135 (170)
T ss_pred ceeecCCCCcCcEEE---E-CCeEEEEeccccc
Confidence 999999999999 4 4579999999874
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph |
| >PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases | Back alignment and domain information |
|---|
Probab=99.14 E-value=1.2e-10 Score=85.42 Aligned_cols=104 Identities=20% Similarity=0.331 Sum_probs=69.2
Q ss_pred HHhhhhHHHHHHHHhcCCCc--CeeeeeeEEeecCeEEEEEeccC--CCChHHHHHhcCCCCHHHHHHHHHHHHHH-HHH
Q 026253 7 KHLKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCA--GGNLSSYIRLHGRVPEQTARKFLQQLGAG-LEI 81 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~--~i~~~~~~~~~~~~~~lv~e~~~--~~~L~~~l~~~~~~~~~~~~~~~~~i~~~-l~~ 81 (241)
...+...++|++.|.++... ++++++++. ..++||||++ |..+..+.... ++.+....++.+++.. ...
T Consensus 49 ~~~~~~~~~E~~~L~~l~~~Gv~vP~p~~~~----~~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~~~~~~ 122 (188)
T PF01163_consen 49 YLIREWAKKEFRNLKRLYEAGVPVPKPYDYN----RNVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILEEIIKM 122 (188)
T ss_dssp HHHHHHHHHHHHHHHHCCCTT-SS--EEEEE----TTEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHHHCCccCCcEEEEe----CCEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHHHHHHH
Confidence 34467889999999999765 466666442 3469999998 66665543322 1234566677777774 445
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccC
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~ 120 (241)
+|+.|++|||+++.||+++ ++ .+.++|||.+....
T Consensus 123 ~~~~givHGDLs~~NIlv~---~~-~~~iIDf~qav~~~ 157 (188)
T PF01163_consen 123 LHKAGIVHGDLSEYNILVD---DG-KVYIIDFGQAVDSS 157 (188)
T ss_dssp HHCTTEEESS-STTSEEEE---TT-CEEE--GTTEEETT
T ss_pred HHhcCceecCCChhhEEee---cc-eEEEEecCcceecC
Confidence 6899999999999999994 44 89999999886654
|
Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A. |
| >COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only] | Back alignment and domain information |
|---|
Probab=99.09 E-value=3e-09 Score=85.25 Aligned_cols=177 Identities=15% Similarity=0.195 Sum_probs=121.5
Q ss_pred EEEEEeccCCC-ChHHHHHh------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeec
Q 026253 41 IFLVVEFCAGG-NLSSYIRL------HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113 (241)
Q Consensus 41 ~~lv~e~~~~~-~L~~~l~~------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df 113 (241)
..++|+.+.|. .+.++++- ..-..+.-..+.++.++.+.+.||..|.+-||++++|+++ ++++.+.|.|-
T Consensus 85 iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lV---sd~~~V~LVds 161 (637)
T COG4248 85 IGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLV---SDDSKVVLVDS 161 (637)
T ss_pred eEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceee---ecCceEEEEcc
Confidence 77888888664 23333321 1126788899999999999999999999999999999999 67888888875
Q ss_pred CCccccCCCCccccccCCCCccCccccc-----ccCCCCchhHHHHHHHHHHHHhC-CCCCCCCC-------hHH-----
Q 026253 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNG-YPPFSGRN-------NVQ----- 175 (241)
Q Consensus 114 ~~a~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~l~~g-~~p~~~~~-------~~~----- 175 (241)
..-....++.......+...|.+||.-. +..-+...|.|.||+++++++.| ..||.+.. +.+
T Consensus 162 Dsfqi~~ng~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI~~~~~ap~p~E~~Ia~ 241 (637)
T COG4248 162 DSFQINANGTLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGIPLISDAPNPLETDIAH 241 (637)
T ss_pred cceeeccCCceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcccccCCCCCcchhhhhc
Confidence 5433333333444566888999999854 34456789999999999999885 88997522 111
Q ss_pred -HH---HHhhcCCCCCCCCccCCCCChHHHHHHHHhcccC--ccccCCHHH
Q 026253 176 -LV---RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSAN--TVDRLSFNE 220 (241)
Q Consensus 176 -~~---~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~--p~~Rps~~~ 220 (241)
.+ .+-..+...+....-+.-++++++.+..+|+... +.-|||++.
T Consensus 242 g~f~ya~~~~~g~~p~P~~~P~~~Lpp~vqAlF~qaF~~~~~~~~RP~a~a 292 (637)
T COG4248 242 GRFAYASDQRRGLKPPPRSIPLSMLPPDVQALFQQAFTESGVATPRPTAKA 292 (637)
T ss_pred ceeeechhccCCCCCCCCCCChhhcCHHHHHHHHHHhcccCCCCCCCCHHH
Confidence 00 0111111111111122356788999999998754 457999765
|
|
| >KOG1035 consensus eIF-2alpha kinase GCN2 [Translation, ribosomal structure and biogenesis] | Back alignment and domain information |
|---|
Probab=99.07 E-value=2.3e-09 Score=95.20 Aligned_cols=214 Identities=24% Similarity=0.250 Sum_probs=156.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCe----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
.+.....-|+..+.++.|+|+..++.+-.++.. ..+..+++.+.++.+.++..+..+.+....+..++.+|+.++|
T Consensus 224 ~~i~~~E~e~~~l~k~~~~n~~~~~~~~le~~~~g~~~~v~~~~~s~~~~~~~~q~v~~i~~~~~r~~~~~~~~GL~~~h 303 (1351)
T KOG1035|consen 224 KEIQTTEIELESLSKIAHDNLGGYFVYGLERLFRGIVLDVLQEICSKVELRSLLQSVGSIPLETLRILHQKLLEGLAYLH 303 (1351)
T ss_pred HHHHHHHHHHHHHHhhccccccceeEEeehhhcchHHHHHHHhhcCccchHHHHhhccccCHHHHHHHHHHHhhhHHHHH
Confidence 455667778888899999999999988654322 2355588999999999998899999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEe--ecCCccccCCCCccccccCCCCccCcccccccCC--CCchhHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIA--DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY--DEKVDMWSVGAILF 159 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~--df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~--~~~~Dv~slG~~l~ 159 (241)
+....|.-+......-...+..+.+..+ ||+...................+.++|......+ +...|+|++|....
T Consensus 304 ~~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~~~~~~~~~~~~~e~~~~~~~~~~r~~dL~~lgll~~ 383 (1351)
T KOG1035|consen 304 SLSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKSFSDLLAEIRNADEDLKENTAKKSRLTDLWCLGLLLL 383 (1351)
T ss_pred HhccceeEEecccccccccCccceeecchhhhcccccCCCcccchhhcCccccccccccccccchhhhhhHHHHHHHHHh
Confidence 9976666665553332223556666666 8888877766555555555666788887765544 44579999999999
Q ss_pred HHHhCCCCCCCC-ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCCC
Q 026253 160 ELLNGYPPFSGR-NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRA 236 (241)
Q Consensus 160 ~l~~g~~p~~~~-~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~ 236 (241)
.+..|..+-... .....+ +. .......+.+.+|+.-++++|+++.+++.|+|++-.......
T Consensus 384 ~~~~~~~i~~~~~~~~~~l-----------~~----~~~~~~~d~~~~~~~~~~~~Rl~~~~ll~~~f~~~~~~~~~~ 446 (1351)
T KOG1035|consen 384 QLSQGEDISEKSAVPVSLL-----------DV----LSTSELLDALPKCLDEDSEERLSALELLTHPFLRFPTDNESS 446 (1351)
T ss_pred hhhhcCcccccccchhhhh-----------cc----ccchhhhhhhhhhcchhhhhccchhhhhhchhcccccccccc
Confidence 988775543321 111111 11 111278899999999999999999999999999886665553
|
|
| >KOG3741 consensus Poly(A) ribonuclease subunit [RNA processing and modification] | Back alignment and domain information |
|---|
Probab=99.04 E-value=7.9e-09 Score=84.73 Aligned_cols=179 Identities=18% Similarity=0.265 Sum_probs=128.8
Q ss_pred HHHHHHHhcCCCcCeeeeeeEEee----cCeEEEEEeccCC-CChHHHHHh---------------cCCCCHHHHHHHHH
Q 026253 14 DCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAG-GNLSSYIRL---------------HGRVPEQTARKFLQ 73 (241)
Q Consensus 14 ~~E~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~-~~L~~~l~~---------------~~~~~~~~~~~~~~ 73 (241)
..-++.++++.|.||+++.+.+.+ +..+++|++|.++ ++|.++.-. ....+++.+|.++.
T Consensus 321 t~lve~wkkl~h~NvV~frevf~t~tF~D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~y~~ 400 (655)
T KOG3741|consen 321 TSLVEAWKKLCHTNVVPFREVFLTYTFGDLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWSYIS 400 (655)
T ss_pred hHHHHHHHHhccCceeehhhhhhhhccCcceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHHHHH
Confidence 344888999999999999998863 4579999998864 566655421 11268899999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHH
Q 026253 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (241)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 153 (241)
|+..||.++|+.|+..+-|.|.+|++ .....++|..-|......++.. +.+. -..+.|.=.
T Consensus 401 QLtaaL~sIHssGLAck~L~~~kIlv---~G~~RIriS~C~i~Dvl~~d~~-------------~~le---~~Qq~D~~~ 461 (655)
T KOG3741|consen 401 QLTAALYSIHSSGLACKTLDLKKILV---TGKMRIRISGCGIMDVLQEDPT-------------EPLE---SQQQNDLRD 461 (655)
T ss_pred HHHHHHHHHHhcCceeecccHhHeEe---eCcceEEEecccceeeecCCCC-------------cchh---HHhhhhHHH
Confidence 99999999999999999999999999 4555788876665544333220 1111 123679999
Q ss_pred HHHHHHHHHhCCCC-CCCCChH-HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 154 VGAILFELLNGYPP-FSGRNNV-QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 154 lG~~l~~l~~g~~p-~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
||.+++.+.+|..- +...... ..+..|. +.+|.++++++..+...++.+ -++.+++.+
T Consensus 462 lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~------------~~yS~D~rn~v~yl~s~~~~~-ksI~~llp~ 521 (655)
T KOG3741|consen 462 LGLLLLALATGTENSNRTDSTQSSHLTRIT------------TTYSTDLRNVVEYLESLNFRE-KSIQDLLPM 521 (655)
T ss_pred HHHHHHHHhhcccccccccchHHHHHHHhh------------hhhhHHHHHHHHHHHhcCccc-ccHHHHHHH
Confidence 99999999998543 2222221 1133331 267889999999999988876 577777644
|
|
| >PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed | Back alignment and domain information |
|---|
Probab=98.94 E-value=8.6e-10 Score=93.08 Aligned_cols=74 Identities=24% Similarity=0.317 Sum_probs=52.1
Q ss_pred cCeEEEEEeccCCCChHHHH--HhcC----CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCc----e
Q 026253 38 ENCIFLVVEFCAGGNLSSYI--RLHG----RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV----M 107 (241)
Q Consensus 38 ~~~~~lv~e~~~~~~L~~~l--~~~~----~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~----~ 107 (241)
.+..++||||++|+++.++- ...+ .+.+..+..+ +..+...|++|+|++|.||++ +.++ .
T Consensus 233 st~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~-------~~Qif~~GffHaDpHPGNIlv---~~~g~~~~~ 302 (537)
T PRK04750 233 CSETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVF-------FTQVFRDGFFHADMHPGNIFV---SYDPPENPR 302 (537)
T ss_pred CCCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHH-------HHHHHhCCeeeCCCChHHeEE---ecCCCCCCe
Confidence 34567999999999998753 2222 1222223333 334456899999999999999 4444 8
Q ss_pred EEEeecCCccccCC
Q 026253 108 LKIADFGLSCTLYP 121 (241)
Q Consensus 108 ~~l~df~~a~~~~~ 121 (241)
+++.|||++.....
T Consensus 303 i~llDFGivg~l~~ 316 (537)
T PRK04750 303 YIALDFGIVGSLNK 316 (537)
T ss_pred EEEEecceEEECCH
Confidence 99999999877643
|
|
| >COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.89 E-value=8.8e-09 Score=78.27 Aligned_cols=99 Identities=19% Similarity=0.258 Sum_probs=79.7
Q ss_pred hhhhHHHHHHHHhcCCCc--CeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHP--NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~--~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.+....+|+++|.+|... .|++.+ +.+...+|||+++|..|... +++.+.+..++..|+.-+..+-..|
T Consensus 152 sRl~A~rEf~~L~~L~~~G~~VP~P~----~~nRHaVvMe~ieG~eL~~~-----r~~~en~~~il~~il~~~~~~~~~G 222 (304)
T COG0478 152 SRLAAEREFEALQRLYPEGVKVPKPI----AWNRHAVVMEYIEGVELYRL-----RLDVENPDEILDKILEEVRKAYRRG 222 (304)
T ss_pred HHHHHHHHHHHHHHhhhcCCCCCCcc----ccccceeeeehcccceeecc-----cCcccCHHHHHHHHHHHHHHHHHcC
Confidence 467789999999999765 788887 56778899999998766643 2245566667777777777777999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCcccc
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~ 119 (241)
++|||+++.||++ ++++.+.++||-.+...
T Consensus 223 iVHGDlSefNIlV---~~dg~~~vIDwPQ~v~~ 252 (304)
T COG0478 223 IVHGDLSEFNILV---TEDGDIVVIDWPQAVPI 252 (304)
T ss_pred ccccCCchheEEE---ecCCCEEEEeCcccccC
Confidence 9999999999999 78889999999876443
|
|
| >PRK09902 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=98.85 E-value=3.3e-08 Score=73.15 Aligned_cols=108 Identities=14% Similarity=0.163 Sum_probs=81.5
Q ss_pred hhhhHHHHHHHHhcCCCcC--eeeeeeEEee-----cCeEEEEEeccCC-CChHHHHHhc--CCCCHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPN--IIRLFDAFQA-----ENCIFLVVEFCAG-GNLSSYIRLH--GRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~--i~~~~~~~~~-----~~~~~lv~e~~~~-~~L~~~l~~~--~~~~~~~~~~~~~~i~~~ 78 (241)
.+..+.+|+..+++|...+ ++++. ++.. .-..+||+|-+.| .+|.+++... .+.+......++.+++.+
T Consensus 62 g~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va~~ 140 (216)
T PRK09902 62 GRPTIVREVAVIKELERAGVIVPKIV-FGEAVKIEGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVALA 140 (216)
T ss_pred CchHHHHHHHHHHHHHHcCCCCCccc-eeeeeccCCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHHHH
Confidence 5788999999999994333 55555 3321 1246799997742 6899998653 345777788999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
++-||+.|+.|+|+.+.||+++. ++...+.++||..++.
T Consensus 141 ia~LH~~Gv~Hgdly~khIll~~-~g~~~v~lIDlEk~r~ 179 (216)
T PRK09902 141 FKKMHSVNRQHGCCYVRHIYVKT-EGKAEAGFLDLEKSRR 179 (216)
T ss_pred HHHHHHCCCcCCCCCHhheeecC-CCCeeEEEEEhhccch
Confidence 99999999999999999999942 1223499999987643
|
|
| >cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins | Back alignment and domain information |
|---|
Probab=98.76 E-value=3.4e-08 Score=74.83 Aligned_cols=104 Identities=17% Similarity=0.274 Sum_probs=75.6
Q ss_pred hhhHHHHHHHHhcCCCcC--eeeeeeEEeec---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~--i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
...+.+|+++++.+.+.+ +++++.+.... +..++|||+++|.++.+.+.. ..++.+....++.+++.++..||+
T Consensus 39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~~~~~~~~v~e~i~G~~l~~~~~~-~~~~~~~~~~i~~~i~~~l~~lH~ 117 (223)
T cd05154 39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPSVLGTPFYVMERVDGRVLRDRLLR-PELSPEERRALARALADTLAALHS 117 (223)
T ss_pred cccHHHHHHHHHHhhCCCCCCCCEEEECCCCCccCCceEEEEEeCCEecCCCCCC-CCCCHHHHHHHHHHHHHHHHHHhC
Confidence 567899999999996544 56777776553 367899999999888765421 345555556666666666666652
Q ss_pred --------------------------------------------------------CCccccCCCCCCeEEeecCC--Cc
Q 026253 85 --------------------------------------------------------HHIIHRDLKPENILLSGLDD--DV 106 (241)
Q Consensus 85 --------------------------------------------------------~~i~H~dl~~~nil~~~~~~--~~ 106 (241)
..++|+|+.+.||+++ + .+
T Consensus 118 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~---~~~~~ 194 (223)
T cd05154 118 VDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFH---PDEPR 194 (223)
T ss_pred CChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEc---CCCCc
Confidence 2468999999999994 4 56
Q ss_pred eEEEeecCCcc
Q 026253 107 MLKIADFGLSC 117 (241)
Q Consensus 107 ~~~l~df~~a~ 117 (241)
.+.++||+.+.
T Consensus 195 ~~~iID~e~~~ 205 (223)
T cd05154 195 VVAVLDWELAT 205 (223)
T ss_pred EEEEEeccccc
Confidence 68999999774
|
This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain |
| >PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY) | Back alignment and domain information |
|---|
Probab=98.74 E-value=9e-08 Score=71.20 Aligned_cols=66 Identities=21% Similarity=0.351 Sum_probs=51.9
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCcc
Q 026253 40 CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (241)
Q Consensus 40 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~ 117 (241)
..+++|||++|..|.+... +++ .++..+.+++..+|+.|++|||.+|.|+++ + ++.++++||+..+
T Consensus 117 ~~~ll~EYIeG~~l~d~~~----i~e----~~~~ki~~~ikqlH~~G~~HGD~hpgNFlv---~-~~~i~iID~~~k~ 182 (229)
T PF06176_consen 117 SYVLLMEYIEGVELNDIED----IDE----DLAEKIVEAIKQLHKHGFYHGDPHPGNFLV---S-NNGIRIIDTQGKR 182 (229)
T ss_pred EEEEEEEEecCeecccchh----cCH----HHHHHHHHHHHHHHHcCCccCCCCcCcEEE---E-CCcEEEEECcccc
Confidence 4668999999998887643 222 244567788999999999999999999999 3 3459999998653
|
The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process |
| >KOG0576 consensus Mitogen-activated protein kinase kinase kinase kinase (MAP4K), germinal center kinase family [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=98.66 E-value=4.5e-09 Score=88.16 Aligned_cols=212 Identities=20% Similarity=0.247 Sum_probs=146.1
Q ss_pred hhHHHHHHHHhcCCCcC-eeeeeeEEeecCeEEEEEeccCCC-ChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 11 SCLDCELNFLSSVNHPN-IIRLFDAFQAENCIFLVVEFCAGG-NLSSYIR-LHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~-i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
-..+-++++|.+++||| .+..++.++.+...+++++++.++ +...... ....+..-......+.-..+++++|+..-
T Consensus 278 l~~rl~~eLLdK~n~P~~~v~~~~d~~~E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~~l~~~~~ 357 (829)
T KOG0576|consen 278 LSRRLAIELLDKVNNPNPVVRYLEDYDGEDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLAELHSSYK 357 (829)
T ss_pred hhhHHHHHHHHHccCCCCcccccccCCcccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhcccccccccccc
Confidence 45667899999999999 777777788888999999999766 2222111 01123344455666677888999998876
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+| ||+- .+...+.++|+...............+++.+++||......+..+.|.|++|.-..++..|-+|
T Consensus 358 ~~~d----~~l~----s~~~~~~~~~~v~~~L~~~~~~~t~~~~~~~~~pev~~~~~~~~~p~~~~~~~~~~~~ap~~pP 429 (829)
T KOG0576|consen 358 VHRD----NILG----SEEEVKLLDFAVPPQLTRTMKPRTAIGTPEPLAPEVIQENTIDGCPDSGSLAVSAIQMAPGLPP 429 (829)
T ss_pred cCcc----cccc----cccccccccccCCcccCcccccccCCCCCCCCCchhhcccccccCCCccCCCcchhhcCCCCCC
Confidence 7888 7775 4567889999988776655556677789999999999988899999999999877777777666
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHH-HHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCV-DMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~-~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
-.. +......+..+...+..... ..-+.... ++...|+...|..|+..-.++.|.+|++++-.
T Consensus 430 r~~--P~~~~~~~g~~p~s~~L~~~-~aw~~~~~~~~~~~~~~g~P~~pkv~mgacfsKvfngCpl~ 493 (829)
T KOG0576|consen 430 RSS--PPAVLPMIGNGPNSPMLTDK-SAWSPVFHRDFPAPCLNGLPPTPKVHMGACFSKVFNGCPLR 493 (829)
T ss_pred CCC--CccccCCCCCCCCccccchh-hhcCcccccCCcccccCCCCCCCcchhhHHHHHHhccCccc
Confidence 543 11111122111111110000 00111112 47788999999999999999999999987654
|
|
| >PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP | Back alignment and domain information |
|---|
Probab=98.45 E-value=3.3e-06 Score=62.61 Aligned_cols=103 Identities=27% Similarity=0.376 Sum_probs=77.9
Q ss_pred hhhhHHHHHHHHhcCC------CcCeeeeeeEEeecCeEEEEEeccC------CCChHHHHHhcCCCCHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVN------HPNIIRLFDAFQAENCIFLVVEFCA------GGNLSSYIRLHGRVPEQTARKFLQQLG 76 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~------~~~i~~~~~~~~~~~~~~lv~e~~~------~~~L~~~l~~~~~~~~~~~~~~~~~i~ 76 (241)
..++..+|+..+.++. +.+|.+++|..+++-...+|+|.+. +.+|.+++.. +.++. . +...+-
T Consensus 54 ~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G~Glv~e~I~d~dG~~s~TL~~~l~~-~~~~~-~---~~~~L~ 128 (199)
T PF10707_consen 54 RYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLGLGLVVELIRDADGNISPTLEDYLKE-GGLTE-E---LRQALD 128 (199)
T ss_pred hhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCceEEEEEEEECCCCCcCccHHHHHHc-CCccH-H---HHHHHH
Confidence 4677788888887776 8889999999999988899998764 3578888853 44554 3 333444
Q ss_pred HHHHHHHhCCccccCCCCCCeEEeecCCCc-eEEEee-cCCc
Q 026253 77 AGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIAD-FGLS 116 (241)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nil~~~~~~~~-~~~l~d-f~~a 116 (241)
.-..+|-+.+|+.+|++|.||++...+++. .+.|+| ||..
T Consensus 129 ~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~~ 170 (199)
T PF10707_consen 129 EFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGEK 170 (199)
T ss_pred HHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCCc
Confidence 555678889999999999999997655555 677887 6643
|
PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner []. |
| >cd05150 APH Aminoglycoside 3'-phosphotransferase (APH) | Back alignment and domain information |
|---|
Probab=98.28 E-value=4e-06 Score=64.64 Aligned_cols=47 Identities=13% Similarity=0.082 Sum_probs=36.7
Q ss_pred hhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHH
Q 026253 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 56 (241)
...+.+|+++++.+. +--+++++++...++..++||++++|.++...
T Consensus 35 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~ 82 (244)
T cd05150 35 TYELEREAERLRWLAGKLPVPEVIDYGSDDGRAWLLTSAVPGVPAAAL 82 (244)
T ss_pred ccchHHHHHHHHHHHhcCCCCeEEEEEecCCccEEEEEeeCCccHhHh
Confidence 456789999999993 44466778777776778999999999887654
|
The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio |
| >TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172 | Back alignment and domain information |
|---|
Probab=98.13 E-value=2.8e-05 Score=59.19 Aligned_cols=43 Identities=19% Similarity=0.188 Sum_probs=34.3
Q ss_pred hhhHHHHHHHHhcCCCcC--eeeeeeEEeecCeEEEEEeccCCCC
Q 026253 10 KSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGN 52 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~ 52 (241)
...+.+|.++++.+..-+ +++++++.+..+...+||++++|.+
T Consensus 36 ~~~i~~E~~~l~~l~~~glpvP~~~~~~~~~~~~glv~e~i~G~~ 80 (226)
T TIGR02172 36 KETIKREFDASRKVFSLGIPTPHPFDLVEDGGRLGLIYELIVGKR 80 (226)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCceEEEEecCCeeeeeeeecCCcc
Confidence 456799999999996444 5777888878788889999998863
|
This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636. |
| >COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=98.10 E-value=1.7e-05 Score=60.07 Aligned_cols=101 Identities=18% Similarity=0.126 Sum_probs=69.4
Q ss_pred hhhHHHHHHHHhcCC--CcCeeeeeeEEeecCeEEEEEeccCCCChH--HHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-
Q 026253 10 KSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLS--SYIRLHGRVPEQTARKFLQQLGAGLEILNS- 84 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~--~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~- 84 (241)
..=.++|+.-|+++. +=.+++.+++. ...||||++.. .-. =.|+ .-++..+....+..++++.+.-|-.
T Consensus 112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~----~nVLvMEfIg~-~g~pAP~Lk-Dv~~e~~e~~~~~~~~v~~~~~l~~~ 185 (268)
T COG1718 112 FAWARKEFRNLKRAYEAGVRVPEPIAFR----NNVLVMEFIGD-DGLPAPRLK-DVPLELEEAEGLYEDVVEYMRRLYKE 185 (268)
T ss_pred HHHHHHHHHHHHHHHHcCCCCCCceeec----CCeEEEEeccC-CCCCCCCcc-cCCcCchhHHHHHHHHHHHHHHHHHh
Confidence 344578888888884 44556666443 35699999943 210 0000 1123333566777788888887776
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccC
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~ 120 (241)
.+++|+||+..|||+ . ++.+.++|+|.|....
T Consensus 186 a~LVHgDLSEyNiL~---~-~~~p~iID~~QaV~~~ 217 (268)
T COG1718 186 AGLVHGDLSEYNILV---H-DGEPYIIDVSQAVTID 217 (268)
T ss_pred cCcccccchhhheEE---E-CCeEEEEECccccccC
Confidence 899999999999999 4 7789999999886654
|
|
| >PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C) | Back alignment and domain information |
|---|
Probab=98.06 E-value=2e-05 Score=58.12 Aligned_cols=99 Identities=24% Similarity=0.263 Sum_probs=76.5
Q ss_pred HHHHHHHhcCCC-cCeeeeeeEEeecCeEEEEEeccCCCChHH---HHHhcCCCCHHHHHHHHHHHHHHHHHHHh---CC
Q 026253 14 DCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSS---YIRLHGRVPEQTARKFLQQLGAGLEILNS---HH 86 (241)
Q Consensus 14 ~~E~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~---~l~~~~~~~~~~~~~~~~~i~~~l~~lh~---~~ 86 (241)
.+|.-+++.+.+ +++++++|++-. ++++|+...+++.. .+......++....+++.++++.+.+++. ..
T Consensus 7 ~~E~lll~~l~~~~~~pk~lG~CG~----~~v~E~~~~~~~~~~~~~l~~~~~~~w~~R~~iA~~lL~~l~~l~~~~~~~ 82 (188)
T PF12260_consen 7 NNEPLLLQLLQGSEPFPKLLGSCGR----FYVVEYVGAGSLYGIYRPLSQFLQSPWEQRAKIALQLLELLEELDHGPLGF 82 (188)
T ss_pred ccHHHHHHHcCCCCCCCCeeeECCC----EEEEEeecCccccccccccccccccCHHHHHHHHHHHHHHHHHHhcCCCCc
Confidence 468889999954 699999998832 46788886554431 11112345799999999999999999997 45
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCcccc
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~ 119 (241)
+.-+|++++|+-+ ++++.+++.|...+...
T Consensus 83 ~~lcDv~~~nfgv---~~~~~lk~iDld~v~~~ 112 (188)
T PF12260_consen 83 FYLCDVSPDNFGV---NDDGRLKLIDLDDVFVE 112 (188)
T ss_pred EEEeecchHHeEE---eCCCcEEEEechhcchh
Confidence 8889999999999 67788999999876443
|
Proteins in this uncharacterised family are described as transmembrane proteins. |
| >COG0661 AarF Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=98.05 E-value=3.4e-05 Score=65.27 Aligned_cols=104 Identities=21% Similarity=0.271 Sum_probs=68.4
Q ss_pred HHHHHHHHhcC-----CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 13 LDCELNFLSSV-----NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 13 ~~~E~~~l~~l-----~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
+.+|..-+.++ +.+++.-..=+++-.+.-.++|||++|..+.+..... ...+...+.....++ .+..+-..|
T Consensus 208 y~~EA~n~~~~~~nf~~~~~v~VP~V~we~t~~~VLtmE~i~Gi~i~d~~~l~~~g~d~k~ia~~~~~~--f~~q~~~dg 285 (517)
T COG0661 208 YRREAANAERFRENFKDDPDVYVPKVYWEYTTRRVLTMEWIDGIKISDIAALKSAGIDRKELAELLVRA--FLRQLLRDG 285 (517)
T ss_pred HHHHHHHHHHHHHHcCCCCCeEeceeehhccCCcEEEEEeeCCEecccHHHHHhcCCCHHHHHHHHHHH--HHHHHHhcC
Confidence 34455555555 2444433333344445678999999999999984322 345534433333222 244555689
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~ 121 (241)
++|+|.+|.||++ ..++.+.+.|||......+
T Consensus 286 ffHaDpHpGNi~v---~~~g~i~~lDfGi~g~l~~ 317 (517)
T COG0661 286 FFHADPHPGNILV---RSDGRIVLLDFGIVGRLDP 317 (517)
T ss_pred ccccCCCccceEE---ecCCcEEEEcCcceecCCH
Confidence 9999999999999 6779999999999876644
|
|
| >KOG1093 consensus Predicted protein kinase (contains TBC and RHOD domains) [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.95 E-value=3.2e-05 Score=64.38 Aligned_cols=166 Identities=18% Similarity=0.206 Sum_probs=108.1
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeec-CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~-~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
..+.-.+++++++.|+|...+.++-... ....+|+|++ +.+|.+.+..+. +...... +|
T Consensus 27 ~~ilgr~~~lktl~~~~l~~yl~~~r~~~~r~IVV~e~~-~~Sled~~~~~~-l~~~s~~------------------~~ 86 (725)
T KOG1093|consen 27 IQILGRFQYLKSLQHDNLCQYLDFSRGKHERVIVVMEHY-TMSLEDILKTGN-LKDESLL------------------AH 86 (725)
T ss_pred HHHhhhhHHHHhhcCccceeeEeeecCccceEEEEehhh-ccchHHHHHhcc-cchhhhc------------------cc
Confidence 3456678999999999999999887643 4488999999 689999987653 2221111 23
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 169 (241)
+= .+.|++. ..| -++.. + | ....+++|||++|.++.++..|...+.
T Consensus 87 ~~-~~~~~~~----------~td-~~~t~---------------~--~-----~~~~pKsdVwsl~~i~~el~L~~~l~~ 132 (725)
T KOG1093|consen 87 GV-LHLNIIY----------ITD-HFLTK---------------Y--P-----SPIGPKSDVWSLGFIILELYLGISLEA 132 (725)
T ss_pred cc-ceehhhh----------ccc-ccccc---------------C--C-----CCCCcchhhhhHHHHHHHHHHhhHHHH
Confidence 31 2223322 222 00000 0 0 111249999999999999999988887
Q ss_pred CCChHHHHHHhhcCCCCCCCC-------ccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 170 GRNNVQLVRNINSCKHLPFSQ-------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 170 ~~~~~~~~~~i~~~~~~~~~~-------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
..+..+..+.+..-.-.+... ......++.+.++..+|+...|..||...++.+++-|...
T Consensus 133 ~~~~s~~l~~i~k~~~~d~~~~~~a~e~~~~~~~d~~~~~~~~~c~~~~~~ir~l~~~~~k~~i~~ev 200 (725)
T KOG1093|consen 133 ELTESEYLEILLKYYTDDQELLSTAMEHLIQLLADKKRLPLLKKCLWLEPIIRPLPMELSKRCSFTEV 200 (725)
T ss_pred HHHHHHHHHHHHHhccCchhHHHHHHHHHHHHhhhHhHHHHhccCCccccccccchhHHhcCccHHHH
Confidence 766666665554332221111 1112345667889999999999999999999999888654
|
|
| >cd05155 APH_ChoK_like_1 Uncharacterized bacterial proteins with similarity to Aminoglycoside 3'-phosphotransferase (APH) and Choline kinase (ChoK) family members | Back alignment and domain information |
|---|
Probab=97.76 E-value=8.5e-05 Score=56.96 Aligned_cols=46 Identities=9% Similarity=0.071 Sum_probs=30.8
Q ss_pred hhhhHHHHHHHHhcCCCc---CeeeeeeEEeec---CeEEEEEeccCCCChH
Q 026253 9 LKSCLDCELNFLSSVNHP---NIIRLFDAFQAE---NCIFLVVEFCAGGNLS 54 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~---~i~~~~~~~~~~---~~~~lv~e~~~~~~L~ 54 (241)
....+.+|.++++.+... -++++++..... ...+++|++++|.++.
T Consensus 31 ~~~~~~~E~~~l~~L~~~~~v~vP~~~~~~~~~~~~~~~~~l~~~i~G~~l~ 82 (235)
T cd05155 31 YAGQVRKEQRWLPRLAPHLPLPVPEPLGKGEPGEGYPWPWSVYRWLEGETAT 82 (235)
T ss_pred hHHHHHHHHHHHHHHhccCCCCCCceeecCCCccCCCcceEEEEeecCCCCC
Confidence 345799999999998532 344555443332 2458899999987764
|
The APH/ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates, such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides, and macrolides leads to their inactivation and to bacterial antibiotic resista |
| >KOG1235 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=97.69 E-value=0.00026 Score=60.00 Aligned_cols=88 Identities=18% Similarity=0.296 Sum_probs=57.3
Q ss_pred eeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCCeEEeec-CC
Q 026253 28 IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGL-EILNSHHIIHRDLKPENILLSGL-DD 104 (241)
Q Consensus 28 i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l-~~lh~~~i~H~dl~~~nil~~~~-~~ 104 (241)
|++++-.+. ..-.|+|||++|..+.|.-.-. ..++...+ +..+.++. ..+=..|++|+|-+|.||++... ..
T Consensus 266 VP~Vy~~~s--t~RVLtME~~~G~~i~Dl~~i~~~gi~~~~i---~~~l~~~~~~qIf~~GffHaDPHPGNilv~~~~~~ 340 (538)
T KOG1235|consen 266 VPKVYWDLS--TKRVLTMEYVDGIKINDLDAIDKRGISPHDI---LNKLVEAYLEQIFKTGFFHADPHPGNILVRPNPEG 340 (538)
T ss_pred CCeehhhcC--cceEEEEEecCCccCCCHHHHHHcCCCHHHH---HHHHHHHHHHHHHhcCCccCCCCCCcEEEecCCCC
Confidence 444443333 4467999999998876654322 23444443 34444432 34446789999999999999532 25
Q ss_pred CceEEEeecCCccccC
Q 026253 105 DVMLKIADFGLSCTLY 120 (241)
Q Consensus 105 ~~~~~l~df~~a~~~~ 120 (241)
+..+.+.|||+.....
T Consensus 341 ~~~ivllDhGl~~~is 356 (538)
T KOG1235|consen 341 DEEIVLLDHGLYAVIS 356 (538)
T ss_pred CccEEEEccccccccc
Confidence 7779999999876543
|
|
| >KOG1826 consensus Ras GTPase activating protein RasGAP/neurofibromin [Defense mechanisms] | Back alignment and domain information |
|---|
Probab=97.61 E-value=7.1e-06 Score=75.93 Aligned_cols=217 Identities=14% Similarity=0.042 Sum_probs=136.5
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEe--ecCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l 79 (241)
.+-.++....|..-+++..|+++...+.=.. +....+..++++.+|.+.+.+-+. .++...-+...-.+.+...
T Consensus 1269 sePlkemll~e~de~~~~~h~~~~~~p~rI~ps~s~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~ 1348 (2724)
T KOG1826|consen 1269 SEPLKEMLLSERDELREAKHYLTEVDPLRIPPSESTEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNR 1348 (2724)
T ss_pred hhHHHHhhhhhhhhhhhhhceeeecccccCCCCCChHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhcc
Confidence 4444555566666666778988887775543 344578899999999999998653 2233333333333336666
Q ss_pred HHHHhC-C----ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHH
Q 026253 80 EILNSH-H----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (241)
Q Consensus 80 ~~lh~~-~----i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 153 (241)
.-+|+. | .+|.++++.|.++ ..+..++++++|+.+...+.. ......+++.|+.|+....-.++.++|+|.
T Consensus 1349 ~~~ls~tnlg~T~v~~~Lkf~lpmI---Vtny~v~~gk~gLdKIknp~~sf~Gl~l~sp~~v~qli~N~ik~t~rsdilr 1425 (2724)
T KOG1826|consen 1349 NVILSLTNLGNTNVSKSLKFTLPMI---VTNYNVKLGKGGLDKIKNPVLSFFGLELCSPIYVLQLIKNEIKFTKRSDILR 1425 (2724)
T ss_pred chhhhcccCCccchhhhhhhhccce---ecCCcccccccccccccCchHhhhhhhhCCHHHHHHHHHHHHhhhhHHHHHH
Confidence 665543 1 6899999999999 567779999999998333222 222344566788888887778888899999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 154 VGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
.|+.+|....|..+|-..........+.++.....+.. .|.+.-.....+|-..-..||.-...+.-+.|--
T Consensus 1426 ~s~~ly~rs~~n~~fi~flq~~Lkgiidn~tf~sIe~l----~pgdaNve~~~~Ll~K~~~rp~q~isls~d~~a~ 1497 (2724)
T KOG1826|consen 1426 RSLSLYLRSDGNAYFIFFLQPALKGIIDNHTFFSIEKL----KPGDANVEALHRLLWKYMERPGQYISLSRDHFAV 1497 (2724)
T ss_pred HHHHHHHHhcccHHHHHHHHHHHcCccccccccccccc----CCCcccHHHHHHHHHHhhhcchhhhhcccccccc
Confidence 99999998888777753333333333333333332322 2223323333344444456888777776665543
|
|
| >PLN02876 acyl-CoA dehydrogenase | Back alignment and domain information |
|---|
Probab=97.61 E-value=0.00044 Score=62.66 Aligned_cols=44 Identities=14% Similarity=0.375 Sum_probs=33.6
Q ss_pred hhhHHHHHHHHhcCC-CcCe--eeeeeEEeec---CeEEEEEeccCCCCh
Q 026253 10 KSCLDCELNFLSSVN-HPNI--IRLFDAFQAE---NCIFLVVEFCAGGNL 53 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~-~~~i--~~~~~~~~~~---~~~~lv~e~~~~~~L 53 (241)
...+.+|+++++.+. |.++ ++++.++.+. +..|+|||+++|..+
T Consensus 82 ~~~~~rE~~~l~~L~~~~~vpVP~v~~~~~d~~v~G~~flVME~v~G~~~ 131 (822)
T PLN02876 82 AHAVEREYQVLRALGEHTDVPVPKVYCLCTDASVIGTAFYIMEYLEGRIF 131 (822)
T ss_pred HHHHHHHHHHHHHHhhcCCCCCCcEEEEecCCCcCCCceEEEEecCCccc
Confidence 346889999999995 6665 6777776654 467899999988643
|
|
| >PF01636 APH: Phosphotransferase enzyme family This family is part of the larger protein kinase superfamily | Back alignment and domain information |
|---|
Probab=97.43 E-value=0.0007 Score=51.46 Aligned_cols=48 Identities=17% Similarity=0.224 Sum_probs=34.0
Q ss_pred HhhhhHHHHHHHHhcCCCc--CeeeeeeEEe---ecCeEEEEEeccCCCChHH
Q 026253 8 HLKSCLDCELNFLSSVNHP--NIIRLFDAFQ---AENCIFLVVEFCAGGNLSS 55 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~--~i~~~~~~~~---~~~~~~lv~e~~~~~~L~~ 55 (241)
.....+.+|..+++.+... .+++++.... .....+++|++++|..+..
T Consensus 32 ~~~~~~~~e~~~~~~l~~~~~pvP~~~~~~~~~~~~~~~~~~~~~i~g~~~~~ 84 (239)
T PF01636_consen 32 DAAERLRREAAVLRQLAEHGIPVPRVLAFDTSDEFNGFPYLLMEYIPGRPLDD 84 (239)
T ss_dssp HHHHHHHHHHHHHHHHHHTTSBS--EEEEEEETEETSEEEEEEEEESSEEHHH
T ss_pred CCHHHHHHHHHHHHHHHhcCCCCceEEeecccccccccceEEEEEeccccccc
Confidence 3678889999999999533 3566666443 2345789999999988877
|
; InterPro: IPR002575 This entry consists of bacterial antibiotic resistance proteins, which confer resistance to various aminoglycosides they include:- aminoglycoside 3'-phosphotransferase or kanamycin kinase / neomycin-kanamycin phosphotransferase and streptomycin 3''-kinase or streptomycin 3''-phosphotransferase. The aminoglycoside phosphotransferases inactivate aminoglycoside antibiotics via phosphorylation []. The proteins are found in a range of taxonomic groups.; PDB: 2PPQ_A 2Q83_B 3TDV_B 3TDW_A 3I0O_A 3I0Q_A 3I1A_B 3Q2M_A 3HAV_C 2PUI_B .... |
| >KOG2268 consensus Serine/threonine protein kinase [Signal transduction mechanisms; General function prediction only] | Back alignment and domain information |
|---|
Probab=97.36 E-value=0.00027 Score=55.89 Aligned_cols=97 Identities=20% Similarity=0.274 Sum_probs=69.9
Q ss_pred hhHHHHHHHHhcCCCcC--eeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 11 SCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
=+..+|+.+++.|.-.. |++.+ +-+..++|||++.|..|.+.-.- ..+..+...++..+.-|-..|++
T Consensus 155 laa~kEfafmkaL~e~gfpVPkpi----D~~RH~Vvmelv~g~Pl~~v~~v------~d~~~ly~~lm~~Iv~la~~GlI 224 (465)
T KOG2268|consen 155 LAATKEFAFMKALYERGFPVPKPI----DHNRHCVVMELVDGYPLRQVRHV------EDPPTLYDDLMGLIVRLANHGLI 224 (465)
T ss_pred HHHHHHHHHHHHHHHcCCCCCCcc----cccceeeHHHhhcccceeeeeec------CChHHHHHHHHHHHHHHHHcCce
Confidence 35678999999984322 44555 44667899999999888765321 12333444555566678899999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~ 120 (241)
|||++--||++ .+++.+.++||-......
T Consensus 225 HgDFNEFNimv---~dd~~i~vIDFPQmvS~s 253 (465)
T KOG2268|consen 225 HGDFNEFNIMV---KDDDKIVVIDFPQMVSTS 253 (465)
T ss_pred ecccchheeEE---ecCCCEEEeechHhhccC
Confidence 99999999999 678889999998654443
|
|
| >COG2112 Predicted Ser/Thr protein kinase [Signal transduction mechanisms] | Back alignment and domain information |
|---|
Probab=97.31 E-value=0.0014 Score=47.26 Aligned_cols=98 Identities=17% Similarity=0.190 Sum_probs=69.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCee-eeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~-~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.++-+..+..|++++..+...++. ++|.+-++ ++.|||++|..|.++.... +..++ ..+++..--|..
T Consensus 55 ~ds~r~~l~kEakiLeil~g~~~~p~vy~yg~~----~i~me~i~G~~L~~~~~~~---~rk~l----~~vlE~a~~LD~ 123 (201)
T COG2112 55 RDSPRRNLEKEAKILEILAGEGVTPEVYFYGED----FIRMEYIDGRPLGKLEIGG---DRKHL----LRVLEKAYKLDR 123 (201)
T ss_pred CCcchhhHHHHHHHHHHhhhcCCCceEEEechh----hhhhhhhcCcchhhhhhcc---cHHHH----HHHHHHHHHHHH
Confidence 345588999999999999877766 44443332 2459999998998875421 33333 345566566778
Q ss_pred CCccccCCCC--CCeEEeecCCCceEEEeecCCccc
Q 026253 85 HHIIHRDLKP--ENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 85 ~~i~H~dl~~--~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
.||-|+.++- .||++ ++..+.|+||..|+.
T Consensus 124 ~GI~H~El~~~~k~vlv----~~~~~~iIDFd~At~ 155 (201)
T COG2112 124 LGIEHGELSRPWKNVLV----NDRDVYIIDFDSATF 155 (201)
T ss_pred hccchhhhcCCceeEEe----cCCcEEEEEccchhh
Confidence 8999999954 46666 444899999999864
|
|
| >cd05153 HomoserineK_II Homoserine Kinase, type II | Back alignment and domain information |
|---|
Probab=97.28 E-value=0.0015 Score=51.93 Aligned_cols=112 Identities=24% Similarity=0.282 Sum_probs=64.1
Q ss_pred hhhhHHhhhhHHHHHHHHhcCCCcC--eeeeeeE------EeecCeEEEEEeccCCCChHH----HHHh-----------
Q 026253 3 KKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDA------FQAENCIFLVVEFCAGGNLSS----YIRL----------- 59 (241)
Q Consensus 3 ~~~~~~~~~~~~~E~~~l~~l~~~~--i~~~~~~------~~~~~~~~lv~e~~~~~~L~~----~l~~----------- 59 (241)
|.........+..|+++++.+...+ +++++.. ...++..+.|+++++|..+.. ....
T Consensus 43 r~~~~~~~~~~~~e~~~l~~L~~~g~~vp~~i~~~~g~~~~~~~~~~~~l~~~i~G~~~~~~~~~~~~~lg~~La~lH~~ 122 (296)
T cd05153 43 TLFEKVSAEELPFFLALLDHLAERGLPVPRPIADRDGEYLSELAGKPAALVEFLAGEHLTRPTAAHCRQIGEALARLHLA 122 (296)
T ss_pred EEcCCCChHhccHHHHHHHHHHHCCCCCCccccCCCCcEeeeeCCceEEEEEeCCCCCCCCCCHHHHHHHHHHHHHHHHH
Confidence 3333344567888999999984333 4455432 233456789999999876532 1100
Q ss_pred cCCCC--------HHHHH------------HHHHHHHHHHHHHHh-------CCccccCCCCCCeEEeecCCCceEEEee
Q 026253 60 HGRVP--------EQTAR------------KFLQQLGAGLEILNS-------HHIIHRDLKPENILLSGLDDDVMLKIAD 112 (241)
Q Consensus 60 ~~~~~--------~~~~~------------~~~~~i~~~l~~lh~-------~~i~H~dl~~~nil~~~~~~~~~~~l~d 112 (241)
...+. ..... .....+..++..+.+ .+++|+|+.|.|+++ +++..+.|.|
T Consensus 123 ~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgD~~~~Nil~---~~~~~~~iID 199 (296)
T cd05153 123 AQSFPGERNNLRGLAWIRELGKDLLPLLSAEDRALLADELARQDAFDPSDLPRGVIHADLFRDNVLF---DGDELSGVID 199 (296)
T ss_pred hccCCccCCCcCCcHHHHHHHHHhccccCHHHHHHHHHHHHHHHhhhhhcCCCcCCccCcCcccEEE---eCCceEEEee
Confidence 00000 00000 011112233344442 379999999999999 5666678999
Q ss_pred cCCcc
Q 026253 113 FGLSC 117 (241)
Q Consensus 113 f~~a~ 117 (241)
|+.+.
T Consensus 200 fe~a~ 204 (296)
T cd05153 200 FYFAC 204 (296)
T ss_pred hhhhc
Confidence 99763
|
Homoserine kinase is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of unusual homoserine kinases, from a subset of bacteria, which have a PK fold. These proteins do not bear any similarity to the GHMP family homoserine kinases present in most bacteria and eukaryotes. Homoserine kinase catalyzes the transfer of the gamma-phosphoryl group from ATP to L-homoserine producing L-homoserine phosphate, an intermediate in the production of the amino acids threonine, methionine, and isoleucine. |
| >TIGR02721 ycfN_thiK thiamine kinase | Back alignment and domain information |
|---|
Probab=96.91 E-value=0.0041 Score=48.28 Aligned_cols=29 Identities=21% Similarity=0.385 Sum_probs=23.8
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
.++|+|+.|.||++ ++++ +.++||+.+..
T Consensus 147 ~l~H~Dl~~~Nil~---~~~~-~~lIDwE~a~~ 175 (256)
T TIGR02721 147 APLHMDVHAYNLVV---TPQG-LKLIDWEYASD 175 (256)
T ss_pred eeecCCCCcCcEEE---eCCC-CEEEeccccCc
Confidence 48999999999999 4444 78999998744
|
Members of this family are the ycfN gene product of Escherichia coli, now identified as the salvage enzyme thiamine kinase (thiK), and additional proteobacterial homologs taken to be orthologs with equivalent function. |
| >COG5072 ALK1 Serine/threonine kinase of the haspin family [Cell division and chromosome partitioning] | Back alignment and domain information |
|---|
Probab=96.38 E-value=0.043 Score=44.55 Aligned_cols=74 Identities=26% Similarity=0.319 Sum_probs=57.7
Q ss_pred cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC-CccccCCCCCCeEEeecCCCceEEEeecCCc
Q 026253 38 ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLS 116 (241)
Q Consensus 38 ~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~~~~l~df~~a 116 (241)
....|++|++- |+++... +-...+++..++.+.+..+.-+..+ ..-|+++...||++ + +|+|.|+||.++
T Consensus 298 ~~y~yl~~kdh-gt~is~i----k~~~~~e~lsff~s~~sil~~lekkf~fehrnlt~~niLI---d-~GnvtLIDfkls 368 (488)
T COG5072 298 TLYLYLHFKDH-GTPISII----KADRSEEELSFFWSCISILDILEKKFPFEHRNLTLDNILI---D-EGNVTLIDFKLS 368 (488)
T ss_pred ceEEEEEEecC-Cceeeee----ecccHHHHHHHHHHHHHHHhhhhhcCCcccccccccceee---e-cCceEEEEeeee
Confidence 34567888876 6666532 2335778888999998888888765 68999999999999 5 889999999999
Q ss_pred cccC
Q 026253 117 CTLY 120 (241)
Q Consensus 117 ~~~~ 120 (241)
+...
T Consensus 369 Rl~~ 372 (488)
T COG5072 369 RLSY 372 (488)
T ss_pred eccc
Confidence 7543
|
|
| >PLN02421 phosphotransferase, alcohol group as acceptor/kinase | Back alignment and domain information |
|---|
Probab=96.18 E-value=0.014 Score=47.13 Aligned_cols=30 Identities=30% Similarity=0.490 Sum_probs=25.2
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
++|+|+.+.||++. ++++.++++||+.|..
T Consensus 184 ~CHnDl~~~NiL~~--~~~~~l~lID~EYag~ 213 (330)
T PLN02421 184 FAHNDLLSGNLMLN--EDEGKLYFIDFEYGSY 213 (330)
T ss_pred EEECCCCcccEEEe--CCCCcEEEEcccccCC
Confidence 79999999999994 3456799999998844
|
|
| >COG3001 Uncharacterized protein conserved in bacteria [Function unknown] | Back alignment and domain information |
|---|
Probab=96.13 E-value=0.025 Score=42.80 Aligned_cols=53 Identities=17% Similarity=0.226 Sum_probs=42.4
Q ss_pred hhhhhHHhhhhHHHHHHHHhcCC---CcCeeeeeeEEeecCeEEEEEeccCCCChH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~ 54 (241)
+|.........+..|+.-|+.|. .-.+.+++....+.++.|+|+||.+.+.+.
T Consensus 44 vK~n~~~~~~~f~AEa~gL~~la~s~ti~VP~vi~~G~~~~~sylVle~L~~~~~d 99 (286)
T COG3001 44 VKCNQREQLSMFTAEADGLELLARSNTITVPKVIAVGASRDHSYLVLEYLPTGPLD 99 (286)
T ss_pred EEecchhhHHHHHHHHHHHHHHHhcCCccccceEEecCCCCeeEEEEeeccCCCCC
Confidence 34455666788999999888883 356889999999999999999999876654
|
|
| >COG3173 Predicted aminoglycoside phosphotransferase [General function prediction only] | Back alignment and domain information |
|---|
Probab=95.89 E-value=0.045 Score=43.79 Aligned_cols=110 Identities=15% Similarity=0.241 Sum_probs=63.9
Q ss_pred hhhhHHHHHHHHhcCCC--cCeeeeeeEEeecC--eEEEEEeccCCCChH------------------HHHHhc------
Q 026253 9 LKSCLDCELNFLSSVNH--PNIIRLFDAFQAEN--CIFLVVEFCAGGNLS------------------SYIRLH------ 60 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~--~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~------------------~~l~~~------ 60 (241)
......+|+.+++.+.- --+...++++.++. ..+.||++++|..+. ++|..-
T Consensus 64 ~~~~~~re~~~i~~l~~~~vP~p~~~~~~~~~~~g~pf~v~~~veGe~~~~~~~~~~~~~~~~~~~l~~~La~LH~ida~ 143 (321)
T COG3173 64 SAHDEKREYRVIAALLDVDVPVPRAFGLCGEGYLGTPFYVMEWVEGEVVWSALPPESLGRQFALDALADFLAELHSIDAA 143 (321)
T ss_pred hhhHHHhHHHHHHHhcCCCCCCcccccccccCCCCCceEEEEEecceeccCcCCcccchHHHHHHHHHHHHHHHhCCCCc
Confidence 34567788999999843 23444555555544 679999999883221 111100
Q ss_pred -----C---CCCHHHHHHHHHH--------------HHHHHHHHHhC--------CccccCCCCCCeEEeecCCCceEEE
Q 026253 61 -----G---RVPEQTARKFLQQ--------------LGAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKI 110 (241)
Q Consensus 61 -----~---~~~~~~~~~~~~~--------------i~~~l~~lh~~--------~i~H~dl~~~nil~~~~~~~~~~~l 110 (241)
+ .....++..+..+ ......+++.+ .++|||+++.|+++ +++.-+-|
T Consensus 144 ~~~~~g~~~~~~~rql~~~~~~~~~~~~~~~~~~p~~~~~~~Wl~~~~p~~~~~~~lvHGD~~~gNlii---~~~~~~gV 220 (321)
T COG3173 144 GLPDPGKPNAYRGRQLARWDDEYRRAKKELGGRIPLADRLIKWLEANRPPWAGPPVLVHGDYRPGNLII---DPGRPTGV 220 (321)
T ss_pred CCCCCCccCccccchhhHHHHHHHHHHHhccCCCchHHHHHHHHHhcCCCcCCCceeeeCCcccCCEEE---eCCCeeEE
Confidence 0 0011112222221 12234455533 48999999999999 45555999
Q ss_pred eecCCccccCC
Q 026253 111 ADFGLSCTLYP 121 (241)
Q Consensus 111 ~df~~a~~~~~ 121 (241)
.||+.+..-.+
T Consensus 221 lDwe~~~lGDP 231 (321)
T COG3173 221 LDWELATLGDP 231 (321)
T ss_pred EeccccccCCc
Confidence 99998855433
|
|
| >KOG2270 consensus Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms; Cell cycle control, cell division, chromosome partitioning] | Back alignment and domain information |
|---|
Probab=95.76 E-value=0.055 Score=44.04 Aligned_cols=102 Identities=23% Similarity=0.189 Sum_probs=68.4
Q ss_pred HHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccC
Q 026253 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHIIHRD 91 (241)
Q Consensus 13 ~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~d 91 (241)
..+|++-|.+|...+|+-..-+.- ....|||+++.+..-..-.-+...++...+..+-.+++.-+.-|- ..++||.|
T Consensus 213 AEKE~RNLkRl~~aGIP~PePIlL--k~hVLVM~FlGrdgw~aPkLKd~~ls~~ka~~~Y~~~v~~MR~lY~~c~LVHAD 290 (520)
T KOG2270|consen 213 AEKEMRNLKRLNNAGIPCPEPILL--KNHVLVMEFLGRDGWAAPKLKDASLSTSKARELYQQCVRIMRRLYQKCRLVHAD 290 (520)
T ss_pred HHHHHHHHHHHHhcCCCCCCceee--ecceEeeeeccCCCCcCcccccccCChHHHHHHHHHHHHHHHHHHHHhceeccc
Confidence 467888888988777654443333 235799999843211111112234665666666667777766654 46899999
Q ss_pred CCCCCeEEeecCCCceEEEeecCCccccC
Q 026253 92 LKPENILLSGLDDDVMLKIADFGLSCTLY 120 (241)
Q Consensus 92 l~~~nil~~~~~~~~~~~l~df~~a~~~~ 120 (241)
|+-.|+|+ -++.+.++|.+.+....
T Consensus 291 LSEfN~Ly----hdG~lyiIDVSQSVE~D 315 (520)
T KOG2270|consen 291 LSEFNLLY----HDGKLYIIDVSQSVEHD 315 (520)
T ss_pred hhhhhheE----ECCEEEEEEccccccCC
Confidence 99999998 57789999998875543
|
|
| >PTZ00384 choline kinase; Provisional | Back alignment and domain information |
|---|
Probab=95.67 E-value=0.072 Score=43.99 Aligned_cols=30 Identities=27% Similarity=0.179 Sum_probs=24.3
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
...+|.|+.+.||+. .++.+.++||..|..
T Consensus 227 ~VfCHNDL~~gNIL~----~~~~l~lID~EYA~~ 256 (383)
T PTZ00384 227 VLFCHNDLFFTNILD----FNQGIYFIDFDFAGF 256 (383)
T ss_pred eeeeeccCCcccEEe----cCCCEEEEEeccccC
Confidence 357999999999997 345699999998743
|
|
| >cd05157 ETNK_euk Ethanolamine kinase (ETNK) in eukaryotes | Back alignment and domain information |
|---|
Probab=95.23 E-value=0.027 Score=43.00 Aligned_cols=30 Identities=23% Similarity=0.418 Sum_probs=24.7
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCcc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~ 117 (241)
+++|+|+.+.||+++ +.++.+.++||..|.
T Consensus 171 ~l~H~Dl~~~Nil~~--~~~~~~~lIDwe~a~ 200 (235)
T cd05157 171 VFCHNDLLSGNIIYN--EEKNSVKFIDYEYAG 200 (235)
T ss_pred EEEcCCCCcCcEEEe--CCCCCEEEEEcccCC
Confidence 589999999999994 224679999998773
|
ETNK is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major phospholipid, phosphatidylethanolamine (PtdEtn). Unlike ChoK, ETNK shows specific activity for its substrate, and displays negligible activity towards N-methylated derivatives of Etn. The Drosophila ETNK is implicated in development and neuronal function. Mammals contain two ETNK proteins, ETNK1 and ETNK2. ETNK1 selectively increases Etn uptake and phosphorylation, as well as PtdEtn synthesis. ETNK2 is found primarily in the liver and reproductive tissues. It plays a critical role in regulating placental hemostasis to support late embryo |
| >TIGR00938 thrB_alt homoserine kinase, Neisseria type | Back alignment and domain information |
|---|
Probab=95.07 E-value=0.056 Score=43.22 Aligned_cols=30 Identities=40% Similarity=0.798 Sum_probs=25.2
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCcc
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~ 117 (241)
.+++|+|+++.|+++ ++++...|+||+.+.
T Consensus 187 ~~l~HgD~~~~Nvl~---~~~~~~~vIDfd~~~ 216 (307)
T TIGR00938 187 RGVIHADLFPDNVLF---DGDSVKGVIDFYFAC 216 (307)
T ss_pred CccCCCCCCcCcEEE---ECCceEEEeeccccc
Confidence 589999999999999 455567899999763
|
Homoserine kinase is required in the biosynthesis of threonine from aspartate.The member of this family from Pseudomonas aeruginosa was shown by direct assay and complementation to act specifically as a homoserine kinase. |
| >PRK05231 homoserine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.96 E-value=0.074 Score=42.71 Aligned_cols=31 Identities=32% Similarity=0.644 Sum_probs=25.2
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
.+++|+|+.+.||++ +++....++||+.++.
T Consensus 187 ~~liHgD~~~~Nil~---~~~~~~~iIDf~~~~~ 217 (319)
T PRK05231 187 RGVIHADLFRDNVLF---EGDRLSGFIDFYFACN 217 (319)
T ss_pred cccCCCCCCCCcEEE---ECCceEEEEecccccC
Confidence 379999999999999 4455568999998743
|
|
| >PF13095 FTA2: Kinetochore Sim4 complex subunit FTA2 | Back alignment and domain information |
|---|
Probab=94.86 E-value=0.26 Score=36.74 Aligned_cols=85 Identities=21% Similarity=0.310 Sum_probs=58.7
Q ss_pred hhHHHHHHHHhcCC---CcCe--eeeeeEEeec------------------CeEEEEEeccCCCChHHHHHhcCCCCHHH
Q 026253 11 SCLDCELNFLSSVN---HPNI--IRLFDAFQAE------------------NCIFLVVEFCAGGNLSSYIRLHGRVPEQT 67 (241)
Q Consensus 11 ~~~~~E~~~l~~l~---~~~i--~~~~~~~~~~------------------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~ 67 (241)
+-+..|-+.+.+|+ ++++ ++++|+..-. ....||.||..... .+....
T Consensus 99 ~PF~~ECRAfgRLke~~~e~~~Avkc~Gyl~L~~~~q~~~~~~~~~~~~~~~~~aIVKD~v~~~~---------~~~~~~ 169 (207)
T PF13095_consen 99 DPFNCECRAFGRLKEAGREGLWAVKCHGYLLLTEDQQFEQLRQRGSDHRPLPIRAIVKDFVPDDP---------PLQIRD 169 (207)
T ss_pred ChHHHHHHhhHHHHhccccCceEEEeeEEEEEchHHHHHHhhcccccCCCCccEEEEEeecCCcc---------ccchhH
Confidence 45777888877773 5556 8999987321 12467888775533 233333
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCc
Q 026253 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116 (241)
Q Consensus 68 ~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a 116 (241)
+ .++.+-+..+|..||+-+|+++.|..= -+|+|||.+
T Consensus 170 ~----~~~~~dl~~~~k~gI~~~Dv~~~ny~~--------G~lvDfs~~ 206 (207)
T PF13095_consen 170 I----PQMLRDLKILHKLGIVPRDVKPRNYRG--------GKLVDFSSS 206 (207)
T ss_pred H----HHHHHHHHHHHHCCeeeccCccccccC--------CEEEecccC
Confidence 3 456666777899999999999999872 279999864
|
|
| >TIGR02906 spore_CotS spore coat protein, CotS family | Back alignment and domain information |
|---|
Probab=94.82 E-value=0.076 Score=42.40 Aligned_cols=28 Identities=32% Similarity=0.459 Sum_probs=23.6
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCc
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a 116 (241)
.+++|||+.+.||+++ + +.+.++||+.+
T Consensus 187 ~~liHgD~~~~Nil~~---~-~~i~lIDfd~~ 214 (313)
T TIGR02906 187 RGFCHQDYAYHNILLK---D-NEVYVIDFDYC 214 (313)
T ss_pred CceEcCCCCcccEEEe---C-CcEEEEECccc
Confidence 4789999999999994 4 56889999965
|
Members of this family include the spore coat proteins CotS and YtaA from Bacillus subtilis and, from other endospore-forming bacteria, homologs that are more closely related to these two than to the spore coat proteins YutH and YsxE. The CotS family is more broadly distributed than YutH or YsxE, but still is not universal among spore-formers. |
| >cd05156 ChoK_euk Choline Kinase (ChoK) in eukaryotes | Back alignment and domain information |
|---|
Probab=94.68 E-value=0.067 Score=42.60 Aligned_cols=29 Identities=34% Similarity=0.465 Sum_probs=24.7
Q ss_pred CccccCCCCCCeEEeecCC----CceEEEeecCCcc
Q 026253 86 HIIHRDLKPENILLSGLDD----DVMLKIADFGLSC 117 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~----~~~~~l~df~~a~ 117 (241)
.++|+|+.+.||++ ++ .+.+.++||..|.
T Consensus 180 ~lcH~Dl~~~Nil~---~~~~~~~~~i~lIDwEya~ 212 (302)
T cd05156 180 VFCHNDLQEGNILL---LNPSSETKKLVLIDFEYAS 212 (302)
T ss_pred eEEecCCCcCeEEe---cCCCCCCCcEEEEeeCCCC
Confidence 57999999999999 44 3679999999873
|
The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC) and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. ChoK plays an important role in cell signaling pathways and the regulation of cell growth. Along with PCho, it is involved in malignant transformation through Ras oncogenes in various human cancer |
| >COG0510 ycfN Thiamine kinase and related kinases [Coenzyme transport and metabolism] | Back alignment and domain information |
|---|
Probab=94.64 E-value=0.071 Score=41.77 Aligned_cols=50 Identities=32% Similarity=0.385 Sum_probs=37.0
Q ss_pred HHHHHHHHHHHHHHHHHHhC--CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 66 QTARKFLQQLGAGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 66 ~~~~~~~~~i~~~l~~lh~~--~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
..+.+.+..+-..+...+.. -++|+|+.|.|++. ++.+.+.|+||..|..
T Consensus 132 ~~~~~~~~~l~~~l~~~~~~~~v~cH~Dl~~~N~l~---t~~~~l~LIDWEyAg~ 183 (269)
T COG0510 132 HLLRKKLKELRRALEEVPKDDLVPCHNDLNPGNLLL---TDKGGLFLIDWEYAGL 183 (269)
T ss_pred HHHHHHHHHHHHHhhhcCCCceeeecCCCCccceEE---cCCCcEEEEecccCCC
Confidence 33444555555555555544 58999999999999 6678999999998744
|
|
| >PRK10593 hypothetical protein; Provisional | Back alignment and domain information |
|---|
Probab=94.34 E-value=0.12 Score=41.22 Aligned_cols=71 Identities=13% Similarity=0.067 Sum_probs=52.0
Q ss_pred hhhHHHHHHHHhcCCC---cCeeeeeeEEee---cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNH---PNIIRLFDAFQA---ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~---~~i~~~~~~~~~---~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
...+..|...++.|.- -.++++++.+.. .+..++|||+++|.++.+. .........+..+++.+++.||
T Consensus 51 ~~~~~~Ea~~L~~L~~~~~vpVP~V~~~~~~~~~~g~~~LVmE~i~G~~~~~~-----~~~~~~~~~l~~~l~~~La~LH 125 (297)
T PRK10593 51 PGVAQQEAWKLSMLARSGTVRMPTVYGVMTHEQSPGPDVLLLERLRGVSVEAP-----ARTPERWEQLKDQIVEGLLAWH 125 (297)
T ss_pred chHHHHHHHHHHHHccCCCCCcCcEEEEeccCCcCCCeEEEEeccCCEecCCC-----CCCHHHHHHHHHHHHHHHHHHh
Confidence 4689999999999943 357888887754 3668999999999877651 1233345566677788888888
Q ss_pred hC
Q 026253 84 SH 85 (241)
Q Consensus 84 ~~ 85 (241)
+.
T Consensus 126 ~~ 127 (297)
T PRK10593 126 RI 127 (297)
T ss_pred CC
Confidence 74
|
|
| >PRK10271 thiK thiamine kinase; Provisional | Back alignment and domain information |
|---|
Probab=94.06 E-value=0.048 Score=40.08 Aligned_cols=29 Identities=17% Similarity=0.341 Sum_probs=24.0
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
-.+|+|+.|.|+++ ++++ ++++||+.+..
T Consensus 78 ~p~H~D~~~~N~~~---~~~~-~~lIDwe~a~~ 106 (188)
T PRK10271 78 APLHMDVHAGNLVH---SASG-LRLIDWEYAGD 106 (188)
T ss_pred eeecCCCCCccEEE---ECCC-EEEEeCCcccC
Confidence 36999999999998 4555 88999998844
|
|
| >PF07387 Seadorna_VP7: Seadornavirus VP7; InterPro: IPR009973 This family consists of several Seadornavirus specific VP7 proteins of around 305 residues in length | Back alignment and domain information |
|---|
Probab=93.85 E-value=0.3 Score=37.11 Aligned_cols=86 Identities=21% Similarity=0.239 Sum_probs=55.7
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh--CCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS--HHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~--~~i 87 (241)
.+-+.++++++.++. +|+++..- ..-.+.++.|.|-.... . ...++..=+.+|.-.|+ .+.
T Consensus 102 ~~~y~nky~v~Armh--GilrL~ND--n~~~yGvIlE~Cy~~~i---------~----~~N~i~agi~~L~~fH~~~~~~ 164 (308)
T PF07387_consen 102 DALYFNKYRVFARMH--GILRLKND--NNYKYGVILERCYKIKI---------N----FSNFITAGIKDLMDFHSENQHC 164 (308)
T ss_pred hhhhhhhhhHHHHhh--heeEeecC--CCceeEEEEeeccCccc---------c----hhHHHHHhHHHHHHhhccCCCe
Confidence 345577777777663 56666622 22246688898843111 1 11222222456677784 479
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGL 115 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~ 115 (241)
.|||.+|+||+. +..+-+||.|-+.
T Consensus 165 lHGD~np~NiM~---D~~G~lKlVDP~~ 189 (308)
T PF07387_consen 165 LHGDCNPDNIMC---DKFGYLKLVDPVC 189 (308)
T ss_pred ecCCCChhheee---cCCCCEEecChhh
Confidence 999999999999 8899999998764
|
The function of this family is unknown. |
| >PLN02236 choline kinase | Back alignment and domain information |
|---|
Probab=93.38 E-value=0.13 Score=41.86 Aligned_cols=31 Identities=23% Similarity=0.454 Sum_probs=25.5
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
.++|+|+++.||+++ ++++.+.++||..+..
T Consensus 201 ~~cH~Dl~~~Nil~~--~~~~~~~lID~Eya~~ 231 (344)
T PLN02236 201 GFCHNDLQYGNIMID--EETRAITIIDYEYASY 231 (344)
T ss_pred eEEeCCCCcCcEEEe--CCCCcEEEEeehhccc
Confidence 589999999999994 3346799999998743
|
|
| >PF01633 Choline_kinase: Choline/ethanolamine kinase; InterPro: IPR002573 Choline kinase, (ATP:choline phosphotransferase, 2 | Back alignment and domain information |
|---|
Probab=92.93 E-value=0.15 Score=38.31 Aligned_cols=30 Identities=37% Similarity=0.613 Sum_probs=20.4
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCcc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~ 117 (241)
.++|+|+.+.||++. +.++.++++||..|.
T Consensus 144 v~cHnDl~~~Nil~~--~~~~~~~lIDfEya~ 173 (211)
T PF01633_consen 144 VFCHNDLNPGNILIN--NKDGEVKLIDFEYAG 173 (211)
T ss_dssp EEE-S--SGGGEEET--SSSSCEEE--GTT-E
T ss_pred eEeeccCccccEEec--cCCCeEEEecHHHHh
Confidence 589999999999994 577889999999873
|
7.1.32 from EC) belongs to the choline/ethanolamine kinase family. Ethanolamine and choline are major membrane phospholipids, in the form of glycerophosphoethanolamine and glycerophosphocholine. Ethanolamine is also a component of the glycosylphosphatidylinositol (GPI) anchor, which is necessary for cell-surface protein attachment []. The de novo synthesis of these phospholipids begins with the creation of phosphoethanolamine and phosphocholine by ethanolamine and choline kinases in the first step of the CDP-ethanolamine pathway [, ]. There are two putative choline/ethanolamine kinases (C/EKs) in the Trypanosoma brucei genome. Ethanolamine kinase has no choline kinase activity [] and its activity is inhibited by ADP []. Inositol supplementation represses ethanolamine kinase, decreasing the incorporation of ethanolamine into the CDP-ethanolamine pathway and into phosphatidylethanolamine and phosphatidylcholine []. ; GO: 0016773 phosphotransferase activity, alcohol group as acceptor; PDB: 3C5I_A 2IG7_A 3LQ3_A 3FEG_A 2QG7_E 3FI8_A 1NW1_A 3MES_A 3G15_A 2CKP_B .... |
| >TIGR02904 spore_ysxE spore coat protein YsxE | Back alignment and domain information |
|---|
Probab=92.84 E-value=0.2 Score=40.06 Aligned_cols=30 Identities=17% Similarity=0.207 Sum_probs=26.2
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
+++|+|+.+.|+++ ++++.+.++||..++.
T Consensus 197 ~lcHgD~~~~Nvl~---~~~~~~~iIDfd~~~~ 226 (309)
T TIGR02904 197 VLVHGKLSLSHFLY---DETRGGYFINFEKASF 226 (309)
T ss_pred eeeCCCCcHHhEEE---cCCCCEEEEEhhhccc
Confidence 79999999999999 6777889999998744
|
Members of this family are homologs of the Bacillus subtilis spore coat protein CotS. Members of this family, designated YsxE, are found only in the family Bacillaceae, from among the endospore-forming members of the Firmicutes branch of the Bacteria. As a rule, the ysxE gene is found immediately downstream of spoVID, a gene necessary for spore coat assembly. The protein has been shown to be part of the spore coat. |
| >COG2334 Putative homoserine kinase type II (protein kinase fold) [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.65 E-value=0.22 Score=40.28 Aligned_cols=28 Identities=46% Similarity=0.775 Sum_probs=23.5
Q ss_pred ccccCCCCCCeEEeecCCCc-eEEEeecCCcc
Q 026253 87 IIHRDLKPENILLSGLDDDV-MLKIADFGLSC 117 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~-~~~l~df~~a~ 117 (241)
++|+|+.|.||++ +.+. .+.+.||+-++
T Consensus 199 iIH~D~~~~NVl~---d~~~~~~g~iDFdDa~ 227 (331)
T COG2334 199 IIHGDLHPDNVLF---DDDTDVSGFIDFDDAG 227 (331)
T ss_pred eeecCCCccceeE---cCCCCeeeEEEccccc
Confidence 9999999999999 4444 58899999763
|
|
| >PHA03111 Ser/Thr kinase; Provisional | Back alignment and domain information |
|---|
Probab=92.16 E-value=0.36 Score=38.90 Aligned_cols=47 Identities=23% Similarity=0.403 Sum_probs=30.0
Q ss_pred HHHHHHHHHHHHHHHHHH----hCCccccCCCCCCeEEeecCCCceEEEee
Q 026253 66 QTARKFLQQLGAGLEILN----SHHIIHRDLKPENILLSGLDDDVMLKIAD 112 (241)
Q Consensus 66 ~~~~~~~~~i~~~l~~lh----~~~i~H~dl~~~nil~~~~~~~~~~~l~d 112 (241)
+-+.-+..|++.-.-.+- ..+.+|.||||.|||+-+.+....+++++
T Consensus 279 ~YikfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~~~~ 329 (444)
T PHA03111 279 EYIKFIFLQIALLYIKIYELPCCDNFLHVDLKPDNILIFDSDEPISITLKD 329 (444)
T ss_pred HHHHHHHHHHHHHHHhhhcCCCcceeeeccCCCCcEEEecCCCcEEEEECC
Confidence 345556667766542332 34799999999999996544444455443
|
|
| >smart00587 CHK ZnF_C4 abd HLH domain containing kinases domain | Back alignment and domain information |
|---|
Probab=92.16 E-value=0.42 Score=35.49 Aligned_cols=32 Identities=31% Similarity=0.391 Sum_probs=23.8
Q ss_pred CCccccCCCCCCeEEeecCC--CceEEEeecCCc
Q 026253 85 HHIIHRDLKPENILLSGLDD--DVMLKIADFGLS 116 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~--~~~~~l~df~~a 116 (241)
..++|||+.+.|+++....+ ...+.+.||..+
T Consensus 120 ~vl~HgD~~~~N~~~~~~~~~~~~~~~liDfq~~ 153 (196)
T smart00587 120 NVLNHGDLWANNIMFKYDDEGKPEDVALIDFQLS 153 (196)
T ss_pred eEEeeCCCCccceeeccCCCCCccceEEEecccC
Confidence 35899999999999952111 126899999876
|
subfamily of choline kinases |
| >KOG1236 consensus Predicted unusual protein kinase [General function prediction only] | Back alignment and domain information |
|---|
Probab=92.04 E-value=0.8 Score=38.13 Aligned_cols=61 Identities=23% Similarity=0.367 Sum_probs=45.4
Q ss_pred eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH-HHHHhCCccccCCCCCCeEEee
Q 026253 40 CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL-EILNSHHIIHRDLKPENILLSG 101 (241)
Q Consensus 40 ~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l-~~lh~~~i~H~dl~~~nil~~~ 101 (241)
...++-+|..|.++..+++. ...+++...+++.-...|+ ..+--.+++|.|++|.||++..
T Consensus 319 ~~vl~E~~~~Gl~v~~~v~~-~~~pe~l~kkva~lg~~AllkMl~vDNFvHaDlHPGNVlirf 380 (565)
T KOG1236|consen 319 DLVLVETYERGLSVLRFVKW-KSQPEALVKKVAKLGVNALLKMLIVDNFVHADLHPGNVLIRF 380 (565)
T ss_pred cceeeeeccccccHHhhhhc-ccChHHHHHHHHHHHHHHHHHHHHhhcceecccCCCcEEEEe
Confidence 35577789999999999874 3455666667766666664 4455678999999999999964
|
|
| >cd05152 MPH2' Macrolide 2'-Phosphotransferase (MPH2') | Back alignment and domain information |
|---|
Probab=91.72 E-value=0.14 Score=40.25 Aligned_cols=31 Identities=26% Similarity=0.501 Sum_probs=23.7
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
.++|+|+++.||+++ ++....-|.||+.+..
T Consensus 186 ~lvHGD~~~~Nilv~--~~~~~~gviDWe~a~i 216 (276)
T cd05152 186 VLVHGDLHPGHILID--EDARVTGLIDWTEAKV 216 (276)
T ss_pred eeEeCCCCCCcEEEe--CCCCEEEEECcHhccc
Confidence 489999999999994 2233467999998743
|
MPH2' is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). MPH2' catalyzes the transfer of the gamma-phosphoryl group from ATP to the 2'-hydroxyl of macrolide antibiotics such as erythromycin, clarithromycin, and azithromycin, among others. Macrolides penetrate the bacterial cell and bind to ribosomes, where it interrupts protein elongation, leading ultimately to the demise of the bacterium. Phosphorylation of macrolides leads to their inactivation. Based on substrate specificity and amino acid sequence, MPH2' is divided into types I and II, encoded by mphA and mphB genes, respectively. MPH2'I inactivates 14-membered ring macrolides while MPH2'II inactivates both 14- and 16-membered ring macrolides. Enzymatic inactivation of macrolides has been reported |
| >PF03881 Fructosamin_kin: Fructosamine kinase; InterPro: IPR016477 Ketosamines derive from a non-enzymatic reaction between a sugar and a protein [] | Back alignment and domain information |
|---|
Probab=91.28 E-value=0.18 Score=39.94 Aligned_cols=50 Identities=16% Similarity=0.190 Sum_probs=32.9
Q ss_pred hhhhhHHhhhhHHHHHHHHhcCC---CcCeeeeeeEEeecCeEEEEEeccCCC
Q 026253 2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGG 51 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~~~ 51 (241)
+|.........+..|+.-|+.|. .-.++++++....++..++|+||++.+
T Consensus 45 vK~~~~~~~~~f~~Ea~gL~~L~~~~~~~vP~vi~~G~~~~~~fLlle~l~~~ 97 (288)
T PF03881_consen 45 VKVNSESGRDMFEGEAEGLKALAEANPIRVPKVIAWGEYDDDAFLLLEFLEMG 97 (288)
T ss_dssp EEEEEGGGCCHHHHHHHHHHHHCHTTTSBS--EEEEEE-SSCCEEEEE-----
T ss_pred EEecChhhHHHHHHHHHHHHHHHhcCCCCCCeEEEEEeecCCceEEEEeecCC
Confidence 34445556778999999999993 445889999888877789999999765
|
Ketosamine-3-kinases (KT3K), of which fructosamine-3-kinase (FN3K) is the best-known example, catalyse the phosphorylation of the ketosamine moiety of glycated proteins. The instability of a phosphorylated ketosamine leads to its degradation, and KT3K is thus thought to be involved in protein repair []. The function of the prokaryotic members of this group has not been established. However, several lines of evidence indicate that they may function as fructosamine-3-kinases (FN3K). First, they are similar to characterised FN3K from mouse and human. Second, the Escherichia coli members are found in close proximity on the genome to fructose-6-phosphate kinase (PfkB). Last, FN3K activity has been found in a Anacystis montana (Gloeocapsa montana Kutzing 1843) [], indicating such activity-directly demonstrated in eukaryotes-is nonetheless not confined to eukaryotes. This family includes eukaryotic fructosamine-3-kinase enzymes [] which may initiate a process leading to the deglycation of fructoselysine and of glycated proteins and in the phosphorylation of 1-deoxy-1-morpholinofructose, fructoselysine, fructoseglycine, fructose and glycated lysozyme. The family also includes bacterial members that have not been characterised but probably have a similar or identical function. For additional information please see [].; PDB: 3JR1_B 3F7W_A. |
| >PRK11768 serine/threonine protein kinase; Provisional | Back alignment and domain information |
|---|
Probab=91.05 E-value=0.41 Score=38.68 Aligned_cols=28 Identities=29% Similarity=0.303 Sum_probs=23.0
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCcc
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~ 117 (241)
.+++|+|+.+.||++ ++ .+.++||+.+.
T Consensus 196 ~~liHgD~h~~NvL~---~d--~~~iIDFDd~~ 223 (325)
T PRK11768 196 LLRLHGDCHPGNILW---RD--GPHFVDLDDAR 223 (325)
T ss_pred ccceecCCCchhccc---cC--CcEEEeCCCCC
Confidence 368999999999999 33 47899999763
|
|
| >PF05445 Pox_ser-thr_kin: Poxvirus serine/threonine protein kinase; InterPro: IPR008790 This family of proteins contain poxvirus serine/threonine protein kinases, which are essential for phosphorylation of virion proteins during virion assembly | Back alignment and domain information |
|---|
Probab=89.99 E-value=0.41 Score=38.74 Aligned_cols=43 Identities=26% Similarity=0.372 Sum_probs=26.3
Q ss_pred HHHHHHHHHHHHHH---HHH-hCCccccCCCCCCeEEeecCCCceEE
Q 026253 67 TARKFLQQLGAGLE---ILN-SHHIIHRDLKPENILLSGLDDDVMLK 109 (241)
Q Consensus 67 ~~~~~~~~i~~~l~---~lh-~~~i~H~dl~~~nil~~~~~~~~~~~ 109 (241)
-+.-+..|++.-.- .+- ..+.+|.||||.|||+-+......++
T Consensus 276 YvkfifLQiaLLyikIYelp~c~nF~H~DLKPdNILiFds~~~i~I~ 322 (434)
T PF05445_consen 276 YVKFIFLQIALLYIKIYELPCCTNFLHVDLKPDNILIFDSKEPIRIK 322 (434)
T ss_pred HHHHHHHHHHHHHeeeecCCCcceeeecccCcCcEEEecCCCceEEE
Confidence 34455566655431 221 34799999999999996444433333
|
; GO: 0004672 protein kinase activity, 0005524 ATP binding |
Homologous Structure Templates
Structure Templates Detected by BLAST
Original result of BLAST against Protein Data Bank
| ID | Alignment Graph | Length |
Definition |
E-value | |
| Query | 241 | ||||
| 2wzj_A | 327 | Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82 | 5e-37 | ||
| 2r0i_A | 327 | Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len | 6e-37 | ||
| 1zmv_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-37 | ||
| 1zmu_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-37 | ||
| 2qnj_A | 328 | Kinase And Ubiquitin-Associated Domains Of Mark3PAR | 9e-37 | ||
| 1zmw_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 2e-36 | ||
| 3fe3_A | 328 | Crystal Structure Of The Kinase Mark3PAR-1: T211a-S | 2e-36 | ||
| 2hak_A | 328 | Catalytic And Ubiqutin-Associated Domains Of Mark1P | 4e-36 | ||
| 3iec_A | 319 | Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K | 6e-36 | ||
| 3lij_A | 494 | Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) | 2e-35 | ||
| 3h4j_B | 336 | Crystal Structure Of Pombe Ampk Kdaid Fragment Leng | 4e-35 | ||
| 2wei_A | 287 | Crystal Structure Of The Kinase Domain Of Cryptospo | 7e-35 | ||
| 3dfa_A | 286 | Crystal Structure Of Kinase Domain Of Calcium-depen | 7e-35 | ||
| 1y8g_A | 327 | Catalytic And Ubiqutin-Associated Domains Of Mark2P | 7e-35 | ||
| 3igo_A | 486 | Crystal Structure Of Cryptosporidium Parvum Cdpk1, | 1e-34 | ||
| 3dxn_A | 287 | Crystal Structure Of The Calcium-dependent Kinase F | 9e-34 | ||
| 3hzt_A | 467 | Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4 | 1e-33 | ||
| 3mn3_A | 271 | An Inhibited Conformation For The Protein Kinase Do | 2e-33 | ||
| 3hyh_A | 275 | Crystal Structure Of The Protein Kinase Domain Of Y | 2e-33 | ||
| 3dae_A | 283 | Crystal Structure Of Phosphorylated Snf1 Kinase Dom | 2e-33 | ||
| 2fh9_A | 274 | Structure And Dimerization Of The Kinase Domain Fro | 2e-33 | ||
| 3q5i_A | 504 | Crystal Structure Of Pbanka_031420 Length = 504 | 3e-33 | ||
| 2ycf_A | 322 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-33 | ||
| 2w0j_A | 323 | Crystal Structure Of Chk2 In Complex With Nsc 10955 | 5e-33 | ||
| 2ycr_A | 323 | Crystal Structure Of Checkpoint Kinase 2 In Complex | 5e-33 | ||
| 2xk9_A | 322 | Structural Analysis Of Checkpoint Kinase 2 (Chk2) I | 6e-33 | ||
| 2cn5_A | 329 | Crystal Structure Of Human Chk2 In Complex With Adp | 6e-33 | ||
| 3i6u_A | 419 | Structure And Activation Mechanism Of The Chk2 Dna- | 9e-33 | ||
| 3i6w_A | 443 | Structure And Activation Mechanism Of The Chk2 Dna- | 1e-32 | ||
| 1a06_A | 332 | Calmodulin-Dependent Protein Kinase From Rat Length | 4e-32 | ||
| 2y7j_A | 365 | Structure Of Human Phosphorylase Kinase, Gamma 2 Le | 5e-32 | ||
| 4fg7_A | 293 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-32 | ||
| 4fg9_A | 320 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-32 | ||
| 4fg8_A | 315 | Crystal Structure Of Human Calcium/calmodulin-depen | 7e-32 | ||
| 1phk_A | 298 | Two Structures Of The Catalytic Domain Of Phosphory | 1e-31 | ||
| 3ma6_A | 298 | Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr | 1e-31 | ||
| 2phk_A | 277 | The Crystal Structure Of A Phosphorylase Kinase Pep | 1e-31 | ||
| 2y94_A | 476 | Structure Of An Active Form Of Mammalian Ampk Lengt | 1e-31 | ||
| 3i79_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 1e-31 | ||
| 1ql6_A | 298 | The Catalytic Mechanism Of Phosphorylase Kinase Pro | 2e-31 | ||
| 3ku2_A | 507 | Crystal Structure Of Inactivated Form Of Cdpk1 From | 2e-31 | ||
| 3hx4_A | 508 | Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg | 2e-31 | ||
| 2h6d_A | 276 | Protein Kinase Domain Of The Human 5'-Amp-Activated | 3e-31 | ||
| 2yza_A | 276 | Crystal Structure Of Kinase Domain Of Human 5'-Amp- | 4e-31 | ||
| 3i7c_A | 484 | Calcium-Dependent Protein Kinase 1 From Toxoplasma | 7e-31 | ||
| 3a60_A | 327 | Crystal Structure Of Unphosphorylated P70s6k1 (Form | 1e-30 | ||
| 3a62_A | 327 | Crystal Structure Of Phosphorylated P70s6k1 Length | 1e-30 | ||
| 1fot_A | 318 | Structure Of The Unliganded Camp-Dependent Protein | 1e-30 | ||
| 2jc6_A | 334 | Crystal Structure Of Human Calmodulin-Dependent Pro | 2e-30 | ||
| 2bfy_A | 284 | Complex Of Aurora-B With Incenp And Hesperidin. Len | 4e-30 | ||
| 2bfx_B | 284 | Mechanism Of Aurora-B Activation By Incenp And Inhi | 4e-30 | ||
| 2vrx_A | 285 | Structure Of Aurora B Kinase In Complex With Zm4474 | 5e-30 | ||
| 3daj_A | 272 | Crystal Structure Of Aurora A Complexed With An Inh | 9e-30 | ||
| 3ka0_A | 320 | Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4 | 1e-29 | ||
| 3d14_A | 272 | Crystal Structure Of Mouse Aurora A (Asn186->gly, L | 2e-29 | ||
| 3bhy_A | 283 | Crystal Structure Of Human Death Associated Protein | 2e-29 | ||
| 3fpm_A | 325 | Crystal Structure Of A Squarate Inhibitor Bound To | 2e-29 | ||
| 3r2y_A | 319 | Mk2 Kinase Bound To Compound 1 Length = 319 | 2e-29 | ||
| 3r2b_A | 318 | Mk2 Kinase Bound To Compound 5b Length = 318 | 2e-29 | ||
| 2pzy_A | 324 | Structure Of Mk2 Complexed With Compound 76 Length | 2e-29 | ||
| 2jbo_A | 326 | Protein Kinase Mk2 In Complex With An Inhibitor (Cr | 2e-29 | ||
| 2p3g_X | 327 | Crystal Structure Of A Pyrrolopyridine Inhibitor Bo | 2e-29 | ||
| 3gok_A | 334 | Binding Site Mapping Of Protein Ligands Length = 33 | 2e-29 | ||
| 2onl_C | 406 | Crystal Structure Of The P38a-Mapkap Kinase 2 Heter | 2e-29 | ||
| 2oza_A | 356 | Structure Of P38alpha Complex Length = 356 | 2e-29 | ||
| 1kwp_A | 400 | Crystal Structure Of Mapkap2 Length = 400 | 2e-29 | ||
| 2w4o_A | 349 | Crystal Structure Of Human Camk4 In Complex With 4- | 2e-29 | ||
| 1yrp_A | 278 | Catalytic Domain Of Human Zip Kinase Phosphorylated | 3e-29 | ||
| 2j90_A | 304 | Crystal Structure Of Human Zip Kinase In Complex Wi | 3e-29 | ||
| 2vn9_A | 301 | Crystal Structure Of Human Calcium Calmodulin Depen | 6e-29 | ||
| 2wel_A | 327 | Crystal Structure Of Su6656-Bound CalciumCALMODULIN | 7e-29 | ||
| 3is5_A | 285 | Crystal Structure Of Cdpk Kinase Domain From Toxopl | 1e-28 | ||
| 3r1n_A | 317 | Mk3 Kinase Bound To Compound 5b Length = 317 | 1e-28 | ||
| 3fhr_A | 336 | High Resolution Crystal Structure Of Mitogen-Activa | 1e-28 | ||
| 2jam_A | 304 | Crystal Structure Of Human Calmodulin-Dependent Pro | 1e-28 | ||
| 3f3z_A | 277 | Crystal Structure Of Cryptosporidium Parvum Calcium | 1e-28 | ||
| 2qg5_A | 294 | Cryptosporidium Parvum Calcium Dependent Protein Ki | 2e-28 | ||
| 1koa_A | 491 | Twitchin Kinase Fragment (C.Elegans), Autoregulated | 3e-28 | ||
| 3uto_A | 573 | Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin- | 3e-28 | ||
| 3cok_A | 278 | Crystal Structure Of Plk4 Kinase Length = 278 | 4e-28 | ||
| 2ya9_A | 361 | Crystal Structure Of The Autoinhibited Form Of Mous | 5e-28 | ||
| 2xuu_A | 334 | Crystal Structure Of A Dap-Kinase 1 Mutant Length = | 6e-28 | ||
| 2w4k_A | 302 | X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | 9e-28 | ||
| 3dfc_B | 295 | Crystal Structure Of A Glycine-Rich Loop Mutant Of | 9e-28 | ||
| 3gu4_A | 295 | Crystal Structure Of Dapkq23v-Amppnp Length = 295 | 9e-28 | ||
| 2w4j_A | 277 | X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | 9e-28 | ||
| 1wvw_A | 278 | Crystal Structures Of Kinase Domain Of Dap Kinase I | 9e-28 | ||
| 2xzs_A | 312 | Death Associated Protein Kinase 1 Residues 1-312 Le | 9e-28 | ||
| 2yak_A | 285 | Structure Of Death-Associated Protein Kinase 1 (Dap | 9e-28 | ||
| 2z7q_A | 321 | Crystal Structure Of The N-Terminal Kinase Domain O | 9e-28 | ||
| 2x0g_A | 334 | X-ray Structure Of A Dap-kinase Calmodulin Complex | 9e-28 | ||
| 3f5u_A | 295 | Crystal Structure Of The Death Associated Protein K | 1e-27 | ||
| 1p4f_A | 293 | Death Associated Protein Kinase Catalytic Domain Wi | 1e-27 | ||
| 1ig1_A | 294 | 1.8a X-Ray Structure Of Ternary Complex Of A Cataly | 1e-27 | ||
| 4dfy_A | 371 | Crystal Structure Of R194a Mutant Of Camp-Dependent | 1e-27 | ||
| 4el9_A | 305 | Structure Of N-Terminal Kinase Domain Of Rsk2 With | 1e-27 | ||
| 3ubd_A | 304 | Structure Of N-Terminal Domain Of Rsk2 Kinase In Co | 1e-27 | ||
| 3g51_A | 325 | Structural Diversity Of The Active Conformation Of | 1e-27 | ||
| 2y0a_A | 326 | Structure Of Dapk1 Construct Residues 1-304 Length | 1e-27 | ||
| 2wtw_A | 285 | Aurora-A Inhibitor Structure (2nd Crystal Form) Len | 1e-27 | ||
| 3unz_A | 279 | Aurora A In Complex With Rpm1679 Length = 279 | 1e-27 | ||
| 2gnf_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 1e-27 | ||
| 2gu8_A | 337 | Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel | 2e-27 | ||
| 3r21_A | 271 | Design, Synthesis, And Biological Evaluation Of Pyr | 2e-27 | ||
| 2gnj_A | 350 | Pka Three Fold Mutant Model Of Rho-Kinase With Y-27 | 2e-27 | ||
| 2gng_A | 350 | Protein Kinase A Fivefold Mutant Model Of Rho-Kinas | 2e-27 | ||
| 2xru_A | 280 | Aurora-A T288e Complexed With Pha-828300 Length = 2 | 2e-27 | ||
| 2bmc_A | 306 | Aurora-2 T287d T288d Complexed With Pha-680632 Leng | 2e-27 | ||
| 2w1d_A | 275 | Structure Determination Of Aurora Kinase In Complex | 2e-27 | ||
| 3o50_A | 267 | Crystal Structure Of Benzamide 9 Bound To Auroraa L | 2e-27 | ||
| 1mq4_A | 272 | Crystal Structure Of Aurora-A Protein Kinase Length | 2e-27 | ||
| 2dwb_A | 285 | Aurora-A Kinase Complexed With Amppnp Length = 285 | 2e-27 | ||
| 3gu8_A | 295 | Crystal Structure Of Dapkl93g With N6-Cyclopentylad | 2e-27 | ||
| 3qbn_A | 281 | Structure Of Human Aurora A In Complex With A Diami | 2e-27 | ||
| 2xng_A | 283 | Structure Of Aurora-A Bound To A Selective Imidazop | 3e-27 | ||
| 2w1c_A | 275 | Structure Determination Of Aurora Kinase In Complex | 3e-27 | ||
| 3h0y_A | 268 | Aurora A In Complex With A Bisanilinopyrimidine Len | 3e-27 | ||
| 1bkx_A | 350 | A Binary Complex Of The Catalytic Subunit Of Camp-D | 3e-27 | ||
| 3e5a_A | 268 | Crystal Structure Of Aurora A In Complex With Vx-68 | 3e-27 | ||
| 2erz_E | 351 | Crystal Structure Of C-amp Dependent Kinase (pka) B | 3e-27 | ||
| 3lau_A | 287 | Crystal Structure Of Aurora2 Kinase In Complex With | 3e-27 | ||
| 2wqe_A | 262 | Structure Of S155r Aurora-A Somatic Mutant Length = | 3e-27 | ||
| 1apm_E | 350 | 2.0 Angstrom Refined Crystal Structure Of The Catal | 3e-27 | ||
| 3fdn_A | 279 | Structure-Based Drug Design Of Novel Aurora Kinase | 3e-27 | ||
| 1fmo_E | 350 | Crystal Structure Of A Polyhistidine-Tagged Recombi | 3e-27 | ||
| 2x6d_A | 285 | Aurora-A Bound To An Inhibitor Length = 285 | 3e-27 | ||
| 2j50_A | 280 | Structure Of Aurora-2 In Complex With Pha-739358 Le | 3e-27 | ||
| 2qur_A | 350 | Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe | 3e-27 | ||
| 1jbp_E | 350 | Crystal Structure Of The Catalytic Subunit Of Camp- | 3e-27 | ||
| 3ha6_A | 268 | Crystal Structure Of Aurora A In Complex With Tpx2 | 3e-27 | ||
| 2c6e_A | 283 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-27 | ||
| 1ol5_A | 282 | Structure Of Aurora-A 122-403, Phosphorylated On Th | 3e-27 | ||
| 2c6d_A | 275 | Aurora A Kinase Activated Mutant (T287d) In Complex | 3e-27 | ||
| 1xh9_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 3e-27 | ||
| 1muo_A | 297 | Crystal Structure Of Aurora-2, An Oncogenic Serine- | 3e-27 | ||
| 2j4z_A | 306 | Structure Of Aurora-2 In Complex With Pha-680626 Le | 3e-27 | ||
| 1ydt_E | 350 | Structure Of Camp-Dependent Protein Kinase, Alpha-C | 3e-27 | ||
| 3nrm_A | 283 | Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito | 3e-27 | ||
| 2qcs_A | 350 | A Complex Structure Between The Catalytic And Regul | 3e-27 | ||
| 2v7o_A | 336 | Crystal Structure Of Human Calcium-Calmodulin-Depen | 3e-27 | ||
| 1l3r_E | 350 | Crystal Structure Of A Transition State Mimic Of Th | 4e-27 | ||
| 3pvb_A | 345 | Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca | 4e-27 | ||
| 4dg3_E | 371 | Crystal Structure Of R336a Mutant Of Camp-dependent | 4e-27 | ||
| 4dfx_E | 350 | Crystal Structure Of Myristoylated K7c Catalytic Su | 5e-27 | ||
| 3o7l_B | 350 | Crystal Structure Of Phospholamban (1-19):pka C-Sub | 5e-27 | ||
| 3coh_A | 268 | Crystal Structure Of Aurora-A In Complex With A Pen | 5e-27 | ||
| 3qal_E | 350 | Crystal Structure Of Arg280ala Mutant Of Catalytic | 6e-27 | ||
| 3l9m_A | 351 | Crystal Structure Of Pkab3 (Pka Triple Mutant V123a | 6e-27 | ||
| 2a2a_A | 321 | High-resolution Crystallographic Analysis Of The Au | 6e-27 | ||
| 1z9x_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 7e-27 | ||
| 1syk_A | 350 | Crystal Structure Of E230q Mutant Of Camp-Dependent | 7e-27 | ||
| 1q61_A | 350 | Pka Triple Mutant Model Of Pkb Length = 350 | 7e-27 | ||
| 1zws_A | 288 | Crystal Structure Of The Catalytic Domain Of Human | 7e-27 | ||
| 1nxk_A | 400 | Crystal Structure Of Staurosporine Bound To Map Kap | 7e-27 | ||
| 3ama_A | 351 | Protein Kinase A Sixfold Mutant Model Of Aurora B W | 7e-27 | ||
| 1szm_A | 350 | Dual Binding Mode Of Bisindolylmaleimide 2 To Prote | 8e-27 | ||
| 1smh_A | 350 | Protein Kinase A Variant Complex With Completely Or | 8e-27 | ||
| 1wmk_A | 321 | Human Death-Associated Kinase Drp-1, Mutant S308d D | 9e-27 | ||
| 2vz6_A | 313 | Structure Of Human Calcium Calmodulin Dependent Pro | 9e-27 | ||
| 2a27_A | 321 | Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal | 9e-27 | ||
| 2xne_A | 272 | Structure Of Aurora-A Bound To An Imidazopyrazine I | 1e-26 | ||
| 2uzt_A | 336 | Pka Structures Of Akt, Indazole-Pyridine Inhibitors | 1e-26 | ||
| 1ctp_E | 350 | Structure Of The Mammalian Catalytic Subunit Of Cam | 1e-26 | ||
| 3kl8_A | 269 | Camkiintide Inhibitor Complex Length = 269 | 1e-26 | ||
| 2f7e_E | 351 | Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu | 1e-26 | ||
| 3kk9_A | 282 | Camkii Substrate Complex B Length = 282 | 1e-26 | ||
| 3kk8_A | 284 | Camkii Substrate Complex A Length = 284 | 1e-26 | ||
| 1cmk_E | 350 | Crystal Structures Of The Myristylated Catalytic Su | 1e-26 | ||
| 1cdk_A | 350 | Camp-Dependent Protein Kinase Catalytic Subunit (E. | 1e-26 | ||
| 1ol6_A | 282 | Structure Of Unphosphorylated D274n Mutant Of Auror | 1e-26 | ||
| 3nx8_A | 351 | Human Camp Dependent Protein Kinase In Complex With | 1e-26 | ||
| 3agm_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-26 | ||
| 3agl_A | 351 | Complex Of Pka With The Bisubstrate Protein Kinase | 1e-26 | ||
| 2jdt_A | 351 | Structure Of Pka-Pkb Chimera Complexed With Isoquin | 1e-26 | ||
| 3mvj_A | 371 | Human Cyclic Amp-Dependent Protein Kinase Pka Inhib | 1e-26 | ||
| 1svh_A | 350 | Crystal Structure Of Protein Kinase A In Complex Wi | 1e-26 | ||
| 4ae6_A | 343 | Structure And Function Of The Human Sperm-specific | 1e-26 | ||
| 3qam_E | 350 | Crystal Structure Of Glu208ala Mutant Of Catalytic | 1e-26 | ||
| 2c1a_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 1e-26 | ||
| 2vo0_A | 351 | Structure Of Pka-Pkb Chimera Complexed With C-(4-(4 | 1e-26 | ||
| 3dnd_A | 350 | Camp-Dependent Protein Kinase Pka Catalytic Subunit | 1e-26 | ||
| 1stc_E | 350 | Camp-Dependent Protein Kinase, Alpha-Catalytic Subu | 2e-26 | ||
| 4ae9_A | 343 | Structure And Function Of The Human Sperm-specific | 2e-26 | ||
| 2r5t_A | 373 | Crystal Structure Of Inactive Serum And Glucocortic | 2e-26 | ||
| 2jds_A | 351 | Structure Of Camp-Dependent Protein Kinase Complexe | 2e-26 | ||
| 2bdw_A | 362 | Crystal Structure Of The Auto-Inhibited Kinase Doma | 2e-26 | ||
| 2uvy_A | 351 | Structure Of Pka-pkb Chimera Complexed With Methyl- | 2e-26 | ||
| 1xh7_A | 350 | Crystal Structures Of Protein Kinase B Selective In | 2e-26 | ||
| 1q8w_A | 350 | The Catalytic Subunit Of Camp-Dependent Protein Kin | 2e-26 | ||
| 1q24_A | 350 | Pka Double Mutant Model Of Pkb In Complex With Mgat | 2e-26 | ||
| 2wtv_A | 285 | Aurora-A Inhibitor Structure Length = 285 | 2e-26 | ||
| 3fhi_A | 350 | Crystal Structure Of A Complex Between The Catalyti | 2e-26 | ||
| 1rdq_E | 350 | Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of | 3e-26 | ||
| 3soa_A | 444 | Full-Length Human Camkii Length = 444 | 4e-26 | ||
| 1j3h_A | 350 | Crystal Structure Of Apoenzyme Camp-Dependent Prote | 4e-26 | ||
| 4eqm_A | 294 | Structural Analysis Of Staphylococcus Aureus Serine | 5e-26 | ||
| 1kob_A | 387 | Twitchin Kinase Fragment (Aplysia), Autoregulated P | 6e-26 | ||
| 3uc3_A | 361 | The Crystal Structure Of Snf1-Related Kinase 2.3 Le | 6e-26 | ||
| 2x4f_A | 373 | The Crystal Structure Of The Human Myosin Light Cha | 9e-26 | ||
| 3fpq_A | 290 | Crystal Structure Of The Kinase Domain Of Wnk1 Leng | 1e-25 | ||
| 3bhh_A | 295 | Crystal Structure Of Human Calcium/calmodulin-depen | 1e-25 | ||
| 3udb_A | 317 | Crystal Structure Of Snrk2.6 Length = 317 | 1e-25 | ||
| 3iw4_A | 360 | Crystal Structure Of Pkc Alpha In Complex With Nvp- | 2e-25 | ||
| 3zgw_A | 347 | Crystal Structure Of Maternal Embryonic Leucine Zip | 3e-25 | ||
| 3d5u_A | 317 | Crystal Structure Of A Wildtype Polo-Like Kinase 1 | 3e-25 | ||
| 3txo_A | 353 | Pkc Eta Kinase In Complex With A Naphthyridine Leng | 3e-25 | ||
| 3d5v_A | 317 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 3e-25 | ||
| 3d5w_A | 317 | Crystal Structure Of A Phosphorylated Polo-Like Kin | 4e-25 | ||
| 3db6_A | 301 | Crystal Structure Of An Activated (Thr->asp) Polo-L | 4e-25 | ||
| 4a4x_A | 279 | Nek2-Ede Bound To Cct248662 Length = 279 | 4e-25 | ||
| 1zrz_A | 364 | Crystal Structure Of The Catalytic Domain Of Atypic | 5e-25 | ||
| 4dc2_A | 396 | Structure Of Pkc In Complex With A Substrate Peptid | 5e-25 | ||
| 2w5a_A | 279 | Human Nek2 Kinase Adp-Bound Length = 279 | 6e-25 | ||
| 3zh8_A | 349 | A Novel Small Molecule Apkc Inhibitor Length = 349 | 6e-25 | ||
| 2jav_A | 279 | Human Kinase With Pyrrole-Indolinone Ligand Length | 7e-25 | ||
| 3a8w_A | 345 | Crystal Structure Of Pkciota Kinase Domain Length = | 7e-25 | ||
| 2i0e_A | 353 | Structure Of Catalytic Domain Of Human Protein Kina | 8e-25 | ||
| 3pfq_A | 674 | Crystal Structure And Allosteric Activation Of Prot | 9e-25 | ||
| 3uc4_A | 362 | The Crystal Structure Of Snf1-Related Kinase 2.6 Le | 1e-24 | ||
| 3ujg_A | 361 | Crystal Structure Of Snrk2.6 In Complex With Hab1 L | 1e-24 | ||
| 3qc4_A | 314 | Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = | 1e-24 | ||
| 2v5q_A | 315 | Crystal Structure Of Wild-type Plk-1 Kinase Domain | 1e-24 | ||
| 2yac_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-24 | ||
| 2uv2_A | 287 | Crystal Structure Of Human Ste20-Like Kinase Bound | 1e-24 | ||
| 3kb7_A | 311 | Crystal Structure Of Polo-Like Kinase 1 In Complex | 1e-24 | ||
| 3kn5_A | 325 | Crystal Structure Of The C-Terminal Kinase Domain O | 1e-24 | ||
| 2rku_A | 294 | Structure Of Plk1 In Complex With Bi2536 Length = 2 | 2e-24 | ||
| 3thb_A | 333 | Structure Of Plk1 Kinase Domain In Complex With A B | 2e-24 | ||
| 3nax_A | 311 | Pdk1 In Complex With Inhibitor Mp7 Length = 311 | 2e-24 | ||
| 3nun_A | 292 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea | 2e-24 | ||
| 3pwy_A | 311 | Crystal Structure Of An Extender (Spd28345)-Modifie | 2e-24 | ||
| 2ou7_A | 335 | Structure Of The Catalytic Domain Of Human Polo-Lik | 3e-24 | ||
| 1z5m_A | 286 | Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr | 3e-24 | ||
| 3nay_A | 311 | Pdk1 In Complex With Inhibitor Mp6 Length = 311 | 3e-24 | ||
| 2r7b_A | 312 | Crystal Structure Of The Phosphoinositide-Dependent | 3e-24 | ||
| 2biy_A | 310 | Structure Of Pdk1-S241a Mutant Kinase Domain Length | 3e-24 | ||
| 4af3_A | 292 | Human Aurora B Kinase In Complex With Incenp And Vx | 3e-24 | ||
| 3nus_A | 286 | Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra | 3e-24 | ||
| 1uu9_A | 286 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-24 | ||
| 2xck_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-24 | ||
| 1h1w_A | 289 | High Resolution Crystal Structure Of The Human Pdk1 | 3e-24 | ||
| 3rwp_A | 311 | Discovery Of A Novel, Potent And Selective Inhibito | 3e-24 | ||
| 1uu3_A | 310 | Structure Of Human Pdk1 Kinase Domain In Complex Wi | 3e-24 | ||
| 2xch_A | 309 | Crystal Structure Of Pdk1 In Complex With A Pyrazol | 3e-24 | ||
| 3sc1_A | 311 | Novel Isoquinolone Pdk1 Inhibitors Discovered Throu | 4e-24 | ||
| 3iop_A | 312 | Pdk-1 In Complex With The Inhibitor Compound-8i Len | 4e-24 | ||
| 2j51_A | 325 | Crystal Structure Of Human Ste20-Like Kinase Bound | 4e-24 | ||
| 3h9o_A | 311 | Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) | 4e-24 | ||
| 4a07_A | 311 | Human Pdk1 Kinase Domain In Complex With Allosteric | 4e-24 | ||
| 2jfm_A | 325 | Crystal Structure Of Human Ste20-Like Kinase (Unlig | 5e-24 | ||
| 2jed_A | 352 | The Crystal Structure Of The Kinase Domain Of The P | 5e-24 | ||
| 2jfl_A | 325 | Crystal Structure Of Human Ste20-Like Kinase ( Diph | 5e-24 | ||
| 3orx_A | 316 | Pdk1 Mutant Bound To Allosteric Disulfide Fragment | 6e-24 | ||
| 1xjd_A | 345 | Crystal Structure Of Pkc-Theta Complexed With Staur | 8e-24 | ||
| 3zut_A | 362 | The Structure Of Ost1 (D160a) Kinase Length = 362 | 8e-24 | ||
| 3zuu_A | 362 | The Structure Of Ost1 (D160a, S175d) Kinase In Comp | 9e-24 | ||
| 3hrc_A | 311 | Crystal Structure Of A Mutant Of Human Pdk1 Kinase | 9e-24 | ||
| 2wqm_A | 310 | Structure Of Apo Human Nek7 Length = 310 | 1e-23 | ||
| 4fsu_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 7e-23 | ||
| 4fsm_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-23 | ||
| 4fsy_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 8e-23 | ||
| 2hw6_A | 307 | Crystal Structure Of Mnk1 Catalytic Domain Length = | 8e-23 | ||
| 2x8e_A | 276 | Discovery Of A Novel Class Of Triazolones As Checkp | 9e-23 | ||
| 3jvr_A | 271 | Characterization Of The Chk1 Allosteric Inhibitor B | 9e-23 | ||
| 4fsn_A | 278 | Crystal Structure Of The Chk1 Length = 278 | 9e-23 | ||
| 3ot3_A | 273 | X-Ray Crystal Structure Of Compound 22k Bound To Hu | 9e-23 | ||
| 2r0u_A | 323 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-23 | ||
| 2e9v_A | 268 | Structure Of H-Chk1 Complexed With A859017 Length = | 9e-23 | ||
| 2hog_A | 322 | Crystal Structure Of Chek1 In Complex With Inhibito | 9e-23 | ||
| 2ayp_A | 269 | Crystal Structure Of Chk1 With An Indol Inhibitor L | 9e-23 | ||
| 1zys_A | 273 | Co-Crystal Structure Of Checkpoint Kinase Chk1 With | 1e-22 | ||
| 2ghg_A | 269 | H-Chk1 Complexed With A431994 Length = 269 | 1e-22 | ||
| 2br1_A | 297 | Structure-Based Design Of Novel Chk1 Inhibitors: In | 1e-22 | ||
| 1ia8_A | 289 | The 1.7 A Crystal Structure Of Human Cell Cycle Che | 1e-22 | ||
| 1zlt_A | 295 | Crystal Structure Of Chk1 Complexed With A Hymenald | 1e-22 | ||
| 3sls_A | 304 | Crystal Structure Of Human Mek-1 Kinase In Complex | 1e-22 | ||
| 3fxz_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Ruthen | 1e-22 | ||
| 3q52_A | 306 | Structure Of Phosphorylated Pak1 Kinase Domain Leng | 1e-22 | ||
| 1tki_A | 321 | Autoinhibited Serine Kinase Domain Of The Giant Mus | 1e-22 | ||
| 1yhv_A | 297 | Crystal Structure Of Pak1 Kinase Domain With Two Po | 1e-22 | ||
| 2acx_A | 576 | Crystal Structure Of G Protein Coupled Receptor Kin | 1e-22 | ||
| 3nyn_A | 576 | Crystal Structure Of G Protein-Coupled Receptor Kin | 2e-22 | ||
| 4fr4_A | 384 | Crystal Structure Of Human SerineTHREONINE-Protein | 2e-22 | ||
| 1f3m_C | 297 | Crystal Structure Of Human SerineTHREONINE KINASE P | 2e-22 | ||
| 3kga_A | 299 | Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexe | 2e-22 | ||
| 3mfr_A | 351 | Cask-4m Cam Kinase Domain, Native Length = 351 | 3e-22 | ||
| 3q4z_A | 306 | Structure Of Unphosphorylated Pak1 Kinase Domain Le | 4e-22 | ||
| 3lm0_A | 327 | Crystal Structure Of Human SerineTHREONINE KINASE 1 | 4e-22 | ||
| 1gzn_A | 335 | Structure Of Pkb Kinase Domain Length = 335 | 1e-21 | ||
| 1mrv_A | 339 | Crystal Structure Of An Inactive Akt2 Kinase Domain | 1e-21 | ||
| 4ft3_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 4fsz_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 1gzk_A | 315 | Molecular Mechanism For The Regulation Of Protein K | 1e-21 | ||
| 2ydj_A | 276 | Discovery Of Checkpoint Kinase Inhibitor Azd7762 By | 1e-21 | ||
| 3e87_A | 335 | Crystal Structures Of The Kinase Domain Of Akt2 In | 1e-21 | ||
| 4fsw_A | 279 | Crystal Structure Of The Chk1 Length = 279 | 1e-21 | ||
| 1o6k_A | 336 | Structure Of Activated Form Of Pkb Kinase Domain S4 | 1e-21 | ||
| 1o6l_A | 337 | Crystal Structure Of An Activated Akt/protein Kinas | 1e-21 | ||
| 4fst_A | 269 | Crystal Structure Of The Chk1 Length = 269 | 1e-21 | ||
| 2wnt_A | 330 | Crystal Structure Of The Human Ribosomal Protein S6 | 1e-21 | ||
| 2jdo_A | 342 | Structure Of Pkb-Beta (Akt2) Complexed With Isoquin | 1e-21 | ||
| 3rny_A | 346 | Crystal Structure Of Human Rsk1 C-Terminal Kinase D | 1e-21 | ||
| 1u5q_A | 348 | Crystal Structure Of The Tao2 Kinase Domain: Activa | 3e-21 | ||
| 2gcd_A | 309 | Tao2 Kinase Domain-Staurosporine Structure Length = | 4e-21 | ||
| 2v55_A | 406 | Mechanism Of Multi-site Phosphorylation From A Rock | 5e-21 | ||
| 2esm_A | 415 | Crystal Structure Of Rock 1 Bound To Fasudil Length | 5e-21 | ||
| 3v8s_A | 410 | Human Rho-Associated Protein Kinase 1 (Rock 1) In C | 5e-21 | ||
| 2f2u_A | 402 | Crystal Structure Of The Rho-Kinase Kinase Domain L | 7e-21 | ||
| 3rzf_A | 677 | Crystal Structure Of Inhibitor Of Kappab Kinase Bet | 7e-21 | ||
| 3qa8_A | 676 | Crystal Structure Of Inhibitor Of Kappa B Kinase Be | 8e-21 | ||
| 4an2_A | 301 | Crystal Structures Of Human Mek1 With Carboxamide-B | 9e-21 | ||
| 3com_A | 314 | Crystal Structure Of Mst1 Kinase Length = 314 | 1e-20 | ||
| 3dak_A | 290 | Crystal Structure Of Domain-Swapped Osr1 Kinase Dom | 1e-20 | ||
| 2vwi_A | 303 | Structure Of The Osr1 Kinase, A Hypertension Drug T | 1e-20 | ||
| 2wtk_C | 305 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 2e-20 | ||
| 3bkb_A | 377 | Crystal Structure Of Human Feline Sarcoma Viral Onc | 2e-20 | ||
| 4aw2_A | 437 | Crystal Structure Of Cdc42 Binding Protein Kinase A | 2e-20 | ||
| 2xik_A | 294 | Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K | 3e-20 | ||
| 3c4w_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-20 | ||
| 3c4x_A | 543 | Crystal Structure Of G Protein Coupled Receptor Kin | 3e-20 | ||
| 3t8o_A | 543 | Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu | 3e-20 | ||
| 3qc9_A | 543 | Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4 | 3e-20 | ||
| 3orn_A | 307 | Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In | 4e-20 | ||
| 1jow_B | 308 | Crystal Structure Of A Complex Of Human Cdk6 And A | 4e-20 | ||
| 1bi8_A | 326 | Mechanism Of G1 Cyclin Dependent Kinase Inhibition | 5e-20 | ||
| 3nup_A | 307 | Cdk6 (Monomeric) In Complex With Inhibitor Length = | 5e-20 | ||
| 2ac5_A | 316 | Structure Of Human Mnk2 Kinase Domain Mutant D228g | 8e-20 | ||
| 2j7t_A | 302 | Crystal Structure Of Human Serine Threonine Kinase- | 8e-20 | ||
| 4agu_A | 311 | Crystal Structure Of The Human Cdkl1 Kinase Domain | 8e-20 | ||
| 3c0g_A | 351 | Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len | 9e-20 | ||
| 3ggf_A | 301 | Crystal Structure Of Human SerineTHREONINE-Protein | 9e-20 | ||
| 4bc6_A | 293 | Crystal Structure Of Human Serine Threonine Kinase- | 9e-20 | ||
| 3tac_A | 361 | Crystal Structure Of The Liprin-AlphaCASK COMPLEX L | 9e-20 | ||
| 4apc_A | 350 | Crystal Structure Of Human Nima-Related Kinase 1 (N | 1e-19 | ||
| 3cd3_A | 377 | Crystal Structure Of Phosphorylated Human Feline Sa | 1e-19 | ||
| 2eva_A | 307 | Structural Basis For The Interaction Of Tak1 Kinase | 1e-19 | ||
| 4gs6_A | 315 | Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxoz | 1e-19 | ||
| 3a4o_X | 286 | Lyn Kinase Domain Length = 286 | 2e-19 | ||
| 3ckw_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 2e-19 | ||
| 3zhp_C | 294 | Human Mst3 (stk24) In Complex With Mo25beta Length | 2e-19 | ||
| 2qr8_A | 342 | 2.0a X-ray Structure Of C-terminal Kinase Domain Of | 2e-19 | ||
| 3hko_A | 345 | Crystal Structure Of A Cdpk Kinase Domain From Cryp | 3e-19 | ||
| 3a7f_A | 303 | Human Mst3 Kinase Length = 303 | 3e-19 | ||
| 2c30_A | 321 | Crystal Structure Of The Human P21-Activated Kinase | 3e-19 | ||
| 3ckx_A | 304 | Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3 | 3e-19 | ||
| 2zv7_A | 279 | Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | 3e-19 | ||
| 3o96_A | 446 | Crystal Structure Of Human Akt1 With An Allosteric | 3e-19 | ||
| 4aaa_A | 331 | Crystal Structure Of The Human Cdkl2 Kinase Domain | 4e-19 | ||
| 4gv1_A | 340 | Pkb Alpha In Complex With Azd5363 Length = 340 | 4e-19 | ||
| 4ejn_A | 446 | Crystal Structure Of Autoinhibited Form Of Akt1 In | 4e-19 | ||
| 2x4z_A | 296 | Crystal Structure Of The Human P21-Activated Kinase | 4e-19 | ||
| 3ocb_A | 341 | Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor | 4e-19 | ||
| 3cqu_A | 342 | Crystal Structure Of Akt-1 Complexed With Substrate | 4e-19 | ||
| 2qr7_A | 342 | 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of | 5e-19 | ||
| 2bva_A | 292 | Crystal Structure Of The Human P21-Activated Kinase | 5e-19 | ||
| 2cdz_A | 303 | Crystal Structure Of The Human P21-Activated Kinase | 5e-19 | ||
| 2q0n_A | 301 | Structure Of Human P21 Activating Kinase 4 (Pak4) I | 5e-19 | ||
| 4fif_A | 346 | Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid | 5e-19 | ||
| 2f57_A | 317 | Crystal Structure Of The Human P21-activated Kinase | 5e-19 | ||
| 2ac3_A | 316 | Structure Of Human Mnk2 Kinase Domain Length = 316 | 6e-19 | ||
| 2i6l_A | 320 | Crystal Structure Of Human Mitogen Activated Protei | 7e-19 | ||
| 4fie_A | 423 | Full-Length Human Pak4 Length = 423 | 7e-19 | ||
| 2pk9_A | 317 | Structure Of The Pho85-pho80 Cdk-cyclin Complex Of | 8e-19 | ||
| 3qfv_A | 415 | Mrck Beta In Complex With Tpca-1 Length = 415 | 9e-19 | ||
| 3f69_A | 311 | Crystal Structure Of The Mycobacterium Tuberculosis | 9e-19 | ||
| 1ua2_A | 346 | Crystal Structure Of Human Cdk7 Length = 346 | 1e-18 | ||
| 3tku_A | 433 | Mrck Beta In Complex With Fasudil Length = 433 | 1e-18 | ||
| 1v0o_A | 288 | Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho | 1e-18 | ||
| 2p55_A | 333 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 2qkr_A | 313 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 3niz_A | 311 | Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5 | 1e-18 | ||
| 2y4i_C | 395 | Ksr2-Mek1 Heterodimer Length = 395 | 1e-18 | ||
| 1v0b_A | 288 | Crystal Structure Of The T198a Mutant Of Pfpk5 Leng | 1e-18 | ||
| 3mbl_A | 328 | Crystal Structure Of The Human Mitogen-Activated Pr | 1e-18 | ||
| 3dv3_A | 322 | Mek1 With Pf-04622664 Bound Length = 322 | 1e-18 | ||
| 1s9j_A | 341 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-18 | ||
| 3eqc_A | 360 | X-Ray Structure Of The Human Mitogen-Activated Prot | 2e-18 | ||
| 1ob3_A | 288 | Structure Of P. Falciparum Pfpk5 Length = 288 | 2e-18 | ||
| 3ori_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain L33d | 2e-18 | ||
| 1mru_A | 311 | Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob | 2e-18 | ||
| 4eon_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-18 | ||
| 4eom_A | 301 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum | 2e-18 | ||
| 1o6y_A | 299 | Catalytic Domain Of Pknb Kinase From Mycobacterium | 2e-18 | ||
| 2zv2_A | 298 | Crystal Structure Of Human CalciumCALMODULIN-Depend | 2e-18 | ||
| 3dls_A | 335 | Crystal Structure Of Human Pas Kinase Bound To Adp | 3e-18 | ||
| 2jkk_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 3e-18 | ||
| 3c4c_A | 280 | B-Raf Kinase In Complex With Plx4720 Length = 280 | 3e-18 | ||
| 4fk3_A | 292 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 3e-18 | ||
| 2j0k_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 4e-18 | ||
| 3f61_A | 311 | Crystal Structure Of M. Tuberculosis Pknb Leu33aspV | 4e-18 | ||
| 4eoi_A | 299 | Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc | 4e-18 | ||
| 1gz8_A | 299 | Human Cyclin Dependent Kinase 2 Complexed With The | 4e-18 | ||
| 3kul_B | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 5e-18 | ||
| 4eoo_A | 299 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-18 | ||
| 4gt4_A | 308 | Structure Of Unliganded, Inactive Ror2 Kinase Domai | 5e-18 | ||
| 3e7o_A | 360 | Crystal Structure Of Jnk2 Length = 360 | 5e-18 | ||
| 4eop_A | 300 | Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 | 5e-18 | ||
| 3oht_A | 389 | Crystal Structure Of Salmo Salar P38alpha Length = | 6e-18 | ||
| 4eok_A | 300 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-18 | ||
| 4erw_A | 306 | Cdk2 In Complex With Staurosporine Length = 306 | 6e-18 | ||
| 3vum_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M7 | 6e-18 | ||
| 3og7_A | 289 | B-Raf Kinase V600e Oncogenic Mutant In Complex With | 6e-18 | ||
| 4eoj_A | 302 | Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma | 6e-18 | ||
| 3vul_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 6e-18 | ||
| 3zzw_A | 289 | Crystal Structure Of The Kinase Domain Of Ror2 Leng | 6e-18 | ||
| 3kul_A | 325 | Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep | 7e-18 | ||
| 2iw6_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com | 7e-18 | ||
| 1oit_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 7e-18 | ||
| 3d83_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 8e-18 | ||
| 2j0m_B | 276 | Crystal Structure A Two-Chain Complex Between The F | 8e-18 | ||
| 1oir_A | 299 | Imidazopyridines: A Potent And Selective Class Of C | 8e-18 | ||
| 1h01_A | 298 | Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili | 8e-18 | ||
| 2jkm_A | 276 | Focal Adhesion Kinase Catalytic Domain In Complex W | 8e-18 | ||
| 2w17_A | 299 | Cdk2 In Complex With The Imidazole Pyrimidine Amide | 8e-18 | ||
| 1pf8_A | 298 | Crystal Structure Of Human Cyclin-dependent Kinase | 8e-18 | ||
| 1fin_A | 298 | Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = | 8e-18 | ||
| 1mp8_A | 281 | Crystal Structure Of Focal Adhesion Kinase (Fak) Le | 8e-18 | ||
| 2etm_A | 281 | Crystal Structure Of Focal Adhesion Kinase Domain C | 8e-18 | ||
| 3pj8_A | 299 | Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D] | 9e-18 | ||
| 3ezr_A | 300 | Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ | 9e-18 | ||
| 4ebw_A | 304 | Structure Of Focal Adhesion Kinase Catalytic Domain | 9e-18 | ||
| 1jst_A | 298 | Phosphorylated Cyclin-Dependent Kinase-2 Bound To C | 9e-18 | ||
| 3bz3_A | 276 | Crystal Structure Analysis Of Focal Adhesion Kinase | 9e-18 | ||
| 1qmz_A | 299 | Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com | 9e-18 | ||
| 1vyw_A | 309 | Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = | 9e-18 | ||
| 4i3z_A | 296 | Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES | 9e-18 | ||
| 3pxk_A | 282 | Focal Adhesion Kinase Catalytic Domain In Complex W | 1e-17 | ||
| 3fi4_A | 372 | P38 Kinase Crystal Structure In Complex With Ro4499 | 1e-17 | ||
| 2jgz_A | 289 | Crystal Structure Of Phospho-Cdk2 In Complex With C | 1e-17 | ||
| 3vuk_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M5 | 1e-17 | ||
| 3pxf_A | 306 | Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N | 1e-17 | ||
| 3bht_A | 300 | Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN | 1e-17 | ||
| 1e9h_A | 297 | Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex | 1e-17 | ||
| 2j0j_A | 656 | Crystal Structure Of A Fragment Of Focal Adhesion K | 1e-17 | ||
| 4eoq_A | 301 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-17 | ||
| 4bcq_A | 301 | Structure Of Cdk2 In Complex With Cyclin A And A 2- | 1e-17 | ||
| 3qhr_A | 298 | Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic | 1e-17 | ||
| 2fso_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a) A | 1e-17 | ||
| 1h1p_A | 303 | Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP | 1e-17 | ||
| 2fst_X | 367 | Mitogen Activated Protein Kinase P38alpha (d176a+f3 | 1e-17 | ||
| 1w98_A | 298 | The Structural Basis Of Cdk2 Activation By Cyclin E | 1e-17 | ||
| 1s9i_A | 354 | X-Ray Structure Of The Human Mitogen-Activated Prot | 1e-17 | ||
| 1ogu_A | 302 | Structure Of Human Thr160-phospho Cdk2/cyclin A Com | 1e-17 | ||
| 2fsl_X | 367 | Mitogen Activated Protein Kinase P38alpha (D176a+f3 | 1e-17 | ||
| 3d7z_A | 360 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-17 | ||
| 4eos_A | 300 | Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co | 1e-17 | ||
| 2puu_A | 348 | Crystal Structure Of P38 Complex With 1-(5-Tert-But | 1e-17 | ||
| 2bal_A | 365 | P38alpha Map Kinase Bound To Pyrazoloamine Length = | 1e-17 | ||
| 2w96_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 1e-17 | ||
| 2baq_A | 365 | P38alpha Bound To Ro3201195 Length = 365 | 1e-17 | ||
| 4g31_A | 299 | Crystal Structure Of Gsk6414 Bound To Perk (R587-R1 | 1e-17 | ||
| 4g3d_A | 371 | Crystal Structure Of Human Nf-kappab Inducing Kinas | 1e-17 | ||
| 1vzo_A | 355 | The Structure Of The N-Terminal Kinase Domain Of Ms | 1e-17 | ||
| 3dtc_A | 271 | Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp | 1e-17 | ||
| 3e92_A | 371 | Crystal Structure Of P38 Kinase In Complex With A B | 1e-17 | ||
| 3s3i_A | 349 | P38 Kinase Crystal Structure In Complex With Small | 1e-17 | ||
| 4dn5_A | 356 | Crystal Structure Of Nf-kb-inducing Kinase (nik) Le | 1e-17 | ||
| 2oza_B | 366 | Structure Of P38alpha Complex Length = 366 | 1e-17 | ||
| 2gtm_A | 348 | Mutated Mouse P38 Map Kinase Domain In Complex With | 1e-17 | ||
| 1ove_A | 366 | The Structure Of P38 Alpha In Complex With A Dihydr | 1e-17 | ||
| 3nnu_A | 354 | Crystal Structure Of P38 Alpha In Complex With Dp13 | 1e-17 | ||
| 1zzl_A | 351 | Crystal Structure Of P38 With Triazolopyridine Leng | 2e-17 | ||
| 2lgc_A | 359 | Joint Nmr And X-Ray Refinement Reveals The Structur | 2e-17 | ||
| 3nnx_A | 354 | Crystal Structure Of Phosphorylated P38 Alpha In Co | 2e-17 | ||
| 3kq7_A | 380 | Structure Of Human P38alpha With N-[4-Methyl-3-(6-{ | 2e-17 | ||
| 3k3i_A | 350 | P38alpha Bound To Novel Dgf-Out Compound Pf-0021595 | 2e-17 | ||
| 1cm8_A | 367 | Phosphorylated Map Kinase P38-Gamma Length = 367 | 2e-17 | ||
| 3hec_A | 348 | P38 In Complex With Imatinib Length = 348 | 2e-17 | ||
| 1ian_A | 366 | Human P38 Map Kinase Inhibitor Complex Length = 366 | 2e-17 | ||
| 1m7q_A | 366 | Crystal Structure Of P38 Map Kinase In Complex With | 2e-17 | ||
| 2y8o_A | 362 | Crystal Structure Of Human P38alpha Complexed With | 2e-17 | ||
| 3odz_X | 360 | Crystal Structure Of P38alpha Y323r Active Mutant L | 2e-17 | ||
| 3ody_X | 360 | Crystal Structure Of P38alpha Y323q Active Mutant L | 2e-17 | ||
| 3od6_X | 360 | Crystal Structure Of P38alpha Y323t Active Mutant L | 2e-17 | ||
| 3orm_A | 311 | Mycobacterium Tuberculosis Pknb Kinase Domain D76a | 2e-17 | ||
| 2baj_A | 365 | P38alpha Bound To Pyrazolourea Length = 365 | 2e-17 | ||
| 1omw_A | 689 | Crystal Structure Of The Complex Between G Protein- | 2e-17 | ||
| 3psc_A | 695 | Bovine Grk2 In Complex With Gbetagamma Subunits Len | 2e-17 | ||
| 3hrb_A | 359 | P38 Kinase Crystal Structure In Complex With Small | 2e-17 | ||
| 1di9_A | 360 | The Structure Of P38 Mitogen-Activated Protein Kina | 2e-17 | ||
| 3vui_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 2e-17 | ||
| 3py3_A | 380 | Crystal Structure Of Phosphorylated P38alpha Map Ki | 2e-17 | ||
| 3oef_X | 360 | Crystal Structure Of Y323f Inactive Mutant Of P38al | 2e-17 | ||
| 1lew_A | 360 | Crystal Structure Of Map Kinase P38 Complexed To Th | 2e-17 | ||
| 3p4k_A | 370 | The Third Conformation Of P38a Map Kinase Observed | 2e-17 | ||
| 2npq_A | 367 | A Novel Lipid Binding Site In The P38 Alpha Map Kin | 2e-17 | ||
| 3cik_A | 689 | Human Grk2 In Complex With Gbetagamma Subunits Leng | 2e-17 | ||
| 3tg1_A | 380 | Crystal Structure Of P38alpha In Complex With A Map | 2e-17 | ||
| 3dt1_A | 383 | P38 Complexed With A Quinazoline Inhibitor Length = | 2e-17 | ||
| 3krw_A | 688 | Human Grk2 In Complex With Gbetgamma Subunits And B | 2e-17 | ||
| 2ghl_A | 348 | Mutant Mus Musculus P38 Kinase Domain In Complex Wi | 2e-17 | ||
| 3gcu_A | 360 | Human P38 Map Kinase In Complex With Rl48 Length = | 2e-17 | ||
| 3k3j_A | 362 | P38alpha Bound To Novel Dfg-Out Compound Pf-0041612 | 2e-17 | ||
| 1bl6_A | 379 | The Complex Structure Of The Map Kinase P38SB216995 | 2e-17 | ||
| 1yw2_A | 360 | Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | 2e-17 | ||
| 3hvc_A | 362 | Crystal Structure Of Human P38alpha Map Kinase Leng | 2e-17 | ||
| 1h4l_A | 292 | Structure And Regulation Of The Cdk5-P25(Nck5a) Com | 2e-17 | ||
| 3zsg_A | 362 | X-Ray Structure Of P38alpha Bound To Tak-715 Length | 2e-17 | ||
| 1bmk_A | 379 | The Complex Structure Of The Map Kinase P38SB218655 | 2e-17 | ||
| 1ywr_A | 360 | Crystal Structure Analysis Of Inactive P38 Kinase D | 2e-17 | ||
| 1oz1_A | 372 | P38 Mitogen-Activated Kinase In Complex With 4-Azai | 2e-17 | ||
| 3uiu_A | 306 | Crystal Structure Of Apo-Pkr Kinase Domain Length = | 2e-17 | ||
| 2gfs_A | 372 | P38 Kinase Crystal Structure In Complex With Ro3201 | 2e-17 | ||
| 3mpt_A | 371 | Crystal Structure Of P38 Kinase In Complex With A P | 2e-17 | ||
| 3vuh_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M3 | 2e-17 | ||
| 3g33_A | 308 | Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | 2e-17 | ||
| 4ewq_A | 383 | Human P38 Alpha Mapk In Complex With A Pyridazine B | 2e-17 | ||
| 4g3f_A | 336 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-17 | ||
| 3ii5_A | 306 | The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi | 3e-17 | ||
| 2w99_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 3e-17 | ||
| 3gcp_A | 360 | Human P38 Map Kinase In Complex With Sb203580 Lengt | 3e-17 | ||
| 3idp_A | 300 | B-Raf V600e Kinase Domain In Complex With An Aminoi | 3e-17 | ||
| 3q96_A | 282 | B-Raf Kinase Domain In Complex With A Tetrahydronap | 3e-17 | ||
| 4dbn_A | 284 | Crystal Structure Of The Kinase Domain Of Human B-R | 3e-17 | ||
| 4g9r_A | 307 | B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr | 3e-17 | ||
| 3vug_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M2 | 3e-17 | ||
| 3gc9_A | 370 | The Structure Of P38beta C119s, C162s In Complex Wi | 3e-17 | ||
| 3d4q_A | 307 | Pyrazole-Based Inhibitors Of B-Raf Kinase Length = | 3e-17 | ||
| 2fb8_A | 281 | Structure Of The B-Raf Kinase Domain Bound To Sb-59 | 3e-17 | ||
| 1gii_A | 298 | Human Cyclin Dependent Kinase 2 Complexed With The | 3e-17 | ||
| 4g3c_A | 352 | Crystal Structure Of Apo Murine Nf-kappab Inducing | 3e-17 | ||
| 2psq_A | 370 | Crystal Structure Of Unphosphorylated Unactivated W | 3e-17 | ||
| 2a19_B | 284 | Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng | 3e-17 | ||
| 1uwj_A | 276 | The Complex Of Mutant V599e B-raf And Bay439006 Len | 3e-17 | ||
| 4g3g_A | 350 | Crystal Structure Of Murine Nf-kappab Inducing Kina | 3e-17 | ||
| 3gp0_A | 348 | Crystal Structure Of Human Mitogen Activated Protei | 3e-17 | ||
| 4h58_A | 275 | Braf In Complex With Compound 3 Length = 275 | 3e-17 | ||
| 3mh2_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 4e-17 | ||
| 3gc8_A | 370 | The Structure Of P38beta C162s In Complex With A Di | 4e-17 | ||
| 3b2t_A | 311 | Structure Of Phosphotransferase Length = 311 | 4e-17 | ||
| 3sxr_A | 268 | Crystal Structure Of Bmx Non-Receptor Tyrosine Kina | 4e-17 | ||
| 2pz5_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 2pzp_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 4e-17 | ||
| 3fi3_A | 364 | Crystal Structure Of Jnk3 With Indazole Inhibitor, | 4e-17 | ||
| 2j0l_A | 276 | Crystal Structure Of A The Active Conformation Of T | 5e-17 | ||
| 2w9f_B | 306 | Crystal Structure Of Cdk4 In Complex With A D-Type | 5e-17 | ||
| 1gjo_A | 316 | The Fgfr2 Tyrosine Kinase Domain Length = 316 | 5e-17 | ||
| 3ri1_A | 313 | Crystal Structure Of The Catalytic Domain Of Fgfr2 | 5e-17 | ||
| 2pwl_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 5e-17 | ||
| 2clq_A | 295 | Structure Of Mitogen-Activated Protein Kinase Kinas | 5e-17 | ||
| 4e5a_X | 360 | The W197a Mutant Of P38a Map Kinase Length = 360 | 5e-17 | ||
| 4asz_A | 299 | Crystal Structure Of Apo Trkb Kinase Domain Length | 5e-17 | ||
| 1uwh_A | 276 | The Complex Of Wild Type B-Raf And Bay439006 Length | 5e-17 | ||
| 3fv8_A | 355 | Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le | 5e-17 | ||
| 3npc_A | 364 | Crystal Structure Of Jnk2 Complexed With Birb796 Le | 5e-17 | ||
| 1ung_A | 292 | Structural Mechanism For The Inhibition Of Cdk5-P25 | 6e-17 | ||
| 2iw8_A | 302 | Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82 | 6e-17 | ||
| 3vw6_A | 269 | Crystal Structure Of Human Apoptosis Signal-Regulat | 6e-17 | ||
| 2rei_A | 318 | Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep | 7e-17 | ||
| 3kvx_A | 364 | Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le | 7e-17 | ||
| 3fi2_A | 353 | Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib | 7e-17 | ||
| 2r9s_A | 356 | C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu | 7e-17 | ||
| 2pzr_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 9e-17 | ||
| 2vd5_A | 412 | Structure Of Human Myotonic Dystrophy Protein Kinas | 1e-16 | ||
| 3dzq_A | 361 | Human Epha3 Kinase Domain In Complex With Inhibitor | 1e-16 | ||
| 2qoo_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 2qoc_A | 344 | Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp | 1e-16 | ||
| 1ukh_A | 369 | Structural Basis For The Selective Inhibition Of Jn | 1e-16 | ||
| 3o8p_A | 360 | Conformational Plasticity Of P38 Map Kinase Dfg Mot | 1e-16 | ||
| 2gsf_A | 373 | The Human Epha3 Receptor Tyrosine Kinase And Juxtam | 1e-16 | ||
| 1fgk_A | 310 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-16 | ||
| 3fxx_A | 371 | Human Epha3 Kinase And Juxtamembrane Region Bound T | 1e-16 | ||
| 1pmn_A | 364 | Crystal Structure Of Jnk3 In Complex With An Imidaz | 1e-16 | ||
| 2xrw_A | 371 | Linear Binding Motifs For Jnk And For Calcineurin A | 1e-16 | ||
| 2qoi_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 1e-16 | ||
| 3mh0_A | 360 | Mutagenesis Of P38 Map Kinase Eshtablishes Key Role | 1e-16 | ||
| 2qof_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f | 1e-16 | ||
| 2qod_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y602f | 1e-16 | ||
| 4f63_A | 309 | Crystal Structure Of Human Fibroblast Growth Factor | 1e-16 | ||
| 3js2_A | 317 | Crystal Structure Of Minimal Kinase Domain Of Fibro | 1e-16 | ||
| 4h36_A | 356 | Crystal Structure Of Jnk3 In Complex With Atf2 Pept | 1e-16 | ||
| 3oxi_A | 362 | Design And Synthesis Of Disubstituted Thiophene And | 1e-16 | ||
| 3vud_A | 370 | Crystal Structure Of A Cysteine-deficient Mutant M1 | 1e-16 | ||
| 3kxx_A | 317 | Structure Of The Mutant Fibroblast Growth Factor Re | 1e-16 | ||
| 2hk5_A | 270 | Hck Kinase In Complex With Lck Targetted Inhibitor | 1e-16 | ||
| 3rhx_B | 306 | Crystal Structure Of The Catalytic Domain Of Fgfr1 | 1e-16 | ||
| 3c4f_A | 302 | Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M | 1e-16 | ||
| 2exc_X | 356 | Inhibitor Complex Of Jnk3 Length = 356 | 1e-16 | ||
| 3v3v_A | 379 | Structural And Functional Analysis Of Quercetagetin | 2e-16 | ||
| 2b1p_A | 355 | Inhibitor Complex Of Jnk3 Length = 355 | 2e-16 | ||
| 2o0u_A | 364 | Crystal Structure Of Human Jnk3 Complexed With N-{3 | 2e-16 | ||
| 3ptg_A | 363 | Design And Synthesis Of A Novel, Orally Efficacious | 2e-16 | ||
| 3mh3_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 3gql_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 2e-16 | ||
| 3miy_A | 266 | X-Ray Crystal Structure Of Itk Complexed With Sunit | 2e-16 | ||
| 2ok1_A | 365 | Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3 | 2e-16 | ||
| 3ttj_A | 464 | Crystal Structure Of Jnk3 Complexed With Cc-359, A | 2e-16 | ||
| 3mh1_A | 360 | Mutagenesis Of P38 Map Kinase Establishes Key Roles | 2e-16 | ||
| 1jnk_A | 423 | The C-Jun N-Terminal Kinase (Jnk3s) Complexed With | 2e-16 | ||
| 1qcf_A | 454 | Crystal Structure Of Hck In Complex With A Src Fami | 2e-16 | ||
| 1zy4_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-16 | ||
| 4fnw_A | 327 | Crystal Structure Of The Apo F1174l Anaplastic Lymp | 2e-16 | ||
| 2yjr_A | 342 | Structure Of F1174l Mutant Anaplastic Lymphoma Kina | 2e-16 | ||
| 3omv_A | 307 | Crystal Structure Of C-Raf (Raf-1) Length = 307 | 2e-16 | ||
| 3vnt_A | 318 | Crystal Structure Of The Kinase Domain Of Human Veg | 2e-16 | ||
| 2pvy_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 3t9t_A | 267 | Crystal Structure Of Btk Mutant (F435t,K596r) Compl | 2e-16 | ||
| 3tt0_A | 382 | Co-Structure Of Fibroblast Growth Factor Receptor 1 | 2e-16 | ||
| 4e7w_A | 394 | Structure Of Gsk3 From Ustilago Maydis Length = 394 | 2e-16 | ||
| 3gi3_A | 360 | Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana | 2e-16 | ||
| 2q0b_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 2e-16 | ||
| 2g01_A | 370 | Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit | 2e-16 | ||
| 2pvf_A | 334 | Crystal Structure Of Tyrosine Phosphorylated Activa | 2e-16 | ||
| 3cly_A | 334 | Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase | 2e-16 | ||
| 2yfx_A | 327 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 4fnx_A | 327 | Crystal Structure Of The Apo R1275q Anaplastic Lymp | 3e-16 | ||
| 4dce_A | 333 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 3aox_A | 344 | X-Ray Crystal Structure Of Human Anaplastic Lymphom | 3e-16 | ||
| 2xp2_A | 327 | Structure Of The Human Anaplastic Lymphoma Kinase I | 3e-16 | ||
| 3o17_A | 370 | Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3 | 3e-16 | ||
| 2yhv_A | 342 | Structure Of L1196m Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 2xb7_A | 315 | Structure Of Human Anaplastic Lymphoma Kinase In Co | 3e-16 | ||
| 1sm2_A | 264 | Crystal Structure Of The Phosphorylated Interleukin | 3e-16 | ||
| 2xs0_A | 386 | Linear Binding Motifs For Jnk And For Calcineurin A | 3e-16 | ||
| 4fob_A | 353 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 3v5j_A | 266 | Crystal Structure Of Interleukin-2 Inducible T-Cell | 3e-16 | ||
| 2qok_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 3e-16 | ||
| 4fnz_A | 327 | Crystal Structure Of Human Anaplastic Lymphoma Kina | 3e-16 | ||
| 3qgw_A | 286 | Crystal Structure Of Itk Kinase Bound To An Inhibit | 3e-16 | ||
| 2py3_A | 324 | Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D | 3e-16 | ||
| 2yjs_A | 342 | Structure Of C1156y Mutant Anaplastic Lymphoma Kina | 3e-16 | ||
| 3lct_A | 344 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-16 | ||
| 3l9p_A | 367 | Crystal Structure Of The Anaplastic Lymphoma Kinase | 3e-16 | ||
| 4hct_A | 269 | Crystal Structure Of Itk In Complex With Compound 5 | 3e-16 | ||
| 3v5q_A | 297 | Discovery Of A Selective Trk Inhibitor With Efficac | 3e-16 | ||
| 2x7f_A | 326 | Crystal Structure Of The Kinase Domain Of Human Tra | 3e-16 | ||
| 4agc_A | 353 | Crystal Structure Of Vegfr2 (Juxtamembrane And Kina | 4e-16 | ||
| 1vr2_A | 316 | Human Vascular Endothelial Growth Factor Receptor 2 | 4e-16 | ||
| 2xir_A | 316 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 4e-16 | ||
| 2qob_A | 344 | Human Epha3 Kinase Domain, Base Structure Length = | 4e-16 | ||
| 2qol_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596:y | 4e-16 | ||
| 2qon_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Y596f: | 4e-16 | ||
| 2xyu_A | 285 | Crystal Structure Of Epha4 Kinase Domain In Complex | 5e-16 | ||
| 2qo7_A | 373 | Human Epha3 Kinase And Juxtamembrane Region, Dephos | 5e-16 | ||
| 3coi_A | 353 | Crystal Structure Of P38delta Kinase Length = 353 | 5e-16 | ||
| 2y6m_A | 291 | Crystal Structure Of Epha4 Kinase Domain Length = 2 | 5e-16 | ||
| 2hel_A | 306 | Crystal Structure Of A Mutant Epha4 Kinase Domain ( | 5e-16 | ||
| 3f66_A | 298 | Human C-Met Kinase In Complex With Quinoxaline Inhi | 5e-16 | ||
| 3lq8_A | 302 | Structure Of The Kinase Domain Of C-Met Bound To Xl | 6e-16 | ||
| 3i5n_A | 309 | Crystal Structure Of C-Met With Triazolopyridazine | 6e-16 | ||
| 3f88_A | 349 | Glycogen Synthase Kinase 3beta Inhibitor Complex Le | 6e-16 | ||
| 2wd1_A | 292 | Human C-Met Kinase In Complex With Azaindole Inhibi | 6e-16 | ||
| 1jpa_A | 312 | Crystal Structure Of Unphosphorylated Ephb2 Recepto | 6e-16 | ||
| 1o9u_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 6e-16 | ||
| 3q6u_A | 308 | Structure Of The Apo Met Receptor Kinase In The Dua | 6e-16 | ||
| 2wgj_A | 306 | X-Ray Structure Of Pf-02341066 Bound To The Kinase | 6e-16 | ||
| 2g15_A | 318 | Structural Characterization Of Autoinhibited C-Met | 6e-16 | ||
| 2rfn_A | 310 | X-ray Structure Of C-met With Inhibitor. Length = 3 | 6e-16 | ||
| 4gg5_A | 319 | Crystal Structure Of Cmet In Complex With Novel Inh | 7e-16 | ||
| 3gqi_A | 326 | Crystal Structure Of Activated Receptor Tyrosine Ki | 8e-16 | ||
| 3ewh_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 8e-16 | ||
| 3pze_A | 358 | Jnk1 In Complex With Inhibitor Length = 358 | 9e-16 | ||
| 3u6j_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 9e-16 | ||
| 3elj_A | 369 | Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine | 9e-16 | ||
| 2ofv_A | 277 | Crystal Structure Of Aminoquinazoline 1 Bound To Lc | 1e-15 | ||
| 2of2_A | 271 | Crystal Structure Of Furanopyrimidine 8 Bound To Lc | 1e-15 | ||
| 3bys_A | 277 | Co-Crystal Structure Of Lck And Aminopyrimidine Ami | 1e-15 | ||
| 2og8_A | 265 | Crystal Structure Of Aminoquinazoline 36 Bound To L | 1e-15 | ||
| 4afj_A | 367 | 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec | 1e-15 | ||
| 3zrk_A | 371 | Identification Of 2-(4-Pyridyl)thienopyridinones As | 1e-15 | ||
| 3f7z_A | 350 | X-ray Co-crystal Structure Of Glycogen Synthase Kin | 1e-15 | ||
| 2vx3_A | 382 | Crystal Structure Of The Human Dual Specificity Tyr | 1e-15 | ||
| 2pl0_A | 289 | Lck Bound To Imatinib Length = 289 | 1e-15 | ||
| 4aze_A | 382 | Human Dyrk1a In Complex With Leucettine L41 Length | 1e-15 | ||
| 3zdi_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With Axin | 1e-15 | ||
| 1gng_A | 378 | Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With | 1e-15 | ||
| 4dit_A | 382 | Crystal Structure Of Gsk3beta In Complex With A Imi | 1e-15 | ||
| 3gb2_A | 353 | Gsk3beta Inhibitor Complex Length = 353 | 1e-15 | ||
| 2oh4_A | 316 | Crystal Structure Of Vegfr2 With A Benzimidazole-Ur | 1e-15 | ||
| 3anq_A | 368 | Human Dyrk1aINHIBITOR COMPLEX Length = 368 | 1e-15 | ||
| 3cjf_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 1e-15 | ||
| 3say_A | 430 | Crystal Structure Of Human Glycogen Synthase Kinase | 1e-15 | ||
| 2ow3_A | 352 | Glycogen Synthase Kinase-3 Beta In Complex With Bis | 1e-15 | ||
| 1h8f_A | 352 | Glycogen Synthase Kinase 3 Beta. Length = 352 | 1e-15 | ||
| 1r0p_A | 312 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 3a4p_A | 319 | Human C-Met Kinase Domain Complexed With 6-Benzylox | 1e-15 | ||
| 3sd0_A | 350 | Identification Of A Glycogen Synthase Kinase-3b Inh | 1e-15 | ||
| 1uv5_A | 350 | Glycogen Synthase Kinase 3 Beta Complexed With 6-Br | 1e-15 | ||
| 3dkc_A | 317 | Sgx Clone 5698a65kfg1h1 Length = 317 | 1e-15 | ||
| 2o5k_A | 372 | Crystal Structure Of Gsk3beta In Complex With A Ben | 1e-15 | ||
| 3qti_A | 314 | C-Met Kinase In Complex With Nvp-Bvu972 Length = 31 | 1e-15 | ||
| 3cth_A | 314 | Crystal Structure Of The Tyrosine Kinase Domain Of | 1e-15 | ||
| 4exu_A | 371 | Mapk13, Inactive Form Length = 371 | 2e-15 | ||
| 1r0e_A | 391 | Glycogen Synthase Kinase-3 Beta In Complex With 3-I | 2e-15 | ||
| 1i09_A | 420 | Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len | 2e-15 | ||
| 1q5k_A | 414 | Crystal Structure Of Glycogen Synthase Kinase 3 In | 2e-15 | ||
| 1zyc_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 2e-15 | ||
| 3c1x_A | 373 | Crystal Structure Of The Tyrosine Kinase Domain Of | 2e-15 | ||
| 1pyx_A | 422 | Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | 2e-15 | ||
| 4acc_A | 465 | Gsk3b In Complex With Inhibitor Length = 465 | 2e-15 | ||
| 1q3d_A | 424 | Gsk-3 Beta Complexed With Staurosporine Length = 42 | 2e-15 | ||
| 1u59_A | 287 | Crystal Structure Of The Zap-70 Kinase Domain In Co | 2e-15 | ||
| 2dyl_A | 318 | Crystal Structure Of Human Mitogen-Activated Protei | 2e-15 | ||
| 3ppz_A | 309 | Crystal Structure Of Ctr1 Kinase Domain In Complex | 2e-15 | ||
| 2r2p_A | 295 | Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep | 2e-15 | ||
| 2p2i_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 2e-15 | ||
| 3cjg_A | 309 | Crystal Structure Of Vegfr2 In Complex With A 3,4,5 | 2e-15 | ||
| 3dk7_A | 277 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 3e-15 | ||
| 3c7q_A | 316 | Structure Of Vegfr2 Kinase Domain In Complex With B | 3e-15 | ||
| 1ywn_A | 316 | Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p | 3e-15 | ||
| 4aw5_A | 291 | Complex Of The Ephb4 Kinase Domain With An Oxindole | 3e-15 | ||
| 2p0c_A | 313 | Catalytic Domain Of The Proto-Oncogene Tyrosine-Pro | 3e-15 | ||
| 2ivs_A | 314 | Crystal Structure Of Non-Phosphorylated Ret Tyrosin | 4e-15 | ||
| 3mpm_A | 267 | Lck Complexed With A Pyrazolopyrimidine Length = 26 | 4e-15 | ||
| 2hen_A | 286 | Crystal Structure Of The Ephb2 Receptor Kinase Doma | 4e-15 | ||
| 3oy3_A | 284 | Crystal Structure Of Abl T315i Mutant Kinase Domain | 5e-15 | ||
| 3q6w_A | 307 | Structure Of Dually-phosphorylated Met Receptor Kin | 5e-15 | ||
| 3mtl_A | 324 | Crystal Structure Of The Pctaire1 Kinase In Complex | 6e-15 | ||
| 3dk6_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 6e-15 | ||
| 3p86_A | 309 | Crystal Structure Of Ctr1 Kinase Domain Mutant D676 | 6e-15 | ||
| 2z60_A | 288 | Crystal Structure Of The T315i Mutant Of Abl Kinase | 6e-15 | ||
| 1qpd_A | 279 | Structural Analysis Of The Lymphocyte-specific Kina | 6e-15 | ||
| 2p2h_A | 314 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 6e-15 | ||
| 4gt5_A | 306 | Crystal Structure Of The Inactive Trka Kinase Domai | 7e-15 | ||
| 2v7a_A | 286 | Crystal Structure Of The T315i Abl Mutant In Comple | 7e-15 | ||
| 4f0i_A | 300 | Crystal Structure Of Apo Trka Length = 300 | 7e-15 | ||
| 3qrj_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain T | 7e-15 | ||
| 3lck_A | 271 | The Kinase Domain Of Human Lymphocyte Kinase (Lck), | 8e-15 | ||
| 3bym_A | 272 | X-Ray Co-Crystal Structure Aminobenzimidazole Triaz | 8e-15 | ||
| 2vwu_A | 302 | Ephb4 Kinase Domain Inhibitor Complex Length = 302 | 8e-15 | ||
| 2ofu_A | 273 | X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam | 8e-15 | ||
| 3tub_A | 293 | Crystal Structure Of Syk Kinase Domain With 1-(5-(6 | 8e-15 | ||
| 3vf8_A | 299 | Crystal Structure Of Spleen Tyrosine Kinase Syk Cat | 8e-15 | ||
| 1xba_A | 291 | Crystal Structure Of Apo Syk Tyrosine Kinase Domain | 8e-15 | ||
| 1ad5_A | 438 | Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | 8e-15 | ||
| 3emg_A | 291 | Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami | 9e-15 | ||
| 1k2p_A | 263 | Crystal Structure Of Bruton's Tyrosine Kinase Domai | 9e-15 | ||
| 4dfl_A | 274 | Crystal Structure Of Spleen Tyrosine Kinase Complex | 9e-15 | ||
| 3gvu_A | 292 | The Crystal Structure Of Human Abl2 In Complex With | 9e-15 | ||
| 2ivt_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-15 | ||
| 4aoj_A | 329 | Human Trka In Complex With The Inhibitor Az-23 Leng | 9e-15 | ||
| 3srv_A | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-15 | ||
| 3kmm_A | 288 | Structure Of Human Lck Kinase With A Small Molecule | 9e-15 | ||
| 4f4p_A | 273 | Syk In Complex With Ligand Lasw836 Length = 273 | 9e-15 | ||
| 3srv_B | 277 | Crystal Structure Of Spleen Tyrosine Kinase (Syk) I | 9e-15 | ||
| 2zm1_A | 285 | Crystal Structure Of Imidazo Pyrazin 1 Bound To The | 9e-15 | ||
| 1fpu_A | 293 | Crystal Structure Of Abl Kinase Domain In Complex W | 9e-15 | ||
| 2ivv_A | 314 | Crystal Structure Of Phosphorylated Ret Tyrosine Ki | 9e-15 | ||
| 1qpe_A | 279 | Structural Analysis Of The Lymphocyte-Specific Kina | 1e-14 | ||
| 2ozo_A | 613 | Autoinhibited Intact Human Zap-70 Length = 613 | 1e-14 | ||
| 3kxz_A | 287 | The Complex Crystal Structure Of Lck With A Probe M | 1e-14 | ||
| 3oxz_A | 284 | Crystal Structure Of Abl Kinase Domain Bound With A | 1e-14 | ||
| 3p08_A | 267 | Crystal Structure Of The Human Btk Kinase Domain Le | 1e-14 | ||
| 3qd2_B | 332 | Crsytal Structure Of Mouse Perk Kinase Domain Lengt | 1e-14 | ||
| 3dk3_A | 293 | Crystal Structure Of Mutant Abl Kinase Domain In Co | 1e-14 | ||
| 2qoh_A | 288 | Crystal Structure Of Abl Kinase Bound With Ppy-a Le | 1e-14 | ||
| 4fl3_A | 635 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 4fl2_A | 636 | Structural And Biophysical Characterization Of The | 1e-14 | ||
| 3ocs_A | 271 | Crystal Structure Of Bruton's Tyrosine Kinase In Co | 1e-14 | ||
| 3pix_A | 274 | Crystal Structure Of Btk Kinase Domain Complexed Wi | 1e-14 | ||
| 2gqg_A | 278 | X-Ray Crystal Structure Of Dasatinib (Bms-354825) B | 1e-14 | ||
| 3dkg_A | 317 | Sgx Clone 5698a109kfg1h1 Length = 317 | 1e-14 | ||
| 3qup_A | 323 | Inhibitor Bound Structure Of The Kinase Domain Of T | 1e-14 | ||
| 3qri_A | 277 | The Crystal Structure Of Human Abl1 Kinase Domain I | 1e-14 | ||
| 2hz0_A | 270 | Abl Kinase Domain In Complex With Nvp-Aeg082 Length | 1e-14 | ||
| 2hzi_A | 277 | Abl Kinase Domain In Complex With Pd180970 Length = | 1e-14 | ||
| 2hyy_A | 273 | Human Abl Kinase Domain In Complex With Imatinib (S | 2e-14 | ||
| 3gen_A | 283 | The 1.6 A Crystal Structure Of Human Bruton's Tyros | 2e-14 | ||
| 2f4j_A | 287 | Structure Of The Kinase Domain Of An Imatinib-Resis | 2e-14 | ||
| 2g2f_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 2g1t_A | 287 | A Src-Like Inactive Conformation In The Abl Tyrosin | 2e-14 | ||
| 4azf_A | 417 | Human Dyrk2 In Complex With Leucettine L41 Length = | 2e-14 | ||
| 3s95_A | 310 | Crystal Structure Of The Human Limk1 Kinase Domain | 2e-14 | ||
| 3pyy_A | 298 | Discovery And Characterization Of A Cell-Permeable, | 2e-14 | ||
| 2e2b_A | 293 | Crystal Structure Of The C-Abl Kinase Domain In Com | 2e-14 | ||
| 2hiw_A | 287 | Crystal Structure Of Inactive Conformation Abl Kina | 2e-14 | ||
| 3kvw_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-14 | ||
| 3k2l_A | 429 | Crystal Structure Of Dual-Specificity Tyrosine Phos | 2e-14 | ||
| 1pme_A | 380 | Structure Of Penta Mutant Human Erk2 Map Kinase Com | 2e-14 | ||
| 3gbz_A | 329 | Structure Of The Cmgc Cdk Kinase From Giardia Lambl | 3e-14 | ||
| 1irk_A | 306 | Crystal Structure Of The Tyrosine Kinase Domain Of | 3e-14 | ||
| 3eta_A | 317 | Kinase Domain Of Insulin Receptor Complexed With A | 4e-14 | ||
| 1mqb_A | 333 | Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro | 4e-14 | ||
| 3nyx_A | 302 | Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T | 4e-14 | ||
| 1opk_A | 495 | Structural Basis For The Auto-Inhibition Of C-Abl T | 5e-14 | ||
| 3eb0_A | 383 | Crystal Structure Of Cgd4_240 From Cryptosporidium | 6e-14 | ||
| 3oct_A | 265 | Crystal Structure Of Bruton's Tyrosine Kinase Mutan | 6e-14 | ||
| 3sa0_A | 360 | Complex Of Erk2 With Norathyriol Length = 360 | 6e-14 | ||
| 1i44_A | 306 | Crystallographic Studies Of An Activation Loop Muta | 7e-14 | ||
| 3nz0_A | 302 | Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3 | 7e-14 | ||
| 1luf_A | 343 | Crystal Structure Of The Musk Tyrosine Kinase: Insi | 8e-14 | ||
| 1opl_A | 537 | Structural Basis For The Auto-Inhibition Of C-Abl T | 8e-14 | ||
| 4fv7_A | 360 | Crystal Structure Of The Erk2 Complexed With E94 Le | 8e-14 | ||
| 1byg_A | 278 | Kinase Domain Of Human C-Terminal Src Kinase (Csk) | 9e-14 | ||
| 2fo0_A | 495 | Organization Of The Sh3-Sh2 Unit In Active And Inac | 9e-14 | ||
| 3d7u_A | 263 | Structural Basis For The Recognition Of C-Src By It | 9e-14 | ||
| 1k9a_A | 450 | Crystal Structure Analysis Of Full-Length Carboxyl- | 1e-13 | ||
| 4b99_A | 398 | Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le | 1e-13 | ||
| 3qyw_A | 364 | Crystal Structure Of Erk2 In Complex With An Inhibi | 1e-13 | ||
| 4h3q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 1e-13 | ||
| 1zxe_A | 303 | Crystal Structure Of Eif2alpha Protein Kinase Gcn2: | 1e-13 | ||
| 4fux_A | 360 | Crystal Structure Of The Erk2 Complexed With E75 Le | 1e-13 | ||
| 4gsb_A | 364 | Monoclinic Crystal Form Of The Apo-Erk2 Length = 36 | 1e-13 | ||
| 1p14_A | 306 | Crystal Structure Of A Catalytic-Loop Mutant Of The | 1e-13 | ||
| 3ekk_A | 307 | Insulin Receptor Kinase Complexed With An Inhibitor | 2e-13 | ||
| 2oo8_X | 317 | Synthesis, Structural Analysis, And Sar Studies Of | 2e-13 | ||
| 3k54_A | 283 | Structures Of Human Bruton's Tyrosine Kinase In Act | 2e-13 | ||
| 1fvr_A | 327 | Tie2 Kinase Domain Length = 327 | 2e-13 | ||
| 4f0f_A | 287 | Crystal Structure Of The Roco4 Kinase Domain Bound | 2e-13 | ||
| 4ic7_A | 442 | Crystal Structure Of The Erk5 Kinase Domain In Comp | 2e-13 | ||
| 2dq7_X | 283 | Crystal Structure Of Fyn Kinase Domain Complexed Wi | 2e-13 | ||
| 4e1z_A | 291 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 4e20_A | 290 | Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda | 2e-13 | ||
| 3lxn_A | 318 | Structural And Thermodynamic Characterization Of Th | 2e-13 | ||
| 3rgf_A | 405 | Crystal Structure Of Human Cdk8CYCC Length = 405 | 3e-13 | ||
| 3o71_A | 358 | Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length | 3e-13 | ||
| 3r63_A | 358 | Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | 3e-13 | ||
| 1gol_A | 364 | Coordinates Of Rat Map Kinase Erk2 With An Arginine | 3e-13 | ||
| 3zuv_A | 364 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 3zu7_A | 365 | Crystal Structure Of A Designed Selected Ankyrin Re | 3e-13 | ||
| 2z7l_A | 366 | Unphosphorylated Mitogen Activated Protein Kinase E | 3e-13 | ||
| 3c9w_A | 357 | Crystal Structure Of Erk-2 With Hypothemycin Covale | 3e-13 | ||
| 2fys_B | 364 | Crystal Structure Of Erk2 Complex With Kim Peptide | 3e-13 | ||
| 2erk_A | 365 | Phosphorylated Map Kinase Erk2 Length = 365 | 3e-13 | ||
| 3g6h_A | 286 | Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma | 3e-13 | ||
| 2gph_A | 364 | Docking Motif Interactions In The Map Kinase Erk2 L | 3e-13 | ||
| 2iwi_A | 312 | Crystal Structure Of The Human Pim2 In Complex With | 3e-13 | ||
| 4fv6_A | 360 | Crystal Structure Of The Erk2 Complexed With E57 Le | 3e-13 | ||
| 3oez_A | 286 | Crystal Structure Of The L317i Mutant Of The Chicke | 3e-13 | ||
| 1wzy_A | 368 | Crystal Structure Of Human Erk2 Complexed With A Py | 3e-13 | ||
| 1tvo_A | 368 | The Structure Of Erk2 In Complex With A Small Molec | 3e-13 | ||
| 2y9q_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 4ewh_B | 275 | Co-Crystal Structure Of Ack1 With Inhibitor Length | 3e-13 | ||
| 2ojg_A | 380 | Crystal Structure Of Erk2 In Complex With N,n-dimet | 3e-13 | ||
| 3tei_A | 362 | Crystal Structure Of Human Erk2 Complexed With A Ma | 3e-13 | ||
| 4e6d_A | 298 | Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W | 4e-13 | ||
| 4eut_A | 396 | Structure Of Bx-795 Complexed With Unphosphorylated | 4e-13 | ||
| 1fmk_A | 452 | Crystal Structure Of Human Tyrosine-Protein Kinase | 4e-13 | ||
| 1y57_A | 452 | Structure Of Unphosphorylated C-Src In Complex With | 4e-13 | ||
| 2bdf_A | 279 | Src Kinase In Complex With Inhibitor Ap23451 Length | 4e-13 | ||
| 1u54_A | 291 | Crystal Structures Of The Phosphorylated And Unphos | 4e-13 | ||
| 2xa4_A | 298 | Inhibitors Of Jak2 Kinase Domain Length = 298 | 5e-13 | ||
| 3eqp_B | 276 | Crystal Structure Of Ack1 With Compound T95 Length | 5e-13 | ||
| 4id7_A | 273 | Ack1 Kinase In Complex With The Inhibitor Cis-3-[8- | 5e-13 | ||
| 2oiq_A | 286 | Crystal Structure Of Chicken C-Src Kinase Domain In | 5e-13 | ||
| 3d7u_B | 277 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 3d7t_A | 269 | Structural Basis For The Recognition Of C-Src By It | 5e-13 | ||
| 4hzr_A | 277 | Crystal Structure Of Ack1 Kinase Domain Length = 27 | 5e-13 | ||
| 3u4w_A | 275 | Src In Complex With Dna-Templated Macrocyclic Inhib | 6e-13 | ||
| 4euu_A | 319 | Structure Of Bx-795 Complexed With Human Tbk1 Kinas | 6e-13 | ||
| 4f1o_A | 287 | Crystal Structure Of The L1180t Mutant Roco4 Kinase | 6e-13 | ||
| 1u46_A | 291 | Crystal Structure Of The Unphosphorylated Kinase Do | 6e-13 | ||
| 2wqb_A | 324 | Structure Of The Tie2 Kinase Domain In Complex With | 7e-13 | ||
| 4hzs_A | 341 | Crystal Structure Of Ack1 Kinase Domain With C-term | 7e-13 | ||
| 2w1i_A | 326 | Structure Determination Of Aurora Kinase In Complex | 7e-13 | ||
| 2zoq_A | 382 | Structural Dissection Of Human Mitogen-Activated Ki | 8e-13 | ||
| 3rvg_A | 303 | Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido | 8e-13 | ||
| 2ptk_A | 453 | Chicken Src Tyrosine Kinase Length = 453 | 8e-13 | ||
| 3pg1_A | 362 | Map Kinase Lmampk10 From Leishmania Major (1.95 Ang | 8e-13 | ||
| 3e62_A | 293 | Fragment Based Discovery Of Jak-2 Inhibitors Length | 8e-13 | ||
| 2h8h_A | 535 | Src Kinase In Complex With A Quinazoline Inhibitor | 8e-13 | ||
| 4e4m_A | 302 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 3 | 8e-13 | ||
| 3jy9_A | 311 | Janus Kinase 2 Inhibitors Length = 311 | 8e-13 | ||
| 2b7a_A | 293 | The Structural Basis Of Janus Kinase 2 Inhibition B | 8e-13 | ||
| 3lpb_A | 295 | Crystal Structure Of Jak2 Complexed With A Potent 2 | 8e-13 | ||
| 3hmn_A | 342 | Crystal Structure Of Human Mps1 Catalytic Domain In | 8e-13 | ||
| 4hge_A | 300 | Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 | 8e-13 | ||
| 3uib_A | 362 | Map Kinase Lmampk10 From Leishmania Major In Comple | 8e-13 | ||
| 3q32_A | 301 | Structure Of Janus Kinase 2 With A Pyrrolotriazine | 8e-13 | ||
| 2x9e_A | 317 | Human Mps1 In Complex With Nms-P715 Length = 317 | 8e-13 | ||
| 4aqc_A | 301 | Triazolopyridine-Based Inhibitor Of Janus Kinase 2 | 9e-13 | ||
| 3tjc_A | 298 | Co-Crystal Structure Of Jak2 With Thienopyridine 8 | 9e-13 | ||
| 3io7_A | 313 | 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel | 9e-13 | ||
| 3cek_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 9e-13 | ||
| 3vqu_A | 320 | Crystal Structure Of Human Mps1 Catalytic Domain In | 9e-13 | ||
| 3pls_A | 298 | Ron In Complex With Ligand Amp-Pnp Length = 298 | 9e-13 | ||
| 1ksw_A | 452 | Structure Of Human C-Src Tyrosine Kinase (Thr338gly | 1e-12 | ||
| 4f1m_A | 287 | Crystal Structure Of The G1179s Roco4 Kinase Domain | 1e-12 | ||
| 3dbq_A | 343 | Crystal Structure Of Ttk Kinase Domain Length = 343 | 1e-12 | ||
| 3svv_A | 286 | Crystal Structure Of T338c C-Src Covalently Bound T | 1e-12 | ||
| 2zmc_A | 390 | Crystal Structure Of Human Mitotic Checkpoint Kinas | 1e-12 | ||
| 3geq_A | 286 | Structural Basis For The Chemical Rescue Of Src Kin | 1e-12 | ||
| 3lvp_A | 336 | Crystal Structure Of Bisphosphorylated Igf1-R Kinas | 1e-12 | ||
| 2oj9_A | 307 | Structure Of Igf-1r Kinase Domain Complexed With A | 1e-12 | ||
| 3d94_A | 301 | Crystal Structure Of The Insulin-Like Growth Factor | 1e-12 | ||
| 2zmd_A | 390 | Crystal Structure Of Human Mps1 Catalytic Domain T6 | 1e-12 | ||
| 3o23_A | 305 | Human Unphosphorylated Igf1-R Kinase Domain In Comp | 1e-12 | ||
| 3qqu_A | 301 | Cocrystal Structure Of Unphosphorylated Igf With Py | 1e-12 | ||
| 1jqh_A | 308 | Igf-1 Receptor Kinase Domain Length = 308 | 1e-12 | ||
| 2nry_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 1e-12 | ||
| 3i81_A | 315 | Crystal Structure Of Insulin-Like Growth Factor 1 R | 1e-12 | ||
| 2z8c_A | 303 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 1ir3_A | 306 | Phosphorylated Insulin Receptor Tyrosine Kinase In | 2e-12 | ||
| 2qq7_A | 286 | Crystal Structure Of Drug Resistant Src Kinase Doma | 2e-12 | ||
| 1yol_A | 283 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 2nru_A | 307 | Crystal Structure Of Irak-4 Length = 307 | 2e-12 | ||
| 1rqq_A | 306 | Crystal Structure Of The Insulin Receptor Kinase In | 2e-12 | ||
| 1m7n_A | 322 | Crystal Structure Of Unactivated Apo Insulin-Like G | 2e-12 | ||
| 2hwo_A | 286 | Crystal Structure Of Src Kinase Domain In Complex W | 2e-12 | ||
| 3dqw_A | 286 | C-Src Kinase Domain Thr338ile Mutant In Complex Wit | 2e-12 | ||
| 2oib_A | 301 | Crystal Structure Of Irak4 Kinase Domain Apo Form L | 2e-12 | ||
| 3lw0_A | 304 | Igf-1rk In Complex With Ligand Msc1609119a-1 Length | 2e-12 | ||
| 3h9f_A | 313 | Crystal Structure Of Human Dual Specificity Protein | 2e-12 | ||
| 1p4o_A | 322 | Structure Of Apo Unactivated Igf-1r Kinase Domain A | 2e-12 | ||
| 3kex_A | 325 | Crystal Structure Of The Catalytically Inactive Kin | 3e-12 | ||
| 3fzo_A | 277 | Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosin | 3e-12 | ||
| 3lmg_A | 344 | Crystal Structure Of The Erbb3 Kinase Domain In Com | 3e-12 | ||
| 3ugc_A | 295 | Structural Basis Of Jak2 Inhibition By The Type Ii | 3e-12 | ||
| 4h1j_A | 293 | Crystal Structure Of Pyk2 With The Pyrazole 13a Len | 3e-12 | ||
| 3cc6_A | 281 | Crystal Structure Of Kinase Domain Of Protein Tyros | 3e-12 | ||
| 4alu_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 4e-12 | ||
| 1yxs_A | 293 | Crystal Structure Of Kinase Pim1 With P123m Mutatio | 4e-12 | ||
| 2f9g_A | 353 | Crystal Structure Of Fus3 Phosphorylated On Tyr182 | 4e-12 | ||
| 1yoj_A | 283 | Crystal Structure Of Src Kinase Domain Length = 283 | 5e-12 | ||
| 2xj0_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-4 Fro | 5e-12 | ||
| 1xws_A | 313 | Crystal Structure Of The Human Pim1 Kinase Domain L | 5e-12 | ||
| 1ywv_A | 293 | Crystal Structures Of Proto-Oncogene Kinase Pim1: A | 5e-12 | ||
| 2b9f_A | 353 | Crystal Structure Of Non-Phosphorylated Fus3 Length | 6e-12 | ||
| 4alv_A | 328 | Benzofuropyrimidinone Inhibitors Of Pim-1 Length = | 6e-12 | ||
| 1xqz_A | 300 | Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut | 6e-12 | ||
| 3r00_A | 299 | The Discovery Of Novel Benzofuran-2-Carboxylic Acid | 6e-12 | ||
| 3c4e_A | 273 | Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7 | 6e-12 | ||
| 3jxw_A | 294 | Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4- | 6e-12 | ||
| 4dtk_A | 276 | Novel And Selective Pan-Pim Kinase Inhibitor Length | 6e-12 | ||
| 3uix_A | 298 | Crystal Structure Of Pim1 Kinase In Complex With Sm | 6e-12 | ||
| 3rp9_A | 458 | Crystal Structure Of The Apo Mapk From Toxoplasma G | 6e-12 | ||
| 2b9h_A | 353 | Crystal Structure Of Fus3 With A Docking Motif From | 6e-12 | ||
| 1yhs_A | 273 | Crystal Structure Of Pim-1 Bound To Staurosporine L | 6e-12 | ||
| 3a99_A | 320 | Structure Of Pim-1 Kinase Crystallized In The Prese | 6e-12 | ||
| 4bbe_A | 298 | Aminoalkylpyrimidine Inhibitor Complexes With Jak2 | 7e-12 | ||
| 3nie_A | 429 | Crystal Structure Of Pf11_0147 Length = 429 | 7e-12 | ||
| 1yi6_A | 276 | C-Term Tail Segment Of Human Tyrosine Kinase (258-5 | 1e-11 | ||
| 3e3p_A | 360 | Glycogen Synthase Kinase From Leishmania Major Leng | 1e-11 | ||
| 2xix_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-1 Fro | 1e-11 | ||
| 3dcv_A | 328 | Crystal Structure Of Human Pim1 Kinase Complexed Wi | 1e-11 | ||
| 3aln_A | 327 | Crystal Structure Of Human Non-Phosphorylated Mkk4 | 1e-11 | ||
| 2obj_A | 333 | Crystal Structure Of Human Pim-1 Kinase In Complex | 1e-11 | ||
| 2i1m_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An | 1e-11 | ||
| 3f2a_A | 300 | Crystal Structure Of Human Pim-1 In Complex With Da | 1e-11 | ||
| 2xiy_A | 301 | Protein Kinase Pim-1 In Complex With Fragment-2 Fro | 1e-11 | ||
| 3oz6_A | 388 | Crystal Structure Of Mapk From Cryptosporidium Parv | 1e-11 | ||
| 4a7c_A | 308 | Crystal Structure Of Pim1 Kinase With Etp46546 Leng | 1e-11 | ||
| 3n9x_A | 432 | Crystal Structure Of Map Kinase From Plasmodium Ber | 2e-11 | ||
| 3cxw_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2bil_B | 313 | The Human Protein Kinase Pim1 In Complex With Its C | 2e-11 | ||
| 3bea_A | 333 | Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P | 2e-11 | ||
| 3jpv_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 2e-11 | ||
| 2j2i_B | 312 | Crystal Structure Of The Humab Pim1 In Complex With | 2e-11 | ||
| 2o8y_A | 298 | Apo Irak4 Kinase Domain Length = 298 | 2e-11 | ||
| 4as0_A | 273 | Cyclometalated Phthalimides As Protein Kinase Inhib | 2e-11 | ||
| 3p23_A | 432 | Crystal Structure Of The Human Kinase And Rnase Dom | 3e-11 | ||
| 1k3a_A | 299 | Structure Of The Insulin-Like Growth Factor 1 Recep | 3e-11 | ||
| 2bik_B | 313 | Human Pim1 Phosphorylated On Ser261 Length = 313 | 3e-11 | ||
| 3p1a_A | 311 | Structure Of Human Membrane-Associated Tyrosine- An | 3e-11 | ||
| 3cy3_A | 314 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 3juh_A | 335 | Crystal Structure Of A Mutant Of Human Protein Kina | 3e-11 | ||
| 3ma3_A | 313 | Crystal Structure Of Human Proto-Oncogene Serine Th | 3e-11 | ||
| 3hgk_A | 327 | Crystal Structure Of Effect Protein Avrptob Complex | 4e-11 | ||
| 1na7_A | 329 | Crystal Structure Of The Catalytic Subunit Of Human | 4e-11 | ||
| 2qkw_B | 321 | Structural Basis For Activation Of Plant Immunity B | 4e-11 | ||
| 3fme_A | 290 | Crystal Structure Of Human Mitogen-Activated Protei | 4e-11 | ||
| 2buj_A | 317 | Crystal Structure Of The Human Serine-Threonine Kin | 4e-11 | ||
| 3nsz_A | 330 | Human Ck2 Catalytic Domain In Complex With Amppn Le | 4e-11 | ||
| 3mb6_A | 331 | Human Ck2 Catalytic Domain In Complex With A Difura | 5e-11 | ||
| 3u87_A | 349 | Structure Of A Chimeric Construct Of Human Ck2alpha | 5e-11 | ||
| 1pjk_A | 334 | Crystal Structure Of A C-terminal Deletion Mutant O | 5e-11 | ||
| 3h30_A | 334 | Crystal Structure Of The Catalytic Subunit Of Human | 5e-11 | ||
| 2r7i_A | 335 | Crystal Structure Of Catalytic Subunit Of Protein K | 5e-11 | ||
| 3q04_A | 328 | Crystal Structure Of The Apo-Form Of Human Ck2 Alph | 5e-11 | ||
| 3nga_A | 333 | Human Ck2 Catalytic Domain In Complex With Cx-4945 | 5e-11 | ||
| 3bqc_A | 335 | High Ph-Value Crystal Structure Of Emodin In Comple | 5e-11 | ||
| 1jwh_A | 337 | Crystal Structure Of Human Protein Kinase Ck2 Holoe | 5e-11 | ||
| 3q9w_A | 336 | Crystal Structure Of Human Ck2 Alpha In Complex Wit | 5e-11 | ||
| 2wtk_B | 373 | Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2 | 5e-11 | ||
| 2h34_A | 309 | Apoenzyme Crystal Structure Of The Tuberculosis Ser | 5e-11 | ||
| 3gni_B | 389 | Structure Of Strad And Mo25 Length = 389 | 6e-11 | ||
| 2zjw_A | 340 | Crystal Structure Of Human Ck2 Alpha Complexed With | 6e-11 | ||
| 3vn9_A | 340 | Rifined Crystal Structure Of Non-Phosphorylated Map | 7e-11 | ||
| 1rjb_A | 344 | Crystal Structure Of Flt3 Length = 344 | 7e-11 | ||
| 2zm3_A | 308 | Complex Structure Of Insulin-Like Growth Factor Rec | 8e-11 | ||
| 2z2w_A | 285 | Humand Wee1 Kinase Complexed With Inhibitor Pf03357 | 8e-11 | ||
| 4dgl_C | 335 | Crystal Structure Of The Ck2 Tetrameric Holoenzyme | 9e-11 | ||
| 3vhe_A | 359 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 9e-11 | ||
| 3bbt_B | 328 | Crystal Structure Of The Erbb4 Kinase In Complex Wi | 9e-11 | ||
| 3vid_A | 356 | Crystal Structure Of Human Vegfr2 Kinase Domain Wit | 1e-10 | ||
| 1y6a_A | 366 | Crystal Structure Of Vegfr2 In Complex With A 2-Ani | 1e-10 | ||
| 3vhk_A | 368 | Crystal Structure Of The Vegfr2 Kinase Domain In Co | 1e-10 | ||
| 2r4b_A | 321 | Erbb4 Kinase Domain Complexed With A Thienopyrimidi | 1e-10 | ||
| 3ofm_A | 350 | Structure Of A Human Ck2alpha Prime, The Paralog Is | 1e-10 | ||
| 3e3b_X | 339 | Crystal Structure Of Catalytic Subunit Of Human Pro | 1e-10 | ||
| 2ogv_A | 317 | Crystal Structure Of The Autoinhibited Human C-Fms | 1e-10 | ||
| 3lcd_A | 329 | Inhibitor Bound To A Dfg-In Structure Of The Kinase | 2e-10 | ||
| 3eyg_A | 290 | Crystal Structures Of Jak1 And Jak2 Inhibitor Compl | 2e-10 | ||
| 4e4l_A | 302 | Jak1 Kinase (Jh1 Domain) In Complex With Compound 3 | 2e-10 | ||
| 3hng_A | 360 | Crystal Structure Of Vegfr1 In Complex With N-(4-ch | 2e-10 | ||
| 1daw_A | 327 | Crystal Structure Of A Binary Complex Of Protein Ki | 2e-10 | ||
| 3mi9_A | 351 | Crystal Structure Of Hiv-1 Tat Complexed With Human | 2e-10 | ||
| 2qc6_A | 332 | Protein Kinase Ck2 In Complex With Dbc Length = 332 | 2e-10 | ||
| 4hvd_A | 314 | Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h | 2e-10 | ||
| 1m2p_A | 325 | Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra | 2e-10 | ||
| 3pvg_A | 331 | Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C | 2e-10 | ||
| 3blh_A | 331 | Crystal Structure Of Human Cdk9CYCLINT1 Length = 33 | 2e-10 | ||
| 2pvh_A | 352 | Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri | 2e-10 | ||
| 4anm_A | 335 | Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | 2e-10 | ||
| 4dgn_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-10 | ||
| 1ds5_A | 332 | Dimeric Crystal Structure Of The Alpha Subunit In C | 2e-10 | ||
| 4dgm_A | 326 | Crystal Structure Of Maize Ck2 In Complex With The | 2e-10 | ||
| 3kxg_A | 327 | Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun | 2e-10 | ||
| 1how_A | 373 | The X-Ray Crystal Structure Of Sky1p, An Sr Protein | 2e-10 | ||
| 1q8y_A | 373 | The Structure Of The Yeast Sr Protein Kinase, Sky1p | 2e-10 |
| >pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327 | Back alignment and structure |
|
| >pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327 | Back alignment and structure |
|
| >pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327 | Back alignment and structure |
|
| >pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327 | Back alignment and structure |
|
| >pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328 | Back alignment and structure |
|
| >pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328 | Back alignment and structure |
|
| >pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319 | Back alignment and structure |
|
| >pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494 | Back alignment and structure |
|
| >pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336 | Back alignment and structure |
|
| >pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287 | Back alignment and structure |
|
| >pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286 | Back alignment and structure |
|
| >pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327 | Back alignment and structure |
|
| >pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486 | Back alignment and structure |
|
| >pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467 | Back alignment and structure |
|
| >pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271 | Back alignment and structure |
|
| >pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275 | Back alignment and structure |
|
| >pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274 | Back alignment and structure |
|
| >pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504 | Back alignment and structure |
|
| >pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322 | Back alignment and structure |
|
| >pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323 | Back alignment and structure |
|
| >pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323 | Back alignment and structure |
|
| >pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322 | Back alignment and structure |
|
| >pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329 | Back alignment and structure |
|
| >pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419 | Back alignment and structure |
|
| >pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443 | Back alignment and structure |
|
| >pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332 | Back alignment and structure |
|
| >pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365 | Back alignment and structure |
|
| >pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293 | Back alignment and structure |
|
| >pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320 | Back alignment and structure |
|
| >pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315 | Back alignment and structure |
|
| >pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298 | Back alignment and structure |
|
| >pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298 | Back alignment and structure |
|
| >pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277 | Back alignment and structure |
|
| >pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476 | Back alignment and structure |
|
| >pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484 | Back alignment and structure |
|
| >pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298 | Back alignment and structure |
|
| >pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507 | Back alignment and structure |
|
| >pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508 | Back alignment and structure |
|
| >pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276 | Back alignment and structure |
|
| >pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276 | Back alignment and structure |
|
| >pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484 | Back alignment and structure |
|
| >pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327 | Back alignment and structure |
|
| >pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327 | Back alignment and structure |
|
| >pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318 | Back alignment and structure |
|
| >pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334 | Back alignment and structure |
|
| >pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284 | Back alignment and structure |
|
| >pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285 | Back alignment and structure |
|
| >pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272 | Back alignment and structure |
|
| >pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320 | Back alignment and structure |
|
| >pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272 | Back alignment and structure |
|
| >pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283 | Back alignment and structure |
|
| >pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325 | Back alignment and structure |
|
| >pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319 | Back alignment and structure |
|
| >pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318 | Back alignment and structure |
|
| >pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324 | Back alignment and structure |
|
| >pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326 | Back alignment and structure |
|
| >pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327 | Back alignment and structure |
|
| >pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334 | Back alignment and structure |
|
| >pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406 | Back alignment and structure |
|
| >pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356 | Back alignment and structure |
|
| >pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400 | Back alignment and structure |
|
| >pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349 | Back alignment and structure |
|
| >pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278 | Back alignment and structure |
|
| >pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304 | Back alignment and structure |
|
| >pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301 | Back alignment and structure |
|
| >pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327 | Back alignment and structure |
|
| >pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285 | Back alignment and structure |
|
| >pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317 | Back alignment and structure |
|
| >pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336 | Back alignment and structure |
|
| >pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304 | Back alignment and structure |
|
| >pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277 | Back alignment and structure |
|
| >pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294 | Back alignment and structure |
|
| >pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491 | Back alignment and structure |
|
| >pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573 | Back alignment and structure |
|
| >pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278 | Back alignment and structure |
|
| >pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361 | Back alignment and structure |
|
| >pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334 | Back alignment and structure |
|
| >pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302 | Back alignment and structure |
|
| >pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295 | Back alignment and structure |
|
| >pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277 | Back alignment and structure |
|
| >pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278 | Back alignment and structure |
|
| >pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312 | Back alignment and structure |
|
| >pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285 | Back alignment and structure |
|
| >pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321 | Back alignment and structure |
|
| >pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334 | Back alignment and structure |
|
| >pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295 | Back alignment and structure |
|
| >pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293 | Back alignment and structure |
|
| >pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294 | Back alignment and structure |
|
| >pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371 | Back alignment and structure |
|
| >pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305 | Back alignment and structure |
|
| >pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304 | Back alignment and structure |
|
| >pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325 | Back alignment and structure |
|
| >pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326 | Back alignment and structure |
|
| >pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285 | Back alignment and structure |
|
| >pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279 | Back alignment and structure |
|
| >pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337 | Back alignment and structure |
|
| >pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271 | Back alignment and structure |
|
| >pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350 | Back alignment and structure |
|
| >pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280 | Back alignment and structure |
|
| >pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306 | Back alignment and structure |
|
| >pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267 | Back alignment and structure |
|
| >pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272 | Back alignment and structure |
|
| >pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285 | Back alignment and structure |
|
| >pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295 | Back alignment and structure |
|
| >pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281 | Back alignment and structure |
|
| >pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268 | Back alignment and structure |
|
| >pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350 | Back alignment and structure |
|
| >pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268 | Back alignment and structure |
|
| >pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351 | Back alignment and structure |
|
| >pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262 | Back alignment and structure |
|
| >pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279 | Back alignment and structure |
|
| >pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350 | Back alignment and structure |
|
| >pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285 | Back alignment and structure |
|
| >pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280 | Back alignment and structure |
|
| >pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350 | Back alignment and structure |
|
| >pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268 | Back alignment and structure |
|
| >pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283 | Back alignment and structure |
|
| >pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282 | Back alignment and structure |
|
| >pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275 | Back alignment and structure |
|
| >pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297 | Back alignment and structure |
|
| >pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306 | Back alignment and structure |
|
| >pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350 | Back alignment and structure |
|
| >pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283 | Back alignment and structure |
|
| >pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350 | Back alignment and structure |
|
| >pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336 | Back alignment and structure |
|
| >pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345 | Back alignment and structure |
|
| >pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371 | Back alignment and structure |
|
| >pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350 | Back alignment and structure |
|
| >pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350 | Back alignment and structure |
|
| >pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268 | Back alignment and structure |
|
| >pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351 | Back alignment and structure |
|
| >pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321 | Back alignment and structure |
|
| >pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350 | Back alignment and structure |
|
| >pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350 | Back alignment and structure |
|
| >pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288 | Back alignment and structure |
|
| >pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400 | Back alignment and structure |
|
| >pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351 | Back alignment and structure |
|
| >pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350 | Back alignment and structure |
|
| >pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350 | Back alignment and structure |
|
| >pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321 | Back alignment and structure |
|
| >pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313 | Back alignment and structure |
|
| >pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321 | Back alignment and structure |
|
| >pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272 | Back alignment and structure |
|
| >pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336 | Back alignment and structure |
|
| >pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350 | Back alignment and structure |
|
| >pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269 | Back alignment and structure |
|
| >pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351 | Back alignment and structure |
|
| >pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282 | Back alignment and structure |
|
| >pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284 | Back alignment and structure |
|
| >pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350 | Back alignment and structure |
|
| >pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350 | Back alignment and structure |
|
| >pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282 | Back alignment and structure |
|
| >pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351 | Back alignment and structure |
|
| >pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351 | Back alignment and structure |
|
| >pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351 | Back alignment and structure |
|
| >pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351 | Back alignment and structure |
|
| >pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371 | Back alignment and structure |
|
| >pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350 | Back alignment and structure |
|
| >pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351 | Back alignment and structure |
|
| >pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351 | Back alignment and structure |
|
| >pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350 | Back alignment and structure |
|
| >pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350 | Back alignment and structure |
|
| >pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343 | Back alignment and structure |
|
| >pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373 | Back alignment and structure |
|
| >pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351 | Back alignment and structure |
|
| >pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362 | Back alignment and structure |
|
| >pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351 | Back alignment and structure |
|
| >pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350 | Back alignment and structure |
|
| >pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350 | Back alignment and structure |
|
| >pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350 | Back alignment and structure |
|
| >pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285 | Back alignment and structure |
|
| >pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350 | Back alignment and structure |
|
| >pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350 | Back alignment and structure |
|
| >pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444 | Back alignment and structure |
|
| >pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350 | Back alignment and structure |
|
| >pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294 | Back alignment and structure |
|
| >pdb|1KOB|A Chain A, Twitchin Kinase Fragment (Aplysia), Autoregulated Protein Kinase Domain Length = 387 | Back alignment and structure |
|
| >pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361 | Back alignment and structure |
|
| >pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373 | Back alignment and structure |
|
| >pdb|3FPQ|A Chain A, Crystal Structure Of The Kinase Domain Of Wnk1 Length = 290 | Back alignment and structure |
|
| >pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295 | Back alignment and structure |
|
| >pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317 | Back alignment and structure |
|
| >pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360 | Back alignment and structure |
|
| >pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317 | Back alignment and structure |
|
| >pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353 | Back alignment and structure |
|
| >pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317 | Back alignment and structure |
|
| >pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317 | Back alignment and structure |
|
| >pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301 | Back alignment and structure |
|
| >pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279 | Back alignment and structure |
|
| >pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364 | Back alignment and structure |
|
| >pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396 | Back alignment and structure |
|
| >pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279 | Back alignment and structure |
|
| >pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279 | Back alignment and structure |
|
| >pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345 | Back alignment and structure |
|
| >pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353 | Back alignment and structure |
|
| >pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674 | Back alignment and structure |
|
| >pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362 | Back alignment and structure |
|
| >pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361 | Back alignment and structure |
|
| >pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314 | Back alignment and structure |
|
| >pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315 | Back alignment and structure |
|
| >pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311 | Back alignment and structure |
|
| >pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311 | Back alignment and structure |
|
| >pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325 | Back alignment and structure |
|
| >pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294 | Back alignment and structure |
|
| >pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311 | Back alignment and structure |
|
| >pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292 | Back alignment and structure |
|
| >pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311 | Back alignment and structure |
|
| >pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335 | Back alignment and structure |
|
| >pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286 | Back alignment and structure |
|
| >pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311 | Back alignment and structure |
|
| >pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312 | Back alignment and structure |
|
| >pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310 | Back alignment and structure |
|
| >pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292 | Back alignment and structure |
|
| >pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286 | Back alignment and structure |
|
| >pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286 | Back alignment and structure |
|
| >pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289 | Back alignment and structure |
|
| >pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311 | Back alignment and structure |
|
| >pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310 | Back alignment and structure |
|
| >pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309 | Back alignment and structure |
|
| >pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311 | Back alignment and structure |
|
| >pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312 | Back alignment and structure |
|
| >pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311 | Back alignment and structure |
|
| >pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311 | Back alignment and structure |
|
| >pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325 | Back alignment and structure |
|
| >pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352 | Back alignment and structure |
|
| >pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325 | Back alignment and structure |
|
| >pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316 | Back alignment and structure |
|
| >pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345 | Back alignment and structure |
|
| >pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362 | Back alignment and structure |
|
| >pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362 | Back alignment and structure |
|
| >pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311 | Back alignment and structure |
|
| >pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310 | Back alignment and structure |
|
| >pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|2HW6|A Chain A, Crystal Structure Of Mnk1 Catalytic Domain Length = 307 | Back alignment and structure |
|
| >pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276 | Back alignment and structure |
|
| >pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271 | Back alignment and structure |
|
| >pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278 | Back alignment and structure |
|
| >pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273 | Back alignment and structure |
|
| >pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323 | Back alignment and structure |
|
| >pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268 | Back alignment and structure |
|
| >pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322 | Back alignment and structure |
|
| >pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273 | Back alignment and structure |
|
| >pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269 | Back alignment and structure |
|
| >pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297 | Back alignment and structure |
|
| >pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289 | Back alignment and structure |
|
| >pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295 | Back alignment and structure |
|
| >pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304 | Back alignment and structure |
|
| >pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297 | Back alignment and structure |
|
| >pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321 | Back alignment and structure |
|
| >pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297 | Back alignment and structure |
|
| >pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576 | Back alignment and structure |
|
| >pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576 | Back alignment and structure |
|
| >pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384 | Back alignment and structure |
|
| >pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297 | Back alignment and structure |
|
| >pdb|3KGA|A Chain A, Crystal Structure Of Mapkap Kinase 2 (Mk2) Complexed With A Potent 3-Aminopyrazole Atp Site Inhibitor Length = 299 | Back alignment and structure |
|
| >pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351 | Back alignment and structure |
|
| >pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327 | Back alignment and structure |
|
| >pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335 | Back alignment and structure |
|
| >pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339 | Back alignment and structure |
|
| >pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315 | Back alignment and structure |
|
| >pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276 | Back alignment and structure |
|
| >pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335 | Back alignment and structure |
|
| >pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279 | Back alignment and structure |
|
| >pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336 | Back alignment and structure |
|
| >pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337 | Back alignment and structure |
|
| >pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269 | Back alignment and structure |
|
| >pdb|2WNT|A Chain A, Crystal Structure Of The Human Ribosomal Protein S6 Kinase Length = 330 | Back alignment and structure |
|
| >pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342 | Back alignment and structure |
|
| >pdb|3RNY|A Chain A, Crystal Structure Of Human Rsk1 C-Terminal Kinase Domain Length = 346 | Back alignment and structure |
|
| >pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348 | Back alignment and structure |
|
| >pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309 | Back alignment and structure |
|
| >pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406 | Back alignment and structure |
|
| >pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415 | Back alignment and structure |
|
| >pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410 | Back alignment and structure |
|
| >pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402 | Back alignment and structure |
|
| >pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677 | Back alignment and structure |
|
| >pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676 | Back alignment and structure |
|
| >pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301 | Back alignment and structure |
|
| >pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314 | Back alignment and structure |
|
| >pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290 | Back alignment and structure |
|
| >pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303 | Back alignment and structure |
|
| >pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305 | Back alignment and structure |
|
| >pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377 | Back alignment and structure |
|
| >pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437 | Back alignment and structure |
|
| >pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294 | Back alignment and structure |
|
| >pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543 | Back alignment and structure |
|
| >pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543 | Back alignment and structure |
|
| >pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543 | Back alignment and structure |
|
| >pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543 | Back alignment and structure |
|
| >pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307 | Back alignment and structure |
|
| >pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308 | Back alignment and structure |
|
| >pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326 | Back alignment and structure |
|
| >pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2AC5|A Chain A, Structure Of Human Mnk2 Kinase Domain Mutant D228g Length = 316 | Back alignment and structure |
|
| >pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302 | Back alignment and structure |
|
| >pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311 | Back alignment and structure |
|
| >pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351 | Back alignment and structure |
|
| >pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301 | Back alignment and structure |
|
| >pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293 | Back alignment and structure |
|
| >pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361 | Back alignment and structure |
|
| >pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350 | Back alignment and structure |
|
| >pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377 | Back alignment and structure |
|
| >pdb|2EVA|A Chain A, Structural Basis For The Interaction Of Tak1 Kinase With Its Activating Protein Tab1 Length = 307 | Back alignment and structure |
|
| >pdb|4GS6|A Chain A, Irreversible Inhibition Of Tak1 Kinase By 5z-7-oxozeaenol Length = 315 | Back alignment and structure |
|
| >pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286 | Back alignment and structure |
|
| >pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304 | Back alignment and structure |
|
| >pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294 | Back alignment and structure |
|
| >pdb|2QR8|A Chain A, 2.0a X-ray Structure Of C-terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 (rsk2) Length = 342 | Back alignment and structure |
|
| >pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345 | Back alignment and structure |
|
| >pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303 | Back alignment and structure |
|
| >pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321 | Back alignment and structure |
|
| >pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304 | Back alignment and structure |
|
| >pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279 | Back alignment and structure |
|
| >pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446 | Back alignment and structure |
|
| >pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331 | Back alignment and structure |
|
| >pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340 | Back alignment and structure |
|
| >pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446 | Back alignment and structure |
|
| >pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296 | Back alignment and structure |
|
| >pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341 | Back alignment and structure |
|
| >pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342 | Back alignment and structure |
|
| >pdb|2QR7|A Chain A, 2.0a X-Ray Structure Of C-Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2: Se-Met Derivative Length = 342 | Back alignment and structure |
|
| >pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292 | Back alignment and structure |
|
| >pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303 | Back alignment and structure |
|
| >pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301 | Back alignment and structure |
|
| >pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346 | Back alignment and structure |
|
| >pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317 | Back alignment and structure |
|
| >pdb|2AC3|A Chain A, Structure Of Human Mnk2 Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320 | Back alignment and structure |
|
| >pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423 | Back alignment and structure |
|
| >pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317 | Back alignment and structure |
|
| >pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415 | Back alignment and structure |
|
| >pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311 | Back alignment and structure |
|
| >pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346 | Back alignment and structure |
|
| >pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433 | Back alignment and structure |
|
| >pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288 | Back alignment and structure |
|
| >pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333 | Back alignment and structure |
|
| >pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313 | Back alignment and structure |
|
| >pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311 | Back alignment and structure |
|
| >pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395 | Back alignment and structure |
|
| >pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328 | Back alignment and structure |
|
| >pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322 | Back alignment and structure |
|
| >pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341 | Back alignment and structure |
|
| >pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360 | Back alignment and structure |
|
| >pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288 | Back alignment and structure |
|
| >pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311 | Back alignment and structure |
|
| >pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311 | Back alignment and structure |
|
| >pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299 | Back alignment and structure |
|
| >pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298 | Back alignment and structure |
|
| >pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335 | Back alignment and structure |
|
| >pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280 | Back alignment and structure |
|
| >pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292 | Back alignment and structure |
|
| >pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656 | Back alignment and structure |
|
| >pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311 | Back alignment and structure |
|
| >pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299 | Back alignment and structure |
|
| >pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299 | Back alignment and structure |
|
| >pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299 | Back alignment and structure |
|
| >pdb|4GT4|A Chain A, Structure Of Unliganded, Inactive Ror2 Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360 | Back alignment and structure |
|
| >pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389 | Back alignment and structure |
|
| >pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300 | Back alignment and structure |
|
| >pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306 | Back alignment and structure |
|
| >pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289 | Back alignment and structure |
|
| >pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302 | Back alignment and structure |
|
| >pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3ZZW|A Chain A, Crystal Structure Of The Kinase Domain Of Ror2 Length = 289 | Back alignment and structure |
|
| >pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325 | Back alignment and structure |
|
| >pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276 | Back alignment and structure |
|
| >pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299 | Back alignment and structure |
|
| >pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299 | Back alignment and structure |
|
| >pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298 | Back alignment and structure |
|
| >pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281 | Back alignment and structure |
|
| >pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281 | Back alignment and structure |
|
| >pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299 | Back alignment and structure |
|
| >pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300 | Back alignment and structure |
|
| >pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304 | Back alignment and structure |
|
| >pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298 | Back alignment and structure |
|
| >pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299 | Back alignment and structure |
|
| >pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309 | Back alignment and structure |
|
| >pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296 | Back alignment and structure |
|
| >pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282 | Back alignment and structure |
|
| >pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372 | Back alignment and structure |
|
| >pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289 | Back alignment and structure |
|
| >pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306 | Back alignment and structure |
|
| >pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300 | Back alignment and structure |
|
| >pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297 | Back alignment and structure |
|
| >pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656 | Back alignment and structure |
|
| >pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301 | Back alignment and structure |
|
| >pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298 | Back alignment and structure |
|
| >pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303 | Back alignment and structure |
|
| >pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367 | Back alignment and structure |
|
| >pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298 | Back alignment and structure |
|
| >pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354 | Back alignment and structure |
|
| >pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367 | Back alignment and structure |
|
| >pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300 | Back alignment and structure |
|
| >pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348 | Back alignment and structure |
|
| >pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365 | Back alignment and structure |
|
| >pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365 | Back alignment and structure |
|
| >pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299 | Back alignment and structure |
|
| >pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371 | Back alignment and structure |
|
| >pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355 | Back alignment and structure |
|
| >pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271 | Back alignment and structure |
|
| >pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349 | Back alignment and structure |
|
| >pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356 | Back alignment and structure |
|
| >pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366 | Back alignment and structure |
|
| >pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348 | Back alignment and structure |
|
| >pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366 | Back alignment and structure |
|
| >pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354 | Back alignment and structure |
|
| >pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351 | Back alignment and structure |
|
| >pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359 | Back alignment and structure |
|
| >pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354 | Back alignment and structure |
|
| >pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350 | Back alignment and structure |
|
| >pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367 | Back alignment and structure |
|
| >pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348 | Back alignment and structure |
|
| >pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366 | Back alignment and structure |
|
| >pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360 | Back alignment and structure |
|
| >pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311 | Back alignment and structure |
|
| >pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365 | Back alignment and structure |
|
| >pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695 | Back alignment and structure |
|
| >pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360 | Back alignment and structure |
|
| >pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360 | Back alignment and structure |
|
| >pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370 | Back alignment and structure |
|
| >pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367 | Back alignment and structure |
|
| >pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689 | Back alignment and structure |
|
| >pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380 | Back alignment and structure |
|
| >pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688 | Back alignment and structure |
|
| >pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348 | Back alignment and structure |
|
| >pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360 | Back alignment and structure |
|
| >pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362 | Back alignment and structure |
|
| >pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379 | Back alignment and structure |
|
| >pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360 | Back alignment and structure |
|
| >pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362 | Back alignment and structure |
|
| >pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292 | Back alignment and structure |
|
| >pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362 | Back alignment and structure |
|
| >pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379 | Back alignment and structure |
|
| >pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360 | Back alignment and structure |
|
| >pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372 | Back alignment and structure |
|
| >pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371 | Back alignment and structure |
|
| >pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308 | Back alignment and structure |
|
| >pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383 | Back alignment and structure |
|
| >pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336 | Back alignment and structure |
|
| >pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306 | Back alignment and structure |
|
| >pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360 | Back alignment and structure |
|
| >pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300 | Back alignment and structure |
|
| >pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282 | Back alignment and structure |
|
| >pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284 | Back alignment and structure |
|
| >pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370 | Back alignment and structure |
|
| >pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307 | Back alignment and structure |
|
| >pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281 | Back alignment and structure |
|
| >pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352 | Back alignment and structure |
|
| >pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370 | Back alignment and structure |
|
| >pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284 | Back alignment and structure |
|
| >pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350 | Back alignment and structure |
|
| >pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348 | Back alignment and structure |
|
| >pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275 | Back alignment and structure |
|
| >pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370 | Back alignment and structure |
|
| >pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311 | Back alignment and structure |
|
| >pdb|3SXR|A Chain A, Crystal Structure Of Bmx Non-Receptor Tyrosine Kinase Complex With Dasatinib Length = 268 | Back alignment and structure |
|
| >pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364 | Back alignment and structure |
|
| >pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276 | Back alignment and structure |
|
| >pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306 | Back alignment and structure |
|
| >pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313 | Back alignment and structure |
|
| >pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295 | Back alignment and structure |
|
| >pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299 | Back alignment and structure |
|
| >pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276 | Back alignment and structure |
|
| >pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355 | Back alignment and structure |
|
| >pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364 | Back alignment and structure |
|
| >pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292 | Back alignment and structure |
|
| >pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269 | Back alignment and structure |
|
| >pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318 | Back alignment and structure |
|
| >pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364 | Back alignment and structure |
|
| >pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353 | Back alignment and structure |
|
| >pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356 | Back alignment and structure |
|
| >pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2VD5|A Chain A, Structure Of Human Myotonic Dystrophy Protein Kinase In Complex With The Bisindoylmaleide Inhibitor Bim Viii Length = 412 | Back alignment and structure |
|
| >pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361 | Back alignment and structure |
|
| >pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344 | Back alignment and structure |
|
| >pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369 | Back alignment and structure |
|
| >pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360 | Back alignment and structure |
|
| >pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373 | Back alignment and structure |
|
| >pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310 | Back alignment and structure |
|
| >pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371 | Back alignment and structure |
|
| >pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371 | Back alignment and structure |
|
| >pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373 | Back alignment and structure |
|
| >pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309 | Back alignment and structure |
|
| >pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317 | Back alignment and structure |
|
| >pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356 | Back alignment and structure |
|
| >pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362 | Back alignment and structure |
|
| >pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370 | Back alignment and structure |
|
| >pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317 | Back alignment and structure |
|
| >pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270 | Back alignment and structure |
|
| >pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306 | Back alignment and structure |
|
| >pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302 | Back alignment and structure |
|
| >pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356 | Back alignment and structure |
|
| >pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379 | Back alignment and structure |
|
| >pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355 | Back alignment and structure |
|
| >pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364 | Back alignment and structure |
|
| >pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363 | Back alignment and structure |
|
| >pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266 | Back alignment and structure |
|
| >pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365 | Back alignment and structure |
|
| >pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464 | Back alignment and structure |
|
| >pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360 | Back alignment and structure |
|
| >pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423 | Back alignment and structure |
|
| >pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454 | Back alignment and structure |
|
| >pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|4FNW|A Chain A, Crystal Structure Of The Apo F1174l Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|2YJR|A Chain A, Structure Of F1174l Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307 | Back alignment and structure |
|
| >pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318 | Back alignment and structure |
|
| >pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324 | Back alignment and structure |
|
| >pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267 | Back alignment and structure |
|
| >pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382 | Back alignment and structure |
|
| >pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394 | Back alignment and structure |
|
| >pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360 | Back alignment and structure |
|
| >pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370 | Back alignment and structure |
|
| >pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334 | Back alignment and structure |
|
| >pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334 | Back alignment and structure |
|
| >pdb|2YFX|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase In Complex With Crizotinib Length = 327 | Back alignment and structure |
|
| >pdb|4FNX|A Chain A, Crystal Structure Of The Apo R1275q Anaplastic Lymphoma Kinase Catalytic Domain Length = 327 | Back alignment and structure |
|
| >pdb|4DCE|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With A Piperidine-Carboxamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3AOX|A Chain A, X-Ray Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Ch5424802 Length = 344 | Back alignment and structure |
|
| >pdb|2XP2|A Chain A, Structure Of The Human Anaplastic Lymphoma Kinase In Complex With Crizotinib (Pf-02341066) Length = 327 | Back alignment and structure |
|
| >pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370 | Back alignment and structure |
|
| >pdb|2YHV|A Chain A, Structure Of L1196m Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|2XB7|A Chain A, Structure Of Human Anaplastic Lymphoma Kinase In Complex With Nvp- Tae684 Length = 315 | Back alignment and structure |
|
| >pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264 | Back alignment and structure |
|
| >pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386 | Back alignment and structure |
|
| >pdb|4FOB|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Acyliminobenzimidazole Inhibitor 1 Length = 353 | Back alignment and structure |
|
| >pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266 | Back alignment and structure |
|
| >pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|4FNZ|A Chain A, Crystal Structure Of Human Anaplastic Lymphoma Kinase In Complex With Piperidine-Carboxamide Inhibitor 2 Length = 327 | Back alignment and structure |
|
| >pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324 | Back alignment and structure |
|
| >pdb|2YJS|A Chain A, Structure Of C1156y Mutant Anaplastic Lymphoma Kinase Length = 342 | Back alignment and structure |
|
| >pdb|3LCT|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 344 | Back alignment and structure |
|
| >pdb|3L9P|A Chain A, Crystal Structure Of The Anaplastic Lymphoma Kinase Catalytic Domain Length = 367 | Back alignment and structure |
|
| >pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269 | Back alignment and structure |
|
| >pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297 | Back alignment and structure |
|
| >pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353 | Back alignment and structure |
|
| >pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316 | Back alignment and structure |
|
| >pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316 | Back alignment and structure |
|
| >pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344 | Back alignment and structure |
|
| >pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373 | Back alignment and structure |
|
| >pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285 | Back alignment and structure |
|
| >pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373 | Back alignment and structure |
|
| >pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353 | Back alignment and structure |
|
| >pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306 | Back alignment and structure |
|
| >pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302 | Back alignment and structure |
|
| >pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309 | Back alignment and structure |
|
| >pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349 | Back alignment and structure |
|
| >pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292 | Back alignment and structure |
|
| >pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312 | Back alignment and structure |
|
| >pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350 | Back alignment and structure |
|
| >pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308 | Back alignment and structure |
|
| >pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306 | Back alignment and structure |
|
| >pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318 | Back alignment and structure |
|
| >pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310 | Back alignment and structure |
|
| >pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326 | Back alignment and structure |
|
| >pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358 | Back alignment and structure |
|
| >pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369 | Back alignment and structure |
|
| >pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277 | Back alignment and structure |
|
| >pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271 | Back alignment and structure |
|
| >pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277 | Back alignment and structure |
|
| >pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265 | Back alignment and structure |
|
| >pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367 | Back alignment and structure |
|
| >pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371 | Back alignment and structure |
|
| >pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350 | Back alignment and structure |
|
| >pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382 | Back alignment and structure |
|
| >pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289 | Back alignment and structure |
|
| >pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382 | Back alignment and structure |
|
| >pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350 | Back alignment and structure |
|
| >pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378 | Back alignment and structure |
|
| >pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382 | Back alignment and structure |
|
| >pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353 | Back alignment and structure |
|
| >pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316 | Back alignment and structure |
|
| >pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368 | Back alignment and structure |
|
| >pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430 | Back alignment and structure |
|
| >pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352 | Back alignment and structure |
|
| >pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352 | Back alignment and structure |
|
| >pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312 | Back alignment and structure |
|
| >pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319 | Back alignment and structure |
|
| >pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350 | Back alignment and structure |
|
| >pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350 | Back alignment and structure |
|
| >pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372 | Back alignment and structure |
|
| >pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314 | Back alignment and structure |
|
| >pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371 | Back alignment and structure |
|
| >pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391 | Back alignment and structure |
|
| >pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420 | Back alignment and structure |
|
| >pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414 | Back alignment and structure |
|
| >pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303 | Back alignment and structure |
|
| >pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373 | Back alignment and structure |
|
| >pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422 | Back alignment and structure |
|
| >pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465 | Back alignment and structure |
|
| >pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424 | Back alignment and structure |
|
| >pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287 | Back alignment and structure |
|
| >pdb|2DYL|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 7 Activated Mutant (S287d, T291d) Length = 318 | Back alignment and structure |
|
| >pdb|3PPZ|A Chain A, Crystal Structure Of Ctr1 Kinase Domain In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295 | Back alignment and structure |
|
| >pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309 | Back alignment and structure |
|
| >pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277 | Back alignment and structure |
|
| >pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316 | Back alignment and structure |
|
| >pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316 | Back alignment and structure |
|
| >pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|2P0C|A Chain A, Catalytic Domain Of The Proto-Oncogene Tyrosine-Protein Kina Length = 313 | Back alignment and structure |
|
| >pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267 | Back alignment and structure |
|
| >pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286 | Back alignment and structure |
|
| >pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284 | Back alignment and structure |
|
| >pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307 | Back alignment and structure |
|
| >pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324 | Back alignment and structure |
|
| >pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|3P86|A Chain A, Crystal Structure Of Ctr1 Kinase Domain Mutant D676n In Complex With Staurosporine Length = 309 | Back alignment and structure |
|
| >pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288 | Back alignment and structure |
|
| >pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314 | Back alignment and structure |
|
| >pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306 | Back alignment and structure |
|
| >pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286 | Back alignment and structure |
|
| >pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300 | Back alignment and structure |
|
| >pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277 | Back alignment and structure |
|
| >pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271 | Back alignment and structure |
|
| >pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272 | Back alignment and structure |
|
| >pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302 | Back alignment and structure |
|
| >pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273 | Back alignment and structure |
|
| >pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293 | Back alignment and structure |
|
| >pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299 | Back alignment and structure |
|
| >pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291 | Back alignment and structure |
|
| >pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438 | Back alignment and structure |
|
| >pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291 | Back alignment and structure |
|
| >pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263 | Back alignment and structure |
|
| >pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274 | Back alignment and structure |
|
| >pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292 | Back alignment and structure |
|
| >pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314 | Back alignment and structure |
|
| >pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329 | Back alignment and structure |
|
| >pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288 | Back alignment and structure |
|
| >pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273 | Back alignment and structure |
|
| >pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277 | Back alignment and structure |
|
| >pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285 | Back alignment and structure |
|
| >pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314 | Back alignment and structure |
|
| >pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279 | Back alignment and structure |
|
| >pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613 | Back alignment and structure |
|
| >pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287 | Back alignment and structure |
|
| >pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284 | Back alignment and structure |
|
| >pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267 | Back alignment and structure |
|
| >pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332 | Back alignment and structure |
|
| >pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293 | Back alignment and structure |
|
| >pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288 | Back alignment and structure |
|
| >pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635 | Back alignment and structure |
|
| >pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636 | Back alignment and structure |
|
| >pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271 | Back alignment and structure |
|
| >pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274 | Back alignment and structure |
|
| >pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278 | Back alignment and structure |
|
| >pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317 | Back alignment and structure |
|
| >pdb|3QUP|A Chain A, Inhibitor Bound Structure Of The Kinase Domain Of The Murine Receptor Tyrosine Kinase Tyro3 (Sky) Length = 323 | Back alignment and structure |
|
| >pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277 | Back alignment and structure |
|
| >pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270 | Back alignment and structure |
|
| >pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277 | Back alignment and structure |
|
| >pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273 | Back alignment and structure |
|
| >pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283 | Back alignment and structure |
|
| >pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287 | Back alignment and structure |
|
| >pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287 | Back alignment and structure |
|
| >pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417 | Back alignment and structure |
|
| >pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310 | Back alignment and structure |
|
| >pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298 | Back alignment and structure |
|
| >pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293 | Back alignment and structure |
|
| >pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287 | Back alignment and structure |
|
| >pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429 | Back alignment and structure |
|
| >pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429 | Back alignment and structure |
|
| >pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380 | Back alignment and structure |
|
| >pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329 | Back alignment and structure |
|
| >pdb|1IRK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Human Insulin Receptor Length = 306 | Back alignment and structure |
|
| >pdb|3ETA|A Chain A, Kinase Domain Of Insulin Receptor Complexed With A Pyrrolo Pyridine Inhibitor Length = 317 | Back alignment and structure |
|
| >pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333 | Back alignment and structure |
|
| >pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302 | Back alignment and structure |
|
| >pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495 | Back alignment and structure |
|
| >pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383 | Back alignment and structure |
|
| >pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265 | Back alignment and structure |
|
| >pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360 | Back alignment and structure |
|
| >pdb|1I44|A Chain A, Crystallographic Studies Of An Activation Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302 | Back alignment and structure |
|
| >pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343 | Back alignment and structure |
|
| >pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537 | Back alignment and structure |
|
| >pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360 | Back alignment and structure |
|
| >pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278 | Back alignment and structure |
|
| >pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263 | Back alignment and structure |
|
| >pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450 | Back alignment and structure |
|
| >pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398 | Back alignment and structure |
|
| >pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364 | Back alignment and structure |
|
| >pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303 | Back alignment and structure |
|
| >pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360 | Back alignment and structure |
|
| >pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|1P14|A Chain A, Crystal Structure Of A Catalytic-Loop Mutant Of The Insulin Receptor Tyrosine Kinase Length = 306 | Back alignment and structure |
|
| >pdb|3EKK|A Chain A, Insulin Receptor Kinase Complexed With An Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|2OO8|X Chain X, Synthesis, Structural Analysis, And Sar Studies Of Triazine Derivatives As Potent, Selective Tie-2 Inhibitors Length = 317 | Back alignment and structure |
|
| >pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283 | Back alignment and structure |
|
| >pdb|1FVR|A Chain A, Tie2 Kinase Domain Length = 327 | Back alignment and structure |
|
| >pdb|4F0F|A Chain A, Crystal Structure Of The Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442 | Back alignment and structure |
|
| >pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283 | Back alignment and structure |
|
| >pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291 | Back alignment and structure |
|
| >pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290 | Back alignment and structure |
|
| >pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318 | Back alignment and structure |
|
| >pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405 | Back alignment and structure |
|
| >pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358 | Back alignment and structure |
|
| >pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358 | Back alignment and structure |
|
| >pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364 | Back alignment and structure |
|
| >pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366 | Back alignment and structure |
|
| >pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357 | Back alignment and structure |
|
| >pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364 | Back alignment and structure |
|
| >pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365 | Back alignment and structure |
|
| >pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286 | Back alignment and structure |
|
| >pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364 | Back alignment and structure |
|
| >pdb|2IWI|A Chain A, Crystal Structure Of The Human Pim2 In Complex With A Ruthenium Organometallic Ligand Ru1 Length = 312 | Back alignment and structure |
|
| >pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360 | Back alignment and structure |
|
| >pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286 | Back alignment and structure |
|
| >pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368 | Back alignment and structure |
|
| >pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368 | Back alignment and structure |
|
| >pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275 | Back alignment and structure |
|
| >pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380 | Back alignment and structure |
|
| >pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362 | Back alignment and structure |
|
| >pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298 | Back alignment and structure |
|
| >pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396 | Back alignment and structure |
|
| >pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452 | Back alignment and structure |
|
| >pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452 | Back alignment and structure |
|
| >pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279 | Back alignment and structure |
|
| >pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291 | Back alignment and structure |
|
| >pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276 | Back alignment and structure |
|
| >pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273 | Back alignment and structure |
|
| >pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286 | Back alignment and structure |
|
| >pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277 | Back alignment and structure |
|
| >pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269 | Back alignment and structure |
|
| >pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277 | Back alignment and structure |
|
| >pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275 | Back alignment and structure |
|
| >pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319 | Back alignment and structure |
|
| >pdb|4F1O|A Chain A, Crystal Structure Of The L1180t Mutant Roco4 Kinase Domain From D. Discoideum Bound To Appcp Length = 287 | Back alignment and structure |
|
| >pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291 | Back alignment and structure |
|
| >pdb|2WQB|A Chain A, Structure Of The Tie2 Kinase Domain In Complex With A Thiazolopyrimidine Inhibitor Length = 324 | Back alignment and structure |
|
| >pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341 | Back alignment and structure |
|
| >pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326 | Back alignment and structure |
|
| >pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382 | Back alignment and structure |
|
| >pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303 | Back alignment and structure |
|
| >pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453 | Back alignment and structure |
|
| >pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362 | Back alignment and structure |
|
| >pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293 | Back alignment and structure |
|
| >pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535 | Back alignment and structure |
|
| >pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311 | Back alignment and structure |
|
| >pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293 | Back alignment and structure |
|
| >pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295 | Back alignment and structure |
|
| >pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342 | Back alignment and structure |
|
| >pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300 | Back alignment and structure |
|
| >pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362 | Back alignment and structure |
|
| >pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301 | Back alignment and structure |
|
| >pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317 | Back alignment and structure |
|
| >pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301 | Back alignment and structure |
|
| >pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298 | Back alignment and structure |
|
| >pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313 | Back alignment and structure |
|
| >pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313 | Back alignment and structure |
|
| >pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320 | Back alignment and structure |
|
| >pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298 | Back alignment and structure |
|
| >pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452 | Back alignment and structure |
|
| >pdb|4F1M|A Chain A, Crystal Structure Of The G1179s Roco4 Kinase Domain Bound To Appcp From D. Discoideum Length = 287 | Back alignment and structure |
|
| >pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343 | Back alignment and structure |
|
| >pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286 | Back alignment and structure |
|
| >pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390 | Back alignment and structure |
|
| >pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286 | Back alignment and structure |
|
| >pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336 | Back alignment and structure |
|
| >pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307 | Back alignment and structure |
|
| >pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301 | Back alignment and structure |
|
| >pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390 | Back alignment and structure |
|
| >pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305 | Back alignment and structure |
|
| >pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301 | Back alignment and structure |
|
| >pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308 | Back alignment and structure |
|
| >pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315 | Back alignment and structure |
|
| >pdb|2Z8C|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin-2- Yl]amino}phenyl)acetic Acid Length = 303 | Back alignment and structure |
|
| >pdb|1IR3|A Chain A, Phosphorylated Insulin Receptor Tyrosine Kinase In Complex With Peptide Substrate And Atp Analog Length = 306 | Back alignment and structure |
|
| >pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283 | Back alignment and structure |
|
| >pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307 | Back alignment and structure |
|
| >pdb|1RQQ|A Chain A, Crystal Structure Of The Insulin Receptor Kinase In Complex With The Sh2 Domain Of Aps Length = 306 | Back alignment and structure |
|
| >pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322 | Back alignment and structure |
|
| >pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286 | Back alignment and structure |
|
| >pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286 | Back alignment and structure |
|
| >pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301 | Back alignment and structure |
|
| >pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304 | Back alignment and structure |
|
| >pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313 | Back alignment and structure |
|
| >pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322 | Back alignment and structure |
|
| >pdb|3KEX|A Chain A, Crystal Structure Of The Catalytically Inactive Kinase Domain Of The Human Epidermal Growth Factor Receptor 3 (Her3) Length = 325 | Back alignment and structure |
|
| >pdb|3FZO|A Chain A, Crystal Structure Of Pyk2-Apo, Proline-Rich Tyrosine Kinase Length = 277 | Back alignment and structure |
|
| >pdb|3LMG|A Chain A, Crystal Structure Of The Erbb3 Kinase Domain In Complex With Amp-Pnp Length = 344 | Back alignment and structure |
|
| >pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295 | Back alignment and structure |
|
| >pdb|4H1J|A Chain A, Crystal Structure Of Pyk2 With The Pyrazole 13a Length = 293 | Back alignment and structure |
|
| >pdb|3CC6|A Chain A, Crystal Structure Of Kinase Domain Of Protein Tyrosine Kinase 2 Beta (ptk2b) Length = 281 | Back alignment and structure |
|
| >pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293 | Back alignment and structure |
|
| >pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353 | Back alignment and structure |
|
| >pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283 | Back alignment and structure |
|
| >pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313 | Back alignment and structure |
|
| >pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293 | Back alignment and structure |
|
| >pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353 | Back alignment and structure |
|
| >pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328 | Back alignment and structure |
|
| >pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300 | Back alignment and structure |
|
| >pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299 | Back alignment and structure |
|
| >pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273 | Back alignment and structure |
|
| >pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294 | Back alignment and structure |
|
| >pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276 | Back alignment and structure |
|
| >pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298 | Back alignment and structure |
|
| >pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458 | Back alignment and structure |
|
| >pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353 | Back alignment and structure |
|
| >pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273 | Back alignment and structure |
|
| >pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320 | Back alignment and structure |
|
| >pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298 | Back alignment and structure |
|
| >pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429 | Back alignment and structure |
|
| >pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276 | Back alignment and structure |
|
| >pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360 | Back alignment and structure |
|
| >pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328 | Back alignment and structure |
|
| >pdb|3ALN|A Chain A, Crystal Structure Of Human Non-Phosphorylated Mkk4 Kinase Domain Complexed With Amp-Pnp Length = 327 | Back alignment and structure |
|
| >pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300 | Back alignment and structure |
|
| >pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301 | Back alignment and structure |
|
| >pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388 | Back alignment and structure |
|
| >pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308 | Back alignment and structure |
|
| >pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432 | Back alignment and structure |
|
| >pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314 | Back alignment and structure |
|
| >pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313 | Back alignment and structure |
|
| >pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333 | Back alignment and structure |
|
| >pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313 | Back alignment and structure |
|
| >pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312 | Back alignment and structure |
|
| >pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298 | Back alignment and structure |
|
| >pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273 | Back alignment and structure |
|
| >pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432 | Back alignment and structure |
|
| >pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299 | Back alignment and structure |
|
| >pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313 | Back alignment and structure |
|
| >pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311 | Back alignment and structure |
|
| >pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314 | Back alignment and structure |
|
| >pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335 | Back alignment and structure |
|
| >pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313 | Back alignment and structure |
|
| >pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327 | Back alignment and structure |
|
| >pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329 | Back alignment and structure |
|
| >pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321 | Back alignment and structure |
|
| >pdb|3FME|A Chain A, Crystal Structure Of Human Mitogen-Activated Protein Kinase Kinase 6 (Mek6) Activated Mutant (S207d, T211d) Length = 290 | Back alignment and structure |
|
| >pdb|2BUJ|A Chain A, Crystal Structure Of The Human Serine-Threonine Kinase 16 In Complex With Staurosporine Length = 317 | Back alignment and structure |
|
| >pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330 | Back alignment and structure |
|
| >pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331 | Back alignment and structure |
|
| >pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349 | Back alignment and structure |
|
| >pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334 | Back alignment and structure |
|
| >pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334 | Back alignment and structure |
|
| >pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328 | Back alignment and structure |
|
| >pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333 | Back alignment and structure |
|
| >pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335 | Back alignment and structure |
|
| >pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337 | Back alignment and structure |
|
| >pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336 | Back alignment and structure |
|
| >pdb|2WTK|B Chain B, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 373 | Back alignment and structure |
|
| >pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309 | Back alignment and structure |
|
| >pdb|3GNI|B Chain B, Structure Of Strad And Mo25 Length = 389 | Back alignment and structure |
|
| >pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340 | Back alignment and structure |
|
| >pdb|3VN9|A Chain A, Rifined Crystal Structure Of Non-Phosphorylated Map2k6 In A Putative Auto-Inhibition State Length = 340 | Back alignment and structure |
|
| >pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344 | Back alignment and structure |
|
| >pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308 | Back alignment and structure |
|
| >pdb|2Z2W|A Chain A, Humand Wee1 Kinase Complexed With Inhibitor Pf0335770 Length = 285 | Back alignment and structure |
|
| >pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335 | Back alignment and structure |
|
| >pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359 | Back alignment and structure |
|
| >pdb|3BBT|B Chain B, Crystal Structure Of The Erbb4 Kinase In Complex With Lapatinib Length = 328 | Back alignment and structure |
|
| >pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356 | Back alignment and structure |
|
| >pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366 | Back alignment and structure |
|
| >pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368 | Back alignment and structure |
|
| >pdb|2R4B|A Chain A, Erbb4 Kinase Domain Complexed With A Thienopyrimidine Inhibitor Length = 321 | Back alignment and structure |
|
| >pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350 | Back alignment and structure |
|
| >pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339 | Back alignment and structure |
|
| >pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317 | Back alignment and structure |
|
| >pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329 | Back alignment and structure |
|
| >pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290 | Back alignment and structure |
|
| >pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302 | Back alignment and structure |
|
| >pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360 | Back alignment and structure |
|
| >pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327 | Back alignment and structure |
|
| >pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351 | Back alignment and structure |
|
| >pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332 | Back alignment and structure |
|
| >pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314 | Back alignment and structure |
|
| >pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325 | Back alignment and structure |
|
| >pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331 | Back alignment and structure |
|
| >pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331 | Back alignment and structure |
|
| >pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352 | Back alignment and structure |
|
| >pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335 | Back alignment and structure |
|
| >pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326 | Back alignment and structure |
|
| >pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332 | Back alignment and structure |
|
| >pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326 | Back alignment and structure |
|
| >pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327 | Back alignment and structure |
|
| >pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373 | Back alignment and structure |
|
| >pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373 | Back alignment and structure |
|
Structure Templates Detected by RPS-BLAST
Original result of RPS-BLAST against PDB70 database
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 228 bits (584), Expect = 8e-75
Identities = 56/260 (21%), Positives = 102/260 (39%), Gaps = 39/260 (15%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLH 60
+ + E L +NH NI++LF + L++EFC G+L + +
Sbjct: 45 ISFLRPVDV-QMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEP 103
Query: 61 GR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLS 116
+PE L+ + G+ L + I+HR++KP NI+ G D + K+ DFG +
Sbjct: 104 SNAYGLPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAA 163
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPF 168
L + G+ Y+ P++ + ++Y VD+WS+G + G PF
Sbjct: 164 RELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223
Query: 169 ----SGRNNVQLVRNINSCK--------------------HLPFSQLIVPALHPDCVDMC 204
R N +++ I + K +P S + L +
Sbjct: 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVL 283
Query: 205 LKLLSANTVDRLSFNEFYHH 224
+L A+ F++F+
Sbjct: 284 ANILEADQEKCWGFDQFFAE 303
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284 | Back alignment and structure |
|---|
Score = 226 bits (579), Expect = 2e-74
Identities = 74/236 (31%), Positives = 117/236 (49%), Gaps = 15/236 (6%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
+ L+ E+ S + HPNI+R+++ F I+L++EF G L ++ HGR
Sbjct: 56 GVEHQLRR----EIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRF 111
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
EQ + F+++L L + +IHRD+KPEN+L + LKIADFG S P
Sbjct: 112 DEQRSATFMEELADALHYCHERKVIHRDIKPENLL---MGYKGELKIADFGWS-VHAPSL 167
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSC 183
+CG+ Y+ PE+++ + +DEKVD+W G + +E L G PPF ++ + R I +
Sbjct: 168 RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFDSPSHTETHRRIVNV 227
Query: 184 K-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 238
P P L D+ KLL + RL H +++ NS + P
Sbjct: 228 DLKFP------PFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPV 277
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 225 bits (576), Expect = 4e-74
Identities = 67/229 (29%), Positives = 111/229 (48%), Gaps = 15/229 (6%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV 63
+ L+ E+ S + HPNI+RL+ F ++L++E+ G + ++ +
Sbjct: 51 GVEHQLRR----EVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKF 106
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
EQ ++ +L L +S +IHRD+KPEN+L L LKIADFG S P +
Sbjct: 107 DEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGWS-VHAPSS 162
Query: 124 YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSC 183
+CG+ Y+ PE+++ + +DEKVD+WS+G + +E L G PPF + + I+
Sbjct: 163 RRTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 222
Query: 184 KHLPFSQLIVPA-LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
+ P + D+ +LL N R E H ++ NS
Sbjct: 223 E------FTFPDFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 265
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676 | Back alignment and structure |
|---|
Score = 229 bits (586), Expect = 1e-71
Identities = 59/254 (23%), Positives = 100/254 (39%), Gaps = 28/254 (11%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSY 56
++L+ + E+ + +NHPN++ + + L +E+C GG+L Y
Sbjct: 49 QELSPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKY 108
Query: 57 IRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ + E R L + + L L+ + IIHRDLKPENI+L ++ KI D
Sbjct: 109 LNQFENCCGLKEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDL 168
Query: 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
G + L G + G+ Y+APE+L+ ++Y VD WS G + FE + G+ PF
Sbjct: 169 GYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGTLAFECITGFRPFLPNWQ 228
Query: 174 VQLVRNINSCK-------------------HLPFSQLIVPALHPDCVDMCLKLLSANTVD 214
K LP + L +L +
Sbjct: 229 PVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQ 288
Query: 215 RLSFNEFYHHRFLR 228
R + + + +
Sbjct: 289 RGTDPQNPNVGCFQ 302
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396 | Back alignment and structure |
|---|
Score = 222 bits (567), Expect = 3e-71
Identities = 56/247 (22%), Positives = 100/247 (40%), Gaps = 38/247 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCAGGNLSSYIRLHGR---VPEQTARK 70
E L +NH NI++LF + L++EFC G+L + + +PE
Sbjct: 57 EFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLI 116
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLS-GLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L+ + G+ L + I+HR++KP NI+ G D + K+ DFG + L +
Sbjct: 117 VLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLY 176
Query: 130 GSPLYMAPEVLQF--------QRYDEKVDMWSVGAILFELLNGYPPF----SGRNNVQLV 177
G+ Y+ P++ + ++Y VD+WS+G + G PF R N +++
Sbjct: 177 GTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVM 236
Query: 178 RNINSCK--------------------HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217
I + K +P S + L + +L A+
Sbjct: 237 YKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEADQEKCWG 296
Query: 218 FNEFYHH 224
F++F+
Sbjct: 297 FDQFFAE 303
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 1e-70
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 11/217 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ S+ H +++ F+ + +F+V+E C +L + + E AR +L+Q+
Sbjct: 65 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 124
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
G + L+ + +IHRDLK N+ L++D+ +KI DFGL+ + Y G + +CG+P Y
Sbjct: 125 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 181
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIV 193
+APEVL + + +VD+WS+G I++ LL G PPF + I + +P
Sbjct: 182 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH---- 237
Query: 194 PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
++P + K+L + R + NE + F
Sbjct: 238 --INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 272
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335 | Back alignment and structure |
|---|
Score = 218 bits (557), Expect = 2e-70
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 11/217 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ S+ H +++ F+ + +F+V+E C +L + + E AR +L+Q+
Sbjct: 91 EISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQI 150
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLY 134
G + L+ + +IHRDLK N+ L++D+ +KI DFGL+ + Y G + +CG+P Y
Sbjct: 151 VLGCQYLHRNRVIHRDLKLGNLF---LNEDLEVKIGDFGLATKVEYDGERKKVLCGTPNY 207
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIV 193
+APEVL + + +VD+WS+G I++ LL G PPF + I + +P
Sbjct: 208 IAPEVLSKKGHSFEVDVWSIGCIMYTLLVGKPPFETSCLKETYLRIKKNEYSIPKH---- 263
Query: 194 PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
++P + K+L + R + NE + F
Sbjct: 264 --INPVAASLIQKMLQTDPTARPTINELLNDEFFTSG 298
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 6e-70
Identities = 57/249 (22%), Positives = 109/249 (43%), Gaps = 27/249 (10%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
L++ + E+ +L+ + + IIRL+D + I++V+E C +L+S+++
Sbjct: 43 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 101
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ + + + + + ++ H I+H DLKP N L+ D MLK+ DFG++ +
Sbjct: 102 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 157
Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
P + G+ YM PE ++ + K D+WS+G IL+ + G
Sbjct: 158 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 217
Query: 166 PPFSG-RNNVQLVRNINSCKH-LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223
PF N + + I H + F + D D+ L + R+S E
Sbjct: 218 TPFQQIINQISKLHAIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 273
Query: 224 HRFLRRNSA 232
H +++ +
Sbjct: 274 HPYVQIQTH 282
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313 | Back alignment and structure |
|---|
Score = 215 bits (549), Expect = 1e-69
Identities = 57/248 (22%), Positives = 109/248 (43%), Gaps = 27/248 (10%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
L++ + E+ +L+ + + IIRL+D + I++V+E C +L+S+++
Sbjct: 62 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 120
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ + + + + + ++ H I+H DLKP N L+ D MLK+ DFG++ +
Sbjct: 121 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 176
Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
P + G+ YM PE ++ + K D+WS+G IL+ + G
Sbjct: 177 QPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 236
Query: 166 PPFSG-RNNVQLVRNINSCKH-LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223
PF N + + I H + F + D D+ L + R+S E
Sbjct: 237 TPFQQIINQISKLHAIIDPNHEIEFPDIP----EKDLQDVLKCCLKRDPKQRISIPELLA 292
Query: 224 HRFLRRNS 231
H +++ +
Sbjct: 293 HPYVQIQT 300
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277 | Back alignment and structure |
|---|
Score = 213 bits (544), Expect = 3e-69
Identities = 64/217 (29%), Positives = 110/217 (50%), Gaps = 2/217 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + S++HPNIIRL++ F+ I+LV+E C GG L + E A + ++ +
Sbjct: 56 EIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDV 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+ + + ++ HRDLKPEN L D LK+ DFGL+ PG G+P Y+
Sbjct: 116 LSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYV 175
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPA 195
+P+VL+ Y + D WS G +++ LL GYPPFS + +++ I F +
Sbjct: 176 SPQVLE-GLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEVMLKIREGT-FTFPEKDWLN 233
Query: 196 LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232
+ P + +LL+ + R++ + H + + +
Sbjct: 234 VSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLS 270
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390 | Back alignment and structure |
|---|
Score = 216 bits (552), Expect = 4e-69
Identities = 56/248 (22%), Positives = 106/248 (42%), Gaps = 25/248 (10%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
L++ + E+ +L+ + + IIRL+D + I++V+E C +L+S+++
Sbjct: 90 LEEADNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVME-CGNIDLNSWLKK 148
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ + + + + + ++ H I+H DLKP N L+ D MLK+ DFG++ +
Sbjct: 149 KKSIDPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLI----VDGMLKLIDFGIANQM 204
Query: 120 YPG---NYAEKVCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGY 165
P + G+ YM PE ++ + K D+WS+G IL+ + G
Sbjct: 205 QPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGK 264
Query: 166 PPFSG-RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
PF N + + I H D D+ L + R+S E H
Sbjct: 265 TPFQQIINQISKLHAIIDPNHEI---EFPDIPEKDLQDVLKCCLKRDPKQRISIPELLAH 321
Query: 225 RFLRRNSA 232
+++ +
Sbjct: 322 PYVQIQTH 329
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 5e-69
Identities = 71/222 (31%), Positives = 116/222 (52%), Gaps = 2/222 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L ++HPNI++L++ F+ + +LV E GG L I R E A + ++Q+
Sbjct: 76 EVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQV 135
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G+ ++ + I+HRDLKPEN+LL D ++I DFGLS + G+ Y+
Sbjct: 136 LSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYI 195
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPA 195
APEVL YDEK D+WS G IL+ LL+G PPF+G N +++ + K F
Sbjct: 196 APEVLH-GTYDEKCDVWSTGVILYILLSGCPPFNGANEYDILKKVEKGK-YTFELPQWKK 253
Query: 196 LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 237
+ D+ K+L+ R+S + H +++ + +
Sbjct: 254 VSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYTKEQISV 295
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504 | Back alignment and structure |
|---|
Score = 218 bits (558), Expect = 9e-69
Identities = 74/222 (33%), Positives = 125/222 (56%), Gaps = 2/222 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L S++HPNII+LFD F+ + +LV EF GG L I + E A ++Q+
Sbjct: 96 EISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQI 155
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G+ L+ H+I+HRD+KPENILL + + +KI DFGLS G+ Y+
Sbjct: 156 LSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYI 215
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPA 195
APEVL+ ++Y+EK D+WS G I++ LL GYPPF G+N+ +++ + K F
Sbjct: 216 APEVLK-KKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKVEKGK-YYFDFNDWKN 273
Query: 196 LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 237
+ + ++ +L+ + R + E + R++++ + +
Sbjct: 274 ISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANNINKS 315
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486 | Back alignment and structure |
|---|
Score = 217 bits (555), Expect = 1e-68
Identities = 75/230 (32%), Positives = 124/230 (53%), Gaps = 2/230 (0%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
S + E+ L ++HPNI++LF+ + + ++V E GG L I R
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A + ++Q+ +G+ ++ H+I+HRDLKPENILL + D +KI DFGLS
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINS 182
+ G+ Y+APEVL+ YDEK D+WS G IL+ LL+G PPF G+N +++ + +
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
Query: 183 CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232
K F + D D+ K+L+ + R++ + H ++++ S+
Sbjct: 237 GK-YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278 | Back alignment and structure |
|---|
Score = 210 bits (538), Expect = 3e-68
Identities = 70/219 (31%), Positives = 113/219 (51%), Gaps = 12/219 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E+ + HP+I+ L++ F+ N ++LV+E C G ++ Y++ E AR F+ Q
Sbjct: 61 EVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQ 120
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPL 133
+ G+ L+SH I+HRDL N+LL ++ +KIADFGL+ L P +CG+P
Sbjct: 121 IITGMLYLHSHGILHRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPN 177
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLI 192
Y++PE+ + + D+WS+G + + LL G PPF + + +P
Sbjct: 178 YISPEIATRSAHGLESDVWSLGCMFYTLLIGRPPFDTDTVKNTLNKVVLADYEMPSF--- 234
Query: 193 VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
L + D+ +LL N DRLS + H F+ RNS
Sbjct: 235 ---LSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS 270
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494 | Back alignment and structure |
|---|
Score = 217 bits (554), Expect = 3e-68
Identities = 78/239 (32%), Positives = 132/239 (55%), Gaps = 2/239 (0%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
++ S L E+ L ++HPNI++L+D F+ + +LV+E GG L I +
Sbjct: 73 TSVSTSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMK 132
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A ++Q+ +G+ L+ H+I+HRDLKPEN+LL + D ++KI DFGLS
Sbjct: 133 FNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQ 192
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINS 182
++ G+ Y+APEVL+ ++YDEK D+WS+G ILF LL GYPPF G+ + +++R +
Sbjct: 193 KKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILRKVEK 251
Query: 183 CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
K F + D+ ++L ++ R+S + H +++ + + +P
Sbjct: 252 GK-YTFDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEMCSKKESGIELP 309
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 4e-68
Identities = 75/230 (32%), Positives = 124/230 (53%), Gaps = 2/230 (0%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
S + E+ L ++HPNI++LF+ + + ++V E GG L I R
Sbjct: 58 ASAKNKDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKR 117
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A + ++Q+ +G+ ++ H+I+HRDLKPENILL + D +KI DFGLS
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINS 182
+ G+ Y+APEVL+ YDEK D+WS G IL+ LL+G PPF G+N +++ + +
Sbjct: 178 TKMKDRIGTAYYIAPEVLR-GTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDILKRVET 236
Query: 183 CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232
K F + D D+ K+L+ + R++ + H ++++ S+
Sbjct: 237 GK-YAFDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322 | Back alignment and structure |
|---|
Score = 210 bits (537), Expect = 1e-67
Identities = 80/217 (36%), Positives = 119/217 (54%), Gaps = 6/217 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L +NHP II++ + F AE+ ++V+E GG L + + R+ E T + + Q+
Sbjct: 65 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 123
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
++ L+ + IIHRDLKPEN+LLS ++D ++KI DFG S L + +CG+P Y+
Sbjct: 124 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 183
Query: 136 APEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSGRNN-VQLVRNINSCKHLPFSQL 191
APEVL Y+ VD WS+G ILF L+GYPPFS V L I S K F
Sbjct: 184 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-YNFIPE 242
Query: 192 IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
+ + +D+ KLL + R + E H +L+
Sbjct: 243 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQ 279
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419 | Back alignment and structure |
|---|
Score = 212 bits (542), Expect = 3e-67
Identities = 80/221 (36%), Positives = 119/221 (53%), Gaps = 6/221 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L +NHP II++ + F AE+ ++V+E GG L + + R+ E T + + Q+
Sbjct: 190 EIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQM 248
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
++ L+ + IIHRDLKPEN+LLS ++D ++KI DFG S L + +CG+P Y+
Sbjct: 249 LLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYL 308
Query: 136 APEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSGRNN-VQLVRNINSCKHLPFSQL 191
APEVL Y+ VD WS+G ILF L+GYPPFS V L I S K F
Sbjct: 309 APEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQVSLKDQITSGK-YNFIPE 367
Query: 192 IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232
+ + +D+ KLL + R + E H +L+
Sbjct: 368 VWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDEDM 408
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284 | Back alignment and structure |
|---|
Score = 207 bits (530), Expect = 4e-67
Identities = 64/182 (35%), Positives = 96/182 (52%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
KKL+ L+ E + HPNI+RL D+ Q E+ +LV + GG L I
Sbjct: 42 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 101
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A +QQ+ + +S+ I+HR+LKPEN+LL+ +K+ADFGL+ +
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 161
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINS 182
G+P Y++PEVL+ Y + VD+W+ G IL+ LL GYPPF + +L I +
Sbjct: 162 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 221
Query: 183 CK 184
Sbjct: 222 GA 223
|
| >4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350 | Back alignment and structure |
|---|
Score = 209 bits (535), Expect = 4e-67
Identities = 59/239 (24%), Positives = 111/239 (46%), Gaps = 10/239 (4%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH- 60
+ +++ + E+ L+++ HPNI++ ++F+ +++V+++C GG+L I
Sbjct: 59 ISRMSSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQK 118
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
E + Q+ L+ ++ I+HRD+K +NI L D +++ DFG++ L
Sbjct: 119 GVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVL 175
Query: 120 YPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVR 178
A G+P Y++PE+ + + Y+ K D+W++G +L+EL F + LV
Sbjct: 176 NSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235
Query: 179 NINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 237
I S P S D + +L N DR S N F+ + +P
Sbjct: 236 KIISGSFPPVS----LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKRIEKFLSP 290
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 5e-67
Identities = 77/230 (33%), Positives = 129/230 (56%), Gaps = 11/230 (4%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+LN L E+ + +NHPNI++LF+ + E ++L++E+ +GG + Y+ HGR
Sbjct: 51 TQLNPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGR 110
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ E+ AR +Q+ + ++ + I+HRDLK EN+L LD D+ +KIADFG S G
Sbjct: 111 MKEKEARSKFRQIVSAVQYCHQKRIVHRDLKAENLL---LDADMNIKIADFGFSNEFTVG 167
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
+ CG+P Y APE+ Q ++YD +VD+WS+G IL+ L++G PF G+N +L +
Sbjct: 168 GKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDGQNLKELRERVL 227
Query: 182 SCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
K +PF + DC ++ + L N + R + + R++
Sbjct: 228 RGKYRIPFY------MSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG 271
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362 | Back alignment and structure |
|---|
Score = 209 bits (533), Expect = 1e-66
Identities = 64/182 (35%), Positives = 96/182 (52%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
KKL+ L+ E + HPNI+RL D+ Q E+ +LV + GG L I
Sbjct: 65 KKLSARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREF 124
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A +QQ+ + +S+ I+HR+LKPEN+LL+ +K+ADFGL+ +
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDS 184
Query: 123 NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINS 182
G+P Y++PEVL+ Y + VD+W+ G IL+ LL GYPPF + +L I +
Sbjct: 185 EAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGYPPFWDEDQHRLYAQIKA 244
Query: 183 CK 184
Sbjct: 245 GA 246
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285 | Back alignment and structure |
|---|
Score = 206 bits (526), Expect = 2e-66
Identities = 57/186 (30%), Positives = 99/186 (53%), Gaps = 5/186 (2%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI----R 58
K ++ ++ E+ L S++HPNII++F+ F+ + +++V+E C GG L I
Sbjct: 57 KDRSQVPMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQA 116
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ E + ++Q+ L +S H++H+DLKPENIL +KI DFGL+
Sbjct: 117 RGKALSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAEL 176
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVR 178
++ G+ LYMAPEV + + K D+WS G +++ LL G PF+G + ++ +
Sbjct: 177 FKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEVQQ 235
Query: 179 NINSCK 184
+
Sbjct: 236 KATYKE 241
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276 | Back alignment and structure |
|---|
Score = 204 bits (522), Expect = 5e-66
Identities = 74/217 (34%), Positives = 115/217 (52%), Gaps = 11/217 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L HP+II+L+ F+V+E+ +GG L YI HGRV E AR+ QQ+
Sbjct: 61 EIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQI 120
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+ ++ + H ++HRDLKPEN+L LD + KIADFGLS + G + CGSP Y
Sbjct: 121 LSAVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 177
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIV 193
APEV+ + Y +VD+WS G IL+ LL G PF + L + I ++P
Sbjct: 178 APEVISGRLYAGPEVDIWSCGVILYALLCGTLPFDDEHVPTLFKKIRGGVFYIPEY---- 233
Query: 194 PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
L+ + + +L + + R + + H + +++
Sbjct: 234 --LNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD 268
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298 | Back alignment and structure |
|---|
Score = 201 bits (514), Expect = 1e-64
Identities = 79/230 (34%), Positives = 116/230 (50%), Gaps = 11/230 (4%)
Query: 16 ELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E++ L V+ HPNII+L D ++ FLV + G L Y+ + E+ RK ++
Sbjct: 73 EVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRA 132
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
L + L+ +I+HRDLKPENIL LDDD+ +K+ DFG SC L PG +VCG+P Y
Sbjct: 133 LLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDPGEKLREVCGTPSY 189
Query: 135 MAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPF 188
+APE+++ Y ++VDMWS G I++ LL G PPF R + ++R I S F
Sbjct: 190 LAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQMLMLRMIMSGN-YQF 248
Query: 189 SQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 238
D+ + L R + E H F ++ F
Sbjct: 249 GSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEVRHF 298
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 2e-64
Identities = 65/184 (35%), Positives = 99/184 (53%), Gaps = 1/184 (0%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+KK S L+ E+ L + H NI+ L D +++ +LV++ +GG L I
Sbjct: 41 CIKKSPAFRDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILER 100
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
G E+ A +QQ+ + ++ L+ + I+HRDLKPEN+L +++ + I DFGLS
Sbjct: 101 GVYTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQ 160
Query: 121 PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
G + CG+P Y+APEVL + Y + VD WS+G I + LL GYPPF +L I
Sbjct: 161 NGIMST-ACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESKLFEKI 219
Query: 181 NSCK 184
Sbjct: 220 KEGY 223
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 4e-64
Identities = 45/241 (18%), Positives = 93/241 (38%), Gaps = 30/241 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--------RVPEQT 67
EL ++ + + + + ++++ E+ ++ + +P Q
Sbjct: 93 ELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQV 152
Query: 68 ARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
+ ++ + +++ +I HRD+KP NIL +D + +K++DFG S +
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNIL---MDKNGRVKLSDFGES-EYMVDKKIK 208
Query: 127 KVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSGRNNVQ-LVRNINSC 183
G+ +M PE + KVD+WS+G L+ + PFS + ++ L NI +
Sbjct: 209 GSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTK 268
Query: 184 K--------------HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
S L + +D L N +R++ + H +L
Sbjct: 269 NIEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWLAD 328
Query: 230 N 230
Sbjct: 329 T 329
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 5e-64
Identities = 66/241 (27%), Positives = 113/241 (46%), Gaps = 19/241 (7%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRL 59
+ + K L E+N L + HPNI+R +D +++V+E+C GG+L+S I
Sbjct: 41 YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 100
Query: 60 HGR----VPEQTARKFLQQLGAGLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ + E+ + + QL L+ H ++HRDLKP N+ L D +K+
Sbjct: 101 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 157
Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFGL+ L +A+ G+P YM+PE + Y+EK D+WS+G +L+EL PPF+
Sbjct: 158 GDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 217
Query: 170 GRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
+ +L I K + ++ ++L+ R S E + +
Sbjct: 218 AFSQKELAGKIREGKFRRIPYRY----SDELNEIITRMLNLKDYHRPSVEEILENPLILE 273
Query: 230 N 230
+
Sbjct: 274 H 274
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345 | Back alignment and structure |
|---|
Score = 201 bits (512), Expect = 1e-63
Identities = 73/277 (26%), Positives = 116/277 (41%), Gaps = 49/277 (17%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
++++N + E+ + ++HPNI RL++ ++ E I LV+E C GG+L + +
Sbjct: 64 IRQINPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFI 123
Query: 62 RVP----------------------------------------EQTARKFLQQLGAGLEI 81
E+ ++Q+ + L
Sbjct: 124 DDSTGKCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHY 183
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE-----KVCGSPLYMA 136
L++ I HRD+KPEN L S + +K+ DFGLS Y N E G+P ++A
Sbjct: 184 LHNQGICHRDIKPENFLFST-NKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVA 242
Query: 137 PEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
PEVL + Y K D WS G +L LL G PF G N+ + + + K L F
Sbjct: 243 PEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKK-LCFENPNYN 301
Query: 195 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
L P D+ LL+ N +R H ++ + S
Sbjct: 302 VLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS 338
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283 | Back alignment and structure |
|---|
Score = 198 bits (507), Expect = 1e-63
Identities = 59/170 (34%), Positives = 99/170 (58%), Gaps = 1/170 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+N L + HPNII L D F+ + + L++E +GG L ++ + E A +FL+Q+
Sbjct: 58 EVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQI 117
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L+S I H DLKPENI+L + +K+ DFG++ + GN + + G+P +
Sbjct: 118 LDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEF 177
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK 184
+APE++ ++ + DMWS+G I + LL+G PF G + + NI++
Sbjct: 178 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGETKQETLTNISAVN 227
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327 | Back alignment and structure |
|---|
Score = 200 bits (510), Expect = 1e-63
Identities = 63/233 (27%), Positives = 114/233 (48%), Gaps = 4/233 (1%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI--RL 59
++ + ++ + E+ L P +I L + ++ + I L++E+ AGG + S L
Sbjct: 65 RRRGQDCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPEL 124
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
V E + ++Q+ G+ L+ ++I+H DLKP+NILLS + +KI DFG+S +
Sbjct: 125 AEMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI 184
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRN 179
++ G+P Y+APE+L + DMW++G I + LL PF G +N + N
Sbjct: 185 GHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTHTSPFVGEDNQETYLN 244
Query: 180 INSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232
I+ + +S+ ++ D LL N R + H +L++
Sbjct: 245 ISQVN-VDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF 296
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-63
Identities = 65/220 (29%), Positives = 109/220 (49%), Gaps = 11/220 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ +NH N+++ + + N +L +E+C+GG L I +PE A++F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 132
AG+ L+ I HRD+KPEN+L LD+ LKI+DFGL+ N K+CG+
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 133 LYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF-SGRNNVQLVRNINSCKHLPFSQ 190
Y+APE+L+ + + E VD+WS G +L +L G P+ ++ Q + K
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKK---TYL 228
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
+ + + K+L N R++ + R+ +
Sbjct: 229 NPWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-63
Identities = 55/170 (32%), Positives = 94/170 (55%), Gaps = 1/170 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L V H N+I L D ++ + L++E +GG L ++ + E+ A F++Q+
Sbjct: 65 EVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L++ I H DLKPENI+L +K+ DFGL+ + G + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK 184
+APE++ ++ + DMWS+G I + LL+G PF G + + NI S
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITSVS 234
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336 | Back alignment and structure |
|---|
Score = 199 bits (509), Expect = 3e-63
Identities = 79/217 (36%), Positives = 121/217 (55%), Gaps = 12/217 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+++L + HP+II+L+D I +V+E+ AGG L YI R+ E R+F QQ+
Sbjct: 59 EISYLKLLRHPHIIKLYDVITTPTDIVMVIEY-AGGELFDYIVEKKRMTEDEGRRFFQQI 117
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+E + H I+HRDLKPEN+L LDD++ +KIADFGLS + GN+ + CGSP Y
Sbjct: 118 ICAIEYCHRHKIVHRDLKPENLL---LDDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYA 174
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIV 193
APEV+ + Y +VD+WS G +L+ +L G PF L + +NSC +P
Sbjct: 175 APEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPFDDEFIPNLFKKVNSCVYVMPDF---- 230
Query: 194 PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
L P + +++ A+ + R++ E + N
Sbjct: 231 --LSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVN 265
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 3e-63
Identities = 63/218 (28%), Positives = 113/218 (51%), Gaps = 2/218 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L + HPN+I L + ++ + + L++E AGG L ++ + E+ A +FL+Q+
Sbjct: 64 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 123
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L+S I H DLKPENI+L +KI DFGL+ + GN + + G+P +
Sbjct: 124 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 183
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
+APE++ ++ + DMWS+G I + LL+G PF G + + N+++ F
Sbjct: 184 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVN-YEFEDEYFS 242
Query: 195 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232
D +LL + R++ + H +++
Sbjct: 243 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKDT 280
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361 | Back alignment and structure |
|---|
Score = 200 bits (511), Expect = 3e-63
Identities = 56/170 (32%), Positives = 95/170 (55%), Gaps = 1/170 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L V HPNII L D ++ + L++E +GG L ++ + E+ A F++Q+
Sbjct: 65 EVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQI 124
Query: 76 GAGLEILNSHHIIHRDLKPENILL-SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L++ I H DLKPENI+L +K+ DFGL+ + G + + G+P +
Sbjct: 125 LDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEF 184
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK 184
+APE++ ++ + DMWS+G I + LL+G PF G + + NI +
Sbjct: 185 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANITAVS 234
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476 | Back alignment and structure |
|---|
Score = 203 bits (518), Expect = 3e-63
Identities = 74/217 (34%), Positives = 119/217 (54%), Gaps = 11/217 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L HP+II+L+ + IF+V+E+ +GG L YI +GR+ E+ +R+ QQ+
Sbjct: 66 EIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQI 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G++ + H ++HRDLKPEN+L LD + KIADFGLS + G + CGSP Y
Sbjct: 126 LSGVDYCHRHMVVHRDLKPENVL---LDAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYA 182
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIV 193
APEV+ + Y +VD+WS G IL+ LL G PF + L + I + P
Sbjct: 183 APEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDGIFYTPQY---- 238
Query: 194 PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
L+P + + +L + + R + + H + +++
Sbjct: 239 --LNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD 273
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365 | Back alignment and structure |
|---|
Score = 199 bits (508), Expect = 6e-63
Identities = 63/167 (37%), Positives = 102/167 (61%), Gaps = 9/167 (5%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
HP+II L D++++ + +FLV + G L Y+ + E+ R ++ L + L+
Sbjct: 158 GHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLH 217
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-- 141
+++I+HRDLKPENIL LDD++ ++++DFG SC L PG ++CG+P Y+APE+L+
Sbjct: 218 ANNIVHRDLKPENIL---LDDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCS 274
Query: 142 ----FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK 184
Y ++VD+W+ G ILF LL G PPF R + ++R I +
Sbjct: 275 MDETHPGYGKEVDLWACGVILFTLLAGSPPFWHRRQILMLRMIMEGQ 321
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444 | Back alignment and structure |
|---|
Score = 201 bits (513), Expect = 1e-62
Identities = 61/183 (33%), Positives = 94/183 (51%), Gaps = 1/183 (0%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
KKL+ L+ E + HPNI+RL D+ E +L+ + GG L I
Sbjct: 47 KKLSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREY 106
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
E A +QQ+ + + ++HR+LKPEN+LL+ +K+ADFGL+ +
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGE 166
Query: 123 NYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNIN 181
A G+P Y++PEVL+ Y + VD+W+ G IL+ LL GYPPF + +L + I
Sbjct: 167 QQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQQIK 226
Query: 182 SCK 184
+
Sbjct: 227 AGA 229
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349 | Back alignment and structure |
|---|
Score = 198 bits (505), Expect = 2e-62
Identities = 69/170 (40%), Positives = 97/170 (57%), Gaps = 1/170 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ L ++HPNII+L + F+ I LV+E GG L I G E+ A ++Q+
Sbjct: 98 EIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQI 157
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+ L+ + I+HRDLKPEN+L + D LKIADFGLS + + VCG+P Y
Sbjct: 158 LEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYC 217
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ-LVRNINSCK 184
APE+L+ Y +VDMWSVG I + LL G+ PF Q + R I +C+
Sbjct: 218 APEILRGCAYGPEVDMWSVGIITYILLCGFEPFYDERGDQFMFRRILNCE 267
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303 | Back alignment and structure |
|---|
Score = 196 bits (501), Expect = 2e-62
Identities = 58/245 (23%), Positives = 99/245 (40%), Gaps = 36/245 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN-------------CIFLVVEFCAGGNLSSYIRLHGR 62
E+ L+S+NH ++R + A+ +F+ +E+C G L I
Sbjct: 52 EVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENL 111
Query: 63 -VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-- 119
+ +Q+ L ++S IIHRDLKP NI +D+ +KI DFGL+ +
Sbjct: 112 NQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIF---IDESRNVKIGDFGLAKNVHR 168
Query: 120 -------------YPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165
+ G+ +Y+A EVL Y+EK+DM+S+G I FE++ Y
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEMI--Y 226
Query: 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 225
P +G V +++ + S F + L+ + R +
Sbjct: 227 PFSTGMERVNILKKLRSVSI-EFPPDFDDNKMKVEKKIIRLLIDHDPNKRPGARTLLNSG 285
Query: 226 FLRRN 230
+L
Sbjct: 286 WLPVK 290
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323 | Back alignment and structure |
|---|
Score = 197 bits (502), Expect = 2e-62
Identities = 66/222 (29%), Positives = 112/222 (50%), Gaps = 15/222 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ +NH N+++ + + N +L +E+C+GG L I +PE A++F QL
Sbjct: 55 EICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQL 114
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---EKVCGSP 132
AG+ L+ I HRD+KPEN+L LD+ LKI+DFGL+ N K+CG+
Sbjct: 115 MAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFRYNNRERLLNKMCGTL 171
Query: 133 LYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPF-SGRNNVQLVRNINSCK--HLPF 188
Y+APE+L+ + + E VD+WS G +L +L G P+ ++ Q + K P+
Sbjct: 172 PYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQEYSDWKEKKTYLNPW 231
Query: 189 SQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
+ + + + K+L N R++ + R+ +
Sbjct: 232 KK-----IDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 268
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-62
Identities = 60/248 (24%), Positives = 108/248 (43%), Gaps = 31/248 (12%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE----------------NCIFLVV 45
+K++ + + E+ L+ ++H NI+ + C+F+ +
Sbjct: 41 IKRVKYNNEKAER-EVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQM 99
Query: 46 EFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
EFC G L +I R ++ + A + +Q+ G++ ++S +I+RDLKP NI L
Sbjct: 100 EFCDKGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFL---V 156
Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163
D +KI DFGL +L + G+ YM+PE + Q Y ++VD++++G IL ELL+
Sbjct: 157 DTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLYALGLILAELLH 216
Query: 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223
+ + S + + KLLS DR + +E
Sbjct: 217 VCDTAFETSKF-----FTDLRDGIISDIFDKKEK----TLLQKLLSKKPEDRPNTSEILR 267
Query: 224 HRFLRRNS 231
+ + S
Sbjct: 268 TLTVWKKS 275
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387 | Back alignment and structure |
|---|
Score = 198 bits (506), Expect = 3e-62
Identities = 61/225 (27%), Positives = 116/225 (51%), Gaps = 3/225 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ ++ ++HP +I L DAF+ + + L++EF +GG L I E +++Q
Sbjct: 98 EISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQ 157
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL+ ++ H I+H D+KPENI+ +KI DFGL+ L P + + +
Sbjct: 158 ACEGLKHMHEHSIVHLDIKPENIMCETKKAS-SVKIIDFGLATKLNPDEIVKVTTATAEF 216
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
APE++ + DMW++G + + LL+G PF+G ++++ ++N+ C F +
Sbjct: 217 AAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETLQNVKRCD-WEFDEDAFS 275
Query: 195 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFH 239
++ P+ D LL RL+ ++ H +L+ + + L +
Sbjct: 276 SVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSRIP 320
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573 | Back alignment and structure |
|---|
Score = 202 bits (515), Expect = 6e-62
Identities = 68/218 (31%), Positives = 117/218 (53%), Gaps = 3/218 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E+ +S + HP ++ L DAF+ +N + ++ EF +GG L + H ++ E A ++++Q
Sbjct: 204 EIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQ 263
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ GL ++ ++ +H DLKPENI+ + + LK+ DFGL+ L P + G+ +
Sbjct: 264 VCKGLCHMHENNYVHLDLKPENIMFTTKRSN-ELKLIDFGLTAHLDPKQSVKVTTGTAEF 322
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
APEV + + DMWSVG + + LL+G PF G N+ + +RN+ SC
Sbjct: 323 AAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRNVKSC-DWNMDDSAFS 381
Query: 195 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232
+ D D KLL A+ R++ ++ H +L +A
Sbjct: 382 GISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNA 419
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305 | Back alignment and structure |
|---|
Score = 194 bits (495), Expect = 1e-61
Identities = 68/236 (28%), Positives = 103/236 (43%), Gaps = 20/236 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGN--LSSYIRLHGRVPEQTARKF 71
E+ L + H N+I+L D E +++V+E+C G + + R P A +
Sbjct: 56 EIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCGMQEMLDSV-PEKRFPVCQAHGY 114
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKV 128
QL GLE L+S I+H+D+KP N+L L LKI+ G++ L+P +
Sbjct: 115 FCQLIDGLEYLHSQGIVHKDIKPGNLL---LTTGGTLKISALGVAEALHPFAADDTCRTS 171
Query: 129 CGSPLYMAPEVLQFQR-YD-EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-H 185
GSP + PE+ + KVD+WS G L+ + G PF G N +L NI
Sbjct: 172 QGSPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITTGLYPFEGDNIYKLFENIGKGSYA 231
Query: 186 LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
+P P D+ +L R S + H + R+ AP IP
Sbjct: 232 IPGD------CGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPVPIP 281
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-61
Identities = 60/227 (26%), Positives = 109/227 (48%), Gaps = 7/227 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVP----EQTARKF 71
E + + HP+I+ L + + ++ +++V EF G +L I E A +
Sbjct: 76 EASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHY 135
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCG 130
++Q+ L + ++IIHRD+KP +LL+ ++ +K+ FG++ L G A G
Sbjct: 136 MRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVG 195
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+P +MAPEV++ + Y + VD+W G ILF LL+G PF G +L I K +
Sbjct: 196 TPHFMAPEVVKREPYGKPVDVWGCGVILFILLSGCLPFYGTKE-RLFEGIIKGK-YKMNP 253
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 237
+ D+ ++L + +R++ E +H +L+
Sbjct: 254 RQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKERDRYAYKI 300
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361 | Back alignment and structure |
|---|
Score = 195 bits (498), Expect = 2e-61
Identities = 74/221 (33%), Positives = 107/221 (48%), Gaps = 11/221 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ S+ HPNI+R + + +++E+ +GG L I GR E AR F QQL
Sbjct: 66 EIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQL 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
+G+ +S I HRDLK EN LL G LKI DFG S + + + G+P Y+
Sbjct: 126 LSGVSYCHSMQICHRDLKLENTLLDG-SPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYI 184
Query: 136 APEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRN----INSCK-HLPFS 189
APEVL Q YD + D+WS G L+ +L G PF + R I S K +P
Sbjct: 185 APEVLLRQEYDGKIADVWSCGVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYSIPDD 244
Query: 190 QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
+ P+C + ++ A+ R+S E H + +N
Sbjct: 245 ----IRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 3e-61
Identities = 57/174 (32%), Positives = 95/174 (54%), Gaps = 2/174 (1%)
Query: 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+K ++K +++ E+ L HPNI++L + F + FLV+E GG L I+
Sbjct: 41 VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKK 100
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
E A +++L + + ++ ++HRDLKPEN+L + +D++ +KI DFG +
Sbjct: 101 KHFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKP 160
Query: 121 PGNYA-EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
P N + C + Y APE+L YDE D+WS+G IL+ +L+G PF +
Sbjct: 161 PDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILYTMLSGQVPFQSHDR 214
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373 | Back alignment and structure |
|---|
Score = 194 bits (494), Expect = 1e-60
Identities = 70/217 (32%), Positives = 115/217 (52%), Gaps = 3/217 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
E++ ++ ++H N+I+L+DAF+++N I LV+E+ GG L I + E F++Q
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQ 195
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ G+ ++ +I+H DLKPENIL D +KI DFGL+ P + G+P +
Sbjct: 196 ICEGIRHMHQMYILHLDLKPENILCVNRDAK-QIKIIDFGLARRYKPREKLKVNFGTPEF 254
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
+APEV+ + DMWSVG I + LL+G PF G N+ + + NI +C+
Sbjct: 255 LAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLSPFLGDNDAETLNNILACR-WDLEDEEFQ 313
Query: 195 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
+ + + KLL R+S +E H +L +
Sbjct: 314 DISEEAKEFISKLLIKEKSWRISASEALKHPWLSDHK 350
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 191 bits (488), Expect = 1e-60
Identities = 63/221 (28%), Positives = 104/221 (47%), Gaps = 15/221 (6%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
E+ L ++HPN+++L + E+ +++V E G + + E AR + Q
Sbjct: 86 EIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQ 144
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSP 132
L G+E L+ IIHRD+KP N+L + +D +KIADFG+S + G+P
Sbjct: 145 DLIKGIEYLHYQKIIHRDIKPSNLL---VGEDGHIKIADFGVSNEFKGSDALLSNTVGTP 201
Query: 133 LYMAPEVLQFQR--YD-EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPF 188
+MAPE L R + + +D+W++G L+ + G PF + L I S P
Sbjct: 202 AFMAPESLSETRKIFSGKALDVWAMGVTLYCFVFGQCPFMDERIMCLHSKIKSQALEFPD 261
Query: 189 SQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
P + D D+ ++L N R+ E H ++ R
Sbjct: 262 Q----PDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321 | Back alignment and structure |
|---|
Score = 192 bits (489), Expect = 2e-60
Identities = 60/218 (27%), Positives = 111/218 (50%), Gaps = 3/218 (1%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQ 74
E++ L+ H NI+ L ++F++ + ++ EF +G ++ I + E+ ++ Q
Sbjct: 51 EISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQ 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
+ L+ L+SH+I H D++PENI+ +KI +FG + L PG+ + +P Y
Sbjct: 111 VCEALQFLHSHNIGHFDIRPENIIYQTRRSS-TIKIIEFGQARQLKPGDNFRLLFTAPEY 169
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
APEV Q DMWS+G +++ LL+G PF N Q++ NI + + F +
Sbjct: 170 YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIENIMNAE-YTFDEEAFK 228
Query: 195 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232
+ + +D +LL R++ +E H +L++
Sbjct: 229 EISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIE 266
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335 | Back alignment and structure |
|---|
Score = 191 bits (487), Expect = 4e-60
Identities = 61/218 (27%), Positives = 100/218 (45%), Gaps = 18/218 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E+ LS V H NII++ D F+ + LV+E +G +L ++I H R+ E A +Q
Sbjct: 79 EIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQ 138
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
L + + L IIHRD+K ENI+ + +D +K+ DFG + L G CG+ Y
Sbjct: 139 LVSAVGYLRLKDIIHRDIKDENIV---IAEDFTIKLIDFGSAAYLERGKLFYTFCGTIEY 195
Query: 135 MAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLI 192
APEVL Y +++MWS+G L+ L+ PF + H P+
Sbjct: 196 CAPEVLMGNPYRGPELEMWSLGVTLYTLVFEENPFCE------LEETVEAAIHPPYL--- 246
Query: 193 VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
+ + + + LL R + + ++ +
Sbjct: 247 ---VSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP 281
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 189 bits (481), Expect = 2e-59
Identities = 57/235 (24%), Positives = 90/235 (38%), Gaps = 18/235 (7%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K+ + D E+ V HP +RL A++ ++L E C G +L
Sbjct: 87 VKRSMSPFRGPKDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQ 145
Query: 56 YIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ G +PE +L+ L L+S ++H D+KP NI L K+ DFG
Sbjct: 146 HCEAWGASLPEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIF---LGPRGRCKLGDFG 202
Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
L L E G P YMAPE+LQ Y D++S+G + E+ G
Sbjct: 203 LLVELGTAGAGEVQEGDPRYMAPELLQ-GSYGTAADVFSLGLTILEVACNMELPHGGEGW 261
Query: 175 QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
Q +R L + + + +L + R + LR+
Sbjct: 262 QQLRQGYLPPEFT------AGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 4e-59
Identities = 52/153 (33%), Positives = 78/153 (50%), Gaps = 2/153 (1%)
Query: 23 VNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82
HPNII L D + +++V E GG L I E+ A L + +E L
Sbjct: 73 GQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYL 132
Query: 83 NSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPGNYA-EKVCGSPLYMAPEVL 140
++ ++HRDLKP NIL + ++I DFG + L N C + ++APEVL
Sbjct: 133 HAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVL 192
Query: 141 QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
+ Q YD D+WS+G +L+ +L GY PF+ +
Sbjct: 193 ERQGYDAACDIWSLGVLLYTMLTGYTPFANGPD 225
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384 | Back alignment and structure |
|---|
Score = 189 bits (482), Expect = 8e-59
Identities = 63/221 (28%), Positives = 109/221 (49%), Gaps = 17/221 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL + + HP ++ L+ +FQ E +F+VV+ GG+L +++ + E+T + F+ +L
Sbjct: 65 ELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICEL 124
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
L+ L + IIHRD+KP+NIL LD+ + I DF ++ L + G+ YM
Sbjct: 125 VMALDYLQNQRIIHRDMKPDNIL---LDEHGHVHITDFNIAAMLPRETQITTMAGTKPYM 181
Query: 136 APEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSGR---NNVQLVRNINSCK-HLPF 188
APE+ ++ Y VD WS+G +ELL G P+ R ++ ++V + P
Sbjct: 182 APEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSSTSSKEIVHTFETTVVTYP- 240
Query: 189 SQLIVPALHPDCVDMCLKLLSANTVDRL-SFNEFYHHRFLR 228
A + V + KLL N R ++ + ++
Sbjct: 241 -----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMN 276
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320 | Back alignment and structure |
|---|
Score = 187 bits (476), Expect = 1e-58
Identities = 54/221 (24%), Positives = 97/221 (43%), Gaps = 20/221 (9%)
Query: 16 ELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFL 72
E+ L V+ +IRL D F+ + L++E +L +I G + E+ AR F
Sbjct: 96 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 155
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM-LKIADFGLSCTLYPGNYAEKVCGS 131
Q+ + ++ ++HRD+K ENIL +D + LK+ DFG L G+
Sbjct: 156 WQVLEAVRHCHNCGVLHRDIKDENIL---IDLNRGELKLIDFGSG-ALLKDTVYTDFDGT 211
Query: 132 PLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ 190
+Y PE +++ RY +WS+G +L++++ G PF + I
Sbjct: 212 RVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----IRGQVFFRQR- 265
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
+ +C + L+ DR +F E +H +++
Sbjct: 266 -----VSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVL 301
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400 | Back alignment and structure |
|---|
Score = 188 bits (478), Expect = 5e-58
Identities = 66/228 (28%), Positives = 115/228 (50%), Gaps = 11/228 (4%)
Query: 24 NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
P+I+R+ D ++ C+ +V+E GG L S I R E+ A + ++ +G
Sbjct: 113 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
++ L+S +I HRD+KPEN+L + + +LK+ DFG + N C +P Y+AP
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAP 232
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV----QLVRNINSCKHLPFSQLIV 193
EVL ++YD+ DMWS+G I++ LL GYPPF + + + I + F
Sbjct: 233 EVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-YEFPNPEW 291
Query: 194 PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
+ + + LL R++ EF +H ++ +++ + + P H
Sbjct: 292 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 339
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 9e-58
Identities = 55/211 (26%), Positives = 92/211 (43%), Gaps = 18/211 (8%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
+ HP +IRL D F+ + LV+E +L YI G + E +R F Q+ A +
Sbjct: 93 AGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAI 152
Query: 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
+ +S ++HRD+K ENIL+ K+ DFG L G+ +Y PE
Sbjct: 153 QHCHSRGVVHRDIKDENILIDLRRGCA--KLIDFGSG-ALLHDEPYTDFDGTRVYSPPEW 209
Query: 140 LQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALH 197
+ +Y +WS+G +L++++ G PF + I + H P +
Sbjct: 210 ISRHQYHALPATVWSLGILLYDMVCGDIPFERD------QEILEAELHFPAH------VS 257
Query: 198 PDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
PDC + + L+ R S E +++
Sbjct: 258 PDCCALIRRCLAPKPSSRPSLEEILLDPWMQ 288
|
| >1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (470), Expect = 1e-57
Identities = 62/205 (30%), Positives = 105/205 (51%), Gaps = 13/205 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + +S ++HP ++L+ FQ + ++ + + G L YIR G E R + ++
Sbjct: 80 ERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEI 139
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSP 132
+ LE L+ IIHRDLKPENIL L++D+ ++I DFG + L P + + G+
Sbjct: 140 VSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGTAKVLSPESKQARANSFVGTA 196
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQL 191
Y++PE+L + + D+W++G I+++L+ G PPF N + + I + P
Sbjct: 197 QYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFP---- 252
Query: 192 IVPALHPDCVDMCLKLLSANTVDRL 216
P D+ KLL + RL
Sbjct: 253 --EKFFPKARDLVEKLLVLDATKRL 275
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316 | Back alignment and structure |
|---|
Score = 184 bits (469), Expect = 1e-57
Identities = 59/163 (36%), Positives = 86/163 (52%), Gaps = 13/163 (7%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83
H N++ L + F+ E+ +LV E GG++ S+I E A +Q + + L+ L+
Sbjct: 69 GHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLH 128
Query: 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV--------CGSPLYM 135
+ I HRDLKPENIL + +KI DF L + + CGS YM
Sbjct: 129 NKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYM 188
Query: 136 APEVL-----QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
APEV+ + YD++ D+WS+G IL+ LL+GYPPF GR
Sbjct: 189 APEVVEAFSEEASIYDKRCDLWSLGVILYILLSGYPPFVGRCG 231
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 2e-57
Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 17/224 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKF 71
E++ L +NHPN+I+ + +F +N + +V+E G+LS I+ + +PE+T K+
Sbjct: 82 EIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKY 141
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCG 130
QL + LE ++S ++HRD+KP N+ + ++K+ D GL A + G
Sbjct: 142 FVQLCSALEHMHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVG 198
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG--RNNVQLVRNINSCKHLPF 188
+P YM+PE + Y+ K D+WS+G +L+E+ PF G N L + I C + P
Sbjct: 199 TPYYMSPERIHENGYNFKSDIWSLGCLLYEMAALQSPFYGDKMNLYSLCKKIEQCDYPP- 257
Query: 189 SQLIVPALH--PDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
+P+ H + + ++ + R Y
Sbjct: 258 ----LPSDHYSEELRQLVNMCINPDPEKRPDVTYVYDVAKRMHA 297
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336 | Back alignment and structure |
|---|
Score = 184 bits (468), Expect = 3e-57
Identities = 67/228 (29%), Positives = 118/228 (51%), Gaps = 12/228 (5%)
Query: 24 NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
P+I+ + D ++ + C+ +++E GG L S I R E+ A + ++ +G
Sbjct: 80 GGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGT 139
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
++ L+SH+I HRD+KPEN+L + + D +LK+ DFG + N + C +P Y+AP
Sbjct: 140 AIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFA-KETTQNALQTPCYTPYYVAP 198
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ----LVRNINSCKHLPFSQLIV 193
EVL ++YD+ DMWS+G I++ LL G+PPF + R I + F
Sbjct: 199 EVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQAISPGMKRRIRLGQ-YGFPNPEW 257
Query: 194 PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
+ D + LL + +RL+ +F +H ++ ++ + + P H
Sbjct: 258 SEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTPLHTA 305
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299 | Back alignment and structure |
|---|
Score = 179 bits (456), Expect = 8e-56
Identities = 59/256 (23%), Positives = 103/256 (40%), Gaps = 38/256 (14%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------------IFLVVEFCA 49
L + + E+ L+ + HP I+R F+A+ +N +++ ++ C
Sbjct: 40 LPNRELAREKVMR-EVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCR 98
Query: 50 GGNLSSYIRLHGRV---PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106
NL ++ + Q+ +E L+S ++HRDLKP NI D
Sbjct: 99 KENLKDWMNGRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD 155
Query: 107 MLKIADFGLSCTL-------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153
++K+ DFGL + G+ LYM+PE + Y KVD++S
Sbjct: 156 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNSYSHKVDIFS 215
Query: 154 VGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTV 213
+G ILFELL YP + V+ + ++ + K P P + M +LS + +
Sbjct: 216 LGLILFELL--YPFSTQMERVRTLTDVRNLKFPPLFTQKYPCEY----VMVQDMLSPSPM 269
Query: 214 DRLSFNEFYHHRFLRR 229
+R +
Sbjct: 270 ERPEAINIIENAVFED 285
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318 | Back alignment and structure |
|---|
Score = 176 bits (450), Expect = 1e-54
Identities = 73/209 (34%), Positives = 111/209 (53%), Gaps = 26/209 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E LS V HP IIR++ FQ IF+++++ GG L S +R R P A+ + ++
Sbjct: 56 ERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEV 115
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-------CTLYPGNYAEKV 128
LE L+S II+RDLKPENIL LD + +KI DFG + TL
Sbjct: 116 CLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGFAKYVPDVTYTL--------- 163
Query: 129 CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLP 187
CG+P Y+APEV+ + Y++ +D WS G +++E+L GY PF N ++ I + + P
Sbjct: 164 CGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKILNAELRFP 223
Query: 188 FSQLIVPALHPDCVDMCLKLLSANTVDRL 216
P + D D+ +L++ + RL
Sbjct: 224 ------PFFNEDVKDLLSRLITRDLSQRL 246
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350 | Back alignment and structure |
|---|
Score = 177 bits (452), Expect = 1e-54
Identities = 67/226 (29%), Positives = 115/226 (50%), Gaps = 26/226 (11%)
Query: 2 LKKLNK----------HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG 51
+K L+K H + E L +VN P +++L +F+ + +++V+E+ AGG
Sbjct: 71 MKILDKQKVVKLKQIEHTLN----EKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGG 126
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+ S++R GR E AR + Q+ E L+S +I+RDLKPEN+L +D +++
Sbjct: 127 EMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVT 183
Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
DFG + + +CG+P +APE++ + Y++ VD W++G +++E+ GYPPF
Sbjct: 184 DFGFAKRV--KGRTWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFAD 241
Query: 172 NNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRL 216
+Q+ I S K P D D+ LL + R
Sbjct: 242 QPIQIYEKIVSGKVRFP------SHFSSDLKDLLRNLLQVDLTKRF 281
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327 | Back alignment and structure |
|---|
Score = 175 bits (447), Expect = 5e-54
Identities = 79/224 (35%), Positives = 115/224 (51%), Gaps = 16/224 (7%)
Query: 12 CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E N L V HP I+ L AFQ ++L++E+ +GG L + G E TA +
Sbjct: 67 HTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFY 126
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCG 130
L ++ L L+ II+RDLKPENI+ L+ +K+ DFGL +++ G CG
Sbjct: 127 LAEISMALGHLHQKGIIYRDLKPENIM---LNHQGHVKLTDFGLCKESIHDGTVTHTFCG 183
Query: 131 SPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFS 189
+ YMAPE+L ++ VD WS+GA+++++L G PPF+G N + + I CK +LP
Sbjct: 184 TIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKILKCKLNLP-- 241
Query: 190 QLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 228
P L + D+ KLL N RL E H F R
Sbjct: 242 ----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFR 281
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432 | Back alignment and structure |
|---|
Score = 178 bits (453), Expect = 6e-54
Identities = 63/245 (25%), Positives = 99/245 (40%), Gaps = 15/245 (6%)
Query: 3 KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
K++ S D E+ L S HPN+IR F + ++ +E C L Y+
Sbjct: 54 KRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELC-AATLQEYVEQKD 112
Query: 62 RV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCT 118
LQQ +GL L+S +I+HRDLKP NIL+S + I+DFGL
Sbjct: 113 FAHLGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKK 172
Query: 119 LYPGNYAEK----VCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELL-NGYPPFSG 170
L G ++ V G+ ++APE+L + VD++S G + + ++ G PF
Sbjct: 173 LAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGK 232
Query: 171 RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
Q NI ++ K+++ + R S H F
Sbjct: 233 SLQRQA--NILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWSL 290
Query: 231 SAILR 235
L+
Sbjct: 291 EKQLQ 295
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434 | Back alignment and structure |
|---|
Score = 177 bits (451), Expect = 1e-53
Identities = 60/265 (22%), Positives = 115/265 (43%), Gaps = 36/265 (13%)
Query: 3 KKLNKHLKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
K++ E+ L+ S +HPN+IR + + + +++ +E C NL +
Sbjct: 45 KRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELC-NLNLQDLVESKN 103
Query: 62 -------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS----------GLDD 104
E L+Q+ +G+ L+S IIHRDLKP+NIL+S +
Sbjct: 104 VSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAE 163
Query: 105 DVMLKIADFGLSCTLYPGNYAEK-----VCGSPLYMAPEVLQ-------FQRYDEKVDMW 152
++ + I+DFGL L G + + G+ + APE+L+ +R +D++
Sbjct: 164 NLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIF 223
Query: 153 SVGAILFELL-NGYPPFSGRNN--VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLS 209
S+G + + +L G PF + + ++R I S + +L + D+ +++
Sbjct: 224 SMGCVFYYILSKGKHPFGDKYSRESNIIRGIFSLDEMKCLHD--RSLIAEATDLISQMID 281
Query: 210 ANTVDRLSFNEFYHHRFLRRNSAIL 234
+ + R + + H S L
Sbjct: 282 HDPLKRPTAMKVLRHPLFWPKSKKL 306
|
| >3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325 | Back alignment and structure |
|---|
Score = 173 bits (442), Expect = 2e-53
Identities = 74/220 (33%), Positives = 114/220 (51%), Gaps = 16/220 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E + L VNHP I++L AFQ E ++L+++F GG+L + + E+ + +L +L
Sbjct: 76 ERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAEL 135
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLY 134
L+ L+S II+RDLKPENIL LD++ +K+ DFGLS ++ A CG+ Y
Sbjct: 136 ALALDHLHSLGIIYRDLKPENIL---LDEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEY 192
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIV 193
MAPEV+ + + + D WS G ++FE+L G PF G++ + + I K +P
Sbjct: 193 MAPEVVNRRGHTQSADWWSFGVLMFEMLTGTLPFQGKDRKETMTMILKAKLGMP------ 246
Query: 194 PALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 228
L P+ + L N +RL E H F
Sbjct: 247 QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFS 286
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337 | Back alignment and structure |
|---|
Score = 172 bits (438), Expect = 1e-52
Identities = 69/237 (29%), Positives = 112/237 (47%), Gaps = 19/237 (8%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
L+K + K + E L + HP + L AFQ + + V+E+ GG L ++
Sbjct: 38 LRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLS 97
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-C 117
E+ AR + ++ + LE L+S +++RD+K EN++ LD D +KI DFGL
Sbjct: 98 RERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGLCKE 154
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLV 177
+ G + CG+P Y+APEVL+ Y VD W +G +++E++ G PF +++ +L
Sbjct: 155 GISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLF 214
Query: 178 RNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 228
I + P L P+ + LL + RL E HRF
Sbjct: 215 ELILMEEIRFP------RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290 | Back alignment and structure |
|---|
Score = 169 bits (431), Expect = 3e-52
Identities = 67/236 (28%), Positives = 116/236 (49%), Gaps = 12/236 (5%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF----QAENCIFLVVEFCAGGNLSSYI 57
+KL K + E L + HPNI+R +D++ + + CI LV E G L +Y+
Sbjct: 61 DRKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYL 120
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ + + R + +Q+ GL+ L++ IIHRDLK +NI ++G V KI D GL
Sbjct: 121 KRFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSV--KIGDLGL 178
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
TL ++A+ V G+P +MAPE+ + ++YDE VD+++ G + E+ P+S N
Sbjct: 179 -ATLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAA 236
Query: 176 LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
+ + P P+ ++ + N +R S + +H F + +
Sbjct: 237 QIYRRVTSGVKP--ASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEET 290
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336 | Back alignment and structure |
|---|
Score = 170 bits (433), Expect = 5e-52
Identities = 60/235 (25%), Positives = 96/235 (40%), Gaps = 14/235 (5%)
Query: 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA 68
L+ EL + ++ P I+ L+ A + + + +E GG+L I+ G +PE A
Sbjct: 93 LEVFRVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRA 152
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK- 127
+L Q GLE L++ I+H D+K +N+LLS D + DFG + L P +
Sbjct: 153 LYYLGQALEGLEYLHTRRILHGDVKADNVLLS--SDGSRAALCDFGHALCLQPDGLGKSL 210
Query: 128 -----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI-- 180
+ G+ +MAPEV+ + D KVD+WS ++ +LNG P++ L I
Sbjct: 211 LTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGCHPWTQYFRGPLCLKIAS 270
Query: 181 NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 235
P + L+ V R S E
Sbjct: 271 EPPPIREIPPSCAPLTA-QAIQEGLRK---EPVHRASAMELRRKVGKALQEVGGL 321
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446 | Back alignment and structure |
|---|
Score = 172 bits (437), Expect = 2e-51
Identities = 69/239 (28%), Positives = 112/239 (46%), Gaps = 20/239 (8%)
Query: 1 MLKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+LKK + K + E L + HP + L +FQ + + V+E+ GG L ++
Sbjct: 180 ILKKEVIVAKDEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHL 239
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
E AR + ++ + L+ L+S +++RDLK EN++L D D +KI DFGL
Sbjct: 240 SRERVFSEDRARFYGAEIVSALDYLHSEKNVVYRDLKLENLML---DKDGHIKITDFGLC 296
Query: 117 -CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ G + CG+P Y+APEVL+ Y VD W +G +++E++ G PF +++ +
Sbjct: 297 KEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK 356
Query: 176 LVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 228
L I + P L P+ + LL + RL E HRF
Sbjct: 357 LFELILMEEIRFP------RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFA 409
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-51
Identities = 73/234 (31%), Positives = 111/234 (47%), Gaps = 16/234 (6%)
Query: 2 LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK L C E + HP + +F FQ + +F V+E+ GG+L +I
Sbjct: 50 LKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHI 109
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
+ + A + ++ GL+ L+S I++RDLK +NIL LD D +KIADFG+
Sbjct: 110 QSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFGMCK 166
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+ CG+P Y+APE+L Q+Y+ VD WS G +L+E+L G PF G++ +L
Sbjct: 167 ENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDEEEL 226
Query: 177 VRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-SFNEFYHHRFLR 228
+I P L + D+ +KL RL + H R
Sbjct: 227 FHSIRMDNPFYP------RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 274
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437 | Back alignment and structure |
|---|
Score = 171 bits (435), Expect = 3e-51
Identities = 72/244 (29%), Positives = 125/244 (51%), Gaps = 25/244 (10%)
Query: 2 LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K LNK LK +C E + L + + I L AFQ +N ++LV+++ GG+L +
Sbjct: 104 MKILNKWEMLKRAETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLT 163
Query: 56 YI-RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ + R+PE+ AR +L ++ ++ ++ H +HRD+KP+NIL +D + +++ADFG
Sbjct: 164 LLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNIL---MDMNGHIRLADFG 220
Query: 115 LSCTLYPGNYAEK---VCGSPLYMAPEVLQFQ-----RYDEKVDMWSVGAILFELLNGYP 166
C + + G+P Y++PE+LQ RY + D WS+G ++E+L G
Sbjct: 221 S-CLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGET 279
Query: 167 PFSGRNNVQLVRNI-NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN---EFY 222
PF + V+ I N + F V + + D+ +L+ + RL N +F
Sbjct: 280 PFYAESLVETYGKIMNHKERFQFPT-QVTDVSENAKDLIRRLICSRE-HRLGQNGIEDFK 337
Query: 223 HHRF 226
H F
Sbjct: 338 KHPF 341
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 4e-51
Identities = 77/237 (32%), Positives = 117/237 (49%), Gaps = 19/237 (8%)
Query: 2 LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
L+K L K + + E N L +V HP ++ L +FQ + ++ V+++ GG L ++
Sbjct: 71 LQKKAILKKKEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHL 130
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
+ E AR + ++ + L L+S +I++RDLKPENIL LD + + DFGL
Sbjct: 131 QRERCFLEPRARFYAAEIASALGYLHSLNIVYRDLKPENIL---LDSQGHIVLTDFGLCK 187
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+ + CG+P Y+APEVL Q YD VD W +GA+L+E+L G PPF RN ++
Sbjct: 188 ENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEM 247
Query: 177 VRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRL----SFNEFYHHRFLR 228
NI + L P + + LL + RL F E H F
Sbjct: 248 YDNILNKPLQLK------PNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFS 298
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317 | Back alignment and structure |
|---|
Score = 167 bits (424), Expect = 8e-51
Identities = 55/265 (20%), Positives = 97/265 (36%), Gaps = 33/265 (12%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLS 54
LK++ H + + E + NHPNI+RL E + +L++ F G L
Sbjct: 59 LKRILCHEQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLW 118
Query: 55 SYI----RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ I + E L + GLE +++ HRDLKP NIL L D+ +
Sbjct: 119 NEIERLKDKGNFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNIL---LGDEGQPVL 175
Query: 111 ADFGLSCTL--YPGNYAE--------KVCGSPLYMAPEVLQFQRY---DEKVDMWSVGAI 157
D G + + + Y APE+ Q + DE+ D+WS+G +
Sbjct: 176 MDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCV 235
Query: 158 LFELLNGYPPFSGRNNV--QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDR 215
L+ ++ G P+ + + + +P S P + +++ + R
Sbjct: 236 LYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQS----PRHSSALWQLLNSMMTVDPHQR 291
Query: 216 LSFNEFYHHRFLRRNSAILRAPFHI 240
+ A + I
Sbjct: 292 PHIPLLLSQLEALQPPAPGQHTTQI 316
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410 | Back alignment and structure |
|---|
Score = 169 bits (429), Expect = 1e-50
Identities = 72/241 (29%), Positives = 118/241 (48%), Gaps = 23/241 (9%)
Query: 2 LKKLNKH--LK----SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L+K +K + E + ++ N P +++LF AFQ + +++V+E+ GG+L +
Sbjct: 99 MKLLSKFEMIKRSDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVN 158
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ + VPE+ AR + ++ L+ ++S IHRD+KP+N+L LD LK+ADFG
Sbjct: 159 LMS-NYDVPEKWARFYTAEVVLALDAIHSMGFIHRDVKPDNML---LDKSGHLKLADFGT 214
Query: 116 S--CTLYPGNYAEKVCGSPLYMAPEVLQFQ----RYDEKVDMWSVGAILFELLNGYPPFS 169
+ G+P Y++PEVL+ Q Y + D WSVG L+E+L G PF
Sbjct: 215 CMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEMLVGDTPFY 274
Query: 170 GRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN---EFYHHR 225
+ V I + K L F + + ++ L+ RL N E H
Sbjct: 275 ADSLVGTYSKIMNHKNSLTFPD--DNDISKEAKNLICAFLTDRE-VRLGRNGVEEIKRHL 331
Query: 226 F 226
F
Sbjct: 332 F 332
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 4e-50
Identities = 72/239 (30%), Positives = 119/239 (49%), Gaps = 22/239 (9%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK + C E L+ P + +L FQ + ++ V+E+ GG+L +I
Sbjct: 53 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 112
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ GR E A + ++ GL L S II+RDLK +N++ LD + +KIADFG+ C
Sbjct: 113 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGM-C 168
Query: 118 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
++ G + CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G PF G + +
Sbjct: 169 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228
Query: 176 LVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 228
L ++I P ++ + V +C L++ + RL + H F R
Sbjct: 229 LFQSIMEHNVAYP------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFR 281
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365 | Back alignment and structure |
|---|
Score = 166 bits (422), Expect = 5e-50
Identities = 41/233 (17%), Positives = 82/233 (35%), Gaps = 22/233 (9%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ K N + L ++ + A +N LV E + G L + I L+
Sbjct: 102 VQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLY 161
Query: 61 GR-----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL--------SGLDDDVM 107
+P+ F ++ +E ++ IIH D+KP+N +L D
Sbjct: 162 KNTPEKVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAG 221
Query: 108 LKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
L + D G S + G C + + E+L + ++ ++D + V A ++ +L G
Sbjct: 222 LALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSNKPWNYQIDYFGVAATVYCMLFG 281
Query: 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217
+ F +L + + + L + + + L
Sbjct: 282 TYMKVKNEGGECKPEG------LFRRLPHLDMWNEFFHVMLNIPDCHHLPSLD 328
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576 | Back alignment and structure |
|---|
Score = 169 bits (430), Expect = 2e-49
Identities = 70/240 (29%), Positives = 111/240 (46%), Gaps = 17/240 (7%)
Query: 2 LKKLNK-HLKS-----CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
KKL K +K E L VN ++ L A++ ++ + LV+ GG+L
Sbjct: 214 CKKLEKKRIKKRKGEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKF 273
Query: 56 YIRLHGRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+I G+ PE A + ++ GLE L+ I++RDLKPENILL DD ++I+D
Sbjct: 274 HIYHMGQAGFPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILL---DDHGHIRISDL 330
Query: 114 GLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
GL+ + G + G+ YMAPEV++ +RY D W++G +L+E++ G PF R
Sbjct: 331 GLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQSPFQQRKK 390
Query: 174 VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 228
+ + P +C +LL + +RL S E H +
Sbjct: 391 KIKREEVERLV-KEVPEEYSERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFK 449
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 164 bits (418), Expect = 2e-49
Identities = 75/221 (33%), Positives = 109/221 (49%), Gaps = 15/221 (6%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK L C E LS NHP + +LF FQ + +F V+EF GG+L +I
Sbjct: 56 LKKDVILQDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHI 115
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
+ R E AR + ++ + L L+ II+RDLK +N+L LD + K+ADFG+
Sbjct: 116 QKSRRFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVL---LDHEGHCKLADFGMCK 172
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
+ G CG+P Y+APE+LQ Y VD W++G +L+E+L G+ PF N L
Sbjct: 173 EGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLCGHAPFEAENEDDL 232
Query: 177 VRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRL 216
I + + P LH D + ++ N RL
Sbjct: 233 FEAILNDEVVYP------TWLHEDATGILKSFMTKNPTMRL 267
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289 | Back alignment and structure |
|---|
Score = 162 bits (412), Expect = 2e-49
Identities = 49/238 (20%), Positives = 93/238 (39%), Gaps = 32/238 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV----PEQTARK 70
E+ + + H +++R F A+ ++ + + E+C GG+L+ I + R+ E +
Sbjct: 60 EVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKD 119
Query: 71 FLQQLGAGLEILNSHHIIHRDLKPENILLS----------------GLDDDVMLKIADFG 114
L Q+G GL ++S ++H D+KP NI +S + VM KI D G
Sbjct: 120 LLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLG 179
Query: 115 LSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
+ + + G ++A EVLQ + K D++++ + P N
Sbjct: 180 HVTRI---SSPQVEEGDSRFLANEVLQENYTHLPKADIFALALTVVCAAGAEPLP---RN 233
Query: 174 VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
I + Q++ + + + + + R S H L S
Sbjct: 234 GDQWHEIRQGRLPRIPQVLSQEFT-ELLKVMIHP---DPERRPSAMALVKHSVLLSAS 287
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412 | Back alignment and structure |
|---|
Score = 165 bits (420), Expect = 3e-49
Identities = 66/245 (26%), Positives = 115/245 (46%), Gaps = 25/245 (10%)
Query: 2 LKKLNKHL---KSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K +NK + + C E + L + + I +L AFQ EN ++LV+E+ GG+L +
Sbjct: 91 MKIMNKWDMLKRGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLT 150
Query: 56 YIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ G R+P + AR +L ++ ++ ++ +HRD+KP+NIL LD +++ADFG
Sbjct: 151 LLSKFGERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNIL---LDRCGHIRLADFG 207
Query: 115 LSCTLYPGNY--AEKVCGSPLYMAPEVLQFQ-------RYDEKVDMWSVGAILFELLNGY 165
L + G+P Y++PE+LQ Y + D W++G +E+ G
Sbjct: 208 SCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEMFYGQ 267
Query: 166 PPFSGRNNVQLVRNI-NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN---EF 221
PF + + I + +HL + + + D +LL RL +F
Sbjct: 268 TPFYADSTAETYGKIVHYKEHLSLPL-VDEGVPEEARDFIQRLLC-PPETRLGRGGAGDF 325
Query: 222 YHHRF 226
H F
Sbjct: 326 RTHPF 330
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377 | Back alignment and structure |
|---|
Score = 161 bits (409), Expect = 4e-48
Identities = 35/242 (14%), Positives = 70/242 (28%), Gaps = 36/242 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--IFLVVEFCA------GGNLSSYIRLHGRVPEQT 67
+ + +IR+ + F + G L S+ H +
Sbjct: 148 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 207
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
+ Q+ L L+ + ++H L+P +I+ LD + + F
Sbjct: 208 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLV---RDGARVV 261
Query: 128 VCGSPLYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
S + PE+ + D W++G +++ + P + +
Sbjct: 262 SSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGG 321
Query: 177 VRNI-NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 235
I SCK++P + L DRL + + L
Sbjct: 322 SEWIFRSCKNIP----------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELS 371
Query: 236 AP 237
A
Sbjct: 372 AA 373
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355 | Back alignment and structure |
|---|
Score = 160 bits (407), Expect = 6e-48
Identities = 63/228 (27%), Positives = 107/228 (46%), Gaps = 24/228 (10%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E L + P ++ L AFQ E + L++++ GG L +++ R E + ++ +
Sbjct: 108 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 167
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS--CTLYPGNYAEKVCGSP 132
+ LE L+ II+RD+K ENIL LD + + + DFGLS A CG+
Sbjct: 168 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 224
Query: 133 LYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSG----RNNVQLVRNINSCK-H 185
YMAP++++ +D+ VD WS+G +++ELL G PF+ + ++ R I +
Sbjct: 225 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP 284
Query: 186 LPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 228
P + D+ +LL + RL +E H F +
Sbjct: 285 YP------QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 326
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332 | Back alignment and structure |
|---|
Score = 160 bits (405), Expect = 7e-48
Identities = 49/241 (20%), Positives = 90/241 (37%), Gaps = 25/241 (10%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI---RLH 60
+ ++ + + N + + +++ ++ C NL ++
Sbjct: 99 LSSPSPMDAPSVKIRRMDPFSTKNTVGQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSL 158
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
Q+ +E L+S ++HRDLKP NI D ++K+ DFGL +
Sbjct: 159 EDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMD 215
Query: 120 ------------YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
G+ LYM+PE + Y KVD++S+G ILFELL Y
Sbjct: 216 QDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELL--YSF 273
Query: 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
+ V+++ ++ + K P H M +LS + +R + +
Sbjct: 274 STQMERVRIITDVRNLKFPLLFTQKYPQEH----MMVQDMLSPSPTERPEATDIIENAIF 329
Query: 228 R 228
Sbjct: 330 E 330
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543 | Back alignment and structure |
|---|
Score = 164 bits (417), Expect = 8e-48
Identities = 68/244 (27%), Positives = 109/244 (44%), Gaps = 25/244 (10%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
L K + E L+ V+ I+ L AF+ + + LV+ GG++ +I
Sbjct: 218 LNKKRLKKRKGYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIY 277
Query: 58 ---RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+ E A + Q+ +GLE L+ +II+RDLKPEN+LL DDD ++I+D G
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQIVSGLEHLHQRNIIYRDLKPENVLL---DDDGNVRISDLG 334
Query: 115 LSC-TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN- 172
L+ + G+P +MAPE+L + YD VD +++G L+E++ PF R
Sbjct: 335 LAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIAARGPFRARGE 394
Query: 173 ---NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHH 224
N +L + + + + P D C LL + RL S + H
Sbjct: 395 KVENKELKQRVLEQA-VTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTH 449
Query: 225 RFLR 228
R
Sbjct: 450 PLFR 453
|
| >3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695 | Back alignment and structure |
|---|
Score = 166 bits (421), Expect = 1e-47
Identities = 64/228 (28%), Positives = 106/228 (46%), Gaps = 22/228 (9%)
Query: 2 LKKLNK-HLKS-----CLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGN 52
+K L+K +K E LS V+ P I+ + AF + + +++ GG+
Sbjct: 219 MKCLDKKRIKMKQGETLALNERIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGD 278
Query: 53 LSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
L ++ HG E R + ++ GLE +++ +++RDLKP NIL LD+ ++I+D
Sbjct: 279 LHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISD 335
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGR 171
GL+C G+ YMAPEVLQ YD D +S+G +LF+LL G+ PF
Sbjct: 336 LGLACDF-SKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQH 394
Query: 172 NNV---QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL 216
++ R + + + P+ + LL + RL
Sbjct: 395 KTKDKHEIDRMTLTMA-VELP----DSFSPELRSLLEGLLQRDVNRRL 437
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345 | Back alignment and structure |
|---|
Score = 156 bits (396), Expect = 3e-46
Identities = 68/248 (27%), Positives = 119/248 (47%), Gaps = 30/248 (12%)
Query: 2 LKK---LNKHLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+KK + + E + F + NHP ++ L FQ E+ +F V+E+ GG+L ++
Sbjct: 42 VKKELVNDDEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHM 101
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS- 116
+ ++PE+ AR + ++ L L+ II+RDLK +N+L LD + +K+ D+G+
Sbjct: 102 QRQRKLPEEHARFYSAEISLALNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCK 158
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS------- 169
L PG+ CG+P Y+APE+L+ + Y VD W++G ++FE++ G PF
Sbjct: 159 EGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDN 218
Query: 170 --GRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRL------SFNE 220
L + I + +P +L + L+ + +RL F +
Sbjct: 219 PDQNTEDYLFQVILEKQIRIP------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFAD 272
Query: 221 FYHHRFLR 228
H F R
Sbjct: 273 IQGHPFFR 280
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674 | Back alignment and structure |
|---|
Score = 162 bits (410), Expect = 3e-46
Identities = 72/240 (30%), Positives = 119/240 (49%), Gaps = 22/240 (9%)
Query: 2 LKK---LNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
LKK + C E L+ P + +L FQ + ++ V+E+ GG+L +I
Sbjct: 374 LKKDVVIQDDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHI 433
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ GR E A + ++ GL L S II+RDLK +N++ LD + +KIADFG+ C
Sbjct: 434 QQVGRFKEPHAVFYAAEIAIGLFFLQSKGIIYRDLKLDNVM---LDSEGHIKIADFGM-C 489
Query: 118 --TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
++ G + CG+P Y+APE++ +Q Y + VD W+ G +L+E+L G PF G + +
Sbjct: 490 KENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549
Query: 176 LVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229
L ++I P ++ + V +C L++ + RL + H F R
Sbjct: 550 LFQSIMEHNVAYP------KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271 | Back alignment and structure |
|---|
Score = 153 bits (388), Expect = 6e-46
Identities = 57/171 (33%), Positives = 85/171 (49%), Gaps = 12/171 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + + HPNII L E + LV+EF GG L+ L G+ +P + Q
Sbjct: 56 EAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRV--LSGKRIPPDILVNWAVQ 113
Query: 75 LGAGLEILNSHH---IIHRDLKPENILLS-----GLDDDVMLKIADFGLSCTLYPGNYAE 126
+ G+ L+ IIHRDLK NIL+ G + +LKI DFGL+ +
Sbjct: 114 IARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWH-RTTKM 172
Query: 127 KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLV 177
G+ +MAPEV++ + + D+WS G +L+ELL G PF G + + +
Sbjct: 173 SAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWELLTGEVPFRGIDGLAVA 223
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299 | Back alignment and structure |
|---|
Score = 153 bits (390), Expect = 7e-46
Identities = 59/228 (25%), Positives = 105/228 (46%), Gaps = 32/228 (14%)
Query: 24 NHPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYI--RLHGRVPEQTARKFLQQLGA 77
P+I+R+ D ++ C+ +V+E GG L S I R E+ A + ++ +G
Sbjct: 69 QCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137
++ L+S +I HRD+KPEN+L + + +LK+ DFG A
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF--------------------AK 168
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV----QLVRNINSCKHLPFSQLIV 193
E ++YD+ DMWS+G I++ LL GYPPF + + + I + F
Sbjct: 169 ETTG-EKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQ-YEFPNPEW 226
Query: 194 PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
+ + + LL R++ EF +H ++ +++ + + P H
Sbjct: 227 SEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPLHTS 274
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309 | Back alignment and structure |
|---|
Score = 153 bits (389), Expect = 1e-45
Identities = 49/168 (29%), Positives = 84/168 (50%), Gaps = 9/168 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFL 72
E+ + + HPNI+ A + +V E+ + G+L + G + E+
Sbjct: 84 EVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMA 143
Query: 73 QQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVC 129
+ G+ L++ + I+HR+LK N+L+ D +K+ DFGLS ++
Sbjct: 144 YDVAKGMNYLHNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAA 200
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLV 177
G+P +MAPEVL+ + +EK D++S G IL+EL P+ N Q+V
Sbjct: 201 GTPEWMAPEVLRDEPSNEKSDVYSFGVILWELATLQQPWGNLNPAQVV 248
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396 | Back alignment and structure |
|---|
Score = 155 bits (393), Expect = 2e-45
Identities = 65/227 (28%), Positives = 112/227 (49%), Gaps = 26/227 (11%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
F + NHP ++ L FQ E+ +F V+E+ GG+L +++ ++PE+ AR + ++
Sbjct: 106 FEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLA 165
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS-CTLYPGNYAEKVCGSPLYMAP 137
L L+ II+RDLK +N+L LD + +K+ D+G+ L PG+ CG+P Y+AP
Sbjct: 166 LNYLHERGIIYRDLKLDNVL---LDSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAP 222
Query: 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFS---------GRNNVQLVRNINSCK-HLP 187
E+L+ + Y VD W++G ++FE++ G PF L + I + +P
Sbjct: 223 EILRGEDYGFSVDWWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQIRIP 282
Query: 188 FSQLIVPALHPDCVDMCLKLLSANTVDRL------SFNEFYHHRFLR 228
+L + L+ + +RL F + H F R
Sbjct: 283 ------RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289 | Back alignment and structure |
|---|
Score = 150 bits (381), Expect = 1e-44
Identities = 58/214 (27%), Positives = 95/214 (44%), Gaps = 14/214 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQ 73
E+ L H NI+ A I V ++C G +L ++ + + +
Sbjct: 70 EVGVLRKTRHVNILLFMGYSTAPQLAI--VTQWCEGSSLYHHLHASETKFEMKKLIDIAR 127
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC---TLYPGNYAEKVCG 130
Q G++ L++ IIHRDLK NI L +D +KI DFGL+ + E++ G
Sbjct: 128 QTARGMDYLHAKSIIHRDLKSNNIF---LHEDNTVKIGDFGLATEKSRWSGSHQFEQLSG 184
Query: 131 SPLYMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLP 187
S L+MAPEV++ Q Y + D+++ G +L+EL+ G P+S NN + + L
Sbjct: 185 SILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIEMVGRGSLS 244
Query: 188 FSQLIVPA-LHPDCVDMCLKLLSANTVDRLSFNE 220
V + + + L +R SF
Sbjct: 245 PDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPR 278
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 3e-44
Identities = 62/226 (27%), Positives = 105/226 (46%), Gaps = 12/226 (5%)
Query: 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVP--EQTAR 69
L E+ + H NI++ +F I + +E GG+LS+ +R G + EQT
Sbjct: 66 LHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIG 125
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-V 128
+ +Q+ GL+ L+ + I+HRD+K +N+L++ + KI+DFG S L N +
Sbjct: 126 FYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVL--KISDFGTSKRLAGINPCTETF 183
Query: 129 CGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSG-RNNVQLVRNINSCKH 185
G+ YMAPE++ Y + D+WS+G + E+ G PPF + + K
Sbjct: 184 TGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKPPFYELGEPQAAMFKVGMFKV 243
Query: 186 LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
P I ++ + LK + R N+ FL+ +S
Sbjct: 244 HP---EIPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS 286
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307 | Back alignment and structure |
|---|
Score = 149 bits (379), Expect = 4e-44
Identities = 66/218 (30%), Positives = 102/218 (46%), Gaps = 28/218 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---KFL 72
EL LS VNHPNI++L+ A C+ V+E+ GG+L + + +P TA +
Sbjct: 51 ELRQLSRVNHPNIVKLYGACLNPVCL--VMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWC 108
Query: 73 QQLGAGLEILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
Q G+ L+S +IHRDLKP N+LL +LKI DFG +C + +
Sbjct: 109 LQCSQGVAYLHSMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQ--THMTNNK 164
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN--VQLVRNINSCKHLP 187
GS +MAPEV + Y EK D++S G IL+E++ PF +++ +++ P
Sbjct: 165 GSAAWMAPEVFEGSNYSEKCDVFSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRPP 224
Query: 188 FSQLIVPALHPDCVDMCLKLL-----SANTVDRLSFNE 220
+ ++ L S + R S E
Sbjct: 225 L---------IKNLPKPIESLMTRCWSKDPSQRPSMEE 253
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371 | Back alignment and structure |
|---|
Score = 149 bits (378), Expect = 1e-43
Identities = 29/228 (12%), Positives = 57/228 (25%), Gaps = 19/228 (8%)
Query: 24 NHPNIIRLFDAFQAENC--IFLVVEFCAG------GNLSSYIRLHGRVPEQTARKFLQQL 75
+ P +L L++ + L G QL
Sbjct: 144 SQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYVFRGDEGILALHILTAQL 203
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
L S ++H P+N+ + D L + D G Y
Sbjct: 204 IRLAANLQSKGLVHGHFTPDNLF---IMPDGRLMLGDVSAL--WKVGTRGPASSVPVTYA 258
Query: 136 APEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ--- 190
E L + ++ W +G ++ + + PF +P +
Sbjct: 259 PREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA 318
Query: 191 -LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 237
L + + L+ + RL E + + +
Sbjct: 319 FGSCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQLQNEISSS 366
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 1e-43
Identities = 49/167 (29%), Positives = 82/167 (49%), Gaps = 11/167 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ +S++NHPNI++L+ + V+EF G+L + + + +
Sbjct: 73 EVFIMSNLNHPNIVKLYGLMHNPPRM--VMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLD 130
Query: 75 LGAGLEILNSHH--IIHRDLKPENILLSGLD--DDVMLKIADFGLSCTLYPGNYAEKVCG 130
+ G+E + + + I+HRDL+ NI L LD V K+ADFGLS + + G
Sbjct: 131 IALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV--HSVSGLLG 188
Query: 131 SPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ +MAPE + + Y EK D +S IL+ +L G PF + +
Sbjct: 189 NFQWMAPETIGAEEESYTEKADTYSFAMILYTILTGEGPFDEYSYGK 235
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-43
Identities = 43/221 (19%), Positives = 89/221 (40%), Gaps = 23/221 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ H N++ A + + ++ C G L S +R V R+ Q+
Sbjct: 79 EVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQE 138
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------V 128
+ G+ L++ I+H+DLK +N+ D+ + I DFGL +
Sbjct: 139 IVKGMGYLHAKGILHKDLKSKNVFY----DNGKVVITDFGLFSISGVLQAGRREDKLRIQ 194
Query: 129 CGSPLYMAPEVLQFQR---------YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRN 179
G ++APE+++ + + D++++G I +EL PF + ++
Sbjct: 195 NGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAREWPFKTQPAEAIIWQ 254
Query: 180 INSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220
+ + SQ+ + + D+ L + +R +F +
Sbjct: 255 MGTGMKPNLSQIGMG---KEISDILLFCWAFEQEERPTFTK 292
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 147 bits (374), Expect = 3e-43
Identities = 58/273 (21%), Positives = 98/273 (35%), Gaps = 44/273 (16%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSV-NHPNIIRLFDAF-------QAENCIFLVVEFCAG 50
LK+L + + E+ F+ + HPNI++ A FL++
Sbjct: 58 LKRLLSNEEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK 117
Query: 51 GNLSSYI---RLHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDD 105
G L ++ G + T K Q ++ ++ IIHRDLK EN+LL +
Sbjct: 118 GQLVEFLKKMESRGPLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQ 174
Query: 106 VMLKIADFGLSCTLYPGNYAEK-------------VCGSPLYMAPEVLQFQR---YDEKV 149
+K+ DFG + T+ +P+Y PE++ EK
Sbjct: 175 GTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQ 234
Query: 150 DMWSVGAILFELLNGYPPFSGRNNVQLVR-NINSCKHLPFSQLIVPALHPDCVDMCLKLL 208
D+W++G IL+ L PF +++V + H + +L
Sbjct: 235 DIWALGCILYLLCFRQHPFEDGAKLRIVNGKYSIPPHDTQY--------TVFHSLIRAML 286
Query: 209 SANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
N +RLS E H + + I
Sbjct: 287 QVNPEERLSIAEVVHQLQEIAAARNVNPKSPIT 319
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360 | Back alignment and structure |
|---|
Score = 146 bits (370), Expect = 2e-42
Identities = 57/184 (30%), Positives = 87/184 (47%), Gaps = 5/184 (2%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
EL L N P I+ + AF ++ I + +E GG+L ++ GR+PEQ K +
Sbjct: 81 ELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAV 140
Query: 76 GAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
GL L H I+HRD+KP NIL++ + +K+ DFG+S L + A G+ Y
Sbjct: 141 IKGLTYLREKHKIMHRDVKPSNILVNSRGE---IKLCDFGVSGQLI-DSMANSFVGTRSY 196
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
M+PE LQ Y + D+WS+G L E+ G P + +L ++
Sbjct: 197 MSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPR 256
Query: 195 ALHP 198
P
Sbjct: 257 PRTP 260
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 2e-42
Identities = 61/205 (29%), Positives = 104/205 (50%), Gaps = 21/205 (10%)
Query: 21 SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80
S ++H NI+ + D + ++C +LV+E+ G LS YI HG + TA F Q+ G++
Sbjct: 66 SQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIK 125
Query: 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYM 135
+ I+HRD+KP+NIL +D + LKI DFG+ +L V G+ Y
Sbjct: 126 HAHDMRIVHRDIKPQNIL---IDSNKTLKIFDFGIAKALSETSL---TQTNHVLGTVQYF 179
Query: 136 APEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHL-----PFSQ 190
+PE + + DE D++S+G +L+E+L G PPF+G V + KH+ +
Sbjct: 180 SPEQAKGEATDECTDIYSIGIVLYEMLVGEPPFNGETAVSIAI-----KHIQDSVPNVTT 234
Query: 191 LIVPALHPDCVDMCLKLLSANTVDR 215
+ + ++ L+ + +R
Sbjct: 235 DVRKDIPQSLSNVILRATEKDKANR 259
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420 | Back alignment and structure |
|---|
Score = 147 bits (373), Expect = 3e-42
Identities = 74/262 (28%), Positives = 117/262 (44%), Gaps = 41/262 (15%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
+KK+ + + EL + ++H NI+RL F + E + LV+++ +
Sbjct: 84 IKKVLQDKRFKNR-ELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYV-PETVYR 141
Query: 56 YIRLHGR----VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
R + R +P + ++ QL L ++S I HRD+KP+N+LL D +LK+
Sbjct: 142 VARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDP--DTAVLKLC 199
Query: 112 DFGLSCTLYPGN-YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFG + L G +C S Y APE+ Y +D+WS G +L ELL G P F
Sbjct: 200 DFGSAKQLVRGEPNVSYIC-SRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFP 258
Query: 170 GRNNV-QLV--------------RNINS---------CKHLPFSQLIVPALHPDCVDMCL 205
G + V QLV R +N K P++++ P P+ + +C
Sbjct: 259 GDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCS 318
Query: 206 KLLSANTVDRLSFNEFYHHRFL 227
+LL RL+ E H F
Sbjct: 319 RLLEYTPTARLTPLEACAHSFF 340
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 6e-42
Identities = 63/252 (25%), Positives = 103/252 (40%), Gaps = 50/252 (19%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L + H NII L + + L+ E+ +L Y+ + V + + FL QL
Sbjct: 83 EVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAEN-DLKKYMDKNPDVSMRVIKSFLYQL 141
Query: 76 GAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
G+ +S +HRDLKP+N+LLS + +LKI DFGL+ + G P+
Sbjct: 142 INGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLA----------RAFGIPI 191
Query: 134 -----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVRNI 180
Y PE+L + Y VD+WS+ I E+L P F G + + QL +
Sbjct: 192 RQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSEIDQLFKIF 251
Query: 181 NSC-----------KHLP-------------FSQLIVPALHPDCVDMCLKLLSANTVDRL 216
LP +++ L + +D+ +L + V R+
Sbjct: 252 EVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRI 311
Query: 217 SFNEFYHHRFLR 228
S H +
Sbjct: 312 SAKNALEHPYFS 323
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346 | Back alignment and structure |
|---|
Score = 144 bits (366), Expect = 8e-42
Identities = 77/238 (32%), Positives = 109/238 (45%), Gaps = 50/238 (21%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L ++HPNII L DAF ++ I LV +F +L I+ + V + ++
Sbjct: 62 EIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLM 120
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
GLE L+ H I+HRDLKP N+L LD++ +LK+ADFGL+ K GSP
Sbjct: 121 TLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADFGLA----------KSFGSPNR 167
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVR--- 178
Y APE+L + Y VDMW+VG IL ELL P G +++ QL R
Sbjct: 168 AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTRIFE 227
Query: 179 -----------------NINSCKHLPFSQL--IVPALHPDCVDMCLKLLSANTVDRLS 217
+ + K P L I A D +D+ L N R++
Sbjct: 228 TLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARIT 285
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311 | Back alignment and structure |
|---|
Score = 143 bits (362), Expect = 1e-41
Identities = 68/251 (27%), Positives = 113/251 (45%), Gaps = 52/251 (20%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L ++HPNI+ L D +E C+ LV EF +L + + + + +L Q
Sbjct: 69 EISLLKELHHPNIVSLIDVIHSERCLTLVFEFMEK-DLKKVLDENKTGLQDSQIKIYLYQ 127
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L G+ + H I+HRDLKP+N+L ++ D LK+ADFGL+ + G P+
Sbjct: 128 LLRGVAHCHQHRILHRDLKPQNLL---INSDGALKLADFGLA----------RAFGIPVR 174
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL----- 176
Y AP+VL ++Y VD+WS+G I E++ G P F G + QL
Sbjct: 175 SYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQLPKIFS 234
Query: 177 ------------VRNINSCKHLPFSQ-------LIVPALHPDCVDMCLKLLSANTVDRLS 217
V+ + K F I+P + +D+ +L + R+S
Sbjct: 235 ILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRIS 294
Query: 218 FNEFYHHRFLR 228
+ +H + +
Sbjct: 295 ARDAMNHPYFK 305
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310 | Back alignment and structure |
|---|
Score = 142 bits (361), Expect = 2e-41
Identities = 50/223 (22%), Positives = 92/223 (41%), Gaps = 25/223 (11%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ + + HPN+++ + + + E+ GG L I+ P F +
Sbjct: 57 EVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKD 116
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK------- 127
+ +G+ L+S +IIHRDL N L+ ++ + +ADFGL+ + +
Sbjct: 117 IASGMAYLHSMNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKK 173
Query: 128 --------VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN--NVQLV 177
V G+P +MAPE++ + YDEKVD++S G +L E++ +
Sbjct: 174 PDRKKRYTVVGNPYWMAPEMINGRSYDEKVDVFSFGIVLCEIIGRVNADPDYLPRTMDFG 233
Query: 178 RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220
N+ P P + ++ + R SF +
Sbjct: 234 LNVRGFLDRY----CPPNCPPSFFPITVRCCDLDPEKRPSFVK 272
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288 | Back alignment and structure |
|---|
Score = 141 bits (359), Expect = 2e-41
Identities = 65/250 (26%), Positives = 108/250 (43%), Gaps = 51/250 (20%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L + H NI++L+D + + LV E +L + + TA+ FL Q
Sbjct: 50 EISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQ-DLKKLLDVCEGGLESVTAKSFLLQ 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L G+ + ++HRDLKP+N+L ++ + LKIADFGL+ + G P+
Sbjct: 109 LLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLA----------RAFGIPVR 155
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVRNIN 181
Y AP+VL ++Y +D+WSVG I E++NG P F G + QL+R
Sbjct: 156 KYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMRIFR 215
Query: 182 SC-----------KHLPFSQL------------IVPALHPDCVDMCLKLLSANTVDRLSF 218
LP + L +D+ K+L + R++
Sbjct: 216 ILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITA 275
Query: 219 NEFYHHRFLR 228
+ H + +
Sbjct: 276 KQALEHAYFK 285
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311 | Back alignment and structure |
|---|
Score = 142 bits (360), Expect = 2e-41
Identities = 59/252 (23%), Positives = 105/252 (41%), Gaps = 53/252 (21%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L + HPN++ L + F+ + + LV E+C + + + R VPE + Q
Sbjct: 52 EIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDH-TVLHELDRYQRGVPEHLVKSITWQ 110
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ + H+ IHRD+KPENIL + ++K+ DFG + ++ P
Sbjct: 111 TLQAVNFCHKHNCIHRDVKPENIL---ITKHSVIKLCDFGFA----------RLLTGPSD 157
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVRNIN 181
Y +PE+L +Y VD+W++G + ELL+G P + G+++V QL
Sbjct: 158 YYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIRK 217
Query: 182 SC-----KHLP-FSQL-------------------IVPALHPDCVDMCLKLLSANTVDRL 216
+ +H FS P + + + L + +RL
Sbjct: 218 TLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERL 277
Query: 217 SFNEFYHHRFLR 228
+ + HH +
Sbjct: 278 TCEQLLHHPYFE 289
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394 | Back alignment and structure |
|---|
Score = 144 bits (364), Expect = 3e-41
Identities = 69/248 (27%), Positives = 109/248 (43%), Gaps = 40/248 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLHGR----VPE 65
EL + V HPN++ L F + E + LV+E+ + R + + +P
Sbjct: 82 ELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYV-PETVYRASRHYAKLKQTMPM 140
Query: 66 QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-Y 124
+ ++ QL L ++S I HRD+KP+N+LL +LK+ DFG + L G
Sbjct: 141 LLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSG--VLKLIDFGSAKILIAGEPN 198
Query: 125 AEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLV----- 177
+C S Y APE+ Y +D+WS G ++ EL+ G P F G + + QLV
Sbjct: 199 VSYIC-SRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVEIIKV 257
Query: 178 ---------RNINS---------CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN 219
+ +N + PFS++ P PD +D+ +LL RL+
Sbjct: 258 LGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARLTAI 317
Query: 220 EFYHHRFL 227
E H F
Sbjct: 318 EALCHPFF 325
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318 | Back alignment and structure |
|---|
Score = 142 bits (359), Expect = 3e-41
Identities = 61/236 (25%), Positives = 93/236 (39%), Gaps = 41/236 (17%)
Query: 16 ELNFL-SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
+L+ + S + P I++ F F +F+ +E R+ G +PE+ K
Sbjct: 73 DLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVA 132
Query: 75 LGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
+ L L H +IHRD+KP NILL +K+ DFG+S L ++ G
Sbjct: 133 IVKALYYLKEKHGVIHRDVKPSNILLDERGQ---IKLCDFGISGRLVDDKAKDRSAGCAA 189
Query: 134 YMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPF 188
YMAPE + YD + D+WS+G L EL G P+ F
Sbjct: 190 YMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKT-------------DF 236
Query: 189 SQL--IV----PALHP---------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
L ++ P L V CL + R +N+ H F++R
Sbjct: 237 EVLTKVLQEEPPLLPGHMGFSGDFQSFVKDCLT---KDHRKRPKYNKLLEHSFIKR 289
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331 | Back alignment and structure |
|---|
Score = 140 bits (356), Expect = 1e-40
Identities = 62/254 (24%), Positives = 108/254 (42%), Gaps = 53/254 (20%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E+ L + H N++ L + + + +LV EF + + L + Q +K+L Q
Sbjct: 74 EIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDH-TILDDLELFPNGLDYQVVQKYLFQ 132
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ +SH+IIHRD+KPENIL + ++K+ DFG + + +P
Sbjct: 133 IINGIGFCHSHNIIHRDIKPENIL---VSQSGVVKLCDFGFA----------RTLAAPGE 179
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVRNIN 181
Y APE+L +Y + VD+W++G ++ E+ G P F G +++ QL +
Sbjct: 180 VYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHIMM 239
Query: 182 SC-----KHLP-FSQL-------------------IVPALHPDCVDMCLKLLSANTVDRL 216
+H F++ P L +D+ K L + R
Sbjct: 240 CLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRP 299
Query: 217 SFNEFYHHRFLRRN 230
E HH F + +
Sbjct: 300 FCAELLHHDFFQMD 313
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 4e-40
Identities = 68/251 (27%), Positives = 103/251 (41%), Gaps = 53/251 (21%)
Query: 17 LNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRV--PEQTAR 69
L L + HPN++RL D + LV E +L +Y+ P +T +
Sbjct: 65 LRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVDQ-DLRTYLDKAPPPGLPAETIK 123
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
++Q GL+ L+++ I+HRDLKPENIL+ +K+ADFGL+ ++
Sbjct: 124 DLMRQFLRGLDFLHANCIVHRDLKPENILV---TSGGTVKLADFGLA----------RIY 170
Query: 130 GSPL----------YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVR 178
+ Y APEVL Y VDMWSVG I E+ P F G + QL +
Sbjct: 171 SYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFAEMFRRKPLFCGNSEADQLGK 230
Query: 179 NINSC-----------KHLPFSQL----------IVPALHPDCVDMCLKLLSANTVDRLS 217
+ LP +VP + + L++L+ N R+S
Sbjct: 231 IFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290
Query: 218 FNEFYHHRFLR 228
H +L
Sbjct: 291 AFRALQHSYLH 301
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326 | Back alignment and structure |
|---|
Score = 139 bits (352), Expect = 5e-40
Identities = 70/248 (28%), Positives = 106/248 (42%), Gaps = 53/248 (21%)
Query: 20 LSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTARKFL 72
L + HPN++RLFD E + LV E +L++Y+ P +T + +
Sbjct: 68 LETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQ-DLTTYLDKVPEPGVPTETIKDMM 126
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
QL GL+ L+SH ++HRDLKP+NIL+ +K+ADFGL+ ++
Sbjct: 127 FQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLA----------RIYSFQ 173
Query: 133 L----------YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLVRNIN 181
+ Y APEVL Y VD+WSVG I E+ P F G ++V QL + ++
Sbjct: 174 MALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILD 233
Query: 182 SC-----------KHLPFSQL----------IVPALHPDCVDMCLKLLSANTVDRLSFNE 220
LP V + D+ LK L+ N R+S
Sbjct: 234 VIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYS 293
Query: 221 FYHHRFLR 228
H + +
Sbjct: 294 ALSHPYFQ 301
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321 | Back alignment and structure |
|---|
Score = 139 bits (351), Expect = 6e-40
Identities = 58/217 (26%), Positives = 112/217 (51%), Gaps = 11/217 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + H N++ ++ ++ +++++EF GG L+ + R+ E+ + +
Sbjct: 92 EVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVS-QVRLNEEQIATVCEAV 150
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
L L++ +IHRD+K ++ILL+ LD V K++DFG + K + G+P +
Sbjct: 151 LQALAYLHAQGVIHRDIKSDSILLT-LDGRV--KLSDFGFCAQISKDVPKRKSLVGTPYW 207
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI--NSCKHLPFSQLI 192
MAPEV+ Y +VD+WS+G ++ E+++G PP+ + VQ ++ + + L S +
Sbjct: 208 MAPEVISRSLYATEVDIWSLGIMVIEMVDGEPPYFSDSPVQAMKRLRDSPPPKLKNSHKV 267
Query: 193 VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
P L D ++ L + +R + E H FL +
Sbjct: 268 SPVLR-DFLERMLVR---DPQERATAQELLDHPFLLQ 300
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297 | Back alignment and structure |
|---|
Score = 138 bits (350), Expect = 6e-40
Identities = 63/217 (29%), Positives = 112/217 (51%), Gaps = 11/217 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ + +PNI+ D++ + +++V+E+ AGG+L+ + + E ++
Sbjct: 67 EILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-ETCMDEGQIAAVCREC 125
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK-VCGSPLY 134
LE L+S+ +IHRD+K +NILL +D V K+ DFG + P + G+P +
Sbjct: 126 LQALEFLHSNQVIHRDIKSDNILLG-MDGSV--KLTDFGFCAQITPEQSKRSTMVGTPYW 182
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI--NSCKHLPFSQLI 192
MAPEV+ + Y KVD+WS+G + E++ G PP+ N ++ + I N L + +
Sbjct: 183 MAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLIATNGTPELQNPEKL 242
Query: 193 VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
D ++ CL++ + R S E H+FL+
Sbjct: 243 SAIFR-DFLNRCLEM---DVEKRGSAKELLQHQFLKI 275
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271 | Back alignment and structure |
|---|
Score = 137 bits (347), Expect = 7e-40
Identities = 38/174 (21%), Positives = 76/174 (43%), Gaps = 16/174 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKF 71
E L +HPN++ + A Q+ L+ + G+L + + V + A KF
Sbjct: 57 ECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKF 116
Query: 72 LQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ G+ L++ I L ++++ D+D+ +I+ + +
Sbjct: 117 ALDMARGMAFLHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQSPG----RM 169
Query: 130 GSPLYMAPEVLQFQRYD---EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
+P ++APE LQ + D DMWS +L+EL+ PF+ +N+++ +
Sbjct: 170 YAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTREVPFADLSNMEIGMKV 223
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413 | Back alignment and structure |
|---|
Score = 140 bits (355), Expect = 8e-40
Identities = 35/238 (14%), Positives = 71/238 (29%), Gaps = 29/238 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCI--FLVVEFCAG------GNLSSYIRLHGRVPEQT 67
+ + +IR+ + + F + L S+ H +
Sbjct: 153 PFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSHSSTHKSLVHHA 212
Query: 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE- 126
+ Q+ L L+ + ++H L+P +I+ LD + + F +
Sbjct: 213 RLQLTLQVIRLLASLHHYGLVHTYLRPVDIV---LDQRGGVFLTGFEHLVRDGASAVSPI 269
Query: 127 -KVCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
+ P A +L F + D W++G ++ + P + + I
Sbjct: 270 GRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI 329
Query: 181 -NSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 237
SCK++P + L DRL + + L A
Sbjct: 330 FRSCKNIP----------QPVRALLEGFLRYPKEDRLLPLQAMETPEYEQLRTELSAA 377
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292 | Back alignment and structure |
|---|
Score = 137 bits (348), Expect = 9e-40
Identities = 73/251 (29%), Positives = 106/251 (42%), Gaps = 52/251 (20%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L + H NI+RL D ++ + LV EFC +L Y + + FL Q
Sbjct: 51 EICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQ 109
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L GL +S +++HRDLKP+N+L ++ + LK+A+FGL+ + G P+
Sbjct: 110 LLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLA----------RAFGIPVR 156
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV-QLVRNI 180
Y P+VL + Y +DMWS G I EL N G P F G + QL R
Sbjct: 157 CYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLKRIF 216
Query: 181 NSC-----------KHLP----FSQ--------LIVPALHPDCVDMCLKLLSANTVDRLS 217
LP + +VP L+ D+ LL N V R+S
Sbjct: 217 RLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRIS 276
Query: 218 FNEFYHHRFLR 228
E H +
Sbjct: 277 AEEALQHPYFS 287
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324 | Back alignment and structure |
|---|
Score = 138 bits (349), Expect = 2e-39
Identities = 65/251 (25%), Positives = 100/251 (39%), Gaps = 52/251 (20%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E++ L + H NI+ L D E + LV E+ +L Y+ G + + FL Q
Sbjct: 50 EVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLDK-DLKQYLDDCGNIINMHNVKLFLFQ 108
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
L GL + ++HRDLKP+N+L +++ LK+ADFGL+ + P
Sbjct: 109 LLRGLAYCHRQKVLHRDLKPQNLL---INERGELKLADFGLA----------RAKSIPTK 155
Query: 134 ----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL----- 176
Y P++L Y ++DMW VG I +E+ G P F G QL
Sbjct: 156 TYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLHFIFR 215
Query: 177 ------------VRNINSCKHLPFSQ-------LIVPALHPDCVDMCLKLLSANTVDRLS 217
+ + K + + P L D D+ KLL +R+S
Sbjct: 216 ILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRIS 275
Query: 218 FNEFYHHRFLR 228
+ H F
Sbjct: 276 AEDAMKHPFFL 286
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 3e-39
Identities = 63/221 (28%), Positives = 111/221 (50%), Gaps = 17/221 (7%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS + P + + + ++ + +++++E+ GG+ + G + E L+++
Sbjct: 70 EITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLE-PGPLDETQIATILREI 128
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLY 134
GL+ L+S IHRD+K N+LLS + +K+ADFG++ L G+P +
Sbjct: 129 LKGLDYLHSEKKIHRDIKAANVLLS---EHGEVKLADFGVAGQLTDTQIKRNTFVGTPFW 185
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI--NSCKHL--PFSQ 190
MAPEV++ YD K D+WS+G EL G PP S + ++++ I N+ L +S
Sbjct: 186 MAPEVIKQSAYDSKADIWSLGITAIELARGEPPHSELHPMKVLFLIPKNNPPTLEGNYS- 244
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
L + V+ CL R + E H+F+ RN+
Sbjct: 245 ---KPLK-EFVEACLN---KEPSFRPTAKELLKHKFILRNA 278
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-39
Identities = 53/207 (25%), Positives = 97/207 (46%), Gaps = 20/207 (9%)
Query: 21 SSVNHPNIIRLFD----AFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLG 76
+++NHP I+ ++D A ++V+E+ G L + G + + A + +
Sbjct: 67 AALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADAC 126
Query: 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL----SCTLYPGNYAEKVCGSP 132
L + + IIHRD+KP NI++S +K+ DFG+ + + V G+
Sbjct: 127 QALNFSHQNGIIHRDVKPANIMIS---ATNAVKVMDFGIARAIADSGNSVTQTAAVIGTA 183
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHL----PF 188
Y++PE + D + D++S+G +L+E+L G PPF+G + V + +H+
Sbjct: 184 QYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVAY-----QHVREDPIP 238
Query: 189 SQLIVPALHPDCVDMCLKLLSANTVDR 215
L D + LK L+ N +R
Sbjct: 239 PSARHEGLSADLDAVVLKALAKNPENR 265
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314 | Back alignment and structure |
|---|
Score = 136 bits (345), Expect = 4e-39
Identities = 61/218 (27%), Positives = 105/218 (48%), Gaps = 11/218 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E++ + + P++++ + ++ +++V+E+C G++S IRL + E LQ
Sbjct: 74 EISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQS 133
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPL 133
GLE L+ IHRD+K NILL+ + K+ADFG++ L V G+P
Sbjct: 134 TLKGLEYLHFMRKIHRDIKAGNILLN-TEGHA--KLADFGVAGQLTDTMAKRNTVIGTPF 190
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI--NSCKHLPFSQL 191
+MAPEV+Q Y+ D+WS+G E+ G PP++ + ++ + I N +L
Sbjct: 191 WMAPEVIQEIGYNCVADIWSLGITAIEMAEGKPPYADIHPMRAIFMIPTNPPPTFRKPEL 250
Query: 192 IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
D V CL + R + + H F+R
Sbjct: 251 WSDNFT-DFVKQCLVK---SPEQRATATQLLQHPFVRS 284
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290 | Back alignment and structure |
|---|
Score = 135 bits (341), Expect = 1e-38
Identities = 62/237 (26%), Positives = 94/237 (39%), Gaps = 42/237 (17%)
Query: 16 ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY---IRLHGRVPEQTARKF 71
+L+ + +V+ P + + A E +++ +E Y I +PE K
Sbjct: 55 DLDISMRTVDCPFTVTFYGALFREGDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKI 114
Query: 72 LQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG 130
+ LE L+S +IHRD+KP N+L++ V K+ DFG+S L + G
Sbjct: 115 AVSIVKALEHLHSKLSVIHRDVKPSNVLIN-ALGQV--KMCDFGISGYLVDDVAKDIDAG 171
Query: 131 SPLYMAPEV----LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHL 186
YMAPE L + Y K D+WS+G + EL P+
Sbjct: 172 CKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWGT------------- 218
Query: 187 PFSQL--IV----PALHP--------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
PF QL +V P L D CLK N+ +R ++ E H F
Sbjct: 219 PFQQLKQVVEEPSPQLPADKFSAEFVDFTSQCLK---KNSKERPTYPELMQHPFFTL 272
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317 | Back alignment and structure |
|---|
Score = 135 bits (343), Expect = 1e-38
Identities = 72/265 (27%), Positives = 104/265 (39%), Gaps = 70/265 (26%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV------PEQTAR 69
E++ + + H NI+RL+D EN + LV EF +L Y+ +
Sbjct: 53 EISLMKELKHENIVRLYDVIHTENKLTLVFEFMDN-DLKKYMDSRTVGNTPRGLELNLVK 111
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
F QL GL + + I+HRDLKP+N+L ++ LK+ DFGL+ +
Sbjct: 112 YFQWQLLQGLAFCHENKILHRDLKPQNLL---INKRGQLKLGDFGLA----------RAF 158
Query: 130 GSPL-----------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
G P+ Y AP+VL + Y +D+WS G IL E++ G P F G N+ QL
Sbjct: 159 GIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTNDEEQL 218
Query: 177 VRNINSC-----------KHLP-----------------FSQLIVPALHPDCVDMCLKLL 208
+ LP L + +D LL
Sbjct: 219 KLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLL 278
Query: 209 SANTVDRLS---------FNEFYHH 224
N RLS F E+YHH
Sbjct: 279 QLNPDMRLSAKQALHHPWFAEYYHH 303
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348 | Back alignment and structure |
|---|
Score = 132 bits (335), Expect = 2e-37
Identities = 72/229 (31%), Positives = 99/229 (43%), Gaps = 36/229 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ FL + HPN I+ + E+ +LV+E+C G + E
Sbjct: 104 EVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGA 163
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
GL L+SH++IHRD+K NILLS V K+ DFG + + P N G+P +M
Sbjct: 164 LQGLAYLHSHNMIHRDVKAGNILLS-EPGLV--KLGDFGSASIMAPAN---SFVGTPYWM 217
Query: 136 APEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLI 192
APEV+ YD KVD+WS+G EL PP N+N+ L I
Sbjct: 218 APEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLF---------NMNAMSAL---YHI 265
Query: 193 V----PALHP--------DCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
PAL + VD CL+ DR + HRF+ R
Sbjct: 266 AQNESPALQSGHWSEYFRNFVDSCLQK---IPQDRPTSEVLLKHRFVLR 311
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 3e-37
Identities = 46/203 (22%), Positives = 93/203 (45%), Gaps = 21/203 (10%)
Query: 22 SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
+ P+++ + D + + +++ + G +L++ +R G + A ++Q+G+ L+
Sbjct: 90 RLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDA 149
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL-----SCTLYPGNYAEKVCGSPLYMA 136
++ HRD+KPENIL+S DD + DFG+ L G+ YMA
Sbjct: 150 AHAAGATHRDVKPENILVSA-DDFA--YLVDFGIASATTDEKL---TQLGNTVGTLYYMA 203
Query: 137 PEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHL----PFSQLI 192
PE + D++++ +L+E L G PP+ G + + ++ H+ P +
Sbjct: 204 PERFSESHATYRADIYALTCVLYECLTGSPPYQG-DQLSVMG-----AHINQAIPRPSTV 257
Query: 193 VPALHPDCVDMCLKLLSANTVDR 215
P + + + ++ N DR
Sbjct: 258 RPGIPVAFDAVIARGMAKNPEDR 280
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 7e-37
Identities = 53/163 (32%), Positives = 89/163 (54%), Gaps = 14/163 (8%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQ 74
E+ L++ +HP I++L A+ + +++++EFC GG + + + R E + +Q
Sbjct: 66 EIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQ 125
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGS 131
+ L L+S IIHRDLK N+L++ L+ D+ ++ADFG+S +K G+
Sbjct: 126 MLEALNFLHSKRIIHRDLKAGNVLMT-LEGDI--RLADFGVSAKN--LKTLQKRDSFIGT 180
Query: 132 PLYMAPEV-----LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
P +MAPEV ++ YD K D+WS+G L E+ PP
Sbjct: 181 PYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEPPHH 223
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 9e-37
Identities = 74/279 (26%), Positives = 121/279 (43%), Gaps = 56/279 (20%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F + +LV+ F
Sbjct: 54 IKKLSRPFQSEIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPF-MQ 112
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L + + E+ + + Q+ GL+ ++S ++HRDLKP N+ + ++D LKI
Sbjct: 113 TDLQKIMG--LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAV---NEDCELKI 167
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFGL+ V + Y APEV L + Y++ VD+WSVG I+ E+L G F
Sbjct: 168 LDFGLARHADA-EMTGYV-VTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFK 225
Query: 170 GRNNV-QL--------------------------VRNINSCKHLPFSQLIVPALHPDCVD 202
G++ + QL ++++ F+QL P P D
Sbjct: 226 GKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQAAD 284
Query: 203 MCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
+ K+L + RL+ + H F PF P
Sbjct: 285 LLEKMLELDVDKRLTAAQALTHPFF--------EPFRDP 315
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367 | Back alignment and structure |
|---|
Score = 131 bits (332), Expect = 1e-36
Identities = 72/287 (25%), Positives = 121/287 (42%), Gaps = 71/287 (24%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL + +S L EL L + H N+I L D F + +LV+ F G
Sbjct: 55 IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPF-MG 113
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L ++ H ++ E + + Q+ GL +++ IIHRDLKP N+ + ++D LKI
Sbjct: 114 TDLGKLMK-HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKI 169
Query: 111 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFEL 161
DFGL+ + S + Y APEV L + RY + VD+WSVG I+ E+
Sbjct: 170 LDFGLA----------RQADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEM 219
Query: 162 LNGYPPFSGRNNV-QL--------------------------VRNINSCKHLPFSQLIVP 194
+ G F G +++ QL ++ + + F+ ++
Sbjct: 220 ITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL-T 278
Query: 195 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
P V++ K+L + R++ E H + H
Sbjct: 279 NASPLAVNLLEKMLVLDAEQRVTAGEALAHPYF--------ESLHDT 317
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 2e-36
Identities = 55/169 (32%), Positives = 89/169 (52%), Gaps = 18/169 (10%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF---- 71
E+ +S +HPNI+ + +F ++ ++LV++ +GG++ I+ E +
Sbjct: 63 EIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDEST 122
Query: 72 ----LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127
L+++ GLE L+ + IHRD+K NIL L +D ++IADFG+S L G +
Sbjct: 123 IATILREVLEGLEYLHKNGQIHRDVKAGNIL---LGEDGSVQIADFGVSAFLATGGDITR 179
Query: 128 ------VCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFS 169
G+P +MAPEV+ Q + YD K D+WS G EL G P+
Sbjct: 180 NKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFGITAIELATGAAPYH 228
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 2e-36
Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 30/233 (12%)
Query: 16 ELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR----LHGRVPEQTARK 70
+L+ + S + P I++ + A E ++ +E + Y L +PE+ K
Sbjct: 70 DLDVVMRSSDCPYIVQFYGALFREGDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGK 129
Query: 71 FLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
L L IIHRD+KP NILL ++ K+ DFG+S L +
Sbjct: 130 ITLATVKALNHLKENLKIIHRDIKPSNILLD-RSGNI--KLCDFGISGQLVDSIAKTRDA 186
Query: 130 GSPLYMAPEVLQFQR----YDEKVDMWSVGAILFELLNGYPPFSGRNNV-----QLVRN- 179
G YMAPE + YD + D+WS+G L+EL G P+ N+V Q+V+
Sbjct: 187 GCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKWNSVFDQLTQVVKGD 246
Query: 180 ---INSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
+++ + FS P+ + V++CL + R + E H F+
Sbjct: 247 PPQLSNSEEREFS----PSFI-NFVNLCLT---KDESKRPKYKELLKHPFILM 291
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353 | Back alignment and structure |
|---|
Score = 130 bits (329), Expect = 2e-36
Identities = 63/290 (21%), Positives = 114/290 (39%), Gaps = 65/290 (22%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK+ L E+ L H NII +F+ + ++ ++++ E
Sbjct: 41 IKKIEP-FDKPLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQEL-MQT 98
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L I + + + F+ Q +++L+ ++IHRDLKP N+L+ + + LK+
Sbjct: 99 DLHRVIS-TQMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLI---NSNCDLKVC 154
Query: 112 DFGLSCTLYPGNYAEKVCGSPL-----------YMAPEV-LQFQRYDEKVDMWSVGAILF 159
DFGL+ + Y APEV L +Y +D+WS G IL
Sbjct: 155 DFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILA 214
Query: 160 ELLNGYPPFSGRNNV-QL---------------------------VRNINSCKHLPFSQL 191
EL P F GR+ QL ++++ P ++
Sbjct: 215 ELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM 274
Query: 192 IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
P ++P +D+ ++L + R++ E H +L +H P
Sbjct: 275 F-PRVNPKGIDLLQRMLVFDPAKRITAKEALEHPYL--------QTYHDP 315
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681 | Back alignment and structure |
|---|
Score = 133 bits (337), Expect = 4e-36
Identities = 46/202 (22%), Positives = 90/202 (44%), Gaps = 26/202 (12%)
Query: 19 FLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQ 73
FL+ V HP+I+++F+ + + ++V+E+ G +L ++P A +L
Sbjct: 132 FLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKG--QKLPVAEAIAYLL 189
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
++ L L+S +++ DLKPENI+L+ ++ + K+ D G + N + G+P
Sbjct: 190 EILPALSYLHSIGLVYNDLKPENIMLT--EEQL--KLIDLGAVSRI---NSFGYLYGTPG 242
Query: 134 YMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV 193
+ APE+++ D+++VG L L P +GR LP V
Sbjct: 243 FQAPEIVR-TGPTVATDIYTVGRTLAALTLDLPTRNGR----------YVDGLP-EDDPV 290
Query: 194 PALHPDCVDMCLKLLSANTVDR 215
+ + + + + R
Sbjct: 291 LKTYDSYGRLLRRAIDPDPRQR 312
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 4e-36
Identities = 48/166 (28%), Positives = 77/166 (46%), Gaps = 15/166 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQ 73
EL+ NHPNI+ F A+N +++V F A G+ I H + E LQ
Sbjct: 76 ELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQ 135
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC---- 129
+ L+ ++ +HR +K +IL+S D V ++ + ++ ++V
Sbjct: 136 GVLKALDYIHHMGYVHRSVKASHILISV-DGKV--YLSGLRSNLSMISHGQRQRVVHDFP 192
Query: 130 ----GSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFELLNGYPPFS 169
+++PEVLQ Q YD K D++SVG EL NG+ PF
Sbjct: 193 KYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 238
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360 | Back alignment and structure |
|---|
Score = 129 bits (327), Expect = 6e-36
Identities = 68/254 (26%), Positives = 105/254 (41%), Gaps = 46/254 (18%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQA-------ENCIFLVVEFCAGGNLSSYIRLHGR----VP 64
+ L+ ++HPNI++L F + + +V+E+ L R + R P
Sbjct: 69 IMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYV-PDTLHRCCRNYYRRQVAPP 127
Query: 65 EQTARKFLQQLGAGLEIL--NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+ FL QL + L S ++ HRD+KP N+L++ D LK+ DFG + L P
Sbjct: 128 PILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGT--LKLCDFGSAKKLSPS 185
Query: 123 N-YAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLV-- 177
+C S Y APE+ Q Y VD+WSVG I E++ G P F G N+ QL
Sbjct: 186 EPNVAYIC-SRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSAGQLHEI 244
Query: 178 ------------RNINS---------CKHLPFSQL---IVPALHPDCVDMCLKLLSANTV 213
R +N K +P+S + + D+ LL
Sbjct: 245 VRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSALLQYLPE 304
Query: 214 DRLSFNEFYHHRFL 227
+R+ E H +
Sbjct: 305 ERMKPYEALCHPYF 318
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405 | Back alignment and structure |
|---|
Score = 130 bits (328), Expect = 6e-36
Identities = 52/185 (28%), Positives = 85/185 (45%), Gaps = 38/185 (20%)
Query: 15 CELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRLHGR---------V 63
E+ L + HPN+I L F A+ ++L+ ++ +L I+ H +
Sbjct: 67 REIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAEH-DLWHIIKFHRASKANKKPVQL 125
Query: 64 PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV-MLKIADFGLSCTLYPG 122
P + L Q+ G+ L+++ ++HRDLKP NIL+ G + +KIAD G +
Sbjct: 126 PRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFA------ 179
Query: 123 NYAEKVCGSPL--------------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPP 167
++ SPL Y APE+L + Y + +D+W++G I ELL P
Sbjct: 180 ----RLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSEPI 235
Query: 168 FSGRN 172
F R
Sbjct: 236 FHCRQ 240
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367 | Back alignment and structure |
|---|
Score = 129 bits (326), Expect = 9e-36
Identities = 70/287 (24%), Positives = 126/287 (43%), Gaps = 71/287 (24%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ +S + EL L + H N+I L D F ++LV G
Sbjct: 59 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHL-MG 117
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+L++ ++ ++ + + + Q+ GL+ ++S IIHRDLKP N+ +++D LKI
Sbjct: 118 ADLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLA---VNEDCELKI 173
Query: 111 ADFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFEL 161
DFGL+ + + Y APE+ L + Y++ VD+WSVG I+ EL
Sbjct: 174 LDFGLA----------RHTADEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAEL 223
Query: 162 LNGYPPFSGRNNV-QL--------------------------VRNINSCKHLPFSQLIVP 194
L G F G +++ QL ++++ + F+ +
Sbjct: 224 LTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-I 282
Query: 195 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
+P VD+ K+L ++ R++ + H + A +H P
Sbjct: 283 GANPLAVDLLEKMLVLDSDKRITAAQALAHAYF--------AQYHDP 321
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 1e-35
Identities = 74/288 (25%), Positives = 116/288 (40%), Gaps = 62/288 (21%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ ++ EL + VNH NII L + F + +++V+E
Sbjct: 55 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMEL-MD 113
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
NL I++ + + L Q+ G++ L+S IIHRDLKP NI++ D LKI
Sbjct: 114 ANLCQVIQME--LDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKI 168
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
DFGL+ T + Y APEV+ Y E VD+WSVG I+ E++ G F G
Sbjct: 169 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMIKGGVLFPG 228
Query: 171 RNNV-QL-------------------------VRNINSCKHLPFSQLIVPALH------- 197
+++ Q V N F +L L
Sbjct: 229 TDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHN 288
Query: 198 ----PDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
D+ K+L + R+S +E H ++ ++ P
Sbjct: 289 KLKASQARDLLSKMLVIDASKRISVDEALQHPYI--------NVWYDP 328
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-35
Identities = 66/275 (24%), Positives = 125/275 (45%), Gaps = 66/275 (24%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC--------------IFLVVEFCAGGNLSSYIRLHG 61
E+ + ++H NI+++F+ +++V E+ +L++ + G
Sbjct: 58 EIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEY-METDLANVLE-QG 115
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ E+ AR F+ QL GL+ ++S +++HRDLKP N+ ++ +D++LKI DFGL+ + P
Sbjct: 116 PLLEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINT--EDLVLKIGDFGLARIMDP 173
Query: 122 GNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
L Y +P + L Y + +DMW+ G I E+L G F+G +
Sbjct: 174 ----HYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAH 229
Query: 173 NV-QL-------------------------VRNINSCKHLPFSQLIVPALHPDCVDMCLK 206
+ Q+ +RN + H P +QL+ P + + VD +
Sbjct: 230 ELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLL-PGISREAVDFLEQ 288
Query: 207 LLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
+L+ + +DRL+ E H ++ + + P
Sbjct: 289 ILTFSPMDRLTAEEALSHPYM--------SIYSFP 315
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 127 bits (320), Expect = 2e-35
Identities = 65/243 (26%), Positives = 107/243 (44%), Gaps = 45/243 (18%)
Query: 16 ELNFLSSV-NHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQ 66
E+N L +H NI + AF ++ ++LV+EFC G+++ I+ + E+
Sbjct: 70 EINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEE 129
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
+++ GL L+ H +IHRD+K +N+LL+ + +V K+ DFG+S L
Sbjct: 130 WIAYICREILRGLSHLHQHKVIHRDIKGQNVLLT-ENAEV--KLVDFGVSAQLDRTVGRR 186
Query: 127 K-VCGSPLYMAPEVLQFQR-----YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNI 180
G+P +MAPEV+ YD K D+WS+G E+ G PP ++
Sbjct: 187 NTFIGTPYWMAPEVIACDENPDATYDFKSDLWSLGITAIEMAEGAPPLC---------DM 237
Query: 181 NSCKHLPFSQLIV----PALHP--------DCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
+ + L LI P L ++ CL N R + + H F+R
Sbjct: 238 HPMRAL---FLIPRNPAPRLKSKKWSKKFQSFIESCLVK---NHSQRPATEQLMKHPFIR 291
Query: 229 RNS 231
Sbjct: 292 DQP 294
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364 | Back alignment and structure |
|---|
Score = 127 bits (322), Expect = 2e-35
Identities = 68/286 (23%), Positives = 120/286 (41%), Gaps = 65/286 (22%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK++ + C E+ L H NII + D +A +++V +
Sbjct: 57 IKKISP-FEHQTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDL-MET 114
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L ++ + FL Q+ GL+ ++S +++HRDLKP N+LL + LKI
Sbjct: 115 DLYKLLK-TQHLSNDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLL---NTTCDLKIC 170
Query: 112 DFGLSCTLYPGNYAEKVCGSPL--------YMAPEV-LQFQRYDEKVDMWSVGAILFELL 162
DFGL+ P + L Y APE+ L + Y + +D+WSVG IL E+L
Sbjct: 171 DFGLARVADP----DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEML 226
Query: 163 NGYPPFSGRNNV-QL--------------------------VRNINSCKHLPFSQLIVPA 195
+ P F G++ + QL + ++ +P+++L P
Sbjct: 227 SNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF-PN 285
Query: 196 LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
+D+ K+L+ N R+ + H +L ++ P
Sbjct: 286 ADSKALDLLDKMLTFNPHKRIEVEQALAHPYL--------EQYYDP 323
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464 | Back alignment and structure |
|---|
Score = 129 bits (325), Expect = 4e-35
Identities = 74/288 (25%), Positives = 115/288 (39%), Gaps = 62/288 (21%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ ++ EL + VNH NII L + F + ++LV+E
Sbjct: 92 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMEL-MD 150
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
NL I+ + + L Q+ G++ L+S IIHRDLKP NI++ D LKI
Sbjct: 151 ANLCQVIQ--MELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVV---KSDCTLKI 205
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
DFGL+ T + Y APEV+ Y E VD+WSVG I+ E++ F G
Sbjct: 206 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 265
Query: 171 RNNV-QL-------------------------VRNINSCKHLPFSQLIVPA--------- 195
R+ + Q V N L F +L +
Sbjct: 266 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 325
Query: 196 --LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
D+ K+L + R+S ++ H ++ ++ P
Sbjct: 326 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYI--------NVWYDP 365
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383 | Back alignment and structure |
|---|
Score = 127 bits (321), Expect = 4e-35
Identities = 67/308 (21%), Positives = 117/308 (37%), Gaps = 77/308 (25%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------------------------ 37
LKK+ + + EL+ + ++H NII+L D F
Sbjct: 37 LKKVLQDPRYKNR-ELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNG 95
Query: 38 --------------ENCIFLVVEFCAGGNLSSYIRLHGR----VPEQTARKFLQQLGAGL 79
+ +++E+ L ++ R +P ++ QL +
Sbjct: 96 VNNHHKSVIVNPSQNKYLNVIMEYV-PDTLHKVLKSFIRSGRSIPMNLISIYIYQLFRAV 154
Query: 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPE 138
++S I HRD+KP+N+L++ D+ LK+ DFG + L P +C S Y APE
Sbjct: 155 GFIHSLGICHRDIKPQNLLVNSKDNT--LKLCDFGSAKKLIPSEPSVAYIC-SRFYRAPE 211
Query: 139 V-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QLV--------------RNINS 182
+ L Y +D+WS+G + EL+ G P FSG ++ QLV +N
Sbjct: 212 LMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNP 271
Query: 183 ---------CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233
K + +++ +D+ ++L R++ E H F
Sbjct: 272 HYTEVRFPTLKAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF----DH 327
Query: 234 LRAPFHIP 241
LR +
Sbjct: 328 LRNSYESE 335
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 3e-34
Identities = 52/181 (28%), Positives = 87/181 (48%), Gaps = 11/181 (6%)
Query: 15 CELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFL 72
E + +HPN++ L ++E +V+ + G+L ++IR P + F
Sbjct: 75 TEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFG 134
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCG 130
Q+ G++ L S +HRDL N +L + + K+ADFGL+ +Y Y G
Sbjct: 135 LQVAKGMKYLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEYYSVHNKTG 191
Query: 131 SPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHL 186
+ L +MA E LQ Q++ K D+WS G +L+EL+ G PP+ N + + + L
Sbjct: 192 AKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRL 251
Query: 187 P 187
Sbjct: 252 L 252
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362 | Back alignment and structure |
|---|
Score = 124 bits (314), Expect = 3e-34
Identities = 64/262 (24%), Positives = 102/262 (38%), Gaps = 50/262 (19%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVP--EQTA 68
E+ L+ +HPNI+ L D F ++LV E +L+ I R+ Q
Sbjct: 79 EIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTEL-MRTDLAQVIH-DQRIVISPQHI 136
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ F+ + GL +L+ ++HRDL P NILL D+ + I DF L+
Sbjct: 137 QYFMYHILLGLHVLHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHY 193
Query: 129 CGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL---------- 176
Y APE+ +QF+ + + VDMWS G ++ E+ N F G QL
Sbjct: 194 VTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIVEVVGTP 253
Query: 177 ----VRNINS-------------CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN 219
V +S ++ ++ P P +D+ K+L N R+S
Sbjct: 254 KIEDVVMFSSPSARDYLRNSLSNVPARAWTAVV-PTADPVALDLIAKMLEFNPQRRISTE 312
Query: 220 EFYHHRFLRRNSAILRAPFHIP 241
+ H + P
Sbjct: 313 QALRHPYF--------ESLFDP 326
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 3e-34
Identities = 57/242 (23%), Positives = 101/242 (41%), Gaps = 24/242 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
E +S NH NI+R F+++E AGG+L S++R P Q +
Sbjct: 83 EALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDL 142
Query: 70 -KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ + G + L +H IHRD+ N LL+ + KI DFG++ +Y +Y K
Sbjct: 143 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKG 202
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLVRNINSCK 184
+ L +M PE + K D WS G +L+E+ GY P+ ++N +++ + S
Sbjct: 203 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 262
Query: 185 HLPFSQLIVPALHPDCVDMCLKLL----SANTVDRLSFNEFYHH-RFLRRNSAILRAPFH 239
+ P +C +++ DR +F + ++ ++
Sbjct: 263 RMD-----PP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 314
Query: 240 IP 241
I
Sbjct: 315 IE 316
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327 | Back alignment and structure |
|---|
Score = 123 bits (312), Expect = 4e-34
Identities = 46/177 (25%), Positives = 81/177 (45%), Gaps = 9/177 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E ++SV++P++ RL + + L+ + G L Y+R H + Q + Q
Sbjct: 67 EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--P 132
+ G+ L ++HRDL N+L+ +KI DFGL+ L G P
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ +MA E + + Y + D+WS G ++EL+ G P+ G ++ + + LP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298 | Back alignment and structure |
|---|
Score = 123 bits (310), Expect = 5e-34
Identities = 52/180 (28%), Positives = 84/180 (46%), Gaps = 11/180 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
E + +NHPN++ L E +++ + G+L +IR R P + F
Sbjct: 72 EGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGL 131
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 131
Q+ G+E L +HRDL N +L + +K+ADFGL+ + Y ++ +
Sbjct: 132 QVARGMEYLAEQKFVHRDLAARNCMLD---ESFTVKVADFGLARDILDREYYSVQQHRHA 188
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
L + A E LQ R+ K D+WS G +L+ELL G PP+ + L + + LP
Sbjct: 189 RLPVKWTALESLQTYRFTTKSDVWSFGVLLWELLTRGAPPYRHIDPFDLTHFLAQGRRLP 248
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367 | Back alignment and structure |
|---|
Score = 124 bits (312), Expect = 8e-34
Identities = 57/242 (23%), Positives = 100/242 (41%), Gaps = 24/242 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
E +S NH NI+R F+++E AGG+L S++R P Q +
Sbjct: 124 EALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDL 183
Query: 70 -KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128
+ + G + L +H IHRD+ N LL+ + KI DFG++ +Y Y K
Sbjct: 184 LHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKG 243
Query: 129 CGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLVRNINSCK 184
+ L +M PE + K D WS G +L+E+ GY P+ ++N +++ + S
Sbjct: 244 GCAMLPVKWMPPEAFMEGIFTSKTDTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGG 303
Query: 185 HLPFSQLIVPALHPDCVDMCLKLL----SANTVDRLSFNEFYHH-RFLRRNSAILRAPFH 239
+ P +C +++ DR +F + ++ ++
Sbjct: 304 RMD-----PP---KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCTQDPDVINTALP 355
Query: 240 IP 241
I
Sbjct: 356 IE 357
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373 | Back alignment and structure |
|---|
Score = 123 bits (311), Expect = 1e-33
Identities = 51/180 (28%), Positives = 87/180 (48%), Gaps = 11/180 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVP-EQTARKFLQ 73
E + +HPN++ L ++E +V+ + G+L ++IR P + F
Sbjct: 140 EGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGL 199
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGS 131
Q+ G++ L S +HRDL N +L + + K+ADFGL+ +Y + G+
Sbjct: 200 QVAKGMKFLASKKFVHRDLAARNCMLD--EKFTV-KVADFGLARDMYDKEFDSVHNKTGA 256
Query: 132 PL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
L +MA E LQ Q++ K D+WS G +L+EL+ G PP+ N + + + L
Sbjct: 257 KLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYLLQGRRLL 316
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 1e-33
Identities = 42/184 (22%), Positives = 74/184 (40%), Gaps = 27/184 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
EL + H NI+ + + ++L+ + G+L Y++L + + +
Sbjct: 52 ELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQLT-TLDTVSCLRI 110
Query: 72 LQQLGAGLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ + +GL L+ I HRDLK +NIL + + IAD GL+
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNIL---VKKNGQCCIADLGLAVMHSQST 167
Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
V G+ YMAPEVL ++VD+W+ G +L+E+
Sbjct: 168 NQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVE 227
Query: 173 NVQL 176
+ +
Sbjct: 228 DYKP 231
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-33
Identities = 52/197 (26%), Positives = 93/197 (47%), Gaps = 20/197 (10%)
Query: 1 MLKKLNKHLKSCLD--CELNFLSSVNHPNIIRLF-----DAFQAENCIFLVVEFCAGGNL 53
+K N + + E + +HPN+IRL + Q +++ F G+L
Sbjct: 69 TMKLDNSSQREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDL 128
Query: 54 SSYIRLH------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
+Y+ +P QT KF+ + G+E L++ + +HRDL N +L DD +
Sbjct: 129 HTYLLYSRLETGPKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLR--DDMTV 186
Query: 108 LKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163
+ADFGLS +Y G+Y + + + ++A E L + Y K D+W+ G ++E+
Sbjct: 187 -CVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR 245
Query: 164 GYPPFSGRNNVQLVRNI 180
G P+ G N ++ +
Sbjct: 246 GMTPYPGVQNHEMYDYL 262
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-33
Identities = 47/182 (25%), Positives = 87/182 (47%), Gaps = 21/182 (11%)
Query: 16 ELNFLSSVNHPNIIRLF------DAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
E + +HP++ +L A +++ F G+L +++ R+ E
Sbjct: 75 EAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLAS-RIGENPFN 133
Query: 70 -------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
+F+ + G+E L+S + IHRDL N +L+ +D + +ADFGLS +Y G
Sbjct: 134 LPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLA--EDMTV-CVADFGLSRKIYSG 190
Query: 123 NYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVR 178
+Y + C S L ++A E L Y D+W+ G ++E++ G P++G N ++
Sbjct: 191 DYYRQGCASKLPVKWLALESLADNLYTVHSDVWAFGVTMWEIMTRGQTPYAGIENAEIYN 250
Query: 179 NI 180
+
Sbjct: 251 YL 252
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322 | Back alignment and structure |
|---|
Score = 122 bits (307), Expect = 2e-33
Identities = 44/186 (23%), Positives = 83/186 (44%), Gaps = 17/186 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR------ 69
E + + N +++RL +++E G+L SY+R
Sbjct: 78 EASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSL 137
Query: 70 ----KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA 125
+ ++ G+ LN++ +HRDL N +++ +D +KI DFG++ +Y +Y
Sbjct: 138 SKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVA---EDFTVKIGDFGMTRDIYETDYY 194
Query: 126 EKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNIN 181
K L +M+PE L+ + D+WS G +L+E+ P+ G +N Q++R +
Sbjct: 195 RKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATLAEQPYQGLSNEQVLRFVM 254
Query: 182 SCKHLP 187
L
Sbjct: 255 EGGLLD 260
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325 | Back alignment and structure |
|---|
Score = 121 bits (305), Expect = 4e-33
Identities = 44/177 (24%), Positives = 86/177 (48%), Gaps = 9/177 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
+ + S++H +I+RL + + LV ++ G+L ++R H G + Q + Q
Sbjct: 65 HMLAIGSLDHAHIVRLL-GLCPGSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQ 123
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L H ++HR+L N+LL +++ADFG++ L P + +
Sbjct: 124 IAKGMYYLEEHGMVHRNLAARNVLLK---SPSQVQVADFGVADLLPPDDKQLLYSEAKTP 180
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+MA E + F +Y + D+WS G ++EL+ G P++G ++ + + L
Sbjct: 181 IKWMALESIHFGKYTHQSDVWSYGVTVWELMTFGAEPYAGLRLAEVPDLLEKGERLA 237
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278 | Back alignment and structure |
|---|
Score = 119 bits (300), Expect = 8e-33
Identities = 46/177 (25%), Positives = 89/177 (50%), Gaps = 11/177 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFL 72
E + ++ + H N+++L + + +++V E+ A G+L Y+R GR KF
Sbjct: 64 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 123
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+ +E L ++ +HRDL N+L+S +D + K++DFGL+ K+ P
Sbjct: 124 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 177
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ + APE L+ +++ K D+WS G +L+E+ + G P+ +V + +
Sbjct: 178 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 234
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 9e-33
Identities = 45/177 (25%), Positives = 80/177 (45%), Gaps = 9/177 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E ++SV++P++ RL + + L+ + G L Y+R H + Q + Q
Sbjct: 67 EAYVMASVDNPHVCRLL-GICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQ 125
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ G+ L ++HRDL N+L+ +KI DFGL+ L G +
Sbjct: 126 IAKGMNYLEDRRLVHRDLAARNVLVK---TPQHVKITDFGLAKLLGAEEKEYHAEGGKVP 182
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+MA E + + Y + D+WS G ++EL+ G P+ G ++ + + LP
Sbjct: 183 IKWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLP 239
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 1e-32
Identities = 42/184 (22%), Positives = 72/184 (39%), Gaps = 27/184 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ + H NI+ A ++LV ++ G+L Y+ + V + K
Sbjct: 86 EIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKL 144
Query: 72 LQQLGAGLEILNSHH--------IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+GL L+ I HRDLK +NIL+ + IAD GL+
Sbjct: 145 ALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSAT 201
Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
+ G+ YMAPEVL + ++ D++++G + +E+
Sbjct: 202 DTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHE 261
Query: 173 NVQL 176
+ QL
Sbjct: 262 DYQL 265
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 1e-32
Identities = 45/182 (24%), Positives = 82/182 (45%), Gaps = 26/182 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAE--------NCIFLVVEFCAGGNLSSYI-RLHGRVPEQ 66
E+ L + H N++ L + + + I+LV +FC +L+ + + +
Sbjct: 66 EIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLS 124
Query: 67 TARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE 126
++ +Q L GL ++ + I+HRD+K N+L + D +LK+ADFGL+ + + A+
Sbjct: 125 EIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADFGLA-RAF--SLAK 178
Query: 127 KVCGSPL--------YMAPEVL-QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV-QL 176
+ Y PE+L + Y +D+W G I+ E+ P G QL
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238
Query: 177 VR 178
Sbjct: 239 AL 240
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 59/241 (24%), Positives = 99/241 (41%), Gaps = 43/241 (17%)
Query: 24 NHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81
PNII L D + LV E + + + + R ++ ++ L+
Sbjct: 89 GGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKALDY 145
Query: 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVL 140
+S I+HRD+KP N+++ L++ D+GL+ +PG Y +V S + PE+L
Sbjct: 146 CHSMGIMHRDVKPHNVMIDHEHRK--LRLIDWGLAEFYHPGQEYNVRV-ASRYFKGPELL 202
Query: 141 -QFQRYDEKVDMWSVGAILFELLNGYPP-FSGRNNV-QLVR-----------------NI 180
+Q YD +DMWS+G +L ++ P F G +N QLVR NI
Sbjct: 203 VDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNI 262
Query: 181 NSCKHL----------PFSQLI----VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226
+ + + + P+ +D KLL + RL+ E H +
Sbjct: 263 ELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPY 322
Query: 227 L 227
Sbjct: 323 F 323
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 2e-32
Identities = 44/184 (23%), Positives = 72/184 (39%), Gaps = 27/184 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDA----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ + H NI+ A + ++L+ ++ G+L Y++ + ++ K
Sbjct: 81 EIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKST-TLDAKSMLKL 139
Query: 72 LQQLGAGL-----EILNSHH---IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+GL EI ++ I HRDLK +NIL + + IAD GL+
Sbjct: 140 AYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNIL---VKKNGTCCIADLGLAVKFISDT 196
Query: 124 YAEKV-----CGSPLYMAPEVL------QFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
+ G+ YM PEVL + DM+S G IL+E+
Sbjct: 197 NEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVE 256
Query: 173 NVQL 176
QL
Sbjct: 257 EYQL 260
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388 | Back alignment and structure |
|---|
Score = 120 bits (303), Expect = 2e-32
Identities = 71/313 (22%), Positives = 124/313 (39%), Gaps = 86/313 (27%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVN-HPNIIRLFDAFQAENC--IFLVVEFCAGGNL 53
+KK+ ++ D E+ L+ ++ H NI+ L + +A+N ++LV ++ +L
Sbjct: 39 VKKIFDAFQNSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDY-METDL 97
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ IR + + + QL ++ L+S ++HRD+KP NILL + + +K+ADF
Sbjct: 98 HAVIR-ANILEPVHKQYVVYQLIKVIKYLHSGGLLHRDMKPSNILL---NAECHVKVADF 153
Query: 114 GLSCTLYPGNYAEKVCGSPL----------------------YMAPEV-LQFQRYDEKVD 150
GLS + + Y APE+ L +Y + +D
Sbjct: 154 GLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGID 213
Query: 151 MWSVGAILFELLNGYPPFSGRNNV-QL--------------------------VRNINSC 183
MWS+G IL E+L G P F G + + QL + ++
Sbjct: 214 MWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEK 273
Query: 184 KHLPFSQLIV---------------PALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
+ S + + +D+ KLL N R+S N+ H F+
Sbjct: 274 VEIRQSNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFV- 332
Query: 229 RNSAILRAPFHIP 241
+ FH P
Sbjct: 333 -------SIFHNP 338
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450 | Back alignment and structure |
|---|
Score = 120 bits (304), Expect = 4e-32
Identities = 46/177 (25%), Positives = 90/177 (50%), Gaps = 11/177 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFL 72
E + ++ + H N+++L + + +++V E+ A G+L Y+R GR + KF
Sbjct: 236 EASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFS 295
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
+ +E L ++ +HRDL N+L+S +D + K++DFGL+ K+ P
Sbjct: 296 LDVCEAMEYLEGNNFVHRDLAARNVLVS---EDNVAKVSDFGLTKEASSTQDTGKL---P 349
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ + APE L+ +++ K D+WS G +L+E+ + G P+ +V + +
Sbjct: 350 VKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD 406
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377 | Back alignment and structure |
|---|
Score = 119 bits (301), Expect = 4e-32
Identities = 62/203 (30%), Positives = 97/203 (47%), Gaps = 14/203 (6%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEIL 82
+HPNI+RL + I++V+E GG+ +++R G + +T + + AG+E L
Sbjct: 170 SHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYL 229
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEV 139
S IHRDL N L++ + +LKI+DFG+S G YA + + APE
Sbjct: 230 ESKCCIHRDLAARNCLVT---EKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEA 286
Query: 140 LQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHP 198
L + RY + D+WS G +L+E G P+ +N Q + LP P L P
Sbjct: 287 LNYGRYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFVEKGGRLPC-----PELCP 341
Query: 199 DCV-DMCLKLLSANTVDRLSFNE 220
D V + + + R SF+
Sbjct: 342 DAVFRLMEQCWAYEPGQRPSFST 364
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429 | Back alignment and structure |
|---|
Score = 120 bits (302), Expect = 5e-32
Identities = 62/194 (31%), Positives = 85/194 (43%), Gaps = 18/194 (9%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ L K K N N+I + + F N I + E NL I+ +
Sbjct: 146 ILEHLRKQDKD------------NTMNVIHMLENFTFRNHICMTFE-LLSMNLYELIKKN 192
Query: 61 G--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
RKF + L+ L+ + IIH DLKPENILL +K+ DFG SC
Sbjct: 193 KFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQ-QGRSGIKVIDFGSSC- 250
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVR 178
Y S Y APEV+ RY +DMWS+G IL ELL GYP G + +
Sbjct: 251 -YEHQRVYTYIQSRFYRAPEVILGARYGMPIDMWSLGCILAELLTGYPLLPGEDEGDQLA 309
Query: 179 NINSCKHLPFSQLI 192
+ +P +L+
Sbjct: 310 CMIELLGMPSQKLL 323
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 6e-32
Identities = 50/206 (24%), Positives = 93/206 (45%), Gaps = 22/206 (10%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
LK+ ++ + E L+ + H +I+R F + +V E+ G+L+ ++R H
Sbjct: 78 ALKEASESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSH 137
Query: 61 GRVPEQTAR---------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDD 105
G + A Q+ AG+ L H +HRDL N L+
Sbjct: 138 GPDAKLLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVG---QG 194
Query: 106 VMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+++KI DFG+S +Y +Y + L +M PE + ++++ + D+WS G +L+E+
Sbjct: 195 LVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTTESDVWSFGVVLWEIF 254
Query: 163 N-GYPPFSGRNNVQLVRNINSCKHLP 187
G P+ +N + + I + L
Sbjct: 255 TYGKQPWYQLSNTEAIDCITQGRELE 280
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 8e-32
Identities = 47/176 (26%), Positives = 89/176 (50%), Gaps = 7/176 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQ 74
E + ++HP +++ + E I++V E+ + G L +Y+R HG+ + +
Sbjct: 53 EAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYD 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
+ G+ L SH IHRDL N L+ D+ +K++DFG++ + Y V P+
Sbjct: 113 VCEGMAFLESHQFIHRDLAARNCLVD---RDLCVKVSDFGMTRYVLDDQYVSSVGTKFPV 169
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ APEV + +Y K D+W+ G +++E+ + G P+ N ++V ++ L
Sbjct: 170 KWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLGKMPYDLYTNSEVVLKVSQGHRLY 225
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288 | Back alignment and structure |
|---|
Score = 116 bits (294), Expect = 8e-32
Identities = 48/178 (26%), Positives = 83/178 (46%), Gaps = 10/178 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E + + HPN+++L E +++ EF GNL Y+R R
Sbjct: 59 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 118
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ + +E L + IHRDL N L+ ++ ++K+ADFGLS L G+ G+
Sbjct: 119 QISSAMEYLEKKNFIHRDLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 174
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ APE L + ++ K D+W+ G +L+E+ G P+ G + Q+ + +
Sbjct: 175 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 232
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-31
Identities = 50/176 (28%), Positives = 89/176 (50%), Gaps = 7/176 (3%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + ++HP +++L+ + I LV EF G LS Y+R G +T
Sbjct: 53 EAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLD 112
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-PL 133
+ G+ L +IHRDL N L+ ++ ++K++DFG++ + Y P+
Sbjct: 113 VCEGMAYLEEACVIHRDLAARNCLVG---ENQVIKVSDFGMTRFVLDDQYTSSTGTKFPV 169
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ +PEV F RY K D+WS G +++E+ + G P+ R+N ++V +I++ L
Sbjct: 170 KWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDISTGFRLY 225
|
| >3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 1e-31
Identities = 52/208 (25%), Positives = 100/208 (48%), Gaps = 24/208 (11%)
Query: 1 MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
LK L+ E + + HPN++ L + + ++ +C+ G+L ++ +
Sbjct: 46 TLKDKAEGPLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVM 105
Query: 60 HGRVPEQTAR----------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
+ + + Q+ AG+E L+SHH++H+DL N+L+
Sbjct: 106 RSPHSDVGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVY--- 162
Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFE 160
D + +KI+D GL +Y +Y + + S L +MAPE + + ++ D+WS G +L+E
Sbjct: 163 DKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSIDSDIWSYGVVLWE 222
Query: 161 LLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ + G P+ G +N +V I + + LP
Sbjct: 223 VFSYGLQPYCGYSNQDVVEMIRNRQVLP 250
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 2e-31
Identities = 48/189 (25%), Positives = 86/189 (45%), Gaps = 20/189 (10%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC----IFLVVEFCAGGNLSSY 56
+L+++N + D +I++L D F + + +V E G NL +
Sbjct: 68 LLQRVNDADNTKEDSM-------GANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLAL 119
Query: 57 IRL--HGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGLDD---DVMLKI 110
I+ H +P ++ +QL GL+ ++ IIH D+KPEN+L+ +D + +KI
Sbjct: 120 IKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKI 179
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
AD G +C + + + Y +PEVL + D+WS ++FEL+ G F
Sbjct: 180 ADLGNAC--WYDEHYTNSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEP 237
Query: 171 RNNVQLVRN 179
++
Sbjct: 238 DEGHSYTKD 246
|
| >3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-31
Identities = 48/207 (23%), Positives = 93/207 (44%), Gaps = 23/207 (11%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
LK + E L+++ H +I++ + + + +V E+ G+L+ ++R H
Sbjct: 52 ALKDPTLAARKDFQREAELLTNLQHEHIVKFYGVCGDGDPLIMVFEYMKHGDLNKFLRAH 111
Query: 61 GRVPEQTAR----------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD 104
G Q+ +G+ L S H +HRDL N L+
Sbjct: 112 GPDAMILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVG---A 168
Query: 105 DVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFEL 161
++++KI DFG+S +Y +Y + L +M PE + ++++ + D+WS G IL+E+
Sbjct: 169 NLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTESDVWSFGVILWEI 228
Query: 162 LN-GYPPFSGRNNVQLVRNINSCKHLP 187
G P+ +N +++ I + L
Sbjct: 229 FTYGKQPWFQLSNTEVIECITQGRVLE 255
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279 | Back alignment and structure |
|---|
Score = 115 bits (290), Expect = 3e-31
Identities = 46/178 (25%), Positives = 88/178 (49%), Gaps = 11/178 (6%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E N + + H ++RL+ A + I+++ E+ G+L +++ + +
Sbjct: 58 EANLMKQLQHQRLVRLY-AVVTQEPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAA 116
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ G+ + + IHRDL+ NIL+S D + KIADFGL+ + Y + G+
Sbjct: 117 QIAEGMAFIEERNYIHRDLRAANILVS---DTLSCKIADFGLARLIEDNEYTARE-GAKF 172
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ APE + + + K D+WS G +L E++ G P+ G N ++++N+ +
Sbjct: 173 PIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV 230
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452 | Back alignment and structure |
|---|
Score = 117 bits (296), Expect = 4e-31
Identities = 43/177 (24%), Positives = 87/177 (49%), Gaps = 9/177 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E + + H +++L+ E I++V E+ + G+L +++ + +
Sbjct: 229 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 287
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+ + Y + P
Sbjct: 288 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 344
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ + APE + R+ K D+WS G +L EL G P+ G N +++ + +P
Sbjct: 345 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 401
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535 | Back alignment and structure |
|---|
Score = 118 bits (298), Expect = 5e-31
Identities = 43/177 (24%), Positives = 87/177 (49%), Gaps = 9/177 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E + + H +++L+ E I++V E+ + G+L +++ + +
Sbjct: 312 EAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAA 370
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+ + Y + P
Sbjct: 371 QIASGMAYVERMNYVHRDLRAANILVG---ENLVCKVADFGLARLIEDNEYTARQGAKFP 427
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ + APE + R+ K D+WS G +L EL G P+ G N +++ + +P
Sbjct: 428 IKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQVERGYRMP 484
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382 | Back alignment and structure |
|---|
Score = 116 bits (293), Expect = 5e-31
Identities = 66/196 (33%), Positives = 85/196 (43%), Gaps = 20/196 (10%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ +NKH I+ L F N + LV E NL +R
Sbjct: 103 LLELMNKHDTE------------MKYYIVHLKRHFMFRNHLCLVFE-MLSYNLYDLLRNT 149
Query: 61 GRVP--EQTARKFLQQLGAGLEILNSH--HIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
RKF QQ+ L L + IIH DLKPENILL +KI DFG S
Sbjct: 150 NFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSS 208
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
C G + S Y +PEVL YD +DMWS+G IL E+ G P FSG N V
Sbjct: 209 C--QLGQRIYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCILVEMHTGEPLFSGANEVDQ 266
Query: 177 VRNINSCKHLPFSQLI 192
+ I +P + ++
Sbjct: 267 MNKIVEVLGIPPAHIL 282
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495 | Back alignment and structure |
|---|
Score = 118 bits (297), Expect = 5e-31
Identities = 48/178 (26%), Positives = 84/178 (47%), Gaps = 10/178 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQ 73
E + + HPN+++L E +++ EF GNL Y+R R V
Sbjct: 266 EAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMAT 325
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133
Q+ + +E L + IHR+L N L+ ++ ++K+ADFGLS L G+ G+
Sbjct: 326 QISSAMEYLEKKNFIHRNLAARNCLVG---ENHLVKVADFGLS-RLMTGDTYTAHAGAKF 381
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLVRNINSCKHLP 187
+ APE L + ++ K D+W+ G +L+E+ G P+ G + Q+ + +
Sbjct: 382 PIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQVYELLEKDYRME 439
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 9e-31
Identities = 46/177 (25%), Positives = 80/177 (45%), Gaps = 26/177 (14%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ L + H NI++ A + + +L+ F G+LS +++ + V
Sbjct: 68 EVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKAN-VVSWNELCHI 126
Query: 72 LQQLGAGLEILNSH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ + GL L+ I HRD+K +N+L L +++ IADFGL+
Sbjct: 127 AETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVL---LKNNLTACIADFGLALKFEA 183
Query: 122 GNYAEK---VCGSPLYMAPEVLQF-----QRYDEKVDMWSVGAILFELLNGYPPFSG 170
G A G+ YMAPEVL+ + ++DM+++G +L+EL + G
Sbjct: 184 GKSAGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAADG 240
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291 | Back alignment and structure |
|---|
Score = 113 bits (286), Expect = 1e-30
Identities = 47/177 (26%), Positives = 89/177 (50%), Gaps = 9/177 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E N + +++P I+R+ +AE+ LV+E G L+ Y++ + V ++ + + Q+
Sbjct: 68 EANVMQQLDNPYIVRMIGICEAES-WMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQV 126
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGS--P 132
G++ L + +HRDL N+LL KI+DFGLS L NY + P
Sbjct: 127 SMGMKYLEESNFVHRDLAARNVLLV---TQHYAKISDFGLSKALRADENYYKAQTHGKWP 183
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ + APE + + ++ K D+WS G +++E + G P+ G ++ + + +
Sbjct: 184 VKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLEKGERMG 240
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283 | Back alignment and structure |
|---|
Score = 113 bits (285), Expect = 1e-30
Identities = 49/191 (25%), Positives = 91/191 (47%), Gaps = 13/191 (6%)
Query: 7 KHLKSCLDCELNFLS------SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
K +K E F+ +++H +++L+ + IF++ E+ A G L +Y+R
Sbjct: 54 KMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREM 113
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
R Q + + + +E L S +HRDL N L++ D ++K++DFGLS +
Sbjct: 114 RHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVN---DQGVVKVSDFGLSRYV 170
Query: 120 YPGNYAEKVCGS-PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL 176
Y V P+ + PEVL + ++ K D+W+ G +++E+ + G P+ N +
Sbjct: 171 LDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSET 230
Query: 177 VRNINSCKHLP 187
+I L
Sbjct: 231 AEHIAQGLRLY 241
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 2e-30
Identities = 49/177 (27%), Positives = 91/177 (51%), Gaps = 9/177 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR--KFLQ 73
E N + ++ H +++L A + I+++ EF A G+L +++ + + F
Sbjct: 233 EANVMKTLQHDKLVKLH-AVVTKEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSA 291
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS-P 132
Q+ G+ + + IHRDL+ NIL+S ++ KIADFGL+ + Y + P
Sbjct: 292 QIAEGMAFIEQRNYIHRDLRAANILVS---ASLVCKIADFGLARVIEDNEYTAREGAKFP 348
Query: 133 L-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ + APE + F + K D+WS G +L E++ G P+ G +N +++R + +P
Sbjct: 349 IKWTAPEAINFGSFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRALERGYRMP 405
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281 | Back alignment and structure |
|---|
Score = 113 bits (284), Expect = 2e-30
Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 8/176 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +HP+I++L +++++E C G L S++++ + + + Q
Sbjct: 66 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 124
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 133
L L L S +HRD+ N+L+S + +K+ DFGLS + Y + G P+
Sbjct: 125 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 181
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+MAPE + F+R+ D+W G ++E+L G PF G N ++ I + + LP
Sbjct: 182 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 237
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656 | Back alignment and structure |
|---|
Score = 116 bits (292), Expect = 5e-30
Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 8/176 (4%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +HP+I++L +++++E C G L S++++ + + + Q
Sbjct: 441 EALTMRQFDHPHIVKLIGVITENP-VWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQ 499
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-SPL 133
L L L S +HRD+ N+L+S + +K+ DFGLS + Y + G P+
Sbjct: 500 LSTALAYLESKRFVHRDIAARNVLVS---SNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 556
Query: 134 -YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+MAPE + F+R+ D+W G ++E+L G PF G N ++ I + + LP
Sbjct: 557 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLP 612
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325 | Back alignment and structure |
|---|
Score = 112 bits (283), Expect = 6e-30
Identities = 50/178 (28%), Positives = 87/178 (48%), Gaps = 9/178 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + + +HPNIIRL +V E+ G+L +++R H G+ L+
Sbjct: 100 EASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRG 159
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGS--- 131
+GAG+ L+ +HRDL N+L+ +++ K++DFGLS L A
Sbjct: 160 VGAGMRYLSDLGYVHRDLAARNVLVD---SNLVCKVSDFGLSRVLEDDPDAAYTTTGGKI 216
Query: 132 PL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
P+ + APE + F+ + D+WS G +++E+L G P+ N ++ ++ LP
Sbjct: 217 PIRWTAPEAIAFRTFSSASDVWSFGVVMWEVLAYGERPYWNMTNRDVISSVEEGYRLP 274
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287 | Back alignment and structure |
|---|
Score = 111 bits (281), Expect = 6e-30
Identities = 46/178 (25%), Positives = 81/178 (45%), Gaps = 10/178 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +++P I+RL + LV+E GG L ++ +P + L Q
Sbjct: 60 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 118
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
+ G++ L + +HRDL N+LL + KI+DFGLS L +Y
Sbjct: 119 VSMGMKYLEEKNFVHRDLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 175
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ APE + F+++ + D+WS G ++E L+ G P+ +++ I K +
Sbjct: 176 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 233
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432 | Back alignment and structure |
|---|
Score = 114 bits (288), Expect = 6e-30
Identities = 54/206 (26%), Positives = 86/206 (41%), Gaps = 38/206 (18%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK+N+ + +DC E+ L+ + IIRL+D ++ +++V+E A
Sbjct: 56 IKKVNRMFEDLIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEI-ADS 114
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L + + E+ + L L G ++ IIHRDLKP N L L+ D +K+
Sbjct: 115 DLKKLFKTPIFLTEEHIKTILYNLLLGENFIHESGIIHRDLKPANCL---LNQDCSVKVC 171
Query: 112 DFGLSCTLYPGNYAEKVCGSPL-----------------------YMAPEV-LQFQRYDE 147
DFGL+ T+ V Y APE+ L + Y +
Sbjct: 172 DFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTK 231
Query: 148 KVDMWSVGAILFELLNGYPPFSGRNN 173
+D+WS G I ELLN
Sbjct: 232 SIDIWSTGCIFAELLNMLQSHINDPT 257
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 8e-30
Identities = 44/177 (24%), Positives = 85/177 (48%), Gaps = 10/177 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +++HP+I++L + E ++++E G L Y+ + + T + Q
Sbjct: 63 EAVIMKNLDHPHIVKLIGIIEEEP-TWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQ 121
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL- 133
+ + L S + +HRD+ NIL++ +K+ DFGLS + +Y K + L
Sbjct: 122 ICKAMAYLESINCVHRDIAVRNILVA---SPECVKLGDFGLSRYIEDEDY-YKASVTRLP 177
Query: 134 --YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+M+PE + F+R+ D+W ++E+L+ G PF N ++ + LP
Sbjct: 178 IKWMSPESINFRRFTTASDVWMFAVCMWEILSFGKQPFFWLENKDVIGVLEKGDRLP 234
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458 | Back alignment and structure |
|---|
Score = 114 bits (287), Expect = 8e-30
Identities = 67/337 (19%), Positives = 116/337 (34%), Gaps = 110/337 (32%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGG 51
+KK+ + + +DC E+ L+ +NH +++++ D ++ +++V+E A
Sbjct: 83 IKKILRVFEDLIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEI-ADS 141
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+ R + E + L L G++ ++S I+HRDLKP N L ++ D +K+
Sbjct: 142 DFKKLFRTPVYLTELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCL---VNQDCSVKVC 198
Query: 112 DFGLSCTLYPGNYAEKVCGSPL----------------------------YMAPEV-LQF 142
DFGL+ T+ Y APE+ L
Sbjct: 199 DFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQ 258
Query: 143 QRYDEKVDMWSVGAILFELLN-----------GYPPFSGRNNV----------------- 174
+ Y E +D+WS+G I ELLN P F G +
Sbjct: 259 ENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTR 318
Query: 175 ----QL--------------------------VRNINSCKHLPFSQLIVPALHPDCVDMC 204
QL +R + ++ PA D + +
Sbjct: 319 GNRDQLNVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAER-FPASSADAIHLL 377
Query: 205 LKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFHIP 241
++L N R++ NE H F I
Sbjct: 378 KRMLVFNPNKRITINECLAHPFF--------KEVRIA 406
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291 | Back alignment and structure |
|---|
Score = 111 bits (279), Expect = 1e-29
Identities = 50/171 (29%), Positives = 80/171 (46%), Gaps = 10/171 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E+N + S++H N+IRL+ + +V E G+L +R H G T ++ Q
Sbjct: 71 EVNAMHSLDHRNLIRLY-GVVLTPPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQ 129
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
+ G+ L S IHRDL N+LL+ ++KI DFGL L ++ +
Sbjct: 130 VAEGMGYLESKRFIHRDLAARNLLLA---TRDLVKIGDFGLMRALPQNDDHYVMQEHRKV 186
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNI 180
+ APE L+ + + D W G L+E+ G P+ G N Q++ I
Sbjct: 187 PFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 237
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 53/193 (27%), Positives = 88/193 (45%), Gaps = 31/193 (16%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ--------- 66
E N L VNHP++I+L+ A + + L+VE+ G+L ++R +V
Sbjct: 76 EFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRN 135
Query: 67 ------------TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
T + Q+ G++ L ++HRDL NIL++ + M KI+
Sbjct: 136 SSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVA--EGRKM-KIS 192
Query: 112 DFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPP 167
DFGLS +Y + K + +MA E L Y + D+WS G +L+E++ G P
Sbjct: 193 DFGLSRDVYEEDSYVKRSQGRIPVKWMAIESLFDHIYTTQSDVWSFGVLLWEIVTLGGNP 252
Query: 168 FSGRNNVQLVRNI 180
+ G +L +
Sbjct: 253 YPGIPPERLFNLL 265
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333 | Back alignment and structure |
|---|
Score = 111 bits (280), Expect = 2e-29
Identities = 47/178 (26%), Positives = 88/178 (49%), Gaps = 9/178 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +H NIIRL + ++ E+ G L ++R G L+
Sbjct: 96 EAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRG 155
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC-GSPL 133
+ AG++ L + + +HRDL NIL++ +++ K++DFGLS L A G +
Sbjct: 156 IAAGMKYLANMNYVHRDLAARNILVN---SNLVCKVSDFGLSRVLEDDPEATYTTSGGKI 212
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ APE + ++++ D+WS G +++E++ G P+ +N ++++ IN LP
Sbjct: 213 PIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAINDGFRLP 270
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373 | Back alignment and structure |
|---|
Score = 112 bits (281), Expect = 3e-29
Identities = 46/179 (25%), Positives = 91/179 (50%), Gaps = 9/179 (5%)
Query: 15 CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQ 73
E + + +HPNIIRL + +V E+ G+L S++R H + L+
Sbjct: 95 GEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLR 154
Query: 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV-CGSP 132
+ +G++ L+ +HRDL NIL++ +++ K++DFGL L A G
Sbjct: 155 GIASGMKYLSDMGYVHRDLAARNILIN---SNLVCKVSDFGLGRVLEDDPEAAYTTRGGK 211
Query: 133 L---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ + +PE + ++++ D+WS G +L+E+++ G P+ +N +++ ++ LP
Sbjct: 212 IPIRWTSPEAIAYRKFTSASDVWSYGIVLWEVMSYGERPYWEMSNQDVIKAVDEGYRLP 270
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333 | Back alignment and structure |
|---|
Score = 110 bits (278), Expect = 4e-29
Identities = 51/185 (27%), Positives = 87/185 (47%), Gaps = 23/185 (12%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
EL +S + H NI+ L A + ++ E+C G+L +++R RV E
Sbjct: 99 ELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIAN 158
Query: 67 ---TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+ R L Q+ G+ L S + IHRD+ N+LL+ + + KI DFGL+ +
Sbjct: 159 STASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLT---NGHVAKIGDFGLARDIM 215
Query: 121 PGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG-RNNVQ 175
+ + L +MAPE + Y + D+WS G +L+E+ + G P+ G N +
Sbjct: 216 NDSNYIVKGNARLPVKWMAPESIFDCVYTVQSDVWSYGILLWEIFSLGLNPYPGILVNSK 275
Query: 176 LVRNI 180
+ +
Sbjct: 276 FYKLV 280
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 5e-29
Identities = 52/195 (26%), Positives = 83/195 (42%), Gaps = 25/195 (12%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
E+ L ++ H NI++ N I L++EF G+L Y+ + ++ + K+
Sbjct: 72 KEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKY 131
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
Q+ G++ L S +HRDL N+L+ + +KI DFGL+ + Y K
Sbjct: 132 AVQICKGMDYLGSRQYVHRDLAARNVLVE---SEHQVKIGDFGLTKAIETDKEYYTVKDD 188
Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL---------------NGYPPFSGRN 172
SP+ + APE L ++ D+WS G L ELL P
Sbjct: 189 RDSPVFWYAPECLMQSKFYIASDVWSFGVTLHELLTYCDSDSSPMALFLKMIGPTHGQMT 248
Query: 173 NVQLVRNINSCKHLP 187
+LV + K LP
Sbjct: 249 VTRLVNTLKEGKRLP 263
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355 | Back alignment and structure |
|---|
Score = 110 bits (277), Expect = 6e-29
Identities = 55/286 (19%), Positives = 96/286 (33%), Gaps = 72/286 (25%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+LKK+ + K N + + D F + + E G N +++ +
Sbjct: 69 VLKKIKEKDKE------------NKFLCVLMSDWFNFHGHMCIAFE-LLGKNTFEFLKEN 115
Query: 61 GRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM----------- 107
P R QL L L+ + + H DLKPENIL + + +
Sbjct: 116 NFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKS 175
Query: 108 -----LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+++ADFG + + + + + Y PEV+ + + D+WS+G ILFE
Sbjct: 176 VKNTSIRVADFGSAT--FDHEHHTTIVATRHYRPPEVILELGWAQPCDVWSIGCILFEYY 233
Query: 163 NGYPPFSGRNNVQLVRNI---------------------------------------NSC 183
G+ F N + + + +C
Sbjct: 234 RGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENC 293
Query: 184 KHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
K L L H D+ ++L + R++ E H F
Sbjct: 294 KPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG 339
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316 | Back alignment and structure |
|---|
Score = 109 bits (275), Expect = 8e-29
Identities = 56/188 (29%), Positives = 90/188 (47%), Gaps = 26/188 (13%)
Query: 16 ELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYIRLH------------- 60
EL L + +H N++ L A + + ++VEFC GNLS+Y+R
Sbjct: 80 ELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPED 139
Query: 61 GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
T + Q+ G+E L S IHRDL NILLS + ++KI DFGL+
Sbjct: 140 LYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLAR 196
Query: 118 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG-RN 172
+Y + + L +MAPE + + Y + D+WS G +L+E+ + G P+ G +
Sbjct: 197 DIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKI 256
Query: 173 NVQLVRNI 180
+ + R +
Sbjct: 257 DEEFCRRL 264
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 2e-28
Identities = 51/196 (26%), Positives = 84/196 (42%), Gaps = 26/196 (13%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
E+ L S+ H NI++ + L++E+ G+L Y++ H R+ ++
Sbjct: 60 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 119
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
Q+ G+E L + IHRDL NIL+ ++ +KI DFGL+ L + K
Sbjct: 120 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEFFKVKEP 176
Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----------------NGYPPFSGR 171
G SP+ + APE L ++ D+WS G +L+EL G
Sbjct: 177 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 236
Query: 172 NNVQLVRNINSCKHLP 187
L+ + + LP
Sbjct: 237 IVFHLIELLKNNGRLP 252
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289 | Back alignment and structure |
|---|
Score = 107 bits (270), Expect = 2e-28
Identities = 40/196 (20%), Positives = 91/196 (46%), Gaps = 13/196 (6%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L K +++ + +S ++H +++ + + LV EF G+L +Y++ +
Sbjct: 47 VLDKAHRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKN 106
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD-----DDVMLKIADFG 114
+ + +QL A + L + +IH ++ +NILL + + +K++D G
Sbjct: 107 KNCINILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPG 166
Query: 115 LSCTLYPGNYAEKVCGSPL-YMAPEVLQ-FQRYDEKVDMWSVGAILFELL-NGYPPFSGR 171
+S T+ P + ++ + ++ PE ++ + + D WS G L+E+ G P S
Sbjct: 167 ISITVLPKDILQE----RIPWVPPECIENPKNLNLATDKWSFGTTLWEICSGGDKPLSAL 222
Query: 172 NNVQLVRNINSCKHLP 187
++ + ++ LP
Sbjct: 223 DSQRKLQFYEDRHQLP 238
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343 | Back alignment and structure |
|---|
Score = 108 bits (273), Expect = 3e-28
Identities = 49/216 (22%), Positives = 97/216 (44%), Gaps = 32/216 (14%)
Query: 1 MLKK-LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
MLK+ + +++ E ++ ++PNI++L + L+ E+ A G+L+ ++R
Sbjct: 84 MLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRS 143
Query: 60 HGRVPEQTAR------------------------KFLQQLGAGLEILNSHHIIHRDLKPE 95
+ +Q+ AG+ L+ +HRDL
Sbjct: 144 MSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATR 203
Query: 96 NILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMW 152
N L+ ++ V+ KIADFGLS +Y +Y + + +M PE + + RY + D+W
Sbjct: 204 NCLVG--ENMVV-KIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESDVW 260
Query: 153 SVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ G +L+E+ + G P+ G + +++ + L
Sbjct: 261 AYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA 296
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339 | Back alignment and structure |
|---|
Score = 108 bits (272), Expect = 3e-28
Identities = 43/198 (21%), Positives = 81/198 (40%), Gaps = 33/198 (16%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+L+ LN + + +++ + F+ I +V E G + +I+ +
Sbjct: 64 VLEHLNTTDPN------------STFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKEN 110
Query: 61 GRV--PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL----------------SGL 102
G + RK Q+ + L+S+ + H DLKPENIL
Sbjct: 111 GFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERT 170
Query: 103 DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162
+ +K+ DFG + Y + + + Y APEV+ + + D+WS+G IL E
Sbjct: 171 LINPDIKVVDFGSAT--YDDEHHSTLVSTRHYRAPEVILALGWSQPCDVWSIGCILIEYY 228
Query: 163 NGYPPFSGRNNVQLVRNI 180
G+ F ++ + + +
Sbjct: 229 LGFTVFPTHDSKEHLAMM 246
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 3e-28
Identities = 52/194 (26%), Positives = 87/194 (44%), Gaps = 25/194 (12%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFL 72
E++ L ++ H +II+ + LV+E+ G+L Y+ H + F
Sbjct: 82 QEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFA 140
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCG-- 130
QQ+ G+ L++ H IHRDL N+LL +D ++KI DFGL+ + G+ +V
Sbjct: 141 QQICEGMAYLHAQHYIHRDLAARNVLLD---NDRLVKIGDFGLAKAVPEGHEYYRVREDG 197
Query: 131 -SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL---------------NGYPPFSGRNN 173
SP+ + APE L+ ++ D+WS G L+ELL
Sbjct: 198 DSPVFWYAPECLKEYKFYYASDVWSFGVTLYELLTHCDSSQSPPTKFLELIGIAQGQMTV 257
Query: 174 VQLVRNINSCKHLP 187
++L + + LP
Sbjct: 258 LRLTELLERGERLP 271
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613 | Back alignment and structure |
|---|
Score = 111 bits (278), Expect = 4e-28
Identities = 45/178 (25%), Positives = 81/178 (45%), Gaps = 10/178 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQ 74
E + +++P I+RL + LV+E GG L ++ +P + L Q
Sbjct: 386 EAQIMHQLDNPYIVRLI-GVCQAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQ 444
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPL 133
+ G++ L + +HR+L N+LL + KI+DFGLS L +Y
Sbjct: 445 VSMGMKYLEEKNFVHRNLAARNVLLV---NRHYAKISDFGLSKALGADDSYYTARSAGKW 501
Query: 134 ---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLP 187
+ APE + F+++ + D+WS G ++E L+ G P+ +++ I K +
Sbjct: 502 PLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFIEQGKRME 559
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326 | Back alignment and structure |
|---|
Score = 108 bits (271), Expect = 4e-28
Identities = 52/196 (26%), Positives = 84/196 (42%), Gaps = 26/196 (13%)
Query: 15 CELNFLSSVNHPNIIRLFDA--FQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKF 71
E+ L S+ H NI++ + L++E+ G+L Y++ H R+ ++
Sbjct: 91 REIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQY 150
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVC 129
Q+ G+E L + IHRDL NIL+ ++ +KI DFGL+ L Y K
Sbjct: 151 TSQICKGMEYLGTKRYIHRDLATRNILVE---NENRVKIGDFGLTKVLPQDKEYYKVKEP 207
Query: 130 G-SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELL----------------NGYPPFSGR 171
G SP+ + APE L ++ D+WS G +L+EL G
Sbjct: 208 GESPIFWYAPESLTESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGNDKQGQM 267
Query: 172 NNVQLVRNINSCKHLP 187
L+ + + LP
Sbjct: 268 IVFHLIELLKNNGRLP 283
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 6e-28
Identities = 47/195 (24%), Positives = 74/195 (37%), Gaps = 37/195 (18%)
Query: 15 CELNFLSSVNHPNIIRLFDA-----FQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR 69
+ + + H NI R LV+E+ G+L Y+ LH ++
Sbjct: 56 KNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSC 114
Query: 70 KFLQQLGAGL-----EILNSHH----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+ + GL E+ H I HRDL N+L + +D I+DFGLS L
Sbjct: 115 RLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVL---VKNDGTCVISDFGLSMRLT 171
Query: 121 PGNYAEK---------VCGSPLYMAPEVLQ-------FQRYDEKVDMWSVGAILFELLNG 164
G+ YMAPEVL+ + ++VDM+++G I +E+
Sbjct: 172 GNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMR 231
Query: 165 ---YPPFSGRNNVQL 176
P Q+
Sbjct: 232 CTDLFPGESVPEYQM 246
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334 | Back alignment and structure |
|---|
Score = 106 bits (268), Expect = 9e-28
Identities = 53/193 (27%), Positives = 92/193 (47%), Gaps = 24/193 (12%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
E+ + + H NII L A + ++++VE+ + GNL Y+R +
Sbjct: 90 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 149
Query: 67 -----TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
T + + QL G+E L S IHRDL N+L++ ++ ++KIADFGL+
Sbjct: 150 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT---ENNVMKIADFGLARD 206
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
+ +Y +K L +MAPE L + Y + D+WS G +++E+ G P+ G
Sbjct: 207 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 266
Query: 175 QLVRNINSCKHLP 187
+L + + +
Sbjct: 267 ELFKLLKEGHRMD 279
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370 | Back alignment and structure |
|---|
Score = 107 bits (269), Expect = 1e-27
Identities = 54/193 (27%), Positives = 91/193 (47%), Gaps = 24/193 (12%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR----- 69
E+ + + H NII L A + ++++VE+ + GNL Y+R + +
Sbjct: 136 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRV 195
Query: 70 -----------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
QL G+E L S IHRDL N+L++ +++VM KIADFGL+
Sbjct: 196 PEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVT--ENNVM-KIADFGLARD 252
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
+ +Y +K L +MAPE L + Y + D+WS G +++E+ G P+ G
Sbjct: 253 INNIDYYKKTTNGRLPVKWMAPEALFDRVYTHQSDVWSFGVLMWEIFTLGGSPYPGIPVE 312
Query: 175 QLVRNINSCKHLP 187
+L + + +
Sbjct: 313 ELFKLLKEGHRMD 325
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 2e-27
Identities = 30/201 (14%), Positives = 58/201 (28%), Gaps = 39/201 (19%)
Query: 20 LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79
LS ++ P + R+ D +V E+ GG+L P R +Q L A
Sbjct: 85 LSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVAD-TSPSPVGAIR-AMQSLAAAA 142
Query: 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEV 139
+ + + P + +S D DV +A M
Sbjct: 143 DAAHRAGVALSIDHPSRVRVSI-DGDV--VLAYPA-------------------TMPDA- 179
Query: 140 LQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHL-----PFSQLIVP 194
+ + D+ +GA L+ LL P + + + +
Sbjct: 180 ------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPAE--RDTAGQPIEPADI-DR 230
Query: 195 ALHPDCVDMCLKLLSANTVDR 215
+ + + + + R
Sbjct: 231 DIPFQISAVAARSVQGDGGIR 251
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360 | Back alignment and structure |
|---|
Score = 106 bits (266), Expect = 3e-27
Identities = 43/194 (22%), Positives = 74/194 (38%), Gaps = 32/194 (16%)
Query: 16 ELNFLSSVNH-----PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV--PEQTA 68
E + L + + NI++ F + + L+ E G +L I + +
Sbjct: 81 EADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDI 139
Query: 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILL----------------------SGLDDDV 106
+ + ++ L L + H DLKPENILL
Sbjct: 140 KLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKST 199
Query: 107 MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166
+K+ DFG + + +Y + + Y APEV+ +D DMWS G +L EL G
Sbjct: 200 GIKLIDFGCAT--FKSDYHGSIINTRQYRAPEVILNLGWDVSSDMWSFGCVLAELYTGSL 257
Query: 167 PFSGRNNVQLVRNI 180
F +++ + +
Sbjct: 258 LFRTHEHMEHLAMM 271
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 3e-27
Identities = 53/189 (28%), Positives = 82/189 (43%), Gaps = 27/189 (14%)
Query: 15 CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTAR---- 69
EL L + +HPNII L A + ++L +E+ GNL ++R + A
Sbjct: 74 GELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIAN 133
Query: 70 ------------KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
F + G++ L+ IHRDL NIL+ ++ + KIADFGLS
Sbjct: 134 STASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVG---ENYVAKIADFGLSR 190
Query: 118 TLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN 173
K L +MA E L + Y D+WS G +L+E+++ G P+ G
Sbjct: 191 G---QEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVSLGGTPYCGMTC 247
Query: 174 VQLVRNINS 182
+L +
Sbjct: 248 AELYEKLPQ 256
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313 | Back alignment and structure |
|---|
Score = 105 bits (264), Expect = 3e-27
Identities = 57/206 (27%), Positives = 87/206 (42%), Gaps = 30/206 (14%)
Query: 1 MLKKLNKHLKSCLD--CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
MLK + HL EL LS + NH NI+ L A ++ E+C G+L +++
Sbjct: 60 MLKP-SAHLTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFL 118
Query: 58 R---------------LHGRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILL 99
R + L Q+ G+ L S + IHRDL NILL
Sbjct: 119 RRKRDSFICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILL 178
Query: 100 SGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGA 156
+ + KI DFGL+ + + + L +MAPE + Y + D+WS G
Sbjct: 179 T--HGRIT-KICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGI 235
Query: 157 ILFELLN-GYPPFSGR-NNVQLVRNI 180
L+EL + G P+ G + + + I
Sbjct: 236 FLWELFSLGSSPYPGMPVDSKFYKMI 261
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327 | Back alignment and structure |
|---|
Score = 105 bits (263), Expect = 4e-27
Identities = 45/166 (27%), Positives = 74/166 (44%), Gaps = 11/166 (6%)
Query: 16 ELNFLSSVNHPNIIRLFD--AFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFL 72
E+ L +++ I++ + LV+E+ G L +++ H R+ +
Sbjct: 74 EIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYS 133
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCG- 130
Q+ G+E L S +HRDL NIL+ + +KIADFGL+ L +Y
Sbjct: 134 SQICKGMEYLGSRRCVHRDLAARNILVE---SEAHVKIADFGLAKLLPLDKDYYVVREPG 190
Query: 131 -SPL-YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN 173
SP+ + APE L + + D+WS G +L+EL S
Sbjct: 191 QSPIFWYAPESLSDNIFSRQSDVWSFGVVLYELFTYCDKSCSPSAE 236
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382 | Back alignment and structure |
|---|
Score = 105 bits (265), Expect = 6e-27
Identities = 52/186 (27%), Positives = 93/186 (50%), Gaps = 24/186 (12%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQ-------- 66
E+ + + H NII L A + ++++VE+ + GNL Y++ +
Sbjct: 124 EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHN 183
Query: 67 -----TARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+++ + Q+ G+E L S IHRDL N+L++ +D ++KIADFGL+
Sbjct: 184 PEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVT---EDNVMKIADFGLARD 240
Query: 119 LYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
++ +Y +K L +MAPE L + Y + D+WS G +L+E+ G P+ G
Sbjct: 241 IHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVLLWEIFTLGGSPYPGVPVE 300
Query: 175 QLVRNI 180
+L + +
Sbjct: 301 ELFKLL 306
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344 | Back alignment and structure |
|---|
Score = 102 bits (257), Expect = 4e-26
Identities = 52/202 (25%), Positives = 86/202 (42%), Gaps = 32/202 (15%)
Query: 15 CELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------- 60
EL ++ + +H NI+ L A I+L+ E+C G+L +Y+R
Sbjct: 97 SELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYEN 156
Query: 61 -------GRVPEQTARKFLQ---QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ T L Q+ G+E L +HRDL N+L++ V+ KI
Sbjct: 157 QKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVT--HGKVV-KI 213
Query: 111 ADFGLSCTLYPGNYAEKVCGSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYP 166
DFGL+ + + + L +MAPE L Y K D+WS G +L+E+ + G
Sbjct: 214 CDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWSYGILLWEIFSLGVN 273
Query: 167 PFSG-RNNVQLVRNINSCKHLP 187
P+ G + + I + +
Sbjct: 274 PYPGIPVDANFYKLIQNGFKMD 295
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321 | Back alignment and structure |
|---|
Score = 93.4 bits (233), Expect = 9e-23
Identities = 52/162 (32%), Positives = 78/162 (48%), Gaps = 16/162 (9%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E+ LS HP+++ L N + L+ ++ GNL + L+G + + Q+L
Sbjct: 85 EIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRH--LYGSDLPTMSMSWEQRL 142
Query: 76 ----GA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE--- 126
GA GL L++ IIHRD+K NIL LD++ + KI DFG+S
Sbjct: 143 EICIGAARGLHYLHTRAIIHRDVKSINIL---LDENFVPKITDFGIS-KKGTELDQTHLS 198
Query: 127 -KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167
V G+ Y+ PE R EK D++S G +LFE+L
Sbjct: 199 TVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFEVLCARSA 240
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397 | Back alignment and structure |
|---|
Score = 85.3 bits (211), Expect = 2e-19
Identities = 57/237 (24%), Positives = 89/237 (37%), Gaps = 70/237 (29%)
Query: 2 LK--KLNKHLKSCLDCELNFLSSV-----NHPN---IIRLFDAFQAEN------CIFLVV 45
+K K +H E+ L SV N PN +++L D F+ C +V
Sbjct: 67 MKVVKSAEHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC--MVF 124
Query: 46 EFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSH-HIIHRDLKPENILLSGL 102
E G +L +I + +P +K +QQ+ GL+ L++ IIH D+KPENILLS
Sbjct: 125 EV-LGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183
Query: 103 DDDVM----------------------------------------------LKIADFGLS 116
+ + +KIAD G +
Sbjct: 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA 243
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
C + + + + Y + EVL Y+ D+WS + FEL G F +
Sbjct: 244 C--WVHKHFTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSG 298
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326 | Back alignment and structure |
|---|
Score = 83.4 bits (207), Expect = 4e-19
Identities = 52/177 (29%), Positives = 78/177 (44%), Gaps = 28/177 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTA----RKF 71
E+ +S H N++RL LV + A G+++S L R Q ++
Sbjct: 77 EVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVAS--CLRERPESQPPLDWPKRQ 134
Query: 72 LQQLGA--GLEILNSH-----HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY 124
LG+ GL L H IIHRD+K NIL LD++ + DFGL+ L
Sbjct: 135 RIALGSARGLAYL--HDHCDPKIIHRDVKAANIL---LDEEFEAVVGDFGLA-KLMDYKD 188
Query: 125 AE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVR 178
V G+ ++APE L + EK D++ G +L EL+ +G+ L R
Sbjct: 189 THVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLLELI------TGQRAFDLAR 239
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307 | Back alignment and structure |
|---|
Score = 81.4 bits (202), Expect = 2e-18
Identities = 47/175 (26%), Positives = 72/175 (41%), Gaps = 36/175 (20%)
Query: 16 ELNFLSSVNHPNIIRL--FDAFQAENCI-----FLVVEFCAGGNLSSYIRLHGRVPEQT- 67
E+ ++ H N++ L F LV + G+L RL
Sbjct: 80 EIKVMAKCQHENLVELLGF-------SSDGDDLCLVYVYMPNGSLLD--RLSCLDGTPPL 130
Query: 68 --ARKFLQQLGA--GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN 123
+ GA G+ L+ +H IHRD+K NIL LD+ KI+DFGL+
Sbjct: 131 SWHMRCKIAQGAANGINFLHENHHIHRDIKSANIL---LDEAFTAKISDFGLA-RASEKF 186
Query: 124 YAE----KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
++ G+ YMAPE L+ K D++S G +L E++ +G V
Sbjct: 187 AQTVMTSRIVGTTAYMAPEALR-GEITPKSDIYSFGVVLLEII------TGLPAV 234
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 81.1 bits (200), Expect = 4e-18
Identities = 38/118 (32%), Positives = 62/118 (52%), Gaps = 8/118 (6%)
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ Q+ G+E L S IHRDL NILLS + ++KI DFGL+ +Y +
Sbjct: 197 CYSFQVAKGMEFLASRKCIHRDLAARNILLS---EKNVVKICDFGLARDIYKDPDYVRKG 253
Query: 130 GSPL---YMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSG-RNNVQLVRNINS 182
+ L +MAPE + + Y + D+WS G +L+E+ + G P+ G + + + R +
Sbjct: 254 DARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKE 311
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359 | Back alignment and structure |
|---|
Score = 40.3 bits (94), Expect = 3e-04
Identities = 28/136 (20%), Positives = 47/136 (34%), Gaps = 7/136 (5%)
Query: 1 MLKK-LNKHLKSCLDCELNFLSSV-NHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSYI 57
MLK+ L EL L + +H N++ L A + + ++VEFC GNLS+Y+
Sbjct: 59 MLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYL 118
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
R K + + + I DLK ++ +
Sbjct: 119 RSKRNEFVPYKTKGARF----RQGKDYVGAIPVDLKRRLDSITSSQSSASSGFVEEKSLS 174
Query: 118 TLYPGNYAEKVCGSPL 133
+ E + L
Sbjct: 175 DVEEEEAPEDLYKDFL 190
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345 | Back alignment and structure |
|---|
Score = 59.0 bits (143), Expect = 2e-10
Identities = 26/117 (22%), Positives = 50/117 (42%), Gaps = 3/117 (2%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRL-FDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+++ K E L + P F+ + F+V+E G +L
Sbjct: 86 FYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQ 144
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+G + T + ++ LE ++ + +H D+K N+LL G + + +AD+GLS
Sbjct: 145 NGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLL-GYKNPDQVYLADYGLS 200
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364 | Back alignment and structure |
|---|
Score = 57.5 bits (139), Expect = 6e-10
Identities = 32/195 (16%), Positives = 69/195 (35%), Gaps = 30/195 (15%)
Query: 4 KLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-------------------FLV 44
K+ L EL F P I+ + + + F++
Sbjct: 71 KVEPSDNGPLFTELKFYQRAAKPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMI 130
Query: 45 VEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
++ G +L + + +T + ++ LE ++ H +H D+K N+LL
Sbjct: 131 MDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGDIKASNLLL-NYK 188
Query: 104 DDVMLKIADFGLSCTLYPGN------YAEKVC--GSPLYMAPEVLQFQRYDEKVDMWSVG 155
+ + + D+GL+ P K C G+ + + + + D+ +G
Sbjct: 189 NPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILG 248
Query: 156 AILFELLNGYPPFSG 170
+ + L G+ P+
Sbjct: 249 YCMIQWLTGHLPWED 263
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296 | Back alignment and structure |
|---|
Score = 56.6 bits (137), Expect = 8e-10
Identities = 36/157 (22%), Positives = 61/157 (38%), Gaps = 16/157 (10%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNS 84
I + + +V+E G +L R +T Q+ + +E ++S
Sbjct: 65 VGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHS 123
Query: 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEK--VCGSPLYMA 136
+ IHRD+KP+N L+ ++ I DFGL+ Y E + G+ Y +
Sbjct: 124 KNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYAS 183
Query: 137 PEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSG 170
R D D+ S+G +L G P+ G
Sbjct: 184 INTHLGIEQSRRD---DLESLGYVLMYFNLGSLPWQG 217
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483 | Back alignment and structure |
|---|
Score = 56.2 bits (135), Expect = 2e-09
Identities = 36/159 (22%), Positives = 60/159 (37%), Gaps = 16/159 (10%)
Query: 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEIL 82
I + + LV++ G +L R +T Q+ +E +
Sbjct: 61 GGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFV 119
Query: 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEK--VCGSPLY 134
+S +HRD+KP+N L+ + I DFGL+ + Y E + G+ Y
Sbjct: 120 HSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARY 179
Query: 135 MAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSG 170
+ R D D+ S+G +L L G P+ G
Sbjct: 180 ASVNTHLGIEQSRRD---DLESLGYVLMYFLRGSLPWQG 215
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298 | Back alignment and structure |
|---|
Score = 52.7 bits (127), Expect = 2e-08
Identities = 37/159 (23%), Positives = 69/159 (43%), Gaps = 18/159 (11%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNS 84
I ++ Q LV++ G +L + L GR +T +Q+ A ++ ++
Sbjct: 66 TGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHE 124
Query: 85 HHIIHRDLKPENILL--SGLDDDVMLKIADFGLS------CTLYPGNYAEK--VCGSPLY 134
+++RD+KP+N L+ + M+ + DFG+ T Y EK + G+ Y
Sbjct: 125 KSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARY 184
Query: 135 MAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSG 170
M+ + R D D+ ++G + L G P+ G
Sbjct: 185 MSINTHLGREQSRRD---DLEALGHVFMYFLRGSLPWQG 220
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330 | Back alignment and structure |
|---|
Score = 52.0 bits (125), Expect = 4e-08
Identities = 40/160 (25%), Positives = 68/160 (42%), Gaps = 20/160 (12%)
Query: 26 PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-PEQTARKFLQQLGAGLEILNS 84
I +++ +V+E G +L L R +T QL + +E ++S
Sbjct: 65 DGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHS 123
Query: 85 HHIIHRDLKPENILL--SGLDDDVMLKIADFGLSCTLY--PGN-----YAEK--VCGSPL 133
++I+RD+KPEN L+ G ++ I DF L+ Y P Y E + G+
Sbjct: 124 KNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALA-KEYIDPETKKHIPYREHKSLTGTAR 182
Query: 134 YMAPEVLQFQ---RYDEKVDMWSVGAILFELLNGYPPFSG 170
YM+ + R D D+ ++G + L G P+ G
Sbjct: 183 YMSINTHLGKEQSRRD---DLEALGHMFMYFLRGSLPWQG 219
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352 | Back alignment and structure |
|---|
Score = 51.7 bits (124), Expect = 6e-08
Identities = 18/77 (23%), Positives = 39/77 (50%), Gaps = 4/77 (5%)
Query: 42 FLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99
FLV+ G +L S + + + + E++ + +L LE L+ + +H ++ ENI +
Sbjct: 134 FLVLPSL-GRSLQSALDVSPKHVLSERSVLQVACRLLDALEFLHENEYVHGNVTAENIFV 192
Query: 100 SGLDDDVMLKIADFGLS 116
+D + +A +G +
Sbjct: 193 -DPEDQSQVTLAGYGFA 208
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336 | Back alignment and structure |
|---|
Score = 49.1 bits (116), Expect = 4e-07
Identities = 27/139 (19%), Positives = 46/139 (33%), Gaps = 17/139 (12%)
Query: 38 ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL-NSHHIIHRDLKPEN 96
++ +F+V+EF GG +R A+ L QL A L + S HRDL N
Sbjct: 134 DDQLFIVLEFEFGGIDLEQMRTKLSSLAT-AKSILHQLTASLAVAEASLRFEHRDLHWGN 192
Query: 97 ILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156
+L L + K+ + + +V Y
Sbjct: 193 VL---LKKTSLKKLHYTLNGKSSTIPSCGLQVSI------------IDYTLSRLERDGIV 237
Query: 157 ILFELLNGYPPFSGRNNVQ 175
+ ++ F+G + Q
Sbjct: 238 VFCDVSMDEDLFTGDGDYQ 256
|
| >1vt4_I APAF-1 related killer DARK; drosophila apoptosome, apoptosis, programmed cell death; HET: DTP; 6.90A {Drosophila melanogaster} PDB: 3iz8_A* Length = 1221 | Back alignment and structure |
|---|
Score = 39.5 bits (91), Expect = 8e-04
Identities = 42/270 (15%), Positives = 85/270 (31%), Gaps = 70/270 (25%)
Query: 2 LKKL--NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLV------VEFCAGGNL 53
L++L +K ++CL L +V + F+ +C L+ V
Sbjct: 234 LRRLLKSKPYENCLL----VLLNVQNAKAWNAFNL----SCKILLTTRFKQVTDFLSAAT 285
Query: 54 SSYIRL----HGRVPEQTARKFLQQLGAGLEIL----NSHH-----IIHRDLKPENILLS 100
+++I L P++ L+ L + L + + II ++
Sbjct: 286 TTHISLDHHSMTLTPDEVKSLLLKYLDCRPQDLPREVLTTNPRRLSIIAESIRDGLATWD 345
Query: 101 G---LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDM------ 151
++ D + I + L+ L P Y + ++ V +
Sbjct: 346 NWKHVNCDKLTTIIESSLNV-LEPAEYRK------MFDRLSVF---PPSAHIPTILLSLI 395
Query: 152 WS------VGAILFELLNGYPPFS--GRNNVQLVRNINSCKHLPFSQLI--VPALHPDCV 201
W V ++ +L +S + + +I S +L + ALH V
Sbjct: 396 WFDVIKSDVMVVVNKLHK----YSLVEKQPKESTISIPSI-YLELKVKLENEYALHRSIV 450
Query: 202 D-------MCLKLLSANTVDRLSFNEFYHH 224
D L +D+ ++ HH
Sbjct: 451 DHYNIPKTFDSDDLIPPYLDQYFYSHIGHH 480
|
Structure Templates Detected by HHsearch
Original result of HHsearch against PDB70 database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 241 | |||
| 4fih_A | 346 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4b9d_A | 350 | Serine/threonine-protein kinase NEK1; transferase, | 100.0 | |
| 4aw0_A | 311 | HPDK1, 3-phosphoinositide-dependent protein kinase | 100.0 | |
| 3hyh_A | 275 | Carbon catabolite-derepressing protein kinase; kin | 100.0 | |
| 3fpq_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3ubd_A | 304 | Ribosomal protein S6 kinase alpha-3; kinase-inhibi | 100.0 | |
| 4fie_A | 423 | Serine/threonine-protein kinase PAK 4; kinase doma | 100.0 | |
| 4g3f_A | 336 | NF-kappa-beta-inducing kinase; non-RD kinase, prot | 100.0 | |
| 4asz_A | 299 | BDNF/NT-3 growth factors receptor; transferase, TR | 100.0 | |
| 4aoj_A | 329 | High affinity nerve growth factor receptor; transf | 100.0 | |
| 4gt4_A | 308 | Tyrosine-protein kinase transmembrane receptor RO; | 100.0 | |
| 3omv_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 4b99_A | 398 | Mitogen-activated protein kinase 7; transferase, i | 100.0 | |
| 3uto_A | 573 | Twitchin; kinase, muscle sarcomere, transferase; H | 100.0 | |
| 4g31_A | 299 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 4f9c_A | 361 | Cell division cycle 7-related protein kinase; Ser/ | 100.0 | |
| 3v5w_A | 689 | G-protein coupled receptor kinase 2; inhibitor com | 100.0 | |
| 4ase_A | 353 | Vascular endothelial growth factor receptor 2; tra | 100.0 | |
| 3fe3_A | 328 | MAP/microtubule affinity-regulating kinase 3; seri | 100.0 | |
| 2yab_A | 361 | Death-associated protein kinase 2; apoptosis, tran | 100.0 | |
| 3soa_A | 444 | Calcium/calmodulin-dependent protein kinase type a | 100.0 | |
| 2bdw_A | 362 | Hypothetical protein K11E8.1D; kinase, calmodulin | 100.0 | |
| 3kn6_A | 325 | Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1 | 100.0 | |
| 1tki_A | 321 | Titin; serine kinase, muscle, autoinhibition; 2.00 | 100.0 | |
| 1o6l_A | 337 | RAC-beta serine/threonine protein kinase; protein | 100.0 | |
| 2y0a_A | 326 | Death-associated protein kinase 1; transferase, ca | 100.0 | |
| 3txo_A | 353 | PKC-L, NPKC-ETA, protein kinase C ETA type; phosph | 100.0 | |
| 3zgw_A | 347 | Maternal embryonic leucine zipper kinase; transfer | 100.0 | |
| 3kk8_A | 284 | Calcium/calmodulin dependent protein kinase II; AT | 100.0 | |
| 3fxz_A | 297 | Serine/threonine-protein kinase PAK 1; transferase | 100.0 | |
| 1kob_A | 387 | Twitchin; kinase, intrasteric regulation; 2.30A {A | 100.0 | |
| 3h4j_B | 336 | AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin | 100.0 | |
| 3f3z_A | 277 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 2w4o_A | 349 | Calcium/calmodulin-dependent protein kinase type I | 100.0 | |
| 1fot_A | 318 | TPK1 delta, CAMP-dependent protein kinase type 1; | 100.0 | |
| 1xjd_A | 345 | Protein kinase C, theta type; PKC-theta, ATP, AMP, | 100.0 | |
| 2x4f_A | 373 | Myosin light chain kinase family member 4; LUNG, b | 100.0 | |
| 4dc2_A | 396 | Protein kinase C IOTA type; kinase, substrate, cel | 100.0 | |
| 1rdq_E | 350 | PKA C-alpha, CAMP-dependent protein kinase, alpha- | 100.0 | |
| 3lij_A | 494 | Calcium/calmodulin dependent protein kinase with A | 100.0 | |
| 2i0e_A | 353 | Protein kinase C-beta II; serine/threonine protein | 100.0 | |
| 3a8x_A | 345 | Protein kinase C IOTA type; transferase; HET: TPO; | 100.0 | |
| 3is5_A | 285 | Calcium-dependent protein kinase; CDPK, structural | 100.0 | |
| 4fr4_A | 384 | YANK1, serine/threonine-protein kinase 32A; struct | 100.0 | |
| 3mwu_A | 486 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2a2a_A | 321 | Death-associated protein kinase 2; autoinhibition, | 100.0 | |
| 3a62_A | 327 | Ribosomal protein S6 kinase beta-1; kinase domain, | 100.0 | |
| 3niz_A | 311 | Rhodanese family protein; structural genomics, str | 100.0 | |
| 2eue_A | 275 | Carbon catabolite derepressing protein kinase; kin | 100.0 | |
| 2vgo_A | 284 | Serine/threonine-protein kinase 12-A; nucleotide-b | 100.0 | |
| 3c0i_A | 351 | Peripheral plasma membrane protein CASK; neurexin, | 100.0 | |
| 3nyv_A | 484 | Calmodulin-domain protein kinase 1; serine/threoni | 100.0 | |
| 2y94_A | 476 | 5'-AMP-activated protein kinase catalytic subunit; | 100.0 | |
| 3q5i_A | 504 | Protein kinase; CDPK, malaria, phosphotransferase, | 100.0 | |
| 2c30_A | 321 | Serine/threonine-protein kinase PAK 6; CRIB domain | 100.0 | |
| 4aw2_A | 437 | Serine/threonine-protein kinase MRCK alpha; transf | 100.0 | |
| 2qr7_A | 342 | Ribosomal protein S6 kinase alpha-3; kinase domain | 100.0 | |
| 4ejn_A | 446 | RAC-alpha serine/threonine-protein kinase; AKT1, a | 100.0 | |
| 2jam_A | 304 | Calcium/calmodulin-dependent protein kinase type 1 | 100.0 | |
| 3o0g_A | 292 | Cell division protein kinase 5; kinase activator c | 100.0 | |
| 2pmi_A | 317 | Negative RE, cyclin-dependent protein kinase PHO85 | 100.0 | |
| 3gni_B | 389 | Strad alpha; kinase fold, pseudokinase, alpha heli | 100.0 | |
| 3v8s_A | 410 | RHO-associated protein kinase 1; dimerization, myo | 100.0 | |
| 3hmm_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 2vd5_A | 412 | DMPK protein; serine/threonine-protein kinase, kin | 100.0 | |
| 3fdn_A | 279 | Serine/threonine-protein kinase 6; aurora kinase i | 100.0 | |
| 1ob3_A | 288 | PFPK5, cell division control protein 2 homolog; tr | 100.0 | |
| 3bhy_A | 283 | Death-associated protein kinase 3; death associate | 100.0 | |
| 3uc3_A | 361 | Serine/threonine-protein kinase SRK2I; SNRK2, ABA | 100.0 | |
| 2r5t_A | 373 | Serine/threonine-protein kinase SGK1; AGC protein | 100.0 | |
| 2h6d_A | 276 | 5'-AMP-activated protein kinase catalytic subunit | 100.0 | |
| 3g33_A | 308 | Cell division protein kinase 4; Ser/Thr protein ki | 100.0 | |
| 3tki_A | 323 | Serine/threonine-protein kinase CHK1; cell checkpo | 100.0 | |
| 2y7j_A | 365 | Phosphorylase B kinase gamma catalytic chain, test | 100.0 | |
| 2ac3_A | 316 | MAP kinase-interacting serine/threonine kinase 2; | 100.0 | |
| 1nxk_A | 400 | MAP kinase-activated protein kinase 2; MK2, phosph | 100.0 | |
| 2rku_A | 294 | Serine/threonine-protein kinase PLK1; structure of | 100.0 | |
| 4agu_A | 311 | Cyclin-dependent kinase-like 1; transferase, phosp | 100.0 | |
| 3i6u_A | 419 | CDS1, serine/threonine-protein kinase CHK2; Ser/Th | 100.0 | |
| 2zv2_A | 298 | Calcium/calmodulin-dependent protein kinase kinas; | 100.0 | |
| 2acx_A | 576 | G protein-coupled receptor kinase 6; GRK, G transf | 100.0 | |
| 1phk_A | 298 | Phosphorylase kinase; glycogen metabolism, transfe | 100.0 | |
| 3lm5_A | 327 | Serine/threonine-protein kinase 17B; STK17B, serin | 100.0 | |
| 2owb_A | 335 | Serine/threonine-protein kinase PLK1; catalytic do | 100.0 | |
| 1t4h_A | 290 | Serine/threonine-protein kinase WNK1; protein seri | 100.0 | |
| 3gbz_A | 329 | Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide- | 100.0 | |
| 3hko_A | 345 | Calcium/calmodulin-dependent protein kinase with d | 100.0 | |
| 3pfq_A | 674 | PKC-B, PKC-beta, protein kinase C beta type; phosp | 100.0 | |
| 2wei_A | 287 | Calmodulin-domain protein kinase 1, putative; nucl | 100.0 | |
| 3ttj_A | 464 | Mitogen-activated protein kinase 10; JNK3, protein | 100.0 | |
| 3cok_A | 278 | Serine/threonine-protein kinase PLK4; POLO-like ki | 100.0 | |
| 3mtl_A | 324 | Cell division protein kinase 16; pctaire1, indirub | 100.0 | |
| 4aaa_A | 331 | Cyclin-dependent kinase-like 2; transferase, phosp | 100.0 | |
| 3oz6_A | 388 | Mitogen-activated protein kinase 1, serine/threon | 100.0 | |
| 3c4z_A | 543 | Rhodopsin kinase; Ser/Thr kinase, RGS homology dom | 100.0 | |
| 3dls_A | 335 | PAS domain-containing serine/threonine-protein KI; | 100.0 | |
| 2ycf_A | 322 | Serine/threonine-protein kinase CHK2; transferase, | 100.0 | |
| 1u5q_A | 348 | Serine/threonine protein kinase TAO2; transferase; | 100.0 | |
| 3eqc_A | 360 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 1cm8_A | 367 | Phosphorylated MAP kinase P38-gamma; phosphorylati | 100.0 | |
| 3llt_A | 360 | Serine/threonine kinase-1, pflammer; lammer kinase | 100.0 | |
| 3rp9_A | 458 | Mitogen-activated protein kinase; structural genom | 100.0 | |
| 3a7i_A | 303 | MST3 kinase, serine/threonine kinase 24 (STE20 hom | 100.0 | |
| 1x8b_A | 289 | WEE1HU, WEE1-like protein kinase; cell cycle, tran | 100.0 | |
| 4eqm_A | 294 | Protein kinase; transferase; HET: ANP; 3.00A {Stap | 100.0 | |
| 1ua2_A | 346 | CAK, cell division protein kinase 7; cell cycle, p | 100.0 | |
| 2r3i_A | 299 | Cell division protein kinase 2; serine/threonine-p | 100.0 | |
| 2yex_A | 276 | Serine/threonine-protein kinase CHK1; transferase, | 100.0 | |
| 2xrw_A | 371 | Mitogen-activated protein kinase 8; transcription, | 100.0 | |
| 4e7w_A | 394 | Glycogen synthase kinase 3; GSK3, PTyr195, transfe | 100.0 | |
| 3n9x_A | 432 | Phosphotransferase; malaria kinase, structural gen | 100.0 | |
| 3com_A | 314 | Serine/threonine-protein kinase 4; MST1, STE20-lik | 100.0 | |
| 3eb0_A | 383 | Putative uncharacterized protein; kinase cryptospo | 100.0 | |
| 2fst_X | 367 | Mitogen-activated protein kinase 14; active mutant | 100.0 | |
| 3nsz_A | 330 | CK II alpha, casein kinase II subunit alpha; inhib | 100.0 | |
| 2w5a_A | 279 | Serine/threonine-protein kinase NEK2; Ser/Thr prot | 100.0 | |
| 3mi9_A | 351 | Cell division protein kinase 9; P-TEFB, HIV-1, pro | 100.0 | |
| 2wtk_C | 305 | Serine/threonine-protein kinase 11; transferase-me | 100.0 | |
| 3fme_A | 290 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3l9p_A | 367 | Anaplastic lymphoma kinase; kinase domain, ATP-bin | 100.0 | |
| 3ork_A | 311 | Serine/threonine protein kinase; structural genomi | 100.0 | |
| 2vwi_A | 303 | Serine/threonine-protein kinase OSR1; STE kinase, | 100.0 | |
| 2psq_A | 370 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 2pml_X | 348 | PFPK7, Ser/Thr protein kinase; phosphorylati trans | 100.0 | |
| 3dbq_A | 343 | Dual specificity protein kinase TTK; MPS1 structur | 100.0 | |
| 3p1a_A | 311 | MYT1 kinase, membrane-associated tyrosine- and thr | 100.0 | |
| 3kul_A | 325 | Ephrin type-A receptor 8; ATP-binding, kinase, nuc | 100.0 | |
| 3p86_A | 309 | Serine/threonine-protein kinase CTR1; ETR1, ERS1, | 100.0 | |
| 3pg1_A | 362 | Mitogen-activated protein kinase, putative (MAP K | 100.0 | |
| 3qd2_B | 332 | Eukaryotic translation initiation factor 2-alpha; | 100.0 | |
| 2x7f_A | 326 | TRAF2 and NCK-interacting protein kinase; serine/t | 100.0 | |
| 3qup_A | 323 | Tyrosine-protein kinase receptor TYRO3; protein ki | 100.0 | |
| 2j7t_A | 302 | Serine/threonine-protein kinase 10; transferase, A | 100.0 | |
| 2zmd_A | 390 | Dual specificity protein kinase TTK; MPS1, T686A, | 100.0 | |
| 1j1b_A | 420 | Glycogen synthase kinase-3 beta; complex, TAU, AMP | 100.0 | |
| 1blx_A | 326 | Cyclin-dependent kinase 6; inhibitor protein, cycl | 100.0 | |
| 2i6l_A | 320 | Mitogen-activated protein kinase 6; MAPK6, ERK3, e | 100.0 | |
| 3qyz_A | 364 | Mitogen-activated protein kinase 1; transferase, s | 100.0 | |
| 3rgf_A | 405 | Cyclin-dependent kinase 8; protein kinase complex, | 100.0 | |
| 3tt0_A | 382 | Basic fibroblast growth factor receptor 1; kinase | 100.0 | |
| 4hcu_A | 269 | Tyrosine-protein kinase ITK/TSK; transferase-trans | 100.0 | |
| 2ivs_A | 314 | Proto-oncogene tyrosine-protein kinase receptor RE | 100.0 | |
| 3kvw_A | 429 | DYRK2, dual specificity tyrosine-phosphorylation-r | 100.0 | |
| 1fvr_A | 327 | Tyrosine-protein kinase TIE-2; tyrosine kinase, tr | 100.0 | |
| 1vzo_A | 355 | Ribosomal protein S6 kinase alpha 5; protein kinas | 100.0 | |
| 2b9h_A | 353 | MAP kinase FUS3, mitogen-activated protein kinase | 100.0 | |
| 1luf_A | 343 | Muscle-specific tyrosine kinase receptor MUSK; pho | 100.0 | |
| 3gen_A | 283 | Tyrosine-protein kinase BTK; bruton'S tyrosine kin | 100.0 | |
| 2clq_A | 295 | Mitogen-activated protein kinase kinase kinase 5; | 100.0 | |
| 3byv_A | 377 | Rhoptry kinase; malaria, transferase, structural g | 100.0 | |
| 3sxs_A | 268 | Cytoplasmic tyrosine-protein kinase BMX; transfera | 100.0 | |
| 3lb7_A | 307 | RAF proto-oncogene serine/threonine-protein kinas; | 100.0 | |
| 3an0_A | 340 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3cbl_A | 377 | C-FES, proto-oncogene tyrosine-protein kinase FES/ | 100.0 | |
| 1z57_A | 339 | Dual specificity protein kinase CLK1; protein tyro | 100.0 | |
| 1mp8_A | 281 | Focal adhesion kinase 1; tyrosine protein kinase, | 100.0 | |
| 4euu_A | 319 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 3fhr_A | 336 | MAP kinase-activated protein kinase 3; kinase-inhi | 100.0 | |
| 1zy4_A | 303 | Serine/threonine-protein kinase GCN2; translation | 100.0 | |
| 3e3p_A | 360 | Protein kinase, putative glycogen synthase kinase; | 100.0 | |
| 2qol_A | 373 | Ephrin receptor; receptor tyrosine kinase, juxtame | 100.0 | |
| 4exu_A | 371 | Mitogen-activated protein kinase 13; P38 kinase, t | 100.0 | |
| 1p4o_A | 322 | Insulin-like growth factor I receptor protein; IGF | 100.0 | |
| 3aln_A | 327 | Dual specificity mitogen-activated protein kinase; | 100.0 | |
| 3s95_A | 310 | LIMK-1, LIM domain kinase 1; structural genomics, | 100.0 | |
| 2rio_A | 434 | Serine/threonine-protein kinase/endoribonuclease I | 100.0 | |
| 3t9t_A | 267 | Tyrosine-protein kinase ITK/TSK; kinase domain, al | 100.0 | |
| 2yfx_A | 327 | Tyrosine-protein kinase receptor; nucleotide-bindi | 100.0 | |
| 3poz_A | 327 | Epidermal growth factor receptor; kinase domain, a | 100.0 | |
| 3p23_A | 432 | Serine/threonine-protein kinase/endoribonuclease; | 100.0 | |
| 1xbb_A | 291 | Tyrosine-protein kinase SYK; gleevec, STI-571, ima | 100.0 | |
| 1k9a_A | 450 | Carboxyl-terminal SRC kinase; COOH-terminal SRC ki | 100.0 | |
| 1mqb_A | 333 | Ephrin type-A receptor 2; tyrosine protein kinase, | 100.0 | |
| 1u59_A | 287 | Tyrosine-protein kinase ZAP-70; transferase; HET: | 100.0 | |
| 3dtc_A | 271 | Mitogen-activated protein kinase kinase kinase 9; | 100.0 | |
| 3vhe_A | 359 | Vascular endothelial growth factor receptor 2; kin | 100.0 | |
| 2pvf_A | 334 | Fibroblast growth factor receptor 2; kinase domain | 100.0 | |
| 3coi_A | 353 | Mitogen-activated protein kinase 13; P38D, P38delt | 100.0 | |
| 2dyl_A | 318 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| 3cek_A | 313 | Dual specificity protein kinase TTK; HMPS1, PYT, E | 100.0 | |
| 3kfa_A | 288 | Tyrosine-protein kinase ABL1; CML, drug resistance | 100.0 | |
| 3cc6_A | 281 | Protein tyrosine kinase 2 beta; focal adhesion kin | 100.0 | |
| 3ugc_A | 295 | Tyrosine-protein kinase JAK2; small molecule inhib | 100.0 | |
| 2h34_A | 309 | Serine/threonine-protein kinase PKNE; apoenzyme, t | 100.0 | |
| 3q60_A | 371 | ROP5B; pseudokinase, transferase; HET: ATP; 1.72A | 100.0 | |
| 3kex_A | 325 | Receptor tyrosine-protein kinase ERBB-3; kinase do | 100.0 | |
| 1rjb_A | 344 | FL cytokine receptor; kinase, structure, autoinhib | 100.0 | |
| 1t46_A | 313 | HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom | 100.0 | |
| 3brb_A | 313 | Proto-oncogene tyrosine-protein kinase MER; ATP-bi | 100.0 | |
| 4fvq_A | 289 | Tyrosine-protein kinase JAK2; janus protein kinase | 100.0 | |
| 3og7_A | 289 | AKAP9-BRAF fusion protein; proto-oncogene, V600E, | 100.0 | |
| 1qcf_A | 454 | Haematopoetic cell kinase (HCK); tyrosine kinase-i | 100.0 | |
| 1opk_A | 495 | P150, C-ABL, proto-oncogene tyrosine-protein kinas | 100.0 | |
| 2eu9_A | 355 | Dual specificity protein kinase CLK3; kinase domai | 100.0 | |
| 2izr_A | 330 | Casein kinase I isoform gamma-3; serine/threonine- | 100.0 | |
| 4fl3_A | 635 | Tyrosine-protein kinase SYK; transferase; HET: ANP | 100.0 | |
| 1csn_A | 298 | Casein kinase-1; phosphotransferase; HET: ATP; 2.0 | 100.0 | |
| 1wak_A | 397 | Serine/threonine-protein kinase SPRK1; SRPK, trans | 100.0 | |
| 3lzb_A | 327 | Epidermal growth factor receptor; epidermal growth | 100.0 | |
| 3kmu_A | 271 | ILK, integrin-linked kinase; cell adhesion, ANK re | 100.0 | |
| 2vx3_A | 382 | Dual specificity tyrosine-phosphorylation- regula | 100.0 | |
| 3pls_A | 298 | Macrophage-stimulating protein receptor; protein k | 100.0 | |
| 3c1x_A | 373 | Hepatocyte growth factor receptor; receptor tyrosi | 100.0 | |
| 1fmk_A | 452 | C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros | 100.0 | |
| 3f66_A | 298 | Hepatocyte growth factor receptor; C-Met, protein | 100.0 | |
| 1qpc_A | 279 | LCK kinase; alpha beta fold, transferase; HET: PTR | 100.0 | |
| 3qa8_A | 676 | MGC80376 protein; kinase ubiquitin-like domain, ph | 100.0 | |
| 2qkw_B | 321 | Protein kinase; three-helix bundle motif, AVRPTO-P | 100.0 | |
| 3lxl_A | 327 | Tyrosine-protein kinase JAK3; TYK2, inflammation, | 100.0 | |
| 1byg_A | 278 | CSK, protein (C-terminal SRC kinase); protein kina | 100.0 | |
| 3a99_A | 320 | Proto-oncogene serine/threonine-protein kinase PI; | 100.0 | |
| 2xir_A | 316 | Vascular endothelial growth factor receptor 2; ang | 100.0 | |
| 2ozo_A | 613 | Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t | 100.0 | |
| 4e5w_A | 302 | Tyrosine-protein kinase JAK1; kinase domain, trans | 100.0 | |
| 1q8y_A | 373 | SR protein kinase; transferase; HET: ADP ADE; 2.05 | 100.0 | |
| 2i1m_A | 333 | Macrophage colony-stimulating factor 1 receptor; k | 100.0 | |
| 2v62_A | 345 | Serine/threonine-protein kinase VRK2; transferase, | 100.0 | |
| 2wqm_A | 310 | Serine/threonine-protein kinase NEK7; ATP-binding, | 100.0 | |
| 1u46_A | 291 | ACK-1, activated CDC42 kinase 1; tyrosine kinase, | 100.0 | |
| 2a19_B | 284 | Interferon-induced, double-stranded RNA-activated | 100.0 | |
| 3soc_A | 322 | Activin receptor type-2A; structural genomics cons | 100.0 | |
| 3m2w_A | 299 | MAP kinase-activated protein kinase 2; small molec | 100.0 | |
| 3lxp_A | 318 | Non-receptor tyrosine-protein kinase TYK2; JAK3, i | 100.0 | |
| 2eva_A | 307 | TAK1 kinase - TAB1 chimera fusion protein; transfe | 100.0 | |
| 2iwi_A | 312 | Serine/threonine-protein kinase PIM-2; nucleotide- | 100.0 | |
| 2h8h_A | 535 | Proto-oncogene tyrosine-protein kinase SRC; SRC ki | 100.0 | |
| 3op5_A | 364 | Serine/threonine-protein kinase VRK1; adenosine tr | 100.0 | |
| 4f0f_A | 287 | Serine/threonine-protein kinase ROCO4; LRRK2, ATP- | 100.0 | |
| 3uim_A | 326 | Brassinosteroid insensitive 1-associated receptor; | 100.0 | |
| 2y4i_B | 319 | KSR2, HKSR2, kinase suppressor of RAS 2; transfera | 100.0 | |
| 2j0j_A | 656 | Focal adhesion kinase 1; cell migration, FERM, tra | 100.0 | |
| 3uzp_A | 296 | CKI-delta, CKID, casein kinase I isoform delta; CK | 100.0 | |
| 3q4u_A | 301 | Activin receptor type-1; structural genomics conso | 100.0 | |
| 2buj_A | 317 | Serine/threonine-protein kinase 16; transferase, A | 100.0 | |
| 2jii_A | 352 | Serine/threonine-protein kinase VRK3 molecule: VA | 100.0 | |
| 2nru_A | 307 | Interleukin-1 receptor-associated kinase 4; inhibi | 100.0 | |
| 4eut_A | 396 | Serine/threonine-protein kinase TBK1; ATP binding, | 100.0 | |
| 2w1i_A | 326 | JAK2; chromosomal rearrangement, nucleotide-bindin | 100.0 | |
| 4hgt_A | 296 | Casein kinase I isoform delta; CK1D, inhibitor, tr | 100.0 | |
| 1b6c_B | 342 | TGF-B superfamily receptor type I; complex (isomer | 100.0 | |
| 3mdy_A | 337 | Bone morphogenetic protein receptor type-1B; compl | 100.0 | |
| 3ll6_A | 337 | Cyclin G-associated kinase; transferase, protein k | 100.0 | |
| 3sv0_A | 483 | Casein kinase I-like; typical kinase domain fold, | 100.0 | |
| 3g2f_A | 336 | Bone morphogenetic protein receptor type-2; kinase | 100.0 | |
| 3e7e_A | 365 | HBUB1, BUB1A, mitotic checkpoint serine/threonine- | 100.0 | |
| 3gxj_A | 303 | TGF-beta receptor type-1; ALK5, kinase, inhibitor, | 100.0 | |
| 3dzo_A | 413 | Rhoptry kinase domain; parasitic disease, transfer | 100.0 | |
| 2pzi_A | 681 | Probable serine/threonine-protein kinase PKNG; ATP | 100.0 | |
| 2vuw_A | 336 | Serine/threonine-protein kinase haspin; cell cycle | 100.0 | |
| 3uqc_A | 286 | Probable conserved transmembrane protein; structur | 100.0 | |
| 4azs_A | 569 | Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15 | 100.0 | |
| 3en9_A | 540 | Glycoprotease, O-sialoglycoprotein endopeptidase/p | 99.91 | |
| 1zar_A | 282 | RIO2 kinase; serine kinase, winged-helix, RIO doma | 99.78 | |
| 1zth_A | 258 | RIO1 serine protein kinase; ribosome biogenesis, r | 99.59 | |
| 4gyi_A | 397 | RIO2 kinase; protein kinase, ADP complex, phosphoa | 99.3 | |
| 3tm0_A | 263 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.22 | |
| 1nd4_A | 264 | Aminoglycoside 3'-phosphotransferase; protein kina | 99.02 | |
| 3dxp_A | 359 | Putative acyl-COA dehydrogenase; protein kinase-li | 98.9 | |
| 3sg8_A | 304 | APH(2'')-ID; antibiotic resistance enzyme, transfe | 98.85 | |
| 3r70_A | 320 | Aminoglycoside phosphotransferase; structural geno | 98.55 | |
| 4gkh_A | 272 | Aminoglycoside 3'-phosphotransferase APHA1-IAB; py | 98.52 | |
| 3tdw_A | 306 | Gentamicin resistance protein; kinase, phosphoryl | 98.39 | |
| 2yle_A | 229 | Protein spire homolog 1; actin-binding protein, ac | 98.18 | |
| 3ovc_A | 362 | Hygromycin-B 4-O-kinase; aminoglycoside phosphotra | 97.92 | |
| 3ats_A | 357 | Putative uncharacterized protein; hypothetical pro | 97.84 | |
| 2q83_A | 346 | YTAA protein; 2635576, structural genomics, joint | 97.61 | |
| 3csv_A | 333 | Aminoglycoside phosphotransferase; YP_614837.1, ph | 97.16 | |
| 3d1u_A | 288 | Putative fructosamine-3-kinase; YP_290396.1, struc | 97.02 | |
| 3dxq_A | 301 | Choline/ethanolamine kinase family protein; NP_106 | 96.99 | |
| 3jr1_A | 312 | Putative fructosamine-3-kinase; YP_719053.1, struc | 96.98 | |
| 2olc_A | 397 | MTR kinase, methylthioribose kinase; kinase ADP-2H | 96.71 | |
| 3feg_A | 379 | Choline/ethanolamine kinase; non-protein kinase, c | 96.42 | |
| 3f2s_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 95.83 | |
| 2pyw_A | 420 | Uncharacterized protein; 5-methylthioribose kinase | 95.03 | |
| 1zyl_A | 328 | Hypothetical protein YIHE; putative protein kinase | 92.89 | |
| 2ppq_A | 322 | HSK, HK, homoserine kinase; structural genomics, M | 92.75 | |
| 3i1a_A | 339 | Spectinomycin phosphotransferase; protein kinase, | 91.78 | |
| 3c5i_A | 369 | Choline kinase; choline, kinase, malaria, transfer | 90.98 | |
| 2qg7_A | 458 | Ethanolamine kinase PV091845; malaria, SGC, struct | 90.06 | |
| 1nw1_A | 429 | Choline kinase (49.2 KD); phospholipid synthesis, | 88.07 | |
| 3g15_A | 401 | CK, chetk-alpha, choline kinase alpha; non-protein | 86.91 | |
| 4ano_A | 219 | ESSB; membrane protein, membrane secretion, ESS ty | 80.92 |
| >4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-59 Score=370.06 Aligned_cols=220 Identities=24% Similarity=0.493 Sum_probs=198.5
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+....+.+.+|++++++++||||+++++++++++.+|+|||||+||+|.+++.+ +++++..+..++.||+.||+|||++
T Consensus 111 ~~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~-~~l~e~~~~~~~~qi~~aL~ylH~~ 189 (346)
T 4fih_A 111 KQQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQ 189 (346)
T ss_dssp GCSSGGGGHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEECCCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 344567799999999999999999999999999999999999999999999875 5799999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
||+||||||+|||+ +.++.+||+|||+|+..... ......+||+.|+|||.+.+..|+.++||||+||++|+|++|
T Consensus 190 ~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G 266 (346)
T 4fih_A 190 GVIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDG 266 (346)
T ss_dssp TEECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CcccccCCHHHEEE---CCCCCEEEecCcCceecCCCCCcccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999999 78899999999999876543 344567899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
.+||.+.+..+.+..+......... ....+|+++.+||.+||+.||++|||++|+|+||||++..
T Consensus 267 ~~PF~~~~~~~~~~~i~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~ 331 (346)
T 4fih_A 267 EPPYFNEPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 331 (346)
T ss_dssp SCTTTTSCHHHHHHHHHHSSCCCCS--CGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCCCcCHHHHHHHHHcCCCCCCC--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCC
Confidence 9999999999999888766543332 2347899999999999999999999999999999999753
|
| >4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-59 Score=371.13 Aligned_cols=218 Identities=27% Similarity=0.504 Sum_probs=197.6
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+....+.+.+|++++++|+||||+++++++++++..|+|||||+||+|.+++... ..+++..+..++.||+.||.|||
T Consensus 63 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL~ylH 142 (350)
T 4b9d_A 63 SSKEREESRREVAVLANMKHPNIVQYRESFEENGSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLALKHVH 142 (350)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4566788999999999999999999999999999999999999999999999755 34799999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
++||+||||||+|||+ +.++.+||+|||+|+...... .....+||+.|+|||.+.+..|+.++|||||||++|+|+
T Consensus 143 ~~~IiHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~l~~~~y~~~~DiwSlGvilyeml 219 (350)
T 4b9d_A 143 DRKILHRDIKSQNIFL---TKDGTVQLGDFGIARVLNSTVELARACIGTPYYLSPEICENKPYNNKSDIWALGCVLYELC 219 (350)
T ss_dssp HTTCEETTCCGGGEEE---CTTCCEEECSTTEESCCCHHHHHHHHHHSCCTTCCHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred HCCeeeccCCHHHEEE---CCCCCEEEcccccceeecCCcccccccCCCccccCHHHHCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999999 788899999999998765432 233467999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+|+.||.+.+..+++..+..+...+.+ ..+|+++.+||.+||++||.+|||++|+|+||||++.
T Consensus 220 tG~~PF~~~~~~~~~~~i~~~~~~~~~----~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 283 (350)
T 4b9d_A 220 TLKHAFEAGSMKNLVLKIISGSFPPVS----LHYSYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR 283 (350)
T ss_dssp HSSCSCCCSSHHHHHHHHHHTCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred HCCCCCCCcCHHHHHHHHHcCCCCCCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence 999999999999999888777654443 3789999999999999999999999999999999864
|
| >4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-59 Score=364.20 Aligned_cols=216 Identities=31% Similarity=0.579 Sum_probs=196.9
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|++++++++||||+++++++++++.+|+|||||+||+|.+++++.+++++..+..++.||+.||.|||++|
T Consensus 73 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~yivmEy~~gG~L~~~i~~~~~l~e~~~~~~~~qi~~al~ylH~~~ 152 (311)
T 4aw0_A 73 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 152 (311)
T ss_dssp TTCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34467899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCC---CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
|+||||||+|||+ +.++.+||+|||+|+..... ......+||+.|+|||.+.+..++.++|+||+||++|+|++
T Consensus 153 IiHRDlKPeNILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~ 229 (311)
T 4aw0_A 153 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 229 (311)
T ss_dssp EECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTTTCCCBCCCCSCGGGCCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred CccCCCCHHHeEE---cCCCCEEEEEcCCceecCCCCCcccccCcccCcccCCHHHHcCCCCCcHHHHHHHHHHHHHHHh
Confidence 9999999999999 78899999999999876433 23445789999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHH------HhcCcccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE------FYHHRFLRRN 230 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------il~~~~~~~~ 230 (241)
|.+||.+.+..+++..|..+. ..++ ..+|+++.+||++||++||.+|||++| +++||||++.
T Consensus 230 G~~PF~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~i 297 (311)
T 4aw0_A 230 GLPPFRAGNEGLIFAKIIKLE-YDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 297 (311)
T ss_dssp SSCSSCCSSHHHHHHHHHHTC-CCCC----TTCCHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CCCCCCCCCHHHHHHHHHcCC-CCCC----cccCHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCCC
Confidence 999999999999998887654 3333 378999999999999999999999988 5899999873
|
| >3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-58 Score=357.12 Aligned_cols=215 Identities=35% Similarity=0.682 Sum_probs=184.3
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.+..+.+.+|++++++++||||+++++++++++..|+||||+ +|+|.+++.+.+++++..+..++.|++.||+|||++|
T Consensus 54 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~-~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~ 132 (275)
T 3hyh_A 54 SDMQGRIEREISYLRLLRHPHIIKLYDVIKSKDEIIMVIEYA-GNELFDYIVQRDKMSEQEARRFFQQIISAVEYCHRHK 132 (275)
T ss_dssp --CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECC-CEEHHHHHHHSCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEeCC-CCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 344678999999999999999999999999999999999999 6899999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~ 165 (241)
|+||||||+||++ +.++.+||+|||+|+...........+||+.|+|||.+.+..+ +.++|+||+||++|+|++|+
T Consensus 133 IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvily~lltg~ 209 (275)
T 3hyh_A 133 IVHRDLKPENLLL---DEHLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVILYVMLCRR 209 (275)
T ss_dssp CCCCCCCTTTEEE---CTTCCEEECCSSCC---------------CTTSCHHHHSSSSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred cccccCChHHeEE---CCCCCEEEeecCCCeecCCCCccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHHHHHHHCC
Confidence 9999999999999 7888999999999987766655667789999999999998876 58999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
.||.+.+..++++.+..+. ..++ ..+|+++.++|++||+.||.+|||++|+++||||+..
T Consensus 210 ~PF~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~~ 269 (275)
T 3hyh_A 210 LPFDDESIPVLFKNISNGV-YTLP----KFLSPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKVD 269 (275)
T ss_dssp CSSCCSSHHHHHHHHHHTC-CCCC----TTSCHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHTT
T ss_pred CCCCCCCHHHHHHHHHcCC-CCCC----CCCCHHHHHHHHHHccCChhHCcCHHHHHcCcccccC
Confidence 9999999989888887654 2333 3789999999999999999999999999999999753
|
| >3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.4e-58 Score=356.98 Aligned_cols=218 Identities=28% Similarity=0.543 Sum_probs=187.5
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
+....+.+.+|++++++++||||+++++++++ ++.+|+|||||+||+|.+++.+.+++++..+..++.|++.||+|
T Consensus 65 ~~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~lvmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~y 144 (290)
T 3fpq_A 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144 (290)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEEETTEEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEeeccCCCcEEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence 45567889999999999999999999999875 35689999999999999999998999999999999999999999
Q ss_pred HHhCC--ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 82 lh~~~--i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
||++| |+||||||+|||++ +.++.+||+|||+|+.... ......+||+.|+|||.+.+ .++.++|||||||++|
T Consensus 145 lH~~~~~IiHRDlKp~NILl~--~~~g~vKl~DFGla~~~~~-~~~~~~~GTp~YmAPE~~~~-~y~~~~DiwSlGvily 220 (290)
T 3fpq_A 145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRA-SFAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML 220 (290)
T ss_dssp HHTSSSCCCCCCCCGGGEEES--STTSCEEECCTTGGGGCCT-TSBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred HHHCCCCEEecccChhheeEE--CCCCCEEEEeCcCCEeCCC-CccCCcccCccccCHHHcCC-CCCcHHHHHHHHHHHH
Confidence 99998 99999999999993 3468899999999976433 34456789999999998865 6999999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 160 ELLNGYPPFSGRN-NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 160 ~l~~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+|++|+.||.+.+ ...+.+.+..+.. +.......++++.++|.+||+.||++|||++|+|+||||++.
T Consensus 221 elltg~~Pf~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~ 289 (290)
T 3fpq_A 221 EMATSEYPYSECQNAAQIYRRVTSGVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHHCCCCCCCCCcHHHHHHHHHcCCC---CCCCCccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence 9999999997654 4555666654433 223344688999999999999999999999999999999874
|
| >3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-59 Score=365.09 Aligned_cols=226 Identities=34% Similarity=0.536 Sum_probs=193.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|++++++++||||+++++++++++..|+|||||+||+|.+++.+.+++++..+..++.|++.||.|||++||
T Consensus 68 ~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~I 147 (304)
T 3ubd_A 68 RDRVRTKMERDILVEVNHPFIVKLHYAFQTEGKLYLILDFLRGGDLFTRLSKEVMFTEEDVKFYLAELALALDHLHSLGI 147 (304)
T ss_dssp EECC------CCCCCCCCTTEECEEEEEEETTEEEEEECCCTTCEEHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHHCCCCCCCeEEEEEEECCEEEEEEEcCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 34557889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+||||||+|||+ +.++.+||+|||+|+.... .......+||+.|+|||.+.+..++.++|+||+||++|+|++|..
T Consensus 148 iHRDlKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~~ 224 (304)
T 3ubd_A 148 IYRDLKPENILL---DEEGHIKLTDFGLSKESIDHEKKAYSFCGTVEYMAPEVVNRRGHTQSADWWSFGVLMFEMLTGTL 224 (304)
T ss_dssp CCSSCCGGGEEE---CTTSCEEEESSEEEEC-----CCCCSCCCCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred cCCCCCHHHeEE---cCCCCEEecccccceeccCCCccccccccCcccCCHHHhccCCCCCCCcccchHHHHHHHHhCCC
Confidence 999999999999 7889999999999986543 333456789999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCcccccc-----cccCCC
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN-----SAILRA 236 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~-----~~~~~~ 236 (241)
||.+.+..+.+..+.... .+++ ..+|+++.++|++||++||.+||| ++|+++||||++. .....+
T Consensus 225 PF~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~idw~~l~~~~~~ 299 (304)
T 3ubd_A 225 PFQGKDRKETMTMILKAK-LGMP----QFLSPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNKLYRREIH 299 (304)
T ss_dssp SSCCSSHHHHHHHHHHCC-CCCC----TTSCHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTTCCHHHHHTTCSC
T ss_pred CCCCcCHHHHHHHHHcCC-CCCC----CcCCHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccCCCHHHHHhCCCC
Confidence 999999999998886654 3333 378999999999999999999998 5899999999873 223344
Q ss_pred CCCCC
Q 026253 237 PFHIP 241 (241)
Q Consensus 237 ~~~~~ 241 (241)
|+.+|
T Consensus 300 pP~~P 304 (304)
T 3ubd_A 300 PPFKP 304 (304)
T ss_dssp CSSCC
T ss_pred cCcCC
Confidence 55666
|
| >4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-57 Score=370.05 Aligned_cols=219 Identities=24% Similarity=0.494 Sum_probs=198.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|+.++++++||||+++++++.+++.+|+|||||+||+|.++++. +++++..+..++.||+.||+|||++|
T Consensus 189 ~~~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~~~~~iVmEy~~gG~L~~~i~~-~~l~e~~~~~~~~qil~aL~ylH~~~ 267 (423)
T 4fie_A 189 QQRRELLFNEVVIMRDYQHENVVEMYNSYLVGDELWVVMEFLEGGALTDIVTH-TRMNEEQIAAVCLAVLQALSVLHAQG 267 (423)
T ss_dssp CSSGGGHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCceEEEEEECCEEEEEEeCCCCCcHHHHHhc-cCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 44567899999999999999999999999999999999999999999999864 57999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
|+||||||+|||+ +.++.+||+|||+|+..... ......+||+.|+|||++.+..|+.++|||||||++|+|++|.
T Consensus 268 IiHRDiKp~NILl---~~~g~vKl~DFGla~~~~~~~~~~~~~~GTp~YmAPEvl~~~~y~~~~DiWSlGvilyeml~G~ 344 (423)
T 4fie_A 268 VIHRDIKSDSILL---THDGRVKLSDFGFCAQVSKEVPRRKSLVGTPYWMAPELISRLPYGPEVDIWSLGIMVIEMVDGE 344 (423)
T ss_dssp EECCCCSTTTEEE---CTTCCEEECCCTTCEECCSSCCCBCCCEECTTTCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred eecccCCHHHEEE---cCCCCEEEecCccceECCCCCccccccccCcCcCCHHHHCCCCCCcHHHHHHHHHHHHHHHHCC
Confidence 9999999999999 78889999999999876543 3445678999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
+||.+.+..+.+..+......... ....+|+++.+||.+||+.||.+|||++|+|+||||++..
T Consensus 345 ~PF~~~~~~~~~~~i~~~~~~~~~--~~~~~s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~ 408 (423)
T 4fie_A 345 PPYFNEPPLKAMKMIRDNLPPRLK--NLHKVSPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAG 408 (423)
T ss_dssp CTTTTSCHHHHHHHHHHSCCCCCS--CTTSSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCCcCHHHHHHHHHcCCCCCCc--ccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCC
Confidence 999999999999888766543332 2347899999999999999999999999999999999753
|
| >4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-56 Score=352.86 Aligned_cols=214 Identities=29% Similarity=0.412 Sum_probs=187.5
Q ss_pred HHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 026253 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL 92 (241)
Q Consensus 13 ~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl 92 (241)
..+|+.++++++|||||++++++.+++..|+|||||+||+|.+++++.+++++..+..++.|++.||.|||++||+||||
T Consensus 97 ~~~E~~il~~l~HpnIV~l~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~aL~ylH~~~IiHRDl 176 (336)
T 4g3f_A 97 RVEELVACAGLSSPRIVPLYGAVREGPWVNIFMELLEGGSLGQLIKQMGCLPEDRALYYLGQALEGLEYLHTRRILHGDV 176 (336)
T ss_dssp CTHHHHTTTTCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEECSCC
T ss_pred HHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCceeccc
Confidence 45799999999999999999999999999999999999999999999899999999999999999999999999999999
Q ss_pred CCCCeEEeecCCCc-eEEEeecCCccccCCCCc------cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 93 KPENILLSGLDDDV-MLKIADFGLSCTLYPGNY------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 93 ~~~nil~~~~~~~~-~~~l~df~~a~~~~~~~~------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
||+|||+ +.++ .+||+|||+|+....... ....+||+.|+|||.+.+..++.++||||+||++|+|++|.
T Consensus 177 Kp~NILl---~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~y~~~~DiwSlGvilyemltG~ 253 (336)
T 4g3f_A 177 KADNVLL---SSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKPCDAKVDIWSSCCMMLHMLNGC 253 (336)
T ss_dssp CGGGEEE---CTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CHHHEEE---eCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCCCCcHHHHHHHHHHHHHHHHCc
Confidence 9999999 5555 699999999987654321 22357999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHH-------------hcCccccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEF-------------YHHRFLRRNS 231 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i-------------l~~~~~~~~~ 231 (241)
.||.+.+..++...+...... ....++.+|+++.++|.+||++||.+|||+.|+ ++|||+.+..
T Consensus 254 ~Pf~~~~~~~~~~~i~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~ 330 (336)
T 4g3f_A 254 HPWTQYFRGPLCLKIASEPPP--IREIPPSCAPLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYK 330 (336)
T ss_dssp CSSTTTCCSCCHHHHHHSCCG--GGGSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCC
T ss_pred CCCCCCCHHHHHHHHHcCCCC--chhcCccCCHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCC
Confidence 999988877777777654421 223456899999999999999999999999997 6899997653
|
| >4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-56 Score=347.87 Aligned_cols=219 Identities=23% Similarity=0.503 Sum_probs=195.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-------------CCCHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------------RVPEQTARKFL 72 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------------~~~~~~~~~~~ 72 (241)
+.+..+++.+|++++++++||||++++|++.+++..++|||||++|+|.+++.+.+ .+++..+..++
T Consensus 55 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~ 134 (299)
T 4asz_A 55 SDNARKDFHREAELLTNLQHEHIVKFYGVCVEGDPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQMLHIA 134 (299)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHHHHH
Confidence 45667889999999999999999999999999999999999999999999997643 58999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCch
Q 026253 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKV 149 (241)
Q Consensus 73 ~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~ 149 (241)
.|++.||.|||+++|+||||||+|||+ +.++.+||+|||+|+....... .....+|+.|+|||.+.+..++.++
T Consensus 135 ~qia~gl~yLH~~~iiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~k~ 211 (299)
T 4asz_A 135 QQIAAGMVYLASQHFVHRDLATRNCLV---GENLLVKIGDFGMSRDVYSTDYYRVGGHTMLPIRWMPPESIMYRKFTTES 211 (299)
T ss_dssp HHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCEEETTTEEECGGGCCHHHHHHCCCCHHH
T ss_pred HHHHHHHHHHHhCCcccCccCHhhEEE---CCCCcEEECCcccceecCCCCceeecCceecChhhcCHHHHcCCCCCchh
Confidence 999999999999999999999999999 7889999999999976543322 2234578999999999999999999
Q ss_pred hHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 026253 150 DMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228 (241)
Q Consensus 150 Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 228 (241)
||||||+++|||+| |+.||.+.+..+....+..+...+.+. .+|+++.+++.+||+.||++|||++++ ++||+
T Consensus 212 DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~~i--~~~L~ 285 (299)
T 4asz_A 212 DVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQRPR----TCPQEVYELMLGCWQREPHMRKNIKGI--HTLLQ 285 (299)
T ss_dssp HHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHH--HHHHH
T ss_pred hHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCCc----cchHHHHHHHHHHcCCChhHCcCHHHH--HHHHH
Confidence 99999999999998 899999999999999998887766554 789999999999999999999999999 46887
Q ss_pred ccccc
Q 026253 229 RNSAI 233 (241)
Q Consensus 229 ~~~~~ 233 (241)
+....
T Consensus 286 ~~~~~ 290 (299)
T 4asz_A 286 NLAKA 290 (299)
T ss_dssp HHHHH
T ss_pred HHHhc
Confidence 64443
|
| >4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.9e-54 Score=342.64 Aligned_cols=212 Identities=23% Similarity=0.464 Sum_probs=185.3
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc---------------CCCCHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH---------------GRVPEQTARK 70 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~---------------~~~~~~~~~~ 70 (241)
+....+.+.+|++++++++|||||+++|++.+++..++|||||++|+|.+++++. +++++..+..
T Consensus 83 ~~~~~~~f~~E~~il~~l~HpnIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 162 (329)
T 4aoj_A 83 SESARQDFQREAELLTMLQHQHIVRFFGVCTEGRPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQLLA 162 (329)
T ss_dssp SHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHHHHH
Confidence 5566788999999999999999999999999999999999999999999999753 3589999999
Q ss_pred HHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCC
Q 026253 71 FLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDE 147 (241)
Q Consensus 71 ~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~ 147 (241)
++.|++.||.|||+.+|+||||||+|||+ +.++.+||+|||+|+...... ......+|+.|+|||.+.+..++.
T Consensus 163 i~~qia~gl~yLH~~~iiHRDLKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~gt~~ymAPE~~~~~~~~~ 239 (329)
T 4aoj_A 163 VASQVAAGMVYLAGLHFVHRDLATRNCLV---GQGLVVKIGDFGMSRDIYSTDYYRVGGRTMLPIRWMPPESILYRKFTT 239 (329)
T ss_dssp HHHHHHHHHHHHHHTTCCCSCCCGGGEEE---ETTTEEEECCCC----------------CCCCGGGCCHHHHTTCCCCH
T ss_pred HHHHHHHHHHHHhcCCeecccccHhhEEE---CCCCcEEEcccccceeccCCCcceecCcccccccccChhhhcCCCCCc
Confidence 99999999999999999999999999999 788999999999998664332 223456899999999999999999
Q ss_pred chhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 148 KVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 148 ~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
++||||||+++|||+| |+.||.+.+..+....+..+...+.+. .+|+++.+++.+||+.||++|||++|++++
T Consensus 240 ~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~ei~~~ 313 (329)
T 4aoj_A 240 ESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELERPR----ACPPEVYAIMRGCWQREPQQRHSIKDVHAR 313 (329)
T ss_dssp HHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred cccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCCcc----cccHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence 9999999999999999 899999999999999998887766654 789999999999999999999999999864
|
| >4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-53 Score=335.88 Aligned_cols=210 Identities=23% Similarity=0.493 Sum_probs=189.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTARKF 71 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~~~~ 71 (241)
...+.+.+|+.++++++||||++++|++.+++..++|||||++|+|.+++... ..+++..+..+
T Consensus 71 ~~~~~f~~E~~il~~l~HpNIV~l~g~~~~~~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i 150 (308)
T 4gt4_A 71 PLREEFRHEAMLRARLQHPNVVCLLGVVTKDQPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEPPDFVHL 150 (308)
T ss_dssp -CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCCCCcceEEEECCEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCHHHHHHH
Confidence 34678999999999999999999999999999999999999999999999653 35899999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCCc
Q 026253 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEK 148 (241)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~ 148 (241)
+.|++.||.|||+++++||||||.|||+ ++++.+||+|||+|+...... ......+|+.|+|||.+.+..++.+
T Consensus 151 ~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~~Ki~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~~s~k 227 (308)
T 4gt4_A 151 VAQIAAGMEYLSSHHVVHKDLATRNVLV---YDKLNVKISDLGLFREVYAADYYKLLGNSLLPIRWMAPEAIMYGKFSID 227 (308)
T ss_dssp HHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCSCCBCGGGGGGCBCSSSSSCBCGGGCCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHHhCCCCCCCccccceEE---CCCCCEEECCcccceeccCCCceeEecccccCCcccCHHHHhCCCCCcc
Confidence 9999999999999999999999999999 788999999999997653322 2334568999999999999999999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 149 VDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+||||||+++|||+| |..||.+.+..+....+..+...+.+. .+|+++.+++.+||+.||.+|||++|++++
T Consensus 228 sDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~----~~~~~~~~li~~C~~~dP~~RPs~~ei~~~ 300 (308)
T 4gt4_A 228 SDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCPD----DCPAWVYALMIECWNEFPSRRPRFKDIHSR 300 (308)
T ss_dssp HHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred chhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCcc----cchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 999999999999998 899999999999999998877766554 789999999999999999999999999865
|
| >3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-53 Score=331.33 Aligned_cols=215 Identities=23% Similarity=0.387 Sum_probs=180.1
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+.+..+.+.+|++++++++||||++++|++.+ +..++|||||+||+|.+++... .++++..+..++.|++.||+|||+
T Consensus 72 ~~~~~~~f~~E~~il~~l~HpNIV~l~g~~~~-~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~yLH~ 150 (307)
T 3omv_A 72 TPEQFQAFRNEVAVLRKTRHVNILLFMGYMTK-DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDYLHA 150 (307)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEC-CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999998765 5689999999999999999764 579999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC---CccccccCCCCccCcccccc---cCCCCchhHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAIL 158 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~---~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l 158 (241)
++|+||||||+|||+ +.++.+||+|||+|+..... .......||+.|+|||.+.+ ..++.++||||||+++
T Consensus 151 ~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gvvl 227 (307)
T 3omv_A 151 KNIIHRDMKSNNIFL---HEGLTVKIGDFGLATVKSRWSGSQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGIVL 227 (307)
T ss_dssp TTCBCSCCCSSSEEE---ETTEEEEECCCSSCBC------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHHHH
T ss_pred CCccCCccCHHHEEE---CCCCcEEEeeccCceecccCCcceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHHHH
Confidence 999999999999999 68899999999999765432 22345679999999999864 3589999999999999
Q ss_pred HHHHhCCCCCCCCChHHHH-HHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 159 FELLNGYPPFSGRNNVQLV-RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|||++|+.||.+.+..... ..+..+...+......+.+|+++.+++.+||+.||++|||+.|++++
T Consensus 228 ~Elltg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 294 (307)
T 3omv_A 228 YELMTGELPYSHINNRDQIIFMVGRGYASPDLSKLYKNCPKAMKRLVADCVKKVKEERPLFPQILSS 294 (307)
T ss_dssp HHHHHSSCTTTTCCCHHHHHHHHHTTCCCCCSTTSCTTSCHHHHHHHHHHTCSSSTTSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCChHHHHHHHHhcCCCCCCcccccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 9999999999987665444 44444444444444556889999999999999999999999988654
|
| >4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-52 Score=341.71 Aligned_cols=220 Identities=28% Similarity=0.459 Sum_probs=188.6
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEee------cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (241)
....+.+.+|++++++++||||+++++++.. .+..|+|||||+ |+|.+++.+.+++++..+..++.||+.||.
T Consensus 94 ~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~~~~~~~ivmE~~~-g~L~~~i~~~~~l~~~~~~~~~~qil~al~ 172 (398)
T 4b99_A 94 VTNAKRTLRELKILKHFKHDNIIAIKDILRPTVPYGEFKSVYVVLDLME-SDLHQIIHSSQPLTLEHVRYFLYQLLRGLK 172 (398)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSSCTTTCCCEEEEEECCS-EEHHHHHTSSSCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCcceEeeeeecccccccCCEEEEEEeCCC-CCHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Confidence 3456778899999999999999999998754 367899999995 689999998899999999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-----CccccccCCCCccCccccccc-CCCCchhHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSV 154 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-----~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~sl 154 (241)
|||++||+||||||+|||+ +.++.+||+|||+|+..... ......+||+.|+|||++.+. .++.++|+||+
T Consensus 173 ylH~~~iiHRDlKP~NIl~---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSl 249 (398)
T 4b99_A 173 YMHSAQVIHRDLKPSNLLV---NENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSV 249 (398)
T ss_dssp HHHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHH
T ss_pred HHHHCcCcCCCcCcccccc---CCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehh
Confidence 9999999999999999999 78899999999999865432 233456899999999998775 56999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC--------------------------CccCCCCChHHHHHHHHhc
Q 026253 155 GAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS--------------------------QLIVPALHPDCVDMCLKLL 208 (241)
Q Consensus 155 G~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l 208 (241)
||++|+|++|.+||.+.+..+.+..|......+.. ....+.+|+++.+||++||
T Consensus 250 G~il~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL 329 (398)
T 4b99_A 250 GCIFGEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYPGADRQALSLLGRML 329 (398)
T ss_dssp HHHHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHSTTCCHHHHHHHHHHS
T ss_pred HHHHHHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCCCCCHHHHHHHHHHC
Confidence 99999999999999999988888777543322211 1123467899999999999
Q ss_pred ccCccccCCHHHHhcCcccccc
Q 026253 209 SANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 209 ~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+.||.+|||++|+|+||||++.
T Consensus 330 ~~dP~~R~ta~e~L~Hp~f~~~ 351 (398)
T 4b99_A 330 RFEPSARISAAAALRHPFLAKY 351 (398)
T ss_dssp CSSTTTSCCHHHHTTSGGGTTT
T ss_pred cCChhHCcCHHHHhcCHhhCcC
Confidence 9999999999999999999874
|
| >3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-52 Score=356.56 Aligned_cols=223 Identities=30% Similarity=0.551 Sum_probs=200.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+.+.+|++++++++||||+++++++++++.+|+|||||+||+|.+++.. .+.+++..+..++.||+.||.|||+
T Consensus 194 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~ylH~ 273 (573)
T 3uto_A 194 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 273 (573)
T ss_dssp SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEECSSEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345577899999999999999999999999999999999999999999999964 4679999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
+||+||||||+||+++. +..+.+||+|||+|+...........+||+.|+|||.+.+..++.++|+||+||++|+|++|
T Consensus 274 ~~iiHRDlKp~Nill~~-~~~~~vKl~DFG~a~~~~~~~~~~~~~GT~~y~APEv~~~~~y~~~~DiWSlGvilyeml~G 352 (573)
T 3uto_A 274 NNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 352 (573)
T ss_dssp TTEECCCCCGGGEEESS-SSCCCEEECCCSSCEECCTTSEEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred CCeeeccCChhhccccC-CCCCCEEEeeccceeEccCCCceeeeEECccccCHHHhCCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999999942 23478999999999988776666677899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
.+||.+.+..+.+..+.... ..++....+.+|+++.+||++||+.||.+|||++|+|+||||+..
T Consensus 353 ~~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~ 417 (573)
T 3uto_A 353 LSPFGGENDDETLRNVKSCD-WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 417 (573)
T ss_dssp CCSSCCSSHHHHHHHHHTTC-CCCCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred CCCCCCcCHHHHHHHHHhCC-CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCC
Confidence 99999999999998886544 334455556899999999999999999999999999999999863
|
| >4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-52 Score=330.45 Aligned_cols=214 Identities=28% Similarity=0.495 Sum_probs=170.1
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC------------eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKF 71 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~------------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~ 71 (241)
+...+.+.+|++++++|+||||+++++++.+.+ ..|+|||||+|++|.++++..+. .++..+..+
T Consensus 44 ~~~~~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i 123 (299)
T 4g31_A 44 ELAREKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHI 123 (299)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHH
Confidence 455678999999999999999999999987544 37999999999999999987654 455678899
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-------------cccccCCCCccCcc
Q 026253 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-------------AEKVCGSPLYMAPE 138 (241)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-------------~~~~~~~~~~~~PE 138 (241)
+.|++.||+|||++||+||||||+|||+ +.++.+||+|||+|+....... ....+||+.|+|||
T Consensus 124 ~~qi~~al~ylH~~~IiHRDlKp~NILl---~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE 200 (299)
T 4g31_A 124 FLQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPE 200 (299)
T ss_dssp HHHHHHHHHHHHHTTCCCCCCCGGGEEE---CTTCCEEECCCCCC--------------------------CCCTTSCHH
T ss_pred HHHHHHHHHHHHHCcCccccCcHHHeEE---CCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHH
Confidence 9999999999999999999999999999 7888999999999987654321 12346999999999
Q ss_pred cccccCCCCchhHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC
Q 026253 139 VLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN-VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
.+.+..++.++|||||||++|+|++ ||.+... ...+..+.... ++. ..+..++...++|++||+.||.+|||
T Consensus 201 ~~~~~~y~~~~DiwSlGvilyell~---Pf~~~~~~~~~~~~~~~~~---~p~-~~~~~~~~~~~li~~~L~~dP~~Rps 273 (299)
T 4g31_A 201 QIHGNSYSHKVDIFSLGLILFELLY---PFSTQMERVRTLTDVRNLK---FPP-LFTQKYPCEYVMVQDMLSPSPMERPE 273 (299)
T ss_dssp HHTTCCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHTTC---CCH-HHHHHCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHcCCCCCCHHHHHHHHHHHHHHcc---CCCCccHHHHHHHHHhcCC---CCC-CCcccCHHHHHHHHHHcCCChhHCcC
Confidence 9999999999999999999999996 7754322 23333333322 222 12245667889999999999999999
Q ss_pred HHHHhcCcccccc
Q 026253 218 FNEFYHHRFLRRN 230 (241)
Q Consensus 218 ~~~il~~~~~~~~ 230 (241)
+.|+++||||++.
T Consensus 274 ~~eil~h~~~~~~ 286 (299)
T 4g31_A 274 AINIIENAVFEDL 286 (299)
T ss_dssp HHHHHTSGGGCCC
T ss_pred HHHHhcCHhhCCC
Confidence 9999999999874
|
| >4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-52 Score=333.77 Aligned_cols=218 Identities=22% Similarity=0.363 Sum_probs=177.5
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....++.+|+++++++ +||||++++++++++++.|+||||++|++|.++++ .+++..+..++.|++.||+|||++|
T Consensus 61 ~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~~~~~lvmE~~~g~~L~~~~~---~l~~~~~~~~~~qll~al~ylH~~g 137 (361)
T 4f9c_A 61 SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKNDHVVIAMPYLEHESFLDILN---SLSFQEVREYMLNLFKALKRIHQFG 137 (361)
T ss_dssp SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEETTEEEEEEECCCCCCHHHHHT---TCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCHHHHHHHHHHHHHhcCCCCCceEEEEEEECCEEEEEEeCCCcccHHHHHc---CCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999999 69999999999999999999999999999999984 5899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-----------------------------ccccccCCCCccCc
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----------------------------YAEKVCGSPLYMAP 137 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-----------------------------~~~~~~~~~~~~~P 137 (241)
|+||||||+|||++ .+.+.+||+|||+|+...... .....+||+.|+||
T Consensus 138 IiHRDiKPeNiLl~--~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~Y~AP 215 (361)
T 4f9c_A 138 IVHRDVKPSNFLYN--RRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAP 215 (361)
T ss_dssp EECSCCSGGGEEEE--TTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCCCGGGCCH
T ss_pred eEeCcCCHHHeEEe--CCCCeEEECcCCCCcccCCccccccccccccccccccccccccccccccccccccccCccccCH
Confidence 99999999999995 445799999999997654321 11234699999999
Q ss_pred cccccc-CCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcCC-------------------------------
Q 026253 138 EVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSG-RNNVQLVRNINSCK------------------------------- 184 (241)
Q Consensus 138 E~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~------------------------------- 184 (241)
|.+.+. .++.++|+||+||++|+|++|+.||.. .+..+.+..|....
T Consensus 216 E~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~ 295 (361)
T 4f9c_A 216 EVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPAQDLRKLC 295 (361)
T ss_dssp HHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCCCCHHHHH
T ss_pred HHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcchhhhHHH
Confidence 998765 589999999999999999999999854 44444443332100
Q ss_pred ------C------------CCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 185 ------H------------LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 185 ------~------------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
. ..........+|+++.|||++||+.||++|+|++|+|+||||++.
T Consensus 296 ~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i 359 (361)
T 4f9c_A 296 ERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM 359 (361)
T ss_dssp HHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred HhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence 0 000111234688999999999999999999999999999999874
|
| >3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-50 Score=344.29 Aligned_cols=207 Identities=29% Similarity=0.512 Sum_probs=181.6
Q ss_pred HHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 026253 14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93 (241)
Q Consensus 14 ~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~ 93 (241)
++++.+++.++||||++++++|++.+.+|+||||++||+|.+++.+.+.+++..+..++.||+.||.|||++||+|||||
T Consensus 240 ~~~l~ll~~~~HP~IV~l~~~f~~~~~lylVmEy~~GGdL~~~l~~~~~l~E~~a~~y~~qIl~aL~yLH~~gIiHRDLK 319 (689)
T 3v5w_A 240 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 319 (689)
T ss_dssp HHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHTTTEECCCCS
T ss_pred HHHHHHHhhCCCCCEeEEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccccCCc
Confidence 34467777889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCCCCC-
Q 026253 94 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSGR- 171 (241)
Q Consensus 94 ~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~- 171 (241)
|+|||+ +.++.+||+|||+|+...... ....+||+.|+|||++.+ ..|+.++|+|||||++|+|++|.+||.+.
T Consensus 320 PeNILl---d~~G~vKL~DFGlA~~~~~~~-~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGvilYEmLtG~~PF~~~~ 395 (689)
T 3v5w_A 320 PANILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 395 (689)
T ss_dssp GGGEEE---CTTSCEEECCCTTCEECSSCC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCTTCGGG
T ss_pred hHHeEE---eCCCCEEecccceeeecCCCC-CCCccCCcCccCHHHHhCCCCCCcHHHHHHHHHHHHHHHhCCCCCCCCC
Confidence 999999 788999999999998765433 445789999999999964 57999999999999999999999999753
Q ss_pred --ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc
Q 026253 172 --NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 229 (241)
Q Consensus 172 --~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~ 229 (241)
+..++.+.+... ...++ ..+|+++.+||++||+.||.+|++ ++|+++||||++
T Consensus 396 ~~~~~~i~~~i~~~-~~~~p----~~~S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~ 455 (689)
T 3v5w_A 396 TKDKHEIDRMTLTM-AVELP----DSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS 455 (689)
T ss_dssp CCCHHHHHHHHHHC-CCCCC----TTSCHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred hHHHHHHHHhhcCC-CCCCC----ccCCHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence 333444444332 23333 478999999999999999999998 799999999997
|
| >4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-51 Score=328.59 Aligned_cols=216 Identities=28% Similarity=0.499 Sum_probs=187.0
Q ss_pred HHhhhhHHHHHHHHhcCCC-cCeeeeeeEEee-cCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNH-PNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTA 68 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~ 68 (241)
....+.+.+|++++++++| ||||+++|++.+ ++..++|||||++|+|.+++++. ..+++..+
T Consensus 108 ~~~~~~~~~E~~il~~l~hhpnIV~l~g~~~~~~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~~~~ 187 (353)
T 4ase_A 108 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 187 (353)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcEEEEEEEEEecCCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCHHHH
Confidence 4557789999999999975 899999999866 45689999999999999999753 23789999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCC
Q 026253 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY 145 (241)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~ 145 (241)
..++.|++.||.|||+++++||||||+|||+ +.++.+||+|||+|+....... .....+|+.|+|||.+.+..+
T Consensus 188 ~~~~~qia~gl~yLH~~~iiHRDLK~~NILl---~~~~~vKi~DFGlar~~~~~~~~~~~~~~~gt~~ymAPE~l~~~~y 264 (353)
T 4ase_A 188 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 264 (353)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHhHhhCCeecCccCccceee---CCCCCEEECcchhhhhcccCCCceeeccccccccccCHHHHhcCCC
Confidence 9999999999999999999999999999999 7889999999999987644322 234567899999999999999
Q ss_pred CCchhHHHHHHHHHHHHh-CCCCCCCCC-hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 146 DEKVDMWSVGAILFELLN-GYPPFSGRN-NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 146 ~~~~Dv~slG~~l~~l~~-g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+.++|||||||++|||++ |..||.+.+ .....+.+..+.+.+.+. .+++++.+++.+||+.||.+|||++|+++
T Consensus 265 ~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~p~----~~~~~~~~li~~c~~~dP~~RPt~~eil~ 340 (353)
T 4ase_A 265 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVE 340 (353)
T ss_dssp CHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCCCc----cCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 999999999999999998 999998865 456667777777666654 78999999999999999999999999998
Q ss_pred C--ccccc
Q 026253 224 H--RFLRR 229 (241)
Q Consensus 224 ~--~~~~~ 229 (241)
| .+++.
T Consensus 341 ~L~~llq~ 348 (353)
T 4ase_A 341 HLGNLLQA 348 (353)
T ss_dssp HHHHHHHH
T ss_pred HHHHHHHH
Confidence 8 44443
|
| >3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-49 Score=315.46 Aligned_cols=218 Identities=34% Similarity=0.654 Sum_probs=197.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++...+++++..+..++.|++.||.+||++
T Consensus 54 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~l~~~~~~~~~~qi~~al~~lH~~ 133 (328)
T 3fe3_A 54 NPTSLQKLFREVRIMKILNHPNIVKLFEVIETEKTLYLIMEYASGGEVFDYLVAHGRMKEKEARSKFRQIVSAVQYCHQK 133 (328)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCEEEEEEECCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44566788999999999999999999999999999999999999999999999889999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCC-CchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~-~~~Dv~slG~~l~~l~~g 164 (241)
|++||||||+||++ +.++.++|+|||++.............+++.|+|||.+.+..+. .++|+||+|+++|+|++|
T Consensus 134 ~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g 210 (328)
T 3fe3_A 134 RIVHRDLKAENLLL---DADMNIKIADFGFSNEFTVGGKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSG 210 (328)
T ss_dssp TCCCSCCCGGGEEE---CTTSCEEECSTTCCGGGSSSCGGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHHHHHHHS
T ss_pred CEeccCCCHHHEEE---cCCCCEEEeeccCceecCCCCccccccCCcceeCcccccCCCcCCchhhhhhhHHHHHHHHhC
Confidence 99999999999999 78889999999999877666556667899999999999887764 899999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
..||.+.+..+....+..+.. ..+ ..++.++.+++++||+.||.+|||++|+++||||+...
T Consensus 211 ~~pf~~~~~~~~~~~i~~~~~-~~p----~~~s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 272 (328)
T 3fe3_A 211 SLPFDGQNLKELRERVLRGKY-RIP----FYMSTDCENLLKRFLVLNPIKRGTLEQIMKDRWINAGH 272 (328)
T ss_dssp SCSSCCSSHHHHHHHHHHCCC-CCC----TTSCHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTTC
T ss_pred CCCCCCCCHHHHHHHHHhCCC-CCC----CCCCHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCCC
Confidence 999999998888888866543 222 36799999999999999999999999999999998743
|
| >2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-49 Score=319.38 Aligned_cols=216 Identities=31% Similarity=0.577 Sum_probs=196.4
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
.+.+.+|+.++++++||||+++++++.+++..++||||++|++|.+++...+.+++..+..++.|++.||.+||+.|++|
T Consensus 59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 138 (361)
T 2yab_A 59 REEIEREVSILRQVLHPNIITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138 (361)
T ss_dssp HHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTCSCCBHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCcCCCcEEEEEEeCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 56789999999999999999999999999999999999999999999988888999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCc----eEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 90 RDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~----~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+||||+||++. ..+ .++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 139 rDlkp~NIll~---~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslGvil~~ll~g~ 215 (361)
T 2yab_A 139 FDLKPENIMLL---DKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215 (361)
T ss_dssp CCCSGGGEEES---CTTSSSCCEEECCCSSCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred CCCCHHHEEEe---CCCCCccCEEEEecCCceEcCCCCccccCCCCccEECchHHcCCCCCccccHHHHHHHHHHHHhCC
Confidence 99999999994 433 79999999998876655556677999999999999889999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
.||.+.+..+.+..+.... ..++...+..++.++.++|++||..||.+|||++|+++||||+.
T Consensus 216 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~ 278 (361)
T 2yab_A 216 SPFLGDTKQETLANITAVS-YDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWITP 278 (361)
T ss_dssp CSSCCSSHHHHHHHHHTTC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred CCCCCCCHHHHHHHHHhcC-CCCCchhccCCCHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence 9999999988888886543 34444455688999999999999999999999999999999985
|
| >3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.3e-49 Score=325.01 Aligned_cols=226 Identities=30% Similarity=0.500 Sum_probs=202.0
Q ss_pred hhHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 5 LNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.+....+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++...+.+++..+..++.|++.||.|||+
T Consensus 49 ~~~~~~~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~e~~~~~i~~qil~aL~~lH~ 128 (444)
T 3soa_A 49 LSARDHQKLEREARICRLLKHPNIVRLHDSISEEGHHYLIFDLVTGGELFEDIVAREYYSEADASHCIQQILEAVLHCHQ 128 (444)
T ss_dssp CHHHHHHHHHHHHHHHHHCCBTTBCCEEEEEECSSEEEEEECCCBCCBHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CCHHHHHHHHHHHHHHHhCCCcCCCeEEEEEEECCEEEEEEEeCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 35566788999999999999999999999999999999999999999999999988899999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+|++||||||+||+++...+++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 129 ~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwSlGvilyell~ 208 (444)
T 3soa_A 129 MGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQQAWFGFAGTPGYLSPEVLRKDPYGKPVDLWACGVILYILLV 208 (444)
T ss_dssp TTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTCCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCCceeecccCCcccCCHHHhcCCCCCCccccHHHHHHHHHHHh
Confidence 999999999999999654467889999999997765433 2345678999999999998899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|.+||.+.+..+....+..+.. .++....+.+++++.++|++||+.||.+|||+.|+|+||||++..
T Consensus 209 G~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~~~ 275 (444)
T 3soa_A 209 GYPPFWDEDQHRLYQQIKAGAY-DFPSPEWDTVTPEAKDLINKMLTINPSKRITAAEALKHPWISHRS 275 (444)
T ss_dssp SSCSCCCSSHHHHHHHHHHTCC-CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHHHH
T ss_pred CCCCCCCccHHHHHHHHHhCCC-CCCccccccCCHHHHHHHHHHcCCChhHCCCHHHHhcCccccCCc
Confidence 9999999999888888866543 334444568899999999999999999999999999999998754
|
| >2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B | Back alignment and structure |
|---|
Probab=100.00 E-value=5.2e-49 Score=318.72 Aligned_cols=224 Identities=29% Similarity=0.497 Sum_probs=200.2
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.....+.+.+|++++++++||||+++++++.+++..++||||+.|++|.+++.....+++..+..++.|++.||.|||++
T Consensus 68 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~ 147 (362)
T 2bdw_A 68 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 147 (362)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34566789999999999999999999999999999999999999999999998888899999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
|++|+||||+||+++..+..+.++|+|||++.............+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 148 ~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 227 (362)
T 2bdw_A 148 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 227 (362)
T ss_dssp TCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCCSCCCSCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred CeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCcccccCCCCccccCHHHHccCCCCchhhHHHHHHHHHHHHHCC
Confidence 99999999999999644455679999999998776655555677999999999999889999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
.||.+.+..+....+..+.. .++......+++++.++|.+||+.||.+|||+.++|+||||...
T Consensus 228 ~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~ 291 (362)
T 2bdw_A 228 PPFWDEDQHRLYAQIKAGAY-DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNR 291 (362)
T ss_dssp CSSCCSSHHHHHHHHHHTCC-CCCTTGGGGSCHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHTH
T ss_pred CCCCCCCHHHHHHHHHhCCC-CCCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHhcCcccCCC
Confidence 99999998888888866543 33444445789999999999999999999999999999999864
|
| >3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-49 Score=315.10 Aligned_cols=237 Identities=29% Similarity=0.536 Sum_probs=183.3
Q ss_pred hhhhhHHhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (241)
+|.++......+.+|+.+++++. ||||+++++++.+++..++||||+++++|.+++...+.+++..+..++.|++.||.
T Consensus 41 vK~~~~~~~~~~~~e~~~l~~l~~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~ 120 (325)
T 3kn6_A 41 VKIISKRMEANTQKEITALKLCEGHPNIVKLHEVFHDQLHTFLVMELLNGGELFERIKKKKHFSETEASYIMRKLVSAVS 120 (325)
T ss_dssp EEEEEGGGHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHCSCCCHHHHHHHHHHHHHHHH
T ss_pred EEEEChhhhhhHHHHHHHHHHhcCCCCeeEEEEEEEcCCEEEEEEEccCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHH
Confidence 45566667788999999999996 99999999999999999999999999999999999889999999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
+||++|++||||||+||+++..+....++|+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|
T Consensus 121 ~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwslG~il~ 200 (325)
T 3kn6_A 121 HMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDNQPLKTPCFTLHYAAPELLNQNGYDESCDLWSLGVILY 200 (325)
T ss_dssp HHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC----------------------CCCCHHHHHHHHHHHHH
T ss_pred HHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCCCcccccCCCcCccCHHHhcCCCCCCccchHHHHHHHH
Confidence 9999999999999999999643444489999999997654432 234456799999999999999999999999999999
Q ss_pred HHHhCCCCCCCCCh-------HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 160 ELLNGYPPFSGRNN-------VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 160 ~l~~g~~p~~~~~~-------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
+|++|..||.+.+. .+....+..+. ..++......+++++.++|++||+.||.+|||++|+++||||++...
T Consensus 201 ~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~~~ 279 (325)
T 3kn6_A 201 TMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGD-FSFEGEAWKNVSQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDGSQ 279 (325)
T ss_dssp HHHHSSCTTC-------CCCHHHHHHHHTTTC-CCCCSHHHHTSCHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTTCC
T ss_pred HHHhCCCCCCCCccccccccHHHHHHHHHcCC-CCCCcccccCCCHHHHHHHHHHCCCChhHCCCHHHHhcChhhccCcc
Confidence 99999999986433 45666664433 33343334578999999999999999999999999999999999877
Q ss_pred cCCCCCC
Q 026253 233 ILRAPFH 239 (241)
Q Consensus 233 ~~~~~~~ 239 (241)
....|+.
T Consensus 280 ~~~~~~~ 286 (325)
T 3kn6_A 280 LSSNPLM 286 (325)
T ss_dssp CCCSCCS
T ss_pred CCCCCCC
Confidence 6666654
|
| >1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6.4e-49 Score=313.48 Aligned_cols=226 Identities=27% Similarity=0.474 Sum_probs=199.2
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
......+.+|++++++++||||+++++++.+.+..++||||++|++|.+++... ..+++..+..++.|++.||.+||+.
T Consensus 42 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~ 121 (321)
T 1tki_A 42 GTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSH 121 (321)
T ss_dssp THHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cccHHHHHHHHHHHHhCCCCCCCeEeEEEecCCEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345567899999999999999999999999999999999999999999999765 3699999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
|++|+||||+||+++. +.++.++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 122 givH~Dlkp~NIl~~~-~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g~ 200 (321)
T 1tki_A 122 NIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGI 200 (321)
T ss_dssp TEECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSS
T ss_pred CCCcCCCCHHHEEEcc-CCCCCEEEEECCCCeECCCCCccccccCChhhcCcHHhcCCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999942 126889999999998876665555677899999999999888899999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccC
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 234 (241)
.||.+.+..+....+..... .++....+.+|.++.++|++||+.||.+|||+.|+++||||++.....
T Consensus 201 ~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~~ 268 (321)
T 1tki_A 201 NPFLAETNQQIIENIMNAEY-TFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERV 268 (321)
T ss_dssp CTTCCSSHHHHHHHHHHTCC-CCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGS
T ss_pred CCCcCCCHHHHHHHHHcCCC-CCChhhhccCCHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCcccc
Confidence 99999998888888866543 333334457899999999999999999999999999999999865443
|
| >1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-48 Score=308.85 Aligned_cols=214 Identities=31% Similarity=0.519 Sum_probs=193.7
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.|++.||.+||++|+
T Consensus 47 ~~~~~~~~E~~~l~~l~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 126 (337)
T 1o6l_A 47 DEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRDV 126 (337)
T ss_dssp TCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHHhCCCCcCcceEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 44677899999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccC-CCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+||||||+||++ +.++.++|+|||++.... ........++|+.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 127 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 203 (337)
T 1o6l_A 127 VYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRL 203 (337)
T ss_dssp BCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred ecCcCCHHHEEE---CCCCCEEEeeccchhhcccCCCcccccccChhhCChhhhcCCCCCchhhcccchhHHHHHhcCCC
Confidence 999999999999 788899999999997643 2334455678999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
||.+.+.......+.... ..++ ..+++++.++|++||+.||.+|| +++|+++||||+.
T Consensus 204 Pf~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~ 266 (337)
T 1o6l_A 204 PFYNQDHERLFELILMEE-IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp SSCCSSHHHHHHHHHHCC-CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCCHHHHHHHHHcCC-CCCC----CCCCHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence 999988888888776543 2333 37899999999999999999999 9999999999986
|
| >2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-48 Score=310.88 Aligned_cols=219 Identities=29% Similarity=0.565 Sum_probs=195.9
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++
T Consensus 57 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH~~~iv 136 (326)
T 2y0a_A 57 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA 136 (326)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHTTSSCCBHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEEcCCCCCHHHHHHhcCCcCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 35679999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCc----eEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 89 HRDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~----~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
|+||||+||++ +.++ .++|+|||++.............+++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 137 H~Dlkp~NIll---~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 213 (326)
T 2y0a_A 137 HFDLKPENIML---LDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSG 213 (326)
T ss_dssp CCCCCGGGEEE---SCSSSSSCCEEECCCTTCEECCTTSCCCCCCSCTTTCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred cCCCCHHHEEE---ecCCCCCCCEEEEECCCCeECCCCCccccccCCcCcCCceeecCCCCCcHHHHHHHHHHHHHHHHC
Confidence 99999999999 4444 7999999999877655555566789999999999988999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
..||.+.+..+....+.... ..++....+.++..+.++|++||+.||.+|||++|+++||||+...
T Consensus 214 ~~pf~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~ 279 (326)
T 2y0a_A 214 ASPFLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPKD 279 (326)
T ss_dssp CCSSCCSSHHHHHHHHHHTC-CCCCHHHHTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred cCCCCCCCHHHHHHHHHhcC-CCcCccccccCCHHHHHHHHHHccCChhhCCCHHHHhcCCCccCCc
Confidence 99999988888877775543 3334444567899999999999999999999999999999998643
|
| >3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-48 Score=311.28 Aligned_cols=217 Identities=33% Similarity=0.540 Sum_probs=191.3
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+.+.+|..+++.+ +||||+++++++.+.+..|+||||++|++|.+++.+.+.+++..+..++.|++.||.+||+
T Consensus 63 ~~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~ 142 (353)
T 3txo_A 63 QDDDVECTMTEKRILSLARNHPFLTQLFCCFQTPDRLFFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEIISALMFLHD 142 (353)
T ss_dssp HHTTHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHHhccCCCceeeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 344567788999999998 7999999999999999999999999999999999988999999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+|++||||||+||++ +.++.++|+|||++..... .......++|+.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 143 ~givHrDlkp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 219 (353)
T 3txo_A 143 KGIIYRDLKLDNVLL---DHEGHCKLADFGMCKEGICNGVTTATFCGTPDYIAPEILQEMLYGPAVDWWAMGVLLYEMLC 219 (353)
T ss_dssp TTCBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCC---------CCGGGCCHHHHHHHHCTTHHHHHHHHHHHHHHHH
T ss_pred CCCcccCCCHHHEEE---CCCCCEEEccccceeecccCCccccccCCCcCeEChhhcCCCCcCCccCCCcchHHHHHHHh
Confidence 999999999999999 7889999999999976432 334455679999999999998899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH------HHHhcCcccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF------NEFYHHRFLRRN 230 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~il~~~~~~~~ 230 (241)
|..||.+.+..+....+..... .++ ..++.++.++|++||+.||.+||++ +++++||||++.
T Consensus 220 G~~Pf~~~~~~~~~~~i~~~~~-~~p----~~~~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~~ 287 (353)
T 3txo_A 220 GHAPFEAENEDDLFEAILNDEV-VYP----TWLHEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEI 287 (353)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCC-CCC----TTSCHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred CCCCCCCCCHHHHHHHHHcCCC-CCC----CCCCHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccCC
Confidence 9999999999999988866542 233 3689999999999999999999998 899999999873
|
| >3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-47 Score=301.18 Aligned_cols=228 Identities=29% Similarity=0.491 Sum_probs=202.3
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+....+.+.+|++++++++||||+++++++.+++..++|||++++++|.+++.....+++..+..++.|++.||.+||+.
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 124 (284)
T 3kk8_A 45 SARDFQKLEREARICRKLQHPNIVRLHDSIQEESFHYLVFDLVTGGELFEDIVAREFYSEADASHCIQQILESIAYCHSN 124 (284)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHHcCCCCcCeEEEEEEcCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44556789999999999999999999999999999999999999999999998888899999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
|++|+||+|+||+++..+..+.++|+|||.+.............+++.|+|||.+.+..++.++|+||+|+++|+|++|.
T Consensus 125 ~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 204 (284)
T 3kk8_A 125 GIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEAWHGFAGTPGYLSPEVLKKDPYSKPVDIWACGVILYILLVGY 204 (284)
T ss_dssp TEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSCBCCCSCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCccccCCCCCcCCcCchhhcCCCCCcccchHHHHHHHHHHHHCC
Confidence 99999999999999644455569999999998776665555677899999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccC
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 234 (241)
.||.+.+.......+..+.. ..+......+++++.+++++||+.||.+|||++|+++||||++.....
T Consensus 205 ~pf~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 272 (284)
T 3kk8_A 205 PPFWDEDQHRLYAQIKAGAY-DYPSPEWDTVTPEAKSLIDSMLTVNPKKRITADQALKVPWICNRERVA 272 (284)
T ss_dssp CSSCCSSHHHHHHHHHHTCC-CCCTTTTTTSCHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCCCGG
T ss_pred CCCCCCchhHHHHHHHhccc-cCCchhhcccCHHHHHHHHHHcccChhhCCCHHHHhcCccccCChhHH
Confidence 99999988888887765543 333334457899999999999999999999999999999999865443
|
| >3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-47 Score=303.33 Aligned_cols=219 Identities=28% Similarity=0.490 Sum_probs=192.4
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.++++++||||+++++++..++..++||||++|++|.+++... .+++..+..++.|++.||.+||++|+
T Consensus 59 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~qi~~~l~~lH~~~i 137 (297)
T 3fxz_A 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTET-CMDEGQIAAVCRECLQALEFLHSNQV 137 (297)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHS-CCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cHHHHHHHHHHHHhcCCCCCCCeEeEEEEECCEEEEEEECCCCCCHHHHHhhc-CCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 34667899999999999999999999999999999999999999999999764 69999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+||||||+||++ +.++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++|..
T Consensus 138 ~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~ 214 (297)
T 3fxz_A 138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (297)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHHCSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeCCCCHHHEEE---CCCCCEEEeeCCCceecCCcccccCCccCCcCccChhhhcCCCCCcHHHHHHHHHHHHHHHhCCC
Confidence 999999999999 788899999999987765433 3345678999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
||.+.+.......+.......... ...++..+.++|.+||+.||.+|||++|+++||||+....
T Consensus 215 pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~ 278 (297)
T 3fxz_A 215 PYLNENPLRALYLIATNGTPELQN--PEKLSAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAKP 278 (297)
T ss_dssp TTTTSCHHHHHHHHHHHCSCCCSC--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCCC--ccccCHHHHHHHHHHccCChhHCcCHHHHhhChhhcccCc
Confidence 999888877666665444332221 2468899999999999999999999999999999997543
|
| >1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.7e-48 Score=313.65 Aligned_cols=225 Identities=28% Similarity=0.559 Sum_probs=197.9
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.....+.+|++++++++||||+++++++.+++..++||||+.|++|.+++.... .+++..+..++.|++.||.+||+.|
T Consensus 90 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~g 169 (387)
T 1kob_A 90 LDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEHS 169 (387)
T ss_dssp HHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHHhCCCcCCCeEEEEEEeCCEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 455689999999999999999999999999999999999999999999987553 6999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
++|+||||+||+++. +..+.++|+|||++.............+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 170 ivHrDlkp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~elltg~~ 248 (387)
T 1kob_A 170 IVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLS 248 (387)
T ss_dssp EECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSCC
T ss_pred eeecccchHHeEEec-CCCCceEEEecccceecCCCcceeeeccCCCccCchhccCCCCCCcccEeeHhHHHHHHHhCCC
Confidence 999999999999942 2356799999999988766555556678999999999998899999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccC
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 234 (241)
||.+.+..+....+.... ..++......++.++.++|++||+.||.+|||++|+++||||+......
T Consensus 249 Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~ 315 (387)
T 1kob_A 249 PFAGEDDLETLQNVKRCD-WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNL 315 (387)
T ss_dssp SSCCSSHHHHHHHHHHCC-CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTC
T ss_pred CCCCCCHHHHHHHHHhCC-CCCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCcccc
Confidence 999988888887776544 2334444567899999999999999999999999999999999765443
|
| >3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-48 Score=310.82 Aligned_cols=215 Identities=36% Similarity=0.678 Sum_probs=189.2
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
...+.+|+.++++++||||+++++++.+.+..++||||+ +++|.+++...+++++..+..++.|++.||.+||+.|++|
T Consensus 53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~lv~E~~-~g~l~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~givH 131 (336)
T 3h4j_B 53 HMRVEREISYLKLLRHPHIIKLYDVITTPTDIVMVIEYA-GGELFDYIVEKKRMTEDEGRRFFQQIICAIEYCHRHKIVH 131 (336)
T ss_dssp SHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCC-CEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHTCCC
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEECC-CCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCeEe
Confidence 467899999999999999999999999999999999999 7899999988889999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHhCCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPF 168 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p~ 168 (241)
|||||+||++ +.++.++|+|||++.............+++.|+|||.+.+..+ +.++|+||+|+++|+|++|..||
T Consensus 132 ~Dlkp~NIll---~~~~~~kl~DFG~s~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~~Pf 208 (336)
T 3h4j_B 132 RDLKPENLLL---DDNLNVKIADFGLSNIMTDGNFLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVLYVMLVGRLPF 208 (336)
T ss_dssp CCCSTTTEEE---CTTCCEEECCSSCTBTTTTSBTTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHHHHHHHSSCSS
T ss_pred cCCchhhEEE---cCCCCEEEEEeccceeccCCcccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHHHHHHhCCCCC
Confidence 9999999999 7888999999999987766665666789999999999987775 78999999999999999999999
Q ss_pred CCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 169 SGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
.+.......+.+..+. . ..+..+|+++.++|++||+.||.+|||++|+++||||+.....
T Consensus 209 ~~~~~~~~~~~i~~~~-~----~~p~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 268 (336)
T 3h4j_B 209 DDEFIPNLFKKVNSCV-Y----VMPDFLSPGAQSLIRRMIVADPMQRITIQEIRRDPWFNVNLPD 268 (336)
T ss_dssp BCSSSTTCBCCCCSSC-C----CCCTTSCHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHTTCCG
T ss_pred CCccHHHHHHHHHcCC-C----CCcccCCHHHHHHHHHHcCCChhHCcCHHHHHhChhhccCCcc
Confidence 8766554444332221 1 1234689999999999999999999999999999999875443
|
| >3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-48 Score=302.01 Aligned_cols=225 Identities=28% Similarity=0.551 Sum_probs=200.0
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...+.+++..+..++.|++.||.+||++|+
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 127 (277)
T 3f3z_A 48 EDVDRFKQEIEIMKSLDHPNIIRLYETFEDNTDIYLVMELCTGGELFERVVHKRVFRESDAARIMKDVLSAVAYCHKLNV 127 (277)
T ss_dssp SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred chHHHHHHHHHHHHhCCCCCEeeEEEEEecCCeEEEEEeccCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 44678999999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|+||++...+.++.++|+|||.+.............+++.|+|||.+.+. ++.++|+||||+++|+|++|..|
T Consensus 128 ~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~-~~~~~Di~slG~~l~~l~~g~~p 206 (277)
T 3f3z_A 128 AHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGKMMRTKVGTPYYVSPQVLEGL-YGPECDEWSAGVMMYVLLCGYPP 206 (277)
T ss_dssp ECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHTTC-BCTTHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCCHHHEEEecCCCCCcEEEEecccceeccCccchhccCCCCCccChHHhccc-CCchhhehhHHHHHHHHHHCCCC
Confidence 99999999999955456788999999999887766666667799999999998754 89999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccC
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 234 (241)
|...+..+....+..+.. ..+......+++.+.+++++||+.||.+|||+.++++||||++.....
T Consensus 207 ~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~~~~~~ 272 (277)
T 3f3z_A 207 FSAPTDSEVMLKIREGTF-TFPEKDWLNVSPQAESLIRRLLTKSPKQRITSLQALEHEWFEKQLSSS 272 (277)
T ss_dssp SCCSSHHHHHHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHHHHCCS
T ss_pred CCCCCHHHHHHHHHhCCC-CCCchhhhcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHHhcccccc
Confidence 999988888888766543 333333447899999999999999999999999999999998855443
|
| >2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-48 Score=311.36 Aligned_cols=224 Identities=35% Similarity=0.532 Sum_probs=179.1
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++
T Consensus 91 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~L~~LH~~~iv 170 (349)
T 2w4o_A 91 DKKIVRTEIGVLLRLSHPNIIKLKEIFETPTEISLVLELVTGGELFDRIVEKGYYSERDAADAVKQILEAVAYLHENGIV 170 (349)
T ss_dssp --------CHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHTTCSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred hHHHHHHHHHHHHhCCCCCCcceeeeEecCCeEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCeE
Confidence 45678899999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 168 (241)
|+||||+||+++..+.++.++|+|||++.............+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 171 H~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 250 (349)
T 2w4o_A 171 HRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQVLMKTVCGTPGYCAPEILRGCAYGPEVDMWSVGIITYILLCGFEPF 250 (349)
T ss_dssp CCCCCGGGEEESSSSTTCCEEECCCC----------------CGGGSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCTT
T ss_pred ecCCCcccEEEecCCCCCCEEEccCccccccCcccccccccCCCCccCHHHhcCCCCCcccchHHHHHHHHHHHhCCCCC
Confidence 99999999999543458889999999998765554445567899999999999889999999999999999999999999
Q ss_pred CCCChHH-HHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 169 SGRNNVQ-LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 169 ~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
......+ ....+.... ..........++.++.++|++||+.||.+|||+.|+++||||++....
T Consensus 251 ~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~~ 315 (349)
T 2w4o_A 251 YDERGDQFMFRRILNCE-YYFISPWWDEVSLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAAN 315 (349)
T ss_dssp CCTTCHHHHHHHHHTTC-CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTCC
T ss_pred CCCcccHHHHHHHHhCC-CccCCchhhhCCHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCccc
Confidence 8766554 555554443 233333445789999999999999999999999999999999986554
|
| >1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-47 Score=301.49 Aligned_cols=211 Identities=35% Similarity=0.639 Sum_probs=192.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|..+++.++||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.|++.||.+||++|++
T Consensus 49 ~~~~~~~E~~~l~~l~hp~Iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~iv 128 (318)
T 1fot_A 49 QVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDII 128 (318)
T ss_dssp CHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHhhCCCCCCceEeEEEEeCCEEEEEEeCCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45678899999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 168 (241)
||||||+||++ +.++.++|+|||++...... .....+|+.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 129 HrDlkp~NIll---~~~g~~kL~Dfg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~pf 203 (318)
T 1fot_A 129 YRDLKPENILL---DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPF 203 (318)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCChheEEE---cCCCCEEEeecCcceecCCc--cccccCCccccCHhHhcCCCCCcccchhhhHHHHHHHHhCCCCC
Confidence 99999999999 78899999999999775432 34567899999999999999999999999999999999999999
Q ss_pred CCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 169 SGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
.+.+..+....+.... ..++ +.++.++.++|++||+.||.+|| +++++++||||++
T Consensus 204 ~~~~~~~~~~~i~~~~-~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~ 264 (318)
T 1fot_A 204 YDSNTMKTYEKILNAE-LRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 264 (318)
T ss_dssp CCSSHHHHHHHHHHCC-CCCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CCCCHHHHHHHHHhCC-CCCC----CCCCHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence 9998888888876653 2233 37899999999999999999999 9999999999986
|
| >1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=306.07 Aligned_cols=215 Identities=33% Similarity=0.552 Sum_probs=193.8
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
+..+.+.+|..+++++ +||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.|++.||.+||++|
T Consensus 59 ~~~~~~~~E~~il~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ 138 (345)
T 1xjd_A 59 DDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKG 138 (345)
T ss_dssp TCHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHHhcCCCCCCCcEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 3456788999999987 999999999999999999999999999999999998889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++||||||+||++ +.++.++|+|||++..... .......++|+.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 139 ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 215 (345)
T 1xjd_A 139 IVYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQ 215 (345)
T ss_dssp CBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSS
T ss_pred eEeCCCChhhEEE---CCCCCEEEeEChhhhhcccCCCcccCCCCCcccCChhhhcCCCCCChhhhHHHHHHHHHHhcCC
Confidence 9999999999999 7888999999999976432 23345667899999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHH-HHhcCcccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN-EFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~~~~~~~ 230 (241)
.||.+.+..+....+.... ..++ ..++.++.++|++||+.||.+||++. ++++||||++.
T Consensus 216 ~Pf~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~~ 276 (345)
T 1xjd_A 216 SPFHGQDEEELFHSIRMDN-PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFREI 276 (345)
T ss_dssp CSSCCSSHHHHHHHHHHCC-CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTTC
T ss_pred CCCCCCCHHHHHHHHHhCC-CCCC----cccCHHHHHHHHHHhcCCHhHcCCChHHHHcCccccCC
Confidence 9999999988888886654 2233 36899999999999999999999998 99999999874
|
| >2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-47 Score=310.74 Aligned_cols=221 Identities=32% Similarity=0.538 Sum_probs=196.5
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++... ..+++..+..++.|++.||.+||+.|
T Consensus 128 ~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 207 (373)
T 2x4f_A 128 KDKEEVKNEISVMNQLDHANLIQLYDAFESKNDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIRHMHQMY 207 (373)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678999999999999999999999999999999999999999999988654 46999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
++|+||||+||++.. +..+.++|+|||++.............+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 208 ivH~Dlkp~NIll~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~ 286 (373)
T 2x4f_A 208 ILHLDLKPENILCVN-RDAKQIKIIDFGLARRYKPREKLKVNFGTPEFLAPEVVNYDFVSFPTDMWSVGVIAYMLLSGLS 286 (373)
T ss_dssp EECCCCCGGGEEEEE-TTTTEEEECCCSSCEECCTTCBCCCCCSSCTTCCHHHHTTCBCCHHHHHHHHHHHHHHHHHSSC
T ss_pred cccccCCHHHEEEec-CCCCcEEEEeCCCceecCCccccccccCCCcEeChhhccCCCCCcHHhHHHHHHHHHHHHhCCC
Confidence 999999999999843 3557899999999988766655556678999999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
||.+.+..+.+..+..... .++....+.+++++.++|.+||+.||.+|||++|+++||||++.
T Consensus 287 pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~ 349 (373)
T 2x4f_A 287 PFLGDNDAETLNNILACRW-DLEDEEFQDISEEAKEFISKLLIKEKSWRISASEALKHPWLSDH 349 (373)
T ss_dssp TTCCSSHHHHHHHHHHTCC-CSCSGGGTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred CCCCCCHHHHHHHHHhccC-CCChhhhccCCHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence 9999998888887765543 23334446789999999999999999999999999999999874
|
| >4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-47 Score=310.69 Aligned_cols=216 Identities=29% Similarity=0.560 Sum_probs=187.0
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|..+++++ +||||+++++++.+++..++||||++|++|.+++.+.+.+++..+..++.|++.||.+||++
T Consensus 93 ~~~~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 172 (396)
T 4dc2_A 93 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 172 (396)
T ss_dssp ---CCHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcCCCCCcCeeEEEEEECCEEEEEEEcCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34456788999999987 89999999999999999999999999999999999888999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCcccc-CCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL-YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~-~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
|++||||||+||++ +.++.++|+|||+++.. .........++|+.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 173 givHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~gt~~Y~aPE~l~~~~~~~~~DiwslGvllyell~G 249 (396)
T 4dc2_A 173 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 249 (396)
T ss_dssp TCBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCBCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CEEeccCCHHHEEE---CCCCCEEEeecceeeecccCCCccccccCCcccCCchhhcCCCCChHHHHHHHHHHHHHHHhC
Confidence 99999999999999 78899999999999763 334445567899999999999999999999999999999999999
Q ss_pred CCCCCCCC---------hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH------HHHhcCccccc
Q 026253 165 YPPFSGRN---------NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF------NEFYHHRFLRR 229 (241)
Q Consensus 165 ~~p~~~~~---------~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~il~~~~~~~ 229 (241)
..||.... .....+.+.. ....++ ..++.++.++|++||+.||.+||++ +|+++||||++
T Consensus 250 ~~Pf~~~~~~~~~~~~~~~~~~~~i~~-~~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~ 324 (396)
T 4dc2_A 250 RSPFDIVGSSDNPDQNTEDYLFQVILE-KQIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 324 (396)
T ss_dssp SCSSTTTTC------CCHHHHHHHHHH-CCCCCC----TTSCHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred CCCCcccccccccchhhHHHHHHHHhc-cccCCC----CcCCHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence 99996432 2234444433 333333 3789999999999999999999985 89999999987
Q ss_pred c
Q 026253 230 N 230 (241)
Q Consensus 230 ~ 230 (241)
.
T Consensus 325 i 325 (396)
T 4dc2_A 325 V 325 (396)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-47 Score=305.41 Aligned_cols=212 Identities=31% Similarity=0.580 Sum_probs=193.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++.+.+++++..+..++.|++.||.+||++|+
T Consensus 83 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 162 (350)
T 1rdq_E 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162 (350)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEcCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34567889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||||||+||++ +.++.++|+|||++...... .....+|+.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 163 vHrDlkp~NIll---~~~g~~kL~DFg~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 237 (350)
T 1rdq_E 163 IYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp ECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ccccCccceEEE---CCCCCEEEcccccceeccCC--cccccCCccccCHHHhcCCCCCCcCCEecccHhHhHHhhCCCC
Confidence 999999999999 78889999999999876543 3345789999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 229 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~ 229 (241)
|.+.+..+....+..+. ..++ ..++.++.++|++||+.||.+||+ ++++++||||+.
T Consensus 238 f~~~~~~~~~~~i~~~~-~~~p----~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~ 299 (350)
T 1rdq_E 238 FFADQPIQIYEKIVSGK-VRFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp SCCSSHHHHHHHHHHCC-CCCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCCCCHHHHHHHHHcCC-CCCC----CCCCHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence 99999988888887654 2333 378999999999999999999998 999999999987
|
| >3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-47 Score=322.21 Aligned_cols=222 Identities=35% Similarity=0.618 Sum_probs=198.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
......+.+|+.++++++||||+++++++.+.+..++||||+.+++|.+++....++++..+..++.|++.||.|||+.|
T Consensus 77 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 156 (494)
T 3lij_A 77 TSSNSKLLEEVAVLKLLDHPNIMKLYDFFEDKRNYYLVMECYKGGELFDEIIHRMKFNEVDAAVIIKQVLSGVTYLHKHN 156 (494)
T ss_dssp -CTTHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHHHhCCCCCCCeEEEEEEeCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34467889999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
++||||||+||+++..+..+.++|+|||++.............+++.|+|||.+. ..++.++|+||+|+++|+|++|.+
T Consensus 157 ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~-~~~~~~~DiwslG~il~~ll~g~~ 235 (494)
T 3lij_A 157 IVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQKKMKERLGTAYYIAPEVLR-KKYDEKCDVWSIGVILFILLAGYP 235 (494)
T ss_dssp EECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTBCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCccccccCCCcCeeCHHHHc-ccCCCchhHHHHHHHHHHHHhCCC
Confidence 9999999999999654556679999999998776665566678999999999986 568999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
||.+.+..+....+..+... ++...+..+|+.+.++|++||+.||.+|||+.|+|+||||++.
T Consensus 236 pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~~ 298 (494)
T 3lij_A 236 PFGGQTDQEILRKVEKGKYT-FDSPEWKNVSEGAKDLIKQMLQFDSQRRISAQQALEHPWIKEM 298 (494)
T ss_dssp SSCCSSHHHHHHHHHHTCCC-CCSGGGTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHHH
T ss_pred CCCCCCHHHHHHHHHhCCCC-CCchhcccCCHHHHHHHHHHCCCChhhCccHHHHhcCcccccC
Confidence 99999999988888665533 3334456789999999999999999999999999999999874
|
| >2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=304.41 Aligned_cols=214 Identities=31% Similarity=0.599 Sum_probs=193.4
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|.++++.+ +||+|+++++++.+.+..|+||||++|++|.+++...+.+++..+..++.|++.||.+||++|
T Consensus 62 ~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g 141 (353)
T 2i0e_A 62 DDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSKG 141 (353)
T ss_dssp TCHHHHHHHHHHHTCTTCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHHhcCCCCEEeeEEEEEEcCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 4467788999999998 899999999999999999999999999999999998889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccC-CCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++||||||+||++ +.++.++|+|||++.... ........+||+.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 142 ivHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~ 218 (353)
T 2i0e_A 142 IIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAGQ 218 (353)
T ss_dssp CBCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBSTHHHHHHHHHHHHHHHHSS
T ss_pred EEeccCCHHHEEE---cCCCcEEEEeCCcccccccCCcccccccCCccccChhhhcCCCcCCcccccchHHHHHHHHcCC
Confidence 9999999999999 788899999999997643 233445667999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~ 229 (241)
.||.+.+..+..+.+.... ..++ ..++.++.++|++||+.||.+||+ ++++++||||+.
T Consensus 219 ~Pf~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~ 282 (353)
T 2i0e_A 219 APFEGEDEDELFQSIMEHN-VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 282 (353)
T ss_dssp CSSCCSSHHHHHHHHHHCC-CCCC----TTSCHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHHHHHHhCC-CCCC----CCCCHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence 9999999988888886643 2333 378999999999999999999994 699999999986
|
| >3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-46 Score=302.34 Aligned_cols=216 Identities=29% Similarity=0.554 Sum_probs=188.6
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|..+++++ +||||+++++++.+.+..++||||++|++|.+++.+.+.+++..+..++.|++.||.+||++
T Consensus 50 ~~~~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 129 (345)
T 3a8x_A 50 DEDIDWVQTEKHVFEQASNHPFLVGLHSCFQTESRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEISLALNYLHER 129 (345)
T ss_dssp HHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHHhcCCCCccCeEEEEEEeCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44567789999999998 89999999999999999999999999999999999888999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccC-CCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
|++||||||+||++ +.++.++|+|||+++... ........++|+.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 130 ~ivHrDlkp~NIll---~~~g~~kL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g 206 (345)
T 3a8x_A 130 GIIYRDLKLDNVLL---DSEGHIKLTDYGMCKEGLRPGDTTSTFCGTPNYIAPEILRGEDYGFSVDWWALGVLMFEMMAG 206 (345)
T ss_dssp TCBCCCCCGGGEEE---CTTSCEEECCGGGCBCSCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHS
T ss_pred CceecCCCHHHEEE---CCCCCEEEEeccccccccCCCCcccccCCCccccCccccCCCCCChHHhHHHHHHHHHHHHhC
Confidence 99999999999999 788899999999997643 33344556799999999999999999999999999999999999
Q ss_pred CCCCCCC---------ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH------HHHhcCccccc
Q 026253 165 YPPFSGR---------NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF------NEFYHHRFLRR 229 (241)
Q Consensus 165 ~~p~~~~---------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~------~~il~~~~~~~ 229 (241)
..||... ......+.+... ...++ ..++.++.++|++||+.||.+||++ +|+++||||++
T Consensus 207 ~~pf~~~~~~~~~~~~~~~~~~~~i~~~-~~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~ 281 (345)
T 3a8x_A 207 RSPFDIVGSSDNPDQNTEDYLFQVILEK-QIRIP----RSLSVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN 281 (345)
T ss_dssp SCTTTTTTC-------CHHHHHHHHHHC-CCCCC----TTSCHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred CCCcCCcccccccccccHHHHHHHHHcC-CCCCC----CCCCHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence 9999752 233444555433 33333 3789999999999999999999995 89999999987
Q ss_pred c
Q 026253 230 N 230 (241)
Q Consensus 230 ~ 230 (241)
.
T Consensus 282 ~ 282 (345)
T 3a8x_A 282 V 282 (345)
T ss_dssp C
T ss_pred C
Confidence 3
|
| >3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.8e-47 Score=296.47 Aligned_cols=218 Identities=30% Similarity=0.557 Sum_probs=184.4
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
..+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++... ..+++..+..++.|++.||.+||+
T Consensus 63 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 142 (285)
T 3is5_A 63 PMEQIEAEIEVLKSLDHPNIIKIFEVFEDYHNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMNALAYFHS 142 (285)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCchHHhHHHheecCCeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3578999999999999999999999999999999999999999999998543 679999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
.|++|+||+|+||+++..+..+.++|+|||++.............+++.|+|||.+. ..++.++|+||||+++|+|++|
T Consensus 143 ~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~il~~ll~g 221 (285)
T 3is5_A 143 QHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDEHSTNAAGTALYMAPEVFK-RDVTFKCDIWSAGVVMYFLLTG 221 (285)
T ss_dssp TTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC----------CTTGGGCCHHHHT-TCCCHHHHHHHHHHHHHHHHHS
T ss_pred CCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcccCcCcccccCcCChHHhc-cCCCcccCeehHHHHHHHHHhC
Confidence 999999999999999655566789999999998766555555677899999999986 5688999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
..||.+.+..+....+......... ....+++++.+++++||+.||.+|||++|+++||||++
T Consensus 222 ~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~ 284 (285)
T 3is5_A 222 CLPFTGTSLEEVQQKATYKEPNYAV--ECRPLTPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ 284 (285)
T ss_dssp SCSSCCSSHHHHHHHHHHCCCCCCC----CCCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred CCCCCCCCHHHHHhhhccCCccccc--ccCcCCHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence 9999998888777766544332211 12357899999999999999999999999999999986
|
| >4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-46 Score=305.35 Aligned_cols=214 Identities=29% Similarity=0.537 Sum_probs=189.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++.+.+..++||||+.|++|.+++...+.+++..+..++.|++.||.+||+.|+
T Consensus 57 ~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~l~~~~~~~~~~qi~~aL~~LH~~gi 136 (384)
T 4fr4_A 57 NEVRNVFKELQIMQGLEHPFLVNLWYSFQDEEDMFMVVDLLLGGDLRYHLQQNVHFKEETVKLFICELVMALDYLQNQRI 136 (384)
T ss_dssp TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 34578889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc---cCCCCchhHHHHHHHHHHHHhC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g 164 (241)
+||||||+||++ +.++.++|+|||++.............+|+.|+|||.+.+ ..++.++|+||||+++|+|++|
T Consensus 137 vHrDlkp~NIll---~~~g~vkL~DFG~a~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG~il~elltG 213 (384)
T 4fr4_A 137 IHRDMKPDNILL---DEHGHVHITDFNIAAMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRG 213 (384)
T ss_dssp ECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHHHHHHHHHHS
T ss_pred eeccCcHHHeEE---CCCCCEEEeccceeeeccCCCceeccCCCccccCCeeeccCCCCCCCccceeechHHHHHHHHhC
Confidence 999999999999 7889999999999988766666667789999999999864 4589999999999999999999
Q ss_pred CCCCCCC---ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-HHHHhcCccccc
Q 026253 165 YPPFSGR---NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-FNEFYHHRFLRR 229 (241)
Q Consensus 165 ~~p~~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-~~~il~~~~~~~ 229 (241)
..||... ...+....+... ...++ ..++..+.++|++||+.||.+||+ ++++++||||++
T Consensus 214 ~~Pf~~~~~~~~~~~~~~~~~~-~~~~p----~~~s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~ 277 (384)
T 4fr4_A 214 RRPYHIRSSTSSKEIVHTFETT-VVTYP----SAWSQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND 277 (384)
T ss_dssp SCSSCCCTTSCHHHHHHHHHHC-CCCCC----TTSCHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred CCCCCCCCCccHHHHHHHHhhc-ccCCC----CcCCHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence 9999743 334444444332 22333 378999999999999999999998 999999999987
|
| >3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=319.52 Aligned_cols=223 Identities=34% Similarity=0.607 Sum_probs=197.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|++++++++||||+++++++.+.+..++||||+.+++|.+++...+++++..+..++.|++.||.|||++|+
T Consensus 63 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~~~i 142 (486)
T 3mwu_A 63 KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142 (486)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHHhCCCCCcCeEEEEEEcCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34678899999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||||||+||+++..+.++.++|+|||++.............+++.|+|||.+.+ .++.++|+||+|+++|+|++|.+|
T Consensus 143 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 221 (486)
T 3mwu_A 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221 (486)
T ss_dssp CCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC----CCTTGGGGCCGGGGGS-CCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred EeccCchHHEEEecCCCCCCEEEEECCcCeECCCCCccCCCcCCCCCCCHHHhCC-CCCchhhHHHHHHHHHHHHhCCCC
Confidence 9999999999996555677899999999987766655566779999999999875 589999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
|.+.+..+....+..+... ++......+|+++.++|++||+.||.+|||+.++|+||||++...
T Consensus 222 f~~~~~~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~~ 285 (486)
T 3mwu_A 222 FYGKNEYDILKRVETGKYA-FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYSS 285 (486)
T ss_dssp SCCSSHHHHHHHHHHTCCC-SCSGGGGGSCHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTCC
T ss_pred CCCCCHHHHHHHHHhCCCC-CCCcccCCCCHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCcc
Confidence 9999998888888665432 233334578999999999999999999999999999999998654
|
| >2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-47 Score=302.86 Aligned_cols=217 Identities=30% Similarity=0.554 Sum_probs=195.1
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
.+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.|++|
T Consensus 59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH~~~ivH 138 (321)
T 2a2a_A 59 REEIEREVSILRQVLHHNVITLHDVYENRTDVVLILELVSGGELFDFLAQKESLSEEEATSFIKQILDGVNYLHTKKIAH 138 (321)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCEEHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred HHHHHHHHHHHHhCCCCCcceEEEEEecCCEEEEEEEcCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Confidence 56799999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCc----eEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 90 RDLKPENILLSGLDDDV----MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~----~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+||+|+||++ +.++ .++|+|||.+.............+++.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 139 ~dikp~NIl~---~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 215 (321)
T 2a2a_A 139 FDLKPENIML---LDKNIPIPHIKLIDFGLAHEIEDGVEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGA 215 (321)
T ss_dssp CCCSGGGEEE---SCTTSSSCCEEECCCTTCEECCTTCCCCCCCSCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSC
T ss_pred CCCChHHEEE---ecCCCCcCCEEEccCccceecCccccccccCCCCCccCcccccCCCCCCccccHHHHHHHHHHHHCC
Confidence 9999999999 4444 79999999998776655555667899999999999889999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
.||.+.+..+....+.... ...+......++..+.++|++||+.||.+|||++|+++||||+..
T Consensus 216 ~pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~~ 279 (321)
T 2a2a_A 216 SPFLGDTKQETLANITSVS-YDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWITPV 279 (321)
T ss_dssp CSSCCSSHHHHHHHHHTTC-CCCCHHHHTTCCHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred CCCCCCCHHHHHHHHHhcc-cccChhhhcccCHHHHHHHHHHcCCChhhCcCHHHHhcCccccCC
Confidence 9999988888887775543 233444445789999999999999999999999999999999864
|
| >3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-46 Score=299.96 Aligned_cols=215 Identities=36% Similarity=0.606 Sum_probs=183.3
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.....+.+|+.++++++||||+++++++.+++..++||||++|++|.+++...+.+++..+..++.|++.||.+||++|+
T Consensus 63 ~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 142 (327)
T 3a62_A 63 KDTAHTKAERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGELFMQLEREGIFMEDTACFYLAEISMALGHLHQKGI 142 (327)
T ss_dssp --------HHHHHHHCCCTTBCCEEEEEECSSCEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHHhCCCCCccceeEEEEcCCEEEEEEeCCCCCcHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 34567889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+||||||+||++ +.++.++|+|||++..... ........+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 143 vH~Dlkp~Nill---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~el~~g~~ 219 (327)
T 3a62_A 143 IYRDLKPENIML---NHQGHVKLTDFGLCKESIHDGTVTHTFCGTIEYMAPEILMRSGHNRAVDWWSLGALMYDMLTGAP 219 (327)
T ss_dssp CCCCCCTTTEEE---CTTSCEEECCCSCC----------CTTSSCCTTSCHHHHTTSCCCTHHHHHHHHHHHHHHHHSSC
T ss_pred EcccCCHHHeEE---CCCCcEEEEeCCcccccccCCccccccCCCcCccCHhhCcCCCCCCcccchhHHHHHHHHHHCCC
Confidence 999999999999 7888999999999876433 223345678999999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCcccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 230 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~ 230 (241)
||.+.+..+....+..... .++ +.++.++.++|++||+.||.+|| +++++++||||++.
T Consensus 220 pf~~~~~~~~~~~i~~~~~-~~p----~~~~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~~ 283 (327)
T 3a62_A 220 PFTGENRKKTIDKILKCKL-NLP----PYLTQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRHI 283 (327)
T ss_dssp SCCCSSHHHHHHHHHHTCC-CCC----TTSCHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSSC
T ss_pred CCCCCCHHHHHHHHHhCCC-CCC----CCCCHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccCC
Confidence 9999988888877765432 222 37899999999999999999999 88999999999863
|
| >3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.6e-47 Score=301.10 Aligned_cols=221 Identities=29% Similarity=0.516 Sum_probs=184.7
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|++++++++||||+++++++.+++..++||||++ ++|.+++... ..+++..+..++.|++.||.+||+.|+
T Consensus 62 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i 140 (311)
T 3niz_A 62 IPSTAIREISLLKELHHPNIVSLIDVIHSERCLTLVFEFME-KDLKKVLDENKTGLQDSQIKIYLYQLLRGVAHCHQHRI 140 (311)
T ss_dssp HHHHHHHHHHHHHHCCCTTBCCEEEEECCSSCEEEEEECCS-EEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhHHHHHHHHHHHHcCCCCEeeeeeEEccCCEEEEEEcCCC-CCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 45778999999999999999999999999999999999996 5888888765 459999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||||+||++ +.++.++|+|||++...... .......+++.|+|||.+.+ ..++.++|+||+|+++|+|++|.
T Consensus 141 vH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g~ 217 (311)
T 3niz_A 141 LHRDLKPQNLLI---NSDGALKLADFGLARAFGIPVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGK 217 (311)
T ss_dssp ECCCCCGGGEEE---CTTCCEEECCCTTCEETTSCCC---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCchHhEEE---CCCCCEEEccCcCceecCCCcccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHHHHHHhCC
Confidence 999999999999 78889999999999876533 23334567999999999876 56899999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCC-------------------------CccCCCCChHHHHHHHHhcccCccccCCHHH
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFS-------------------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~-------------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~ 220 (241)
.||.+.+..+....+......+.+ ....+.+++++.++|++||+.||.+|||++|
T Consensus 218 ~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e 297 (311)
T 3niz_A 218 PLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFCQEGIDLLSNMLCFDPNKRISARD 297 (311)
T ss_dssp CSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHSTTCCHHHHHHHHHHSCSCTTTSCCHHH
T ss_pred CCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhCcccCHHHHHHHHHHcCCChhHCCCHHH
Confidence 999987766655554332111111 0123457889999999999999999999999
Q ss_pred HhcCccccccccc
Q 026253 221 FYHHRFLRRNSAI 233 (241)
Q Consensus 221 il~~~~~~~~~~~ 233 (241)
+++||||++...+
T Consensus 298 ll~hp~f~~~~~~ 310 (311)
T 3niz_A 298 AMNHPYFKDLDPQ 310 (311)
T ss_dssp HHTSGGGTTSCTT
T ss_pred HhcCcccccCCcc
Confidence 9999999986543
|
| >2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=294.53 Aligned_cols=221 Identities=33% Similarity=0.601 Sum_probs=198.2
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
.+.+.+|++++++++|+||+++++++.+++..++|||++++++|.+++...+.+++..+..++.|++.||.+||+.|++|
T Consensus 58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~H 137 (284)
T 2vgo_A 58 EHQLRREIEIQSHLRHPNILRMYNYFHDRKRIYLMLEFAPRGELYKELQKHGRFDEQRSATFMEELADALHYCHERKVIH 137 (284)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTEEC
T ss_pred HHHHHHHHHHHhcCCCCCEeeEEEEEEcCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcee
Confidence 56789999999999999999999999999999999999999999999998889999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~ 169 (241)
+||+|+||++ +.++.++|+|||.+...... ......++..|+|||.+.+..++.++|+||||+++|+|++|..||.
T Consensus 138 ~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~ 213 (284)
T 2vgo_A 138 RDIKPENLLM---GYKGELKIADFGWSVHAPSL-RRRTMCGTLDYLPPEMIEGKTHDEKVDLWCAGVLCYEFLVGMPPFD 213 (284)
T ss_dssp CCCSGGGEEE---CTTCCEEECCCTTCEECSSS-CBCCCCSCGGGCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCTTC
T ss_pred cCCCHHHEEE---cCCCCEEEecccccccCccc-ccccccCCCCcCCHHHhccCCCCcccchhhHHHHHHHHHHCCCCCC
Confidence 9999999999 78889999999998665432 2334568999999999998889999999999999999999999999
Q ss_pred CCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCCCCCC
Q 026253 170 GRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPFH 239 (241)
Q Consensus 170 ~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~~ 239 (241)
..+..+....+.... ..+ .+.++.++.++|.+||+.||.+|||++++++||||+.......+|..
T Consensus 214 ~~~~~~~~~~~~~~~-~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~~~~~p~~~ 278 (284)
T 2vgo_A 214 SPSHTETHRRIVNVD-LKF----PPFLSDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANSRRVLPPVY 278 (284)
T ss_dssp CSSHHHHHHHHHTTC-CCC----CTTSCHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHCCCCCCCCC
T ss_pred CCCHhHHHHHHhccc-cCC----CCcCCHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhccccCCCcc
Confidence 888888777775433 222 24789999999999999999999999999999999998887777764
|
| >3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-47 Score=305.58 Aligned_cols=220 Identities=27% Similarity=0.500 Sum_probs=188.5
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
..+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++.+. ..+++..+..++.|++.||.+||+
T Consensus 69 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~lH~ 148 (351)
T 3c0i_A 69 STEDLKREASICHMLKHPHIVELLETYSSDGMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILEALRYCHD 148 (351)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3577999999999999999999999999999999999999999999888643 248999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+|++|+||||+||+++..+....++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 149 ~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~ 228 (351)
T 3c0i_A 149 NNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESGLVAGGRVGTPHFMAPEVVKREPYGKPVDVWGCGVILFILLS 228 (351)
T ss_dssp TTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTSCBCCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred CCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCCeeecCCcCCcCccCHHHHcCCCCCchHhhHHHHHHHHHHHH
Confidence 9999999999999996444455699999999987655432 345678999999999998899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
|..||.+.. .+....+..+.. ..+....+.++.++.++|++||+.||.+|||+.++++||||+..
T Consensus 229 g~~pf~~~~-~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~ 293 (351)
T 3c0i_A 229 GCLPFYGTK-ERLFEGIIKGKY-KMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293 (351)
T ss_dssp SSCSSCSSH-HHHHHHHHHTCC-CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTH
T ss_pred CCCCCCCcH-HHHHHHHHcCCC-CCCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcChhhcCC
Confidence 999998754 455555544432 22333335789999999999999999999999999999999874
|
| >3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-47 Score=319.52 Aligned_cols=222 Identities=33% Similarity=0.580 Sum_probs=199.7
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++.+.+..++|||++.+++|.+++...+++++..+..++.|++.||.|||++|+
T Consensus 68 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 147 (484)
T 3nyv_A 68 TDKESLLREVQLLKQLDHPNIMKLYEFFEDKGYFYLVGEVYTGGELFDEIISRKRFSEVDAARIIRQVLSGITYMHKNKI 147 (484)
T ss_dssp SCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCBHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 45678999999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||||||+||+++..+.++.++|+|||++.............+++.|+|||.+.+ .++.++|+||+|+++|+|++|.+|
T Consensus 148 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~~ll~g~~p 226 (484)
T 3nyv_A 148 VHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASKKMKDKIGTAYYIAPEVLHG-TYDEKCDVWSTGVILYILLSGCPP 226 (484)
T ss_dssp CCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCCSHHHHTTGGGTCCHHHHHT-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eeCCCCHHHEEEecCCCCCcEEEEeeeeeEEcccccccccCCCCccccCceeecC-CCCCcceeHHHHHHHHHHHHCCCC
Confidence 9999999999996555678899999999988766655566779999999999875 689999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|.+.+..+....+..+... ++...+..+|+++.++|++||+.||.+|||++|+|+||||+...
T Consensus 227 f~~~~~~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~~~ 289 (484)
T 3nyv_A 227 FNGANEYDILKKVEKGKYT-FELPQWKKVSESAKDLIRKMLTYVPSMRISARDALDHEWIQTYT 289 (484)
T ss_dssp SCCSSHHHHHHHHHHCCCC-CCSGGGGGSCHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHHHT
T ss_pred CCCCCHHHHHHHHHcCCCC-CCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhhChhhcccc
Confidence 9999999988888665532 23333457899999999999999999999999999999998754
|
| >2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=313.82 Aligned_cols=215 Identities=34% Similarity=0.645 Sum_probs=195.0
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
....+.+|++++++++||||+++++++.+.+..++||||++|++|.+++.+.+++++..+..++.|++.||.+||+.|++
T Consensus 59 ~~~~~~~Ei~~l~~l~HpnIv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~l~~~~~~~i~~qi~~aL~~LH~~giv 138 (476)
T 2y94_A 59 VVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNGRLDEKESRRLFQQILSGVDYCHRHMVV 138 (476)
T ss_dssp THHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSSEEHHHHTTSSSSCCHHHHHHHHHHHHHHHHHHHTTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCCC
Confidence 35678999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p 167 (241)
||||||+||++ +.++.++|+|||++............++++.|+|||.+.+..+ +.++|+||+|+++|+|++|..|
T Consensus 139 HrDLkp~NIll---~~~~~vkL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~elltG~~P 215 (476)
T 2y94_A 139 HRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLP 215 (476)
T ss_dssp CSCCSGGGEEE---CTTCCEEECCCSSCEECCTTCCBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSCS
T ss_pred cccccHHHEEE---ecCCCeEEEeccchhhccccccccccCCCcCeEChhhccCCCCCCCcceehhhHHHHHHHhhCCCC
Confidence 99999999999 7888999999999988766555566789999999999987765 6899999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|.+.+.......+..+.. ..+ ..+++++.++|++||+.||.+|||++|+++||||++..
T Consensus 216 f~~~~~~~~~~~i~~~~~-~~p----~~~s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~~ 274 (476)
T 2y94_A 216 FDDDHVPTLFKKICDGIF-YTP----QYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDL 274 (476)
T ss_dssp SCCSSSHHHHHHHHTTCC-CCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTTC
T ss_pred CCCCCHHHHHHHHhcCCc-CCC----ccCCHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhcC
Confidence 999988888888865542 222 36889999999999999999999999999999998753
|
| >3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.5e-47 Score=318.24 Aligned_cols=224 Identities=33% Similarity=0.602 Sum_probs=199.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.++++++||||+++++++.+++..++||||++|++|.+++...+.+++..+..++.|++.||.+||+.|+
T Consensus 88 ~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 167 (504)
T 3q5i_A 88 KFHEEIYNEISLLKSLDHPNIIKLFDVFEDKKYFYLVTEFYEGGELFEQIINRHKFDECDAANIMKQILSGICYLHKHNI 167 (504)
T ss_dssp CTHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEcCCEEEEEEecCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34678999999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||||||+||+++..+....++|+|||++.............+++.|+|||.+. ..++.++|+||+|+++|+|++|..|
T Consensus 168 vH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~DiwslG~il~~ll~g~~p 246 (504)
T 3q5i_A 168 VHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDYKLRDRLGTAYYIAPEVLK-KKYNEKCDVWSCGVIMYILLCGYPP 246 (504)
T ss_dssp ECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTTSCBCCCCSCTTTCCHHHHT-TCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred EeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCCCccccccCCcCCCCHHHhc-cCCCchHHHHHHHHHHHHHHhCCCC
Confidence 999999999999543333479999999998877666666678999999999987 4689999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
|.+.+..+....+..+.. .++...+..+|+++.++|++||+.||.+|||++|+|+||||++....
T Consensus 247 f~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~~ 311 (504)
T 3q5i_A 247 FGGQNDQDIIKKVEKGKY-YFDFNDWKNISDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYANN 311 (504)
T ss_dssp SCCSSHHHHHHHHHHCCC-CCCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCCC
T ss_pred CCCCCHHHHHHHHHcCCC-CCCccccCCCCHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchhc
Confidence 999999999888876553 23333345789999999999999999999999999999999886544
|
| >2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-46 Score=298.11 Aligned_cols=218 Identities=24% Similarity=0.490 Sum_probs=192.9
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.++++++|+||+++++++..++..++||||+++++|.+++.. .++++..+..++.|++.||.+||+.|+
T Consensus 84 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~l~~~~~~~i~~qi~~~L~~LH~~~i 162 (321)
T 2c30_A 84 QRRELLFNEVVIMRDYQHFNVVEMYKSYLVGEELWVLMEFLQGGALTDIVSQ-VRLNEEQIATVCEAVLQALAYLHAQGV 162 (321)
T ss_dssp CSHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTT-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHHHhCCCCCcceEEEEEEECCEEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3456789999999999999999999999999999999999999999999864 579999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||||+||++ +.++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 163 vH~Dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Dv~slG~il~el~~g~~ 239 (321)
T 2c30_A 163 IHRDIKSDSILL---TLDGRVKLSDFGFCAQISKDVPKRKSLVGTPYWMAPEVISRSLYATEVDIWSLGIMVIEMVDGEP 239 (321)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSSSCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ecCCCCHHHEEE---CCCCcEEEeeeeeeeecccCccccccccCCccccCHhhhcCCCCCchhhHHHHHHHHHHHHhCCC
Confidence 999999999999 778899999999987665432 2345678999999999998899999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
||.+.+..+....+.......... ...+++.+.+++.+||+.||.+|||++++++||||++..
T Consensus 240 pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 302 (321)
T 2c30_A 240 PYFSDSPVQAMKRLRDSPPPKLKN--SHKVSPVLRDFLERMLVRDPQERATAQELLDHPFLLQTG 302 (321)
T ss_dssp TTTTSCHHHHHHHHHHSSCCCCTT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCC
T ss_pred CCCCCCHHHHHHHHhcCCCCCcCc--cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhccCC
Confidence 999988888887776655433222 236789999999999999999999999999999998754
|
| >4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-47 Score=311.49 Aligned_cols=217 Identities=29% Similarity=0.557 Sum_probs=190.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|..++++++||||+++++++.+++..++||||++|++|.+++.+ .+.+++..+..++.|++.||.+||+.|+
T Consensus 117 ~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~~LH~~gi 196 (437)
T 4aw2_A 117 ETACFREERDVLVNGDSKWITTLHYAFQDDNNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHY 196 (437)
T ss_dssp TTCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEEEEEEEEeeCCEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 345589999999999999999999999999999999999999999999987 4679999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCccccc-----ccCCCCchhHHHHHHHHHH
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~ 160 (241)
+||||||+||++ +.++.++|+|||++........ ....+||+.|+|||.+. ...++.++|+||+|+++|+
T Consensus 197 iHrDLKp~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwSlGvil~e 273 (437)
T 4aw2_A 197 VHRDIKPDNILM---DMNGHIRLADFGSCLKLMEDGTVQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYE 273 (437)
T ss_dssp ECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHHHHHHHHH
T ss_pred EecccCHHHeeE---cCCCCEEEcchhhhhhcccCCCcccccccCCcCeeChHHHhhcccCCCCCCCcCeeHHHHHHHHH
Confidence 999999999999 7889999999999977654332 23357999999999986 4568999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCChHHHHHHHHhcccCccc--cCCHHHHhcCccccc
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRR 229 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~il~~~~~~~ 229 (241)
|++|..||.+.+..+.+..+.... ...++. ....+|+++.++|++||..+|.+ |++++|+++||||++
T Consensus 274 lltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~-~~~~~s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~ 344 (437)
T 4aw2_A 274 MLYGETPFYAESLVETYGKIMNHKERFQFPT-QVTDVSENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG 344 (437)
T ss_dssp HHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS-SCCCSCHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred HHhCCCCCCCCChhHHHHhhhhccccccCCc-ccccCCHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence 999999999999888888775432 223332 22468999999999999999988 999999999999986
|
| >2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=302.66 Aligned_cols=220 Identities=29% Similarity=0.486 Sum_probs=189.3
Q ss_pred hhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 11 SCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 11 ~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
....+|++++.++ +||||+++++++.+++..++||||++|++|.+++...+.+++..+..++.|++.||.+||++|++|
T Consensus 60 ~~~~~E~~~l~~~~~hp~iv~~~~~~~~~~~~~lv~E~~~gg~L~~~i~~~~~~~~~~~~~~~~qi~~al~~lH~~givH 139 (342)
T 2qr7_A 60 RDPTEEIEILLRYGQHPNIITLKDVYDDGKYVYVVTELMKGGELLDKILRQKFFSEREASAVLFTITKTVEYLHAQGVVH 139 (342)
T ss_dssp CCCHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCTTCCHHHHHHHHHHHHHHHHHHHHTTEEC
T ss_pred CChHHHHHHHHHhcCCCCcCeEEEEEEcCCEEEEEEeCCCCCcHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcEe
Confidence 3457899999888 799999999999999999999999999999999998888999999999999999999999999999
Q ss_pred cCCCCCCeEEeecC-CCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 90 RDLKPENILLSGLD-DDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 90 ~dl~~~nil~~~~~-~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|||||+||++.+.+ ..+.++|+|||++...... .......+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 140 rDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~~P 219 (342)
T 2qr7_A 140 RDLKPSNILYVDESGNPESIRICDFGFAKQLRAENGLLMTPCYTANFVAPEVLERQGYDAACDIWSLGVLLYTMLTGYTP 219 (342)
T ss_dssp SCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTTCCBCCSSCCSSCCCHHHHHHHHHHHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCCCceeccCCCccccCHHHhcCCCCCCccCeeeHhHHHHHHhcCCCC
Confidence 99999999984322 2245999999999865433 234456789999999999888889999999999999999999999
Q ss_pred CCC---CChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 168 FSG---RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 168 ~~~---~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|.+ .+..+....+..+. ..++...++.+|.++.++|++||+.||.+|||+.++++||||.+..
T Consensus 220 f~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~~~ 285 (342)
T 2qr7_A 220 FANGPDDTPEEILARIGSGK-FSLSGGYWNSVSDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVHWD 285 (342)
T ss_dssp SCSSTTSCHHHHHHHHHHCC-CCCCSTTTTTSCHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHTGG
T ss_pred CCCCCcCCHHHHHHHHccCC-cccCccccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCCeecCcc
Confidence 985 45566777775544 3344445568999999999999999999999999999999997643
|
| >4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-46 Score=312.61 Aligned_cols=215 Identities=30% Similarity=0.508 Sum_probs=183.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-CC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS-HH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~-~~ 86 (241)
.....+.+|++++++++||||+++++++.+.+..++||||+++++|.+++...+.+++..+..++.|++.||.|||+ .|
T Consensus 190 ~~~~~~~~e~~~l~~l~h~~iv~l~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~g 269 (446)
T 4ejn_A 190 DEVAHTLTENRVLQNSRHPFLTALKYSFQTHDRLCFVMEYANGGELFFHLSRERVFSEDRARFYGAEIVSALDYLHSEKN 269 (446)
T ss_dssp -----------CCCCCSCTTSCCEEEEEEETTEEEEEECCCSSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHHTC
T ss_pred HHHHHHHHHHHHHHhCCCCeEeeEEEEEeeCCEEEEEEeeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHhhcCC
Confidence 34567889999999999999999999999999999999999999999999988899999999999999999999998 99
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++||||||+||++ +.++.++|+|||++..... ........+|+.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 270 iiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~g~ 346 (446)
T 4ejn_A 270 VVYRDLKLENLML---DKDGHIKITDFGLCKEGIKDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 346 (446)
T ss_dssp CCCCCCCGGGEEE---CSSSCEEECCCCCCCTTCC-----CCSSSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSS
T ss_pred EEECCCCHHHEEE---CCCCCEEEccCCCceeccCCCcccccccCCccccCHhhcCCCCCCCccchhhhHHHHHHHhhCC
Confidence 9999999999999 7888999999999976432 33344567899999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCcccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~ 230 (241)
.||.+.+.......+.... ..++ ..+++++.++|.+||+.||.+|| |++|+++||||++.
T Consensus 347 ~Pf~~~~~~~~~~~i~~~~-~~~p----~~~~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~~ 411 (446)
T 4ejn_A 347 LPFYNQDHEKLFELILMEE-IRFP----RTLGPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAGI 411 (446)
T ss_dssp CSSCCSSHHHHHHHHHHCC-CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred CCCCCCCHHHHHHHHHhCC-CCCC----ccCCHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccCC
Confidence 9999999888888775543 2233 36899999999999999999999 99999999999973
|
| >2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=296.36 Aligned_cols=224 Identities=32% Similarity=0.548 Sum_probs=196.2
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|++++++++||||+++++++.+++..++|||++++++|.+++...+.+++..+..++.|++.||.+||+.|++
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 128 (304)
T 2jam_A 49 RDSSLENEIAVLKKIKHENIVTLEDIYESTTHYYLVMQLVSGGELFDRILERGVYTEKDASLVIQQVLSAVKYLHENGIV 128 (304)
T ss_dssp ---HHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred chHHHHHHHHHHHhCCCCCeeehhhhcccCCEEEEEEEcCCCccHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 45678999999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 168 (241)
|+||+|+||++...+.++.++|+|||.+...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 129 H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf 207 (304)
T 2jam_A 129 HRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG-IMSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVITYILLCGYPPF 207 (304)
T ss_dssp CCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB-TTHHHHSCCCBCCTTTBSSCSCCHHHHHHHHHHHHHHHHHSSCTT
T ss_pred ccCCCHHHEEEecCCCCCCEEEccCCcceecCCC-ccccccCCCCccChHHhccCCCCchhhHHHHHHHHHHHHHCCCCC
Confidence 9999999999954456788999999998654432 233456899999999999889999999999999999999999999
Q ss_pred CCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccC
Q 026253 169 SGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 234 (241)
...+.......+..+.. .++......++.++.++|.+||+.||.+|||++++++||||+......
T Consensus 208 ~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 272 (304)
T 2jam_A 208 YEETESKLFEKIKEGYY-EFESPFWDDISESAKDFICHLLEKDPNERYTCEKALSHPWIDGNTALH 272 (304)
T ss_dssp TTSCHHHHHHHHHHCCC-CCCTTTTTTSCHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSCSCC
T ss_pred CCCCHHHHHHHHHcCCC-CCCccccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCCccc
Confidence 99888888888766543 233344557899999999999999999999999999999999866543
|
| >3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-46 Score=294.19 Aligned_cols=219 Identities=32% Similarity=0.507 Sum_probs=182.0
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|+.++++++||||+++++++.+++..++||||+++ ++.+++.. .+.+++..+..++.|++.||.+||++|
T Consensus 43 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~lH~~~ 121 (292)
T 3o0g_A 43 GVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQ-DLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CcchHHHHHHHHHhcCCCCCEeeEEeEEEeCCEEEEEEecCCC-CHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3457788999999999999999999999999999999999975 56555544 578999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccC-CCCchhHHHHHHHHHHHHhC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g 164 (241)
++|+||||+||++ +.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+||+|+++|+|++|
T Consensus 122 ivH~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~~ 198 (292)
T 3o0g_A 122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_dssp EECCCCSGGGEEE---CTTSCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred eecCCCCHHHEEE---cCCCCEEEeecccceecCCccccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHHHHHHHc
Confidence 9999999999999 78889999999999876432 2334456799999999987765 79999999999999999987
Q ss_pred CCC-CCCCChHHHHHHhhcCCCCCC------------------------CCccCCCCChHHHHHHHHhcccCccccCCHH
Q 026253 165 YPP-FSGRNNVQLVRNINSCKHLPF------------------------SQLIVPALHPDCVDMCLKLLSANTVDRLSFN 219 (241)
Q Consensus 165 ~~p-~~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 219 (241)
..| |.+.+..+....+......+. .....+.++.++.++|++||+.||.+|||++
T Consensus 199 ~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~ 278 (292)
T 3o0g_A 199 GRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278 (292)
T ss_dssp SCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcchhhcccccChHHHHHHHHHhccChhhCCCHH
Confidence 666 566666666665543211111 0112346788999999999999999999999
Q ss_pred HHhcCcccccc
Q 026253 220 EFYHHRFLRRN 230 (241)
Q Consensus 220 ~il~~~~~~~~ 230 (241)
|+++||||++.
T Consensus 279 e~l~hp~f~~~ 289 (292)
T 3o0g_A 279 EALQHPYFSDF 289 (292)
T ss_dssp HHHTSGGGTTC
T ss_pred HHhcCcccccC
Confidence 99999999863
|
| >2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.2e-46 Score=296.84 Aligned_cols=221 Identities=30% Similarity=0.455 Sum_probs=186.8
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc------CCCCHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------GRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------~~~~~~~~~~~~~~i~~~l~~l 82 (241)
..+.+.+|++++++++||||+++++++.+++..++||||++ ++|.+++... ..+++..+..++.|++.||.+|
T Consensus 46 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~l 124 (317)
T 2pmi_A 46 TPSTAIREISLMKELKHENIVRLYDVIHTENKLTLVFEFMD-NDLKKYMDSRTVGNTPRGLELNLVKYFQWQLLQGLAFC 124 (317)
T ss_dssp SCHHHHHHHHHHTTCCBTTBCCEEEEECCTTEEEEEEECCC-CBHHHHHHHHHSSSCCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhcCCCCcceEEEEEEECCeEEEEEEecC-CCHHHHHHhccccccccCCCHHHHHHHHHHHHHHHHHH
Confidence 34678899999999999999999999999999999999997 6999998754 3589999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCccccccc-CCCCchhHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~ 160 (241)
|+.|++|+||||+||++ +.++.++|+|||.+...... .......+++.|+|||.+.+. .++.++|+||||+++|+
T Consensus 125 H~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~e 201 (317)
T 2pmi_A 125 HENKILHRDLKPQNLLI---NKRGQLKLGDFGLARAFGIPVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAE 201 (317)
T ss_dssp HHTTEECCCCCGGGEEE---CTTCCEEECCCSSCEETTSCCCCCCCCCSCCTTCCHHHHTTCCCCCTHHHHHHHHHHHHH
T ss_pred HHCCeeeCCCChHHeEE---cCCCCEEECcCccceecCCCcccCCCCcccccccCchHhhCCCCCCcHHHHHHHHHHHHH
Confidence 99999999999999999 78889999999999876432 233445689999999998764 68999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCC-----------------------------CCccCCCCChHHHHHHHHhcccC
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPF-----------------------------SQLIVPALHPDCVDMCLKLLSAN 211 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~-----------------------------~~~~~~~~~~~~~~li~~~l~~~ 211 (241)
|++|..||.+.+..+....+......+. .......++.++.++|++||+.|
T Consensus 202 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~d 281 (317)
T 2pmi_A 202 MITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDFLHGLLQLN 281 (317)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHHHHHHSCSS
T ss_pred HHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHHHHHHCCCC
Confidence 9999999999888777766643211100 00112357889999999999999
Q ss_pred ccccCCHHHHhcCccccccccc
Q 026253 212 TVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 212 p~~Rps~~~il~~~~~~~~~~~ 233 (241)
|.+|||++|+++||||++....
T Consensus 282 P~~Rpt~~e~l~hp~f~~~~~~ 303 (317)
T 2pmi_A 282 PDMRLSAKQALHHPWFAEYYHH 303 (317)
T ss_dssp GGGSCCHHHHTTSGGGGGGCC-
T ss_pred cccCCCHHHHhCChhhhcccch
Confidence 9999999999999999986544
|
| >3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-46 Score=305.91 Aligned_cols=224 Identities=25% Similarity=0.339 Sum_probs=183.2
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
.....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++... ..+++..+..++.|++.||.|||
T Consensus 66 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH 145 (389)
T 3gni_B 66 SNEMVTFLQGELHVSKLFNHPNIVPYRATFIADNELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALDYIH 145 (389)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCCCcEeEEEEECCEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3556788999999999999999999999999999999999999999999999876 67999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC--------CccccccCCCCccCcccccc--cCCCCchhHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--------NYAEKVCGSPLYMAPEVLQF--QRYDEKVDMWS 153 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~--------~~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~s 153 (241)
++|++||||||+||++ +.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||
T Consensus 146 ~~~ivHrDlkp~NIll---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws 222 (389)
T 3gni_B 146 HMGYVHRSVKASHILI---SVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS 222 (389)
T ss_dssp HTTEECCCCSGGGEEE---CTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHH
T ss_pred hCCeecCCCCHHHEEE---cCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHH
Confidence 9999999999999999 78889999999987544221 11223467888999999987 57899999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCC-----------------------------------------CCCcc
Q 026253 154 VGAILFELLNGYPPFSGRNNVQLVRNINSCKHLP-----------------------------------------FSQLI 192 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-----------------------------------------~~~~~ 192 (241)
|||++|+|++|..||.+.+..+....+..+.... .....
T Consensus 223 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 302 (389)
T 3gni_B 223 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY 302 (389)
T ss_dssp HHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------------------------------
T ss_pred HHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcc
Confidence 9999999999999998766555444332211100 01112
Q ss_pred CCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 193 VPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 193 ~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
...+++++.++|++||+.||.+|||++|+|+||||++...
T Consensus 303 ~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~ 342 (389)
T 3gni_B 303 HRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR 342 (389)
T ss_dssp ---CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred ccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence 3467889999999999999999999999999999998543
|
| >3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-46 Score=307.42 Aligned_cols=217 Identities=31% Similarity=0.542 Sum_probs=190.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.+++.++||||+++++++.+++..|+||||++|++|.++++. ..+++..+..++.|++.||.+||++|+
T Consensus 111 ~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~-~~~~e~~~~~~~~qi~~aL~~LH~~gi 189 (410)
T 3v8s_A 111 SDSAFFWEERDIMAFANSPWVVQLFYAFQDDRYLYMVMEYMPGGDLVNLMSN-YDVPEKWARFYTAEVVLALDAIHSMGF 189 (410)
T ss_dssp CCCSTHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEeCCCCCcHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 3455688999999999999999999999999999999999999999999875 579999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccC----CCCchhHHHHHHHHHHH
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQR----YDEKVDMWSVGAILFEL 161 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~----~~~~~Dv~slG~~l~~l 161 (241)
+||||||+||++ +.++.++|+|||++........ ....++|+.|+|||.+.+.. ++.++|+||||+++|+|
T Consensus 190 vHrDLKp~NILl---~~~g~ikL~DFG~a~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwSlGvilyel 266 (410)
T 3v8s_A 190 IHRDVKPDNMLL---DKSGHLKLADFGTCMKMNKEGMVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM 266 (410)
T ss_dssp ECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSEEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHHHHHHHHHH
T ss_pred EeccCCHHHeeE---CCCCCEEEeccceeEeeccCCcccccCCcCCccccCHHHhhccCCCcCCCCcceEecchHHHHHH
Confidence 999999999999 7889999999999987654432 33567999999999987655 78999999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCChHHHHHHHHhcccCccc--cCCHHHHhcCcccccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVD--RLSFNEFYHHRFLRRN 230 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~--Rps~~~il~~~~~~~~ 230 (241)
++|..||.+.+..+.+..+.... ...++. ...+|.++.++|++||+.+|.+ ||+++|+++||||++.
T Consensus 267 l~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~--~~~~s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~ 336 (410)
T 3v8s_A 267 LVGDTPFYADSLVGTYSKIMNHKNSLTFPD--DNDISKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND 336 (410)
T ss_dssp HHSSCTTCCSSHHHHHHHHHTHHHHCCCCT--TCCCCHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred HhCCCCCCCCChhhHHHHHHhccccccCCC--cccccHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence 99999999999988888886542 222222 2378999999999999999988 9999999999999873
|
| >3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-47 Score=299.73 Aligned_cols=219 Identities=21% Similarity=0.255 Sum_probs=165.9
Q ss_pred hhhhhHHhhhhHH--HHHHHHhcCCCcCeeeeeeEEeecC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLD--CELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (241)
Q Consensus 2 ~~~~~~~~~~~~~--~E~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (241)
+|.++.+..+.+. .|+..+.+++||||+++++++.+++ ..++|||||++|+|.++++. .+++++.+.+++.|+
T Consensus 31 vK~l~~~~~~~~~~e~Ei~~~~~l~HpNIv~l~g~~~~~~~~~~~~~lV~Ey~~~gsL~~~l~~-~~l~~~~~~~i~~~i 109 (303)
T 3hmm_A 31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALST 109 (303)
T ss_dssp EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred EEEECccchhhHHHHHHHHHHhcCCCCCCCcEEEEEEecCCCceEEEEEecCCCCCcHHHHHHh-CCCCHHHHHHHHHHH
Confidence 4555444444444 4566667889999999999987654 58999999999999999975 478999999999999
Q ss_pred HHHHHHHHhC--------CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----cccccCCCCccCcccccc
Q 026253 76 GAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF 142 (241)
Q Consensus 76 ~~~l~~lh~~--------~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~~~~~~~~~PE~~~~ 142 (241)
+.||+|||++ +|+||||||+|||+ +.++.+||+|||+|+....... .....||+.|+|||.+.+
T Consensus 110 a~gl~ylH~~~~~~~~~~~IiHRDlKp~NILl---~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~ 186 (303)
T 3hmm_A 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp HHHHHHHHCCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTT
T ss_pred HHHHHHHHHhhhhccCCCCEeeccCCcccEEE---CCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcc
Confidence 9999999987 99999999999999 7889999999999976644322 223579999999999865
Q ss_pred c------CCCCchhHHHHHHHHHHHHhCCCCCCCC---------------ChHHHHHHhhcCC-CCCCCCccC-CCCChH
Q 026253 143 Q------RYDEKVDMWSVGAILFELLNGYPPFSGR---------------NNVQLVRNINSCK-HLPFSQLIV-PALHPD 199 (241)
Q Consensus 143 ~------~~~~~~Dv~slG~~l~~l~~g~~p~~~~---------------~~~~~~~~i~~~~-~~~~~~~~~-~~~~~~ 199 (241)
. .++.++|||||||++|||++|.+||... ...+..+.+.... ++..+.... ...+..
T Consensus 187 ~~~~~~~~~~~k~DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p~~~~~~~~~~~ 266 (303)
T 3hmm_A 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 266 (303)
T ss_dssp CSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHH
T ss_pred cccccCCccChhHhhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCCccccchHHHHH
Confidence 4 4678999999999999999997765321 1223333332222 223332211 123457
Q ss_pred HHHHHHHhcccCccccCCHHHHhcC
Q 026253 200 CVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 200 ~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+.+++.+||+.||++|||+.|+++.
T Consensus 267 l~~li~~cl~~dP~~RPt~~ei~~~ 291 (303)
T 3hmm_A 267 MAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHH
Confidence 8999999999999999999999864
|
| >2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=306.94 Aligned_cols=218 Identities=30% Similarity=0.532 Sum_probs=189.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|..++.+++|+||+++++++.+++..|+||||++|++|.+++.+.+ .+++..+..++.|++.||.+||++
T Consensus 102 ~~~~~~~~~E~~il~~~~hp~Iv~l~~~~~~~~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~LH~~ 181 (412)
T 2vd5_A 102 RGEVSCFREERDVLVNGDRRWITQLHFAFQDENYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAIDSVHRL 181 (412)
T ss_dssp HGGGCCHHHHHHHHHHSCTTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3456678999999999999999999999999999999999999999999998754 799999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCccccc-------ccCCCCchhHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQ-------FQRYDEKVDMWSVGA 156 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~-------~~~~~~~~Dv~slG~ 156 (241)
|++||||||+||++ +.++.++|+|||++........ ....++|+.|+|||.+. +..++.++|+||||+
T Consensus 182 giiHrDLKp~NILl---d~~g~vkL~DFGla~~~~~~~~~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~DiwSlGv 258 (412)
T 2vd5_A 182 GYVHRDIKPDNILL---DRCGHIRLADFGSCLKLRADGTVRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGV 258 (412)
T ss_dssp TEECCCCSGGGEEE---CTTSCEEECCCTTCEECCTTSCEECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHHHHHHH
T ss_pred CeeecccCHHHeee---cCCCCEEEeechhheeccCCCccccceeccccCcCCHHHHhhcccCcCCCCCChHHhhhHHhH
Confidence 99999999999999 7889999999999987654432 23457899999999987 356899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCChHHHHHHHHhcccCcccc---CCHHHHhcCccccc
Q 026253 157 ILFELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDR---LSFNEFYHHRFLRR 229 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R---ps~~~il~~~~~~~ 229 (241)
++|+|++|..||.+.+..+.+..+.... ...++ .....+|.++.++|++||. +|.+| |+++|+++||||++
T Consensus 259 ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-~~~~~~s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~ 333 (412)
T 2vd5_A 259 FAYEMFYGQTPFYADSTAETYGKIVHYKEHLSLP-LVDEGVPEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG 333 (412)
T ss_dssp HHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCC-----CCCHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred HHHHHHhCCCCCCCCCHHHHHHHHHhcccCcCCC-ccccCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence 9999999999999999888887775432 11222 1234789999999999999 99998 59999999999987
|
| >3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=291.93 Aligned_cols=216 Identities=31% Similarity=0.563 Sum_probs=190.4
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
....+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++....++++..+..++.|++.||.+||+.|++
T Consensus 52 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~qi~~~l~~LH~~~i~ 131 (279)
T 3fdn_A 52 VEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRVI 131 (279)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHTTTCE
T ss_pred HHHHHHHHHHHHHcCCCCCCcchhheEecCCEEEEEEecCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCEe
Confidence 36678999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPF 168 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~ 168 (241)
|+||+|+||++ +.++.++|+|||.+....... .....++..|+|||.+.+..++.++|+||||+++|+|++|..||
T Consensus 132 H~dlkp~Nili---~~~~~~~l~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p~ 207 (279)
T 3fdn_A 132 HRDIKPENLLL---GSAGELKIADFGWSVHAPSSR-RTDLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPF 207 (279)
T ss_dssp ECCCCGGGEEE---CTTSCEEECSCCEESCC---------CCCCTTCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCTT
T ss_pred cccCChHhEEE---cCCCCEEEEeccccccCCccc-ccccCCCCCccCHhHhccCCCCccchhHhHHHHHHHHHHCCCCC
Confidence 99999999999 788899999999886544332 33456899999999999888999999999999999999999999
Q ss_pred CCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 169 SGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 169 ~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
...+..+....+..... ..+ ..++..+.++|++||+.||.+|||++|+++||||+.....
T Consensus 208 ~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~~~~ 267 (279)
T 3fdn_A 208 EANTYQETYKRISRVEF-TFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANSSK 267 (279)
T ss_dssp CCSSHHHHHHHHHHTCC-CCC----TTSCHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHHCSS
T ss_pred CCCcHHHHHHHHHhCCC-CCC----CcCCHHHHHHHHHHhccChhhCCCHHHHhhCccccCCccC
Confidence 99988888877755432 222 3678999999999999999999999999999999986543
|
| >1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-46 Score=294.72 Aligned_cols=218 Identities=29% Similarity=0.496 Sum_probs=181.2
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|++++++++||||+++++++.+++..++|||++. ++|.+++... +.+++..+..++.|++.||.+||++|+
T Consensus 43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 121 (288)
T 1ob3_A 43 IPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLD-QDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDRRV 121 (288)
T ss_dssp CCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cchhHHHHHHHHHhcCCCCEeeeeeEEccCCeEEEEEEecC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 35778899999999999999999999999999999999996 5999998764 679999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||||+||++ +.++.++|+|||.+...... .......+++.|+|||.+.+. .++.++|+||+|+++|+|++|.
T Consensus 122 ~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~ 198 (288)
T 1ob3_A 122 LHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGT 198 (288)
T ss_dssp CCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHHSS
T ss_pred ecCCCCHHHEEE---cCCCCEEEeECccccccCccccccccccccccccCchheeCCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 999999999999 78889999999999765432 223345679999999998764 5899999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCC------------------------CCccCCCCChHHHHHHHHhcccCccccCCHHHH
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPF------------------------SQLIVPALHPDCVDMCLKLLSANTVDRLSFNEF 221 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~------------------------~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i 221 (241)
.||.+.+..+....+......+. .......+++++.++|++||+.||.+|||++|+
T Consensus 199 ~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~ 278 (288)
T 1ob3_A 199 PLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAKQA 278 (288)
T ss_dssp CSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHHHH
T ss_pred CCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccccccccCccHHHHhhhcCHHHHHHHHHHcCCCcccCCCHHHH
Confidence 99998887766655533111000 011234678999999999999999999999999
Q ss_pred hcCcccccc
Q 026253 222 YHHRFLRRN 230 (241)
Q Consensus 222 l~~~~~~~~ 230 (241)
++||||++.
T Consensus 279 l~hp~f~~~ 287 (288)
T 1ob3_A 279 LEHAYFKEN 287 (288)
T ss_dssp HTSGGGGC-
T ss_pred hcCcchhhc
Confidence 999999864
|
| >3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-46 Score=293.47 Aligned_cols=222 Identities=29% Similarity=0.566 Sum_probs=191.0
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|++++++++||||+++++++.+++..++|||++++++|.+++.....+++..+..++.|++.||.+||+.|++
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i~ 130 (283)
T 3bhy_A 51 SREEIEREVNILREIRHPNIITLHDIFENKTDVVLILELVSGGELFDFLAEKESLTEDEATQFLKQILDGVHYLHSKRIA 130 (283)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCeeehhheecCCCeEEEEEeecCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Confidence 36789999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred ccCCCCCCeEEeecC-CCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~-~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|+||+|+||+++..+ ....++|+|||.+.............+++.|+|||.+.+..++.++|+||||+++|+|++|..|
T Consensus 131 H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 210 (283)
T 3bhy_A 131 HFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 210 (283)
T ss_dssp CSCCSGGGEEESCSSSSSCCEEECCCTTCEECC--------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCT
T ss_pred CCCCChHHEEEecCCCCCCceEEEecccceeccCCCcccccCCCcCccCcceecCCCCCcchhhhhHHHHHHHHHHCCCC
Confidence 999999999994211 1237999999999877655444556789999999999988999999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|.+.+..+....+.... ...+....+.++..+.+++++||+.||.+|||+.++++||||+...
T Consensus 211 ~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~ 273 (283)
T 3bhy_A 211 FLGETKQETLTNISAVN-YDFDEEYFSNTSELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKAIR 273 (283)
T ss_dssp TCCSSHHHHHHHHHTTC-CCCCHHHHTTCCHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHHHH
T ss_pred CCCcchHHHHHHhHhcc-cCCcchhcccCCHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHHHH
Confidence 99988888877775443 3334444457899999999999999999999999999999998743
|
| >3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.7e-46 Score=302.01 Aligned_cols=216 Identities=34% Similarity=0.558 Sum_probs=172.8
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|+.++++++||||+++++++.+.+..++||||+++++|.+++...+++++..+..++.|++.||++||+.|++
T Consensus 59 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~ql~~~L~~LH~~~iv 138 (361)
T 3uc3_A 59 IDENVQREIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICNAGRFSEDEARFFFQQLLSGVSYCHSMQIC 138 (361)
T ss_dssp SCHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred ccHHHHHHHHHHHhCCCCCCCcEEEEEeeCCEEEEEEEeCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 35678899999999999999999999999999999999999999999998888999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCc--eEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCc-hhHHHHHHHHHHHHhCC
Q 026253 89 HRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK-VDMWSVGAILFELLNGY 165 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~--~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~-~Dv~slG~~l~~l~~g~ 165 (241)
||||||+||++ +.++ .++|+|||++.............+++.|+|||.+.+..++.+ +|+||+|+++|+|++|.
T Consensus 139 H~Dlkp~Nill---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~ 215 (361)
T 3uc3_A 139 HRDLKLENTLL---DGSPAPRLKICDFGYSKSSVLHSQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVMLVGA 215 (361)
T ss_dssp SCCCCGGGEEE---CSSSSCCEEECCCCCC---------------CTTSCHHHHHCSSCCHHHHHHHHHHHHHHHHHHSS
T ss_pred cCCCCHHHEEE---cCCCCceEEEeecCccccccccCCCCCCcCCCCcCChhhhcCCCCCCCeeeeehhHHHHHHHHhCC
Confidence 99999999999 4444 499999999976554444555678999999999987777655 89999999999999999
Q ss_pred CCCCCCCh----HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 166 PPFSGRNN----VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~----~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
.||.+... ....+.+.... ...+. ...+++++.++|++||+.||.+|||++|+++||||.+.
T Consensus 216 ~Pf~~~~~~~~~~~~~~~~~~~~-~~~~~--~~~~s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~ 281 (361)
T 3uc3_A 216 YPFEDPEEPRDYRKTIQRILSVK-YSIPD--DIRISPECCHLISRIFVADPATRISIPEIKTHSWFLKN 281 (361)
T ss_dssp CSCC----CCCHHHHHHHHHTTC-CCCCT--TSCCCHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred CCCCCCccHHHHHHHHHHHhcCC-CCCCC--cCCCCHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence 99986443 33344443222 12222 22678999999999999999999999999999999664
|
| >2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=301.56 Aligned_cols=214 Identities=33% Similarity=0.560 Sum_probs=183.7
Q ss_pred HhhhhHHHHHHH-HhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNF-LSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~-l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.....+.+|..+ ++.++||||+++++++.+.+..|+||||++|++|.+++.+.+.+++..+..++.|++.||.+||++|
T Consensus 80 ~~~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~g 159 (373)
T 2r5t_A 80 KEEKHIMSERNVLLKNVKHPFLVGLHFSFQTADKLYFVLDYINGGELFYHLQRERCFLEPRARFYAAEIASALGYLHSLN 159 (373)
T ss_dssp -----------CCBCCCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCCEEEEEEeCCEEEEEEeCCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 345567777777 4678999999999999999999999999999999999998889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccC-CCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++||||||+||++ +.++.++|+|||+++... ........++|+.|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 160 ivHrDlkp~NIll---~~~g~ikL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~G~ 236 (373)
T 2r5t_A 160 IVYRDLKPENILL---DSQGHIVLTDFGLCKENIEHNSTTSTFCGTPEYLAPEVLHKQPYDRTVDWWCLGAVLYEMLYGL 236 (373)
T ss_dssp CCCCCCCGGGEEE---CTTSCEEECCCCBCGGGBCCCCCCCSBSCCCCCCCHHHHTTCCCCTHHHHHHHHHHHHHHHHSS
T ss_pred ceecCCCHHHEEE---CCCCCEEEeeCccccccccCCCccccccCCccccCHHHhCCCCCCchhhhHHHHHHHHHHHcCC
Confidence 9999999999999 788899999999997633 333455677999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH----HHHhcCccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF----NEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~----~~il~~~~~~~ 229 (241)
.||.+.+..+.++.+..... .+ .+.++.++.++|++||+.||.+||++ +++++||||+.
T Consensus 237 ~Pf~~~~~~~~~~~i~~~~~-~~----~~~~~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~ 299 (373)
T 2r5t_A 237 PPFYSRNTAEMYDNILNKPL-QL----KPNITNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL 299 (373)
T ss_dssp CTTCCSBHHHHHHHHHHSCC-CC----CSSSCHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred CCCCCCCHHHHHHHHHhccc-CC----CCCCCHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence 99999999888888866532 22 34789999999999999999999986 69999999987
|
| >2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-46 Score=290.23 Aligned_cols=216 Identities=34% Similarity=0.638 Sum_probs=184.3
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|++++++++||||+++++++.+.+..++|||++++++|.+++...+++++..+..++.|++.||.+||++|++
T Consensus 54 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 133 (276)
T 2h6d_A 54 VVGKIKREIQNLKLFRHPHIIKLYQVISTPTDFFMVMEYVSGGELFDYICKHGRVEEMEARRLFQQILSAVDYCHRHMVV 133 (276)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHHCSS
T ss_pred HHHHHHHHHHHHhcCCCCCEeEEEEEEecCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCCc
Confidence 35688999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|+||+|+||++ +.++.++|+|||.+.............+++.|+|||.+.+..+ +.++|+||||+++|+|++|..|
T Consensus 134 H~dl~p~Nil~---~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l~~l~~g~~p 210 (276)
T 2h6d_A 134 HRDLKPENVLL---DAHMNAKIADFGLSNMMSDGEFLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVILYALLCGTLP 210 (276)
T ss_dssp CCCCCGGGEEE---CTTSCEEECCCCGGGCCCC-------------CCTGGGTTSCCCHHHHHHHHHHHHHHHHHHSSCS
T ss_pred cCCCChhhEEE---CCCCCEEEeecccccccCCCcceecccCCccccCHHHHcCCCCCCccchHHHHHHHHHHHHhCCCC
Confidence 99999999999 7888999999999987765554455678899999999987665 6899999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
|...+.....+.+..... ..+ ..++..+.+++.+||+.||.+|||++++++||||++...
T Consensus 211 ~~~~~~~~~~~~~~~~~~-~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~~~ 270 (276)
T 2h6d_A 211 FDDEHVPTLFKKIRGGVF-YIP----EYLNRSVATLLMHMLQVDPLKRATIKDIREHEWFKQDLP 270 (276)
T ss_dssp SCCSSHHHHHHHHHHCCC-CCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTTCC
T ss_pred CCCCcHHHHHHHhhcCcc-cCc----hhcCHHHHHHHHHHccCChhhCCCHHHHHhChhhccCch
Confidence 999888888887765432 222 367899999999999999999999999999999987643
|
| >3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8e-46 Score=294.05 Aligned_cols=219 Identities=31% Similarity=0.509 Sum_probs=184.7
Q ss_pred hhhHHHHHHHHhcCC---CcCeeeeeeEEeecC-----eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVN---HPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGL 79 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l 79 (241)
...+.+|+.++++++ ||||+++++++.... ..++|||++. ++|.+++..... +++..+..++.|++.||
T Consensus 55 ~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~~~i~~qi~~al 133 (308)
T 3g33_A 55 PISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDREIKVTLVFEHVD-QDLRTYLDKAPPPGLPAETIKDLMRQFLRGL 133 (308)
T ss_dssp CHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSSSEEEEEEEEECCC-CBHHHHHHTCCTTCSCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCCCceeEEEEehhhh-cCHHHHHhhccCCCCCHHHHHHHHHHHHHHH
Confidence 346778888888774 999999999998755 5899999995 699999987654 99999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
++||++|++|+||||+||++ +.++.++|+|||.+.............+++.|+|||.+.+..++.++|+||||+++|
T Consensus 134 ~~lH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 210 (308)
T 3g33_A 134 DFLHANCIVHRDLKPENILV---TSGGTVKLADFGLARIYSYQMALTPVVVTLWYRAPEVLLQSTYATPVDMWSVGCIFA 210 (308)
T ss_dssp HHHHHTTCCCSCCCTTTEEE---CTTSCEEECSCSCTTTSTTCCCSGGGGCCCSSCCHHHHHTSCCCSTHHHHHHHHHHH
T ss_pred HHHHHCCcccCCCCHHHEEE---cCCCCEEEeeCccccccCCCcccCCccccccccCchHHcCCCCCchHHHHHHHHHHH
Confidence 99999999999999999999 788899999999998776665566678899999999999889999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCC----------------------ccCCCCChHHHHHHHHhcccCccccCC
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ----------------------LIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
+|++|..||.+.+..+....+......+... ...+.+++++.++|.+||+.||.+|||
T Consensus 211 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 290 (308)
T 3g33_A 211 EMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGAFPPRGPRPVQSVVPEMEESGAQLLLEMLTFNPHKRIS 290 (308)
T ss_dssp HTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGGSCCCCCCCHHHHSCSCCHHHHHHHHHHTCSSTTTSCC
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccccCCCCCCcHHHhCccccHHHHHHHHHHhcCCCccCCC
Confidence 9999999999988887776664432211111 123467889999999999999999999
Q ss_pred HHHHhcCcccccccc
Q 026253 218 FNEFYHHRFLRRNSA 232 (241)
Q Consensus 218 ~~~il~~~~~~~~~~ 232 (241)
+.|+|+||||++...
T Consensus 291 ~~e~l~h~~~~~~~~ 305 (308)
T 3g33_A 291 AFRALQHSYLHKDEG 305 (308)
T ss_dssp HHHHHTSTTC-----
T ss_pred HHHHhcCccccCCCC
Confidence 999999999998643
|
| >3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-46 Score=300.69 Aligned_cols=217 Identities=30% Similarity=0.527 Sum_probs=183.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|+.++++++||||+++++++.+++..++||||+++++|.+++.....+++..+..++.|++.||.+||+.|++
T Consensus 48 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~~giv 127 (323)
T 3tki_A 48 CPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGIT 127 (323)
T ss_dssp ---CHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCcc
Confidence 35778999999999999999999999999999999999999999999998888899999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHhC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g 164 (241)
|+||||+||++ +.++.++|+|||++....... ......+++.|+|||.+.+..+ +.++|+||||+++|+|++|
T Consensus 128 H~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~~ll~g 204 (323)
T 3tki_A 128 HRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAG 204 (323)
T ss_dssp CSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHHHHHHHHS
T ss_pred ccccchHHEEE---eCCCCEEEEEeeccceeccCCcccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHHHHHHHhC
Confidence 99999999999 788899999999997653222 2334678999999999987765 7899999999999999999
Q ss_pred CCCCCCCChH-HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 165 YPPFSGRNNV-QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 165 ~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
..||...+.. ............. +. ...++..+.++|++||+.||.+|||++|+++||||++..
T Consensus 205 ~~pf~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~~ 269 (323)
T 3tki_A 205 ELPWDQPSDSCQEYSDWKEKKTYL-NP--WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPL 269 (323)
T ss_dssp SCSCSSSCTTSHHHHHHHTTCTTS-TT--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCC
T ss_pred CCCCCCCchHHHHHHHHhcccccC-Cc--cccCCHHHHHHHHHHccCChhhCcCHHHHhhChhhcccc
Confidence 9999865543 3333332222211 11 236889999999999999999999999999999998743
|
| >2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.9e-46 Score=301.76 Aligned_cols=218 Identities=35% Similarity=0.675 Sum_probs=193.7
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|+.+++++ +||||+++++++...+..++||||++|++|.+++.....+++..+..++.|++.||.+||+.|
T Consensus 141 ~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~g 220 (365)
T 2y7j_A 141 EVREATRRETHILRQVAGHPHIITLIDSYESSSFMFLVFDLMRKGELFDYLTEKVALSEKETRSIMRSLLEAVSFLHANN 220 (365)
T ss_dssp HHHHHHHHHHHHHHHHTTCTTBCCEEEEEEBSSEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeEEEEEEeeCCEEEEEEEeCCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3467889999999999 899999999999999999999999999999999998888999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc------cCCCCchhHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Dv~slG~~l~~ 160 (241)
++|+||+|+||++ +.++.++|+|||++.............+++.|+|||.+.+ ..++.++|+||||+++|+
T Consensus 221 i~H~Dlkp~NIl~---~~~~~ikl~DfG~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~il~e 297 (365)
T 2y7j_A 221 IVHRDLKPENILL---DDNMQIRLSDFGFSCHLEPGEKLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFT 297 (365)
T ss_dssp EECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHHHHHHHHHH
T ss_pred eecCCCCHHHEEE---CCCCCEEEEecCcccccCCCcccccCCCCCCccChhhccccccccCcCCCchhhHHhHHHHHHH
Confidence 9999999999999 7888999999999987766555566778999999998853 357899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
|++|..||.+.+.......+..+... .+......++..+.++|++||+.||.+|||++++++||||++
T Consensus 298 ll~g~~pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~r 365 (365)
T 2y7j_A 298 LLAGSPPFWHRRQILMLRMIMEGQYQ-FSSPEWDDRSSTVKDLISRLLQVDPEARLTAEQALQHPFFER 365 (365)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHTCCC-CCHHHHSSSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred HHHCCCCCCCCCHHHHHHHHHhCCCC-CCCcccccCCHHHHHHHHHHcCCChhHCcCHHHHhcCcccCC
Confidence 99999999998888887777655432 222233478899999999999999999999999999999974
|
| >2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-46 Score=299.47 Aligned_cols=229 Identities=33% Similarity=0.529 Sum_probs=181.1
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|+++++++ +||||+++++++.+++..++||||+++++|.+++...+.+++..+..++.|++.||.+||++|
T Consensus 52 ~~~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 131 (316)
T 2ac3_A 52 HIRSRVFREVEMLYQCQGHRNVLELIEFFEEEDRFYLVFEKMRGGSILSHIHKRRHFNELEASVVVQDVASALDFLHNKG 131 (316)
T ss_dssp CCHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHHHHhcCCCCeeeEEEEEeeCCEEEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3467889999999996 799999999999999999999999999999999998889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--------ccccccCCCCccCcccccc-----cCCCCchhHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF-----QRYDEKVDMWS 153 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--------~~~~~~~~~~~~~PE~~~~-----~~~~~~~Dv~s 153 (241)
++|+||||+||+++..+....++|+|||++....... ......++..|+|||.+.+ ..++.++|+||
T Consensus 132 ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diws 211 (316)
T 2ac3_A 132 IAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWS 211 (316)
T ss_dssp CCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHTTTHHHHH
T ss_pred ceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCCcccccHh
Confidence 9999999999999533333449999999987653211 1223458899999999865 55889999999
Q ss_pred HHHHHHHHHhCCCCCCCCCh---------------HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH
Q 026253 154 VGAILFELLNGYPPFSGRNN---------------VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF 218 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 218 (241)
||+++|+|++|..||.+... ......+.... ..++......++.++.++|++||+.||.+|||+
T Consensus 212 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~ 290 (316)
T 2ac3_A 212 LGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQEGK-YEFPDKDWAHISCAAKDLISKLLVRDAKQRLSA 290 (316)
T ss_dssp HHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHHCC-CCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCH
T ss_pred HHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhccC-cccCchhcccCCHHHHHHHHHHhhCChhhCCCH
Confidence 99999999999999986542 33455554433 333433334789999999999999999999999
Q ss_pred HHHhcCcccccccccCCCC
Q 026253 219 NEFYHHRFLRRNSAILRAP 237 (241)
Q Consensus 219 ~~il~~~~~~~~~~~~~~~ 237 (241)
+|+++||||++.......|
T Consensus 291 ~e~l~hp~~~~~~~~~~~~ 309 (316)
T 2ac3_A 291 AQVLQHPWVQGCAPENTLP 309 (316)
T ss_dssp HHHHHSTTCC---------
T ss_pred HHHhcChhhcCCCCcccCC
Confidence 9999999999865444333
|
| >1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-46 Score=307.52 Aligned_cols=222 Identities=29% Similarity=0.585 Sum_probs=178.7
Q ss_pred hhHHHHHHHHhcC-CCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 026253 11 SCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 11 ~~~~~E~~~l~~l-~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (241)
..+.+|+.++.++ +|+||+++++++.. ++..++||||++|++|.+++...+ .+++..+..++.|++.||.|||
T Consensus 99 ~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~aL~~LH 178 (400)
T 1nxk_A 99 PKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYLH 178 (400)
T ss_dssp HHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHhcCCCCcceEeEEEeecccCCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4677899988554 89999999999876 667999999999999999998653 5999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+.|++||||||+||+++....++.++|+|||++.............+|+.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 179 ~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ell~ 258 (400)
T 1nxk_A 179 SINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLC 258 (400)
T ss_dssp HTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC-----------CTTCCGGGSCCCCSSSHHHHHHHHHHHHHHHH
T ss_pred HCCccccCcCcceEEEecCCCCccEEEEecccccccCCCCccccCCCCCCccCHhhcCCCCCCCcccHHHHHHHHHHHHh
Confidence 99999999999999995433378899999999987665554556778999999999998999999999999999999999
Q ss_pred CCCCCCCCChHH----HHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 164 GYPPFSGRNNVQ----LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 164 g~~p~~~~~~~~----~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
|..||.+.+... ....+..+. ..++......++.++.++|++||+.||.+|||++|+++||||.+....
T Consensus 259 g~~pf~~~~~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~~~~ 331 (400)
T 1nxk_A 259 GYPPFYSNHGLAISPGMKTRIRMGQ-YEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKV 331 (400)
T ss_dssp SSCSCCCCTTCSSCCSHHHHHHHTC-CCCCTTTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTTTTS
T ss_pred CCCCCCCCccccccHHHHHHHHcCc-ccCCCcccccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccCCCCC
Confidence 999998654321 333343322 233333345789999999999999999999999999999999876544
|
| >2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=289.28 Aligned_cols=218 Identities=28% Similarity=0.538 Sum_probs=194.1
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|+.++++++|+||+++++++.+++..++|||++++++|.+++...+.+++..+..++.|++.||.+||+.|
T Consensus 56 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 135 (294)
T 2rku_A 56 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 135 (294)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeeeeeeccCCEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678899999999999999999999999999999999999999999999988889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 136 i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~l~~g~ 212 (294)
T 2rku_A 136 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 212 (294)
T ss_dssp EECCCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHTTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred ccccCCChHhEEE---cCCCCEEEEeccCceecccCccccccccCCCCcCCcchhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 9999999999999 78889999999999775432 2334456889999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
.||......+....+.... ...+ ..++..+.+++++||+.||.+|||++|+++||||++...
T Consensus 213 ~p~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 274 (294)
T 2rku_A 213 PPFETSCLKETYLRIKKNE-YSIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 274 (294)
T ss_dssp CTTCCSSHHHHHHHHHTTC-CCCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred CCCCCCCHHHHHHHHhhcc-CCCc----cccCHHHHHHHHHHcccChhhCcCHHHHhhChheecCCc
Confidence 9999988887777775443 2222 377899999999999999999999999999999987543
|
| >4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=296.54 Aligned_cols=225 Identities=27% Similarity=0.520 Sum_probs=185.1
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...+.+++..+..++.|++.||.+||+.
T Consensus 42 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~lH~~ 121 (311)
T 4agu_A 42 DPVIKKIALREIRMLKQLKHPNLVNLLEVFRRKRRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFCHKH 121 (311)
T ss_dssp -HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHHHhCCCCCccchhheeecCCeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34456788899999999999999999999999999999999999999999988888899999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHh
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~ 163 (241)
|++|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++
T Consensus 122 ~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 198 (311)
T 4agu_A 122 NCIHRDVKPENILI---TKHSVIKLCDFGFARLLTGPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLS 198 (311)
T ss_dssp TEECCCCSGGGEEE---CTTSCEEECCCTTCEECC------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHHHHHH
T ss_pred CCcCCCCChhhEEE---cCCCCEEEeeCCCchhccCcccccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHHHHHh
Confidence 99999999999999 78889999999999776532 22344568899999999876 567999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCC--------------------CCCCC------ccCCCCChHHHHHHHHhcccCccccCC
Q 026253 164 GYPPFSGRNNVQLVRNINSCKH--------------------LPFSQ------LIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~--------------------~~~~~------~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
|..||.+.+..+....+..... .+.+. ...+.++.++.+++++||+.||.+|||
T Consensus 199 g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 278 (311)
T 4agu_A 199 GVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGCLHMDPTERLT 278 (311)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHCTTCCHHHHHHHHHHCCSSTTTSCC
T ss_pred CCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhcccccHHHHHHHHHHccCChhhcCC
Confidence 9999998887766655433211 11110 112468889999999999999999999
Q ss_pred HHHHhcCccccccccc
Q 026253 218 FNEFYHHRFLRRNSAI 233 (241)
Q Consensus 218 ~~~il~~~~~~~~~~~ 233 (241)
++|+++||||++....
T Consensus 279 ~~ell~hp~f~~~~~~ 294 (311)
T 4agu_A 279 CEQLLHHPYFENIREI 294 (311)
T ss_dssp HHHHHTSGGGTTCC--
T ss_pred HHHHhcChHHHhccCH
Confidence 9999999999986543
|
| >3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.3e-47 Score=311.39 Aligned_cols=219 Identities=35% Similarity=0.610 Sum_probs=178.1
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
...+.+|++++++++||||+++++++.. +..++||||+++++|.+++...+++++..+..++.|++.||.+||++|++|
T Consensus 184 ~~~~~~E~~~l~~l~hpniv~l~~~~~~-~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH 262 (419)
T 3i6u_A 184 ALNVETEIEILKKLNHPCIIKIKNFFDA-EDYYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGIIH 262 (419)
T ss_dssp -CCHHHHHHHHHHCCCTTBCCCCEEEES-SEEEEEEECCTTCBGGGGTSSSCCCCHHHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEec-CceEEEEEcCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCccc
Confidence 4468999999999999999999999854 558999999999999999988888999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc---cCCCCchhHHHHHHHHHHHHhCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
|||||+||+++..+....++|+|||++.............+++.|+|||.+.+ ..++.++|+||||+++|+|++|..
T Consensus 263 rDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~~lltg~~ 342 (419)
T 3i6u_A 263 RDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYP 342 (419)
T ss_dssp SCCCGGGEEESSSSSSCCEEECCSSTTTSCC-----------CTTCCTTTTC----CTTHHHHHHHHHHHHHHHHHHSSC
T ss_pred cCCChHhEEEecCCCcceEEEeecccceecCCCccccccCCCCCccCceeeecCCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999996444555699999999988766555566778999999999853 567889999999999999999999
Q ss_pred CCCCCChH-HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 167 PFSGRNNV-QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 167 p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
||...... .....+..+ ...........+++.+.++|++||+.||.+|||++|+++||||++.
T Consensus 343 pf~~~~~~~~~~~~i~~~-~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~ 406 (419)
T 3i6u_A 343 PFSEHRTQVSLKDQITSG-KYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406 (419)
T ss_dssp SSCCCSSSCCHHHHHHTT-CCCCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCCH
T ss_pred CCCCCcchHHHHHHHhcC-CCCCCchhhcccCHHHHHHHHHHccCChhHCcCHHHHhCCcccCCh
Confidence 99865433 333444333 3333334445789999999999999999999999999999999863
|
| >2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.3e-46 Score=293.76 Aligned_cols=213 Identities=30% Similarity=0.521 Sum_probs=184.0
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+.+.+|++++++++||||+++++++.+ ++..++||||+++++|.+++. ..++++..+..++.|++.||.+||++|+
T Consensus 80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~-~~~~~~~~~~~~~~qi~~~l~~lH~~~i 158 (298)
T 2zv2_A 80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPNEDHLYMVFELVNQGPVMEVPT-LKPLSEDQARFYFQDLIKGIEYLHYQKI 158 (298)
T ss_dssp -CHHHHHHHHHHTCCCTTBCCEEEEEECSSSSEEEEEEECCTTCBSCCSSC-SSCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhCCCCCCCeEEEEEEcCCCCEEEEEEecCCCCcHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 5678999999999999999999999986 578999999999999988654 4579999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccC---CCCchhHHHHHHHHHHHHh
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~---~~~~~Dv~slG~~l~~l~~ 163 (241)
+|+||||+||++ +.++.++|+|||++....... ......+++.|+|||.+.+.. ++.++|+||||+++|+|++
T Consensus 159 vH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~~l~~l~~ 235 (298)
T 2zv2_A 159 IHRDIKPSNLLV---GEDGHIKIADFGVSNEFKGSDALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCFVF 235 (298)
T ss_dssp ECCCCCGGGEEE---CTTSCEEECCCTTCEECSSSSCEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHHHHHHHHHH
T ss_pred eccCCCHHHEEE---CCCCCEEEecCCCccccccccccccCCcCCccccChhhhccCCCCCCCchhhhHhHHHHHHHHHH
Confidence 999999999999 788899999999997765432 234457899999999997655 4788999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
|..||.+.+.......+...... .+ ..+.+++++.++|.+||+.||.+|||++|+++||||++
T Consensus 236 g~~pf~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~~ 298 (298)
T 2zv2_A 236 GQCPFMDERIMCLHSKIKSQALE-FP--DQPDIAEDLKDLITRMLDKNPESRIVVPEIKLHPWVTR 298 (298)
T ss_dssp SSCSSCCSSHHHHHHHHHHCCCC-CC--SSSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHHC
T ss_pred CCCCCCCccHHHHHHHHhcccCC-CC--CccccCHHHHHHHHHHhhcChhhCCCHHHHhcCccccC
Confidence 99999988887777776554322 22 12478999999999999999999999999999999974
|
| >2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=313.67 Aligned_cols=213 Identities=31% Similarity=0.542 Sum_probs=188.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+|++++++++||||+++++++.+++..++||||++|++|.+++...+. +++..+..++.|++.||.|||++|
T Consensus 227 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL~yLH~~g 306 (576)
T 2acx_A 227 GEAMALNEKQILEKVNSRFVVSLAYAYETKDALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGLEDLHRER 306 (576)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHcCCCCEeeEEEEEeeCCEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 456788999999999999999999999999999999999999999999986544 999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
++||||||+||++ +.++.++|+|||++.............+|+.|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 307 IvHrDLKPeNILl---d~~g~vKL~DFGla~~~~~~~~~~~~~GT~~Y~APEvl~~~~~~~~~DiwSLGvilyeLltG~~ 383 (576)
T 2acx_A 307 IVYRDLKPENILL---DDHGHIRISDLGLAVHVPEGQTIKGRVGTVGYMAPEVVKNERYTFSPDWWALGCLLYEMIAGQS 383 (576)
T ss_dssp EECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCEECCCSCGGGCCHHHHTTCEESSHHHHHHHHHHHHHHHHSSC
T ss_pred EeccCCchheEEE---eCCCCeEEEecccceecccCccccccCCCccccCHHHHcCCCCCccchHHHHHHHHHHHHhCCC
Confidence 9999999999999 7888999999999988766555556689999999999998889999999999999999999999
Q ss_pred CCCCCC----hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 167 PFSGRN----NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 167 p~~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
||.+.+ ..+..+.+... ...+ ...+|.++.++|++||+.||.+|| +++|+++||||++
T Consensus 384 PF~~~~~~~~~~~i~~~i~~~-~~~~----p~~~s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~ 450 (576)
T 2acx_A 384 PFQQRKKKIKREEVERLVKEV-PEEY----SERFSPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK 450 (576)
T ss_dssp SSSCSSSCCCHHHHHHHHHHC-CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred CCcccccchhHHHHHHHhhcc-cccC----CccCCHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence 998753 34445555332 2222 347899999999999999999999 7999999999997
|
| >1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-45 Score=290.54 Aligned_cols=222 Identities=36% Similarity=0.643 Sum_probs=195.5
Q ss_pred HHhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+...+.+.+|+++++++. ||||+++++++..++..++|||++++++|.+++.....+++..+..++.|++.||.+||+.
T Consensus 64 ~~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 143 (298)
T 1phk_A 64 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 143 (298)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHhcCCCCEeeeeeeeccCCeEEEEEeccCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678899999999995 9999999999999999999999999999999999888999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc------ccCCCCchhHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~------~~~~~~~~Dv~slG~~l~ 159 (241)
|++|+||+|+||++ +.++.++|+|||.+.............++..|.|||.+. ...++.++|+||||+++|
T Consensus 144 ~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~slG~~l~ 220 (298)
T 1phk_A 144 NIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 220 (298)
T ss_dssp TEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred CcccCCCCcceEEE---cCCCcEEEecccchhhcCCCcccccccCCccccCHHHhccccccccccCCcccccHhHHHHHH
Confidence 99999999999999 788899999999998776655555667899999999874 446789999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
+|++|..||.+.+.......+..+... .+......++..+.+++.+||+.||.+|||++++++||||++...
T Consensus 221 ~l~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 292 (298)
T 1phk_A 221 TLLAGSPPFWHRKQMLMLRMIMSGNYQ-FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQYVV 292 (298)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCC-CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTTC-
T ss_pred HHHHCCCCCcCccHHHHHHHHhcCCcc-cCcccccccCHHHHHHHHHHccCCcccCCCHHHHHhChHhhhccc
Confidence 999999999998888877777655432 222333478999999999999999999999999999999997644
|
| >3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.7e-46 Score=297.25 Aligned_cols=222 Identities=28% Similarity=0.471 Sum_probs=190.2
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+.+|+.+++++ .||||+++++++.+.+..++||||+++++|.+++... +.+++..+..++.|++.||.+||+
T Consensus 70 ~~~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~L~~LH~ 149 (327)
T 3lm5_A 70 DCRAEILHEIAVLELAKSCPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEGVYYLHQ 149 (327)
T ss_dssp ECHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhccCCCCEEEEEEEEEeCCeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3467889999999999 5699999999999999999999999999999998543 669999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
.|++||||||+||+++.....+.++|+|||++.............+++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 150 ~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~~ll~g 229 (327)
T 3lm5_A 150 NNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHACELREIMGTPEYLAPEILNYDPITTATDMWNIGIIAYMLLTH 229 (327)
T ss_dssp TTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC---------CCCGGGCCHHHHTTCCCCTHHHHHHHHHHHHHHHHS
T ss_pred CCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCccccccccCCcCccCCeeecCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999953334788999999999887665555566789999999999989999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
..||.+.+..+....+..... ..+......++..+.++|++||+.||.+|||++++++||||++.
T Consensus 230 ~~pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~ 294 (327)
T 3lm5_A 230 TSPFVGEDNQETYLNISQVNV-DYSEETFSSVSQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQW 294 (327)
T ss_dssp SCSSCCSSHHHHHHHHHHTCC-CCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred CCCCCCCCchHHHHHHHhccc-ccCchhhcccCHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccc
Confidence 999999888888777755442 33444456789999999999999999999999999999999874
|
| >2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=294.41 Aligned_cols=218 Identities=28% Similarity=0.535 Sum_probs=194.3
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++...+.+++..+..++.|++.||.+||++|
T Consensus 82 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ 161 (335)
T 2owb_A 82 PHQREKMSMEISIHRSLAHQHVVGFHGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPEARYYLRQIVLGCQYLHRNR 161 (335)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCeEEEEEecCCeEEEEEecCCCCCHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678899999999999999999999999999999999999999999999998889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||+|+||++ +.++.++|+|||++...... .......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 162 ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 238 (335)
T 2owb_A 162 VIHRDLKLGNLFL---NEDLEVKIGDFGLATKVEYDGERKKVLCGTPNYIAPEVLSKKGHSFEVDVWSIGCIMYTLLVGK 238 (335)
T ss_dssp EECSCCCGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCCSSCCHHHHHTSCBCTHHHHHHHHHHHHHHHHSS
T ss_pred CEecCCCchhEEE---cCCCCEEEeeccCceecccCcccccccCCCccccCHHHhccCCCCchhhHHHHHHHHHHHHHCc
Confidence 9999999999999 78889999999999776432 2334456899999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
.||......+....+..... ..+ ..++..+.++|++||+.||.+|||++|+++||||+....
T Consensus 239 ~pf~~~~~~~~~~~~~~~~~-~~~----~~~~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~ 300 (335)
T 2owb_A 239 PPFETSCLKETYLRIKKNEY-SIP----KHINPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYI 300 (335)
T ss_dssp CTTCCSSHHHHHHHHHHTCC-CCC----TTSCHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCC
T ss_pred CCCCCCCHHHHHHHHhcCCC-CCC----ccCCHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCc
Confidence 99998888777777655432 222 367899999999999999999999999999999987543
|
| >1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-45 Score=287.44 Aligned_cols=218 Identities=29% Similarity=0.557 Sum_probs=184.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
+....+.+.+|+.++++++||||+++++++.. ++..++||||+++++|.+++...+.+++..+..++.|++.||.+
T Consensus 65 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~ 144 (290)
T 1t4h_A 65 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 144 (290)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeeeeeeccccCCCceEEEEEEecCCCCHHHHHHHccCCCHHHHHHHHHHHHHHHHH
Confidence 45667889999999999999999999998875 45689999999999999999988899999999999999999999
Q ss_pred HHhCC--ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 82 lh~~~--i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
||+.| ++|+||+|+||+++ ..++.++|+|||++...... ......+++.|+|||.+. ..++.++|+||||+++|
T Consensus 145 lH~~~~~i~H~dikp~Nil~~--~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~-~~~~~~~Di~slG~~l~ 220 (290)
T 1t4h_A 145 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCML 220 (290)
T ss_dssp HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGG-TCCCTHHHHHHHHHHHH
T ss_pred HHcCCCCEEECCCCHHHEEEE--CCCCCEEEeeCCCccccccc-ccccccCCcCcCCHHHHh-ccCCCcchHHHHHHHHH
Confidence 99999 99999999999993 37789999999999765433 333456899999999886 45899999999999999
Q ss_pred HHHhCCCCCCCCCh-HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 160 ELLNGYPPFSGRNN-VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 160 ~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+|++|..||..... ......+..... +.......++++.++|++||+.||.+|||++|+++||||++.
T Consensus 221 ~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~ 289 (290)
T 1t4h_A 221 EMATSEYPYSECQNAAQIYRRVTSGVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE 289 (290)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred HHHhCCCCCCCcCcHHHHHHHHhccCC---ccccCCCCCHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence 99999999987544 444454543322 223334678899999999999999999999999999999874
|
| >3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-46 Score=297.60 Aligned_cols=224 Identities=27% Similarity=0.435 Sum_probs=179.1
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|++++++++||||+++++++.+++..++||||++ ++|.+++.....+++..+..++.|++.||.+||++|
T Consensus 74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~~~~~~~~~i~~ql~~~l~~LH~~~ 152 (329)
T 3gbz_A 74 EGVPGTAIREVSLLKELQHRNIIELKSVIHHNHRLHLIFEYAE-NDLKKYMDKNPDVSMRVIKSFLYQLINGVNFCHSRR 152 (329)
T ss_dssp ------CHHHHHHGGGCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cccchhHHHHHHHHHHcCCCCcceEEEEEecCCEEEEEEecCC-CCHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 3345678899999999999999999999999999999999996 599999998889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeec--CCCceEEEeecCCccccCCC-CccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 87 i~H~dl~~~nil~~~~--~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~ 162 (241)
++|+||||+||+++.. +..+.++|+|||++...... .......++..|+|||.+.+. .++.++|+||||+++|+|+
T Consensus 153 ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell 232 (329)
T 3gbz_A 153 CLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEML 232 (329)
T ss_dssp CCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC-----------CCTTCCHHHHTTCCCCCTHHHHHHHHHHHHHHH
T ss_pred EECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcccccCCCcCCccccCHHHhcCCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999532 34556999999999766432 223345679999999998764 4899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCc-------------------------cCCCCChHHHHHHHHhcccCccccCC
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQL-------------------------IVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
+|..||.+.+..+....+......+.... ....++.++.++|++||+.||.+|||
T Consensus 233 ~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t 312 (329)
T 3gbz_A 233 MKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQSFPKFRGKTLKRVLGALLDDEGLDLLTAMLEMDPVKRIS 312 (329)
T ss_dssp HSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCHHHHHGGGSCHHHHHHHHHHTCSSGGGSCC
T ss_pred HCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhhhhhhhccccHhhhcccccCHHHHHHHHHHccCChhhCCC
Confidence 99999999888777666644322111110 01126789999999999999999999
Q ss_pred HHHHhcCccccccc
Q 026253 218 FNEFYHHRFLRRNS 231 (241)
Q Consensus 218 ~~~il~~~~~~~~~ 231 (241)
++|+++||||++..
T Consensus 313 ~~e~l~hp~f~~~~ 326 (329)
T 3gbz_A 313 AKNALEHPYFSHND 326 (329)
T ss_dssp HHHHHTSGGGSSSC
T ss_pred HHHHhCCcccCCCC
Confidence 99999999999753
|
| >3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.3e-46 Score=300.60 Aligned_cols=225 Identities=31% Similarity=0.527 Sum_probs=187.1
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-------------------------
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------- 60 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------- 60 (241)
+....+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++...
T Consensus 68 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (345)
T 3hko_A 68 NPKDVERIKTEVRLMKKLHHPNIARLYEVYEDEQYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPECNE 147 (345)
T ss_dssp --CHHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCcceeehhhccCCeEEEEEeCCCCCcHHHHHHHhhcccccccccccccccccccccccc
Confidence 3455688999999999999999999999999999999999999999999998521
Q ss_pred ---------------CCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCc--eEEEeecCCccccCCCC
Q 026253 61 ---------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGN 123 (241)
Q Consensus 61 ---------------~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~--~~~l~df~~a~~~~~~~ 123 (241)
..+++..+..++.|++.||.+||+.|++|+||+|+||++ +.++ .++|+|||.+.......
T Consensus 148 ~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll---~~~~~~~~kl~Dfg~a~~~~~~~ 224 (345)
T 3hko_A 148 EAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLF---STNKSFEIKLVDFGLSKEFYKLN 224 (345)
T ss_dssp HHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---SCSSSCCEEECCCTTCEEGGGTT
T ss_pred cccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEE---ecCCCceEEEeeccccccccccC
Confidence 113677889999999999999999999999999999999 4444 79999999997653211
Q ss_pred -----ccccccCCCCccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCC
Q 026253 124 -----YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPAL 196 (241)
Q Consensus 124 -----~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~ 196 (241)
......+++.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+.+..+....+...... ++......+
T Consensus 225 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~ 303 (345)
T 3hko_A 225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLC-FENPNYNVL 303 (345)
T ss_dssp CC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCC-TTSGGGGGS
T ss_pred ccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccc-cCCcccccC
Confidence 1234568999999999865 67889999999999999999999999998888887777555432 233333468
Q ss_pred ChHHHHHHHHhcccCccccCCHHHHhcCcccccccccC
Q 026253 197 HPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 197 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 234 (241)
++++.++|.+||+.||.+|||+.++++||||++....+
T Consensus 304 ~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~~~~ 341 (345)
T 3hko_A 304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFSDKI 341 (345)
T ss_dssp CHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTSSCS
T ss_pred CHHHHHHHHHHcCCChhHCCCHHHHhcChhhccChHhh
Confidence 99999999999999999999999999999999876554
|
| >3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-45 Score=316.87 Aligned_cols=215 Identities=31% Similarity=0.602 Sum_probs=195.3
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+..|..++..+ +|++|+++++++.+.+..|+||||++|++|.+++...+.+++..+..++.|++.||.|||++
T Consensus 382 ~~~~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~~~~~lV~E~~~gg~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~ 461 (674)
T 3pfq_A 382 DDDVECTMVEKRVLALPGKPPFLTQLHSCFQTMDRLYFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEIAIGLFFLQSK 461 (674)
T ss_dssp TTTTHHHHHHHHHHTCTTCCTTBCCEEEECBCSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhccCCCeEEEEEEEEEeCCEEEEEEeCcCCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34567788999999998 79999999999999999999999999999999999888999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccC-CCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~-~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
||+||||||+|||+ +.++.++|+|||+++... .........||+.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 462 gIiHrDLKp~NILl---~~~g~ikL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DvwSlGvilyelltG 538 (674)
T 3pfq_A 462 GIIYRDLKLDNVML---DSEGHIKIADFGMCKENIWDGVTTKTFCGTPDYIAPEIIAYQPYGKSVDWWAFGVLLYEMLAG 538 (674)
T ss_dssp SEECCCCCSTTEEE---CSSSCEEECCCTTCEECCCTTCCBCCCCSCSSSCCHHHHTCCCBSTHHHHHHHHHHHHHHHHS
T ss_pred CeEeccCChhhEEE---cCCCcEEEeecceeeccccCCcccccccCCCcccCHhhhcCCCCCccceEechHHHHHHHHcC
Confidence 99999999999999 788899999999998643 33345567899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCH-----HHHhcCccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF-----NEFYHHRFLRR 229 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~-----~~il~~~~~~~ 229 (241)
..||.+.+..++++.|.... ..++ ..++.++.++|++||+.||.+||++ +|+++||||+.
T Consensus 539 ~~Pf~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~ 603 (674)
T 3pfq_A 539 QAPFEGEDEDELFQSIMEHN-VAYP----KSMSKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY 603 (674)
T ss_dssp SCSSCCSSHHHHHHHHHSSC-CCCC----TTSCHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred CCCCCCCCHHHHHHHHHhCC-CCCC----ccCCHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence 99999999999998886544 3333 3789999999999999999999997 99999999987
|
| >2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-45 Score=289.92 Aligned_cols=222 Identities=34% Similarity=0.608 Sum_probs=194.9
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++.+.+..++|||++++++|.+++...+.+++..+..++.|++.||.+||+.|+
T Consensus 63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 142 (287)
T 2wei_A 63 KDTSTILREVELLKKLDHPNIMKLFEILEDSSSFYIVGELYTGGELFDEIIKRKRFSEHDAARIIKQVFSGITYMHKHNI 142 (287)
T ss_dssp SCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhccCCCccEEEEEEeCCCeEEEEEEccCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34678899999999999999999999999999999999999999999999888899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+|+||+|+||+++..+....++|+|||.+.............++..|+|||.+.+ .++.++|+||||+++|+|++|..|
T Consensus 143 ~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~-~~~~~~Di~slG~~l~~l~~g~~p 221 (287)
T 2wei_A 143 VHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNTKMKDRIGTAYYIAPEVLRG-TYDEKCDVWSAGVILYILLSGTPP 221 (287)
T ss_dssp CCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCSSCSCHHHHHTTCCHHHHTT-CCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eccCCChhhEEEecCCCcccEEEeccCcceeecCCCccccccCcccccChHHhcC-CCCCchhhHhHHHHHHHHHhCCCC
Confidence 9999999999996444456799999999987765554455567889999999875 489999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|.+.+..+....+..+... .+......++.++.++|++||+.||.+|||++++++||||++..
T Consensus 222 ~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~~~ 284 (287)
T 2wei_A 222 FYGKNEYDILKRVETGKYA-FDLPQWRTISDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS 284 (287)
T ss_dssp SCCSSHHHHHHHHHHCCCC-CCSGGGTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHHHC
T ss_pred CCCCCHHHHHHHHHcCCCC-CCchhhhhcCHHHHHHHHHHcccChhhCcCHHHHhcCHHHhccc
Confidence 9998888888877665432 22223357899999999999999999999999999999998754
|
| >3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-46 Score=310.80 Aligned_cols=218 Identities=31% Similarity=0.463 Sum_probs=177.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l 79 (241)
+....+.+.+|+.+++.++||||+++++++... +..|+||||+++ +|.+.+. ..+++..+..++.|++.||
T Consensus 101 ~~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~E~~~~-~l~~~~~--~~l~~~~~~~~~~qil~aL 177 (464)
T 3ttj_A 101 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA-NLCQVIQ--MELDHERMSYLLYQMLCGI 177 (464)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSE-EHHHHHT--SCCCHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhCCCCCCCcEEEEEccCCccccCCeEEEEEeCCCC-CHHHHHh--hcCCHHHHHHHHHHHHHHH
Confidence 445677899999999999999999999998654 467999999965 6777664 3589999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
+|||+.|++||||||+||++ +.++.++|+|||+++............+|+.|+|||.+.+..++.++|+||+||++|
T Consensus 178 ~~lH~~~iiHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~il~ 254 (464)
T 3ttj_A 178 KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 254 (464)
T ss_dssp HHHHHTTCCCCCCCGGGEEE---CTTSCEEECCCCCC-----CCCC----CCCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HHHHHCCcccCCCChHhEEE---eCCCCEEEEEEEeeeecCCCcccCCCcccccccCHHHHcCCCCCHHHHHHHHHHHHH
Confidence 99999999999999999999 788899999999998876665566678999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCC--------------------------ccCCC-----------CChHHHH
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ--------------------------LIVPA-----------LHPDCVD 202 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~--------------------------~~~~~-----------~~~~~~~ 202 (241)
+|++|+.||.+.+..+.+..+......+.+. ..... .++++.+
T Consensus 255 ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 334 (464)
T 3ttj_A 255 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 334 (464)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHHH
Confidence 9999999999988877776664432221110 00000 1567899
Q ss_pred HHHHhcccCccccCCHHHHhcCccccc
Q 026253 203 MCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 203 li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
||++||+.||.+|||++|+|+||||+.
T Consensus 335 Ll~~mL~~dP~~R~ta~e~L~Hp~~~~ 361 (464)
T 3ttj_A 335 LLSKMLVIDPAKRISVDDALQHPYINV 361 (464)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHHcCCChhhCCCHHHHhcChhhhh
Confidence 999999999999999999999999985
|
| >3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-45 Score=288.37 Aligned_cols=217 Identities=31% Similarity=0.596 Sum_probs=162.5
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
.+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++... .++++..+..++.|++.||.+||+.|++
T Consensus 55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i~ 134 (278)
T 3cok_A 55 VQRVQNEVKIHCQLKHPSILELYNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGMLYLHSHGIL 134 (278)
T ss_dssp HHHHHHHHHHHTTBCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHhCCCCCeEeEEEEEccCCeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 477899999999999999999999999999999999999999999999865 5799999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|+||+|+||++ +.++.++|+|||.+...... .......+++.|+|||.+.+..++.++|+||+|+++|+|++|..|
T Consensus 135 H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~p 211 (278)
T 3cok_A 135 HRDLTLSNLLL---TRNMNIKIADFGLATQLKMPHEKHYTLCGTPNYISPEIATRSAHGLESDVWSLGCMFYTLLIGRPP 211 (278)
T ss_dssp CSSCCGGGEEE---CTTCCEEECCCTTCEECC----------------------------CTHHHHHHHHHHHHHHSSCS
T ss_pred cCCCCHHHEEE---cCCCCEEEEeecceeeccCCCCcceeccCCCCcCCcchhcCCCCCchhhHHHHHHHHHHHHhCCCC
Confidence 99999999999 78889999999999776432 222345678999999999988899999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccC
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 234 (241)
|...+..+....+.... .. ....++.++.++|.+||+.||.+|||++++++||||.+.....
T Consensus 212 ~~~~~~~~~~~~~~~~~-~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~~~~ 273 (278)
T 3cok_A 212 FDTDTVKNTLNKVVLAD-YE----MPSFLSIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNSSTK 273 (278)
T ss_dssp SCCCSCC-----CCSSC-CC----CCTTSCHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC------
T ss_pred CCChhHHHHHHHHhhcc-cC----CccccCHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCCCcc
Confidence 98776655555443221 11 2346789999999999999999999999999999999866543
|
| >3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=8.2e-46 Score=296.00 Aligned_cols=221 Identities=29% Similarity=0.468 Sum_probs=182.3
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
..+.+|++++++++||||+++++++.+++..++||||++ ++|.+++...+ .+++..+..++.|++.||.+||+.|++|
T Consensus 45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~LH~~~ivH 123 (324)
T 3mtl_A 45 CTAIREVSLLKDLKHANIVTLHDIIHTEKSLTLVFEYLD-KDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYCHRQKVLH 123 (324)
T ss_dssp CCCCCCHHHHSCCCCTTBCCEEEEEECSSCEEEEEECCS-EEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTEEE
T ss_pred hhHHHHHHHHHhcCCCCCCeeeeEEeeCCEEEEEecccc-cCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCCccC
Confidence 356689999999999999999999999999999999996 59999987654 5899999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||||+||++ +.++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+||+|+++|+|++|..|
T Consensus 124 ~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~l~~g~~p 200 (324)
T 3mtl_A 124 RDLKPQNLLI---NERGELKLADFGLARAKSIPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPL 200 (324)
T ss_dssp SSCCGGGEEE---CTTCCEEECSSSEEECC------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred CCcCHHHEEE---CCCCCEEEccCcccccccCCccccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHHHHHhCCCC
Confidence 9999999999 78889999999998765432 22334567999999999876 5689999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCc-------------------------cCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQL-------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
|.+.+..+....+......+.... ..+.+++++.++|++||+.||.+|||++|++
T Consensus 201 f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l 280 (324)
T 3mtl_A 201 FPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRLDSDGADLLTKLLQFEGRNRISAEDAM 280 (324)
T ss_dssp CCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHHCTTSCHHHHHHHHHHSCSSGGGSCCHHHHT
T ss_pred CCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhhcCCCCHHHHHHHHHHcCcCcccCCCHHHHh
Confidence 999888877766654322221111 1235788999999999999999999999999
Q ss_pred cCcccccccccCC
Q 026253 223 HHRFLRRNSAILR 235 (241)
Q Consensus 223 ~~~~~~~~~~~~~ 235 (241)
+||||.+......
T Consensus 281 ~hp~f~~~~~~~~ 293 (324)
T 3mtl_A 281 KHPFFLSLGERIH 293 (324)
T ss_dssp TSGGGGGGCSTTS
T ss_pred cChhhhhcccccc
Confidence 9999998665443
|
| >4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-45 Score=294.26 Aligned_cols=221 Identities=29% Similarity=0.494 Sum_probs=183.6
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|++++++++||||+++++++.+++..++||||+++++|.++......+++..+..++.|++.||.+||+.|
T Consensus 65 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 144 (331)
T 4aaa_A 65 KMVKKIAMREIKLLKQLRHENLVNLLEVCKKKKRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFCHSHN 144 (331)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHHhhCCCCCEeeEEEEeecCCEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34567788999999999999999999999999999999999999999998877788999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g 164 (241)
++|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+. .++.++|+||||+++|+|++|
T Consensus 145 ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~g 221 (331)
T 4aaa_A 145 IIHRDIKPENILV---SQSGVVKLCDFGFARTLAAPGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMG 221 (331)
T ss_dssp CCCCCCCGGGEEE---CTTSCEEECCCTTC------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHHHHHHS
T ss_pred EEccCcChheEEE---cCCCcEEEEeCCCceeecCCccccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHHHHHhC
Confidence 9999999999999 78889999999999765432 233445689999999998765 689999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCC------------------CCC--------CccCCCCChHHHHHHHHhcccCccccCCH
Q 026253 165 YPPFSGRNNVQLVRNINSCKHL------------------PFS--------QLIVPALHPDCVDMCLKLLSANTVDRLSF 218 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~------------------~~~--------~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 218 (241)
..||.+.+..+....+...... ..+ ....+.+++++.+++.+||+.||.+|||+
T Consensus 222 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~ 301 (331)
T 4aaa_A 222 EPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVVIDLAKKCLHIDPDKRPFC 301 (331)
T ss_dssp SCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHSTTSCHHHHHHHHHHTCSSGGGSCCG
T ss_pred CCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcccchhHHHHHHHHHHhccCcccCCCH
Confidence 9999988877665544321110 000 11234678999999999999999999999
Q ss_pred HHHhcCcccccc
Q 026253 219 NEFYHHRFLRRN 230 (241)
Q Consensus 219 ~~il~~~~~~~~ 230 (241)
+|+|+||||+..
T Consensus 302 ~ell~hp~f~~~ 313 (331)
T 4aaa_A 302 AELLHHDFFQMD 313 (331)
T ss_dssp GGGGGSHHHHGG
T ss_pred HHHhcCchhccC
Confidence 999999999874
|
| >3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-45 Score=299.61 Aligned_cols=220 Identities=30% Similarity=0.458 Sum_probs=183.0
Q ss_pred hHHhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecC--eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
+......+.+|+.+++++. |+||+++++++...+ ..|+||||++ ++|.++++. ..+++..+..++.|++.||+||
T Consensus 48 ~~~~~~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~i~~qi~~~L~~L 125 (388)
T 3oz6_A 48 NSTDAQRTFREIMILTELSGHENIVNLLNVLRADNDRDVYLVFDYME-TDLHAVIRA-NILEPVHKQYVVYQLIKVIKYL 125 (388)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECTTSSCEEEEEECCS-EEHHHHHHH-TCCCHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhccCCCCCCeeeeEEecCCCCEEEEEecccC-cCHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH
Confidence 3456677889999999996 999999999997544 7899999996 699999875 5799999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC----------------------CccccccCCCCccCcccc
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----------------------NYAEKVCGSPLYMAPEVL 140 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~----------------------~~~~~~~~~~~~~~PE~~ 140 (241)
|+.|++||||||+||++ +.++.++|+|||+++..... .......+|+.|+|||.+
T Consensus 126 H~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~ 202 (388)
T 3oz6_A 126 HSGGLLHRDMKPSNILL---NAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEIL 202 (388)
T ss_dssp HHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHH
T ss_pred HhCCEEeCCCCHHHeEE---cCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHh
Confidence 99999999999999999 78889999999999765321 112335689999999998
Q ss_pred cc-cCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCc----------------------------
Q 026253 141 QF-QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQL---------------------------- 191 (241)
Q Consensus 141 ~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~---------------------------- 191 (241)
.+ ..++.++|+||+||++|+|++|.+||.+.+....+..+......+....
T Consensus 203 ~~~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 282 (388)
T 3oz6_A 203 LGSTKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKR 282 (388)
T ss_dssp TTCCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CC
T ss_pred cCCCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHH
Confidence 76 6789999999999999999999999999888877766643222211100
Q ss_pred --------------cCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 192 --------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 192 --------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
....+++++.++|++||+.||.+|||++|+|+||||+..
T Consensus 283 ~~~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~ 335 (388)
T 3oz6_A 283 DIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIF 335 (388)
T ss_dssp CCHHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred HhCcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence 012678899999999999999999999999999999763
|
| >3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=305.24 Aligned_cols=213 Identities=31% Similarity=0.495 Sum_probs=186.8
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+.+|++++++++||||+++++++.+.+..|+||||++|++|.+++... ..+++..+..++.|++.||.|||+
T Consensus 228 ~~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~aL~~LH~ 307 (543)
T 3c4z_A 228 GYQGAMVEKKILAKVHSRFIVSLAYAFETKTDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSGLEHLHQ 307 (543)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEeeCCEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHHHHHHHH
Confidence 3567889999999999999999999999999999999999999999999764 359999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+|++||||||+||++ +.++.++|+|||++........ .....||+.|+|||.+.+..++.++|+||||+++|+|++
T Consensus 308 ~gIvHrDLKP~NILl---~~~g~vkL~DFGla~~~~~~~~~~~~~~GT~~Y~APE~l~~~~~~~~~DiwSlGvilyellt 384 (543)
T 3c4z_A 308 RNIIYRDLKPENVLL---DDDGNVRISDLGLAVELKAGQTKTKGYAGTPGFMAPELLLGEEYDFSVDYFALGVTLYEMIA 384 (543)
T ss_dssp TTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCTTCCCBCCCCSCTTTSCHHHHTTCCBCTHHHHHHHHHHHHHHHH
T ss_pred cCCcccCCChHHEEE---eCCCCEEEeecceeeeccCCCcccccccCCccccChhhhcCCCCChHHhcCcchHHHHHHHh
Confidence 999999999999999 7889999999999987654433 334579999999999999999999999999999999999
Q ss_pred CCCCCCCCC----hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc
Q 026253 164 GYPPFSGRN----NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 229 (241)
Q Consensus 164 g~~p~~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~ 229 (241)
|..||.+.+ ..+..+.+.... ..++ ..++.++.++|++||+.||.+||+ ++++++||||++
T Consensus 385 G~~PF~~~~~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~ 454 (543)
T 3c4z_A 385 ARGPFRARGEKVENKELKQRVLEQA-VTYP----DKFSPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD 454 (543)
T ss_dssp SSCSSCCTTCCCCHHHHHHHHHHCC-CCCC----TTSCHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred CCCCCCCCccchhHHHHHHHHhhcc-cCCC----cccCHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence 999998753 355555554432 2233 478999999999999999999996 589999999997
|
| >3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-45 Score=294.71 Aligned_cols=209 Identities=28% Similarity=0.454 Sum_probs=183.7
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCC-ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~-~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|+.++++++||||+++++++.+++..++|||++.++ +|.+++...+.+++..+..++.|++.||.+||+.|+
T Consensus 72 ~~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~~~~~lv~e~~~~g~~l~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 151 (335)
T 3dls_A 72 KLGKVTLEIAILSRVEHANIIKVLDIFENQGFFQLVMEKHGSGLDLFAFIDRHPRLDEPLASYIFRQLVSAVGYLRLKDI 151 (335)
T ss_dssp TTEEEEHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTSCBHHHHHHTCCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEeeCCEEEEEEEeCCCCccHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4567889999999999999999999999999999999988666 999999988899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||||+||++ +.++.++|+|||++.............+++.|+|||.+.+..+ +.++|+||||+++|+|++|..
T Consensus 152 vH~Dlkp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~el~~g~~ 228 (335)
T 3dls_A 152 IHRDIKDENIVI---AEDFTIKLIDFGSAAYLERGKLFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTLYTLVFEEN 228 (335)
T ss_dssp ECSCCSGGGEEE---CTTSCEEECCCTTCEECCTTCCBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHHHHHHHHHSSC
T ss_pred EEeccCHHHEEE---cCCCcEEEeecccceECCCCCceeccCCCccccChhhhcCCCCCCCcccchhHHHHHHHHHhCCC
Confidence 999999999999 7788999999999988766665666779999999999988776 789999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
||..... .. ..... ....+++++.++|++||+.||.+|||++++++||||++..
T Consensus 229 pf~~~~~------~~-~~~~~----~~~~~~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~~ 282 (335)
T 3dls_A 229 PFCELEE------TV-EAAIH----PPYLVSKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQPV 282 (335)
T ss_dssp SCSSGGG------GT-TTCCC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCCC
T ss_pred chhhHHH------HH-hhccC----CCcccCHHHHHHHHHHccCChhhCcCHHHHhcCccccCCc
Confidence 9975322 11 11111 1236899999999999999999999999999999998744
|
| >2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.9e-46 Score=296.15 Aligned_cols=219 Identities=36% Similarity=0.619 Sum_probs=182.7
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
....+.+|++++++++||||+++++++..++ .++||||+++++|.+++.....+++..+..++.|++.||.+||++|++
T Consensus 58 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~-~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 136 (322)
T 2ycf_A 58 PALNVETEIEILKKLNHPCIIKIKNFFDAED-YYIVLELMEGGELFDKVVGNKRLKEATCKLYFYQMLLAVQYLHENGII 136 (322)
T ss_dssp ---CHHHHHHHHHHCCCTTBCCEEEEEESSS-EEEEEECCTTEETHHHHSTTCCCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred hhhhHHHHHHHHHhCCCCCCceEeeEEcCCc-eEEEEecCCCCcHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCee
Confidence 3457899999999999999999999987655 899999999999999998888899999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc---ccCCCCchhHHHHHHHHHHHHhCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
|+||+|+||+++..+....++|+|||.+.............++..|+|||.+. +..++.++|+||||+++|+|++|.
T Consensus 137 H~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il~~l~~g~ 216 (322)
T 2ycf_A 137 HRDLKPENVLLSSQEEDCLIKITDFGHSKILGETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGY 216 (322)
T ss_dssp CCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCHHHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHHHHHHHHHHHHSS
T ss_pred ccCCCHHHEEEecCCCCCeEEEccCccceecccccccccccCCcCccCchhhccCCCCCCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999543344569999999998776544444566899999999973 456889999999999999999999
Q ss_pred CCCCCCChH-HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 166 PPFSGRNNV-QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
.||...... .....+..+.. .........++..+.++|++||+.||.+|||++++++||||++
T Consensus 217 ~pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~ 280 (322)
T 2ycf_A 217 PPFSEHRTQVSLKDQITSGKY-NFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQD 280 (322)
T ss_dssp CSSCSTTCSSCHHHHHHHTCC-CCCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred CCCcccchHHHHHHHHHhCcc-ccCchhhhhcCHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence 999865433 33344433332 2223334578999999999999999999999999999999986
|
| >1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=291.63 Aligned_cols=215 Identities=29% Similarity=0.479 Sum_probs=187.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|++++++++||||+++++++.+++..++||||+. |+|.+++.. ..++++..+..++.|++.||.+||+.
T Consensus 95 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~-g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 173 (348)
T 1u5q_A 95 NEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCL-GSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 173 (348)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCeEEEEEecCC-CCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4456789999999999999999999999999999999999996 688888754 46799999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc---ccCCCCchhHHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l~~l~ 162 (241)
|++|+||||+||++ +.++.++|+|||++..... .....+++.|+|||.+. +..++.++|+||||+++|+|+
T Consensus 174 ~ivH~Dlkp~NIll---~~~~~~kL~DfG~a~~~~~---~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~il~ell 247 (348)
T 1u5q_A 174 NMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 247 (348)
T ss_dssp TCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHHHHHHH
T ss_pred CeeeCCCCHHHEEE---CCCCCEEEeeccCceecCC---CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHHHHHHH
Confidence 99999999999999 6788999999999976543 23456899999999984 567899999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
+|..||.+.+.......+......... ...+++.+.++|.+||+.||.+|||++++++||||....
T Consensus 248 ~g~~p~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~ 313 (348)
T 1u5q_A 248 ERKPPLFNMNAMSALYHIAQNESPALQ---SGHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRER 313 (348)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCC---CTTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCC
T ss_pred hCCCCCCCCChHHHHHHHHhcCCCCCC---CCCCCHHHHHHHHHHcccChhhCcCHHHHhhChhhhccC
Confidence 999999988887777666655543322 247889999999999999999999999999999998743
|
| >3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-45 Score=297.06 Aligned_cols=219 Identities=29% Similarity=0.471 Sum_probs=186.5
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...+.+++..+..++.+++.||.+||+.
T Consensus 71 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~~i~~~l~~lh~~ 150 (360)
T 3eqc_A 71 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 150 (360)
T ss_dssp CHHHHHHHHHHHGGGGGCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEEEEeEEEEECCEEEEEEECCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 35567889999999999999999999999999999999999999999999999888999999999999999999999996
Q ss_pred -CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 86 -HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 86 -~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
|++|+||||+||++ +.++.++|+|||.+...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|
T Consensus 151 ~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g 226 (360)
T 3eqc_A 151 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 226 (360)
T ss_dssp HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH-C----CCCCTTCCHHHHTTCCCSHHHHHHHHHHHHHHHHHT
T ss_pred CCEEcCCccHHHEEE---CCCCCEEEEECCCCcccccc-cccCCCCCCCeECHHHHcCCCCCchhhHHHHHHHHHHHHhC
Confidence 99999999999999 78889999999998654322 22345689999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHh------------------------------------------hcCCCCCCCCccCCCCChHHHH
Q 026253 165 YPPFSGRNNVQLVRNI------------------------------------------NSCKHLPFSQLIVPALHPDCVD 202 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i------------------------------------------~~~~~~~~~~~~~~~~~~~~~~ 202 (241)
..||...+..+....+ ........+ ...++.++.+
T Consensus 227 ~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~ 303 (360)
T 3eqc_A 227 RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLP---SGVFSLEFQD 303 (360)
T ss_dssp SCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCC---TTTSCHHHHH
T ss_pred CCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCC---cccccHHHHH
Confidence 9999876655433222 112211111 2357889999
Q ss_pred HHHHhcccCccccCCHHHHhcCccccccc
Q 026253 203 MCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 203 li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
+|++||+.||.+|||++|+++||||++..
T Consensus 304 li~~~L~~dP~~Rpt~~ell~hp~~~~~~ 332 (360)
T 3eqc_A 304 FVNKCLIKNPAERADLKQLMVHAFIKRSD 332 (360)
T ss_dssp HHHHHHCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred HHHHHhhcChhhCCCHHHHhhChHhhcch
Confidence 99999999999999999999999999854
|
| >1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=293.85 Aligned_cols=219 Identities=29% Similarity=0.484 Sum_probs=186.2
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (241)
....+.+.+|++++++++||||+++++++... ..+++|||++ +++|.++++. ..+++..+..++.|++.||.
T Consensus 65 ~~~~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~~~~qi~~~L~ 142 (367)
T 1cm8_A 65 ELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMKH-EKLGEDRIQFLVYQMLKGLR 142 (367)
T ss_dssp HHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCcCCCCceeeEecCCccccCceEEEEEecC-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999998765 3469999999 8899999876 67999999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF 159 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~ 159 (241)
+||+.|++||||||+||++ +.++.++|+|||+++..... .....++..|+|||.+.+ ..++.++|+||+||++|
T Consensus 143 ~LH~~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 217 (367)
T 1cm8_A 143 YIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA 217 (367)
T ss_dssp HHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred HHHHCCccccCcCHHHEEE---cCCCCEEEEeeecccccccc--cCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHH
Confidence 9999999999999999999 78889999999999875433 334568999999999876 67899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCC--------------------------CCCccCCCCChHHHHHHHHhcccCcc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLP--------------------------FSQLIVPALHPDCVDMCLKLLSANTV 213 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~~p~ 213 (241)
+|++|+.||.+.+..+.+..+......+ ......+..++.+.++|++||+.||.
T Consensus 218 ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~mL~~dP~ 297 (367)
T 1cm8_A 218 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDAE 297 (367)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSSTT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHccCChh
Confidence 9999999999888777666554321111 01123456789999999999999999
Q ss_pred ccCCHHHHhcCcccccccc
Q 026253 214 DRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 214 ~Rps~~~il~~~~~~~~~~ 232 (241)
+|||++|+|+||||+....
T Consensus 298 ~R~t~~e~l~hp~f~~~~~ 316 (367)
T 1cm8_A 298 QRVTAGEALAHPYFESLHD 316 (367)
T ss_dssp TSCCHHHHHHSGGGTTTC-
T ss_pred HCCCHHHHhcChHHHhhcC
Confidence 9999999999999987543
|
| >3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=295.88 Aligned_cols=219 Identities=25% Similarity=0.337 Sum_probs=183.2
Q ss_pred HHhhhhHHHHHHHHhcCC-----CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVN-----HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~-----~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l 79 (241)
....+....|+.+++++. |+||+++++++...+..++|||++ +++|.+++.... .+++..+..++.|++.||
T Consensus 72 ~~~~~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~i~~qi~~aL 150 (360)
T 3llt_A 72 KKYTRSAKIEADILKKIQNDDINNNNIVKYHGKFMYYDHMCLIFEPL-GPSLYEIITRNNYNGFHIEDIKLYCIEILKAL 150 (360)
T ss_dssp HHHHHHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEETTEEEEEECCC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred hhhhhhhHHHHHHHHHhcccCCCCCCeecccceeeECCeeEEEEcCC-CCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence 455677888999999996 999999999999999999999999 899999998764 499999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeec----------------------CCCceEEEeecCCccccCCCCccccccCCCCccCc
Q 026253 80 EILNSHHIIHRDLKPENILLSGL----------------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP 137 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~----------------------~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~P 137 (241)
.+||+.|++||||||+||+++.. ...+.++|+|||++...... .....+++.|+||
T Consensus 151 ~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~--~~~~~gt~~y~aP 228 (360)
T 3llt_A 151 NYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY--HGSIINTRQYRAP 228 (360)
T ss_dssp HHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC--CCSCCSCGGGCCH
T ss_pred HHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC--CcCccCcccccCc
Confidence 99999999999999999999421 13778999999999765432 3345689999999
Q ss_pred ccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC-------------------------C--
Q 026253 138 EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS-------------------------Q-- 190 (241)
Q Consensus 138 E~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-------------------------~-- 190 (241)
|.+.+..++.++|+||||+++|+|++|..||.+.+..+....+......... .
T Consensus 229 E~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~p~~~ 308 (360)
T 3llt_A 229 EVILNLGWDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELKLAWPENA 308 (360)
T ss_dssp HHHTTCCCCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTTTEECTTTTC
T ss_pred HHHcCCCCCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCcccceecCcccc
Confidence 9999999999999999999999999999999988877766655443221110 0
Q ss_pred --------------ccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 026253 191 --------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228 (241)
Q Consensus 191 --------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 228 (241)
......++.+.++|++||+.||.+|||++|+|+||||+
T Consensus 309 ~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~ 360 (360)
T 3llt_A 309 SSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE 360 (360)
T ss_dssp SCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred cchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence 00011236788999999999999999999999999996
|
| >3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=301.59 Aligned_cols=220 Identities=26% Similarity=0.409 Sum_probs=174.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEee-----cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
....+.+.+|++++++++|+||+++++++.. .+..|+|||++ +++|.+++.....+++..+..++.||+.||.|
T Consensus 93 ~~~~~~~~~E~~~l~~l~h~niv~l~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~l~~~~~~~~~~qi~~aL~~ 171 (458)
T 3rp9_A 93 LIDCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFDELYVVLEIA-DSDFKKLFRTPVYLTELHIKTLLYNLLVGVKY 171 (458)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEECCC-SEEHHHHHHSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCceEEEEecCCcccCceEEEEEecc-ccchhhhcccCCCCCHHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999999843 35799999998 67999999888889999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC----------------------------ccccccCCCC
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----------------------------YAEKVCGSPL 133 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~----------------------------~~~~~~~~~~ 133 (241)
||+.|++||||||+||++ +.++.++|+|||+++...... ......+|+.
T Consensus 172 LH~~~iiHrDlKp~NILl---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~ 248 (458)
T 3rp9_A 172 VHSAGILHRDLKPANCLV---NQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRW 248 (458)
T ss_dssp HHHTTCBCCCCCGGGEEE---CTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCT
T ss_pred HHhCCcCCCCCChhhEEE---CCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCccccc
Confidence 999999999999999999 788899999999998764321 1233467999
Q ss_pred ccCcccc-cccCCCCchhHHHHHHHHHHHHh-----------CCCCCCCCCh--------------------HHHHHHhh
Q 026253 134 YMAPEVL-QFQRYDEKVDMWSVGAILFELLN-----------GYPPFSGRNN--------------------VQLVRNIN 181 (241)
Q Consensus 134 ~~~PE~~-~~~~~~~~~Dv~slG~~l~~l~~-----------g~~p~~~~~~--------------------~~~~~~i~ 181 (241)
|+|||.+ .+..++.++|+|||||++|+|++ |.++|.+.+. ...+..+.
T Consensus 249 Y~aPE~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~ 328 (458)
T 3rp9_A 249 YRAPELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIF 328 (458)
T ss_dssp TCCHHHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHH
T ss_pred ccChHHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHH
Confidence 9999976 55679999999999999999998 7777766441 11111111
Q ss_pred cCC--------------------------CCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 182 SCK--------------------------HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 182 ~~~--------------------------~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
... .........+..+.++.+||++||+.||.+|||++|+|+||||++.
T Consensus 329 ~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~ 403 (458)
T 3rp9_A 329 NILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEV 403 (458)
T ss_dssp HHHCCCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTT
T ss_pred HHcCCCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHCCCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhc
Confidence 100 0001112345678999999999999999999999999999999985
|
| >3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=285.84 Aligned_cols=217 Identities=26% Similarity=0.478 Sum_probs=193.0
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.++++++|+||+++++++.+++..++||||+++++|.+++.. +++++..+..++.|++.||.+||+.|+
T Consensus 62 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~qi~~~l~~lH~~~i 140 (303)
T 3a7i_A 62 DEIEDIQQEITVLSQCDSPYVTKYYGSYLKDTKLWIIMEYLGGGSALDLLEP-GPLDETQIATILREILKGLDYLHSEKK 140 (303)
T ss_dssp TTHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHTT-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCEeEEEEEEecCCeEEEEEEeCCCCcHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 4467899999999999999999999999999999999999999999999864 579999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+|++|..
T Consensus 141 ~H~dl~p~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 217 (303)
T 3a7i_A 141 IHRDIKAANVLL---SEHGEVKLADFGVAGQLTDTQIKRNTFVGTPFWMAPEVIKQSAYDSKADIWSLGITAIELARGEP 217 (303)
T ss_dssp ECCCCSGGGEEE---CTTSCEEECCCTTCEECBTTBCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred ccCCCChheEEE---CCCCCEEEeecccceecCccccccCccCCCcCccCHHHHhcCCCCchhhhHHHHHHHHHHccCCC
Confidence 999999999999 788899999999997654432 2334568899999999998899999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
||...........+........+ ..++..+.+++.+||+.||.+|||++++++||||.+...
T Consensus 218 p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~ 279 (303)
T 3a7i_A 218 PHSELHPMKVLFLIPKNNPPTLE----GNYSKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK 279 (303)
T ss_dssp TTTTSCHHHHHHHHHHSCCCCCC----SSCCHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred CCCCcCHHHHHHHhhcCCCCCCc----cccCHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence 99998888877777655543333 478999999999999999999999999999999987654
|
| >1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-44 Score=282.81 Aligned_cols=216 Identities=22% Similarity=0.341 Sum_probs=178.4
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l~~ 81 (241)
......+.+|+..+.++ +||||+++++++.+++..++||||+++++|.+++... ..+++..+..++.|++.||.+
T Consensus 51 ~~~~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~al~~ 130 (289)
T 1x8b_A 51 SVDEQNALREVYAHAVLGQHSHVVRYFSAWAEDDHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVGRGLRY 130 (289)
T ss_dssp SHHHHHHHHHHHHHHHSCSCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCeeeeeeeeecCCeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHHHHHHH
Confidence 34567888999999999 9999999999999999999999999999999999765 669999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecC----------------CCceEEEeecCCccccCCCCccccccCCCCccCccccccc-C
Q 026253 82 LNSHHIIHRDLKPENILLSGLD----------------DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-R 144 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~----------------~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~-~ 144 (241)
||++|++|+||||+||+++..+ ....++|+|||.+....... ...++..|+|||.+.+. .
T Consensus 131 lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~---~~~gt~~y~aPE~~~~~~~ 207 (289)
T 1x8b_A 131 IHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSPQ---VEEGDSRFLANEVLQENYT 207 (289)
T ss_dssp HHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCSC---CCCCCGGGCCHHHHTTCCT
T ss_pred HHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCcc---ccCCCccccChhHhcCCCC
Confidence 9999999999999999994322 45579999999997765432 34588999999998765 5
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 145 YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 145 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
++.++|+||||+++|++++|.+++..... ...+..+.....+ ..+++++.+++++||+.||.+|||++++++|
T Consensus 208 ~~~~~Di~slG~il~~l~~~~~~~~~~~~---~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h 280 (289)
T 1x8b_A 208 HLPKADIFALALTVVCAAGAEPLPRNGDQ---WHEIRQGRLPRIP----QVLSQEFTELLKVMIHPDPERRPSAMALVKH 280 (289)
T ss_dssp THHHHHHHHHHHHHHHHTTCCCCCSSSHH---HHHHHTTCCCCCS----SCCCHHHHHHHHHHTCSSGGGSCCHHHHHTC
T ss_pred CCchhhHHHHHHHHHHHhcCCCCCcchhH---HHHHHcCCCCCCC----cccCHHHHHHHHHHhCCCcccCCCHHHHhhC
Confidence 66899999999999999999887765433 3344444433333 4789999999999999999999999999999
Q ss_pred cccccccc
Q 026253 225 RFLRRNSA 232 (241)
Q Consensus 225 ~~~~~~~~ 232 (241)
|||++...
T Consensus 281 ~~~~~~~~ 288 (289)
T 1x8b_A 281 SVLLSASR 288 (289)
T ss_dssp TTC-----
T ss_pred hHhhhhcc
Confidence 99998653
|
| >4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-44 Score=285.66 Aligned_cols=219 Identities=27% Similarity=0.472 Sum_probs=185.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.....+.+.+|+.++++++||||+++++++.+++..++||||++|++|.+++...+++++..+..++.|++.||.+||+.
T Consensus 51 ~~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 130 (294)
T 4eqm_A 51 KEETLKRFEREVHNSSQLSHQNIVSMIDVDEEDDCYYLVMEYIEGPTLSEYIESHGPLSVDTAINFTNQILDGIKHAHDM 130 (294)
T ss_dssp CHHHHHHHHHHHHHHTTCCBTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred cHHHHHHHHHHHHHHhcCCCCCCceEEEeeeeCCeEEEEEeCCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 34556789999999999999999999999999999999999999999999999888999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
|++|+||||+||++ +.++.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|+++|+|++
T Consensus 131 ~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~ 207 (294)
T 4eqm_A 131 RIVHRDIKPQNILI---DSNKTLKIFDFGIAKALSETSLTQTNHVLGTVQYFSPEQAKGEATDECTDIYSIGIVLYEMLV 207 (294)
T ss_dssp TCCCCCCCGGGEEE---CTTSCEEECCCSSSTTC-------------CCSSCCHHHHHTCCCCTTHHHHHHHHHHHHHHH
T ss_pred CcccCCCCHHHEEE---CCCCCEEEEeCCCccccccccccccCccccCccccCHhHhcCCCCCchHhHHHHHHHHHHHHh
Confidence 99999999999999 788899999999997664432 2234568999999999999899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
|..||.+.+.....................+.+++.+.+++.+||+.||.+||+..+.+.+.|.
T Consensus 208 g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~R~~~~~~l~~~l~ 271 (294)
T 4eqm_A 208 GEPPFNGETAVSIAIKHIQDSVPNVTTDVRKDIPQSLSNVILRATEKDKANRYKTIQEMKDDLS 271 (294)
T ss_dssp SSCSSCSSCHHHHHHHHHSSCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGSCSSHHHHHHHHH
T ss_pred CCCCCCCCChHHHHHHHhhccCCCcchhcccCCCHHHHHHHHHHhcCCHhHccccHHHHHHHHH
Confidence 9999999888776655555554444445566899999999999999999999955555555554
|
| >1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=292.25 Aligned_cols=218 Identities=31% Similarity=0.467 Sum_probs=185.2
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
.+.+.+|++++++++||||+++++++.+.+..++||||+++ +|.+++... ..+++..+..++.|++.||.+||+.|++
T Consensus 56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~iv 134 (346)
T 1ua2_A 56 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMET-DLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWIL 134 (346)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSE-EHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCC
T ss_pred hHHHHHHHHHHhhCCCCCCCeEEEEEeeCCceEEEEEcCCC-CHHHHHHhcCcCCCHHHHHHHHHHHHHHHHHHHHCCEE
Confidence 45788999999999999999999999999999999999975 899888765 3589999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCCC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
|+||||+||++ +.++.++|+|||++...... .......+++.|+|||.+.+. .++.++|+||||+++|+|++|.+
T Consensus 135 H~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~ 211 (346)
T 1ua2_A 135 HRDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVP 211 (346)
T ss_dssp CCCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSC
T ss_pred CCCCCHHHEEE---cCCCCEEEEecccceeccCCcccCCcccccccccCchHhhCCCCCCchhhhHhHHHHHHHHHHCCC
Confidence 99999999999 78889999999999876433 233445689999999998654 47899999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCC-----------------------ccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQ-----------------------LIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~-----------------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
||.+.+..+.+..+......+... .....++.++.++|++||+.||.+|||++|+++
T Consensus 212 ~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~ 291 (346)
T 1ua2_A 212 FLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALK 291 (346)
T ss_dssp SSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHT
T ss_pred CCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccCCCChHHhhccCCHHHHHHHHHHhccChhhCCCHHHHhc
Confidence 999988877776664432111111 012456789999999999999999999999999
Q ss_pred Cccccccc
Q 026253 224 HRFLRRNS 231 (241)
Q Consensus 224 ~~~~~~~~ 231 (241)
||||++..
T Consensus 292 h~~f~~~~ 299 (346)
T 1ua2_A 292 MKYFSNRP 299 (346)
T ss_dssp SGGGTSSS
T ss_pred ChhhhcCC
Confidence 99998754
|
| >2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=283.89 Aligned_cols=220 Identities=30% Similarity=0.519 Sum_probs=185.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
+..+.+.+|+.++++++||||+++++++.+++..++|||++++++|.+++.....+++..+..++.|++.||.+||+.|+
T Consensus 47 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 126 (276)
T 2yex_A 47 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 126 (276)
T ss_dssp THHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hhhHHHHHHHHHHHhcCCCCceeeeeEEEcCCEEEEEEEecCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 34578899999999999999999999999999999999999999999999877789999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHh
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLN 163 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~ 163 (241)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|.|||.+.+..+ +.++|+||||+++|+|++
T Consensus 127 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~~ 203 (276)
T 2yex_A 127 THRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 203 (276)
T ss_dssp ECSCCSGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred eccCCChHHEEE---ccCCCEEEeeCCCccccCCCcchhcccCCccccCccChHHHhcCCCCCCcchHHHHHHHHHHHHh
Confidence 999999999999 788899999999987653221 2334568899999999987665 789999999999999999
Q ss_pred CCCCCCCCChH-HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 164 GYPPFSGRNNV-QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 164 g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
|..||...+.. .....+...... .+ ....++..+.++|.+||+.||.+|||++|+++||||++....
T Consensus 204 g~~p~~~~~~~~~~~~~~~~~~~~-~~--~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 271 (276)
T 2yex_A 204 GELPWDQPSDSCQEYSDWKEKKTY-LN--PWKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKPLKK 271 (276)
T ss_dssp SSCCCSCSCTTSHHHHHHHTTCTT-ST--TGGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCCCC-
T ss_pred CCCCCCCCchHHHHHHHhhhcccc-cC--chhhcCHHHHHHHHHHCCCCchhCCCHHHHhcCccccChhhc
Confidence 99999875543 333333332221 11 123688999999999999999999999999999999986443
|
| >2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=294.79 Aligned_cols=217 Identities=30% Similarity=0.478 Sum_probs=174.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (241)
....+.+.+|+.++++++||||+++++++...+ ..++||||++ ++|.+++. ..+++..+..++.|++.||.
T Consensus 65 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~ 141 (371)
T 2xrw_A 65 QTHAKRAYRELVLMKCVNHKNIIGLLNVFTPQKSLEEFQDVYIVMELMD-ANLCQVIQ--MELDHERMSYLLYQMLCGIK 141 (371)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSCCSTTTCCEEEEEEECCS-EEHHHHHH--SCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCccceEEeeccccccccccceEEEEEcCC-CCHHHHHh--hccCHHHHHHHHHHHHHHHH
Confidence 455678899999999999999999999987654 7899999996 58888875 46899999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+||++|++|+||||+||++ +.++.++|+|||++.............+++.|+|||.+.+..++.++|+||+|+++|+
T Consensus 142 ~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~e 218 (371)
T 2xrw_A 142 HLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGE 218 (371)
T ss_dssp HHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCC----------------CTTCCHHHHTTCCCCTTHHHHHHHHHHHH
T ss_pred HHHHCCeecccCCHHHEEE---cCCCCEEEEEeecccccccccccCCceecCCccCHHHhcCCCCCchHhHHHHHHHHHH
Confidence 9999999999999999999 7888999999999987665544555678999999999999899999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCCCCc------------------------------cCC-------CCChHHHHH
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPFSQL------------------------------IVP-------ALHPDCVDM 203 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~------------------------------~~~-------~~~~~~~~l 203 (241)
|++|..||.+.+..+.+..+......+.+.. ..+ ..+.++.++
T Consensus 219 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l 298 (371)
T 2xrw_A 219 MIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARDL 298 (371)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHHH
Confidence 9999999999888877777655433221100 000 015678999
Q ss_pred HHHhcccCccccCCHHHHhcCccccc
Q 026253 204 CLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 204 i~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
|++||+.||.+|||++|+++||||+.
T Consensus 299 i~~mL~~dP~~R~t~~e~l~hp~~~~ 324 (371)
T 2xrw_A 299 LSKMLVIDASKRISVDEALQHPYINV 324 (371)
T ss_dssp HHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred HHHHCcCChhhCCCHHHHhCCcchhh
Confidence 99999999999999999999999986
|
| >4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-44 Score=295.58 Aligned_cols=217 Identities=30% Similarity=0.490 Sum_probs=179.7
Q ss_pred hHHHHHHHHhcCCCcCeeeeeeEEeecC------eEEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHHHHHH
Q 026253 12 CLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 12 ~~~~E~~~l~~l~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
...+|++++++++||||+++++++...+ ..++||||+.+ ++.+.+. ....+++..+..++.|++.||+|
T Consensus 78 ~~~~E~~il~~l~h~niv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~ 156 (394)
T 4e7w_A 78 FKNRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVFLNLVLEYVPE-TVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY 156 (394)
T ss_dssp SCCHHHHHHHTCCCTTBCCEEEEEEEESSSSSCEEEEEEEECCSE-EHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHhCCCCCcceEEEEEEecCCCCCceEEEEEeeccCc-cHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence 3457999999999999999999986543 38899999975 4444333 24679999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccccc-CCCCchhHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~ 160 (241)
||+.|++||||||+||+++ ..++.++|+|||+++............+++.|+|||.+.+. .++.++|+||+||++|+
T Consensus 157 LH~~~ivHrDlkp~Nill~--~~~~~~kL~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~e 234 (394)
T 4e7w_A 157 IHSIGICHRDIKPQNLLLD--PPSGVLKLIDFGSAKILIAGEPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAE 234 (394)
T ss_dssp HHHTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHHCCccCCCCCHHHEEEc--CCCCcEEEeeCCCcccccCCCCCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHHHHH
Confidence 9999999999999999994 37889999999999887666556667789999999998765 58999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCC------------------------CCCCccCCCCChHHHHHHHHhcccCccccC
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHL------------------------PFSQLIVPALHPDCVDMCLKLLSANTVDRL 216 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 216 (241)
|++|+.||.+.+..+.+..+...... ++.....+.+++++.++|.+||+.||.+||
T Consensus 235 ll~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~ 314 (394)
T 4e7w_A 235 LMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPDAIDLISRLLEYTPSARL 314 (394)
T ss_dssp HHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCGGGSSSCCCCCCCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSC
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccccccCCcHHHhccccCCHHHHHHHHHHhCCChhhCC
Confidence 99999999998877666555432111 111123345889999999999999999999
Q ss_pred CHHHHhcCccccccc
Q 026253 217 SFNEFYHHRFLRRNS 231 (241)
Q Consensus 217 s~~~il~~~~~~~~~ 231 (241)
|+.|+++||||++..
T Consensus 315 t~~e~l~hp~f~~~~ 329 (394)
T 4e7w_A 315 TAIEALCHPFFDELR 329 (394)
T ss_dssp CHHHHHTSGGGSTTT
T ss_pred CHHHHhcChhhhhhc
Confidence 999999999999743
|
| >3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-44 Score=297.83 Aligned_cols=223 Identities=26% Similarity=0.420 Sum_probs=176.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
....+.+.+|++++++++|+||+++++++... +..|+|||+++ ++|.++++....+++..+..++.|++.||+|
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~~~~l~~~~~~~i~~qil~aL~~ 144 (432)
T 3n9x_A 66 LIDCKRILREITILNRLKSDYIIRLYDLIIPDDLLKFDELYIVLEIAD-SDLKKLFKTPIFLTEEHIKTILYNLLLGENF 144 (432)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCTTTCCCEEEEEECCS-EEHHHHHHSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCcceEEEEEecCCCCcCCeEEEEEecCC-cCHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence 34567899999999999999999999998766 57999999995 6999999988889999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----------------------cccccCCCCccCcc
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----------------------AEKVCGSPLYMAPE 138 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----------------------~~~~~~~~~~~~PE 138 (241)
||+.|++||||||+||++ +.++.++|+|||+++....... .....+|+.|+|||
T Consensus 145 LH~~givHrDlkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE 221 (432)
T 3n9x_A 145 IHESGIIHRDLKPANCLL---NQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPE 221 (432)
T ss_dssp HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHH
T ss_pred HHHCCCCCCCCCHHHeEE---CCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHH
Confidence 999999999999999999 7888999999999987644321 24567899999999
Q ss_pred cc-cccCCCCchhHHHHHHHHHHHHh-----------CCCCCCCCCh-----------------HHHHHHhhcCCC----
Q 026253 139 VL-QFQRYDEKVDMWSVGAILFELLN-----------GYPPFSGRNN-----------------VQLVRNINSCKH---- 185 (241)
Q Consensus 139 ~~-~~~~~~~~~Dv~slG~~l~~l~~-----------g~~p~~~~~~-----------------~~~~~~i~~~~~---- 185 (241)
.+ .+..++.++|+||+||++|+|++ |.++|.+.+. ...+..+.....
T Consensus 222 ~~~~~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~ 301 (432)
T 3n9x_A 222 LILLQENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTE 301 (432)
T ss_dssp HHTTCSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCH
T ss_pred HHhcCCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCH
Confidence 86 55679999999999999999997 4555544331 111111111000
Q ss_pred -------------------CCC---CCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 186 -------------------LPF---SQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 186 -------------------~~~---~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
... .....+.+++++.++|++||+.||.+|||++|+|+||||++....
T Consensus 302 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~~ 371 (432)
T 3n9x_A 302 DDLKNINKPEVIKYIKLFPHRKPINLKQKYPSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371 (432)
T ss_dssp HHHHTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCCT
T ss_pred HHHHhccCHHHHHHHHhCCCCCCCCHHHHCCCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccCc
Confidence 000 011235689999999999999999999999999999999985443
|
| >3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=284.17 Aligned_cols=218 Identities=27% Similarity=0.476 Sum_probs=190.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|+.++++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.+||+.|+
T Consensus 67 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i 146 (314)
T 3com_A 67 DLQEIIKEISIMQQCDSPHVVKYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLEYLHFMRK 146 (314)
T ss_dssp CCHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHhCCCCCCccEEEEEEeCCEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 456789999999999999999999999999999999999999999999974 5679999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|.|||.+.+..++.++|+||||+++|+|++|..
T Consensus 147 ~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~ 223 (314)
T 3com_A 147 IHRDIKAGNILL---NTEGHAKLADFGVAGQLTDTMAKRNTVIGTPFWMAPEVIQEIGYNCVADIWSLGITAIEMAEGKP 223 (314)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECBTTBSCBCCCCSCGGGCCHHHHSSSCBCTTHHHHHHHHHHHHHHHSSC
T ss_pred cCCCcCHHHEEE---CCCCCEEEeecccchhhhhhccccCccCCCCCccChhhcCCCCCCccccHHHHHHHHHHHHhCCC
Confidence 999999999999 778899999999997654432 2334568899999999998889999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
||...+.......+.......+. ....++..+.++|.+||+.||.+|||++++++||||+...
T Consensus 224 p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~ 286 (314)
T 3com_A 224 PYADIHPMRAIFMIPTNPPPTFR--KPELWSDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAK 286 (314)
T ss_dssp TTTTSCHHHHHHHHHHSCCCCCS--SGGGSCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCC
T ss_pred CCCCCChHHHHHHHhcCCCcccC--CcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCC
Confidence 99988877766665554433222 1235789999999999999999999999999999999754
|
| >3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-44 Score=295.40 Aligned_cols=217 Identities=26% Similarity=0.457 Sum_probs=182.1
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEee--------------------------------------cCeEEEEEeccCCCC
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQA--------------------------------------ENCIFLVVEFCAGGN 52 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~--------------------------------------~~~~~lv~e~~~~~~ 52 (241)
....+|+++++.++|+||+++++++.. +...++||||++ ++
T Consensus 45 ~~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~ 123 (383)
T 3eb0_A 45 RYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVP-DT 123 (383)
T ss_dssp TSCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCS-EE
T ss_pred chHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCC-cc
Confidence 445689999999999999999999843 334889999996 57
Q ss_pred hHHHHH----hcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccc
Q 026253 53 LSSYIR----LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKV 128 (241)
Q Consensus 53 L~~~l~----~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~ 128 (241)
|.+.+. ....+++..+..++.|++.||.+||+.|++||||||+||+++ ..++.++|+|||.+............
T Consensus 124 L~~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~ 201 (383)
T 3eb0_A 124 LHKVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVN--SKDNTLKLCDFGSAKKLIPSEPSVAY 201 (383)
T ss_dssp HHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEE--TTTTEEEECCCTTCEECCTTSCCCCC
T ss_pred HHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEc--CCCCcEEEEECCCCcccCCCCCCcCc
Confidence 777665 346799999999999999999999999999999999999994 36789999999999887666666667
Q ss_pred cCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCC----------------CC--
Q 026253 129 CGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLP----------------FS-- 189 (241)
Q Consensus 129 ~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------------~~-- 189 (241)
.+++.|+|||.+.+. .++.++|+||+|+++|+|++|+.||.+.+..+.+..+......+ ++
T Consensus 202 ~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~ 281 (383)
T 3eb0_A 202 ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNPHYTEVRFPTL 281 (383)
T ss_dssp CCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTC--CCCCCC
T ss_pred ccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCcccccccCCcc
Confidence 789999999998765 48999999999999999999999999988877766654321111 11
Q ss_pred ------CccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 190 ------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 190 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
......+++++.++|++||+.||.+|||+.|+++||||++.
T Consensus 282 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~ 328 (383)
T 3eb0_A 282 KAKDWRKILPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDHL 328 (383)
T ss_dssp CCCCHHHHSCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHHH
T ss_pred CcccHHhhCCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHHH
Confidence 11234578899999999999999999999999999999864
|
| >2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-44 Score=292.60 Aligned_cols=220 Identities=28% Similarity=0.475 Sum_probs=172.3
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (241)
....+.+.+|+++++.++||||+++++++... +..++|+|++ +++|.++++. ..+++..+..++.|++.||.
T Consensus 69 ~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~-~~l~~~~~~~i~~qi~~aL~ 146 (367)
T 2fst_X 69 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLM-GADLNNIVKC-QKLTDDHVQFLIYQILRGLK 146 (367)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECC-CEECC------CCCCHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCccccCCeEEEEeccc-CCCHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence 34567888999999999999999999998653 5689999999 7899999875 67999999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF 159 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~ 159 (241)
+||+.|++||||||+||++ +.++.++|+|||+++..... .....++..|+|||.+.+ ..++.++|+||+||++|
T Consensus 147 ~LH~~givH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 221 (367)
T 2fst_X 147 YIHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTADE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA 221 (367)
T ss_dssp HHHHTTCCCCCCCGGGEEE---CTTCCEEECC-----------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHH
T ss_pred HHHHCCeeeCCCCHhhEEE---CCCCCEEEeecccccccccc--CCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHH
Confidence 9999999999999999999 78889999999999765432 334578999999999876 67899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCC----------------------C----CccCCCCChHHHHHHHHhcccCcc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPF----------------------S----QLIVPALHPDCVDMCLKLLSANTV 213 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~----------------------~----~~~~~~~~~~~~~li~~~l~~~p~ 213 (241)
+|++|..||.+.+..+.+..+......+. + ....+..++++.++|++||+.||.
T Consensus 222 ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL~~dP~ 301 (367)
T 2fst_X 222 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSD 301 (367)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHTTTCCHHHHHHHHHHSCSSGG
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHCCCCCHHHHHHHHHhCCCCcc
Confidence 99999999999887776665543211110 0 112346788999999999999999
Q ss_pred ccCCHHHHhcCccccccccc
Q 026253 214 DRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 214 ~Rps~~~il~~~~~~~~~~~ 233 (241)
+|||++|+|+||||+.....
T Consensus 302 ~R~t~~e~L~hp~~~~~~~~ 321 (367)
T 2fst_X 302 KRITAAQALAHAYFAQYHDP 321 (367)
T ss_dssp GSCCHHHHHTSGGGTTTCCG
T ss_pred cCcCHHHHhcChhhhhccCC
Confidence 99999999999999975443
|
| >3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-45 Score=290.88 Aligned_cols=225 Identities=25% Similarity=0.392 Sum_probs=183.5
Q ss_pred hhhhhHHhhhhHHHHHHHHhcCC-CcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 78 (241)
+|.++....+.+.+|++++++++ |+||+++++++.+ ....++|||++++++|.++++ .+++..+..++.|++.|
T Consensus 66 vK~~~~~~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~---~~~~~~~~~~~~qi~~~ 142 (330)
T 3nsz_A 66 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ---TLTDYDIRFYMYEILKA 142 (330)
T ss_dssp EEEECSCCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCCEEEEEECCCCCCHHHHGG---GCCHHHHHHHHHHHHHH
T ss_pred EEEecccchHHHHHHHHHHHHcCCCCCEEEeeeeeccCCCCceEEEEeccCchhHHHHHH---hCCHHHHHHHHHHHHHH
Confidence 45555566788999999999996 9999999999987 678999999999999999875 48899999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAI 157 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~ 157 (241)
|.+||+.|++|+||||+||+++ .++..++|+|||++.............++..|+|||.+.+ ..++.++|+||||++
T Consensus 143 l~~lH~~~ivH~Dikp~Nil~~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i 220 (330)
T 3nsz_A 143 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 220 (330)
T ss_dssp HHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred HHHHHhCCeeeCCCCHHHEEEc--CCCCEEEEEeCCCceEcCCCCccccccccccccChhhhcCCCcCCchhhHHHHHHH
Confidence 9999999999999999999994 3445899999999987766555566778999999999876 668999999999999
Q ss_pred HHHHHhCCCCCCCC-ChHHHHHHhhc------------CCCCCC--------------------CCccCCCCChHHHHHH
Q 026253 158 LFELLNGYPPFSGR-NNVQLVRNINS------------CKHLPF--------------------SQLIVPALHPDCVDMC 204 (241)
Q Consensus 158 l~~l~~g~~p~~~~-~~~~~~~~i~~------------~~~~~~--------------------~~~~~~~~~~~~~~li 204 (241)
+|+|++|..||... +..+....+.. ...... .......+++++.++|
T Consensus 221 l~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li 300 (330)
T 3nsz_A 221 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 300 (330)
T ss_dssp HHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGGCCHHHHHHH
T ss_pred HHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhHHHHhccccccchhhhhhhccccchhhhccccccccCCHHHHHHH
Confidence 99999999999543 32222221111 000000 0111223789999999
Q ss_pred HHhcccCccccCCHHHHhcCccccccc
Q 026253 205 LKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 205 ~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
++||+.||.+|||++|+|+||||++..
T Consensus 301 ~~~L~~dP~~Rpta~e~l~hp~f~~~~ 327 (330)
T 3nsz_A 301 DKLLRYDHQSRLTAREAMEHPYFYTVV 327 (330)
T ss_dssp HTTSCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred HHHhcCCcccCCCHHHHhcCccHhhhc
Confidence 999999999999999999999999754
|
| >2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.8e-45 Score=283.81 Aligned_cols=220 Identities=30% Similarity=0.552 Sum_probs=190.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEe--ecCeEEEEEeccCCCChHHHHHhc----CCCCHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH----GRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~----~~~~~~~~~~~~~~i~~~l 79 (241)
+....+.+.+|++++++++||||+++++++. .++..++||||+++++|.+++... ..+++..+..++.|++.||
T Consensus 45 ~~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l 124 (279)
T 2w5a_A 45 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 124 (279)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEEEGGGTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCCCeEEEEEecCCCceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHHH
Confidence 4556788999999999999999999999874 467899999999999999999754 2499999999999999999
Q ss_pred HHHHhCC-----ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-cccccCCCCccCcccccccCCCCchhHHH
Q 026253 80 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (241)
Q Consensus 80 ~~lh~~~-----i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 153 (241)
.+||+.| ++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||
T Consensus 125 ~~lH~~~~~~~~ivH~dl~p~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 201 (279)
T 2w5a_A 125 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKTFVGTPYYMSPEQMNRMSYNEKSDIWS 201 (279)
T ss_dssp HHHHHHC------CCCCCSGGGEEE---CSSSCEEECCCCHHHHC---CHHHHHHHSCCTTCCHHHHHCC-CCHHHHHHH
T ss_pred HHHhcccCCCCeeEEeccchhhEEE---cCCCCEEEecCchheeeccccccccccCCCccccChHHhccCCCCchhhHHH
Confidence 9999999 9999999999999 7888999999999877644322 23356889999999999888999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 154 VGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
||+++|+|++|..||...+..+....+..+.....+. .++.++.+++.+||+.||.+|||++|+++|+|+....+
T Consensus 202 lG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~ 276 (279)
T 2w5a_A 202 LGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIPY----RYSDELNEIITRMLNLKDYHRPSVEEILENPLILEHHH 276 (279)
T ss_dssp HHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGGS
T ss_pred HHHHHHHHHHCCCCCcccCHHHHHHHHhhcccccCCc----ccCHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhcc
Confidence 9999999999999999998888888887766544443 78999999999999999999999999999999988654
|
| >3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=289.75 Aligned_cols=217 Identities=24% Similarity=0.433 Sum_probs=179.5
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEee--------cCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~ 80 (241)
...+.+|++++++++||||+++++++.. ++..++||||+++ +|.+.+... ..+++..+..++.|++.||.
T Consensus 60 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~l~~~~~~~~~~~~~~i~~qi~~~l~ 138 (351)
T 3mi9_A 60 PITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEH-DLAGLLSNVLVKFTLSEIKRVMQMLLNGLY 138 (351)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSE-EHHHHHHCTTSCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCC-CHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence 4567899999999999999999999876 4578999999964 777777654 57999999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-----CccccccCCCCccCcccccc-cCCCCchhHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-----NYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSV 154 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-----~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~sl 154 (241)
+||+.|++|+||||+||++ +.++.++|+|||++...... .......+++.|+|||.+.+ ..++.++|+|||
T Consensus 139 ~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl 215 (351)
T 3mi9_A 139 YIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGA 215 (351)
T ss_dssp HHHHTTEECCCCSGGGEEE---CTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHH
T ss_pred HHHHCCeeCCCCCHHHEEE---cCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHH
Confidence 9999999999999999999 78889999999999765422 12234567899999999876 457999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCC----------------------------CChHHHHHHHH
Q 026253 155 GAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPA----------------------------LHPDCVDMCLK 206 (241)
Q Consensus 155 G~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~----------------------------~~~~~~~li~~ 206 (241)
|+++|+|++|..||.+.+.......+........+.. .+. .++++.++|++
T Consensus 216 G~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 294 (351)
T 3mi9_A 216 GCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEV-WPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDK 294 (351)
T ss_dssp HHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTT-STTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHH
T ss_pred HHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhh-ccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHH
Confidence 9999999999999999888877766654322211111 111 26779999999
Q ss_pred hcccCccccCCHHHHhcCccccccc
Q 026253 207 LLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 207 ~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
||+.||.+|||++|+++||||+...
T Consensus 295 ~L~~dP~~R~t~~e~l~hp~f~~~~ 319 (351)
T 3mi9_A 295 LLVLDPAQRIDSDDALNHDFFWSDP 319 (351)
T ss_dssp HSCSSGGGSCCHHHHHTSGGGGSSS
T ss_pred HhcCChhhCCCHHHHhCCCCcCCCC
Confidence 9999999999999999999998743
|
| >2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-44 Score=283.01 Aligned_cols=225 Identities=29% Similarity=0.519 Sum_probs=187.9
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEE--eecCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~--~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
...+.+.+|++++++++|+||+++++++ .+.+..++||||++++ |.+++.. ...+++..+..++.|++.||.+||
T Consensus 48 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~-l~~~~~~~~~~~~~~~~~~~~~~qi~~al~~LH 126 (305)
T 2wtk_C 48 NGEANVKKEIQLLRRLRHKNVIQLVDVLYNEEKQKMYMVMEYCVCG-MQEMLDSVPEKRFPVCQAHGYFCQLIDGLEYLH 126 (305)
T ss_dssp THHHHHHHHHHHHTTCCCTTBCCEEEEEECC---CEEEEEECCSEE-HHHHHHHSTTCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCeeEEEEEEEcCCCCeEEEEehhccCC-HHHHHHhCcccccCHHHHHHHHHHHHHHHHHHH
Confidence 3467899999999999999999999998 4556899999999765 8787765 356999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC---CccccccCCCCccCcccccccC--CCCchhHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAIL 158 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~---~~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l 158 (241)
++|++|+||+|+||++ +.++.++|+|||.+...... .......++..|+|||.+.+.. ++.++|+||||+++
T Consensus 127 ~~~i~H~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il 203 (305)
T 2wtk_C 127 SQGIVHKDIKPGNLLL---TTGGTLKISALGVAEALHPFAADDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGVTL 203 (305)
T ss_dssp HTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCSSCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHHHH
T ss_pred HCCeeecCCCcccEEE---cCCCcEEeeccccccccCccccccccccCCCCCCCcChhhccCcccCCcchhhHHHHHHHH
Confidence 9999999999999999 78889999999999776432 2223456889999999987644 47899999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCCCCC
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 238 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~ 238 (241)
|+|++|..||.+.+..+....+..... .. ...++..+.++|++||+.||.+|||++|+++||||++.......+.
T Consensus 204 ~~l~~g~~p~~~~~~~~~~~~i~~~~~-~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~~~~~~ 278 (305)
T 2wtk_C 204 YNITTGLYPFEGDNIYKLFENIGKGSY-AI----PGDCGPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHPPAEAPV 278 (305)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHCCC-CC----CSSSCHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCCC-CCCC
T ss_pred HHHHhCCCCCCCchHHHHHHHHhcCCC-CC----CCccCHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCCCcCCCC
Confidence 999999999999888888887765532 22 2378899999999999999999999999999999998766555554
Q ss_pred CCC
Q 026253 239 HIP 241 (241)
Q Consensus 239 ~~~ 241 (241)
.+|
T Consensus 279 ~~~ 281 (305)
T 2wtk_C 279 PIP 281 (305)
T ss_dssp CCC
T ss_pred CCC
Confidence 443
|
| >3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-44 Score=282.36 Aligned_cols=219 Identities=24% Similarity=0.392 Sum_probs=171.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
....+.+.++...++.++||||+++++++.+++..++||||++ ++|.+++.. ...+++..+..++.|++.||.+|
T Consensus 47 ~~~~~~~~~~~~~~~~~~h~~iv~~~~~~~~~~~~~lv~e~~~-~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l 125 (290)
T 3fme_A 47 QEQKRLLMDLDISMRTVDCPFTVTFYGALFREGDVWICMELMD-TSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL 125 (290)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSSEEEEEECCS-EEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCeEEEEeeeeeccCCEEEEEehhc-cchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence 3344556666666888899999999999999999999999996 588877754 46799999999999999999999
Q ss_pred HhC-CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccc----cccCCCCchhHHHHHHH
Q 026253 83 NSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVDMWSVGAI 157 (241)
Q Consensus 83 h~~-~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Dv~slG~~ 157 (241)
|++ |++|+||||+||++ +.++.++|+|||.+.............+++.|+|||.+ .+..++.++|+||+|++
T Consensus 126 H~~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG~i 202 (290)
T 3fme_A 126 HSKLSVIHRDVKPSNVLI---NALGQVKMCDFGISGYLVDDVAKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLGIT 202 (290)
T ss_dssp HHHSCCCCCCCSGGGCEE---CTTCCEEBCCC---------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHHHH
T ss_pred hhcCCeecCCCCHHHEEE---CCCCCEEEeecCCcccccccccccccCCCccccChhhcChhhcCcCCCcHHHHHHHHHH
Confidence 998 99999999999999 77889999999999877665555556789999999996 55678999999999999
Q ss_pred HHHHHhCCCCCCC-CChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 158 LFELLNGYPPFSG-RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 158 l~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
+|+|++|..||.. ..................+. ..++.++.+++.+||+.||.+|||++|+++||||+....
T Consensus 203 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~~~~ 275 (290)
T 3fme_A 203 MIELAILRFPYDSWGTPFQQLKQVVEEPSPQLPA---DKFSAEFVDFTSQCLKKNSKERPTYPELMQHPFFTLHES 275 (290)
T ss_dssp HHHHHHTSCSSCCCSCHHHHHHHHHHSCCCCCCT---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHCCCCccccCchHHHHHHHhccCCCCccc---ccCCHHHHHHHHHHhhcChhhCcCHHHHHhCcccccCcc
Confidence 9999999999986 34444444444444333332 368999999999999999999999999999999987544
|
| >3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.7e-45 Score=294.33 Aligned_cols=220 Identities=22% Similarity=0.353 Sum_probs=192.0
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAG 78 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~ 78 (241)
.......+.+|+.++++++||||+++++++.+++..++||||+++++|.+++...+ .+++..+..++.|++.|
T Consensus 114 ~~~~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a 193 (367)
T 3l9p_A 114 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 193 (367)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHHHHH
T ss_pred ChhhHHHHHHHHHHHHhCCCCCCCeEEEEEecCCCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHHHHH
Confidence 45566788999999999999999999999999999999999999999999998653 48999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCC---CCccccccCCCCccCcccccccCCCCchhHHHHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP---GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~---~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 155 (241)
|.+||++|++||||||+||+++..+.+..++|+|||+++.... ........+++.|+|||.+.+..++.++|+||||
T Consensus 194 L~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DvwslG 273 (367)
T 3l9p_A 194 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 273 (367)
T ss_dssp HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSSCTTCCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccccccCCCcCCcccEECHHHhcCCCCCcHHHHHHHH
Confidence 9999999999999999999995433555699999999975422 2223345578899999999888999999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 156 AILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 156 ~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
+++|+|++ |..||.+.+..+....+..+.....+. .++..+.+++++||+.||.+|||+++++++.++..
T Consensus 274 ~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~~ 344 (367)
T 3l9p_A 274 VLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPPK----NCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 344 (367)
T ss_dssp HHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHh
Confidence 99999998 999999999999998887776555443 78899999999999999999999999999976654
|
| >3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-45 Score=290.38 Aligned_cols=221 Identities=25% Similarity=0.438 Sum_probs=184.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
......+.+|++++++++||||+++++++.... ..++||||++|++|.+++...+++++..+..++.|++.||.+|
T Consensus 53 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~l 132 (311)
T 3ork_A 53 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 132 (311)
T ss_dssp HHHHHHHHHHHTTCCCCCCTTBCCEEEEEEEEETTEEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHcCCCCCcceEEEeeeccCCCCcccEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence 344668899999999999999999999987654 3499999999999999999888999999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC----ccccccCCCCccCcccccccCCCCchhHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 158 (241)
|++|++|+||||+||++ +.++.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||||+++
T Consensus 133 H~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~~l 209 (311)
T 3ork_A 133 HQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 209 (311)
T ss_dssp HHTTCCCCCCCGGGEEE---ETTSCEEECCCSCC------------------CCTTCCHHHHHTCCCCHHHHHHHHHHHH
T ss_pred HHCCCCcCCCCHHHEEE---cCCCCEEEeeccCcccccccccccccccccCcCcccCCHHHhcCCCCCchHhHHHHHHHH
Confidence 99999999999999999 677889999999997654332 22234589999999999988999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|+|++|..||.+.+..+...........+ +......++.++.++|.+||+.||.+||+..+++.|+|++...
T Consensus 210 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~~~ 281 (311)
T 3ork_A 210 YEVLTGEPPFTGDSPVSVAYQHVREDPIP-PSARHEGLSADLDAVVLKALAKNPENRYQTAAEMRADLVRVHN 281 (311)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHCCCCC-HHHHSTTCCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHHHT
T ss_pred HHHHhCCCCCCCCChHHHHHHHhcCCCCC-cccccCCCCHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHHhc
Confidence 99999999999988877766654444332 2233457899999999999999999999999999999998643
|
| >2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-44 Score=285.94 Aligned_cols=224 Identities=28% Similarity=0.472 Sum_probs=172.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh--------cCCCCHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--------HGRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--------~~~~~~~~~~~~~~~i~~~ 78 (241)
....+.+.+|++++++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.|
T Consensus 54 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~qi~~~ 133 (303)
T 2vwi_A 54 QTSMDELLKEIQAMSQCHHPNIVSYYTSFVVKDELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILREVLEG 133 (303)
T ss_dssp ------------CCCCCCCTTBCCEEEEEESSSCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHhhcCCCCEeeEEEEEeecCCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHHHHHHH
Confidence 34467788999999999999999999999999999999999999999999974 3558999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC------ccccccCCCCccCcccccc-cCCCCchhH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN------YAEKVCGSPLYMAPEVLQF-QRYDEKVDM 151 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~------~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv 151 (241)
|.+||+.|++|+||+|+||++ +.++.++|+|||.+....... ......+++.|+|||.+.+ ..++.++|+
T Consensus 134 l~~lH~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di 210 (303)
T 2vwi_A 134 LEYLHKNGQIHRDVKAGNILL---GEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADI 210 (303)
T ss_dssp HHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHHHH
T ss_pred HHHHHhCCCCCCCCChhhEEE---cCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchhhH
Confidence 999999999999999999999 788899999999987654321 1234568899999999875 568999999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC-----CccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcc
Q 026253 152 WSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS-----QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRF 226 (241)
Q Consensus 152 ~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~ 226 (241)
||||+++|+|++|..||...+................. ......++.++.+++.+||+.||.+|||++++++|||
T Consensus 211 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~ 290 (303)
T 2vwi_A 211 WSFGITAIELATGAAPYHKYPPMKVLMLTLQNDPPSLETGVQDKEMLKKYGKSFRKMISLCLQKDPEKRPTAAELLRHKF 290 (303)
T ss_dssp HHHHHHHHHHHHSSCTTTTSCGGGHHHHHHTSSCCCTTC-----CCCCCCCHHHHHHHHHHCCSSGGGSCCHHHHHTSTT
T ss_pred HHHHHHHHHHHhCCCCCccCchhhHHHHHhccCCCccccccccchhhhhhhHHHHHHHHHHccCChhhCcCHHHHhhChh
Confidence 99999999999999999987766555444333322211 1233568899999999999999999999999999999
Q ss_pred ccccccc
Q 026253 227 LRRNSAI 233 (241)
Q Consensus 227 ~~~~~~~ 233 (241)
|++....
T Consensus 291 ~~~~~~~ 297 (303)
T 2vwi_A 291 FQKAKNK 297 (303)
T ss_dssp C------
T ss_pred hhcCCCC
Confidence 9986543
|
| >2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-44 Score=290.63 Aligned_cols=212 Identities=26% Similarity=0.431 Sum_probs=187.4
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHH
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA 68 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~ 68 (241)
.....+.+.+|+++++++ +||||+++++++.+++..++||||+++++|.+++.... .++...+
T Consensus 126 ~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 205 (370)
T 2psq_A 126 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 205 (370)
T ss_dssp BHHHHHHHHHHHHHHHHSCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHhcCCCCEeeEEEEEccCCCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCHHHH
Confidence 345567899999999999 89999999999999999999999999999999998653 3789999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCC
Q 026253 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY 145 (241)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~ 145 (241)
..++.|++.||.|||++|++||||||+||++ +.++.++|+|||++....... ......+++.|+|||.+.+..+
T Consensus 206 ~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 282 (370)
T 2psq_A 206 VSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 282 (370)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCCSSCEETTCCCTTCTTTTTTSCGGGCCHHHHHTCCC
T ss_pred HHHHHHHHHHHHHHHhCCeeccccchhhEEE---CCCCCEEEccccCCcccCcccceecccCCCcccceECHhHhcCCCC
Confidence 9999999999999999999999999999999 788899999999998654432 2233456778999999998899
Q ss_pred CCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 146 DEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 146 ~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+.++|+||||+++|+|++ |..||.+.+..+....+..+.....+. .++.++.+++++||+.||.+|||+.|++++
T Consensus 283 ~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rpt~~ell~~ 358 (370)
T 2psq_A 283 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKPA----NCTNELYMMMRDCWHAVPSQRPTFKQLVED 358 (370)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999 999999988888888887766555443 788999999999999999999999999864
|
| >2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-44 Score=290.87 Aligned_cols=216 Identities=21% Similarity=0.402 Sum_probs=187.2
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHH------HHh--cCCCCHHHHHHHHHHHHHHHHHH
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY------IRL--HGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~------l~~--~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
+.+.+|++++++++||||+++++++.+.+..++||||+++++|.++ +.. ...+++..+..++.|++.||.+|
T Consensus 88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 167 (348)
T 2pml_X 88 DDFKNELQIITDIKNEYCLTCEGIITNYDEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKSVLNSFSYI 167 (348)
T ss_dssp HHHHHHHHHHTTCCCTTBCCCSEEEESSSEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCcceEEEEEeeCCeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHHHHHHHHHH
Confidence 7899999999999999999999999999999999999999999998 665 56799999999999999999999
Q ss_pred Hh-CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccccc-CCCC-chhHHHHHHHHH
Q 026253 83 NS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDE-KVDMWSVGAILF 159 (241)
Q Consensus 83 h~-~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~-~~Dv~slG~~l~ 159 (241)
|+ .|++|+||+|+||++ +.++.++|+|||.+...... ......++..|+|||.+.+. .++. ++|+||+|+++|
T Consensus 168 H~~~~i~H~dl~p~Nil~---~~~~~~kl~dfg~~~~~~~~-~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~ 243 (348)
T 2pml_X 168 HNEKNICHRDVKPSNILM---DKNGRVKLSDFGESEYMVDK-KIKGSRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLY 243 (348)
T ss_dssp HHTSCEECCCCCGGGEEE---CTTSCEEECCCTTCEECBTT-EECSSCSCGGGCCGGGGSSCCCEEHHHHHHHHHHHHHH
T ss_pred hccCCEeecCCChHhEEE---cCCCcEEEeccccccccccc-cccCCCCCcCccCchhhcCCCCCCcchhhHHHHHHHHH
Confidence 99 999999999999999 78889999999999775443 33456689999999999877 5555 999999999999
Q ss_pred HHHhCCCCCCCCCh-HHHHHHhhcCCCCCCCCc---------------cCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 160 ELLNGYPPFSGRNN-VQLVRNINSCKHLPFSQL---------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 160 ~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~---------------~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+|++|..||...+. .+....+.... ...+.. ....++.++.++|++||+.||.+|||++|+++
T Consensus 244 ~l~~g~~pf~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rps~~e~l~ 322 (348)
T 2pml_X 244 VMFYNVVPFSLKISLVELFNNIRTKN-IEYPLDRNHFLYPLTNKKSTCSNNFLSNEDIDFLKLFLRKNPAERITSEDALK 322 (348)
T ss_dssp HHHHSSCSSCCSSCSHHHHHHHTSCC-CCCCCSSSSSTTTTCC--------CCCHHHHHHHHHHCCSSGGGSCCHHHHHT
T ss_pred HHHhCCCCCCCCCcHHHHHHHHhccC-cCCccchhhhhccccccccccchhhcCHHHHHHHHHHccCChhhCCCHHHHhc
Confidence 99999999998776 67777775443 222211 11468999999999999999999999999999
Q ss_pred Cccccccc
Q 026253 224 HRFLRRNS 231 (241)
Q Consensus 224 ~~~~~~~~ 231 (241)
||||++..
T Consensus 323 hp~f~~~~ 330 (348)
T 2pml_X 323 HEWLADTN 330 (348)
T ss_dssp SGGGTTCC
T ss_pred CccccCCC
Confidence 99998754
|
| >3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-44 Score=288.90 Aligned_cols=218 Identities=25% Similarity=0.471 Sum_probs=178.3
Q ss_pred hHHhhhhHHHHHHHHhcCCC--cCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNH--PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~--~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+....+.+.+|+.++++++| +||+++++++.+++..++|||+ .+++|.+++...+.+++..+..++.|++.||.+||
T Consensus 47 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~al~~lH 125 (343)
T 3dbq_A 47 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 125 (343)
T ss_dssp CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhhhhcCCceEEEeeeEeeCCEEEEEEeC-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 44556889999999999976 9999999999999999999995 48899999999889999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccc-----------cCCCCch
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----------QRYDEKV 149 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~-----------~~~~~~~ 149 (241)
+.|++||||||+||+++ ++.++|+|||++........ .....+++.|+|||.+.+ ..++.++
T Consensus 126 ~~~iiHrDikp~NIll~----~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 201 (343)
T 3dbq_A 126 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 201 (343)
T ss_dssp HTTCCCCCCCGGGEEEE----TTEEEECCCSSSCCC------------CCCCSSCCHHHHHHCC-----------CCHHH
T ss_pred hCCeecCCCCcceEEEE----CCcEEEeecccccccCcccccccCCCCcCCcCcCCHHHHhhccccccccccccCCCchh
Confidence 99999999999999993 46799999999987654322 234578999999999864 5688999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhc-CCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 150 DMWSVGAILFELLNGYPPFSGRNN-VQLVRNINS-CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 150 Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~i~~-~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
||||||+++|+|++|..||..... ......+.. .....+ ....+.++.+++.+||+.||.+|||+.|+++||||
T Consensus 202 DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~ 277 (343)
T 3dbq_A 202 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEF----PDIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 277 (343)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCC----CCCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred hHHHHHHHHHHHHhCCCcchhhhhHHHHHHHHhcCCcccCC----cccCCHHHHHHHHHHcCCChhHCCCHHHHHhCccc
Confidence 999999999999999999986443 233333322 222222 23567899999999999999999999999999999
Q ss_pred ccccc
Q 026253 228 RRNSA 232 (241)
Q Consensus 228 ~~~~~ 232 (241)
+....
T Consensus 278 ~~~~~ 282 (343)
T 3dbq_A 278 QIQTH 282 (343)
T ss_dssp HSCCC
T ss_pred cccCC
Confidence 86443
|
| >3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.6e-44 Score=284.94 Aligned_cols=211 Identities=25% Similarity=0.370 Sum_probs=173.9
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
........|+..+.++ +|+||+++++++.+++..++|||++ +++|.+++... ..+++..+..++.|++.||.+||+.
T Consensus 98 ~~~~~~~~e~~~~~~~~~h~~iv~l~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~ 176 (311)
T 3p1a_A 98 KDRARKLAEVGSHEKVGQHPCCVRLEQAWEEGGILYLQTELC-GPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHLHSQ 176 (311)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhcCCCcEEEEEEEEEeCCEEEEEEecc-CCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 3444555566666555 9999999999999999999999999 67999988765 4599999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
|++|+||||+||++ +.++.++|+|||++.............+++.|+|||.+.+ .++.++|+||+|+++|+|++|.
T Consensus 177 ~ivH~Dikp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~DiwslG~il~el~~g~ 252 (311)
T 3p1a_A 177 GLVHLDVKPANIFL---GPRGRCKLGDFGLLVELGTAGAGEVQEGDPRYMAPELLQG-SYGTAADVFSLGLTILEVACNM 252 (311)
T ss_dssp TEECCCCSGGGEEE---CGGGCEEECCCTTCEECC------CCCCCGGGCCGGGGGT-CCSTHHHHHHHHHHHHHHHHTC
T ss_pred CEecCCCCHHHEEE---CCCCCEEEccceeeeecccCCCCcccCCCccccCHhHhcC-CCCchhhHHHHHHHHHHHHhCC
Confidence 99999999999999 7888999999999987766555556678999999999875 7899999999999999999997
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
.++.+... ...+.... .+......+++++.++|++||+.||.+|||++|+++||||++
T Consensus 253 ~~~~~~~~---~~~~~~~~---~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~ 310 (311)
T 3p1a_A 253 ELPHGGEG---WQQLRQGY---LPPEFTAGLSSELRSVLVMMLEPDPKLRATAEALLALPVLRQ 310 (311)
T ss_dssp CCCSSHHH---HHHHTTTC---CCHHHHTTSCHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred CCCCCccH---HHHHhccC---CCcccccCCCHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence 76654332 33333222 223344578999999999999999999999999999999986
|
| >3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-44 Score=286.40 Aligned_cols=211 Identities=25% Similarity=0.455 Sum_probs=185.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+.+.+|+.++++++||||+++++++.+++..++||||+++++|.++++.. +.+++..+..++.|++.||.+||+
T Consensus 90 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 169 (325)
T 3kul_A 90 TERQRRDFLSEASIMGQFDHPNIIRLEGVVTRGRLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRYLSD 169 (325)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECGGGCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEeCCccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 4556788999999999999999999999999999999999999999999999755 579999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
.|++|+||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+
T Consensus 170 ~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~e 246 (325)
T 3kul_A 170 LGYVHRDLAARNVLV---DSNLVCKVSDFGLSRVLEDDPDAAYTTTGGKIPIRWTAPEAIAFRTFSSASDVWSFGVVMWE 246 (325)
T ss_dssp TTEECSCCSGGGEEE---CTTCCEEECCCSSCEECC----CCEECC---CCGGGSCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred CCeeCCCCCcceEEE---CCCCCEEECCCCcccccccCccceeeccCCCCcccccCHhHhcCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999 7888999999999987654321 222345668999999998889999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 161 LLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 161 l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|++ |..||.+.+..+....+..+...+.+. .++..+.+++.+||+.||.+|||++++++
T Consensus 247 ll~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~eil~ 306 (325)
T 3kul_A 247 VLAYGERPYWNMTNRDVISSVEEGYRLPAPM----GCPHALHQLMLDCWHKDRAQRPRFSQIVS 306 (325)
T ss_dssp HHTTSCCTTTTSCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCcccCCHHHHHHHHHcCCCCCCCC----CcCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 999 999999999999998887776655443 78999999999999999999999999885
|
| >3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.2e-44 Score=282.88 Aligned_cols=217 Identities=25% Similarity=0.417 Sum_probs=179.6
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~l 82 (241)
.....+.+.+|++++++++||||+++++++.+.+..++||||+++++|.+++...+. +++..+..++.|++.||++|
T Consensus 74 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL~~L 153 (309)
T 3p86_A 74 HAERVNEFLREVAIMKRLRHPNIVLFMGAVTQPPNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGMNYL 153 (309)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEECCceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHHHHH
Confidence 345567889999999999999999999999999999999999999999999986543 89999999999999999999
Q ss_pred HhCC--ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 83 NSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 83 h~~~--i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
|+.| ++||||||+||++ +.++.++|+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|
T Consensus 154 H~~~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~ 230 (309)
T 3p86_A 154 HNRNPPIVHRNLKSPNLLV---DKKYTVKVCDFGLSRLKASTFLSSKSAAGTPEWMAPEVLRDEPSNEKSDVYSFGVILW 230 (309)
T ss_dssp HTSSSCCCCTTCCGGGEEE---CTTCCEEECCCC-----------------CCTTSCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HcCCCCEECCCCChhhEEE---eCCCcEEECCCCCCccccccccccccCCCCccccChhhhcCCCCCchhhHHHHHHHHH
Confidence 9999 9999999999999 788899999999997554332 233456899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCC-CCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc--Cccccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH--HRFLRR 229 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~ 229 (241)
+|++|..||.+.+..+....+.... ....+ ..+++++.++|++||+.||.+|||++++++ .++++.
T Consensus 231 elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~~ 299 (309)
T 3p86_A 231 ELATLQQPWGNLNPAQVVAAVGFKCKRLEIP----RNLNPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIKS 299 (309)
T ss_dssp HHHHCCCTTTTSCHHHHHHHHHHSCCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC-
T ss_pred HHHhCCCCCCCCCHHHHHHHHHhcCCCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHh
Confidence 9999999999998888777664333 22333 478999999999999999999999999986 455543
|
| >3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-44 Score=291.36 Aligned_cols=219 Identities=27% Similarity=0.431 Sum_probs=175.3
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEee-----cCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~ 81 (241)
...+.+.+|++++++++||||+++++++.. ....++|||++. ++|.+++... ..+++..+..++.|++.||.+
T Consensus 71 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~ 149 (362)
T 3pg1_A 71 FLCKRVLREIRLLNHFHHPNILGLRDIFVHFEEPAMHKLYLVTELMR-TDLAQVIHDQRIVISPQHIQYFMYHILLGLHV 149 (362)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCCSEEEEECCTTTCCEEEEEEECCS-EEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHhCCCcCccceeeeEEeccCCCcceEEEEEccCC-CCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence 345789999999999999999999999854 346899999996 6888887654 469999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~ 160 (241)
||+.|++|+||||+||++ +.++.++|+|||.+.............+++.|+|||.+.+ ..++.++|+||+|+++|+
T Consensus 150 lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~~ 226 (362)
T 3pg1_A 150 LHEAGVVHRDLHPGNILL---ADNNDITICDFNLAREDTADANKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAE 226 (362)
T ss_dssp HHHTTCCCCCCCGGGEEE---CTTCCEEECCTTC---------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHHH
T ss_pred HHHCcCEecCCChHHEEE---cCCCCEEEEecCcccccccccccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHHH
Confidence 999999999999999999 7888999999999986655555556678899999999876 678999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCC---------------------------CCCccCCCCChHHHHHHHHhcccCcc
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLP---------------------------FSQLIVPALHPDCVDMCLKLLSANTV 213 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~---------------------------~~~~~~~~~~~~~~~li~~~l~~~p~ 213 (241)
|++|..||.+.+..+....+......+ ......+..++.+.++|.+||+.||.
T Consensus 227 l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 306 (362)
T 3pg1_A 227 MFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVVPTADPVALDLIAKMLEFNPQ 306 (362)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCHHHHSTTSCHHHHHHHHHHTCSSGG
T ss_pred HHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhHHhhCCCCCHHHHHHHHHHhcCChh
Confidence 999999999988777666554321111 01112346788999999999999999
Q ss_pred ccCCHHHHhcCcccccc
Q 026253 214 DRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 214 ~Rps~~~il~~~~~~~~ 230 (241)
+|||++|+++||||++.
T Consensus 307 ~Rpt~~ell~hp~f~~~ 323 (362)
T 3pg1_A 307 RRISTEQALRHPYFESL 323 (362)
T ss_dssp GSCCHHHHHTSGGGTTT
T ss_pred hCCCHHHHHcCchhhhc
Confidence 99999999999999974
|
| >3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-44 Score=289.46 Aligned_cols=214 Identities=26% Similarity=0.487 Sum_probs=175.1
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC-----------------------------------------------
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----------------------------------------------- 39 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~----------------------------------------------- 39 (241)
+...+.+.+|++++++++||||+++++++.+.+
T Consensus 45 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 124 (332)
T 3qd2_B 45 ELAREKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTV 124 (332)
T ss_dssp TTHHHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC-------------------------------------
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCccccc
Confidence 445678999999999999999999999886543
Q ss_pred ----------eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCc
Q 026253 40 ----------CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV 106 (241)
Q Consensus 40 ----------~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~ 106 (241)
..++||||+++++|.+++..... .++..+..++.|++.||.+||++|++|+||||+||++ +.++
T Consensus 125 ~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~ 201 (332)
T 3qd2_B 125 GQLQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFF---TMDD 201 (332)
T ss_dssp -------CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEE---CTTC
T ss_pred ccccCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEE---eCCC
Confidence 38999999999999999987643 5666789999999999999999999999999999999 7888
Q ss_pred eEEEeecCCccccCCCC-------------ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCCh
Q 026253 107 MLKIADFGLSCTLYPGN-------------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173 (241)
Q Consensus 107 ~~~l~df~~a~~~~~~~-------------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~ 173 (241)
.++|+|||++....... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..|+.. .
T Consensus 202 ~~kL~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~~~~~~~--~ 279 (332)
T 3qd2_B 202 VVKVGDFGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNNYSHKVDIFSLGLILFELLYSFSTQME--R 279 (332)
T ss_dssp CEEECCCTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCCCCTHHHHHHHHHHHHHHHSCCCCHHH--H
T ss_pred CEEEeecCcccccccchhhccccccccccccccccCCCcCccChHHhcCCCCcchhhHHHHHHHHHHHHHcCCChhH--H
Confidence 99999999998765432 22335689999999999988999999999999999999998766532 2
Q ss_pred HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 174 VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 174 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
......+..... + ......++++.++|.+||+.||.+|||++|+++||||++
T Consensus 280 ~~~~~~~~~~~~---~-~~~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~ 331 (332)
T 3qd2_B 280 VRIITDVRNLKF---P-LLFTQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN 331 (332)
T ss_dssp HHHHHHHHTTCC---C-HHHHHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred HHHHHHhhccCC---C-cccccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence 222333322221 1 112245678899999999999999999999999999986
|
| >2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=283.96 Aligned_cols=219 Identities=27% Similarity=0.473 Sum_probs=181.8
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEee------cCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~ 78 (241)
...+.+.+|+.+++++ +||||+++++++.. .+..++||||+++++|.+++... ..+++..+..++.|++.|
T Consensus 62 ~~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~ 141 (326)
T 2x7f_A 62 DEEEEIKQEINMLKKYSHHRNIATYYGAFIKKNPPGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG 141 (326)
T ss_dssp STTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC--CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHHhccCCCCeeeeeeEEeeccCccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHHH
Confidence 3467889999999999 89999999999876 56899999999999999999864 469999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccc-----ccCCCCchhHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMW 152 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~ 152 (241)
|.+||+.|++|+||+|+||++ +.++.++|+|||++....... ......++..|+|||.+. +..++.++|+|
T Consensus 142 l~~lH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~ 218 (326)
T 2x7f_A 142 LSHLHQHKVIHRDIKGQNVLL---TENAEVKLVDFGVSAQLDRTVGRRNTFIGTPYWMAPEVIACDENPDATYDFKSDLW 218 (326)
T ss_dssp HHHHHHTTCCCCCCSGGGEEE---CTTCCEEECCCTTTC-------------CCGGGCCHHHHC--------CCTTHHHH
T ss_pred HHHHHHCCccccCCcHHHEEE---cCCCCEEEeeCcCceecCcCccccccccCCccccChhhhccccccCcCCCccchHH
Confidence 999999999999999999999 788899999999987654322 233456889999999986 45688999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 153 SVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 153 slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
|||+++|+|++|..||.+.+.......+........ ....++..+.++|++||..||.+|||++++++||||++.+.
T Consensus 219 slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~ 295 (326)
T 2x7f_A 219 SLGITAIEMAEGAPPLCDMHPMRALFLIPRNPAPRL---KSKKWSKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN 295 (326)
T ss_dssp HHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC---SCSCSCHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred HHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCccccC---CccccCHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence 999999999999999998887777666655443322 23478999999999999999999999999999999997543
|
| >3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-44 Score=285.74 Aligned_cols=221 Identities=24% Similarity=0.413 Sum_probs=177.0
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeE------EEEEeccCCCChHHHHHhcC------CCCHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHG------RVPEQTARKFLQ 73 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~------~~~~~~~~~~~~ 73 (241)
.....+.+.+|++++++++||||+++++++...+.. ++||||+++++|.+++.... .+++..+..++.
T Consensus 65 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~ 144 (323)
T 3qup_A 65 ASSDIEEFLREAACMKEFDHPHVAKLVGVSLRSRAKGRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMV 144 (323)
T ss_dssp -CHHHHHHHHHHHHHTTCCCTTBCCCCEEEECC-------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCceehhhceeeccccccCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHH
Confidence 345578899999999999999999999999876654 99999999999999996543 589999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchh
Q 026253 74 QLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVD 150 (241)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~D 150 (241)
|++.||.+||+.|++|+||||+||++ +.++.++|+|||.+........ .....+++.|+|||.+.+..++.++|
T Consensus 145 qi~~al~~LH~~~ivH~Dikp~NIli---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~D 221 (323)
T 3qup_A 145 DIACGMEYLSSRNFIHRDLAARNCML---AEDMTVCVADFGLSRKIYSGDYYRQGCASKLPVKWLALESLADNLYTVHSD 221 (323)
T ss_dssp HHHHHHHHHHHTTCCCSCCSGGGEEE---CTTSCEEECCCCC-----------------CCGGGCCHHHHHHCCCCHHHH
T ss_pred HHHHHHHHHHcCCcccCCCCcceEEE---cCCCCEEEeeccccccccccccccccccccCcccccCchhhcCCCCCCccc
Confidence 99999999999999999999999999 7888999999999976644322 22334567899999999889999999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-------HHHHh
Q 026253 151 MWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-------FNEFY 222 (241)
Q Consensus 151 v~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-------~~~il 222 (241)
+||||+++|+|++ |..||.+.+..+....+........+. .++.++.+++.+||+.||.+||| +++++
T Consensus 222 i~slG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l 297 (323)
T 3qup_A 222 VWAFGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQPP----ECMEEVYDLMYQCWSADPKQRPSFTCLRMELENIL 297 (323)
T ss_dssp HHHHHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHH
T ss_pred hhhHHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCCCC----ccCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHH
Confidence 9999999999999 999999998888888887666554443 78899999999999999999999 88899
Q ss_pred cCccccccccc
Q 026253 223 HHRFLRRNSAI 233 (241)
Q Consensus 223 ~~~~~~~~~~~ 233 (241)
.|+|+...+..
T Consensus 298 ~~~~~~~~~~~ 308 (323)
T 3qup_A 298 GHLSVLSTSQD 308 (323)
T ss_dssp HC---------
T ss_pred HHhhhcCCCCC
Confidence 99999986654
|
| >2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-44 Score=284.38 Aligned_cols=221 Identities=26% Similarity=0.455 Sum_probs=185.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|++++++++||||+++++++..++..++||||+++++|.+++.. ...+++..+..++.|++.||.+||+.
T Consensus 57 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 136 (302)
T 2j7t_A 57 EEELEDYIVEIEILATCDHPYIVKLLGAYYHDGKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNFLHSK 136 (302)
T ss_dssp -CCHHHHHHHHHHHHHCCCTTBCCEEEEEECC-CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHhcCCCCCEeeeeeeeeeCCeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHhcC
Confidence 34467889999999999999999999999999999999999999999999876 46699999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccc-----cccCCCCchhHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVL-----QFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~-----~~~~~~~~~Dv~slG~~l~ 159 (241)
|++|+||+|+||++ +.++.++|+|||++...... .......++..|+|||.+ .+..++.++|+||||+++|
T Consensus 137 ~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~ 213 (302)
T 2j7t_A 137 RIIHRDLKAGNVLM---TLEGDIRLADFGVSAKNLKTLQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLI 213 (302)
T ss_dssp TCCCCCCSGGGEEE---CTTSCEEECCCHHHHHHHHHHHC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHHHHHHH
T ss_pred CcccCCCCHHHEEE---CCCCCEEEEECCCCccccccccccccccCChhhcCCeeeccccCCCCCCchhhhHHHHHHHHH
Confidence 99999999999999 77889999999987542211 112334678999999988 3567889999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
+|++|..||...+.......+......... ....++..+.++|.+||+.||.+|||++++++||||+....
T Consensus 214 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~ 284 (302)
T 2j7t_A 214 EMAQIEPPHHELNPMRVLLKIAKSDPPTLL--TPSKWSVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS 284 (302)
T ss_dssp HHHHSSCTTTTSCHHHHHHHHHHSCCCCCS--SGGGSCHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred HHhcCCCCCccCCHHHHHHHHhccCCcccC--CccccCHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence 999999999998888777766555433221 22367899999999999999999999999999999998553
|
| >2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.1e-44 Score=291.73 Aligned_cols=217 Identities=25% Similarity=0.472 Sum_probs=179.7
Q ss_pred hHHhhhhHHHHHHHHhcCC--CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+....+.+.+|++++++++ |+||+++++++..++..++|||+ .+++|.+++.....+++..+..++.|++.||.|||
T Consensus 94 ~~~~~~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~E~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~lH 172 (390)
T 2zmd_A 94 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 172 (390)
T ss_dssp CHHHHHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEEEC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHHcccCCCeEEEEEEEEecCCEEEEEEec-CCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556788999999999996 59999999999999999999995 58899999998888999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccc-----------cCCCCch
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF-----------QRYDEKV 149 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~-----------~~~~~~~ 149 (241)
+.|++||||||+||++ + ++.++|+|||++....... ......+++.|+|||.+.+ ..++.++
T Consensus 173 ~~~ivHrDlkp~NIll---~-~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 248 (390)
T 2zmd_A 173 QHGIVHSDLKPANFLI---V-DGMLKLIDFGIANQMQPDTTSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKS 248 (390)
T ss_dssp TTTCCCCCCCGGGEEE---S-SSCEEECCCSSSCCC---------CCSCCCGGGCCHHHHHCC------------CCHHH
T ss_pred HCCeeecCCCHHHEEE---E-CCeEEEEecCccccccCCCccccCCCCCcCCCccChHHhhhccccccccccccCCCChh
Confidence 9999999999999999 3 4689999999998765432 2234578999999999864 3688999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhcCC-CCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 150 DMWSVGAILFELLNGYPPFSGRNN-VQLVRNINSCK-HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 150 Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~i~~~~-~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
||||||+++|+|++|..||..... ...+..+.... ...++ ...+.++.++|++||+.||.+|||+.|+++||||
T Consensus 249 DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~L~~dP~~Rps~~ell~hp~~ 324 (390)
T 2zmd_A 249 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 324 (390)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHHHCTTSCCCCC----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred hHHHHHHHHHHHHHCCCcchhhhHHHHHHHHHhCccccCCCC----ccchHHHHHHHHHHcccChhhCCCHHHHhhCcCc
Confidence 999999999999999999987543 34444443322 22222 2557899999999999999999999999999999
Q ss_pred cccc
Q 026253 228 RRNS 231 (241)
Q Consensus 228 ~~~~ 231 (241)
+...
T Consensus 325 ~~~~ 328 (390)
T 2zmd_A 325 QIQT 328 (390)
T ss_dssp HSCC
T ss_pred cccC
Confidence 8643
|
| >1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-43 Score=293.03 Aligned_cols=217 Identities=30% Similarity=0.483 Sum_probs=178.1
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHH
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~ 80 (241)
+...+|++++++++|+||+++++++... ...++||||+.+ ++.+.+.. ...+++..+..++.|++.||.
T Consensus 92 ~~~~~E~~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~ 170 (420)
T 1j1b_A 92 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPE-TVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA 170 (420)
T ss_dssp TSCCHHHHHHHTCCCTTBCCEEEEEEEEETTTTEEEEEEEEECCCE-EHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHcCCCCccceeeEEeccCCCCcceeEEeehhcccc-cHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence 4456899999999999999999987542 236799999964 67666542 467999999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccccc-CCCCchhHHHHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILF 159 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~ 159 (241)
|||+.|++||||||+||+++ .+.+.+||+|||+++............+++.|+|||.+.+. .++.++|+||+||++|
T Consensus 171 ~LH~~~ivHrDlkp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~il~ 248 (420)
T 1j1b_A 171 YIHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLA 248 (420)
T ss_dssp HHHTTTEECSCCSGGGEEEE--TTTTEEEECCCTTCEECCTTCCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHH
T ss_pred HHHHCCccccCCChhhEEEe--CCCCeEEeccchhhhhcccCCCceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHHHH
Confidence 99999999999999999994 35567999999999876655555567789999999998764 6899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCC----------------CCCCCC--------ccCCCCChHHHHHHHHhcccCcccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCK----------------HLPFSQ--------LIVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~----------------~~~~~~--------~~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
+|++|+.||.+.+..+.+..+.... ...++. ...+.++.++.++|++||+.||.+|
T Consensus 249 ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~Li~~~L~~dP~~R 328 (420)
T 1j1b_A 249 ELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTAR 328 (420)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCSCCCCCCCCCCCCCCHHHHSCTTSCHHHHHHHHHHSCSSGGGS
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhChhhhhhccCccCCCCHHHhcCCCCCHHHHHHHHHhccCChhHC
Confidence 9999999999888766555443311 111111 1234678999999999999999999
Q ss_pred CCHHHHhcCcccccc
Q 026253 216 LSFNEFYHHRFLRRN 230 (241)
Q Consensus 216 ps~~~il~~~~~~~~ 230 (241)
||+.|+++||||++.
T Consensus 329 ~t~~e~l~hp~f~~~ 343 (420)
T 1j1b_A 329 LTPLEACAHSFFDEL 343 (420)
T ss_dssp CCHHHHHTSGGGGGG
T ss_pred CCHHHHhCCHhhccc
Confidence 999999999999874
|
| >1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=282.65 Aligned_cols=218 Identities=33% Similarity=0.496 Sum_probs=185.6
Q ss_pred hhhHHHHHHHHhcC---CCcCeeeeeeEEe-----ecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSV---NHPNIIRLFDAFQ-----AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 10 ~~~~~~E~~~l~~l---~~~~i~~~~~~~~-----~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l 79 (241)
...+.+|+.+++.+ +||||+++++++. .....++|||++. ++|.+++.... .+++..+..++.|++.||
T Consensus 55 ~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l 133 (326)
T 1blx_A 55 PLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVD-QDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 133 (326)
T ss_dssp BCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCS-CBHHHHHHHSCTTCSCHHHHHHHHHHHHHHH
T ss_pred CchhhHHHHHHHhhhccCCCCeEeeeeeeeecccCCCceEEEEEecCC-CCHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence 44677888888877 8999999999987 4567999999996 69999998753 489999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
.+||+.|++|+||+|+||++ +.++.++|+|||.+.............++..|+|||.+.+..++.++|+||||+++|
T Consensus 134 ~~lH~~gi~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 210 (326)
T 1blx_A 134 DFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 210 (326)
T ss_dssp HHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHHHHCCceeccCCHHHeEE---cCCCCEEEecCcccccccCCCCccccccccceeCHHHHhcCCCCcchhHHHHHHHHH
Confidence 99999999999999999999 788899999999997765444445567899999999999888999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCC----------------------CCCccCCCCChHHHHHHHHhcccCccccCC
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLP----------------------FSQLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~----------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
+|++|..||.+.+.......+......+ ......+.++..+.++|.+||+.||.+|||
T Consensus 211 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt 290 (326)
T 1blx_A 211 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 290 (326)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCcchhhhccccCCHHHHHHHHHHcCCCcccCCC
Confidence 9999999999988877766654321111 111234578899999999999999999999
Q ss_pred HHHHhcCccccccc
Q 026253 218 FNEFYHHRFLRRNS 231 (241)
Q Consensus 218 ~~~il~~~~~~~~~ 231 (241)
+.|+++||||++..
T Consensus 291 ~~e~l~hp~~~~~~ 304 (326)
T 1blx_A 291 AYSALSHPYFQDLE 304 (326)
T ss_dssp HHHHHTSGGGTTCC
T ss_pred HHHHhcCccccccc
Confidence 99999999998754
|
| >2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.7e-44 Score=284.03 Aligned_cols=226 Identities=27% Similarity=0.510 Sum_probs=183.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEe--------------ecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------------AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--------------~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~ 71 (241)
+....+.+.+|++++++++||||+++++++. +.+..++||||++ ++|.++++ .+++++..+..+
T Consensus 48 ~~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~-~~~~~~~~~~~~ 125 (320)
T 2i6l_A 48 DPQSVKHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYME-TDLANVLE-QGPLLEEHARLF 125 (320)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCS-EEHHHHHT-TCCCCHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccC-CCHHHHhh-cCCccHHHHHHH
Confidence 3456778899999999999999999999873 4467899999996 69999986 467999999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC----CccccccCCCCccCcccccc-cCCC
Q 026253 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQF-QRYD 146 (241)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~----~~~~~~~~~~~~~~PE~~~~-~~~~ 146 (241)
+.|++.||.+||++|++|+||||+||+++ .+++.++|+|||.+...... .......++..|+|||.+.+ ..++
T Consensus 126 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~ 203 (320)
T 2i6l_A 126 MYQLLRGLKYIHSANVLHRDLKPANLFIN--TEDLVLKIGDFGLARIMDPHYSHKGHLSEGLVTKWYRSPRLLLSPNNYT 203 (320)
T ss_dssp HHHHHHHHHHHHHTTCBCCCCSGGGEEEE--TTTTEEEECCCTTCBCC--------CCCGGGSCCTTCCHHHHHCTTCCC
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHEEEc--CCCCeEEEccCccccccCCCcccccccccccccccccCcHHhcCcccCC
Confidence 99999999999999999999999999995 45678999999999765432 12234456889999998765 6789
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCC-------------------------CCccCCCCChHHH
Q 026253 147 EKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPF-------------------------SQLIVPALHPDCV 201 (241)
Q Consensus 147 ~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------------------~~~~~~~~~~~~~ 201 (241)
.++|+||||+++|+|++|..||.+.+..+....+........ .....+.++.++.
T Consensus 204 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 283 (320)
T 2i6l_A 204 KAIDMWAAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREAV 283 (320)
T ss_dssp HHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHHTTSCHHHHHHTTSCCCCHHHHSTTCCHHHH
T ss_pred chhhhHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhhhcCcccccccccCCCCChhHhcchhhHHHH
Confidence 999999999999999999999998887776665543321110 0112346899999
Q ss_pred HHHHHhcccCccccCCHHHHhcCcccccccccCC
Q 026253 202 DMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 235 (241)
Q Consensus 202 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 235 (241)
++|++||+.||.+|||++|+++||||+...--..
T Consensus 284 ~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~ 317 (320)
T 2i6l_A 284 DFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD 317 (320)
T ss_dssp HHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred HHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence 9999999999999999999999999997554433
|
| >3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-44 Score=289.28 Aligned_cols=220 Identities=27% Similarity=0.464 Sum_probs=183.4
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
....+.+.+|++++++++||||+++++++... ...++|||+++ ++|.++++. ..+++..+..++.|++.||.+
T Consensus 66 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~iv~e~~~-~~L~~~l~~-~~~~~~~~~~i~~qi~~aL~~ 143 (364)
T 3qyz_A 66 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYIVQDLME-TDLYKLLKT-QHLSNDHICYFLYQILRGLKY 143 (364)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEECCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHhcCCCCCccceeEEecCCccccceEEEEEcccC-cCHHHHHHh-CCCCHHHHHHHHHHHHHHHHH
Confidence 34457889999999999999999999998654 46899999996 699999875 579999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccc-cCCCCchhHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~ 156 (241)
||++|++|+||||+||++ +.++.++|+|||.+........ .....+++.|+|||.+.+ ..++.++|+||+|+
T Consensus 144 LH~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~ 220 (364)
T 3qyz_A 144 IHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 220 (364)
T ss_dssp HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHH
T ss_pred HHHCCeecCCCChHhEEE---CCCCCEEEEeCcceEecCCCCCccccccccccccCCCCCHHhcCCCCCCcchhHHHHHH
Confidence 999999999999999999 7888999999999976643321 234578999999998654 45899999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCCCCCC--------------------------CCccCCCCChHHHHHHHHhccc
Q 026253 157 ILFELLNGYPPFSGRNNVQLVRNINSCKHLPF--------------------------SQLIVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~ 210 (241)
++|+|++|..||.+.+..+....+......+. .....+.++.++.++|++||+.
T Consensus 221 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~ 300 (364)
T 3qyz_A 221 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 300 (364)
T ss_dssp HHHHHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHTCS
T ss_pred HHHHHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhCCCCCHHHHHHHHHHcCC
Confidence 99999999999998877666655532111110 0112356789999999999999
Q ss_pred CccccCCHHHHhcCccccccc
Q 026253 211 NTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 211 ~p~~Rps~~~il~~~~~~~~~ 231 (241)
||.+|||++|+++||||++..
T Consensus 301 dP~~R~t~~e~l~hp~~~~~~ 321 (364)
T 3qyz_A 301 NPHKRIEVEQALAHPYLEQYY 321 (364)
T ss_dssp STTTSCCHHHHHTSGGGTTTC
T ss_pred ChhhCCCHHHHhcCcchhhcc
Confidence 999999999999999999853
|
| >3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.7e-44 Score=292.72 Aligned_cols=221 Identities=25% Similarity=0.446 Sum_probs=169.7
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhc---------CCCCHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLH---------GRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~---------~~~~~~~~~~~~~~i~~~ 78 (241)
...+.+|+.++++++||||+++++++.. +...++||||+. ++|.+++... ..+++..+..++.|++.|
T Consensus 62 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~a 140 (405)
T 3rgf_A 62 SMSACREIALLRELKHPNVISLQKVFLSHADRKVWLLFDYAE-HDLWHIIKFHRASKANKKPVQLPRGMVKSLLYQILDG 140 (405)
T ss_dssp CHHHHHHHHHHHHCCCTTBCCCCEEEEETTTTEEEEEEECCS-EEHHHHHHHHHHHC-------CCHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHhcCCCCeeeEeeEEecCCCCeEEEEEeCCC-CCHHHHHHHhccccccccccCCCHHHHHHHHHHHHHH
Confidence 4578899999999999999999999954 678999999995 6888887532 248999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeec-CCCceEEEeecCCccccCCC----CccccccCCCCccCccccccc-CCCCchhHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGL-DDDVMLKIADFGLSCTLYPG----NYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMW 152 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~-~~~~~~~l~df~~a~~~~~~----~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~ 152 (241)
|.|||+.|++||||||+||++... +..+.++|+|||++...... .......+|+.|+|||.+.+. .++.++|||
T Consensus 141 l~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw 220 (405)
T 3rgf_A 141 IHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLKPLADLDPVVVTFWYRAPELLLGARHYTKAIDIW 220 (405)
T ss_dssp HHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC----------------CCCTTCCHHHHTTCCSCCHHHHHH
T ss_pred HHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCcccccCCCceecCcccCchhhcCCCcccchhhhH
Confidence 999999999999999999999542 45678999999999876432 223345789999999998874 589999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChH---------HHHHHhhcCCCCCCCCc--------------------------------
Q 026253 153 SVGAILFELLNGYPPFSGRNNV---------QLVRNINSCKHLPFSQL-------------------------------- 191 (241)
Q Consensus 153 slG~~l~~l~~g~~p~~~~~~~---------~~~~~i~~~~~~~~~~~-------------------------------- 191 (241)
||||++|+|++|.+||.+.+.. +.+..+......+....
T Consensus 221 SlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (405)
T 3rgf_A 221 AIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNCSLIKYME 300 (405)
T ss_dssp HHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGTTCCHHHHHH
T ss_pred HHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCCcchhhhhHh
Confidence 9999999999999999765442 33333322111111100
Q ss_pred -cCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 192 -IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 192 -~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
.....+..+.+||++||+.||.+|||++|+|+||||++..
T Consensus 301 ~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~ 341 (405)
T 3rgf_A 301 KHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDP 341 (405)
T ss_dssp TTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSS
T ss_pred hcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCC
Confidence 0112367899999999999999999999999999998754
|
| >3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-43 Score=288.49 Aligned_cols=212 Identities=26% Similarity=0.432 Sum_probs=188.9
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHH
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA 68 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~ 68 (241)
.....+.+.+|+++++++ +||||+++++++.+++..++||||+++++|.+++.... .+++..+
T Consensus 114 ~~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 193 (382)
T 3tt0_A 114 TEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKDL 193 (382)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCHHHH
T ss_pred CHHHHHHHHHHHHHHHHhcCCchhhhheeeeccCCceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCHHHH
Confidence 345567899999999999 99999999999999999999999999999999998754 4899999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCC
Q 026253 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY 145 (241)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~ 145 (241)
..++.|++.||.+||+.|++||||||+||++ +.++.++|+|||++....... ......++..|+|||.+.+..+
T Consensus 194 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 270 (382)
T 3tt0_A 194 VSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIY 270 (382)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTCCEEECSCSCCCCSSCCCTTCCCTTCCCGGGGSCHHHHHSCCC
T ss_pred HHHHHHHHHHHHHHHhCCEecCCCCcceEEE---cCCCcEEEcccCcccccccccccccccCCCCCcceeCHHHhcCCCC
Confidence 9999999999999999999999999999999 778899999999998664432 2233456778999999998899
Q ss_pred CCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 146 DEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 146 ~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+.++||||||+++|+|++ |..||.+.+..+..+.+........+. .++.++.+++++||+.||.+|||++|++++
T Consensus 271 ~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 346 (382)
T 3tt0_A 271 THQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVED 346 (382)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999999999999999 999999999999888887776655543 789999999999999999999999999965
|
| >4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=275.79 Aligned_cols=208 Identities=25% Similarity=0.457 Sum_probs=184.8
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
.+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++... +.+++..+..++.|++.||.+||+.|++
T Consensus 49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~~lH~~~i~ 128 (269)
T 4hcu_A 49 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACVI 128 (269)
T ss_dssp HHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTCC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEecCCceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHHHHHhCCee
Confidence 567899999999999999999999999999999999999999999999754 4589999999999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CC
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GY 165 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~ 165 (241)
|+||||+||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++ |.
T Consensus 129 H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ll~~g~ 205 (269)
T 4hcu_A 129 HRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGK 205 (269)
T ss_dssp CSCCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTSC
T ss_pred cCCcchheEEE---cCCCCEEeccccccccccccccccccCcccccccCCHHHhcCCCCCchhhhHHHHHHHHHHhcCCC
Confidence 99999999999 778899999999997654432 1223345677999999998899999999999999999999 99
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.||.+.+..+....+........+. ..+..+.+++++||+.||.+|||+++++++
T Consensus 206 ~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~~ll~~ 260 (269)
T 4hcu_A 206 IPYENRSNSEVVEDISTGFRLYKPR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQ 260 (269)
T ss_dssp CTTTTCCHHHHHHHHHTTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCHHHHHHHHhcCccCCCCC----cCCHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence 9999999999888887765544443 678999999999999999999999999975
|
| >2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=282.36 Aligned_cols=212 Identities=25% Similarity=0.432 Sum_probs=186.6
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC-----------------------
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR----------------------- 62 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~----------------------- 62 (241)
.....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.....
T Consensus 66 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (314)
T 2ivs_A 66 SPSELRDLLSEFNVLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHPDER 145 (314)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTTTSTTEEC----------------C
T ss_pred CHHHHHHHHHHHHHHhhCCCCceeeEEEEEecCCceEEEEeecCCCCHHHHHHHHhhccCCccccccccccccccccccc
Confidence 345567899999999999999999999999999999999999999999999987543
Q ss_pred -CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcc
Q 026253 63 -VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPE 138 (241)
Q Consensus 63 -~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE 138 (241)
+++..+..++.|++.||.+||++|++|+||||+||++ +.++.++|+|||++........ .....++..|+|||
T Consensus 146 ~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE 222 (314)
T 2ivs_A 146 ALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILV---AEGRKMKISDFGLSRDVYEEDSYVKRSQGRIPVKWMAIE 222 (314)
T ss_dssp EECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEE---ETTTEEEECCCTTCEECTTTSCEECSSCCCSCGGGCCHH
T ss_pred CcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEE---cCCCCEEEccccccccccccccceeccCCCCcccccChh
Confidence 8899999999999999999999999999999999999 6788999999999976644322 22344677899999
Q ss_pred cccccCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC
Q 026253 139 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
.+.+..++.++|+||||+++|+|++ |..||.+.+.......+........+ ..+++++.+++.+||+.||.+|||
T Consensus 223 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~li~~~l~~dp~~Rps 298 (314)
T 2ivs_A 223 SLFDHIYTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRMERP----DNCSEEMYRLMLQCWKQEPDKRPV 298 (314)
T ss_dssp HHHHCEECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhcCCCcCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCCCC----ccCCHHHHHHHHHHccCChhhCcC
Confidence 9988889999999999999999999 99999998888888877666554444 378999999999999999999999
Q ss_pred HHHHhcC
Q 026253 218 FNEFYHH 224 (241)
Q Consensus 218 ~~~il~~ 224 (241)
+++++++
T Consensus 299 ~~~l~~~ 305 (314)
T 2ivs_A 299 FADISKD 305 (314)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999865
|
| >3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=293.10 Aligned_cols=219 Identities=30% Similarity=0.450 Sum_probs=180.6
Q ss_pred HhhhhHHHHHHHHhcC------CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSV------NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l------~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l 79 (241)
...+.+.+|+++++.+ +|+||+++++.+...+..++|||++. ++|.+++.... .+++..+..++.|++.||
T Consensus 135 ~~~~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~aL 213 (429)
T 3kvw_A 135 RFHRQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFRNHICMTFELLS-MNLYELIKKNKFQGFSLPLVRKFAHSILQCL 213 (429)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEETTEEEEEECCCC-CBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHhhccccCCcCEEEEEeecccCCeEEEEEeccC-CCHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 3456788899988887 57799999999999999999999995 69999998754 489999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCce--EEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVM--LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~--~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~ 157 (241)
++||+.|++||||||+||++ +.++. ++|+|||+++..... .....+++.|+|||.+.+..++.++|||||||+
T Consensus 214 ~~LH~~~ivHrDlKp~NILl---~~~~~~~vkL~DFG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~i 288 (429)
T 3kvw_A 214 DALHKNRIIHCDLKPENILL---KQQGRSGIKVIDFGSSCYEHQR--VYTYIQSRFYRAPEVILGARYGMPIDMWSLGCI 288 (429)
T ss_dssp HHHHHHTEECSCCSGGGEEE---SSTTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHHTBCCCTHHHHHHHHHH
T ss_pred HHHHHCCeecCCCCHHHeEE---ccCCCcceEEeecccceecCCc--ccccCCCCCccChHHHhCCCCCchHHHHhHHHH
Confidence 99999999999999999999 55555 999999999765433 334578999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC------------------------------------------------
Q 026253 158 LFELLNGYPPFSGRNNVQLVRNINSCKHLPFS------------------------------------------------ 189 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~------------------------------------------------ 189 (241)
+|+|++|.+||.+.+..+.+..+......+..
T Consensus 289 l~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 368 (429)
T 3kvw_A 289 LAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGKLRGPP 368 (429)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTTCCEECST
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccchhhccCCc
Confidence 99999999999998887766555432111110
Q ss_pred ------CccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 190 ------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 190 ------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
.......++.+.+||++||+.||.+|||++|+|+||||++...
T Consensus 369 ~~~~~~~~l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~~~ 417 (429)
T 3kvw_A 369 ESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRRLP 417 (429)
T ss_dssp TCSCHHHHTTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC----
T ss_pred cchhhHhhccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccCCC
Confidence 0011234778999999999999999999999999999998543
|
| >1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=283.81 Aligned_cols=212 Identities=27% Similarity=0.439 Sum_probs=183.5
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHH
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA 68 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~ 68 (241)
.....+.+.+|+++++++ +||||+++++++.+++..++||||+++++|.+++...+ .+++..+
T Consensus 65 ~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 144 (327)
T 1fvr_A 65 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 144 (327)
T ss_dssp -----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred chHHHHHHHHHHHHHHhccCCCchhhhceeeeeCCceEEEEecCCCCCHHHHHHhcccccccccccccccccccCCHHHH
Confidence 345567899999999999 99999999999999999999999999999999997654 6899999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCc
Q 026253 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK 148 (241)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~ 148 (241)
..++.|++.||.+||+.|++|+||||+||++ +.++.++|+|||++.............++..|+|||.+.+..++.+
T Consensus 145 ~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 221 (327)
T 1fvr_A 145 LHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 221 (327)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHHHHhCCccCCCCccceEEE---cCCCeEEEcccCcCccccccccccCCCCCccccChhhhccccCCch
Confidence 9999999999999999999999999999999 7788999999999875443333334456788999999988889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 149 VDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+|+||||+++|+|++ |..||.+.+..+....+..+.....+ ..++..+.+++.+||+.||.+|||+++++++
T Consensus 222 ~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 294 (327)
T 1fvr_A 222 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQILVS 294 (327)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCC----TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999998 99999999998888888766544433 3788999999999999999999999999975
|
| >1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-43 Score=284.99 Aligned_cols=214 Identities=29% Similarity=0.510 Sum_probs=181.9
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|+++++++ .|+||+++++++..++..++||||+++++|.+++....++++..+..++.|++.||.+||++|+
T Consensus 101 ~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~aL~~LH~~~i 180 (355)
T 1vzo_A 101 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 180 (355)
T ss_dssp SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHccCCCceeEEEEEEeeCceEEEEeecCCCCCHHHHHHHcCCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 356788899999999 7999999999999999999999999999999999988899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccc--cCCCCchhHHHHHHHHHHHHh
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+|+||||+||++ +.++.++|+|||++....... ......+++.|+|||.+.+ ..++.++|+||||+++|+|++
T Consensus 181 vH~Dlkp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG~il~ell~ 257 (355)
T 1vzo_A 181 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 257 (355)
T ss_dssp CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred ccCCCCHHHEEE---CCCCcEEEeeCCCCeecccCCCCcccCcccCcCccChhhhcCCCCCCCchhhHHHHHHHHHHHHH
Confidence 999999999999 788899999999997654322 2234568999999999985 347899999999999999999
Q ss_pred CCCCCCCCC----hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCcccccc
Q 026253 164 GYPPFSGRN----NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRRN 230 (241)
Q Consensus 164 g~~p~~~~~----~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~~ 230 (241)
|..||...+ .....+.+... ..+. ...++..+.++|++||+.||.+|| |++++++||||++.
T Consensus 258 g~~pf~~~~~~~~~~~~~~~~~~~-~~~~----~~~~~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~~ 328 (355)
T 1vzo_A 258 GASPFTVDGEKNSQAEISRRILKS-EPPY----PQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKI 328 (355)
T ss_dssp SSCTTSCTTSCCCHHHHHHHHHHC-CCCC----CTTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTTC
T ss_pred CCCCCccCCccchHHHHHHHHhcc-CCCC----CcccCHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhcC
Confidence 999997432 33344444322 2222 347889999999999999999999 99999999999873
|
| >2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.5e-43 Score=283.74 Aligned_cols=222 Identities=26% Similarity=0.455 Sum_probs=181.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
......+.+|++++++++||||+++++++..+ +..++|||++. ++|.+++.. +.+++..+..++.|++.||.+
T Consensus 50 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~~~~-~~~~~~~~~~~~~qi~~~L~~ 127 (353)
T 2b9h_A 50 PLFALRTLREIKILKHFKHENIITIFNIQRPDSFENFNEVYIIQELMQ-TDLHRVIST-QMLSDDHIQYFIYQTLRAVKV 127 (353)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEECCCSCSTTCCCEEEEECCCS-EEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHhCcCCCcCCeeeeecccccCccceEEEEEeccC-ccHHHHHhh-cCCCHHHHHHHHHHHHHHHHH
Confidence 34466788999999999999999999987654 67999999996 699999875 579999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----------cccccCCCCccCcccccc-cCCCCch
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----------AEKVCGSPLYMAPEVLQF-QRYDEKV 149 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----------~~~~~~~~~~~~PE~~~~-~~~~~~~ 149 (241)
||+.|++|+||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+ ..++.++
T Consensus 128 LH~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~ 204 (353)
T 2b9h_A 128 LHGSNVIHRDLKPSNLLI---NSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAM 204 (353)
T ss_dssp HHHTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHH
T ss_pred HHHCCeecCCCCHHHeEE---cCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchh
Confidence 999999999999999999 7888999999999976643221 122467899999998754 6789999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCC---------------------------CCccCCCCChHHHH
Q 026253 150 DMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPF---------------------------SQLIVPALHPDCVD 202 (241)
Q Consensus 150 Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~---------------------------~~~~~~~~~~~~~~ 202 (241)
|+||||+++|+|++|..||.+.+..+....+......+. .....+.++.++.+
T Consensus 205 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 284 (353)
T 2b9h_A 205 DVWSCGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMFPRVNPKGID 284 (353)
T ss_dssp HHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHHSTTSCHHHHH
T ss_pred hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhhcccCCHHHHH
Confidence 999999999999999999998877665544432111100 01123478899999
Q ss_pred HHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 203 MCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 203 li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
+|++||+.||.+|||++|+++||||+.....
T Consensus 285 li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~ 315 (353)
T 2b9h_A 285 LLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315 (353)
T ss_dssp HHHHHSCSSGGGSCCHHHHHTSGGGTTTCCT
T ss_pred HHHHhcCcCcccCCCHHHHhcCccccccCCc
Confidence 9999999999999999999999999985443
|
| >1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-43 Score=284.79 Aligned_cols=212 Identities=23% Similarity=0.444 Sum_probs=186.0
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc------------------------C
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH------------------------G 61 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~------------------------~ 61 (241)
..+..+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++... .
T Consensus 90 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (343)
T 1luf_A 90 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 169 (343)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------C
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEccCCceEEEEecCCCCcHHHHHHHhCcccccccccccccccccccccCCC
Confidence 3455778999999999999999999999999999999999999999999999864 5
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcc
Q 026253 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPE 138 (241)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE 138 (241)
++++..+..++.|++.||.+||++|++|+||||+||++ +.++.++|+|||++....... ......++..|+|||
T Consensus 170 ~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 246 (343)
T 1luf_A 170 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 246 (343)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEE---CCCCeEEEeecCCCcccccCccccccCCCcccceecChh
Confidence 68999999999999999999999999999999999999 788899999999987654321 223345678899999
Q ss_pred cccccCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC
Q 026253 139 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
.+.+..++.++|+||||+++|+|++ |..||.+.+..+....+..+.....+ ..++.++.+++++||+.||.+|||
T Consensus 247 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps 322 (343)
T 1luf_A 247 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACP----ENCPLELYNLMRLCWSKLPADRPS 322 (343)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCC
T ss_pred hhccCCcCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCCCC----CCCCHHHHHHHHHHcccCcccCCC
Confidence 9988889999999999999999999 99999999988888888776654444 378899999999999999999999
Q ss_pred HHHHhcC
Q 026253 218 FNEFYHH 224 (241)
Q Consensus 218 ~~~il~~ 224 (241)
+.+++++
T Consensus 323 ~~~~~~~ 329 (343)
T 1luf_A 323 FCSIHRI 329 (343)
T ss_dssp HHHHHHH
T ss_pred HHHHHHH
Confidence 9999853
|
| >3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-43 Score=278.39 Aligned_cols=209 Identities=22% Similarity=0.416 Sum_probs=185.9
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|++++++++|+||+++++++.+++..++||||+++++|.+++.. ...+++..+..++.|++.||.+||++|+
T Consensus 62 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 141 (283)
T 3gen_A 62 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQF 141 (283)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHhcCCCCCEeeEEEEEecCCCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHHCCc
Confidence 356789999999999999999999999999999999999999999999976 4679999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+|+||||+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++ |
T Consensus 142 ~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~~l~~l~t~g 218 (283)
T 3gen_A 142 LHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLG 218 (283)
T ss_dssp CCSSCSGGGEEE---CTTSCEEECSTTGGGGBCCHHHHSTTSTTSCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHTTT
T ss_pred cCCCCccceEEE---cCCCCEEEccccccccccccccccccCCccCcccCCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999 7888999999999976644221 222345677999999998889999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
..||...+..+....+........+. ..++.+.+++++||+.||.+|||++++++|
T Consensus 219 ~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 274 (283)
T 3gen_A 219 KMPYERFTNSETAEHIAQGLRLYRPH----LASEKVYTIMYSCWHEKADERPTFKILLSN 274 (283)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccChhHHHHHHhcccCCCCCC----cCCHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence 99999999998888887766554443 678999999999999999999999999976
|
| >2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=279.72 Aligned_cols=220 Identities=29% Similarity=0.451 Sum_probs=178.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHHHHHHHHHh
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
...+.+.+|+.++++++||||+++++++...+..++|||++++++|.+++.... .+++..+..++.|++.||.+||+
T Consensus 61 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~ 140 (295)
T 2clq_A 61 RYSQPLHEEIALHKHLKHKNIVQYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEGLKYLHD 140 (295)
T ss_dssp ---HHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEeeEEEeCCcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHHHHHHHh
Confidence 446778999999999999999999999999999999999999999999998652 46789999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccC--CCCchhHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR--YDEKVDMWSVGAILFEL 161 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~--~~~~~Dv~slG~~l~~l 161 (241)
.|++|+||+|+||+++ ..++.++|+|||.+....... ......++..|+|||.+.+.. ++.++|+||||+++|+|
T Consensus 141 ~~i~H~dl~p~Nil~~--~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~il~~l 218 (295)
T 2clq_A 141 NQIVHRDIKGDNVLIN--TYSGVLKISDFGTSKRLAGINPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEM 218 (295)
T ss_dssp TTEECCCCSGGGEEEE--TTTCCEEECCTTTCEESCC-----CCCCCCGGGCCHHHHHHGGGGCSHHHHHHHHHHHHHHH
T ss_pred CCEEccCCChhhEEEE--CCCCCEEEeecccccccCCCCCcccccCCCccccChhhhcCCCCCCCcHHHHHHHHHHHHHH
Confidence 9999999999999995 337889999999997764322 233456889999999987643 78999999999999999
Q ss_pred HhCCCCCCCCChHHH--HHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 162 LNGYPPFSGRNNVQL--VRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
++|..||........ ........... ....++.++.+++.+||+.||.+|||++++++||||+....+
T Consensus 219 ~~g~~pf~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~~ 288 (295)
T 2clq_A 219 ATGKPPFYELGEPQAAMFKVGMFKVHPE----IPESMSAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSSKK 288 (295)
T ss_dssp HHTSCTTGGGSSHHHHHHHHHHHCCCCC----CCTTSCHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC----
T ss_pred HHCCCCccCCCchhHHHHhhcccccccc----ccccCCHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcccc
Confidence 999999976443322 22221222222 234789999999999999999999999999999999986544
|
| >3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-45 Score=298.11 Aligned_cols=209 Identities=13% Similarity=0.116 Sum_probs=170.2
Q ss_pred HHhhhhHHHHH---HHHhcCCCcCeeeee-------eEEeecC-----------------eEEEEEeccCCCChHHHHHh
Q 026253 7 KHLKSCLDCEL---NFLSSVNHPNIIRLF-------DAFQAEN-----------------CIFLVVEFCAGGNLSSYIRL 59 (241)
Q Consensus 7 ~~~~~~~~~E~---~~l~~l~~~~i~~~~-------~~~~~~~-----------------~~~lv~e~~~~~~L~~~l~~ 59 (241)
....+.+.+|+ +++++++||||++++ +++++.+ ..++||||+ +|+|.+++..
T Consensus 114 ~~~~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~-~g~L~~~l~~ 192 (377)
T 3byv_A 114 SNAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEV 192 (377)
T ss_dssp TTHHHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECC-SEEHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEecc-CCCHHHHHHh
Confidence 34568899999 455555899999998 6665543 388999999 6899999987
Q ss_pred cCCCCH-------HHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCC
Q 026253 60 HGRVPE-------QTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132 (241)
Q Consensus 60 ~~~~~~-------~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~ 132 (241)
.+.+++ ..+..++.|++.||+|||++|++||||||+||++ +.++.++|+|||++..... ......+ +
T Consensus 193 ~~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~--~~~~~~g-~ 266 (377)
T 3byv_A 193 LLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGA--RVVSSVS-R 266 (377)
T ss_dssp HHHTTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTC--EEECCCC-T
T ss_pred ccccccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEE---cCCCCEEEEechhheecCC--cccCCCC-c
Confidence 655555 7888899999999999999999999999999999 7788999999999986443 2334456 8
Q ss_pred CccCccccccc-----------CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHH
Q 026253 133 LYMAPEVLQFQ-----------RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCV 201 (241)
Q Consensus 133 ~~~~PE~~~~~-----------~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~ 201 (241)
.|+|||.+.+. .++.++|+||||+++|+|++|..||.+.+.......+.. ..+.+++++.
T Consensus 267 ~y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~ 337 (377)
T 3byv_A 267 GFEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIFR---------SCKNIPQPVR 337 (377)
T ss_dssp TCCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGGS---------SCCCCCHHHH
T ss_pred CccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhhh---------hccCCCHHHH
Confidence 99999999877 799999999999999999999999987655443333321 1247899999
Q ss_pred HHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 202 DMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 202 ~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
++|.+||+.||.+|||+.|+++||||++..
T Consensus 338 ~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~ 367 (377)
T 3byv_A 338 ALLEGFLRYPKEDRLLPLQAMETPEYEQLR 367 (377)
T ss_dssp HHHHHHTCSSGGGCCCHHHHHTSHHHHHHH
T ss_pred HHHHHHcCCCchhCCCHHHHhhChHHHHHH
Confidence 999999999999999999999999998754
|
| >3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=274.25 Aligned_cols=209 Identities=23% Similarity=0.450 Sum_probs=185.3
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...+ .+++..+..++.|++.||.+||+.|+
T Consensus 46 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 125 (268)
T 3sxs_A 46 SEDEFFQEAQTMMKLSHPKLVKFYGVCSKEYPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMAFLESHQF 125 (268)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred cHHHHHHHHHHHHhCCCCCEeeEEEEEccCCceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 35678999999999999999999999999999999999999999999998754 49999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|++ |
T Consensus 126 ~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (268)
T 3sxs_A 126 IHRDLAARNCLV---DRDLCVKVSDFGMTRYVLDDQYVSSVGTKFPVKWSAPEVFHYFKYSSKSDVWAFGILMWEVFSLG 202 (268)
T ss_dssp EESSCSGGGEEE---CTTCCEEECCTTCEEECCTTCEEECCSCCCCGGGCCHHHHHHSEEETTHHHHHHHHHHHHHHTTT
T ss_pred ecCCcCcceEEE---CCCCCEEEccCccceecchhhhhcccCCCcCcccCCHHHHhccCCchhhhhHHHHHHHHHHHcCC
Confidence 999999999999 7888999999999976654432 222334567999999988889999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
..||...+..+....+........+. ..++.+.+++++||+.||.+|||+.+++++
T Consensus 203 ~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (268)
T 3sxs_A 203 KMPYDLYTNSEVVLKVSQGHRLYRPH----LASDTIYQIMYSCWHELPEKRPTFQQLLSS 258 (268)
T ss_dssp CCTTTTSCHHHHHHHHHTTCCCCCCT----TSCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCccccChHHHHHHHHcCCCCCCCC----cChHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999888888887666554443 678999999999999999999999999976
|
| >3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.4e-44 Score=289.56 Aligned_cols=211 Identities=30% Similarity=0.501 Sum_probs=185.5
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
..+..+.+.+|++++++++||||+++++++..++..++||||+++++|.++++..+ .+++..+..++.|++.||++||+
T Consensus 152 ~~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~ 231 (377)
T 3cbl_A 152 PPDLKAKFLQEARILKQYSHPNIVRLIGVCTQKQPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEYLES 231 (377)
T ss_dssp CHHHHTTTTHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEEEEEEEEecCCCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34556789999999999999999999999999999999999999999999998654 59999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccc---cccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAE---KVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~---~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
+|++||||+|+||++ +.++.++|+|||++.......... ...++..|+|||.+.+..++.++|+||||+++|++
T Consensus 232 ~~ivHrDlkp~Nil~---~~~~~~kl~DfG~s~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~il~el 308 (377)
T 3cbl_A 232 KCCIHRDLAARNCLV---TEKNVLKISDFGMSREEADGVYAASGGLRQVPVKWTAPEALNYGRYSSESDVWSFGILLWET 308 (377)
T ss_dssp TTEECSCCSGGGEEE---CTTCCEEECCGGGCEECTTSEEECCSSCCEEEGGGSCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred CCcCCcccCHHHEEE---cCCCcEEECcCCCceecCCCceeecCCCCCCCcCcCCHhHhccCCCCchhhHHHHHHHHHHH
Confidence 999999999999999 788899999999997654332111 12235679999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++ |..||.+.+..+....+..+...+.+. .++.++.+++.+||+.||.+|||++++++
T Consensus 309 ~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~ 367 (377)
T 3cbl_A 309 FSLGASPYPNLSNQQTREFVEKGGRLPCPE----LCPDAVFRLMEQCWAYEPGQRPSFSTIYQ 367 (377)
T ss_dssp HTTSCCSSTTSCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HhCCCCCCCCCCHHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 98 999999999888888887776665554 67899999999999999999999999975
|
| >1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-43 Score=282.74 Aligned_cols=223 Identities=23% Similarity=0.369 Sum_probs=182.9
Q ss_pred HhhhhHHHHHHHHhcCCCcC------eeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l 79 (241)
...+.+.+|+++++.++|++ ++++++++...+..++|||++ +++|.+++...+ ++++..+..++.|++.||
T Consensus 53 ~~~~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~~l 131 (339)
T 1z57_A 53 RYCEAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHHGHICIVFELL-GLSTYDFIKENGFLPFRLDHIRKMAYQICKSV 131 (339)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred chhHHHHHHHHHHHHhhhcCCCCceeeEeeecccccCCcEEEEEcCC-CCCHHHHHHhcCCCCCcHHHHHHHHHHHHHHH
Confidence 44678899999999997664 999999999999999999999 899999998765 689999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCC----------------CceEEEeecCCccccCCCCccccccCCCCccCccccccc
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDD----------------DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ 143 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~----------------~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~ 143 (241)
.+||++|++|+||||+||+++..+. ++.++|+|||.+...... .....+++.|+|||.+.+.
T Consensus 132 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~ 209 (339)
T 1z57_A 132 NFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH--HSTLVSTRHYRAPEVILAL 209 (339)
T ss_dssp HHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC--CCSSCSCGGGCCHHHHTTS
T ss_pred HHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc--cccccCCccccChHHhhCC
Confidence 9999999999999999999942111 567999999999765433 3345689999999999988
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC----------------------------------
Q 026253 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS---------------------------------- 189 (241)
Q Consensus 144 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------------- 189 (241)
.++.++|+||||+++|+|++|..||...+..+....+.........
T Consensus 210 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (339)
T 1z57_A 210 GWSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRACK 289 (339)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred CCCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhccccccccccccchhhhcCc
Confidence 9999999999999999999999999988876655544322111000
Q ss_pred -----CccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccccc
Q 026253 190 -----QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233 (241)
Q Consensus 190 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~ 233 (241)
.......++++.++|++||+.||.+|||++|+++||||+.....
T Consensus 290 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~ 338 (339)
T 1z57_A 290 PLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDLLKKS 338 (339)
T ss_dssp CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGGGC-
T ss_pred chhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHHHhcc
Confidence 00011235678999999999999999999999999999986543
|
| >1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-43 Score=276.69 Aligned_cols=210 Identities=27% Similarity=0.513 Sum_probs=173.6
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++...+ .+++..+..++.|++.||.+||+.
T Consensus 57 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 135 (281)
T 1mp8_A 57 DSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLESK 135 (281)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCccceEEEEEc-cCccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 455778999999999999999999999985 467899999999999999998654 699999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
|++|+||||+||++ +.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||||+++|++++
T Consensus 136 ~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~ell~ 212 (281)
T 1mp8_A 136 RFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEILM 212 (281)
T ss_dssp TCCCSCCSGGGEEE---EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred CeecccccHHHEEE---CCCCCEEECccccccccCcccccccccCCCcccccChhhcccCCCCCccCchHHHHHHHHHHh
Confidence 99999999999999 5678999999999977644322 223345678999999988889999999999999999996
Q ss_pred -CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 164 -GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 164 -g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|..||.+.+..+....+......+.+ +.+++.+.+++.+||+.||.+|||+.+++++
T Consensus 213 ~g~~pf~~~~~~~~~~~i~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 270 (281)
T 1mp8_A 213 HGVKPFQGVKNNDVIGRIENGERLPMP----PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 270 (281)
T ss_dssp TSCCTTTTCCGGGHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred cCCCCCCcCCHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999998888888888766655444 3789999999999999999999999999864
|
| >4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-43 Score=282.52 Aligned_cols=218 Identities=25% Similarity=0.434 Sum_probs=178.8
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecC--eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh 83 (241)
..+.+.+|++++++++||||+++++++...+ ..++||||+++++|.+++..... +++..+..++.|++.||.+||
T Consensus 50 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L~~LH 129 (319)
T 4euu_A 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129 (319)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCcceEEEEeecCCCceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3567889999999999999999999988654 78999999999999999986533 899999999999999999999
Q ss_pred hCCccccCCCCCCeEEee-cCCCceEEEeecCCccccCCCCccccccCCCCccCccccc--------ccCCCCchhHHHH
Q 026253 84 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--------FQRYDEKVDMWSV 154 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~-~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~--------~~~~~~~~Dv~sl 154 (241)
+.|++|+||||+||++.. .+..+.++|+|||++.............++..|+|||.+. +..++.++|+|||
T Consensus 130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~Diwsl 209 (319)
T 4euu_A 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (319)
T ss_dssp HTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHTSCCCCCCCBCTTHHHHHH
T ss_pred HCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCCceeecccCCCccCHHHhhhccccccccCCCCcHHHHHHH
Confidence 999999999999999732 3456679999999998876665555677899999999875 4678999999999
Q ss_pred HHHHHHHHhCCCCCCCCC----hHHHHHHhhcCCCC--------------------CCCCccCCCCChHHHHHHHHhccc
Q 026253 155 GAILFELLNGYPPFSGRN----NVQLVRNINSCKHL--------------------PFSQLIVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 155 G~~l~~l~~g~~p~~~~~----~~~~~~~i~~~~~~--------------------~~~~~~~~~~~~~~~~li~~~l~~ 210 (241)
|+++|+|++|..||.... ..+....+..+... +........++..+.++|++||+.
T Consensus 210 G~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~ll~~~L~~ 289 (319)
T 4euu_A 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (319)
T ss_dssp HHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCCccccCccCCcccccchhHHHHhHHHHHHhccC
Confidence 999999999999997432 23444444332211 111122234456799999999999
Q ss_pred CccccCCHHHHhcCcc
Q 026253 211 NTVDRLSFNEFYHHRF 226 (241)
Q Consensus 211 ~p~~Rps~~~il~~~~ 226 (241)
||.+|||++|+|+||-
T Consensus 290 dP~~R~s~~ell~h~~ 305 (319)
T 4euu_A 290 DQEKCWGFDQFFAETS 305 (319)
T ss_dssp CTTTSCCHHHHHHHHH
T ss_pred ChhhhccHHHhhhccH
Confidence 9999999999999974
|
| >3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-43 Score=284.47 Aligned_cols=220 Identities=29% Similarity=0.615 Sum_probs=156.7
Q ss_pred HHHHhcCCCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCCcccc
Q 026253 17 LNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHR 90 (241)
Q Consensus 17 ~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~i~H~ 90 (241)
...++.++|+||+++++++.. ++..++||||++|++|.+++...+ .+++..+..++.|++.||.+||++|++|+
T Consensus 73 ~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~~LH~~~ivH~ 152 (336)
T 3fhr_A 73 DHHWQASGGPHIVCILDVYENMHHGKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQFLHSHNIAHR 152 (336)
T ss_dssp HHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHHHHHHTTEECS
T ss_pred HHHHHhcCCCChHHHHHHHhhccCCCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCeecC
Confidence 334566799999999999876 456899999999999999998764 59999999999999999999999999999
Q ss_pred CCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCC
Q 026253 91 DLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170 (241)
Q Consensus 91 dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~ 170 (241)
||||+||+++..+..+.++|+|||++...... ......+++.|+|||.+.+..++.++|+||||+++|+|++|..||.+
T Consensus 153 dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~-~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~~pf~~ 231 (336)
T 3fhr_A 153 DVKPENLLYTSKEKDAVLKLTDFGFAKETTQN-ALQTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGFPPFYS 231 (336)
T ss_dssp CCSGGGEEESCSSTTCCEEECCCTTCEEC-----------------------CHHHHHHHHHHHHHHHHHHHHSSCCC--
T ss_pred CCCHHHEEEEecCCCceEEEeccccceecccc-ccccCCCCcCccChhhhCCCCCCchhhHHHHHHHHHHHHHCCCCCCC
Confidence 99999999965445667999999999765433 23345679999999999888899999999999999999999999987
Q ss_pred CChHHHHHHhh---cCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCCCC
Q 026253 171 RNNVQLVRNIN---SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 237 (241)
Q Consensus 171 ~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~ 237 (241)
........... .......+......++.++.++|++||+.||.+|||++|+++||||++.......|
T Consensus 232 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~~~~ 301 (336)
T 3fhr_A 232 NTGQAISPGMKRRIRLGQYGFPNPEWSEVSEDAKQLIRLLLKTDPTERLTITQFMNHPWINQSMVVPQTP 301 (336)
T ss_dssp -------------------CCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTGGGSCCCB
T ss_pred ccchhhhhhHHHhhhccccccCchhhccCCHHHHHHHHHHCCCChhHCcCHHHHhcCccccccccCCCCc
Confidence 65543321111 11222233334457899999999999999999999999999999999866544443
|
| >1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A | Back alignment and structure |
|---|
Probab=100.00 E-value=8.6e-43 Score=275.54 Aligned_cols=217 Identities=27% Similarity=0.482 Sum_probs=175.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEee-------------cCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-------------ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFL 72 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-------------~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~ 72 (241)
....+.+.+|++++++++||||+++++++.+ .+..++||||+++++|.+++.... .+++..+..++
T Consensus 43 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~ 122 (303)
T 1zy4_A 43 EEKLSTILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLF 122 (303)
T ss_dssp HHHHHHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHH
Confidence 4456789999999999999999999998754 457899999999999999998653 57889999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC---------------CccccccCCCCccCc
Q 026253 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---------------NYAEKVCGSPLYMAP 137 (241)
Q Consensus 73 ~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~---------------~~~~~~~~~~~~~~P 137 (241)
.|++.||.+||++|++|+||+|+||++ +.++.++|+|||.+...... .......++..|+||
T Consensus 123 ~qi~~~l~~LH~~~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aP 199 (303)
T 1zy4_A 123 RQILEALSYIHSQGIIHRDLKPMNIFI---DESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVAT 199 (303)
T ss_dssp HHHHHHHHHHHHTTCCCSCCCGGGEEE---CTTSCEEECCCCCCSCTTC-------------------------CTTSCH
T ss_pred HHHHHHHHHHHhCCeecccCCHHhEEE---cCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCc
Confidence 999999999999999999999999999 78889999999998765422 112344578899999
Q ss_pred cccccc-CCCCchhHHHHHHHHHHHHhCCCCCCC-CChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCcccc
Q 026253 138 EVLQFQ-RYDEKVDMWSVGAILFELLNGYPPFSG-RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 138 E~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
|.+.+. .++.++|+||||+++|+|++ ||.. .+.......+.. ....++.......+..+.+++++||+.||.+|
T Consensus 200 E~~~~~~~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~dp~~R 275 (303)
T 1zy4_A 200 EVLDGTGHYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRS-VSIEFPPDFDDNKMKVEKKIIRLLIDHDPNKR 275 (303)
T ss_dssp HHHTSCSCCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHS-TTCCCCTTCCTTTSHHHHHHHHHHTCSSGGGS
T ss_pred ccccCCCCCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccc-cccccCccccccchHHHHHHHHHHHhcCcccC
Confidence 998764 68999999999999999998 5543 333444455533 33444555556778889999999999999999
Q ss_pred CCHHHHhcCcccccc
Q 026253 216 LSFNEFYHHRFLRRN 230 (241)
Q Consensus 216 ps~~~il~~~~~~~~ 230 (241)
||++++++||||+..
T Consensus 276 ps~~~ll~h~~~~~~ 290 (303)
T 1zy4_A 276 PGARTLLNSGWLPVK 290 (303)
T ss_dssp CCHHHHHHSSCSCCC
T ss_pred cCHHHHhCCCCcCCC
Confidence 999999999999764
|
| >3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-43 Score=282.87 Aligned_cols=221 Identities=27% Similarity=0.371 Sum_probs=180.7
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCe-------EEEEEeccCCCChHHHHH----hcCCCCHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-------IFLVVEFCAGGNLSSYIR----LHGRVPEQTARKFLQQLGA 77 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~-------~~lv~e~~~~~~L~~~l~----~~~~~~~~~~~~~~~~i~~ 77 (241)
......+|++.++.++||||+++++++...+. .++||||+.+ +|.+.+. ....+++..+..++.|++.
T Consensus 62 ~~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~~lv~e~~~~-~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~ 140 (360)
T 3e3p_A 62 FRNRELQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIYLNVVMEYVPD-TLHRCCRNYYRRQVAPPPILIKVFLFQLIR 140 (360)
T ss_dssp CCCHHHHHHHHHHHHCCTTBCCEEEEEEEECSSCTTCEEEEEEEECCSC-BHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred ccHHHHHHHHHHHhcCCCCcccHHHhhhccccccccceeEEEEeecccc-cHHHHHHHHhhcccCCCHHHHHHHHHHHHH
Confidence 34567788888899999999999999866433 8899999975 5554443 4567899999999999999
Q ss_pred HHHHHH--hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccC-CCCchhHHHH
Q 026253 78 GLEILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSV 154 (241)
Q Consensus 78 ~l~~lh--~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~sl 154 (241)
|+.+|| +.|++|+||||+||+++ ..++.++|+|||++.............+++.|+|||.+.+.. ++.++|+|||
T Consensus 141 al~~lH~~~~~ivH~Dlkp~NIll~--~~~~~~kl~Dfg~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl 218 (360)
T 3e3p_A 141 SIGCLHLPSVNVCHRDIKPHNVLVN--EADGTLKLCDFGSAKKLSPSEPNVAYICSRYYRAPELIFGNQHYTTAVDIWSV 218 (360)
T ss_dssp HHHHHTSTTTCCBCSCCCGGGEEEE--TTTTEEEECCCTTCBCCCTTSCCCSTTSCGGGCCHHHHTTCSSCCTHHHHHHH
T ss_pred HHHHHhCCCCCeecCcCCHHHEEEe--CCCCcEEEeeCCCceecCCCCCcccccCCcceeCHHHHcCCCCCCcHHHHHHH
Confidence 999999 99999999999999994 347899999999998877666566677899999999986554 8999999999
Q ss_pred HHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC---------------------------CccCCCCChHHHHHHHHh
Q 026253 155 GAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS---------------------------QLIVPALHPDCVDMCLKL 207 (241)
Q Consensus 155 G~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------~~~~~~~~~~~~~li~~~ 207 (241)
|+++|+|++|..||.+.+.......+......+.. .......+.++.++|.+|
T Consensus 219 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~ 298 (360)
T 3e3p_A 219 GCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLSAL 298 (360)
T ss_dssp HHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCCGGGGCCCCCCHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred HHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhhccccccccCCcccccchhhccccHHHHHHHHHH
Confidence 99999999999999998887777666432111100 001123577899999999
Q ss_pred cccCccccCCHHHHhcCcccccccc
Q 026253 208 LSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 208 l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
|+.||.+|||+.|+++||||++...
T Consensus 299 L~~dP~~Rpt~~e~l~hp~f~~~~~ 323 (360)
T 3e3p_A 299 LQYLPEERMKPYEALCHPYFDELHD 323 (360)
T ss_dssp TCSSGGGSCCHHHHTTSGGGGGGGC
T ss_pred hccCccccCCHHHHhcCccccccCC
Confidence 9999999999999999999998543
|
| >2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-43 Score=285.14 Aligned_cols=211 Identities=22% Similarity=0.438 Sum_probs=175.6
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...+ .+++..+..++.|++.||.+||+
T Consensus 86 ~~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 165 (373)
T 2qol_A 86 TEKQRRDFLGEASIMGQFDHPNIIRLEGVVTKSKPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKYLSD 165 (373)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34567789999999999999999999999999999999999999999999998654 69999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
.|++||||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+
T Consensus 166 ~~ivH~Dlkp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~SlG~il~e 242 (373)
T 2qol_A 166 MGYVHRDLAARNILI---NSNLVCKVSDFGLGRVLEDDPEAAYTTRGGKIPIRWTSPEAIAYRKFTSASDVWSYGIVLWE 242 (373)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCC----------------------CTTSCHHHHHHCCCCHHHHHHHHHHHHHH
T ss_pred CCeeCCCCCcceEEE---cCCCCEEECcCccccccccCCccceeccCCCcCCCccChhhhccCCcCchhcHHHHHHHHHH
Confidence 999999999999999 7888999999999977643321 112234678999999998899999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 161 LLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 161 l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+++ |..||...+..+....+..+...+.+. .++..+.+++.+||+.||.+|||++++++
T Consensus 243 llt~g~~P~~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPs~~~i~~ 302 (373)
T 2qol_A 243 VMSYGERPYWEMSNQDVIKAVDEGYRLPPPM----DCPAALYQLMLDCWQKDRNNRPKFEQIVS 302 (373)
T ss_dssp HHTTC-CTTTTCCHHHHHHHHHTTEECCCCT----TCBHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc----cccHHHHHHHHHHhCcChhhCcCHHHHHH
Confidence 998 999999999888888886665444333 78899999999999999999999999875
|
| >4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-43 Score=285.29 Aligned_cols=216 Identities=29% Similarity=0.484 Sum_probs=178.9
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeE------EEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI------FLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~------~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (241)
+...+.+.+|+.++++++||||+++++++...+.. ++|||++. ++|.+++. ..+++..+..++.|++.||.
T Consensus 82 ~~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~aL~ 158 (371)
T 4exu_A 82 EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--MEFSEEKIQYLVYQMLKGLK 158 (371)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSSTTCCCCEEEEECCC-EEHHHHTT--SCCCHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHHhcCCCCchhhhhheeccCCcccceeEEEEEcccc-ccHHHHhh--cCCCHHHHHHHHHHHHHHHH
Confidence 44567889999999999999999999999876654 99999996 68888764 45999999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF 159 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~ 159 (241)
+||+.|++|+||||+||++ +.++.++|+|||.+...... .....+++.|+|||.+.+ ..++.++|+||||+++|
T Consensus 159 ~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ 233 (371)
T 4exu_A 159 YIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 233 (371)
T ss_dssp HHHHTTCCCSCCCGGGEEE---CTTCCEEECSTTCC----------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred HHHHCCCcCCCcCHHHeEE---CCCCCEEEEecCcccccccC--cCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHH
Confidence 9999999999999999999 78889999999999765433 334567999999999877 67899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCC--------------------------CCccCCCCChHHHHHHHHhcccCcc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPF--------------------------SQLIVPALHPDCVDMCLKLLSANTV 213 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~~~p~ 213 (241)
+|++|..||.+.+..+....+......+. .....+.+++++.++|++||+.||.
T Consensus 234 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~ 313 (371)
T 4exu_A 234 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD 313 (371)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHHSTTSCHHHHHHHHHHSCSCTT
T ss_pred HHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHhccccChHHHHHHHHHCCCChh
Confidence 99999999998887766665533211110 0112346789999999999999999
Q ss_pred ccCCHHHHhcCcccccc
Q 026253 214 DRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 214 ~Rps~~~il~~~~~~~~ 230 (241)
+|||++|+++||||+..
T Consensus 314 ~Rpt~~ell~hp~f~~~ 330 (371)
T 4exu_A 314 KRLTAAQALTHPFFEPF 330 (371)
T ss_dssp TSCCHHHHHTSGGGTTT
T ss_pred hcCCHHHHhcCcccccC
Confidence 99999999999999863
|
| >1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=6.8e-43 Score=278.75 Aligned_cols=211 Identities=23% Similarity=0.370 Sum_probs=184.9
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQLG 76 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i~ 76 (241)
......+.+|++++++++|+||+++++++.+++..++|||++++++|.+++... .++++..+..++.|++
T Consensus 69 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~qi~ 148 (322)
T 1p4o_A 69 MRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEIA 148 (322)
T ss_dssp HHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCEeeeEEEEccCCccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHHHHH
Confidence 345667899999999999999999999999999999999999999999999753 3568999999999999
Q ss_pred HHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHH
Q 026253 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (241)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 153 (241)
.||.+||++|++|+||||+||++ +.++.++|+|||++........ .....+++.|+|||.+.+..++.++|+||
T Consensus 149 ~~l~~lH~~~i~H~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~s 225 (322)
T 1p4o_A 149 DGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWS 225 (322)
T ss_dssp HHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHHH
T ss_pred HHHHHHHHCCCccCCCccceEEE---cCCCeEEECcCccccccccccccccccCCCCCCCccChhhhccCCCCchhhHHH
Confidence 99999999999999999999999 7788999999999876543221 22334578899999998888999999999
Q ss_pred HHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 154 VGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 154 lG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
||+++|+|++ |..||.+.+..+....+........+ ..++..+.+++.+||+.||.+|||+.+++++
T Consensus 226 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~e~l~~ 293 (322)
T 1p4o_A 226 FGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKP----DNCPDMLFELMRMCWQYNPKMRPSFLEIISS 293 (322)
T ss_dssp HHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHhcCCCccccCCHHHHHHHHHcCCcCCCC----CCCCHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 9999999999 89999999988888888766554443 3789999999999999999999999999976
|
| >3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.2e-43 Score=281.31 Aligned_cols=221 Identities=26% Similarity=0.442 Sum_probs=162.1
Q ss_pred HhhhhHHHHHH-HHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELN-FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 8 ~~~~~~~~E~~-~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
.....+.+|+. +++.++||||+++++++.+++..++||||++ ++|.+++.. ...+++..+..++.|++.||.+
T Consensus 62 ~~~~~~~~e~~~~~~~~~h~niv~~~~~~~~~~~~~lv~e~~~-~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~ 140 (327)
T 3aln_A 62 KEQKQLLMDLDVVMRSSDCPYIVQFYGALFREGDCWICMELMS-TSFDKFYKYVYSVLDDVIPEEILGKITLATVKALNH 140 (327)
T ss_dssp HHHHHHHHHHHHHHSSCCCTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHcCCCCcEeeeeeEEEeCCceEEEEeecC-CChHHHHHHHHhhhcccCcHHHHHHHHHHHHHHHHH
Confidence 34455556665 7777899999999999999999999999996 588888764 4679999999999999999999
Q ss_pred HHhC-CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccc----cccCCCCchhHHHHHH
Q 026253 82 LNSH-HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVL----QFQRYDEKVDMWSVGA 156 (241)
Q Consensus 82 lh~~-~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~----~~~~~~~~~Dv~slG~ 156 (241)
||+. |++|+||+|+||++ +.++.++|+|||++.............++..|+|||.+ .+..++.++|+||||+
T Consensus 141 lH~~~~ivH~dlkp~NIll---~~~~~~kl~Dfg~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di~slG~ 217 (327)
T 3aln_A 141 LKENLKIIHRDIKPSNILL---DRSGNIKLCDFGISGQLVDSIAKTRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGI 217 (327)
T ss_dssp HHHHHSCCCSCCCGGGEEE---ETTTEEEECCCSSSCC------------------------------CCSHHHHHHHHH
T ss_pred HhccCCEeECCCCHHHEEE---cCCCCEEEccCCCceecccccccccCCCCccccCceeeccccCcCCCCchhhHHHHHH
Confidence 9998 99999999999999 67889999999999876655444455789999999998 4566899999999999
Q ss_pred HHHHHHhCCCCCCCCCh-HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 157 ILFELLNGYPPFSGRNN-VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
++|+|++|..||.+... .+....+..+....++......++..+.+++++||+.||.+|||++++++||||.....
T Consensus 218 il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~ 294 (327)
T 3aln_A 218 TLYELATGRFPYPKWNSVFDQLTQVVKGDPPQLSNSEEREFSPSFINFVNLCLTKDESKRPKYKELLKHPFILMYEE 294 (327)
T ss_dssp HHHHHHHSCCCSSCC-------CCCCCSCCCCCCCCSSCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHHHHH
T ss_pred HHHHHHHCCCCCCCcchHHHHHHHHhcCCCCCCCCcccccCCHHHHHHHHHHhhCChhhCcCHHHHHhChHHHHhHh
Confidence 99999999999987543 23333333333333444344578999999999999999999999999999999987543
|
| >3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-43 Score=281.65 Aligned_cols=211 Identities=24% Similarity=0.452 Sum_probs=178.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+....+.+.+|++++++++||||+++++++.+++..++||||+++++|.++++. ...+++..+..++.|++.||++||+
T Consensus 47 ~~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~ 126 (310)
T 3s95_A 47 DEETQRTFLKEVKVMRCLEHPNVLKFIGVLYKDKRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMAYLHS 126 (310)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCcCcccEEEEEecCCeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 566788899999999999999999999999999999999999999999999987 4679999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc---------------ccccCCCCccCcccccccCCCCch
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA---------------EKVCGSPLYMAPEVLQFQRYDEKV 149 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~---------------~~~~~~~~~~~PE~~~~~~~~~~~ 149 (241)
.|++|+||||+||++ +.++.++|+|||.+......... ....+++.|+|||.+.+..++.++
T Consensus 127 ~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 203 (310)
T 3s95_A 127 MNIIHRDLNSHNCLV---RENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRSYDEKV 203 (310)
T ss_dssp TTEECSCCSTTSEEE---CTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCCCCTHH
T ss_pred CCccCCCCCcCeEEE---CCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCCCCcHH
Confidence 999999999999999 78889999999999776443221 145689999999999999999999
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCChHH------HHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 150 DMWSVGAILFELLNGYPPFSGRNNVQ------LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 150 Dv~slG~~l~~l~~g~~p~~~~~~~~------~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
||||+|+++|+|++|..||....... ..... .....+.+++.+.+++.+||+.||.+|||++++++
T Consensus 204 Di~slG~~l~el~~g~~~~~~~~~~~~~~~~~~~~~~--------~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~~l~~ 275 (310)
T 3s95_A 204 DVFSFGIVLCEIIGRVNADPDYLPRTMDFGLNVRGFL--------DRYCPPNCPPSFFPITVRCCDLDPEKRPSFVKLEH 275 (310)
T ss_dssp HHHHHHHHHHHHHHTCCSSTTTSCBCTTSSBCHHHHH--------HHTCCTTCCTTHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHhcCCCCCcchhhhHHHHhhhhhccc--------cccCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence 99999999999999999987532211 00111 01123478889999999999999999999999985
Q ss_pred Cccccc
Q 026253 224 HRFLRR 229 (241)
Q Consensus 224 ~~~~~~ 229 (241)
+++.
T Consensus 276 --~L~~ 279 (310)
T 3s95_A 276 --WLET 279 (310)
T ss_dssp --HHHH
T ss_pred --HHHH
Confidence 5544
|
| >2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-43 Score=292.10 Aligned_cols=227 Identities=25% Similarity=0.452 Sum_probs=172.4
Q ss_pred hhhhhHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCC-------CHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRV-------PEQTARKFLQ 73 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~-------~~~~~~~~~~ 73 (241)
+|.+..+..+.+.+|+++++++ +||||+++++++.+++..++|||+++ ++|.+++...... ++..+..++.
T Consensus 44 vK~~~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~lv~E~~~-gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~ 122 (434)
T 2rio_A 44 VKRMLIDFCDIALMEIKLLTESDDHPNVIRYYCSETTDRFLYIALELCN-LNLQDLVESKNVSDENLKLQKEYNPISLLR 122 (434)
T ss_dssp EEEEEGGGHHHHHHHHHHHHHHTTSTTBCCEEEEEECSSEEEEEECCCS-EEHHHHHHTC------------CCHHHHHH
T ss_pred EEEEcHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCeEEEEEecCC-CCHHHHHhccCCCchhhhhccchhHHHHHH
Confidence 4555555566788999999987 89999999999999999999999995 6999999865432 2234567999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeEEeec----------CCCceEEEeecCCccccCCCCc-----cccccCCCCccCcc
Q 026253 74 QLGAGLEILNSHHIIHRDLKPENILLSGL----------DDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPE 138 (241)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nil~~~~----------~~~~~~~l~df~~a~~~~~~~~-----~~~~~~~~~~~~PE 138 (241)
|++.||.+||+.|++||||||+||+++.. +....++|+|||++........ .....+++.|+|||
T Consensus 123 qi~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE 202 (434)
T 2rio_A 123 QIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPE 202 (434)
T ss_dssp HHHHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHH
T ss_pred HHHHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHH
Confidence 99999999999999999999999999532 2345899999999987654321 22356899999999
Q ss_pred cccc-------cCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCC-CCccCCCCChHHHHHHHHhcc
Q 026253 139 VLQF-------QRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPF-SQLIVPALHPDCVDMCLKLLS 209 (241)
Q Consensus 139 ~~~~-------~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~-~~~~~~~~~~~~~~li~~~l~ 209 (241)
.+.+ ..++.++|+|||||++|+|++ |..||......+ ...+......+. .......++.++.++|.+||+
T Consensus 203 ~~~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~ 281 (434)
T 2rio_A 203 LLEESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE-SNIIRGIFSLDEMKCLHDRSLIAEATDLISQMID 281 (434)
T ss_dssp HHSCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH-HHHHHTCCCCCCCTTCCCHHHHHHHHHHHHHHTC
T ss_pred HhccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH-HHHhcCCCCcccccccccccchHHHHHHHHHHhh
Confidence 9865 568999999999999999999 999998665443 222222211111 111112356789999999999
Q ss_pred cCccccCCHHHHhcCcccccc
Q 026253 210 ANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 210 ~~p~~Rps~~~il~~~~~~~~ 230 (241)
.||.+|||+.++++||||...
T Consensus 282 ~dP~~Rps~~eil~hp~f~~~ 302 (434)
T 2rio_A 282 HDPLKRPTAMKVLRHPLFWPK 302 (434)
T ss_dssp SSGGGSCCHHHHHTSGGGSCH
T ss_pred CChhhCCCHHHHHhCCccCCc
Confidence 999999999999999999753
|
| >3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=271.99 Aligned_cols=209 Identities=24% Similarity=0.452 Sum_probs=184.5
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|++++++++||||+++++++.+++..++|||++++++|.+++... ..+++..+..++.|++.||.+||+.|+
T Consensus 46 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~i 125 (267)
T 3t9t_A 46 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 125 (267)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred CHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHHHHHhCCc
Confidence 3467899999999999999999999999999999999999999999999875 468999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+|+||+|+||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||+|+++|+|++ |
T Consensus 126 ~H~dl~p~Nili---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~~g 202 (267)
T 3t9t_A 126 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 202 (267)
T ss_dssp CCSSCCGGGEEE---CGGGCEEECCTTGGGGBCCHHHHSTTSTTCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred ccCCCchheEEE---CCCCCEEEcccccccccccccccccccccccccccChhhhcCCCccchhchhhhHHHHHHHhccC
Confidence 999999999999 778899999999997654321 1223345678999999988889999999999999999999 8
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
..||...+..+....+..+.....+. ..+..+.+++.+||+.||.+|||+++++++
T Consensus 203 ~~p~~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 258 (267)
T 3t9t_A 203 KIPYENRSNSEVVEDISTGFRLYKPR----LASTHVYQIMNHCWRERPEDRPAFSRLLRQ 258 (267)
T ss_dssp CCTTTTCCHHHHHHHHHTTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCcCCCCc----cCcHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 99999999888888887665444333 678999999999999999999999999864
|
| >2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.9e-43 Score=279.75 Aligned_cols=220 Identities=22% Similarity=0.357 Sum_probs=190.6
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-------CCCHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-------RVPEQTARKFLQQLGAG 78 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-------~~~~~~~~~~~~~i~~~ 78 (241)
.......+.+|+.++++++||||+++++++.+++..++||||+++++|.+++.... .+++..+..++.|++.|
T Consensus 73 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi~~a 152 (327)
T 2yfx_A 73 SEQDELDFLMEALIISKFNHQNIVRCIGVSLQSLPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDIACG 152 (327)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHhhCCCCCCCeEEEEEcCCCCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHHHHH
Confidence 34566788999999999999999999999999999999999999999999998753 38999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCCchhHHHHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 155 (241)
|.+||+.|++|+||+|+||+++..+....++|+|||.+....... ......++..|+|||.+.+..++.++|+||||
T Consensus 153 l~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG 232 (327)
T 2yfx_A 153 CQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASYYRKGGCAMLPVKWMPPEAFMEGIFTSKTDTWSFG 232 (327)
T ss_dssp HHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC------CCGGGSCGGGCCHHHHHHCCCCHHHHHHHHH
T ss_pred HHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccccccCCCcCCCcceeCHhHhcCCCCCchhhHHHHH
Confidence 999999999999999999999543456679999999987543222 22334568889999999888899999999999
Q ss_pred HHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 156 AILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 156 ~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
+++|+|++ |..||...+..+....+..+.....+ ..++..+.+++.+||+.||.+|||+++++++.|+..
T Consensus 233 ~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~~ 303 (327)
T 2yfx_A 233 VLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDPP----KNCPGPVYRIMTQCWQHQPEDRPNFAIILERIEYCT 303 (327)
T ss_dssp HHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHH
T ss_pred HHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHhcCChhhCcCHHHHHHHHHHHh
Confidence 99999998 99999999888888888776655444 378899999999999999999999999999988754
|
| >3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-43 Score=280.02 Aligned_cols=210 Identities=24% Similarity=0.384 Sum_probs=182.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|++++++++||||+++++++.+++ .++|++++.+++|.+++... ..+++..+..++.|++.||.+||+.
T Consensus 58 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~-~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 136 (327)
T 3poz_A 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136 (327)
T ss_dssp --CHHHHHHHHHHHHHCCBTTBCCEEEEEESSS-EEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeEEEEEEecCC-eEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 345678999999999999999999999998755 78899999999999999874 5699999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
|++||||||+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++|+||||+++|+++
T Consensus 137 ~ivH~Dikp~NIll---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell 213 (327)
T 3poz_A 137 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213 (327)
T ss_dssp TCCCSCCCGGGEEE---EETTEEEECCTTHHHHHTTTCC-------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CeeCCCCChheEEE---CCCCCEEEccCcceeEccCCcccccccCCCccccccChHHhccCCCCchhhhhhhHHHHHHHH
Confidence 99999999999999 6778899999999987644332 22334577899999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+ |..||.+.+..+....+......+.+. .++.++.+++.+||+.||.+|||+.+++++
T Consensus 214 t~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~~p~~Rps~~ell~~ 272 (327)
T 3poz_A 214 TFGSKPYDGIPASEISSILEKGERLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIE 272 (327)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTTCCCCCCT----TBCHHHHHHHHHHTCSCGGGSCCHHHHHHH
T ss_pred hcCCCCccCCCHHHHHHHHHcCCCCCCCc----cCCHHHHHHHHHHcCCChhhCCCHHHHHHH
Confidence 9 999999988888888777666555443 678899999999999999999999999865
|
| >3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-43 Score=292.46 Aligned_cols=225 Identities=27% Similarity=0.410 Sum_probs=174.8
Q ss_pred hhhhhHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l 79 (241)
+|.+..+..+.+.+|+++++++ +||||+++++++.+++..++|||++. ++|.+++.... ...+..+..++.|++.||
T Consensus 53 vK~~~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~E~~~-g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL 131 (432)
T 3p23_A 53 VKRILPECFSFADREVQLLRESDEHPNVIRYFCTEKDRQFQYIAIELCA-ATLQEYVEQKDFAHLGLEPITLLQQTTSGL 131 (432)
T ss_dssp EEEECTTTEEECHHHHHHHHHSCCCTTBCCEEEEEEETTEEEEEEECCS-EEHHHHHHSSSCCCCSSCHHHHHHHHHHHH
T ss_pred EEEECHHHHHHHHHHHHHHHhccCCCCcCeEEEEEecCCEEEEEEECCC-CCHHHHHHhcCCCccchhHHHHHHHHHHHH
Confidence 4555555666788999999999 89999999999999999999999995 69999997653 355556789999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeec--CCCceEEEeecCCccccCCCC----ccccccCCCCccCccccc---ccCCCCchh
Q 026253 80 EILNSHHIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQ---FQRYDEKVD 150 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~--~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~---~~~~~~~~D 150 (241)
.+||+.|++||||||+||+++.. +....++|+|||++....... ......+|+.|+|||.+. +..++.++|
T Consensus 132 ~~LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~D 211 (432)
T 3p23_A 132 AHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRHSFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVD 211 (432)
T ss_dssp HHHHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC------------CCSCTTSCCGGGTSCC---CCCTHHH
T ss_pred HHHHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCcceeeccccCCCcCccChhhhhcccccCCCcHHH
Confidence 99999999999999999999532 223358899999997765332 233456899999999987 456788999
Q ss_pred HHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 151 MWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 151 v~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
+|||||++|+|++ |..||...........+.......... ....+..+.++|.+||+.||.+|||++++++||||..
T Consensus 212 iwSlG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~ 289 (432)
T 3p23_A 212 IFSAGCVFYYVISEGSHPFGKSLQRQANILLGACSLDCLHP--EKHEDVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS 289 (432)
T ss_dssp HHHHHHHHHHHHTTSCBTTBSTTTHHHHHHTTCCCCTTSCT--TCHHHHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred HHHHHHHHHHHHcCCCCCcchhhHHHHHHHhccCCccccCc--cccccHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence 9999999999999 999997666555443332221111111 1234556899999999999999999999999999975
|
| >1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-42 Score=274.05 Aligned_cols=208 Identities=23% Similarity=0.428 Sum_probs=183.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++ ..+..++|||++++++|.+++...+.+++..+..++.|++.||.+||+.|+
T Consensus 60 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 138 (291)
T 1xbb_A 60 ALKDELLAEANVMQQLDNPYIVRMIGIC-EAESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 138 (291)
T ss_dssp HHHHHHHHHHHHHHTCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEE-CCCCcEEEEEeCCCCCHHHHHHhCcCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3467899999999999999999999999 567789999999999999999988889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+|+||+|+||++ +.++.++|+|||++........ .....++..|.|||.+.+..++.++|+||||+++|+|++
T Consensus 139 ~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~ 215 (291)
T 1xbb_A 139 VHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 215 (291)
T ss_dssp ECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHHT
T ss_pred EcCCCCcceEEE---eCCCcEEEccCCcceeeccCCCcccccccCCCCceeeChHHhccCCCChhhhHHHHHHHHHHHHh
Confidence 999999999999 5678999999999977654332 122335678999999988888999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 -GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 -g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||.+.+..+....+..+.....+ ..++..+.+++++||+.||.+|||+.++++
T Consensus 216 ~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 272 (291)
T 1xbb_A 216 YGQKPYRGMKGSEVTAMLEKGERMGCP----AGCPREMYDLMNLCWTYDVENRPGFAAVEL 272 (291)
T ss_dssp TTCCSSTTCCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred cCCCCCCCCCHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999999988888888776655444 378999999999999999999999999885
|
| >1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=287.97 Aligned_cols=206 Identities=23% Similarity=0.447 Sum_probs=181.3
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecC-eEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
..+.+.+|++++++++||||+++++++...+ ..++||||+++++|.+++...+. +++..+..++.|++.||.+||++
T Consensus 229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~ 308 (450)
T 1k9a_A 229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 308 (450)
T ss_dssp TSHHHHHHHHHHHTCCCTTBCCEEEEEECTTSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhccCCCEEEEEEEEEcCCCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 4678999999999999999999999977654 79999999999999999987654 79999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
|++||||+|+||++ +.++.++|+|||+++...... ....++..|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 309 ~ivHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g 383 (450)
T 1k9a_A 309 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 383 (450)
T ss_dssp TEECSCCCGGGEEE---CTTSCEEECCCTTCEECC--------CCCTTTSCHHHHHSSCCCHHHHHHHHHHHHHHHHTTT
T ss_pred CeeCCCCCHhhEEE---CCCCCEEEeeCCCcccccccc--cCCCCCcceeCHHHhcCCCCCcHHHHHHHHHHHHHHHhCC
Confidence 99999999999999 788899999999997654322 22356788999999998999999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
..||.+.+..+....+..+...+.+. .+++++.+++.+||+.||.+|||+.++++
T Consensus 384 ~~P~~~~~~~~~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~dp~~Rpt~~~l~~ 438 (450)
T 1k9a_A 384 RVPYPRIPLKDVVPRVEKGYKMDAPD----GCPPAVYDVMKNCWHLDAATRPTFLQLRE 438 (450)
T ss_dssp CCSSTTSCTTTHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCC----cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 99999988888888887776655543 78999999999999999999999999874
|
| >1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=277.44 Aligned_cols=211 Identities=22% Similarity=0.415 Sum_probs=180.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
......+.+|++++++++||||+++++++.+.+..++|||++++++|.+++... +.+++..+..++.|++.||.+||+.
T Consensus 87 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 166 (333)
T 1mqb_A 87 EKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLANM 166 (333)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCCcEEEEEecCCCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 455678999999999999999999999999999999999999999999999765 5799999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|++|+||||+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|++
T Consensus 167 ~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 243 (333)
T 1mqb_A 167 NYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEV 243 (333)
T ss_dssp TCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHHH
T ss_pred CeeCCCCChheEEE---CCCCcEEECCCCcchhhccccccccccCCCCccccccCchhcccCCCCchhhhHHHHHHHHHH
Confidence 99999999999999 7888999999999977643321 1223356789999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
++ |..||.+.+..+....+..+...+.+. .++..+.+++++||+.||.+|||+.+++++
T Consensus 244 lt~g~~pf~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~l~~~ 303 (333)
T 1mqb_A 244 MTYGERPYWELSNHEVMKAINDGFRLPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVSI 303 (333)
T ss_dssp HTTSCCTTTTCCHHHHHHHHHTTCCCCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HcCCCCCcccCCHHHHHHHHHCCCcCCCcc----cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 98 999999998888888887765554443 789999999999999999999999998864
|
| >1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=273.19 Aligned_cols=211 Identities=24% Similarity=0.430 Sum_probs=184.9
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|++++++++||||+++++++ ..+..++|||++++++|.+++... ..+++..+..++.|++.||.+||+.
T Consensus 51 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~ 129 (287)
T 1u59_A 51 KADTEEMMREAQIMHQLDNPYIVRLIGVC-QAEALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEK 129 (287)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEE-ESSSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHHhCCCCCEeEEEEEe-cCCCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 45677899999999999999999999999 556799999999999999999654 4699999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|
T Consensus 130 ~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el 206 (287)
T 1u59_A 130 NFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEA 206 (287)
T ss_dssp TEECCCCSGGGEEE---EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHH
T ss_pred CEeeCCCchheEEE---cCCCCEEECcccceeeeccCcceeeccccccccccccCHHHhccCCCCchhhHHHHHHHHHHH
Confidence 99999999999999 5778999999999987654322 1223457889999999888899999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCc
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 225 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 225 (241)
++ |..||.+.+..+....+..+.....+ +.+++++.++|.+||+.||.+|||+.+++++.
T Consensus 207 lt~g~~p~~~~~~~~~~~~i~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~~l 267 (287)
T 1u59_A 207 LSYGQKPYKKMKGPEVMAFIEQGKRMECP----PECPPELYALMSDCWIYKWEDRPDFLTVEQRM 267 (287)
T ss_dssp HTTSCCTTTTCCTHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHHH
T ss_pred HcCCCCCcccCCHHHHHHHHhcCCcCCCC----CCcCHHHHHHHHHHcCCChhhCcCHHHHHHHH
Confidence 98 99999998888888888776655444 37899999999999999999999999999774
|
| >3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.6e-42 Score=270.09 Aligned_cols=211 Identities=28% Similarity=0.454 Sum_probs=173.4
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC--
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH-- 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~-- 86 (241)
..+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++. ..++++..+..++.|++.||.+||++|
T Consensus 49 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~~~-~~~~~~~~~~~i~~~l~~~l~~lH~~~~~ 127 (271)
T 3dtc_A 49 TIENVRQEAKLFAMLKHPNIIALRGVCLKEPNLCLVMEFARGGPLNRVLS-GKRIPPDILVNWAVQIARGMNYLHDEAIV 127 (271)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECCC--CEEEEECCTTEEHHHHHT-SSCCCHHHHHHHHHHHHHHHHHHHHSSSS
T ss_pred HHHHHHHHHHHHHhcCCCCEeeEEEEEecCCceEEEEEcCCCCCHHHHhh-cCCCCHHHHHHHHHHHHHHHHHHHhCCCC
Confidence 35778999999999999999999999999999999999999999999986 567999999999999999999999999
Q ss_pred -ccccCCCCCCeEEeecC-----CCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 87 -IIHRDLKPENILLSGLD-----DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 87 -i~H~dl~~~nil~~~~~-----~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
++|+||||+||+++... .++.++|+|||.+....... .....+++.|+|||.+.+..++.++|+||+|+++|+
T Consensus 128 ~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~~ 206 (271)
T 3dtc_A 128 PIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT-KMSAAGAYAWMAPEVIRASMFSKGSDVWSYGVLLWE 206 (271)
T ss_dssp CCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC--------------CCGGGSCHHHHHHCCCSHHHHHHHHHHHHHH
T ss_pred ceeecCCchHHEEEecccccccccCcceEEccCCccccccccc-ccCCCCccceeCHHHhccCCCCchhhHHHHHHHHHH
Confidence 88999999999994211 26779999999997654433 234568999999999998889999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+++|..||.+.+.......+....... .....+++.+.+++.+||+.||.+|||++|++++
T Consensus 207 l~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~ 267 (271)
T 3dtc_A 207 LLTGEVPFRGIDGLAVAYGVAMNKLAL---PIPSTCPEPFAKLMEDCWNPDPHSRPSFTNILDQ 267 (271)
T ss_dssp HHHCCCTTTTSCHHHHHHHHHTSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhCCCCCCCCCHHHHHHhhhcCCCCC---CCCcccCHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence 999999999988877766664443221 1234789999999999999999999999999864
|
| >3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-43 Score=282.34 Aligned_cols=211 Identities=28% Similarity=0.499 Sum_probs=179.6
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecC-eEEEEEeccCCCChHHHHHhcCC----------------------
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR---------------------- 62 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~---------------------- 62 (241)
....+.+.+|+++++++ +||||+++++++.+.+ ..++||||+++++|.+++.....
T Consensus 66 ~~~~~~~~~E~~~l~~l~~hpniv~~~~~~~~~~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 145 (359)
T 3vhe_A 66 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYVGAI 145 (359)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTEEHHHHHHTTTTSBCSCC----------------
T ss_pred HHHHHHHHHHHHHHHhhcCCcceeeeeeeeecCCCceEEEEEecCCCcHHHHHHhccccccccccccchhhccccccccc
Confidence 44567899999999999 7899999999988754 48999999999999999976533
Q ss_pred --------------------------------------------CCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeE
Q 026253 63 --------------------------------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENIL 98 (241)
Q Consensus 63 --------------------------------------------~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil 98 (241)
+++..+..++.|++.||++||++|++|+||||+||+
T Consensus 146 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~NIl 225 (359)
T 3vhe_A 146 PVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL 225 (359)
T ss_dssp --------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEE
T ss_pred chhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChhhEE
Confidence 889999999999999999999999999999999999
Q ss_pred EeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-CCCCCCCCCh-
Q 026253 99 LSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNN- 173 (241)
Q Consensus 99 ~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~- 173 (241)
+ +.++.++|+|||++....... ......++..|+|||.+.+..++.++||||||+++|+|++ |..||.+...
T Consensus 226 l---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ellt~g~~p~~~~~~~ 302 (359)
T 3vhe_A 226 L---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKID 302 (359)
T ss_dssp E---CGGGCEEECCCGGGSCTTSCTTCEEC--CEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCS
T ss_pred E---cCCCcEEEEeccceeeecccccchhccccCCCceeEChhhhcCCCCCchhhhhhHHHHHHHHHhcCCCCCCccchh
Confidence 9 788899999999997654332 2223456788999999998899999999999999999998 9999987664
Q ss_pred HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 174 VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 174 ~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
......+........+. .+++++.+++.+||+.||.+|||++|+++|
T Consensus 303 ~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~Rps~~ell~~ 349 (359)
T 3vhe_A 303 EEFCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVEH 349 (359)
T ss_dssp HHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence 44455555555444443 688999999999999999999999999976
|
| >2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.8e-42 Score=277.71 Aligned_cols=212 Identities=26% Similarity=0.447 Sum_probs=187.1
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHHH
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQTA 68 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~~ 68 (241)
.....+.+.+|+++++++ +||||+++++++.+++..++||||+++++|.+++.... .+++..+
T Consensus 80 ~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (334)
T 2pvf_A 80 TEKDLSDLVSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTFKDL 159 (334)
T ss_dssp CHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCHHHH
T ss_pred cHHHHHHHHHHHHHHHHhhcCCCEeeEEEEEccCCceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCHHHH
Confidence 345567899999999999 89999999999999999999999999999999998654 3899999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCC
Q 026253 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY 145 (241)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~ 145 (241)
..++.|++.||.+||+.|++|+||||+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..+
T Consensus 160 ~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 236 (334)
T 2pvf_A 160 VSCTYQLARGMEYLASQKCIHRDLAARNVLV---TENNVMKIADFGLARDINNIDYYKKTTNGRLPVKWMAPEALFDRVY 236 (334)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CTTCCEEECCCTTCEECTTTSSEECCSCCCCCGGGCCHHHHHHCEE
T ss_pred HHHHHHHHHHHHHHHhCCeeCCCCccceEEE---cCCCCEEEccccccccccccccccccCCCCcccceeChHHhcCCCc
Confidence 9999999999999999999999999999999 7888999999999977654322 223445778999999988889
Q ss_pred CCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 146 DEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 146 ~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+.++|+||||+++|+|++ |..||.+.+..+....+..+.....+ ..++..+.+++++||+.||.+|||+.+++++
T Consensus 237 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 312 (334)
T 2pvf_A 237 THQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDKP----ANCTNELYMMMRDCWHAVPSQRPTFKQLVED 312 (334)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCCC----ccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 999999999999999999 99999999988888888776655444 3789999999999999999999999999865
|
| >3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=279.00 Aligned_cols=216 Identities=28% Similarity=0.472 Sum_probs=177.9
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCe------EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE 80 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~ 80 (241)
....+.+.+|+.++++++||||+++++++...+. .++|||++. ++|.+++. ..+++..+..++.|++.||.
T Consensus 64 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~lv~e~~~-~~l~~~~~--~~~~~~~~~~i~~qi~~al~ 140 (353)
T 3coi_A 64 EIFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFYDFYLVMPFMQ-TDLQKIMG--LKFSEEKIQYLVYQMLKGLK 140 (353)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSGGGCCCCEEEEECCS-EEGGGTTT--SCCCHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCcccHhheEecccccccceeEEEEecccc-CCHHHHhc--CCCCHHHHHHHHHHHHHHHH
Confidence 4456788999999999999999999999987653 599999996 68888764 35899999999999999999
Q ss_pred HHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHH
Q 026253 81 ILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILF 159 (241)
Q Consensus 81 ~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~ 159 (241)
+||++|++|+||+|+||++ +.++.++|+|||.+...... .....+++.|+|||.+.+ ..++.++|+||||+++|
T Consensus 141 ~LH~~~ivH~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~ 215 (353)
T 3coi_A 141 YIHSAGVVHRDLKPGNLAV---NEDCELKILDFGLARHADAE--MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA 215 (353)
T ss_dssp HHHHTTCCCSSCCGGGEEE---CTTCCEEECSTTCTTC----------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred HHHHCCcccCCCCHHHEeE---CCCCcEEEeecccccCCCCC--ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHH
Confidence 9999999999999999999 78889999999999765432 234567899999999876 67899999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCC--------------------------CCCCccCCCCChHHHHHHHHhcccCcc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHL--------------------------PFSQLIVPALHPDCVDMCLKLLSANTV 213 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~ 213 (241)
+|++|..||.+.+..+.+..+...... .......+.++.++.++|++||+.||.
T Consensus 216 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dp~ 295 (353)
T 3coi_A 216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLFPRASPQAADLLEKMLELDVD 295 (353)
T ss_dssp HHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTTTCTTSCHHHHHHHHHHSCSCTT
T ss_pred HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHHhcCCcCHHHHHHHHHHcCCCcc
Confidence 999999999988876655554321100 001123346789999999999999999
Q ss_pred ccCCHHHHhcCcccccc
Q 026253 214 DRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 214 ~Rps~~~il~~~~~~~~ 230 (241)
+|||++++++||||+..
T Consensus 296 ~Rpt~~e~l~hp~f~~~ 312 (353)
T 3coi_A 296 KRLTAAQALTHPFFEPF 312 (353)
T ss_dssp TSCCHHHHHTSGGGTTT
T ss_pred cCCCHHHHhcCcchhhc
Confidence 99999999999999864
|
| >2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.1e-42 Score=273.65 Aligned_cols=218 Identities=27% Similarity=0.454 Sum_probs=172.4
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC-
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH- 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~- 85 (241)
...+.+.++..+++.++||||+++++++.+++..++||||+ ++.+..+... .+.+++..+..++.|++.||.+||++
T Consensus 66 ~~~~~~~~~~~~~~~~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 144 (318)
T 2dyl_A 66 ENKRILMDLDVVLKSHDCPYIVQCFGTFITNTDVFIAMELM-GTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH 144 (318)
T ss_dssp HHHHHHHHHHHHHHTTTCTTBCCEEEEEECSSEEEEEECCC-SEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhcCCCceeeEEEEEecCCcEEEEEecc-CCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence 34455666667788889999999999999999999999999 6666666654 46799999999999999999999995
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc-----ccCCCCchhHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l~~ 160 (241)
|++|+||+|+||++ +.++.++|+|||.+.............+++.|+|||.+. +..++.++|+||+|+++|+
T Consensus 145 ~i~H~dlkp~Nil~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il~~ 221 (318)
T 2dyl_A 145 GVIHRDVKPSNILL---DERGQIKLCDFGISGRLVDDKAKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVE 221 (318)
T ss_dssp CCCCCCCCGGGEEE---CTTSCEEECCCTTC--------------CCTTCCHHHHC--------CCTHHHHHHHHHHHHH
T ss_pred CEEeCCCCHHHEEE---CCCCCEEEEECCCchhccCCccccccCCCccccChhhcccccccccCCccccchhhHHHHHHH
Confidence 99999999999999 788899999999997765554455567899999999984 4568899999999999999
Q ss_pred HHhCCCCCCC-CChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 161 LLNGYPPFSG-RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 161 l~~g~~p~~~-~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|++|..||.. ....+....+........+. ...++.++.+++.+||+.||.+|||++++++||||++..
T Consensus 222 l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~ 291 (318)
T 2dyl_A 222 LATGQFPYKNCKTDFEVLTKVLQEEPPLLPG--HMGFSGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKRYE 291 (318)
T ss_dssp HHHSSCTTTTCCSHHHHHHHHHHSCCCCCCS--SSCCCHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHHHH
T ss_pred HHhCCCCCCCCCccHHHHHHHhccCCCCCCc--cCCCCHHHHHHHHHHccCChhHCcCHHHHhhCHHHHhcc
Confidence 9999999987 44555666665554433332 236899999999999999999999999999999998743
|
| >3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=275.05 Aligned_cols=219 Identities=25% Similarity=0.464 Sum_probs=176.9
Q ss_pred hHHhhhhHHHHHHHHhcCC--CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+....+.+.+|++++++++ |+||+++++++.+++..++|||+ .+++|.+++...+.+++..+..++.|++.||.+||
T Consensus 66 ~~~~~~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~~~~~lv~e~-~~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH 144 (313)
T 3cek_A 66 DNQTLDSYRNEIAYLNKLQQHSDKIIRLYDYEITDQYIYMVMEC-GNIDLNSWLKKKKSIDPWERKSYWKNMLEAVHTIH 144 (313)
T ss_dssp CHHHHHHHHHHHHHHHHHGGGCTTBCCEEEEEECSSEEEEEECC-CSEEHHHHHHHCSSCCHHHHHHHHHHHHHHHHHHH
T ss_pred cccchHHHHHHHHHHHhccccCCceEEEEEEeecCCEEEEEEec-CCCcHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 4556788999999999996 59999999999999999999995 58899999998889999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccc-----------cCCCCch
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----------QRYDEKV 149 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~-----------~~~~~~~ 149 (241)
+.|++|+||+|+||+++ ++.++|+|||.+........ .....+++.|+|||.+.+ ..++.++
T Consensus 145 ~~~ivH~dlkp~NIl~~----~~~~kL~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~~~ 220 (313)
T 3cek_A 145 QHGIVHSDLKPANFLIV----DGMLKLIDFGIANQMQPDTTSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKS 220 (313)
T ss_dssp HTTCCCCCCCGGGEEEE----TTEEEECCCSSSCC--------------CCGGGCCHHHHTTCC----------CCCHHH
T ss_pred HCCceecCCCcccEEEE----CCeEEEeeccccccccCccccccccCCCCCCCcCCHHHHhhcccccccccccccCCchH
Confidence 99999999999999993 37899999999977644322 234568999999999865 4678899
Q ss_pred hHHHHHHHHHHHHhCCCCCCCCCh-HHHHHHhhcC-CCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 150 DMWSVGAILFELLNGYPPFSGRNN-VQLVRNINSC-KHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 150 Dv~slG~~l~~l~~g~~p~~~~~~-~~~~~~i~~~-~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
|+||||+++|+|++|..||..... ......+... ....++ ...+.++.+++++||+.||.+|||++|+++||||
T Consensus 221 Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~h~~~ 296 (313)
T 3cek_A 221 DVWSLGCILYYMTYGKTPFQQIINQISKLHAIIDPNHEIEFP----DIPEKDLQDVLKCCLKRDPKQRISIPELLAHPYV 296 (313)
T ss_dssp HHHHHHHHHHHHHHSSCTTTTCCSHHHHHHHHHCTTSCCCCC----CCSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHH
T ss_pred HHHHHHHHHHHHHhCCCchhhHHHHHHHHHHHHhcccccCCc----ccchHHHHHHHHHHccCCcccCcCHHHHhcCccc
Confidence 999999999999999999986543 3333333222 222222 3568899999999999999999999999999999
Q ss_pred cccccc
Q 026253 228 RRNSAI 233 (241)
Q Consensus 228 ~~~~~~ 233 (241)
+.....
T Consensus 297 ~~~~~~ 302 (313)
T 3cek_A 297 QIQTHP 302 (313)
T ss_dssp HCC---
T ss_pred cCCCCc
Confidence 986543
|
| >3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=2e-42 Score=271.85 Aligned_cols=209 Identities=25% Similarity=0.420 Sum_probs=184.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+.+|++++++++||||+++++++.+++..++|||++++++|.+++... ..+++..+..++.|++.||.+||+.
T Consensus 51 ~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~~ 130 (288)
T 3kfa_A 51 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 130 (288)
T ss_dssp THHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEccCCCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHHHHHHHC
Confidence 34678899999999999999999999999999999999999999999999874 3489999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 131 ~i~H~dikp~Nil~---~~~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ll~ 207 (288)
T 3kfa_A 131 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 207 (288)
T ss_dssp TCCCSCCSGGGEEE---CGGGCEEECCCCGGGTSCSSSSEEETTEEECGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CccCCCCCcceEEE---cCCCCEEEccCccceeccCCccccccCCccccCcCChhhhccCCCCchhhHHHHHHHHHHHHh
Confidence 99999999999999 7788999999999977654332 223345678999999998899999999999999999999
Q ss_pred -CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 -GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 -g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||.+.+.......+........+ ..+++.+.+++++||+.||.+|||++++++
T Consensus 208 ~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~~~~ 264 (288)
T 3kfa_A 208 YGMSPYPGIDLSQVYELLEKDYRMERP----EGCPEKVYELMRACWQWNPSDRPSFAEIHQ 264 (288)
T ss_dssp TSCCSSTTCCGGGHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHhccCCCCCC----CCCCHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence 99999998888888777666554444 378999999999999999999999999975
|
| >3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=270.46 Aligned_cols=210 Identities=23% Similarity=0.406 Sum_probs=180.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
.+..+.+.+|+.++++++||||+++++++.++ ..++|||++.+++|.+++... ..+++..+..++.|++.||.+||+.
T Consensus 54 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~-~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 132 (281)
T 3cc6_A 54 LDNKEKFMSEAVIMKNLDHPHIVKLIGIIEEE-PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMAYLESI 132 (281)
T ss_dssp HHHHHHHHHHHHHHHHHCCTTBCCEEEEECSS-SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHHhCCCCCcceEEEEEcCC-CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHHHHHHC
Confidence 44678899999999999999999999998754 568999999999999999765 4599999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 133 ~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~llt 209 (281)
T 3cc6_A 133 NCVHRDIAVRNILV---ASPECVKLGDFGLSRYIEDEDYYKASVTRLPIKWMSPESINFRRFTTASDVWMFAVCMWEILS 209 (281)
T ss_dssp TCCCCCCSGGGEEE---EETTEEEECCCCGGGCC---------CCCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred CcccCCCccceEEE---CCCCcEEeCccCCCcccccccccccccCCCCcceeCchhhccCCCCchhccHHHHHHHHHHHh
Confidence 99999999999999 5678999999999976644321 223445778999999988889999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 164 -GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 164 -g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|..||...+.......+......+.+. .+++.+.+++.+||+.||.+|||+++++++
T Consensus 210 ~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~~ 267 (281)
T 3cc6_A 210 FGKQPFFWLENKDVIGVLEKGDRLPKPD----LCPPVLYTLMTRCWDYDPSDRPRFTELVCS 267 (281)
T ss_dssp TTCCTTTTSCGGGHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCcccCChHHHHHHHhcCCCCCCCC----CCCHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence 999999887777777776666555443 688999999999999999999999999864
|
| >3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=274.30 Aligned_cols=211 Identities=24% Similarity=0.398 Sum_probs=172.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~l 82 (241)
+....+.+.+|++++++++||||+++++++.. ....++||||+++++|.+++...+ ++++..+..++.|++.||.+|
T Consensus 51 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~l 130 (295)
T 3ugc_A 51 TEEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYL 130 (295)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECHHHHTSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecCCCCceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHHH
Confidence 44556789999999999999999999998854 466899999999999999998754 499999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC----ccccccCCCCccCcccccccCCCCchhHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 158 (241)
|+.|++|+||||+||++ +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||+|+++
T Consensus 131 H~~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l 207 (295)
T 3ugc_A 131 GTKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEFFKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVL 207 (295)
T ss_dssp HHTTCCCSCCSGGGEEE---EETTEEEECCCCSCC-------------CTTCGGGGCCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred hcCCcccCCCCHhhEEE---cCCCeEEEccCcccccccCCcceeeeccCCCCccceeCcHHhcCCCCChHHHHHHHHHHH
Confidence 99999999999999999 677889999999997764432 12233456679999999988999999999999999
Q ss_pred HHHHhCCCCCCCCChH----------------HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 159 FELLNGYPPFSGRNNV----------------QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~----------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
|+|++|..|+...... .....+......+.+ ..+++++.+++++||+.||.+|||++|++
T Consensus 208 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~el~ 283 (295)
T 3ugc_A 208 YELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----DGCPDEIYMIMTECWNNNVNQRPSFRDLA 283 (295)
T ss_dssp HHHHHTTCTTCSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHSCSSGGGSCCHHHHH
T ss_pred HHHHhcccccCCChHHHHhhhcCccccchhHHHHHHHHhccCcCCCC----cCcCHHHHHHHHHHcCCChhhCCCHHHHH
Confidence 9999999988643221 233334344444433 37899999999999999999999999998
Q ss_pred c
Q 026253 223 H 223 (241)
Q Consensus 223 ~ 223 (241)
+
T Consensus 284 ~ 284 (295)
T 3ugc_A 284 L 284 (295)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-42 Score=271.31 Aligned_cols=211 Identities=21% Similarity=0.409 Sum_probs=173.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++..++..++|||++++++|.+++...+++++..+..++.|++.||.+||+.|+
T Consensus 76 ~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~i~~qi~~~l~~lH~~~i 155 (309)
T 2h34_A 76 VFRTRMQREARTAGRLQEPHVVPIHDFGEIDGQLYVDMRLINGVDLAAMLRRQGPLAPPRAVAIVRQIGSALDAAHAAGA 155 (309)
T ss_dssp HHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCCCEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhhcCCCCeeEEEEEEeeCCeEEEEEEecCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHCcC
Confidence 34578999999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
+|+||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+|++|.
T Consensus 156 ~H~dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~~g~ 232 (309)
T 2h34_A 156 THRDVKPENILV---SADDFAYLVDFGIASATTDEKLTQLGNTVGTLYYMAPERFSESHATYRADIYALTCVLYECLTGS 232 (309)
T ss_dssp CCSCCCGGGEEE---CTTSCEEECSCCC----------------CCGGGCCGGGTCC----CCCHHHHHHHHHHHHHHSS
T ss_pred CcCCCChHHEEE---cCCCCEEEecCccCccccccccccccccCCCcCccCHHHHcCCCCCchHhHHHHHHHHHHHHHCC
Confidence 999999999999 778899999999987654432 223456889999999999888999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-CHHHHhc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-SFNEFYH 223 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~il~ 223 (241)
.||.+.+.......+.... +.+....+.++.++.++|.+||+.||.+|| |++++++
T Consensus 233 ~pf~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~l~~li~~~l~~dP~~Rp~s~~~l~~ 289 (309)
T 2h34_A 233 PPYQGDQLSVMGAHINQAI--PRPSTVRPGIPVAFDAVIARGMAKNPEDRYVTCGDLSA 289 (309)
T ss_dssp CSSCSCHHHHHHHHHHSCC--CCGGGTSTTCCTHHHHHHHHHTCSSGGGSCSSHHHHHH
T ss_pred CCCCCchHHHHHHHhccCC--CCccccCCCCCHHHHHHHHHhccCCHHHHHHhHHHHHH
Confidence 9999877765555553322 223344568899999999999999999999 8888774
|
| >3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-43 Score=286.49 Aligned_cols=220 Identities=13% Similarity=0.073 Sum_probs=161.8
Q ss_pred hHHhhhhHHHHHHHHhcC--CCcCeeeee-------eEEeec-----------------CeEEEEEeccCCCChHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSV--NHPNIIRLF-------DAFQAE-----------------NCIFLVVEFCAGGNLSSYIRL 59 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l--~~~~i~~~~-------~~~~~~-----------------~~~~lv~e~~~~~~L~~~l~~ 59 (241)
.....+.+.+|+.+++.+ +||||++++ +.+... ...++||||++ ++|.+++..
T Consensus 102 ~~~~~~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~ 180 (371)
T 3q60_A 102 SRSELERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAAS-VDLELLFST 180 (371)
T ss_dssp HHHHHHHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCS-EEHHHHHHH
T ss_pred cccHHHHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCC-CCHHHHHHH
Confidence 345577888885555555 699988755 444433 33899999997 899999986
Q ss_pred c-CCCCHHHH------HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCC
Q 026253 60 H-GRVPEQTA------RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132 (241)
Q Consensus 60 ~-~~~~~~~~------~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~ 132 (241)
. ..++.... ..++.|++.||+|||++|++||||||+||++ +.++.++|+|||++....... ....+++
T Consensus 181 ~~~~~~~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll---~~~~~~kL~DFG~a~~~~~~~--~~~~~t~ 255 (371)
T 3q60_A 181 LDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFI---MPDGRLMLGDVSALWKVGTRG--PASSVPV 255 (371)
T ss_dssp HHHSCCCCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---CTTSCEEECCGGGEEETTCEE--EGGGSCG
T ss_pred hccccchhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEE---CCCCCEEEEecceeeecCCCc--cCccCCc
Confidence 4 33444455 6777999999999999999999999999999 788899999999998764322 2445669
Q ss_pred CccCcccccc--cCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHH--HHHh--hcCCCCCCCCccCCCCChHHHHHHHH
Q 026253 133 LYMAPEVLQF--QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL--VRNI--NSCKHLPFSQLIVPALHPDCVDMCLK 206 (241)
Q Consensus 133 ~~~~PE~~~~--~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~--~~~i--~~~~~~~~~~~~~~~~~~~~~~li~~ 206 (241)
.|+|||.+.+ ..++.++|+||||+++|+|++|..||.+...... .... .............+.+++.+.++|.+
T Consensus 256 ~y~aPE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~ 335 (371)
T 3q60_A 256 TYAPREFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLAFGSCTPLPDFVKTLIGR 335 (371)
T ss_dssp GGCCHHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTCTTCCCBCCTTSCCCCSCCCTTSSCCCHHHHHHHHH
T ss_pred CCcChhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCcccccchhhhhhhhccccccchhhccCCCHHHHHHHHH
Confidence 9999999987 6799999999999999999999999987643211 1000 00011111122234789999999999
Q ss_pred hcccCccccCCHHHHhcCccccccc
Q 026253 207 LLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 207 ~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
||+.||.+|||+.++++||||++..
T Consensus 336 ~L~~dP~~Rpt~~e~l~hp~f~~~~ 360 (371)
T 3q60_A 336 FLNFDRRRRLLPLEAMETPEFLQLQ 360 (371)
T ss_dssp HTCSSTTTCCCHHHHTTSHHHHHHH
T ss_pred HcCCChhhCCCHHHHhcCHHHHHHH
Confidence 9999999999999999999998753
|
| >3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-43 Score=278.25 Aligned_cols=208 Identities=24% Similarity=0.402 Sum_probs=180.9
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
....+.+|+.++++++||||+++++++. ++..++||||+.+++|.+++... +.+++..+..++.|++.||.+||+.|+
T Consensus 58 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~-~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~i 136 (325)
T 3kex_A 58 SFQAVTDHMLAIGSLDHAHIVRLLGLCP-GSSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYYLEEHGM 136 (325)
T ss_dssp CBCSCCHHHHHHHTCCCTTBCCEEEEEC-BSSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhcCCCCCcCeEEEEEc-CCccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHHHHhCCC
Confidence 3467889999999999999999999886 46689999999999999999764 578999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
+||||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|++++
T Consensus 137 vH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~~l~el~~~ 213 (325)
T 3kex_A 137 VHRNLAARNVLL---KSPSQVQVADFGVADLLPPDDKQLLYSEAKTPIKWMALESIHFGKYTHQSDVWSYGVTVWELMTF 213 (325)
T ss_dssp CCSCCSSTTEEE---SSSSCEEECSCSGGGGSCCCTTCCC-----CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred CCCccchheEEE---CCCCeEEECCCCcccccCcccccccccCCCCcccccChHHhccCCCChhhHhHHhHHHHHHHHhC
Confidence 999999999999 7888999999999987644322 233456778999999998899999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|..||.+....+....+........+. .++.++.+++.+||+.||.+|||+.+++++
T Consensus 214 g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~li~~~l~~dp~~Rps~~el~~~ 270 (325)
T 3kex_A 214 GAEPYAGLRLAEVPDLLEKGERLAQPQ----ICTIDVYMVMVKCWMIDENIRPTFKELANE 270 (325)
T ss_dssp SCCTTTTSCTTHHHHHHHTTCBCCCCT----TBCTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred CCCCccccCHHHHHHHHHcCCCCCCCC----cCcHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 999999988888888887666555544 578899999999999999999999999876
|
| >1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-42 Score=279.65 Aligned_cols=213 Identities=25% Similarity=0.395 Sum_probs=178.9
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-----------------------
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------- 61 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------- 61 (241)
.....+.+.+|+++++++ +||||+++++++..++..++||||+++++|.+++....
T Consensus 88 ~~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 167 (344)
T 1rjb_A 88 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 167 (344)
T ss_dssp ----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred CHHHHHHHHHHHHHHHhhcCCCCeeeEEEEEeeCCccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccccccc
Confidence 344577899999999999 89999999999999999999999999999999997653
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcc
Q 026253 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPE 138 (241)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE 138 (241)
.+++..+..++.|++.||.+||+.|++|+||||+||++ +.++.++|+|||++........ .....+++.|+|||
T Consensus 168 ~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE 244 (344)
T 1rjb_A 168 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 244 (344)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred cCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEE---cCCCcEEeCCCccCcccccCccceeccCccCccCccCHH
Confidence 27899999999999999999999999999999999999 6788999999999976543321 22344677899999
Q ss_pred cccccCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHHH-HHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC
Q 026253 139 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQL-VRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL 216 (241)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 216 (241)
.+.+..++.++|+||||+++|+|++ |..||.+...... ...+........+ ..+++++.+++.+||+.||.+||
T Consensus 245 ~~~~~~~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rp 320 (344)
T 1rjb_A 245 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQP----FYATEEIYIIMQSCWAFDSRKRP 320 (344)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSC
T ss_pred HhccCCCChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHcCCCchhCc
Confidence 9988889999999999999999998 9999987765443 3444443333333 36799999999999999999999
Q ss_pred CHHHHhcCc
Q 026253 217 SFNEFYHHR 225 (241)
Q Consensus 217 s~~~il~~~ 225 (241)
|+.+++++-
T Consensus 321 s~~~l~~~l 329 (344)
T 1rjb_A 321 SFPNLTSFL 329 (344)
T ss_dssp CHHHHHHHH
T ss_pred CHHHHHHHH
Confidence 999999763
|
| >1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.4e-42 Score=274.40 Aligned_cols=210 Identities=27% Similarity=0.416 Sum_probs=180.1
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC------------------CCCHHHH
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQTA 68 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~~ 68 (241)
...+.+.+|+++++++ +||||+++++++.+++..++||||+++++|.+++.... ++++..+
T Consensus 68 ~~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 147 (313)
T 1t46_A 68 TEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLEDL 147 (313)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHHH
T ss_pred HHHHHHHHHHHHHhhcccCCCeeeEEEEEecCCCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccCCHHHH
Confidence 4568899999999999 99999999999999999999999999999999998654 4899999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCC
Q 026253 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY 145 (241)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~ 145 (241)
..++.|++.||.+||+.|++|+||||+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..+
T Consensus 148 ~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~ 224 (313)
T 1t46_A 148 LSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCVY 224 (313)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHHCCeecCCCccceEEE---cCCCCEEEccccccccccccccceeccCCCCcceeeChHHhcCCCC
Confidence 9999999999999999999999999999999 6788999999999977654332 223345678999999988889
Q ss_pred CCchhHHHHHHHHHHHHh-CCCCCCCCChHH-HHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 146 DEKVDMWSVGAILFELLN-GYPPFSGRNNVQ-LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 146 ~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+.++|+||||+++|+|++ |..||.+..... ....+........+ ..++..+.+++.+||+.||.+|||++++++
T Consensus 225 ~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 300 (313)
T 1t46_A 225 TFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIVQ 300 (313)
T ss_dssp CHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCCCc----ccCCHHHHHHHHHHcCCCchhCcCHHHHHH
Confidence 999999999999999998 999998766543 33444443333222 378899999999999999999999999986
Q ss_pred C
Q 026253 224 H 224 (241)
Q Consensus 224 ~ 224 (241)
+
T Consensus 301 ~ 301 (313)
T 1t46_A 301 L 301 (313)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4e-42 Score=273.31 Aligned_cols=211 Identities=25% Similarity=0.440 Sum_probs=176.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC-----eEEEEEeccCCCChHHHHHh------cCCCCHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRL------HGRVPEQTARKFLQQL 75 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~------~~~~~~~~~~~~~~~i 75 (241)
....+.+.+|++++++++||||+++++++.+.+ ..++||||+++++|.+++.. ...+++..+..++.|+
T Consensus 77 ~~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi 156 (313)
T 3brb_A 77 QREIEEFLSEAACMKDFSHPNVIRLLGVCIEMSSQGIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDI 156 (313)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEEEC-------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCCeeeeeEEEeeccccCCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHH
Confidence 455678999999999999999999999987654 35999999999999999943 3469999999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCCchhHH
Q 026253 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (241)
Q Consensus 76 ~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~ 152 (241)
+.||.+||+.|++|+||||+||++ +.++.++|+|||.+....... ......+++.|+|||.+.+..++.++|+|
T Consensus 157 ~~aL~~LH~~~ivH~dikp~NIli---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 233 (313)
T 3brb_A 157 ALGMEYLSNRNFLHRDLAARNCML---RDDMTVCVADFGLSKKIYSGDYYRQGRIAKMPVKWIAIESLADRVYTSKSDVW 233 (313)
T ss_dssp HHHHHHHHTTTCCCCCCSGGGEEE---CTTSCEEECSCSCC----------------CCGGGSCHHHHHSSCCCHHHHHH
T ss_pred HHHHHHHHhCCcccCCCCcceEEE---cCCCcEEEeecCcceecccccccCcccccCCCccccCchhhcCCCccchhhhH
Confidence 999999999999999999999999 788899999999997654332 12234467789999999988899999999
Q ss_pred HHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 153 SVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 153 slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|||+++|+|++ |..||.+.+..+....+..+.....+ ..+++.+.+++.+||+.||.+|||+++++++
T Consensus 234 slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 302 (313)
T 3brb_A 234 AFGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLKQP----EDCLDELYEIMYSCWRTDPLDRPTFSVLRLQ 302 (313)
T ss_dssp HHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCCB----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCCCC----ccccHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 99999999999 99999998888888877666655444 3788999999999999999999999999864
|
| >4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-42 Score=272.07 Aligned_cols=210 Identities=19% Similarity=0.335 Sum_probs=174.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC-CCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR-VPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~-~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++...+. +++..+..++.|++.||.+||+
T Consensus 52 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~LH~ 131 (289)
T 4fvq_A 52 HRNYSESFFEAASMMSKLSHKHLVLNYGVCVCGDENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMHFLEE 131 (289)
T ss_dssp GGGGHHHHHHHHHHHHTSCCTTBCCEEEEECCTTCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHHHHhCCCCCEeEEEEEEEeCCCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 445567899999999999999999999999999999999999999999999987654 9999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCC-----CceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDD-----DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~-----~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l 158 (241)
+|++|+||||+||+++.... .+.++|+|||.+...... ....++..|+|||.+.+ ..++.++|+||+|+++
T Consensus 132 ~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~---~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il 208 (289)
T 4fvq_A 132 NTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK---DILQERIPWVPPECIENPKNLNLATDKWSFGTTL 208 (289)
T ss_dssp TTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH---HHHHHTTTTSCHHHHHCGGGCCHHHHHHHHHHHH
T ss_pred CCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc---cccCCcCcccCHHHhCCCCCCCchhHHHHHHHHH
Confidence 99999999999999953211 112999999998655332 23456888999999987 6789999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 159 FELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 159 ~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|+|++ +.+||...+............. . ....+.++.+++++||+.||.+|||+++++++
T Consensus 209 ~el~~g~~~~~~~~~~~~~~~~~~~~~~--~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~~ 269 (289)
T 4fvq_A 209 WEICSGGDKPLSALDSQRKLQFYEDRHQ--L----PAPKAAELANLINNCMDYEPDHRPSFRAIIRD 269 (289)
T ss_dssp HHHHTTTCCTTTTSCHHHHHHHHHTTCC--C----CCCSSCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHcCCCCCccccchHHHHHHhhccCC--C----CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999 5566666666555554433222 2 23568899999999999999999999999975
|
| >3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-42 Score=269.68 Aligned_cols=214 Identities=25% Similarity=0.410 Sum_probs=170.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+.+.+|++++++++|+||++++++. ..+..++||||+++++|.+++... ..+++..+..++.|++.||.+||+
T Consensus 60 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~lH~ 138 (289)
T 3og7_A 60 TPQQLQAFKNEVGVLRKTRHVNILLFMGYS-TAPQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDYLHA 138 (289)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEE-CSSSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCcEEEEEeec-cCCccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 455678899999999999999999999954 556789999999999999999644 569999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC---CccccccCCCCccCccccc---ccCCCCchhHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG---NYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~---~~~~~~~~~~~~~~PE~~~---~~~~~~~~Dv~slG~~l 158 (241)
.|++|+||||+||++ +.++.++|+|||.+...... .......++..|+|||.+. +..++.++|+||||+++
T Consensus 139 ~~i~H~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~il 215 (289)
T 3og7_A 139 KSIIHRDLKSNNIFL---HEDNTVKIGDFGLATEKSRWSGSHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVL 215 (289)
T ss_dssp TTCCCSCCCGGGEEE---ETTTEEEECCCC------------------CCCTTCCHHHHC----CCSCHHHHHHHHHHHH
T ss_pred CCcccccCccceEEE---CCCCCEEEccceeccccccccccccccccCCCccccCchhhcccCCCCCCcccchHHHHHHH
Confidence 999999999999999 67789999999998765431 2223456899999999986 56688899999999999
Q ss_pred HHHHhCCCCCCCCChHH-HHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 159 FELLNGYPPFSGRNNVQ-LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|+|++|..||.+....+ ....+......+........+++.+.+++.+||+.||.+|||++++++
T Consensus 216 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rps~~ell~ 281 (289)
T 3og7_A 216 YELMTGQLPYSNINNRDQIIEMVGRGSLSPDLSKVRSNCPKRMKRLMAECLKKKRDERPSFPRILA 281 (289)
T ss_dssp HHHHHSSCTTSSCCCHHHHHHHHHHTSCCCCTTSSCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHCCCCccccchHHHHHHHhcccccCcchhhccccCCHHHHHHHHHHccCChhhCCCHHHHHH
Confidence 99999999998765544 444444444444344455678999999999999999999999999985
|
| >1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=286.66 Aligned_cols=207 Identities=24% Similarity=0.492 Sum_probs=182.9
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|++++++++||||+++++++. ++..++||||+.+++|.+++... ..++...+..++.|++.||.|||++|
T Consensus 226 ~~~~~~~E~~~l~~l~h~~iv~l~~~~~-~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~~LH~~~ 304 (454)
T 1qcf_A 226 SVEAFLAEANVMKTLQHDKLVKLHAVVT-KEPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGMAFIEQRN 304 (454)
T ss_dssp CHHHHHHHHHHHTTCCCTTBCCEEEEEC-SSSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHhhCCCCCEeeEEEEEe-CCccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4678999999999999999999999986 56789999999999999999754 36889999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
++||||||+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 305 ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwslG~~l~el~t~ 381 (454)
T 1qcf_A 305 YIHRDLRAANILV---SASLVCKIADFGLARVIEDNEYTAREGAKFPIKWTAPEAINFGSFTIKSDVWSFGILLMEIVTY 381 (454)
T ss_dssp CCCSSCSGGGEEE---CTTCCEEECSTTGGGGBCCHHHHTTCSSSSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred ccCCCCCHHHEEE---CCCCcEEEeeCCCceEcCCCceeccCCCcccccccCHHHhccCCCCcHHHHHhHHHHHHHHHhC
Confidence 9999999999999 7888999999999987643221 122335678999999988889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||.+.+..+....+..+...+.+. .+++++.+++.+||+.||.+|||++++++
T Consensus 382 g~~P~~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~dp~~RPt~~~i~~ 437 (454)
T 1qcf_A 382 GRIPYPGMSNPEVIRALERGYRMPRPE----NCPEELYNIMMRCWKNRPEERPTFEYIQS 437 (454)
T ss_dssp SCCSSTTCCHHHHHHHHHHTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHccCChhHCcCHHHHHH
Confidence 999999999999988888776665543 78999999999999999999999999874
|
| >1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5e-42 Score=288.30 Aligned_cols=208 Identities=25% Similarity=0.424 Sum_probs=184.3
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|++++++++||||+++++++..++..++||||+++++|.+++... ..+++..+..++.|++.||.|||++|
T Consensus 259 ~~~~~~~E~~~l~~l~hpniv~l~~~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L~~LH~~~ 338 (495)
T 1opk_A 259 EVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKKN 338 (495)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHhcCCCCEeeEEEEEecCCcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 4677999999999999999999999999999999999999999999999864 35899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
++||||||.||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 339 ivHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlG~~l~el~t~ 415 (495)
T 1opk_A 339 FIHRNLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATY 415 (495)
T ss_dssp EECSCCSGGGEEE---CGGGCEEECCTTCEECCTTCCEECCTTCCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred cccCCCChhhEEE---CCCCcEEEeecccceeccCCceeecCCCcCCcceeCHhHHhcCCCCcHHhHHhHHHHHHHHHhC
Confidence 9999999999999 7888999999999987644322 122334678999999988889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||.+.+..+..+.+........+. .++..+.+++.+||+.||.+|||+.++++
T Consensus 416 g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPs~~el~~ 471 (495)
T 1opk_A 416 GMSPYPGIDLSQVYELLEKDYRMERPE----GCPEKVYELMRACWQWNPSDRPSFAEIHQ 471 (495)
T ss_dssp SCCSSTTCCGGGHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCcChhHCcCHHHHHH
Confidence 999999988888888887666555443 78999999999999999999999999975
|
| >2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3e-42 Score=278.23 Aligned_cols=221 Identities=23% Similarity=0.378 Sum_probs=180.8
Q ss_pred HhhhhHHHHHHHHhcCCCcC------eeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPN------IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~------i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l 79 (241)
...+.+.+|+.++++++|++ ++.+++++...+..++|||++ ++++.+++.... ++++..+..++.|++.||
T Consensus 58 ~~~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~l~~~~~~~~~~~~~~~i~~qi~~~L 136 (355)
T 2eu9_A 58 KYREAARLEINVLKKIKEKDKENKFLCVLMSDWFNFHGHMCIAFELL-GKNTFEFLKENNFQPYPLPHVRHMAYQLCHAL 136 (355)
T ss_dssp HHHHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred cchhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeCCeEEEEEecc-CCChHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence 45678899999999997666 899999999999999999999 677877776653 699999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeec----------------CCCceEEEeecCCccccCCCCccccccCCCCccCccccccc
Q 026253 80 EILNSHHIIHRDLKPENILLSGL----------------DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ 143 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~----------------~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~ 143 (241)
.+||++|++|+||||+||++... +..+.++|+|||.+...... .....+++.|+|||.+.+.
T Consensus 137 ~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~ 214 (355)
T 2eu9_A 137 RFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHEH--HTTIVATRHYRPPEVILEL 214 (355)
T ss_dssp HHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTSC--CCSSCSCGGGCCHHHHTTC
T ss_pred HHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCcccccccc--ccCCcCCCcccCCeeeecC
Confidence 99999999999999999999422 25678999999999765433 2345689999999999988
Q ss_pred CCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCC----------------------------------
Q 026253 144 RYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS---------------------------------- 189 (241)
Q Consensus 144 ~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~---------------------------------- 189 (241)
.++.++|+||||+++|+|++|..||.+.+..+....+.........
T Consensus 215 ~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 294 (355)
T 2eu9_A 215 GWAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKENCK 294 (355)
T ss_dssp CCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTSHHHHHHHHHCC
T ss_pred CCCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhcccccccccccchhccccccCC
Confidence 9999999999999999999999999988776655444332111000
Q ss_pred -----CccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 190 -----QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 190 -----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
.......+.++.++|++||+.||.+|||++|+++||||++..
T Consensus 295 ~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~ 341 (355)
T 2eu9_A 295 PLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGLT 341 (355)
T ss_dssp CGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGCC
T ss_pred cccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCCC
Confidence 000011245788999999999999999999999999999854
|
| >2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-42 Score=276.84 Aligned_cols=210 Identities=18% Similarity=0.244 Sum_probs=176.3
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|+++++++ +|+||+++++++..++..++|||++ +++|.+++... +.+++..+..++.|++.||.+||+.|
T Consensus 47 ~~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ 125 (330)
T 2izr_A 47 RAPQLHLEYRFYKQLGSGDGIPQVYYFGPCGKYNAMVLELL-GPSLEDLFDLCDRTFSLKTVLMIAIQLISRMEYVHSKN 125 (330)
T ss_dssp SSCCHHHHHHHHHHHCSCTTSCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chHHHHHHHHHHHHhhCCCCCCEEEEEEecCCccEEEEEeC-CCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 356789999999999 9999999999999999999999999 99999999874 67999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCce-----EEEeecCCccccCCCCc--------cccccCCCCccCcccccccCCCCchhHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVM-----LKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~-----~~l~df~~a~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 153 (241)
++||||||+||++ +.++. ++|+|||++........ .....+|+.|+|||.+.+..++.++|+||
T Consensus 126 iiHrDlkp~Nill---~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~s 202 (330)
T 2izr_A 126 LIYRDVKPENFLI---GRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKEQSRRDDLEA 202 (330)
T ss_dssp EECCCCCGGGEEE---CCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHH
T ss_pred eeccCCCHHHeee---ccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCCCCchhHHHH
Confidence 9999999999999 55555 99999999987543322 23567899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCC---hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 154 VGAILFELLNGYPPFSGRN---NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
||+++|+|++|..||.+.+ ..+.+..+................+ ++.+++..||+.||.+||+++++++
T Consensus 203 lG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~p-~~~~li~~~l~~~p~~RP~~~~l~~ 274 (330)
T 2izr_A 203 LGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRATPIEVLCENFP-EMATYLRYVRRLDFFEKPDYDYLRK 274 (330)
T ss_dssp HHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHSCHHHHTTTCH-HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccCCHHHHhccCh-HHHHHHHHHHhCCCCCCCCHHHHHH
Confidence 9999999999999998743 3344444433222222222223455 9999999999999999999998875
|
| >4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.5e-42 Score=295.71 Aligned_cols=208 Identities=24% Similarity=0.433 Sum_probs=182.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++.. +..++||||+++++|.+++...+.+++..+..++.|++.||.|||++|+
T Consensus 412 ~~~~~~~~E~~il~~l~hpnIv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~~L~yLH~~~i 490 (635)
T 4fl3_A 412 ALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESNF 490 (635)
T ss_dssp GGHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEec-CCEEEEEEccCCCCHHHHHhhCCCCCHHHHHHHHHHHHHHHHHHHHCCE
Confidence 346789999999999999999999999865 5588999999999999999988889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+||||||+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 491 iHrDLkp~NILl---~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~sDvwSlGv~l~ellt 567 (635)
T 4fl3_A 491 VHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFS 567 (635)
T ss_dssp CCSCCSGGGEEE---EETTEEEECCTTHHHHTTC-------------CGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred eCCCCChHhEEE---eCCCCEEEEEcCCccccccCccccccccCCCCceeeeChhhhcCCCCCcHHHHHHHHHHHHHHHh
Confidence 999999999999 5778999999999987644321 222345678999999998899999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 -GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 -g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||.+.+..+....+..+.....+. .++.++.++|.+||+.||.+|||++++++
T Consensus 568 ~G~~Pf~~~~~~~~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~RPs~~~l~~ 624 (635)
T 4fl3_A 568 YGQKPYRGMKGSEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVEL 624 (635)
T ss_dssp TTCCSSTTCCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 999999999999999888777666554 78999999999999999999999999874
|
| >1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-42 Score=271.49 Aligned_cols=216 Identities=17% Similarity=0.205 Sum_probs=179.8
Q ss_pred HhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+.+|+++++++ +|++++++++++.++...++|||++ +++|.+++...+ ++++..+..++.|++.||.+||+.
T Consensus 47 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~lH~~ 125 (298)
T 1csn_A 47 SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 125 (298)
T ss_dssp TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred CccHHHHHHHHHHHHHhcCCCCCeEEeecCCCceeEEEEEec-CCCHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 3456789999999999 8999999999999999999999999 999999998754 599999999999999999999999
Q ss_pred CccccCCCCCCeEEeec--CCCceEEEeecCCccccCCCCc--------cccccCCCCccCcccccccCCCCchhHHHHH
Q 026253 86 HIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~--~~~~~~~l~df~~a~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 155 (241)
|++|+||||+||+++.. .....++|+|||.+........ .....+++.|+|||.+.+..++.++|+||||
T Consensus 126 ~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG 205 (298)
T 1csn_A 126 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 205 (298)
T ss_dssp TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCCCChHHHHHHHH
Confidence 99999999999999421 1223499999999987654322 2345689999999999998999999999999
Q ss_pred HHHHHHHhCCCCCCCC---ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 156 AILFELLNGYPPFSGR---NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 156 ~~l~~l~~g~~p~~~~---~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+++|+|++|..||.+. +..+....+.............+.+++++.+++.+||+.||.+|||++++++.
T Consensus 206 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~RP~~~~l~~~ 277 (298)
T 1csn_A 206 HVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGL 277 (298)
T ss_dssp HHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHH
T ss_pred HHHHHHHcCCCCcchhhccccHHHHHHHHhhccCccHHHHHhhCcHHHHHHHHHHhcCCcccCCCHHHHHHH
Confidence 9999999999999874 34444444433332222333445789999999999999999999999998753
|
| >1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=284.85 Aligned_cols=217 Identities=28% Similarity=0.379 Sum_probs=172.1
Q ss_pred HHhhhhHHHHHHHHhcCC--------CcCeeeeeeEEe----ecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVN--------HPNIIRLFDAFQ----AENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~--------~~~i~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~ 72 (241)
....+.+.+|++++++++ |+||+++++++. .+...++|||++ ++++.+++... ..+++..+..++
T Consensus 74 ~~~~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~~~~~~~~~~~~~~~i~ 152 (397)
T 1wak_A 74 EHYTETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHICMVFEVL-GHHLLKWIIKSNYQGLPLPCVKKII 152 (397)
T ss_dssp HHHHHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEETTEEEEEEEECCC-CCBHHHHHHHTTTSCCCHHHHHHHH
T ss_pred CcchHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCCCCceEEEEEecc-CccHHHHHHhcccCCCCHHHHHHHH
Confidence 345678899999999995 788999999987 456899999999 66777776554 469999999999
Q ss_pred HHHHHHHHHHHhC-CccccCCCCCCeEEeecCCCc---------------------------------------------
Q 026253 73 QQLGAGLEILNSH-HIIHRDLKPENILLSGLDDDV--------------------------------------------- 106 (241)
Q Consensus 73 ~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~~~~~--------------------------------------------- 106 (241)
.|++.||.+||++ |++||||||+||+++ .++
T Consensus 153 ~qi~~aL~~lH~~~givHrDikp~NIll~---~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 229 (397)
T 1wak_A 153 QQVLQGLDYLHTKCRIIHTDIKPENILLS---VNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKN 229 (397)
T ss_dssp HHHHHHHHHHHHTTCEECCCCSGGGEEEC---CCHHHHHHHHHHHC---------------------CCTTSCCTTSGGG
T ss_pred HHHHHHHHHHHHhCCEecCCCCHHHeeEe---ccchhhhhhhhhhHHHhhcCCCCCCCCccccCCccccccccccccccc
Confidence 9999999999998 999999999999994 333
Q ss_pred ----eEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCCh------HHH
Q 026253 107 ----MLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN------VQL 176 (241)
Q Consensus 107 ----~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~ 176 (241)
.++|+|||.+...... .....+|..|+|||.+.+..++.++||||||+++|+|++|..||.+.+. ...
T Consensus 230 ~~~~~~kl~DfG~a~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~~~~ 307 (397)
T 1wak_A 230 AEKLKVKIADLGNACWVHKH--FTEDIQTRQYRSLEVLIGSGYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDH 307 (397)
T ss_dssp GGGCCEEECCGGGCEETTBC--SCSCCSCGGGCCHHHHHTSCCCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHHHHH
T ss_pred ccccceEecccccccccccc--CccCCCCCcccCChhhcCCCCCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCchHHH
Confidence 7999999999776533 3345689999999999988899999999999999999999999986542 222
Q ss_pred HHHhhcCCCCC-----------------------CCC--------------ccCCCCChHHHHHHHHhcccCccccCCHH
Q 026253 177 VRNINSCKHLP-----------------------FSQ--------------LIVPALHPDCVDMCLKLLSANTVDRLSFN 219 (241)
Q Consensus 177 ~~~i~~~~~~~-----------------------~~~--------------~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 219 (241)
...+....... ... ......+..+.++|.+||+.||.+|||++
T Consensus 308 ~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ 387 (397)
T 1wak_A 308 IALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRATAA 387 (397)
T ss_dssp HHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSCCHH
T ss_pred HHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcCCHH
Confidence 22221100000 000 00112345788999999999999999999
Q ss_pred HHhcCccccc
Q 026253 220 EFYHHRFLRR 229 (241)
Q Consensus 220 ~il~~~~~~~ 229 (241)
|+|+||||++
T Consensus 388 e~l~hp~~~~ 397 (397)
T 1wak_A 388 ECLRHPWLNS 397 (397)
T ss_dssp HHHTSGGGGC
T ss_pred HHhhCccccC
Confidence 9999999974
|
| >3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-42 Score=274.60 Aligned_cols=209 Identities=24% Similarity=0.379 Sum_probs=177.4
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|+.++++++||||+++++++..++ .++|++++.+++|.+++... ..+++..+..++.|++.||.+||+.
T Consensus 58 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~-~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~~ 136 (327)
T 3lzb_A 58 PKANKEILDEAYVMASVDNPHVCRLLGICLTST-VQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLEDR 136 (327)
T ss_dssp CCCHHHHHHHHHHHTTCCBTTBCCCCEEEESSS-EEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeEEEEEEecCC-ceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHhhC
Confidence 345678999999999999999999999998765 78899999999999999864 5699999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
|++|+||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 137 ~ivH~Dikp~NIl~---~~~~~~kL~DfG~a~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~Di~slG~il~ell 213 (327)
T 3lzb_A 137 RLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWELM 213 (327)
T ss_dssp TCCCSCCCGGGEEE---EETTEEEECCTTC----------------CCCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCcCCCCCHHHEEE---cCCCCEEEccCcceeEccCccccccccCCCccccccCHHHHcCCCCChHHHHHHHHHHHHHHH
Confidence 99999999999999 5778899999999977644322 22334567899999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+ |..||.+.+..+....+......+.+. .++.++.+++++||+.||.+|||++|+++
T Consensus 214 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~dp~~Rps~~ell~ 271 (327)
T 3lzb_A 214 TFGSKPYDGIPASEISSILEKGERLPQPP----ICTIDVYMIMRKCWMIDADSRPKFRELII 271 (327)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTTCCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9 999999988888888887666555443 68899999999999999999999999985
|
| >3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-41 Score=265.04 Aligned_cols=208 Identities=21% Similarity=0.351 Sum_probs=178.1
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~ 81 (241)
.....+.+.+|+.++++++||||+++++++.+. +..++||||+++++|.+++.... .+++..+..++.|++.||.+
T Consensus 47 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~ 126 (271)
T 3kmu_A 47 STRKSRDFNEECPRLRIFSHPNVLPVLGACQSPPAPHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMAF 126 (271)
T ss_dssp CHHHHHHHHHHGGGGCCCSCTTEECEEEEECTTTSSSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCchhheEEEEccCCCCCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHHH
Confidence 345667899999999999999999999999876 78899999999999999998765 48999999999999999999
Q ss_pred HHhCC--ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCC---chhHHHHHH
Q 026253 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDE---KVDMWSVGA 156 (241)
Q Consensus 82 lh~~~--i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~---~~Dv~slG~ 156 (241)
||+.| ++|+||+|+||++ +.++.++++||+++.... .....+++.|+|||.+.+..++. ++|+||||+
T Consensus 127 lH~~~~~i~H~dikp~Nil~---~~~~~~~l~~~~~~~~~~----~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~slG~ 199 (271)
T 3kmu_A 127 LHTLEPLIPRHALNSRSVMI---DEDMTARISMADVKFSFQ----SPGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAV 199 (271)
T ss_dssp HTTSSSCCTTCCCSGGGEEE---CTTSCEEEEGGGSCCTTS----CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHHHHH
T ss_pred HhcCCCceecCCCccceEEE---cCCcceeEEeccceeeec----ccCccCCccccChhhhccCCCCCCCchhhHHHHHH
Confidence 99999 9999999999999 788889999888765432 22346789999999998665444 799999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 157 ILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++|+|++|..||.+.+..+....+......+ .....++.++.+++.+||+.||.+|||++++++
T Consensus 200 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 263 (271)
T 3kmu_A 200 LLWELVTREVPFADLSNMEIGMKVALEGLRP---TIPPGISPHVSKLMKICMNEDPAKRPKFDMIVP 263 (271)
T ss_dssp HHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHhCCCCccccChHHHHHHHHhcCCCC---CCCCCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999999999999888877766654443222 223478999999999999999999999999985
|
| >2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.5e-42 Score=279.25 Aligned_cols=219 Identities=34% Similarity=0.480 Sum_probs=179.0
Q ss_pred HhhhhHHHHHHHHhcCC-Cc-----CeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVN-HP-----NIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-~~-----~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l 79 (241)
...+.+.+|+++++.++ |+ +|+++++++...+..++|||++. ++|.+++... +.+++..+..++.|++.||
T Consensus 92 ~~~~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~~~~~lv~e~~~-~~L~~~l~~~~~~~~~~~~~~~i~~qi~~al 170 (382)
T 2vx3_A 92 AFLNQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFRNHLCLVFEMLS-YNLYDLLRNTNFRGVSLNLTRKFAQQMCTAL 170 (382)
T ss_dssp HHHHHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEETTEEEEEEECCC-CBHHHHHHHTTTSCCCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHHHhcccccceeEEEeeeeeccCCceEEEEecCC-CCHHHHHhhcCcCCCCHHHHHHHHHHHHHHH
Confidence 34577888999999884 55 49999999999999999999995 5999999865 4589999999999999999
Q ss_pred HHHH--hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHH
Q 026253 80 EILN--SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (241)
Q Consensus 80 ~~lh--~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~ 157 (241)
.+|| +.|++||||||+||+++. +..+.++|+|||+++..... .....+++.|+|||.+.+..++.++|+||||++
T Consensus 171 ~~lH~~~~~ivHrDlkp~NIll~~-~~~~~~kL~DFG~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~i 247 (382)
T 2vx3_A 171 LFLATPELSIIHCDLKPENILLCN-PKRSAIKIVDFGSSCQLGQR--IYQYIQSRFYRSPEVLLGMPYDLAIDMWSLGCI 247 (382)
T ss_dssp HHHTSTTTCEECCCCSGGGEEESS-TTSCCEEECCCTTCEETTCC--CCSSCSCGGGCCHHHHTTCCCCTHHHHHHHHHH
T ss_pred HHhccCCCCEEcCCCCcccEEEec-CCCCcEEEEeccCceecccc--cccccCCccccChHHHcCCCCCcHHHHHHHHHH
Confidence 9999 579999999999999942 23667999999999876543 334568999999999999899999999999999
Q ss_pred HHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCc------------------------------c-CC------------
Q 026253 158 LFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQL------------------------------I-VP------------ 194 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~------------------------------~-~~------------ 194 (241)
+|+|++|..||.+.+..+....+......+.... . .+
T Consensus 248 l~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~ 327 (382)
T 2vx3_A 248 LVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKLHNILGVE 327 (382)
T ss_dssp HHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCSCHHHHHTTT
T ss_pred HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchhhHHHHhhcc
Confidence 9999999999999888777766644221110000 0 00
Q ss_pred ---------C-------CChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 195 ---------A-------LHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 195 ---------~-------~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+ .+.++.+||++||+.||.+|||++|+|+||||++.
T Consensus 328 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~ 379 (382)
T 2vx3_A 328 TGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT 379 (382)
T ss_dssp TTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred ccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence 0 01368999999999999999999999999999875
|
| >3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=1.9e-41 Score=267.51 Aligned_cols=211 Identities=24% Similarity=0.405 Sum_probs=181.4
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeE-EEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCI-FLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~-~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+.+.+|++++++++||||+++++++.+.+.. ++|||++.+++|.+++.. ...+++..+..++.|++.||.+||+
T Consensus 63 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~ 142 (298)
T 3pls_A 63 MQQVEAFLREGLLMRGLNHPNVLALIGIMLPPEGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEYLAE 142 (298)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeEEEEEecCCCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34567889999999999999999999999866554 999999999999999976 3568999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-----ccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
.|++|+||||+||++ +.++.++|+|||.+....... ......++..|.|||.+.+..++.++|+||||+++|
T Consensus 143 ~~i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 219 (298)
T 3pls_A 143 QKFVHRDLAARNCML---DESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYRFTTKSDVWSFGVLLW 219 (298)
T ss_dssp TTCCCSCCSGGGEEE---CTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred CCcccCCCCcceEEE---cCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCCCChhhchhhHHHHHH
Confidence 999999999999999 788899999999997654321 223345678899999999989999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 160 ELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 160 ~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+|++ |.+||...+..+....+......+.+. .++..+.+++++||+.||.+|||++++++.
T Consensus 220 ~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~~ll~~ 281 (298)
T 3pls_A 220 ELLTRGAPPYRHIDPFDLTHFLAQGRRLPQPE----YCPDSLYQVMQQCWEADPAVRPTFRVLVGE 281 (298)
T ss_dssp HHHHTSCCTTTTSCGGGHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHhhCCCCCCccCCHHHHHHHhhcCCCCCCCc----cchHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence 9999 666677777777777776666554443 688999999999999999999999999853
|
| >3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-42 Score=280.44 Aligned_cols=211 Identities=27% Similarity=0.424 Sum_probs=173.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEe-ecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+.+.+|+.++++++||||+++++++. .++..++||||+++++|.++++.. ..+++..+..++.|++.||.+||+
T Consensus 131 ~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH~ 210 (373)
T 3c1x_A 131 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLAS 210 (373)
T ss_dssp SHHHHHHHHHHTTSTTCCCTTBCCCCEEECCCSSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCcceEEEEEEcCCCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 345678999999999999999999999864 556889999999999999999765 458899999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----cccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
+|++||||||+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++|+||||+++|
T Consensus 211 ~~ivHrDlkp~NIll---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~DvwSlG~il~ 287 (373)
T 3c1x_A 211 KKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 287 (373)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCC---------------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred CCEecCccchheEEE---CCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCCCCcHHHHHHHHHHHH
Confidence 999999999999999 7888999999999976543221 12334567899999999889999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 160 ELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 160 ~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+|++ |.+||.+.+..+....+..+.....+ ..++..+.+++.+||+.||.+|||+++++++
T Consensus 288 ellt~~~~p~~~~~~~~~~~~~~~~~~~~~p----~~~~~~l~~li~~cl~~dp~~RPs~~ell~~ 349 (373)
T 3c1x_A 288 ELMTRGAPPYPDVNTFDITVYLLQGRRLLQP----EYCPDPLYEVMLKCWHPKAEMRPSFSELVSR 349 (373)
T ss_dssp HHHTTSCCSCTTSCSSCHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHhCcCCCCCCCCHHHHHHHHHcCCCCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence 9999 78899887776666666666554443 3688999999999999999999999999864
|
| >1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=7.5e-42 Score=284.36 Aligned_cols=212 Identities=21% Similarity=0.416 Sum_probs=180.8
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+.+.+|++++++++||||+++++++.+ +..++||||+++++|.+++... ..+++..+..++.|++.||.+||++|+
T Consensus 223 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~-~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~i 301 (452)
T 1fmk_A 223 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 301 (452)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEcC-CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 5678999999999999999999999876 6789999999999999999743 568999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+||||+|+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 302 vHrDlkp~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwslG~~l~el~t~g 378 (452)
T 1fmk_A 302 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 378 (452)
T ss_dssp CCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTT
T ss_pred eCCCCChhhEEE---CCCCCEEECCCccceecCCCceecccCCcccccccCHhHHhcCCCCccccHHhHHHHHHHHHhCC
Confidence 999999999999 7788999999999976543321 223345678999999988899999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC--ccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH--RFLRR 229 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~--~~~~~ 229 (241)
..||.+.+..+....+..+...+.+. .+++.+.+++.+||+.||.+|||++++++. .++..
T Consensus 379 ~~P~~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~~l~~~L~~~~~~ 441 (452)
T 1fmk_A 379 RVPYPGMVNREVLDQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTS 441 (452)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSC
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhcc
Confidence 99999999999888887776655543 789999999999999999999999999863 44443
|
| >3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-41 Score=268.42 Aligned_cols=210 Identities=27% Similarity=0.435 Sum_probs=179.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEE-eecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+.+.+|+.++++++||||+++++++ ..++..++||||+++++|.+++... ..+++..+..++.|++.||.+||+
T Consensus 67 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~lH~ 146 (298)
T 3f66_A 67 IGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKYLAS 146 (298)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCCCEEECCSSSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeeeeEEEcCCCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 44567899999999999999999999985 5567889999999999999999754 458999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----cccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
.|++|+||||+||++ +.++.++|+|||.+........ .....+++.|+|||.+.+..++.++|+||+|+++|
T Consensus 147 ~~i~H~dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 223 (298)
T 3f66_A 147 KKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLW 223 (298)
T ss_dssp TTCCCSCCSGGGEEE---CTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCCCCHHHHHHHHHHHHH
T ss_pred CCccCCCCchheEEE---CCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCCCChHHHHHHHHHHHH
Confidence 999999999999999 7888999999999976543221 22334567899999999889999999999999999
Q ss_pred HHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 160 ELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 160 ~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++++ |.+||.+.+..+....+..+.....+. .++..+.+++++||+.||.+|||++++++
T Consensus 224 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~~l~~~p~~Rps~~ell~ 284 (298)
T 3f66_A 224 ELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVS 284 (298)
T ss_dssp HHHTTSCCSSTTSCTTTHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHhCCCCCCccCCHHHHHHHHhcCCCCCCCc----cCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 9999 777888877777777776655544443 67899999999999999999999999985
|
| >1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.3e-41 Score=266.09 Aligned_cols=207 Identities=23% Similarity=0.452 Sum_probs=181.2
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|++++++++||||+++++++.. +..++|||++++++|.+++.... .+++..+..++.|++.||.+||+.|
T Consensus 51 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~-~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 129 (279)
T 1qpc_A 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129 (279)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cHHHHHHHHHHHHhCCCcCcceEEEEEcC-CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 45778999999999999999999998874 56899999999999999997543 6999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|++
T Consensus 130 i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~el~~~ 206 (279)
T 1qpc_A 130 YIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206 (279)
T ss_dssp EECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred eeccCCCHhhEEE---cCCCCEEECCCcccccccCcccccccCCCCccCccChhhhccCCCCchhhhHHHHHHHHHHHhC
Confidence 9999999999999 7888999999999987654322 223345678999999988889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|..||.+.+..+....+..+.....+ ..++.++.+++.+||+.||.+|||++++++
T Consensus 207 g~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 262 (279)
T 1qpc_A 207 GRIPYPGMTNPEVIQNLERGYRMVRP----DNCPEELYQLMRLCWKERPEDRPTFDYLRS 262 (279)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCcccCHHHHHHHHhcccCCCCc----ccccHHHHHHHHHHhccChhhCCCHHHHHH
Confidence 99999999888888888766544433 378999999999999999999999999886
|
| >3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-42 Score=297.28 Aligned_cols=228 Identities=26% Similarity=0.427 Sum_probs=184.7
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee------cCeEEEEEeccCCCChHHHHHhcC---CCCHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHG---RVPEQTARKFLQQLG 76 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~---~~~~~~~~~~~~~i~ 76 (241)
.....+.+.+|++++++++||||+++++++.. ++..++||||++|++|.+++.... .+++..+..++.|++
T Consensus 52 ~~~~~~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl 131 (676)
T 3qa8_A 52 SPKNRERWCLEIQIMKKLNHPNVVSAREVPDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDIS 131 (676)
T ss_dssp CHHHHHHHHHHHHHHHHCCBTTBCCEEECCTTTCCCCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCceeeeecccccccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHH
Confidence 45567889999999999999999999998765 677899999999999999998654 589999999999999
Q ss_pred HHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHH
Q 026253 77 AGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (241)
Q Consensus 77 ~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~ 156 (241)
.||.+||+.|++|+||+|+||+++..+....++|+|||.+.............++..|+|||.+.+..++.++|+||+|+
T Consensus 132 ~aL~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~~~~~~~gt~~Y~APE~l~~~~~s~ksDIwSLGv 211 (676)
T 3qa8_A 132 SALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGELCTEFVGTLQYLAPELLEQKKYTVTVDYWSFGT 211 (676)
T ss_dssp HHHHHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCCCCCCCCSCCTTCSSCSSCCSCCSTTHHHHHHHH
T ss_pred HHHHHHHHCCCccCCCCHHHeEeecCCCceeEEEcccccccccccccccccccCCcccCChHHhccCCCCchhHHHHHHH
Confidence 99999999999999999999999644445569999999998876665556678899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHH---------Hhhc----------CCCCCCCCccCCCCChHHHHHHHHhcccCccccCC
Q 026253 157 ILFELLNGYPPFSGRNNVQLVR---------NINS----------CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~---------~i~~----------~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
++|++++|..||.+........ .+.. ....+.+....+.++..+.++|++||+.||.+|||
T Consensus 212 iLyeLltG~~Pf~~~~~~~~~~~~i~~~~~~~~~~~~~l~g~~~~~~~lp~p~~l~~~ls~~L~dLI~~mL~~DP~kRPT 291 (676)
T 3qa8_A 212 LAFECITGFRPFLPNWQPVQWHGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLERWLQCMLMWHQRQRGT 291 (676)
T ss_dssp HHHHHHSSCSSCCSSCHHHHSSTTCC------CCSCCCCSSSCCCCSSSCCSCCCCGGGHHHHHHHHHHHSCSSCC---C
T ss_pred HHHHHHHCCCCCCcccchhhhhhhhhcccchhhhhhhhhccccccccccCCchhhchhhhHHHHHHHHHHccCCHhhCcC
Confidence 9999999999997653322110 0000 00112222233446788999999999999999999
Q ss_pred HHHHhcCccccccccc
Q 026253 218 FNEFYHHRFLRRNSAI 233 (241)
Q Consensus 218 ~~~il~~~~~~~~~~~ 233 (241)
+.++++||||+.....
T Consensus 292 a~elL~hp~F~~l~~i 307 (676)
T 3qa8_A 292 DPQNPNVGCFQALDSI 307 (676)
T ss_dssp CTTCCCCTTHHHHHHH
T ss_pred HHHHhcCHHHHHHHHH
Confidence 9999999999884433
|
| >2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=7.6e-43 Score=278.46 Aligned_cols=215 Identities=26% Similarity=0.358 Sum_probs=175.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh 83 (241)
...+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.... .+++..+..++.|++.||.+||
T Consensus 77 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 156 (321)
T 2qkw_B 77 QGIEEFETEIETLSFCRHPHLVSLIGFCDERNEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARGLHYLH 156 (321)
T ss_dssp SHHHHHHHHHHGGGSCCCTTBCCEEEECCCTTCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEEcCCCeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHHHHHhc
Confidence 446789999999999999999999999999999999999999999999986543 4899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
++|++|+||||+||++ +.++.++|+|||.+....... ......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 157 ~~~ivH~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 233 (321)
T 2qkw_B 157 TRAIIHRDVKSINILL---DENFVPKITDFGISKKGTELDQTHLSTVVKGTLGYIDPEYFIKGRLTEKSDVYSFGVVLFE 233 (321)
T ss_dssp HTTEECSCCCSTTEEE---CTTCCEEECCCTTCEECSSSSCCCCBCCCEEETTTCCHHHHHHCBCCTHHHHHHHHHHHHH
T ss_pred CCCeecCCCCHHHEEE---CCCCCEEEeecccccccccccccccccccCCCccccCHHHhcCCCCCcccchHhHHHHHHH
Confidence 9999999999999999 788899999999997643321 2233457899999999988899999999999999999
Q ss_pred HHhCCCCCCCCChHHHH-------HHhhcCC-----CCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCc
Q 026253 161 LLNGYPPFSGRNNVQLV-------RNINSCK-----HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 225 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~-------~~i~~~~-----~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 225 (241)
|++|..||.+..+.+.. ....... .........+..+..+.+++.+||+.||.+|||++|++++-
T Consensus 234 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~L 310 (321)
T 2qkw_B 234 VLCARSAIVQSLPREMVNLAEWAVESHNNGQLEQIVDPNLADKIRPESLRKFGDTAVKCLALSSEDRPSMGDVLWKL 310 (321)
T ss_dssp HHHCCTTCSCSSSSSCCCHHHHTHHHHTTTCCCSSSSSSCTTCSCHHHHHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred HHhCCCcccccCcHHHHHHHHHhhhccccccHHHhcChhhccccCHHHHHHHHHHHHHHcCCCcccCcCHHHHHHHH
Confidence 99999999764432111 1111111 01111122234556799999999999999999999999763
|
| >3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.2e-42 Score=273.84 Aligned_cols=212 Identities=24% Similarity=0.392 Sum_probs=177.8
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEe--ecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~--~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~l 82 (241)
.....+.+.+|++++++++|+||+++++++. +.+..++||||+++++|.+++... ..+++..+..++.|++.||.+|
T Consensus 64 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~l 143 (327)
T 3lxl_A 64 GPDQQRDFQREIQILKALHSDFIVKYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEYL 143 (327)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEECSSSCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCceeEEEEEEecCCCceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence 3455678999999999999999999999876 456799999999999999999864 5699999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 158 (241)
|+.|++|+||||+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++
T Consensus 144 H~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il 220 (327)
T 3lxl_A 144 GSRRCVHRDLAARNILV---ESEAHVKIADFGLAKLLPLDKDYYVVREPGQSPIFWYAPESLSDNIFSRQSDVWSFGVVL 220 (327)
T ss_dssp HHTTEECSCCSGGGEEE---EETTEEEECCGGGCEECCTTCSEEECSSCCCSCGGGSCHHHHHHCEEEHHHHHHHHHHHH
T ss_pred HhCCccCCCCChhhEEE---CCCCCEEEcccccceecccCCccceeeccCCccccccCHHHhccCCCChHHhHHHHHHHH
Confidence 99999999999999999 6778899999999987654332 2334567779999999888899999999999999
Q ss_pred HHHHhCCCCCCCCCh---------------HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 159 FELLNGYPPFSGRNN---------------VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~---------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|+|++|..||..... ......+......+.+ +.+++.+.+++++||+.||.+|||++++++
T Consensus 221 ~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 296 (327)
T 3lxl_A 221 YELFTYCDKSCSPSAEFLRMMGCERDVPALSRLLELLEEGQRLPAP----PACPAEVHELMKLCWAPSPQDRPSFSALGP 296 (327)
T ss_dssp HHHHTTTCGGGSHHHHHHHHCC----CCHHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHhCCCCCccccchhhhhcccccccccHHHHHHHhhcccCCCCC----CcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999864332 2333444444433333 478999999999999999999999999964
Q ss_pred C
Q 026253 224 H 224 (241)
Q Consensus 224 ~ 224 (241)
+
T Consensus 297 ~ 297 (327)
T 3lxl_A 297 Q 297 (327)
T ss_dssp H
T ss_pred H
Confidence 4
|
| >1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=9.2e-42 Score=266.88 Aligned_cols=206 Identities=23% Similarity=0.433 Sum_probs=172.3
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEee-cCeEEEEEeccCCCChHHHHHhcCC--CCHHHHHHHHHHHHHHHHHHHhC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLHGR--VPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~~~--~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
..+.+.+|++++++++||||+++++++.+ ++..++|||++++++|.+++...+. +++..+..++.|++.||.+||+.
T Consensus 57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 136 (278)
T 1byg_A 57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLEGN 136 (278)
T ss_dssp --HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHHHHhC
Confidence 46778999999999999999999998654 4579999999999999999986543 89999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
|++|+||+|+||++ +.++.++|+|||.+....... ....++..|+|||.+.+..++.++|+||||+++|+|++ |
T Consensus 137 ~i~H~dlkp~Nil~---~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~t~g 211 (278)
T 1byg_A 137 NFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFG 211 (278)
T ss_dssp TCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred CccccCCCcceEEE---eCCCcEEEeeccccccccccc--cCCCccccccCHHHhCCCCCCchhcHHHHHHHHHHHHhCC
Confidence 99999999999999 788899999999987654332 23356788999999988889999999999999999998 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
..||...+..+....+..+.....+ ..+++.+.+++++||+.||.+|||+.++++
T Consensus 212 ~~p~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 266 (278)
T 1byg_A 212 RVPYPRIPLKDVVPRVEKGYKMDAP----DGCPPAVYEVMKNCWHLDAAMRPSFLQLRE 266 (278)
T ss_dssp CCSCTTSCGGGHHHHHTTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCCHHHHHHHHhcCCCCCCc----ccCCHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence 9999988887777777665544433 378999999999999999999999999885
|
| >3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=3.4e-42 Score=274.61 Aligned_cols=207 Identities=26% Similarity=0.458 Sum_probs=178.4
Q ss_pred hhhHHHHHHHHhcCC--CcCeeeeeeEEeecCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 10 KSCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.+.+.+|+.++++++ |+||+++++++..++..++|||++.+ ++|.+++...+.+++..+..++.|++.||.+||+.|
T Consensus 90 ~~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~~~~~lv~e~~~~~~~L~~~l~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 169 (320)
T 3a99_A 90 GTRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCG 169 (320)
T ss_dssp CCEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hhHHHHHHHHHHhhccCCCCceEEEEEEecCCcEEEEEEcCCCCccHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 366788999999996 59999999999999999999999976 899999998889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~ 165 (241)
++|+||+|+||+++ .+++.++|+|||++....... .....++..|+|||.+.+..+ +.++|+||||+++|+|++|.
T Consensus 170 ivH~Dlkp~NIll~--~~~~~~kL~Dfg~~~~~~~~~-~~~~~gt~~y~aPE~~~~~~~~~~~~Di~slG~il~el~~g~ 246 (320)
T 3a99_A 170 VLHRDIKDENILID--LNRGELKLIDFGSGALLKDTV-YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGD 246 (320)
T ss_dssp EECCCCSGGGEEEE--TTTTEEEECCCTTCEECCSSC-BCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSS
T ss_pred cEeCCCCHHHEEEe--CCCCCEEEeeCcccccccccc-ccCCCCCccCCChHHhccCCCCCccchHHhHHHHHHHHHHCC
Confidence 99999999999994 367899999999997765432 334568999999999876665 68899999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
.||..... +.... .. ....+++++.++|++||+.||.+|||++++++||||++.
T Consensus 247 ~pf~~~~~------~~~~~-~~----~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~ 300 (320)
T 3a99_A 247 IPFEHDEE------IIRGQ-VF----FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 300 (320)
T ss_dssp CSCCSHHH------HHHCC-CC----CSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCCChhh------hhccc-cc----ccccCCHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCc
Confidence 99975321 11111 11 224789999999999999999999999999999999874
|
| >2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... | Back alignment and structure |
|---|
Probab=100.00 E-value=1.1e-41 Score=270.84 Aligned_cols=211 Identities=28% Similarity=0.495 Sum_probs=179.9
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecC-eEEEEEeccCCCChHHHHHhcCC----------------CCHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAEN-CIFLVVEFCAGGNLSSYIRLHGR----------------VPEQTA 68 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~-~~~lv~e~~~~~~L~~~l~~~~~----------------~~~~~~ 68 (241)
....+.+.+|+++++++ +||||+++++++...+ ..++||||+++++|.+++..... +++..+
T Consensus 71 ~~~~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 150 (316)
T 2xir_A 71 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 150 (316)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECCTTSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEHHHH
T ss_pred cHHHHHHHHHHHHHHhcccCCCeeeEEEEEecCCCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCHHHH
Confidence 44567899999999999 7999999999987654 59999999999999999987544 789999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCC
Q 026253 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRY 145 (241)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~ 145 (241)
..++.|++.||.+||+.|++|+||||+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..+
T Consensus 151 ~~~~~qi~~al~~lH~~~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~ 227 (316)
T 2xir_A 151 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 227 (316)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCGGGSCTTTCTTSEEETTEEECGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCCcccccCccceEEE---CCCCCEEECCCccccccccCccceeccCCCcceeecCchhhccccc
Confidence 9999999999999999999999999999999 7788999999999976644322 223456788999999998889
Q ss_pred CCchhHHHHHHHHHHHHh-CCCCCCCCCh-HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 146 DEKVDMWSVGAILFELLN-GYPPFSGRNN-VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 146 ~~~~Dv~slG~~l~~l~~-g~~p~~~~~~-~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+.++|+||||+++|+|++ |..||.+... ......+..+.....+ ..+++.+.+++.+||+.||.+|||+.++++
T Consensus 228 ~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~ 303 (316)
T 2xir_A 228 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAP----DYTTPEMYQTMLDCWHGEPSQRPTFSELVE 303 (316)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred cchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCCCC----CCCCHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 999999999999999998 9999987653 4455555555544433 367899999999999999999999999997
Q ss_pred C
Q 026253 224 H 224 (241)
Q Consensus 224 ~ 224 (241)
|
T Consensus 304 ~ 304 (316)
T 2xir_A 304 H 304 (316)
T ss_dssp H
T ss_pred H
Confidence 6
|
| >2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=290.26 Aligned_cols=207 Identities=24% Similarity=0.425 Sum_probs=180.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|++++++++||||+++++++.. +..++||||+.+++|.+++... ..+++..+..++.|++.||.|||++|
T Consensus 378 ~~~~~~~~E~~il~~l~hpniv~l~~~~~~-~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~ 456 (613)
T 2ozo_A 378 ADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEEKN 456 (613)
T ss_dssp TTHHHHHHHHHHHTTCCCTTBCCEEEEEES-SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCEeeEEEEecc-CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 356789999999999999999999999876 5699999999999999999754 45999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
++||||||+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|+
T Consensus 457 iiHrDlkp~NILl---~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~y~APE~~~~~~~~~~sDvwSlGv~l~ell 533 (613)
T 2ozo_A 457 FVHRNLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEAL 533 (613)
T ss_dssp CCCSCCSGGGEEE---EETTEEEECCCSTTTTCC--------------CCTTSCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred EEcCcCCHHHEEE---cCCCcEEEeeccCcccccCCCceeeeccCCCCccceeCHhhhcCCCCCcHHHHHHHHHHHHHHH
Confidence 9999999999999 5778999999999987643321 11233457899999999889999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
+ |..||.+.+..+....+..+.....+. .++.++.+++.+||+.||.+|||+++++
T Consensus 534 t~G~~Pf~~~~~~~~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~RPs~~~l~ 590 (613)
T 2ozo_A 534 SYGQKPYKKMKGPEVMAFIEQGKRMECPP----ECPPELYALMSDCWIYKWEDRPDFLTVE 590 (613)
T ss_dssp TTSCCTTTTCCSHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSTTTSCCHHHHH
T ss_pred HCCCCCCCCCCHHHHHHHHHcCCCCCCCC----cCCHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 8 999999999999999888777665554 7899999999999999999999999985
|
| >4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.5e-41 Score=268.59 Aligned_cols=208 Identities=26% Similarity=0.430 Sum_probs=174.8
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
..+.+.+|++++++++|+||+++++++... +..++||||+++++|.+++... ..+++..+..++.|++.||.+||+.
T Consensus 66 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~ 145 (302)
T 4e5w_A 66 HIADLKKEIEILRNLYHENIVKYKGICTEDGGNGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDYLGSR 145 (302)
T ss_dssp CHHHHHHHHHHHHTCCCTTBCCEEEEEEC---CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hHHHHHHHHHHHHhCCCCCeeeeeeEEecCCCceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHHhhcC
Confidence 457899999999999999999999999876 6789999999999999999544 5699999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
|++|+||||+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|+++|+|
T Consensus 146 ~i~H~dikp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l 222 (302)
T 4e5w_A 146 QYVHRDLAARNVLV---ESEHQVKIGDFGLTKAIETDKEYYTVKDDRDSPVFWYAPECLMQSKFYIASDVWSFGVTLHEL 222 (302)
T ss_dssp TEECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCCEEECCCCTTCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHH
T ss_pred CcccCCCchheEEE---cCCCCEEECcccccccccCCCcceeccCCCCCCccccCCeeecCCCCCcchhHHHHHHHHHHH
Confidence 99999999999999 5678999999999987654432 2334567789999999888899999999999999999
Q ss_pred HhCCCCCCCC---------------ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 162 LNGYPPFSGR---------------NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 162 ~~g~~p~~~~---------------~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++|..|+... ........+......+.+ +.+++++.+++++||+.||.+|||++++++
T Consensus 223 ~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 295 (302)
T 4e5w_A 223 LTYCDSDSSPMALFLKMIGPTHGQMTVTRLVNTLKEGKRLPCP----PNCPDEVYQLMRKCWEFQPSNRTSFQNLIE 295 (302)
T ss_dssp HTTTCGGGSHHHHHHHHHCSCCGGGHHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred HHccCCCcchhhHHhhccCCcccccCHHHHHHHHhccCCCCCC----CCCCHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence 9998876421 122334444444444433 378999999999999999999999999985
|
| >1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.5e-42 Score=278.66 Aligned_cols=224 Identities=25% Similarity=0.383 Sum_probs=176.0
Q ss_pred HhhhhHHHHHHHHhcCC-----------CcCeeeeeeEEeecC----eEEEEEeccCCCChHHHHHhc--CCCCHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVN-----------HPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLH--GRVPEQTARK 70 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~-----------~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~ 70 (241)
...+.+.+|+.++++++ |+||+++++++...+ ..++|||++ +++|.+++... ..+++..+..
T Consensus 57 ~~~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~~ 135 (373)
T 1q8y_A 57 VYTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVL-GENLLALIKKYEHRGIPLIYVKQ 135 (373)
T ss_dssp HHHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCC-CEEHHHHHHHTTTSCCCHHHHHH
T ss_pred cchhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCCCCceEEEEEecC-CCCHHHHHHHhhccCCcHHHHHH
Confidence 34677889999999986 789999999987654 789999999 89999999864 4599999999
Q ss_pred HHHHHHHHHHHHHhC-CccccCCCCCCeEEeec---CCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCC
Q 026253 71 FLQQLGAGLEILNSH-HIIHRDLKPENILLSGL---DDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYD 146 (241)
Q Consensus 71 ~~~~i~~~l~~lh~~-~i~H~dl~~~nil~~~~---~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~ 146 (241)
++.|++.||.+||++ |++|+||||+||+++.. +....++|+|||++...... .....+++.|+|||.+.+..++
T Consensus 136 i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~ 213 (373)
T 1q8y_A 136 ISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH--YTNSIQTREYRSPEVLLGAPWG 213 (373)
T ss_dssp HHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC--CCSCCSCGGGCCHHHHHTCCCC
T ss_pred HHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC--CCCCCCCccccCcHHHhCCCCC
Confidence 999999999999998 99999999999999532 24457999999999776433 2345689999999999988999
Q ss_pred CchhHHHHHHHHHHHHhCCCCCCCCCh------HHHHHHhhcCCC-CCC-------------------------------
Q 026253 147 EKVDMWSVGAILFELLNGYPPFSGRNN------VQLVRNINSCKH-LPF------------------------------- 188 (241)
Q Consensus 147 ~~~Dv~slG~~l~~l~~g~~p~~~~~~------~~~~~~i~~~~~-~~~------------------------------- 188 (241)
.++|+||||+++|+|++|..||.+.+. ......+..... .+.
T Consensus 214 ~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 293 (373)
T 1q8y_A 214 CGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLE 293 (373)
T ss_dssp THHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHH
T ss_pred chHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhcccccccccchh
Confidence 999999999999999999999986542 222222211000 000
Q ss_pred -----CCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccC
Q 026253 189 -----SQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 189 -----~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 234 (241)
........+.++.++|++||+.||.+|||++|+++||||++.....
T Consensus 294 ~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~~ 344 (373)
T 1q8y_A 294 DVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGME 344 (373)
T ss_dssp HHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTTCT
T ss_pred hhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhcccCcc
Confidence 0001123467899999999999999999999999999999865443
|
| >2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6.6e-42 Score=274.28 Aligned_cols=210 Identities=23% Similarity=0.415 Sum_probs=178.0
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--------------CCCCHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--------------GRVPEQTARKF 71 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--------------~~~~~~~~~~~ 71 (241)
.+..+.+.+|+++++++ +||||+++++++.+++..++||||+++++|.+++... ..+++..+..+
T Consensus 90 ~~~~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 169 (333)
T 2i1m_A 90 ADEKEALMSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRDLLHF 169 (333)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhhcCCCCeeeEEEEEecCCceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHHHHHH
Confidence 34577899999999999 8999999999999999999999999999999999753 35799999999
Q ss_pred HHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCc
Q 026253 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEK 148 (241)
Q Consensus 72 ~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~ 148 (241)
+.|++.||.+||+.|++|+||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.+
T Consensus 170 ~~qi~~~l~~lH~~~ivH~Dlkp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~ 246 (333)
T 2i1m_A 170 SSQVAQGMAFLASKNCIHRDVAARNVLL---TNGHVAKIGDFGLARDIMNDSNYIVKGNARLPVKWMAPESIFDCVYTVQ 246 (333)
T ss_dssp HHHHHHHHHHHHHTTEECSCCSGGGCEE---EGGGEEEBCCCGGGCCGGGCTTSEECSSCEECGGGSCHHHHHHCCCCHH
T ss_pred HHHHHHHHHHHhcCCcccCCcccceEEE---CCCCeEEECccccccccccccceeecCCCCCCccccCHHHhccCCCChH
Confidence 9999999999999999999999999999 6788999999999976543221 223345678999999988889999
Q ss_pred hhHHHHHHHHHHHHh-CCCCCCCCChHHHH-HHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 149 VDMWSVGAILFELLN-GYPPFSGRNNVQLV-RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+|+||||+++|+|++ |..||.+....... ..+........+ ...+..+.+++.+||+.||.+|||++++++
T Consensus 247 ~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 319 (333)
T 2i1m_A 247 SDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMAQP----AFAPKNIYSIMQACWALEPTHRPTFQQICS 319 (333)
T ss_dssp HHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCCCC----CCCCHHHHHHHHHHhccChhhCcCHHHHHH
Confidence 999999999999998 99999876654433 344333333322 367899999999999999999999999986
|
| >2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-42 Score=278.24 Aligned_cols=211 Identities=15% Similarity=0.147 Sum_probs=171.9
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
..+.+.+|+..++.++|+||+++++++.. ++..++|||++ +++|.+++...+.+++..+..++.|++.||.+||+
T Consensus 91 ~~~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~~~~~~~i~~qi~~aL~~LH~ 169 (345)
T 2v62_A 91 AKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYRFMVMERL-GIDLQKISGQNGTFKKSTVLQLGIRMLDVLEYIHE 169 (345)
T ss_dssp CCHHHHHHHHHHHTCSCCCCCCEEEEEEEESSSCEEEEEEEECE-EEEHHHHCBGGGBCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhhHHHHHHHhhccccccCcceeecccccccCCCcEEEEEEecc-CCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34557789999999999999999999887 67899999999 99999999887789999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCc--eEEEeecCCccccCCCC--------ccccccCCCCccCcccccccCCCCchhHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSV 154 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~--~~~l~df~~a~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~sl 154 (241)
.|++|+||||+||+++ .++ .++|+|||++....... ......++..|+|||.+.+..++.++|+|||
T Consensus 170 ~~ivH~Dlkp~NIll~---~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~sl 246 (345)
T 2v62_A 170 NEYVHGDIKAANLLLG---YKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVALSRRSDVEIL 246 (345)
T ss_dssp TTEECSCCSGGGEEEE---SSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCCCCHHHHHHHH
T ss_pred CCeeCCCcCHHHEEEc---cCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCCCCchhhHHHH
Confidence 9999999999999994 344 89999999997653321 1134568999999999998889999999999
Q ss_pred HHHHHHHHhCCCCCCCC-ChHHHHHHhhcCCCCCCCCc---c--CCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 155 GAILFELLNGYPPFSGR-NNVQLVRNINSCKHLPFSQL---I--VPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 155 G~~l~~l~~g~~p~~~~-~~~~~~~~i~~~~~~~~~~~---~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|+++|+|++|..||.+. .................+.. . ...+++++.+++.+||+.||.+|||++++++
T Consensus 247 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~ 321 (345)
T 2v62_A 247 GYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDELPQSVLKWAPSGSSCCEIAQFLVCAHSLAYDEKPNYQALKK 321 (345)
T ss_dssp HHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTTTHHHHHHSCTTSCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHHHhCCCCccccccccHHHHHHHHhhcccccHHHHhhccccccHHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence 99999999999999642 22222222211111111111 1 1168889999999999999999999999884
|
| >2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=1.7e-40 Score=263.60 Aligned_cols=212 Identities=28% Similarity=0.545 Sum_probs=171.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
+....+.+.+|++++++++|+||+++++++.+++..++|||++++++|.+++.. ...+++..+..++.|++.||.+
T Consensus 72 ~~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~ 151 (310)
T 2wqm_A 72 DAKARADCIKEIDLLKQLNHPNVIKYYASFIEDNELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSALEH 151 (310)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEEcCCcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHHHHH
Confidence 355678899999999999999999999999999999999999999999999874 3568999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
||+.|++|+||+|+||++ +.++.++|+|||++....... ......++..|+|||.+.+..++.++|+||||+++|+
T Consensus 152 LH~~~i~H~dl~p~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Dv~slG~il~~ 228 (310)
T 2wqm_A 152 MHSRRVMHRDIKPANVFI---TATGVVKLGDLGLGRFFSSKTTAAHSLVGTPYYMSPERIHENGYNFKSDIWSLGCLLYE 228 (310)
T ss_dssp HHHTTCCCCCCCGGGEEE---CTTSCEEECCC------------------CCSSCCHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred HhhCCeeCCCCcHHHEEE---cCCCCEEEEeccceeeecCCCccccccCCCeeEeChHHhCCCCCCchhhHHHHHHHHHH
Confidence 999999999999999999 788899999999987654332 2234568899999999998889999999999999999
Q ss_pred HHhCCCCCCCC--ChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 161 LLNGYPPFSGR--NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 161 l~~g~~p~~~~--~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|++|..||.+. ........+......+.. ...++.++.+++.+||+.||.+|||++++++
T Consensus 229 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~l~~li~~~l~~dp~~Rps~~~il~ 290 (310)
T 2wqm_A 229 MAALQSPFYGDKMNLYSLCKKIEQCDYPPLP---SDHYSEELRQLVNMCINPDPEKRPDVTYVYD 290 (310)
T ss_dssp HHHSSCTTC---CCHHHHHHHHHTTCSCCCC---TTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCCCcccchhHHHHHHHhhcccCCCCc---ccccCHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence 99999999754 334455555444333222 2478999999999999999999999999985
|
| >1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-41 Score=266.14 Aligned_cols=209 Identities=26% Similarity=0.400 Sum_probs=179.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|++++++++||||+++++++.+++ .++|||++.+++|.+++... +.+++..+..++.|++.||.+||+.|
T Consensus 63 ~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~-~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~ 141 (291)
T 1u46_A 63 EAMDDFIREVNAMHSLDHRNLIRLYGVVLTPP-MKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 141 (291)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECSSS-CEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCcccEEEEEccCC-ceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45678999999999999999999999998765 88999999999999999764 56999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+|+
T Consensus 142 i~H~dikp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~l~ 218 (291)
T 1u46_A 142 FIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 218 (291)
T ss_dssp EECSCCCGGGEEE---EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred cccCCCchheEEE---cCCCCEEEccccccccccccccchhhhccCCCCceeeCchhhcCCCCCchhhHHHHHHHHHHHH
Confidence 9999999999999 5678899999999977654322 22334567899999998888899999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+ |..||.+.+..+....+........ ....++.++.+++.+||+.||.+|||+.++++
T Consensus 219 ~~g~~p~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~l~~li~~~l~~~p~~Rps~~~l~~ 277 (291)
T 1u46_A 219 TYGQEPWIGLNGSQILHKIDKEGERLP---RPEDCPQDIYNVMVQCWAHKPEDRPTFVALRD 277 (291)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTSCCCCC---CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred hCCCCCcccCCHHHHHHHHHccCCCCC---CCcCcCHHHHHHHHHHccCCcccCcCHHHHHH
Confidence 9 9999999988888877755432221 22478999999999999999999999999986
|
| >2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=264.82 Aligned_cols=209 Identities=28% Similarity=0.473 Sum_probs=178.4
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEee----------------cCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHH
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQA----------------ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~----------------~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~ 72 (241)
+.+.+|++++++++||||+++++++.. .+..++||||+++++|.+++... ..+++..+..++
T Consensus 49 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~ 128 (284)
T 2a19_B 49 EKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALELF 128 (284)
T ss_dssp GGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHHH
Confidence 568899999999999999999998854 45689999999999999999754 579999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHH
Q 026253 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (241)
Q Consensus 73 ~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~ 152 (241)
.|++.||.+||+.|++|+||+|+||++ +.++.++|+|||.+.............+++.|+|||.+.+..++.++|+|
T Consensus 129 ~qi~~~l~~lH~~~i~H~dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~ 205 (284)
T 2a19_B 129 EQITKGVDYIHSKKLINRDLKPSNIFL---VDTKQVKIGDFGLVTSLKNDGKRTRSKGTLRYMSPEQISSQDYGKEVDLY 205 (284)
T ss_dssp HHHHHHHHHHHHTTEECSCCSGGGEEE---EETTEEEECCCTTCEESSCCSCCCCCCSCCTTSCHHHHHCSCCCTHHHHH
T ss_pred HHHHHHHHHHHhCCeeeccCCHHHEEE---cCCCCEEECcchhheeccccccccccCCcccccChhhhccCCCcchhhhH
Confidence 999999999999999999999999999 57788999999999877665555566789999999999988899999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 153 SVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 153 slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|||+++|+|++|..|+... ......+.... ....++..+.+++.+||+.||.+|||+.|++++.+.-...
T Consensus 206 slG~il~~l~~~~~~~~~~--~~~~~~~~~~~-------~~~~~~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~~~ 275 (284)
T 2a19_B 206 ALGLILAELLHVCDTAFET--SKFFTDLRDGI-------ISDIFDKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWKKS 275 (284)
T ss_dssp HHHHHHHHHHSCCSSHHHH--HHHHHHHHTTC-------CCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHTC-
T ss_pred HHHHHHHHHHhcCCcchhH--HHHHHHhhccc-------ccccCCHHHHHHHHHHccCChhhCcCHHHHHHHHHHHhhC
Confidence 9999999999998887532 23333333221 1236789999999999999999999999999997765543
|
| >3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.6e-41 Score=269.76 Aligned_cols=213 Identities=24% Similarity=0.325 Sum_probs=169.3
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
........+|+.++++++||||+++++++.... ..++||||+++++|.++++. ..+++..+..++.|++.||.+|
T Consensus 59 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~qi~~al~~L 137 (322)
T 3soc_A 59 DKQSWQNEYEVYSLPGMKHENILQFIGAEKRGTSVDVDLWLITAFHEKGSLSDFLKA-NVVSWNELCHIAETMARGLAYL 137 (322)
T ss_dssp GHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHH-CCBCHHHHHHHHHHHHHHHHHH
T ss_pred chHHHHHHHHHHHHhcCCCCCchhhcceeccCCCCCceEEEEEecCCCCCHHHHHHh-cCCCHHHHHHHHHHHHHHHHHH
Confidence 334556677999999999999999999998754 47999999999999999975 4699999999999999999999
Q ss_pred HhC----------CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccc-----cC
Q 026253 83 NSH----------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQF-----QR 144 (241)
Q Consensus 83 h~~----------~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~-----~~ 144 (241)
|+. |++|+||||+||++ +.++.++|+|||.+........ .....+++.|+|||.+.+ ..
T Consensus 138 H~~~~~l~~~~~~~ivH~Dlkp~Nill---~~~~~~kL~DFg~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~ 214 (322)
T 3soc_A 138 HEDIPGLKDGHKPAISHRDIKSKNVLL---KNNLTACIADFGLALKFEAGKSAGDTHGQVGTRRYMAPEVLEGAINFQRD 214 (322)
T ss_dssp TCCEEEETTEEECEEECSCCSGGGEEE---CTTCCEEECCCTTCEEECTTSCCCCCTTCCCCGGGCCHHHHTTCCCCCHH
T ss_pred HhhccccccccCCCEEeCCCChHhEEE---CCCCeEEEccCCcccccccccCccccccCccCccccCHhhcccccccCcC
Confidence 999 99999999999999 7888999999999976644322 233568999999999876 35
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCC----------------hHHHHHHhhcCCCCCCCCccC--CCCChHHHHHHHH
Q 026253 145 YDEKVDMWSVGAILFELLNGYPPFSGRN----------------NVQLVRNINSCKHLPFSQLIV--PALHPDCVDMCLK 206 (241)
Q Consensus 145 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~----------------~~~~~~~i~~~~~~~~~~~~~--~~~~~~~~~li~~ 206 (241)
++.++||||||+++|+|++|..||.+.. .......+......+...... ...+.++.+++++
T Consensus 215 ~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~ 294 (322)
T 3soc_A 215 AFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSLEDMQEVVVHKKKRPVLRDYWQKHAGMAMLCETIEE 294 (322)
T ss_dssp HHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCGGGGSSHHHHHHHHHHHH
T ss_pred CCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCchhhhhhhhhcccCCCCccccccccchHHHHHHHHHH
Confidence 6678999999999999999999997532 122233332222222111111 1224459999999
Q ss_pred hcccCccccCCHHHHhc
Q 026253 207 LLSANTVDRLSFNEFYH 223 (241)
Q Consensus 207 ~l~~~p~~Rps~~~il~ 223 (241)
||+.||.+|||++++++
T Consensus 295 cl~~dP~~Rps~~ell~ 311 (322)
T 3soc_A 295 CWDHDAEARLSAGCVGE 311 (322)
T ss_dssp HTCSSGGGSCCHHHHHH
T ss_pred HccCChhhCcCHHHHHH
Confidence 99999999999999985
|
| >3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.1e-41 Score=266.64 Aligned_cols=208 Identities=27% Similarity=0.566 Sum_probs=165.8
Q ss_pred hhhHHHHHHHH-hcCCCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFL-SSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 10 ~~~~~~E~~~l-~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~l 82 (241)
...+.+|+.++ +.++||||+++++++.. ++..++||||+++++|.+++.... .+++..+..++.|++.||.+|
T Consensus 54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~~l 133 (299)
T 3m2w_A 54 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 133 (299)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhccCCCchhHHhhhhhhcCCCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Confidence 35678899998 55599999999999887 678999999999999999998764 699999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
|+.|++|+||||+||+++..+.++.++|+|||++.... +..++.++|+||+|+++|+|+
T Consensus 134 H~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~---------------------~~~~~~~~DiwslG~il~el~ 192 (299)
T 3m2w_A 134 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETT---------------------GEKYDKSCDMWSLGVIMYILL 192 (299)
T ss_dssp HHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECT---------------------TCGGGGHHHHHHHHHHHHHHH
T ss_pred HhCCcccCCCCHHHEEEecCCCCCcEEEeccccccccc---------------------cccCCchhhHHHHHHHHHHHH
Confidence 99999999999999999543337889999999885432 244678999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCC---CCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCCCCC
Q 026253 163 NGYPPFSGRNNVQLVRNINSCK---HLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAPF 238 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~---~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~~~ 238 (241)
+|..||.+.+.......+.... ....+......+++++.+++.+||+.||.+|||++|+++||||++....-..|.
T Consensus 193 tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~~~~~~~~~ 271 (299)
T 3m2w_A 193 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVPQTPL 271 (299)
T ss_dssp HSSCSCCC-------CCSCCSSCTTCCSSCHHHHTTSCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTGGGSCCCBC
T ss_pred HCCCCCCCCcchhhhHHHHHHHhhccccCCchhcccCCHHHHHHHHHHcccChhhCCCHHHHhcChhhcccccCCCCCC
Confidence 9999998766544332221111 112222222468999999999999999999999999999999998776555443
|
| >3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.5e-41 Score=269.36 Aligned_cols=209 Identities=26% Similarity=0.417 Sum_probs=175.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+.+.+|++++++++||||+++++++.+ ....++||||+++++|.+++... .+++..+..++.|++.||.+||+
T Consensus 74 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~i~~~l~~~l~~LH~ 152 (318)
T 3lxp_A 74 PQHRSGWKQEIDILRTLYHEHIIKYKGCCEDAGAASLQLVMEYVPLGSLRDYLPRH-SIGLAQLLLFAQQICEGMAYLHA 152 (318)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCEEEEEEETTTTEEEEEECCCTTCBHHHHGGGS-CCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCcchhhEEEEEecCCCceEEEEEecccCCcHHHHHhhC-CCCHHHHHHHHHHHHHHHHHHHh
Confidence 4557789999999999999999999999987 46789999999999999999754 59999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
.|++|+||||+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|+
T Consensus 153 ~~ivH~Dikp~Nil~---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~~ 229 (318)
T 3lxp_A 153 QHYIHRDLAARNVLL---DNDRLVKIGDFGLAKAVPEGHEYYRVREDGDSPVFWYAPECLKEYKFYYASDVWSFGVTLYE 229 (318)
T ss_dssp TTEECSCCSGGGEEE---CTTCCEEECCGGGCEECCTTCSEEEC---CCCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHH
T ss_pred CCccCCCCchheEEE---cCCCCEEECCccccccccccccccccccCCCCCceeeChHHhcCCCCCcHHHHHHHHHHHHH
Confidence 999999999999999 7888999999999987654322 233456778999999998889999999999999999
Q ss_pred HHhCCCCCCCCChH---------------HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 161 LLNGYPPFSGRNNV---------------QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 161 l~~g~~p~~~~~~~---------------~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|++|..||...... .....+......+.+ ..++.++.++|++||+.||.+|||++++++
T Consensus 230 ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dP~~Rps~~ell~ 303 (318)
T 3lxp_A 230 LLTHCDSSQSPPTKFLELIGIAQGQMTVLRLTELLERGERLPRP----DKCPAEVYHLMKNCWETEASFRPTFENLIP 303 (318)
T ss_dssp HHTTTCGGGSHHHHHHHHHCSCCHHHHHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHhCCCcccccchhhhhhhcccccchhHHHHHHHHhcccCCCCC----ccccHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence 99999999753221 223333333333333 378999999999999999999999999984
|
| >2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9e-41 Score=264.92 Aligned_cols=208 Identities=31% Similarity=0.490 Sum_probs=167.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+.+|++++++++||||+++++++.+ ..++||||+++++|.+++..... ++...+..++.|++.||.+||
T Consensus 42 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~l~~LH 119 (307)
T 2eva_A 42 ESERKAFIVELRQLSRVNHPNIVKLYGACLN--PVCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQGVAYLH 119 (307)
T ss_dssp TTHHHHHHHHHHHHHHCCCTTBCCEEEBCTT--TTEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHHhcCCCCCcCeEEEEEcC--CcEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHHHHHHH
Confidence 3456789999999999999999999998873 47899999999999999986543 789999999999999999999
Q ss_pred h---CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 84 S---HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 84 ~---~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+ +|++|+||||+||+++ .++..++|+|||.+...... .....++..|+|||.+.+..++.++|+||||+++|+
T Consensus 120 ~~~~~~ivH~dlkp~NIll~--~~~~~~kl~Dfg~~~~~~~~--~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~e 195 (307)
T 2eva_A 120 SMQPKALIHRDLKPPNLLLV--AGGTVLKICDFGTACDIQTH--MTNNKGSAAWMAPEVFEGSNYSEKCDVFSWGIILWE 195 (307)
T ss_dssp TCSSSCCCCCCCSGGGEEEE--TTTTEEEECCCCC--------------CCTTSSCHHHHTCCCCCTHHHHHHHHHHHHH
T ss_pred hCCCCCeecCCCChhHEEEe--CCCCEEEEcccccccccccc--cccCCCCCceEChhhhCCCCCCcHHHHHHHHHHHHH
Confidence 9 8999999999999994 33335899999999765432 223458999999999998899999999999999999
Q ss_pred HHhCCCCCCCCC--hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 161 LLNGYPPFSGRN--NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 161 l~~g~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|++|..||.... .......+......+.. ..++..+.+++.+||+.||.+|||+++++++
T Consensus 196 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~~l~~dp~~Rps~~ell~~ 257 (307)
T 2eva_A 196 VITRRKPFDEIGGPAFRIMWAVHNGTRPPLI----KNLPKPIESLMTRCWSKDPSQRPSMEEIVKI 257 (307)
T ss_dssp HHHTCCTTTTTCSSHHHHHHHHHTTCCCCCB----TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHCCCCchhhCccHHHHHHHHhcCCCCCcc----cccCHHHHHHHHHHhcCChhhCcCHHHHHHH
Confidence 999999998543 23333344444433333 4789999999999999999999999999873
|
| >2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.4e-42 Score=271.65 Aligned_cols=213 Identities=27% Similarity=0.461 Sum_probs=173.1
Q ss_pred hhhhHHHHHHHHhcC----CCcCeeeeeeEEeecCeEEEEEec-cCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSV----NHPNIIRLFDAFQAENCIFLVVEF-CAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l----~~~~i~~~~~~~~~~~~~~lv~e~-~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+|+.+++++ +|+||+++++++...+..++|||+ +.+++|.+++...+.+++..+..++.|++.||.+||
T Consensus 77 ~~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~~~~~~v~e~~~~~~~L~~~l~~~~~~~~~~~~~~~~qi~~~l~~lH 156 (312)
T 2iwi_A 77 DSVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQEGFMLVLERPLPAQDLFDYITEKGPLGEGPSRCFFGQVVAAIQHCH 156 (312)
T ss_dssp --CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-----CEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHHHhhcccCCCCCeeeEEEEEecCCeEEEEEEecCCCCCHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Confidence 455677899999999 899999999999999999999999 789999999998888999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELL 162 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~ 162 (241)
+.|++|+||+|+||+++ ..++.++|+|||.+....... .....++..|+|||.+.+..+ +.++|+||||+++|+++
T Consensus 157 ~~~i~H~dlkp~Nil~~--~~~~~~kl~dfg~~~~~~~~~-~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~l~ 233 (312)
T 2iwi_A 157 SRGVVHRDIKDENILID--LRRGCAKLIDFGSGALLHDEP-YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDMV 233 (312)
T ss_dssp HHTEECCCCSGGGEEEE--TTTTEEEECCCSSCEECCSSC-BCCCCSCTTTSCHHHHHHSCBCHHHHHHHHHHHHHHHHH
T ss_pred HCCeeecCCChhhEEEe--CCCCeEEEEEcchhhhcccCc-ccccCCcccccCceeeecCCCCCccchHHHHHHHHHHHH
Confidence 99999999999999994 377899999999997765433 334568999999999876665 45899999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCC
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 235 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 235 (241)
+|..||..... +... ...+ ...++..+.++|++||+.||.+|||++|+++||||+.....+.
T Consensus 234 ~g~~pf~~~~~------~~~~-~~~~----~~~~~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~~~~~~ 295 (312)
T 2iwi_A 234 CGDIPFERDQE------ILEA-ELHF----PAHVSPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTPAEDVP 295 (312)
T ss_dssp HSSCSCCSHHH------HHHT-CCCC----CTTSCHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC------
T ss_pred HCCCCCCChHH------Hhhh-ccCC----cccCCHHHHHHHHHHccCChhhCcCHHHHhcChhhcCchhccc
Confidence 99999975321 1111 1222 2478999999999999999999999999999999998765544
|
| >2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=2.7e-41 Score=286.19 Aligned_cols=207 Identities=21% Similarity=0.416 Sum_probs=182.5
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.+.+.+|++++++++|+||+++++++.+ +..++||||+++++|.+++... ..+++..+..++.|++.||.|||++|+
T Consensus 306 ~~~~~~E~~~l~~l~hpniv~~~~~~~~-~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~~i 384 (535)
T 2h8h_A 306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMNY 384 (535)
T ss_dssp HHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHhCCCCCEeeEEEEEee-ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 4678999999999999999999999876 6789999999999999999743 568999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+||||+|+||++ +.++.++|+|||+++....... .....++..|+|||.+.+..++.++||||||+++|+|++ |
T Consensus 385 vHrDlkp~NIll---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~sDvwSlGv~l~el~t~g 461 (535)
T 2h8h_A 385 VHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKG 461 (535)
T ss_dssp CCSCCSGGGEEE---CGGGCEEECCTTSTTTCCCHHHHTTCSTTSCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHTTTT
T ss_pred eCCCCCHhhEEE---cCCCcEEEcccccceecCCCceecccCCcCcccccCHHHhccCCCCchhhHHHHHHHHHHHHhCC
Confidence 999999999999 7788999999999976543211 122345678999999988889999999999999999999 9
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
..||.+.+..+....+..+...+.+. .++..+.++|.+||+.||++|||++++++.
T Consensus 462 ~~P~~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~RPt~~~l~~~ 517 (535)
T 2h8h_A 462 RVPYPGMVNREVLDQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAF 517 (535)
T ss_dssp CCSSTTCCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence 99999999999888887776655443 789999999999999999999999999864
|
| >3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.1e-42 Score=278.19 Aligned_cols=212 Identities=13% Similarity=0.173 Sum_probs=168.6
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeec----CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+|+..++.++|+||+++++++... ...++||||+ |++|.+++... +.+++..+..++.|++.||.|||+
T Consensus 92 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~-g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH~ 170 (364)
T 3op5_A 92 KPEQIQKWIRTRKLKYLGVPKYWGSGLHDKNGKSYRFMIMDRF-GSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHE 170 (364)
T ss_dssp CHHHHHHHHHHTTCSCCCSCCEEEEEEEEETTEEEEEEEEECE-EEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hhHHHHHHHHHhhccCCCCCeEEeeeeeccCCcceEEEEEeCC-CCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 34455677778888999999999998764 5589999999 99999999876 679999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--------cccccCCCCccCcccccccCCCCchhHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~ 156 (241)
.|++||||||+||+++. +.++.++|+|||++........ .....+|+.|+|||.+.+..++.++||||||+
T Consensus 171 ~~iiHrDlkp~Nill~~-~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~ 249 (364)
T 3op5_A 171 HEYVHGDIKASNLLLNY-KNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVAPSRRGDLEILGY 249 (364)
T ss_dssp TTEECCCCCGGGEEEES-SCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCCCCHHHHHHHHHH
T ss_pred CCeEEecCCHHHEEEec-CCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCCCCchhhHHHHHH
Confidence 99999999999999942 2678899999999976543221 12345899999999999999999999999999
Q ss_pred HHHHHHhCCCCCCCCC-hHHHHHHhhcCCCCCCCCc-----cCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 157 ILFELLNGYPPFSGRN-NVQLVRNINSCKHLPFSQL-----IVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~-----~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++|+|++|..||.+.. ................... ....++.++.+++..||+.||.+|||++++++
T Consensus 250 ~l~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~cl~~~p~~RP~~~~l~~ 322 (364)
T 3op5_A 250 CMIQWLTGHLPWEDNLKDPKYVRDSKIRYRENIASLMDKCFPAANAPGEIAKYMETVKLLDYTEKPLYENLRD 322 (364)
T ss_dssp HHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHCHHHHHHHHSCTTCCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHHHhCCCCccccccCHHHHHHHHHHhhhhHHHHHHHhcccccCHHHHHHHHHHHhcCCCCCCCCHHHHHH
Confidence 9999999999998532 2222211111110000000 01377899999999999999999999999884
|
| >4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.3e-40 Score=260.03 Aligned_cols=203 Identities=26% Similarity=0.391 Sum_probs=169.0
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC--c
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH--I 87 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~--i 87 (241)
+.+.+|++++++++||||+++++++.+.. ++||||+++++|.+++... .++++..+..++.|++.||.+||+.| +
T Consensus 68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~--~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~lH~~~~~i 145 (287)
T 4f0f_A 68 QEFQREVFIMSNLNHPNIVKLYGLMHNPP--RMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEYMQNQNPPI 145 (287)
T ss_dssp HHHHHHHHHHTTCCCTTBCCEEEEETTTT--EEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHHHTSSSCC
T ss_pred HHHHHHHHHHHhCCCCCchhhheeecCCC--eEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHHHHhCCCCe
Confidence 78899999999999999999999987665 6999999999999888654 46999999999999999999999999 9
Q ss_pred cccCCCCCCeEEeecCCCce-----EEEeecCCccccCCCCccccccCCCCccCccccc--ccCCCCchhHHHHHHHHHH
Q 026253 88 IHRDLKPENILLSGLDDDVM-----LKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ--FQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~-----~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~--~~~~~~~~Dv~slG~~l~~ 160 (241)
+|+||||+||+++ ..+. ++|+|||.+..... ......+++.|+|||.+. ...++.++|+||+|+++|+
T Consensus 146 vH~dikp~Nil~~---~~~~~~~~~~kl~Dfg~~~~~~~--~~~~~~g~~~y~aPE~~~~~~~~~~~~~Di~slG~~l~~ 220 (287)
T 4f0f_A 146 VHRDLRSPNIFLQ---SLDENAPVCAKVADFGLSQQSVH--SVSGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYT 220 (287)
T ss_dssp BCSCCSGGGEEES---CCCTTCSCCEEECCCTTCBCCSS--CEECCCCCCTTSCGGGSSCSSCEECHHHHHHHHHHHHHH
T ss_pred ecCCCCcceEEEe---ccCCCCceeEEeCCCCccccccc--cccccCCCccccCchhhccCCCCcCchhhHHHHHHHHHH
Confidence 9999999999994 4443 99999999975443 233456899999999984 4557899999999999999
Q ss_pred HHhCCCCCCCCChHHH--HHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 161 LLNGYPPFSGRNNVQL--VRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~--~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|++|..||...+.... ...+...... ......+++++.+++.+||+.||.+|||++++++
T Consensus 221 l~~g~~pf~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~ll~ 282 (287)
T 4f0f_A 221 ILTGEGPFDEYSYGKIKFINMIREEGLR---PTIPEDCPPRLRNVIELCWSGDPKKRPHFSYIVK 282 (287)
T ss_dssp HHHSSCTTTTCCCCHHHHHHHHHHSCCC---CCCCTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HHcCCCCCccccccHHHHHHHHhccCCC---CCCCcccCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 9999999986554332 3333332221 1223478999999999999999999999999985
|
| >3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=268.23 Aligned_cols=215 Identities=24% Similarity=0.335 Sum_probs=173.9
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----CCCHHHHHHHHHHHHHHHHHHHh
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----RVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
....+.+|++++++++||||+++++++.+.+..++||||+++++|.+++.... ++++..+..++.|++.||.+||+
T Consensus 70 ~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~l~~lH~ 149 (326)
T 3uim_A 70 GELQFQTEVEMISMAVHRNLLRLRGFCMTPTERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSARGLAYLHD 149 (326)
T ss_dssp CCCHHHHHHHGGGTCCCTTBCCCCEEECCSSCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhccCCCccceEEEEecCCceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34478999999999999999999999999999999999999999999998643 38999999999999999999999
Q ss_pred C---CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 85 H---HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 85 ~---~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
. |++|+||||+||++ +.++.++|+|||.+....... ......+++.|+|||.+.+..++.++|+||+|+++|
T Consensus 150 ~~~~~ivH~Dlkp~Nil~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il~ 226 (326)
T 3uim_A 150 HCDPKIIHRDVKAANILL---DEEFEAVVGDFGLAKLMDYKDTHVTTAVRGTIGHIAPEYLSTGKSSEKTDVFGYGVMLL 226 (326)
T ss_dssp SSSSCEECCCCSGGGEEE---CTTCCEEECCCSSCEECCSSSSCEECCCCSCGGGCCHHHHHHSEECHHHHHHHHHHHHH
T ss_pred CCCCCeEeCCCchhhEEE---CCCCCEEeccCccccccCcccccccccccCCcCccCHHHhccCCCCccccchhHHHHHH
Confidence 9 99999999999999 788899999999998664332 233445899999999998888999999999999999
Q ss_pred HHHhCCCCCCC-----CChHHHHHHhhc---CCC------CCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCc
Q 026253 160 ELLNGYPPFSG-----RNNVQLVRNINS---CKH------LPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHR 225 (241)
Q Consensus 160 ~l~~g~~p~~~-----~~~~~~~~~i~~---~~~------~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~ 225 (241)
+|++|..||.. .........+.. ... ...........+..+.+++.+||+.||.+|||++++++|-
T Consensus 227 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~ell~~L 306 (326)
T 3uim_A 227 ELITGQRAFDLARLANDDDVMLLDWVKGLLKEKKLEALVDVDLQGNYKDEEVEQLIQVALLCTQSSPMERPKMSEVVRML 306 (326)
T ss_dssp HHHHCCCSBCHHHHTTTSCSBHHHHHTTTTSSCCSTTSSCTTCTTSCCHHHHHHHHHHHHHHTCSCGGGSCCHHHHHHHH
T ss_pred HHHhCCCcccccccccccchhHHHHHHHHhhchhhhhhcChhhccccCHHHHHHHHHHHHHHhCcCCccCCCHHHHHHHh
Confidence 99999999962 111111111111 110 0111111223346799999999999999999999999875
Q ss_pred c
Q 026253 226 F 226 (241)
Q Consensus 226 ~ 226 (241)
.
T Consensus 307 ~ 307 (326)
T 3uim_A 307 E 307 (326)
T ss_dssp H
T ss_pred c
Confidence 4
|
| >2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.1e-41 Score=269.78 Aligned_cols=209 Identities=20% Similarity=0.322 Sum_probs=177.1
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|+.++++++|+||+++++++.+.+..++||||+++++|.+++...+ .+++..+..++.|++.||.+||+.|
T Consensus 71 ~~~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~~ 150 (319)
T 2y4i_B 71 DQLKAFKREVMAYRQTRHENVVLFMGACMSPPHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMGYLHAKG 150 (319)
T ss_dssp CCCCCCCTTGGGGTTCCCTTBCCCCEEEECSSCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHhcCCCCCEeEEEEEEecCCceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 345678899999999999999999999999999999999999999999997654 6899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCC------CccccccCCCCccCcccccc---------cCCCCchhH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG------NYAEKVCGSPLYMAPEVLQF---------QRYDEKVDM 151 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~------~~~~~~~~~~~~~~PE~~~~---------~~~~~~~Dv 151 (241)
++|+||+|+||++ + ++.++|+|||++...... .......++..|+|||.+.+ ..++.++|+
T Consensus 151 i~H~dlkp~NIl~---~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~~Di 226 (319)
T 2y4i_B 151 ILHKDLKSKNVFY---D-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDV 226 (319)
T ss_dssp CCCCCCCSTTEEE---C---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHHHHH
T ss_pred ccccCCChhhEEE---e-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCchhhH
Confidence 9999999999999 4 568999999998654321 12223457888999999864 347889999
Q ss_pred HHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 152 WSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 152 ~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
||||+++|+|++|..||...+.......+..+....... ..++.++.+++.+||+.||.+|||++++++
T Consensus 227 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 295 (319)
T 2y4i_B 227 FALGTIWYELHAREWPFKTQPAEAIIWQMGTGMKPNLSQ---IGMGKEISDILLFCWAFEQEERPTFTKLMD 295 (319)
T ss_dssp HHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCCCCCCC---SSCCTTHHHHHHHHHCSSTTTSCCHHHHHH
T ss_pred HHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCCCCCCc---CCCCHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999999999999998888887776665443332 368899999999999999999999999985
|
| >2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-40 Score=286.18 Aligned_cols=210 Identities=26% Similarity=0.500 Sum_probs=181.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+.+.+|+.++++++||||+++++++. ++..++||||+++++|.+++...+ .+++..+..++.|++.||.+||+
T Consensus 431 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~LH~ 509 (656)
T 2j0j_A 431 SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAYLES 509 (656)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEC-SSSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEe-cCceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 3445678999999999999999999999985 466899999999999999998654 68999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
+|++||||||+||++ +.++.++|+|||++........ .....++..|+|||.+.+..++.++|+||+|+++|+|+
T Consensus 510 ~givHrDikp~NILl---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~DiwSlG~il~ell 586 (656)
T 2j0j_A 510 KRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 586 (656)
T ss_dssp TTCCCSCCSGGGEEE---EETTEEEECCCCCCCSCCC----------CCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHH
T ss_pred CCccccccchHhEEE---eCCCCEEEEecCCCeecCCCcceeccCCCCCcceeCHHHhcCCCCCchhhHHHHHHHHHHHH
Confidence 999999999999999 5678999999999987644322 22344567899999998889999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+ |..||.+.+..+....+..+...+.+. .+++.+.+++.+||+.||.+|||+.++++
T Consensus 587 t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~~l~~dP~~RPs~~el~~ 644 (656)
T 2j0j_A 587 MHGVKPFQGVKNNDVIGRIENGERLPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKA 644 (656)
T ss_dssp TTSCCTTTTCCHHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred HcCCCCCCCCCHHHHHHHHHcCCCCCCCc----cccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 7 999999999988888887777665544 78999999999999999999999999885
|
| >3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=264.64 Aligned_cols=215 Identities=18% Similarity=0.195 Sum_probs=173.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEE-eecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|+.++++++|++++..+..+ ..++..++||||+ +++|.+++.. ...+++..+..++.|++.||.+||++|
T Consensus 47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~lH~~~ 125 (296)
T 3uzp_A 47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 125 (296)
T ss_dssp SCCHHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred chhHHHHHHHHHHHhhcCCCCCccccccCCCCceEEEEEec-CCCHHHHHHhhccCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 346789999999999988866666554 6678889999999 8999999974 457999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--------cccccCCCCccCcccccccCCCCchhHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 158 (241)
++|+||||+||+++..+.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++
T Consensus 126 ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~il 205 (296)
T 3uzp_A 126 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 205 (296)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred eeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCCCCcchhhHHHHHHH
Confidence 99999999999995334677899999999977654322 2345689999999999998999999999999999
Q ss_pred HHHHhCCCCCCCCCh---HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 159 FELLNGYPPFSGRNN---VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|+|++|..||.+.+. .+....+...............+|+++.+++++||+.||.+|||++++++.
T Consensus 206 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~ 274 (296)
T 3uzp_A 206 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQL 274 (296)
T ss_dssp HHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHHH
T ss_pred HHHHhCCCCCCCcCchhhhhhhhhhcccccCCchHHHHhhCCHHHHHHHHHHHhcCcCcCCCHHHHHHH
Confidence 999999999986432 223333322211111122334789999999999999999999999998853
|
| >3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=5.4e-41 Score=265.23 Aligned_cols=218 Identities=22% Similarity=0.338 Sum_probs=171.1
Q ss_pred hhhhhHHhhhhHHHHHHHHhc--CCCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~--l~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (241)
+|.+..+..+.+.+|.+++.. ++||||+++++++.. .+..++||||+++++|.++++ ...+++..+..++.|+
T Consensus 36 vK~~~~~~~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~-~~~~~~~~~~~i~~~i 114 (301)
T 3q4u_A 36 VKIFSSRDEKSWFRETELYNTVMLRHENILGFIASDMTSRHSSTQLWLITHYHEMGSLYDYLQ-LTTLDTVSCLRIVLSI 114 (301)
T ss_dssp EEEECGGGHHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEETTEEEEEEEECCCTTCBHHHHHT-TCCBCHHHHHHHHHHH
T ss_pred EEEeccccchhhHHHHHHHHHhhccCcCeeeEEEeeccccCCCceeEEehhhccCCCHHHHHh-hcccCHHHHHHHHHHH
Confidence 455666667777778888877 799999999998654 356899999999999999996 4579999999999999
Q ss_pred HHHHHHHH--------hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----cccccCCCCccCcccccc
Q 026253 76 GAGLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQF 142 (241)
Q Consensus 76 ~~~l~~lh--------~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~~~~~~~~~PE~~~~ 142 (241)
+.||.+|| +.|++|+||||+||++ +.++.++|+|||++........ .....+++.|+|||.+.+
T Consensus 115 ~~~l~~lH~~~~~~~~~~~ivH~Dlkp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 191 (301)
T 3q4u_A 115 ASGLAHLHIEIFGTQGKPAIAHRDLKSKNILV---KKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDE 191 (301)
T ss_dssp HHHHHHHHSCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTT
T ss_pred HHHHHHHHHhhhhccCCCCeecCCCChHhEEE---cCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcC
Confidence 99999999 9999999999999999 7888999999999876543322 223468999999999987
Q ss_pred c------CCCCchhHHHHHHHHHHHHhC----------CCCCCCCC----hHHHHHHhh-cC-CCCCCCCc-cCCCCChH
Q 026253 143 Q------RYDEKVDMWSVGAILFELLNG----------YPPFSGRN----NVQLVRNIN-SC-KHLPFSQL-IVPALHPD 199 (241)
Q Consensus 143 ~------~~~~~~Dv~slG~~l~~l~~g----------~~p~~~~~----~~~~~~~i~-~~-~~~~~~~~-~~~~~~~~ 199 (241)
. .++.++|+||+|+++|+|++| ..||.... ......... .. .....+.. .....+.+
T Consensus 192 ~~~~~~~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 271 (301)
T 3q4u_A 192 TIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQQRPNIPNRWFSDPTLTS 271 (301)
T ss_dssp CCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHH
T ss_pred cCCCCcccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccCCCCCCChhhccCccHHH
Confidence 6 455799999999999999999 88886432 222232222 11 12222211 11235578
Q ss_pred HHHHHHHhcccCccccCCHHHHhc
Q 026253 200 CVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 200 ~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+.+++++||+.||.+|||++++++
T Consensus 272 l~~li~~cl~~dP~~Rps~~~i~~ 295 (301)
T 3q4u_A 272 LAKLMKECWYQNPSARLTALRIKK 295 (301)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred HHHHHHHHhhcChhhCCCHHHHHH
Confidence 999999999999999999999985
|
| >2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.8e-41 Score=266.28 Aligned_cols=212 Identities=23% Similarity=0.323 Sum_probs=172.0
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGA 77 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~ 77 (241)
+....+.+.+|++++++++||||+++++++.. ....++||||+.+++|.+++.. ...+++..+..++.|++.
T Consensus 66 ~~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~ 145 (317)
T 2buj_A 66 EQQDREEAQREADMHRLFNHPNILRLVAYCLRERGAKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR 145 (317)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEEEETTEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHhhcCCCCeeeEEEEEEeccCCCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence 45567889999999999999999999999863 3478999999999999999976 366999999999999999
Q ss_pred HHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----------cccccCCCCccCcccccccC---
Q 026253 78 GLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----------AEKVCGSPLYMAPEVLQFQR--- 144 (241)
Q Consensus 78 ~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----------~~~~~~~~~~~~PE~~~~~~--- 144 (241)
||.+||+.|++|+||+|+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..
T Consensus 146 ~L~~LH~~~ivH~dlkp~NIl~---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ 222 (317)
T 2buj_A 146 GLEAIHAKGYAHRDLKPTNILL---GDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCV 222 (317)
T ss_dssp HHHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEE
T ss_pred HHHHHHhCCcccCCCCHHHEEE---cCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcC
Confidence 9999999999999999999999 7888999999998866532111 11234688999999987543
Q ss_pred CCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 145 YDEKVDMWSVGAILFELLNGYPPFSGRN--NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 145 ~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
++.++|+||||+++|+|++|..||.... .......+......+. .+.++.++.++|++||+.||.+|||+++++
T Consensus 223 ~~~~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~l~~li~~~l~~dp~~Rps~~~ll 298 (317)
T 2buj_A 223 IDERTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQNQLSIPQ----SPRHSSALWQLLNSMMTVDPHQRPHIPLLL 298 (317)
T ss_dssp ECTHHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHHCC--CCC----CTTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCchhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhhccCCCCc----cccCCHHHHHHHHHHhhcChhhCCCHHHHH
Confidence 6899999999999999999999996311 1112222222222222 247889999999999999999999999999
Q ss_pred cC
Q 026253 223 HH 224 (241)
Q Consensus 223 ~~ 224 (241)
++
T Consensus 299 ~~ 300 (317)
T 2buj_A 299 SQ 300 (317)
T ss_dssp HH
T ss_pred HH
Confidence 76
|
| >2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.9e-41 Score=272.60 Aligned_cols=210 Identities=16% Similarity=0.230 Sum_probs=171.4
Q ss_pred hhHHHHHHHHhcCCCcCeee---------------eeeEEee-cCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHH
Q 026253 11 SCLDCELNFLSSVNHPNIIR---------------LFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFL 72 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~---------------~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~ 72 (241)
+.+.+|++++++++||||++ +++++.. ++..++||||+ +++|.+++... ..+++..+..++
T Consensus 87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~~~~~~lv~e~~-~~~L~~~l~~~~~~~l~~~~~~~i~ 165 (352)
T 2jii_A 87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQDKYRFLVLPSL-GRSLQSALDVSPKHVLSERSVLQVA 165 (352)
T ss_dssp STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEETTTEEEEEEECC-CEEHHHHHHHSGGGCCCHHHHHHHH
T ss_pred chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccCCcEEEEEecCC-CcCHHHHHHhCCcCCCCHHHHHHHH
Confidence 57899999999999999887 5667665 68899999999 99999999876 779999999999
Q ss_pred HHHHHHHHHHHhCCccccCCCCCCeEEeecCCCc--eEEEeecCCccccCCCC--------ccccccCCCCccCcccccc
Q 026253 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDV--MLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQF 142 (241)
Q Consensus 73 ~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~--~~~l~df~~a~~~~~~~--------~~~~~~~~~~~~~PE~~~~ 142 (241)
.|++.||.+||++|++|+||||+||++ +.++ .++|+|||++....... ......+++.|+|||.+.+
T Consensus 166 ~qi~~~L~~LH~~~ivH~Dikp~NIl~---~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 242 (352)
T 2jii_A 166 CRLLDALEFLHENEYVHGNVTAENIFV---DPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDLHKG 242 (352)
T ss_dssp HHHHHHHHHHHHTTCBCSCCCGGGEEE---ETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHHHTT
T ss_pred HHHHHHHHHHHhCCccCCCCCHHHEEE---cCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHHHcc
Confidence 999999999999999999999999999 4565 89999999997654322 1233468999999999998
Q ss_pred cCCCCchhHHHHHHHHHHHHhCCCCCCCCC--hHHHHHHhhc--CCCCCCCC--ccCCCCChHHHHHHHHhcccCccccC
Q 026253 143 QRYDEKVDMWSVGAILFELLNGYPPFSGRN--NVQLVRNINS--CKHLPFSQ--LIVPALHPDCVDMCLKLLSANTVDRL 216 (241)
Q Consensus 143 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~--~~~~~~~i~~--~~~~~~~~--~~~~~~~~~~~~li~~~l~~~p~~Rp 216 (241)
..++.++|+||||+++|+|++|..||.... .......... .....+.. .....+++++.+++.+||+.||.+||
T Consensus 243 ~~~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dp~~Rp 322 (352)
T 2jii_A 243 CGPSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGPFVGPCGHWIRPSETLQKYLKVVMALTYEEKP 322 (352)
T ss_dssp CCCCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCCEECTTSCEECCCHHHHHHHHHHHTCCTTCCC
T ss_pred CCCCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhhhhhhccccCCCcHHHHHHHHHHHhCChhhCC
Confidence 899999999999999999999999998753 3322222211 11111111 11235789999999999999999999
Q ss_pred CHHHHhcC
Q 026253 217 SFNEFYHH 224 (241)
Q Consensus 217 s~~~il~~ 224 (241)
|++++++.
T Consensus 323 s~~~l~~~ 330 (352)
T 2jii_A 323 PYAMLRNN 330 (352)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999853
|
| >2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=3.8e-41 Score=266.91 Aligned_cols=214 Identities=24% Similarity=0.363 Sum_probs=173.7
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+...+.+.+|++++++++||||+++++++.+++..++||||+++++|.+++.. ..++++..+..++.|++.||.+||
T Consensus 71 ~~~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~l~~lH 150 (307)
T 2nru_A 71 EELKQQFDQEIKVMAKCQHENLVELLGFSSDGDDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANGINFLH 150 (307)
T ss_dssp TTHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEEEEecCCceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHHHHHHh
Confidence 34577899999999999999999999999999999999999999999999974 346899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+.|++|+||+|+||++ +.++.++|+|||.+........ .....+++.|+|||.+.+ .++.++|+||||+++|+
T Consensus 151 ~~~i~H~dlkp~Nili---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~-~~~~~~Dv~slG~il~~ 226 (307)
T 2nru_A 151 ENHHIHRDIKSANILL---DEAFTAKISDFGLARASEKFAQTVMTSRIVGTTAYMAPEALRG-EITPKSDIYSFGVVLLE 226 (307)
T ss_dssp HTTEECSCCCGGGEEE---CTTCCEEECCCTTCEECCSCSSCEECSSCCSCGGGCCHHHHTT-EECTHHHHHHHHHHHHH
T ss_pred cCCeecCCCCHHHEEE---cCCCcEEEeecccccccccccccccccccCCCcCcCChHHhcC-CCCccchhHHHHHHHHH
Confidence 9999999999999999 7888999999999876543221 233568999999998875 47899999999999999
Q ss_pred HHhCCCCCCCCChHH----HHHHhhcCCCC------CCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 161 LLNGYPPFSGRNNVQ----LVRNINSCKHL------PFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 161 l~~g~~p~~~~~~~~----~~~~i~~~~~~------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|++|..||......+ ....+...... ..........+..+.+++.+||+.||.+|||+++++++
T Consensus 227 l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~cl~~~p~~Rps~~~l~~~ 300 (307)
T 2nru_A 227 IITGLPAVDEHREPQLLLDIKEEIEDEEKTIEDYIDKKMNDADSTSVEAMYSVASQCLHEKKNKRPDIKKVQQL 300 (307)
T ss_dssp HHHCCCSBCTTBSSSBTTHHHHHHHTTSCCHHHHSCSSCSCCCHHHHHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHCCCCcccCcchHHHHHHHHHhhhhhhhhhhhccccccccchHHHHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence 999999998654332 11222111100 00011122345679999999999999999999999864
|
| >4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-41 Score=275.29 Aligned_cols=215 Identities=25% Similarity=0.440 Sum_probs=174.9
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecC--eEEEEEeccCCCChHHHHHhcCC---CCHHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAEN--CIFLVVEFCAGGNLSSYIRLHGR---VPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~--~~~lv~e~~~~~~L~~~l~~~~~---~~~~~~~~~~~~i~~~l~~lh 83 (241)
..+.+.+|++++++++||||+++++++...+ ..++||||+++++|.+++..... +++..+..++.|++.||.+||
T Consensus 50 ~~~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL~~LH 129 (396)
T 4eut_A 50 PVDVQMREFEVLKKLNHKNIVKLFAIEEETTTRHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGMNHLR 129 (396)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECTTTCCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHhcCCCCCCeEEEeeccCCCCeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 3567789999999999999999999988654 78999999999999999976433 999999999999999999999
Q ss_pred hCCccccCCCCCCeEEee-cCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc--------cCCCCchhHHHH
Q 026253 84 SHHIIHRDLKPENILLSG-LDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF--------QRYDEKVDMWSV 154 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~-~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~--------~~~~~~~Dv~sl 154 (241)
+.|++||||||+||++.. .+..+.++|+|||.+.............++..|+|||.+.+ ..++.++|+|||
T Consensus 130 ~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~DiwSl 209 (396)
T 4eut_A 130 ENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDEQFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSI 209 (396)
T ss_dssp HTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGGGSSCSSSCCTTCCHHHHHHHCC--CHHHHHHHHHHHHHH
T ss_pred HCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCCccccccCCccccCHHHhhccccccccccCCCcHHHHHHH
Confidence 999999999999999732 34566799999999988766555556678999999999865 567889999999
Q ss_pred HHHHHHHHhCCCCCCC----CChHHHHHHhhcCCCCC--------------------CCCccCCCCChHHHHHHHHhccc
Q 026253 155 GAILFELLNGYPPFSG----RNNVQLVRNINSCKHLP--------------------FSQLIVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 155 G~~l~~l~~g~~p~~~----~~~~~~~~~i~~~~~~~--------------------~~~~~~~~~~~~~~~li~~~l~~ 210 (241)
|+++|+|++|..||.. ....+....+..+.... ........++..+.+++++||+.
T Consensus 210 G~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~ll~~~L~~ 289 (396)
T 4eut_A 210 GVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPVSCSLSRGLQVLLTPVLANILEA 289 (396)
T ss_dssp HHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTTCCEEEESSCCTTCSSCHHHHHHHHHHHHHHSCC
T ss_pred HHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccCCCcccCccCCcccccchHHHhhchHHHHHhhcc
Confidence 9999999999999964 23344454444433211 11111223456789999999999
Q ss_pred CccccCCHHHHhc
Q 026253 211 NTVDRLSFNEFYH 223 (241)
Q Consensus 211 ~p~~Rps~~~il~ 223 (241)
||.+|||++++++
T Consensus 290 dP~~R~s~~e~l~ 302 (396)
T 4eut_A 290 DQEKCWGFDQFFA 302 (396)
T ss_dssp CTTTSCCHHHHHH
T ss_pred ChhhhccHHHHHH
Confidence 9999999999854
|
| >2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=1.4e-40 Score=265.90 Aligned_cols=210 Identities=24% Similarity=0.399 Sum_probs=173.3
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec--CeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE--NCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~--~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
....+.+.+|++++++++|+||+++++++... +..++|||++++++|.+++... ..+++..+..++.|++.||.+||
T Consensus 83 ~~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~LH 162 (326)
T 2w1i_A 83 EEHLRDFEREIEILKSLQHDNIVKYKGVCYSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEYLG 162 (326)
T ss_dssp SHHHHHHHHHHHHHHTCCCTTBCCEEEEECC----CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCeeeEEEEEEecCCCceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHHH
Confidence 44567899999999999999999999988654 4789999999999999999876 45999999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
+.|++|+||||+||++ +.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||||+++|
T Consensus 163 ~~~ivH~dikp~NIli---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~Di~slG~il~ 239 (326)
T 2w1i_A 163 TKRYIHRDLATRNILV---ENENRVKIGDFGLTKVLPQDKEYYKVKEPGESPIFWYAPESLTESKFSVASDVWSFGVVLY 239 (326)
T ss_dssp HTTEECSCCCGGGEEE---EETTEEEECCCTTCEECCSSCSEEECSSCCSCCGGGCCHHHHHHCEEEHHHHHHHHHHHHH
T ss_pred hCCEeccCCCcceEEE---cCCCcEEEecCcchhhccccccccccccCCCCceeEECchhhcCCCCCchhhHHHHHHHHH
Confidence 9999999999999999 5678999999999987654322 22334567799999998888999999999999999
Q ss_pred HHHhCCCCCCCCCh----------------HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 160 ELLNGYPPFSGRNN----------------VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 160 ~l~~g~~p~~~~~~----------------~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+|++|..||..... ......+......+.+ ..++.++.+++++||+.||.+|||+.++++
T Consensus 240 el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~l~~li~~cl~~dP~~Rps~~el~~ 315 (326)
T 2w1i_A 240 ELFTYIEKSKSPPAEFMRMIGNDKQGQMIVFHLIELLKNNGRLPRP----DGCPDEIYMIMTECWNNNVNQRPSFRDLAL 315 (326)
T ss_dssp HHHHTTCGGGSHHHHHHHHHCTTCCTHHHHHHHHHHHHTTCCCCCC----TTCCHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred HHHhcCCCCCCCHHHHHHhhccccchhhhHHHHHHHhhcCCCCCCC----CcccHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence 99999998864211 0122333333333333 478999999999999999999999999884
|
| >4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A | Back alignment and structure |
|---|
Probab=100.00 E-value=9.5e-41 Score=263.16 Aligned_cols=215 Identities=18% Similarity=0.200 Sum_probs=173.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEE-eecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~-~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+.+|++++++++|++++..++.+ ..++..++|||++ +++|.+++.. ...+++..+..++.|++.||.+||+.
T Consensus 46 ~~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~~~~~~lv~e~~-~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~ 124 (296)
T 4hgt_A 46 TKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSK 124 (296)
T ss_dssp --CCCHHHHHHHHHHHTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ccchHHHHHHHHHHHhcCCCCCCeeeeecCCCCceEEEEEcc-CCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 4456789999999999888877666654 6778899999999 8999999985 45799999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--------cccccCCCCccCcccccccCCCCchhHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~ 157 (241)
|++|+||||+||+++..+.++.++|+|||.+........ .....++..|+|||.+.+..++.++|+||+|++
T Consensus 125 ~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~Di~slG~i 204 (296)
T 4hgt_A 125 NFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYV 204 (296)
T ss_dssp TEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCCCCHHHHHHHHHHH
T ss_pred CeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCCCCchhHHHHHHHH
Confidence 999999999999995445677899999999976644322 234568999999999999999999999999999
Q ss_pred HHHHHhCCCCCCCCChH---HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 158 LFELLNGYPPFSGRNNV---QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~---~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+|+|++|..||.+.+.. +....+...............+++++.+++.+||+.||.+|||++++++
T Consensus 205 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~~p~~Rpt~~~l~~ 273 (296)
T 4hgt_A 205 LMYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQ 273 (296)
T ss_dssp HHHHHHSSCTTSSCCCSSSSSHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred HHHHhcCCCCCcccchhhhhhhhhhhhcccccchhhhhhccCCHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence 99999999999864332 2222222211111122223477899999999999999999999999985
|
| >1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=4.3e-40 Score=264.57 Aligned_cols=219 Identities=22% Similarity=0.284 Sum_probs=176.0
Q ss_pred hhhhhHHhhhhHHHHHHHHhc--CCCcCeeeeeeEEeecC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSS--VNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~--l~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (241)
+|.++....+.+.+|.++++. ++||||+++++++...+ ..++||||+++++|.+++++ .++++..+..++.|+
T Consensus 70 vK~~~~~~~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i 148 (342)
T 1b6c_B 70 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNR-YTVTVEGMIKLALST 148 (342)
T ss_dssp EEEECGGGHHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSSCCCEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred EEEeCchhHHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCccceeEEEEeecCCCcHHHHHhc-cCccHHHHHHHHHHH
Confidence 566666677788899999988 68999999999998765 79999999999999999975 478999999999999
Q ss_pred HHHHHHHH--------hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-----ccccccCCCCccCcccccc
Q 026253 76 GAGLEILN--------SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF 142 (241)
Q Consensus 76 ~~~l~~lh--------~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~~~~~~~~~PE~~~~ 142 (241)
+.||.+|| +.|++|+||||+||++ +.++.++|+|||++....... ......++..|+|||.+.+
T Consensus 149 ~~~l~~lH~~~~~~~~~~~ivH~Dlkp~NIll---~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 225 (342)
T 1b6c_B 149 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 225 (342)
T ss_dssp HHHHHHHHCCBCSTTCBCEEECSCCSGGGEEE---CTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTS
T ss_pred HHHHHHHHHHHhhhcccCCeeeCCCCHHHEEE---CCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcc
Confidence 99999999 8999999999999999 778899999999997664433 1234568999999999876
Q ss_pred c------CCCCchhHHHHHHHHHHHHhC----------CCCCCCCC-----hHHHHHHhhcCC-CCCCCCcc-CCCCChH
Q 026253 143 Q------RYDEKVDMWSVGAILFELLNG----------YPPFSGRN-----NVQLVRNINSCK-HLPFSQLI-VPALHPD 199 (241)
Q Consensus 143 ~------~~~~~~Dv~slG~~l~~l~~g----------~~p~~~~~-----~~~~~~~i~~~~-~~~~~~~~-~~~~~~~ 199 (241)
. .++.++|+||||+++|+|++| ..||.... .......+.... ....+... ....+..
T Consensus 226 ~~~~~~~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 305 (342)
T 1b6c_B 226 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 305 (342)
T ss_dssp CCCTTCHHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGTSHHHHH
T ss_pred cccccccccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHHHHHHHhCCCCcccccchhHHHH
Confidence 5 234689999999999999999 78887542 233344432222 22222211 1234467
Q ss_pred HHHHHHHhcccCccccCCHHHHhcC
Q 026253 200 CVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 200 ~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+.+++.+||+.||.+|||+++++++
T Consensus 306 l~~li~~cl~~dp~~Rps~~~i~~~ 330 (342)
T 1b6c_B 306 MAKIMRECWYANGAARLTALRIKKT 330 (342)
T ss_dssp HHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHhccChhhCCCHHHHHHH
Confidence 9999999999999999999999976
|
| >3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7 | Back alignment and structure |
|---|
Probab=100.00 E-value=8.1e-40 Score=262.38 Aligned_cols=219 Identities=23% Similarity=0.322 Sum_probs=169.6
Q ss_pred hhhhhHHhhhhHHHHHHHHhcC--CCcCeeeeeeEEeec----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSV--NHPNIIRLFDAFQAE----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l--~~~~i~~~~~~~~~~----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (241)
+|.+.........+|.+++..+ +|+||+++++++... +..++||||+++++|.++++. ..+++..+..++.|+
T Consensus 65 vK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~i~~~i 143 (337)
T 3mdy_A 65 VKVFFTTEEASWFRETEIYQTVLMRHENILGFIAADIKGTGSWTQLYLITDYHENGSLYDYLKS-TTLDAKSMLKLAYSS 143 (337)
T ss_dssp EEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGGGCEEEEEECCCTTCBHHHHHHH-CCBCHHHHHHHHHHH
T ss_pred EEEEeccccchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCCCCceEEEEeccCCCcHHHHhhc-cCCCHHHHHHHHHHH
Confidence 4455455556666677777665 899999999998877 789999999999999999975 479999999999999
Q ss_pred HHHHHHHHhC--------CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc-----ccccCCCCccCcccccc
Q 026253 76 GAGLEILNSH--------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-----EKVCGSPLYMAPEVLQF 142 (241)
Q Consensus 76 ~~~l~~lh~~--------~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~-----~~~~~~~~~~~PE~~~~ 142 (241)
+.||.+||+. |++|+||||+||++ +.++.++|+|||++......... ....++..|+|||.+.+
T Consensus 144 ~~~l~~lH~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 220 (337)
T 3mdy_A 144 VSGLCHLHTEIFSTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDE 220 (337)
T ss_dssp HHHHHHHHSCBCSTTCBCCEECSCCCGGGEEE---CTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHhhhhhccCCCEEecccchHHEEE---CCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccc
Confidence 9999999998 99999999999999 78889999999999765433221 24568999999999987
Q ss_pred cCCCCc------hhHHHHHHHHHHHHhC----------CCCCCCCC----hHHHHHHhhcCC--CCCCCCcc-CCCCChH
Q 026253 143 QRYDEK------VDMWSVGAILFELLNG----------YPPFSGRN----NVQLVRNINSCK--HLPFSQLI-VPALHPD 199 (241)
Q Consensus 143 ~~~~~~------~Dv~slG~~l~~l~~g----------~~p~~~~~----~~~~~~~i~~~~--~~~~~~~~-~~~~~~~ 199 (241)
...+.. +|+||||+++|+|++| +.||.... ............ ....+... ...++.+
T Consensus 221 ~~~~~~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 300 (337)
T 3mdy_A 221 SLNRNHFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKKLRPSFPNRWSSDECLRQ 300 (337)
T ss_dssp CCCTTCTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGSHHHHH
T ss_pred ccCCccccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhccCccccccchhhHHHHH
Confidence 766554 9999999999999999 77775432 222222222211 22222211 1245677
Q ss_pred HHHHHHHhcccCccccCCHHHHhcC
Q 026253 200 CVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 200 ~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+.+++.+||+.||.+|||+++++++
T Consensus 301 l~~li~~~l~~dP~~Rps~~ell~~ 325 (337)
T 3mdy_A 301 MGKLMTECWAHNPASRLTALRVKKT 325 (337)
T ss_dssp HHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHhhhhChhhCCCHHHHHHH
Confidence 9999999999999999999999975
|
| >3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=4.8e-40 Score=263.54 Aligned_cols=210 Identities=26% Similarity=0.438 Sum_probs=155.5
Q ss_pred hHHhhhhHHHHHHHHhcCC-CcCeeeeeeEEe--------ecCeEEEEEeccCCCChHHHHHh---cCCCCHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--------AENCIFLVVEFCAGGNLSSYIRL---HGRVPEQTARKFLQ 73 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~--------~~~~~~lv~e~~~~~~L~~~l~~---~~~~~~~~~~~~~~ 73 (241)
.....+.+.+|+.+++++. ||||+++++++. .....++|||++. ++|.+++.. .+++++..+..++.
T Consensus 65 ~~~~~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~-g~L~~~l~~~~~~~~~~~~~~~~i~~ 143 (337)
T 3ll6_A 65 EEEKNRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCK-GQLVEFLKKMESRGPLSCDTVLKIFY 143 (337)
T ss_dssp SHHHHHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCS-EEHHHHHHHHHTTCSCCHHHHHHHHH
T ss_pred chHHHHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecC-CCHHHHHHHhhccCCCCHHHHHHHHH
Confidence 3455678899999999995 999999999984 3445899999995 799998865 45699999999999
Q ss_pred HHHHHHHHHHhCC--ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc-------------ccccCCCCccCcc
Q 026253 74 QLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA-------------EKVCGSPLYMAPE 138 (241)
Q Consensus 74 ~i~~~l~~lh~~~--i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~-------------~~~~~~~~~~~PE 138 (241)
|++.||.+||+.| ++|+||||+||++ +.++.++|+|||++......... ....+++.|+|||
T Consensus 144 qi~~~l~~LH~~~~~ivH~Dikp~NIl~---~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE 220 (337)
T 3ll6_A 144 QTCRAVQHMHRQKPPIIHRDLKVENLLL---SNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPE 220 (337)
T ss_dssp HHHHHHHHHHTSSSCCBCCCCCGGGCEE---CTTSCEEBCCCTTCBCCSSCC----------------------------
T ss_pred HHHHHHHHHHhCCCCEEEccCCcccEEE---CCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChh
Confidence 9999999999999 9999999999999 78889999999999776543221 1345788999999
Q ss_pred cc---cccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCcccc
Q 026253 139 VL---QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDR 215 (241)
Q Consensus 139 ~~---~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~R 215 (241)
.+ .+..++.++|+||||+++|+|++|..||............ ...+. ....+..+.+++++||+.||.+|
T Consensus 221 ~~~~~~~~~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~~---~~~~~----~~~~~~~~~~li~~~l~~~p~~R 293 (337)
T 3ll6_A 221 IIDLYSNFPIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNGK---YSIPP----HDTQYTVFHSLIRAMLQVNPEER 293 (337)
T ss_dssp ---CCTTSCSSHHHHHHHHHHHHHHHHHSSCCC---------------CCCCT----TCCSSGGGHHHHHHHSCSSGGGS
T ss_pred hhhccccCCCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcCc---ccCCc----ccccchHHHHHHHHHccCChhhC
Confidence 98 5667889999999999999999999999865554333221 11111 23677889999999999999999
Q ss_pred CCHHHHhcCcc
Q 026253 216 LSFNEFYHHRF 226 (241)
Q Consensus 216 ps~~~il~~~~ 226 (241)
||++|++++-+
T Consensus 294 ps~~e~l~~l~ 304 (337)
T 3ll6_A 294 LSIAEVVHQLQ 304 (337)
T ss_dssp CCHHHHHHHHH
T ss_pred cCHHHHHHHHH
Confidence 99999998743
|
| >3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} | Back alignment and structure |
|---|
Probab=100.00 E-value=2.2e-39 Score=270.46 Aligned_cols=214 Identities=18% Similarity=0.195 Sum_probs=175.5
Q ss_pred hhhhHHHHHHHHhcCCC-cCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|+++++.++| +++..+..++...+..++||||+ +++|.+++.. ...+++..+..++.||+.||.|||++|
T Consensus 45 ~~~~~~~E~~il~~L~~~~~i~~i~~~~~~~~~~~lvme~~-g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~yLH~~g 123 (483)
T 3sv0_A 45 KHPQLLYESKIYRILQGGTGIPNVRWFGVEGDYNVLVMDLL-GPSLEDLFNFCSRKLSLKTVLMLADQMINRVEFVHSKS 123 (483)
T ss_dssp SSCCHHHHHHHHHHTTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccHHHHHHHHHHHHhcCCCCCCeEEEEEeeCCEEEEEEECC-CCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence 34578999999999976 55666666777888999999999 8999999985 457999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--------cccccCCCCccCcccccccCCCCchhHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--------~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 158 (241)
++|+||||+|||++..+..+.++|+|||++........ .....++..|+|||.+.+..++.++||||||+++
T Consensus 124 IvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~s~~sDvwSlGvil 203 (483)
T 3sv0_A 124 FLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIEQSRRDDLESLGYVL 203 (483)
T ss_dssp EECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred EeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCCCChHHHHHHHHHHH
Confidence 99999999999995444678899999999987654322 2256789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCCh---HHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 159 FELLNGYPPFSGRNN---VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~---~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|+|++|..||.+... .+.+..+...............++.++.+++..||+.+|.+||+++++++
T Consensus 204 ~elltG~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~li~~cl~~dP~~RPs~~el~~ 271 (483)
T 3sv0_A 204 MYFLRGSLPWQGLKAGTKKQKYEKISEKKVATSIEALCRGYPTEFASYFHYCRSLRFDDKPDYSYLKR 271 (483)
T ss_dssp HHHHHSSCTTSSCCCSSHHHHHHHHHHHHHHSCHHHHHTTSCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred HHHHhCCCCCccccchhHHHHHHHHhhccccccHHHHhcCCcHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence 999999999987543 33344333322222222233478999999999999999999999998774
|
| >3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=9.9e-40 Score=261.89 Aligned_cols=225 Identities=23% Similarity=0.300 Sum_probs=163.9
Q ss_pred hhhhhHHhhhhHHHHHHH--HhcCCCcCeeeeeeEEee-----cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNF--LSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~--l~~l~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~ 74 (241)
+|.++......+..|.++ +..++|+||+++++.+.. ...+++||||+++++|.++++.. ..++..+..++.|
T Consensus 41 vK~~~~~~~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~-~~~~~~~~~i~~q 119 (336)
T 3g2f_A 41 VKVFSFANRQNFINEKNIYRVPLMEHDNIARFIVGDERVTADGRMEYLLVMEYYPNGSLXKYLSLH-TSDWVSSCRLAHS 119 (336)
T ss_dssp EEEEEGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECTTSCEEEEEEECCCTTCBHHHHHHHC-CBCHHHHHHHHHH
T ss_pred EEEeeccchhhHHHHHHHHHHHhccCcchhhheecccccccCCCceEEEEEecCCCCcHHHHHhhc-ccchhHHHHHHHH
Confidence 344444444455555555 445899999999986532 33678999999999999999754 5588999999999
Q ss_pred HHHHHHHHHhC---------CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---------ccccccCCCCccC
Q 026253 75 LGAGLEILNSH---------HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---------YAEKVCGSPLYMA 136 (241)
Q Consensus 75 i~~~l~~lh~~---------~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---------~~~~~~~~~~~~~ 136 (241)
++.||.+||+. |++|+||||+||++ +.++.++|+|||++....... ......++..|+|
T Consensus 120 i~~~L~~LH~~~~~~~~~~~~ivH~Dikp~Nill---~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~a 196 (336)
T 3g2f_A 120 VTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLV---KNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMA 196 (336)
T ss_dssp HHHHHHHHHCCBCCGGGCBCCEECSSCSGGGEEE---CTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCC
T ss_pred HHHHHHHHHhhhccccccccceeecccccceEEE---cCCCcEEEeeccceeecccccccCccccccccccCCCccceeC
Confidence 99999999999 99999999999999 778899999999997654321 1223468999999
Q ss_pred cccccc-------cCCCCchhHHHHHHHHHHHHhCCCCCCC-CCh-----------------HHHHHHhhc-CCCCCCCC
Q 026253 137 PEVLQF-------QRYDEKVDMWSVGAILFELLNGYPPFSG-RNN-----------------VQLVRNINS-CKHLPFSQ 190 (241)
Q Consensus 137 PE~~~~-------~~~~~~~Dv~slG~~l~~l~~g~~p~~~-~~~-----------------~~~~~~i~~-~~~~~~~~ 190 (241)
||.+.+ ..++.++||||||+++|+|++|..||.. ... ......+.. .....++.
T Consensus 197 PE~~~~~~~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 276 (336)
T 3g2f_A 197 PEVLEGAVNLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPTFEDMQVLVSREKQRPKFPE 276 (336)
T ss_dssp HHHHTTCCCGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCCHHHHHHHHTTSCCCCCCCT
T ss_pred chhhcCCcccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCchHHHHHhhhcccccCCCCCc
Confidence 999876 4567899999999999999999666532 110 111111111 11222222
Q ss_pred cc--CCCCChHHHHHHHHhcccCccccCCHHHHh------cCcccccc
Q 026253 191 LI--VPALHPDCVDMCLKLLSANTVDRLSFNEFY------HHRFLRRN 230 (241)
Q Consensus 191 ~~--~~~~~~~~~~li~~~l~~~p~~Rps~~~il------~~~~~~~~ 230 (241)
.. ....++++.++|.+||+.||.+|||++|++ -++|-++.
T Consensus 277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~ 324 (336)
T 3g2f_A 277 AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK 324 (336)
T ss_dssp TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence 11 112445799999999999999999999994 46666654
|
| >3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.1e-40 Score=265.67 Aligned_cols=212 Identities=18% Similarity=0.220 Sum_probs=170.3
Q ss_pred hhhhhHHhhhhHHHHHHHHhcCC---CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-----cCCCCHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-----HGRVPEQTARKFLQ 73 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-----~~~~~~~~~~~~~~ 73 (241)
+|.++......+.+|+++++.++ |+||+++++++..++..++||||+++++|.+++.. ...+++..+..++.
T Consensus 100 vK~~~~~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i~~ 179 (365)
T 3e7e_A 100 LKVQKPANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQNGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISFAM 179 (365)
T ss_dssp EEEESSCCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECSSCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHHHH
T ss_pred EEEeCCCChhHHHHHHHHHHHhhhhhhhhhhhhheeeecCCCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHHHH
Confidence 45555566778889999999996 89999999999999999999999999999999974 45699999999999
Q ss_pred HHHHHHHHHHhCCccccCCCCCCeEEee--------cCCCceEEEeecCCccccC---CCCccccccCCCCccCcccccc
Q 026253 74 QLGAGLEILNSHHIIHRDLKPENILLSG--------LDDDVMLKIADFGLSCTLY---PGNYAEKVCGSPLYMAPEVLQF 142 (241)
Q Consensus 74 ~i~~~l~~lh~~~i~H~dl~~~nil~~~--------~~~~~~~~l~df~~a~~~~---~~~~~~~~~~~~~~~~PE~~~~ 142 (241)
|++.||+|||+.|++||||||+||+++. ....+.++|+|||+|+... .........+|..|+|||.+.+
T Consensus 180 qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 259 (365)
T 3e7e_A 180 RMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPKGTIFTAKCETSGFQCVEMLSN 259 (365)
T ss_dssp HHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCTTEEECCSSCTTSCCCHHHHTT
T ss_pred HHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCCCceeeeecCCCCCCChHHhcC
Confidence 9999999999999999999999999932 1117889999999996542 2333445678999999999999
Q ss_pred cCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 143 QRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 143 ~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
..++.++|+||||+++|+|++|..||....... . .....+.. ...++.+.+++..||+.+|.+|++..+.+
T Consensus 260 ~~~~~~~DiwslG~il~elltg~~pf~~~~~~~----~--~~~~~~~~---~~~~~~~~~~~~~~l~~~p~~r~~~~~~l 330 (365)
T 3e7e_A 260 KPWNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----C--KPEGLFRR---LPHLDMWNEFFHVMLNIPDCHHLPSLDLL 330 (365)
T ss_dssp CCBSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----E--EECSCCTT---CSSHHHHHHHHHHHHCCCCTTCCCCHHHH
T ss_pred CCCCccccHHHHHHHHHHHHhCCCccccCCCCc----e--eechhccc---cCcHHHHHHHHHHHcCCCCCCcchHHHHH
Confidence 999999999999999999999999996432210 0 00011111 13467899999999999999997544333
|
| >3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} | Back alignment and structure |
|---|
Probab=100.00 E-value=1e-38 Score=262.74 Aligned_cols=207 Identities=15% Similarity=0.097 Sum_probs=162.7
Q ss_pred HhhhhHHHHHHHHhcCCC-cCeee---------ee------------eEEee-----cCeEEEEEeccCCCChHHHHHh-
Q 026253 8 HLKSCLDCELNFLSSVNH-PNIIR---------LF------------DAFQA-----ENCIFLVVEFCAGGNLSSYIRL- 59 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~-~~i~~---------~~------------~~~~~-----~~~~~lv~e~~~~~~L~~~l~~- 59 (241)
...+.+.+|+.+++.++| ++... .. .++.. ...++++|+.+ +++|.++++.
T Consensus 120 ~~~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~L~~ll~~l 198 (413)
T 3dzo_A 120 NAIKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRM-QSNLQTFGEVL 198 (413)
T ss_dssp -CCHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECC-SEEHHHHHHHH
T ss_pred HHHHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehh-cCCHHHHHHHh
Confidence 346789999999999976 22111 11 11111 23467888877 6899999852
Q ss_pred ------cCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCC
Q 026253 60 ------HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPL 133 (241)
Q Consensus 60 ------~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~ 133 (241)
.+.+++..+..++.|++.||.|||++|++||||||+||++ +.++.++|+|||+++..... .....+ +.
T Consensus 199 ~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl---~~~~~~kL~DFG~a~~~~~~--~~~~~g-~~ 272 (413)
T 3dzo_A 199 LSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVL---DQRGGVFLTGFEHLVRDGAS--AVSPIG-RG 272 (413)
T ss_dssp HHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEE---CTTCCEEECCGGGCEETTEE--ECCCCC-TT
T ss_pred hcccccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEE---ecCCeEEEEeccceeecCCc--cccCCC-Cc
Confidence 2337788899999999999999999999999999999999 78888999999998765443 334456 99
Q ss_pred ccCcccc----------cccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHH
Q 026253 134 YMAPEVL----------QFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDM 203 (241)
Q Consensus 134 ~~~PE~~----------~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~l 203 (241)
|+|||.+ .+..++.++|+||||+++|+|++|+.||.+.+..+....+.. ....+|+++.++
T Consensus 273 y~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~~~---------~~~~~~~~~~~l 343 (413)
T 3dzo_A 273 FAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWIFR---------SCKNIPQPVRAL 343 (413)
T ss_dssp TCCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGGGS---------SCCCCCHHHHHH
T ss_pred eeCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHHHh---------hcccCCHHHHHH
Confidence 9999998 556688999999999999999999999987665443333311 123678999999
Q ss_pred HHHhcccCccccCCHHHHhcCcccccc
Q 026253 204 CLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 204 i~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
|.+||+.||.+|||+.++++||||++.
T Consensus 344 i~~~l~~dP~~Rpt~~~~l~~~~~~~~ 370 (413)
T 3dzo_A 344 LEGFLRYPKEDRLLPLQAMETPEYEQL 370 (413)
T ss_dssp HHHHTCSSGGGSCCHHHHTTSHHHHHH
T ss_pred HHHHccCChhhCcCHHHHHhCHHHHHH
Confidence 999999999999999999999999874
|
| >2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} | Back alignment and structure |
|---|
Probab=100.00 E-value=7.9e-38 Score=272.09 Aligned_cols=202 Identities=24% Similarity=0.358 Sum_probs=165.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCe-----EEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENC-----IFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~-----~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
......+.+|++++++++||||+++++++...+. .|+||||++|++|.+++.. ++++..+..++.|++.||.|
T Consensus 120 ~~~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~~~~~~~lv~E~~~g~~L~~~~~~--~l~~~~~~~~~~qi~~aL~~ 197 (681)
T 2pzi_A 120 AEAQAMAMAERQFLAEVVHPSIVQIFNFVEHTDRHGDPVGYIVMEYVGGQSLKRSKGQ--KLPVAEAIAYLLEILPALSY 197 (681)
T ss_dssp HHHHHHHHHHHGGGGGCCCTTBCCEEEEEEEECTTSCEEEEEEEECCCCEECC----C--CCCHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCcCeEeeeEeecCCCCCceeEEEEEeCCCCcHHHHHhC--CCCHHHHHHHHHHHHHHHHH
Confidence 4556788999999999999999999999987665 7999999999999998754 79999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
||++|++||||||+||++ +. +.++|+|||++...... ....+|+.|+|||.+.+. ++.++||||||+++|+|
T Consensus 198 lH~~giiHrDlkp~NIll---~~-~~~kl~DFG~a~~~~~~---~~~~gt~~y~aPE~~~~~-~~~~sDi~slG~~l~~l 269 (681)
T 2pzi_A 198 LHSIGLVYNDLKPENIML---TE-EQLKLIDLGAVSRINSF---GYLYGTPGFQAPEIVRTG-PTVATDIYTVGRTLAAL 269 (681)
T ss_dssp HHHTTEECCCCSGGGEEE---CS-SCEEECCCTTCEETTCC---SCCCCCTTTSCTTHHHHC-SCHHHHHHHHHHHHHHH
T ss_pred HHHCCCeecccChHHeEE---eC-CcEEEEecccchhcccC---CccCCCccccCHHHHcCC-CCCceehhhhHHHHHHH
Confidence 999999999999999999 44 38999999999876543 345689999999998755 48899999999999999
Q ss_pred HhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 162 LNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 162 ~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
++|.+||.+.... ..+ ........++.+.++|.+||+.||.+||+..+.+.|+|+.-
T Consensus 270 ~~g~~~~~~~~~~----------~~~-~~~~~~~~~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~ 326 (681)
T 2pzi_A 270 TLDLPTRNGRYVD----------GLP-EDDPVLKTYDSYGRLLRRAIDPDPRQRFTTAEEMSAQLTGV 326 (681)
T ss_dssp HSCCCEETTEECS----------SCC-TTCHHHHHCHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred HhCCCCCcccccc----------ccc-ccccccccCHHHHHHHhhhccCChhhCCCHHHHHHHHHHHH
Confidence 9999888752110 000 00001124578999999999999999999999999988753
|
| >2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A | Back alignment and structure |
|---|
Probab=100.00 E-value=4.6e-39 Score=258.13 Aligned_cols=208 Identities=20% Similarity=0.248 Sum_probs=157.9
Q ss_pred hhhHHHHHHHHhcCC---------C-----------------cCeeeeeeEEee-------------cCeEEEEEeccCC
Q 026253 10 KSCLDCELNFLSSVN---------H-----------------PNIIRLFDAFQA-------------ENCIFLVVEFCAG 50 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~---------~-----------------~~i~~~~~~~~~-------------~~~~~lv~e~~~~ 50 (241)
.+.+.+|+.++++++ | |||+++++++.+ ++..++||||+++
T Consensus 67 ~~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~ 146 (336)
T 2vuw_A 67 FEEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFG 146 (336)
T ss_dssp HHHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECC
T ss_pred HHHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCC
Confidence 477899999999886 4 455555554443 6889999999999
Q ss_pred CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH-hCCccccCCCCCCeEEeecC-----------------CCceEEEee
Q 026253 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN-SHHIIHRDLKPENILLSGLD-----------------DDVMLKIAD 112 (241)
Q Consensus 51 ~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh-~~~i~H~dl~~~nil~~~~~-----------------~~~~~~l~d 112 (241)
|++.+.+.+ +.+++..+..++.|++.||.||| +.|++||||||+||+++..+ ....+||+|
T Consensus 147 g~ll~~~~~-~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D 225 (336)
T 2vuw_A 147 GIDLEQMRT-KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID 225 (336)
T ss_dssp CEETGGGTT-TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred CccHHHHHh-cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence 976666643 67899999999999999999999 99999999999999996322 123899999
Q ss_pred cCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHH-HHHHHhCCCCCCCCCh-HHHHHHhhcCCC--CCC
Q 026253 113 FGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAI-LFELLNGYPPFSGRNN-VQLVRNINSCKH--LPF 188 (241)
Q Consensus 113 f~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~-l~~l~~g~~p~~~~~~-~~~~~~i~~~~~--~~~ 188 (241)
||+|+..... ...+|+.|+|||.+.+.. +.++|+||++++ .++++.|..||.+... ......+..... ...
T Consensus 226 FG~a~~~~~~----~~~gt~~y~aPE~~~g~~-~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~ 300 (336)
T 2vuw_A 226 YTLSRLERDG----IVVFCDVSMDEDLFTGDG-DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKC 300 (336)
T ss_dssp CTTCBEEETT----EEECCCCTTCSGGGCCCS-SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTCCCSSCC
T ss_pred ccccEecCCC----cEEEeecccChhhhcCCC-ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhhccCccc
Confidence 9999876432 347899999999998766 889999998777 6677889988854211 112223222111 111
Q ss_pred CCccCCCCChHHHHHHHHhcccCccccCCHHHHh-cCcccc
Q 026253 189 SQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY-HHRFLR 228 (241)
Q Consensus 189 ~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il-~~~~~~ 228 (241)
.....+.+|+++.+||++||+.| |++|+| +||||+
T Consensus 301 ~~~~~~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~ 336 (336)
T 2vuw_A 301 NTPAMKQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK 336 (336)
T ss_dssp CSHHHHHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred chhhhhhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence 22223357889999999999976 999999 999995
|
| >3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A | Back alignment and structure |
|---|
Probab=100.00 E-value=1.2e-36 Score=238.72 Aligned_cols=185 Identities=15% Similarity=0.124 Sum_probs=151.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|++++++++|+||+++++++.+++..|+||||++|++|.++++. + .....+..++.|++.||.+||++|
T Consensus 72 ~~~~~~~~~e~~~l~~l~hp~iv~~~~~~~~~~~~~lv~e~~~g~~L~~~l~~-~-~~~~~~~~i~~ql~~aL~~lH~~g 149 (286)
T 3uqc_A 72 DDVLQETLSRTLRLSRIDKPGVARVLDVVHTRAGGLVVAEWIRGGSLQEVADT-S-PSPVGAIRAMQSLAAAADAAHRAG 149 (286)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCCEEEHHHHHTT-C-CCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhcCCCCCcceeeEEEEECCcEEEEEEecCCCCHHHHHhc-C-CChHHHHHHHHHHHHHHHHHHHCC
Confidence 34558899999999999999999999999999999999999999999999964 3 356678899999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
++|+||||+||++ +.++.++|++++. ++ .++.++|+||||+++|+|++|..
T Consensus 150 ivH~Dikp~NIll---~~~g~~kl~~~~~-------------------~~-------~~~~~~Di~slG~il~elltg~~ 200 (286)
T 3uqc_A 150 VALSIDHPSRVRV---SIDGDVVLAYPAT-------------------MP-------DANPQDDIRGIGASLYALLVNRW 200 (286)
T ss_dssp CCCCCCSGGGEEE---ETTSCEEECSCCC-------------------CT-------TCCHHHHHHHHHHHHHHHHHSEE
T ss_pred CccCCCCcccEEE---cCCCCEEEEeccc-------------------cC-------CCCchhHHHHHHHHHHHHHHCCC
Confidence 9999999999999 6778899885442 22 36889999999999999999999
Q ss_pred CCCCCChHHHHHHhhc--CCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 167 PFSGRNNVQLVRNINS--CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~--~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
||.+.+.......... ......+....+.+++++.++|.+||+.||.+| |+.|+++
T Consensus 201 Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~l~~dP~~R-s~~el~~ 258 (286)
T 3uqc_A 201 PLPEAGVRSGLAPAERDTAGQPIEPADIDRDIPFQISAVAARSVQGDGGIR-SASTLLN 258 (286)
T ss_dssp CSCCCSBCCCSEECCBCTTSCBCCHHHHCTTSCHHHHHHHHHHHCTTSSCC-CHHHHHH
T ss_pred CCCcCCcchhhHHHHHHhccCCCChhhcccCCCHHHHHHHHHHcccCCccC-CHHHHHH
Confidence 9987665332211101 111122223445789999999999999999999 9999985
|
| >4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A* | Back alignment and structure |
|---|
Probab=100.00 E-value=6e-35 Score=248.27 Aligned_cols=152 Identities=20% Similarity=0.204 Sum_probs=118.9
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
++...+++.+|+++|+++ .|+||+++++++++++..||||||++|++|.+++...+++++. .++.||+.||.|+|+
T Consensus 281 ~~~~~~~~~~E~~~l~~~~~~~~i~~~~~~~ed~~~~yLVMEyv~G~~L~d~i~~~~~l~~~---~I~~QIl~AL~ylH~ 357 (569)
T 4azs_A 281 SQRNKYELHNEIKFLTQPPAGFDAPAVLAHGENAQSGWLVMEKLPGRLLSDMLAAGEEIDRE---KILGSLLRSLAALEK 357 (569)
T ss_dssp HHHHHHHHHHHHHHHHSCCTTCCCCCEEEEEECSSEEEEEEECCCSEEHHHHHHTTCCCCHH---HHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCeeEEEEEEEECCEEEEEEecCCCCcHHHHHHhCCCCCHH---HHHHHHHHHHHHHHH
Confidence 456678899999999999 7999999999999999999999999999999999998888875 478999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+||+||||||+|||+ +.++.+||+|||+|+..... ......+||+.|+|||.+.+ .+..++|+|++|++++.+.+
T Consensus 358 ~GIIHRDIKPeNILL---~~dg~vKL~DFGlAr~~~~~~~~~~t~vGTp~YmAPE~l~g-~~~~~~d~~s~g~~~~~l~~ 433 (569)
T 4azs_A 358 QGFWHDDVRPWNVMV---DARQHARLIDFGSIVTTPQDCSWPTNLVQSFFVFVNELFAE-NKSWNGFWRSAPVHPFNLPQ 433 (569)
T ss_dssp TTCEESCCCGGGEEE---CTTSCEEECCCTTEESCC---CCSHHHHHHHHHHHHHHC------------------CCCCT
T ss_pred CCceeccCchHhEEE---CCCCCEEEeecccCeeCCCCCccccCceechhhccHHHhCC-CCCCcccccccccchhhhcc
Confidence 999999999999999 78889999999999876543 23445678999999999875 45678999999998876654
Q ss_pred C
Q 026253 164 G 164 (241)
Q Consensus 164 g 164 (241)
+
T Consensus 434 ~ 434 (569)
T 4azs_A 434 P 434 (569)
T ss_dssp T
T ss_pred c
Confidence 4
|
| >3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A* | Back alignment and structure |
|---|
Probab=99.91 E-value=6.5e-26 Score=191.82 Aligned_cols=147 Identities=19% Similarity=0.200 Sum_probs=125.1
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+++.+|++++++++||||+++..+....+..++||||++|++|.+++.. +..++.|++.||.+||++|++
T Consensus 382 ~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lVmE~~~ggsL~~~l~~--------~~~i~~qi~~aL~~LH~~gIi 453 (540)
T 3en9_A 382 RKSRTAREARYLALVKDFGIPAPYIFDVDLDNKRIMMSYINGKLAKDVIED--------NLDIAYKIGEIVGKLHKNDVI 453 (540)
T ss_dssp HHHHHHHHHHHHHHGGGGTCCCCCEEEEETTTTEEEEECCCSEEHHHHSTT--------CTHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcCCCCcCceEEEEEeCCccEEEEECCCCCCHHHHHHH--------HHHHHHHHHHHHHHHHHCcCc
Confidence 356789999999999999999777776677888999999999999999875 568999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--------cccccCCCCccCcccccc--cCCCCchhHHHHHHHH
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--------AEKVCGSPLYMAPEVLQF--QRYDEKVDMWSVGAIL 158 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--------~~~~~~~~~~~~PE~~~~--~~~~~~~Dv~slG~~l 158 (241)
||||||+||++ +. .++|+|||+++....... .....+|+.|+|||.+.+ ..|+...|.|+..+-.
T Consensus 454 HrDiKp~NILl---~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~vl~~ 528 (540)
T 3en9_A 454 HNDLTTSNFIF---DK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEIILEL 528 (540)
T ss_dssp CTTCCTTSEEE---SS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHHHHHH
T ss_pred cCCCCHHHEEE---CC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHHHHHH
Confidence 99999999999 44 999999999988755322 124578999999999976 5678888999988877
Q ss_pred HHHHhCCCCC
Q 026253 159 FELLNGYPPF 168 (241)
Q Consensus 159 ~~l~~g~~p~ 168 (241)
.+-..++.+|
T Consensus 529 l~~v~~r~rY 538 (540)
T 3en9_A 529 MKDVERRARY 538 (540)
T ss_dssp HHHHHTCSCC
T ss_pred HHHHHhcccc
Confidence 7777666555
|
| >1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A* | Back alignment and structure |
|---|
Probab=99.78 E-value=1.3e-19 Score=141.33 Aligned_cols=106 Identities=17% Similarity=0.201 Sum_probs=87.4
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
....+.+|+.++++++ | +++.+++.. +..++||||++|++|.+ +.. .....++.|++.|+.+||+.|++
T Consensus 147 ~~~~~~~E~~~l~~l~--~-~~v~~~~~~-~~~~lvmE~~~g~~L~~-l~~------~~~~~i~~qi~~~l~~lH~~gii 215 (282)
T 1zar_A 147 AIRSARNEFRALQKLQ--G-LAVPKVYAW-EGNAVLMELIDAKELYR-VRV------ENPDEVLDMILEEVAKFYHRGIV 215 (282)
T ss_dssp HHHHHHHHHHHHHHTT--T-SSSCCEEEE-ETTEEEEECCCCEEGGG-CCC------SCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhcc--C-CCcCeEEec-cceEEEEEecCCCcHHH-cch------hhHHHHHHHHHHHHHHHHHCCCE
Confidence 4677999999999999 5 777776654 55699999999999998 421 23557999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccc
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQ 141 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~ 141 (241)
|+||||.||++ + ++.++|+|||+|+. +..+.|||.+.
T Consensus 216 HrDlkp~NILl---~-~~~vkl~DFG~a~~------------~~~~~a~e~l~ 252 (282)
T 1zar_A 216 HGDLSQYNVLV---S-EEGIWIIDFPQSVE------------VGEEGWREILE 252 (282)
T ss_dssp CSCCSTTSEEE---E-TTEEEECCCTTCEE------------TTSTTHHHHHH
T ss_pred eCCCCHHHEEE---E-CCcEEEEECCCCeE------------CCCCCHHHHHH
Confidence 99999999999 5 78999999999854 23367788764
|
| >1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A* | Back alignment and structure |
|---|
Probab=99.59 E-value=1.2e-15 Score=117.56 Aligned_cols=98 Identities=19% Similarity=0.233 Sum_probs=77.1
Q ss_pred hhhHHHHHHHHhcCCCcCe--eeeeeEEeecCeEEEEEeccCC-C----ChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSVNHPNI--IRLFDAFQAENCIFLVVEFCAG-G----NLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i--~~~~~~~~~~~~~~lv~e~~~~-~----~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
...+.+|+++++++.|+++ +.+++. +..++||||+.+ | +|.++... .++..+..++.|++.++.+|
T Consensus 114 ~~~~~~E~~~l~~l~~~~i~~p~~~~~----~~~~lVmE~~g~~g~~~~~L~~~~~~---~~~~~~~~i~~qi~~~l~~l 186 (258)
T 1zth_A 114 FIWTEKEFRNLERAKEAGVSVPQPYTY----MKNVLLMEFIGEDELPAPTLVELGRE---LKELDVEGIFNDVVENVKRL 186 (258)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCCCEEEE----ETTEEEEECCEETTEECCBHHHHGGG---GGGSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCCeEEEc----CCCEEEEEecCCCCCccccHHHHhhc---cChHHHHHHHHHHHHHHHHH
Confidence 3478999999999988764 333332 357899999932 3 77776432 23456788999999999999
Q ss_pred H-hCCccccCCCCCCeEEeecCCCceEEEeecCCcccc
Q 026253 83 N-SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (241)
Q Consensus 83 h-~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~ 119 (241)
| +.|++||||||.||++ ++ .++|+|||+|...
T Consensus 187 H~~~givHrDlkp~NILl---~~--~~~liDFG~a~~~ 219 (258)
T 1zth_A 187 YQEAELVHADLSEYNIMY---ID--KVYFIDMGQAVTL 219 (258)
T ss_dssp HHTSCEECSSCSTTSEEE---SS--SEEECCCTTCEET
T ss_pred HHHCCEEeCCCCHHHEEE---cC--cEEEEECcccccC
Confidence 9 9999999999999999 44 8999999998654
|
| >4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A | Back alignment and structure |
|---|
Probab=99.30 E-value=1.8e-12 Score=104.38 Aligned_cols=100 Identities=16% Similarity=0.127 Sum_probs=70.8
Q ss_pred HHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCC
Q 026253 13 LDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDL 92 (241)
Q Consensus 13 ~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl 92 (241)
..+|+..+.++.+.++.... .+... ..++||||++|++|.++.. .+....++.|++.++.+||+.|++||||
T Consensus 160 A~kE~~nL~rL~~~gv~vp~-p~~~~-~~~LVME~i~G~~L~~l~~------~~~~~~l~~qll~~l~~lH~~gIVHrDL 231 (397)
T 4gyi_A 160 AIKEFAFMKALYEEGFPVPE-PIAQS-RHTIVMSLVDALPMRQVSS------VPDPASLYADLIALILRLAKHGLIHGDF 231 (397)
T ss_dssp HHHHHHHHHHHHHTTCSCCC-EEEEE-TTEEEEECCSCEEGGGCCC------CSCHHHHHHHHHHHHHHHHHTTEECSCC
T ss_pred HHHHHHHHHHHHhcCCCCCe-eeecc-CceEEEEecCCccHhhhcc------cHHHHHHHHHHHHHHHHHHHCCCcCCCC
Confidence 45678888888554443222 22222 2479999999988865432 1235678899999999999999999999
Q ss_pred CCCCeEEeecCCC-------ceEEEeecCCccccC
Q 026253 93 KPENILLSGLDDD-------VMLKIADFGLSCTLY 120 (241)
Q Consensus 93 ~~~nil~~~~~~~-------~~~~l~df~~a~~~~ 120 (241)
||.|||++...+. ..+.|+||+.+....
T Consensus 232 Kp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~~~ 266 (397)
T 4gyi_A 232 NEFNILIREEKDAEDPSSITLTPIIIXFPQMVSMD 266 (397)
T ss_dssp STTSEEEEEEECSSCTTSEEEEEEECCCTTCEETT
T ss_pred CHHHEEEeCCCCcccccccccceEEEEeCCcccCC
Confidence 9999999532211 138999999876544
|
| >3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A* | Back alignment and structure |
|---|
Probab=99.22 E-value=1.7e-11 Score=94.41 Aligned_cols=100 Identities=17% Similarity=0.198 Sum_probs=81.5
Q ss_pred hhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh---
Q 026253 9 LKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS--- 84 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~--- 84 (241)
....+.+|+.+++.+ .+..+++++++....+..++|||+++|.+|.+.+. +......++.+++.++..||+
T Consensus 52 ~~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~~~~~lv~e~i~G~~l~~~~~-----~~~~~~~~~~~l~~~l~~LH~~~~ 126 (263)
T 3tm0_A 52 TTYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEEYE-----DEQSPEKIIELYAECIRLFHSIDI 126 (263)
T ss_dssp STTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHHCC-----TTTCHHHHHHHHHHHHHHHHHSCC
T ss_pred CHHHHHHHHHHHHHHhcCCCCCeEEEEEecCCceEEEEEecCCeehhhccC-----CcccHHHHHHHHHHHHHHHhCCCc
Confidence 355799999999999 46778899999999899999999999999987531 122344678899999999998
Q ss_pred --------------------------------------------------------CCccccCCCCCCeEEeecCCCceE
Q 026253 85 --------------------------------------------------------HHIIHRDLKPENILLSGLDDDVML 108 (241)
Q Consensus 85 --------------------------------------------------------~~i~H~dl~~~nil~~~~~~~~~~ 108 (241)
..++|+|++|.||++ +++..+
T Consensus 127 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~ 203 (263)
T 3tm0_A 127 SDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFV---KDGKVS 203 (263)
T ss_dssp TTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEE---ETTEEE
T ss_pred ccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEE---ECCcEE
Confidence 348899999999999 455566
Q ss_pred EEeecCCc
Q 026253 109 KIADFGLS 116 (241)
Q Consensus 109 ~l~df~~a 116 (241)
.|+||+.+
T Consensus 204 ~lIDwe~a 211 (263)
T 3tm0_A 204 GFIDLGRS 211 (263)
T ss_dssp EECCCTTC
T ss_pred EEEEchhc
Confidence 79999876
|
| >1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=99.02 E-value=3.1e-10 Score=87.00 Aligned_cols=97 Identities=15% Similarity=0.175 Sum_probs=73.4
Q ss_pred hhhhHHHHHHHHhcCCCcC--eeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+|+.+++.+.+.+ +++++++...++..++|||+++|.++. .. ... ...++.+++..+..||+..
T Consensus 56 ~~~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~~~~~~v~e~i~G~~l~--~~---~~~---~~~~~~~l~~~l~~lh~~~ 127 (264)
T 1nd4_A 56 ALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDLL--SS---HLA---PAEKVSIMADAMRRLHTLD 127 (264)
T ss_dssp TTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEETT--TS---CCC---HHHHHHHHHHHHHHHTTSC
T ss_pred cchhhhHHHHHHHHHHhCCCCCCeEEEeccCCCCCEEEEEecCCcccC--cC---cCC---HhHHHHHHHHHHHHHhCCC
Confidence 3467889999999995444 566888888888899999999998884 21 122 2245667777777777643
Q ss_pred ----------------------------------------------------------ccccCCCCCCeEEeecCCCceE
Q 026253 87 ----------------------------------------------------------IIHRDLKPENILLSGLDDDVML 108 (241)
Q Consensus 87 ----------------------------------------------------------i~H~dl~~~nil~~~~~~~~~~ 108 (241)
++|+|++|.||++ +++..+
T Consensus 128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~---~~~~~~ 204 (264)
T 1nd4_A 128 PATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMV---ENGRFS 204 (264)
T ss_dssp GGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEE---ETTEEE
T ss_pred CCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEE---ECCcEE
Confidence 8999999999999 455566
Q ss_pred EEeecCCc
Q 026253 109 KIADFGLS 116 (241)
Q Consensus 109 ~l~df~~a 116 (241)
.|+||+.+
T Consensus 205 ~liD~~~a 212 (264)
T 1nd4_A 205 GFIDCGRL 212 (264)
T ss_dssp EECCCTTC
T ss_pred EEEcchhc
Confidence 79999976
|
| >3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134} | Back alignment and structure |
|---|
Probab=98.90 E-value=3.7e-09 Score=85.01 Aligned_cols=104 Identities=14% Similarity=0.324 Sum_probs=81.7
Q ss_pred hhhHHHHHHHHhcCC--CcCeeeeeeEEeec---CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 10 KSCLDCELNFLSSVN--HPNIIRLFDAFQAE---NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~--~~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
...+.+|+.+++.+. +..+++++.++.+. +..++|||+++|..+.+. ....++......++.+++..|..||+
T Consensus 80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~~g~~~~vme~v~G~~l~~~--~~~~l~~~~~~~~~~~l~~~La~LH~ 157 (359)
T 3dxp_A 80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESVIGRAFYIMEFVSGRVLWDQ--SLPGMSPAERTAIYDEMNRVIAAMHT 157 (359)
T ss_dssp --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTTTSSCEEEEECCCCBCCCCT--TCTTCCHHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCccCCeEEEEEecCCeecCCC--ccccCCHHHHHHHHHHHHHHHHHHhC
Confidence 457899999999996 34578888887766 458999999999877541 12346788888899999999999997
Q ss_pred ----------------------------------------------------------CCccccCCCCCCeEEeecCCC-
Q 026253 85 ----------------------------------------------------------HHIIHRDLKPENILLSGLDDD- 105 (241)
Q Consensus 85 ----------------------------------------------------------~~i~H~dl~~~nil~~~~~~~- 105 (241)
..++|+|+++.||+++ ++
T Consensus 158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~---~~~ 234 (359)
T 3dxp_A 158 VDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFH---PTE 234 (359)
T ss_dssp SCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEEC---SSS
T ss_pred CCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEe---CCC
Confidence 3589999999999994 33
Q ss_pred -ceEEEeecCCccc
Q 026253 106 -VMLKIADFGLSCT 118 (241)
Q Consensus 106 -~~~~l~df~~a~~ 118 (241)
..+.|+||+.+..
T Consensus 235 ~~v~~viDwe~a~~ 248 (359)
T 3dxp_A 235 PRVLAVLDWELSTL 248 (359)
T ss_dssp SCEEEECCCTTCEE
T ss_pred CcEEEEECcccccc
Confidence 3468999998754
|
| >3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A | Back alignment and structure |
|---|
Probab=98.85 E-value=2.8e-09 Score=83.79 Aligned_cols=157 Identities=22% Similarity=0.272 Sum_probs=100.0
Q ss_pred hhhhHHHHHHHHhcC-CCcC--eeeeeeEEeecC---eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSV-NHPN--IIRLFDAFQAEN---CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l-~~~~--i~~~~~~~~~~~---~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
....+.+|+.+++.+ .+.. +++++.....++ ..|+||++++|.++.+... ..++.+....++.+++..++.|
T Consensus 53 ~~~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~~~~~~~~vm~~i~G~~l~~~~~--~~l~~~~~~~~~~~l~~~la~L 130 (304)
T 3sg8_A 53 GSTNLFNEVNILKRIHNKLPLPIPEVVFTGMPSETYQMSFAGFTKIKGVPLTPLLL--NNLPKQSQNQAAKDLARFLSEL 130 (304)
T ss_dssp HHHHHHHHHHHHHHHTTSSSSCCCCEEEECCCCSSCSCSCEEEECCCCEECCHHHH--HTSCHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCCCCceEeecCCCCCCCcceEEEcccCCeECCcccc--ccCCHHHHHHHHHHHHHHHHHH
Confidence 467899999999988 4333 344544433333 3578999999998876432 3466777778888888888888
Q ss_pred Hh----------------------------------------------------------CCccccCCCCCCeEEeecCC
Q 026253 83 NS----------------------------------------------------------HHIIHRDLKPENILLSGLDD 104 (241)
Q Consensus 83 h~----------------------------------------------------------~~i~H~dl~~~nil~~~~~~ 104 (241)
|+ ..++|+|++|.||+++ ++
T Consensus 131 H~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~--~~ 208 (304)
T 3sg8_A 131 HSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFD--TE 208 (304)
T ss_dssp HHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEE--TT
T ss_pred HcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEe--CC
Confidence 85 1369999999999994 22
Q ss_pred -CceEEEeecCCccccCCCCccccccCCCCccCcccccc---c-----------CCCCchhHHHHHHHHHHHHhCCCCCC
Q 026253 105 -DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---Q-----------RYDEKVDMWSVGAILFELLNGYPPFS 169 (241)
Q Consensus 105 -~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~---~-----------~~~~~~Dv~slG~~l~~l~~g~~p~~ 169 (241)
...+.++||+.+....+............-.+|+.... . ......+.|+++.++|.+.+|..+|.
T Consensus 209 ~~~~~~~iD~~~~~~~~~~~Dl~~~~~~~~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~~g~~~~~ 288 (304)
T 3sg8_A 209 KNTICGIIDFGDAAISDPDNDFISLMEDDEEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKEYGYMDWY 288 (304)
T ss_dssp TTEEEEECCCTTCEEECTTHHHHTTCCTTTSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHHTTCHHHH
T ss_pred CCCEEEEEeCCCCccCChHHHHHHHHhhccccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHHcCCHHHH
Confidence 56688999998765322111000000000022222110 0 01122689999999999999987663
|
| >4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A* | Back alignment and structure |
|---|
Probab=98.52 E-value=5e-07 Score=69.49 Aligned_cols=107 Identities=14% Similarity=0.178 Sum_probs=76.4
Q ss_pred hhhhHHhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 3 KKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 3 ~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
|.-.......+.+|..+++.+. +--+.+++++.++++..++||++++|.++.+..... ......+..++...|..
T Consensus 56 k~~~~~~~~~~~~E~~~l~~l~~~vPVP~v~~~~~~~~~~~lvme~l~G~~~~~~~~~~----~~~~~~~~~~l~~~L~~ 131 (272)
T 4gkh_A 56 KHGKGSVANDVTDEMVRLNWLTAFMPLPTIKHFIRTPDDAWLLTTAIPGKTAFQVLEEY----PDSGENIVDALAVFLRR 131 (272)
T ss_dssp EEEETHHHHHHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCCSEEHHHHHHHC----GGGHHHHHHHHHHHHHH
T ss_pred EECCCCCHhHHHHHHHHHHHhccCCCcCeEEEEEEECCeEEEEEEeeCCccccccccCC----HHHHHHHHHHHHHHHHH
Confidence 3334445667899999999884 334778888999999999999999998887765432 11223344455555555
Q ss_pred HHhC----------------------------------------------------------CccccCCCCCCeEEeecC
Q 026253 82 LNSH----------------------------------------------------------HIIHRDLKPENILLSGLD 103 (241)
Q Consensus 82 lh~~----------------------------------------------------------~i~H~dl~~~nil~~~~~ 103 (241)
||+. .++|+|+.+.||++ +
T Consensus 132 Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~---~ 208 (272)
T 4gkh_A 132 LHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIF---D 208 (272)
T ss_dssp HHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEE---E
T ss_pred hcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEE---E
Confidence 5521 16899999999999 5
Q ss_pred CCceEEEeecCCc
Q 026253 104 DDVMLKIADFGLS 116 (241)
Q Consensus 104 ~~~~~~l~df~~a 116 (241)
+++.+-|+||+.+
T Consensus 209 ~~~~~~viDwe~a 221 (272)
T 4gkh_A 209 EGKLIGCIDVGRV 221 (272)
T ss_dssp TTEEEEECCCTTC
T ss_pred CCeEEEEEECccc
Confidence 6666789999976
|
| >3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A* | Back alignment and structure |
|---|
Probab=98.39 E-value=3.2e-06 Score=66.34 Aligned_cols=109 Identities=20% Similarity=0.224 Sum_probs=72.0
Q ss_pred HhhhhHHHHHHHHhcCCCc---CeeeeeeEEe-ecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHH
Q 026253 8 HLKSCLDCELNFLSSVNHP---NIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~---~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
.....+.+|+.+++.+.+. .+++++.+.. ..+..++||++++|.++.+.. ...++......++.++...|..||
T Consensus 51 ~~~~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~~g~~~~v~e~i~G~~l~~~~--~~~l~~~~~~~~~~~lg~~La~LH 128 (306)
T 3tdw_A 51 QGADELNKEIQLLPLLVGCVKVNIPQYVYIGKRSDGNPFVGYRKVQGQILGEDG--MAVLPDDAKDRLALQLAEFMNELS 128 (306)
T ss_dssp HHHHHHHHHHHHHHHHTTTCSSBCCCEEEEEECTTSCEEEEEECCCSEECHHHH--HTTSCHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHHhcCCCCCCCeEeecccCCCceEEEEeccCCeECchhh--hhhCCHHHHHHHHHHHHHHHHHHh
Confidence 3467899999999999643 3566666664 456678999999998887632 122344444444444444444444
Q ss_pred hC------------------------------------------------------------CccccCCCCCCeEEeecC
Q 026253 84 SH------------------------------------------------------------HIIHRDLKPENILLSGLD 103 (241)
Q Consensus 84 ~~------------------------------------------------------------~i~H~dl~~~nil~~~~~ 103 (241)
+. .++|+|+++.||+++...
T Consensus 129 ~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~~~~ 208 (306)
T 3tdw_A 129 AFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFLTNLNS 208 (306)
T ss_dssp HSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEEECTTC
T ss_pred cCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEEEecCC
Confidence 32 358999999999994211
Q ss_pred C-CceEEEeecCCccc
Q 026253 104 D-DVMLKIADFGLSCT 118 (241)
Q Consensus 104 ~-~~~~~l~df~~a~~ 118 (241)
. ...+.|+||+.+..
T Consensus 209 ~~~~~~~~iD~~~a~~ 224 (306)
T 3tdw_A 209 RQTPLTGIIDFGDAAI 224 (306)
T ss_dssp SSCCEEEECCCTTCEE
T ss_pred CCCceEEEEehhhcCC
Confidence 1 34458999998754
|
| >2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A | Back alignment and structure |
|---|
Probab=98.18 E-value=4.1e-05 Score=56.20 Aligned_cols=136 Identities=17% Similarity=0.125 Sum_probs=87.3
Q ss_pred CCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh-CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcccc
Q 026253 50 GGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK 127 (241)
Q Consensus 50 ~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~ 127 (241)
..+|.+.|+.. .+++++++|.++.|.+.+|..+-. ..-...=+.|..|++ ..+|.|.+.+ ..+
T Consensus 32 ~vSL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l---~~dG~V~f~~-~~s----------- 96 (229)
T 2yle_A 32 ALSLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRV---WRDGAVTLAP-AAD----------- 96 (229)
T ss_dssp EEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEE---ETTSCEEECC-C-------------
T ss_pred cccHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEE---ecCCceeccc-ccc-----------
Confidence 35899999865 579999999999999999887732 121233335678888 5666665553 111
Q ss_pred ccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHh
Q 026253 128 VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKL 207 (241)
Q Consensus 128 ~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~ 207 (241)
......+.|||... ...+.+.-|||||+++|.-+--.. ++.....+|+.+.++|..|
T Consensus 97 ~~~~~~~~~pe~~~-~~~te~~~IysLG~tLY~ALDygL----------------------~e~eE~eLS~~LE~LL~~M 153 (229)
T 2yle_A 97 DAGEPPPVAGKLGY-SQCMETEVIESLGIIIYKALDYGL----------------------KENEERELSPPLEQLIDHM 153 (229)
T ss_dssp ----------CCSS-SSSCHHHHHHHHHHHHHHHHTTTC----------------------CTTEEECCCHHHHHHHHHH
T ss_pred cccccCCCChhhcc-ccchHHHHHHHHHHHHHHHhhcCC----------------------CcccchhhCHHHHHHHHHH
Confidence 01233467887763 345678899999999998764111 1122237899999999999
Q ss_pred ccc-------------------------CccccCCHHHHhc
Q 026253 208 LSA-------------------------NTVDRLSFNEFYH 223 (241)
Q Consensus 208 l~~-------------------------~p~~Rps~~~il~ 223 (241)
.+- .+..|.+++++++
T Consensus 154 t~~~~d~~~~DeG~~~~~eg~~d~~~~~~~~~~~sl~~Vi~ 194 (229)
T 2yle_A 154 ANTVEADGSNDEGYEAAEEGLGDEDEKRKISAIRSYRDVMK 194 (229)
T ss_dssp TTCCC--------------------CCSCCCCCCSHHHHHH
T ss_pred HhcccccccccccccccccccccccccccccCcCCHHHHHH
Confidence 766 2457888888873
|
| >3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A* | Back alignment and structure |
|---|
Probab=97.84 E-value=1.6e-05 Score=63.64 Aligned_cols=44 Identities=14% Similarity=0.157 Sum_probs=33.0
Q ss_pred hhHHHHHHHHhcCCC---cCeeeeeeEEeec---CeEEEEEeccCCCChH
Q 026253 11 SCLDCELNFLSSVNH---PNIIRLFDAFQAE---NCIFLVVEFCAGGNLS 54 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~---~~i~~~~~~~~~~---~~~~lv~e~~~~~~L~ 54 (241)
..+.+|+.+++.+.. -.+++++.+..+. +..++|||+++|.++.
T Consensus 72 ~~~~~E~~~l~~L~~~~~vpvP~v~~~~~~~~~~g~~~~v~e~l~G~~l~ 121 (357)
T 3ats_A 72 YRLDHQFEVIRLVGELTDVPVPRVRWIETTGDVLGTPFFLMDYVEGVVPP 121 (357)
T ss_dssp CCHHHHHHHHHHHHHHCCSCCCCEEEEECSSTTTSSCEEEEECCCCBCCC
T ss_pred hHHHHHHHHHHHHhhcCCCCCCcEEEEccCCCccCCceEEEEecCCCChh
Confidence 568899999999942 3477788776654 3578999999886654
|
| >2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis} | Back alignment and structure |
|---|
Probab=97.61 E-value=0.00019 Score=56.80 Aligned_cols=30 Identities=20% Similarity=0.354 Sum_probs=26.1
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCcc
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~ 117 (241)
..++|+|+++.||++ +.++.+.++||+.+.
T Consensus 222 ~~l~HgD~~~~Nil~---~~~~~~~lIDfe~a~ 251 (346)
T 2q83_A 222 PNLCHQDYGTGNTLL---GENEQIWVIDLDTVS 251 (346)
T ss_dssp CCEECSSCSTTSEEE---CGGGCEEECCCTTCE
T ss_pred CceecCCCCcccEEE---eCCCcEEEEehhhcc
Confidence 579999999999999 556789999999763
|
| >3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP} | Back alignment and structure |
|---|
Probab=97.16 E-value=0.00052 Score=54.22 Aligned_cols=35 Identities=20% Similarity=0.224 Sum_probs=26.1
Q ss_pred CCccccCCCCCCeEEeecCC-CceEEEeecCCcccc
Q 026253 85 HHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCTL 119 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~-~~~~~l~df~~a~~~ 119 (241)
..++|||+.+.||+++.... .+.+.|+||+.+..-
T Consensus 183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~G 218 (333)
T 3csv_A 183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKLG 218 (333)
T ss_dssp CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEEE
T ss_pred CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCcC
Confidence 36899999999999941100 267899999987554
|
| >3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti} | Back alignment and structure |
|---|
Probab=96.99 E-value=0.0017 Score=50.46 Aligned_cols=29 Identities=28% Similarity=0.160 Sum_probs=23.5
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
.++|+|+.+.||+. .++.+.++||..+..
T Consensus 174 ~l~HgDl~~~Nil~----~~~~~~lID~e~a~~ 202 (301)
T 3dxq_A 174 AACHCDPLCENFLD----TGERMWIVDWEYSGM 202 (301)
T ss_dssp EEECSCCCGGGEEE----CSSCEEECCCTTCEE
T ss_pred eeeccCCCcCCEEE----CCCCEEEEecccccC
Confidence 37999999999995 344579999998754
|
| >3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT} | Back alignment and structure |
|---|
Probab=96.98 E-value=0.0021 Score=50.41 Aligned_cols=51 Identities=16% Similarity=0.175 Sum_probs=39.7
Q ss_pred hhhhHHhhhhHHHHHHHHhcCC---CcCeeeeeeEEeecCeEEEEEeccCCCCh
Q 026253 3 KKLNKHLKSCLDCELNFLSSVN---HPNIIRLFDAFQAENCIFLVVEFCAGGNL 53 (241)
Q Consensus 3 ~~~~~~~~~~~~~E~~~l~~l~---~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 53 (241)
|.........+..|+..++.|. ...++++++.....+..++|||+++|..+
T Consensus 65 K~~~~~~~~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~g~~~lvme~l~G~~~ 118 (312)
T 3jr1_A 65 KINERSYRSMFRAEADQLALLAKTNSINVPLVYGIGNSQGHSFLLLEALNKSKN 118 (312)
T ss_dssp EEEEGGGHHHHHHHHHHHHHHHHTTSSBCCCEEEEEECSSEEEEEEECCCCCCC
T ss_pred EeCCcccHHHHHHHHHHHHHHHhhCCCCcceEEEEeecCCceEEEEEeccCCCC
Confidence 3333344677899999999983 35688888888878889999999998764
|
| >2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A* | Back alignment and structure |
|---|
Probab=96.71 E-value=0.0047 Score=49.98 Aligned_cols=30 Identities=23% Similarity=0.362 Sum_probs=24.2
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
..++|||+.+.||++ +++ .+.++||..+..
T Consensus 227 ~~L~HGDl~~~Nil~---~~~-~~~lID~e~a~~ 256 (397)
T 2olc_A 227 ETLIHGDLHTGSIFA---SEH-ETKVIDPEFAFY 256 (397)
T ss_dssp CEEECSCCSGGGEEE---CSS-CEEECCCTTCEE
T ss_pred CceeeCCCCcCcEEE---eCC-CeEEEeCccccc
Confidence 468999999999999 333 489999987643
|
| >3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A* | Back alignment and structure |
|---|
Probab=96.42 E-value=0.0024 Score=51.44 Aligned_cols=105 Identities=19% Similarity=0.210 Sum_probs=61.7
Q ss_pred hhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHH--------------HHHh---c-----CCC--C
Q 026253 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSS--------------YIRL---H-----GRV--P 64 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~--------------~l~~---~-----~~~--~ 64 (241)
...+.+|.++++.|. +.-.+++++.+.+ .+||||++|.+|.. .+.+ . +.. -
T Consensus 97 ~~~~~rE~~vl~~L~~~gv~P~ll~~~~~----g~v~e~i~G~~l~~~~l~~p~~~~~ia~~La~LH~~~~~~~~~~~~l 172 (379)
T 3feg_A 97 VDSLVLESVMFAILAERSLGPQLYGVFPE----GRLEQYIPSRPLKTQELREPVLSAAIATKMAQFHGMEMPFTKEPHWL 172 (379)
T ss_dssp HHHHHHHHHHHHHHHHTTSSCCEEEEETT----EEEEECCSEEECCGGGGGCHHHHHHHHHHHHHHHTCCCSSCCSCCHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCeEEEEcCC----ccEEEEecCccCChhHhCCHHHHHHHHHHHHHHhCCCCCCCCCcccH
Confidence 345668999999984 3233566665543 29999998865431 1110 0 011 1
Q ss_pred HHHHHHHHHHHHH-------------------HHHHH----HhC----CccccCCCCCCeEEeec-CCCceEEEeecCCc
Q 026253 65 EQTARKFLQQLGA-------------------GLEIL----NSH----HIIHRDLKPENILLSGL-DDDVMLKIADFGLS 116 (241)
Q Consensus 65 ~~~~~~~~~~i~~-------------------~l~~l----h~~----~i~H~dl~~~nil~~~~-~~~~~~~l~df~~a 116 (241)
...+.++..++.. .+..| ... .++|+|+.+.||++... +..+.+.++||..+
T Consensus 173 ~~~i~~w~~~~~~~~~~~~~~~~~~~~~~l~~~~~~L~~~L~~~~~~~~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a 252 (379)
T 3feg_A 173 FGTMERYLKQIQDLPPTGLPEMNLLEMYSLKDEMGNLRKLLESTPSPVVFCHNDIQEGNILLLSEPENADSLMLVDFEYS 252 (379)
T ss_dssp HHHHHHHHHHHHHCCCCSCCSCCHHHHTTHHHHHHHHHHHHHTSCCCEEEECSCCCGGGEEEESCC---CCEEECCCTTC
T ss_pred HHHHHHHHHHHHhccCcccchhhhhhhHHHHHHHHHHHHHHhhcCCCcEEEcCCCCCCeEEEcCCCCccCcEEEEecccC
Confidence 3455666554422 12222 222 58999999999999521 11367999999987
Q ss_pred cc
Q 026253 117 CT 118 (241)
Q Consensus 117 ~~ 118 (241)
..
T Consensus 253 ~~ 254 (379)
T 3feg_A 253 SY 254 (379)
T ss_dssp EE
T ss_pred Cc
Confidence 43
|
| >2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana} | Back alignment and structure |
|---|
Probab=95.03 E-value=0.019 Score=46.86 Aligned_cols=32 Identities=22% Similarity=0.413 Sum_probs=26.2
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
+...++|||+++.||++ ++++ +.++||+.+..
T Consensus 230 ~~~~liHGDl~~~Nil~---~~~~-~~lID~e~a~~ 261 (420)
T 2pyw_A 230 RAQALIHGDLHTGSVMV---TQDS-TQVIDPEFSFY 261 (420)
T ss_dssp BCCEEECSCCSGGGEEE---CSSC-EEECCCTTCEE
T ss_pred CCCeEEecCCCCCcEEE---eCCC-CEEEeCccccc
Confidence 35679999999999999 4444 99999998754
|
| >1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.89 E-value=0.097 Score=40.85 Aligned_cols=29 Identities=24% Similarity=0.190 Sum_probs=24.0
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
..++|||+++.||++ + + .+.++||+.+..
T Consensus 195 ~~l~HgD~~~~Nil~---~-~-~~~lIDfe~a~~ 223 (328)
T 1zyl_A 195 VLRLHGDCHAGNILW---R-D-GPMFVDLDDARN 223 (328)
T ss_dssp CEECCSSCSGGGEEE---S-S-SEEECCCTTCCE
T ss_pred eeeeeCCCCcccEeE---c-C-CCEEEECCCCCc
Confidence 358999999999999 4 3 789999987643
|
| >2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6 | Back alignment and structure |
|---|
Probab=92.75 E-value=0.034 Score=43.39 Aligned_cols=30 Identities=30% Similarity=0.592 Sum_probs=24.5
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
+++|+|+++.||++ +++..+.++||+.+..
T Consensus 188 ~liHgDl~~~Nil~---~~~~~~~lIDf~~a~~ 217 (322)
T 2ppq_A 188 GVIHADLFQDNVFF---LGDELSGLIDFYFACN 217 (322)
T ss_dssp EEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred ccCCCCCCccCEEE---eCCceEEEecchhccC
Confidence 68999999999999 4555568999987643
|
| >3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A* | Back alignment and structure |
|---|
Probab=91.78 E-value=0.12 Score=40.88 Aligned_cols=31 Identities=19% Similarity=0.367 Sum_probs=26.1
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCcccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~ 119 (241)
.++|+|+.+.||++ ++++.+.++||+.+...
T Consensus 207 ~~~HgD~~~~N~l~---~~~~~~~~iD~e~~~~~ 237 (339)
T 3i1a_A 207 VLCHSDIHAGNVLV---GNEESIYIIDWDEPMLA 237 (339)
T ss_dssp EEECSCCCGGGEEE---CGGGCEEECCCSSCEEE
T ss_pred eeEeCCCCcCCEEE---eCCCeEEEEECCCCeeC
Confidence 68999999999999 55677999999876543
|
| >3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A* | Back alignment and structure |
|---|
Probab=90.98 E-value=0.23 Score=39.54 Aligned_cols=29 Identities=31% Similarity=0.481 Sum_probs=23.3
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
.++|+|+.+.||++ +++ .+.++||..+..
T Consensus 213 ~l~HgDl~~~Nil~---~~~-~~~lID~e~a~~ 241 (369)
T 3c5i_A 213 VFCHNDLQENNIIN---TNK-CLRLIDFEYSGF 241 (369)
T ss_dssp EEECSCCCGGGEEE---CC--CEEECCCTTCEE
T ss_pred EEEeCCCCcccEEe---cCC-cEEEEEecCCCC
Confidence 58999999999999 433 489999987743
|
| >2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax} | Back alignment and structure |
|---|
Probab=90.06 E-value=0.24 Score=40.85 Aligned_cols=36 Identities=25% Similarity=0.301 Sum_probs=25.4
Q ss_pred HHHHHHHhcCCCcCe-eeeeeEEeecCeEEEEEeccCCCCh
Q 026253 14 DCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNL 53 (241)
Q Consensus 14 ~~E~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 53 (241)
.+|+.+++.|...++ +++++.+. + ..||+|++|.+|
T Consensus 152 ~~E~~vl~~L~~~gl~P~ll~~~~--~--G~v~e~I~G~~l 188 (458)
T 2qg7_A 152 EREKKISCILYNKNIAKKIYVFFT--N--GRIEEFMDGYAL 188 (458)
T ss_dssp HHHHHHHHHHTTSSSBCCEEEEET--T--EEEEECCCSEEC
T ss_pred HHHHHHHHHHHhcCCCCCEEEEeC--C--eEEEEeeCCccC
Confidence 689999999965554 56666653 2 259999987544
|
| >1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8 | Back alignment and structure |
|---|
Probab=88.07 E-value=0.15 Score=41.78 Aligned_cols=39 Identities=18% Similarity=0.254 Sum_probs=26.1
Q ss_pred hhHHHHHHHHhcCCCcCe-eeeeeEEeecCeEEEEEeccCCCCh
Q 026253 11 SCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNL 53 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~L 53 (241)
..+.+|+.+++.|...++ +++++.+.+ .+|++|++|.++
T Consensus 120 ~~li~E~~~l~~L~~~g~~P~l~~~~~~----g~v~e~l~G~~l 159 (429)
T 1nw1_A 120 SHLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 159 (429)
T ss_dssp HHHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHHhCCCCCcEEEEeCC----CEEEEEeCCccc
Confidence 456689999999843343 566665432 289999986443
|
| >3g15_A CK, chetk-alpha, choline kinase alpha; non-protein kinase, structural genomics CONS SGC, hemicholinium-3, transferase; HET: ADP HC6; 1.70A {Homo sapiens} PDB: 3f2r_A* 2i7q_A 2cko_A 2ckp_A* 2ckq_A* | Back alignment and structure |
|---|
Probab=86.91 E-value=0.29 Score=39.53 Aligned_cols=32 Identities=31% Similarity=0.378 Sum_probs=25.8
Q ss_pred ccccCCCCCCeEEee---cCCCceEEEeecCCccc
Q 026253 87 IIHRDLKPENILLSG---LDDDVMLKIADFGLSCT 118 (241)
Q Consensus 87 i~H~dl~~~nil~~~---~~~~~~~~l~df~~a~~ 118 (241)
++|+|+.+.||++.. .++...+.++||.+|..
T Consensus 246 fcHnDl~~gNil~~~~~~~~~~~~l~vIDwEya~~ 280 (401)
T 3g15_A 246 FCHNDCQEGNILLLEGRENSEKQKLMLIDFEYSSY 280 (401)
T ss_dssp EECSCCCGGGEEEETTGGGCSSCCEEECCCTTCEE
T ss_pred eEEecCCCCeEEEecCcccCcCCeEEEechHhccC
Confidence 679999999999953 24567799999998754
|
| >4ano_A ESSB; membrane protein, membrane secretion, ESS type V secretion S; HET: MSE; 1.70A {Geobacillus thermodenitrificans ng80-2organism_taxid} | Back alignment and structure |
|---|
Probab=80.92 E-value=6.8 Score=28.65 Aligned_cols=82 Identities=13% Similarity=0.058 Sum_probs=57.4
Q ss_pred CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHH-HHHhCCccccCCCCCCeEEeec
Q 026253 24 NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLE-ILNSHHIIHRDLKPENILLSGL 102 (241)
Q Consensus 24 ~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~-~lh~~~i~H~dl~~~nil~~~~ 102 (241)
.||++ -..+-++++.+.+.++.-+++.=...+ ...+....++++.+++.... ++ ..-+|--++|+|+++
T Consensus 48 ~~~~f--~~~I~~~eD~~~i~y~~~~~~~~f~~i---~~~~~~eKlrll~nl~~L~~~~~--~~r~tf~l~P~NL~f--- 117 (219)
T 4ano_A 48 VDPCI--VRDIDVSEDEVKVVIKPPSSFLTFAAI---RKTTLLSRIRAAIHLVSKVKHHS--ARRLIFIVCPENLMF--- 117 (219)
T ss_dssp SCSSS--EEEEEECSSEEEEEEECCTTCEEHHHH---HTSCHHHHHHHHHHHHHHHSSCC--SSSEECCCCGGGEEE---
T ss_pred cCCCC--CeEEEEeCCEEEEEEEcCcccCcHHHH---HhcCHHHHHHHHHHHHHHHHHhh--hCceeEEEeCceEEE---
Confidence 57777 444557777777877765333223333 35678888888888887654 33 456788999999999
Q ss_pred CCCceEEEeecCC
Q 026253 103 DDDVMLKIADFGL 115 (241)
Q Consensus 103 ~~~~~~~l~df~~ 115 (241)
+.++.+++.=.|.
T Consensus 118 ~~~~~p~i~hRGi 130 (219)
T 4ano_A 118 NRALEPFFLHVGV 130 (219)
T ss_dssp CTTCCEEESCCEE
T ss_pred eCCCcEEEEEcCC
Confidence 7888899886664
|
Homologous Structure Domains
Structure Domains Detected by RPS-BLAST
Original result of RPS-BLAST against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
E-value |
| 241 | ||||
| d1koaa2 | 350 | d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C | 5e-65 | |
| d1a06a_ | 307 | d.144.1.7 (A:) Calmodulin-dependent protein kinase | 1e-64 | |
| d2j4za1 | 263 | d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur | 2e-64 | |
| d1koba_ | 352 | d.144.1.7 (A:) Twitchin, kinase domain {California | 2e-63 | |
| d2jfla1 | 288 | d.144.1.7 (A:21-308) STE20-like serine/threonine-p | 1e-61 | |
| d1t4ha_ | 270 | d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa | 5e-61 | |
| d1tkia_ | 321 | d.144.1.7 (A:) Titin, kinase domain {Human (Homo s | 7e-61 | |
| d1u5ra_ | 309 | d.144.1.7 (A:) Serine/threonine protein kinase TAO | 4e-60 | |
| d1uu3a_ | 288 | d.144.1.7 (A:) 3-phosphoinositide dependent protei | 3e-59 | |
| d1yhwa1 | 293 | d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [ | 4e-59 | |
| d1phka_ | 277 | d.144.1.7 (A:) gamma-subunit of glycogen phosphory | 3e-58 | |
| d2ozaa1 | 335 | d.144.1.7 (A:51-385) MAP kinase activated protein | 6e-58 | |
| d2java1 | 269 | d.144.1.7 (A:3-271) Serine/threonine-protein kinas | 9e-58 | |
| d1uwha_ | 276 | d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) | 2e-57 | |
| d1nvra_ | 271 | d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 { | 6e-57 | |
| d1s9ja_ | 322 | d.144.1.7 (A:) Dual specificity mitogen-activated | 9e-57 | |
| d1jksa_ | 293 | d.144.1.7 (A:) Death-associated protein kinase, Da | 6e-55 | |
| d1xjda_ | 320 | d.144.1.7 (A:) Protein kinase C, theta type {Human | 6e-52 | |
| d1byga_ | 262 | d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) | 8e-51 | |
| d1o6ya_ | 277 | d.144.1.7 (A:) Mycobacterial protein kinase PknB, | 5e-50 | |
| d1fota_ | 316 | d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni | 9e-50 | |
| d1sm2a_ | 263 | d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu | 1e-49 | |
| d1xbba_ | 277 | d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human | 2e-49 | |
| d1k2pa_ | 258 | d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum | 5e-49 | |
| d1u59a_ | 285 | d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum | 5e-48 | |
| d1qpca_ | 272 | d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom | 1e-47 | |
| d1jpaa_ | 299 | d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou | 2e-47 | |
| d1omwa3 | 364 | d.144.1.7 (A:186-549) G-protein coupled receptor k | 2e-47 | |
| d1q5ka_ | 350 | d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs | 1e-46 | |
| d1xwsa_ | 273 | d.144.1.7 (A:) Proto-oncogene serine/threonine-pro | 2e-46 | |
| d1o6la_ | 337 | d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap | 2e-46 | |
| d1mp8a_ | 273 | d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma | 3e-46 | |
| d1ua2a_ | 299 | d.144.1.7 (A:) Cell division protein kinase 7, CDK | 3e-46 | |
| d1fmka3 | 285 | d.144.1.7 (A:249-533) c-src tyrosine kinase {Human | 6e-46 | |
| d1xkka_ | 317 | d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb- | 6e-46 | |
| d1fvra_ | 309 | d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [ | 6e-46 | |
| d1u46a_ | 273 | d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum | 1e-45 | |
| d1opja_ | 287 | d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou | 2e-44 | |
| d1blxa_ | 305 | d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H | 6e-44 | |
| d1r0pa_ | 311 | d.144.1.7 (A:) Hepatocyte growth factor receptor, | 1e-43 | |
| d1rjba_ | 325 | d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s | 1e-43 | |
| d1lufa_ | 301 | d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n | 2e-43 | |
| d1ob3a_ | 286 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod | 4e-43 | |
| d1gz8a_ | 298 | d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H | 6e-43 | |
| d1rdqe_ | 350 | d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni | 2e-42 | |
| d3blha1 | 318 | d.144.1.7 (A:8-325) Cell division protein kinase 9 | 3e-42 | |
| d1p4oa_ | 308 | d.144.1.7 (A:) Insulin-like growth factor 1 recept | 7e-42 | |
| d1mqba_ | 283 | d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum | 2e-41 | |
| d1fgka_ | 299 | d.144.1.7 (A:) Fibroblast growth factor receptor 1 | 9e-41 | |
| d1pmea_ | 345 | d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien | 2e-40 | |
| d1vzoa_ | 322 | d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5 | 4e-40 | |
| d3bqca1 | 328 | d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu | 1e-39 | |
| d1ckia_ | 299 | d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n | 5e-39 | |
| d1cm8a_ | 346 | d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s | 1e-38 | |
| d1unla_ | 292 | d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H | 2e-38 | |
| d1t46a_ | 311 | d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens | 1e-37 | |
| d1csna_ | 293 | d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast | 1e-37 | |
| d1vjya_ | 303 | d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human | 5e-37 | |
| d2gfsa1 | 348 | d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa | 1e-35 | |
| d1ywna1 | 299 | d.144.1.7 (A:818-1166) Vascular endothelial growth | 4e-35 | |
| d2b1pa1 | 355 | d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3 | 1e-33 | |
| d1q8ya_ | 362 | d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces | 2e-26 | |
| d1zara2 | 191 | d.144.1.9 (A:91-281) Rio2 serine protein kinase C- | 4e-14 |
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Score = 203 bits (518), Expect = 5e-65
Identities = 70/238 (29%), Positives = 122/238 (51%), Gaps = 3/238 (1%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RL 59
+ ++ K + E+ +S + HP ++ L DAF+ +N + ++ EF +GG L +
Sbjct: 58 FVMTPHESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADE 117
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
H ++ E A ++++Q+ GL ++ ++ +H DLKPENI+ + LK+ DFGL+ L
Sbjct: 118 HNKMSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFT-TKRSNELKLIDFGLTAHL 176
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRN 179
P + G+ + APEV + + DMWSVG + + LL+G PF G N+ + +RN
Sbjct: 177 DPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 236
Query: 180 INSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 237
+ SC + D D KLL A+ R++ ++ H +L +A R
Sbjct: 237 VKSCD-WNMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDS 293
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 201 bits (512), Expect = 1e-64
Identities = 73/236 (30%), Positives = 123/236 (52%), Gaps = 5/236 (2%)
Query: 2 LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K + K + ++ E+ L + HPNI+ L D +++ ++L+++ +GG L I
Sbjct: 39 IKCIAKKALEGKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRI 98
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
G E+ A + + Q+ ++ L+ I+HRDLKPEN+L LD+D + I+DFGLS
Sbjct: 99 VEKGFYTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK 158
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLV 177
PG+ CG+P Y+APEVL + Y + VD WS+G I + LL GYPPF N+ +L
Sbjct: 159 MEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKLF 218
Query: 178 RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI 233
I ++ F + D L+ + R + + H ++ ++A+
Sbjct: 219 EQILKAEY-EFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDTAL 273
|
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 199 bits (506), Expect = 2e-64
Identities = 71/237 (29%), Positives = 116/237 (48%), Gaps = 15/237 (6%)
Query: 2 LKKLNKH------LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
LK L K ++ L E+ S + HPNI+RL+ F ++L++E+ G +
Sbjct: 36 LKVLFKAQLEKAGVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYR 95
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++ + EQ ++ +L L +S +IHRD+KPEN+L L LKIADFG
Sbjct: 96 ELQKLSKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLL---LGSAGELKIADFGW 152
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
S P + +CG+ Y+ PE+++ + +DEKVD+WS+G + +E L G PPF +
Sbjct: 153 SVHA-PSSRRTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQE 211
Query: 176 LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232
+ I+ + F + D+ +LL N R E H ++ NS+
Sbjct: 212 TYKRISRVE-FTFPDFV----TEGARDLISRLLKHNPSQRPMLREVLEHPWITANSS 263
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Score = 199 bits (508), Expect = 2e-63
Identities = 64/240 (26%), Positives = 123/240 (51%), Gaps = 6/240 (2%)
Query: 2 LKKLNKHL---KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR 58
K +N K + E++ ++ ++HP +I L DAF+ + + L++EF +GG L I
Sbjct: 59 AKFINTPYPLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIA 118
Query: 59 LHG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
++ E +++Q GL+ ++ H I+H D+KPENI+ +KI DFGL+
Sbjct: 119 AEDYKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCET-KKASSVKIIDFGLAT 177
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLV 177
L P + + + APE++ + DMW++G + + LL+G PF+G ++++ +
Sbjct: 178 KLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237
Query: 178 RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRAP 237
+N+ C F + ++ P+ D LL RL+ ++ H +L+ + + L +
Sbjct: 238 QNVKRCD-WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTSR 296
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Score = 193 bits (491), Expect = 1e-61
Identities = 72/240 (30%), Positives = 118/240 (49%), Gaps = 15/240 (6%)
Query: 2 LKKLNKHLKSCLDC---ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI- 57
K ++ + L+ E++ L+S +HPNI++L DAF EN +++++EFCAGG + + +
Sbjct: 42 AKVIDTKSEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVML 101
Query: 58 RLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
L + E + +Q L L+ + IIHRDLK NIL D +K+ADFG+S
Sbjct: 102 ELERPLTESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILF---TLDGDIKLADFGVSA 158
Query: 118 TLY-PGNYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
+ G+P +MAPEV+ + YD K D+WS+G L E+ PP
Sbjct: 159 KNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHEL 218
Query: 172 NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
N ++++ I + +Q + D K L N R + ++ H F+ +S
Sbjct: 219 NPMRVLLKIAKSEPPTLAQ--PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 190 bits (484), Expect = 5e-61
Identities = 66/232 (28%), Positives = 117/232 (50%), Gaps = 12/232 (5%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIR 58
+KL K + E L + HPNI+R +D++++ + CI LV E G L +Y++
Sbjct: 45 RKLTKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLK 104
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+ + R + +Q+ GL+ L++ IIHRDLK +NI ++ +KI D GL+
Sbjct: 105 RFKVMKIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLA 162
Query: 117 CTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
TL ++A+ V G+P +MAPE+ + ++YDE VD+++ G + E+ P+S N
Sbjct: 163 -TLKRASFAKAVIGTPEFMAPEMYE-EKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQ 220
Query: 177 VRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
+ + P S P+ ++ + N +R S + +H F +
Sbjct: 221 IYRRVTSGVKPAS--FDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Score = 192 bits (488), Expect = 7e-61
Identities = 61/232 (26%), Positives = 114/232 (49%), Gaps = 5/232 (2%)
Query: 2 LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
K + + E++ L+ H NI+ L ++F++ + ++ EF +G ++ I
Sbjct: 35 AKFVKVKGTDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINT 94
Query: 60 HG-RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ E+ ++ Q+ L+ L+SH+I H D++PENI+ +KI +FG +
Sbjct: 95 SAFELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQT-RRSSTIKIIEFGQARQ 153
Query: 119 LYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVR 178
L PG+ + +P Y APEV Q DMWS+G +++ LL+G PF N Q++
Sbjct: 154 LKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLAETNQQIIE 213
Query: 179 NINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
NI + + F + + + +D +LL R++ +E H +L++
Sbjct: 214 NIMNAE-YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK 264
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 189 bits (482), Expect = 4e-60
Identities = 65/238 (27%), Positives = 101/238 (42%), Gaps = 18/238 (7%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+KK++ K + E+ FL + HPN I+ + E+ +LV+E+C G
Sbjct: 45 IKKMSYSGKQSNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDL 104
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ E GL L+SH++IHRD+K NIL L + ++K+ DFG
Sbjct: 105 LEVHKKPLQEVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNIL---LSEPGLVKLGDFGS 161
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQ---FQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
+ + P N G+P +MAPEV+ +YD KVD+WS+G EL PP N
Sbjct: 162 ASIMAPANS---FVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMN 218
Query: 173 NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
+ + +I + + L DR + HRF+ R
Sbjct: 219 AMSALYHIAQNESPALQSGHWS---EYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 3e-59
Identities = 67/237 (28%), Positives = 115/237 (48%), Gaps = 17/237 (7%)
Query: 2 LKKLNKHL------KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L K + E + +S ++HP ++L+ FQ + ++ + + G L
Sbjct: 38 IKILEKRHIIKENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLK 97
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
YIR G E R + ++ + LE L+ IIHRDLKPENIL L++D+ ++I DFG
Sbjct: 98 YIRKIGSFDETCTRFYTAEIVSALEYLHGKGIIHRDLKPENIL---LNEDMHIQITDFGT 154
Query: 116 SCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRN 172
+ L P + A G+ Y++PE+L + + D+W++G I+++L+ G PPF N
Sbjct: 155 AKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVAGLPPFRAGN 214
Query: 173 NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
+ + I ++ + P D+ KLL + RL E + L+
Sbjct: 215 EYLIFQKIIKLEYDFPEK-----FFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKA 266
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 186 bits (474), Expect = 4e-59
Identities = 60/231 (25%), Positives = 109/231 (47%), Gaps = 7/231 (3%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ + K + E+ + +PNI+ D++ + +++V+E+ AGG+L+ +
Sbjct: 52 QMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVT-E 110
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL- 119
+ E ++ LE L+S+ +IHRD+K +NILL D +K+ DFG +
Sbjct: 111 TCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILL---GMDGSVKLTDFGFCAQIT 167
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRN 179
+ + G+P +MAPEV+ + Y KVD+WS+G + E++ G PP+ N ++ +
Sbjct: 168 PEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYL 227
Query: 180 INSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
I + L D + L + R S E H+FL+
Sbjct: 228 IATNGTPELQ--NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIA 276
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Score = 183 bits (466), Expect = 3e-58
Identities = 79/234 (33%), Positives = 119/234 (50%), Gaps = 11/234 (4%)
Query: 3 KKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
+ + L+ E++ L V+ HPNII+L D ++ FLV + G L Y+
Sbjct: 46 AEEVQELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKV 105
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP 121
+ E+ RK ++ L + L+ +I+HRDLKPENIL LDDD+ +K+ DFG SC L P
Sbjct: 106 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENIL---LDDDMNIKLTDFGFSCQLDP 162
Query: 122 GNYAEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
G +VCG+P Y+APE+++ Y ++VDMWS G I++ LL G PPF R +
Sbjct: 163 GEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQML 222
Query: 176 LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
++R I S F D+ + L R + E H F ++
Sbjct: 223 MLRMIMSGN-YQFGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ 275
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 184 bits (469), Expect = 6e-58
Identities = 71/249 (28%), Positives = 125/249 (50%), Gaps = 10/249 (4%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYI 57
LK L K+ + EL + P+I+R+ D ++ C+ +V+E GG L S I
Sbjct: 42 LKMLQDCPKARREVEL-HWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRI 100
Query: 58 RLHG--RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+ G E+ A + ++ +G ++ L+S +I HRD+KPEN+L + + +LK+ DFG
Sbjct: 101 QDRGDQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGF 160
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ N C +P Y+APEVL ++YD+ DMWS+G I++ LL GYPPF + +
Sbjct: 161 AKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220
Query: 176 LVRNINSC---KHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232
+ + + F + + + LL R++ EF +H ++ +++
Sbjct: 221 ISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTK 280
Query: 233 ILRAPFHIP 241
+ + P H
Sbjct: 281 VPQTPLHTS 289
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (463), Expect = 9e-58
Identities = 66/238 (27%), Positives = 113/238 (47%), Gaps = 19/238 (7%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF--QAENCIFLVVEFCAGGNLSSYI-- 57
+ + K L E+N L + HPNI+R +D + +++V+E+C GG+L+S I
Sbjct: 39 YGSMTEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITK 98
Query: 58 --RLHGRVPEQTARKFLQQLGAGLEIL-----NSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ + E+ + + QL L+ H ++HRDLKP N+ L D +K+
Sbjct: 99 GTKERQYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKL 155
Query: 111 ADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFGL+ L +A+ G+P YM+PE + Y+EK D+WS+G +L+EL PPF+
Sbjct: 156 GDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWSLGCLLYELCALMPPFT 215
Query: 170 GRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
+ +L I K + ++ ++L+ R S E + +
Sbjct: 216 AFSQKELAGKIREGKFRRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 182 bits (462), Expect = 2e-57
Identities = 56/238 (23%), Positives = 102/238 (42%), Gaps = 13/238 (5%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LH 60
+ E+ L H NI+ + + +V ++C G +L ++ +
Sbjct: 40 VTAPTPQQLQAFKNEVGVLRKTRHVNILLFMG-YSTAPQLAIVTQWCEGSSLYHHLHIIE 98
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+ +Q G++ L++ IIHRDLK NI L +D+ +KI DFGL+
Sbjct: 99 TKFEMIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKS 155
Query: 121 PGNYAEK---VCGSPLYMAPEVLQFQR---YDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
+ + + + GS L+MAPEV++ Q Y + D+++ G +L+EL+ G P+S NN
Sbjct: 156 RWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNR 215
Query: 175 -QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH-RFLRRN 230
Q++ + P + + + L +R F + L R+
Sbjct: 216 DQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILASIELLARS 273
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 180 bits (458), Expect = 6e-57
Identities = 65/234 (27%), Positives = 112/234 (47%), Gaps = 9/234 (3%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ K + E+ +NH N+++ + + N +L +E+C+GG L I
Sbjct: 38 VDMKRAVDCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPD 97
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+PE A++F QL AG+ L+ I HRD+KPEN+L LD+ LKI+DFGL+
Sbjct: 98 IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLL---LDERDNLKISDFGLATVFR 154
Query: 121 PGNYAE---KVCGSPLYMAPEVLQFQRYD-EKVDMWSVGAILFELLNGYPPFSGRNNVQL 176
N K+CG+ Y+APE+L+ + + E VD+WS G +L +L G P+ ++
Sbjct: 155 YNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQ 214
Query: 177 VRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
+ K + + + + K+L N R++ + R+ +
Sbjct: 215 EYSDWKEKKTYLNPW--KKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 181 bits (460), Expect = 9e-57
Identities = 66/270 (24%), Positives = 110/270 (40%), Gaps = 44/270 (16%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ ++ +++ + EL L N P I+ + AF ++ I + +E GG+L ++
Sbjct: 39 IHLEIKPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKA 98
Query: 61 GRVPEQTARKFLQQLGAGLEILNS-HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
GR+PEQ K + GL L H I+HRD+KP NIL ++ +K+ DFG+S L
Sbjct: 99 GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNIL---VNSRGEIKLCDFGVSGQL 155
Query: 120 YPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQL--- 176
+ A G+ YM+PE LQ Y + D+WS+G L E+ G P + +L
Sbjct: 156 -IDSMANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELM 214
Query: 177 ------------------------------------VRNINSCKHLPFSQLIVPALHPDC 200
++ + P +L +
Sbjct: 215 FGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSLEF 274
Query: 201 VDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
D K L N +R + H F++R+
Sbjct: 275 QDFVNKCLIKNPAERADLKQLMVHAFIKRS 304
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Score = 176 bits (446), Expect = 6e-55
Identities = 63/214 (29%), Positives = 115/214 (53%), Gaps = 2/214 (0%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E++ L + HPN+I L + ++ + + L++E AGG L ++ + E+ A +FL+Q+
Sbjct: 63 EVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQI 122
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDD-DVMLKIADFGLSCTLYPGNYAEKVCGSPLY 134
G+ L+S I H DLKPENI+L + +KI DFGL+ + GN + + G+P +
Sbjct: 123 LNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEF 182
Query: 135 MAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
+APE++ ++ + DMWS+G I + LL+G PF G + + N+++ + F
Sbjct: 183 VAPEIVNYEPLGLEADMWSIGVITYILLSGASPFLGDTKQETLANVSAVNY-EFEDEYFS 241
Query: 195 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
D +LL + R++ + H +++
Sbjct: 242 NTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Score = 169 bits (428), Expect = 6e-52
Identities = 71/236 (30%), Positives = 112/236 (47%), Gaps = 17/236 (7%)
Query: 2 LKKLNKHLKSCLDCELNFL-------SSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLS 54
+K L K + D + + HP + +F FQ + +F V+E+ GG+L
Sbjct: 32 IKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLM 91
Query: 55 SYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+I+ + A + ++ GL+ L+S I++RDLK +NIL LD D +KIADFG
Sbjct: 92 YHIQSCHKFDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNIL---LDKDGHIKIADFG 148
Query: 115 LSCTLYPGNYAEK-VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNN 173
+ G+ CG+P Y+APE+L Q+Y+ VD WS G +L+E+L G PF G++
Sbjct: 149 MCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQSPFHGQDE 208
Query: 174 VQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSF-NEFYHHRFLR 228
+L +I L + D+ +KL RL + H R
Sbjct: 209 EELFHSIRMDNPFYPRW-----LEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFR 259
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 164 bits (416), Expect = 8e-51
Identities = 48/228 (21%), Positives = 96/228 (42%), Gaps = 14/228 (6%)
Query: 2 LKKLNKH-LKSCLDCELNFLSSVNHPNIIRLFDAF-QAENCIFLVVEFCAGGNLSSYIRL 59
+K + E + ++ + H N+++L + + +++V E+ A G+L Y+R
Sbjct: 35 VKCIKNDATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRS 94
Query: 60 HGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
GR + KF + +E L ++ +HRDL N+L+ +D + K++DFGL+
Sbjct: 95 RGRSVLGGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLV---SEDNVAKVSDFGLTK 151
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQL 176
+ + APE L+ +++ K D+WS G +L+E+ G P+ +
Sbjct: 152 EASSTQ--DTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDV 209
Query: 177 VRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
V + + P ++ + R SF +
Sbjct: 210 VPRVEKGYKMD----APDGCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Score = 162 bits (412), Expect = 5e-50
Identities = 57/227 (25%), Positives = 101/227 (44%), Gaps = 12/227 (5%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGG 51
+K L L E +++NHP I+ ++D +AE ++V+E+ G
Sbjct: 37 VKVLRADLARDPSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGV 96
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDD-DVMLKI 110
L + G + + A + + L + + IIHRD+KP NI++S + VM
Sbjct: 97 TLRDIVHTEGPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFG 156
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
++ + V G+ Y++PE + D + D++S+G +L+E+L G PPF+G
Sbjct: 157 IARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVLYEVLTGEPPFTG 216
Query: 171 RNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217
+ V + +P S L D + LK L+ N +R
Sbjct: 217 DSPVSVAYQHVREDPIPPSARH-EGLSADLDAVVLKALAKNPENRYQ 262
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 163 bits (413), Expect = 9e-50
Identities = 78/238 (32%), Positives = 124/238 (52%), Gaps = 21/238 (8%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L K + L E LS V HP IIR++ FQ IF+++++ GG L S
Sbjct: 34 MKVLKKEIVVRLKQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFS 93
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
+R R P A+ + ++ LE L+S II+RDLKPENIL LD + +KI DFG
Sbjct: 94 LLRKSQRFPNPVAKFYAAEVCLALEYLHSKDIIYRDLKPENIL---LDKNGHIKITDFGF 150
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ + Y +CG+P Y+APEV+ + Y++ +D WS G +++E+L GY PF N ++
Sbjct: 151 AKYVPDVTY--TLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMK 208
Query: 176 LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 228
I + + L F P + D D+ +L++ + RL + +H + +
Sbjct: 209 TYEKILNAE-LRFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFK 261
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 1e-49
Identities = 55/229 (24%), Positives = 99/229 (43%), Gaps = 13/229 (5%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IR 58
+K + + S D E + ++HP +++L+ + I LV EF G LS Y
Sbjct: 34 IKTIREGAMSEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRT 93
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
G +T + G+ L +IHRDL N L+ ++ ++K++DFG++
Sbjct: 94 QRGLFAAETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLV---GENQVIKVSDFGMTRF 150
Query: 119 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQ 175
+ Y + +PEV F RY K D+WS G +++E+ + G P+ R+N +
Sbjct: 151 VLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEGKIPYENRSNSE 210
Query: 176 LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
+V +I++ L +L + DR +F+
Sbjct: 211 VVEDISTGFRLYKPRLA----STHVYQIMNHCWKERPEDRPAFSRLLRQ 255
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Score = 161 bits (408), Expect = 2e-49
Identities = 51/223 (22%), Positives = 98/223 (43%), Gaps = 13/223 (5%)
Query: 3 KKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGR 62
+ + LK L E N + +++P I+R+ +AE+ LV+E G L+ Y++ +
Sbjct: 45 EANDPALKDELLAEANVMQQLDNPYIVRMIGICEAESW-MLVMEMAELGPLNKYLQQNRH 103
Query: 63 VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG 122
V ++ + + Q+ G++ L + +HRDL N+L L KI+DFGLS L
Sbjct: 104 VKDKNIIELVHQVSMGMKYLEESNFVHRDLAARNVL---LVTQHYAKISDFGLSKALRAD 160
Query: 123 NYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLV 177
K + APE + + ++ K D+WS G +++E + G P+ G ++
Sbjct: 161 ENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVT 220
Query: 178 RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220
+ + + + D+ + + +R F
Sbjct: 221 AMLEKGERMGCP----AGCPREMYDLMNLCWTYDVENRPGFAA 259
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Score = 159 bits (404), Expect = 5e-49
Identities = 49/229 (21%), Positives = 96/229 (41%), Gaps = 13/229 (5%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K + + S + E + +++H +++L+ + IF++ E+ A G L +Y+R
Sbjct: 33 IKMIKEGSMSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLRE 92
Query: 60 -HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
R Q + + + +E L S +HRDL N L ++D ++K++DFGLS
Sbjct: 93 MRHRFQTQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCL---VNDQGVVKVSDFGLSRY 149
Query: 119 LYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQ 175
+ Y + PEVL + ++ K D+W+ G +++E+ G P+ N +
Sbjct: 150 VLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSLGKMPYERFTNSE 209
Query: 176 LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
+I L L + +R +F +
Sbjct: 210 TAEHIAQGLRLYRPHLAS----EKVYTIMYSCWHEKADERPTFKILLSN 254
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Score = 157 bits (399), Expect = 5e-48
Identities = 54/226 (23%), Positives = 94/226 (41%), Gaps = 14/226 (6%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ + K + E + +++P I+RL QAE + LV+E GG L ++
Sbjct: 44 LKQGTEKADTEEMMREAQIMHQLDNPYIVRLIGVCQAEA-LMLVMEMAGGGPLHKFLVGK 102
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+P + L Q+ G++ L + +HRDL N+L L + KI+DFGLS L
Sbjct: 103 REEIPVSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVL---LVNRHYAKISDFGLSKAL 159
Query: 120 YPGNYAEK----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
+ + APE + F+++ + D+WS G ++E L+ G P+
Sbjct: 160 GADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGP 219
Query: 175 QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220
+++ I K + P P+ + DR F
Sbjct: 220 EVMAFIEQGKRMECP----PECPPELYALMSDCWIYKWEDRPDFLT 261
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (396), Expect = 1e-47
Identities = 49/226 (21%), Positives = 96/226 (42%), Gaps = 15/226 (6%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K L + S E N + + H ++RL+ + I+++ E+ G+L +++
Sbjct: 42 VKSLKQGSMSPDAFLAEANLMKQLQHQRLVRLYAVVT-QEPIYIITEYMENGSLVDFLKT 100
Query: 60 HGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
+ Q+ G+ + + IHRDL+ NIL + D + KIADFGL+
Sbjct: 101 PSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANIL---VSDTLSCKIADFGLAR 157
Query: 118 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNV 174
+ Y + + APE + + + K D+WS G +L E++ +G P+ G N
Sbjct: 158 LIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTHGRIPYPGMTNP 217
Query: 175 QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220
++++N+ + + + DR +F+
Sbjct: 218 EVIQNLERGYRMVRP----DNCPEELYQLMRLCWKERPEDRPTFDY 259
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Score = 156 bits (396), Expect = 2e-47
Identities = 56/245 (22%), Positives = 106/245 (43%), Gaps = 16/245 (6%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH 60
+ + + E + + +HPN+I L + ++ EF G+L S++R +
Sbjct: 62 LKSGYTEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQN 121
Query: 61 -GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
G+ L+ + AG++ L + +HRDL NIL ++ +++ K++DFGLS L
Sbjct: 122 DGQFTVIQLVGMLRGIAAGMKYLADMNYVHRDLAARNIL---VNSNLVCKVSDFGLSRFL 178
Query: 120 YPGNYAEKV------CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRN 172
+ APE +Q++++ D+WS G +++E+++ G P+
Sbjct: 179 EDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVMWEVMSYGERPYWDMT 238
Query: 173 NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH-RFLRRNS 231
N ++ I LP ALH + L + R F + + + RN
Sbjct: 239 NQDVINAIEQDYRLPPPMDCPSALH----QLMLDCWQKDRNHRPKFGQIVNTLDKMIRNP 294
Query: 232 AILRA 236
L+A
Sbjct: 295 NSLKA 299
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Score = 158 bits (400), Expect = 2e-47
Identities = 60/219 (27%), Positives = 101/219 (46%), Gaps = 12/219 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
L+ +S+ + P I+ + AF + + +++ GG+L ++ HG E R + ++
Sbjct: 57 MLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEI 116
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYM 135
GLE +++ +++RDLKP NIL LD+ ++I+D GL+C + G+ YM
Sbjct: 117 ILGLEHMHNRFVVYRDLKPANIL---LDEHGHVRISDLGLAC-DFSKKKPHASVGTHGYM 172
Query: 136 APEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVP 194
APEVLQ YD D +S+G +LF+LL G+ PF + +
Sbjct: 173 APEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKHEIDRMTLTMAVE--LPD 230
Query: 195 ALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLR 228
+ P+ + LL + RL E F R
Sbjct: 231 SFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFR 269
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Score = 156 bits (394), Expect = 1e-46
Identities = 69/261 (26%), Positives = 109/261 (41%), Gaps = 37/261 (14%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAF------QAENCIFLVVEFCAGGNLSS 55
+KK+ + K + EL + ++H NI+RL F + E + LV+++
Sbjct: 50 IKKVLQD-KRFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRV 108
Query: 56 ---YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIAD 112
Y R +P + ++ QL L ++S I HRD+KP+N+LL D +LK+ D
Sbjct: 109 ARHYSRAKQTLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLD--PDTAVLKLCD 166
Query: 113 FGLSCTLYPGNYAEKVCGSPLYMAP-EVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
FG + L G S Y AP + Y +D+WS G +L ELL G P F G
Sbjct: 167 FGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGD 226
Query: 172 NNVQLVRNI------------------------NSCKHLPFSQLIVPALHPDCVDMCLKL 207
+ V + I K P++++ P P+ + +C +L
Sbjct: 227 SGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRL 286
Query: 208 LSANTVDRLSFNEFYHHRFLR 228
L RL+ E H F
Sbjct: 287 LEYTPTARLTPLEACAHSFFD 307
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 2e-46
Identities = 52/217 (23%), Positives = 96/217 (44%), Gaps = 18/217 (8%)
Query: 16 ELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAGG-NLSSYIRLHGRVPEQTARKFL 72
E+ L V+ +IRL D F+ + L++E +L +I G + E+ AR F
Sbjct: 57 EVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFF 116
Query: 73 QQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSP 132
Q+ + ++ ++HRD+K ENIL+ + LK+ DFG L G+
Sbjct: 117 WQVLEAVRHCHNCGVLHRDIKDENILID--LNRGELKLIDFGSGA-LLKDTVYTDFDGTR 173
Query: 133 LYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQL 191
+Y PE +++ RY +WS+G +L++++ G PF + +
Sbjct: 174 VYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEI-----------IRGQVF 222
Query: 192 IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
+ +C + L+ DR +F E +H +++
Sbjct: 223 FRQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQ 259
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Score = 154 bits (391), Expect = 2e-46
Identities = 70/239 (29%), Positives = 112/239 (46%), Gaps = 20/239 (8%)
Query: 2 LKKLNKHLKSCLDC------ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L K + D E L + HP + L AFQ + + V+E+ GG L
Sbjct: 35 MKILRKEVIIAKDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFF 94
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++ E+ AR + ++ + LE L+S +++RD+K EN++ LD D +KI DFGL
Sbjct: 95 HLSRERVFTEERARFYGAEIVSALEYLHSRDVVYRDIKLENLM---LDKDGHIKITDFGL 151
Query: 116 SCTLY-PGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNV 174
G + CG+P Y+APEVL+ Y VD W +G +++E++ G PF +++
Sbjct: 152 CKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHE 211
Query: 175 QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN-----EFYHHRFLR 228
+L I + + F L P+ + LL + RL E HRF
Sbjct: 212 RLFELILMEE-IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFL 265
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (386), Expect = 3e-46
Identities = 56/213 (26%), Positives = 95/213 (44%), Gaps = 12/213 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI-RLHGRVPEQTARKFLQQ 74
E + +HP+I++L EN +++++E C G L S++ + + + Q
Sbjct: 58 EALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQ 116
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSP 132
L L L S +HRD+ N+L + + +K+ DFGLS + Y A K
Sbjct: 117 LSTALAYLESKRFVHRDIAARNVL---VSSNDCVKLGDFGLSRYMEDSTYYKASKGKLPI 173
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNVQLVRNINSCKHLPFSQL 191
+MAPE + F+R+ D+W G ++E+L +G PF G N ++ I + + LP
Sbjct: 174 KWMAPESINFRRFTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRIENGERLPMP-- 231
Query: 192 IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
P P + K + + R F E
Sbjct: 232 --PNCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (388), Expect = 3e-46
Identities = 71/260 (27%), Positives = 109/260 (41%), Gaps = 36/260 (13%)
Query: 2 LKKLNKHLKSCLD--------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNL 53
+KK+ +S E+ L ++HPNII L DAF ++ I LV +F
Sbjct: 28 IKKIKLGHRSEAKDGINRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLE 87
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ + ++ GLE L+ H I+HRDLKP N+L LD++ +LK+ADF
Sbjct: 88 VIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLL---LDENGVLKLADF 144
Query: 114 GLSCTLYPGNYAEK-VCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
GL+ + N A + Y APE+L + Y VDMW+VG IL ELL P G
Sbjct: 145 GLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGD 204
Query: 172 NNVQLVRNINSCKHLPFSQL-----------------------IVPALHPDCVDMCLKLL 208
+++ + I P + I A D +D+ L
Sbjct: 205 SDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLF 264
Query: 209 SANTVDRLSFNEFYHHRFLR 228
N R++ + ++
Sbjct: 265 LFNPCARITATQALKMKYFS 284
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 152 bits (385), Expect = 6e-46
Identities = 49/226 (21%), Positives = 95/226 (42%), Gaps = 15/226 (6%)
Query: 2 LKKLNKHLKS--CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K L S E + + H +++L+ E I++V E+ + G+L +++
Sbjct: 46 IKTLKPGTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP-IYIVTEYMSKGSLLDFLKG 104
Query: 60 HGRVP--EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
Q+ +G+ + + +HRDL+ NIL+ ++++ K+ADFGL+
Sbjct: 105 ETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILV---GENLVCKVADFGLAR 161
Query: 118 TLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGRNNV 174
+ Y + + APE + R+ K D+WS G +L EL G P+ G N
Sbjct: 162 LIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTKGRVPYPGMVNR 221
Query: 175 QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220
+++ + +P P D+ + +R +F
Sbjct: 222 EVLDQVERGYRMPCP----PECPESLHDLMCQCWRKEPEERPTFEY 263
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (387), Expect = 6e-46
Identities = 48/213 (22%), Positives = 81/213 (38%), Gaps = 11/213 (5%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75
E ++SV++P++ RL + G L + Q + Q+
Sbjct: 61 EAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQI 120
Query: 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSP 132
G+ L ++HRDL N+L + +KI DFGL+ L AE
Sbjct: 121 AKGMNYLEDRRLVHRDLAARNVL---VKTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPI 177
Query: 133 LYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQL 191
+MA E + + Y + D+WS G ++EL+ G P+ G ++ + + LP
Sbjct: 178 KWMALESILHRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILEKGERLPQP-- 235
Query: 192 IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
P D + +K + R F E
Sbjct: 236 --PICTIDVYMIMVKCWMIDADSRPKFRELIIE 266
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 153 bits (386), Expect = 6e-46
Identities = 58/238 (24%), Positives = 93/238 (39%), Gaps = 25/238 (10%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
M + +K EL L + +HPNII L A + ++L +E+ GNL ++R
Sbjct: 45 MKEYASKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRK 104
Query: 60 H----------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLD 103
+ Q F + G++ L+ IHRDL NIL+
Sbjct: 105 SRVLETDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILV---G 161
Query: 104 DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL- 162
++ + KIADFGLS +MA E L + Y D+WS G +L+E++
Sbjct: 162 ENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTNSDVWSYGVLLWEIVS 221
Query: 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220
G P+ G +L + L + D+ + +R SF +
Sbjct: 222 LGGTPYCGMTCAELYEKLPQGYRLEKP----LNCDDEVYDLMRQCWREKPYERPSFAQ 275
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 151 bits (382), Expect = 1e-45
Identities = 58/231 (25%), Positives = 94/231 (40%), Gaps = 19/231 (8%)
Query: 2 LKKLNKHLKS------CLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L + S E+N + S++H N+IRL+ + +V E G+L
Sbjct: 41 VKCLKPDVLSQPEAMDDFIREVNAMHSLDHRNLIRLYGVVL-TPPMKMVTELAPLGSLLD 99
Query: 56 YIRLH-GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFG 114
+R H G T ++ Q+ G+ L S IHRDL N+L L ++KI DFG
Sbjct: 100 RLRKHQGHFLLGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLL---LATRDLVKIGDFG 156
Query: 115 LSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFS 169
L L + E + APE L+ + + D W G L+E+ G P+
Sbjct: 157 LMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMFTYGQEPWI 216
Query: 170 GRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220
G N Q++ I+ D ++ ++ + DR +F
Sbjct: 217 GLNGSQILHKIDKEGERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVA 264
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Score = 148 bits (374), Expect = 2e-44
Identities = 56/235 (23%), Positives = 97/235 (41%), Gaps = 16/235 (6%)
Query: 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K L + + E + + HPN+++L E +++ EF GNL Y+R
Sbjct: 47 VKTLKEDTMEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRE 106
Query: 60 HGR--VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSC 117
R V Q+ + +E L + IHRDL N L + ++ ++K+ADFGLS
Sbjct: 107 CNRQEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCL---VGENHLVKVADFGLSR 163
Query: 118 TLYPGNYAEK--VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNV 174
+ Y + APE L + ++ K D+W+ G +L+E+ G P+ G +
Sbjct: 164 LMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIATYGMSPYPGIDLS 223
Query: 175 QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229
Q+ + + + ++ N DR SF E H+
Sbjct: 224 QVYELLEKDYRMERPEGCP----EKVYELMRACWQWNPSDRPSFAEI--HQAFET 272
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Score = 148 bits (373), Expect = 6e-44
Identities = 70/241 (29%), Positives = 102/241 (42%), Gaps = 31/241 (12%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTAR 69
L L + HPN++RLFD E + LV E + ++ VP +T +
Sbjct: 60 VLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIK 119
Query: 70 KFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVC 129
+ QL GL+ L+SH ++HRDLKP+NIL+ +K+ADFGL+ V
Sbjct: 120 DMMFQLLRGLDFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVV 176
Query: 130 GSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFS 189
+ Y APEVL Y VD+WSVG I E+ P F G ++V + I LP
Sbjct: 177 VTLWYRAPEVLLQSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGE 236
Query: 190 QL----------------------IVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227
+ V + D+ LK L+ N R+S H +
Sbjct: 237 EDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSALSHPYF 296
Query: 228 R 228
+
Sbjct: 297 Q 297
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-43
Identities = 60/235 (25%), Positives = 101/235 (42%), Gaps = 19/235 (8%)
Query: 2 LKKLNKHLK----SCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSSY 56
+K LN+ S E + +HPN++ L ++E +V+ + G+L ++
Sbjct: 60 VKSLNRITDIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNF 119
Query: 57 IRLHGRVP-EQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
IR P + F Q+ G++ L S +HRDL N +L D+ +K+ADFGL
Sbjct: 120 IRNETHNPTVKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCML---DEKFTVKVADFGL 176
Query: 116 SCTLYPGNYAEK-----VCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFS 169
+ +Y + +MA E LQ Q++ K D+WS G +L+EL+ G PP+
Sbjct: 177 ARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLLWELMTRGAPPYP 236
Query: 170 GRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224
N + + + L + ++ LK R SF+E
Sbjct: 237 DVNTFDITVYLLQGRRLLQPEYC----PDPLYEVMLKCWHPKAEMRPSFSELVSR 287
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 147 bits (372), Expect = 1e-43
Identities = 53/252 (21%), Positives = 93/252 (36%), Gaps = 34/252 (13%)
Query: 1 MLKKLNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+ +K + + L EL ++ + +H NI+ L A I+L+ E+C G+L +Y+R
Sbjct: 75 LKEKADSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRS 134
Query: 60 H-----------------------GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPEN 96
+ + F Q+ G+E L +HRDL N
Sbjct: 135 KREKFSEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARN 194
Query: 97 ILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWS 153
+L + ++KI DFGL+ + + +MAPE L Y K D+WS
Sbjct: 195 VL---VTHGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPESLFEGIYTIKSDVWS 251
Query: 154 VGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANT 212
G +L+E+ + G P+ G + + + + ++
Sbjct: 252 YGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYAT---EEIYIIMQSCWAFDS 308
Query: 213 VDRLSFNEFYHH 224
R SF
Sbjct: 309 RKRPSFPNLTSF 320
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 146 bits (369), Expect = 2e-43
Identities = 56/260 (21%), Positives = 109/260 (41%), Gaps = 41/260 (15%)
Query: 2 LKKLNKHLKSCLDC----ELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K L + + + E ++ ++PNI++L + L+ E+ A G+L+ ++
Sbjct: 48 VKMLKEEASADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFL 107
Query: 58 RLHGR------------------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93
R + +Q+ AG+ L+ +HRDL
Sbjct: 108 RSMSPHTVCSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLA 167
Query: 94 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVD 150
N L + +++++KIADFGLS +Y +Y + +M PE + + RY + D
Sbjct: 168 TRNCL---VGENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPESIFYNRYTTESD 224
Query: 151 MWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLS 209
+W+ G +L+E+ + G P+ G + +++ + L + + ++ S
Sbjct: 225 VWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCP----LELYNLMRLCWS 280
Query: 210 ANTVDRLSFNEFYHHRFLRR 229
DR SF HR L+R
Sbjct: 281 KLPADRPSFCSI--HRILQR 298
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Score = 145 bits (366), Expect = 4e-43
Identities = 65/253 (25%), Positives = 110/253 (43%), Gaps = 29/253 (11%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L+K ++ + S E++ L + H NI++L+D + + LV E G
Sbjct: 36 LEKEDEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEG 95
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 120
+ TA+ FL QL G+ + ++HRDLKP+N+L ++ + LKIADFGL+
Sbjct: 96 GLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLL---INREGELKIADFGLARAFGI 152
Query: 121 PGNYAEKVCGSPLYMAPEVLQ-FQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRN 179
P + Y AP+VL ++Y +D+WSVG I E++NG P F G + +
Sbjct: 153 PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQLMR 212
Query: 180 INSCKHLPFS------------------------QLIVPALHPDCVDMCLKLLSANTVDR 215
I P S + + L +D+ K+L + R
Sbjct: 213 IFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQR 272
Query: 216 LSFNEFYHHRFLR 228
++ + H + +
Sbjct: 273 ITAKQALEHAYFK 285
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 145 bits (366), Expect = 6e-43
Identities = 66/254 (25%), Positives = 107/254 (42%), Gaps = 30/254 (11%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY-IRLH 60
L + + S E++ L +NHPNI++L D EN ++LV EF
Sbjct: 37 LDTETEGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQDLKKFMDASAL 96
Query: 61 GRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY 120
+P + +L QL GL +SH ++HRDLKP+N+L+ + + +K+ADFGL+
Sbjct: 97 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFG 153
Query: 121 -PGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYPPFSGRNNVQLVR 178
P + Y APE+L +Y VD+WS+G I E++ F G + + +
Sbjct: 154 VPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQLF 213
Query: 179 NINSCKHLPFSQL------------------------IVPALHPDCVDMCLKLLSANTVD 214
I P + +VP L D + ++L +
Sbjct: 214 RIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNK 273
Query: 215 RLSFNEFYHHRFLR 228
R+S H F +
Sbjct: 274 RISAKAALAHPFFQ 287
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Score = 145 bits (366), Expect = 2e-42
Identities = 69/238 (28%), Positives = 121/238 (50%), Gaps = 21/238 (8%)
Query: 2 LKKLNKHLKSCLD------CELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSS 55
+K L+K L E L +VN P +++L +F+ + +++V+E+ AGG + S
Sbjct: 71 MKILDKQKVVKLKQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFS 130
Query: 56 YIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGL 115
++R GR E AR + Q+ E L+S +I+RDLKPEN+L +D +++ DFG
Sbjct: 131 HLRRIGRFSEPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLL---IDQQGYIQVTDFGF 187
Query: 116 SCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGRNNVQ 175
+ + + +CG+P +APE++ + Y++ VD W++G +++E+ GYPPF +Q
Sbjct: 188 AKRVKGRTW--TLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQ 245
Query: 176 LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLR 228
+ I S K S D D+ LL + R N+ +H++
Sbjct: 246 IYEKIVSGKVRFPSH-----FSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFA 298
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Score = 143 bits (362), Expect = 3e-42
Identities = 53/270 (19%), Positives = 98/270 (36%), Gaps = 44/270 (16%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--------AENCIFLVVEFCAGGNL 53
++ + E+ L + H N++ L + + + I+LV +FC
Sbjct: 45 MENEKEGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLA 104
Query: 54 SSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADF 113
+ + ++ +Q L GL ++ + I+HRD+K N+L + D +LK+ADF
Sbjct: 105 GLLSNVLVKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVL---ITRDGVLKLADF 161
Query: 114 GLSCTLYPG-----NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPP 167
GL+ N + Y PE+L +R Y +D+W G I+ E+ P
Sbjct: 162 GLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPI 221
Query: 168 FSGRNNVQLVRNINSCKHLP---------------------------FSQLIVPALHPDC 200
G + I+ +L P
Sbjct: 222 MQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYA 281
Query: 201 VDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230
+D+ KLL + R+ ++ +H F +
Sbjct: 282 LDLIDKLLVLDPAQRIDSDDALNHDFFWSD 311
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 142 bits (359), Expect = 7e-42
Identities = 50/237 (21%), Positives = 94/237 (39%), Gaps = 25/237 (10%)
Query: 2 LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYI 57
+K +N+ + E + + N +++RL +++E G+L SY+
Sbjct: 55 IKTVNEAASMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYL 114
Query: 58 RLHGRV----------PEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVM 107
R + ++ G+ LN++ +HRDL N + + +D
Sbjct: 115 RSLRPAMANNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCM---VAEDFT 171
Query: 108 LKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164
+KI DFG++ +Y +Y K +M+PE L+ + D+WS G +L+E+
Sbjct: 172 VKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVWSFGVVLWEIATL 231
Query: 165 -YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220
P+ G +N Q++R + L ++ N R SF E
Sbjct: 232 AEQPYQGLSNEQVLRFVMEGGLLD----KPDNCPDMLFELMRMCWQYNPKMRPSFLE 284
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Score = 140 bits (354), Expect = 2e-41
Identities = 52/246 (21%), Positives = 100/246 (40%), Gaps = 22/246 (8%)
Query: 2 LKKLNKHL----KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY- 56
+K L + E + +H NIIRL + ++ E+ G L +
Sbjct: 41 IKTLKAGYTEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFL 100
Query: 57 IRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
G L+ + AG++ L + + +HRDL NIL+ + +++ K++DFGLS
Sbjct: 101 REKDGEFSVLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILV---NSNLVCKVSDFGLS 157
Query: 117 CTLYPGNYAEKV----CGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL-NGYPPFSGR 171
L A + APE + ++++ D+WS G +++E++ G P+
Sbjct: 158 RVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWEVMTYGERPYWEL 217
Query: 172 NNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231
+N ++++ IN LP + ++ R F + +
Sbjct: 218 SNHEVMKAINDGFRLPTP----MDCPSAIYQLMMQCWQQERARRPKFAD-----IVSILD 268
Query: 232 AILRAP 237
++RAP
Sbjct: 269 KLIRAP 274
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (351), Expect = 9e-41
Identities = 59/244 (24%), Positives = 102/244 (41%), Gaps = 32/244 (13%)
Query: 2 LKKLNKHL----KSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56
+K L S L E+ + + H NII L A + ++++VE+ + GNL Y
Sbjct: 50 VKMLKSDATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREY 109
Query: 57 IRLHG----------------RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS 100
++ ++ + Q+ G+E L S IHRDL N+L
Sbjct: 110 LQARRPPGLEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVL-- 167
Query: 101 GLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGAI 157
+ +D ++KIADFGL+ ++ +Y +K +MAPE L + Y + D+WS G +
Sbjct: 168 -VTEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRIYTHQSDVWSFGVL 226
Query: 158 LFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL 216
L+E+ G P+ G +L + + + + M A R
Sbjct: 227 LWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKP----SNCTNELYMMMRDCWHAVPSQRP 282
Query: 217 SFNE 220
+F +
Sbjct: 283 TFKQ 286
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Score = 139 bits (352), Expect = 2e-40
Identities = 61/249 (24%), Positives = 106/249 (42%), Gaps = 39/249 (15%)
Query: 16 ELNFLSSVNHPNIIRLFDAFQAENCI----FLVVEFCAGGNLSSYIRLHGRVPEQTARKF 71
E+ L H NII + D +A +V G +L ++ + F
Sbjct: 56 EIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTHLMGADLYKLLK-TQHLSNDHICYF 114
Query: 72 LQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEK 127
L Q+ GL+ ++S +++HRDLKP N+L L+ LKI DFGL+ P + + +
Sbjct: 115 LYQILRGLKYIHSANVLHRDLKPSNLL---LNTTCDLKICDFGLARVADPDHDHTGFLTE 171
Query: 128 VCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHL 186
+ Y APE++ + Y + +D+WSVG IL E+L+ P F G++ + + +I
Sbjct: 172 YVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILGILGS 231
Query: 187 PFSQL--------------------------IVPALHPDCVDMCLKLLSANTVDRLSFNE 220
P + + P +D+ K+L+ N R+ +
Sbjct: 232 PSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQ 291
Query: 221 FYHHRFLRR 229
H +L +
Sbjct: 292 ALAHPYLEQ 300
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Score = 138 bits (348), Expect = 4e-40
Identities = 62/223 (27%), Positives = 103/223 (46%), Gaps = 14/223 (6%)
Query: 16 ELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQ 74
E L + P ++ L AFQ E + L++++ GG L +++ R E + ++ +
Sbjct: 78 ERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGE 137
Query: 75 LGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL--YPGNYAEKVCGSP 132
+ LE L+ II+RD+K ENIL LD + + + DFGLS A CG+
Sbjct: 138 IVLALEHLHKLGIIYRDIKLENIL---LDSNGHVVLTDFGLSKEFVADETERAYDFCGTI 194
Query: 133 LYMAPEVLQFQR--YDEKVDMWSVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQ 190
YMAP++++ +D+ VD WS+G +++ELL G PF+ I+ + L
Sbjct: 195 EYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEISR-RILKSEP 253
Query: 191 LIVPALHPDCVDMCLKLLSANTVDRLSFN-----EFYHHRFLR 228
+ D+ +LL + RL E H F +
Sbjct: 254 PYPQEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQ 296
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Score = 137 bits (345), Expect = 1e-39
Identities = 56/264 (21%), Positives = 100/264 (37%), Gaps = 42/264 (15%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQ--AENCIFLVVEFCAGGNLSSYIR 58
+K L K + E+ L ++ PNII L D + LV E + +
Sbjct: 65 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLYQ 124
Query: 59 LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118
+ + R ++ ++ L+ +S I+HRD+KP N+++ + L++ D+GL+
Sbjct: 125 ---TLTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEF 179
Query: 119 LYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPF-SGRNNVQL 176
+PG S + PE+ + +Q YD +DMWS+G +L ++ PF G +N
Sbjct: 180 YHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 239
Query: 177 VRNINSCKHLP--------------------------------FSQLIVPALHPDCVDMC 204
+ I + P+ +D
Sbjct: 240 LVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299
Query: 205 LKLLSANTVDRLSFNEFYHHRFLR 228
KLL + RL+ E H +
Sbjct: 300 DKLLRYDHQSRLTAREAMEHPYFY 323
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Score = 134 bits (339), Expect = 5e-39
Identities = 40/245 (16%), Positives = 79/245 (32%), Gaps = 16/245 (6%)
Query: 2 LKKLNKHLKSC-LDCELNFLSSVNHPNIIRLFDAFQAE-NCIFLVVEFCAGGNLSSYIRL 59
+K K L E + I AE + +V+E +
Sbjct: 37 IKLECVKTKHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELLGPSLEDLFNFC 96
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTL 119
+ +T Q+ + +E ++S + IHRD+KP+N L+ ++ I DFGL+
Sbjct: 97 SRKFSLKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKY 156
Query: 120 YPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR 171
+ + G+ Y + + D+ S+G +L G P+ G
Sbjct: 157 RDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVLMYFNLGSLPWQGL 216
Query: 172 NNVQLVRNINSCKHLPFS---QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY---HHR 225
+ S +++ + S D+ ++ +
Sbjct: 217 KAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNL 276
Query: 226 FLRRN 230
F R+
Sbjct: 277 FHRQG 281
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Score = 134 bits (339), Expect = 1e-38
Identities = 69/265 (26%), Positives = 114/265 (43%), Gaps = 45/265 (16%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL + +S L EL L + H N+I L D F + +LV+ F
Sbjct: 48 IKKLYRPFQSELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-- 105
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
G + H ++ E + + Q+ GL +++ IIHRDLKP N+ + ++D LKI
Sbjct: 106 GTDLGKLMKHEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAV---NEDCELKI 162
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
DFGL+ + + Y APEV L + RY + VD+WSVG I+ E++ G F
Sbjct: 163 LDFGLARQ--ADSEMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFK 220
Query: 170 GRNNVQLVRNINSCKHLPFSQL--------------------------IVPALHPDCVDM 203
G +++ ++ I P ++ I+ P V++
Sbjct: 221 GSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNL 280
Query: 204 CLKLLSANTVDRLSFNEFYHHRFLR 228
K+L + R++ E H +
Sbjct: 281 LEKMLVLDAEQRVTAGEALAHPYFE 305
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Score = 133 bits (335), Expect = 2e-38
Identities = 69/254 (27%), Positives = 108/254 (42%), Gaps = 30/254 (11%)
Query: 2 LKKLNKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG 61
L ++ + S E+ L + H NI+RL D ++ + LV EFC + +G
Sbjct: 37 LDDDDEGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNG 96
Query: 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLY- 120
+ + + FL QL GL +S +++HRDLKP+N+L ++ + LK+A+FGL+
Sbjct: 97 DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLL---INRNGELKLANFGLARAFGI 153
Query: 121 PGNYAEKVCGSPLYMAPEVL-QFQRYDEKVDMWSVGAILFELLNG-YPPFSGRNNVQLVR 178
P + Y P+VL + Y +DMWS G I EL N P F G + ++
Sbjct: 154 PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQLK 213
Query: 179 NINSCKHLPFSQL------------------------IVPALHPDCVDMCLKLLSANTVD 214
I P + +VP L+ D+ LL N V
Sbjct: 214 RIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQ 273
Query: 215 RLSFNEFYHHRFLR 228
R+S E H +
Sbjct: 274 RISAEEALQHPYFS 287
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Score = 131 bits (331), Expect = 1e-37
Identities = 56/228 (24%), Positives = 88/228 (38%), Gaps = 29/228 (12%)
Query: 16 ELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR---------------- 58
EL LS + NH NI+ L A ++ E+C G+L +++R
Sbjct: 76 ELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIM 135
Query: 59 --LHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLS 116
+ + F Q+ G+ L S + IHRDL NIL L + KI DFGL+
Sbjct: 136 EDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNIL---LTHGRITKICDFGLA 192
Query: 117 CTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRN 172
+ + +MAPE + Y + D+WS G L+EL + G P+ G
Sbjct: 193 RDIKNDSNYVVKGNARLPVKWMAPESIFNCVYTFESDVWSYGIFLWELFSLGSSPYPGMP 252
Query: 173 NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE 220
+ S P + D+ A+ + R +F +
Sbjct: 253 VDSKFYKMIKEGFRMLSPEHAP---AEMYDIMKTCWDADPLKRPTFKQ 297
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Score = 131 bits (329), Expect = 1e-37
Identities = 35/254 (13%), Positives = 80/254 (31%), Gaps = 17/254 (6%)
Query: 2 LKKLNKHLKS-CLDCELNFLSSVNHPNII-RLFDAFQAENCIFLVVEFCAGGNLSSYIRL 59
+K + + L E + I ++ Q LV++
Sbjct: 35 IKFEPRRSDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLLGPSLEDLLDLC 94
Query: 60 HGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLS--GLDDDVMLKIADFGLSC 117
+ +T +Q+ A ++ ++ +++RD+KP+N L+ + M+ + DFG+
Sbjct: 95 GRKFSVKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVK 154
Query: 118 TLYPG--------NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFS 169
+ + G+ YM+ + + D+ ++G + L G P+
Sbjct: 155 FYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALGHVFMYFLRGSLPWQ 214
Query: 170 GRNNV---QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH--H 224
G Q I K + + + + ++
Sbjct: 215 GLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFS 274
Query: 225 RFLRRNSAILRAPF 238
+ L R + F
Sbjct: 275 KVLERLNTTEDENF 288
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Score = 129 bits (326), Expect = 5e-37
Identities = 47/260 (18%), Positives = 85/260 (32%), Gaps = 44/260 (16%)
Query: 2 LKKLNKHLKSCL--DCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSS 55
+K + + + E+ + H NI+ A +N ++LV ++ G+L
Sbjct: 31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFD 90
Query: 56 YIRLHGRVPEQTARKFLQQLGA-------GLEILNSHHIIHRDLKPENILLSGLDDDVML 108
Y+ + E + L + I HRDLK +NIL + +
Sbjct: 91 YLNRYTVTVEGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNIL---VKKNGTC 147
Query: 109 KIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQ------FQRYDEKVDMWSVGAI 157
IAD GL+ G+ YMAPEVL ++ D++++G +
Sbjct: 148 CIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLV 207
Query: 158 LFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQL----IVPALHPDC------------- 200
+E+ + QL ++ L P+
Sbjct: 208 FWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVM 267
Query: 201 VDMCLKLLSANTVDRLSFNE 220
+ + AN RL+
Sbjct: 268 AKIMRECWYANGAARLTALR 287
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Score = 127 bits (319), Expect = 1e-35
Identities = 67/265 (25%), Positives = 121/265 (45%), Gaps = 43/265 (16%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQA-----ENCIFLVVEFCAGG 51
+KKL++ +S + EL L + H N+I L D F E +V G
Sbjct: 48 VKKLSRPFQSIIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGA 107
Query: 52 NLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIA 111
+L++ ++ ++ + + + Q+ GL+ ++S IIHRDLKP N+ + ++D LKI
Sbjct: 108 DLNNIVK-CQKLTDDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAV---NEDCELKIL 163
Query: 112 DFGLSCTLYPGNYAEKVCGSPLYMAPEV-LQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
DFGL+ + + + Y APE+ L + Y++ VD+WSVG I+ ELL G F G
Sbjct: 164 DFGLAR--HTDDEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPG 221
Query: 171 RNNVQLVRNINSCKHLPFSQL--------------------------IVPALHPDCVDMC 204
+++ ++ I P ++L + +P VD+
Sbjct: 222 TDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLL 281
Query: 205 LKLLSANTVDRLSFNEFYHHRFLRR 229
K+L ++ R++ + H + +
Sbjct: 282 EKMLVLDSDKRITAAQALAHAYFAQ 306
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Score = 124 bits (313), Expect = 4e-35
Identities = 59/259 (22%), Positives = 103/259 (39%), Gaps = 36/259 (13%)
Query: 2 LKKLNKH-----LKSCLDCELNFLSSVNHPNIIRLFDA-FQAENCIFLVVEFCAGGNLSS 55
+K L + ++ + + +H N++ L A + + ++VEFC GNLS+
Sbjct: 48 VKMLKEGATHSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLST 107
Query: 56 YIRLHGR----------------VPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILL 99
Y+R + + + Q+ G+E L S IHRDL NIL
Sbjct: 108 YLRSKRNEFVPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNIL- 166
Query: 100 SGLDDDVMLKIADFGLSCTLYPGNYAEK---VCGSPLYMAPEVLQFQRYDEKVDMWSVGA 156
L + ++KI DFGL+ +Y + +MAPE + + Y + D+WS G
Sbjct: 167 --LSEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVYTIQSDVWSFGV 224
Query: 157 ILFELLNGY-PPFSGRNNVQ-LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVD 214
+L+E+ + P+ G + R + + P+ L
Sbjct: 225 LLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR----APDYTTPEMYQTMLDCWHGEPSQ 280
Query: 215 RLSFNEFYHH--RFLRRNS 231
R +F+E H L+ N+
Sbjct: 281 RPTFSELVEHLGNLLQANA 299
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Score = 122 bits (306), Expect = 1e-33
Identities = 69/275 (25%), Positives = 108/275 (39%), Gaps = 54/275 (19%)
Query: 2 LKKLNKHLKSCLDC-----ELNFLSSVNHPNIIRLFDAFQAENC------IFLVVEFCAG 50
+KKL++ ++ EL + VNH NII L + F + ++LV+E
Sbjct: 47 IKKLSRPFQNQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDA 106
Query: 51 GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKI 110
+ + + L Q+ G++ L+S IIHRDLKP NI + D LKI
Sbjct: 107 NLCQ---VIQMELDHERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNI---VVKSDCTLKI 160
Query: 111 ADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSG 170
DFGL+ T + Y APEV+ Y E VD+WSVG I+ E++ F G
Sbjct: 161 LDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMGEMVRHKILFPG 220
Query: 171 RNNVQLVRNINSC--------------------------KHLPFSQLIVPALHP------ 198
R+ + + L F +L +L P
Sbjct: 221 RDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHN 280
Query: 199 -----DCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228
D+ K+L + R+S ++ H ++
Sbjct: 281 KLKASQARDLLSKMLVIDPAKRISVDDALQHPYIN 315
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Score = 103 bits (256), Expect = 2e-26
Identities = 61/286 (21%), Positives = 105/286 (36%), Gaps = 56/286 (19%)
Query: 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ--AENCIFLVVEFCAGGN---LSSYIRLHG 61
K L+ D + S+ +I++L D F N + +V+ F G H
Sbjct: 61 KLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHR 120
Query: 62 RVPEQTARKFLQQLGAGLEILNSHH-IIHRDLKPENILLSGLD---DDVMLKIADFGLSC 117
+P ++ +QL GL+ ++ IIH D+KPEN+L+ +D + + +KIAD G +C
Sbjct: 121 GIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNAC 180
Query: 118 TLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPPFSGR------ 171
+ Y +PEVL + D+WS ++FEL+ G F
Sbjct: 181 WYDEHYT--NSIQTREYRSPEVLLGAPWGCGADIWSTACLIFELITGDFLFEPDEGHSYT 238
Query: 172 -------------------------------NNVQLVRNINSCKHLPFSQLI------VP 194
N+ L+RNI+ K P ++
Sbjct: 239 KDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDVLTEKYKFSK 298
Query: 195 ALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAI--LRAPF 238
+ D +L + R +H +L+ + +R P
Sbjct: 299 DEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLGMEEIRVPD 344
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191 | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Score = 66.3 bits (161), Expect = 4e-14
Identities = 20/147 (13%), Positives = 46/147 (31%), Gaps = 27/147 (18%)
Query: 19 FLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78
L + + +++ +++E RV + + L +
Sbjct: 67 ALQKLQGLAVPKVYAWEG----NAVLMELIDAKE-------LYRVRVENPDEVLDMILEE 115
Query: 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPE 138
+ I+H DL N+L+ + + I DF S + + E + +
Sbjct: 116 VAKFYHRGIVHGDLSQYNVLV----SEEGIWIIDFPQSVEVGEEGWRE-------ILERD 164
Query: 139 VLQF-----QRYDEKVDMWSVGAILFE 160
V + Y + D+ S + +
Sbjct: 165 VRNIITYFSRTYRTEKDINSAIDRILQ 191
|
Homologous Domains Detected by HHsearch
Original result of HHsearch against SCOP70(version1.75) database
| ID | Alignment Graph | Length |
Definition |
Probability |
| Query | 241 | |||
| d2j4za1 | 263 | Aurora-related kinase 1 (aurora-2) {Human (Homo sa | 100.0 | |
| d1a06a_ | 307 | Calmodulin-dependent protein kinase {Rat (Rattus n | 100.0 | |
| d1yhwa1 | 293 | pak1 {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1nvra_ | 271 | Cell cycle checkpoint kinase chk1 {Human (Homo sap | 100.0 | |
| d1t4ha_ | 270 | Protein kinase wnk1 {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1uu3a_ | 288 | 3-phosphoinositide dependent protein kinase-1 Pdk1 | 100.0 | |
| d1koba_ | 352 | Twitchin, kinase domain {California sea hare (Aply | 100.0 | |
| d1koaa2 | 350 | Twitchin, kinase domain {Caenorhabditis elegans, p | 100.0 | |
| d2jfla1 | 288 | STE20-like serine/threonine-protein kinase, SLK {H | 100.0 | |
| d1jksa_ | 293 | Death-associated protein kinase, Dap {Human (Homo | 100.0 | |
| d2java1 | 269 | Serine/threonine-protein kinase Nek2 {Human (Homo | 100.0 | |
| d1o6la_ | 337 | Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9 | 100.0 | |
| d1u5ra_ | 309 | Serine/threonine protein kinase TAO2 {Rat (Rattus | 100.0 | |
| d1phka_ | 277 | gamma-subunit of glycogen phosphorylase kinase (Ph | 100.0 | |
| d1s9ja_ | 322 | Dual specificity mitogen-activated protein kinase | 100.0 | |
| d1fota_ | 316 | cAMP-dependent PK, catalytic subunit {Baker's yeas | 100.0 | |
| d1tkia_ | 321 | Titin, kinase domain {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1rdqe_ | 350 | cAMP-dependent PK, catalytic subunit {Mouse (Mus m | 100.0 | |
| d1xjda_ | 320 | Protein kinase C, theta type {Human (Homo sapiens) | 100.0 | |
| d2ozaa1 | 335 | MAP kinase activated protein kinase 2, mapkap2 {Hu | 100.0 | |
| d1ua2a_ | 299 | Cell division protein kinase 7, CDK7 {Human (Homo | 100.0 | |
| d1xbba_ | 277 | Tyrosine-protein kinase SYK {Human (Homo sapiens) | 100.0 | |
| d1omwa3 | 364 | G-protein coupled receptor kinase 2 {Cow (Bos taur | 100.0 | |
| d1jpaa_ | 299 | ephb2 receptor tyrosine kinase {Mouse (Mus musculu | 100.0 | |
| d1u59a_ | 285 | Tyrosine-protein kinase ZAP-70 {Human (Homo sapien | 100.0 | |
| d1uwha_ | 276 | B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1sm2a_ | 263 | Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie | 100.0 | |
| d1k2pa_ | 258 | Bruton's tyrosine kinase (Btk) {Human (Homo sapien | 100.0 | |
| d1gz8a_ | 298 | Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T | 100.0 | |
| d1qpca_ | 272 | Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax | 100.0 | |
| d1rjba_ | 325 | Fl cytokine receptor {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1opja_ | 287 | Abelsone tyrosine kinase (abl) {Mouse (Mus musculu | 100.0 | |
| d1ob3a_ | 286 | Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) | 100.0 | |
| d1blxa_ | 305 | Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T | 100.0 | |
| d1xwsa_ | 273 | Proto-oncogene serine/threonine-protein kinase Pim | 100.0 | |
| d1mp8a_ | 273 | Focal adhesion kinase 1 (fak) {Human (Homo sapiens | 100.0 | |
| d1fvra_ | 309 | Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | 100.0 | |
| d1mqba_ | 283 | epha2 receptor tyrosine kinase {Human (Homo sapien | 100.0 | |
| d1fmka3 | 285 | c-src tyrosine kinase {Human (Homo sapiens) [TaxId | 100.0 | |
| d1o6ya_ | 277 | Mycobacterial protein kinase PknB, catalytic domai | 100.0 | |
| d1byga_ | 262 | Carboxyl-terminal src kinase (csk) {Human (Homo sa | 100.0 | |
| d1q5ka_ | 350 | Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho | 100.0 | |
| d1xkka_ | 317 | EGF receptor tyrosine kinase, Erbb-1 {Human (Homo | 100.0 | |
| d1cm8a_ | 346 | MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: | 100.0 | |
| d1fgka_ | 299 | Fibroblast growth factor receptor 1 {Human (Homo s | 100.0 | |
| d1lufa_ | 301 | Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d3bqca1 | 328 | Protein kinase CK2, alpha subunit {Rattus norvegic | 100.0 | |
| d1unla_ | 292 | Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T | 100.0 | |
| d3blha1 | 318 | Cell division protein kinase 9, CDK9 {Human (Homo | 100.0 | |
| d1vzoa_ | 322 | Ribosomal protein S6 kinase alpha 5, Msk1 {Human ( | 100.0 | |
| d1u46a_ | 273 | Activated CDC42 kinase 1, ACK1 {Human (Homo sapien | 100.0 | |
| d1pmea_ | 345 | MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606 | 100.0 | |
| d1p4oa_ | 308 | Insulin-like growth factor 1 receptor {Human (Homo | 100.0 | |
| d1ywna1 | 299 | Vascular endothelial growth factor receptor 2 (kdr | 100.0 | |
| d1r0pa_ | 311 | Hepatocyte growth factor receptor, c-MET {Human (H | 100.0 | |
| d2b1pa1 | 355 | c-jun N-terminal kinase (jnk3s) {Human (Homo sapie | 100.0 | |
| d2gfsa1 | 348 | MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1t46a_ | 311 | c-KIT receptor {Human (Homo sapiens) [TaxId: 9606] | 100.0 | |
| d1ckia_ | 299 | Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax | 100.0 | |
| d1vjya_ | 303 | Type I TGF-beta receptor R4 {Human (Homo sapiens) | 100.0 | |
| d1csna_ | 293 | Casein kinase-1, CK1 {Fission yeast (Schizosacchar | 100.0 | |
| d1q8ya_ | 362 | Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T | 100.0 | |
| d1zara2 | 191 | Rio2 serine protein kinase C-terminal domain {Arch | 99.73 | |
| d1j7la_ | 263 | Type IIIa 3',5"-aminoglycoside phosphotransferase | 98.07 | |
| d1nd4a_ | 255 | Aminoglycoside 3'-phosphotransferase IIa (Kanamyci | 97.85 | |
| d2pula1 | 392 | Methylthioribose kinase MtnK {Bacillus subtilis [T | 97.2 | |
| d1nw1a_ | 395 | Choline kinase {Caenorhabditis elegans [TaxId: 623 | 96.32 | |
| d2ppqa1 | 316 | Homoserine kinase ThrB {Agrobacterium tumefaciens | 94.99 | |
| d1zyla1 | 325 | RdoA {Escherichia coli [TaxId: 562]} | 91.73 |
| >d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Aurora-related kinase 1 (aurora-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-57 Score=350.00 Aligned_cols=215 Identities=31% Similarity=0.568 Sum_probs=195.7
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++.+++..++||||+++|+|.+++.+.+++++..+..++.|++.||+|||++|+
T Consensus 48 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~ivmEy~~~g~L~~~l~~~~~l~e~~~~~i~~qi~~al~~lH~~~i 127 (263)
T d2j4za1 48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDATRVYLILEYAPLGTVYRELQKLSKFDEQRTATYITELANALSYCHSKRV 127 (263)
T ss_dssp TCHHHHHHHHHHHHTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhcCCCCCCeEEEEEEECCEEEEEEeecCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHCCe
Confidence 34678899999999999999999999999999999999999999999999988999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||||||+||++ +.++.+||+|||+|....... .....||+.|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus 128 vHrDiKp~Nill---~~~~~~kl~DFG~a~~~~~~~-~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyell~G~~P 203 (263)
T d2j4za1 128 IHRDIKPENLLL---GSAGELKIADFGWSVHAPSSR-RTTLCGTLDYLPPEMIEGRMHDEKVDLWSLGVLCYEFLVGKPP 203 (263)
T ss_dssp CCCCCCGGGEEE---CTTSCEEECCCCSCSCCCCCC-CEETTEEGGGCCHHHHTTCCCCTTHHHHHHHHHHHHHHHSSCT
T ss_pred eeeeecccccee---cCCCCEeecccceeeecCCCc-ccccCCCCcccCHHHHcCCCCCchhhhhhHhHHHHHHhcCCCC
Confidence 999999999999 788899999999997665433 3456789999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|.+.+..+.++.+.... ..++ ..+|+++.++|.+||+.||.+|||++|+|+||||+..+
T Consensus 204 f~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~~s 262 (263)
T d2j4za1 204 FEANTYQETYKRISRVE-FTFP----DFVTEGARDLISRLLKHNPSQRPMLREVLEHPWITANS 262 (263)
T ss_dssp TCCSSHHHHHHHHHTTC-CCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred CCCCCHHHHHHHHHcCC-CCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCCcC
Confidence 99999988888886544 2333 37899999999999999999999999999999998754
|
| >d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Calmodulin-dependent protein kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=5.5e-57 Score=354.78 Aligned_cols=223 Identities=31% Similarity=0.590 Sum_probs=184.5
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.++++++||||+++++++.+++..|+||||++|++|.+++.+.+++++..+..++.|++.||+|||++|+
T Consensus 49 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~lvmE~~~gg~L~~~l~~~~~l~e~~~~~~~~qi~~al~ylH~~~i 128 (307)
T d1a06a_ 49 GKEGSMENEIAVLHKIKHPNIVALDDIYESGGHLYLIMQLVSGGELFDRIVEKGFYTERDASRLIFQVLDAVKYLHDLGI 128 (307)
T ss_dssp ------CHHHHHHHTCCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHTCSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred hHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEeccCCCcHHHhhhcccCCCHHHHHHHHHHHHHHHHhhhhcee
Confidence 34567889999999999999999999999999999999999999999999988899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||||||+||++...++++.+||+|||+|+............||+.|+|||.+.+..++.++|+||+||++|+|++|..|
T Consensus 129 iHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~GT~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 208 (307)
T d1a06a_ 129 VHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGSVLSTACGTPGYVAPEVLAQKPYSKAVDCWSIGVIAYILLCGYPP 208 (307)
T ss_dssp CCSCCCGGGEEESSSSTTCCEEECCC------------------CTTSCHHHHTTCCCCTHHHHHHHHHHHHHHHHSSCS
T ss_pred eeEEecccceeecccCCCceEEEeccceeEEccCCCeeeeeeeCccccCcHHHcCCCCCcHHHhhhhhHHHHHHHhCCCC
Confidence 99999999999965556788999999999877666656667899999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|.+.+..+....+.... ..++....+.+|+++.++|++||+.||.+|||++|+++||||++..
T Consensus 209 f~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~ 271 (307)
T d1a06a_ 209 FYDENDAKLFEQILKAE-YEFDSPYWDDISDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT 271 (307)
T ss_dssp CCCSSHHHHHHHHHTTC-CCCCTTTTTTSCHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred CCCCCHHHHHHHHhccC-CCCCCccccCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence 99999888888886554 3334445568999999999999999999999999999999998644
|
| >d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: pak1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.4e-56 Score=345.77 Aligned_cols=218 Identities=28% Similarity=0.486 Sum_probs=193.4
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++.+++..|+||||++|++|.+++.+ +.+++..+..++.|++.||.|||++|+
T Consensus 59 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~~~~-~~l~~~~~~~i~~qi~~aL~yLH~~~i 137 (293)
T d1yhwa1 59 PKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVVTE-TCMDEGQIAAVCRECLQALEFLHSNQV 137 (293)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTCBHHHHHHH-SCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEeEEEEECCEEEEEEEecCCCcHHHHhhc-cCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 3456799999999999999999999999999999999999999999998765 579999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+||||||+||++ +.++.+||+|||+|+..... .......||+.|+|||.+.+..++.++||||+||++|+|++|..
T Consensus 138 iHrDiKp~NILl---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 214 (293)
T d1yhwa1 138 IHRDIKSDNILL---GMDGSVKLTDFGFCAQITPEQSKRSTMVGTPYWMAPEVVTRKAYGPKVDIWSLGIMAIEMIEGEP 214 (293)
T ss_dssp ECCCCSGGGEEE---CTTCCEEECCCTTCEECCSTTCCBCCCCSCGGGCCHHHHSSSCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred cccCCcHHHeEE---CCCCcEeeccchhheeeccccccccccccCCCccChhhhcCCCCCchhceehHhHHHHHHhhCCC
Confidence 999999999999 77889999999999876543 34455679999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
||.+.+..+....+......... .++.+|+++.++|++||+.||.+|||++|+|+||||+...
T Consensus 215 Pf~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~~~ 277 (293)
T d1yhwa1 215 PYLNENPLRALYLIATNGTPELQ--NPEKLSAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKIAK 277 (293)
T ss_dssp TTTTSCHHHHHHHHHHHCSCCCS--SGGGSCHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred CCCCCCHHHHHHHHHhCCCCCCC--CcccCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCC
Confidence 99998887777666554433322 2347899999999999999999999999999999998643
|
| >d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell cycle checkpoint kinase chk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-56 Score=346.93 Aligned_cols=217 Identities=30% Similarity=0.525 Sum_probs=184.7
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
+..+.+.+|++++++++||||+++++++.+++..|+||||++||+|.+++.+.+.+++..+..++.|++.||+|||++|+
T Consensus 45 ~~~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~~~~~ivmEy~~gg~L~~~l~~~~~l~e~~~~~i~~qi~~al~ylH~~~I 124 (271)
T d1nvra_ 45 DCPENIKKEICINKMLNHENVVKFYGHRREGNIQYLFLEYCSGGELFDRIEPDIGMPEPDAQRFFHQLMAGVVYLHGIGI 124 (271)
T ss_dssp ----CHHHHHHHHHTCCCTTBCCEEEEEEETTEEEEEEECCTTEEGGGGSBTTTBCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred hHHHHHHHHHHHHHhCCCCCEeeEeeeeccCceeEEEEeccCCCcHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcCC
Confidence 34568999999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHh
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLN 163 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~ 163 (241)
+||||||+||++ +.++.+||+|||+|+...... ......||+.|+|||.+.+..+ +.++|+||+||++|+|++
T Consensus 125 iHrDiKp~NILl---~~~~~~KL~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvilyeml~ 201 (271)
T d1nvra_ 125 THRDIKPENLLL---DERDNLKISDFGLATVFRYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLA 201 (271)
T ss_dssp ECSCCCGGGEEE---CTTCCEEECCCTTCEECEETTEECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHHHHHHHH
T ss_pred ccCcccHHHEEE---CCCCCEEEccchhheeeccCCccccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHHHHHHHh
Confidence 999999999999 778899999999998754322 2345679999999999987775 678999999999999999
Q ss_pred CCCCCCCCChH-HHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 164 GYPPFSGRNNV-QLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 164 g~~p~~~~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
|+.||...+.. .....+........+ ...+|+++.++|++||+.||++|||++|+++||||++.
T Consensus 202 G~~pf~~~~~~~~~~~~~~~~~~~~~~---~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~~ 266 (271)
T d1nvra_ 202 GELPWDQPSDSCQEYSDWKEKKTYLNP---WKKIDSAPLALLHKILVENPSARITIPDIKKDRWYNKP 266 (271)
T ss_dssp SSCSCSSSSTTSHHHHHHHTTCTTSTT---GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred CCCCCCCCChHHHHHHHHhcCCCCCCc---cccCCHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCcC
Confidence 99999865443 333333333222211 24789999999999999999999999999999999864
|
| >d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase wnk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.9e-55 Score=338.99 Aligned_cols=216 Identities=29% Similarity=0.545 Sum_probs=186.5
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
+....+.+.+|++++++++||||+++++++++ +..+++||||+++++|.+++.+...+++..+..++.|++.||+|
T Consensus 48 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~~~~~~~~~~~~qi~~gl~y 127 (270)
T d1t4ha_ 48 TKSERQRFKEEAEMLKGLQHPNIVRFYDSWESTVKGKKCIVLVTELMTSGTLKTYLKRFKVMKIKVLRSWCRQILKGLQF 127 (270)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEEESSSCEEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCeeeEEEEEeeccccCCEEEEEEeCCCCCcHHHHHhccccccHHHHHHHHHHHHHHHHH
Confidence 45567789999999999999999999999875 35689999999999999999988899999999999999999999
Q ss_pred HHhCC--ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 82 LNSHH--IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 82 lh~~~--i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
||++| ++||||||+||+++ ++++.+||+|||+|+..... ......||+.|+|||.+.+ .++.++||||+||++|
T Consensus 128 LH~~~~~IiHrDiKp~NILl~--~~~~~~Kl~DFGla~~~~~~-~~~~~~GT~~Y~aPE~~~~-~~~~~~DIwSlGvily 203 (270)
T d1t4ha_ 128 LHTRTPPIIHRDLKCDNIFIT--GPTGSVKIGDLGLATLKRAS-FAKAVIGTPEFMAPEMYEE-KYDESVDVYAFGMCML 203 (270)
T ss_dssp HHTSSSCCCCSCCCGGGEEES--STTSCEEECCTTGGGGCCTT-SBEESCSSCCCCCGGGGGT-CCCTHHHHHHHHHHHH
T ss_pred HHHCCCCEEeCCcChhhceee--CCCCCEEEeecCcceeccCC-ccCCcccCccccCHHHhCC-CCCCcCchhhHHHHHH
Confidence 99998 99999999999994 35678999999999764433 3445679999999999875 5999999999999999
Q ss_pred HHHhCCCCCCCCC-hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccc
Q 026253 160 ELLNGYPPFSGRN-NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLR 228 (241)
Q Consensus 160 ~l~~g~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~ 228 (241)
+|++|+.||.+.. ..++.+.+..+.. +.......++++.++|++||+.||++|||++|+|+||||+
T Consensus 204 el~~g~~Pf~~~~~~~~~~~~i~~~~~---~~~~~~~~~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk 270 (270)
T d1t4ha_ 204 EMATSEYPYSECQNAAQIYRRVTSGVK---PASFDKVAIPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ 270 (270)
T ss_dssp HHHHSSCTTTTCSSHHHHHHHHTTTCC---CGGGGGCCCHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred HHHHCCCCCCCcccHHHHHHHHHcCCC---CcccCccCCHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence 9999999998654 4555566654433 2233447889999999999999999999999999999996
|
| >d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: 3-phosphoinositide dependent protein kinase-1 Pdk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.4e-56 Score=344.58 Aligned_cols=216 Identities=31% Similarity=0.588 Sum_probs=192.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
+...+.+.+|++++++++||||+++++++.+++..|+||||++||+|.+++...+.+++..+..++.|++.||.|||+.|
T Consensus 49 ~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~ivmEy~~gg~L~~~~~~~~~l~e~~~~~~~~qi~~al~ylH~~~ 128 (288)
T d1uu3a_ 49 ENKVPYVTRERDVMSRLDHPFFVKLYFTFQDDEKLYFGLSYAKNGELLKYIRKIGSFDETCTRFYTAEIVSALEYLHGKG 128 (288)
T ss_dssp TTCHHHHHHHHHHHHHCCSTTBCCEEEEEECSSEEEEEECCCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHHcCCCCeeEEEEEEEECCEEEEEEEccCCCCHHHhhhccCCCCHHHHHHHHHHHHHHHHhhcccc
Confidence 34457799999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
++||||||+||++ +.++.++|+|||+|+...... ......||+.|+|||.+.+..++.++||||+||++|+|++
T Consensus 129 iiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~GT~~Y~APE~~~~~~~~~~~DiwSlGvilyell~ 205 (288)
T d1uu3a_ 129 IIHRDLKPENILL---NEDMHIQITDFGTAKVLSPESKQARANSFVGTAQYVSPELLTEKSACKSSDLWALGCIIYQLVA 205 (288)
T ss_dssp EECSCCSGGGEEE---CTTSCEEECCCTTCEECC----------CCCCGGGCCHHHHHTCCCCHHHHHHHHHHHHHHHHH
T ss_pred EEcCcCCcccccc---CCCceEEecccccceecccCCcccccccccCCccccCceeeccCCCCcccceehhhHHHHHHhh
Confidence 9999999999999 788899999999998764332 2334579999999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHH------HhcCcccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNE------FYHHRFLRRN 230 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~------il~~~~~~~~ 230 (241)
|..||.+.+..+.++.+.... ..++ ..+|+++.++|++||+.||++|||++| +++||||++.
T Consensus 206 g~~Pf~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~i 273 (288)
T d1uu3a_ 206 GLPPFRAGNEYLIFQKIIKLE-YDFP----EKFFPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFESV 273 (288)
T ss_dssp SSCSSCCSSHHHHHHHHHTTC-CCCC----TTCCHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTTC
T ss_pred CCCCCCCcCHHHHHHHHHcCC-CCCC----ccCCHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCCC
Confidence 999999999999888886544 3333 378999999999999999999999988 5889999874
|
| >d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]
Probab=100.00 E-value=1.2e-55 Score=353.05 Aligned_cols=228 Identities=27% Similarity=0.546 Sum_probs=203.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
....+.+.+|++++++++||||+++++++++++..|+|||||+|++|.+++... .++++..+..++.||+.||+|||++
T Consensus 67 ~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~ylH~~ 146 (352)
T d1koba_ 67 PLDKYTVKNEISIMNQLHHPKLINLHDAFEDKYEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKHMHEH 146 (352)
T ss_dssp HHHHHHHHHHHHHHTTCCSTTBCCEEEEEECSSEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHHHHHT
T ss_pred hhHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHC
Confidence 345678899999999999999999999999999999999999999999987654 4699999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
|++||||||+|||++. ...+.++|+|||+|.............+++.|+|||.+.+..++.++|||||||++|+|++|.
T Consensus 147 ~iiHRDiKp~NILl~~-~~~~~vkL~DFGla~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyelltG~ 225 (352)
T d1koba_ 147 SIVHLDIKPENIMCET-KKASSVKIIDFGLATKLNPDEIVKVTTATAEFAAPEIVDREPVGFYTDMWAIGVLGYVLLSGL 225 (352)
T ss_dssp TEECCCCCGGGEEESS-TTCCCEEECCCTTCEECCTTSCEEEECSSGGGCCHHHHTTCCBCHHHHHHHHHHHHHHHHHSC
T ss_pred Ceeecccccccccccc-cCCCeEEEeecccceecCCCCceeeccCcccccCHHHHcCCCCCCccchHHHHHHHHHHHhCC
Confidence 9999999999999942 256789999999999887776666778999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCCC
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILRA 236 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~~ 236 (241)
.||.+.+..+.+..+..+. ..++....+.+|+++.+||++||+.||.+|||++|+|+||||+.....+..
T Consensus 226 ~Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~~~~~~~ 295 (352)
T d1koba_ 226 SPFAGEDDLETLQNVKRCD-WEFDEDAFSSVSPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDHSNLTS 295 (352)
T ss_dssp CSSCCSSHHHHHHHHHHCC-CCCCSSTTTTSCHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCCTTCCC
T ss_pred CCCCCCCHHHHHHHHHhCC-CCCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCCcchhcc
Confidence 9999999999888886654 344555566899999999999999999999999999999999875544433
|
| >d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Twitchin, kinase domain species: Caenorhabditis elegans, pjk4 [TaxId: 6239]
Probab=100.00 E-value=1.8e-55 Score=351.62 Aligned_cols=223 Identities=30% Similarity=0.552 Sum_probs=199.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHH-hcCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIR-LHGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~-~~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.....+.+.+|++++++++||||+++++++.+++..|+||||++||+|.+++. ..+++++..+..++.||+.||.|||+
T Consensus 63 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~ylH~ 142 (350)
T d1koaa2 63 HESDKETVRKEIQTMSVLRHPTLVNLHDAFEDDNEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLCHMHE 142 (350)
T ss_dssp SHHHHHHHHHHHHHHHHTCCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHHHHHH
T ss_pred chhhHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHh
Confidence 34556789999999999999999999999999999999999999999999985 44679999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
+|++||||||+||+++. +.++.+||+|||+|+............+|+.|+|||.+.+..++.++||||+||++|+|++|
T Consensus 143 ~~iiHrDiKp~NIll~~-~~~~~vkL~DFG~a~~~~~~~~~~~~~gT~~Y~aPEv~~~~~~~~~~DiwSlGvilyell~G 221 (350)
T d1koaa2 143 NNYVHLDLKPENIMFTT-KRSNELKLIDFGLTAHLDPKQSVKVTTGTAEFAAPEVAEGKPVGYYTDMWSVGVLSYILLSG 221 (350)
T ss_dssp TTEECCCCCGGGEEESS-TTSCCEEECCCTTCEECCTTSCEEEECSCTTTCCHHHHHTCCBCHHHHHHHHHHHHHHHHHS
T ss_pred cCCeeeeechhHeeecc-CCCCeEEEeecchheecccccccceecCcccccCHHHHcCCCCChhHhhhhhhHHHHHHHhC
Confidence 99999999999999942 23568999999999888776666678899999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
..||.+.+..+.+..+..... .++....+.+|+++.++|++||+.||++|||++|+|+||||+..
T Consensus 222 ~~Pf~~~~~~~~~~~i~~~~~-~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~ 286 (350)
T d1koaa2 222 LSPFGGENDDETLRNVKSCDW-NMDDSAFSGISEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPG 286 (350)
T ss_dssp SCSSCCSSHHHHHHHHHHTCC-CSCCGGGGGCCHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCT
T ss_pred CCCCCCCCHHHHHHHHHhCCC-CCCcccccCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence 999999999998888866543 33444456789999999999999999999999999999999864
|
| >d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: STE20-like serine/threonine-protein kinase, SLK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.5e-56 Score=344.74 Aligned_cols=221 Identities=31% Similarity=0.499 Sum_probs=193.1
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+.+..+.+.+|++++++++||||+++++++.+++..++||||++||+|.+++.+. +++++..+..++.|++.||.|||+
T Consensus 49 ~~~~~~~~~~E~~il~~l~HpnIv~l~~~~~~~~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~ylH~ 128 (288)
T d2jfla1 49 SEEELEDYMVEIDILASCDHPNIVKLLDAFYYENNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALNYLHD 128 (288)
T ss_dssp SSGGGGGTHHHHHHHHHCCCTTBCCEEEEEEETTEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCeEEEEEeeCCeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHH
Confidence 3456788999999999999999999999999999999999999999999997654 569999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCccccc-----ccCCCCchhHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQ-----FQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~-----~~~~~~~~Dv~slG~~l 158 (241)
+|++||||||+||++ +.++.+||+|||+|...... .......||+.|+|||.+. +..++.++||||+||++
T Consensus 129 ~~ivHrDiKp~NIll---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwSlGvil 205 (288)
T d2jfla1 129 NKIIHRDLKAGNILF---TLDGDIKLADFGVSAKNTRTIQRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITL 205 (288)
T ss_dssp TTEECCCCSGGGEEE---CTTSCEEECCCTTCEECHHHHHHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHHHHHHH
T ss_pred CCEEEeecChhheeE---CCCCCEEEEechhhhccCCCcccccccccccccCCHHHHhhcccCCCCCChhhhHHHHHHHH
Confidence 999999999999999 77889999999998654322 1233567899999999984 45688999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccccc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
|+|++|..||.+.+..+.+..+..+....... .+.+|+++.++|++||+.||.+|||++|+++||||+...
T Consensus 206 yemltg~~Pf~~~~~~~~~~~i~~~~~~~~~~--~~~~s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~~ 276 (288)
T d2jfla1 206 IEMAEIEPPHHELNPMRVLLKIAKSEPPTLAQ--PSRWSSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVDS 276 (288)
T ss_dssp HHHHHSSCTTTTSCGGGHHHHHHHSCCCCCSS--GGGSCHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCCC
T ss_pred HHHhhCCCCCCCCCHHHHHHHHHcCCCCCCCc--cccCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCC
Confidence 99999999999988888888877665433322 247899999999999999999999999999999998643
|
| >d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Death-associated protein kinase, Dap species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.5e-55 Score=342.59 Aligned_cols=220 Identities=29% Similarity=0.558 Sum_probs=198.0
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
..+.+.+|++++++++||||+++++++++++..|+|||||+||+|.+++...+++++..+..++.|++.||+|||+.|++
T Consensus 56 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~gg~L~~~i~~~~~l~~~~~~~~~~qi~~al~yLH~~~iv 135 (293)
T d1jksa_ 56 SREDIEREVSILKEIQHPNVITLHEVYENKTDVILILELVAGGELFDFLAEKESLTEEEATEFLKQILNGVYYLHSLQIA 135 (293)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEEECSSEEEEEEECCCSCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCccccchhccccccchhHHHHHHHHHHHHHHhhhhccee
Confidence 35779999999999999999999999999999999999999999999999888999999999999999999999999999
Q ss_pred ccCCCCCCeEEeecC-CCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 89 HRDLKPENILLSGLD-DDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 89 H~dl~~~nil~~~~~-~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
||||||+||+++..+ ....++++|||+|.............+++.|+|||.+.+..++.++||||+||++|+|++|..|
T Consensus 136 HrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~~~~~~~~t~~y~APE~~~~~~~~~~~DiwSlGvilyell~g~~P 215 (293)
T d1jksa_ 136 HFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGNEFKNIFGTPEFVAPEIVNYEPLGLEADMWSIGVITYILLSGASP 215 (293)
T ss_dssp CCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSCBCSCCCCCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecccccceEEEecCCCcccceEecchhhhhhcCCCccccccCCCCcccCHHHHcCCCCCCcccchhhhHHHHHHHcCCCC
Confidence 999999999994321 2235999999999887666666667889999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
|.+.+..+.+..+.... ..++....+.+|+++.++|++||+.||.+|||++|+++||||+.
T Consensus 216 f~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~ 276 (293)
T d1jksa_ 216 FLGDTKQETLANVSAVN-YEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP 276 (293)
T ss_dssp SCCSSHHHHHHHHHTTC-CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred CCCCCHHHHHHHHHhcC-CCCCchhcCCCCHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence 99999999888886544 33444455688999999999999999999999999999999986
|
| >d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine-protein kinase Nek2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-55 Score=338.84 Aligned_cols=215 Identities=30% Similarity=0.576 Sum_probs=181.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHh----cCCCCHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRL----HGRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~----~~~~~~~~~~~~~~~i~~~l 79 (241)
++...+.+.+|++++++++||||+++++++.+ ++..|+||||++||+|.+++.+ ...+++..++.++.|++.||
T Consensus 43 ~~~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~al 122 (269)
T d2java1 43 TEAEKQMLVSEVNLLRELKHPNIVRYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLAL 122 (269)
T ss_dssp CHHHHHHHHHHHHHTTSCCCTTBCCEEEEEEC----CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEeCCCCEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHHH
Confidence 55667889999999999999999999998854 5678999999999999999864 35799999999999999999
Q ss_pred HHHHhCC-----ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccCCCCchhHHH
Q 026253 80 EILNSHH-----IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQRYDEKVDMWS 153 (241)
Q Consensus 80 ~~lh~~~-----i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~s 153 (241)
.|||++| |+||||||+||++ +.++.+||+|||+|+...... ......+|+.|+|||.+.+..++.++||||
T Consensus 123 ~ylH~~~~~~~~IiHrDiKp~NIll---~~~~~vkl~DFG~a~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~~DIwS 199 (269)
T d2java1 123 KECHRRSDGGHTVLHRDLKPANVFL---DGKQNVKLGDFGLARILNHDTSFAKAFVGTPYYMSPEQMNRMSYNEKSDIWS 199 (269)
T ss_dssp HHHHHHCC---------CCGGGEEE---CTTSCEEECCHHHHHHC-----------CCCSCCCHHHHTTCCCCHHHHHHH
T ss_pred HHHHHhcCCCCCEEeCcCchhhcCc---CCCCcEEEeeccceeecccCCCccccCCCCcccCCHHHHcCCCCChHHHHHh
Confidence 9999976 9999999999999 788899999999998765433 334567899999999999999999999999
Q ss_pred HHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccc
Q 026253 154 VGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFL 227 (241)
Q Consensus 154 lG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~ 227 (241)
|||++|+|++|+.||.+.+..+....+..+.....+ ..+|+++.++|++||+.||.+|||++|+++|||+
T Consensus 200 lGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~~----~~~s~~l~~li~~~L~~dp~~Rps~~ell~hp~i 269 (269)
T d2java1 200 LGCLLYELCALMPPFTAFSQKELAGKIREGKFRRIP----YRYSDELNEIITRMLNLKDYHRPSVEEILENPLI 269 (269)
T ss_dssp HHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred hCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCCC----cccCHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence 999999999999999999999999888777655444 3789999999999999999999999999999996
|
| >d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Pkb kinase (Akt-2) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.9e-54 Score=341.46 Aligned_cols=215 Identities=31% Similarity=0.523 Sum_probs=196.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|+.++++++||||+++++++.+++.+|+||||++||+|.+++.+.+.++++.+..++.|++.||.|||++|
T Consensus 46 ~~~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~~~~~iv~ey~~gg~L~~~~~~~~~~~e~~~~~~~~qil~al~ylH~~~ 125 (337)
T d1o6la_ 46 KDEVAHTVTESRVLQNTRHPFLTALKYAFQTHDRLCFVMEYANGGELFFHLSRERVFTEERARFYGAEIVSALEYLHSRD 125 (337)
T ss_dssp TTCHHHHHHHHHHHHSCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhCCCCCEEEEEeeeccccccccceeccCCCchhhhhhcccCCcHHHHHHHHHHHhhhhhhhhhcC
Confidence 33567889999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCC-CCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYP-GNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGY 165 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~-~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~ 165 (241)
++||||||+||++ +.++.+||+|||+|+.... .......+||+.|+|||.+.+..++.++|+||+||++|+|++|+
T Consensus 126 iiHRDlKP~NILl---~~~g~vkl~DFG~a~~~~~~~~~~~~~~GT~~Y~aPE~~~~~~y~~~~DiwSlGvilyeml~G~ 202 (337)
T d1o6la_ 126 VVYRDIKLENLML---DKDGHIKITDFGLCKEGISDGATMKTFCGTPEYLAPEVLEDNDYGRAVDWWGLGVVMYEMMCGR 202 (337)
T ss_dssp CBCCCCCGGGEEE---CTTSCEEECCCTTCBCSCCTTCCBCCCEECGGGCCGGGGSSSCBCTTHHHHHHHHHHHHHHHSS
T ss_pred ccccccCHHHeEe---cCCCCEEEeecccccccccCCcccccceeCHHHhhhhhccCCCCChhhcccchhhHHHHHHHCC
Confidence 9999999999999 7889999999999987644 33445678999999999999999999999999999999999999
Q ss_pred CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCccccc
Q 026253 166 PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRR 229 (241)
Q Consensus 166 ~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~ 229 (241)
+||.+.+..++.+.+..+. ..++ ..+|+++.+||++||++||.+|++ ++|+++||||++
T Consensus 203 ~pf~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~ 266 (337)
T d1o6la_ 203 LPFYNQDHERLFELILMEE-IRFP----RTLSPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS 266 (337)
T ss_dssp CSSCCSSHHHHHHHHHHCC-CCCC----TTSCHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred CCCCCcCHHHHHHHHhcCC-CCCC----ccCCHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence 9999999999888886654 3444 378999999999999999999994 899999999986
|
| >d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Serine/threonine protein kinase TAO2 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.1e-54 Score=340.11 Aligned_cols=216 Identities=29% Similarity=0.456 Sum_probs=192.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+....+.+.+|++++++++||||+++++++.+++..|+|||||.+++|..++...+++++..+..++.|++.||.|||++
T Consensus 55 ~~~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yLH~~ 134 (309)
T d1u5ra_ 55 SNEKWQDIIKEVRFLQKLRHPNTIQYRGCYLREHTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYLHSH 134 (309)
T ss_dssp HHHHHHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred CHHHHHHHHHHHHHHHHCCCCCEeeEEEEEEECCEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhC
Confidence 34556789999999999999999999999999999999999999999988888888999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc---cCCCCchhHHHHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l~~l~ 162 (241)
|++||||||+||++ +.++.+||+|||+|..... .....||+.|+|||.+.+ ..++.++||||+||++|+|+
T Consensus 135 ~iiHrDiKp~NILl---~~~~~~Kl~DFG~a~~~~~---~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvilyel~ 208 (309)
T d1u5ra_ 135 NMIHRDVKAGNILL---SEPGLVKLGDFGSASIMAP---ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELA 208 (309)
T ss_dssp TCBCCCCSGGGEEE---ETTTEEEECCCTTCBSSSS---BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHHHHHHH
T ss_pred CEeccCCCcceEEE---CCCCCEEEeecccccccCC---CCccccCccccCHHHHhccCCCCcCchhhhhhHHHHHHHHH
Confidence 99999999999999 6788999999999976543 334679999999999864 45889999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+|..||.+.+..+.+..+.......... ..+|+++.++|++||+.||.+|||++|+|+||||.+.
T Consensus 209 ~g~~Pf~~~~~~~~~~~i~~~~~~~~~~---~~~s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~ 273 (309)
T d1u5ra_ 209 ERKPPLFNMNAMSALYHIAQNESPALQS---GHWSEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRE 273 (309)
T ss_dssp HSSCTTTTSCHHHHHHHHHHSCCCCCSC---TTSCHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSC
T ss_pred HCCCCCCCCCHHHHHHHHHhCCCCCCCC---CCCCHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCC
Confidence 9999999988888887776665544332 4789999999999999999999999999999999864
|
| >d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: gamma-subunit of glycogen phosphorylase kinase (Phk) species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]
Probab=100.00 E-value=5.6e-54 Score=332.94 Aligned_cols=220 Identities=36% Similarity=0.649 Sum_probs=197.7
Q ss_pred HHhhhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 7 KHLKSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
+...+.+.+|+.++++++ ||||+++++++.+++..|+||||++|++|.++++..+++++..+..++.||+.||+|||++
T Consensus 50 ~~~~~~~~~E~~~l~~l~~hpnIv~~~~~~~~~~~~~ivmE~~~~g~L~~~l~~~~~l~e~~~~~~~~qi~~al~~lH~~ 129 (277)
T d1phka_ 50 QELREATLKEVDILRKVSGHPNIIQLKDTYETNTFFFLVFDLMKKGELFDYLTEKVTLSEKETRKIMRALLEVICALHKL 129 (277)
T ss_dssp HHHHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred HHHHHHHHHHHHHHHHhcCCCCeEEEEeecccCcceEEEEEcCCCchHHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHHc
Confidence 345667899999999996 9999999999999999999999999999999999999999999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc------cCCCCchhHHHHHHHHH
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF------QRYDEKVDMWSVGAILF 159 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~------~~~~~~~Dv~slG~~l~ 159 (241)
|++||||||+||++ +.++.+||+|||+++............+|..|.|||.+.+ ..++.++|+||+||++|
T Consensus 130 ~ivHrDlkp~Nill---~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~DiwslGvily 206 (277)
T d1phka_ 130 NIVHRDLKPENILL---DDDMNIKLTDFGFSCQLDPGEKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMY 206 (277)
T ss_dssp TEECSCCSGGGEEE---CTTCCEEECCCTTCEECCTTCCBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHHHHHHHHH
T ss_pred CCcccccccceEEE---cCCCCeEEccchheeEccCCCceeeeeccCCCCCHHHhhccccccCCCCCchheEcccchhhh
Confidence 99999999999999 7889999999999988776656666789999999998753 34688999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+|++|+.||.+.+.....+.+..+... .+....+.+|+++.+++.+||+.||.+|||++|+++||||++.
T Consensus 207 eml~g~~Pf~~~~~~~~~~~i~~~~~~-~~~~~~~~~s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~~ 276 (277)
T d1phka_ 207 TLLAGSPPFWHRKQMLMLRMIMSGNYQ-FGSPEWDDYSDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY 276 (277)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHTCCC-CCTTTGGGSCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred hhccCCCCCCCCCHHHHHHHHHhCCCC-CCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHHHHh
Confidence 999999999999988888877665432 3333445799999999999999999999999999999999863
|
| >d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.4e-55 Score=345.75 Aligned_cols=219 Identities=30% Similarity=0.491 Sum_probs=184.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHh-
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNS- 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~- 84 (241)
++...+.+.+|++++++++||||+++++++.+++..++||||++|++|.+++.+.+++++..+..++.|++.||.|||+
T Consensus 44 ~~~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~~~iVmEy~~gg~L~~~l~~~~~l~~~~~~~~~~qil~aL~yLH~~ 123 (322)
T d1s9ja_ 44 KPAIRNQIIRELQVLHECNSPYIVGFYGAFYSDGEISICMEHMDGGSLDQVLKKAGRIPEQILGKVSIAVIKGLTYLREK 123 (322)
T ss_dssp CTTHHHHHHHHGGGGGGCCCTTBCCEEEEEECSSEEEEEEECCTTEEHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCCcEEEEEEECCEEEEEEEcCCCCcHHHHHhhcCCCCHHHHHHHHHHHHHHHHHHHHh
Confidence 3455678999999999999999999999999999999999999999999999988999999999999999999999997
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhC
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g 164 (241)
+||+||||||+||++ +.++.+||+|||+|...... ......||+.|+|||.+.+..++.++||||+||++|+|++|
T Consensus 124 ~~IiHRDiKP~NILl---~~~~~vkl~DFGla~~~~~~-~~~~~~GT~~Y~APEvl~~~~y~~~~DiWSlGvil~ell~G 199 (322)
T d1s9ja_ 124 HKIMHRDVKPSNILV---NSRGEIKLCDFGVSGQLIDS-MANSFVGTRSYMSPERLQGTHYSVQSDIWSMGLSLVEMAVG 199 (322)
T ss_dssp HCCCCSCCSGGGEEE---CTTCCEEECCCCCCHHHHHH-TC---CCSSCCCCHHHHHCSCCCTTHHHHHHHHHHHHHHHS
T ss_pred CCEEccccCHHHeeE---CCCCCEEEeeCCCccccCCC-ccccccCCccccCchHHcCCCCCcHHHHHHHHHHHHHHHHC
Confidence 499999999999999 78889999999999865432 23356799999999999999999999999999999999999
Q ss_pred CCCCCCCChHHHHH------------------------------------------HhhcCCCCCCCCccCCCCChHHHH
Q 026253 165 YPPFSGRNNVQLVR------------------------------------------NINSCKHLPFSQLIVPALHPDCVD 202 (241)
Q Consensus 165 ~~p~~~~~~~~~~~------------------------------------------~i~~~~~~~~~~~~~~~~~~~~~~ 202 (241)
+.||.+.+..+... .+..... +......+|.++.+
T Consensus 200 ~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~~~d 276 (322)
T d1s9ja_ 200 RYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPP---PKLPSGVFSLEFQD 276 (322)
T ss_dssp SCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCC---CCCCBTTBCHHHHH
T ss_pred CCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCC---ccCccccCCHHHHH
Confidence 99998655432211 1111111 11111246889999
Q ss_pred HHHHhcccCccccCCHHHHhcCccccccc
Q 026253 203 MCLKLLSANTVDRLSFNEFYHHRFLRRNS 231 (241)
Q Consensus 203 li~~~l~~~p~~Rps~~~il~~~~~~~~~ 231 (241)
+|++||+.||.+|||++|+|+||||++..
T Consensus 277 li~~~L~~dP~~R~ta~e~L~Hpf~~~~~ 305 (322)
T d1s9ja_ 277 FVNKCLIKNPAERADLKQLMVHAFIKRSD 305 (322)
T ss_dssp HHHHHTCSSTTTSCCHHHHHTSHHHHHHH
T ss_pred HHHHHcCCChhHCcCHHHHhhCHhhCcCC
Confidence 99999999999999999999999998754
|
| >d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=4.2e-53 Score=333.84 Aligned_cols=212 Identities=34% Similarity=0.628 Sum_probs=194.4
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|+.++++++||||+++++++.+++..|+||||++|++|..++.....+++..+..++.|++.||.|||++|+
T Consensus 46 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~ivmE~~~gg~l~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i 125 (316)
T d1fota_ 46 KQVEHTNDERLMLSIVTHPFIIRMWGTFQDAQQIFMIMDYIEGGELFSLLRKSQRFPNPVAKFYAAEVCLALEYLHSKDI 125 (316)
T ss_dssp TCHHHHHHHHHHHHSCCBTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHTSSCCHHHHHHHHHHHHHHHHHHHTTTE
T ss_pred HHHHHHHHHHHHHHhccCcChhheeeeEeeCCeeeeEeeecCCccccccccccccccccHHHHHHHHHHHhhhhhccCcE
Confidence 34678899999999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||||||+||++ +.++.+||+|||+|+..... .....||+.|+|||.+.+..++.++|+||+||++|+|++|+.|
T Consensus 126 iHrDiKp~NILl---~~~g~vkL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~l~~~~y~~~~DiwSlGvilyemltG~~P 200 (316)
T d1fota_ 126 IYRDLKPENILL---DKNGHIKITDFGFAKYVPDV--TYTLCGTPDYIAPEVVSTKPYNKSIDWWSFGILIYEMLAGYTP 200 (316)
T ss_dssp ECCCCCGGGEEE---CTTSCEEECCCSSCEECSSC--BCCCCSCTTTCCHHHHTTCCBCTTHHHHHHHHHHHHHHHSSCT
T ss_pred EccccCchheeE---cCCCCEEEecCccceEeccc--cccccCcccccCHHHHcCCCCCchhhccccchhHHHHHhCCCC
Confidence 999999999999 78889999999999876543 3356799999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
|.+.+..+....+..+.. .++ +.+|+++.+++++||+.||.+|+ |++++++||||++
T Consensus 201 f~~~~~~~~~~~i~~~~~-~~p----~~~s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~ 262 (316)
T d1fota_ 201 FYDSNTMKTYEKILNAEL-RFP----PFFNEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE 262 (316)
T ss_dssp TCCSSHHHHHHHHHHCCC-CCC----TTSCHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred CCCcCHHHHHHHHHcCCC-CCC----CCCCHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence 999999998888866542 233 47899999999999999999996 9999999999987
|
| >d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Titin, kinase domain species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.2e-54 Score=339.94 Aligned_cols=226 Identities=27% Similarity=0.487 Sum_probs=200.5
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
.....+.+|++++++++||||+++++++++++.+|+|||||+|++|.+++...+ ++++..+..++.||+.||.|||++|
T Consensus 43 ~~~~~~~~Ei~il~~l~HpnIv~~~~~~~~~~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~yLH~~~ 122 (321)
T d1tkia_ 43 TDQVLVKKEISILNIARHRNILHLHESFESMEELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQFLHSHN 122 (321)
T ss_dssp HHHHHHHHHHHHHHHSCCTTBCCEEEEEEETTEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred ccHHHHHHHHHHHHhCCCCCCCeEEEEEEECCEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHcC
Confidence 345568899999999999999999999999999999999999999999998665 7999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
++||||||+||+++. ++...++|+|||++.............+++.|+|||...+..++.++|+||+||++|+|++|..
T Consensus 123 iiHrDlKp~NIll~~-~~~~~ikl~DFG~~~~~~~~~~~~~~~~t~~y~ape~~~~~~~~~~~DiWSlGvily~ll~G~~ 201 (321)
T d1tkia_ 123 IGHFDIRPENIIYQT-RRSSTIKIIEFGQARQLKPGDNFRLLFTAPEYYAPEVHQHDVVSTATDMWSLGTLVYVLLSGIN 201 (321)
T ss_dssp EECCCCCGGGEEESS-SSCCCEEECCCTTCEECCTTCEEEEEESCGGGSCHHHHTTCEECHHHHHHHHHHHHHHHHHSSC
T ss_pred CCcccccccceeecC-CCceEEEEcccchhhccccCCcccccccccccccchhccCCCCCchhhcccHHHHHHHHHhCCC
Confidence 999999999999942 2455799999999988776666666778999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccCC
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAILR 235 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~~ 235 (241)
||.+.+..+.+..+.... ..++....+.+|+++.+||++||+.||.+|||++|+++||||++......
T Consensus 202 Pf~~~~~~~~~~~i~~~~-~~~~~~~~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~~~~ 269 (321)
T d1tkia_ 202 PFLAETNQQIIENIMNAE-YTFDEEAFKEISIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKIERVS 269 (321)
T ss_dssp TTCCSSHHHHHHHHHHTC-CCCCHHHHTTSCHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCGGGSC
T ss_pred CCCCCCHHHHHHHHHhCC-CCCChhhccCCCHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCccccC
Confidence 999999999988886654 33444455678999999999999999999999999999999987544433
|
| >d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: cAMP-dependent PK, catalytic subunit species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.3e-52 Score=335.23 Aligned_cols=212 Identities=31% Similarity=0.574 Sum_probs=193.8
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
...+.+.+|++++++++||||+++++++.+.+..++|||++.|++|.+++.+.+.+++..+..++.||+.||.|||++|+
T Consensus 83 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~l~~~~~l~e~~~~~i~~qi~~aL~yLH~~~i 162 (350)
T d1rdqe_ 83 KQIEHTLNEKRILQAVNFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARFYAAQIVLTFEYLHSLDL 162 (350)
T ss_dssp TCHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHCCCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHHHHcCCCcEeecccccccccccccccccccccchhhhHhhcCCCCHHHHHHHHHHHHHHHHHHHhCCE
Confidence 34567899999999999999999999999999999999999999999999998999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
+||||||+|||+ +.++.+||+|||+|+..... .....||+.|+|||.+.+..++.++|+|||||++|+|++|..|
T Consensus 163 iHRDIKP~NILl---~~~g~ikL~DFG~a~~~~~~--~~~~~Gt~~Y~APE~~~~~~~~~~~DiwSlGvilyemltG~~P 237 (350)
T d1rdqe_ 163 IYRDLKPENLLI---DQQGYIQVTDFGFAKRVKGR--TWTLCGTPEALAPEIILSKGYNKAVDWWALGVLIYEMAAGYPP 237 (350)
T ss_dssp ECCCCSGGGEEE---CTTSCEEECCCTTCEECSSC--BCCCEECGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSCS
T ss_pred ecCcCCHHHccc---CCCCCEEeeeceeeeecccc--cccccCccccCCHHHHcCCCCCccccccchhHHHHHHHhCCCC
Confidence 999999999999 78889999999999876543 3346789999999999999999999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 168 FSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
|.+.+.......+..+.. ..+ ..+|+++.++|++||+.||.+|+ |++++++||||++
T Consensus 238 f~~~~~~~~~~~i~~~~~-~~p----~~~s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~ 299 (350)
T d1rdqe_ 238 FFADQPIQIYEKIVSGKV-RFP----SHFSSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT 299 (350)
T ss_dssp SCCSSHHHHHHHHHHCCC-CCC----TTCCHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred CCCcCHHHHHHHHhcCCC-CCC----ccCCHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence 999999988888866543 222 37899999999999999999995 9999999999986
|
| >d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase C, theta type species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.5e-52 Score=330.00 Aligned_cols=213 Identities=33% Similarity=0.572 Sum_probs=191.0
Q ss_pred hhhhHHHHHHHHh-cCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLS-SVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~-~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+..|..++. .++||||+++++++.+++..|+||||+++|+|.+++...+++++..+..++.|++.||.|||++|+
T Consensus 45 ~~~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~~~~yivmEy~~~g~L~~~i~~~~~~~e~~~~~~~~qi~~al~ylH~~~i 124 (320)
T d1xjda_ 45 DVECTMVEKRVLSLAWEHPFLTHMFCTFQTKENLFFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEIILGLQFLHSKGI 124 (320)
T ss_dssp CHHHHHHHHHHHHHHTTCTTBCCEEEEEECSSEEEEEEECCTTCBHHHHHHHHSSCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHHhCCCCcEEEEEEEEccCCceeEEEeecCCCcHHHHhhccCCCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence 3455667777665 689999999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+||||||+||++ +..+.++|+|||.++..... .......||+.|+|||.+.+..++.++|+||+||++|+|++|..
T Consensus 125 iHrDikp~NiL~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlGvilyemltG~~ 201 (320)
T d1xjda_ 125 VYRDLKLDNILL---DKDGHIKIADFGMCKENMLGDAKTNTFCGTPDYIAPEILLGQKYNHSVDWWSFGVLLYEMLIGQS 201 (320)
T ss_dssp BCCCCCGGGEEE---CTTSCEEECCCTTCBCCCCTTCCBCCCCSCGGGCCHHHHTTCCBCTHHHHHHHHHHHHHHHHSSC
T ss_pred eeccCcccceee---cCCCceeccccchhhhcccccccccccCCCCCcCCHHHHcCCCCCchhhhhhhhHHHHHHHhCCC
Confidence 999999999999 78899999999999865433 33445678999999999999999999999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHH-HHhcCccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN-EFYHHRFLRR 229 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~-~il~~~~~~~ 229 (241)
||.+.+..++.+.+..+. ..++ ..+|+++.++|++||+.||.+|||+. ++++||||++
T Consensus 202 PF~~~~~~~~~~~i~~~~-~~~p----~~~s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~ 260 (320)
T d1xjda_ 202 PFHGQDEEELFHSIRMDN-PFYP----RWLEKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE 260 (320)
T ss_dssp SSCCSSHHHHHHHHHHCC-CCCC----TTSCHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred CCCCCCHHHHHHHHHcCC-CCCC----ccCCHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence 999999999998886554 3333 37899999999999999999999996 8999999987
|
| >d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase activated protein kinase 2, mapkap2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.2e-53 Score=339.62 Aligned_cols=225 Identities=28% Similarity=0.561 Sum_probs=188.2
Q ss_pred hhhHHHHHHHHhcC-CCcCeeeeeeEEee----cCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Q 026253 10 KSCLDCELNFLSSV-NHPNIIRLFDAFQA----ENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 10 ~~~~~~E~~~l~~l-~~~~i~~~~~~~~~----~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~l 82 (241)
.+.+.+|+.++.++ +||||++++++|++ ++.+|+|||||+||+|.+++.+. .++++..+..++.|++.||+||
T Consensus 48 ~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~al~yl 127 (335)
T d2ozaa1 48 CPKARREVELHWRASQCPHIVRIVDVYENLYAGRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEAIQYL 127 (335)
T ss_dssp SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEETTEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHHHHHH
T ss_pred cHHHHHHHHHHHHhcCCCCCCeEEEEEeecccCCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHHHHHH
Confidence 35678899987655 89999999999876 46799999999999999999865 3699999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
|++|++||||||+||+++..++.+.+||+|||+|+............||+.|+|||.+.+..++.++|+||+||++|+|+
T Consensus 128 H~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~y~~~~DiwSlGvily~ll 207 (335)
T d2ozaa1 128 HSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHNSLTTPCYTPYYVAPEVLGPEKYDKSCDMWSLGVIMYILL 207 (335)
T ss_dssp HHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCCCCCCCSCCCSSCCCCCCCGGGGSHHHHHHHHHHHHHHHT
T ss_pred HHcCCccccccccccccccccccccccccccceeeeccCCCccccccCCcccCCcHHHcCCCCCHHHHHHhhchhHHHHh
Confidence 99999999999999999655567789999999998877766667788999999999999999999999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhc---CCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccccC
Q 026253 163 NGYPPFSGRNNVQLVRNINS---CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSAIL 234 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~~~ 234 (241)
+|+.||.+.+.......+.. .....++....+.+|+++.+||++||+.||++|||++|+++||||++.....
T Consensus 208 tg~~Pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~~~~ 282 (335)
T d2ozaa1 208 CGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQSTKVP 282 (335)
T ss_dssp TSSCSCEETTCC--------CCCSCSSSCCTTHHHHSCHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHTTTSSC
T ss_pred hCCCCCCCCCHHHHHHHHHHHHhcCCCCCCCcccccCCHHHHHHHHHHccCChhHCcCHHHHHcCHHhhCCCCCC
Confidence 99999987665444433322 2222333333446899999999999999999999999999999998765443
|
| >d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 7, CDK7 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-52 Score=329.05 Aligned_cols=220 Identities=30% Similarity=0.433 Sum_probs=188.7
Q ss_pred hhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccc
Q 026253 10 KSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIH 89 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H 89 (241)
.+.+.+|++++++++||||+++++++.+++..++||||+.++++..+....+.+++..+..++.|++.||+|||++|++|
T Consensus 44 ~~~~~~Ei~il~~l~hpnIv~~~~~~~~~~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL~~lH~~~iiH 123 (299)
T d1ua2a_ 44 NRTALREIKLLQELSHPNIIGLLDAFGHKSNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLEYLHQHWILH 123 (299)
T ss_dssp CTHHHHHHHHHHHCCCTTBCCEEEEECCTTCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHHHHHHTTCCC
T ss_pred HHHHHHHHHHHHhCCCCCEeEEEeeeccCCceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHHHHhhccceec
Confidence 46788999999999999999999999999999999999988887777666678999999999999999999999999999
Q ss_pred cCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHhCCCC
Q 026253 90 RDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLNGYPP 167 (241)
Q Consensus 90 ~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~g~~p 167 (241)
|||||+||++ +.++.+||+|||.|....... ......+|+.|+|||.+.+. .++.++||||+||++|+|++|.+|
T Consensus 124 rDiKp~NIli---~~~~~~KL~DFG~a~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el~~g~~p 200 (299)
T d1ua2a_ 124 RDLKPNNLLL---DENGVLKLADFGLAKSFGSPNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPF 200 (299)
T ss_dssp CCCCGGGEEE---CTTCCEEECCCGGGSTTTSCCCCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHHHHHHHHSSCS
T ss_pred ccCCcceEEe---cCCCccccccCccccccCCCcccccceecChhhccHHHHccCCCCChhhhhhhcchHHHHHHhCcCC
Confidence 9999999999 788999999999997765433 33456789999999998654 579999999999999999999999
Q ss_pred CCCCChHHHHHHhhcCCCCCCC-----------------------CccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 168 FSGRNNVQLVRNINSCKHLPFS-----------------------QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 168 ~~~~~~~~~~~~i~~~~~~~~~-----------------------~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|.+.+..+.+..+......+.. ....+.+++++.+||++||+.||++|||++|+|+|
T Consensus 201 f~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~dP~~R~sa~e~L~H 280 (299)
T d1ua2a_ 201 LPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFPGIPLHHIFSAAGDDLLDLIQGLFLFNPCARITATQALKM 280 (299)
T ss_dssp SCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCCCCCHHHHCTTCCHHHHHHHHHHHCSSTTTSCCHHHHHTS
T ss_pred CCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCCCCChHHhcccCCHHHHHHHHHHccCChhhCcCHHHHhCC
Confidence 9999888877766442111100 01234678899999999999999999999999999
Q ss_pred cccccccc
Q 026253 225 RFLRRNSA 232 (241)
Q Consensus 225 ~~~~~~~~ 232 (241)
|||++.+.
T Consensus 281 p~f~~~p~ 288 (299)
T d1ua2a_ 281 KYFSNRPG 288 (299)
T ss_dssp GGGTSSSC
T ss_pred HhhCCCCC
Confidence 99997553
|
| >d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase SYK species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-52 Score=325.49 Aligned_cols=214 Identities=23% Similarity=0.435 Sum_probs=188.8
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
....+.+.+|++++++++||||+++++++++ +..++||||+++|+|.+++.+..++++..+..++.|++.||+|||++|
T Consensus 49 ~~~~~~~~~E~~il~~l~HpnIv~~~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~l~~~~~~~i~~qi~~gl~ylH~~~ 127 (277)
T d1xbba_ 49 PALKDELLAEANVMQQLDNPYIVRMIGICEA-ESWMLVMEMAELGPLNKYLQQNRHVKDKNIIELVHQVSMGMKYLEESN 127 (277)
T ss_dssp CHHHHHHHHHHHHHHTCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHHHCTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHHhCCCCCCceEEEEecc-CCEEEEEEcCCCCcHHHHHhhccCCCHHHHHHHHHHHHHHHhhHHhCC
Confidence 3446789999999999999999999999865 457899999999999999998889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
++||||||+||++ +.++.++|+|||+++....... .....+|+.|+|||.+.+..++.++||||||+++|+|+
T Consensus 128 iiHrDlKp~Nill---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDiwS~Gv~l~ell 204 (277)
T d1xbba_ 128 FVHRDLAARNVLL---VTQHYAKISDFGLSKALRADENYYKAQTHGKWPVKWYAPECINYYKFSSKSDVWSFGVLMWEAF 204 (277)
T ss_dssp EECSCCSGGGEEE---EETTEEEECCCTTCEECCTTCSEEEC----CCCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred cccCCCcchhhcc---cccCcccccchhhhhhccccccccccccccCCCceecCchhhcCCCCCchhhhccchhhhhHHh
Confidence 9999999999999 6788999999999987644322 22345788999999999889999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHH---hcCcccc
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEF---YHHRFLR 228 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i---l~~~~~~ 228 (241)
+ |+.||.+.+..+....+..+...+.+. .+|+++.+++.+||+.||.+|||++++ |+|+|++
T Consensus 205 t~g~~Pf~~~~~~~~~~~i~~~~~~~~p~----~~~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~~ 270 (277)
T d1xbba_ 205 SYGQKPYRGMKGSEVTAMLEKGERMGCPA----GCPREMYDLMNLCWTYDVENRPGFAAVELRLRNYYYD 270 (277)
T ss_dssp TTTCCSSTTCCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHHH
T ss_pred hCCCCCCCCCCHHHHHHHHHcCCCCCCCc----ccCHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHhh
Confidence 8 899999999999999888877666554 789999999999999999999999998 4666654
|
| >d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: G-protein coupled receptor kinase 2 species: Cow (Bos taurus) [TaxId: 9913]
Probab=100.00 E-value=2.2e-51 Score=329.72 Aligned_cols=211 Identities=28% Similarity=0.469 Sum_probs=180.3
Q ss_pred HHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCccccCCC
Q 026253 14 DCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHIIHRDLK 93 (241)
Q Consensus 14 ~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~ 93 (241)
.+|+++++.++||||+++++++.+++..|+||||++|++|.+++.+.+.+++..+..++.||+.||.|||++|++|||||
T Consensus 55 ~~~~~~l~~~~hpnIv~l~~~~~~~~~~~ivmE~~~gg~L~~~l~~~~~~~e~~~~~~~~qi~~aL~ylH~~~iiHrDlK 134 (364)
T d1omwa3 55 RIMLSLVSTGDCPFIVCMSYAFHTPDKLSFILDLMNGGDLHYHLSQHGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLK 134 (364)
T ss_dssp HHHHHHHSSSCCTTBCCEEEEEECSSEEEEEECCCCSCBHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTEECCCCS
T ss_pred HHHHHHHhcCCCCcEEEEEEEEEECCEEEEEEEecCCCcHHHHHHhcccccHHHHHHHHHHHHHHHHHHHHCCccceeec
Confidence 34477778889999999999999999999999999999999999999999999999999999999999999999999999
Q ss_pred CCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHHHHhCCCCCCCCC
Q 026253 94 PENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFELLNGYPPFSGRN 172 (241)
Q Consensus 94 ~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~l~~g~~p~~~~~ 172 (241)
|+|||+ +..+.+||+|||+|+...... .....||+.|+|||.+.+ ..++.++|+|||||++|+|++|+.||.+.+
T Consensus 135 P~NILl---~~~g~iKl~DFGla~~~~~~~-~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGvilyemltG~~Pf~~~~ 210 (364)
T d1omwa3 135 PANILL---DEHGHVRISDLGLACDFSKKK-PHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHK 210 (364)
T ss_dssp GGGEEE---CSSSCEEECCCTTCEECSSSC-CCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHHHHHHHHHSSCSSCSSC
T ss_pred cceeEE---cCCCcEEEeeeceeeecCCCc-ccccccccccchhHHhhcCCCCCcccchhHHHHHHHHHHhCCCCCCCCC
Confidence 999999 788899999999998765443 345679999999999864 568999999999999999999999998755
Q ss_pred hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC-----HHHHhcCcccccc
Q 026253 173 NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS-----FNEFYHHRFLRRN 230 (241)
Q Consensus 173 ~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps-----~~~il~~~~~~~~ 230 (241)
.............. +...+..+|+++.++|.+||+.||.+||| ++|+++||||++.
T Consensus 211 ~~~~~~~~~~~~~~--~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~i 271 (364)
T d1omwa3 211 TKDKHEIDRMTLTM--AVELPDSFSPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRSL 271 (364)
T ss_dssp SSCHHHHHHHSSSC--CCCCCSSSCHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred HHHHHHHHHhcccC--CCCCCCCCCHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccCC
Confidence 43333222222111 12223478999999999999999999999 7999999999873
|
| >d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: ephb2 receptor tyrosine kinase species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=1.1e-51 Score=323.68 Aligned_cols=212 Identities=23% Similarity=0.432 Sum_probs=181.2
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+....+.+.+|++++++++||||++++|++.+++..++||||+++|+|.+++... +.+++..+..++.|++.||.|||+
T Consensus 67 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~yLH~ 146 (299)
T d1jpaa_ 67 TEKQRRDFLSEASIMGQFDHPNVIHLEGVVTKSTPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKYLAD 146 (299)
T ss_dssp CHHHHHHHHHHHHHHTTCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCCccEEEEEeeCCEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHHHhh
Confidence 4556778999999999999999999999999999999999999999999988764 569999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCcc------ccccCCCCccCcccccccCCCCchhHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYA------EKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~------~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 158 (241)
+|++||||||+|||+ +.++.+||+|||+|+........ ....+++.|+|||.+.+..++.++||||||+++
T Consensus 147 ~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~sDvwS~Gvvl 223 (299)
T d1jpaa_ 147 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRKFTSASDVWSYGIVM 223 (299)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCC-----------------------CGGGSCHHHHHSCCCCHHHHHHHHHHHH
T ss_pred CCCccCccccceEEE---CCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCCCCcccccccchHHH
Confidence 999999999999999 78889999999999876543221 123468889999999989999999999999999
Q ss_pred HHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 159 FELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 159 ~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|||++ |..||.+.+..+....+..+...+.+. .+++++.+++.+||+.||.+|||+.|+++.
T Consensus 224 ~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~~P~~RPs~~ei~~~ 286 (299)
T d1jpaa_ 224 WEVMSYGERPYWDMTNQDVINAIEQDYRLPPPM----DCPSALHQLMLDCWQKDRNHRPKFGQIVNT 286 (299)
T ss_dssp HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCCc----cchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99998 899999999999999988777666554 789999999999999999999999998875
|
| >d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase ZAP-70 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.1e-51 Score=321.25 Aligned_cols=219 Identities=24% Similarity=0.418 Sum_probs=192.2
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.+...+++.+|++++++++||||++++|++.+ +..++||||+++|+|.+++... ..+++..+..++.|++.||+|||+
T Consensus 49 ~~~~~~~~~~E~~il~~l~HpnIv~l~g~~~~-~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~ylH~ 127 (285)
T d1u59a_ 49 EKADTEEMMREAQIMHQLDNPYIVRLIGVCQA-EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKYLEE 127 (285)
T ss_dssp CHHHHHHHHHHHHHHHHCCCTTBCCEEEEEES-SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEeeeecc-CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHHHHh
Confidence 45567889999999999999999999999875 4589999999999999998654 579999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
+|++||||||+||++ +.++.+||+|||+|+....... .....+++.|+|||.+.+..++.++||||+|+++||
T Consensus 128 ~~iiHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDVwS~Gv~l~E 204 (285)
T d1u59a_ 128 KNFVHRDLAARNVLL---VNRHYAKISDFGLSKALGADDSYYTARSAGKWPLKWYAPECINFRKFSSRSDVWSYGVTMWE 204 (285)
T ss_dssp TTEECCCCSGGGEEE---EETTEEEECCCTTCEECTTCSCEECCCCSSCCCGGGCCHHHHHHCEECHHHHHHHHHHHHHH
T ss_pred CCeecCcCchhheee---ccCCceeeccchhhhcccccccccccccccccCccccChHHHhCCCCCccchhhcchHHHHH
Confidence 999999999999999 6788999999999987654332 223457889999999998899999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHH---hcCcccccccc
Q 026253 161 LLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEF---YHHRFLRRNSA 232 (241)
Q Consensus 161 l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~i---l~~~~~~~~~~ 232 (241)
|++ |..||.+.+..+....+..+.+.+.+. .+|+++.+++.+||+.||++|||+.++ |+|+|+.-...
T Consensus 205 ~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~~~~~~ 276 (285)
T d1u59a_ 205 ALSYGQKPYKKMKGPEVMAFIEQGKRMECPP----ECPPELYALMSDCWIYKWEDRPDFLTVEQRMRACYYSLASK 276 (285)
T ss_dssp HHTTSCCTTTTCCTHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHHHHTT
T ss_pred HHhCCCCCCCCCCHHHHHHHHHcCCCCCCCC----cCCHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHHHhhhc
Confidence 998 999999999999999998877766654 789999999999999999999999888 67888765443
|
| >d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: B-Raf kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.7e-51 Score=316.46 Aligned_cols=215 Identities=25% Similarity=0.402 Sum_probs=180.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+.+..+.+.+|++++++++||||+++++++.+ +..++||||+++|+|.+++... .++++..+..++.|++.||+|||+
T Consensus 44 ~~~~~~~~~~E~~~l~~l~HpnIv~~~~~~~~-~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~yLH~ 122 (276)
T d1uwha_ 44 TPQQLQAFKNEVGVLRKTRHVNILLFMGYSTA-PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDYLHA 122 (276)
T ss_dssp CTTHHHHHHHHHHHHTTCCCTTBCCEEEEECS-SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeeeEEEec-cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHHHhc
Confidence 45567889999999999999999999998654 5689999999999999999755 569999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccc---cCCCCchhHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQF---QRYDEKVDMWSVGAIL 158 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~---~~~~~~~Dv~slG~~l 158 (241)
+|++||||||+||++ +.++.+||+|||+|+...... ......+|+.|+|||.+.+ ..++.++||||+|+++
T Consensus 123 ~~ivHrDlKp~NiLl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv~l 199 (276)
T d1uwha_ 123 KSIIHRDLKSNNIFL---HEDLTVKIGDFGLATVKSRWSGSHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVL 199 (276)
T ss_dssp TTCCCSCCCGGGEEE---ETTSSEEECCCCCSCC------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHHHH
T ss_pred CCEeccccCHHHEEE---cCCCCEEEccccceeeccccCCcccccccccCcccCCHHHHhcccCCCCCchhhhhhhHHHH
Confidence 999999999999999 678899999999997654322 2334578999999999864 3478999999999999
Q ss_pred HHHHhCCCCCCCCChHHH-HHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 159 FELLNGYPPFSGRNNVQL-VRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~-~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|+|++|+.||.+.+.... ...+..+...+........+|+++.+++.+||+.||.+|||++|++++
T Consensus 200 ~el~tg~~Pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~l~~li~~cl~~dp~~RPt~~~il~~ 266 (276)
T d1uwha_ 200 YELMTGQLPYSNINNRDQIIFMVGRGYLSPDLSKVRSNCPKAMKRLMAECLKKKRDERPLFPQILAS 266 (276)
T ss_dssp HHHHHSSCTTTTCCCHHHHHHHHHHTSCCCCGGGSCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCChHHHHHHHHhcCCCCCcchhccccchHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 999999999998766544 445545554444455566889999999999999999999999999987
|
| >d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tyrosine-protein kinase Itk/Tsk species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.3e-50 Score=312.41 Aligned_cols=209 Identities=25% Similarity=0.468 Sum_probs=178.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|++++++++||||++++|++.+++..++||||+++|+|.+++... ..++++.+..++.|++.||.|||++++
T Consensus 43 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl~~lH~~~i 122 (263)
T d1sm2a_ 43 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQAPICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMAYLEEACV 122 (263)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred cHHHHHHHHHHHHhcCCCCcccccceeccCCceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHhhhccce
Confidence 4577999999999999999999999999999999999999999999998755 568999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-C
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN-G 164 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~-g 164 (241)
+||||||+||++ +.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||+|+++|||++ |
T Consensus 123 iHrDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~k~DVwS~Gvil~el~t~~ 199 (263)
T d1sm2a_ 123 IHRDLAARNCLV---GENQVIKVSDFGMTRFVLDDQYTSSTGTKFPVKWASPEVFSFSRYSSKSDVWSFGVLMWEVFSEG 199 (263)
T ss_dssp CCTTCSGGGEEE---CGGGCEEECSCC------------------CTTSCCHHHHTTCCCCHHHHHHHHHHHHHHHHTTS
T ss_pred eecccchhheee---cCCCCeEecccchheeccCCCceeecceecCcccCChHHhcCCCCCchhhhcchHHHHHHHHHCC
Confidence 999999999999 7888999999999977654322 233567899999999999999999999999999999999 6
Q ss_pred CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 165 YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 165 ~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
.+||...+..+....+..+.....+. ..++++.+++.+||+.||++|||++|+++|
T Consensus 200 ~~~~~~~~~~~~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~~p~~Rps~~~il~~ 255 (263)
T d1sm2a_ 200 KIPYENRSNSEVVEDISTGFRLYKPR----LASTHVYQIMNHCWKERPEDRPAFSRLLRQ 255 (263)
T ss_dssp CCTTCSCCHHHHHHHHHHTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCHHHHHHHHHhcCCCCCcc----ccCHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 78888888888888888877665554 678999999999999999999999999986
|
| >d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Bruton's tyrosine kinase (Btk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-50 Score=308.03 Aligned_cols=210 Identities=22% Similarity=0.412 Sum_probs=188.6
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
...+.+.+|++++++++||||++++|++.+++..++||||+++|+|.+++.. ...+++..+..++.|++.||+|||+.|
T Consensus 41 ~~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~~LH~~~ 120 (258)
T d1k2pa_ 41 MSEDEFIEEAKVMMNLSHEKLVQLYGVCTKQRPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAMEYLESKQ 120 (258)
T ss_dssp SCHHHHHHHHHHHHTCCCTTBCCEEEEECCSSSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CCHHHHHHHHHHHHhcCCCceeeEEEEEeeCCceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHHHHHhhcC
Confidence 3467899999999999999999999999999999999999999999999754 456899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
++||||||+||++ +.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||+|+++|+|++
T Consensus 121 iiH~dlk~~Nill---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~ksDiwS~G~~l~el~t~ 197 (258)
T d1k2pa_ 121 FLHRDLAARNCLV---NDQGVVKVSDFGLSRYVLDDEYTSSVGSKFPVRWSPPEVLMYSKFSSKSDIWAFGVLMWEIYSL 197 (258)
T ss_dssp BCCSCCSGGGEEE---CTTCCEEECCCSSCCBCSSSSCCCCCCSCCCGGGCCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred cccccccceeEEE---cCCCcEEECcchhheeccCCCceeecccCCCCCcCCcHHhcCCCCCcceeecccchhhHhHHhc
Confidence 9999999999999 7888999999999976543322 223557889999999999999999999999999999998
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|..||.+.+..+....+..+...+.+. ..++++.+++++||+.||++|||++++++|
T Consensus 198 g~~Pf~~~~~~~~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~RPt~~eil~~ 254 (258)
T d1k2pa_ 198 GKMPYERFTNSETAEHIAQGLRLYRPH----LASEKVYTIMYSCWHEKADERPTFKILLSN 254 (258)
T ss_dssp SCCTTTTSCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCHHHHHHHHHhCCCCCCcc----cccHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence 899999999999999998877666554 778999999999999999999999999986
|
| >d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=7.7e-50 Score=313.54 Aligned_cols=221 Identities=29% Similarity=0.496 Sum_probs=182.9
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+...+++.+|++++++++||||+++++++.+++..|+||||+.+ .+.+++.. .+.+++..+..++.|++.||.|||+
T Consensus 42 ~~~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~~~~~iv~e~~~~-~~~~~~~~~~~~~l~e~~~~~~~~qil~~L~yLH~ 120 (298)
T d1gz8a_ 42 EGVPSTAIREISLLKELNHPNIVKLLDVIHTENKLYLVFEFLHQ-DLKKFMDASALTGIPLPLIKSYLFQLLQGLAFCHS 120 (298)
T ss_dssp --CCHHHHHHHHHHTTCCCTTBCCEEEEEEETTEEEEEEECCSE-EHHHHHHHTTTTCCCHHHHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhCCCCcEEEeccccccccceeEEEeecCC-chhhhhhhhcccCCCHHHHHHHHHHHHHHHHHhhc
Confidence 34477899999999999999999999999999999999999965 55555533 3569999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCC-CccccccCCCCccCcccccccC-CCCchhHHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG-NYAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELL 162 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~-~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~ 162 (241)
+||+||||||+||++ +.++.++|+|||.|...... .......+++.|+|||.+.... ++.++|+||+|+++|+|+
T Consensus 121 ~~IiHrDiKpeNIl~---~~~~~~kl~DFG~a~~~~~~~~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGvily~m~ 197 (298)
T d1gz8a_ 121 HRVLHRDLKPQNLLI---NTEGAIKLADFGLARAFGVPVRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMV 197 (298)
T ss_dssp TTCCCSCCCGGGEEE---CTTSCEEECSTTHHHHHCCCSBCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHHHHHHHH
T ss_pred CCEEccccCchheee---cccCcceeccCCcceeccCCcccceeecccceeeehhhhccccCCCccccccccchhhhHHh
Confidence 999999999999999 78889999999999776543 3444567899999999877655 588999999999999999
Q ss_pred hCCCCCCCCChHHHHHHhhcCCCCCC-----------------C-------CccCCCCChHHHHHHHHhcccCccccCCH
Q 026253 163 NGYPPFSGRNNVQLVRNINSCKHLPF-----------------S-------QLIVPALHPDCVDMCLKLLSANTVDRLSF 218 (241)
Q Consensus 163 ~g~~p~~~~~~~~~~~~i~~~~~~~~-----------------~-------~~~~~~~~~~~~~li~~~l~~~p~~Rps~ 218 (241)
+|+.||.+.+..+....+......+. + ....+.+|+++.+||++||+.||.+|||+
T Consensus 198 ~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~t~ 277 (298)
T d1gz8a_ 198 TRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPSFPKWARQDFSKVVPPLDEDGRSLLSQMLHYDPNKRISA 277 (298)
T ss_dssp HSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTSCCCCCCCHHHHSTTCCHHHHHHHHHHTCSSTTTSCCH
T ss_pred hCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccccccccccchhhhccCCCHHHHHHHHHHccCChhHCcCH
Confidence 99999998887776655432111000 0 01134677899999999999999999999
Q ss_pred HHHhcCccccccc
Q 026253 219 NEFYHHRFLRRNS 231 (241)
Q Consensus 219 ~~il~~~~~~~~~ 231 (241)
+|+|+||||++..
T Consensus 278 ~ell~H~ff~~~~ 290 (298)
T d1gz8a_ 278 KAALAHPFFQDVT 290 (298)
T ss_dssp HHHHTSGGGTTCC
T ss_pred HHHhCCHhhccCC
Confidence 9999999998653
|
| >d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Lymphocyte kinase (lck) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-50 Score=312.89 Aligned_cols=214 Identities=22% Similarity=0.430 Sum_probs=187.4
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|++++++++||||+++++++.+ +..++||||+++|+|.+++... .++++..+..++.|++.||.|||++|
T Consensus 51 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~-~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl~~lH~~~ 129 (272)
T d1qpca_ 51 SPDAFLAEANLMKQLQHQRLVRLYAVVTQ-EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGMAFIEERN 129 (272)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHhCCCCCEeEEEeeecc-CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHHHHHHhCC
Confidence 45679999999999999999999998765 5678999999999999987543 35899999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
++||||||+||++ ++++.+||+|||+|+...... ......+++.|+|||.+.+..++.++||||||+++|+|++
T Consensus 130 ivHrDiKp~NIll---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~gt~~y~APE~~~~~~~~~~sDvwS~Gvvl~ellt~ 206 (272)
T d1qpca_ 130 YIHRDLRAANILV---SDTLSCKIADFGLARLIEDNEYTAREGAKFPIKWTAPEAINYGTFTIKSDVWSFGILLTEIVTH 206 (272)
T ss_dssp EECSCCSGGGEEE---CTTSCEEECCCTTCEECSSSCEECCTTCCCCTTTSCHHHHHHCEECHHHHHHHHHHHHHHHHTT
T ss_pred cccCccchhheee---ecccceeeccccceEEccCCccccccccCCcccccChHHHhCCCCCchhhhhhhHHHHHHHHhC
Confidence 9999999999999 788999999999998765433 2334567889999999998889999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc--Ccccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH--HRFLRRN 230 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~ 230 (241)
|.+|+...+..+..+.+..+.....+. .+++++.+++++||+.||++|||++++++ ++||..+
T Consensus 207 ~~~~~~~~~~~~~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ftst 271 (272)
T d1qpca_ 207 GRIPYPGMTNPEVIQNLERGYRMVRPD----NCPEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFTAT 271 (272)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHC
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCcc----cChHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhhcC
Confidence 566777888888888887776665554 78999999999999999999999999998 7888653
|
| >d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fl cytokine receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.4e-50 Score=321.06 Aligned_cols=212 Identities=25% Similarity=0.410 Sum_probs=180.8
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-----------------------
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------------- 61 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------------- 61 (241)
+......+.+|+.+++++ +||||+++++++.+.+..++||||+++|+|.++++...
T Consensus 80 ~~~~~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~ 159 (325)
T d1rjba_ 80 DSSEREALMSELKMMTQLGSHENIVNLLGACTLSGPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEEEDLN 159 (325)
T ss_dssp ----CHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHTTTTCC--------------------
T ss_pred CHHHHHHHHHHHHHHHHhcCCCcEeEEEEEEeeCCeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccccccC
Confidence 445567899999999998 89999999999999999999999999999999997542
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcc
Q 026253 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPE 138 (241)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE 138 (241)
.+++..+..++.|++.||+|||++||+||||||+||++ +.++.+||+|||+|+....... .....+|+.|+|||
T Consensus 160 ~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~aPE 236 (325)
T d1rjba_ 160 VLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLV---THGKVVKICDFGLARDIMSDSNYVVRGNARLPVKWMAPE 236 (325)
T ss_dssp -CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEE---ETTTEEEECCCGGGSCGGGCTTSEEETTEEECGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhcccc---ccCCeEEEeeccccccccCCCceeeeccccCCCccCChH
Confidence 37899999999999999999999999999999999999 6788999999999976544332 22455789999999
Q ss_pred cccccCCCCchhHHHHHHHHHHHHh-CCCCCCCCChHH-HHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC
Q 026253 139 VLQFQRYDEKVDMWSVGAILFELLN-GYPPFSGRNNVQ-LVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL 216 (241)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~-~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 216 (241)
.+.+..++.++||||||+++|+|++ |..||.+.+..+ ..+.+..+...+.+. .+|+++.++|.+||+.||++||
T Consensus 237 ~l~~~~~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~RP 312 (325)
T d1rjba_ 237 SLFEGIYTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPF----YATEEIYIIMQSCWAFDSRKRP 312 (325)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSC
T ss_pred HHcCCCCCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCC----cCCHHHHHHHHHHcCCChhHCc
Confidence 9999999999999999999999997 899998866544 444555554444443 7899999999999999999999
Q ss_pred CHHHHhcC
Q 026253 217 SFNEFYHH 224 (241)
Q Consensus 217 s~~~il~~ 224 (241)
|++||++|
T Consensus 313 t~~ei~~~ 320 (325)
T d1rjba_ 313 SFPNLTSF 320 (325)
T ss_dssp CHHHHHHH
T ss_pred CHHHHHHH
Confidence 99999975
|
| >d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Abelsone tyrosine kinase (abl) species: Mouse (Mus musculus) [TaxId: 10090]
Probab=100.00 E-value=5.9e-50 Score=312.03 Aligned_cols=209 Identities=24% Similarity=0.401 Sum_probs=183.2
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc--CCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH--GRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+++.+|++++++++||||+++++++.+++..++||||+++|+|.+++... ..+++..+..++.|++.||+|||++
T Consensus 55 ~~~~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL~yLH~~ 134 (287)
T d1opja_ 55 MEVEEFLKEAAVMKEIKHPNLVQLLGVCTREPPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAMEYLEKK 134 (287)
T ss_dssp SCHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHHHHHHHT
T ss_pred chHHHHHHHHHHHHhCCCCCEecCCccEeeCCeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHHHHHHHC
Confidence 34667999999999999999999999999999999999999999999999764 4689999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc--cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY--AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~--~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
|++||||||+|||+ +.++.+||+|||+|+....... .....++..|+|||.+.+..++.++||||+|+++|+|++
T Consensus 135 ~iiHrDlKp~NILl---~~~~~~Kl~DFG~a~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~k~DiwS~Gv~l~ell~ 211 (287)
T d1opja_ 135 NFIHRDLAARNCLV---GENHLVKVADFGLSRLMTGDTYTAHAGAKFPIKWTAPESLAYNKFSIKSDVWAFGVLLWEIAT 211 (287)
T ss_dssp TCCCSCCSGGGEEE---CGGGCEEECCCCCTTTCCSSSSEEETTEEECGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHHT
T ss_pred CcccCccccCeEEE---CCCCcEEEccccceeecCCCCceeeccccccccccChHHHcCCCCCchhhhhhHHHHHHHHHh
Confidence 99999999999999 7888999999999987654332 223447888999999999999999999999999999999
Q ss_pred CC-CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 164 GY-PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 164 g~-~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|. +||.+.+..+..+.+..+...+.+. .+|+++.+++.+||+.||.+|||++|+++
T Consensus 212 ~~~p~~~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~ei~~ 268 (287)
T d1opja_ 212 YGMSPYPGIDLSQVYELLEKDYRMERPE----GCPEKVYELMRACWQWNPSDRPSFAEIHQ 268 (287)
T ss_dssp TSCCSSTTCCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCCCCCCcchHHHHHHHHhcCCCCCCCc----cchHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence 54 5566777777777776666555543 78999999999999999999999999975
|
| >d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK2 species: (Plasmodium falciparum) [TaxId: 5833]
Probab=100.00 E-value=6.5e-50 Score=312.45 Aligned_cols=221 Identities=28% Similarity=0.447 Sum_probs=184.5
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
++...+++.+|+.++++++||||+++++++.+++..+++|+++.++.+..+....+.+++..+..++.|++.||.+||+.
T Consensus 40 ~~~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L~~LH~~ 119 (286)
T d1ob3a_ 40 DEGIPSTTIREISILKELKHSNIVKLYDVIHTKKRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIAYCHDR 119 (286)
T ss_dssp GGCCCHHHHHHHHGGGGCCCTTBCCEEEEEECSSCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHHHHHHT
T ss_pred ChHHHHHHHHHHHHHHhCCCCcEEeeeeecccCCceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHHHHhccC
Confidence 34446789999999999999999999999999999999999998877777777678899999999999999999999999
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCccccccc-CCCCchhHHHHHHHHHHHHh
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~l~~ 163 (241)
||+||||||+||++ +.++.++++|||.+....... ......+++.|.|||.+.+. .++.++|+||+|+++|+|++
T Consensus 120 ~IvHrDiKp~NIll---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv~l~el~~ 196 (286)
T d1ob3a_ 120 RVLHRDLKPQNLLI---NREGELKIADFGLARAFGIPVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVN 196 (286)
T ss_dssp TCCCSCCCGGGEEE---CTTSCEEECCTTHHHHHCC---------CCCTTCCHHHHTTCCSCCTHHHHHHHHHHHHHHHH
T ss_pred cEEecCCCCceeeE---cCCCCEEecccccceecccCccccceecccchhhhHHHHhCCCCCCcceeehhcCcHHHHHHH
Confidence 99999999999999 788999999999998765432 23445688999999998754 56899999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCC------------------------CCCccCCCCChHHHHHHHHhcccCccccCCHH
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLP------------------------FSQLIVPALHPDCVDMCLKLLSANTVDRLSFN 219 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~------------------------~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 219 (241)
|+.||.+.+..+.+..+......+ ......+.+++++.+||++||+.||++|||++
T Consensus 197 G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~~L~~dP~~R~s~~ 276 (286)
T d1ob3a_ 197 GTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPNFTVYEPLPWESFLKGLDESGIDLLSKMLKLDPNQRITAK 276 (286)
T ss_dssp SSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTTCCCCCCCCGGGTCCSCCHHHHHHHHHHTCSSTTTSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccccccccCcchhhhcccCCHHHHHHHHHHccCChhHCcCHH
Confidence 999999888777766543211100 01122456788999999999999999999999
Q ss_pred HHhcCccccc
Q 026253 220 EFYHHRFLRR 229 (241)
Q Consensus 220 ~il~~~~~~~ 229 (241)
|+|+||||++
T Consensus 277 ell~Hp~f~~ 286 (286)
T d1ob3a_ 277 QALEHAYFKE 286 (286)
T ss_dssp HHHTSGGGGC
T ss_pred HHhcCcccCc
Confidence 9999999985
|
| >d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK6 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.9e-50 Score=314.46 Aligned_cols=219 Identities=32% Similarity=0.458 Sum_probs=184.5
Q ss_pred hhhhHHHHHHHHhcC---CCcCeeeeeeEEee-----cCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSV---NHPNIIRLFDAFQA-----ENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l---~~~~i~~~~~~~~~-----~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l 79 (241)
....+.+|+.+++.| +||||+++++++.. +...+++||+++++++...... ...+++..+..++.|++.||
T Consensus 50 ~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL 129 (305)
T d1blxa_ 50 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLLRGL 129 (305)
T ss_dssp CBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEECSSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhhcCCCCcceeeeeecccccccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHHHHHHH
Confidence 345677888887776 79999999998853 3568999999987766554443 35689999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
+|||++|++||||||+|||+ +..+.++|+|||.+.............||+.|+|||.+.+..++.++|+||+||++|
T Consensus 130 ~yLH~~~ivHrDiKp~NILi---~~~~~~kl~dfg~~~~~~~~~~~~~~~gT~~Y~APE~~~~~~y~~~~DiwSlG~il~ 206 (305)
T d1blxa_ 130 DFLHSHRVVHRDLKPQNILV---TSSGQIKLADFGLARIYSFQMALTSVVVTLWYRAPEVLLQSSYATPVDLWSVGCIFA 206 (305)
T ss_dssp HHHHHTTCCCCCCCGGGEEE---CTTCCEEECSCCSCCCCCGGGGGCCCCCCCTTCCHHHHTTCCCCTHHHHHHHHHHHH
T ss_pred HHHHhCCEEecCCCccEEEE---cCCCCeeecchhhhhhhcccccCCCcccChhhcCcchhcCCCCChhehhhchHHHHH
Confidence 99999999999999999999 788899999999998766666666778999999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCC----------------------CCCCccCCCCChHHHHHHHHhcccCccccCC
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHL----------------------PFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~----------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
+|++|+.||.+.+..+.+..+...... .........+++++.+||++||+.||.+|||
T Consensus 207 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~R~s 286 (305)
T d1blxa_ 207 EMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRIS 286 (305)
T ss_dssp HHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCCCGGGTCCSCCHHHHHHHHHHSCSSTTTSCC
T ss_pred HHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhccccccchhhccccCCHHHHHHHHHHCcCChhHCcC
Confidence 999999999999888777665432111 1112234567899999999999999999999
Q ss_pred HHHHhcCcccccc
Q 026253 218 FNEFYHHRFLRRN 230 (241)
Q Consensus 218 ~~~il~~~~~~~~ 230 (241)
++|+|+||||++.
T Consensus 287 a~e~L~Hpff~~i 299 (305)
T d1blxa_ 287 AYSALSHPYFQDL 299 (305)
T ss_dssp HHHHHTSGGGTTC
T ss_pred HHHHhcChhhcCc
Confidence 9999999999874
|
| >d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Proto-oncogene serine/threonine-protein kinase Pim-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5e-50 Score=310.69 Aligned_cols=206 Identities=26% Similarity=0.474 Sum_probs=177.9
Q ss_pred hhHHHHHHHHhcCC--CcCeeeeeeEEeecCeEEEEEeccCC-CChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 11 SCLDCELNFLSSVN--HPNIIRLFDAFQAENCIFLVVEFCAG-GNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 11 ~~~~~E~~~l~~l~--~~~i~~~~~~~~~~~~~~lv~e~~~~-~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
.++.+|+.++++++ ||||+++++++.+++..++|||++.+ +++.+++.+.+.+++..+..++.|++.||.|||++|+
T Consensus 52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~~~~~lv~e~~~~~~~l~~~~~~~~~l~e~~~~~~~~qi~~al~~lH~~~i 131 (273)
T d1xwsa_ 52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFWQVLEAVRHCHNCGV 131 (273)
T ss_dssp CEEEHHHHHHHHHCSSSCSBCCEEEEEECSSEEEEEEECCSSEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHHHHTTE
T ss_pred HHHHHHHHHHHHhccCCCCccEEEEEEeeCCeEEEEEEeccCcchHHHHHhccCCCCHHHHHHHHHHHHHHHHHHHHCCC
Confidence 45789999999996 89999999999999999999999975 6888999888899999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCC-CCchhHHHHHHHHHHHHhCCC
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRY-DEKVDMWSVGAILFELLNGYP 166 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~-~~~~Dv~slG~~l~~l~~g~~ 166 (241)
+||||||+||+++ .+.+.++|+|||+|+..... ......||+.|+|||.+.+..+ +.++|+||+||++|+|++|..
T Consensus 132 iHrDiKp~NIll~--~~~~~vkl~DFG~a~~~~~~-~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSlGvilyell~g~~ 208 (273)
T d1xwsa_ 132 LHRDIKDENILID--LNRGELKLIDFGSGALLKDT-VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDI 208 (273)
T ss_dssp ECSCCSGGGEEEE--TTTTEEEECCCTTCEECCSS-CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHHHHHHHHHHHSSC
T ss_pred ccccCcccceEEe--cCCCeEEECccccceecccc-cccccccCCCcCCHHHHcCCCCCCcccccccceeeehhHhhCCC
Confidence 9999999999995 35678999999999765433 3345679999999999987665 678999999999999999999
Q ss_pred CCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccc
Q 026253 167 PFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 167 p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
||.+.+ .+.... ..+ .+.+|+++.++|++||+.||++|||++|+++||||++.
T Consensus 209 Pf~~~~------~i~~~~-~~~----~~~~s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~ 261 (273)
T d1xwsa_ 209 PFEHDE------EIIRGQ-VFF----RQRVSSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDV 261 (273)
T ss_dssp SCCSHH------HHHHCC-CCC----SSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSC
T ss_pred CCCCch------HHhhcc-cCC----CCCCCHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCC
Confidence 998632 122222 222 34789999999999999999999999999999999874
|
| >d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Focal adhesion kinase 1 (fak) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-49 Score=307.62 Aligned_cols=211 Identities=26% Similarity=0.479 Sum_probs=177.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
.+..++.+.+|++++++++||||+++++++. ++..++||||+++|+|.+++... +.+++..+..++.|++.||.|||+
T Consensus 48 ~~~~~~~~~~E~~~l~~l~HpnIv~l~~~~~-~~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~ 126 (273)
T d1mp8a_ 48 SDSVREKFLQEALTMRQFDHPHIVKLIGVIT-ENPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAYLES 126 (273)
T ss_dssp SHHHHHHHHHHHHHHHTCCCTTBCCEEEEEC-SSSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEe-cCeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhhhcc
Confidence 4556788999999999999999999999986 46789999999999999987654 569999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
.|++||||||+||++ +.++.+||+|||+|+...... ......+++.|+|||.+.+..++.++||||||+++|+|+
T Consensus 127 ~~iiHrDlKp~NIll---~~~~~~Kl~DfG~a~~~~~~~~~~~~~~~gt~~y~apE~l~~~~~~~~~DiwSlGvil~e~l 203 (273)
T d1mp8a_ 127 KRFVHRDIAARNVLV---SSNDCVKLGDFGLSRYMEDSTYYKASKGKLPIKWMAPESINFRRFTSASDVWMFGVCMWEIL 203 (273)
T ss_dssp TTCCCSCCSGGGEEE---EETTEEEECC-------------------CCGGGCCHHHHHHCCCSHHHHHHHHHHHHHHHH
T ss_pred cCeeccccchhheee---cCCCcEEEccchhheeccCCcceeccceecCcccchhhHhccCCCCCccccccchHHHHHHH
Confidence 999999999999999 677899999999998754332 223455788999999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+ |.+||.+.+..+....+..+...+.+. .+|+++.++|.+||+.||.+|||++|++++
T Consensus 204 t~g~~P~~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~li~~cl~~dp~~Rps~~ei~~~ 262 (273)
T d1mp8a_ 204 MHGVKPFQGVKNNDVIGRIENGERLPMPP----NCPPTLYSLMTKCWAYDPSRRPRFTELKAQ 262 (273)
T ss_dssp TTSCCTTTTCCGGGHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred hcCCCCCCCCCHHHHHHHHHcCCCCCCCC----CCCHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 8 899999999999999888877666554 789999999999999999999999999976
|
| >d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Tie2 kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.5e-49 Score=311.11 Aligned_cols=221 Identities=26% Similarity=0.425 Sum_probs=190.6
Q ss_pred hHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHH
Q 026253 6 NKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTA 68 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~ 68 (241)
..+..+.+.+|+++++++ +||||+++++++.+++..++||||+++|+|.+++.+. ..+++..+
T Consensus 50 ~~~~~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 129 (309)
T d1fvra_ 50 SKDDHRDFAGELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSSQQL 129 (309)
T ss_dssp -----CHHHHHHHHHTTCCCCTTBCCEEEEEEETTEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSCHHHH
T ss_pred ChHHHHHHHHHHHHHHhccCCCCEeeEEEEEecCCeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCCHHHH
Confidence 445677899999999999 7999999999999999999999999999999999754 45899999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCc
Q 026253 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK 148 (241)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~ 148 (241)
..++.|++.|+.|+|+.|++||||||+|||+ +.++.+||+|||+++............++..|+|||.+.+..++.+
T Consensus 130 ~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~---~~~~~~kl~DfG~a~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~ 206 (309)
T d1fvra_ 130 LHFAADVARGMDYLSQKQFIHRDLAARNILV---GENYVAKIADFGLSRGQEVYVKKTMGRLPVRWMAIESLNYSVYTTN 206 (309)
T ss_dssp HHHHHHHHHHHHHHHHTTEECSCCSGGGEEE---CGGGCEEECCTTCEESSCEECCC----CCTTTCCHHHHHHCEECHH
T ss_pred HHHHHHHHHHHHhhhcCCccccccccceEEE---cCCCceEEccccccccccccccccceecCCcccchHHhccCCCCcc
Confidence 9999999999999999999999999999999 7888999999999987665555556678999999999999999999
Q ss_pred hhHHHHHHHHHHHHhC-CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC--c
Q 026253 149 VDMWSVGAILFELLNG-YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH--R 225 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~--~ 225 (241)
+||||||+++|+|++| .+||.+.+..+....+..+...+.+. .+++++.++|.+||+.||++|||++|++++ .
T Consensus 207 sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~L~~ 282 (309)
T d1fvra_ 207 SDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRLEKPL----NCDDEVYDLMRQCWREKPYERPSFAQILVSLNR 282 (309)
T ss_dssp HHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHH
T ss_pred ceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHHHHHH
Confidence 9999999999999996 56899999999999998877665554 789999999999999999999999999987 4
Q ss_pred cccccccc
Q 026253 226 FLRRNSAI 233 (241)
Q Consensus 226 ~~~~~~~~ 233 (241)
.+++.+..
T Consensus 283 i~~~~~~~ 290 (309)
T d1fvra_ 283 MLEERKTY 290 (309)
T ss_dssp HHHSSSCS
T ss_pred HHhcCcCC
Confidence 55444433
|
| >d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: epha2 receptor tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.7e-49 Score=304.94 Aligned_cols=211 Identities=22% Similarity=0.420 Sum_probs=180.5
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
++.....+.+|++++++++||||++++|++.+.+..++||||+.++++.+++... +.+++..+..++.|++.|+.|||+
T Consensus 49 ~~~~~~~~~~E~~il~~l~H~nIv~~~g~~~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~lH~ 128 (283)
T d1mqba_ 49 TEKQRVDFLGEAGIMGQFSHHNIIRLEGVISKYKPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKYLAN 128 (283)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCEeeeeEEEecCCceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhhccc
Confidence 4455678999999999999999999999999999999999999999999988765 569999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC----ccccccCCCCccCcccccccCCCCchhHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~ 160 (241)
.|++||||||+|||+ +.++.+||+|||+|+...... ......+|..|+|||.+.+..++.++||||||+++||
T Consensus 129 ~~iiHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~gt~~Y~APE~l~~~~~~~~sDI~S~Gvil~e 205 (283)
T d1mqba_ 129 MNYVHRDLAARNILV---NSNLVCKVSDFGLSRVLEDDPEATYTTSGGKIPIRWTAPEAISYRKFTSASDVWSFGIVMWE 205 (283)
T ss_dssp TTCCCSCCCGGGEEE---CTTCCEEECCCCC-----------------CCCGGGSCHHHHHSCCCCHHHHHHHHHHHHHH
T ss_pred cccccCccccceEEE---CCCCeEEEcccchhhcccCCCccceEeccCCCCccccCHHHHccCCCCCcccccccHHHHHH
Confidence 999999999999999 788999999999998754332 2223457889999999999999999999999999999
Q ss_pred HHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 161 LLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 161 l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
|++ |.+|+.+.+..+..+.+..+.+.+.+. .++.++.+++.+||+.||++|||+.|+++
T Consensus 206 l~t~~~~~~~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~~p~~RPt~~eil~ 265 (283)
T d1mqba_ 206 VMTYGERPYWELSNHEVMKAINDGFRLPTPM----DCPSAIYQLMMQCWQQERARRPKFADIVS 265 (283)
T ss_dssp HHTTSCCTTTTCCHHHHHHHHHTTCCCCCCT----TCBHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred HHhCCCCccccCCHHHHHHHHhccCCCCCch----hhHHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence 998 566677778888888888777666554 78999999999999999999999999986
|
| >d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-src tyrosine kinase species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.2e-49 Score=307.10 Aligned_cols=215 Identities=20% Similarity=0.390 Sum_probs=182.1
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHh--cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRL--HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~--~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+.+.+|+.++++++|+||+++++++.+ +..++||||+++|+|..++.. ...+++..+..++.|++.||++||++|
T Consensus 55 ~~~~~~~E~~~l~~l~h~nIv~~~g~~~~-~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl~~LH~~~ 133 (285)
T d1fmka3 55 SPEAFLQEAQVMKKLRHEKLVQLYAVVSE-EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGMAYVERMN 133 (285)
T ss_dssp CHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred CHHHHHHHHHHHHhcccCCEeEEEEEEec-CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHHHHHhhhh
Confidence 35779999999999999999999999865 557899999999999998854 356999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--ccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh-
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN- 163 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~- 163 (241)
++||||||+||++ +.++.+||+|||+|+...... ......+++.|+|||.+.+..++.++||||+|+++|+|++
T Consensus 134 ivH~DlKp~NIll---~~~~~~kl~DfGla~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~S~Giil~el~t~ 210 (285)
T d1fmka3 134 YVHRDLRAANILV---GENLVCKVADFGLARLIEDNEYTARQGAKFPIKWTAPEAALYGRFTIKSDVWSFGILLTELTTK 210 (285)
T ss_dssp CCCSCCSGGGEEE---CGGGCEEECCCCTTC--------------CCGGGSCHHHHHHCCCCHHHHHHHHHHHHHHHHTT
T ss_pred eecccccceEEEE---CCCCcEEEcccchhhhccCCCceeeccccccccccChHHHhCCCCCcHHhhhcchHHHHHHHhC
Confidence 9999999999999 778899999999998664332 2334568899999999999999999999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc--Cccccccc
Q 026253 164 GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH--HRFLRRNS 231 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~~ 231 (241)
|.+|+.+....+.+..+..+...+.+. .+++++.+++.+||+.||++|||++++++ ++||....
T Consensus 211 ~~p~~~~~~~~~~~~~i~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~ 276 (285)
T d1fmka3 211 GRVPYPGMVNREVLDQVERGYRMPCPP----ECPESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE 276 (285)
T ss_dssp TCCSSTTCCHHHHHHHHHTTCCCCCCT----TSCHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred CCCCCCCCCHHHHHHHHHhcCCCCCCc----ccCHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence 466667778888888887766655443 78999999999999999999999999988 88887754
|
| >d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Mycobacterial protein kinase PknB, catalytic domain species: Mycobacterium tuberculosis [TaxId: 1773]
Probab=100.00 E-value=4.2e-49 Score=306.38 Aligned_cols=217 Identities=25% Similarity=0.442 Sum_probs=180.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEIL 82 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~l 82 (241)
+...+.+.+|++++++++||||+++++++...+ ..|+||||++|++|.+++...+++++..+..++.|++.||++|
T Consensus 48 ~~~~~~~~~E~~~l~~~~hpniv~~~~~~~~~~~~~~~~~lvmE~~~g~~L~~~~~~~~~l~~~~~~~i~~qi~~al~~l 127 (277)
T d1o6ya_ 48 PSFYLRFRREAQNAAALNHPAIVAVYDTGEAETPAGPLPYIVMEYVDGVTLRDIVHTEGPMTPKRAIEVIADACQALNFS 127 (277)
T ss_dssp HHHHHHHHHHHHHHHTCCCTTBCCEEEEEEEECSSSEEEEEEEECCCEEEHHHHHHHHCSCCHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhcCCCCCCcccceeeeccCCCceEEEEEECCCCCEehhhhcccCCCCHHHHHHHHHHHHHHHHHH
Confidence 455678999999999999999999999987654 4899999999999999999999999999999999999999999
Q ss_pred HhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC----ccccccCCCCccCcccccccCCCCchhHHHHHHHH
Q 026253 83 NSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 83 h~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 158 (241)
|++|++||||||+||++ +.++..+++|||.+....... ......||+.|+|||.+.+..++.++||||+|+++
T Consensus 128 H~~~iiHrDiKP~NIll---~~~~~~~l~d~~~~~~~~~~~~~~~~~~~~~Gt~~Y~aPE~~~~~~~~~~~DiwSlGvil 204 (277)
T d1o6ya_ 128 HQNGIIHRDVKPANIMI---SATNAVKVMDFGIARAIADSGNSVTQTAAVIGTAQYLSPEQARGDSVDARSDVYSLGCVL 204 (277)
T ss_dssp HHTTEECCCCSGGGEEE---ETTSCEEECCCTTCEECC----------------TTCCHHHHTTCCCCHHHHHHHHHHHH
T ss_pred HhCCccCccccCccccc---CccccceeehhhhhhhhccccccccccccccCcccccCHHHHcCCCCCcceecccchHHH
Confidence 99999999999999999 678889999999886543322 23445789999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccC-CHHHHhcCcccc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-SFNEFYHHRFLR 228 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-s~~~il~~~~~~ 228 (241)
|+|++|.+||.+.+..+....+...... .+....+.+|+++.++|++||+.||.+|| |+++ +.|+|.+
T Consensus 205 yelltG~~Pf~~~~~~~~~~~~~~~~~~-~~~~~~~~~s~~l~~li~~~L~~dp~~R~~sa~~-l~~~l~r 273 (277)
T d1o6ya_ 205 YEVLTGEPPFTGDSPVSVAYQHVREDPI-PPSARHEGLSADLDAVVLKALAKNPENRYQTAAE-MRADLVR 273 (277)
T ss_dssp HHHHHSSCSCCCSSHHHHHHHHHHCCCC-CGGGTSSSCCHHHHHHHHHHTCSSGGGSCSSHHH-HHHHHHH
T ss_pred HHHHhCCCCCCCcCHHHHHHHHHhcCCC-CCchhccCCCHHHHHHHHHHccCCHhHCHhHHHH-HHHHHHH
Confidence 9999999999999888877666554433 23344568999999999999999999999 5555 4566654
|
| >d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Carboxyl-terminal src kinase (csk) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.6e-49 Score=304.25 Aligned_cols=209 Identities=22% Similarity=0.419 Sum_probs=177.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEe-ecCeEEEEEeccCCCChHHHHHhcC--CCCHHHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQ-AENCIFLVVEFCAGGNLSSYIRLHG--RVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~-~~~~~~lv~e~~~~~~L~~~l~~~~--~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+...+.+.+|++++++++||||++++|++. ..+.+++||||+++|+|.+++.+.+ .+++..+..++.|++.||.|||
T Consensus 41 ~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~al~ylH 120 (262)
T d1byga_ 41 DATAQAFLAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAMEYLE 120 (262)
T ss_dssp CC--HHHHHTHHHHTTCCCTTBCCEEEEECCC--CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHHHHHHH
T ss_pred HHHHHHHHHHHHHHHhCCCCCEeeEEEEEEecCCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHhhccccc
Confidence 344677999999999999999999999885 4567899999999999999997543 4899999999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHHHHHh
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~~ 163 (241)
+.+++||||+|+||++ +.++.++++|||+++..... .....++..|+|||.+.+..++.++||||||+++|+|++
T Consensus 121 ~~~ivH~dlkp~Nil~---~~~~~~kl~dfg~s~~~~~~--~~~~~~~~~y~aPE~l~~~~~t~~sDIwSfG~il~el~t 195 (262)
T d1byga_ 121 GNNFVHRDLAARNVLV---SEDNVAKVSDFGLTKEASST--QDTGKLPVKWTAPEALREKKFSTKSDVWSFGILLWEIYS 195 (262)
T ss_dssp HTTCCCSCCSGGGEEE---CTTSCEEECCCCC--------------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHHHT
T ss_pred cCceeccccchHhhee---cCCCCEeecccccceecCCC--CccccccccCCChHHHhCCCCChHHHHHhHHHHHHHHHH
Confidence 9999999999999999 78899999999999765433 334457889999999998999999999999999999998
Q ss_pred -CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 164 -GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 164 -g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|.+||...+..+....+..+.+.+.+. .+++++.++|++||+.||.+|||+.+++++
T Consensus 196 ~~~~p~~~~~~~~~~~~i~~~~~~~~~~----~~~~~~~~li~~cl~~dP~~Rps~~~l~~~ 253 (262)
T d1byga_ 196 FGRVPYPRIPLKDVVPRVEKGYKMDAPD----GCPPAVYEVMKNCWHLDAAMRPSFLQLREQ 253 (262)
T ss_dssp TSCCSCTTSCGGGHHHHHTTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred CCCCCCCCCCHHHHHHHHHcCCCCCCCc----cCCHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence 799999999889999998777766654 788999999999999999999999999864
|
| >d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Glycogen synthase kinase-3 beta (Gsk3b) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.2e-48 Score=308.00 Aligned_cols=218 Identities=29% Similarity=0.478 Sum_probs=178.5
Q ss_pred hhHHHHHHHHhcCCCcCeeeeeeEEeec------CeEEEEEeccCCCChHHHH---HhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 11 SCLDCELNFLSSVNHPNIIRLFDAFQAE------NCIFLVVEFCAGGNLSSYI---RLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 11 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l---~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
....+|++++++++|+||+++++++... .+.++||||+.++.+..+. .....+++..+..++.|++.||+|
T Consensus 58 ~~~~~Ei~il~~l~h~niv~~~~~~~~~~~~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~y 137 (350)
T d1q5ka_ 58 RFKNRELQIMRKLDHCNIVRLRYFFYSSGEKKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY 137 (350)
T ss_dssp SSCCHHHHHHHHCCCTTBCCEEEEEEEC--CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHhcCCCCCCcEEEEEEecCccCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHHH
Confidence 4556899999999999999999998542 3578999999755333322 334579999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAILFE 160 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l~~ 160 (241)
||++||+||||||+||+++ .++..+||+|||++.............++..|.|||.+.+ ..++.++|+||+||++|+
T Consensus 138 LH~~~IiHrDiKp~NILl~--~~~~~~kl~DFG~a~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~il~e 215 (350)
T d1q5ka_ 138 IHSFGICHRDIKPQNLLLD--PDTAVLKLCDFGSAKQLVRGEPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAE 215 (350)
T ss_dssp HHTTTEECCCCCGGGEEEC--TTTCCEEECCCTTCEECCTTSCCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHHHHH
T ss_pred HHhcCCcccCCCcceEEEe--cCCCceeEecccchhhccCCcccccccccccccChHHhhcccCCCcceeecccceEEEe
Confidence 9999999999999999994 3445899999999988776666667789999999998765 568999999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCC----------------CC--------CCCCccCCCCChHHHHHHHHhcccCccccC
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCK----------------HL--------PFSQLIVPALHPDCVDMCLKLLSANTVDRL 216 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~----------------~~--------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp 216 (241)
|++|..||...+..+.+..+.... .. +......+..++++.+||++||+.||.+||
T Consensus 216 l~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dLl~~mL~~dP~~R~ 295 (350)
T d1q5ka_ 216 LLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPNYTEFKFPQIKAHPWTKVFRPRTPPEAIALCSRLLEYTPTARL 295 (350)
T ss_dssp HHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC---CCCCCCCCCCCGGGTSCTTSCHHHHHHHHHHSCSSGGGSC
T ss_pred hhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccchhhccccccccCchhhhcccCCCHHHHHHHHHHccCChhHCc
Confidence 999999999888776665543210 00 111223446789999999999999999999
Q ss_pred CHHHHhcCcccccc
Q 026253 217 SFNEFYHHRFLRRN 230 (241)
Q Consensus 217 s~~~il~~~~~~~~ 230 (241)
|+.|+|+||||++.
T Consensus 296 ta~e~L~Hp~f~~~ 309 (350)
T d1q5ka_ 296 TPLEACAHSFFDEL 309 (350)
T ss_dssp CHHHHHTSGGGGGG
T ss_pred CHHHHhcCHhhccc
Confidence 99999999999874
|
| >d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: EGF receptor tyrosine kinase, Erbb-1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.4e-48 Score=305.80 Aligned_cols=211 Identities=24% Similarity=0.382 Sum_probs=183.4
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHh
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNS 84 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~ 84 (241)
+.+..+.+.+|++++++++||||++++|++.++ ..+++++++.+++|.+++... ..+++..+..++.|++.||+|||+
T Consensus 51 ~~~~~~~~~~E~~~l~~l~HpnIv~l~g~~~~~-~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~yLH~ 129 (317)
T d1xkka_ 51 SPKANKEILDEAYVMASVDNPHVCRLLGICLTS-TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMNYLED 129 (317)
T ss_dssp --CTHHHHHHHHHHHHHCCCTTBCCEEEEEESS-SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeeEEEEEecC-CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHHHHHH
Confidence 344577899999999999999999999999875 467778888899999988764 569999999999999999999999
Q ss_pred CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccCCCCchhHHHHHHHHHHH
Q 026253 85 HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFEL 161 (241)
Q Consensus 85 ~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l 161 (241)
+|++||||||+||++ +.++.+||+|||+|+....... .....+|..|+|||.+.+..++.++||||||+++|+|
T Consensus 130 ~~iiHrDlKp~NIll---~~~~~~kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~~~~sDvwS~Gvil~el 206 (317)
T d1xkka_ 130 RRLVHRDLAARNVLV---KTPQHVKITDFGLAKLLGAEEKEYHAEGGKVPIKWMALESILHRIYTHQSDVWSYGVTVWEL 206 (317)
T ss_dssp TTCCCSCCCGGGEEE---EETTEEEECCCSHHHHTTTTCC--------CCTTTSCHHHHHHCCCCHHHHHHHHHHHHHHH
T ss_pred cCcccCcchhhccee---CCCCCeEeeccccceecccccccccccccccCccccChHHHhcCCCChhhhhhhHHHHHHHH
Confidence 999999999999999 6788999999999987654322 2234578999999999999999999999999999999
Q ss_pred Hh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 162 LN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 162 ~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
++ |.+||.+.+..+....+..+.+.+.+. .+++++.+++.+||+.||.+|||+.|+++|
T Consensus 207 ~t~g~~p~~~~~~~~~~~~i~~~~~~~~p~----~~~~~~~~li~~cl~~dP~~RPs~~eil~~ 266 (317)
T d1xkka_ 207 MTFGSKPYDGIPASEISSILEKGERLPQPP----ICTIDVYMIMVKCWMIDADSRPKFRELIIE 266 (317)
T ss_dssp HTTSCCTTTTSCGGGHHHHHHHTCCCCCCT----TBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHCCCCCCCCCCHHHHHHHHHcCCCCCCCc----ccCHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence 98 899999998888888888877766554 788999999999999999999999999987
|
| >d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38-gamma species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.9e-47 Score=305.91 Aligned_cols=218 Identities=29% Similarity=0.488 Sum_probs=183.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC------eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN------CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l 79 (241)
++...+.+.+|++++++++||||+++++++...+ .+|+||||+ +.+|..+.+ .+++++..+..++.|++.||
T Consensus 57 ~~~~~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~~~~~~~~~lv~e~~-~~~l~~~~~-~~~l~~~~~~~~~~qi~~aL 134 (346)
T d1cm8a_ 57 SELFAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTDFYLVMPFM-GTDLGKLMK-HEKLGEDRIQFLVYQMLKGL 134 (346)
T ss_dssp SHHHHHHHHHHHHHHHHCCBTTBCCCSEEECSCSSTTTCCCCEEEEECC-SEEHHHHHH-HCCCCHHHHHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHhcCCCCeeEEEEEeccCccccccceEEEEEecc-cccHHHHHH-hccccHHHHHHHHHHHHHHH
Confidence 4455778999999999999999999999997654 579999999 678887765 56899999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccc-cCCCCchhHHHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGAIL 158 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~~l 158 (241)
+|||++||+||||||+||++ +.++.++++|||.|...... .....+++.|+|||.+.+ ..++.++|+||+||++
T Consensus 135 ~~LH~~~IiHrDiKp~NIL~---~~~~~~kl~Dfg~a~~~~~~--~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil 209 (346)
T d1cm8a_ 135 RYIHAAGIIHRDLKPGNLAV---NEDCELKILDFGLARQADSE--MTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM 209 (346)
T ss_dssp HHHHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCSS--CCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred HHHHhCCCcccccCcchhhc---ccccccccccccceeccCCc--cccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence 99999999999999999999 78899999999999876543 345678999999999875 4568999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhhcCCCC--------------------------CCCCccCCCCChHHHHHHHHhcccCc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNINSCKHL--------------------------PFSQLIVPALHPDCVDMCLKLLSANT 212 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~~~~~~--------------------------~~~~~~~~~~~~~~~~li~~~l~~~p 212 (241)
|+|++|..||.+.+....+..+...... .......+.+++++.+||++||..||
T Consensus 210 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP 289 (346)
T d1cm8a_ 210 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPLAVNLLEKMLVLDA 289 (346)
T ss_dssp HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGTCTTCCHHHHHHHHHHSCSST
T ss_pred HHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHhccCCCHHHHHHHHHHCcCCh
Confidence 9999999999988776655444321111 11122345678999999999999999
Q ss_pred cccCCHHHHhcCcccccc
Q 026253 213 VDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 213 ~~Rps~~~il~~~~~~~~ 230 (241)
.+|||++|+|+||||+..
T Consensus 290 ~~R~ta~eiL~Hp~f~~~ 307 (346)
T d1cm8a_ 290 EQRVTAGEALAHPYFESL 307 (346)
T ss_dssp TTSCCHHHHHHSGGGTTT
T ss_pred hHCcCHHHHhcChhhCcC
Confidence 999999999999999874
|
| >d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Fibroblast growth factor receptor 1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.7e-47 Score=300.07 Aligned_cols=212 Identities=26% Similarity=0.430 Sum_probs=189.6
Q ss_pred hhHHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC----------------CCCHHH
Q 026253 5 LNKHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG----------------RVPEQT 67 (241)
Q Consensus 5 ~~~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~----------------~~~~~~ 67 (241)
..+.....+.+|...+.++ +||||+++++++.+++..++||||+++|+|.+++.... .+++..
T Consensus 57 ~~~~~~~~~~~e~~~l~~~~~HpnIv~~~~~~~~~~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~~~ 136 (299)
T d1fgka_ 57 ATEKDLSDLISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSSKD 136 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCHHH
T ss_pred cChHHHHHHHHHHHHHHHhcCCCeEEecccccccCCeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCHHH
Confidence 3455678899999999998 89999999999999999999999999999999997543 489999
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccC
Q 026253 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQR 144 (241)
Q Consensus 68 ~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~ 144 (241)
+..++.|++.||+|||+.|++||||||+|||+ +.++.+||+|||.+....... ......+++.|+|||.+.+..
T Consensus 137 ~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~y~aPE~l~~~~ 213 (299)
T d1fgka_ 137 LVSCAYQVARGMEYLASKKCIHRDLAARNVLV---TEDNVMKIADFGLARDIHHIDYYKKTTNGRLPVKWMAPEALFDRI 213 (299)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CTTCCEEECSTTCCCCGGGCCTTCCCTTSCCGGGGSCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHhhhCCEEeeeecccceee---cCCCCeEeccchhhccccccccccccccCCCChhhhhhhHhcCCC
Confidence 99999999999999999999999999999999 788899999999998664432 233456788999999999999
Q ss_pred CCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 145 YDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 145 ~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
++.++||||||+++|+|++ |.+||.+.+..+....+..+...+.+. .+++++.++|.+||+.||++|||+.|+++
T Consensus 214 y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~dP~~Rps~~eil~ 289 (299)
T d1fgka_ 214 YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDKPS----NCTNELYMMMRDCWHAVPSQRPTFKQLVE 289 (299)
T ss_dssp CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCCCS----SCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCCCc----cchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence 9999999999999999998 799999999999999888777666654 78999999999999999999999999986
|
| >d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Musk tyrosine kinase species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=1.9e-47 Score=300.25 Aligned_cols=211 Identities=23% Similarity=0.433 Sum_probs=185.6
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC------------------------
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------------ 61 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------------ 61 (241)
..+..+++.+|++++++++||||+++++++.+.+..+++||++++++|.+++....
T Consensus 56 ~~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 135 (301)
T d1lufa_ 56 SADMQADFQREAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSPGPP 135 (301)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHTCC----------------------C
T ss_pred ChHHHHHHHHHHHHHHhcCCCCcccceeeeccCCceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhccccCCC
Confidence 34557889999999999999999999999999999999999999999999996532
Q ss_pred CCCHHHHHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcc
Q 026253 62 RVPEQTARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPE 138 (241)
Q Consensus 62 ~~~~~~~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE 138 (241)
.+++..+..++.|++.||+|||+.|++||||||+||++ +.++.+||+|||+|+...... ......+++.|+|||
T Consensus 136 ~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILl---d~~~~~Kl~DFGls~~~~~~~~~~~~~~~~~~~~y~aPE 212 (301)
T d1lufa_ 136 PLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLV---GENMVVKIADFGLSRNIYSADYYKADGNDAIPIRWMPPE 212 (301)
T ss_dssp CCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---CGGGCEEECCCSCHHHHTGGGCBC----CCBCGGGCCHH
T ss_pred CCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEE---CCCCcEEEccchhheeccCCccccccCCCCcCcCcCCHH
Confidence 37889999999999999999999999999999999999 778899999999997653322 223456788999999
Q ss_pred cccccCCCCchhHHHHHHHHHHHHhCC-CCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCC
Q 026253 139 VLQFQRYDEKVDMWSVGAILFELLNGY-PPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLS 217 (241)
Q Consensus 139 ~~~~~~~~~~~Dv~slG~~l~~l~~g~-~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps 217 (241)
.+.+..++.++||||||+++|+|++|. +||.+.+..+....+..+...+.+. .+++++.+++.+||+.||++|||
T Consensus 213 ~~~~~~~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~p~----~~~~~~~~li~~cl~~~P~~RPt 288 (301)
T d1lufa_ 213 SIFYNRYTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILACPE----NCPLELYNLMRLCWSKLPADRPS 288 (301)
T ss_dssp HHHHCCCCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCC
T ss_pred HHccCCCChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCCCc----cchHHHHHHHHHHcCCChhHCcC
Confidence 999999999999999999999999984 6899999999999998877655554 78999999999999999999999
Q ss_pred HHHHhc
Q 026253 218 FNEFYH 223 (241)
Q Consensus 218 ~~~il~ 223 (241)
+.|+++
T Consensus 289 ~~ev~~ 294 (301)
T d1lufa_ 289 FCSIHR 294 (301)
T ss_dssp HHHHHH
T ss_pred HHHHHH
Confidence 999964
|
| >d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Protein kinase CK2, alpha subunit species: Rattus norvegicus [TaxId: 10116]
Probab=100.00 E-value=1.1e-47 Score=305.29 Aligned_cols=224 Identities=24% Similarity=0.377 Sum_probs=182.6
Q ss_pred hhhhhHHhhhhHHHHHHHHhcCC-CcCeeeeeeEEee--cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDCELNFLSSVN-HPNIIRLFDAFQA--ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 2 ~~~~~~~~~~~~~~E~~~l~~l~-~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 78 (241)
+|.++....+++.+|++++++++ ||||+++++++.. ....++||||+.+++|.++. +.+++..+..++.||+.|
T Consensus 65 iK~i~~~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~~~~~~v~e~~~~~~L~~~~---~~l~e~~i~~i~~qil~a 141 (328)
T d3bqca1 65 VKILKPVKKKKIKREIKILENLRGGPNIITLADIVKDPVSRTPALVFEHVNNTDFKQLY---QTLTDYDIRFYMYEILKA 141 (328)
T ss_dssp EEEECSSCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTTCSEEEEEECCCSCBGGGTT---TSCCHHHHHHHHHHHHHH
T ss_pred EEEECHHHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCCCceeEEEeecCCCcHHHHh---cCCCHHHHHHHHHHHHHH
Confidence 45556666788999999999995 9999999999874 45799999999999998753 479999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccccc-CCCCchhHHHHHHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAI 157 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~ 157 (241)
|.|||++||+||||||+|||++ .++..++|+|||.|.............+|+.|+|||.+.+. .++.++|+||+||+
T Consensus 142 L~~LH~~gIvHrDiKp~NILi~--~~~~~vkl~DFG~a~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~~ 219 (328)
T d3bqca1 142 LDYCHSMGIMHRDVKPHNVMID--HEHRKLRLIDWGLAEFYHPGQEYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCM 219 (328)
T ss_dssp HHHHHHTTEECCCCSGGGEEEE--TTTTEEEECCGGGCEECCTTCCCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHHHHH
T ss_pred HHHHhhcccccccccccceEEc--CCCCeeeecccccceeccCCCcccccccCccccCcccccCCCCCCcccchhhhhhh
Confidence 9999999999999999999995 45667999999999887766666677889999999998765 47999999999999
Q ss_pred HHHHHhCCCCCCCCChH-HHHHHhhc------------CCCCC--------------------CCCccCCCCChHHHHHH
Q 026253 158 LFELLNGYPPFSGRNNV-QLVRNINS------------CKHLP--------------------FSQLIVPALHPDCVDMC 204 (241)
Q Consensus 158 l~~l~~g~~p~~~~~~~-~~~~~i~~------------~~~~~--------------------~~~~~~~~~~~~~~~li 204 (241)
++++++|..||...... .....+.. ..... ........+++++.+||
T Consensus 220 l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli 299 (328)
T d3bqca1 220 LASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFL 299 (328)
T ss_dssp HHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHHHHH
T ss_pred hHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHHHHH
Confidence 99999999999765432 22111110 00000 01112234788999999
Q ss_pred HHhcccCccccCCHHHHhcCcccccc
Q 026253 205 LKLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 205 ~~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
++||+.||.+|||++|+|+||||+..
T Consensus 300 ~~mL~~dP~~R~ta~e~L~Hp~F~~v 325 (328)
T d3bqca1 300 DKLLRYDHQSRLTAREAMEHPYFYTV 325 (328)
T ss_dssp HHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred HHHccCChhHCcCHHHHhcCcccCCC
Confidence 99999999999999999999999874
|
| >d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cyclin-dependent PK, CDK5 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=5.8e-47 Score=296.60 Aligned_cols=220 Identities=30% Similarity=0.458 Sum_probs=186.0
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
+...+++.+|+.++++++||||+++++++.+....+++++++.++++..++...+.+++..+..++.|++.||+|||++|
T Consensus 42 ~~~~~~~~~E~~il~~l~h~niv~~~~~~~~~~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~lH~~~ 121 (292)
T d1unla_ 42 EGVPSSALREICLLKELKHKNIVRLHDVLHSDKKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGFCHSRN 121 (292)
T ss_dssp TTHHHHHHHHHHHHTTCCCTTBCCEEEEEECSSEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred hHHHHHHHHHHHHHHhcCcCCEEeeccccccccceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHHhhcCC
Confidence 44578899999999999999999999999999999999999999999999888889999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-ccccccCCCCccCcccccccC-CCCchhHHHHHHHHHHHHhC
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-YAEKVCGSPLYMAPEVLQFQR-YDEKVDMWSVGAILFELLNG 164 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~l~~l~~g 164 (241)
|+||||||+||++ +.++.++|+|||.+....... ......++..|.|||.+.+.. ++.++|+||+||++|+|++|
T Consensus 122 IvHrDiKP~NIli---~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il~ell~g 198 (292)
T d1unla_ 122 VLHRDLKPQNLLI---NRNGELKLANFGLARAFGIPVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANA 198 (292)
T ss_dssp EECCCCSGGGEEE---CTTCCEEECCCTTCEECCSCCSCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHTTT
T ss_pred EeeecccCccccc---ccCCceeeeecchhhcccCCCccceeeccccchhhhhHhccCCCCCchhhccccchHHHHHhhC
Confidence 9999999999999 778899999999998765433 333455678899999887655 68999999999999999999
Q ss_pred CCCC-CCCChHHHHHHhhcCCCC------------------------CCCCccCCCCChHHHHHHHHhcccCccccCCHH
Q 026253 165 YPPF-SGRNNVQLVRNINSCKHL------------------------PFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN 219 (241)
Q Consensus 165 ~~p~-~~~~~~~~~~~i~~~~~~------------------------~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~ 219 (241)
..|| .+.+..+....+...... .......+.+++.+.+||++||+.||.+|||++
T Consensus 199 ~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~mL~~dP~~R~sa~ 278 (292)
T d1unla_ 199 GRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAE 278 (292)
T ss_dssp SCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCCCTTTSTTCCHHHHHHHHHHSCSSGGGSCCHH
T ss_pred CCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccchhhhccccCCHHHHHHHHHHccCChhHCcCHH
Confidence 8885 455555555554321111 111123456788999999999999999999999
Q ss_pred HHhcCccccc
Q 026253 220 EFYHHRFLRR 229 (241)
Q Consensus 220 ~il~~~~~~~ 229 (241)
|+|+||||++
T Consensus 279 e~L~Hp~f~~ 288 (292)
T d1unla_ 279 EALQHPYFSD 288 (292)
T ss_dssp HHTTSGGGSS
T ss_pred HHhcChhhcC
Confidence 9999999986
|
| >d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Cell division protein kinase 9, CDK9 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.8e-47 Score=302.79 Aligned_cols=221 Identities=23% Similarity=0.387 Sum_probs=180.3
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEee--------cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQA--------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAG 78 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~--------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~ 78 (241)
+...+++.+|++++++++|+||+++++++.. +++.++|||++.++.+..+......+++..+..++.|++.|
T Consensus 50 ~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~ 129 (318)
T d3blha1 50 EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG 129 (318)
T ss_dssp TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHH
Confidence 3446678899999999999999999998754 45689999999877776666666789999999999999999
Q ss_pred HHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-----ccccccCCCCccCccccccc-CCCCchhHH
Q 026253 79 LEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQFQ-RYDEKVDMW 152 (241)
Q Consensus 79 l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~ 152 (241)
|.|||++|++||||||+||++ +.++.++++|||++....... ......+|+.|+|||.+.+. .++.++|+|
T Consensus 130 l~~lH~~~ivHrDlKp~NILl---~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~Diw 206 (318)
T d3blha1 130 LYYIHRNKILHRDMKAANVLI---TRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLW 206 (318)
T ss_dssp HHHHHHTTEECCCCCGGGEEE---CTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHH
T ss_pred HHHhccCCEEecCcCchheee---cCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcc
Confidence 999999999999999999999 788899999999997654322 22335689999999998755 689999999
Q ss_pred HHHHHHHHHHhCCCCCCCCChHHHHHHhhcCCCCCCCCccC---------------------------CCCChHHHHHHH
Q 026253 153 SVGAILFELLNGYPPFSGRNNVQLVRNINSCKHLPFSQLIV---------------------------PALHPDCVDMCL 205 (241)
Q Consensus 153 slG~~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~---------------------------~~~~~~~~~li~ 205 (241)
|+||++|+|++|+.||.+.+.......+........+.... ...++++.+||.
T Consensus 207 SlGvil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~ 286 (318)
T d3blha1 207 GAGCIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLID 286 (318)
T ss_dssp HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHH
T ss_pred cCCceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHH
Confidence 99999999999999999988877766654432221111100 012567889999
Q ss_pred HhcccCccccCCHHHHhcCcccccc
Q 026253 206 KLLSANTVDRLSFNEFYHHRFLRRN 230 (241)
Q Consensus 206 ~~l~~~p~~Rps~~~il~~~~~~~~ 230 (241)
+||+.||++|||++|+|+||||+..
T Consensus 287 ~mL~~dP~~R~sa~elL~Hpff~~~ 311 (318)
T d3blha1 287 KLLVLDPAQRIDSDDALNHDFFWSD 311 (318)
T ss_dssp HHSCSSTTTSCCHHHHHHSGGGSSS
T ss_pred HHCcCChhHCcCHHHHHcChhhccC
Confidence 9999999999999999999999864
|
| >d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Ribosomal protein S6 kinase alpha 5, Msk1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=9.8e-48 Score=303.94 Aligned_cols=214 Identities=29% Similarity=0.499 Sum_probs=182.5
Q ss_pred hhhhHHHHHHHHhcCCC-cCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCc
Q 026253 9 LKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHI 87 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i 87 (241)
..+.+.+|++++++++| |||+++++++++....+++|||+.+++|.+++...+.+++..+..++.|++.|+.|+|++|+
T Consensus 71 ~~~~~~~E~~il~~l~h~pnIv~~~~~~~~~~~~~~v~e~~~~~~L~~~i~~~~~~~e~~~~~~~~Qi~~al~~lH~~~i 150 (322)
T d1vzoa_ 71 TTEHTRTERQVLEHIRQSPFLVTLHYAFQTETKLHLILDYINGGELFTHLSQRERFTEHEVQIYVGEIVLALEHLHKLGI 150 (322)
T ss_dssp SGGGCCCHHHHHHHHHTCTTBCCEEEEEEETTEEEEEECCCCSCBHHHHHHHHSCCCHHHHHHHHHHHHHHHHHHHHTTC
T ss_pred HHHHHHHHHHHHHhccCCCeEEEeeeeeccCCceeeeeecccccHHHHHHHhcccccHHHHHHHHHHHHHHHHHhhcCCE
Confidence 45678899999999976 79999999999999999999999999999999999999999999999999999999999999
Q ss_pred cccCCCCCCeEEeecCCCceEEEeecCCccccCCC--CccccccCCCCccCccccccc--CCCCchhHHHHHHHHHHHHh
Q 026253 88 IHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPG--NYAEKVCGSPLYMAPEVLQFQ--RYDEKVDMWSVGAILFELLN 163 (241)
Q Consensus 88 ~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~--~~~~~~~~~~~~~~PE~~~~~--~~~~~~Dv~slG~~l~~l~~ 163 (241)
+||||||+||++ +.++.++|+|||++...... .......+++.|++||.+.+. .++.++||||+||++|+|++
T Consensus 151 vHrDiKp~Nill---~~~~~vkL~DFG~a~~~~~~~~~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG~iLyellt 227 (322)
T d1vzoa_ 151 IYRDIKLENILL---DSNGHVVLTDFGLSKEFVADETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLT 227 (322)
T ss_dssp CCCCCCGGGEEE---CTTSCEEESCSSEEEECCGGGGGGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHHHHHHHHHH
T ss_pred EeccCCccceee---cCCCCEEEeeccchhhhcccccccccccccccccchhHHhhcCCcCCCchhhhHHHHHHHHHHHh
Confidence 999999999999 77889999999999765432 233456789999999998654 46889999999999999999
Q ss_pred CCCCCCCCChHHHHHHhhc---CCCCCCCCccCCCCChHHHHHHHHhcccCccccC-----CHHHHhcCccccc
Q 026253 164 GYPPFSGRNNVQLVRNINS---CKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRL-----SFNEFYHHRFLRR 229 (241)
Q Consensus 164 g~~p~~~~~~~~~~~~i~~---~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rp-----s~~~il~~~~~~~ 229 (241)
|..||.+.+.......+.. ....+.+ ..+|+++.++|++||+.||.+|| |++|+++||||++
T Consensus 228 G~~PF~~~~~~~~~~~i~~~~~~~~~~~~----~~~s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~ 297 (322)
T d1vzoa_ 228 GASPFTVDGEKNSQAEISRRILKSEPPYP----QEMSALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK 297 (322)
T ss_dssp SSCTTSCTTSCCCHHHHHHHHHHCCCCCC----TTSCHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred CCCCCCCCCHHHHHHHHHHhcccCCCCCc----ccCCHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence 9999987554333322222 2223333 37899999999999999999999 5899999999987
|
| >d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Activated CDC42 kinase 1, ACK1 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.1e-47 Score=295.54 Aligned_cols=213 Identities=27% Similarity=0.404 Sum_probs=180.9
Q ss_pred HhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 8 HLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
+..+.+.+|+.++++++||||++++|++.+ +..++||||++++++.+++... +.+++..+..++.|++.||.|||++|
T Consensus 53 ~~~~~~~~Ei~~l~~l~H~nIv~~~g~~~~-~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~ylH~~~ 131 (273)
T d1u46a_ 53 EAMDDFIREVNAMHSLDHRNLIRLYGVVLT-PPMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGYLESKR 131 (273)
T ss_dssp HHHHHHHHHHHHHHHCCCTTBCCEEEEECS-SSCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred HHHHHHHHHHHHHHhCCCCCEEEEEEEEee-cchheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHHhhhCC
Confidence 446789999999999999999999999976 4678999999999999887654 56999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc----cccccCCCCccCcccccccCCCCchhHHHHHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILFELL 162 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~~l~ 162 (241)
++||||||+||++ +.++.+||+|||++........ .....++..|+|||.+.+..++.++||||||+++|||+
T Consensus 132 iiHrDikp~NIll---~~~~~vkl~DfGl~~~~~~~~~~~~~~~~~~~~~~~~aPE~~~~~~~~~~~Di~S~Gvil~eml 208 (273)
T d1u46a_ 132 FIHRDLAARNLLL---ATRDLVKIGDFGLMRALPQNDDHYVMQEHRKVPFAWCAPESLKTRTFSHASDTWMFGVTLWEMF 208 (273)
T ss_dssp EECSCCCGGGEEE---EETTEEEECCCTTCEECCC-CCEEEC-----CCGGGCCHHHHHHCEEEHHHHHHHHHHHHHHHH
T ss_pred EeeeeecHHHhcc---ccccceeeccchhhhhcccCCCcceecCccccCcccCCHHHHhCCCCCcchhhhhhHHHHHHHH
Confidence 9999999999999 5677999999999987654432 22334677899999999999999999999999999999
Q ss_pred h-CCCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcCccccc
Q 026253 163 N-GYPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 163 ~-g~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
+ |..||.+.+..+....+......+ ...+.+|+++.+++.+||+.||++|||+++++ ++|++
T Consensus 209 t~G~~Pf~~~~~~~~~~~i~~~~~~~---~~~~~~~~~l~~li~~cl~~dp~~RPt~~ei~--~~L~~ 271 (273)
T d1u46a_ 209 TYGQEPWIGLNGSQILHKIDKEGERL---PRPEDCPQDIYNVMVQCWAHKPEDRPTFVALR--DFLLE 271 (273)
T ss_dssp TTSCCTTTTCCHHHHHHHHHTSCCCC---CCCTTCCHHHHHHHHHHTCSSGGGSCCHHHHH--HHHHH
T ss_pred hCCCCCCCCcCHHHHHHHHHhCCCCC---CCcccccHHHHHHHHHHcCCChhHCcCHHHHH--HHHHh
Confidence 8 899999999999888875554222 12247899999999999999999999999987 45443
|
| >d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase Erk2 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=300.42 Aligned_cols=221 Identities=28% Similarity=0.479 Sum_probs=179.5
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecC-----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAEN-----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~-----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
....+.+.+|++++++++||||+++++++.... ..+++++ +.+++|.++++. .++++..+..++.|++.||+|
T Consensus 47 ~~~~~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~~~~~~~~l~~~-~~~g~L~~~l~~-~~l~~~~i~~i~~qil~al~y 124 (345)
T d1pmea_ 47 QTYCQRTLREIKILLRFRHENIIGINDIIRAPTIEQMKDVYLVTH-LMGADLYKLLKT-QHLSNDHICYFLYQILRGLKY 124 (345)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCCEEECCSSTTTCCCEEEEEE-CCCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHHcCCCCCCcEEEEEeeccccccceEEEEEe-ecCCchhhhhhc-CCCCHHHHHHHHHHHHHHHHH
Confidence 344668889999999999999999999987643 3555555 558999999975 479999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC----ccccccCCCCccCcccccc-cCCCCchhHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN----YAEKVCGSPLYMAPEVLQF-QRYDEKVDMWSVGA 156 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~----~~~~~~~~~~~~~PE~~~~-~~~~~~~Dv~slG~ 156 (241)
||++||+||||||+||++ +.++.+||+|||+|....... ......+++.|+|||.+.. ..++.++|+||+|+
T Consensus 125 LH~~~iiHRDIKp~NILl---~~~~~~kl~DfG~a~~~~~~~~~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~ 201 (345)
T d1pmea_ 125 IHSANVLHRDLKPSNLLL---NTTCDLKICDFGLARVADPDHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGC 201 (345)
T ss_dssp HHHTTEECCCCCGGGEEE---CTTCCEEECCCTTCEECCGGGCBCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHH
T ss_pred HHHCCCcCCCCCcceEEE---CCCCCEEEcccCceeeccCCCccceeeccccccceechHHHhhcCCCCCchhhhhccCc
Confidence 999999999999999999 788899999999997654322 2344568999999999854 46789999999999
Q ss_pred HHHHHHhCCCCCCCCChHHHHHHhhcCCCCC--------------------------CCCccCCCCChHHHHHHHHhccc
Q 026253 157 ILFELLNGYPPFSGRNNVQLVRNINSCKHLP--------------------------FSQLIVPALHPDCVDMCLKLLSA 210 (241)
Q Consensus 157 ~l~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--------------------------~~~~~~~~~~~~~~~li~~~l~~ 210 (241)
++|+|++|..||.+.+..............+ ......+.+|+++.+|+++||+.
T Consensus 202 il~eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~ 281 (345)
T d1pmea_ 202 ILAEMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSKALDLLDKMLTF 281 (345)
T ss_dssp HHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHCTTSCHHHHHHHHHHSCS
T ss_pred eehHHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhCCCCCHHHHHHHHHHccC
Confidence 9999999999999877655444332211000 01123457788999999999999
Q ss_pred CccccCCHHHHhcCcccccccc
Q 026253 211 NTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 211 ~p~~Rps~~~il~~~~~~~~~~ 232 (241)
||.+|||++|+|+||||+....
T Consensus 282 dP~~R~ta~e~L~hpf~~~~~~ 303 (345)
T d1pmea_ 282 NPHKRIEVEQALAHPYLEQYYD 303 (345)
T ss_dssp STTTSCCHHHHHTSGGGTTTCC
T ss_pred ChhHCcCHHHHhcCHhhccCCC
Confidence 9999999999999999996444
|
| >d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Insulin-like growth factor 1 receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2e-46 Score=295.10 Aligned_cols=217 Identities=22% Similarity=0.344 Sum_probs=191.6
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhc----------CCCCHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLH----------GRVPEQTARKFLQQL 75 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~----------~~~~~~~~~~~~~~i 75 (241)
.......+.+|++++++++||||+++++++..++..++||||+++|+|.+++... ..+++..+..++.++
T Consensus 63 ~~~~~~~~~~E~~il~~l~h~nIv~~~~~~~~~~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~i 142 (308)
T d1p4oa_ 63 SMRERIEFLNEASVMKEFNCHHVVRLLGVVSQGQPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAGEI 142 (308)
T ss_dssp CHHHHHHHHHHHHHGGGCCCTTBCCEEEEECSSSSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHHHH
T ss_pred ChHHHHHHHHHHHHHHHcCCCCEeeeeeEEecCCceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHHHH
Confidence 3445567899999999999999999999999999999999999999999998643 236889999999999
Q ss_pred HHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCCCCchhHH
Q 026253 76 GAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRYDEKVDMW 152 (241)
Q Consensus 76 ~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~ 152 (241)
+.||.|||+++++||||||.|||+ +.++.+||+|||+|+...... ......+++.|+|||.+.+..++.++|+|
T Consensus 143 a~gl~~LH~~~ivHrDlk~~NiLl---d~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~t~~y~aPe~l~~~~~~~~~Dv~ 219 (308)
T d1p4oa_ 143 ADGMAYLNANKFVHRDLAARNCMV---AEDFTVKIGDFGMTRDIYETDYYRKGGKGLLPVRWMSPESLKDGVFTTYSDVW 219 (308)
T ss_dssp HHHHHHHHHTTCBCSCCSGGGEEE---CTTCCEEECCTTCCCGGGGGGCEEGGGSSEECGGGCCHHHHHHCCCCHHHHHH
T ss_pred HHHHHHHhhCCeeeceEcCCceee---cCCceEEEeecccceeccCCcceeeccceecccccCCHHHHccCCCCcccccc
Confidence 999999999999999999999999 788999999999997654332 23344678999999999999999999999
Q ss_pred HHHHHHHHHHhC-CCCCCCCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc------Cc
Q 026253 153 SVGAILFELLNG-YPPFSGRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH------HR 225 (241)
Q Consensus 153 slG~~l~~l~~g-~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~------~~ 225 (241)
|+|+++|+|++| .+||.+.+..+.+..+..+...+.+. .+++.+.+++.+||+.||.+|||++++++ +|
T Consensus 220 S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~p~----~~~~~l~~li~~cl~~~P~~RPs~~~il~~L~~~~~~ 295 (308)
T d1p4oa_ 220 SFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDKPD----NCPDMLFELMRMCWQYNPKMRPSFLEIISSIKEEMEP 295 (308)
T ss_dssp HHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHGGGSCT
T ss_pred cHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCCcc----cchHHHHHHHHHHcCCChhHCcCHHHHHHHHHHhcCC
Confidence 999999999997 68999999999999988877665554 78899999999999999999999999997 77
Q ss_pred cccc
Q 026253 226 FLRR 229 (241)
Q Consensus 226 ~~~~ 229 (241)
+|++
T Consensus 296 ~~~~ 299 (308)
T d1p4oa_ 296 GFRE 299 (308)
T ss_dssp THHH
T ss_pred CCcC
Confidence 7765
|
| >d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Vascular endothelial growth factor receptor 2 (kdr) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=1.5e-46 Score=294.98 Aligned_cols=211 Identities=28% Similarity=0.485 Sum_probs=173.2
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEee-cCeEEEEEeccCCCChHHHHHhc----------------CCCCHHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH----------------GRVPEQTA 68 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~----------------~~~~~~~~ 68 (241)
....+.+.+|..++.++ .|+||+.+++++.+ ++..++|||||++|+|.+++... ..+++..+
T Consensus 57 ~~~~~~~~~e~~~l~~~~~h~~iv~~~~~~~~~~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~~~ 136 (299)
T d1ywna1 57 HSEHRALMSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTLEHL 136 (299)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSTTSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCHHHH
T ss_pred cHHHHHHHHHHHHHHhhcCCCeEEEeeeeeccCCCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCHHHH
Confidence 44566788888888887 68899999998765 45789999999999999999753 23789999
Q ss_pred HHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC---ccccccCCCCccCcccccccCC
Q 026253 69 RKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN---YAEKVCGSPLYMAPEVLQFQRY 145 (241)
Q Consensus 69 ~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~---~~~~~~~~~~~~~PE~~~~~~~ 145 (241)
..++.|++.||+|||++|++||||||+||++ +.++.+||+|||+|+...... ......+|+.|+|||.+.+..+
T Consensus 137 ~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl---~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~gt~~y~APE~l~~~~~ 213 (299)
T d1ywna1 137 ICYSFQVAKGMEFLASRKCIHRDLAARNILL---SEKNVVKICDFGLARDIYKDPDYVRKGDARLPLKWMAPETIFDRVY 213 (299)
T ss_dssp HHHHHHHHHHHHHHHHTTCCCSCCCGGGEEE---CGGGCEEECC------CCSCTTSCCTTSCCCGGGGCCHHHHHHCCC
T ss_pred HHHHHHHHHHHHHHHhCCCcCCcCCccceeE---CCCCcEEEccCcchhhccccccccccCceeeCccccchhHhhcCCC
Confidence 9999999999999999999999999999999 788899999999997654332 2334568899999999999999
Q ss_pred CCchhHHHHHHHHHHHHhC-CCCCCCCC-hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc
Q 026253 146 DEKVDMWSVGAILFELLNG-YPPFSGRN-NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH 223 (241)
Q Consensus 146 ~~~~Dv~slG~~l~~l~~g-~~p~~~~~-~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~ 223 (241)
+.++||||+|+++|+|++| .+||.+.+ .....+.+..+...+.+. .+++++.+++.+||+.||.+|||++|+++
T Consensus 214 ~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~l~~li~~cl~~dP~~Rpt~~eil~ 289 (299)
T d1ywna1 214 TIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRAPD----YTTPEMYQTMLDCWHGEPSQRPTFSELVE 289 (299)
T ss_dssp CHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred CcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCCc----cCCHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence 9999999999999999986 56887655 445556666666655443 78999999999999999999999999998
Q ss_pred C
Q 026253 224 H 224 (241)
Q Consensus 224 ~ 224 (241)
|
T Consensus 290 ~ 290 (299)
T d1ywna1 290 H 290 (299)
T ss_dssp H
T ss_pred H
Confidence 7
|
| >d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Hepatocyte growth factor receptor, c-MET species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=4.6e-46 Score=292.95 Aligned_cols=212 Identities=25% Similarity=0.382 Sum_probs=178.9
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee-cCeEEEEEeccCCCChHHHHHhc-CCCCHHHHHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA-ENCIFLVVEFCAGGNLSSYIRLH-GRVPEQTARKFLQQLGAGLEILN 83 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~-~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~lh 83 (241)
+....+++.+|++++++++||||++++|++.+ ++..++||||+++++|.+++... ...++..+..++.|++.||.|||
T Consensus 68 ~~~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~lH 147 (311)
T d1r0pa_ 68 DIGEVSQFLTEGIIMKDFSHPNVLSLLGICLRSEGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKFLA 147 (311)
T ss_dssp CHHHHHHHHHHHHHHHTCCCTTBCCCCEEEEETTTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhCCCCCEeEEeEEEEecCCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhhhc
Confidence 45567889999999999999999999999765 56899999999999999998754 35778889999999999999999
Q ss_pred hCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc-----cccccCCCCccCcccccccCCCCchhHHHHHHHH
Q 026253 84 SHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY-----AEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 84 ~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 158 (241)
+.|++||||||+|||+ +.++.+||+|||+++....... .....++..|+|||.+.+..++.++||||||+++
T Consensus 148 ~~~iiHrDLK~~NILl---~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~ksDI~SfGivl 224 (311)
T d1r0pa_ 148 SKKFVHRDLAARNCML---DEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQKFTTKSDVWSFGVLL 224 (311)
T ss_dssp HTTCCCSCCSGGGEEE---CTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCCCCHHHHHHHHHHHH
T ss_pred ccCcccCCccHHhEeE---CCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCCCCChhHhhhhHHHH
Confidence 9999999999999999 7888999999999987644321 2234578899999999989999999999999999
Q ss_pred HHHHhCCCCCC-CCChHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhcC
Q 026253 159 FELLNGYPPFS-GRNNVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 159 ~~l~~g~~p~~-~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
|||++|..||. ..+..+....+..+.....+. .+++++.+++.+||+.||++|||+.|++++
T Consensus 225 ~El~t~~~p~~~~~~~~~~~~~i~~g~~~~~p~----~~~~~l~~li~~cl~~dP~~RPs~~ei~~~ 287 (311)
T d1r0pa_ 225 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQPE----YCPDPLYEVMLKCWHPKAEMRPSFSELVSR 287 (311)
T ss_dssp HHHHTTSCCSCC------CHHHHHTTCCCCCCT----TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred HHHHHCCCCCCCCCCHHHHHHHHHcCCCCCCcc----cCcHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence 99999666655 455556667776676655443 788999999999999999999999999987
|
| >d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-jun N-terminal kinase (jnk3s) species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=8.8e-47 Score=302.85 Aligned_cols=218 Identities=30% Similarity=0.427 Sum_probs=171.3
Q ss_pred hHHhhhhHHHHHHHHhcCCCcCeeeeeeEEee------cCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHH
Q 026253 6 NKHLKSCLDCELNFLSSVNHPNIIRLFDAFQA------ENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGL 79 (241)
Q Consensus 6 ~~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l 79 (241)
++...+++.+|+.++++++||||+++++++.. .++.|+||||+.++ +.+.+ ...+++..+..++.|++.||
T Consensus 56 ~~~~~~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~~~~~~~~~iv~Ey~~~~-l~~~~--~~~~~~~~i~~~~~qil~gl 132 (355)
T d2b1pa1 56 NQTHAKRAYRELVLMKCVNHKNIISLLNVFTPQKTLEEFQDVYLVMELMDAN-LCQVI--QMELDHERMSYLLYQMLCGI 132 (355)
T ss_dssp SHHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCCSTTTCCEEEEEEECCSEE-HHHHH--TSCCCHHHHHHHHHHHHHHH
T ss_pred CHHHHHHHHHHHHHHHhcCCCCeeEEEEEEecccccccCceeEEEEeccchH-HHHhh--hcCCCHHHHHHHHHHHHHHH
Confidence 35567789999999999999999999999853 46899999999654 44444 35789999999999999999
Q ss_pred HHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCchhHHHHHHHHH
Q 026253 80 EILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAILF 159 (241)
Q Consensus 80 ~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l~ 159 (241)
.+||++|++||||||+||++ +.++.++++|||.++............+|+.|+|||.+.+..++.++|+||+||+++
T Consensus 133 ~~LH~~giiHrDlKP~Nil~---~~~~~~kl~df~~~~~~~~~~~~~~~~~t~~y~aPE~l~~~~~~~~~DiwSlG~~l~ 209 (355)
T d2b1pa1 133 KHLHSAGIIHRDLKPSNIVV---KSDCTLKILDFGLARTAGTSFMMTPYVVTRYYRAPEVILGMGYKENVDIWSVGCIMG 209 (355)
T ss_dssp HHHHHTTCCCSCCCGGGEEE---CTTCCEEECCCCC---------------CCTTCCHHHHTTCCCCTTHHHHHHHHHHH
T ss_pred HHhhhcccccccCCcccccc---ccccceeeechhhhhccccccccccccccccccChhhhcCCCCCCCcccccccchHH
Confidence 99999999999999999999 778889999999988877666666778899999999999999999999999999999
Q ss_pred HHHhCCCCCCCCChHHHHHHhhcCCCCCCC-------------------------------------CccCCCCChHHHH
Q 026253 160 ELLNGYPPFSGRNNVQLVRNINSCKHLPFS-------------------------------------QLIVPALHPDCVD 202 (241)
Q Consensus 160 ~l~~g~~p~~~~~~~~~~~~i~~~~~~~~~-------------------------------------~~~~~~~~~~~~~ 202 (241)
+|++|+.||.+.+.......+......+.+ .......|+++.+
T Consensus 210 ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d 289 (355)
T d2b1pa1 210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD 289 (355)
T ss_dssp HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred HHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHH
Confidence 999999999988776665544322111100 0001123567899
Q ss_pred HHHHhcccCccccCCHHHHhcCccccc
Q 026253 203 MCLKLLSANTVDRLSFNEFYHHRFLRR 229 (241)
Q Consensus 203 li~~~l~~~p~~Rps~~~il~~~~~~~ 229 (241)
||++||..||++|||++|+|+||||+.
T Consensus 290 ll~~mL~~dP~~R~ta~elL~Hpw~~~ 316 (355)
T d2b1pa1 290 LLSKMLVIDPAKRISVDDALQHPYINV 316 (355)
T ss_dssp HHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred HHHHHCcCChhHCcCHHHHhcCcccCC
Confidence 999999999999999999999999986
|
| >d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: MAP kinase p38 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=3.1e-46 Score=299.22 Aligned_cols=220 Identities=27% Similarity=0.441 Sum_probs=177.1
Q ss_pred HHhhhhHHHHHHHHhcCCCcCeeeeeeEEeec-----CeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Q 026253 7 KHLKSCLDCELNFLSSVNHPNIIRLFDAFQAE-----NCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEI 81 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~-----~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~ 81 (241)
....+++.+|++++++++|+||+++++++... ...+++++++.|++|.+++. .+++++..+..++.|++.||+|
T Consensus 58 ~~~~~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~~~~~~~~~i~~~~~gg~L~~~~~-~~~l~e~~~~~i~~qil~aL~~ 136 (348)
T d2gfsa1 58 IIHAKRTYRELRLLKHMKHENVIGLLDVFTPARSLEEFNDVYLVTHLMGADLNNIVK-CQKLTDDHVQFLIYQILRGLKY 136 (348)
T ss_dssp HHHHHHHHHHHHHHHHCCCTTBCCCSEEECSCSSTTTCCCCEEEEECCSEEHHHHHT-TCCCCHHHHHHHHHHHHHHHHH
T ss_pred hHHHHHHHHHHHHHHhcCCCCeeeEEEEEeeccccccCceEEEEEeecCCchhhhcc-cccccHHHHHHHHHHHHHHHHH
Confidence 44566789999999999999999999998532 23355556667999999986 4579999999999999999999
Q ss_pred HHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCccccccc-CCCCchhHHHHHHHHHH
Q 026253 82 LNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQ-RYDEKVDMWSVGAILFE 160 (241)
Q Consensus 82 lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~-~~~~~~Dv~slG~~l~~ 160 (241)
||++|++||||||+||++ +.++.++++|||.+...... .....++..|+|||...+. .++.++|+||+|+++|+
T Consensus 137 LH~~giiHrDiKp~NILi---~~~~~~kl~dfg~a~~~~~~--~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~~ 211 (348)
T d2gfsa1 137 IHSADIIHRDLKPSNLAV---NEDCELKILDFGLARHTDDE--MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAE 211 (348)
T ss_dssp HHHTTCCCCCCCGGGEEE---CTTCCEEECCC----CCTGG--GSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHHH
T ss_pred HHhCCCcccccCCccccc---cccccccccccchhcccCcc--cccccccccccCchhhcCCccCCcccchhhhhHHHHH
Confidence 999999999999999999 78899999999998665432 3345678889999987665 46899999999999999
Q ss_pred HHhCCCCCCCCChHHHHHHhhcCCCCCCC--------------------------CccCCCCChHHHHHHHHhcccCccc
Q 026253 161 LLNGYPPFSGRNNVQLVRNINSCKHLPFS--------------------------QLIVPALHPDCVDMCLKLLSANTVD 214 (241)
Q Consensus 161 l~~g~~p~~~~~~~~~~~~i~~~~~~~~~--------------------------~~~~~~~~~~~~~li~~~l~~~p~~ 214 (241)
|++|..||.+.+.......+......... ......+++++.+||++||+.||.+
T Consensus 212 ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dli~~mL~~dP~~ 291 (348)
T d2gfsa1 212 LLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPLAVDLLEKMLVLDSDK 291 (348)
T ss_dssp HHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHHSTTCCHHHHHHHHHHSCSSGGG
T ss_pred HHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhhcCCCCHHHHHHHHHHCcCChhh
Confidence 99999999988877666655432211110 0113467899999999999999999
Q ss_pred cCCHHHHhcCcccccccc
Q 026253 215 RLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 215 Rps~~~il~~~~~~~~~~ 232 (241)
|||++|+|+||||++...
T Consensus 292 R~ta~elL~Hp~f~~~~~ 309 (348)
T d2gfsa1 292 RITAAQALAHAYFAQYHD 309 (348)
T ss_dssp SCCHHHHHTSGGGTTTCC
T ss_pred CcCHHHHhcCHhhCCCCC
Confidence 999999999999997543
|
| >d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: c-KIT receptor species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=2.2e-45 Score=289.51 Aligned_cols=210 Identities=27% Similarity=0.411 Sum_probs=181.0
Q ss_pred HHhhhhHHHHHHHHhcC-CCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC------------------CCCHHH
Q 026253 7 KHLKSCLDCELNFLSSV-NHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG------------------RVPEQT 67 (241)
Q Consensus 7 ~~~~~~~~~E~~~l~~l-~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~------------------~~~~~~ 67 (241)
......+.+|+.+++++ +||||+++++++.+++..++||||+++++|.+++.+.. .+++..
T Consensus 67 ~~~~~~~~~E~~~~~~l~~HpnIv~~~g~~~~~~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~~ 146 (311)
T d1t46a_ 67 LTEREALMSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELALDLED 146 (311)
T ss_dssp HHHHHHHHHHHHHHHHHCCCTTBCCEEEEECSSSSCEEEEECCTTEEHHHHHHHTTTTC--------------CCCCHHH
T ss_pred HHHHHHHHHHHHHHHhccCCCCEEEEEEEEeeCCEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCCCHHH
Confidence 44567899999999999 79999999999999999999999999999999997643 488999
Q ss_pred HHHHHHHHHHHHHHHHhCCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCCc---cccccCCCCccCcccccccC
Q 026253 68 ARKFLQQLGAGLEILNSHHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNY---AEKVCGSPLYMAPEVLQFQR 144 (241)
Q Consensus 68 ~~~~~~~i~~~l~~lh~~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~---~~~~~~~~~~~~PE~~~~~~ 144 (241)
+..++.|++.|+++||++|++||||||+||++ +..+.++++|||.++....... .....+++.|+|||.+.+..
T Consensus 147 ~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~---~~~~~~ki~DfG~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~ 223 (311)
T d1t46a_ 147 LLSFSYQVAKGMAFLASKNCIHRDLAARNILL---THGRITKICDFGLARDIKNDSNYVVKGNARLPVKWMAPESIFNCV 223 (311)
T ss_dssp HHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEE---ETTTEEEECCCGGGSCTTSCTTSEECSSSEECGGGCCHHHHHHCC
T ss_pred HHHHHHHHHHHHHHHHhCCeeecccccccccc---cccCcccccccchheeccCCCcceEeeecccChHHcCHHHhcCCC
Confidence 99999999999999999999999999999999 6788999999999987654322 23456789999999999899
Q ss_pred CCCchhHHHHHHHHHHHHh-CCCCCCCCChHHHH-HHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHh
Q 026253 145 YDEKVDMWSVGAILFELLN-GYPPFSGRNNVQLV-RNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFY 222 (241)
Q Consensus 145 ~~~~~Dv~slG~~l~~l~~-g~~p~~~~~~~~~~-~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il 222 (241)
++.++||||||+++|+|++ |.+||.+.+..+.+ +.+..+.....+ ...|+.+.++|.+||+.||.+|||+++++
T Consensus 224 ~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~~~----~~~~~~l~~Li~~cl~~dP~~RPs~~~il 299 (311)
T d1t46a_ 224 YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRMLSP----EHAPAEMYDIMKTCWDADPLKRPTFKQIV 299 (311)
T ss_dssp CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCCCC----TTSCHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCCc----ccccHHHHHHHHHHcCCChhHCcCHHHHH
Confidence 9999999999999999998 77778776665544 445454444433 36889999999999999999999999998
Q ss_pred c
Q 026253 223 H 223 (241)
Q Consensus 223 ~ 223 (241)
+
T Consensus 300 ~ 300 (311)
T d1t46a_ 300 Q 300 (311)
T ss_dssp H
T ss_pred H
Confidence 5
|
| >d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Rat (Rattus norvegicus) [TaxId: 10116]
Probab=100.00 E-value=2.2e-43 Score=276.98 Aligned_cols=220 Identities=17% Similarity=0.200 Sum_probs=171.9
Q ss_pred hhhhHHHHHHHHhcCCCcCe-eeeeeEEeecCeEEEEEeccCCCChHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHhCC
Q 026253 9 LKSCLDCELNFLSSVNHPNI-IRLFDAFQAENCIFLVVEFCAGGNLSSYIRL-HGRVPEQTARKFLQQLGAGLEILNSHH 86 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i-~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~lh~~~ 86 (241)
..+++..|++++++++|+++ +.+.+++.+++..++|||++ ++++.+.+.. .+.+++..+..++.|++.||++||++|
T Consensus 45 ~~~~~~~E~~i~~~l~~~~~i~~~~~~~~~~~~~~ivme~~-~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~lH~~~ 123 (299)
T d1ckia_ 45 KHPQLHIESKIYKMMQGGVGIPTIRWCGAEGDYNVMVMELL-GPSLEDLFNFCSRKFSLKTVLLLADQMISRIEYIHSKN 123 (299)
T ss_dssp TSCCHHHHHHHHHHSTTSTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCHHHHHHHHHHHHccCCCcccEEEEEEecCCEEEEEEEEc-CCchhhhhhhccCCCcHHHHHHHHHHHHHHHHHHHHCC
Confidence 45678999999999987665 45556667888999999999 5677666654 457999999999999999999999999
Q ss_pred ccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC--------ccccccCCCCccCcccccccCCCCchhHHHHHHHH
Q 026253 87 IIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 87 i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG~~l 158 (241)
++||||||+||++...+.+..++++|||+|+...... ......||+.|+|||.+.+..++.++|||||||++
T Consensus 124 iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~DiwSlG~~l 203 (299)
T d1ckia_ 124 FIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIEQSRRDDLESLGYVL 203 (299)
T ss_dssp EECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBCCCHHHHHHHHHHHH
T ss_pred eeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCCCCChhhEEecCHHH
Confidence 9999999999998644566779999999998765432 12345689999999999999999999999999999
Q ss_pred HHHHhCCCCCCCCChHHHHHHhh---cCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHH---HHhcCccccc
Q 026253 159 FELLNGYPPFSGRNNVQLVRNIN---SCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFN---EFYHHRFLRR 229 (241)
Q Consensus 159 ~~l~~g~~p~~~~~~~~~~~~i~---~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~---~il~~~~~~~ 229 (241)
|+|++|..||...........+. ........+...+.+|+++.+++..||+.+|.+||+++ ++|+|+|.+.
T Consensus 204 ~el~tg~~P~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~li~~cl~~~p~~RP~~~~i~~~l~~~~~~~ 280 (299)
T d1ckia_ 204 MYFNLGSLPWQGLKAATKRQKYERISEKKMSTPIEVLCKGYPSEFATYLNFCRSLRFDDKPDYSYLRQLFRNLFHRQ 280 (299)
T ss_dssp HHHHHSSCTTCCCC-------HHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHSCTTCCCCHHHHHHHHHHHHHHH
T ss_pred HHHHhCCCcccccchHHHHHHHHHhhcccCCCChhHhccCCCHHHHHHHHHHccCChhHCcCHHHHHHHHHHHHHHc
Confidence 99999999998765543332221 11111112233457899999999999999999999987 4577776543
|
| >d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Type I TGF-beta receptor R4 species: Human (Homo sapiens) [TaxId: 9606]
Probab=100.00 E-value=6.3e-43 Score=274.28 Aligned_cols=219 Identities=21% Similarity=0.249 Sum_probs=164.8
Q ss_pred hhhhhHHhhhhHHH--HHHHHhcCCCcCeeeeeeEEeecC----eEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHH
Q 026253 2 LKKLNKHLKSCLDC--ELNFLSSVNHPNIIRLFDAFQAEN----CIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQL 75 (241)
Q Consensus 2 ~~~~~~~~~~~~~~--E~~~l~~l~~~~i~~~~~~~~~~~----~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i 75 (241)
+|.++.+..+...+ |+..+.+++||||+++++++.+.+ ..++||||+++|+|.+++++. .+++..+..++.++
T Consensus 31 vK~~~~~~~~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~~~~~~lv~Ey~~~g~L~~~l~~~-~l~~~~~~~~~~~i 109 (303)
T d1vjya_ 31 VKIFSSREERSWFREAEIYQTVMLRHENILGFIAADNKDNGTWTQLWLVSDYHEHGSLFDYLNRY-TVTVEGMIKLALST 109 (303)
T ss_dssp EEEECGGGHHHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSSSEEEEEEEECCTTCBHHHHHHHC-CBCHHHHHHHHHHH
T ss_pred EEEECccchhHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCcceEEEEEEecccCCCHHHHHhcC-CCCHHHHHHHHHHH
Confidence 45554444444444 555556789999999999987653 589999999999999999864 68999999999999
Q ss_pred HHHHHHHHh--------CCccccCCCCCCeEEeecCCCceEEEeecCCccccCCCC-----ccccccCCCCccCcccccc
Q 026253 76 GAGLEILNS--------HHIIHRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGN-----YAEKVCGSPLYMAPEVLQF 142 (241)
Q Consensus 76 ~~~l~~lh~--------~~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~-----~~~~~~~~~~~~~PE~~~~ 142 (241)
+.|+.++|+ +||+||||||+||++ +.++.+||+|||++....... ......+|+.|+|||.+.+
T Consensus 110 a~gl~~lH~~~~~~~~~~~IvHrDlKp~NILl---~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~ 186 (303)
T d1vjya_ 110 ASGLAHLHMEIVGTQGKPAIAHRDLKSKNILV---KKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDD 186 (303)
T ss_dssp HHHHHHHHCCBCSTTCBCEEECSCCCGGGEEE---CTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTT
T ss_pred HHHHHHHHHhhhhhccCCCeeccccCccceEE---cCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccc
Confidence 999999996 599999999999999 788999999999997664332 2234568999999999865
Q ss_pred cC------CCCchhHHHHHHHHHHHHhCCCCCCCC---------------ChHHHHHHhhcCC-CCCCCCcc-CCCCChH
Q 026253 143 QR------YDEKVDMWSVGAILFELLNGYPPFSGR---------------NNVQLVRNINSCK-HLPFSQLI-VPALHPD 199 (241)
Q Consensus 143 ~~------~~~~~Dv~slG~~l~~l~~g~~p~~~~---------------~~~~~~~~i~~~~-~~~~~~~~-~~~~~~~ 199 (241)
.. ++.++||||||+++|+|++|..||... ......+.+.... +..++... .......
T Consensus 187 ~~~~~~~~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~ 266 (303)
T d1vjya_ 187 SINMKHFESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRV 266 (303)
T ss_dssp CSCTTCHHHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHHHHH
T ss_pred cccccCCCcCcchhhhhhHHHHHHHhhCCCCCCcccccccchhhcccccchHHHHHHHHhccccCCCCCcccCChHHHHH
Confidence 42 567899999999999999998876421 1122223222222 22222221 1123345
Q ss_pred HHHHHHHhcccCccccCCHHHHhcC
Q 026253 200 CVDMCLKLLSANTVDRLSFNEFYHH 224 (241)
Q Consensus 200 ~~~li~~~l~~~p~~Rps~~~il~~ 224 (241)
+.+++++||+.||++|||+.|++++
T Consensus 267 l~~li~~cl~~dp~~Rps~~ei~~~ 291 (303)
T d1vjya_ 267 MAKIMRECWYANGAARLTALRIKKT 291 (303)
T ss_dssp HHHHHHTTCCSSGGGSCCHHHHHHH
T ss_pred HHHHHHHHcccCHhHCcCHHHHHHH
Confidence 8999999999999999999999863
|
| >d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Casein kinase-1, CK1 species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]
Probab=100.00 E-value=1.7e-42 Score=270.72 Aligned_cols=230 Identities=17% Similarity=0.212 Sum_probs=185.5
Q ss_pred HhhhhHHHHHHHHhcCCC-cCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Q 026253 8 HLKSCLDCELNFLSSVNH-PNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHG-RVPEQTARKFLQQLGAGLEILNSH 85 (241)
Q Consensus 8 ~~~~~~~~E~~~l~~l~~-~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~~i~~~l~~lh~~ 85 (241)
...+.+.+|++.++.++| +|++.+++++.+++..++|||++ +++|.+++...+ .++...+..++.|++.||.+||++
T Consensus 42 ~~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~~~~~~vme~~-~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l~~lH~~ 120 (293)
T d1csna_ 42 SDAPQLRDEYRTYKLLAGCTGIPNVYYFGQEGLHNVLVIDLL-GPSLEDLLDLCGRKFSVKTVAMAAKQMLARVQSIHEK 120 (293)
T ss_dssp TTSCCHHHHHHHHHHTTTCTTCCCEEEEEEETTEEEEEEECC-CCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHHHTT
T ss_pred cCcHHHHHHHHHHHHhcCCCCCCEEEEEeecCCccEEEEEec-CCCHHHHHHhhccchhhHHHHHHHHHHHHHHHHHHHC
Confidence 345678999999999965 89999999999999999999999 789999987654 699999999999999999999999
Q ss_pred CccccCCCCCCeEEeec--CCCceEEEeecCCccccCCCC--------ccccccCCCCccCcccccccCCCCchhHHHHH
Q 026253 86 HIIHRDLKPENILLSGL--DDDVMLKIADFGLSCTLYPGN--------YAEKVCGSPLYMAPEVLQFQRYDEKVDMWSVG 155 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~--~~~~~~~l~df~~a~~~~~~~--------~~~~~~~~~~~~~PE~~~~~~~~~~~Dv~slG 155 (241)
|++||||||+||+++.. ...+.++|+|||+|+...... ......||+.|+|||.+.+..++.++|+||||
T Consensus 121 giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~~~~~~DiwSlG 200 (293)
T d1csna_ 121 SLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGREQSRRDDLEALG 200 (293)
T ss_dssp TEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCCCCHHHHHHHHH
T ss_pred CceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCCCChHHHHHHhh
Confidence 99999999999999532 236779999999998754321 22345689999999999999999999999999
Q ss_pred HHHHHHHhCCCCCCCCC---hHHHHHHhhcCCCCCCCCccCCCCChHHHHHHHHhcccCccccCCHHHHhc--Ccccccc
Q 026253 156 AILFELLNGYPPFSGRN---NVQLVRNINSCKHLPFSQLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYH--HRFLRRN 230 (241)
Q Consensus 156 ~~l~~l~~g~~p~~~~~---~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~--~~~~~~~ 230 (241)
+++|+|++|..||.+.. ..+....+.............+.+|+++.+++..|+..+|.+||+++.+.+ +..+++.
T Consensus 201 ~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~l~~~~p~~l~~ii~~~~~~~~~~rP~y~~l~~~l~~~~~~~ 280 (293)
T d1csna_ 201 HVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQSTPLRELCAGFPEEFYKYMHYARNLAFDATPDYDYLQGLFSKVLERL 280 (293)
T ss_dssp HHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHSCHHHHTTTSCHHHHHHHHHHHHCCTTCCCCHHHHHHHHHHHHHHT
T ss_pred HHHHHHHhCCCcCCCccchhHHHHHHHHHhccCCCChHHhcCCCCHHHHHHHHHHhcCCcccCcCHHHHHHHHHHHHHHc
Confidence 99999999999998543 333444443333223333445678999999999999999999999887754 3445555
Q ss_pred cccCCCCC
Q 026253 231 SAILRAPF 238 (241)
Q Consensus 231 ~~~~~~~~ 238 (241)
......+|
T Consensus 281 ~~~~~~~~ 288 (293)
T d1csna_ 281 NTTEDENF 288 (293)
T ss_dssp TCCSCSCC
T ss_pred CCCCCCCC
Confidence 55554444
|
| >d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Protein kinases, catalytic subunit domain: Sky1p species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]
Probab=100.00 E-value=2.7e-38 Score=254.18 Aligned_cols=222 Identities=25% Similarity=0.376 Sum_probs=161.3
Q ss_pred hhhhHHHHHHHHhcCC-----------CcCeeeeeeEEee--cCeEEEEEeccCCCCh-HHHHHh--cCCCCHHHHHHHH
Q 026253 9 LKSCLDCELNFLSSVN-----------HPNIIRLFDAFQA--ENCIFLVVEFCAGGNL-SSYIRL--HGRVPEQTARKFL 72 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~-----------~~~i~~~~~~~~~--~~~~~lv~e~~~~~~L-~~~l~~--~~~~~~~~~~~~~ 72 (241)
..+.+.+|+++++.++ |+||+++++++.. ....++++.++..... ...... ...+++..+..++
T Consensus 52 ~~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~i~ 131 (362)
T d1q8ya_ 52 YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVKQIS 131 (362)
T ss_dssp HHHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEETTEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHHHHH
T ss_pred chHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccccceeeeeeecccccccccccccccccCCcHHHHHHHH
Confidence 4567889999998885 5789999988764 3456666665544433 332222 3468999999999
Q ss_pred HHHHHHHHHHHh-CCccccCCCCCCeEEeecCC---CceEEEeecCCccccCCCCccccccCCCCccCcccccccCCCCc
Q 026253 73 QQLGAGLEILNS-HHIIHRDLKPENILLSGLDD---DVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAPEVLQFQRYDEK 148 (241)
Q Consensus 73 ~~i~~~l~~lh~-~~i~H~dl~~~nil~~~~~~---~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~ 148 (241)
.|++.||.+||+ .||+||||||+||+++..+. ...++++|||.+..... ......+++.|+|||.+.+..++.+
T Consensus 132 ~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~--~~~~~~gt~~y~aPE~~~~~~~~~~ 209 (362)
T d1q8ya_ 132 KQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE--HYTNSIQTREYRSPEVLLGAPWGCG 209 (362)
T ss_dssp HHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB--CCCSCCSCGGGCCHHHHHTCCCCTH
T ss_pred HHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc--ccccccccccccChhhccccCCCcc
Confidence 999999999998 89999999999999953221 13489999999876543 2345678999999999998899999
Q ss_pred hhHHHHHHHHHHHHhCCCCCCCCChH-------HHHHHhhcCCC------------------C----CCC----------
Q 026253 149 VDMWSVGAILFELLNGYPPFSGRNNV-------QLVRNINSCKH------------------L----PFS---------- 189 (241)
Q Consensus 149 ~Dv~slG~~l~~l~~g~~p~~~~~~~-------~~~~~i~~~~~------------------~----~~~---------- 189 (241)
+|+||+|+++++|++|+.||...... .....+..... . ...
T Consensus 210 ~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ 289 (362)
T d1q8ya_ 210 ADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKFWPLEDV 289 (362)
T ss_dssp HHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCCCCBCCHHHH
T ss_pred ccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhccccccCCchhhh
Confidence 99999999999999999999754321 11111100000 0 000
Q ss_pred ----CccCCCCChHHHHHHHHhcccCccccCCHHHHhcCcccccccc
Q 026253 190 ----QLIVPALHPDCVDMCLKLLSANTVDRLSFNEFYHHRFLRRNSA 232 (241)
Q Consensus 190 ----~~~~~~~~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~~~ 232 (241)
.......++++.+||.+||..||.+|||++|+|+||||++...
T Consensus 290 ~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~~ 336 (362)
T d1q8ya_ 290 LTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTLG 336 (362)
T ss_dssp HHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCTT
T ss_pred cccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCCC
Confidence 0011234567999999999999999999999999999997543
|
| >d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: RIO1-like kinases domain: Rio2 serine protein kinase C-terminal domain species: Archaeoglobus fulgidus [TaxId: 2234]
Probab=99.73 E-value=4.4e-19 Score=128.92 Aligned_cols=128 Identities=16% Similarity=0.170 Sum_probs=93.6
Q ss_pred hhhhHHHHHHHHhcCCCcCeeeeeeEEeecCeEEEEEeccCCCChHHHHHhcCCCCHHHHHHHHHHHHHHHHHHHhCCcc
Q 026253 9 LKSCLDCELNFLSSVNHPNIIRLFDAFQAENCIFLVVEFCAGGNLSSYIRLHGRVPEQTARKFLQQLGAGLEILNSHHII 88 (241)
Q Consensus 9 ~~~~~~~E~~~l~~l~~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~l~~lh~~~i~ 88 (241)
......+|+..+.++.|.+++..+++. ..+++||++++..+.+ ++...+..++.|++.++++||+.|++
T Consensus 57 ~~~~~~~e~~~l~~l~~~~v~~~~~~~----~~~lvme~~~~~~~~~-------l~~~~~~~i~~ql~~~l~~lH~~gii 125 (191)
T d1zara2 57 AIRSARNEFRALQKLQGLAVPKVYAWE----GNAVLMELIDAKELYR-------VRVENPDEVLDMILEEVAKFYHRGIV 125 (191)
T ss_dssp HHHHHHHHHHHHHHTTTSSSCCEEEEE----TTEEEEECCCCEEGGG-------CCCSCHHHHHHHHHHHHHHHHHTTEE
T ss_pred HHHHHHHHHHHHHHccCCCcceEEEec----CCEEEEEeeccccccc-------hhhHHHHHHHHHHHHHHHHHhhCCEE
Confidence 345667899999999999998887553 2379999998765432 34556778999999999999999999
Q ss_pred ccCCCCCCeEEeecCCCceEEEeecCCccccCCCCccccccCCCCccCc--c---cccccCCCCchhHHHHHHHH
Q 026253 89 HRDLKPENILLSGLDDDVMLKIADFGLSCTLYPGNYAEKVCGSPLYMAP--E---VLQFQRYDEKVDMWSVGAIL 158 (241)
Q Consensus 89 H~dl~~~nil~~~~~~~~~~~l~df~~a~~~~~~~~~~~~~~~~~~~~P--E---~~~~~~~~~~~Dv~slG~~l 158 (241)
||||||+||+++ + ..++|+|||.|....++.... |... + .+..+.|+.++|+||+.--+
T Consensus 126 HrDiKP~NILv~---~-~~~~liDFG~a~~~~~~~~~~-------~l~rd~~~~~~~f~r~y~~~~d~~s~~~~~ 189 (191)
T d1zara2 126 HGDLSQYNVLVS---E-EGIWIIDFPQSVEVGEEGWRE-------ILERDVRNIITYFSRTYRTEKDINSAIDRI 189 (191)
T ss_dssp CSCCSTTSEEEE---T-TEEEECCCTTCEETTSTTHHH-------HHHHHHHHHHHHHHHHHCCCCCHHHHHHHH
T ss_pred EccCChhheeee---C-CCEEEEECCCcccCCCCCcHH-------HHHHHHHHHHHHHcCCCCCcccHHHHHHHH
Confidence 999999999994 3 458999999987654332211 1110 0 01235678899999975433
|
| >d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Type IIIa 3',5"-aminoglycoside phosphotransferase species: Enterococcus faecalis [TaxId: 1351]
Probab=98.07 E-value=5.7e-06 Score=61.35 Aligned_cols=47 Identities=9% Similarity=0.014 Sum_probs=37.1
Q ss_pred hhhHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCChHHH
Q 026253 10 KSCLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNLSSY 56 (241)
Q Consensus 10 ~~~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L~~~ 56 (241)
...+.+|..+++.+. +=-+++++.+.+.++..++||++++|.++.+.
T Consensus 53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~~~~~lv~~~l~G~~~~~~ 100 (263)
T d1j7la_ 53 TYDVEREKDMMLWLEGKLPVPKVLHFERHDGWSNLLMSEADGVLCSEE 100 (263)
T ss_dssp TTCHHHHHHHHHHHTTTSCCCCEEEEEEETTEEEEEEECCSSEEHHHH
T ss_pred hhhHHHHHHHHHHHhccCCCCcEEEEEecCCceEEEEEeccccccccc
Confidence 446788999988884 33367888888888999999999998877654
|
| >d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]
Probab=97.85 E-value=4.7e-06 Score=61.51 Aligned_cols=51 Identities=18% Similarity=0.094 Sum_probs=37.4
Q ss_pred hhhhHHhhhhHHHHHHHHhcCCCcC--eeeeeeEEeecCeEEEEEeccCCCCh
Q 026253 3 KKLNKHLKSCLDCELNFLSSVNHPN--IIRLFDAFQAENCIFLVVEFCAGGNL 53 (241)
Q Consensus 3 ~~~~~~~~~~~~~E~~~l~~l~~~~--i~~~~~~~~~~~~~~lv~e~~~~~~L 53 (241)
|.........+..|...++.+...+ ++++++...+++..++||++++|.++
T Consensus 41 K~~~~~~~~~l~~E~~~l~~L~~~gvpvP~v~~~~~~~~~~~~v~~~i~G~~~ 93 (255)
T d1nd4a_ 41 KTDLSGALNELQDEAARLSWLATTGVPCAAVLDVVTEAGRDWLLLGEVPGQDL 93 (255)
T ss_dssp EEECSCTTSCHHHHHHHHHHHHTTTCCBCCEEEEEECSSCEEEEEECCSSEET
T ss_pred EeCCccCHhHHHHHHHHHHHHHhcCCCCCceeeecccccceEEEEEeeecccc
Confidence 3333444556889999998884333 56778887888889999999988665
|
| >d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Methylthioribose kinase MtnK species: Bacillus subtilis [TaxId: 1423]
Probab=97.20 E-value=0.0004 Score=54.40 Aligned_cols=29 Identities=24% Similarity=0.370 Sum_probs=23.7
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
.++|||+.+.||++ +++ .++|+||..+..
T Consensus 224 ~LiHGDl~~gNIlv---~~~-~~~vID~E~a~~ 252 (392)
T d2pula1 224 TLIHGDLHTGSIFA---SEH-ETKVIDPEFAFY 252 (392)
T ss_dssp EEECSCCCGGGEEE---CSS-CEEECCCTTCEE
T ss_pred ceeccCCcCCceeE---cCC-ceEEechhhccc
Confidence 58999999999999 433 489999987743
|
| >d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: Choline kinase domain: Choline kinase species: Caenorhabditis elegans [TaxId: 6239]
Probab=96.32 E-value=0.00098 Score=52.12 Aligned_cols=38 Identities=16% Similarity=0.141 Sum_probs=26.5
Q ss_pred hHHHHHHHHhcCC-CcCeeeeeeEEeecCeEEEEEeccCCCCh
Q 026253 12 CLDCELNFLSSVN-HPNIIRLFDAFQAENCIFLVVEFCAGGNL 53 (241)
Q Consensus 12 ~~~~E~~~l~~l~-~~~i~~~~~~~~~~~~~~lv~e~~~~~~L 53 (241)
...+|..+++.+. +.-.+++++++.+ +.|++|++|.++
T Consensus 90 dr~~E~~i~~~ls~~gl~Pkll~~~~~----g~I~efi~g~~l 128 (395)
T d1nw1a_ 90 HLVAESVIFTLLSERHLGPKLYGIFSG----GRLEEYIPSRPL 128 (395)
T ss_dssp HHHHHHHHHHHHHHTTSSSCEEEEETT----EEEECCCCEEEC
T ss_pred HHHHHHHHHHHHHhCCCCCeEEEEcCC----ceEEEEeccccC
Confidence 4568999999984 4334577776643 588999987544
|
| >d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: Homoserine kinase ThrB species: Agrobacterium tumefaciens [TaxId: 358]
Probab=94.99 E-value=0.0076 Score=45.19 Aligned_cols=30 Identities=30% Similarity=0.592 Sum_probs=25.5
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
|++|+|+.+.|+++ +++...-+.||+.++.
T Consensus 184 giIHgDl~~dNvl~---~~~~v~gvIDF~~~~~ 213 (316)
T d2ppqa1 184 GVIHADLFQDNVFF---LGDELSGLIDFYFACN 213 (316)
T ss_dssp EEECSCCCGGGEEE---ETTEEEEECCCTTCEE
T ss_pred ccccCCcchhhhhc---ccccceeEeccccccc
Confidence 79999999999999 5666678999998743
|
| >d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]} | Back information, alignment and structure |
|---|
class: Alpha and beta proteins (a+b) fold: Protein kinase-like (PK-like) superfamily: Protein kinase-like (PK-like) family: APH phosphotransferases domain: RdoA species: Escherichia coli [TaxId: 562]
Probab=91.73 E-value=0.077 Score=39.72 Aligned_cols=28 Identities=25% Similarity=0.264 Sum_probs=22.3
Q ss_pred CccccCCCCCCeEEeecCCCceEEEeecCCccc
Q 026253 86 HIIHRDLKPENILLSGLDDDVMLKIADFGLSCT 118 (241)
Q Consensus 86 ~i~H~dl~~~nil~~~~~~~~~~~l~df~~a~~ 118 (241)
+++|+|+.+.||++ +++ ..+.||+-++.
T Consensus 193 ~liHgDlh~~NvL~---~~~--~~~IDFdd~~~ 220 (325)
T d1zyla1 193 LRLHGDCHAGNILW---RDG--PMFVDLDDARN 220 (325)
T ss_dssp EECCSSCSGGGEEE---SSS--EEECCCTTCCE
T ss_pred eeecCCCCcccEEE---eCC--ceEEechhccc
Confidence 68999999999999 433 35799997743
|